PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hawtin, SR; Simms, J; Conner, M; Lawson, Z; Parslow, RA; Trim, J; Sheppard, A; Wheatley, M				Hawtin, Stuart R.; Simms, John; Conner, Matthew; Lawson, Zoe; Parslow, Rosemary A.; Trim, Julie; Sheppard, Andrew; Wheatley, Mark			Charged extracellular residues, conserved throughout a G-protein-coupled receptor family, are required for ligand binding, receptor activation, and cell-surface expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-1A VASOPRESSIN RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTORS; SITE-DIRECTED MUTAGENESIS; HIGH-AFFINITY; N-TERMINUS; AGONIST BINDING; ANGIOTENSIN-II; IDENTIFICATION; PEPTIDE; ANTAGONIST	For G-protein-coupled receptors (GPCRs) in general, the roles of extracellular residues are not well defined compared with residues in transmembrane helices (TMs). Nevertheless, extracellular residues are important for various functions in both peptide-GPCRs and amine-GPCRs. In this study, the V-1a vasopressin receptor was used to systematically investigate the role of extracellular charged residues that are highly conserved throughout a subfamily of peptide-GPCRs, using a combination of mutagenesis and molecular modeling. Of the 13 conserved charged residues identified in the extracellular loops (ECLs), Arg(116) (ECL1), Arg(125) ( top of TMIII), and Asp(204) (ECL2) are important for agonist binding and/or receptor activation. Molecular modeling revealed that Arg(125) ( and Lys(125)) stabilizes TMIII by interacting with lipid head groups. Charge reversal (Asp(125)) caused re-ordering of the lipids, altered helical packing, and increased solvent penetration of the TM bundle. Interestingly, a negative charge is excluded at this locus in peptide-GPCRs, whereas a positive charge is excluded in amine-GPCRs. This contrasting conserved charge may reflect differences in GPCR binding modes between peptides and amines, with amines needing to access a binding site crevice within the receptor TM bundle, whereas the binding site of peptide-GPCRs includes more extracellular domains. A conserved negative charge at residue 204 ( ECL2), juxtaposed to the highly conserved disulfide bond, was essential for agonist binding and signaling. Asp(204) ( and Glu(204)) establishes TMIII contacts required for maintaining the beta-hairpin fold of ECL2, which if broken (Ala(204) or Arg(204)) resulted in ECL2 unfolding and receptor dysfunction. This study provides mechanistic insight into the roles of conserved extracellular residues.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Ferring Res Ltd, Southampton SO16 7NP, Hants, England	University of Birmingham	Wheatley, M (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	m.wheatley@bham.ac.uk		Simms, John/0000-0002-4675-0902; Wheatley, Mark/0000-0001-6261-5682	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arthus MF, 2000, J AM SOC NEPHROL, V11, P1044, DOI 10.1681/ASN.V1161044; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BIRNBAUMER M, 1994, MOL ENDOCRINOL, V8, P886, DOI 10.1210/me.8.7.886; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHINI B, 1995, EMBO J, V14, P2176, DOI 10.1002/j.1460-2075.1995.tb07211.x; Conner AC, 2005, MOL PHARMACOL, V67, P20, DOI 10.1124/mol.67.1.20; Cotte N, 1998, J BIOL CHEM, V273, P29462, DOI 10.1074/jbc.273.45.29462; Ding XQ, 2002, MOL PHARMACOL, V61, P1041, DOI 10.1124/mol.61.5.1041; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; FRASER CM, 1989, MOL PHARMACOL, V36, P840; Fromme BJ, 2001, MOL PHARMACOL, V60, P1280, DOI 10.1124/mol.60.6.1280; Gigoux V, 1998, J BIOL CHEM, V273, P14380, DOI 10.1074/jbc.273.23.14380; Gigoux V, 1999, J BIOL CHEM, V274, P20457, DOI 10.1074/jbc.274.29.20457; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gnagey AL, 1999, MOL PHARMACOL, V56, P1245, DOI 10.1124/mol.56.6.1245; Hausmann H, 1996, P NATL ACAD SCI USA, V93, P6907, DOI 10.1073/pnas.93.14.6907; Hawtin SR, 2005, MOL ENDOCRINOL, V19, P2871, DOI 10.1210/me.2005-0148; Hawtin SR, 2003, EUR J BIOCHEM, V270, P4681, DOI 10.1046/j.1432-1033.2003.03865.x; Hawtin SR, 2002, MOL ENDOCRINOL, V16, P600, DOI 10.1210/me.16.3.600; Hawtin SR, 2001, BIOCHEM J, V354, P465, DOI 10.1042/0264-6021:3540465; Hawtin SR, 2001, J BIOL CHEM, V276, P38139; Hawtin SR, 2000, BIOCHEMISTRY-US, V39, P13524, DOI 10.1021/bi0013400; Hibert M, 1999, J RECEPT SIGNAL TR R, V19, P589, DOI 10.3109/10799899909036674; HOWL J, 1995, GEN PHARMACOL-VASC S, V26, P1143, DOI 10.1016/0306-3623(95)00016-T; Howl J, 1997, FASEB J, V11, P582, DOI 10.1096/fasebj.11.7.9212082; Howl J, 1996, BIOCHEM J, V317, P577, DOI 10.1042/bj3170577; Katancik JA, 2000, CYTOKINE, V12, P1480, DOI 10.1006/cyto.2000.0742; KOJRO E, 1993, BIOCHEMISTRY-US, V32, P13537, DOI 10.1021/bi00212a020; KRUSZYNSKI M, 1980, J MED CHEM, V23, P364, DOI 10.1021/jm00178a003; KURTENBACH E, 1990, J BIOL CHEM, V265, P13702; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Marie J, 2001, J BIOL CHEM, V276, P41100, DOI 10.1074/jbc.M104875200; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; MOUILLAC B, 1995, J BIOL CHEM, V270, P25771, DOI 10.1074/jbc.270.43.25771; Ott TR, 2002, MOL ENDOCRINOL, V16, P1079, DOI 10.1210/me.16.5.1079; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHMIDT A, 1991, FEBS LETT, V282, P77, DOI 10.1016/0014-5793(91)80448-C; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; SERRADEILLEGAL C, 1993, J CLIN INVEST, V92, P224, DOI 10.1172/JCI116554; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Tan FI, 2000, BIOL REPROD, V62, P8, DOI 10.1095/biolreprod62.1.8; Thibonnier M, 2001, ANNU REV PHARMACOL, V41, P175, DOI 10.1146/annurev.pharmtox.41.1.175; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wesley VJ, 2002, BIOCHEMISTRY-US, V41, P5086, DOI 10.1021/bi015990v; Zhao MM, 1996, MOL PHARMACOL, V50, P1118	52	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2006	281	50					38478	38488		10.1074/jbc.M607639200	http://dx.doi.org/10.1074/jbc.M607639200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	115BL	16990262	hybrid, Green Accepted			2022-12-27	WOS:000242709500042
J	Opitz, B; Vinzing, M; van Laak, V; Schmeck, B; Heine, G; Gunther, S; Preissner, R; Slevogt, H; N'Guessan, PD; Eitel, J; Goldmann, T; Flieger, A; Suttorp, N; Hippenstiel, S				Opitz, Bastian; Vinzing, Maya; van Laak, Vincent; Schmeck, Bernd; Heine, Guido; Guenther, Stefan; Preissner, Robert; Slevogt, Hortense; N'Guessan, Philippe Dje; Eitel, Julia; Goldmann, Torsten; Flieger, Antje; Suttorp, Norbert; Hippenstiel, Stefan			Legionella pneumophila induces IFN beta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; LISTERIA-MONOCYTOGENES; ADAPTER PROTEIN; RIG-I; RNA HELICASE; P38 MAPK; INFECTION; INTERFERON	Legionella pneumophila, a Gram-negative facultative intracellular bacterium, causes severe pneumonia ( Legionnaires' disease). Type I interferons (IFNs) were so far associated with antiviral immunity, but recent studies also indicated a role of these cytokines in immune responses against ( intracellular) bacteria. Here we show that wild-type L. pneumophila and flagellin-deficient Legionella, but not L. pneumophila lacking a functional type IV secretion system Dot/Icm, or heat-inactivated Legionella induced IFN beta expression in human lung epithelial cells. We found that factor (IRF)-3 and NF-kappa B-p65 translocated into the nucleus and bound to the IFN beta gene enhancer after L. pneumophila infection of lung epithelial cells. RNA interference demonstrated that in addition to IRF3, the caspase recruitment domain (CARD)-containing adapter molecule IPS-1 (interferon-beta promoter stimulator 1) is crucial for L. pneumophila-induced IFN beta expression, whereas other CARD-possessing molecules, such as RIG-I ( retinoic acid-inducible protein I), MDA5 ( melanoma differentiation-associated gene 5), Nod27(nucleotide-binding oligomerization domain protein 27), and ASC (apoptosis-associated speck-like protein containing a CARD) seemed not to be involved. Finally, bacterial multiplication assays in small interfering RNA-treated cells indicated that IPS-1, IRF3, and IFN beta were essential for the control of intracellular replication of L. pneumophila in lung epithelial cells. In conclusion, we demonstrated a critical role of IPS-1, IRF3, and IFN beta in Legionella infection of lung epithelium.	Charite Univ Med Berlin, Dept Internal Med Infect Dis & Resp Med, D-13353 Berlin, Germany; Charite Univ Med Berlin, Allergy Ctr Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany; Inst Biochem Charite, D-10117 Berlin, Germany; Res Ctr Borstel, D-23845 Borstel, Germany; Robert Koch Inst, Res Grp NG5 Pathogenesis Legionella Infect, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Forschungszentrum Borstel; Robert Koch Institute	Opitz, B (corresponding author), Charite Univ Med Berlin, Dept Internal Med Infect Dis & Resp Med, Augustenburguer Pl 1, D-13353 Berlin, Germany.	bastian.opitz@charite.de	Goldmann, Torsten/E-5906-2010; Günther, Stefan/AAY-8944-2020; Heine, Guido/G-1656-2018	Goldmann, Torsten/0000-0002-1621-560X; Heine, Guido/0000-0003-1467-9862; Opitz, Bastian/0000-0003-1276-836X; Flieger, Antje/0000-0003-3819-2979; Hippenstiel, Stefan/0000-0002-5146-1064; Suttorp, Norbert/0000-0002-3958-1151; preissner, robert/0000-0002-2407-1087				Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Neild AL, 2004, CELL MICROBIOL, V6, P1011, DOI 10.1111/j.1462-5822.2004.00450.x; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Philpott DJ, 2004, MOL IMMUNOL, V41, P1099, DOI 10.1016/j.molimm.2004.06.012; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Schiavoni G, 2004, J IMMUNOL, V173, P1266, DOI 10.4049/jimmunol.173.2.1266; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Soulat D, 2006, FEBS LETT, V580, P2341, DOI 10.1016/j.febslet.2006.03.057; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	39	102	106	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36173	36179		10.1074/jbc.M604638200	http://dx.doi.org/10.1074/jbc.M604638200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16984921	hybrid			2022-12-27	WOS:000242100500067
J	Song, R; Koo, BK; Yoon, KJ; Yoon, MJ; Yoo, KW; Kim, HT; Oh, HJ; Kim, YY; Han, JK; Kim, CH; Kong, YY				Song, Ran; Koo, Bon-Kyoung; Yoon, Ki-Jun; Yoon, Mi-Jeong; Yoo, Kyeong-Won; Kim, Hyun-Taek; Oh, Hyeon-Jeong; Kim, Yoon-Young; Han, Jin-Kwan; Kim, Cheol-Hee; Kong, Young-Yun			Neuralized-2 regulates a Notch ligand in cooperation with mind bomb-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; CELL FATE; NEUROGENIC GENES; DROSOPHILA; DELTA; ACTIVATION; ENDOCYTOSIS; EXPRESSION; PROTEINS; HOMOLOG	Mutations in Drosophila neuralized (Dneur) result in a variety of developmental defects that closely resemble those of Notch mutants and other Notch pathway mutants. However, mice with disrupted neur1 do not show any aberrant cell fate specifications in neurogenesis and somitogenesis. Thus, we speculated that other vertebrate neur homolog(s) might compensate for loss of the neur gene. Here, we report the paralog of mouse Neur1, named Neuralized-2 (Neur2), which is a ubiquitin-protein isopeptide ligase (E3) that interacts with and ubiquitinates Delta. Both murine Neur1 and Neur2 have similar degrees of homology to DNeur, and neur2 is expressed in patterns similar to those of neur1 in embryos, suggesting potential functional redundancy. Interestingly, two distinct classes of E3 ligases, Mind bomb-1 (Mib1) and Neur2, have cooperative but distinct roles in Delta endocytosis to Hrs-positive vesicles, i.e. Mib1 functions in the initial step of Delta endocytosis, and Neur2 is required for targeting endocytosed Delta to Hrs-positive vesicles. Thus, our study provides a new insight into how distinct E3 ligases work together in the endocytic pathways for Notch signaling.	Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea	Pohang University of Science & Technology (POSTECH); Chungnam National University	Kong, YY (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea.	ykong@postech.ac.kr	Yoon, Ki-Jun/S-8170-2018; Koo, Bon-Kyoung/V-5219-2017	Koo, Bon-Kyoung/0000-0002-4134-8033; Kim, Cheol-Hee/0000-0002-3019-0699; Yoon, Ki-Jun/0000-0003-2985-2541				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chen WB, 2004, DEV BIOL, V267, P361, DOI 10.1016/j.ydbio.2003.11.010; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Hagedorn EJ, 2006, J CELL BIOL, V173, P443, DOI 10.1083/jcb.200602054; Hamada Y, 1999, DEVELOPMENT, V126, P3415; HARTENSTEIN AY, 1992, DEVELOPMENT, V116, P1203; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kim CH, 1997, NEUROSCI LETT, V239, P113, DOI 10.1016/S0304-3940(97)00908-7; Klueg KM, 1999, J CELL SCI, V112, P3289; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lai EC, 2001, P NATL ACAD SCI USA, V98, P5637, DOI 10.1073/pnas.101135498; Lai EC, 2001, DEV BIOL, V231, P217, DOI 10.1006/dbio.2000.0124; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; OKA C, 1995, DEVELOPMENT, V121, P3291; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pavlopoulos E, 2002, BBA-GENE STRUCT EXPR, V1574, P375, DOI 10.1016/S0167-4781(01)00330-X; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Ruan YL, 2001, P NATL ACAD SCI USA, V98, P9907, DOI 10.1073/pnas.171321098; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; THISSE C, 1993, DEVELOPMENT, V119, P1203; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vollrath B, 2001, MOL CELL BIOL, V21, P7481, DOI 10.1128/MCB.21.21.7481-7494.2001; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9; Yeh E, 2000, EMBO J, V19, P4827, DOI 10.1093/emboj/19.17.4827; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844	49	45	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36391	36400		10.1074/jbc.M606601200	http://dx.doi.org/10.1074/jbc.M606601200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17003037	hybrid			2022-12-27	WOS:000242100500090
J	Aberg, E; Perander, M; Johansen, B; Julien, C; Meloche, S; Keyse, SM; Seternes, OM				Aberg, Espen; Perander, Maria; Johansen, Bjarne; Julien, Catherine; Meloche, Sylvain; Keyse, Stephen M.; Seternes, Ole-Morten			Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; NUCLEAR EXPORT; MESSENGER-RNA; LEPTOMYCIN B; BINDING; ERK3; PATHWAY; FAMILY; GENE; PROGRESSION	MAPK-activated protein kinase 5 (MK5) was recently identified as a physiological substrate of the atypical MAPK ERK3. Complex formation between ERK3 and MK5 results in phosphorylation and activation of MK5, concomitant stabilization of ERK3, and the nuclear exclusion of both proteins. However, ablation of ERK3 in HeLa cells using small interfering RNA or in fibroblasts derived from ERK3 null mice reduces the activity of endogenous MK5 by only 50%, suggesting additional mechanisms of MK5 regulation. Here we identify the ERK3-related kinase ERK4 as a bona fide interaction partner of MK5. Binding of ERK4 to MK5 is accompanied by phosphorylation and activation of MK5. Furthermore, complex formation also results in the relocalization of MK5 from nucleus to cytoplasm. However unlike ERK3, ERK4 is a stable protein, and its half-life is not modified by the presence or absence of MK5. Finally, although knock-down of ERK4 protein in HeLa cells reduces endogenous MK5 activity by similar to 50%, a combination of small interfering RNAs targeting both ERK4 and ERK3 causes a further reduction in the MK5 activity by more than 80%. We conclude that MK5 activation is dependent on both ERK3 and ERK4 in these cells and that these atypical MAPKs are both physiological regulators of MK5 activity.	Univ Tromso, Med Biol Inst, Dept Pharmacol, N-9037 Tromso, Norway; Univ Montreal, Inst Rech Immunovirol & Cancerol, Montreal, PQ H3C 3J7, Canada; Ninewells Hosp & Med Sch, Canc Res UK Stress Response Lab, Dundee DD1 9SY, Scotland	UiT The Arctic University of Tromso; Universite de Montreal; University of Dundee	Seternes, OM (corresponding author), Univ Tromso, Med Biol Inst, Dept Pharmacol, N-9037 Tromso, Norway.	olems@fagmed.uit.no	Keyse, Stephen M./B-9575-2009; Seternes, Ole Morten/M-9520-2019	Keyse, Stephen M./0000-0002-5150-8221; Seternes, Ole Morten/0000-0001-8537-3612; Perander, Maria/0000-0002-1177-2407				BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; Hannigan MO, 2001, J IMMUNOL, V167, P3953, DOI 10.4049/jimmunol.167.7.3953; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ni H, 1998, BIOCHEM BIOPH RES CO, V243, P492, DOI 10.1006/bbrc.1998.8135; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Seternes OM, 2002, MOL CELL BIOL, V22, P6931, DOI 10.1128/MCB.22.20.6931-6945.2002; Shi Y, 2003, MOL CELL BIOL, V23, P7732, DOI 10.1128/MCB.23.21.7732-7741.2003; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Turgeon B, 2002, GENOMICS, V80, P673, DOI 10.1006/geno.2002.7013; Turgeon B, 2000, BIOCHEM J, V346, P169, DOI 10.1042/0264-6021:3460169; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Watanabe N, 2005, DEVELOPMENT, V132, P3175, DOI 10.1242/dev.01895; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yung YV, 2000, J BIOL CHEM, V275, P15799, DOI 10.1074/jbc.M910060199	32	53	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35499	35510		10.1074/jbc.M606225200	http://dx.doi.org/10.1074/jbc.M606225200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16971392	hybrid			2022-12-27	WOS:000241933700083
J	Kubarenko, A; Sergiev, P; Wintermeyer, W; Dontsova, O; Rodnina, MV				Kubarenko, Andrew; Sergiev, Petr; Wintermeyer, Wolfgang; Dontsova, Olga; Rodnina, Marina V.			Involvement of Helix 34 of 16 S rRNA in decoding and translocation on the ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR G; AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI RIBOSOMES; DIRECTED CROSS-LINKING; MESSENGER-RNA; FACTOR TU; TRANSLATIONAL FIDELITY; CONFORMATIONAL-CHANGES; ANGSTROM RESOLUTION; BACTERIAL RIBOSOME	Helix 34 of 16 S rRNA is located in the head of the 30 S ribosomal subunit close to the decoding center and has been invoked in a number of ribosome functions. In the present work, we have studied the effects of mutations in helix 34 both in vivo and in vitro. Several nucleotides in helix 34 that are either highly conserved or form important tertiary contacts in 16 S rRNA (U961, C1109, A1191, and A1201) were mutated, and the mutant ribosomes were expressed in the Escherichia coli MC250 Delta 7 strain that lacks all seven chromosomal rRNA operons. Mutations at positions A1191 and U961 reduced the efficiency of subunit association and resulted in structural rearrangements in helix 27 (position 908) and helix 31 (position 974) of 16 S rRNA. All mutants exhibited increased levels of frameshifting and nonsense readthrough. The effects on frameshifting were specific in that-1 frameshifting was enhanced with mutant A1191G and-1 frameshifting with the other mutants. Mutations of A1191 moderately (similar to 2-fold) inhibited tRNA translocation. No significant effects were found on efficiency and rate of initiation, misreading of sense codons, or binding of tRNA to the E site. The data indicate that helix 34 is involved in controlling the maintenance of the reading frame and in tRNA translocation.	Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119899, Russia; Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany; Univ Witten Herdecke, Inst Mol Biol, D-58448 Witten, Germany	Lomonosov Moscow State University; Witten Herdecke University; Witten Herdecke University	Dontsova, O (corresponding author), Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119899, Russia.	dontsova@genebee.msu.su; rodnina@uni-wh.de	Dontsova, Olga/T-6072-2019; Sergiev, Petr V/D-7493-2012; Rodnina, Marina V./AAD-4667-2019	Sergiev, Petr V/0000-0001-8866-1863; Rodnina, Marina V./0000-0003-0105-3879				Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; BILGIN N, 1990, EMBO J, V9, P735, DOI 10.1002/j.1460-2075.1990.tb08167.x; BRINK MF, 1994, NUCLEIC ACIDS RES, V22, P325, DOI 10.1093/nar/22.3.325; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; DONTSOVA O, 1992, EMBO J, V11, P3105, DOI 10.1002/j.1460-2075.1992.tb05383.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; HERR W, 1979, J MOL BIOL, V130, P433, DOI 10.1016/0022-2836(79)90433-9; HOGAN JJ, 1978, BIOCHEMISTRY-US, V17, P587, DOI 10.1021/bi00597a005; JOHANSON U, 1995, NUCLEIC ACIDS RES, V23, P464, DOI 10.1093/nar/23.3.464; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; LILL R, 1988, J MOL BIOL, V203, P699, DOI 10.1016/0022-2836(88)90203-3; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Matassova NB, 2001, RNA, V7, P1879; Merryman C, 1999, J MOL BIOL, V285, P97, DOI 10.1006/jmbi.1998.2242; MOINE H, 1994, J MOL BIOL, V243, P402, DOI 10.1006/jmbi.1994.1668; Mueller F, 1997, J MOL BIOL, V271, P566, DOI 10.1006/jmbi.1997.1212; OCONNOR M, 1993, P NATL ACAD SCI USA, V90, P9214, DOI 10.1073/pnas.90.19.9214; OConnor M, 1997, NUCLEIC ACIDS RES, V25, P1185, DOI 10.1093/nar/25.6.1185; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 2000, NAT STRUCT BIOL, V7, P104; Peske F, 2004, J MOL BIOL, V343, P1183, DOI 10.1016/j.jmb.2004.08.097; PRESCOTT C, 1991, NUCLEIC ACIDS RES, V19, P5281, DOI 10.1093/nar/19.19.5281; PRESCOTT CD, 1992, NUCLEIC ACIDS RES, V20, P1567, DOI 10.1093/nar/20.7.1567; RODNINA MV, 1994, ANAL BIOCHEM, V219, P380, DOI 10.1006/abio.1994.1282; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 2000, BIOL CHEM, V381, P377, DOI 10.1515/BC.2000.050; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; Rodriguez-Correa D, 2004, RNA, V10, P28, DOI 10.1261/rna.5172104; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2000, J MOL BIOL, V299, P379, DOI 10.1006/jmbi.2000.3739; Sergiev PV, 1997, RNA, V3, P464; Sergiev PV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P963; SIGMUND CD, 1984, NUCLEIC ACIDS RES, V12, P4653, DOI 10.1093/nar/12.11.4653; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; STERN S, 1988, METHOD ENZYMOL, V164, P481; Tama F, 2003, P NATL ACAD SCI USA, V100, P9319, DOI 10.1073/pnas.1632476100; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; TRIMAN K, 1989, J MOL BIOL, V209, P645, DOI 10.1016/0022-2836(89)92000-7; VanLoock MS, 2000, J MOL BIOL, V304, P507, DOI 10.1006/jmbi.2000.4213; Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7; Yassin A, 2005, P NATL ACAD SCI USA, V102, P16620, DOI 10.1073/pnas.0508444102; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	53	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35235	35244		10.1074/jbc.M608060200	http://dx.doi.org/10.1074/jbc.M608060200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16990269	hybrid, Green Published			2022-12-27	WOS:000241933700057
J	Mirza, O; Skov, LK; Sprogoe, D; van den Broek, LAM; Beldman, G; Kastrup, JS; Gajhede, M				Mirza, Osman; Skov, Lars K.; Sprogoe, Desiree; van den Broek, Lambertus A. M.; Beldman, Gerrit; Kastrup, Jette S.; Gajhede, Michael			Structural rearrangements of sucrose phosphorylase from Bifidobacterium adolescentis during sucrose conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE FAMILY; CRYSTAL-STRUCTURE; NEISSERIA-POLYSACCHAREA; AMYLOSUCRASE; MECHANISM; GLUCOSE; COMPLEX; ENZYME	The reaction mechanism of sucrose phosphorylase from Bifidobacterium adolescentis (BiSP) was studied by site-directed mutagenesis and x-ray crystallography. An inactive mutant of BiSP (E232Q) was co-crystallized with sucrose. The structure revealed a substrate-binding mode comparable with that seen in other related sucrose-acting enzymes. Wild-type BiSP was also crystallized in the presence of sucrose. In the dimeric structure, a covalent glucosyl intermediate was formed in one molecule of the BiSP dimer, and after hydrolysis of the glucosyl intermediate, a beta-D-glucose product complex was formed in the other molecule. Although the overall structure of the BiSP-glucosyl intermediate complex is similar to that of the BiSP(E232Q)-sucrose complex, the glucose complex discloses major differences in loop conformations. Two loops ( residues 336-344 and 132-137) in the proximity of the active site move up to 16 and 4 A, respectively. On the basis of these findings, we have suggested a reaction cycle that takes into account the large movements in the active-site entrance loops.	Danish Univ Pharmaceut Sci, Dept Med Chem, Biostruct Res Unit, DK-2100 Copenhagen, Denmark; Univ Wageningen & Res Ctr, Food Chem Lab, NL-6700 EV Wageningen, Netherlands	University of Copenhagen; Wageningen University & Research	Gajhede, M (corresponding author), Danish Univ Pharmaceut Sci, Dept Med Chem, Biostruct Res Unit, Universitetsparken 2, DK-2100 Copenhagen, Denmark.	mig@dfuni.dk	van den Broek, Lambertus/K-4930-2012; Beldman, Gerrit/A-1901-2009; van den Broek, Lambertus/O-1253-2019	van den Broek, Lambertus/0000-0002-4374-5753; van den Broek, Lambertus/0000-0002-4374-5753; Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287; Mirza, Osman Asghar/0000-0001-9435-0690				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L, PYMOL MOL GRAPHICS S; DOUDOROFF M, 1947, J BIOL CHEM, V168, P725; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JOIT CCP4 ESFEACMB N, V26; Mirza O, 2001, BIOCHEMISTRY-US, V40, P9032, DOI 10.1021/bi010706l; Park KH, 2000, BBA-PROTEIN STRUCT M, V1478, P165, DOI 10.1016/S0167-4838(00)00041-8; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; SILVERSTEIN R, 1967, J BIOL CHEM, V242, P1338; Sprogoe D, 2004, BIOCHEMISTRY-US, V43, P1156, DOI 10.1021/bi0356395; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; van den Broek LAM, 2004, APPL MICROBIOL BIOT, V65, P219, DOI 10.1007/s00253-003-1534-x; VOET JG, 1970, J BIOL CHEM, V245, P1020	21	61	66	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35576	35584		10.1074/jbc.M605611200	http://dx.doi.org/10.1074/jbc.M605611200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16990265	hybrid			2022-12-27	WOS:000241933700090
J	Zraly, CB; Middleton, FA; Dingwall, AK				Zraly, Claudia B.; Middleton, Frank A.; Dingwall, Andrew K.			Hormone-response genes are direct in vivo regulatory targets of brahma (SWI/SNF) complex function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; IMMUNE-RESPONSE; RHABDOID TUMORS; DROSOPHILA SNR1; TRANSCRIPTION; EXPRESSION; BRM; ACTIVATION	Metazoan SWI/SNF chromatin remodeling complexes exhibit ATP-dependent activation and repression of target genes. The Drosophila Brahma (SWI/SNF) complex subunits BRM and SNR1 are highly conserved with direct counterparts in yeast (SWI2/SNF2 and SNF5) and mammals (BRG1/hBRM and INI1/hSNF5). BRM encodes the catalytic ATPase required for chromatin remodeling and SNR1 is a regulatory subunit. Importantly, SNR1 mediates ATP-independent repression functions of the complex in cooperation with histone deacetylases and direct contacts with gene-specific repressors. SNR1 and INI1, as components of their respective SWI/SNF complexes, are important for developmental growth control and patterning, with direct function as a tumor suppressor. To identify direct regulatory targets of the Brm complex, we performed oligonucleotide-based transcriptome microarray analyses using RNA isolated from mutant fly strains harboring dominant-negative alleles of snr1 and brm. Steady-state RNA isolated from early pupae was examined, as this developmental stage critically requires Brm complex function. We found the hormone-responsive Ecdys-one-induced genes (Eig) were strongly misregulated and that the Brm complex is directly associated with the promoter regions of these genes in vivo. Our results reveal that the Brm complex assists in coordinating hormone-dependent transcription regulation of the Eig genes.	Loyola Univ Chicago, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Inst Oncol, Maywood, IL 60153 USA; Loyola Univ Chicago, Dept Pathol, Maywood, IL 60153 USA; SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	Loyola University Chicago; Loyola University Chicago; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Dingwall, AK (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Inst Oncol, 2160 S 1st Ave, Maywood, IL 60153 USA.	adingwall@lumc.edu		Middleton, Frank/0000-0002-3107-7188				Ae K, 2002, ONCOGENE, V21, P3112, DOI 10.1038/sj.onc.1205414; Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Beltran S, 2003, P NATL ACAD SCI USA, V100, P3293, DOI 10.1073/pnas.0538075100; Bennicelli Jeannette L., 1999, Current Opinion in Oncology, V11, P267, DOI 10.1097/00001622-199907000-00006; Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Biegel JA, 2002, CLIN CANCER RES, V8, P3461; Biegel Jaclyn A., 2002, Cancer Research, V62, P323; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brumby AM, 2002, EMBO J, V21, P3377, DOI 10.1093/emboj/cdf334; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; Crossgrove K, 1996, DEV BIOL, V180, P745, DOI 10.1006/dbio.1996.0343; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Elfring LK, 1998, GENETICS, V148, P251; Geng FQ, 2001, MOL CELL BIOL, V21, P4311, DOI 10.1128/MCB.21.13.4311-4320.2001; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hassan AH, 2001, FRONT BIOSCI, V6, pD1054, DOI 10.2741/Hassan; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Korayem AM, 2004, INSECT BIOCHEM MOLEC, V34, P1297, DOI 10.1016/j.ibmb.2004.09.001; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee D, 1999, NATURE, V399, P487, DOI 10.1038/20966; Marenda DR, 2004, DEV BIOL, V267, P279, DOI 10.1016/j.ydbio.2003.10.040; Marenda DR, 2003, MOL CELL BIOL, V23, P289, DOI 10.1128/MCB.23.1.289-305.2003; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; Medjkane S, 2004, CANCER RES, V64, P3406, DOI 10.1158/0008-5472.CAN-03-3004; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Papoulas O, 2001, P NATL ACAD SCI USA, V98, P5728, DOI 10.1073/pnas.091533398; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Peterson CL, 2002, EMBO REP, V3, P319, DOI 10.1093/embo-reports/kvf075; Reincke BS, 2003, J CELL PHYSIOL, V194, P303, DOI 10.1002/jcp.10201; RESTIFO LL, 1986, DEV BIOL, V115, P507, DOI 10.1016/0012-1606(86)90271-X; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Tsikitis M, 2005, P NATL ACAD SCI USA, V102, P12129, DOI 10.1073/pnas.0505300102; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Versteege I, 2002, ONCOGENE, V21, P6403, DOI 10.1038/sj.onc.1205841; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wright LG, 1996, J MOL BIOL, V255, P387, DOI 10.1006/jmbi.1996.0032; Wu DY, 2000, J VIROL, V74, P8893, DOI 10.1128/JVI.74.19.8893-8903.2000; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002; Zraly CB, 2004, GENETICS, V168, P199, DOI 10.1534/genetics.104.029439; Zraly CB, 2003, DEV BIOL, V253, P291, DOI 10.1016/S0012-1606(02)00011-8	66	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35305	35315		10.1074/jbc.M607806200	http://dx.doi.org/10.1074/jbc.M607806200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16990270	hybrid			2022-12-27	WOS:000241933700065
J	Cui, HJ; Ma, J; Ding, J; Li, T; Alam, G; Ding, HF				Cui, Hongjuan; Ma, Jun; Ding, Jane; Li, Tai; Alam, Goleeta; Ding, Han-Fei			Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREST STEM-CELLS; NEURO-BLASTOMA CELLS; MYC TRANSGENIC MICE; NERVOUS-SYSTEM; EXPRESSION; GROWTH; LINES; GENE; VARIANTS; INVITRO	Human neuroblastoma I-type cells have been proposed as a population of malignant neural crest stem cells, based on their high tumorigenic potential, expression of stem cell markers, and ability to differentiate into cells of neural crest lineages, including neuroblastic (N-type) and Schwann/glial (S-type) cells. Here, we demonstrate at single cell levels that a subpopulation of I-type cells possess clonogenic self-renewal capacity that requires the Polycomb group family transcription repressor Bmi-1. We further show that Bmi-1 expression levels exert an instructive influence on lineage commitment by I-type cells. Spontaneous and induced differentiation of I-type cells into S-type cells is accompanied by a marked reduction in the level of Bmi-1 expression, and enforced down-regulation of BMI-1 facilitates spontaneous differentiation of I-type cells into S-type cells. By contrast, N-type neuroblastoma cell lines and differentiated N-type cells express higher levels of Bmi-1 relative to I-type cells, and overexpression of BMI-1 promotes the differentiation of I-type cells along the neuronal lineage. Thus, Bmi-1 acts in a concentration-dependent manner in the control of the delicate balance between the self-renewal and differentiation of neuroblastoma I-type cells. These observations suggest that graded activation of a master regulator within individual tumors could trigger divergent developmental programs responsible for both tumor growth and heterogeneity.	Med Univ Ohio, Dept Biochem & Canc Biol, Toledo, OH 43614 USA		Ding, HF (corresponding author), 3035 Arlington Ave, Toledo, OH 43614 USA.	hding@meduohio.edu		Ding, Han-Fei/0000-0001-5702-3439	NATIONAL CANCER INSTITUTE [R01CA106550] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA106550] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson DJ, 1997, TRENDS GENET, V13, P276, DOI 10.1016/S0168-9525(97)01187-6; BIEDLER JL, 1973, CANCER RES, V33, P2643; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; BUICK RN, 1981, BRIT J CANCER, V44, P349, DOI 10.1038/bjc.1981.191; Castleberry RP, 1997, EUR J CANCER, V33, P1430, DOI 10.1016/S0959-8049(97)00308-0; CICCARONE V, 1989, CANCER RES, V49, P219; Cui HJ, 2002, MOL CANCER THER, V1, P679; DECLERCK YA, 1987, CANCER RES, V47, P6505; Dyer MA, 2004, J CLIN PATHOL, V57, P561, DOI 10.1136/jcp.2003.009910; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hoehner JC, 1998, LAB INVEST, V78, P29; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mora J, 2001, CANCER RES, V61, P6892; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; PARYSEK LM, 1988, NEURON, V1, P395, DOI 10.1016/0896-6273(88)90189-4; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; RETTIG WJ, 1987, CANCER RES, V47, P1383; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSS RA, 1983, J NATL CANCER I, V71, P741; ROSS RA, 1985, CANCER RES, V45, P1628; Ross RA, 2003, CANCER LETT, V197, P35, DOI 10.1016/S0304-3835(03)00079-X; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; SIDELL N, 1982, J NATL CANCER I, V68, P589; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; SUGIMOTO T, 1988, CANCER RES, V48, P2531; THOMSON SP, 1982, CANCER RES, V42, P4606; TSOKOS M, 1987, AM J PATHOL, V128, P484; TUCKER GC, 1988, CELL TISSUE RES, V251, P457, DOI 10.1007/BF00215855; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	51	69	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34696	34704		10.1074/jbc.M604009200	http://dx.doi.org/10.1074/jbc.M604009200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16982619	hybrid			2022-12-27	WOS:000241767600088
J	Dolmer, K; Gettins, PGW				Dolmer, Klavs; Gettins, Peter G. W.			Three complement-like repeats compose the complete alpha(2)-macroglobulin binding site in the second ligand binding cluster of the low density lipoprotein receptor-related protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR SOLUTION STRUCTURE; LDL-RECEPTOR; ALPHA-2-MACROGLOBULIN RECEPTOR; HIGH-AFFINITY; ALPHA-MACROGLOBULINS; IN-VIVO; RECOGNITION; CALCIUM; DOMAIN; LRP	Given the importance of the low density lipoprotein receptor-related protein ( LRP) as an essential endocytosis and signaling receptor for many protein ligands, and of alpha(2)-macroglobulin (alpha M-2)-proteinase complexes as one such set of ligands, an understanding of the specificity of their interaction with LRP is an important goal. A starting point is the known role of the 138-residue receptor binding domain (RBD) in binding to LRP. Previous studies have localized high affinity alpha M-2 binding to the eight complement repeat (CR)-containing cluster 2 of LRP. In the present study we have identified the minimum CR domains that constitute the full binding site for RBD and, hence, for alpha M-2 on LRP. We report on the ability of the triple construct of CR3-4-5 to bind RBD with an affinity (K-d = 130 nM) the same as for isolated RBD to intact LRP. This K-d is 30-fold smaller than for RBD to CR5-6-7, demonstrating the specificity of the interaction with CR3-4-5. Binding requires previously identified critical lysine residues but is almost pH-independent within the range of pH values encountered between extracellular and internal compartments, consistent with an earlier proposed model of intracellular ligand displacement by intramolecular YWTD domains. The present findings suggest a model to explain the ability of LRP to bind a wide range of structurally unrelated ligands in which a nonspecific ligand interaction with the acidic region present in most CR domains is augmented by interactions with other CR surface residues that are unique to a particular CR cluster.	UIC, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago	Gettins, PGW (corresponding author), UIC, Dept Biochem & Mol Genet, Coll Med, 900 S Ashland Ave,MC 669, Chicago, IL 60607 USA.	pgettins@uic.edu	Dolmer, Klavs/G-5512-2012	Dolmer, Klavs/0000-0001-7359-360X	NIGMS NIH HHS [GM54414] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen OM, 2000, BIOCHEMISTRY-US, V39, P10627, DOI 10.1021/bi000498h; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; CATTERALL CF, 1987, BIOCHEM J, V242, P849, DOI 10.1042/bj2420849; CROOKSTON KP, 1993, BIOCHEM J, V293, P443, DOI 10.1042/bj2930443; Dolmer K, 1998, BIOCHEMISTRY-US, V37, P17016, DOI 10.1021/bi982022s; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; ENGHILD JJ, 1989, BIOCHEMISTRY-US, V28, P1406, DOI 10.1021/bi00429a069; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Huang W, 2000, J BIOL CHEM, V275, P1089, DOI 10.1074/jbc.275.2.1089; HUANG W, 1998, PROTEIN SCI, V7, P2602; Jeong KJ, 2005, NAT BIOTECHNOL, V23, P1493, DOI 10.1038/nbt1205-1493; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; LEWIS SD, 1985, J BIOL CHEM, V260, P192; Lutz C, 2002, J BIOL CHEM, V277, P43143, DOI 10.1074/jbc.M204426200; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MOESTRUP SK, 1990, J BIOL CHEM, V265, P12623; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Oganesyan Natalia, 2005, Journal of Structural and Functional Genomics, V6, P177, DOI 10.1007/s10969-005-2827-3; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rodenburg KW, 1998, BIOCHEM J, V329, P55; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; VANLEUVEN F, 1982, BIOCHEM J, V203, P405, DOI 10.1042/bj2030405; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537	45	18	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34189	34196		10.1074/jbc.M604389200	http://dx.doi.org/10.1074/jbc.M604389200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16982616	hybrid			2022-12-27	WOS:000241767600039
J	Dougherty, MJ; Boyd, JM; Downs, DM				Dougherty, Michael J.; Boyd, Jeffrey M.; Downs, Diana M.			Inhibition of fructose-1,6-bisphosphatase by aminoimidazole carboxamide ribotide prevents growth of Salmonella enterica purH mutants on glycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN LIVER FRUCTOSE-1,6-BISPHOSPHATASE; ESCHERICHIA-COLI; FRUCTOSE-BISPHOSPHATASE; THIAMINE SYNTHESIS; AMP; PURIFICATION; CONSTRUCTION; MUTAGENESIS; SITE	The enzyme fructose-1,6-bisphosphatase (FBP) is key regulatory point in gluconeogenesis. Mutants of Salmonella enterica lacking purH accumulate 5-amino-4-imidazole carboxamide ribotide (AICAR) and are unable to utilize glycerol as sole carbon and energy sources. The work described here demonstrates this lack of growth is due to inhibition of FBP by AICAR. Mutant alleles of fbp that restore growth on glycerol encode proteins resistant to inhibition by AICAR and the allosteric regulator AMP. This is the first report of biochemical characterization of substitutions causing AMP resistance in a bacterial FBP. Inhibition of FBP activity by AICAR occurs at physiologically relevant concentrations and may represent a form of regulation of gluconeogenic flux in Salmonella enterica.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Downs, DM (corresponding author), 420 Henry Mall, Madison, WI 53706 USA.	downs@bact.wisc.edu		Boyd, Jeffrey/0000-0001-7721-3926	NIGMS NIH HHS [GM47296, T32 GM08349] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047296, T32GM008349] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen S, 2002, J BACTERIOL, V184, P6130, DOI 10.1128/JB.184.22.6130-6137.2002; BABUL J, 1983, ARCH BIOCHEM BIOPHYS, V225, P944, DOI 10.1016/0003-9861(83)90109-1; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Beck BJ, 1998, J BACTERIOL, V180, P885, DOI 10.1128/JB.180.4.885-891.1998; BENKOVIC SJ, 1982, ADV ENZYMOL RAMB, V53, P45; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BOCHNER BR, 1982, CELL, V29, P929, DOI 10.1016/0092-8674(82)90455-X; CAETANOANOLLES G, 1993, PCR METH APPL, V3, P85; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEN M, 1994, J BIOL CHEM, V269, P5554; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DAVIES RW, 1980, ADV BACTERIAL GENETI; DOWNS DM, 1994, J BACTERIOL, V176, P4858, DOI 10.1128/jb.176.16.4858-4864.1994; DOWNS DM, 1987, PURINE METABOLISM CR; FRAENKEL DG, 1965, J BACTERIOL, V90, P837, DOI 10.1128/JB.90.4.837-842.1965; GIDHJAIN M, 1994, J BIOL CHEM, V269, P27732; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; Iancu CV, 2005, J BIOL CHEM, V280, P19737, DOI 10.1074/jbc.M501011200; Iversen LF, 1997, PROTEIN SCI, V6, P971, DOI 10.1002/pro.5560060503; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KE H, 1990, J MOL BIOL, V212, P513, DOI 10.1016/0022-2836(90)90329-K; KE HM, 1990, P NATL ACAD SCI USA, V87, P5243, DOI 10.1073/pnas.87.14.5243; Kelley-Loughnane N, 2002, BBA-PROTEIN STRUCT M, V1594, P6, DOI 10.1016/S0167-4838(01)00261-8; Kelley-Loughnane N, 2001, BBA-PROTEIN STRUCT M, V1548, P66, DOI 10.1016/S0167-4838(01)00218-7; KLECKNER N, 1977, J MOL BIOL, V116, P125, DOI 10.1016/0022-2836(77)90123-1; LIANG JY, 1993, P NATL ACAD SCI USA, V90, P2132, DOI 10.1073/pnas.90.6.2132; MARCUS F, 1984, BIOCHEM BIOPH RES CO, V119, P1103, DOI 10.1016/0006-291X(84)90888-X; McKinney J, 2002, J BACTERIOL, V184, P6056, DOI 10.1128/JB.184.21.6056-6059.2002; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; NIMMO HG, 1975, EUR J BIOCHEM, V58, P575, DOI 10.1111/j.1432-1033.1975.tb02408.x; Petersen L, 1996, GENETICS, V143, P37; PILKIS SJ, 1981, J BIOL CHEM, V256, P3619; PONTREMO.S, 1965, J BIOL CHEM, V240, P3459; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rebora K, 2005, GENETICS, V170, P61, DOI 10.1534/genetics.104.039396; ROBERTS GP, 1978, ISOLATION CHARACTERI; ROHLMAN CE, 1990, J BACTERIOL, V172, P7200, DOI 10.1128/jb.172.12.7200-7210.1990; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; SEDIVY JM, 1986, P NATL ACAD SCI USA, V83, P1656, DOI 10.1073/pnas.83.6.1656; Shyur LF, 1996, J BIOL CHEM, V271, P3005, DOI 10.1074/jbc.271.6.3005; Soberon M, 1997, MOL GEN GENET, V254, P665, DOI 10.1007/s004380050464; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; TAKETA K, 1965, J BIOL CHEM, V240, P651; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; VINCENT MF, 1991, DIABETES, V40, P1259, DOI 10.2337/diabetes.40.10.1259; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; Webb E, 1998, J BIOL CHEM, V273, P8946, DOI 10.1074/jbc.273.15.8946; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; ZHANG R, 1995, J BIOL CHEM, V270, P54, DOI 10.1074/jbc.270.1.54	54	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33892	33899		10.1074/jbc.M604429200	http://dx.doi.org/10.1074/jbc.M604429200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16987812	Green Accepted, hybrid, Green Submitted			2022-12-27	WOS:000241767600010
J	Newton, GL; Ta, P; Bzymek, KP; Fahey, RC				Newton, Gerald L.; Ta, Philong; Bzymek, Krzysztof P.; Fahey, Robert C.			Biochemistry of the initial steps of mycothiol biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INOSITOL MONOPHOSPHATASE; CRYSTAL-STRUCTURE; INOSITOL-1-PHOSPHATE SYNTHASE; STRUCTURAL-ANALYSIS; DEACETYLASE MSHB; ENZYME; IDENTIFICATION; GENE; MYOINOSITOL	Mycothiol is the major thiol produced by mycobacteria and is required for growth of Mycobacterium tuberculosis. The final three steps in the biosynthesis of mycothiol have been fully elucidated but the initial steps have been unclear. A glycosyltransferase, MshA, is required for production of the mycothiol precursor, 1-O-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-D-myo-inositol, but its substrates and immediate products were unknown. In this study, we show that the N-acetylglucosamine donor is UDP-N-acetylglucosamine and that the N-acetylglucosamine acceptor is 1L-myo-inositol 1-phosphate. The reaction generates UDP and 1-O-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-D-myo-inositol 3-phosphate. Using cell-free extracts of M. smegmatis mc(2)155, little activity was obtained with myo-inositol, 1D-myo-inositol 1-phosphate, or myo-inositol 2-phosphate as the N-acetylglucosamine acceptor. A phosphatase, designated MshA2, is required to dephosphorylate 1-O-(2-acetamido-2-deoxy-D-glucopyranosyl)-D- myo-inositol 3-phosphate to produce 1-O-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-D-myo- inositol. The latter is deacetylated, ligated with cysteine, and the cysteinyl amino group acetylated by acetyl-CoA to complete the mycothiol biosynthesis pathway. Uptake and concentration of myo-[C-14] inositol is rapid in Mycobacterium smegmatis and leads to production of radio labeled inositol1-phosphate and my cothiol. This demonstrates the presence of a myo- inositol transporter and a kinase that generates 1L-myo-inositol1-phosphate. The biochemical pathway of mycothiol biosynthesis is now fully elucidated.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Fahey, RC (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92014 USA.	rcfahey@ucsd.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI049174, R01AI049174] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49174] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderberg SJ, 1998, J BIOL CHEM, V273, P30391, DOI 10.1074/jbc.273.46.30391; Bachhawat N, 1999, J MOL BIOL, V291, P531, DOI 10.1006/jmbi.1999.2980; BONE R, 1994, BIOCHEMISTRY-US, V33, P9460, DOI 10.1021/bi00198a011; Bornemann C, 1997, BIOCHEM J, V325, P623, DOI 10.1042/bj3250623; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Buchmeier NA, 2003, MOL MICROBIOL, V47, P1723, DOI 10.1046/j.1365-2958.2003.03416.x; Buchmeier NA, 2006, J BACTERIOL, V188, P6245, DOI 10.1128/JB.00393-06; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Chen LJ, 2000, BIOCHEMISTRY-US, V39, P12415, DOI 10.1021/bi001517q; DANKERT M, 1972, AN ASOC QUIM ARGENT, V60, P257; Gammon DW, 2003, BIOORG MED CHEM LETT, V13, P2045, DOI 10.1016/S0960-894X(03)00157-4; Gu XL, 2006, BIOCHEM BIOPH RES CO, V339, P897, DOI 10.1016/j.bbrc.2005.11.088; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Koledin T, 2002, ARCH MICROBIOL, V178, P331, DOI 10.1007/s00203-002-0462-y; LOEWUS MW, 1982, PLANT PHYSIOL, V70, P1661, DOI 10.1104/pp.70.6.1661; Maynes JT, 2003, J BIOL CHEM, V278, P47166, DOI 10.1074/jbc.M308914200; McCarthy AA, 2004, J MOL BIOL, V335, P1131, DOI 10.1016/j.jmb.2003.11.034; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; Morgan AJ, 2004, J AM CHEM SOC, V126, P15370, DOI 10.1021/ja047360x; Newton GL, 2006, PROTEIN EXPRES PURIF, V47, P542, DOI 10.1016/j.pep.2006.03.003; Newton GL, 2005, J BACTERIOL, V187, P7309, DOI 10.1128/JB.187.21.7309-7316.2005; Newton GL, 2003, J BACTERIOL, V185, P3476, DOI 10.1128/JB.185.11.3476-3479.2003; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; NEWTON GL, 1995, EUR J BIOCHEM, V230, P821; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Newton GL, 2000, BIOCHEMISTRY-US, V39, P10739, DOI 10.1021/bi000356n; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P2641, DOI 10.1016/S0968-0896(03)00154-8; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P601, DOI 10.1016/S0968-0896(02)00345-0; Nigou J, 2002, BIOCHEMISTRY-US, V41, P4392, DOI 10.1021/bi0160056; Patel MP, 2001, BIOCHEMISTRY-US, V40, P5119, DOI 10.1021/bi0029144; Patel MP, 1999, BIOCHEMISTRY-US, V38, P11827, DOI 10.1021/bi991025h; Rawat M, 2003, MICROBIOL-SGM, V149, P1341, DOI 10.1099/mic.0.26084-0; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; SAKUDA S, 1994, BIOSCI BIOTECH BIOCH, V58, P1347, DOI 10.1271/bbb.58.1347; Sareen D, 2003, J BACTERIOL, V185, P6736, DOI 10.1228/JB.185.22.6736-6740.2003; Sareen D, 2002, BIOCHEMISTRY-US, V41, P6885, DOI 10.1021/bi012212u; SPIES HSC, 1994, EUR J BIOCHEM, V224, P203, DOI 10.1111/j.1432-1033.1994.tb20013.x; Steffek M, 2003, BIOCHEMISTRY-US, V42, P12067, DOI 10.1021/bi030080u; STEPHENS LR, 1990, BIOCHEM J, V272, P201, DOI 10.1042/bj2720201; Vetting MW, 2006, J BIOL CHEM, V281, P2795, DOI 10.1074/jbc.M510798200; Vetting MW, 2003, PROTEIN SCI, V12, P1954, DOI 10.1110/ps.03153703; Vogt RN, 2003, BIOCHEM J, V374, P657, DOI 10.1042/BJ20030642; Yoshida KI, 2002, J BACTERIOL, V184, P983, DOI 10.1128/jb.184.4.983-991.2002	44	58	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33910	33920		10.1074/jbc.M604724200	http://dx.doi.org/10.1074/jbc.M604724200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16940050	hybrid			2022-12-27	WOS:000241767600012
J	Grkovich, A; Johnson, CA; Buczynski, MW; Dennis, EA				Grkovich, Andrej; Johnson, Christina A.; Buczynski, Matthew W.; Dennis, Edward A.			Lipopolysaccharide-induced cyclooxygenase-2 expression in human U937 macrophages is phosphatidic acid phosphohydrolase-1-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; INDUCED DIFFERENTIATION; SIGNAL-TRANSDUCTION; WISH CELLS; RAT-LIVER; ACTIVATION; DIACYLGLYCEROL; PATHWAY	Cyclooxygenase (COX) has two isoforms, COX-1 and -2, which catalyze the key step in the conversion of cellular arachidonic acid into prostaglandins. In recent years, interest in COX-2 has significantly increased since it has been a target for the development of specific non-steroidal anti-inflammatory drugs. We report that COX-2 expression is up-regulated in phorbol ester (phorbol myristate acetate, PMA)-differentiated human U937 macrophage-like cells stimulated with lipopolysaccharide (LPS), whereas COX-1 is not up-regulated. We show that the LPS-induced up-regulation of COX-2 depends on the activity of the Mg+2-dependent phosphatidic acid phosphohydrolase 1 (PAP-1). Inhibition of PAP-1 by bromoenol lactone, propranolol, or ethanol resulted in a decrease in LPS-induced COX-2 mRNA transcript production, COX-2 protein expression, and prostaglandin E2 release from U937 macrophages. To ensure that these results did not arise because of PMA treatment of the U937 cells, similar experiments were conducted with the P388D(1) cell line, which does not require PMA differentiation. LPS increased the levels of endogenous cellular diacylglycerol (DAG) within 2 min of stimulation. This increase was observed to be sensitive to the PAP-1 inhibitors. Furthermore, phosphatidic acid phosphohydrolase activity assays showed that the bromoenol lactone-sensitive PAP-1 activity was translocated from the cytosolic fraction to the membrane fraction within 2 min of LPS exposure. Finally, DAG add-back experiments demonstrate that LPS-induced COX-2 expression is enhanced by the addition of exogenous DAG.	Univ Calif San Diego, Dept Pharmacol, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Dept Pharmacol, Dept Chem & Biochem, La Jolla, CA 92093 USA.	edennis@ucsd.edu	Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064611] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK007202] Funding Source: Medline; NIGMS NIH HHS [GM64611] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALBOA MA, 1995, J BIOL CHEM, V270, P11738, DOI 10.1074/jbc.270.20.11738; Balboa MA, 2003, J IMMUNOL, V171, P989, DOI 10.4049/jimmunol.171.2.989; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Burke JR, 1999, BIOCHEM BIOPH RES CO, V260, P232, DOI 10.1006/bbrc.1999.0887; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; DAY CP, 1992, BIOCHIM BIOPHYS ACTA, V1127, P87, DOI 10.1016/0005-2760(92)90205-A; Elabbadi N, 2002, LIPIDS, V37, P69, DOI 10.1007/s11745-002-0865-7; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HASS R, 1989, EUR J CELL BIOL, V48, P282; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Jiang YJ, 2003, MOL CELL BIOCHEM, V246, P31, DOI 10.1023/A:1023495626568; Jiang YW, 1996, J BIOL CHEM, V271, P29529, DOI 10.1074/jbc.271.47.29529; Johnson CA, 1999, J BIOL CHEM, V274, P27689, DOI 10.1074/jbc.274.39.27689; Kai M, 1996, J BIOL CHEM, V271, P18931, DOI 10.1074/jbc.271.31.18931; Lee SC, 2003, MOL CELLS, V15, P320; Lee YN, 2004, BIOCHEM BIOPH RES CO, V318, P839, DOI 10.1016/j.bbrc.2004.04.112; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Linton MF, 2004, CURR OPIN PHARMACOL, V4, P116, DOI 10.1016/j.coph.2003.12.003; Maestre Nicolas, 2003, J Exp Ther Oncol, V3, P36, DOI 10.1046/j.1359-4117.2003.01065.x; Meier KE, 1998, CELL SIGNAL, V10, P415, DOI 10.1016/S0898-6568(97)00140-X; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; PAI JK, 1988, BIOCHEM BIOPH RES CO, V150, P355, DOI 10.1016/0006-291X(88)90528-1; Park DW, 2002, MOL PHARMACOL, V61, P614, DOI 10.1124/mol.61.3.614; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Shen Q, 2003, J MAMMARY GLAND BIOL, V8, P45, DOI 10.1023/A:1025783221557; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; STURTON RG, 1980, BIOCHIM BIOPHYS ACTA, V619, P494, DOI 10.1016/0005-2760(80)90101-0; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; Yamamoto H, 1997, BIOCHEM J, V325, P223, DOI 10.1042/bj3250223; Zhang FH, 2001, INT IMMUNOPHARMACOL, V1, P1375, DOI 10.1016/S1567-5769(01)00069-8	46	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					32978	32987		10.1074/jbc.M605935200	http://dx.doi.org/10.1074/jbc.M605935200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950767	Green Published, hybrid			2022-12-27	WOS:000241621400006
J	Knowles, PP; Murray-Rust, J; Kjaer, S; Scott, RP; Hanrahan, S; Santoro, M; Ibanez, CF; McDonald, NQ				Knowles, Phillip P.; Murray-Rust, Judith; Kjaer, Svend; Scott, Rizaldy P.; Hanrahan, Sarah; Santoro, Massimo; Ibanez, Carlos F.; McDonald, Neil Q.			Structure and chemical inhibition of the RET tyrosine kinase domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; NEOPLASIA TYPE 2B; C-RET; AUTOPHOSPHORYLATION SITES; MOLECULAR-MECHANISMS; HIRSCHSPRUNG-DISEASE; CRYSTAL-STRUCTURE; POINT MUTATIONS; KEY ENZYME; RECEPTOR	The RET proto-oncogene encodes a receptor tyrosine kinase for the glial cell line-derived neurotrophic factor family of ligands. Loss-of-function mutations in RET are implicated in Hirschsprung disease, whereas activating mutations in RET are found in human cancers, including familial medullar thyroid carcinoma and multiple endocrine neoplasias 2A and 2B. We report here the biochemical characterization of the human RET tyrosine kinase domain and the structure determination of the non-phosphorylated and phosphorylated forms. Both structures adopt the same active kinase conformation competent to bind ATP and substrate and have a pre-organized activation loop conformation that is independent of phosphorylation status. In agreement with the structural data, enzyme kinetic data show that autophosphorylation produces only a modest increase in activity. Longer forms of RET containing the juxtamembrane domain and C-terminal tail exhibited similar kinetic behavior, implying that there is no cis-inhibitory mechanism within the RET intracellular domain. Our results suggest the existence of alternative inhibitory mechanisms, possibly in trans, for the autoregulation of RET kinase activity. We also present the structures of the RET tyrosine kinase domain bound to two inhibitors, the pyrazolopyrimidine PP1 and the clinically relevant 4-anilinoquinazoline ZD6474. These structures explain why certain multiple endocrine neoplasia 2-associated RET mutants found in patients are resistant to inhibition and form the basis for design of more effective inhibitors.	Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3PX, England; Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, SE-17177 Stockholm, Sweden; Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale, CNR, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy	Cancer Research UK; University of London; Birkbeck University London; Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	McDonald, NQ (corresponding author), Canc Res UK, Struct Biol Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.	neil.mcdonald@cancer.org.uk	Scott, Rizaldy/AAC-5264-2020; Scott, Rizaldy/Y-7584-2019	Scott, Rizaldy/0000-0002-0288-8862; Kjaer, Susanne/0000-0002-8347-1398				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Anders J, 2001, J BIOL CHEM, V276, P35808, DOI 10.1074/jbc.M104968200; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bongarzone I, 1998, ONCOGENE, V16, P2295, DOI 10.1038/sj.onc.1201759; Borrello MG, 1995, ONCOGENE, V11, P2419; Buckwalter TLF, 2002, ONCOGENE, V21, P8166, DOI 10.1038/sj.onc.1205938; Carlomagno F, 2004, J CHEMOTHERAPY, V16, P49, DOI 10.1179/joc.2004.16.Supplement-1.49; Carlomagno F, 2005, CURR MED CHEM, V12, P1773, DOI 10.2174/0929867054367266; Carlomagno F, 2004, ONCOGENE, V23, P6056, DOI 10.1038/sj.onc.1207810; Carlomagno F, 2002, CANCER RES, V62, P1077; Carlomagno F, 1996, EMBO J, V15, P2717, DOI 10.1002/j.1460-2075.1996.tb00632.x; Chappuis-Flament S, 1998, ONCOGENE, V17, P2851, DOI 10.1038/sj.onc.1202202; Cheetham GMT, 2004, CURR OPIN STRUC BIOL, V14, P700, DOI 10.1016/j.sbi.2004.10.011; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Coulpier M, 2002, J BIOL CHEM, V277, P1991, DOI 10.1074/jbc.M107992200; Craven RA, 2006, PROTEOMICS, V6, P3880, DOI 10.1002/pmic.200500811; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Drosten M, 2003, HUM GENE THER, V14, P971, DOI 10.1089/104303403766682232; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank R, 1996, Methods Mol Biol, V66, P149; Geneste O, 1999, HUM MOL GENET, V8, P1989, DOI 10.1093/hmg/8.11.1989; Hubbard SR, 2002, CURR OPIN STRUC BIOL, V12, P735, DOI 10.1016/S0959-440X(02)00383-4; Iwashita T, 1999, ONCOGENE, V18, P3919, DOI 10.1038/sj.onc.1202742; Iwashita T, 2000, BIOCHEM BIOPH RES CO, V268, P804, DOI 10.1006/bbrc.2000.2227; Iwashita T, 1996, ONCOGENE, V12, P481; Iwashita T, 1996, HUM MOL GENET, V5, P1577, DOI 10.1093/hmg/5.10.1577; Jeffers M, 1999, ONCOGENE, V18, P5120, DOI 10.1038/sj.onc.1202902; Jhiang SM, 2000, ONCOGENE, V19, P5590, DOI 10.1038/sj.onc.1203857; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kashuk CS, 2005, P NATL ACAD SCI USA, V102, P8949, DOI 10.1073/pnas.0503259102; Kawamoto Y, 2004, J BIOL CHEM, V279, P14213, DOI 10.1074/jbc.M312600200; Kjaer S, 2003, HUM MOL GENET, V12, P2133, DOI 10.1093/hmg/ddg227; LESLIE AGW, 1992, JOITN CCP4 ESF EAMCB, V26; Li SQ, 2003, J BIOL CHEM, V278, P26007, DOI 10.1074/jbc.M302425200; Liu Y, 1998, BIOORGAN MED CHEM, V6, P1219, DOI 10.1016/S0968-0896(98)00099-6; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Manley PW, 2005, BBA-PROTEINS PROTEOM, V1754, P3, DOI 10.1016/j.bbapap.2005.07.040; McTigue MA, 1999, STRUCT FOLD DES, V7, P319, DOI 10.1016/S0969-2126(99)80042-2; MISE N, 2006, IN PRESS ONCOGENE; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nozaki C, 1998, ONCOGENE, V16, P293, DOI 10.1038/sj.onc.1201548; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Parast CV, 1998, BIOCHEMISTRY-US, V37, P16788, DOI 10.1021/bi981291f; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Ryan AJ, 2005, BRIT J CANCER, V92, pS6, DOI 10.1038/sj.bjc.6602603; Santoro M, 2004, ENDOCRINOLOGY, V145, P5448, DOI 10.1210/en.2004-0922; Santoro MM, 1998, ONCOGENE, V17, P741, DOI 10.1038/sj.onc.1201994; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schuringa JJ, 2001, ONCOGENE, V20, P5350, DOI 10.1038/sj.onc.1204715; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Takahashi M, 1998, J INTERN MED, V243, P509; Tegge WJ, 1998, METH MOL B, V87, P99; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Uchino S, 1998, JPN J CANCER RES, V89, P411, DOI 10.1111/j.1349-7006.1998.tb00579.x; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Waltenberger J, 1999, CIRC RES, V85, P12; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	78	192	202	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33577	33587		10.1074/jbc.M605604200	http://dx.doi.org/10.1074/jbc.M605604200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16928683	hybrid			2022-12-27	WOS:000241621400067
J	Achur, RN; Agbor-Enoh, ST; Gowda, DC				Achur, Rajeshwara N.; Agbor-Enoh, Sean T.; Gowda, D. Channe			Rat spongiotrophoblast-specific protein is predominantly a unique low sulfated chondroitin sulfate proteoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; HUMAN PLACENTA; ADHERENCE; ADHESION; MALARIA; BERGHEI	We have previously demonstrated that the human placenta contains a uniquely low sulfated extracellular aggrecan family chondroitin sulfate proteoglycan (CSPG). This CSPG is a major receptor for the adherence of Plasmodium falciparum-infected red blood cells (IRBCs) in placentas, causing pregnancy-specific malaria. However, it is not known whether such low sulfated CSPGs occur in placentas of other animals and, if so, whether IRBCs bind to those CSPGs. In this study, we show that rat placenta contains a uniquely low sulfated extracellular CSPG bearing chondroitin sulfate (CS) chains, which comprise only similar to 2% 4-sulfated and the remainder nonsulfated disaccharides. Surprisingly, the core protein of the rat placental CSPG, unlike that of the human placental CSPG, is a spongiotrophoblast-specific protein (SSP), which is expressed in a pregnancy stage-dependent manner. The majority of rat placental SSP is present in the CSPG form, and only similar to 10% occurs without CS chain substitution. Of the total SSP-CSPG in rat placenta, similar to 57% is modified with a single CS chain, and similar to 43% carries two CS chains. These data together with the previous finding on human placental CSPG suggest that the expression of low sulfated CSPG is a common feature of animal placentas. Our data also show that the unique species-specific difference in the biology of the rat and human placentas is reflected in the occurrence of completely different CSPG core protein types. Furthermore, the rat SSP-CSPG binds P. falciparum IRBCs in aCS chain-dependent manner. Since IRBCs have been reported to accumulate in the placentas of malaria parasite-infected rodents, our results have important implications for exploiting pregnant rats as a model for studying chondroitin 4-sulfate-based therapeutics for human placental malaria.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Georgetown University	Gowda, DC (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA USA.	gowda@psu.edu		Gowda, Channe/0000-0002-6860-5108; Agbor-Enoh, Sean/0000-0002-9380-9161; Achur, Rajeshwara/0000-0001-9867-8917	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI045086, R01AI045086] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 45086] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achur RN, 2004, BBA-PROTEINS PROTEOM, V1701, P109, DOI 10.1016/j.bbapap.2004.06.007; Achur RN, 2003, J BIOL CHEM, V278, P11705, DOI 10.1074/jbc.M211015200; Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Bowen JM, 2002, PLACENTA, V23, P239, DOI 10.1053/plac.2001.0781; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; Desowitz R. S., 2001, Malaria in pregnancy: deadly parasite, susceptible host, P127, DOI 10.4324/9780203302255_chapter_5; DISCHE Z, 1947, J BIOL CHEM, V167, P189; Fried M, 2000, EXP PARASITOL, V95, P75, DOI 10.1006/expr.2000.4510; HARDY MR, 1994, METHOD ENZYMOL, V230, P208; Hascall V.C., 1981, CELL BIOL EXTRACELLU, P39; HASSELL JR, 1986, ANNU REV BIOCHEM, V55, P539, DOI 10.1146/annurev.bi.55.070186.002543; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Iwatsuki K, 2000, BIOL REPROD, V62, P1352, DOI 10.1095/biolreprod62.5.1352; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; MITCHELL MD, 1993, PLACENTA, V14, P249, DOI 10.1016/S0143-4004(05)80426-6; Muthusamy A, 2004, AM J PATHOL, V164, P2013, DOI 10.1016/S0002-9440(10)63761-3; NIEFELD JJ, 1994, EXPERIENTIA, V70, P217; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; ODUOLA AMJ, 1986, EXP PARASITOL, V62, P181, DOI 10.1016/0014-4894(86)90022-6; OIKE Y, 1980, BIOCHEM J, V191, P193, DOI 10.1042/bj1910193; POOLE AR, 1986, BIOCHEM J, V236, P1; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; REDINBAUGH MG, 1986, ANAL BIOCHEM, V153, P267, DOI 10.1016/0003-2697(86)90091-6; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SAITO H, 1968, J BIOL CHEM, V243, P1536; Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7; Soares MJ, 1998, BIOL REPROD, V58, P273, DOI 10.1095/biolreprod58.2.273; Soloveva V, 2004, PLACENTA, V25, P29, DOI 10.1016/S0143-4004(03)00215-7; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; TEGOSHI T, 1992, AM J TROP MED HYG, V47, P643, DOI 10.4269/ajtmh.1992.47.643; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003	34	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32327	32334		10.1074/jbc.M605841200	http://dx.doi.org/10.1074/jbc.M605841200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954212	hybrid			2022-12-27	WOS:000241414500030
J	Pautz, A; Linker, K; Hubrich, T; Korhonen, R; Altenhofer, S; Kleinert, H				Pautz, Andrea; Linker, Katrin; Hubrich, Thomas; Korhonen, Riku; Altenhoefer, Sebastian; Kleinert, Hartmut			The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; PYRIMIDINE-RICH SEQUENCE; 3'-UNTRANSLATED REGION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; IN-VITRO; HNRNP L; COMPLEX; DOMAIN; DNA	Human inducible nitric oxide synthase ( iNOS) expression is regulated by transcriptional and post-transcriptional mechanisms. We have recently shown that the multifunctional RNA-binding proteins KH-type splicing regulatory protein and tristetraprolin are critically involved in the post-transcriptional regulation of human iNOS expression. Several reports have shown that KH-type splicing regulatory protein colocalizes with the polypyrimidine tract-binding protein (PTB), and both RNA-binding proteins seem to interact with the same mRNAs. Therefore we analyzed the involvement of PTB in human iNOS expression. In human DLD-1 cells, cytokine incubation necessary to induce iNOS expression did not change PTB localization or expression. However, intracellular binding of PTB to the human iNOS mRNA increased after cytokine stimulation. Overexpression of PTB resulted in enhanced cytokine-induced iNOS expression. Accordingly, small interfering RNA-mediated knock down of PTB reduced cytokine-dependent iNOS expression. Recombinant PTB displayed binding to an UC-rich sequence in the 3'-untranslated region of the human iNOS mRNA. Transfection experiments showed that PTB mediates its effect on iNOS expression via binding to this region. The underlying mechanism is based on a modulation of iNOS mRNA stability. In summary, human iNOS is the first example of a human pro-inflammatory gene regulated by PTB on the level of mRNA stability.	Univ Mainz, Dept Pharmacol, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz	Kleinert, H (corresponding author), Univ Mainz, Dept Pharmacol, Obere Zahlbacher Str 67, D-55101 Mainz, Germany.	kleinert@mail.uni-mainz.de	Kleinert, Hartmut/M-2988-2018	Kleinert, Hartmut/0000-0003-2202-3548; Korhonen, Riku/0000-0002-7264-517X				Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Coles LS, 2004, EUR J BIOCHEM, V271, P648, DOI 10.1111/j.1432-1033.2003.03968.x; Cornelis S, 2005, NUCLEIC ACIDS RES, V33, P3095, DOI 10.1093/nar/gki611; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Domitrovich AM, 2005, VIROLOGY, V335, P72, DOI 10.1016/j.virol.2005.02.009; Donev RM, 2002, MOL CELL BIOCHEM, V233, P181, DOI 10.1023/A:1015504318726; Fechir M, 2005, MOL PHARMACOL, V67, P2148, DOI 10.1124/mol.104.008763; Fiset S, 2001, NUCLEIC ACIDS RES, V29, P2268, DOI 10.1093/nar/29.11.2268; FORSTERMANN U, 1995, BIOCHEM PHARMACOL, V50, P1321, DOI 10.1016/0006-2952(95)00181-6; Fred RG, 2005, BIOCHEM BIOPH RES CO, V328, P38, DOI 10.1016/j.bbrc.2004.12.147; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Hahm B, 1998, FEBS LETT, V425, P401, DOI 10.1016/S0014-5793(98)00269-5; Hall MP, 2004, MOL BIOL CELL, V15, P774, DOI 10.1091/mbc.E03-09-0692; Hamilton BJ, 2003, MOL CELL BIOL, V23, P510, DOI 10.1128/MCB.23.2.510-525.2003; He LS, 2000, NUCLEIC ACIDS RES, V28, P4558, DOI 10.1093/nar/28.22.4558; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Irwin N, 1997, NUCLEIC ACIDS RES, V25, P1281, DOI 10.1093/nar/25.6.1281; Katahira M, 2001, J MOL BIOL, V311, P973, DOI 10.1006/jmbi.2001.4862; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kleinert H, 1996, MOL PHARMACOL, V49, P15; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Misquitta CM, 2001, MOL CELL BIOCHEM, V224, P53, DOI 10.1023/A:1011982932645; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Perez I, 1997, BIOCHEMISTRY-US, V36, P11881, DOI 10.1021/bi9711745; Perez I, 1997, RNA, V3, P764; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Soderberg M, 2002, MOL PHARMACOL, V62, P423, DOI 10.1124/mol.62.2.423; Soderberg M, 2007, MOL IMMUNOL, V44, P434, DOI 10.1016/j.molimm.2006.02.019; Tillmar L, 2002, MOL MED, V8, P263, DOI 10.1007/BF03402152; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001	38	68	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32294	32302		10.1074/jbc.M603915200	http://dx.doi.org/10.1074/jbc.M603915200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950790	hybrid			2022-12-27	WOS:000241414500026
J	Yang, NY; Pasquale, EB; Owen, LB; Ethell, IM				Yang, Nai-Ying; Pasquale, Elena B.; Owen, Laurie B.; Ethell, Iryna M.			The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC SPINE MORPHOGENESIS; FOCAL-ADHESION-KINASE; TUMOR-GROWTH; MALIGNANT-MELANOMA; LIGAND EPHRIN-B2; UP-REGULATION; R-RAS; ACTIVATION; EXPRESSION; OVEREXPRESSION	Several studies have reported the up-regulation of EphB receptor-tyrosine kinases and ephrin-B ligands in a variety of tumors, suggesting a functional relation between EphB/ephrinB signaling and tumor progression. The ability of the EphB receptors to regulate cell migration and promote angiogenesis likely contributes to tumor progression and metastasis. Here we show that EphB receptors, and especially EphB4, regulate the migration of murine melanoma cells. Highly malignant melanoma cells express the highest levels of EphB4 receptor and migrate faster than less malignant melanoma cells. Furthermore, inhibition of EphB receptor forward signaling by overexpression of a form of EphB4 lacking the cytoplasmic portion or by treatment with competitively acting soluble EphB2-Fc results in slower melanoma cell migration. In contrast, overexpression of active EphB4 significantly enhances cell migration. The effects of EphB4 receptor on cell migration and cell morphology require its kinase activity because the inhibition of EphB4 kinase activity by overexpression of kinase dead EphB4 inhibits cell migration and affects the organization of actin cytoskeleton. Activation of EphB4 receptor with its ligand ephrin-B2-Fc enhances the migratory ability of melanoma cells and increases RhoAactivity, whereas inhibiting EphB receptor forward signaling decreases RhoA activity. Moreover, expression of dominant negative RhoA blocks the effects of active EphB4 on cell migration and actin organization. These data suggest that EphB4 forward signaling contributes to the high migratory ability of invasive melanoma cells by influencing RhoA-mediated actin cytoskeleton reorganization.	Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; Burnham Inst Med Res, La Jolla, CA 92037 USA; BioLegend, San Diego, CA 92121 USA	University of California System; University of California Riverside; Sanford Burnham Prebys Medical Discovery Institute	Ethell, IM (corresponding author), Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA.	iryna.ethell@ucr.edu		Ethell, Iryna/0000-0002-1324-6611				Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Bogenrieder T, 2002, CRIT REV ONCOL HEMAT, V44, P1, DOI 10.1016/S1040-8428(01)00196-2; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Daniel TO, 1996, KIDNEY INT, V50, pS73; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; EASTY DJ, 1993, J INVEST DERMATOL, V101, P679, DOI 10.1111/1523-1747.ep12371675; Easty DJ, 2000, MELANOMA RES, V10, P401, DOI 10.1097/00008390-200010000-00001; EASTY DJ, 1995, INT J CANCER, V60, P129, DOI 10.1002/ijc.2910600119; EASTY DJ, 1995, CANCER RES, V55, P2528; Easty DJ, 1999, INT J CANCER, V84, P494, DOI 10.1002/(SICI)1097-0215(19991022)84:5<494::AID-IJC8>3.3.CO;2-F; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; FIDLER IJ, 1981, J NATL CANCER I, V67, P947; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Hess AR, 2001, CANCER RES, V61, P3250; Holash JA, 1997, DEV BIOL, V182, P256, DOI 10.1006/dbio.1996.8496; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; KRIPKE ML, 1979, JNCI-J NATL CANCER I, V63, P541, DOI 10.1093/jnci/63.3.541; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lamorte L, 2001, Surg Oncol Clin N Am, V10, P271; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Liu W, 2004, BRIT J CANCER, V90, P1620, DOI 10.1038/sj.bjc.6601723; Liu WB, 2002, CANCER, V94, P934, DOI 10.1002/cncr.10122; Martiny-Baron G, 2004, NEOPLASIA, V6, P248, DOI 10.1593/neo.03457; Meyer S, 2005, INT J ONCOL, V27, P1197; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Nakada M, 2004, CANCER RES, V64, P3179, DOI 10.1158/0008-5472.CAN-03-3667; Nakamoto M, 2002, MICROSC RES TECHNIQ, V59, P58, DOI 10.1002/jemt.10177; Nikolova Z, 1998, J CELL SCI, V111, P2741; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Ogawa K, 2006, J CELL SCI, V119, P559, DOI 10.1242/jcs.02777; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Owen-Schaub LB, 1998, J EXP MED, V188, P1717, DOI 10.1084/jem.188.9.1717; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Raynor M, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-14; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Steinle JJ, 2003, CELL SIGNAL, V15, P1011, DOI 10.1016/S0898-6568(03)00072-X; Steinle JJ, 2002, J BIOL CHEM, V277, P43830, DOI 10.1074/jbc.M207221200; Takai N, 2001, ONCOL REP, V8, P567; TALMADGE JE, 1982, J NATL CANCER I, V69, P975; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Uyen HD, 2002, J CELL SCI, V115, P3073; Vindis C, 2004, J BIOL CHEM, V279, P27965, DOI 10.1074/jbc.M401295200; Vindis C, 2003, J CELL BIOL, V162, P661, DOI 10.1083/jcb.200302073; Vogt T, 1998, CLIN CANCER RES, V4, P791; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zelinski DP, 2001, CANCER RES, V61, P2301; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	65	76	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32574	32586		10.1074/jbc.M604338200	http://dx.doi.org/10.1074/jbc.M604338200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950769	hybrid			2022-12-27	WOS:000241414500055
J	Van Bodegom, D; Saifudeen, Z; Dipp, S; Puri, S; Magenheimer, BS; Calvet, JP; El-Dahr, SS				Van Bodegom, Diederik; Saifudeen, Zubaida; Dipp, Susana; Puri, Sanjeev; Magenheimer, Brenda S.; Calvet, James P.; El-Dahr, Samir S.			The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; WILD-TYPE P53; EPITHELIAL-CELLS; DNA-DAMAGE; POTENTIAL MEDIATOR; RECEPTOR PROMOTER; SIGNALING PATHWAY; INDUCED APOPTOSIS; DOWN-REGULATION; PKD1	This study provides evidence that the tumor suppressor protein, p53, is a transcriptional repressor of PKD1. Kidneys of p53-null mice expressed higher Pkd1 mRNA levels than wild-type littermates; gamma-irradiation suppressed PKD1 gene expression in p53(+/+) but not p53(-/-) cells; and chromatin immunoprecipitation assays demonstrated the binding of p53 to the PKD1 promoter in vivo. In transient transfection assays, p53 repressed PKD1 promoter activity independently of endogenous p21. Deletion analysis mapped p53-mediated repression to the proximal promoter region of PKD1. Mutations of the DNA binding or C-terminal minimal repression domains of p53 abolished its ability to repress PKD1. Moreover, trichostatin A, an inhibitor of histone deacetylase activity, attenuated p53-induced repression of the PKD1 promoter. These findings, together with previous reports showing that dedifferentiated Pkd1-deficient cells express lower p53 and p21 levels, suggest a model whereby PKD1 signaling activates the p53-p21 differentiation pathway. In turn, p53 cooperates with histone deacetylases to repress PKD1 gene transcription. Loss of a p53-mediated negative feedback loop in PKD1 mutant cells may therefore contribute to deregulated PKD1 expression and cystogenesis.	Tulane Univ, Hlth Sci Ctr, Dept Pediat, Sect Pediat Nephrol, New Orleans, LA 70112 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Tulane University; University of Kansas; University of Kansas Medical Center	El-Dahr, SS (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Pediat, Sect Pediat Nephrol, SL-37,1430 Tulane Ave, New Orleans, LA 70112 USA.	seldahr@tulane.edu		Puri, Sanjeev/0000-0002-4314-9871; Puri, Sanjeev/0000-0002-3967-987X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056264, R01DK062250, P50DK057301] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-57301, DK-62250, DK-56264] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Bogdanova N, 2001, GENOMICS, V74, P333, DOI 10.1006/geno.2001.6568; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; Boucher C, 2004, EUR J HUM GENET, V12, P347, DOI 10.1038/sj.ejhg.5201162; Delmas P, 2004, CELL, V118, P145, DOI 10.1016/j.cell.2004.07.007; DERUIJTER AJ, 2003, BIOCHEM J, V30, P737; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fan H, 2005, AM J PHYSIOL-RENAL, V288, pF98, DOI 10.1152/ajprenal.00246.2004; Gopalkrishnan RV, 1998, J BIOL CHEM, V273, P10972, DOI 10.1074/jbc.273.18.10972; Griffin MD, 1996, P ASSOC AM PHYSICIAN, V108, P185; Guillaume R, 1999, DEV DYNAM, V214, P337, DOI 10.1002/(SICI)1097-0177(199904)214:4<337::AID-AJA6>3.0.CO;2-O; Hong TM, 2001, J BIOL CHEM, V276, P1510, DOI 10.1074/jbc.M008231200; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Kaeser MD, 2004, ONCOGENE, V23, P4007, DOI 10.1038/sj.onc.1207536; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim H, 2004, EUR J HUM GENET, V12, P433, DOI 10.1038/sj.ejhg.5201136; Lantinga-van Leeuwen IS, 2005, EUR J HUM GENET, V13, P649, DOI 10.1038/sj.ejhg.5201392; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Manzati E, 2005, EXP CELL RES, V304, P391, DOI 10.1016/j.yexcr.2004.10.023; Marks J, 2003, J BIOL CHEM, V278, P34158, DOI 10.1074/jbc.M304543200; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nishio S, 2005, J CLIN INVEST, V115, P910, DOI 10.1172/JCI200522850; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ogden SK, 2001, J BIOL CHEM, V276, P42057, DOI 10.1074/jbc.C100381200; Ong ACM, 2005, KIDNEY INT, V67, P1234, DOI 10.1111/j.1523-1755.2005.00201.x; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Rodova M, 2002, J BIOL CHEM, V277, P29577, DOI 10.1074/jbc.M203570200; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Saifudeen Z, 2005, J BIOL CHEM, V280, P23094, DOI 10.1074/jbc.M414575200; Saifudeen Z, 2005, AM J PHYSIOL-RENAL, V288, pF899, DOI 10.1152/ajprenal.00370.2004; Saifudeen Z, 2000, J BIOL CHEM, V275, P15557, DOI 10.1074/jbc.M909810199; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Suehiro T, 2004, MOL CELL ENDOCRINOL, V222, P33, DOI 10.1016/j.mce.2004.05.005; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Thornborrow EC, 1999, J BIOL CHEM, V274, P33747, DOI 10.1074/jbc.274.47.33747; Townsend PA, 2004, J BIOL CHEM, V279, P5811, DOI 10.1074/jbc.M302637200; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wang LQ, 2001, J BIOL CHEM, V276, P43604, DOI 10.1074/jbc.M106570200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wang YX, 1999, FEBS LETT, V445, P269, DOI 10.1016/S0014-5793(99)00136-2; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Zhan MC, 2005, J BIOL CHEM, V280, P4825, DOI 10.1074/jbc.M407450200	60	34	36	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31234	31244		10.1074/jbc.M606510200	http://dx.doi.org/10.1074/jbc.M606510200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16931520	Bronze			2022-12-27	WOS:000241235300008
J	Martowicz, ML; Grass, JA; Bresnick, EH				Martowicz, Melissa L.; Grass, Jeffrey A.; Bresnick, Emery H.			GATA-1-mediated transcriptional repression yields persistent transcription factor IIB-chromatin complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HEMATOPOIETIC STEM-CELLS; CORE PROMOTER ELEMENT; MOUSE GATA-2 GENE; MESSENGER-RNA; ERYTHROID-DIFFERENTIATION; IN-VIVO; C-KIT; EXPRESSION; REGION	The hematopoietic GATA factors GATA-1 and GATA-2, which have distinct and overlapping roles to regulate blood cell development, are reciprocally expressed during erythropoiesis. GATA-1 directly represses Gata2 transcription, and reduced GATA-2 synthesis promotes red blood cell development. Gata2 repression involves "GATA switches" in which GATA-1 displaces GATA-2 from Gata2 regulatory regions. We show that extragenic GATA switch sites occupied by GATA-2 associate with as much RNA polymerase II (Pol II) and basal transcription factors as present at the active Gata2 promoters. Pol II bound to GATA switch sites in the active locus was phosphorylated on serine 5 of the carboxyl-terminal domain, indicative of elongation competence. GATA-1-mediated displacement of GATA-2 from GATA switch sites reduced Pol II recruitment to all sites except the far upstream -77-kb region. Surprisingly, TFIIB occupancy persisted at most sites upon repression. These results indicate that GATA-2-bound extragenic regulatory elements recruit Pol II, GATA-1 binding expels Pol II, and despite the persistent TFIIB-chromatin complexes, Pol II recruitment is blocked.	Univ Wisconsin, Sch Med, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bresnick, EH (corresponding author), Univ Wisconsin, Sch Med, Mol & Cellular Pharmacol Program, 1300 Univ Ave, Madison, WI 53706 USA.	ehbresni@wisc.edu			NIDDK NIH HHS [DK55700, DK68634] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068634, R56DK068634, R01DK055700] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartunek P, 2003, ONCOGENE, V22, P1927, DOI 10.1038/sj.onc.1206281; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; BRIEGEL K, 1993, GENE DEV, V7, P1097, DOI 10.1101/gad.7.6.1097; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; Haussecker D, 2005, MOL CELL BIOL, V25, P9724, DOI 10.1128/MCB.25.21.9724-9733.2005; Heyworth C, 1999, GENE DEV, V13, P1847, DOI 10.1101/gad.13.14.1847; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Im Hogune, 2004, Methods Mol Biol, V284, P129; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Johnson KD, 2003, MOL CELL BIOL, V23, P6484, DOI 10.1128/MCB.23.18.6484-6493.2003; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; Kitajima K, 2002, EMBO J, V21, P3060, DOI 10.1093/emboj/cdf301; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; LEONARD M, 1993, BLOOD, V82, P1071; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Lin PS, 2002, PROG NUCLEIC ACID RE, V72, P333, DOI 10.1016/S0079-6603(02)72074-6; Ling JH, 2004, J BIOL CHEM, V279, P51704, DOI 10.1074/jbc.M404039200; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Martowicz ML, 2005, J BIOL CHEM, V280, P1724, DOI 10.1074/jbc.M406038200; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Minegishi N, 1999, BLOOD, V93, P4196, DOI 10.1182/blood.V93.12.4196.412k23_4196_4207; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PEVNY L, 1995, DEVELOPMENT, V121, P163; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Silver L, 1997, BLOOD, V89, P1154, DOI 10.1182/blood.V89.4.1154; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; ZON LI, 1991, J BIOL CHEM, V266, P22948	61	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37345	37352		10.1074/jbc.M605774200	http://dx.doi.org/10.1074/jbc.M605774200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16963445	hybrid			2022-12-27	WOS:000242477100011
J	Sayanova, O; Haslam, R; Guschina, I; Lloyd, D; Christie, WW; Harwood, JL; Napier, JA				Sayanova, Olga; Haslam, Richard; Guschina, Irina; Lloyd, David; Christie, William W.; Harwood, John L.; Napier, Johnathan A.			A bifunctional Delta 12, Delta 15-desaturase from Acanthamoeba castellanii directs the synthesis of highly unusual n-1 series unsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONT-END-DESATURASES; 4,4-DIMETHYLOXAZOLINE DERIVATIVES; FUNCTIONAL-CHARACTERIZATION; BIOSYNTHETIC-PATHWAY; SKELETONEMA-COSTATUM; TRANSGENIC PLANTS; IN-VIVO; MICROALGA; DIATOM; CDNA	The free-living soil protozoon Acanthamoeba castellanii synthesizes a range of polyunsaturated fatty acids, the balance of which can be altered by environmental changes. We have isolated and functionally characterized in yeast a microsomal desaturase from A. castellanii, which catalyzes the sequential conversion of C-16 and C-18 Delta 9-monounsaturated fatty acids to di- and tri-unsaturated forms. In the case of C-16 substrates, this bifunctional A. castellanii Delta 12, Delta 15-desaturase generated a highly unusual fatty acid, hexadecatrienoic acid (16:3 Delta(9,12,15)(n1)). The identification of a desaturase, which can catalyze the insertion of a double bond between the terminal two carbons of a fatty acid represents a new addition to desaturase functionality and plasticity. We have also co-expressed in yeast the A. castellanii bifunctional Delta 12, Delta 15-desaturase with a microsomal Delta 6-desaturase, resulting in the synthesis of the highly unsaturated C16 fatty acid hexadecatetraenoic acid (16:4 Delta(6,9,12,15)(n-1)), previously only reported in marine microorganisms. Our work therefore demonstrates the feasibility of the heterologous synthesis of polyunsaturated fatty acids of the n-1 series. The presence of a bifunctional Delta 12, Delta 15-desaturase in A. castellanii is also considered with reference to the evolution of desaturases and the lineage of this protist.	Rothamsted Res, Harpenden AL5 2JQ, Herts, England; Univ Cardiff, Cardiff Sch Biosci, Cardiff CF10 1US, S Glam, Wales; Scottish Crop Res Inst, MRS Mylnefield Res Serv, Dundee DD2 5DA, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Cardiff University; James Hutton Institute	Napier, JA (corresponding author), Rothamsted Res, Harpenden AL5 2JQ, Herts, England.	johnathan.napier@bbsrc.ac.uk	Haslam, Richard/B-3865-2009; Harwood, John L/A-4308-2010; Haslam, Richard/C-5966-2014; Lloyd, David/D-2483-2010	Lloyd, David/0000-0002-5656-0571; Napier, Johnathan/0000-0003-3580-3607; Harwood, John/0000-0003-2377-2612; Haslam, Richard/0000-0001-6226-5643	Biotechnology and Biological Sciences Research Council [BBS/E/C/00004156] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AITZETMULLER K, 1994, J PLANT PHYSIOL, V143, P538, DOI 10.1016/S0176-1617(11)81820-1; [Anonymous], 2003, LIPID ANAL; BERGE JP, 1995, PHYTOCHEMISTRY, V39, P1017, DOI 10.1016/0031-9422(94)00156-N; Blee E, 1998, PROG LIPID RES, V37, P33, DOI 10.1016/S0163-7827(98)00004-6; Christie WW, 2000, EUR J LIPID SCI TECH, V102, P23, DOI 10.1002/(SICI)1438-9312(200001)102:1<23::AID-EJLT23>3.3.CO;2-I; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Dayan FE, 2003, J BIOL CHEM, V278, P28607, DOI 10.1074/jbc.M304185200; Domergue F, 2005, BIOCHEM J, V389, P483, DOI 10.1042/BJ20050111; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Doolittle WE, 1998, TRENDS GENET, V14, P307; GARBUS J, 1963, J BIOL CHEM, V238, P59; Graeve M, 2002, MAR ECOL PROG SER, V231, P67, DOI 10.3354/meps231067; Gurr M. I, 2002, LIPID BIOCH; Harwood JL, 1998, ANN NY ACAD SCI, V851, P162, DOI 10.1111/j.1749-6632.1998.tb08990.x; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; Heinz Ernst, 1993, P33; HIGASHI S, 1993, PLANT PHYSIOL, V102, P1275, DOI 10.1104/pp.102.4.1275; HITZ WD, 1994, PLANT PHYSIOL, V105, P635, DOI 10.1104/pp.105.2.635; JONES AL, 1993, BIOCHEM J, V290, P273, DOI 10.1042/bj2900273; JONES AL, 1993, BIOCHEM J, V296, P183, DOI 10.1042/bj2960183; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kates M, 1986, LAB TECHNIQUES BIOCH, V3; KORN ED, 1964, J BIOL CHEM, V239, P396; Mansour MP, 1999, J PHYCOL, V35, P710, DOI 10.1046/j.1529-8817.1999.3540710.x; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Meesapyodsuk D, 2000, BIOCHEM SOC T, V28, P632, DOI 10.1042/BST0280632; Napier JA, 1999, TRENDS PLANT SCI, V4, P2, DOI 10.1016/S1360-1385(98)01357-0; Napier JA, 2004, LIPIDS, V39, P1067, DOI 10.1007/s11745-004-1332-1; Napier JA, 2003, PROSTAG LEUKOTR ESS, V68, P135, DOI 10.1016/S0952-3278(02)00263-6; Napier JA, 2001, LIPIDS, V36, P761, DOI 10.1007/s11745-001-0782-9; PAGE F. C., 1974, Arch. Protistenkunde, V116, P149; Petrini GA, 2004, EUR J BIOCHEM, V271, P1079, DOI 10.1111/j.1432-1033.2004.04005.x; Qi BX, 2002, FEBS LETT, V510, P159, DOI 10.1016/S0014-5793(01)03247-1; Rutter AJ, 2002, BIOCHEM J, V368, P57, DOI 10.1042/BJ20020189; Rychek EA, 2005, LIPIDS, V40, P599, DOI 10.1007/s11745-005-1421-1; Sayanova O, 2006, FEBS LETT, V580, P1946, DOI 10.1016/j.febslet.2006.02.062; Sayanova O, 1999, J EXP BOT, V50, P411, DOI 10.1093/jexbot/50.332.409; Sayanova O, 1997, P NATL ACAD SCI USA, V94, P4211, DOI 10.1073/pnas.94.8.4211; Sayanova OV, 2004, PHYTOCHEMISTRY, V65, P147, DOI 10.1016/j.phytochem.2003.10.017; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Tonon T, 2005, FEBS J, V272, P3401, DOI 10.1111/j.1742-4658.2005.04755.x; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; ZHANG JY, 1989, J AM OIL CHEM SOC, V66, P256, DOI 10.1007/BF02546071; Zhukova NV, 2001, BOT MAR, V44, P287, DOI 10.1515/BOT.2001.037	48	69	81	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36533	36541		10.1074/jbc.M605158200	http://dx.doi.org/10.1074/jbc.M605158200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16950768	hybrid, Green Published			2022-12-27	WOS:000242220800009
J	Kuznetsova, E; Proudfoot, M; Gonzales, CF; Brown, G; Omelchenko, MV; Borozan, I; Carmel, L; Wolf, YI; Mori, H; Savchenko, AV; Arrowsmith, CH; Koonin, EV; Edwards, AM; Yakunin, AF				Kuznetsova, Ekaterina; Proudfoot, Michael; Gonzales, Claudio F.; Brown, Greg; Omelchenko, Marina V.; Borozan, Ivan; Carmel, Liran; Wolf, Yuri I.; Mori, Hirotada; Savchenko, Alexei V.; Arrowsmith, Cheryl H.; Koonin, Eugene V.; Edwards, Aled M.; Yakunin, Alexander F.			Genome-wide analysis of substrate specificities of the Escherichia coli haloacid dehalogenase-like phosphatase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL ENZYMATIC SCREENS; CATALYTIC PROMISCUITY; CRYSTAL-STRUCTURE; NONENZYMATIC GLYCOSYLATION; L-2-HALOACID DEHALOGENASE; PHOSPHOSERINE PHOSPHATASE; BETA-PHOSPHOGLUCOMUTASE; ALKALINE-PHOSPHATASE; ACID DEHALOGENASE; MOLECULAR-CLONING	Haloacid dehalogenase (HAD)-like hydrolases are a vast superfamily of largely uncharacterized enzymes, with a few members shown to possess phosphatase, beta-phosphoglucomutase, phosphonatase, and dehalogenase activities. Using a representative set of 80 phosphorylated substrates, we characterized the substrate specificities of 23 soluble HADs encoded in the Escherichia coli genome. We identified small molecule phosphatase activity in 21 HADs and beta-phosphoglucomutase activity in one protein. The E. coli HAD phosphatases show high catalytic efficiency and affinity to a wide range of phosphorylated metabolites that are intermediates of various metabolic reactions. Rather than following the classical "one enzyme-one substrate" model, most of the E. coli HADs show remarkably broad and overlapping substrate spectra. At least 12 reactions catalyzed by HADs currently have no EC numbers assigned in Enzyme Nomenclature. Surprisingly, most HADs hydrolyzed small phosphodonors ( acetyl phosphate, carbamoyl phosphate, and phosphoramidate), which also serve as substrates for autophosphorylation of the receiver domains of the two-component signal transduction systems. The physiological relevance of the phosphatase activity with the preferred substrate was validated in vivo for one of the HADs, YniC. Many of the secondary activities of HADs might have no immediate physiological function but could comprise a reservoir for evolution of novel phosphatases.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L6, Canada; Ontario Canc Inst, Ontario Ctr Struct Proteom, Toronto, ON M5G 2C4, Canada; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L6, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Nara Institute of Science & Technology; University of Toronto; Structural Genomics Consortium	Edwards, AM (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St,Rm 024, Toronto, ON M5G 1L6, Canada.	aled.edwards@utoronto.ca; a.iakounine@utoronto.ca	Yakunin, Alexander/J-1519-2014; Carmel, Liran/A-9681-2008; Mori, Hirotada/B-4934-2011	Wolf, Yuri/0000-0002-0247-8708; Edwards, Aled/0000-0002-4782-6016; Arrowsmith, Cheryl/0000-0002-4971-3250; Borozan, Ivan/0000-0002-3145-3550; Yakunin, Alexander/0000-0003-0813-6490	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062414] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62414-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi J., 1992, COMPUTER SCI MONOGRA, V27, P1; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; AMEYAMA M, 1981, J BACTERIOL, V145, P814, DOI 10.1128/JB.145.2.814-823.1981; Anantharaman V, 2003, CURR OPIN CHEM BIOL, V7, P12, DOI 10.1016/S1367-5931(02)00018-2; Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; BABUL J, 1983, ARCH BIOCHEM BIOPHYS, V225, P944, DOI 10.1016/0003-9861(83)90109-1; Bartlett GJ, 2003, J MOL BIOL, V331, P829, DOI 10.1016/S0022-2836(03)00734-4; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BHATTACHARYA M, 1995, ANAL BIOCHEM, V232, P98, DOI 10.1006/abio.1995.9954; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bornscheuer UT, 2004, ANGEW CHEM INT EDIT, V43, P6032, DOI 10.1002/anie.200460416; Buchholz A, 2002, BIOMOL ENG, V19, P5, DOI 10.1016/S1389-0344(02)00003-5; Buchholz A, 2001, ANAL BIOCHEM, V295, P129, DOI 10.1006/abio.2001.5183; BUSCHMEIER B, 1985, FEMS MICROBIOL LETT, V29, P231, DOI 10.1111/j.1574-6968.1985.tb00868.x; Charbit A, 1996, J BIOL CHEM, V271, P9997, DOI 10.1074/jbc.271.17.9997; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Chou TF, 2005, J BIOL CHEM, V280, P15356, DOI 10.1074/jbc.M500434200; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DESILVA AO, 1979, J BIOL CHEM, V254, P237; DIETZ GW, 1971, J BIOL CHEM, V246, P2881; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; FONDA ML, 1992, J BIOL CHEM, V267, P15978; Fortpied J, 2006, J BIOL CHEM, V281, P18378, DOI 10.1074/jbc.M513208200; FROMAN BE, 1989, MOL GEN GENET, V217, P126, DOI 10.1007/BF00330951; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hisano T, 1996, J BIOL CHEM, V271, P20322, DOI 10.1074/jbc.271.34.20322; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IWASAKI I, 1956, B CHEM SOC JPN, V29, P860, DOI 10.1246/bcsj.29.860; James LC, 2001, PROTEIN SCI, V10, P2600, DOI 10.1110/ps.ps.14601; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Kim YC, 2004, J BIOL CHEM, V279, P517, DOI 10.1074/jbc.M306054200; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; KURIHARA T, 1995, J BIOCHEM, V117, P1317, DOI 10.1093/oxfordjournals.jbchem.a124861; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; LINN ECC, 1996, ESCHERICHIA COLI SAL, P307; LIPMANN F, 1950, BIOCHIM BIOPHYS ACTA, V4, P301, DOI 10.1016/0006-3002(50)90036-9; LOWRY OH, 1971, J BIOL CHEM, V246, P6511; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; LUMENG L, 1975, J BIOL CHEM, V250, P8126; Lynch M, 2000, GENETICS, V154, P459; Macchiarulo A, 2004, NAT BIOTECHNOL, V22, P1039, DOI 10.1038/nbt999; Massingham T, 2001, BIOESSAYS, V23, P873, DOI 10.1002/bies.1128; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Mironova R, 2005, MOL MICROBIOL, V55, P1801, DOI 10.1111/j.1365-2958.2005.04504.x; Mironova R, 2001, MOL MICROBIOL, V39, P1061, DOI 10.1046/j.1365-2958.2001.02304.x; Morais MC, 2000, BIOCHEMISTRY-US, V39, P10385, DOI 10.1021/bi001171j; Nobeli I, 2003, J MOL BIOL, V334, P697, DOI 10.1016/j.jmb.2003.10.008; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Pellicer MT, 2003, J BACTERIOL, V185, P5815, DOI 10.1128/JB.185.19.5815-5821.2003; PETSKO GA, 1993, TRENDS BIOCHEM SCI, V18, P372, DOI 10.1016/0968-0004(93)90091-Z; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; PRADEL E, 1988, J BACTERIOL, V170, P4916, DOI 10.1128/jb.170.10.4916-4923.1988; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Ridder IS, 1997, J BIOL CHEM, V272, P33015, DOI 10.1074/jbc.272.52.33015; RIMMELE M, 1994, J BACTERIOL, V176, P5654, DOI 10.1128/JB.176.18.5654-5664.1994; Roberts A, 2005, PROTEINS, V58, P790, DOI 10.1002/prot.20267; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Silversmith RE, 1997, BIOCHEMISTRY-US, V36, P14965, DOI 10.1021/bi9715573; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; THOMPSON J, 1987, FEMS MICROBIOL LETT, V46, P221, DOI 10.1111/j.1574-6968.1987.tb02462.x; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200; Zhang GF, 2005, BIOCHEMISTRY-US, V44, P9404, DOI 10.1021/bi050558p; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	80	206	246	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36149	36161		10.1074/jbc.M605449200	http://dx.doi.org/10.1074/jbc.M605449200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16990279	hybrid			2022-12-27	WOS:000242100500065
J	Mbonye, UR; Wada, M; Rieke, CJ; Tang, HY; DeWitt, DL; Smith, WL				Mbonye, Uri R.; Wada, Masayuki; Rieke, Caroline J.; Tang, Hui-Yuan; DeWitt, David L.; Smith, William L.			The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE H SYNTHASES-1; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; SIGNALING PATHWAYS; GENE-EXPRESSION; ER DEGRADATION; UP-REGULATION; PROTEASOME; INHIBITION; GLYCANS	Cyclooxygenase ( COX) isoforms catalyze the committed step in prostaglandin biosynthesis. The primary structures of COX-1 and COX-2 are very similar except that COX-2 has a 19-amino acid (19-AA) segment of unknown function located just inside its C terminus. Here we provide evidence that the major role of the 19-AA cassette is to mediate entry of COX-2 into the ER-associated degradation system that transports ER proteins to the cytoplasm. COX-1 is constitutively expressed in many cells, whereas COX-2 is usually expressed inducibly and transiently. In murine NIH/3T3 fibroblasts, we find that COX-2 protein is degraded with a half-life (t(1/2)) of about 2 h, whereas COX-1 is reasonably stable (t(1/2) > 12 h); COX-2 degradation is retarded by 26 S proteasome inhibitors. Similarly, COX-1 expressed heterologously in HEK293 cells is quite stable (t(1/2) > 24 h), whereas COX-2 expressed heterologously is degraded with a t(1/2) of similar to 5 h, and its degradation is slowed by proteasome inhibitors. A deletion mutant of COX-2 was prepared lacking 18 residues of the 19-AA cassette. This mutant retains native COX-2 activity but, unlike native COX-2, is stable in HEK293 cells. Conversely, inserting the COX-2 19-AA cassette near the C terminus of COX-1 yields a mutant ins594-612 COX-1 that is unstable (t(1/2) similar to 3 h). Mutation of Asn-594,an N-glycosylation site at the beginning of the 19-AA cassette, stabilizes both COX-2 and ins594-612 COX-1; nonetheless, COX mutants that are glycosylated at Asn-594 but lack the remainder of the 19-amino acid cassette (i.e. del597-612 COX-2 and ins594-596 COX-1) are stable. Thus, although glycosylation of Asn-594 is necessary for COX-2 degradation, at least part of the remainder of the 19-AA insert is also required. Finally, kifunensine, a mannosidase inhibitor that can block entry of ER proteins into the	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	University of Michigan System; University of Michigan; Michigan State University	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5416 Med Sci Bldg 1,1301 E Catherine St, Ann Arbor, MI 48109 USA.	smithww@umich.edu	Mbonye, Uri/AAG-8861-2020	Mbonye, Uri/0000-0002-7694-0803	NIGMS NIH HHS [GM68848] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asano K, 1996, AM J PHYSIOL-LUNG C, V271, pL126, DOI 10.1152/ajplung.1996.271.1.L126; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; DEWITT DL, 1993, ARCH BIOCHEM BIOPHYS, V306, P94, DOI 10.1006/abbi.1993.1485; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; EVETT GE, 1993, ARCH BIOCHEM BIOPHYS, V306, P169, DOI 10.1006/abbi.1993.1496; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Figueiredo-Pereira ME, 2002, J BIOL CHEM, V277, P25283, DOI 10.1074/jbc.M109145200; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Harris RC, 2001, AM J PHYSIOL-RENAL, V281, pF1, DOI 10.1152/ajprenal.2001.281.1.F1; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; HERSCHMAN HR, 1993, J LIPID MEDIATOR, V6, P89; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Honda T, 2006, J EXP MED, V203, P325, DOI 10.1084/jem.20051310; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Kitzmuller C, 2003, BIOCHEM J, V376, P687, DOI 10.1042/BJ20030887; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MIRAFZALI Z, 2006, J BIOL CHEM; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Murray BP, 2001, ARCH BIOCHEM BIOPHYS, V393, P106, DOI 10.1006/abbi.2001.2482; Narumiya S, 2001, J CLIN INVEST, V108, P25, DOI 10.1172/JCI200113455; Nemeth JF, 2001, BIOCHEMISTRY-US, V40, P3109, DOI 10.1021/bi002313c; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; OTTO JC, 1993, J BIOL CHEM, V268, P18234; OTTO JC, 1994, J BIOL CHEM, V269, P19868; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Ristimaki A, 1997, CANCER RES, V57, P1276; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Rockwell P, 2000, ARCH BIOCHEM BIOPHYS, V374, P325, DOI 10.1006/abbi.1999.1646; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; SMITH WL, 1987, HDB EICOSANOIDS PROS, P175; Song I, 1996, ARCH BIOCHEM BIOPHYS, V334, P67, DOI 10.1006/abbi.1996.0430; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsuda H, 2006, THROMB RES, V117, P323, DOI 10.1016/j.thromres.2005.02.017; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Wada M, 2004, J BIOCHEM, V135, P455, DOI 10.1093/jb/mvh059; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Xiao GS, 1998, J BIOL CHEM, V273, P6801, DOI 10.1074/jbc.273.12.6801; Yoshida Y, 2003, J BIOCHEM, V134, P183, DOI 10.1093/jb/mvg128; YUAN C, 2006, P NATL ACAD SCI US	61	84	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35770	35778		10.1074/jbc.M608281200	http://dx.doi.org/10.1074/jbc.M608281200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17001073	hybrid			2022-12-27	WOS:000242100500023
J	Misra, S; Toole, BP; Ghatak, S				Misra, Suniti; Toole, Bryan P.; Ghatak, Shibnath			Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD44 CLEAVAGE; TUMOR-CELLS; CANCER-THERAPY; MIGRATION; GROWTH; EXPRESSION; ERBB2; INFLAMMATION; INVASION; TARGETS	Hyaluronan (HA) is enriched in the pericellular matrices of many malignant human tumors, and manipulations of HA interactions have strong effects on tumor progression in animal models. Increased HA production stimulates ERBB2 activation, leading to increased cell survival activities and several malignant cell properties. On the other hand, inhibition of constitutive HA-tumor cell interactions in malignant cells inhibits these properties. We have now investigated the role of HA in activation of several additional receptor tyrosine kinases (RTKs), i.e. IGF1R-beta, PDGFR-beta, EGFR and c-MET, in colon, prostate, and breast carcinoma cells. In each case we show that antagonists of endogenous HA interactions inhibit their tyrosine phosphorylation, i.e. activation. On the other hand, we show that these RTKs are activated in phenotypically normal or relatively benign tumor cells by experimentally increasing HA production. We also investigated the role of HA in constitutive versus ligand-induced activation of RTKs. In HCA7 colon and C4-2 prostate carcinoma cells, ERBB2 is constitutively activated in a ligand-independent manner, whereas IGF1R-beta and PDGFR-beta require ligand interaction for activation. We show that both constitutive activation of ERBB2 and ligand-mediated activation of IGF1R-beta and PDGFR-beta are reversed by co-treatment of the cells with a HA antagonist. We conclude that HA serves a general function in RTK activation.	Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA	Medical University of South Carolina	Misra, S (corresponding author), Med Univ S Carolina, Dept Cell Biol & Anat, 171 Ashley Ave, Charleston, SC 29425 USA.	misra@musc.edu; ghatak@musc.edu			NATIONAL CANCER INSTITUTE [R01CA073839, R01CA082867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698, P20RR016434] Funding Source: NIH RePORTER; NCI NIH HHS [CA082867, CA073839] Funding Source: Medline; NCRR NIH HHS [P20 RR017698, P20 RR016434] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adamia Sophia, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P3, DOI 10.2174/1568006053005056; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Enegd B, 2002, NEUROSURGERY, V50, P1311, DOI 10.1097/00006123-200206000-00023; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lesley J, 2000, J BIOL CHEM, V275, P26967; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Mummert ME, 2005, IMMUNOL RES, V31, P189, DOI 10.1385/IR:31:3:189; Murai T, 2004, J BIOL CHEM, V279, P4541, DOI 10.1074/jbc.M307356200; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Simpson MA, 2006, AM J PATHOL, V169, P247, DOI 10.2353/ajpath.2006.060032; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tsatas D, 2002, J CLIN NEUROSCI, V9, P282, DOI 10.1054/jocn.2001.1063; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wobus M, 2002, APPL IMMUNOHISTO M M, V10, P34, DOI 10.1097/00022744-200203000-00006; Yasuda M, 2002, HISTOL HISTOPATHOL, V17, P945, DOI 10.14670/HH-17.945	32	147	152	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34936	34941		10.1074/jbc.C600138200	http://dx.doi.org/10.1074/jbc.C600138200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16959784	hybrid			2022-12-27	WOS:000241933700026
J	Playford, MP; Lyons, PD; Sastry, SK; Schaller, MD				Playford, Martin P.; Lyons, Patrick D.; Sastry, Sarita K.; Schaller, Michael D.			Identification of a filamin docking site on PTP-PEST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; KINASE P50(CSK); CLEAVAGE FURROW; TARGETS FILAMIN; CELL-DIVISION; SH3 DOMAIN; ASSOCIATION; ACTIN; CYTOKINESIS; SUBSTRATE	PTP-PEST is a cytoplasmic protein-tyrosine phosphatase (PTP) implicated in the regulation of biological processes such as cell motility, cytokinesis, focal adhesion disassembly, and lymphocyte activation. Using a proteomics approach, filamin-A was identified as a novel interacting protein that bound to GST-PTP-PEST. This interaction was confirmed in vitro and in cells by coimmunoprecipitation. The site of filamin interaction on PTP-PEST was mapped to the fourth proline-rich region (Pro4). PTP-PEST has previously been implicated in the regulation of cytokinesis. In further support of this finding, expression of PTP-PEST in HeLa cells resulted in the formation of multinucleated cells. A PTP-PEST mutant lacking Pro4 and unable to bind filamin-A failed to induce the multinucleated phenotype. Further, depletion of filamin-A in HeLa cells was found to reduce the PTP-PEST-dependent multinucleation phenotype. Hence, we conclude that the interaction of PTP-PEST with filamin-A may function in the control of cytokinesis in mammalian cells.	Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA; Univ Texas, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Medical Branch Galveston	Schaller, MD (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, CB 7090,534 Taylor Hall, Chapel Hill, NC 27599 USA.	crispy4@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022; , UNC Flow Cytometry Core/AGU-9839-2022; Sastry, Sarita/A-1291-2013		NCI NIH HHS [CA90901] Funding Source: Medline; NHLBI NIH HHS [HL45100] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; Charest A, 1997, ONCOGENE, V14, P1643, DOI 10.1038/sj.onc.1201008; Cheng J, 1996, BLOOD, V88, P1156, DOI 10.1182/blood.V88.4.1156.bloodjournal8841156; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Field HI, 2002, PROTEOMICS, V2, P36, DOI 10.1002/1615-9861(200201)2:1<36::AID-PROT36>3.0.CO;2-W; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujikawa K, 2002, P NATL ACAD SCI USA, V99, P4313, DOI 10.1073/pnas.052715699; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HABIB T, 1994, J BIOL CHEM, V269, P25243; Haskell MD, 2001, J CELL SCI, V114, P1699; Kim YW, 1996, ONCOGENE, V13, P2275; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; Medley QG, 2003, J BIOL CHEM, V278, P13265, DOI 10.1074/jbc.M300277200; Moasser MM, 1999, CANCER RES, V59, P6145; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; NUNNALLY MH, 1980, J CELL BIOL, V87, P219, DOI 10.1083/jcb.87.1.219; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sastry SK, 2002, J CELL SCI, V115, P4305, DOI 10.1242/jcs.00105; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; Shen Y, 2000, J BIOL CHEM, V275, P1405, DOI 10.1074/jbc.275.2.1405; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; Su L, 2003, J CELL BIOL, V163, P571, DOI 10.1083/jcb.200308007; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037	47	16	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34104	34112		10.1074/jbc.M606277200	http://dx.doi.org/10.1074/jbc.M606277200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973606	hybrid, Green Published			2022-12-27	WOS:000241767600031
J	Brunk, I; Blex, C; Rachakonda, S; Holtje, M; Winter, S; Pahner, I; Walther, DJ; Ahnert-Hilger, G				Brunk, Irene; Blex, Christian; Rachakonda, Sivaramakrishna; Hoeltje, Markus; Winter, Sandra; Pahner, Ingrid; Walther, Diego J.; Ahnert-Hilger, Gudrun			The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLES; DOPAMINE NEURONS; CELLS; EXPRESSION; KNOCKOUT; RELEASE; IDENTIFICATION; ACETYLCHOLINE; SEROTONIN; GRANULE	The activity of vesicular monoamine transporters (VMATs) is down-regulated by the G-protein alpha-subunits of G(o2) and G(q), but the signaling pathways are not known. We show here that no such regulation is observed when VMAT1 or VMAT2 are expressed in Chinese hamster ovary (CHO) cells. However, when the intracellular compartments of VMAT-expressing CHO cells are preloaded with different monoamines, transport becomes susceptible to G-protein-dependent regulation, with differences between the two transporter isoforms. Epinephrine induces G-protein-mediated inhibition of transmitter uptake in CHOVMAT1 cells but prevents inhibition induced by dopamine in CHOVMAT2 cells. Epinephrine also antagonizes G-protein-mediated inhibition of monoamine uptake by VMAT2 expressing platelets or synaptic vesicles. In CHOVMAT2 cells G-protein-mediated inhibition of monoamine uptake can be induced by 5-hydroxytryptamine (serotonin) 1B receptor agonists, whereas alpha 1 receptor agonists modulate uptake into CHOVMAT1 cells. Accordingly, 5-hydroxytryptamine 1B receptor antagonists prevent G-protein-mediated inhibition of uptake in partially filled platelets and synaptic vesicles expressing VMAT2. CHO cells expressing VMAT mutants with a shortened first vesicular loop transport monoamines. However, no or a reduced G-protein regulation of uptake can be initiated. In conclusion, vesicular content is involved in the activation of vesicle associated G-proteins via a structure sensing the luminal monoamine content. The first luminal loop of VMATs may represent a G-protein-coupled receptor that adapts vesicular filling.	Charite, AG Funct Cell Biol, Ctr Anat, D-10115 Berlin, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Ahnert-Hilger, G (corresponding author), Charite, AG Funct Cell Biol, Ctr Anat, Philippstr 12, D-10115 Berlin, Germany.	gudrun.ahnert@charite.de		Brunk, Irene/0000-0002-2668-7002; Holtje, Markus/0000-0003-3193-4140; Rachakonda, Sivaramakrishna/0000-0002-2319-2821; Blex, Christian/0000-0002-8493-3523				Ahnert-Hilger G, 2000, HANDB EXP PHARM, V145, P557; Ahnert-Hilger G, 2004, REV PHYSIOL BIOCH P, V150, P140, DOI 10.1007/s10254-003-0020-2; Ahnert-Hilger G, 1998, EMBO J, V17, P406, DOI 10.1093/emboj/17.2.406; Brunk I, 2006, HANDB EXP PHARM, V175, P305; Croft BG, 2005, MOL BIOL CELL, V16, P306, DOI 10.1091/mbc.e04-07-0559; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Holtje M, 2003, J BIOL CHEM, V278, P15850, DOI 10.1074/jbc.M212816200; Holtje M, 2000, J NEUROSCI, V20, P2131; Hutchinson DS, 2002, BRIT J PHARMACOL, V135, P1903, DOI 10.1038/sj.bjp.0704654; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; NIRENBERG MJ, 1995, P NATL ACAD SCI USA, V92, P8773, DOI 10.1073/pnas.92.19.8773; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; Nurnberg B, 1996, FEBS LETT, V389, P61, DOI 10.1016/0014-5793(96)00584-4; Pahner I, 2002, EUR J CELL BIOL, V81, P449, DOI 10.1078/0171-9335-00269; PETER D, 1994, J BIOL CHEM, V269, P7231; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pothos EN, 2000, J NEUROSCI, V20, P7297; Pullarkat SR, 1998, J NEUROCHEM, V71, P1059; Scheel AA, 1998, J BIOL CHEM, V273, P2467, DOI 10.1074/jbc.273.4.2467; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; STRITTMATTER SM, 1991, J BIOL CHEM, V266, P22465; Travis ER, 2000, P NATL ACAD SCI USA, V97, P162, DOI 10.1073/pnas.97.1.162; Van der Kloot W, 2000, J PHYSIOL-LONDON, V523, P247, DOI 10.1111/j.1469-7793.2000.00247.x; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Winter S, 2005, J NEUROSCI, V25, P4672, DOI 10.1523/JNEUROSCI.0549-05.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101	37	53	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33373	33385		10.1074/jbc.M603204200	http://dx.doi.org/10.1074/jbc.M603204200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16926160	hybrid			2022-12-27	WOS:000241621400047
J	Hein, P; Rochais, F; Hoffmann, C; Dorsch, S; Nikolaev, VO; Engelhardt, S; Berlot, CH; Lohse, MJ; Bunemann, M				Hein, Peter; Rochais, Francesca; Hoffmann, Carsten; Dorsch, Sandra; Nikolaev, Viacheslav O.; Engelhardt, Stefan; Berlot, Catherine H.; Lohse, Martin J.; Buenemann, Moritz			G(S) activation is time-limiting in initiating receptor-mediated signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; LIVING CELLS; BETA(2)-ADRENERGIC RECEPTOR; SUBUNITS; DISSOCIATION; DYNAMICS; MYOCYTES; CHANNELS; BINDING; CAMP	To analyze individual steps of G(S)-linked signaling in intact cells, we used fluorescence resonance energy transfer (FRET)based assays for receptor-G protein interaction, G protein activation, and cAMP effector activation. To do so, we developed a FRET-based sensor to directly monitor G(S) activation in living cells. This was done by coexpressing a G alpha s mutant, in which a yellow fluorescent protein was inserted, together with cyan fluorescent protein-tagged G beta gamma subunits and appropriate receptors in HEK293 cells. Together with assays for receptor activation and receptor-G protein interaction, it is possible to characterize large parts of the G(S) signaling cascade. When A(2A)-adenosine or beta(1)-adrenergic receptors are coexpressed with G(S) in HEK293T cells, the receptor-G(S) interaction was on the same time scale as A(2A) receptor activation with a time constant of < 50 ms. G(S) activation was markedly slower and around 450 ms with similar kinetics following activation of A(2A)-or beta(1)-receptors. Taken together, our kinetic measurements demonstrate that the rate of G(S) activation limits initiation of G(S)-coupled receptor signaling.	Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; Univ Wurzburg, Rudolf Virchow Ctr, DFG, Res Ctr Expt Biomed, Wurzburg, Germany; Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	University of Wurzburg; German Research Foundation (DFG); University of Wurzburg	Bunemann, M (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	m-buenemann@toxi.uni-wuerzburg.de	Rochais, Francesca/ABF-4675-2021; Hein, Peter/A-7477-2008; Rochais, Francesca/A-5326-2017; Nikolaev, Vyacheslav/AAT-7746-2020; Engelhardt, Stefan/AAA-9329-2019; Lohse, Martin J/A-7160-2012	Rochais, Francesca/0000-0001-9355-8916; Hein, Peter/0000-0002-5899-3979; Rochais, Francesca/0000-0001-9355-8916; Engelhardt, Stefan/0000-0001-5378-8661; Lohse, Martin J/0000-0002-0599-3510				Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Bunemann M, 1997, J PHYSIOL-LONDON, V501, P549, DOI 10.1111/j.1469-7793.1997.549bm.x; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Mervine SM, 2006, MOL PHARMACOL, V70, P194, DOI 10.1124/mol.106.022616; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Ruiz-Velasco V, 2001, J PHYSIOL-LONDON, V537, P679; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	31	110	110	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33345	33351		10.1074/jbc.M606713200	http://dx.doi.org/10.1074/jbc.M606713200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16963443	hybrid			2022-12-27	WOS:000241621400044
J	Inoue, K; Mikuni-Takagaki, Y; Oikawa, K; Itoh, T; Inada, M; Noguchi, T; Park, JS; Onodera, T; Krane, SM; Noda, M; Itohara, S				Inoue, Keiichi; Mikuni-Takagaki, Yuko; Oikawa, Kaoru; Itoh, Takeshi; Inada, Masaki; Noguchi, Takanori; Park, Jin-Sung; Onodera, Takashi; Krane, Stephen M.; Noda, Masaki; Itohara, Shigeyoshi			A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASE-2; MULTICENTRIC OSTEOLYSIS; COLLAGENASE CLEAVAGE; IN-VIVO; MINERALIZATION; OSTEOBLASTS; SCLEROSTIN; ARTHRITIS; CARTILAGE; DENSITY	Extracellular matrix production and degradation by bone cells are critical steps in bone metabolism. Mutations of the gene encoding MMP-2, an extracellular matrix-degrading enzyme, are associated with a human genetic disorder characterized by subcutaneous nodules, arthropathy, and focal osteolysis. It is not known how the loss of MMP-2 function results in the pathology. Here, we show that Mmp2(-/-) mice exhibited opposing bone phenotypes caused by an impaired osteocytic canalicular network. Mmp2(-/-) mice showed decreased bone mineral density in the limb and trunk bones but increased bone volume in the calvariae. In the long bones, there was moderate disruption of the osteocytic networks and reduced bone density throughout life, whereas osteoblast and osteoclast function was normal. In contrast, aged but not young Mmp2(-/-) mice had calvarial sclerosis with osteocyte death. Severe disruption of the osteocytic networks preceded osteocyte loss in Mmp2(-/-) calvariae. Successful transplantation of wild-type periosteum restored the osteocytic canalicular networks in the Mmp2(-/-) calvariae, suggesting local roles of MMP-2 in determining bone phenotypes. Our results indicate that MMP-2 plays a crucial role in forming and maintaining the osteocytic canalicular network, and we propose that osteocytic network formation is a determinant of bone remodeling and mineralization.	Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Chiyoda Ku, Tokyo 1010062, Japan; RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; Tokyo Med & Dent Univ, Ctr Excellence Program Mol Destruct & Reconstruct, Chiyoda Ku, Tokyo 1010062, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Mol Immunol, Bunkyo Ku, Tokyo 1138657, Japan; Kanagawa Dent Coll, Dept Funct Biol, Div Biochem & Mol Biol, Kanagawa 2388580, Japan; Shionogi & Co Ltd, Discovery Res Labs, Osaka 5610825, Japan; Massachusetts Gen Hosp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA	Tokyo Medical & Dental University (TMDU); RIKEN; Tokyo Medical & Dental University (TMDU); University of Tokyo; Kanagawa Dental College; Shionogi & Company Limited; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Itohara, S (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.	sitohara@brain.riken.jp	inada, masaki/D-1581-2013; Park, Jin-Sung/F-9867-2011; Itohara, Shigeyoshi/I-8769-2012	inada, masaki/0000-0002-5066-8506; Itohara, Shigeyoshi/0000-0002-2410-9989; Inoue, Keiichi/0000-0002-7101-486X				AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Al Aqeel A, 2000, AM J MED GENET, V93, P11, DOI 10.1002/1096-8628(20000703)93:1<11::AID-AJMG3>3.0.CO;2-3; Al-Mayouf SM, 2000, AM J MED GENET, V93, P5, DOI 10.1002/1096-8628(20000703)93:1<5::AID-AJMG2>3.0.CO;2-Y; Al-Otaibi L, 2002, PEDIATR RADIOL, V32, P523, DOI 10.1007/s00247-001-0649-4; Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BILEZIKIAN J, 2002, PRINCIPLES BONE BIOL, P3; Breckon JJW, 1999, J BONE MINER RES, V14, P1880, DOI 10.1359/jbmr.1999.14.11.1880; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; BYERS PH, 1992, ANNU REV MED, V43, P269, DOI 10.1146/annurev.med.43.1.269; Collins JM, 2005, J BIOMECH, V38, P485, DOI 10.1016/j.jbiomech.2004.04.018; DOTY SB, 1981, CALCIFIED TISSUE INT, V33, P509, DOI 10.1007/BF02409482; Follet H, 2004, BONE, V34, P783, DOI 10.1016/j.bone.2003.12.012; Hatori K, 2004, ANAT REC PART A, V277A, P262, DOI 10.1002/ar.a.20007; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh T, 2002, J IMMUNOL, V169, P2643, DOI 10.4049/jimmunol.169.5.2643; Judex S, 2005, J CELL BIOCHEM, V94, P982, DOI 10.1002/jcb.20363; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; KUSUZAKI K, 1995, ACTA ORTHOP SCAND, V66, P166, DOI 10.3109/17453679508995514; Kusuzaki K, 2000, BONE, V27, P655, DOI 10.1016/S8756-3282(00)00383-5; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Marenzana M, 2005, BONE, V37, P545, DOI 10.1016/j.bone.2005.04.036; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Martin RB, 2000, BONE, V26, P71, DOI 10.1016/S8756-3282(99)00242-2; Metz LN, 2003, BONE, V33, P753, DOI 10.1016/S8756-3282(03)00245-X; Meunier PJ, 1997, BONE, V21, P373, DOI 10.1016/S8756-3282(97)00170-1; Mikuni-Takagaki Y, 1999, J BONE MINER METAB, V17, P57, DOI 10.1007/s007740050065; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamura H, 2004, BONE, V34, P48, DOI 10.1016/j.bone.2003.09.001; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Sasano Y, 2002, J HISTOCHEM CYTOCHEM, V50, P325, DOI 10.1177/002215540205000304; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Suzuki Y, 1998, J DENT RES, V77, P1799, DOI 10.1177/00220345980770100701; TEZUKA K, 1994, J BIOL CHEM, V269, P15006; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Vu TH, 2001, NAT GENET, V28, P202, DOI 10.1038/90023; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Zhu SL, 1997, BIOCHEM J, V323, P637, DOI 10.1042/bj3230637	50	144	150	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33814	33824		10.1074/jbc.M607290200	http://dx.doi.org/10.1074/jbc.M607290200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959767	hybrid			2022-12-27	WOS:000241621400087
J	Toczylowski, T; Yan, H				Toczylowski, Thomas; Yan, Hong			Mechanistic analysis of a DNA end processing pathway mediated by the Xenopus Werner syndrome protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; EGG EXTRACTS; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; TELOMERE MAINTENANCE; EXONUCLEASE ACTIVITY; NUCLEASE ACTIVITY; HUMAN-CELLS; REPAIR	The first step of homology-dependent repair of DNA double-strand breaks is the strand-specific processing of DNA ends to generate 3' single-strand tails. Despite its importance, the molecular mechanism underlying end processing is poorly understood in eukaryotic cells. We have taken a biochemical approach to investigate DNA end processing in nucleoplasmic extracts derived from the unfertilized eggs of Xenopus laevis. We found that double-strand DNA ends are specifically degraded in the 5' -> 3' direction in this system. The reaction consists of two steps: an ATP-dependent unwinding of double-strand ends and an ATP-independent 5' -> 3' degradation of single-strand tails. We also found that the Xenopus Werner syndrome protein, a member of the RecQ helicase family, plays an important role in DNA end processing. Mechanistically, Xenopus Werner syndrome protein (xWRN) is required for the unwinding of DNA ends but not for the degradation of single-strand tails. The xWRN-mediated end processing is remarkably similar to the end processing that has been proposed for the Escherichia coli RecQ helicase and RecJ single-strand nuclease, suggesting that this mechanism might be conserved in prokaryotes and eukaryotes.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Yan, H (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Hong_Yan@fccc.edu			NIGMS NIH HHS [R01 GM57962] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057962] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Carroll D, 1996, PROG NUCLEIC ACID RE, V54, P101, DOI 10.1016/S0079-6603(08)60361-X; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ferguson DO, 1996, P NATL ACAD SCI USA, V93, P5419, DOI 10.1073/pnas.93.11.5419; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Ivancic-Bace I, 2003, GENETICS, V163, P485; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Labhart P, 1999, MOL CELL BIOL, V19, P2585; Lan L, 2005, J CELL SCI, V118, P4153, DOI 10.1242/jcs.02544; Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; MARYON E, 1989, MOL CELL BIOL, V9, P4862, DOI 10.1128/MCB.9.11.4862; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreau S, 2001, GENETICS, V159, P1423; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; NEWMEYER DD, 1991, METHOD CELL BIOL, V36, P607; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; SCHELLENBERG GD, 1998, GENETIC BASIS HUMAN, P347; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; THODE S, 1990, CELL, V60, P921, DOI 10.1016/0092-8674(90)90340-K; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Yan H, 2005, J CELL BIOL, V171, P217, DOI 10.1083/jcb.200502077; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; YAN H, 1995, SCIENCE, V269, P1883, DOI 10.1126/science.7569932	43	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33198	33205		10.1074/jbc.M605044200	http://dx.doi.org/10.1074/jbc.M605044200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959775	hybrid			2022-12-27	WOS:000241621400028
J	Brot, N; Collet, JF; Johnson, LC; Jonsoon, TJ; Weissbach, H; Lowther, WT				Brot, Nathan; Collet, Jean-Francois; Johnson, Lynnette C.; Joensoon, Thomas J.; Weissbach, Herbert; Lowther, W. Todd			The thioredoxin domain of Neisseria gonorrhoeae PiIB can use electrons from DsbD to reduce downstream methionine sulfoxide reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; THIOL-DISULFIDE EXCHANGE; X-RAY-STRUCTURE; ESCHERICHIA-COLI; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; KINETIC CHARACTERIZATION; SUBSTRATE-SPECIFICITY; BOND FORMATION	The PilB protein from Neisseria gonorrhoeae is located in the periplasm and made up of three domains. The N-terminal, thi-oredoxin-like domain (NT domain) is fused to tandem methionine sulfoxide reductase A and B domains (MsrA/B). We show that the alpha domain of Escherichia coli DsbD is able to reduce the oxidized NT domain, which suggests that DsbD in Neisseria can transfer electrons from the cytoplasmic thioredoxin to the periplasm for the reduction of the MsrA/B domains. An analysis of the available complete genomes provides further evidence for this proposition in other bacteria where DsbD/CcdA, Trx, MsrA, and MsrB gene homologs are all located in a gene cluster with a common transcriptional direction. An examination of wild-type PilB and a panel of Cys to Ser mutants of the full-length protein and the individually expressed domains have also shown that the NT domain more efficiently reduces the MsrA/B domains when in the polyprotein context. Within this framework there does not appear to be a preference for the NT domain to reduce the proximal MsrA domain over MsrB domain. Finally, we report the 1.6 angstrom crystal structure of the NT domain. This structure confirms the presence of a surface loop that makes it different from other membrane-tethered, Trx-like molecules, including TlpA, CcmG, and ResA. Subtle differences are observed in this loop when compared with the Neisseria meningitidis NT domain structure. The data taken together supports the formation of specific NT domain interactions with the MsrA/B domains and its in vivo recycling partner, DsbD.	Wake Forest Univ, Sch Med, Dept Biochem, Ctr Struct Biol, Winston Salem, NC 27157 USA; Cornell Univ, Hosp Special Surg, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; Christian Duve Inst Cellular Pathol, B-1200 Brussels, Belgium; Univ Catholique Louvain, BCHM, GRM Unit, B-1200 Brussels, Belgium; Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, Boca Raton, FL 33431 USA	Wake Forest University; Cornell University; Universite Catholique Louvain; State University System of Florida; Florida Atlantic University	Lowther, WT (corresponding author), Wake Forest Univ, Sch Med, Dept Biochem, Ctr Struct Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu	Collet, Jean Francois/F-2105-2010	Collet, Jean-Francois/0000-0001-8069-7036				Ahuja U, 2006, FEBS LETT, V580, P216, DOI 10.1016/j.febslet.2005.12.006; Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2001, PROTEIN SCI, V10, P2272, DOI 10.1110/ps.10701; BROT N, 1982, ANAL BIOCHEM, V122, P291, DOI 10.1016/0003-2697(82)90283-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capitani G, 2001, J MOL BIOL, V311, P1037, DOI 10.1006/jmbi.2001.4913; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Gassner NC, 1999, ACTA CRYSTALLOGR D, V55, P1967, DOI 10.1107/S0907444999013347; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Katzen F, 2002, METHOD ENZYMOL, V348, P54, DOI 10.1016/S0076-6879(02)48626-0; Kauffmann B, 2005, BBA-PROTEINS PROTEOM, V1703, P249, DOI 10.1016/j.bbapap.2004.09.008; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; Krupp R, 2001, J BIOL CHEM, V276, P3696, DOI 10.1074/jbc.M009500200; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; RAHMAN MA, 1992, CELL MOL BIOL, V38, P529; Ranaivoson FM, 2006, J MOL BIOL, V358, P443, DOI 10.1016/j.jmb.2006.02.025; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Sanders C, 2005, J BACTERIOL, V187, P4245, DOI 10.1128/JB.187.12.4245-4256.2005; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wu JZ, 2005, J BIOL CHEM, V280, P12344, DOI 10.1074/jbc.M500385200	44	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32668	32675		10.1074/jbc.M604971200	http://dx.doi.org/10.1074/jbc.M604971200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16926157	hybrid			2022-12-27	WOS:000241414500065
J	Davis-Kaplan, SR; Compton, MA; Flannery, AR; Ward, DM; Kaplan, J; Stevens, TH; Graham, LA				Davis-Kaplan, Sandra R.; Compton, Mark A.; Flannery, Andrew R.; Ward, Diane M.; Kaplan, Jerry; Stevens, Tom H.; Graham, Laurie A.			PKR1 encodes an assembly factor for the yeast V-type ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; ENDOPLASMIC-RETICULUM; GENE ENCODES; MEMBRANE; TRANSPORT; SUBUNIT; MUTANTS; MUTATIONS; HOMOLOG	Deletion of the yeast gene PKR1 (YMR123W) results in an inability to grow on iron-limited medium. Pkr1p is localized to the membrane of the endoplasmic reticulum. Cells lacking Pkr1p show reduced levels of the V-ATPase subunit Vph1p due to increased turnover of the protein in mutant cells. Reduced levels of the V-ATPase lead to defective copper loading of Fet3p, a component of the high affinity iron transport system. Levels of Vph1p in cells lacking Pkr1p are similar to cells unable to assemble a functional V-ATPase due to lack of a V-0 subunit or an endoplasmic reticulum (ER) assembly factor. However, unlike yeast mutants lacking a V-0 subunit or a V-ATPase assembly factor, low levels of Vph1p present in cells lacking Pkr1p are assembled into a V-ATPase complex, which exits the ER and is present on the vacuolar membrane. The V-ATPase assembled in the absence of Pkr1p is fully functional because the mutant cells are able to weakly acidify their vacuoles. Finally, overexpression of the V-ATPase assembly factor Vma21p suppresses the growth and acidification defects of pkr1 Delta cells. Our data indicate that Pkr1p functions together with the other V-ATPase assembly factors in the ER to efficiently assemble the V-ATPase membrane sector.	Univ Utah, Sch Med, Div Cell Biol & Immunol, Dept Pathol, Salt Lake City, UT 84132 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	Utah System of Higher Education; University of Utah; University of Oregon	Kaplan, J (corresponding author), Univ Utah, Sch Med, Div Cell Biol & Immunol, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu; stevens@molbio.uoregon.edu		Stevens, Tom/0000-0001-6427-6848	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, R37DK030534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038006] Funding Source: NIH RePORTER; NCI NIH HHS [CA43014] Funding Source: Medline; NIDDK NIH HHS [DK30534] Funding Source: Medline; NIGMS NIH HHS [GM38006] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Compton MA, 2006, J BIOL CHEM, V281, P15312, DOI 10.1074/jbc.M600890200; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Flannery AR, 2004, J BIOL CHEM, V279, P39856, DOI 10.1074/jbc.M406767200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; HILL KJ, 1995, J BIOL CHEM, V270, P22329, DOI 10.1074/jbc.270.38.22329; HILL KJ, 1994, MOL BIOL CELL, V5, P1039, DOI 10.1091/mbc.5.9.1039; HIRATA R, 1993, J BIOL CHEM, V268, P961; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Oluwatosin YE, 1998, MOL CELL BIOL, V18, P1534, DOI 10.1128/MCB.18.3.1534; Oluwatosin YE, 1997, J BIOL CHEM, V272, P28149, DOI 10.1074/jbc.272.44.28149; Perzov N, 2002, J EXP BIOL, V205, P1209; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Sambade M, 2004, J BIOL CHEM, V279, P17361, DOI 10.1074/jbc.M314104200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Van Ho A, 2002, ANNU REV MICROBIOL, V56, P237, DOI 10.1146/annurev.micro.56.012302.160847; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	34	29	31	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					32025	32035		10.1074/jbc.M606451200	http://dx.doi.org/10.1074/jbc.M606451200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16926153	Bronze			2022-12-27	WOS:000241235300088
J	Deng, WB; Neve, RL; Rosenberg, PA; Volpe, JJ; Jensen, FE				Deng, Wenbin; Neve, Rachael L.; Rosenberg, Paul A.; Volpe, Joseph J.; Jensen, Frances E.			alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit composition and cAMP-response element-binding protein regulate oligodendrocyte excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-MATTER INJURY; GLUTAMATE RECEPTORS; NMDA RECEPTORS; MEDIATE EXCITOTOXICITY; KAINATE RECEPTORS; NERVOUS-SYSTEM; AMPA RECEPTORS; EXPRESSION; TOXICITY; CHANNELS	Developing oligodendrocytes (OLs) are highly vulnerable to glutamate excitotoxicity. Although OL excitotoxicity is mainly mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate ( AMPA) receptors (AMPARs) and is Ca2+-dependent, the molecular basis for AMPAR-mediated Ca2+ influx in OLs remains largely unclear. Ca2+ permeability of AMPARs is inversely correlated with the abundance of the AMPAR subunit glutamate receptor 2 (GluR2). Here we report that GluR2-containing and GluR2-lacking AMPARs are co-expressed in individual OLs and that a subset of AMPARs on each OL are Ca2+ permeable and mediate OL excitotoxicity. Virus-mediated overexpression of GluR2 reduces OL excitotoxicity, whereas expression of its unedited form GluR2(Q) enhances the excitotoxicity. These findings indicate that GluR2 critically controls OL excitotoxicity. During OL excitotoxicity, the transcriptional factor cAMP-response element-binding protein (CREB) is transiently phosphorylated and subsequently down-regulated. Virus-mediated expression of a constitutively active form of CREB, both in cultured OLs in vitro and in developing cerebral white matter in vivo, up-regulates GluR2, inhibits Ca2+ permeability, and protects OLs from excitotoxicity. Overall, these data suggest that targeting GluR2-lacking AMPARs or CREB may be a useful strategy for treating nervous system disorders associated with OL excitotoxicity.	Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Program Neurosci, Boston, MA 02115 USA; McLean Hosp, Dept Psychiat, Boston, MA 02478 USA; McLean Hosp, Program Neurosci, Boston, MA 02478 USA; Harvard Univ, Sch Med, Boston, MA 02478 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Jensen, FE (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	frances.jensen@tch.harvard.edu		Rosenberg, Paul/0000-0002-5185-1118	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038475, R01NS031718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG00222] Funding Source: Medline; NICHD NIH HHS [P30 HD18655] Funding Source: Medline; NINDS NIH HHS [P01 NS38475, R01 NS31718] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberdi E, 2002, NEUROBIOL DIS, V9, P234, DOI 10.1006/nbdi.2001.0457; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Deng WB, 2004, P NATL ACAD SCI USA, V101, P7751, DOI 10.1073/pnas.0307850101; Deng WB, 2003, P NATL ACAD SCI USA, V100, P6801, DOI 10.1073/pnas.1136624100; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Follett PL, 2000, J NEUROSCI, V20, P9235; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Liu YQ, 2002, PEDIATR RES, V51, P25, DOI 10.1203/00006450-200201000-00007; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Pende M, 1997, J NEUROSCI, V17, P1291; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sanchez RM, 2001, J NEUROSCI, V21, P8154, DOI 10.1523/JNEUROSCI.21-20-08154.2001; Sanchez-Gomez MV, 1999, NEUROBIOL DIS, V6, P475, DOI 10.1006/nbdi.1999.0264; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Volpe JJ, 2001, NEUROLOGY NEWBORN, V4th, P217; Washburn MS, 1997, J NEUROSCI, V17, P9393; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yoshioka A, 1996, J NEUROSCI RES, V46, P427; YOSHIOKA A, 1995, J NEUROCHEM, V64, P2442	36	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36004	36011		10.1074/jbc.M606459200	http://dx.doi.org/10.1074/jbc.M606459200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16990276	hybrid			2022-12-27	WOS:000242100500048
J	Nicolas, E; Lee, MG; Hakimi, MA; Cam, HP; Grewal, SIS; Shiekhattar, R				Nicolas, Estelle; Lee, Min Gyu; Hakimi, Mohamed-Ali; Cam, Hugh P.; Grewal, Shiv I. S.; Shiekhattar, Ramin			Fission yeast homologs of human histone H3 lysine 4 demethylase regulate a common set of genes with diverse functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLATION; ANDROGEN-RECEPTOR; SWIRM DOMAIN; COMPLEX; COMPONENT; FAMILY; LSD1; COREST; TRANSCRIPTION; REPRESSION	Schizosaccharomyces pombe contains two proteins, SWIRM1 and SWIRM2, with close homology to human histone H3 lysine 4 demethylase. Both proteins contain the amino oxidase catalytic domain and a recently described DNA interaction SWIRM domain. Here we describe the biochemical isolation and the functional characterization of SWIRM1 and SWIRM2. Our results indicate that while SWIRM2 is an essential gene, cells lacking SWIRM1 are viable. We found that SWIRM1 and SWIRM2 are stably associated in a multiprotein complex, but intriguingly, unlike their human counterpart, S. pombe SWIRM complex contains neither a histone deacetylase nor any detectable demethylase activity. Genome-wide chromatin immunoprecipitation unexpectedly showed the absence of both SWIRM proteins from heterochromatic domains. Instead, consistent with biochemical analyses, SWIRM1 and SWIRM2 co-localize to a common set of target gene promoters whose functions are implicated in diverse processes including mitochondrial metabolism and transcriptional regulation. Importantly, we show that SWIRM1 is not only required for optimum transcription of its target genes but also display a global role in regulation of antisense transcription.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); The Wistar Institute	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov; shiekhattar@wistar.org	HAKIMI, Mohamed-Ali/F-9806-2014; HAKIMI, Mohamed-ali/GYJ-0879-2022; Nicolas, Estelle/C-4425-2008; HAKIMI, Mohamed-ali/Q-6475-2019	HAKIMI, Mohamed-Ali/0000-0002-2547-8233; Nicolas, Estelle/0000-0003-0412-8477; HAKIMI, Mohamed-ali/0000-0002-2547-8233	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061204] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM61204] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Eimer S, 2002, EMBO J, V21, P5787, DOI 10.1093/emboj/cdf561; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Iwase S, 2004, BIOCHEM BIOPH RES CO, V322, P601, DOI 10.1016/j.bbrc.2004.07.163; Iyer L. M, 2002, GENOME BIOL, V3; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakayama J, 2003, EMBO J, V22, P2776, DOI 10.1093/emboj/cdg248; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tochio N, 2006, STRUCTURE, V14, P457, DOI 10.1016/j.str.2005.12.004; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454	33	21	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35983	35988		10.1074/jbc.M606349200	http://dx.doi.org/10.1074/jbc.M606349200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16990277	hybrid			2022-12-27	WOS:000242100500045
J	Sottocornola, B; Visconti, S; Orsi, S; Gazzarrini, S; Giacometti, S; Olivari, C; Camoni, L; Aducci, P; Marra, M; Abenavoli, A; Thiel, G; Moroni, A				Sottocornola, Barbara; Visconti, Sabina; Orsi, Sara; Gazzarrini, Sabrina; Giacometti, Sonia; Olivari, Claudio; Camoni, Lorenzo; Aducci, Patrizia; Marra, Mauro; Abenavoli, Alessandra; Thiel, Gerhard; Moroni, Anna			The potassium channel KAT1 is activated by plant and animal 14-3-3 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							14-3-3 PROTEINS; K+ CHANNEL; FUNCTIONAL EXPRESSION; ARABIDOPSIS; VOLTAGE; MODULATION; MUTATIONS; CELLS	14-3-3 proteins modulate the plant inward rectifier K+ channel KAT1 heterologously expressed in Xenopus oocytes. Injection of recombinant plant 14-3-3 proteins into oocytes shifted the activation curve of KAT1 by + 11 mV and increased the tau on. KAT1 was also modulated by 14-3-3 proteins of Xenopus oocytes. Titration of the endogenous 14-3-3 proteins by injection of the peptide Raf 621p resulted in a strong decrease in KAT1 current (similar to 70% at -150 mV). The mutation K56E performed on plant protein 14-3-3 in a highly conserved recognition site prevented channel activation. Because the maximal conductance of KAT1 was unaffected by 14-3-3, we can exclude that they act by increasing the number of channels, thus ruling out any effect of these proteins on channel trafficking and/or insertion into the oocyte membrane. 14-3-3 proteins also increased KAT1 current in inside-out patches, suggesting a direct interaction with the channel. Direct interaction was confirmed by overlay experiments with radioactive 14-3-3 on oocyte membranes expressing KAT1.	Univ Milan, Dipartimento Biol, I-20133 Milan, Italy; Univ Milan, Ist Biofis, CNR, I-20133 Milan, Italy; Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany; Unita Univ Milan, Ist Nazl Fis Mat, I-20133 Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Rome Tor Vergata; Technical University of Darmstadt; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Milan	Moroni, A (corresponding author), Univ Milan, Dipartimento Biol, Via Celoria 26, I-20133 Milan, Italy.	anna.moroni@unimi.it	moroni, anna/H-2097-2014; Camoni, Lorenzo/C-2584-2012; Olivari, Claudio/D-7768-2017	moroni, anna/0000-0002-1860-406X; Olivari, Claudio/0000-0002-7209-1496; Thiel, Gerhard/0000-0002-2335-1351; gazzarrini, sabrina/0000-0003-3062-7536				Aducci P, 2002, IUBMB LIFE, V53, P49, DOI 10.1080/15216540210813; ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Baizabal-Aguirre VM, 1999, J MEMBRANE BIOL, V167, P119, DOI 10.1007/s002329900476; Booij PP, 1999, PLANT J, V20, P673, DOI 10.1046/j.1365-313X.1999.00643.x; Bruggemann L, 1999, P NATL ACAD SCI USA, V96, P3298, DOI 10.1073/pnas.96.6.3298; Bruggemann L, 1999, PLANTA, V207, P370, DOI 10.1007/s004250050494; Chan HC, 2000, BIOCHEM BIOPH RES CO, V270, P581, DOI 10.1006/bbrc.2000.2454; Cherel I, 2004, J EXP BOT, V55, P337, DOI 10.1093/jxb/erh028; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; Dreyer I, 1997, BIOPHYS J, V72, P2143, DOI 10.1016/S0006-3495(97)78857-X; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fullone MR, 1998, J BIOL CHEM, V273, P7698, DOI 10.1074/jbc.273.13.7698; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Marra M, 2000, PLANT BIOLOGY, V2, P11, DOI 10.1055/s-2000-9458; MARRE MT, 1989, PLANT SCI, V62, P21, DOI 10.1016/0168-9452(89)90184-2; Moroni A, 1998, J MEMBRANE BIOL, V163, P25, DOI 10.1007/s002329900367; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Saalbach G, 1997, FEBS LETT, V413, P294, DOI 10.1016/S0014-5793(97)00865-X; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Szyroki A, 2001, P NATL ACAD SCI USA, V98, P2917, DOI 10.1073/pnas.051616698; Tang HX, 1996, PLANT CELL, V8, P1545, DOI 10.1105/tpc.8.9.1545; Tang XD, 1999, BIOPHYS J, V76, P3089, DOI 10.1016/S0006-3495(99)77461-8; Thiel G, 1997, TRENDS PLANT SCI, V2, P339, DOI 10.1016/S1360-1385(97)84621-3; THIEL G, 1992, J MEMBRANE BIOL, V126, P1; van den Wijngaard PWJ, 2005, PLANT J, V41, P43, DOI 10.1111/j.1365-313X.2004.02273.x; van den Wijngaard PWJ, 2001, FEBS LETT, V488, P100, DOI 10.1016/S0014-5793(00)02394-2; VERY AA, 1995, PLANT J, V7, P321, DOI 10.1046/j.1365-313X.1995.7020321.x; Visconti S, 2003, J BIOL CHEM, V278, P8172, DOI 10.1074/jbc.M211039200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zei PC, 1998, J GEN PHYSIOL, V112, P679, DOI 10.1085/jgp.112.6.679; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; [No title captured]	40	53	60	5	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35735	35741		10.1074/jbc.M603361200	http://dx.doi.org/10.1074/jbc.M603361200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16990282	Green Published, hybrid			2022-12-27	WOS:000242100500018
J	Gastwirt, RF; Slavin, DA; McAndrew, CW; Donoghue, DJ				Gastwirt, Randy F.; Slavin, Daniela A.; McAndrew, Christopher W.; Donoghue, Daniel J.			Spy1 expression prevents normal cellular responses to DNA damage - Inhibition of apoptosis and checkpoint activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; S-PHASE CHECKPOINT; GENE-EXPRESSION; HISTONE H2AX; ATAXIA-TELANGIECTASIA; MAMMALIAN-CELLS; CYCLE REGULATOR; ATR; PHOSPHORYLATION; CHK1	Spy1 is the originally identified member of the Speedy/Ringo family of vertebrate cell cycle regulators, which can control cell proliferation and survival through the atypical activation of cyclin-dependent kinases. Here we report a role for Spy1 in apoptosis and checkpoint activation in response to UV irradiation. Using an inducible system allowing for regulated expression of Spy1, we show that Spy1 expression prevents activation of caspase-3 and suppresses apoptosis in response to UV irradiation. Spy1 expression also allows for UV irradiation-resistant DNA synthesis and permits cells to progress into mitosis, as demonstrated by phosphorylation on histone H3, indicating that Spy1 expression can inhibit the S-phase/replication and G(2)/M checkpoints. We demonstrate that Spy1 expression inhibits phosphorylation of Chk1, RPA, and histone H2A. X, which may directly contribute to the decrease in apoptosis and checkpoint bypass. Furthermore, mutation of the conserved Speedy/Ringo box, known to mediate interaction with CDK2, abrogates the ability of Spy1 to inhibit apoptosis and the phosphorylation of Chk1 and RPA. The data presented indicate that Spy1 expression allows cells to evade checkpoints and apoptosis and suggest that Spy1 regulation of CDK2 is important for the response to DNA damage.	Univ Calif San Diego, Dept Chem & Biochem, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Program, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Donoghue, DJ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Moores Univ Calif San Diego Canc Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ddonoghue@ucsd.edu			NCI NIH HHS [T32 CA009523] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Barnes EA, 2003, CANCER RES, V63, P3701; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Cheng A, 2005, CELL CYCLE, V4, P155, DOI 10.4161/cc.4.1.1347; Cheng Aiyang, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-19; Dinarina A, 2005, BIOCHEM J, V386, P349, DOI 10.1042/BJ20041779; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Garg R, 2004, MOL CANCER RES, V2, P362; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Liu JS, 2006, DNA REPAIR, V5, P369, DOI 10.1016/j.dnarep.2005.11.007; Liu QH, 2000, GENE DEV, V14, P1448; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Porter LA, 2003, MOL BIOL CELL, V14, P3664, DOI 10.1091/mbc.E02-12-0820; Porter LA, 2002, J CELL BIOL, V157, P357, DOI 10.1083/jcb.200109045; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schneider E, 1998, ONCOGENE, V17, P2733, DOI 10.1038/sj.onc.1202504; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Taylor William R, 2004, Methods Mol Biol, V281, P293; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang JL, 2002, CELL CYCLE, V1, P267, DOI 10.4161/cc.1.4.137; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu YH, 2004, CELL CYCLE, V3, P1358, DOI 10.4161/cc.3.11.1226; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	56	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35425	35435		10.1074/jbc.M604720200	http://dx.doi.org/10.1074/jbc.M604720200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16951407	hybrid			2022-12-27	WOS:000241933700076
J	Eren, E; Kennedy, DC; Maroney, MJ; Arguello, JM				Eren, Elif; Kennedy, David C.; Maroney, Michael J.; Arguello, Jose M.			A novel regulatory metal binding domain is present in the C terminus of Arabidopsis Zn2+-ATPase HMA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; WILSONS-DISEASE PROTEIN; FULGIDUS CU+-ATPASE; COPPER-TRANSPORTING ATPASE; CIRCULAR-DICHROISM SPECTRA; MENKES-DISEASE; PLASMA-MEMBRANE; SECONDARY STRUCTURE; CATALYTIC ACTIVITY; ESCHERICHIA-COLI	HMA2 is a Zn2+-ATPase from Arabidopsis thaliana. It contributes to the maintenance of metal homeostasis in cells by driving Zn2+ efflux. Distinct from P-1B-type ATPases, plant Zn2+-ATPases have long C-terminal sequences rich in Cys and His. Removal of the 244 amino acid C terminus of HMA2 leads to a 43% reduction in enzyme turnover without significant effect on the Zn2+ K-1/2 for enzyme activation. Characterization of the isolated HMA2 C terminus showed that this fragment binds three Zn2+ with high affinity (K-d = 16 +/- 3 nM). Circular dichroism spectral analysis indicated the presence of 8% alpha-helix, 45% beta-sheet, and 48% random coil in the C-terminal peptide with noticeable structural changes upon metal binding ( 8% alpha-helix, 39% beta-sheet, and 52% random coil). Zn K-edge XAS of Zn-CMBD in the presence of one equivalent of Zn2+ shows that the average zinc complex formed is composed of three His and one Cys residues. Upon the addition of two extra Zn2+ ions per C-MBD, these appear coordinated primarily by His residues thus, suggesting that the three Zn2+ binding domains might not be identical. Modification of His residues with diethyl pyrocarbonate completely inhibited Zn2+ binding to the C terminus, pointing out the importance of His residues in Zn2+ coordination. In contrast, alkylation of Cys with iodoacetic acid did not prevent Zn2+ binding to the HMA2C terminus. Zn K-edge XAS of the Cys-alkylated protein was consistent with (N/O())4 coordination of the zinc site, with three of those ligands fitting for His residues. In summary, plant Zn2+-ATPases contain novel metal binding domains in their cytoplasmic C terminus. Structurally distinct from the well characterized N-terminal metal binding domains present in most P-1B-type ATPases, they also appear to regulate enzyme turnover rate.	Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Amherst	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	; Arguello, Jose/D-1997-2012	Maroney, Michael/0000-0002-5598-3038; Eren, Elif/0000-0002-7942-4943; Arguello, Jose/0000-0003-3940-6297; Kennedy, David/0000-0002-5110-1886	NIGMS NIH HHS [R01-GM061696] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Bal N, 2001, FEBS LETT, V506, P249, DOI 10.1016/S0014-5793(01)02927-1; Banci L, 2002, J MOL BIOL, V323, P883, DOI 10.1016/S0022-2836(02)01007-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; Clark-Baldwin K, 1998, J AM CHEM SOC, V120, P8401, DOI 10.1021/ja980580o; Cornelius F, 2003, NEWS PHYSIOL SCI, V18, P119, DOI 10.1152/nips.01434.2003; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; Guo JQ, 1997, BIOCHEMISTRY-US, V36, P730, DOI 10.1021/bi9617769; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; Harrison MD, 1999, BBA-MOL BASIS DIS, V1453, P254, DOI 10.1016/S0925-4439(98)00110-0; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Jensen PY, 1999, BBA-PROTEIN STRUCT M, V1434, P103, DOI 10.1016/S0167-4838(99)00161-2; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larin D, 1999, J BIOL CHEM, V274, P28497, DOI 10.1074/jbc.274.40.28497; Liu JB, 2006, BIOCHEMISTRY-US, V45, P763, DOI 10.1021/bi051836n; Liu JB, 2005, BIOCHEMISTRY-US, V44, P5159, DOI 10.1021/bi0476275; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; Mandal AK, 2004, J BIOL CHEM, V279, P54802, DOI 10.1074/jbc.M410854200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mitra B, 2001, BIOCHEMISTRY-US, V40, P7694, DOI 10.1021/bi010576g; Padden KM, 2001, CHEM MATER, V13, P4305, DOI 10.1021/cm010502r; Pennella MA, 2006, J MOL BIOL, V356, P1124, DOI 10.1016/j.jmb.2005.12.019; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; Rimessi A, 2005, J BIOL CHEM, V280, P37195, DOI 10.1074/jbc.M504921200; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Walkup GK, 1997, J AM CHEM SOC, V119, P3443, DOI 10.1021/ja9642121; Wernimont AK, 2004, J BIOL CHEM, V279, P12269, DOI 10.1074/jbc.M311213200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008	64	51	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33881	33891		10.1074/jbc.M605218200	http://dx.doi.org/10.1074/jbc.M605218200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973620	hybrid			2022-12-27	WOS:000241767600009
J	Matsumura, Y; Ban, N; Ueda, K; Inagaki, N				Matsumura, Yoshihiro; Ban, Nobuhiro; Ueda, Kazumitsu; Inagaki, Nobuya			Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CONGENITAL ALVEOLAR PROTEINOSIS; INTERSTITIAL LUNG-DISEASE; PULMONARY SURFACTANT; II CELLS; STARGARDT-DISEASE; SP-C; MEMBRANE-PROTEIN; MESSENGER-RNAS; GENE-MUTATIONS	The ATP-binding cassette transporter ABCA3 is expressed predominantly at the limiting membrane of the lamellar bodies in lung alveolar type II cells. Recent study has shown that mutation of the ABCA3 gene causes fatal surfactant deficiency in newborns. In this study, we investigated in HEK293 cells the intracellular localization and N-glycosylation of the ABCA3 mutants so far identified in fatal surfactant deficiency patients. Green fluorescent protein-tagged L101P, L982P, L1553P, Q1591P, and Ins1518fs/ter1519 mutant proteins remained localized in the endoplasmic reticulum, and processing of oligosaccharide was impaired, whereas wild-type and N568D, G1221S, and L1580P mutant ABCA3 proteins trafficked to the LAMP3-positive intracellular vesicle, accompanied by processing of oligosaccharide from high mannose type to complex type. Vanadate-induced nucleotide trapping and ATP-binding analyses showed that ATP hydrolysis activity was dramatically decreased in the N568D, G1221S, and L1580P mutants, accompanied by a moderate decrease in ATP binding in N568D and L1580P mutants but not in the G1221S mutant, compared with the wild-type ABCA3 protein. In addition, mutational analyses of the Gly-1221 residue in the 11th transmembrane segment and the Leu-1580 residue in the cytoplasmic tail, and homology modeling of nucleotide binding domain 2 demonstrate the significance of these residues for ATP hydrolysis and suggest a mechanism for impaired ATP hydrolysis in G1221S and L1580P mutants. Thus, surfactant deficiency because of ABCA3 gene mutation may be classified into two categories as follows: abnormal intracellular localization (type I) and normal intracellular localization with decreased ATP binding and/or ATP hydrolysis of the ABCA3 protein (type II). These distinct pathophysiologies may reflect both the severity and effective therapy for surfactant deficiency.	Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Sakyo Ku, Kyoto 6068507, Japan; Japan Sci & Technol Program, CREST, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Agr, Lab Cellular Biochem, Div Appl Life Sci, Kyoto 6068502, Japan; Akita Univ, Sch Med, Dept Physiol, Akita 0108543, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Akita University	Inagaki, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Sakyo Ku, 54 Kawahara, Kyoto 6068507, Japan.	inagaki@metab.kuhp.kyoto-u.ac.jp		Matsumura, Yoshihiro/0000-0002-3108-0440; Inagaki, Nobuya/0000-0001-8261-2593; Ueda, Kazumitsu/0000-0003-2980-6078				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; BATENBURG JJ, 1989, BIOCHIM BIOPHYS ACTA, V1006, P329, DOI 10.1016/0005-2760(89)90020-9; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Beneke S, 2001, BBA-MOL CELL BIOL L, V1534, P56, DOI 10.1016/S1388-1981(01)00178-0; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; CHANDER A, 1990, AM J PHYSIOL, V258, P241; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; COLONNA M, 1992, P NATL ACAD SCI USA, V89, P3932, DOI 10.1073/pnas.89.9.3932; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DEMELLO DE, 1994, J PEDIATR-US, V125, P43, DOI 10.1016/S0022-3476(94)70119-9; des Georges Marie, 2004, J Cyst Fibros, V3, P265, DOI 10.1016/j.jcf.2004.04.008; DOBBS LG, 1994, AM J RESP CRIT CARE, V150, pS31, DOI 10.1164/ajrccm/150.5_Pt_2.S31; Dork T, 1997, HUM GENET, V100, P365, DOI 10.1007/s004390050518; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Fumagalli A, 2001, HUM GENET, V109, P326, DOI 10.1007/s004390100583; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HOROWITZ AD, 1993, BIOCHEMISTRY-US, V32, P9513, DOI 10.1021/bi00088a001; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; LILEY HG, 1989, J CLIN INVEST, V83, P1191, DOI 10.1172/JCI114000; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mason RJ, 1998, BBA-MOL BASIS DIS, V1408, P226, DOI 10.1016/S0925-4439(98)00070-2; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mulugeta S, 2002, J BIOL CHEM, V277, P22147, DOI 10.1074/jbc.M201812200; Nagata K, 2004, BIOCHEM BIOPH RES CO, V324, P262, DOI 10.1016/j.bbrc.2004.09.043; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; Prevelige P., 1989, PREDICTION PROTEIN S, P391; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Situ D, 2004, J BIOL CHEM, V279, P38871, DOI 10.1074/jbc.M403832200; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Vankeerberghen A, 1998, HUM MOL GENET, V7, P1761, DOI 10.1093/hmg/7.11.1761; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; Wang WJ, 2002, J BIOL CHEM, V277, P19929, DOI 10.1074/jbc.M201537200; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.physiol.53.1.395; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; Yoshida I, 2004, BIOCHEM BIOPH RES CO, V323, P547, DOI 10.1016/j.bbrc.2004.08.133; Zhang DW, 2003, BIOCHEMISTRY-US, V42, P9989, DOI 10.1021/bi034462b; ZIMMERMANN LJ, 1993, AM J PHYSIOL, V264, pL575, DOI 10.1152/ajplung.1993.264.6.L575	51	91	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34503	34514		10.1074/jbc.M600071200	http://dx.doi.org/10.1074/jbc.M600071200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16959783	hybrid			2022-12-27	WOS:000241767600071
J	Rocha-Viegas, L; Vicent, GP; Baranao, JL; Beato, M; Pecci, A				Rocha-Viegas, Luciana; Vicent, Guillermo P.; Baranao, Jose L.; Beato, Miguel; Pecci, Adali			Glucocorticoids repress bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; SIGNAL TRANSDUCER; PREVENT APOPTOSIS; T-LYMPHOCYTES; IN-VIVO; RECEPTOR; PROTEIN; ACTIVATION; GENE; DEXAMETHASONE	The bcl-X gene plays a critical role in apoptosis. Six different isoforms generated by tissue-specific promoter usage and alternative splicing were described. Some of them exert opposite effects on cell death. In mammary epithelial cells glucocorticoids induce bcl-X expression and increase the ratio bcl-XL (antiapoptotic)/bcl-XS (apoptotic) by activating P4 promoter, which contains two hormone response elements. Here we show that, on mouse thymocytes and T lymphocyte derivative S49 cells, glucocorticoids inhibited transcription from P4 and decreased the ratio bcl-X-L/bcl-X-S favoring apoptosis. Upon hormonal treatment, glucocorticoid receptor (GR), steroid receptor coactivator-1, and RNA polymerase II were transiently recruited to P4 promoter, whereas STAT5B was also recruited but remained bound. Concomitant with the release of GR, silencing mediator for retinoic acid receptor and thyroid hormone receptor and histone deacetylase 3 were recruited, histone H3 was deacetylated, and RNA polymerase II left the promoter. Inhibition of STAT5 activity reverted glucocorticoid repression to activation of transcription and was accompanied by stable recruitment of GR and RNA polymerase II toP4.	Univ Buenos Aires, IFIBYNE, Consejo Nacl Invest Cient & Tecn,Ciudad Univ, Fac Ciencias Exactas & Nat,Dept Fisiol Biol Mol &, Buenos Aires, DF, Argentina; Univ Buenos Aires, IFIBYNE, Consejo Nacl Invest Cient & Tecn,Ciudad Univ, Fac Ciencias Exactas & Nat,Dept Quim Biol, Buenos Aires, DF, Argentina; Univ Pompeu Fabra, Ctr Regulac Genom, Barcelona 08003, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Pecci, A (corresponding author), Univ Buenos Aires, IFIBYNE, Consejo Nacl Invest Cient & Tecn,Ciudad Univ, Fac Ciencias Exactas & Nat,Dept Fisiol Biol Mol &, Intendente Guiraldes 2160,Pab 2,2do Piso,C1428EGA, Buenos Aires, DF, Argentina.	apecci@qb.fcen.uba.ar	Vicent, Guillermo P./K-5432-2015; Beato, Miguel/B-5564-2015	Vicent, Guillermo P./0000-0002-0554-2226; Beato, Miguel/0000-0002-2878-2222; Rocha-Viegas, Luciana/0000-0001-7857-0212				Amsterdam A, 2002, BIOCHEM PHARMACOL, V64, P843, DOI 10.1016/S0006-2952(02)01147-4; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Ariyoshi K, 2000, J BIOL CHEM, V275, P24407, DOI 10.1074/jbc.M909771199; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Berg MN, 2002, ENDOCRINOLOGY, V143, P222, DOI 10.1210/en.143.1.222; Biola A, 2001, MOL ENDOCRINOL, V15, P1062, DOI 10.1210/me.15.7.1062; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bottenstein J, 1979, Methods Enzymol, V58, P94; Broome HE, 2002, LEUKEMIA RES, V26, P311, DOI 10.1016/S0145-2126(01)00118-7; CARONLESLIE LAM, 1994, FASEB J, V8, P639, DOI 10.1096/fasebj.8.9.8005391; *CCAC, 1980, GUID CAR US EXP AN; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Debierre-Grockiego F, 2003, BRIT J HAEMATOL, V123, P933, DOI 10.1046/j.1365-2141.2003.04700.x; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; Eberhardy SR, 2000, J BIOL CHEM, V275, P33798, DOI 10.1074/jbc.M005154200; FANG W, 1994, J IMMUNOL, V153, P4388; Floyd ZE, 2003, DIABETES, V52, P308, DOI 10.2337/diabetes.52.2.308; Gascoyne DM, 2003, J BIOL CHEM, V278, P18022, DOI 10.1074/jbc.M301812200; GEHRING U, 1982, MOL CELL ENDOCRINOL, V28, P605, DOI 10.1016/0303-7207(82)90149-6; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Guenther MG, 2000, GENE DEV, V14, P1048; Heermeier K, 1996, MECH DEVELOP, V56, P197, DOI 10.1016/0925-4773(96)88032-4; Hillier SG, 1998, J REPROD IMMUNOL, V39, P21, DOI 10.1016/S0165-0378(98)00011-4; Hoijman E, 2004, ENDOCRINOLOGY, V145, P418, DOI 10.1210/en.2003-0764; HYMAN R, 1973, J NATL CANCER I, V50, P415, DOI 10.1093/jnci/50.2.415; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; LOTEM J, 1995, CELL GROWTH DIFFER, V6, P647; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nakajima H, 2001, EMBO J, V20, P6836, DOI 10.1093/emboj/20.23.6836; Pecci A, 1997, J BIOL CHEM, V272, P11791, DOI 10.1074/jbc.272.18.11791; Pecci A, 2001, J BIOL CHEM, V276, P21062, DOI 10.1074/jbc.M008665200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Schmitt E, 2004, ONCOGENE, V23, P3915, DOI 10.1038/sj.onc.1207554; Schorr K, 2000, CANCER RES, V60, P5950; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Strutt H, 1999, METH MOL B, V119, P455; Tronche F, 2004, GENE DEV, V18, P492, DOI 10.1101/gad.284704; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Vicent GP, 2002, EXP CELL RES, V276, P142, DOI 10.1006/excr.2002.5532; Viegas LR, 2004, J BIOL CHEM, V279, P9831, DOI 10.1074/jbc.M312402200; Xue LY, 2003, ONCOGENE, V22, P9197, DOI 10.1038/sj.onc.1207019; Yamamoto M, 1998, HEPATOLOGY, V27, P959, DOI 10.1002/hep.510270410; Yang XF, 1997, IMMUNITY, V7, P629, DOI 10.1016/S1074-7613(00)80384-2; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	54	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33959	33970		10.1074/jbc.M602408200	http://dx.doi.org/10.1074/jbc.M602408200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16959781	hybrid, Green Published			2022-12-27	WOS:000241767600017
J	Sopory, S; Nelsen, SM; Degnin, C; Wong, C; Christian, JL				Sopory, Shailaja; Nelsen, Sylvia M.; Degnin, Catherine; Wong, Crispin; Christian, Jan L.			Regulation of bone morphogenetic protein-4 activity by sequence elements within the prodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPEMANN ORGANIZER; SIGNALING RANGE; PRO-DOMAINS; VG1 PROTEIN; XENOPUS; INDUCTION; MESODERM; GROWTH; MATURE; DISRUPTION	Bone morphogenetic protein-4 (BMP-4) is synthesized as a large precursor protein, which undergoes proprotein convertase-mediated proteolytic maturation along the secretory pathway to release the active ligand. Pro-BMP-4 is initially cleaved at a consensus furin motif adjacent to the mature ligand domain (the S1 site), and this allows for subsequent cleavage at an upstream motif (the S2 site). This sequential cleavage liberates a small, evolutionarily conserved, prodomain fragment (the linker peptide) of unknown fate and function. Here we show that the linker domain is essential for proper folding, exit from the endoplasmic reticulum, and thus cleavage of the BMP-4 precursor when overexpressed in Xenopus oocytes and embryos but not in cultured mammalian cells. Mature BMP-4 synthesized from a precursor in which the S1 site is non-cleavable, such that the linker domain remains covalently attached to the ligand, has little or no activity in vivo. Finally, analysis of folding, cleavage, and bioactivity of chimeric precursors containing the BMP-7 prodomain and BMP-4 mature domain, or vice versa, with or without the BMP-4 linker domain revealed that the linker domain is only functional in the context of the BMP-4 prodomain, and that differential cleavage around this domain can regulate the activity of a heterologous	Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Christian, JL (corresponding author), Oregon Hlth Sci Univ, Dept Cell & Dev Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	christia@ohsu.edu	Nelsen, Sylvia/AAD-6878-2022	Nelsen, Sylvia/0000-0002-3770-4728	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037976] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042598] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD037976, R01 HD042598] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cui YZ, 2001, GENE DEV, V15, P2797; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Eimon PM, 2002, DEVELOPMENT, V129, P3089; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; KESSLER DS, 1995, DEVELOPMENT, V121, P2155; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210598200; LOPEZ AR, 1992, MOL CELL BIOL, V12, P1674, DOI 10.1128/MCB.12.4.1674; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Moon R. T., 1989, TECHNIQUE, V1, P76; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Suzuki A, 1997, DEV BIOL, V189, P112, DOI 10.1006/dbio.1997.8652; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; THOMSEN GH, 1993, CELL, V74, P433, DOI 10.1016/0092-8674(93)80045-G; Todorovic V, 2005, INT J BIOCHEM CELL B, V37, P38, DOI 10.1016/j.biocel.2004.03.011; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	28	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34021	34031		10.1074/jbc.M605330200	http://dx.doi.org/10.1074/jbc.M605330200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966322	hybrid			2022-12-27	WOS:000241767600022
J	Castello, A; Alvarez, E; Carrasco, L				Castello, Alfredo; Alvarez, Enrique; Carrasco, Luis			Differential cleavage of eIF4GI and eIF4GII in mammalian cells - Effects on translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4G; POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; POLIOVIRUS INFECTION; HOST TRANSLATION; GENE-EXPRESSION; MESSENGER-RNA; IN-VITRO; P220 CLEAVAGE; 3C PROTEASE	Two isoforms of the translation initiation factor eIF4G, eIF4GI and eIF4GII, have been described in eukaryotic cells. The exact function of each isoform during the initiation of protein synthesis is still under investigation. We have developed an efficient and reliable method of expressing poliovirus 2Apro, which differentially proteolyzes eIF4GI and eIF4GII in a time-and dose-dependent manner. This system is based on the electroporation of an in vitro transcribed mRNA that contains the encephalomyocarditis virus internal ribosome entry site followed by the sequence of poliovirus 2Apro. In contrast to HeLa cells, expression of this protease in BHK-21 cells induces delayed hydrolysis kinetics of eIF4GI with respect to eIF4GII. Moreover, under these conditions the polyadenylate binding protein is not cleaved. Interestingly, translation of de novo synthesized luciferase mRNA is highly dependent on eIF4GI integrity, whereas ongoing translation is inhibited at the same time as eIF4GII cleavage. Moreover, reinitiation of a preexisting mRNA translation after polysome run-off is dependent on the integrity of eIF4GII. Notably, de novo translation of heat shock protein 70 mRNA depends little on eIF4GI integrity but is more susceptible to eIF4GII hydrolysis. Finally, translation of an mRNA containing encephalomyocarditis virus internal ribosome entry site when the two isoforms of eIF4G are differentially hydrolyzed has been examined.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Fac Ciencias, E-28049 Madrid, Spain; Univ Autonoma Madrid, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Carrasco, L (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Fac Ciencias, E-28049 Madrid, Spain.	lcarrasco@cbm.uam.es	Carrasco, Luis/H-3001-2017; Castello, Alfredo/U-6317-2018; Carrasco, Luis/E-2435-2012; Palomares, Alfredo Castello/K-8062-2019	Carrasco, Luis/0000-0003-3833-8835; Castello, Alfredo/0000-0002-1499-4662; Palomares, Alfredo Castello/0000-0002-1499-4662; Alvarez Vazquez, Enrique/0000-0002-4889-175X				Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Barco A, 2000, J VIROL, V74, P2383, DOI 10.1128/JVI.74.5.2383-2392.2000; BERGER A, 1970, PHILOS T R SOC B, V257, P249, DOI 10.1098/rstb.1970.0024; BONNEAU AM, 1987, J VIROL, V61, P986, DOI 10.1128/JVI.61.4.986-991.1987; BORMAN AM, 1995, NUCLEIC ACIDS RES, V23, P3656, DOI 10.1093/nar/23.18.3656; Caron S, 2004, MOL CELL BIOL, V24, P4920, DOI 10.1128/MCB.24.11.4920-4928.2004; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; HELLEN CUT, 1992, J VIROL, V66, P3330, DOI 10.1128/JVI.66.6.3330-3338.1992; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; IRURZUN A, 1995, J VIROL, V69, P7453, DOI 10.1128/JVI.69.12.7453-7460.1995; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Keiper BD, 1997, NUCLEIC ACIDS RES, V25, P395, DOI 10.1093/nar/25.2.395; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; MADER S, 1995, MOL CELL BIOL, V15, P4990; MAEDA Y, 1990, J MOL BIOL, V215, P321, DOI 10.1016/S0022-2836(05)80350-X; Marissen WE, 2000, CELL DEATH DIFFER, V7, P1234, DOI 10.1038/sj.cdd.4400750; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; Michel YM, 2001, MOL CELL BIOL, V21, P4097, DOI 10.1128/MCB.21.13.4097-4109.2001; Novoa I, 1999, MOL CELL BIOL, V19, P2445; PEREZ L, 1992, VIROLOGY, V189, P178, DOI 10.1016/0042-6822(92)90693-J; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Svitkin YV, 2001, RNA, V7, P1743; Svitkin YV, 1999, J VIROL, V73, P3467, DOI 10.1128/JVI.73.4.3467-3472.1999; Ventoso I, 1998, J BIOL CHEM, V273, P27960, DOI 10.1074/jbc.273.43.27960; Yueh A, 2000, GENE DEV, V14, P414	44	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33206	33216		10.1074/jbc.M604340200	http://dx.doi.org/10.1074/jbc.M604340200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959778	hybrid, Green Submitted			2022-12-27	WOS:000241621400029
J	Mulet, JM; Martin, DE; Loewith, R; Hall, MN				Mulet, Jose M.; Martin, Dietmar E.; Loewith, Robbie; Hall, Michael N.			Mutual antagonism of target of rapamycin and calcineurin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CELL-GROWTH; NUCLEAR-LOCALIZATION; YEAST; PATHWAY; TOR2; ORGANIZATION	Growth and stress are generally incompatible states. Stressed cells adapt to an insult by restraining growth, and conversely, growing cells keep stress responses at bay. This is evident in many physiological settings, including for example, the effect of stress on the immune or nervous system, but the underlying signaling mechanisms mediating such mutual antagonism are poorly understood. In eukaryotes, a central activator of cell growth is the protein kinase target of rapamycin (TOR) and its namesake signaling network. Calcineurin is a conserved, Ca2+/calmodulin-dependent protein phosphatase and target of the immunosuppressant FK506 (tacrolimus) that is activated in yeast during stress to promote cell survival. Here we show yeast mutants defective for TOR complex 2 (TORC2) or the essential homologous TORC2 effectors, SLM1 and SLM2, exhibited constitutive activation of calcineurin-dependent transcription and actin depolarization. Conversely, cells defective in calcineurin exhibited SLM1 hyperphosphorylation and enhanced interaction between TORC2 and SLM1. Furthermore, a mutant SLM1 protein (SLM1(Delta C14)) lacking a sequence related to the consensus calcineurin docking site (PxIxIT) was insensitive to calcineurin, and SLM1(Delta C14) slm2 mutant cells were hypersensitive to oxidative stress. Thus, TORC2-SLM signaling negatively regulates calcineurin, and calcineurin negatively regulates TORC2-SLM. These findings provide a molecular basis for the mutual antagonism of growth and stress.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	M.Hall@unibas.ch	Loewith, Robbie J/S-6289-2016; Mulet, Jose Miguel/B-9063-2016	Loewith, Robbie J/0000-0002-2482-603X; Mulet, Jose Miguel/0000-0002-9087-3838; Hall, Michael N/0000-0002-2998-0757				Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Halpain S, 1998, J NEUROSCI, V18, P9835; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Helliwell SB, 1998, GENETICS, V148, P99; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martin DE, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-148; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; Mizunuma M, 1998, NATURE, V392, P303, DOI 10.1038/32695; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shitamukai A, 2004, J BIOL CHEM, V279, P3651, DOI 10.1074/jbc.M306098200; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yokoyama H, 2006, EMBO REP, V7, P519, DOI 10.1038/sj.embor.7400647; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	34	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33000	33007		10.1074/jbc.M604244200	http://dx.doi.org/10.1074/jbc.M604244200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959779	hybrid, Green Accepted			2022-12-27	WOS:000241621400008
J	Peltoniemi, MJ; Karala, AR; Jurvansuu, JK; Kinnula, VL; Ruddock, LW				Peltoniemi, Mirva J.; Karala, Anna-Riikka; Jurvansuu, Jaana K.; Kinnula, Vuokko L.; Ruddock, Lloyd W.			Insights into deglutathionylation reactions - Different intermediates in the glutaredoxin and protein disulfide isomerase catalyzed reactions are defined by the gamma-linkage present in glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI GLUTAREDOXIN; NMR SOLUTION STRUCTURE; MIXED DISULFIDE; DEPENDENT SYNTHESIS; OXIDATIVE STRESS; PH-DEPENDENCE; REDOX STATE; THIOLTRANSFERASE; THIOREDOXIN; IDENTIFICATION	Glutaredoxins are small proteins with a conserved active site (-CXX(C/S)-) and thioredoxin fold. These thiol disulfide oxidoreductases catalyze disulfide reductions, preferring GSH-mixed disulfides as substrates. We have developed a new real-time fluorescence-based method for measuring the deglutathionylation activity of glutaredoxins using a glutathionylated peptide as a substrate. Mass spectrometric analysis showed that the only intermediate in the reaction is the glutaredoxin-GSH mixed disulfide. This specificity was solely dependent on the unusual gamma-linkage present in glutathione. The deglutathionylation activity of both wild-type Escherichia coli glutaredoxin and the C14S mutant was competitively inhibited by oxidized glutathione, with K-i values similar to the Km values for the glutathionylated peptide substrate, implying that glutaredoxin primarily recognizes the substrate via the glutathione moiety. In addition, wildtype glutaredoxin showed a sigmoidal dependence on GSH concentrations, the activity being significantly decreased at low GSH concentrations. Thus, under oxidative stress conditions, where the ratio of GSH/GSSG is decreased, the activity of glutaredoxin is dramatically reduced, and it will only have significant deglutathionylation activity once the oxidative stress has been removed. Different members of the protein disulfide isomerases (PDI) family showed lower activity levels when compared with glutaredoxins; however, their deglutathionylation activities were comparable with their oxidase activities. Furthermore, in contrast to the glutaredoxin-GSH mixed disulfide intermediate, the only intermediate in the PDI-catalyzed reaction was PDI peptide mixed disulfide.	Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Helsinki, Dept Med, Div Pulm Dis, FIN-00029 Helsinki, Finland; Helsinki Univ Hosp, FIN-00029 Helsinki, Finland; Biomed Helsinki, FIN-00029 Helsinki, Finland	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Ruddock, LW (corresponding author), Univ Oulu, Dept Biochem, POB 3000, FIN-90014 Oulu, Finland.	lloyd.ruddock@oulu.fi		Ruddock, Lloyd/0000-0002-6247-686X; Saaranen, Mirva/0000-0003-3399-9415				Alanen HI, 2006, ANTIOXID REDOX SIGN, V8, P283, DOI 10.1089/ars.2006.8.283; Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; APONTOWEIL P, 1975, BIOCHIM BIOPHYS ACTA, V399, P1, DOI 10.1016/0304-4165(75)90205-6; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; Bass R, 2004, J BIOL CHEM, V279, P5257, DOI 10.1074/jbc.M304951200; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Collinson EJ, 2003, J BIOL CHEM, V278, P22492, DOI 10.1074/jbc.M301387200; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; Foloppe N, 2001, J MOL BIOL, V310, P449, DOI 10.1006/jmbi.2001.4767; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Gvakharia BO, 1996, J BIOL CHEM, V271, P15307, DOI 10.1074/jbc.271.26.15307; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HOOG JO, 1983, EUR J BIOCHEM, V136, P223, DOI 10.1111/j.1432-1033.1983.tb07730.x; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jao SC, 2006, BIOCHEMISTRY-US, V45, P4785, DOI 10.1021/bi0516327; Lappi AK, 2004, J MOL BIOL, V335, P283, DOI 10.1016/j.jmb.2003.10.051; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Lundstrom-Ljung J, 1999, FEBS LETT, V443, P85, DOI 10.1016/S0014-5793(98)01698-6; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; RABENSTEIN DL, 1995, BBA-PROTEIN STRUCT M, V1249, P29, DOI 10.1016/0167-4838(95)00067-5; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; RUOPPOLO M, 1995, BIOCHEMISTRY-US, V34, P9380, DOI 10.1021/bi00029a014; Ruoppolo M, 1996, BIOCHEMISTRY-US, V35, P13636, DOI 10.1021/bi960755b; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Sun CH, 1998, J MOL BIOL, V280, P687, DOI 10.1006/jmbi.1998.1913; Takashima Y, 1999, IMMUNOL LETT, V68, P397, DOI 10.1016/S0165-2478(99)00087-5; XIA TH, 1992, PROTEIN SCI, V1, P310; Xiao RY, 2005, J BIOL CHEM, V280, P21099, DOI 10.1074/jbc.M411476200; YANG YF, 1991, J BIOL CHEM, V266, P12759; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504	46	79	83	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33107	33114		10.1074/jbc.M605602200	http://dx.doi.org/10.1074/jbc.M605602200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956877	hybrid			2022-12-27	WOS:000241621400019
J	De Taeye, BM; Novitskaya, T; Gleaves, L; Covington, JW; Vaughan, DE				De Taeye, Bart M.; Novitskaya, Tatiana; Gleaves, Linda; Covington, Joseph W.; Vaughan, Douglas E.			Bone marrow plasminogen activator inhibitor-1 influences the development of obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PLASMA PAI-1 LEVELS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; CELL-MIGRATION; TRANSGENIC MICE; IN-VIVO; CHOROIDAL NEOVASCULARIZATION; GENE-EXPRESSION; FAT	Plasma levels of plasminogen activator inhibitor-1 (PAI-1) are elevated in obesity and correlate with body mass index. The increase in PAI-1 associated with obesity likely contributes to increased cardiovascular risk and may predict the development of type 2 diabetes mellitus. Although adipocytes are capable of synthesizing PAI-1, the bulk of evidence indicates that cells residing in the stromal fraction of visceral fat are the primary source of PAI-1. We hypothesized that bone marrow-derived PAI-1, e. g. derived from macrophages located in visceral fat, contributes to the development of diet-induced obesity. To test this hypothesis, male C57BL/6 wild-type mice and C57BL/6 PAI-1 deficient mice were transplanted with either PAI-1(-/-), PAI-1 (+/-), or PAI-1 (+/+) bone marrow. The transplanted animals were subsequently fed a high fat diet for 24 weeks. Our findings show that only the complete absence of PAI-1 protects from the development of diet-induced obesity, whereas the absence of bone marrow-derived PAI-1 protects against expansion of the visceral fat mass. Remarkably, there is a link between the PAI-1 levels, the degree of inflammation in adipose tissue, and the development of obesity. Based on these findings we suggest that bone marrow-derived PAI-1 has an effect on the development of obesity through its effect on inflammation.	Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA	Vanderbilt University	Vaughan, DE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, 383 Preston Res Bldg,2220 Pierce Ave, Nashville, TN 37232 USA.	Douglas.e.vaughan@vanderbilt.edu			NHLBI NIH HHS [HL 65192, P50 HL 081089, HL 51387] Funding Source: Medline; NIDDK NIH HHS [U24 DK 59637] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065192, R01HL051387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bastelica D, 2002, ARTERIOSCL THROM VAS, V22, P173, DOI 10.1161/hq0102.101552; Chazaud B, 2002, AM J PATHOL, V160, P237, DOI 10.1016/S0002-9440(10)64367-2; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Crandall DL, 1999, J CLIN ENDOCR METAB, V84, P3222, DOI 10.1210/jc.84.9.3222; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Eren M, 2003, J THROMB HAEMOST, V1, P2389, DOI 10.1046/j.1538-7836.2003.00437.x; Eren M, 2002, CIRCULATION, V106, P491, DOI 10.1161/01.CIR.0000023186.60090.FB; Eriksson P, 1998, DIABETOLOGIA, V41, P65, DOI 10.1007/s001250050868; Estelles A, 2001, THROMB HAEMOSTASIS, V86, P647; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; He G, 2003, HORM METAB RES, V35, P178, DOI 10.1055/s-2003-39078; Isogai C, 2001, CANCER RES, V61, P5587; Kjoller L, 1997, EXP CELL RES, V232, P420, DOI 10.1006/excr.1997.3540; Lambert V, 2003, INVEST OPHTH VIS SCI, V44, P2791, DOI 10.1167/iovs.02-1179; Lambert V, 2001, FASEB J, V15, P1021, DOI 10.1096/fj.00-0393com; LAUG WE, 1989, THROMB HAEMOSTASIS, V61, P517; Lijnen HR, 2005, J THROMB HAEMOST, V3, P35, DOI 10.1111/j.1538-7836.2004.00827.x; Lijnen HR, 2003, ARTERIOSCL THROM VAS, V23, P78, DOI 10.1161/01.ATV.0000044457.60665.DD; Lijnen HR, 2005, THROMB HAEMOSTASIS, V93, P816, DOI 10.1160/TH05-01-0043; Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; Loskutoff DJ, 2000, ANN NY ACAD SCI, V902, P272; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Mavri A, 1999, ARTERIOSCL THROM VAS, V19, P1582, DOI 10.1161/01.ATV.19.6.1582; Mavri A, 2001, DIABETOLOGIA, V44, P2025, DOI 10.1007/s001250100007; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Morange PE, 2000, ARTERIOSCL THROM VAS, V20, P1150, DOI 10.1161/01.ATV.20.4.1150; Otero M, 2006, DRUG NEWS PERSPECT, V19, P21, DOI 10.1358/dnp.2006.19.1.966243; Palmieri D, 2002, J BIOL CHEM, V277, P40950, DOI 10.1074/jbc.M202333200; PRIMROSE JN, 1992, THROMB HAEMOSTASIS, V68, P396; Samad F, 1999, P NATL ACAD SCI USA, V96, P6902, DOI 10.1073/pnas.96.12.6902; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Samad F, 1996, MOL MED, V2, P568, DOI 10.1007/BF03401641; Schafer K, 2001, FASEB J, V15, P1840, DOI 10.1096/fj.00-0750fje; Skurk T, 2001, HYPERTENSION, V37, P1336, DOI 10.1161/01.HYP.37.5.1336; SPRENGERS ED, 1985, J LAB CLIN MED, V105, P751; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Stefansson S, 2001, J BIOL CHEM, V276, P8135, DOI 10.1074/jbc.M007609200; Tanaka S, 2002, ARTERIOSCL THROM VAS, V22, P1573, DOI 10.1161/01.ATV.0000028002.60919.4D; Uzun H, 2004, OBES SURG, V14, P659, DOI 10.1381/096089204323093453; von Eyben FE, 2003, INT J OBESITY, V27, P941, DOI 10.1038/sj.ijo.0802309; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	49	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32796	32805		10.1074/jbc.M606214200	http://dx.doi.org/10.1074/jbc.M606214200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16931518	hybrid			2022-12-27	WOS:000241414500078
J	Schmitz, M; Becker, A; Schmitz, A; Weirich, C; Paulsson, M; Zaucke, F; Dinser, R				Schmitz, Markus; Becker, Alexander; Schmitz, Alexander; Weirich, Christian; Paulsson, Mats; Zaucke, Frank; Dinser, Robert			Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; CALCIUM-BINDING; IX COLLAGEN; CELL-TYPE; A-DOMAIN; MUTATION; COMP; TRAFFICKING; GROWTH; MATRILIN-3	Pseudoachondroplasia and multiple epiphyseal dysplasia are two dominantly inherited chondrodysplasias associated with mutations in cartilage oligomeric matrix protein ( COMP). The rarely available patient biopsies show lamellar inclusions in the endoplasmic reticulum. We studied the pathogenesis of these chondrodysplasias by expressing several disease-causing COMP mutations in bovine primary chondrocytes and found that COMP-associated chondrodysplasias are not exclusively storage diseases. Although COMP carrying the mutations D469 Delta and D475N was retained within the endoplasmic reticulum, secretion of COMP H587R was only slightly retarded. All pseudoachondroplasia mutations impair cellular viability and cause a disruption of the extracellular matrix formed in alginate culture irrespective of the degree of cellular retention. The mutation D361Y associated with the clinically milder disease multiple epiphyseal dysplasia gave mild retention and limited matrix alterations, but the transfected cells showed normal viability. The effect of mutated COMP on matrix formation and cell-matrix interaction may be a major element in the pathogenesis of COMP-associated chondrodysplasias.	Univ Hosp Saarland, Dept Internal Med 1, D-66421 Homburg, Germany; Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; Univ Cologne, Fac Med, Ctr Mol Med, D-50931 Cologne, Germany; Univ Giessen, Kerckhoff Hosp, Dept Internal Med & Rheumatol, D-61231 Bad Nauheim, Germany	Universitatsklinikum des Saarlandes; University of Cologne; University of Cologne; Justus Liebig University Giessen; Kerckhoff Clinic	Dinser, R (corresponding author), Univ Hosp Saarland, Dept Internal Med 1, D-66421 Homburg, Germany.	dinser@kerckhoff-klinik.de	Zaucke, Frank/E-2077-2012; Zaucke, Frank/AAT-2688-2021					Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; BREUR GJ, 1992, J BONE JOINT SURG AM, V74A, P516, DOI 10.2106/00004623-199274040-00007; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Cao L, 1999, MATRIX BIOL, V18, P343, DOI 10.1016/S0945-053X(99)00027-X; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; Chen TLL, 2004, MATRIX BIOL, V23, P433, DOI 10.1016/j.matbio.2004.09.005; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; Czarny-Ratajczak M, 2001, AM J HUM GENET, V69, P969, DOI 10.1086/324023; Deere M, 1998, AM J MED GENET, V80, P510, DOI 10.1002/(SICI)1096-8628(19981228)80:5<510::AID-AJMG14>3.0.CO;2-F; Delot E, 1998, J BIOL CHEM, V273, P26692, DOI 10.1074/jbc.273.41.26692; DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x; Dinser R, 2002, J CLIN INVEST, V110, P505, DOI 10.1172/JCI200214386; Dinser R, 2001, HISTOCHEM CELL BIOL, V116, P69; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; Hecht JT, 2005, MATRIX BIOL, V23, P525, DOI 10.1016/j.matbio.2004.09.006; Hecht JT, 2004, J ORTHOP RES, V22, P759, DOI 10.1016/j.orthres.2003.11.010; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.0.CO;2-G; Holden P, 2005, J BIOL CHEM, V280, P17172, DOI 10.1074/jbc.M411716200; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Hou J, 2000, CELL CALCIUM, V27, P309, DOI 10.1054/ceca.2000.0125; Klatt AR, 2001, J BIOL CHEM, V276, P17267, DOI 10.1074/jbc.M100587200; Kleerekoper Q, 2002, J BIOL CHEM, V277, P10581, DOI 10.1074/jbc.M109944200; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lo MY, 2004, J ORTHOPAED RES, V22, P140, DOI 10.1016/S0736-0266(03)00117-7; Loughlin J, 1998, HUM MUTAT, pS10; Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993; Maddox BK, 2000, J BIOL CHEM, V275, P11412, DOI 10.1074/jbc.275.15.11412; Otten C, 2005, J MED GENET, V42, P774, DOI 10.1136/jmg.2004.029462; Paassilta P, 1999, AM J HUM GENET, V64, P1036, DOI 10.1086/302328; Rimoin DL, 1998, AM J MED GENET, V79, P376; ROSENBERG K, 2001, THESIS LUND U LUND; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Spitznagel L, 2004, BIOCHEM J, V377, P479, DOI 10.1042/BJ20031179; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; STANESCU V, 1982, EUR J PEDIATR, V138, P221, DOI 10.1007/BF00441206; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; van Mourik JBA, 1998, AM J MED GENET, V77, P234, DOI 10.1002/(SICI)1096-8628(19980518)77:3<234::AID-AJMG9>3.0.CO;2-P; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Zaucke F, 2001, BIOCHEM J, V358, P17, DOI 10.1042/0264-6021:3580017	50	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32587	32595		10.1074/jbc.M601976200	http://dx.doi.org/10.1074/jbc.M601976200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16928687	hybrid			2022-12-27	WOS:000241414500056
J	Tanos, B; Pendergast, AM				Tanos, Barbara; Pendergast, Ann Marie			Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DOWN-REGULATION; EGF-RECEPTOR; C-CBL; FAMILY KINASES; BREAST-CANCER; DOMAIN; PHOSPHORYLATION; DEGRADATION; SRC; INTERNALIZATION	Signal attenuation from ligand-activated epidermal growth factor receptor ( EGFR) is mediated in part by receptor endocytosis and trafficking to the lysosomal degradative compartment. Uncoupling the activated EGFR from endocytosis and degradation has emerged as a mechanism for oncogenic activation of the EGFR. The Abl nonreceptor tyrosine kinase is activated by ligand-stimulated EGFR, but the role of Abl in EGFR signaling has not been defined. Here we uncovered a novel role for the activated Abl kinase in the regulation of EGFR endocytosis. We show that activated Abl impairs EGFR internalization. Moreover, we show that activated Abl phosphorylates the EGFR primarily on tyrosine 1173, and that mutation of this site to phenylalanine restores ligand-dependent endocytosis of the EGFR in the presence of activated Abl. Furthermore, we show that activated Abl allows the ligand-activated EGFR to escape Cbl-dependent down-regulation by inhibiting the accumulation of Cbl at the plasma membrane in response to epidermal growth factor stimulation and disrupting the formation of the EGFR center dot Cbl complex without affecting Cbl protein stability. These findings reveal a novel role for Abl in promoting increased cell-surface expression of the EGFR and suggest that Abl/EGFR signaling may cooperate in human tumors.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Pendergast, AM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	pende014@mc.duke.edu		Pendergast, Ann Marie/0000-0002-1250-6880; Tanos, Barbara/0000-0002-7045-9496	NCI NIH HHS [CA 70940] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070940] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andoniou CE, 1996, ONCOGENE, V12, P1981; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; BOWTELL DDL, 1995, ONCOGENE, V11, P1561; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; CHOI OR, 1986, MOL CELL BIOL, V6, P1751, DOI 10.1128/MCB.6.5.1751; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; de Melker AA, 2001, J CELL SCI, V114, P2167; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Heimberger AB, 2002, CLIN CANCER RES, V8, P3496; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Klapper LN, 2000, CANCER RES, V60, P3384; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Okamoto I, 2003, CANCER SCI, V94, P50, DOI 10.1111/j.1349-7006.2003.tb01351.x; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Prigent SA, 1996, J BIOL CHEM, V271, P25639, DOI 10.1074/jbc.271.41.25639; PRYWES R, 1986, EMBO J, V5, P2179, DOI 10.1002/j.1460-2075.1986.tb04482.x; Ravid T, 2002, J BIOL CHEM, V277, P31214, DOI 10.1074/jbc.M204677200; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schmidt MHH, 2003, P NATL ACAD SCI USA, V100, P6505, DOI 10.1073/pnas.1031790100; Simpson L, 2005, J UROLOGY, V173, P1883, DOI 10.1097/01.ju.0000158448.56888.09; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Zhang BY, 2005, ONCOGENE, V24, P2585, DOI 10.1038/sj.onc.1208453; ZHU GC, 1993, J BIOL CHEM, V268, P1775	51	74	81	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32714	32723		10.1074/jbc.M603126200	http://dx.doi.org/10.1074/jbc.M603126200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943190	hybrid			2022-12-27	WOS:000241414500070
J	Huang, HY; Kuei, Y; Chao, HY; Chen, SJ; Yeh, LS; Wang, CC				Huang, Hsiao-Yun; Kuei, Yu; Chao, Hen-Yi; Chen, Shun-Jia; Yeh, Lu-Shu; Wang, Chien-Chia			Cross-species and cross-compartmental aminoacylation of isoaccepting tRNAs by a class II tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE TRANSLATION PRODUCT; SACCHAROMYCES-CEREVISIAE; INITIATION CODON; GENE ENCODES; MITOCHONDRIAL; YEAST; AUG; PROTEIN; MECHANISM; SELECTION	It was previously shown that ALA1, the only alanyl-tRNA synthetase gene in Saccharomyces cerevisiae, codes for two functionally exclusive protein isoforms through alternative initiation at two consecutive ACG codons and an in-frame downstream AUG. We reported here the cloning and characterization of a homologous gene from Candida albicans. Functional assays show that this gene can substitute for both the cytoplasmic and mitochondrial functions of ALA1 in S. cerevisiae and codes for two distinct protein isoforms through alternative initiation from two in-frame AUG triplets 8-codons apart. Unexpectedly, although the short form acts exclusively in cytoplasm, the longer form provides function in both compartments. Similar observations are made in fractionation assays. Thus, the alanyl-tRNA synthetase gene of C. albicans has evolved an unusual pattern of translation initiation and protein partitioning and codes for protein isoforms that can aminoacylate isoaccepting tRNAs from a different species and from across cellular compartments.	Tzu Chi Univ, Dept Life Sci, Hualien 97041, Taiwan; Natl Cent Univ, Dept Life Sci, Jungli 32001, Taiwan	Tzu Chi University; National Central University	Yeh, LS (corresponding author), Tzu Chi Univ, Dept Life Sci, Hualien 97041, Taiwan.	susanyeh@mail.tcu.edu.tw; dukewang@cc.ncu.edu.tw		Chen, Shun-Jia/0000-0002-5489-4930				ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; DAUM G, 1982, J BIOL CHEM, V257, P3028; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; HANN SR, 1992, GENE DEV, V6, P1229, DOI 10.1101/gad.6.7.1229; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lovato MA, 2001, EMBO J, V20, P4846, DOI 10.1093/emboj/20.17.4846; MARECHALDROUARD L, 1993, ANN REV CELL BIOL, V8, P115; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, P887; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Pelchat M, 1999, BIOCHEM CELL BIOL, V77, P343, DOI 10.1139/bcb-77-4-343; RIPMASTER TL, 1995, P NATL ACAD SCI USA, V92, P4932, DOI 10.1073/pnas.92.11.4932; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; STEIN I, 1994, MOL CELL BIOL, V14, P4770, DOI 10.1128/MCB.14.7.4770; STEINMETZ A, 1986, METHOD ENZYMOL, V118, P212; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WOLFE CL, 1994, J BIOL CHEM, V269, P13361; WU M, 1987, J BIOL CHEM, V262, P12275	31	9	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31430	31439		10.1074/jbc.M601869200	http://dx.doi.org/10.1074/jbc.M601869200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16928688	Bronze			2022-12-27	WOS:000241235300027
J	Kauth, CW; Woehlbier, U; Kern, M; Mekonnen, Z; Lutz, R; Mucke, N; Langowski, J; Bujard, H				Kauth, Christian W.; Woehlbier, Ute; Kern, Michaela; Mekonnen, Zeleke; Lutz, Rolf; Muecke, Norbert; Langowski, Joerg; Bujard, Hermann			Interactions between merozoite surface proteins 1, 6, and 7 of the malaria parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEROZOITE SURFACE PROTEIN-1; VACCINE CANDIDATE; ESCHERICHIA-COLI; COMPLEX; ANTIBODIES; PURIFICATION; EXPRESSION; FRAGMENTS; PRECURSOR; INVASION	Merozoites of the malaria parasite Plasmodium falciparum expose at their surface a large multiprotein complex, composed of proteolytically processed, noncovalently associated products of at least three genes, msp-1, msp-6, and msp-7. During invasion of erythrocytes, this complex is shed from the surface except for a small glycosylphosphatidylinositol-anchored portion originating from MSP-1. The proteolytic cleavage separating the C-terminal portion of MSP-1 is required for successful invasion. Little is known about the structure and function of the abundant and essential multipartite complex. Using heterologously produced MSP-1, MSP-6, and MSP-7 in precursor and with the exception of MSP-7 in processed form, we have studied in vitro the complex formation between the different proteins to identify the interaction partners within the complex. Both MSP-6(36) and MSP-7 bind only to MSP-1 subunits that are shed, but although MSP-636 contacts just subunit p38, MSP-7 interacts with p83, p30, and p38. The intact C-terminal region of MSP-6 is required for the association with p38 as well as for its multimerization into tetramers. Furthermore, our data suggest that only the processed form and not the precursor form of MSP-1 interacts with MSP-636. MSP-6-as well as MSP-7-specific rabbit antibodies inhibit parasite multiplication in vitro as shown previously for antibodies directed against MSP-1. Our findings raise interesting questions with regard to proteolysis-mediated mechanisms of maturation of the MSP-1-MSP-6-MSP-7 complex and to the mode by which antibodies directed against this complex interfere with parasite multiplication.	Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Bujard, H (corresponding author), Univ Heidelberg, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	h.bujard@zmbh.uni-heidelberg.de	Langowski, Jörg/A-1843-2011; Mekonnen, Zeleke/AAF-3877-2020	Langowski, Jörg/0000-0001-8600-0666; Mekonnen, Zeleke/0000-0003-3418-7291; Mucke, Norbert/0000-0002-0683-4386; Woehlbier, Ute/0000-0003-3114-9708				Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Epp C, 2003, J CHROMATOGR B, V786, P61, DOI 10.1016/S1570-0232(02)00722-5; HOLDER AA, 1984, J EXP MED, V160, P624, DOI 10.1084/jem.160.2.624; Kauth CW, 2003, J BIOL CHEM, V278, P22257, DOI 10.1074/jbc.M302299200; Kumar S, 2002, CHEM IMMUNOL, V80, P262; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; Mello K, 2004, INFECT IMMUN, V72, P1010, DOI 10.1128/IAI.72.2.1010-1018.2004; Mello K, 2002, EUKARYOT CELL, V1, P915, DOI 10.1128/EC.1.6.915-925.2002; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Pan WQ, 1999, NUCLEIC ACIDS RES, V27, P1094, DOI 10.1093/nar/27.4.1094; PATINO JAG, 1997, J EXP MED, V186, P1689, DOI DOI 10.1084/JEM.186.10.1689); Pearce JA, 2004, INFECT IMMUN, V72, P2321, DOI 10.1128/IAI.72.4.2321-2328.2004; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Pizarro JC, 2003, J MOL BIOL, V328, P1091, DOI 10.1016/S0022-2836(03)00376-0; RALSTON G, 1993, BECKMAN INSTRUMENTS, P43; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; STAFFORD WHL, 1994, MOL BIOCHEM PARASIT, V66, P157, DOI 10.1016/0166-6851(94)90048-5; Stafford WHL, 1996, MOL BIOCHEM PARASIT, V80, P159, DOI 10.1016/0166-6851(96)02696-5; Tewari R, 2005, BLOOD, V105, P394, DOI 10.1182/blood-2004-06-2106; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006	31	68	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31517	31527		10.1074/jbc.M604641200	http://dx.doi.org/10.1074/jbc.M604641200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16940297	Bronze			2022-12-27	WOS:000241235300037
J	Pirbhai, M; Dong, F; Zhong, YM; Pan, KZ; Zhong, GM				Pirbhai, Mustak; Dong, Feng; Zhong, Youmin; Pan, Kelvin Z.; Zhong, Guangming			The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY; PROAPOPTOTIC PROTEINS; MITOCHONDRIA; DEGRADATION; DEATH; ACTIVATION; BAX; PATHOGENESIS; INHIBITION	Chlamydia trachomatis has evolved a profound anti-apoptotic activity that may aid in chlamydial evasion of host defense. The C. trachomatis anti-apoptotic activity has been correlated with blockade of mitochondrial cytochrome c release, inhibition of Bax and Bak activation, and degradation of BH3-only proteins. This study presents evidence that a chlamydia-secreted protease factor designated CPAF is both necessary and sufficient for degrading the BH3-only proteins. When the C. trachomatis-infected cell cytosolic extracts were fractionated by column chromatography, both the CPAF protein and activity elution peaks overlapped with the BH3-only protein degradation activity peak. Depletion of CPAF with a CPAF-specific antibody removed the BH3-only protein degradation activity from the infected cell cytosolic extracts, whereas depletion with control antibodies failed to do so. Notably, recombinant CPAF expressed in bacteria was able to degrade the BH3-only proteins, whereas CPAF mutants similarly prepared from bacteria failed to do so. Finally, bacterium-expressed CPAF also degraded the human BH3-only protein Puma alpha purified from bacteria. These results demonstrate that CPAF contributes to the chlamydial anti-apoptotic activity by degrading the pro-apoptotic BH3-only Bcl-2 subfamily members.	Univ Texas, Hlth Sci Ctr, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; Med Coll Ohio, Dept Microbiol & Immunol, Toledo, OH 43614 USA	University of Texas System; University of Texas Health San Antonio	Zhong, GM (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Microbiol & Immunol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Zhongg@uthscsa.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537, R01AI057450, R01AI047997] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI64537, R01 AI47997, R01 AI57450] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beatty Wandy L., 1994, Trends in Microbiology, V2, P94, DOI 10.1016/0966-842X(94)90542-8; Bouchier-Hayes L, 2005, J CLIN INVEST, V115, P2640, DOI 10.1172/JCI26274; Bouillet P, 2002, J CELL SCI, V115, P1567; Dean D, 2001, INFECT IMMUN, V69, P2442, DOI 10.1128/IAI.69.4.2442-2447.2001; Dong F, 2005, INFECT IMMUN, V73, P1861, DOI 10.1128/IAI.73.3.1861-1864.2005; Dong F, 2004, MOL MICROBIOL, V52, P1487, DOI 10.1111/j.1365-2958.2004.04072.x; Dong F, 2004, INFECT IMMUN, V72, P3869, DOI 10.1128/IAI.72.7.3869-3875.2004; Dong F, 2004, INFECT IMMUN, V72, P3863, DOI 10.1128/IAI.72.7.3863-3868.2004; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Fischer SF, 2004, INFECT IMMUN, V72, P1107, DOI 10.1128/IAI.72.2.1107-1115.2004; Greene W, 2004, INFECT IMMUN, V72, P451, DOI 10.1128/IAI.72.1.451-460.2004; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; Hackstadt T, 1998, CURR OPIN MICROBIOL, V1, P82, DOI 10.1016/S1369-5274(98)80146-X; Heimlich G, 2004, BIOCHEM J, V378, P247, DOI 10.1042/BJ20031152; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lanave C, 2004, GENE, V333, P71, DOI 10.1016/j.gene.2004.02.017; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MORRISON RP, 1989, J EXP MED, V170, P1271, DOI 10.1084/jem.170.4.1271; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Xiao YM, 2005, J IMMUNOL, V174, P1701, DOI 10.4049/jimmunol.174.3.1701; Xiao YM, 2004, INFECT IMMUN, V72, P5470, DOI 10.1128/IAI.72.9.5470-5474.2004; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005; Zhong GM, 1999, J EXP MED, V189, P1931, DOI 10.1084/jem.189.12.1931; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856; Zhong GM, 1996, J EXP MED, V184, P2061, DOI 10.1084/jem.184.5.2061; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2000, J EXP MED, V191, P1525, DOI 10.1084/jem.191.9.1525	40	104	119	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31495	31501		10.1074/jbc.M602796200	http://dx.doi.org/10.1074/jbc.M602796200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16940052	Bronze			2022-12-27	WOS:000241235300034
J	Duckwitz, W; Hausmann, R; Aschrafi, A; Schmalzing, G				Duckwitz, Wiebke; Hausmann, Ralf; Aschrafi, Armaz; Schmalzing, Guenther			P2X(5) subunit assembly requires scaffolding by the second transmembrane domain and a conserved aspartate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTIFICIAL TRANSMEMBRANE SEGMENTS; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; XENOPUS-LAEVIS OOCYTES; RECEPTOR SUBUNIT; HYDROPHOBIC MISMATCH; P2X(1) RECEPTOR; GXXXG MOTIF; HELIX; RESIDUES	Functional homomeric and heteromeric ATP-gated P2X receptor channels have been shown to display a characteristic trimeric architecture. Of the seven different isoforms (designated P2X(1)-P2X(7)), P2X(5) occurs in humans primarily as a nonfunctional variant lacking the C-terminal end of the ectodomain and the outer half of the second transmembrane domain. We show that this truncated variant, which results from the splice-skipping of exon 10, is prone to subunit aggregation because the residual transmembrane domain 2 is too short to insert into the membrane. Alleviation of the negative hydrophobic mismatch by the addition of a stretch of moderately hydrophobic residues enabled formation of a second membrane-spanning domain and strictly parallel homotrimerization. Systematic mutagenesis identified only one transmembrane domain 2 residue, Asp(355), which supported homotrimerization in a side chain-specific manner. Our results indicate that transmembrane domain 2 formation contributes 2-fold to hP2X(5) homotrimerization by tethering the end of the ectodomain to the membrane, thereby topologically restricting conformational mobility, and by intramembrane positioning of Asp355. While transmembrane domain 2 appears to favor assembly by enabling productive subunit interactions in the ectodomain, Asp355 seems to assist by simultaneously driving intramembrane helix interactions. Overall, these results indicate a complex interplay between topology, helix-helix interactions, and oligomerization to achieve a correctly folded structure.	Rhein Westfal TH Aachen, Dept Mol Pharmacol, D-52074 Aachen, Germany	RWTH Aachen University	Schmalzing, G (corresponding author), Rhein Westfal TH Aachen, Dept Mol Pharmacol, Wendlingweg 2, D-52074 Aachen, Germany.	gschmalzing@ukaachen.de	Aschrafi, Armaz/E-2202-2012	Aschrafi, Armaz/0000-0003-4089-0960				Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Bechinger B, 2001, BIOPHYS J, V81, P2251, DOI 10.1016/S0006-3495(01)75872-9; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; CHEN HF, 1995, J BIOL CHEM, V270, P14115, DOI 10.1074/jbc.270.23.14115; Choma C, 2000, NAT STRUCT BIOL, V7, P161; CORNEA RL, 1994, BIOCHEMISTRY-US, V33, P2912, DOI 10.1021/bi00176a022; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; de Planque MRR, 2001, BIOCHEMISTRY-US, V40, P5000, DOI 10.1021/bi000804r; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; GarciaGuzman M, 1996, FEBS LETT, V388, P123, DOI 10.1016/0014-5793(96)00499-1; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Jiang LH, 2003, J NEUROSCI, V23, P8903; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones DT, 1998, FEBS LETT, V423, P281, DOI 10.1016/S0014-5793(98)00095-7; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; Le KT, 1997, FEBS LETT, V418, P195, DOI 10.1016/S0014-5793(97)01380-X; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; LEWIS BA, 1983, J MOL BIOL, V166, P203, DOI 10.1016/S0022-2836(83)80006-0; Lewis RNAH, 2001, BIOCHEMISTRY-US, V40, P12103, DOI 10.1021/bi010555m; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Percot A, 1999, BIOPOLYMERS, V50, P647, DOI 10.1002/(SICI)1097-0282(199911)50:6<647::AID-BIP9>3.0.CO;2-T; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Ren JH, 1999, BIOCHEMISTRY-US, V38, P5905, DOI 10.1021/bi982942a; Rettinger J, 2003, J GEN PHYSIOL, V121, P451, DOI 10.1085/jgp.200208730; Rettinger J, 2000, J BIOL CHEM, V275, P33542, DOI 10.1074/jbc.M002918200; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; RYBA NJP, 1992, BIOCHEMISTRY-US, V31, P7511, DOI 10.1021/bi00148a011; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHMALZING G, 1991, BIOCHEM J, V279, P329, DOI 10.1042/bj2790329; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; THOMPSON JA, 1987, BIOCHEMISTRY-US, V26, P743, DOI 10.1021/bi00377a014; Torres GE, 1999, J BIOL CHEM, V274, P22359, DOI 10.1074/jbc.274.32.22359; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WHITE MM, 1990, MOL PHARMACOL, V37, P720; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	61	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2006	281	51					39561	39572		10.1074/jbc.M606113200	http://dx.doi.org/10.1074/jbc.M606113200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117UL	17001079	hybrid, Green Published			2022-12-27	WOS:000242898700064
J	Kirby, TW; Harvey, S; DeRose, EF; Chalov, S; Chikova, AK; Perrino, FW; Schaaper, RM; London, RE; Pedersen, LC				Kirby, Thomas W.; Harvey, Scott; DeRose, Eugene F.; Chalov, Sergey; Chikova, Anna K.; Perrino, Fred W.; Schaaper, Roel M.; London, Robert E.; Pedersen, Lars C.			Structure of the Escherichia coli DNA polymerase III epsilon-HOT proofreading complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; THETA-SUBUNIT; PROTEIN; PROGRAM; DOMAIN; CRYSTALLOGRAPHY; REPLICATION; EXONUCLEASE; MUTANTS; SYSTEM	The epsilon subunit of Escherichia coli DNA polymerase III possesses 3'-exonucleolytic proofreading activity. Within the Pol III core, epsilon is tightly bound between the alpha subunit ( DNA polymerase) and theta subunit. Here, we present the crystal structure of epsilon in complex with HOT, the bacteriophage P1-encoded homolog of theta, at 2.1 angstrom resolution. The epsilon-HOT interface is defined by two areas of contact: an interaction of the previously unstructured N terminus of HOT with an edge of the epsilon central beta-sheet as well as interactions between HOT and the catalytically important helix alpha 1-loop-helix alpha 2 motif of epsilon. This structure provides insight into how HOT and, by implication, theta may stabilize the epsilon subunit, thus promoting efficient proofreading during chromosomal replication.	NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; Wake Forest Univ, Dept Biochem, Winston Salem, NC 27157 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Wake Forest University	London, RE (corresponding author), NIEHS, Struct Biol Lab, NIH, MR 01,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	london@niehs.nih.gov	London, Robert E/F-7990-2019; Pedersen, Lars/C-6173-2019; Schaaper, Roel M/E-6680-2019	London, Robert E/0000-0001-9108-8463; Pedersen, Lars/0000-0002-4488-4077; Schaaper, Roel M/0000-0003-1344-3196; Kirby, Thomas/0000-0002-8791-2488	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065088, Z01ES050111, ZIAES050111, Z01ES065088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069962, GM 069962] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chikova AK, 2005, J BACTERIOL, V187, P5528, DOI 10.1128/JB.187.16.5528-5536.2005; DeLano W.L, PYMOL MOL GRAPHICS S; DeRose EF, 2004, STRUCTURE, V12, P2221, DOI 10.1016/j.str.2004.09.019; DeRose EF, 2002, BIOCHEMISTRY-US, V41, P94, DOI 10.1021/bi0114170; DONNELL M, 2006, J BIOL CHEM, V281, P10653; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; FOSTER PL, 1992, J BACTERIOL, V174, P7509, DOI 10.1128/JB.174.23.7509-7516.1992; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hamdan S, 2000, J STRUCT BIOL, V131, P164, DOI 10.1006/jsbi.2000.4291; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keniry MA, 2006, J BACTERIOL, V188, P4464, DOI 10.1128/JB.01992-05; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANCY ED, 1989, J BACTERIOL, V171, P5572, DOI 10.1128/jb.171.10.5572-5580.1989; Lehtinen DA, 2004, BIOCHEM J, V384, P337, DOI 10.1042/BJ20040660; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Minor W, 2002, ACTA PHYS POL A, V101, P613, DOI 10.12693/APhysPolA.101.613; Mueller GA, 2005, J BACTERIOL, V187, P7081, DOI 10.1128/JB.187.20.7081-7089.2005; Perrino FW, 1999, BIOCHEMISTRY-US, V38, P16001, DOI 10.1021/bi991429+; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Stano NM, 2006, NAT STRUCT MOL BIOL, V13, P458, DOI 10.1038/nsmb1078; Taft-Benz SA, 1999, J BACTERIOL, V181, P2963, DOI 10.1128/JB.181.9.2963-2965.1999; Taft-Benz SA, 2004, J BACTERIOL, V186, P2774, DOI 10.1128/JB.186.9.2774-2780.2004; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wieczorek A, 2006, J BIOL CHEM, V281, P12561, DOI 10.1074/jbc.M513844200	33	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2006	281	50					38466	38471		10.1074/jbc.M606917200	http://dx.doi.org/10.1074/jbc.M606917200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	115BL	16973612	Green Accepted, hybrid			2022-12-27	WOS:000242709500040
J	Zhang, YL; Hernandez-Ono, A; Siri, P; Weisberg, S; Conlon, D; Graham, MJ; Crooke, RM; Huang, LS; Ginsberg, HN				Zhang, Yuan-Li; Hernandez-Ono, Antonio; Siri, Patty; Weisberg, Stuart; Conlon, Donna; Graham, Mark J.; Crooke, Rosanne M.; Huang, Li-Shin; Ginsberg, Henry N.			Aberrant hepatic expression of PPAR gamma 2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; STEROL REGULATORY ELEMENT; BROWN ADIPOSE-TISSUE; APOLIPOPROTEIN-B-LIPOPROTEINS; FATTY-ACID SYNTHESIS; LIVER X-RECEPTORS; PPAR-GAMMA; GENE-EXPRESSION; APO-B; TRANSGENIC MOUSE	Insulin-resistant apoB/BATless mice have hypertriglyceridemia because of increased assembly and secretion of very low density apolipoprotein B ( apoB) and triglycerides compared with mice expressing only apoB (Siri, P., Candela, N., Ko, C., Zhang, Y., Eusufzai, S., Ginsberg, H. N., and Huang, L. S. ( 2001) J. Biol. Chem. 276, 46064-46072). Despite increased very low density lipoprotein secretion, apoB/BATless mice have fatty livers. We found that hepatic mRNA levels of key lipogenic enzymes, acetyl-CoA carboxylase, fatty-acid synthase, and stearoyl-CoA desaturase-1 were increased in apoB/BATless mice compared with levels in apoB mice, suggesting increased lipogenesis in apoB/BATless mice. This was confirmed by determining incorporation of tritiated water into fatty acids. Neither the hepatic mRNA of the lipogenic transcription factor, SREBP-1c ( sterol-response element-binding protein 1c), nor the nuclear levels of the mature form of SREBP-1 protein were elevated in apoB/BATless mice. By contrast, hepatic levels of peroxisomal proliferator-activated receptor 2 ( PPAR gamma 2) mRNA and protein were specifically increased in apoB/BATless mice, as were hepatic mRNA levels of two targets of PPAR gamma, CD36 and aP2. Treatment of apoB/BATless mice for 4 weeks with intraperitoneal injections of a PPAR gamma antisense oligonucleotide resulted in dramatic reductions of both PPAR gamma 1 and PPAR gamma 2 mRNA, PPAR gamma 2 protein, and mRNA levels of fatty-acid synthase and acetyl-CoA carboxylase. These changes were associated with decreased hepatic de novo lipogenesis and hepatic triglyceride concentrations. We conclude that hepatic steatosis in apoB/BATless mice is associated with elevated rates of hepatic lipogenesis that are linked directly to increased hepatic expression of PPAR gamma 2. The mechanism whereby hepatic Ppar gamma 2 gene expression is increased and how PPAR gamma 2 stimulates lipogenesis is under investigation.	Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY 10032 USA; ISIS Pharmaceut, Carlsbad, CA 92672 USA	Columbia University; Isis Pharmaceuticals Inc	Ginsberg, HN (corresponding author), Columbia Univ, Dept Med, Coll Phys & Surg, PH 10-350,630 W 168th St, New York, NY 10032 USA.	hng1@columbia.edu		Conlon, Donna/0000-0002-9471-3081; Weisberg, Stuart/0000-0002-8698-5976	NHLBI NIH HHS [HL55368, HL73030, HL62583] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073030, R01HL062583] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; CABEZAS MC, 1993, J CLIN INVEST, V92, P160, DOI 10.1172/JCI116544; Chan DC, 2004, CLIN SCI, V107, P233, DOI 10.1042/CS20040109; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Costet P, 2000, J BIOL CHEM, V275, P28240; Diraison F, 1998, AM J PHYSIOL-ENDOC M, V274, pE321, DOI 10.1152/ajpendo.1998.274.2.E321; Edvardsson U, 2006, BIOCHEM BIOPH RES CO, V340, P111, DOI 10.1016/j.bbrc.2005.12.008; Elam MB, 2001, J LIPID RES, V42, P2039; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; Hellerstein MK, 1999, EUR J CLIN NUTR, V53, pS53, DOI 10.1038/sj.ejcn.1600744; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; KISSEBAH AH, 1974, CLIN SCI MOL MED, V47, P259, DOI 10.1042/cs0470259; KISSEBAH AH, 1982, DIABETES, V31, P217, DOI 10.2337/diabetes.31.3.217; Ko C, 2003, J LIPID RES, V44, P1946, DOI 10.1194/jlr.M300172-JLR200; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lewis G F, 1999, Curr Opin Lipidol, V10, P475, DOI 10.1097/00041433-199910000-00013; Lou DQ, 2005, HEPATOLOGY, V41, P1056, DOI 10.1002/hep.20663; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Mensenkamp AR, 2004, J HEPATOL, V40, P599, DOI 10.1016/j.jhep.2003.12.011; Miyazaki M, 2001, J LIPID RES, V42, P1018; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Myerson M, 2005, J LIPID RES, V46, P2735, DOI 10.1194/jlr.M500335-JLR200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; SALMON DMW, 1973, BIOCHEM J, V136, P551, DOI 10.1042/bj1360551; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Siri P, 2001, J BIOL CHEM, V276, P46064, DOI 10.1074/jbc.M108909200; Siri PW, 2003, METABOLISM, V52, P659, DOI 10.1016/S0026-0495(03)00061-1; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Taghibiglou C, 2000, J BIOL CHEM, V275, P8416, DOI 10.1074/jbc.275.12.8416; Tanoli T, 2004, J LIPID RES, V45, P941, DOI 10.1194/jlr.M300508-JLR200; Twisk J, 2000, J CLIN INVEST, V105, P521, DOI 10.1172/JCI8623; TZUNG KW, 1994, GENOMICS, V21, P244, DOI 10.1006/geno.1994.1250; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Voyiaziakis E, 1999, J LIPID RES, V40, P2004; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WETTERAU JR, 1992, SCIENCE, V258, P999; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200	62	125	126	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37603	37615		10.1074/jbc.M604709200	http://dx.doi.org/10.1074/jbc.M604709200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16971390	hybrid			2022-12-27	WOS:000242477100037
J	Weigel, PH; Kyossev, Z; Torres, LC				Weigel, Paul H.; Kyossev, Zhetcho; Torres, Lindsey C.			Phospholipid dependence and liposome reconstitution of purified hyaluronan synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							10-N-NONYL ACRIDINE-ORANGE; STREPTOCOCCUS-PYOGENES; MOLECULAR-CLONING; BACILLUS-SUBTILIS; CARDIOLIPIN; BIOSYNTHESIS; EQUISIMILIS; DOMAINS; GENE; DYE	Previous radiation inactivation and enzyme characterization studies demonstrated that the Streptococcus equisimilis hyaluronan synthase (seHAS) is phospholipid-dependent and that cardiolipin (CL) is the best phospholipid for enzyme activation. Here we investigated the ability of seHAS, purified in the absence of added lipid, to be activated by synthetic phosphatidic acid (PA), phosphatidylserine, or CL lipids containing fatty acyl chains of different length or different numbers of double bonds. The most effective lipid was tetraoleoyl CL (TO-CL), whereas tetramyristoyl CL (TMCL) was ineffective. None of the phosphatidylserine species tested gave significant activation. PAs containing C10 to C18 saturated acyl chains were not effective activators, and neither were oleoyl lyso PA, dilinoleoyl PA, or PA containing one oleoyl chain and either a palmitoyl or stearoyl chain. In contrast, dioleoyl PA stimulated seHAS similar to 10-fold, to similar to 20% of the activity observed with TO-CL. The tested acidic lipids such as PA and CL activated the enzyme most efficiently if they contained only oleic acid. Mixing experiments showed that the enzyme interacts preferentially with TO-CL in the presence of TM-CL. Similarly, seHAS incorporated into phosphotidylcholine-based liposomes showed increasing activity with increasing TO-CL, but not TM-CL, content. Inactivation of membrane-bound seHAS by solubilization with Nonidet P-40 was prevented by TO-CL, but not TM-CL. The pH dependence of seHAS in the presence of synthetic or naturally occurring CLs showed the same pattern of lipid preference between pH6 and 10.5. Unexpectedly, HAS showed lipid-independent activity at pH 11.5. The results suggest that Class I HAS enzymes are lipid-dependent and that assembly of active seHAS-lipid complexes has high specificity for the phospholipid head group and the nature of the fatty acyl chains.	Oklahoma Ctr Med Glycobiol, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Weigel, PH (corresponding author), Oklahoma Ctr Med Glycobiol, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	paul-weigel@ouhsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035978] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35978] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bodevin-Authelet S, 2005, J BIOL CHEM, V280, P8813, DOI 10.1074/jbc.M412803200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHANDRA NC, 1991, ARCH BIOCHEM BIOPHYS, V290, P345, DOI 10.1016/0003-9861(91)90550-3; DeAngelis PL, 1999, CELL MOL LIFE SCI, V56, P670, DOI 10.1007/s000180050461; DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001; DEANGELIS PL, 1993, J BIOL CHEM, V268, P19181; DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568; Fernandez MIG, 2004, ANAL BIOCHEM, V328, P174, DOI 10.1016/j.ab.2004.01.020; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Heldermon C, 2001, J BIOL CHEM, V276, P2037, DOI 10.1074/jbc.M002276200; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Kumari K, 1997, J BIOL CHEM, V272, P32539, DOI 10.1074/jbc.272.51.32539; Kumari K, 2006, J BIOL CHEM, V281, P11755, DOI 10.1074/jbc.M600727200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Megli FM, 2000, BIOCHEMISTRY-US, V39, P5534, DOI 10.1021/bi992779z; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pummill PE, 2001, J BIOL CHEM, V276, P39832, DOI 10.1074/jbc.M105489200; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Tlapak-Simmons VL, 2005, J BIOL CHEM, V280, P13012, DOI 10.1074/jbc.M409788200; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4246, DOI 10.1074/jbc.274.7.4246; Tlapak-Simmons VL, 1998, J BIOL CHEM, V273, P26100, DOI 10.1074/jbc.273.40.26100; Tlapak-Simmons VL, 2004, BIOCHEMISTRY-US, V43, P9234, DOI 10.1021/bi049468v; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; VANDENBRINKVAND.E, 2003, J BACTERIOL, V185, P3773, DOI DOI 10.1128/JB.185.13.3773-3779.2003; Ward PN, 2001, INFECT IMMUN, V69, P392, DOI 10.1128/IAI.69.1.392-399.2001; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Weigel PH, 2002, IUBMB LIFE, V54, P201, DOI 10.1080/15216540214931; WEIGEL PH, 2004, GLYCOFORUM HYALURONA; Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497; Zazueta C, 2003, J MEMBRANE BIOL, V191, P113, DOI 10.1007/s00232-002-1047-z; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200	37	16	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36542	36551		10.1074/jbc.M606529200	http://dx.doi.org/10.1074/jbc.M606529200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16984914	hybrid			2022-12-27	WOS:000242220800010
J	Yu, YM; Liang, YH; Brostromer, E; Quan, JM; Panjikar, S; Dong, YH; Su, XD				Yu, Yamei; Liang, Yu-He; Brostromer, Erik; Quan, Jun-Min; Panjikar, Santosh; Dong, Yu-Hui; Su, Xiao-Dong			A catalytic mechanism revealed by the crystal structures of the imidazolonepropionase from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE AMMONIA-LYASE; COLI CYTOSINE DEAMINASE; UROCANIC ACID; DEGRADATION; CRYSTALLIZATION; DICTIONARY; METABOLISM; ENZYMES; CLONING; HUT	Imidazolonepropionase (EC 3.5.2.7) catalyzes the third step in the universal histidine degradation pathway, hydrolyzing the carbon-nitrogen bonds in 4-imidazolone-5-propionic acid to yield N-formimino-L-glutamic acid. Here we report the crystal structures of the Bacillus subtilis imidazolonepropionase and its complex at 2.0-A resolution with substrate analog imidazole-4-acetic acid sodium (I4AA). The structure of the native enzyme contains two domains, a TIM (triose-phosphate isomerase) barrel domain with two insertions and a small beta-sandwich domain. The TIM barrel domain is quite similar to the members of the alpha/beta barrel metallo-dependent hydrolase superfamily, especially to Escherichia coli cytosine deaminase. A metal ion was found in the central cavity of the TIM barrel and was tightly coordinated to residues His-80, His-82, His-249, Asp-324, and a water molecule. X-ray fluorescence scan analysis confirmed that the bound metal ion was a zinc ion. An acetate ion, 6 A away from the zinc ion, was also found in the potential active site. In the complex structure with I4AA, a substrate analog, I4AA replaced the acetate ion and contacted with Arg-89, Try-102, Tyr-152, His-185, and Glu-252, further defining and confirming the active site. The detailed structural studies allowed us to propose a zinc-activated nucleophilic attack mechanism for the hydrolysis reaction catalyzed by the enzyme.	Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 513055, Peoples R China; DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China	Peking University; Peking University; University Town of Shenzhen; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Su, XD (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China.	su-xd@pku.edu.cn	Panjikar, Santosh/D-2709-2012; , LiangYH/B-6704-2012	Panjikar, Santosh/0000-0001-7429-3879; Dong, Yuhui/0000-0002-4422-4685				Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; BROWN DD, 1960, J BIOL CHEM, V235, P2058; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHASIN LA, 1968, J BIOL CHEM, V243, P5165; COWTAN K, 1994, NEWSLETTER PROTEIN C, V31, P34; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kessler D, 2004, J MOL BIOL, V342, P183, DOI 10.1016/j.jmb.2004.07.028; KIMHI Y, 1970, J BIOL CHEM, V245, P3545; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; ODA M, 1988, J BACTERIOL, V170, P3199, DOI 10.1128/jb.170.7.3199-3205.1988; Okabe N, 1999, ACTA CRYSTALLOGR C, V55, P1142, DOI 10.1107/S0108270199004023; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Porter DJT, 2000, BBA-PROTEIN STRUCT M, V1476, P239, DOI 10.1016/S0167-4838(99)00246-0; RAO DR, 1960, BIOCHIM BIOPHYS ACTA, V43, P404; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwede TF, 1999, BIOCHEMISTRY-US, V38, P5355, DOI 10.1021/bi982929q; Schwede TF, 1999, PROTEIN ENG, V12, P151, DOI 10.1093/protein/12.2.151; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; SMITH GR, 1971, J BIOL CHEM, V246, P3320; SNYDER SH, 1961, J BIOL CHEM, V236, P2996; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; YOSHIDA K, 1995, MICROBIOL-UK, V141, P337, DOI 10.1099/13500872-141-2-337; Yu YM, 2006, BBA-PROTEINS PROTEOM, V1764, P153, DOI 10.1016/j.bbapap.2005.08.012	37	15	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36929	36936		10.1074/jbc.M607703200	http://dx.doi.org/10.1074/jbc.M607703200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16990261	Green Published, hybrid			2022-12-27	WOS:000242220800052
J	Hatanaka, T; Hatanaka, Y; Setou, M				Hatanaka, Takahiro; Hatanaka, Yasue; Setou, Mitsutoshi			Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE EXPRESSION PATTERN; EPITHELIAL SODIUM-CHANNEL; COUPLED ACTIVE-TRANSPORT; SKELETAL-MUSCLE CELLS; SYSTEM-A; GLUCOSE-TRANSPORTER; FUNCTIONAL-CHARACTERISTICS; GLUTAMINE TRANSPORTER; DEGRADATION; PROTEIN	We report here that ubiquitin ligase Nedd4-2 regulates amino acid transporter ATA2 activity on the cell surface. We first found that a proteasome inhibitor MG132 increased the uptake of alpha-(methylamino) isobutyric acid, a model substrate for amino acid transport system A, in 3T3-L1 adipocytes as well as the preadipocytes. Transient expression of Nedd4-2 in Xenopus oocytes and Chinese hamster ovary cells down-regulated the ATA2 transport activity induced by injected cRNA and transfected cDNA, respectively. Neither the Nedd4-2 mutant with defective catalytic domain nor c-Cbl affected the ATA2 activity significantly. RNA-mediated interference of Nedd4-2 increased the ATA2 activity in the cells, and this was associated with decreased polyubiquitination of ATA2 on the cell surface membrane. Immunofluorescent analysis of Nedd4-2 in the adipocytes stably transfected with the enhanced green fluorescent protein (EGFP)-tagged ATA2 showed the co-localization of Nedd4-2 and EGFP-ATA2 in the plasma membrane but not in the perinuclear ATA2 storage site, supporting the idea that the primary site for the ubiquitination of ATA2 is the plasma membrane. These data suggest that ATA2 on the plasma membrane is subject to polyubiquitination by Nedd4-2 with consequent endocytotic sequestration and proteasomal degradation and that this process is an important determinant of the density of ATA2 functioning on the cell surface.	Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Setou, M (corresponding author), Mitsubishi Kagaku Inst Life Sci, 11 Minamiooya, Machida, Tokyo 1948511, Japan.	setou@nips.ac.jp						Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; Boehmer C, 2003, BIOCHEM BIOPH RES CO, V306, P156, DOI 10.1016/S0006-291X(03)00921-5; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CHRISTENSEN HN, 1965, J BIOL CHEM, V240, P3609; CHRISTENSEN HN, 1989, METHOD ENZYMOL, V173, P576; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; FEI YJ, 1995, BIOCHEMISTRY-US, V34, P8744, DOI 10.1021/bi00027a025; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; HARRISON SA, 1990, J BIOL CHEM, V265, P20106; Hatanaka T, 2004, J PHARMACOL EXP THER, V308, P1138, DOI 10.1124/jpet.103.057109; Hatanaka T, 2002, BIOCHEM BIOPH RES CO, V291, P291, DOI 10.1006/bbrc.2002.6441; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; Hatanaka T, 2000, BBA-BIOMEMBRANES, V1467, P1, DOI 10.1016/S0005-2736(00)00252-2; Hatanaka T, 2001, J CLIN INVEST, V107, P1035, DOI 10.1172/JCI12060; HAUSSINGER D, 1992, MAMMALIAN AMINO ACID TRANSPORT, P113; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; KILBERG MS, 1986, FED PROC, V45, P2438; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Ritchie JWA, 2001, CELL PHYSIOL BIOCHEM, V11, P259, DOI 10.1159/000047812; Rotmann A, 2004, J BIOL CHEM, V279, P54185, DOI 10.1074/jbc.M409556200; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; SHOTWELL MA, 1983, BIOCHIM BIOPHYS ACTA, V737, P267, DOI 10.1016/0304-4157(83)90003-5; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Wang HP, 2000, BIOCHEM BIOPH RES CO, V273, P1175, DOI 10.1006/bbrc.2000.3061; Xia XF, 2004, J BIOL CHEM, V279, P44931, DOI 10.1074/jbc.M400969200; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200	43	41	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35922	35930		10.1074/jbc.M606577200	http://dx.doi.org/10.1074/jbc.M606577200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17003038	hybrid			2022-12-27	WOS:000242100500039
J	Hagen, T; Cross, DAE; Culbert, AA; West, A; Frame, S; Morrice, N; Reith, AD				Hagen, Thilo; Cross, Darren A. E.; Culbert, Ainsley A.; West, Andrew; Frame, Sheelagh; Morrice, Nick; Reith, Alastair D.			FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; WNT SIGNALING PATHWAY; BETA-CATENIN; CORTICAL ROTATION; CYCLIN D1; PHOSPHORYLATION; GSK-3; AXIN; ACTIVATION; INSULIN	FRAT1, like its Xenopus homolog glycogen synthase kinase-3 (GSK-3)-binding protein, is known to inhibit GSK-3-mediated phosphorylation of beta-catenin. It is currently unknown how FRAT-GSK-3-binding protein activity toward GSK-3 is regulated. FRAT1 has recently been shown to be a phosphoprotein in vivo; however, the responsible kinase(s) have not been determined. In this study, we identified Ser(188) as a phosphorylated residue in FRAT1. The identity of the kinase that catalyzes Ser188 phosphorylation and the significance of this phosphorylation to FRAT1 function were investigated. Protein kinase A (PKA) was found to phosphorylate Ser188 in vitro as well as in intact cells. Importantly, activation of endogenous cAMP-coupled beta-adrenergic receptors with norepinephrine stimulated the phosphorylation of FRAT1 at Ser188. GSK-3 was also able to phosphorylate FRAT1 at Ser188 and other residues in vitro or when overexpressed in intact cells. In contrast, endogenous GSK-3 did not lead to significant FRAT1 phosphorylation in cells, suggesting that GSK-3 is not a major FRAT1 kinase in vivo. Phosphorylation of Ser188 by PKA inhibited the ability of FRAT1 to activate beta-catenin-dependent transcription. In conclusion, PKA phosphorylates FRAT1 in vitro as well as in intact cells and may play a role in regulating the inhibitory activity of FRAT1 toward GSK-3.	GlaxoSmithKline Inc, Discovery Res Biol, Harlow CM19 5AD, Essex, England; GlaxoSmithKline Inc, Neurol Ctr Excellence Drug Discovery, Harlow CM19 5AD, Essex, England; GlaxoSmithKline Inc, Computat Analyt & Struct Sci, Harlow CM19 5AD, Essex, England; Med Res Ctr, Stevenage SG1 2NY, Herts, England; Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; Univ Nottingham, Wolfson Digest Dis Ctr, Nottingham NG7 2UH, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; University of Dundee; University of Nottingham	Hagen, T (corresponding author), GlaxoSmithKline Inc, Discovery Res Biol, Harlow CM19 5AD, Essex, England.	Thilo.Hagen@nottingham.ac.uk						Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Dominguez I, 2000, DEVELOPMENT, V127, P861; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jonkers J, 1997, EMBO J, V16, P441, DOI 10.1093/emboj/16.3.441; Jonkers J, 1999, MECH DEVELOP, V88, P183, DOI 10.1016/S0925-4773(99)00187-2; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Martin CP, 2002, BBA-MOL BASIS DIS, V1586, P113; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Saitoh T, 2001, BIOCHEM BIOPH RES CO, V281, P815, DOI 10.1006/bbrc.2001.4421; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stoothoff WH, 2005, J BIOL CHEM, V280, P270, DOI 10.1074/jbc.M410061200; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; van Amerongen R, 2005, GENE DEV, V19, P425, DOI 10.1101/gad.326705; van Amerongen R, 2004, J BIOL CHEM, V279, P26967, DOI 10.1074/jbc.M400439200; Weaver C, 2003, DEVELOPMENT, V130, P5425, DOI 10.1242/dev.00737; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419	36	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35021	35029		10.1074/jbc.M607003200	http://dx.doi.org/10.1074/jbc.M607003200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16982607	hybrid			2022-12-27	WOS:000241933700035
J	Kant, S; Schumacher, S; Singh, MK; Kispert, A; Kotlyarov, A; Gaestel, M				Kant, Shashi; Schumacher, Stefanie; Singh, Manvendra Kumar; Kispert, Andreas; Kotlyarov, Alexey; Gaestel, Matthias			Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; REGULATED KINASE-3; PROTEASOME; FAMILY; DEGRADATION; MK5/PRAK; HOMOLOG; DEFINES	The extracellular-regulated kinase (ERK) 4 (MAPK4) and ERK3 (MAPK6) are structurally related atypical MAPKs displaying major differences only in the C-terminal extension. ERK3 is known as an unstable mostly cytoplasmic protein that binds, translocates, and activates the MAPK-activated protein kinase (MK) 5. Here we have investigated the stability and expression of ERK4 and have analyzed its ability to bind, translocate, and activate MK5. We show that, in contrast to ERK3, ERK4 is a stable protein that binds to endogenous MK5. Interaction of ERK4 with MK5 leads to translocation of MK5 to the cytoplasm and to its activation by phosphorylation. In transfected HEK293 cells, where overexpressed catalytically dead ERK3 is able to activate MK5, catalytic activity of ERK4 is necessary for activation of MK5, indicating that ERK4 directly phosphorylates MK5. Interestingly, ERK4 dimerizes and/or oligomerizes with ERK3, suggesting that overexpressed inactive ERK3 recruits active endogenous ERK4 to MK5 for its activation. Hence, ERK3 and ERK4 cooperate in activation of MK5.	Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School	Gaestel, M (corresponding author), Hannover Med Sch, Inst Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gaestel.matthias@mh-hannover.de	Kant, Shashi/B-1585-2016; Gaestel, Matthias/A-6560-2013; Singh, Manvendra K./AHE-0676-2022	Kant, Shashi/0000-0001-8772-6813; Gaestel, Matthias/0000-0002-4944-4652; Singh, Manvendra K./0000-0002-2884-0074				Abe MK, 2002, J BIOL CHEM, V277, P16733, DOI 10.1074/jbc.M112483200; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Garcia JI, 1996, MAMM GENOME, V7, P810, DOI 10.1007/s003359900242; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; LI L, 1994, ONCOGENE, V9, P647; Mikalsen T, 2005, INT J BIOCHEM CELL B, V37, P2513, DOI 10.1016/j.biocel.2005.06.007; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ni H, 1998, BIOCHEM BIOPH RES CO, V243, P492, DOI 10.1006/bbrc.1998.8135; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Seternes OM, 2002, MOL CELL BIOL, V22, P6931, DOI 10.1128/MCB.22.20.6931-6945.2002; Shi Y, 2003, MOL CELL BIOL, V23, P7732, DOI 10.1128/MCB.23.21.7732-7741.2003; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; ZHU AX, 1994, MOL CELL BIOL, V14, P8202, DOI 10.1128/MCB.14.12.8202	21	67	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35511	35519		10.1074/jbc.M606693200	http://dx.doi.org/10.1074/jbc.M606693200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16973613	hybrid			2022-12-27	WOS:000241933700084
J	Usatyuk, PV; Parinandi, NL; Natarajan, V				Usatyuk, Peter V.; Parinandi, Narasimham L.; Natarajan, Viswanathan			Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION PRODUCT; PHOSPHOLIPASE-D ACTIVATION; SIGNAL-TRANSDUCTION; N-ACETYLCYSTEINE; ACTIN; KINASE; CELLS; PERMEABILITY; GLUTATHIONE; PHOSPHATASE	4-Hydroxy-2-nonenal (4-HNE), one of the major biologically active aldehydes formed during inflammation and oxidative stress, has been implicated in a number of cardiovascular and pulmonary disorders. 4-HNE has been shown to increase vascular endothelial permeability; however, the underlying mechanisms are unclear. Hence, in the current study, we tested our hypothesis that 4-HNE-induced changes in cellular thiol redox status may contribute to modulation of cell signaling pathways that lead to endothelial barrier dysfunction. Exposure of bovine lung microvascular endothelial cells (BLMVECs) to 4-HNE induced reactive oxygen species generation, depleted intracellular glutathione, and altered cell-cell adhesion as measured by transendothelial electrical resistance. Pretreatment of BLMVECs with thiol protectants, N-acetylcysteine and mercaptopropionyl glycine, attenuated 4-HNE-induced decrease in transendothelial electrical resistance, reactive oxygen species generation, Michael protein adduct formation, protein tyrosine phosphorylation, activation of ERK, JNK, and p38 MAPK, and actin cytoskeletal rearrangement. Treatment of BLMVECs with 4-HNE resulted in the redistribution of FAK, paxillin, VE-cadherin, beta-catenin, and ZO-1, and intercellular gap formation. Western blot analyses confirmed the formation of 4-HNE-derived Michael adducts with the focal adhesion and adherens junction proteins. Also, 4-HNE decreased tyrosine phosphorylation of FAK without affecting total cellular FAK contents, suggesting the modification of integrins, which are natural FAK receptors. 4-HNE caused a decrease in the surface integrin in a time-dependent manner without altering total alpha 5 and beta 3 integrins. These results, for the first time, revealed that 4-HNE in redox-dependent fashion affected endothelial cell permeability by modulating cell-cell adhesion through focal adhesion, adherens, and tight junction proteins as well as integrin signal transduction that may lead dramatic alteration in endothelial cell barrier dysfunction during heart infarction, brain stroke, and lung diseases.	Univ Chicago, Div Biol Sci, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA	University of Chicago; University System of Ohio; Ohio State University	Natarajan, V (corresponding author), Univ Chicago, Dept Med, Ctr Integrat Sci Bldg,Rm 408B,929 E 57th St, Chicago, IL 60637 USA.	vnataraj@medicine.bsd.uchicago.edu			NHLBI NIH HHS [R01 HL 69909, P01 HL 58064] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, R01HL069909] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBELDA SM, 1989, J CLIN INVEST, V83, P1992, DOI 10.1172/JCI114109; Aldini G, 2005, J MASS SPECTROM, V40, P946, DOI 10.1002/jms.872; Awasthi YC, 2004, FREE RADICAL BIO MED, V37, P607, DOI 10.1016/j.freeradbiomed.2004.05.033; BHATTACHARYA S, 1995, J BIOL CHEM, V270, P16781, DOI 10.1074/jbc.270.28.16781; Bianchi M, 2005, MOL CELL BIOCHEM, V272, P85, DOI 10.1007/s11010-005-7639-z; Bogatcheva NV, 2003, J INVEST MED, V51, P341, DOI 10.1136/jim-51-06-30; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Compton CN, 1998, J TRAUMA, V44, P783, DOI 10.1097/00005373-199805000-00007; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DEJANA E, 1988, J CELL BIOL, V107, P1215, DOI 10.1083/jcb.107.3.1215; Dianzani Mario Umberto, 2003, Molecular Aspects of Medicine, V24, P263; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; English D, 1999, J CELL BIOCHEM, V75, P105, DOI 10.1002/(SICI)1097-4644(19991001)75:1<105::AID-JCB11>3.3.CO;2-U; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; GADONI E, 1993, CYTOTECHNOLOGY, V11, P62; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Hamilton RF, 1998, AM J PHYSIOL-LUNG C, V274, pL8, DOI 10.1152/ajplung.1998.274.1.L8; Herbst U, 1999, J CELL PHYSIOL, V181, P295, DOI 10.1002/(SICI)1097-4652(199911)181:2<295::AID-JCP11>3.0.CO;2-I; Hernandez-Hernandez A, 1999, FREE RADICAL BIO MED, V26, P1218, DOI 10.1016/S0891-5849(98)00306-2; Hirase T, 1997, J CELL SCI, V110, P1603; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KIRUKOVA AA, 2004, J CELL PHYSL, V201, P55; Landar A, 2006, AM J PHYSIOL-HEART C, V290, pH1777, DOI 10.1152/ajpheart.01087.2005; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; Mertsch K, 2001, NEUROSCI LETT, V314, P135, DOI 10.1016/S0304-3940(01)02299-6; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Minekura H, 2001, BIOCHEM BIOPH RES CO, V282, P557, DOI 10.1006/bbrc.2001.4586; Natarajan V, 1997, AM J RESP CELL MOL, V17, P251, DOI 10.1165/ajrcmb.17.2.2623; NATARAJAN V, 1995, J LAB CLIN MED, V125, P26; Natarajan V, 2005, ADV MOL CEL, V35, P105, DOI 10.1016/S1569-2558(05)35004-1; NATARAJAN V, 1993, FREE RADICAL BIO MED, V15, P365, DOI 10.1016/0891-5849(93)90036-T; Neely MD, 2005, BRAIN RES, V1037, P90, DOI 10.1016/j.brainres.2004.12.027; Ozeki M, 2005, J CHROMATOGR B, V827, P119, DOI 10.1016/j.jchromb.2005.02.025; Parinandi NL, 1999, ANTIOXID REDOX SIGN, V1, P193, DOI 10.1089/ars.1999.1.2-193; Parola M, 1999, ANTIOXID REDOX SIGN, V1, P255, DOI 10.1089/ars.1999.1.3-255; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; RICHARDSON A, 1995, BIOESSAYS, V17, P229, DOI 10.1002/bies.950170309; Sharma R, 2004, ANTIOXID REDOX SIGN, V6, P289, DOI 10.1089/152308604322899350; Sochman J, 2002, J AM COLL CARDIOL, V39, P1422, DOI 10.1016/S0735-1097(02)01797-7; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; SU G, 2006, P AM THOR SOC NEW YO, V3, pA478; Tang JX, 1999, BIOPHYS J, V76, P2208, DOI 10.1016/S0006-3495(99)77376-5; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Usatyuk PV, 2004, J BIOL CHEM, V279, P11789, DOI 10.1074/jbc.M311184200; Usatyuk PV, 2003, ANTIOXID REDOX SIGN, V5, P723, DOI 10.1089/152308603770380025; VANWINKLE WB, 1994, CELL MOTIL CYTOSKEL, V28, P119, DOI 10.1002/cm.970280204; Waschke J, 2005, AM J PHYSIOL-HEART C, V288, pH1296, DOI 10.1152/ajpheart.00687.2004; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhao XY, 2001, AM J PHYSIOL-LUNG C, V281, pL879, DOI 10.1152/ajplung.2001.281.4.L879	62	138	141	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35554	35566		10.1074/jbc.M607305200	http://dx.doi.org/10.1074/jbc.M607305200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16982627	hybrid			2022-12-27	WOS:000241933700088
J	Hamilton, RF; Thakur, SA; Mayfair, JK; Holian, A				Hamilton, Raymond F., Jr.; Thakur, Sheetal A.; Mayfair, Jolene K.; Holian, Andrij			MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; A SCAVENGER RECEPTORS; SIGNALING PATHWAYS; INDUCED APOPTOSIS; LUNG DEFENSE; MURINE LUNG; CELL-LINE; SR-AI/II; PARTICLES; BINDING	Scavenger receptors (SR), on the surface of the macrophage, appear to be responsible for silica uptake and cell death signaling in the macrophage. The purpose of this study was to isolate which SRs (macrophage receptor with collagenous structure (MARCO), CD204, or CD36) were involved using a variety of SR single and double null mice. The findings indicated that MARCO was the critical SR involved in silica uptake and cytotoxicity in the primary alveolar macrophages (AM) from C57BL/6 mice, as there was no particle uptake or cell death in the absence of this SR. The level of MARCO expression on AM changed significantly with the absence of other SR, and silica uptake was proportional to cell surface MARCO expression. In addition, silica uptake and cytotoxicity were completely blocked by an anti-mouse MARCO antibody. Transfection of Chinese hamster ovary cells with human MARCO supported these conclusions, as silica particles bound to and initiated apoptosis in the MARCO-transfected cells. Strain differences with regard to SR distribution were also examined. There was a differential expression of these SR on AM from each strain, with MARCO dominant for C57BL/6, CD36 dominant on BALB/c, and all three SR expressed on 129/SvJ mice. Similar to the results with C57BL/6 AM, MARCO was involved with silica-induced cell death in the 129/SvJ strain. In contrast, BALB/c AM used an unidentified mechanism for silica uptake because the SR antibodies failed to block particle internalization. Taken together, these results indicate MARCO is the primary AM receptor interacting with silica, depending on mouse strain and level of constitutive expression.	Univ Montana, Dept Biomed & Pharmaceut Sci, Ctr Environm Hlth Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Holian, A (corresponding author), 32 Campus Dr, Missoula, MT 59812 USA.	andrij.holian@umontana.edu		Holian, Andrij/0000-0003-0072-4538	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004804] Funding Source: NIH RePORTER; NCRR NIH HHS [P20-RR-017670] Funding Source: Medline; NIEHS NIH HHS [ES-04804] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Arredouani MS, 2006, AM J RESP CELL MOL, V35, P474, DOI 10.1165/rcmb.2006-0128OC; Arredouani MS, 2004, CELL MOL BIOL, V50, P657; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; Calvo D, 1998, J LIPID RES, V39, P777; Chao SL, 2001, TOXICOL APPL PHARM, V174, P10, DOI 10.1006/taap.2001.9190; Coller SP, 2001, J LEUKOCYTE BIOL, V70, P142; Cooper GS, 2002, INT IMMUNOPHARMACOL, V2, P303, DOI 10.1016/S1567-5769(01)00181-3; CROWELL RE, 1992, EXP LUNG RES, V18, P435, DOI 10.3109/01902149209064338; Daugherty A, 2000, J LIPID RES, V41, P1568; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Hamilton Raymond F. Jr., 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P75; Hamilton RF, 2000, TOXICOL APPL PHARM, V162, P100, DOI 10.1006/taap.1999.8799; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Hsu HY, 1998, J BIOL CHEM, V273, P1240, DOI 10.1074/jbc.273.2.1240; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Jiang Y, 2006, J BIOL CHEM, V281, P9058, DOI 10.1074/jbc.M507874200; Jozefowski S, 2005, J IMMUNOL, V175, P8032, DOI 10.4049/jimmunol.175.12.8032; KOBZIK L, 1995, J IMMUNOL, V155, P367; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Migliaccio CT, 2005, TOXICOL APPL PHARM, V205, P168, DOI 10.1016/j.taap.2004.11.005; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Nakamura K, 2001, BBA-GENE STRUCT EXPR, V1522, P53, DOI 10.1016/S0167-4781(01)00284-6; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Palecanda Aiyappa, 2001, Current Molecular Medicine (Hilversum), V1, P589, DOI 10.2174/1566524013363384; Peretz A, 2006, ISR MED ASSOC J, V8, P114; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; STRINGER B, 1995, CYTOMETRY, V20, P23, DOI 10.1002/cyto.990200106; Su SH, 2001, J IMMUNOL, V167, P5084, DOI 10.4049/jimmunol.167.9.5084; Whitman SC, 2000, J LIPID RES, V41, P807; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	33	111	113	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34218	34226		10.1074/jbc.M605229200	http://dx.doi.org/10.1074/jbc.M605229200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16984918	hybrid			2022-12-27	WOS:000241767600042
J	Lamalice, L; Houle, F; Huot, J				Lamalice, Laurent; Houle, Francois; Huot, Jacques			Phosphorylation of Tyr(1214) within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; ACTIN-BASED MOTILITY; PROTEIN-KINASE; SRC KINASE; AUTOPHOSPHORYLATION SITE; ADAPTER PROTEIN; DNA-SYNTHESIS; KDR; FAMILY; BINDING	VEGFR-2 is the major receptor that regulates the different functions of VEGF in adults. We have previously reported that following VEGF treatment of endothelial cells, VEGFR-2 is phosphorylated on Tyr1214 upstream of the Cdc42-SAPK2/p38MAPKAP K2 pathway. However, little is known of the earliest molecular events that compose the SAPK2/p38 pathway following VEGFR-2 activation. In this study, we address this question using HA-tagged constructs of either wild-type VEGFR-2 or Y1214F VEGFR-2 mutant in immunoprecipitation assays. We show that the Src family kinase member Fyn, but not c-Src itself, is recruited to VEGFR-2 and is activated in a p similar to Tyr(1214)-dependent manner. We also report that the SH2 domain-containing adapter molecule Nck, but not Grb2, is recruited to VEGFR-2 in a p similar to Tyr1214-dependent manner and that it associates with Fyn. Moreover, PAK-2 is phosphorylated in a Fyn-dependent manner. Using chemical and genetic inhibitors, we show that Fyn activity is required for SAPK2/p38 but not for FAK activation in response to VEGF. In contrast, c-Src permits activation of FAK, but not that of SAPK2/p38. In addition, Fyn is required for stress fiber formation and endothelial cell migration. We propose a model in which Fyn forms a molecular complex with Nck and PAK-2 and suggest that this complex assembles in a p similar to Tyr(1214)-dependent manner within VEGFR-2 following VEGF treatment. In turn, this triggers the activation of the SAPK2/p38 MAP kinase module, and promotes stress fiber formation and endothelial cell migration.	Univ Laval, Hotel Dieu, Ctr Rech Cancerol, Quebec City, PQ G1R 2J6, Canada	Laval University	Huot, J (corresponding author), Univ Laval, Hotel Dieu, Ctr Rech Cancerol, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	Jacques.Huot@phc.ulaval.ca						Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Cai J, 2006, MICROVASC RES, V71, P20, DOI 10.1016/j.mvr.2005.10.004; Chou MT, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-32; Cunningham SA, 1997, BIOCHEM BIOPH RES CO, V240, P635, DOI 10.1006/bbrc.1997.7719; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ellis C, 1996, ONCOGENE, V12, P1727; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; HOLMQVIST K, 2004, J BIOL CHEM, V16, P16; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Igarashi K, 1998, BIOCHEM BIOPH RES CO, V246, P95, DOI 10.1006/bbrc.1998.8578; Ito N, 1998, J BIOL CHEM, V273, P23410, DOI 10.1074/jbc.273.36.23410; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lamy S, 2002, CANCER RES, V62, P381; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Lin HM, 1998, J BIOL CHEM, V273, P19914, DOI 10.1074/jbc.273.31.19914; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; MEYER RD, 2002, J BIOL CHEM, V22, P22; Mitola S, 2006, CIRC RES, V98, P45, DOI 10.1161/01.RES.0000199355.32422.7b; Renkema GH, 2002, MOL CELL BIOL, V22, P6719, DOI 10.1128/MCB.22.19.6719-6725.2002; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; ROUSSEAU S, 2006, IN PRESS CELL SIGNAL; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stoletov KV, 2004, EXP CELL RES, V295, P258, DOI 10.1016/j.yexcr.2004.01.008; STOLETOV KV, 2001, J BIOL CHEM, V8, P8; Summy JM, 2003, J CELL SCI, V116, P2585, DOI 10.1242/jcs.00466; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Warner AJ, 2000, BIOCHEM J, V347, P501, DOI 10.1042/0264-6021:3470501; Wu LW, 2000, J BIOL CHEM, V275, P6059, DOI 10.1074/jbc.275.9.6059	44	114	124	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34009	34020		10.1074/jbc.M603928200	http://dx.doi.org/10.1074/jbc.M603928200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966330	hybrid			2022-12-27	WOS:000241767600021
J	Li, YP; Hernandez-Martinez, S; Fernandez, F; Mayoral, JG; Topalis, P; Priestap, H; Perez, M; Navare, A; Noriega, FG				Li, Yiping; Hernandez-Martinez, Salvador; Fernandez, Facundo; Mayoral, Jaime G.; Topalis, Pantelis; Priestap, Horacio; Perez, Mario; Navare, Arti; Noriega, Fernando G.			Biochemical, molecular, and functional characterization of PISCF-allatostatin, a regulator of juvenile hormone biosynthesis in the mosquito Aedes aegypti	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORPORA ALLATA; III BIOSYNTHESIS; IDENTIFICATION; NEUROPEPTIDES; PEPTIDE; PATHWAY; ASSAY; CDNA; ACID; RNA	Aedes aegypti PISCF-allatostatin or allatostatin-C (Ae-AS-C) was isolated using a combination of high performance liquid chromatography and enzyme-linked immunosorbent assay (ELISA). The matrix-assisted laser desorption/ionization time-of-flight (TOF) mass spectrum of positive ELISA fractions revealed a molecular mass of 1919.0 Da, in agreement with the sequence qIRYRQCYFNPISCF, with bridged cysteines. This sequence was confirmed by matrix-assisted laser desorption/ionization tandem TOF/TOF mass spectrometry analysis. The corresponding Ae-AS-C cDNA was amplified by PCR, and the sequence of the peptide was confirmed. An in vitro radiochemical assay was used to study the inhibitory effect of synthetic Ae-AS-C on juvenile hormone biosynthesis by the isolated corpora allata(CA) of adult female A. aegypti. The inhibitory action of synthetic Ae-AS-C was dose-dependent; with a maximum at 10(-9) M. Ae-AS-C showed no inhibitory activity in the presence of farnesoic acid, an immediate precursor of juvenile hormone, indicating that the Ae-AS-C target is located before the formation of farnesoic acid in the pathway. The sensitivity of the CA to inhibition by Ae-AS-C in the in vitro assay varied during the adult life; the CA was most sensitive during periods of low synthetic activity. In addition, the levels of Ae-AS-C in the brain were studied using ELISA and reached a maximum at 3 days after eclosion. These studies suggest that Ae-AS-C is an important regulator of CA activity in A. aegypti.	Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; INSP, Ctr Invest Sobre Enfermedades Infeddiosas, Cuernavaca 62100, Morelos, Mexico; Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Crete, Greece	State University System of Florida; Florida International University; University System of Georgia; Georgia Institute of Technology	Noriega, FG (corresponding author), Florida Int Univ, Dept Biol Sci, 11200 SW 8th St, Miami, FL 33199 USA.	noriegaf@fiu.edu	Fernandez, Facundo Martin/B-7015-2008; G. Mayoral, Jaime/J-5392-2018	Fernandez, Facundo Martin/0000-0002-0302-2534; G. Mayoral, Jaime/0000-0002-8813-6804; Hernandez-Martinez, Salvador/0000-0003-1276-9397	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045545, R01 AI045545-08, AI 45545] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AUDLEY N, 2002, PEPTIDES, V23, P717; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bendena WG, 1999, ANN NY ACAD SCI, V897, P311, DOI 10.1111/j.1749-6632.1999.tb07902.x; BENNETT HPJ, 1981, BIOCHEMISTRY-US, V20, P4530, DOI 10.1021/bi00519a004; ENGELMAN F, 1970, PHYSL INSECT REPROD; FEYEREISEN R, 1987, J BIOL CHEM, V262, P2676; FEYEREISEN R, 1981, ANAL BIOCHEM, V111, P372, DOI 10.1016/0003-2697(81)90575-3; FEYEREISEN R, 1985, METHOD ENZYMOL, V111, P530; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Goodman W.G., 2005, COMPREHENSIVE MOL IN, P55; Hernandez-Martinez S, 2005, CELL TISSUE RES, V321, P105, DOI 10.1007/s00441-005-1133-5; Knudson DL, 2002, INSECT BIOCHEM MOLEC, V32, P1193, DOI 10.1016/S0965-1748(02)00082-6; KRAMER SJ, 1991, P NATL ACAD SCI USA, V88, P9458, DOI 10.1073/pnas.88.21.9458; Kreienkamp HJ, 2002, J BIOL CHEM, V277, P39937, DOI 10.1074/jbc.M206931200; Li YP, 2004, REGUL PEPTIDES, V118, P175, DOI 10.1016/j.regpep.2003.12.004; Li YP, 2003, INSECT BIOCHEM MOLEC, V33, P1307, DOI 10.1016/j.ibmb.2003.07.003; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Matthews HJ, 2006, J INSECT PHYSIOL, V52, P128, DOI 10.1016/j.jinsphys.2005.07.006; Noriega F.G., 1993, Insect Molecular Biology, V2, P21, DOI 10.1111/j.1365-2583.1993.tb00121.x; Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013; Noriega FG, 1999, INSECT BIOCHEM MOLEC, V29, P243, DOI 10.1016/S0965-1748(98)00132-5; PRATT GE, 1990, MOL CELL ENDOCRINOL, V70, P185, DOI 10.1016/0303-7207(90)90158-5; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; SHAPIRO AB, 1986, J INSECT PHYSIOL, V32, P867, DOI 10.1016/0022-1910(86)90102-2; Stay B, 2000, INSECT BIOCHEM MOLEC, V30, P653, DOI 10.1016/S0965-1748(00)00036-9; Sutherland TD, 1996, MOL CELL ENDOCRINOL, V120, P115, DOI 10.1016/0303-7207(96)03825-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Veenstra JA, 1999, PEPTIDES, V20, P1145, DOI 10.1016/S0196-9781(99)00117-5; Veenstra JA, 1997, PEPTIDES, V18, P937, DOI 10.1016/S0196-9781(97)00032-6	29	41	42	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34048	34055		10.1074/jbc.M606341200	http://dx.doi.org/10.1074/jbc.M606341200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16968697	Green Accepted, hybrid			2022-12-27	WOS:000241767600025
J	Panda, SP; Gao, YT; Roman, LJ; Martasek, P; Salerno, JC; Masters, BSS				Panda, Satya Prakash; Gao, Ying Tong; Roman, Linda J.; Martasek, Pavel; Salerno, John C.; Masters, Bettie Sue S.			The role of a conserved serine residue within hydrogen bonding distance of FAD in redox properties and the modulation of catalysis by Ca2+/calmodulin of constitutive nitric-oxide synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 OXIDOREDUCTASE; AUTOINHIBITORY CONTROL ELEMENT; ELECTRON FLOW-THROUGH; MOLECULAR-CLONING; BINDING DOMAIN; FERREDOXIN-NADP(+) REDUCTASE; P-450 OXIDOREDUCTASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FMN	The crystal structure of the neuronal nitric-oxide synthase (nNOS) NADPH/FAD binding domain indicated that Ser-1176 is within hydrogen bonding distance of Asp-1393 and the O4 atom of FAD and is also near the N5 atom of FAD (3.7 angstrom). This serine residue is conserved in most of the ferredoxin-NADP(+) reductase family of proteins and is important in electron transfer. In the present study, the homologous serines of both nNOS(Ser-1176) and endothelial nitric-oxide synthase (eNOS) (Ser-942) were mutated to threonine and alanine. Both substitutions yielded proteins that exhibited decreased rates of electron transfer through the flavin domains, in the presence and absence of Ca2+/CaM, as measured by reduction of potassium ferricyanide and cytochrome c. Rapid kinetics measurements of flavin reduction of all the mutants also showed a decrease in the rate of flavin reduction, in the absence and presence of Ca2+/CaM, as compared with the wild type proteins. The serine to alanine substitution caused both nNOS and eNOS to synthesize NO more slowly; however, the threonine mutants gave equal or slightly higher rates of NO production compared with the wild type enzymes. The midpoint redox potential measurements of all the redox centers revealed that wild type and threonine mutants of both nNOS and eNOS are very similar. However, the redox potentials of the FMN/FMNH center dot couple for alanine substitutions of both nNOS and eNOS are > 100mV higher than those of wild type proteins and are positive. These data presented here suggest that hydrogen bonding of the hydroxyl group of serine or threonine with the isoalloxazine ring of FAD and with the amino acids in its immediate milieu, particularly nNOS Asp-1393, affects the redox potentials of various flavin states, influencing the rate of electron transfer.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA; Kennesaw State Coll, Coll Sci & Math, Dept Biol & Phys Sci, Kennesaw, GA 30144 USA; Charles Univ Prague, Sch Med 1, Dept Pediat, Prague 221, Czech Republic	University of Texas System; University of Texas Health San Antonio; University System of Georgia; Kennesaw State University; Charles University Prague	Masters, BSS (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	masters@uthscsa.edu	salerno, john c/A-2595-2014; Martásek, Pavel/G-6622-2017	Martásek, Pavel/0000-0001-6165-4444	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030050, R37HL030050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052419] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30050] Funding Source: Medline; NIGMS NIH HHS [GM52419] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER LM, 1980, MICROSOMES DRUG OXID, P285; Aliverti A, 1999, METH MOL B, V131, P9; ALIVERTI A, 1995, BIOCHEMISTRY-US, V34, P8371, DOI 10.1021/bi00026a019; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; DUJON B, 1994, NATURE, V369, P371, DOI 10.1038/369371a0; Dunford AJ, 2004, EUR J BIOCHEM, V271, P2548, DOI 10.1111/j.1432-1033.2004.04185.x; Dutton P L, 1978, Methods Enzymol, V54, P411; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Faro M, 2002, EUR J BIOCHEM, V269, P2656, DOI 10.1046/j.1432-1033.2002.02925.x; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Flinspach M, 2004, BIOCHEMISTRY-US, V43, P5181, DOI 10.1021/bi0361867; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2006, J BIOL CHEM, V281, P14173, DOI 10.1074/jbc.M509937200; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Jachymova M, 2005, P NATL ACAD SCI USA, V102, P15833, DOI 10.1073/pnas.0506522102; KARPLUS PA, 1984, BIOCHEMISTRY-US, V23, P6576, DOI 10.1021/bi00321a046; KELM M, 1988, BIOCHEM BIOPH RES CO, V154, P236, DOI 10.1016/0006-291X(88)90675-4; Kimura S, 2003, J BIOL CHEM, V278, P3580, DOI 10.1074/jbc.M209838200; Knight K, 2002, BIOCHEM J, V367, P19, DOI 10.1042/BJ20020667; KURZBAN GP, 1990, J BIOL CHEM, V265, P12272; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Li HY, 2002, BIOCHEMISTRY-US, V41, P13868, DOI 10.1021/bi020417c; Makino K, 1999, GENES GENET SYST, V74, P227, DOI 10.1266/ggs.74.227; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; Martasek P, 1999, METHOD ENZYMOL, V301, P70; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Masters B, 1967, METHOD ENZYMOL, V10, P565; MICHAEL SF, 1994, BIOTECHNIQUES, V16, P410; Miller RT, 1999, BIOCHEM BIOPH RES CO, V265, P184, DOI 10.1006/bbrc.1999.1643; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; OHGIYA S, 1994, BBA-BIOENERGETICS, V1186, P137, DOI 10.1016/0005-2728(94)90146-5; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; PIETRINI G, 1988, P NATL ACAD SCI USA, V85, P7246, DOI 10.1073/pnas.85.19.7246; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Rieske JS, 1967, METHOD ENZYMOL, V10, P488, DOI DOI 10.1016/0076-6879(67)10081-5; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2000, J BIOL CHEM, V275, P21914, DOI 10.1074/jbc.M002449200; Roman LJ, 2003, J BIOL CHEM, V278, P25700, DOI 10.1074/jbc.M212309200; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; RUETTINGER RT, 1989, J BIOL CHEM, V264, P10987; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; SEM DS, 1992, BIOCHEMISTRY-US, V31, P3391, DOI 10.1021/bi00128a013; SHEN AL, 1989, J BIOL CHEM, V264, P7584; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; Shen AL, 1996, BIOCHEMISTRY-US, V35, P9451, DOI 10.1021/bi960587n; Shen AL, 2000, J BIOL CHEM, V275, P41087, DOI 10.1074/jbc.M008380200; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; VAUCHERET H, 1989, MOL GEN GENET, V216, P10, DOI 10.1007/BF00332224; VERMILION JL, 1981, J BIOL CHEM, V256, P266; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200; ZHANG MJ, 1994, BIOCHEMISTRY-US, V33, P1163, DOI 10.1021/bi00171a016	65	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34246	34257		10.1074/jbc.M601041200	http://dx.doi.org/10.1074/jbc.M601041200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966328	Green Published, hybrid			2022-12-27	WOS:000241767600045
J	Watson, IR; Blanch, A; Lin, DCC; Ohh, M; Irwin, MS				Watson, Ian R.; Blanch, Alvaro; Lin, Dan C. C.; Ohh, Michael; Irwin, Meredith S.			Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE C-ABL; P53-RELATED PROTEIN; APOPTOTIC RESPONSE; UBIQUITIN LIGASE; OVARIAN-CANCER; P73; P53; MDM2; DELTA-NP73; EXPRESSION	Mutations in p73 are rare in cancer. Emerging evidence suggests that the relative expression of various p73 isoforms may contribute to tumorigenesis. Alternative promoters and N-terminal splicing result in the transcription and processing of either full-length (TA) or N-terminally truncated (Delta N) p73 isoforms. TAp73 possesses pro-apoptotic functions, while Delta Np73 has anti-apoptotic properties via functional inhibition of TAp73 and p53. Here, we report that TAp73, but not Delta Np73, is covalently modified by NEDD8 under physiologic conditions in an Mdm2-dependent manner. Co-expression of NEDP1, a cysteine protease that specifically cleaves NEDD8 conjugates, was shown to deneddylate TAp73. In addition, blockage of the endogenous NEDD8 pathway increased TAp73-mediated transactivation of p53- and p73-responsive promoter-driven reporter activity, and in conjunction, neddylated TAp73 species were found preferentially in the cytoplasm. These results suggest that Mdm2 attenuates TAp73 transactivation function, at least in part, by promoting NEDD8-dependent TAp73 cytoplasmic localization and provide the first evidence of a covalent post-translational modification exclusively targeting the TA isoforms of p73.	Hosp Sick Children, Canc Res Program, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Paediat, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Irwin, MS (corresponding author), Hosp Sick Children, Canc Res Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	meredith.irwin@sickkids.ca		Watson, Ian/0000-0002-6025-3080				Agami R, 1999, NATURE, V399, P809; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bernassola F, 2004, J EXP MED, V199, P1545, DOI 10.1084/jem.20031943; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993; Concin N, 2004, CANCER RES, V64, P2449, DOI 10.1158/0008-5472.CAN-03-1060; Concin N, 2005, CLIN CANCER RES, V11, P8372, DOI 10.1158/1078-0432.CCR-05-0899; CONSTANZO A, 2002, MOL CELL, V9, P175; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Dobbelstein M, 1999, ONCOGENE, V18, P2101, DOI 10.1038/sj.onc.1202512; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; Douc-Rasy S, 2002, AM J PATHOL, V160, P631, DOI 10.1016/S0002-9440(10)64883-3; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gong JG, 1999, NATURE, V399, P806; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Gu JJ, 2001, CANCER RES, V61, P6703; Guan M, 2005, J CLIN PATHOL, V58, P1175, DOI 10.1136/jcp.2005.026955; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HIRSCHBERG J, 1982, J CELL PHYSIOL, V113, P159, DOI 10.1002/jcp.1041130125; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Inoue T, 2002, J BIOL CHEM, V277, P15053, DOI 10.1074/jbc.M200248200; Irwin MS, 2004, CELL DEATH DIFFER, V11, pS17, DOI 10.1038/sj.cdd.4401452; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Ishimoto O, 2002, CANCER RES, V62, P636; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Miyazaki K, 2003, BIOCHEM BIOPH RES CO, V308, P106, DOI 10.1016/S0006-291X(03)01347-0; Muller M, 2005, CELL DEATH DIFFER, V12, P1564, DOI 10.1038/sj.cdd.4401774; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Oberst A, 2005, BIOCHEM BIOPH RES CO, V331, P707, DOI 10.1016/j.bbrc.2005.03.158; Ongkeko WM, 1999, CURR BIOL, V9, P829, DOI 10.1016/S0960-9822(99)80367-4; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Putzer B, 2003, CELL DEATH DIFFER, V10, P612, DOI 10.1038/sj.cdd.4401205; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Wang XQ, 2001, FEBS LETT, V490, P202, DOI 10.1016/S0014-5793(01)02124-X; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zeng XY, 1999, MOL CELL BIOL, V19, P3257	54	87	95	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34096	34103		10.1074/jbc.M603654200	http://dx.doi.org/10.1074/jbc.M603654200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16980297	hybrid			2022-12-27	WOS:000241767600030
J	Evans, CG; Wisen, S; Gestwicki, JE				Evans, Christopher G.; Wisen, Susanne; Gestwicki, Jason E.			Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; ALPHA-SYNUCLEIN AGGREGATION; ALZHEIMERS-DISEASE; MOLECULAR CHAPERONES; SECRETED OLIGOMERS; FIBRIL FORMATION; LIGANDS ADDLS; HSP70; PEPTIDE; MODULATORS	Alzheimer disease is a neurological disorder that is characterized by the presence of fibrils and oligomers composed of the amyloid beta(A beta) peptide. In models of Alzheimer disease, overexpression of molecular chaperones, specifically heat shock protein 70 (Hsp70), suppresses phenotypes related to A beta aggregation. These observations led to the hypothesis that chaperones might interact with A beta and block self-association. However, although biochemical evidence to support this model has been collected in other neurodegenerative systems, the interaction between chaperones and A beta has not been similarly explored. Here, we examine the effects of Hsp70/40 and Hsp90 on A beta aggregation in vitro. We found that recombinant Hsp70/40 and Hsp90 block A beta self-assembly and that these chaperones are effective at substoichiometric concentrations (similar to 1: 50). The antiaggregation activity of Hsp70 can be inhibited by a nonhydrolyzable nucleotide analog and encouraged by pharmacological stimulation of its ATPase activity. Finally, we were interested in discerning what type of amyloid structures can be acted upon by these chaperones. To address this question, we added Hsp70/ 40 and Hsp90 to pre-formed oligomers and fibrils. Based on thioflavin T reactivity, the combination of Hsp70/40 and Hsp90 caused structural changes in oligomers but had little effect on fibrils. These results suggest that if these chaperones are present in the same cellular compartment in which A beta is produced, Hsp70/40 and Hsp90 may suppress the early stages of self-assembly. Thus, these results are consistent with a model in which pharmacological activation of chaperones might have a favorable therapeutic effect on Alzheimer disease.	Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gestwicki, JE (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	gestwick@umich.edu			NIA NIH HHS [P50 AG08671] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG008671] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguzzi A, 2004, J CLIN INVEST, V114, P153, DOI [10.1172/JCI22438, 10.1172/JCI200422438]; Aisen PS, 2005, CNS DRUGS, V19, P989, DOI 10.2165/00023210-200519120-00002; BAKTHISARAN R, 2005, BIOCHEM J, V392, P573; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bohrmann B, 2000, J STRUCT BIOL, V130, P232, DOI 10.1006/jsbi.2000.4241; Brendza RP, 2005, J CLIN INVEST, V115, P428, DOI 10.1172/JCI200523269; Brodsky JL, 1999, BIOCHEM PHARMACOL, V57, P877, DOI 10.1016/S0006-2952(98)00376-1; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; BURDICK D, 1992, J BIOL CHEM, V267, P546; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705; Esler WP, 1996, BIOCHEMISTRY-US, V35, P749, DOI 10.1021/bi951685w; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Findeis Mark A., 2002, Current Topics in Medicinal Chemistry, V2, P417, DOI 10.2174/1568026024607508; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; FULLER SJ, 1995, BIOCHEMISTRY-US, V34, P8091, DOI 10.1021/bi00025a015; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Grant Susan M., 2000, Journal of Alzheimer's Disease, V2, P207; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; John V, 2006, CURR TOP MED CHEM, V6, P569, DOI 10.2174/156802606776743084; Kappe CO, 2003, METHOD ENZYMOL, V369, P197; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Lee S, 2005, PROTEIN SCI, V14, P593, DOI 10.1110/ps.041020705; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 1999, METHOD ENZYMOL, V309, P467; Lowe TL, 2001, BIOCHEMISTRY-US, V40, P7882, DOI 10.1021/bi002734u; Magrane J, 2005, J NEUROSCI, V25, P10960, DOI 10.1523/JNEUROSCI.1723-05.2005; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; MARTIN BL, 1995, J BIOL CHEM, V270, P26727, DOI 10.1074/jbc.270.45.26727; MATSUMOTO A, 1994, EUR J BIOCHEM, V225, P1055, DOI 10.1111/j.1432-1033.1994.1055b.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Morelli L, 2002, NEUROCHEM RES, V27, P1387, DOI 10.1023/A:1021679817756; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nadler SG, 1998, BIOCHEM BIOPH RES CO, V253, P176, DOI 10.1006/bbrc.1998.9775; Pangalos MN, 2005, BIOCHEM SOC T, V33, P553, DOI 10.1042/BST0330553; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; POLLARD TD, 1981, J CELL BIOL, V88, P654, DOI 10.1083/jcb.88.3.654; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rieger TR, 2006, BIOPHYS J, V90, P886, DOI 10.1529/biophysj.105.066662; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Schmidt B, 2006, CURR TOP MED CHEM, V6, P377, DOI 10.2174/156802606776287027; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; TABATON M, 1991, P NATL ACAD SCI USA, V88, P2098, DOI 10.1073/pnas.88.6.2098; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; UMEZAWA H, 1981, J ANTIBIOT, V34, P1622, DOI 10.7164/antibiotics.34.1622; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yan SD, 1997, NATURE, V389, P689	89	301	323	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33182	33191		10.1074/jbc.M606192200	http://dx.doi.org/10.1074/jbc.M606192200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16973602	hybrid			2022-12-27	WOS:000241621400026
J	Ho, MR; Lou, YC; Lin, WC; Lyu, PC; Huang, WN; Chen, C				Ho, Meng-Ru; Lou, Yuan-Chao; Lin, Wen-Chang; Lyu, Ping-Chiang; Huang, Wei-Ning; Chen, Chinpan			Human pancreatitis-associated protein forms fibrillar aggregates with a native-like conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-LIKE FIBRILS; PROBING SOLVENT ACCESSIBILITY; SOLUTION NMR-SPECTROSCOPY; URE2P PRION FILAMENTS; IN-VITRO; SECONDARY STRUCTURE; MESSENGER-RNA; RESONANCE ASSIGNMENTS; CIRCULAR-DICHROISM; ALZHEIMERS-DISEASE	Human pancreatitis-associated protein was identified in pathognomonic lesions of Alzheimer disease, a disease characterized by the presence of filamentous protein aggregates. Here, we showed that at physiological pH, human pancreatitis-associated protein forms non-Congo Red-binding, proteinase K-resistant fibrillar aggregates with diameters from 6 up to as large as 68 nm. Interestingly, circular dichroism and Fourier transform infrared spectra showed that, unlike typical amyloid fibrils, which have a cross-beta-sheet structure, these aggregates have a very similar secondary structure to that of the native protein, which is composed of two alpha-helices and eight beta-strands, as determined by NMR techniques. Surface structure analysis showed that the positively charged and negatively charged residues were clustered on opposite sides, and strong electrostatic interactions between molecules were therefore very likely, which was confirmed by cross-linking experiments. In addition, several hydrophobic residues were found to constitute a continuous hydrophobic surface. These results and protein aggregation prediction using the TANGO algorithm led us to synthesize peptide Thr(84) to Ser(116), which, very interestingly, was found to form amyloid-like fibrils with a cross-beta structure. Thus, our data suggested that human pancreatitis-associated protein fibrillization is initiated by protein aggregation primarily because of electrostatic interactions, and the loop from residues 84 to 116 may play an important role in the formation of fibrillar aggregates with a native-like conformation.	Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; Natl Tsing Hua Univ, Coll Life Sci, Inst Bioinformat & Struct Biol, Hsinchu 300, Taiwan; Yuanpei Inst Sci & Technol, Dept Biotechnol, Hsinchu 300, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University	Chen, C (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	bmchinp@ibms.sinica.edu.tw	Ho, Meng-Ru/F-9844-2019; Chen, Chinpan/O-4202-2018; Lin, Wen-chang/B-3100-2011; Lin, Wen-chang/ABH-7976-2020	Ho, Meng-Ru/0000-0001-7344-695X; Lin, Wen-chang/0000-0003-0194-1745; Lin, Wen-chang/0000-0003-0194-1745				Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; BERNARD JP, 1992, GASTROENTEROLOGY, V103, P1277, DOI 10.1016/0016-5085(92)91516-7; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELELLIS RA, 1968, J HISTOCHEM CYTOCHEM, V16, P663, DOI 10.1177/16.10.663-a; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dos Reis S, 2002, J BIOL CHEM, V277, P5703, DOI 10.1074/jbc.M110183200; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Duplan L, 2001, NEUROBIOL AGING, V22, P79, DOI 10.1016/S0197-4580(00)00182-2; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Eneqvist T, 2002, BIOCHEMISTRY-US, V41, P13143, DOI 10.1021/bi025800w; Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fowler SB, 2005, P NATL ACAD SCI USA, V102, P10105, DOI 10.1073/pnas.0501215102; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Graf R, 2001, J BIOL CHEM, V276, P21028, DOI 10.1074/jbc.M010717200; Gregoire C, 2001, EMBO J, V20, P3313, DOI 10.1093/emboj/20.13.3313; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Ho MR, 2004, J BIOMOL NMR, V30, P381, DOI 10.1007/s10858-004-3499-1; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; IOVANNA J, 1991, J BIOL CHEM, V266, P24664; Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LASSERRE C, 1992, CANCER RES, V52, P5089; Laurine E, 2003, J BIOL CHEM, V278, P51770, DOI 10.1074/jbc.M306767200; Lin TH, 1998, J BIOMOL NMR, V11, P363, DOI 10.1023/A:1008226515482; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Motoo Y, 1998, INT J PANCREATOL, V23, P11; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; ORELLE B, 1992, J CLIN INVEST, V90, P2284, DOI 10.1172/JCI116115; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Rosty C, 2002, CANCER RES, V62, P1868; SAFAR J, 1993, BIOPOLYMERS, V33, P1461, DOI 10.1002/bip.360330915; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; TACHIBANA K, 1988, MOL ENDOCRINOL, V2, P973, DOI 10.1210/mend-2-10-973; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Wang LM, 2002, P NATL ACAD SCI USA, V99, P15947, DOI 10.1073/pnas.252508399; Waterhouse SH, 2004, AUST J CHEM, V57, P519, DOI 10.1071/CH04070; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099	66	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33566	33576		10.1074/jbc.M604513200	http://dx.doi.org/10.1074/jbc.M604513200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16963458	hybrid			2022-12-27	WOS:000241621400066
J	Cremniter, J; Mainardi, JL; Josseaume, N; Quincampoix, JC; Dubost, L; Hugonnet, JE; Marie, A; Gutmann, L; Rice, LB; Arthur, M				Cremniter, Julie; Mainardi, Jean-Luc; Josseaume, Nathalie; Quincampoix, Jean-Charles; Dubost, Lionel; Hugonnet, Jean-Emmanuel; Marie, Arul; Gutmann, Laurent; Rice, Louis B.; Arthur, Michel			Novel mechanism of resistance to glycopeptide antibiotics in Enterococcus faecium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM RESISTANCE; PEPTIDOGLYCAN PRECURSORS; VANCOMYCIN RESISTANCE; STAPHYLOCOCCUS-AUREUS; PENICILLIN; TRANSPEPTIDATION; PROTEINS; BACTERIA; BM4147; ENZYME	Glycopeptides and beta-lactams are the major antibiotics available for the treatment of infections due to Gram-positive bacteria. Emergence of cross-resistance to these drugs by a single mechanism has been considered as unlikely because they inhibit peptidoglycan polymerization by different mechanisms. The glycopeptides bind to the peptidyl-D-Ala(4)-D-Ala(5) extremity of peptidoglycan precursors and block by steric hindrance the essential glycosyltransferase and D, D-transpeptidase activities of the penicillin-binding proteins (PBPs). The beta-lactams are structural analogues of D-Ala(4)-D-Ala(5) and act as suicide substrates of the D, D-transpeptidase module of the PBPs. Here we have shown that bypass of the PBPs by the recently described beta-lactam-insensitive L, D-transpeptidase from Enterococcus faecium (Ldt(fm)) can lead to high level resistance to glycopeptides and beta-lactams. Cross-resistance was selected by glycopeptides alone or serially by beta-lactams and glycopeptides. In the corresponding mutants, UDP-MurNAc-pentapeptide was extensively converted to UDP-MurNAc-tetrapeptide following hydrolysis of D-Ala(5), thereby providing the substrate of Ldt(fm). Complete elimination of D-Ala(5), a residue essential for glycopeptide binding, was possible because Ldtfm uses the energy of the L-Lys(3)-D-Ala(4) peptide bond for cross-link formation in contrast to PBPs, which use the energy of the D-Ala(4)-D-Ala(5) bond. This novel mechanism of glycopeptide resistance was unrelated to the previously identified replacement of D-Ala(5) by D-Ser or D-lactate.	Univ Paris 06, INSERM U655, LRMA, Ctr Rech Biomed Cordeliers, F-75270 Paris, France; Univ Paris 05, Fac Med Rene Descartes, Ctr Rech Biomed Cordeliers, F-75006 Paris, France; Hop Europeen Georges Pompidou, APHP, F-75015 Paris, France; Museum Natl Hist Nat, USM0502, Plateforme Spectrometrie Masse & Prot Museum, Dept Rech Dev & Divers Mol, F-75005 Paris, France; CNRS, UMR 8041, F-75006 Paris, France; Louis Stokes Cleveland Vet Affairs Med Ctr, Med Serv, Cleveland, OH 44106 USA; Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Arthur, M (corresponding author), Univ Paris 06, INSERM U655, LRMA, Ctr Rech Biomed Cordeliers, 15 Rue Ecole Med, F-75270 Paris, France.	michel.arthur@bhdc.jussieu.fr	MAINARDI, Jean-Luc/E-2714-2014; HUGONNET, Jean-Emmanuel/ABC-7914-2021; Arthur, Michel/G-3680-2013; HUGONNET, Jean-Emmanuel/H-3581-2014	MAINARDI, Jean-Luc/0000-0002-4159-0129; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Arthur, Michel/0000-0003-1007-636X; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; MARIE, Arul/0000-0003-4104-140X; cremniter, julie/0000-0002-2249-8394	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045626] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 45626, R01 AI045626] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; ALOBEID S, 1992, FEMS MICROBIOL LETT, V91, P79, DOI 10.1111/j.1574-6968.1992.tb05187.x; Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; ARTHUR M, 1992, ANTIMICROB AGENTS CH, V36, P867, DOI 10.1128/AAC.36.4.867; Arthur M, 1996, MOL MICROBIOL, V21, P33, DOI 10.1046/j.1365-2958.1996.00617.x; Arthur M, 1998, MOL MICROBIOL, V30, P819, DOI 10.1046/j.1365-2958.1998.01114.x; ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Arthur M, 1996, TRENDS MICROBIOL, V4, P401, DOI 10.1016/0966-842X(96)10063-9; Baptista M, 1997, MOL MICROBIOL, V25, P93, DOI 10.1046/j.1365-2958.1997.4401812.x; Bellais S, 2006, J BIOL CHEM, V281, P11586, DOI 10.1074/jbc.M600114200; Biarrotte-Sorin S, 2006, J MOL BIOL, V359, P533, DOI 10.1016/j.jmb.2006.03.014; BILLOTKLEIN D, 1994, J BACTERIOL, V176, P2398, DOI 10.1128/JB.176.8.2398-2405.1994; Bouhss A, 2002, J BIOL CHEM, V277, P45935, DOI 10.1074/jbc.M207449200; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P902; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Mainard JL, 2002, J BIOL CHEM, V277, P35801, DOI 10.1074/jbc.M204319200; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; NIETO M, 1971, BIOCHEM J, V123, P789, DOI 10.1042/bj1230789; Rammelkamp CH, 1942, P SOC EXP BIOL MED, V51, P386, DOI 10.3181/00379727-51-13986; Reynolds PE, 2005, ANTIMICROB AGENTS CH, V49, P21, DOI 10.1128/AAC.49.1.21-25.2005; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219	27	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32254	32262		10.1074/jbc.M606920200	http://dx.doi.org/10.1074/jbc.M606920200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943188	Green Submitted, Green Accepted, hybrid			2022-12-27	WOS:000241414500022
J	Hayashida, Y; Urata, Y; Muroi, E; Kono, T; Miyata, Y; Nomata, K; Kanetake, H; Kondo, T; Ihara, Y				Hayashida, Yasushi; Urata, Yoshishige; Muroi, Eiji; Kono, Takaaki; Miyata, Yasuyoshi; Nomata, Koichiro; Kanetake, Hiroshi; Kondo, Takahito; Ihara, Yoshito			Calreticulin represses E-cadherin gene expression in Madin-Darby canine kidney cells via slug	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; FINGER TRANSCRIPTION FACTORS; MYOCARDIAL H9C2 CELLS; ENDOPLASMIC-RETICULUM; TUMOR PROGRESSION; BINDING PROTEIN; E47 REPRESSORS; CA2+ INFLUX; SNAIL; ADHESION	Calreticulin (CRT) is a multifunctional Ca2+-binding molecular chaperone in the endoplasmic reticulum. In mammals, the expression level of CRT differs markedly in a variety of organs and tissues, suggesting that CRT plays a specific role in each cell type. In the present study, we focused on CRT functions in the kidney, where overall expression of CRT is quite low, and established CRT-overexpressing kidney epithelial cell-derived Madin-Darby canine kidney cells by gene transfection. We demonstrated that, in CRT-overexpressing cells, the morphology was apparently changed, and the original polarized epithelial cell phenotype was destroyed. Furthermore, CRT-overexpressing cells showed enhanced migration through Matrigel (R)-coated Boyden chamber wells, compared with controls. E-cadherin expression was significantly suppressed at the protein and transcriptional levels in CRT-overexpressing cells compared with controls. On the other hand, the expression of mesenchymal protein markers, such as N-cadherin and fibronectin, was up-regulated. We also found that the expression of Slug, a repressor of the E-cadherin promoter, was up-regulated by overexpression of CRT through altered Ca2+ homeostasis, and this led to enhanced binding of Slug to the E-box element in the E-cadherin promoter. Thus, we conclude that CRT regulates the epithelial-mesenchymal transition-like change of cellular phenotype by modulating the Slug/E-cadherin pathway through altered Ca2+ homeostasis in cells, suggesting a novel function of CRT in cell-cell interaction of epithelial cells.	Nagasaki Univ, Grad Sch Biomed Sci, Dept Biochem & Mol Biol Dis, Atom Bomb Dis Inst, Nagasaki 8528523, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki 8528523, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi 3321102, Japan	Nagasaki University; Nagasaki University; Japan Science & Technology Agency (JST)	Ihara, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Biochem & Mol Biol Dis, Atom Bomb Dis Inst, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	y-ihara@net.nagasaki-u.ac.jp						Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Arnaudeau S, 2002, J BIOL CHEM, V277, P46696, DOI 10.1074/jbc.M202395200; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; Basu S, 1999, J EXP MED, V189, P797, DOI 10.1084/jem.189.5.797; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; BLASCHUK JM, 2001, J BIOL CHEM, V276, P27083; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen WG, 2003, J NEUROSCI, V23, P2572; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; den Dekker E, 2005, PFLUG ARCH EUR J PHY, V450, P236, DOI 10.1007/s00424-005-1409-3; Fadel MP, 2001, J BIOL CHEM, V276, P27083, DOI 10.1074/jbc.M101676200; Fasolato C, 1998, MOL BIOL CELL, V9, P1513, DOI 10.1091/mbc.9.6.1513; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Giroldi LA, 1997, BIOCHEM BIOPH RES CO, V241, P453, DOI 10.1006/bbrc.1997.7831; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Graff JR, 2000, J BIOL CHEM, V275, P2727, DOI 10.1074/jbc.275.4.2727; Graner M, 2000, CLIN CANCER RES, V6, P909; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hajra KM, 2002, CANCER RES, V62, P1613; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Hemavathy K, 2000, MOL CELL BIOL, V20, P5087, DOI 10.1128/MCB.20.14.5087-5095.2000; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; HOGEBOOM GH, 1955, METHOD ENZYMOL, V1, P16, DOI 10.1016/0076-6879(55)01007-0; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Hong SH, 2004, CANCER RES, V64, P5504, DOI 10.1158/0008-5472.CAN-04-0077; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ihara Y, 2006, AM J PHYSIOL-CELL PH, V290, pC208, DOI 10.1152/ajpcell.00075.2005; ImanakaYoshida K, 1996, J MOL CELL CARDIOL, V28, P553, DOI 10.1006/jmcc.1996.0051; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kageyama K, 2002, J BIOL CHEM, V277, P19255, DOI 10.1074/jbc.M112377200; Kageyama S, 2004, CLIN CHEM, V50, P857, DOI 10.1373/clinchem.2003.027425; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; LITTLEWOOD TD, 1995, PROTEIN PROFILE, V2, P621; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; Nakamura K, 2001, J CLIN INVEST, V107, P1245, DOI 10.1172/JCI12412; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Opas M, 1996, J CELL BIOL, V135, P1913, DOI 10.1083/jcb.135.6.1913; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; WAISMAN DM, 1985, J BIOL CHEM, V260, P1652; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Xu W, 2000, J BIOL CHEM, V275, P36676, DOI 10.1074/jbc.M002041200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yasuoka C, 2004, J BIOL CHEM, V279, P51182, DOI 10.1074/jbc.M407225200; Yoon GS, 2000, CANCER RES, V60, P1117; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200	77	30	33	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32469	32484		10.1074/jbc.M607240200	http://dx.doi.org/10.1074/jbc.M607240200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943193	hybrid			2022-12-27	WOS:000241414500045
J	Hiltunen, M; Lu, A; Thomas, AV; Romano, DM; Kim, M; Jones, PB; Xie, Z; Kounnas, MZ; Wagner, SL; Berezovska, O; Hyman, BT; Tesco, G; Bertram, L; Tanzi, RE				Hiltunen, Mikko; Lu, Alice; Thomas, Anne V.; Romano, Donna M.; Kim, Minji; Jones, Phill B.; Xie, Zhongcong; Kounnas, Maria Z.; Wagner, Steven L.; Berezovska, Oksana; Hyman, Bradley T.; Tesco, Giuseppina; Bertram, Lars; Tanzi, Rudolph E.			Ubiquilin 1 modulates amyloid precursor protein trafficking and A beta secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; PRESENILIN ENDOPROTEOLYSIS; MISSENSE MUTATIONS; GENE; ONSET; GAMMA; IDENTIFICATION; OVEREXPRESSION; UBIQUITINATION; ASSOCIATION	Ubiquilin 1 (UBQLN1) is a ubiquitin-like protein, which has been shown to play a central role in regulating the proteasomal degradation of various proteins, including the presenilins. We recently reported that DNA variants in UBQLN1 increase the risk for Alzheimer disease, by influencing expression of this gene in brain. Here we present the first assessment of the effects of UBQLN1 on the metabolism of the amyloid precursor protein (APP). For this purpose, we employed RNA interference to down-regulate UBQLN1 in a variety of neuronal and non-neuronal cell lines. We demonstrate that down-regulation of UBQLN1 accelerates the maturation and intracellular trafficking of APP, while not interfering with alpha-, beta-, or gamma-secretase levels or activity. UBQLN1 knockdown increased the ratio of APP mature/immature, increased levels of full-length APP on the cell surface, and enhanced the secretion of sAPP (alpha- and beta-forms). Moreover, UBQLN1 knockdown increased levels of secreted A beta 40 and A beta 42. Finally, employing a fluorescence resonance energy transfer-based assay, we show that UBQLN1 and APP come into close proximity in intact cells, independently of the presence of the presenilins. Collectively, our findings suggest that UBQLN1 may normally serve as a cytoplasmic "gatekeeper" that may control APP trafficking from intracellular compartments to the cell surface. These findings suggest that changes in UBQLN1 steady-state levels affect APP trafficking and processing, thereby influencing the generation of A beta.	Massachusetts Gen Hosp, Genet & Aging Res Unit, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Alzheimers Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; Torrey Pines Therapeut Inc, La Jolla, CA 92037 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Genet & Aging Res Unit, MassGen Inst Neurodegenerat Dis, 114 16th St C3009, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019; Bertram, Lars/K-3889-2015	Tanzi, Rudolph/0000-0002-7032-1454; Bertram, Lars/0000-0002-0108-124X; Jones, Phill/0000-0003-0525-6323	NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG023667] Funding Source: NIH RePORTER; NIA NIH HHS [5P01 AG 015379-08, 1R01 AG 023667-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Brouwers N, 2006, NEUROSCI LETT, V392, P72, DOI 10.1016/j.neulet.2005.08.064; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Ficklin MB, 2005, J BIOL CHEM, V280, P34088, DOI 10.1074/jbc.M506781200; Fournier KM, 2004, J BIOL CHEM, V279, P34505, DOI 10.1074/jbc.M404032200; Funakoshi M, 1999, EMBO J, V18, P5009, DOI 10.1093/emboj/18.18.5009; Gao L, 2003, J VIROL, V77, P4149, DOI 10.1128/JVI.77.7.4149-4159.2003; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guenette SY, 1999, J NEUROCHEM, V73, P985, DOI 10.1046/j.1471-4159.1999.0730985.x; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kamboh MI, 2006, MOL PSYCHIATR, V11, P273, DOI 10.1038/sj.mp.4001775; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; KLAFTER J, 1986, P NATL ACAD SCI USA, V83, P848, DOI 10.1073/pnas.83.4.848; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Lee EB, 2003, J BIOL CHEM, V278, P4458, DOI 10.1074/jbc.M210105200; Lee KCB, 2001, BIOPHYS J, V81, P1265, DOI 10.1016/S0006-3495(01)75784-0; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Massey LK, 2005, BIOCHEM J, V391, P513, DOI 10.1042/BJ20050491; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Repetto E, 2004, ANN NY ACAD SCI, V1030, P330, DOI 10.1196/annals.1329.041; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slifer MA, 2005, NEW ENGL J MED, V352, P2752; Smemo S, 2006, ANN NEUROL, V59, P21, DOI 10.1002/ana.20673; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	41	83	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32240	32253		10.1074/jbc.M603106200	http://dx.doi.org/10.1074/jbc.M603106200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16945923	hybrid			2022-12-27	WOS:000241414500021
J	Hu, RG; Brower, CS; Wang, HQ; Davydov, IV; Sheng, J; Zhou, JM; Kwon, YT; Varshavsky, A				Hu, Rong-Gui; Brower, Christopher S.; Wang, Haiqing; Davydov, Ilia V.; Sheng, Jun; Zhou, Jianmin; Kwon, Yong Tae; Varshavsky, Alexander			Arginyltransferase, its specificity, putative substrates, bidirectional promoter, and splicing-derived isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; RNA-PROTEIN TRANSFERASE; E3 UBIQUITIN LIGASES; MICE LACKING; SUBCELLULAR-LOCALIZATION; COHESIN SUBUNIT; PATHWAY; GENE; DEGRADATION; PROTEASOME	Substrates of the N-end rule pathway include proteins with destabilizing N-terminal residues. Three of them, Asp, Glu, and (oxidized) Cys, function through their conjugation to Arg, one of destabilizing N-terminal residues that are recognized directly by the pathway's ubiquitin ligases. The conjugation of Arg is mediated by arginyltransferase, encoded by ATE1. Through its regulated degradation of specific proteins, the arginylation branch of the N-end rule pathway mediates, in particular, the cardiovascular development, the fidelity of chromosome segregation, and the control of signaling by nitric oxide. We show that mouse ATE1 specifies at least six mRNA isoforms, which are produced through alternative splicing, encode enzymatically active arginyltransferases, and are expressed at varying levels in mouse tissues. We also show that the ATE1 promoter is bidirectional, mediating the expression of both ATE1 and an oppositely oriented, previously uncharacterized gene. In addition, we identified GRP78 (glucose-regulated protein 78) and protein-disulfide isomerase as putative physiological substrates of arginyltransferase. Purified isoforms of arginyltransferase that contain the alternative first exons differentially arginylate these proteins in extract from ATE1(-/-) embryos, suggesting that specific isoforms may have distinct functions. Although the N-end rule pathway is apparently confined to the cytosol and the nucleus, and although GRP78 and protein-disulfide isomerase are located largely in the endoplasmic reticulum, recent evidence suggests that these proteins are also present in the cytosol and other compartments in vivo, where they may become N-end rule substrates.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Meso Scale Discovery, Gaithersburg, MD 20877 USA; Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA	California Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520, R56DK039520, R37DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530, R01GM074000, R01GM069482] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 39520] Funding Source: Medline; NIGMS NIH HHS [GM 069482, GM 074000, GM 31530] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; BAKER RT, 1991, P NATL ACAD SCI USA, V87, P2374; BALZI E, 1990, J BIOL CHEM, V265, P7464; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Emoto M, 2005, GENE, V357, P47, DOI 10.1016/j.gene.2005.05.009; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FIRE A, 2006, Q REV BIOPHYS, V6, P1; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Grune T, 2002, ARCH BIOCHEM BIOPHYS, V397, P407, DOI 10.1006/abbi.2001.2719; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; LI J, 1995, BIOCHEMISTRY-US, V34, P15829, DOI 10.1021/bi00048a028; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Meier-Noorden M, 2004, GENE, V338, P197, DOI 10.1016/j.gene.2004.05.006; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Patton J, 2006, GENE, V369, P35, DOI 10.1016/j.gene.2005.10.009; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Preger E, 2004, P NATL ACAD SCI USA, V101, P1229, DOI 10.1073/pnas.0307952100; Rai R, 2005, P NATL ACAD SCI USA, V102, P10123, DOI 10.1073/pnas.0504500102; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Saleh A, 2004, IMMUNITY, V21, P55, DOI 10.1016/j.immuni.2004.06.005; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sheng J, 2002, EMBO J, V21, P6061, DOI 10.1093/emboj/cdf626; SHRADER TE, 1993, J BACTERIOL, V175, P4364, DOI 10.1128/JB.175.14.4364-4374.1993; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Stockton JD, 2003, BIOCHEMISTRY-US, V42, P12821, DOI 10.1021/bi035087q; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Takai D, 2004, MOL BIOL EVOL, V21, P463, DOI 10.1093/molbev/msh040; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Travers MT, 2005, GENOMICS, V85, P71, DOI 10.1016/j.ygeno.2004.10.001; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Trotter KW, 1999, J CELL BIOL, V147, P1481, DOI 10.1083/jcb.147.7.1481; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky AV, 2006, PROTEIN SCI, V15, P647, DOI 10.1110/ps.052012306; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; Whitehouse C, 2004, GENE, V326, P87, DOI 10.1016/j.gene.2003.10.008; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	87	55	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32559	32573		10.1074/jbc.M604355200	http://dx.doi.org/10.1074/jbc.M604355200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943202	hybrid, Green Accepted			2022-12-27	WOS:000241414500054
J	Johnson, AA; Sayer, JM; Yagi, H; Patil, SS; Debart, F; Maier, MA; Corey, DR; Vasseur, JJ; Burke, TR; Marquez, VE; Jerina, DM; Pommier, Y				Johnson, Allison A.; Sayer, Jane M.; Yagi, Haruhiko; Patil, Sachindra S.; Debart, Francoise; Maier, Martin A.; Corey, David R.; Vasseur, Jean-Jacques; Burke, Terrence R., Jr.; Marquez, Victor E.; Jerina, Donald M.; Pommier, Yves			Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding - Role of DNA backbone flexibility and an open catalytic site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; DIOL EPOXIDE ADDUCTS; VIRAL-DNA; MINOR-GROOVE; TOPOISOMERASE-I; VACCINIA TOPOISOMERASE; STRAND TRANSFER; CLEAVAGE SITE; DEOXYADENOSINE; POLYMERASE	Integration of the viral cDNA into host chromosomes is required for viral replication. Human immunodeficiency virus integrase catalyzes two sequential reactions, 3'-processing (3'-P) and strand transfer (ST). The first integrase inhibitors are undergoing clinical trial, but interactions of inhibitors with integrase and DNA are not well understood in the absence of a co-crystal structure. To increase our understanding of integrase interactions with DNA, we examined integrase catalysis with oligonucleotides containing DNA backbone, base, and groove modifications placed at unique positions surrounding the 3'-processing site. 3'-Processing was blocked with substrates containing constrained sugars and alpha-anomeric residues, suggesting that integrase requires flexibility of the phosphodiester backbone at the 3'-P site. Of several benzo[a]pyrene 7,8-diol 9,10-epoxide (BaPDE) adducts tested, only the adduct in the minor groove at the 3'-P site inhibited 3'-P, suggesting the importance of the minor groove contacts for 3'-P. ST occurred in the presence of bulky BaP DE DNA adducts attached to the end of the viral DNA suggesting opening of the active site for ST. Position-specific effects of these BaP DE DNA adducts were found for inhibition of integrase by diketo acids. Together, these results demonstrate the importance of DNA structure and specific contacts with the viral DNA processing site for inhibition by integrase inhibitors.	NCI, Mol Pharmacol Lab, Ctr Canc Res, Dept Hlth & Human Serv,NIH, Bethesda, MD 20892 USA; NIDDK, Bioorgan Chem Lab, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA; NCI, Ctr Canc Res, Med Chem Lab, Dept Hlth & Human Serv,NIH, Bethesda, MD 20892 USA; ISIS Pharmaceut, Carlsbad, CA 92008 USA; Univ Montpellier 2, CNRS, LCOBS, UMR 5625, F-34095 Montpellier, France; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Isis Pharmaceuticals Inc; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, Dept Hlth & Human Serv,NIH, Bldg 37,Rm 5068, Bethesda, MD 20892 USA.	pommier@nih.gov	Marquez, Victor/AAP-3549-2021; Burke, Terrence R/N-2601-2014; Debart, Francoise/D-4320-2019	Debart, Francoise/0000-0003-3422-3926; Vasseur, Jean-Jacques/0000-0002-4379-6139; Burke, Terrence/0000-0001-9925-8586	NATIONAL CANCER INSTITUTE [Z01BC007333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060642] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM 60642] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Agapkina J, 2004, EUR J BIOCHEM, V271, P205, DOI 10.1046/j.1432-1033.2003.03921.x; Agapkina JJ, 2004, MOL BIOL+, V38, P718, DOI 10.1023/B:MBIL.0000043941.44399.2f; Aramini JM, 1996, BIOCHEMISTRY-US, V35, P9355, DOI 10.1021/bi960612p; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; BUSHMAN FD, 1992, P NATL ACAD SCI USA, V89, P3458, DOI 10.1073/pnas.89.8.3458; Chiapperino D, 2005, J BIOL CHEM, V280, P39684, DOI 10.1074/jbc.M508008200; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Frank EG, 2002, NUCLEIC ACIDS RES, V30, P5284, DOI 10.1093/nar/gkf643; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Johnson AA, 2004, J BIOL CHEM, V279, P7947, DOI 10.1074/jbc.M311263200; Khan QA, 2003, P NATL ACAD SCI USA, V100, P12498, DOI 10.1073/pnas.2032456100; King PJ, 1998, J VIROL, V72, P8420, DOI 10.1128/JVI.72.10.8420-8424.1998; King PJ, 2003, VIROLOGY, V306, P147, DOI 10.1016/S0042-6822(02)00042-9; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lin ZW, 1999, J MED CHEM, V42, P1401, DOI 10.1021/jm980531m; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Marchand C, 2002, J BIOL CHEM, V277, P12596, DOI 10.1074/jbc.M110758200; Marquez VE, 2004, J AM CHEM SOC, V126, P543, DOI 10.1021/ja037929e; Marquez VE, 1996, J MED CHEM, V39, P3739, DOI 10.1021/jm960306+; MAZUMDER A, 1995, NUCLEIC ACIDS RES, V23, P2865, DOI 10.1093/nar/23.15.2865; Mazumder A, 1996, J BIOL CHEM, V271, P27330, DOI 10.1074/jbc.271.44.27330; MORVAN F, 1987, NUCLEIC ACIDS RES, V15, P3421, DOI 10.1093/nar/15.8.3421; Pommier Y, 2002, J BIOL CHEM, V277, P13666, DOI 10.1074/jbc.M200209200; Pommier Y, 2000, P NATL ACAD SCI USA, V97, P2040, DOI 10.1073/pnas.040397497; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Pommier Y, 2000, P NATL ACAD SCI USA, V97, P10739, DOI 10.1073/pnas.190312697; Pommier Yves, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P421; Pradhan P, 2001, BIOCHEMISTRY-US, V40, P5870, DOI 10.1021/bi002896q; Renisio JG, 2005, NUCLEIC ACIDS RES, V33, P1970, DOI 10.1093/nar/gki346; Shen X, 2002, J BIOL CHEM, V277, P5265, DOI 10.1074/jbc.M109575200; Sinha S, 2005, J VIROL, V79, P8208, DOI 10.1128/JVI.79.13.8208-8216.2005; Tian LE, 2003, J BIOL CHEM, V278, P9905, DOI 10.1074/jbc.M212468200; Van Maele B, 2005, AIDS REV, V7, P26; Volk DE, 2000, BIOCHEMISTRY-US, V39, P14040, DOI 10.1021/bi001669l; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wang T, 2001, J BIOL CHEM, V276, P14710, DOI 10.1074/jbc.M007754200; Wang T, 1999, BIOCHEMISTRY-US, V38, P3624, DOI 10.1021/bi982124i; Yakovleva L, 2003, J BIOL CHEM, V278, P42170, DOI 10.1074/jbc.M308079200; YEH HJC, 1995, BIOCHEMISTRY-US, V34, P13570, DOI 10.1021/bi00041a037; Zegar IS, 1998, BIOCHEMISTRY-US, V37, P16516, DOI 10.1021/bi9817616; Zhang XC, 2003, BIOORG MED CHEM LETT, V13, P1215, DOI 10.1016/S0960-894X(03)00059-3	55	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32428	32438		10.1074/jbc.M605101200	http://dx.doi.org/10.1074/jbc.M605101200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943199	hybrid			2022-12-27	WOS:000241414500040
J	Pineda, AO; Chen, ZW; Bah, A; Garvey, LC; Mathews, FS; Di Cera, E				Pineda, Agustin O.; Chen, Zhi-Wei; Bah, Alaji; Garvey, Laura C.; Mathews, F. Scott; Di Cera, Enrico			Crystal structure of thrombin in a self-inhibited conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW FORM; SERINE PROTEASES; MOLECULAR-BASIS; PROTEIN-C; BINDING; CRYSTALLOGRAPHY; SPECIFICITY; TRANSITION; ALLOSTERY; COMPLEX	The activating effect of Na+ on thrombin is allosteric and depends on the conformational transition from a low activity Na+-free (slow) form to a high activity Na+-bound (fast) form. The structures of these active forms have been solved. Recent structures of thrombin obtained in the absence of Na+ have also documented inactive conformations that presumably exist in equilibrium with the active slow form. The validity of these inactive slow form structures, however, is called into question by the presence of packing interactions involving the Na+ site and the active site regions. Here, we report a 1.87 angstrom resolution structure of thrombin in the absence of inhibitors and salts with a single molecule in the asymmetric unit and devoid of significant packing interactions in regions involved in the allosteric slow -> fast transition. The structure shows an unprecedented self-inhibited conformation where Trp-215 and Arg-221a relocate > 10 angstrom to occlude the active site and the primary specificity pocket, and the guanidinium group of Arg-187 penetrates the protein core to fill the empty Na+-binding site. The extreme mobility of Trp-215 was investigated further with the W215P mutation. Remarkably, the mutation significantly compromises cleavage of the anticoagulant protein C but has no effect on the hydrolysis of fibrinogen and PAR1. These findings demonstrate that thrombin may assume an inactive conformation in the absence of Na+ and that its procoagulant and anticoagulant activities are closely linked to the mobility of residue 215.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231, St Louis, MO 63110 USA.	enrico@wustl.edu			NHLBI NIH HHS [HL 58141, HL 49413, HL 73813] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058141, R29HL049413, R01HL049413, R01HL073813] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; AYALA YM, 1995, J MOL BIOL, V253, P787, DOI 10.1006/jmbi.1995.0591; Ayala YM, 2000, PROTEIN SCI, V9, P1589, DOI 10.1110/ps.9.8.1589; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1992, PROTEIN SCI, V1, P426; BOTTS J, 1953, T FARADAY SOC, V49, P696, DOI 10.1039/tf9534900696; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrell CJ, 2006, BIOPHYS CHEM, V121, P177, DOI 10.1016/j.bpc.2005.12.008; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; GUINTO ER, 1995, P NATL ACAD SCI USA, V92, P11185, DOI 10.1073/pnas.92.24.11185; Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; Krem MM, 2002, J BIOL CHEM, V277, P40260, DOI 10.1074/jbc.M206173200; Lai MT, 1997, J BIOL CHEM, V272, P30275, DOI 10.1074/jbc.272.48.30275; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; Papaconstantinou ME, 2005, J BIOL CHEM, V280, P29393, DOI 10.1074/jbc.C500248200; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2002, J BIOL CHEM, V277, P40177, DOI 10.1074/jbc.C200465200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; Vindigni A, 1996, BIOCHEMISTRY-US, V35, P4417, DOI 10.1021/bi952834d; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200	30	39	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32922	32928		10.1074/jbc.M605530200	http://dx.doi.org/10.1074/jbc.M605530200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954215	hybrid			2022-12-27	WOS:000241414500090
J	Xi, XD; Flevaris, P; Stojanovic, A; Chishti, A; Phillips, DR; Lam, SCT; Du, XP				Xi, Xiaodong; Flevaris, Panagiotis; Stojanovic, Aleksandra; Chishti, Athar; Phillips, David R.; Lam, Stephen C. T.; Du, Xiaoping			Tyrosine phosphorylation of the integrin beta(3) subunit regulates beta(3) cleavage by calpain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROXIMAL REGION; GLYCOPROTEIN-IIB-IIIA; CYTOPLASMIC DOMAIN; GLANZMANN THROMBASTHENIA; TALIN-BINDING; INSIDE-OUT; GPIIB-IIIA; ACTIVATION; ALPHA(IIB)BETA(3); PROTEASE	Outside-in signaling of beta(3) integrins induces and requires phosphorylation at tyrosine 747 (Tyr(747)) and tyrosine 759 (Tyr(759)) of the beta(3) subunit, but the mechanism for this requirement is unclear. On the other hand, a key consequence of integrin signaling, cell spreading, is inhibited by calpain cleavage of beta(3) cytoplasmic domain. Here we show that beta(3) tyrosine phosphorylation inhibits calpain cleavage. Mutating both tyrosines to phenylalanine sensitizes beta(3) to calpain cleavage. Furthermore, phosphorylation at Tyr(747) and Tyr(759) of beta(3) in the focal adhesion sites and the leading edge of spreading platelets was differentially regulated. Selective dephosphorylation of Tyr(759) is associated with calpain cleavage at Tyr(759). Thus, one mechanism by which tyrosine phosphorylation promotes integrin signaling and cell spreading is its inhibition of calpain cleavage of the beta(3) cytoplasmic domain.	Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; Portola Pharmaceut Inc, San Francisco, CA 94080 USA; Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Hematol, Shanghai, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shanghai Jiao Tong University	Du, XP (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave,Rm E403, Chicago, IL 60612 USA.	xdu@uic.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062350, R01HL068819] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62350, R01 HL068819, HL68819, R01 HL062350] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; Bodnar RJ, 1999, J BIOL CHEM, V274, P33474, DOI 10.1074/jbc.274.47.33474; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CHEN YP, 1995, BLOOD, V86, P2606, DOI 10.1182/blood.V86.7.2606.bloodjournal8672606; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; DU XP, 1993, J BIOL CHEM, V268, P23087; FOX JEB, 1985, J BIOL CHEM, V260, P1060; FOX JEB, 1993, J CELL BIOL, V120, P1501, DOI 10.1083/jcb.120.6.1501; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jenkins AL, 1998, J BIOL CHEM, V273, P13878, DOI 10.1074/jbc.273.22.13878; Knezevic I, 1996, J BIOL CHEM, V271, P16416, DOI 10.1074/jbc.271.27.16416; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Leisner TM, 1999, J BIOL CHEM, V274, P12945, DOI 10.1074/jbc.274.18.12945; Meredith J, 1998, J BIOL CHEM, V273, P19525, DOI 10.1074/jbc.273.31.19525; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang RG, 1997, J CLIN INVEST, V100, P2393, DOI 10.1172/JCI119780; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131	36	44	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29426	29430		10.1074/jbc.C600039200	http://dx.doi.org/10.1074/jbc.C600039200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16935858	hybrid			2022-12-27	WOS:000240896300003
J	Duvezin-Caubet, S; Jagasia, R; Wagener, J; Hofmann, S; Trifunovic, A; Hansson, A; Chomyn, A; Bauer, MF; Attardi, G; Larsson, NG; Neupert, W; Reichert, AS				Duvezin-Caubet, Stephane; Jagasia, Ravi; Wagener, Johannes; Hofmann, Sabine; Trifunovic, Aleksandra; Hansson, Anna; Chomyn, Anne; Bauer, Matthias F.; Attardi, Giuseppe; Larsson, Nils-Goeran; Neupert, Walter; Reichert, Andreas S.			Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED PROTEIN; DOMINANT OPTIC ATROPHY; CYTOCHROME-C; HUMAN-CELLS; FUSION; APOPTOSIS; MEMBRANE; DNA; FISSION; GTPASE	Many muscular and neurological disorders are associated with mitochondrial dysfunction and are often accompanied by changes in mitochondrial morphology. Mutations in the gene encoding OPA1, a protein required for fusion of mitochondria, are associated with hereditary autosomal dominant optic atrophy type I. Here we show that mitochondrial fragmentation correlates with processing of large isoforms of OPA1 in cybrid cells from a patient with myoclonus epilepsy and ragged-red fibers syndrome and in mouse embryonic fibroblasts harboring an error-prone mitochondrial mtDNA polymerase gamma. Furthermore, processed OPA1 was observed in heart tissue derived from heart-specific TFAM knock-out mice suffering from mitochondrial cardiomyopathy and in skeletal muscles from patients suffering from mitochondrial myopathies such as myopathy encephalopathy lactic acidosis and stroke-like episodes. Dissipation of the mitochondrial membrane potential leads to fast induction of proteolytic processing of OPA1 and concomitant fragmentation of mitochondria. Recovery of mitochondrial fusion depended on protein synthesis and was accompanied by resynthesis of large isoforms of OPA1. Fragmentation of mitochondria was prevented by overexpressing OPA1. Taken together, our data indicate that proteolytic processing of OPA1 has a key role in inducing fragmentation of energetically compromised mitochondria. We present the hypothesis that this pathway regulates mitochondrial morphology and serves as an early response to prevent fusion of dysfunctional mitochondria with the functional mitochondrial network.	Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany; GSF, Inst Dev Genet, Natl Res Ctr Environm & Hlth, D-85764 Munich, Germany; Karolinska Inst, Dept Lab Med, Div Metrol Dis, Novum, S-14186 Huddinge, Sweden; CALTECH, Div Biol, Pasadena, CA 91125 USA; Acad Hosp, Diabet Res Inst, D-80804 Munich, Germany; Acad Hosp, Inst Clin Chem Mol Diagnost & Mitochondrial Genet, D-80804 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Karolinska Institutet; California Institute of Technology	Reichert, AS (corresponding author), Univ Munich, Adolf Butenandt Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	Andreas.Reichert@med.uni-muenchen.de	Wagener, Johannes/K-5904-2012; Reichert, Andreas/A-4090-2012; Wagener, Johannes/AAN-1359-2021	Wagener, Johannes/0000-0002-5952-9422; Larsson, Nils-Goran/0000-0001-5100-996X; Reichert, Andreas/0000-0001-9340-3113; Duvezin-Caubet, Stephane/0000-0002-0243-2697				Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lyamzaev KG, 2004, BIOCHEM SOC T, V32, P1070, DOI 10.1042/BST0321070; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Meeusen SL, 2005, CURR OPIN CELL BIOL, V17, P389, DOI 10.1016/j.ceb.2005.06.014; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	48	332	334	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37972	37979		10.1074/jbc.M606059200	http://dx.doi.org/10.1074/jbc.M606059200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	17003040	hybrid, Green Accepted			2022-12-27	WOS:000242477100076
J	Pieck, JC; Hennecke, U; Pierik, AJ; Friedel, MG; Carell, T				Pieck, J. Carsten; Hennecke, Ulrich; Pierik, Antonio J.; Friedel, Marcus G.; Carell, Thomas			Characterization of a new thermophilic spore photoproduct lyase from geobacillus stearothermophilus (SplG) with defined lesion containing DNA substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAEROBIC RIBONUCLEOTIDE REDUCTASE; IRON-SULFUR CLUSTERS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BIOTIN SYNTHASE; REPAIR ENZYME; ACID; PHOTOCHEMISTRY; RESISTANCE	The Geobacillus stearothermophilus splG gene encodes a thermophilic spore photoproduct lyase (SplG) that belongs to the family of radical S-adenosylmethionine ( AdoMet) enzymes. The aerobically purified apo-SplG forms a homodimer, which contains one [4Fe-4S] cluster per monomer unit after reconstitution to the holoform. Formation of the [4Fe-4S] cluster was proven by quantification of the amount of iron and sulfur per homodimer and by UV and EPR spectroscopy. The UV spectrum features a characteristic absorbance at 420 nm typical for [4Fe-4S] clusters, and the EPR data were found to be identical to those of other proteins containing an[4Fe-4S](+) center. Probing of the activity of the holo-SplG with oligonucleotides containing one spore photoproduct lesion at a defined site proved that the enzyme is able to turn over substrate. In addition to repair, we observed cleavage of AdoMet to generate 5'-deoxyadenosine. In the presence of aza-AdoMet the SplG is completely inhibited, which provides direct support for the repair mechanism.	Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; Univ Marburg, Dept Microbiol, D-35032 Marburg, Germany	University of Munich; Philipps University Marburg	Carell, T (corresponding author), Univ Munich, Dept Chem & Biochem, Butenandtstr 5-13, D-81377 Munich, Germany.	thomas.carell@cup.uni-muenchen.de	Pierik, Antonio J/G-1108-2010; Hennecke, Ulrich/A-7723-2010; Carell, Thomas/G-4799-2012	Pierik, Antonio J/0000-0002-1509-6370; Hennecke, Ulrich/0000-0002-4904-6793; Carell, Thomas/0000-0001-7898-2831				Becker A, 1999, NAT STRUCT BIOL, V6, P969; BEINERT H, 1982, BIOCHIM BIOPHYS ACTA, V683, P245, DOI 10.1016/0304-4173(82)90003-9; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; CADET J, 1992, J PHOTOCH PHOTOBIO B, V15, P277, DOI 10.1016/1011-1344(92)85135-H; Cheek J, 2002, J AM CHEM SOC, V124, P2860, DOI 10.1021/ja017784g; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; Devine DA, 2001, J APPL MICROBIOL, V91, P786, DOI 10.1046/j.1365-2672.2001.01438.x; DONNELLAN JE, 1968, BIOPHYS J, V8, P17, DOI 10.1016/S0006-3495(68)86471-9; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Douki T, 2005, PHOTOCH PHOTOBIO SCI, V4, P591, DOI 10.1039/b503771a; Douki T, 2005, PHOTOCHEM PHOTOBIOL, V81, P163, DOI 10.1562/2004-08-18-RA-278.1; Douki T, 2003, PHOTOCH PHOTOBIO SCI, V2, P433, DOI 10.1039/b300173c; Duin EC, 1997, BIOCHEMISTRY-US, V36, P11811, DOI 10.1021/bi9706430; Fajardo-Cavazos P, 2005, CURR MICROBIOL, V51, P331, DOI 10.1007/s00284-005-0052-8; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Friedel MG, 2006, CHEM COMMUN, P445, DOI 10.1039/b514103f; GERHARDT P, 1989, REGULATION OF PROCARYOTIC DEVELOPMENT, P43; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Imai T, 2001, J BIOCHEM, V130, P649, DOI 10.1093/oxfordjournals.jbchem.a003030; JACKSON RFW, 1998, J CHEM SOC P1, V12, P1903; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Jarrett JT, 2005, ARCH BIOCHEM BIOPHYS, V433, P312, DOI 10.1016/j.abb.2004.10.003; KING TE, 1967, METHOD ENZYMOL, V10, P634; Mehl RA, 1999, ORG LETT, V1, P1065, DOI 10.1021/ol9908676; MUNAKATA N, 1974, MOL GEN GENET, V130, P239, DOI 10.1007/BF00268802; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; NICHOLSON WL, 1990, J BACTERIOL, V172, P6900, DOI 10.1128/jb.172.12.6900-6906.1990; NICHOLSON WL, 1991, P NATL ACAD SCI USA, V88, P8288, DOI 10.1073/pnas.88.19.8288; NICHOLSON WL, 1995, J CELL BIOCHEM, P275; Ollagnier S, 1999, J AM CHEM SOC, V121, P6344, DOI 10.1021/ja990073m; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; ORMEJOHNSON WH, 1982, IRON SULFUR PROTEINS, P67; Penna TCV, 2002, APPL BIOCHEM BIOTECH, V98, P525, DOI 10.1385/ABAB:98-100:1-9:525; PETROVICH RM, 1992, BIOCHEMISTRY-US, V31, P10774, DOI 10.1021/bi00159a019; Rebeil R, 2001, P NATL ACAD SCI USA, V98, P9038, DOI 10.1073/pnas.161278998; Rebeil R, 1998, J BACTERIOL, V180, P4879, DOI 10.1128/JB.180.18.4879-4885.1998; Sambrook J., 2001, MOL CLONING LAB MANU, P1, DOI DOI 10.1002/HUMU.1186.ABS; Setlow P., 1988, Comments on Molecular and Cellular Biophysics. Comments on Modern Biology: Part A, V5, P253; Setlow P, 2001, ENVIRON MOL MUTAGEN, V38, P97, DOI 10.1002/em.1058; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; Tamarit J, 1999, J BIOL CHEM, V274, P31291, DOI 10.1074/jbc.274.44.31291; Thompson MJ, 1999, J ORG CHEM, V64, P7467, DOI 10.1021/jo9907742; Ugulava NB, 2000, BIOCHEMISTRY-US, V39, P5206, DOI 10.1021/bi9926227; Voegtli WC, 2001, P NATL ACAD SCI USA, V98, P10073, DOI 10.1073/pnas.181336398; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; Yang MM, 2004, J ORG CHEM, V69, P3993, DOI 10.1021/jo040119g	46	33	34	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36317	36326		10.1074/jbc.M607053200	http://dx.doi.org/10.1074/jbc.M607053200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16968710	hybrid			2022-12-27	WOS:000242100500083
J	Shin, EY; Lee, CS; Cho, TG; Kim, YG; Song, S; Juhnn, YS; Park, SC; Manser, E; Kim, EG				Shin, Eun-Young; Lee, Chan-Soo; Cho, Tae Goo; Kim, Young Gyu; Song, Sukgil; Juhnn, Yong-Sung; Park, Sang Chul; Manser, Ed; Kim, Eung-Gook			beta Pak-interacting exchange factor-mediated Rac1 activation requires smgGDS guanine nucleotide exchange factor in basic fibroblast growth factor-induced neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; ACTIN CYTOSKELETON; DEPENDENT PATHWAY; PC12 CELLS; PROTEIN; PIX; FAMILY; MEMBRANE; BINDING; KINASE	Neuritogenesis requires active actin cytoskeleton rearrangement in which Rho GTPases play a pivotal role. In a previous study ( Shin, E. Y., Woo, K. N., Lee, C. S., Koo, S. H., Kim, Y. G., Kim, W. J., Bae, C. D., Chang, S. I., and Kim, E. G. ( 2004) J. Biol. Chem. 279, 1994-2004), we demonstrated that beta Pak-interacting exchange factor (beta PIX) guanine nucleotide exchange factor (GEF) mediates basic fibroblast growth factor (bFGF)-stimulated Rac1 activation through phosphorylation of Ser-525 and Thr-526 at the GIT-binding domain (GBD). However, the mechanism by which this phosphorylation event regulates the Rac1-GEF activity remained elusive. We show here that beta PIX binds to Rac1 via the GBD and also activates the GTPase via an associated GEF, smgGDS, in a phosphorylation-dependent manner. Notably, the Rac1-GEF activity of beta PIX persisted for an extended period of time following bFGF stimulation, unlike other Rho GEFs containing the Dbl homology domain. We demonstrate that C-PIX, containing proline-rich, GBD, and leucine zipper domains can interact with Rac1 via the GBD in vitro and in vivo and also mediated bFGF-stimulated Rac1 activation, as determined by a modified GEF assay and fluorescence resonance energy transfer analysis. However, nonphosphorylatable C-PIX ( S525A/T526A)failed to generate Rac1-GTP. Finally, beta PIX is shown to form a trimeric complex with smgGDS and Rac1; down-regulation of smgGDS expression by short interfering RNA causing significant inhibition of beta PIX-mediated Rac1 activation and neurite outgrowth. These results provide evidence for a new and unexpected mechanism whereby beta PIX can regulate Rac1 activity.	Chungbuk Natl Univ, Coll Med, Dept Biochem, Cheongju 361763, South Korea; Chungbuk Natl Univ, Coll Med, Dept Neurosurg, Cheongju 361763, South Korea; Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea; Seoul Natl Univ, Coll Med, Dept Biochem, Seoul 110799, South Korea; GlaxoSmithKline Inc, Inst Mol & Cell Biol Grp, Inst Mol & Cell Biol, Singapore 138973, Singapore	Chungbuk National University; Chungbuk National University; Chungbuk National University; Seoul National University (SNU); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline	Kim, EG (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Biochem, Cheongju 361763, South Korea.	egkim@chungbuk.ac.kr	Juhnn, Yong-Sung/J-2790-2012; Manser, Edward/ABD-2301-2020					Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Koh CG, 2001, J CELL SCI, V114, P4239; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Lee SH, 2001, J BIOL CHEM, V276, P25066, DOI 10.1074/jbc.M010892200; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shin EY, 2004, J BIOL CHEM, V279, P1994, DOI 10.1074/jbc.M307330200; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Takakura A, 2000, MOL BIOL CELL, V11, P1875, DOI 10.1091/mbc.11.5.1875; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vikis HG, 2002, ONCOGENE, V21, P2425, DOI 10.1038/sj.onc.1205306; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	41	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35954	35964		10.1074/jbc.M602399200	http://dx.doi.org/10.1074/jbc.M602399200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16954223	hybrid			2022-12-27	WOS:000242100500042
J	Lopez-Anton, N; Rudy, A; Barth, N; Schmitz, LM; Pettit, GR; Schulze-Osthoff, K; Dirsch, VM; Vollmar, AM				Lopez-Anton, Nancy; Rudy, Anita; Barth, Nicole; Schmitz, Lienhard M.; Pettit, George R.; Schulze-Osthoff, Klaus; Dirsch, Verena M.; Vollmar, Angelika M.			The marine product cephalostatin 1 activates an endoplasmic reticulum stress-specific and apoptosome-independent apoptotic signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; ER STRESS; CASPASE ACTIVATION; RESISTANCE; PROGRAM; ASK1	Cephalostatin 1, a bis-steroidal marine natural product, has been reported to induce apoptosis without the requirement of an active caspase-8 or mitochondrial cytochrome c release and apoptosome formation. Here we show that despite the absence of these events, caspase-9 activation is essential for cephalostatin 1-induced apoptosis. Cephalostatin 1 initiates a rapid endoplasmic reticulum stress response characterized by phosphorylation of eukaryotic initiation factor-2 alpha-subunit and increased expression of the chaperone immunoglobulin heavy chain-binding protein GRP78 as well as the transcription factor C/EBP homologous protein (CHOP)/GADD153. Cephalostatin 1 activates apoptosis signal-regulating kinase 1 and c-Jun N-terminal kinase (JNK). However, this pathway does not play a major role in cephalostatin 1-induced apoptosis, as assessed by stable expression of a dominant negative apoptosis signal-regulating kinase 1. Importantly, the endoplasmic reticulum-associated caspase-4 is required and as shown by biochemical and genetic inhibition experiments, acts upstream of caspase-9 in cephalostatin-induced apoptosis.	Univ Munich, Dept Pharm, Ctr Drug Res, D-81377 Munich, Germany; Univ Giessen, Inst Biochem, D-35390 Giessen, Germany; Univ Dusseldorf, Inst Mol Med, D-40225 Dusseldorf, Germany; Arizona State Univ, Inst Canc Res, Tempe, AZ 85287 USA	University of Munich; Justus Liebig University Giessen; Heinrich Heine University Dusseldorf; Arizona State University; Arizona State University-Tempe	Vollmar, AM (corresponding author), Univ Munich, Dept Pharm, Ctr Drug Res, Butenandt Str 5-13, D-81377 Munich, Germany.	Angelika.Vollmar@cup.uni-muenchen.de	Schmitz, M. Lienhard/D-9328-2017; Schulze-Osthoff, Klaus/N-9025-2013	Schmitz, M. Lienhard/0000-0002-6984-7192; Schulze-Osthoff, Klaus/0000-0003-1443-2720; Dirsch, Verena/0000-0002-9261-5293				Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Brimmell M, 1998, ONCOGENE, V16, P1803, DOI 10.1038/sj.onc.1201704; Di Sano F, 2006, J BIOL CHEM, V281, P2693, DOI 10.1074/jbc.M509110200; Dirsch VM, 2003, CANCER RES, V63, P8869; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Henderson CJ, 2005, CELL DEATH DIFFER, V12, P1240, DOI 10.1038/sj.cdd.4401729; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hofmann TG, 2001, INT J CANCER, V93, P185, DOI 10.1002/ijc.1316; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1551, DOI 10.1002/cncr.20947; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Obeng EA, 2005, J BIOL CHEM, V280, P29578, DOI 10.1074/jbc.M502685200; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; PETTIT GR, 1988, J AM CHEM SOC, V110, P2006, DOI 10.1021/ja00214a078; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Samraj AK, 2006, ONCOGENE, V25, P186, DOI 10.1038/sj.onc.1209034; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	39	59	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33078	33086		10.1074/jbc.M607904200	http://dx.doi.org/10.1074/jbc.M607904200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16945918	hybrid, Green Published			2022-12-27	WOS:000241621400016
J	Ross, EM; Mateu, D; Gomes, AV; Arana, C; Tran, T; Litosch, I				Ross, Elliott M.; Mateu, Dania; Gomes, Aldrin V.; Arana, Carlos; Tran, Thanh; Litosch, Irene			Structural determinants for phosphatidic acid regulation of phospholipase C-beta(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; PROTEIN-KINASE-C; FEEDBACK-REGULATION; C-BETA(1) ACTIVITY; TERMINAL REGION; BETA; BINDING; ACTIVATION; DOMAIN; MEMBRANES	Signaling from G protein-coupled receptors to phospholipase C-beta (PLC-beta) is regulated by coordinate interactions among multiple intracellular signaling molecules. Phosphatidic acid (PA), a signaling phospholipid, binds to and stimulates PLC-beta(1) through a mechanism that requires the PLC-beta(1) C-terminal domain. PA also modulates G alpha(q) stimulation of PLC-beta(1). These data suggest that PA may have a key role in the regulation of PLC-beta(1) signaling in cells. The present studies addressed the structural requirements and the mechanism for PA regulation of PLC-beta(1). We used a combination of enzymatic assays, PA-binding assays, and circular dichroism spectroscopy to evaluate the interaction of PA with wild-type and mutant PLC-beta(1) proteins and with fragments of theG alpha(q) binding domain. The results identify a region that includes the alpha A helix and flexible loop of the G alpha(q)-binding domain as necessary for PA regulation. A mutant PLC-beta(1) with multiple alanine/glycine replacements for residues (944)LIKEHTTKYNEIQN(957) was markedly impaired in PA regulation. The high affinity and low affinity component of PA stimulation was reduced 70% and PA binding was reduced 45% in this mutant. Relative PLC stimulation by PA increased with PLC-beta(1) concentration in a manner suggesting cooperative binding to PA. Similar concentration dependence was observed in the PLC-beta(1) mutant. These data are consistent with a model for PA regulation of PLC-beta(1) that involves cooperative interactions, probably PLC homodimerization, that require the flexible loop region, as is consistent with the dimeric structure of the G alpha(q)-binding domain. PA regulation of PLC-beta(1) requires unique residues that are not required for G alpha(q) stimulation or GTPase-activating protein activity.	Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Miami; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Litosch, I (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA.	ilitosch@med.miami.edu	Gomes, Aldrin V/I-6529-2018	Gomes, Aldrin V/0000-0002-9819-3036	NIGMS NIH HHS [GM30355, R01 GM030355] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030355, R01GM030355] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; BAHK YY, 1994, J BIOL CHEM, V269, P8240; Baillie GS, 2002, J BIOL CHEM, V277, P28298, DOI 10.1074/jbc.M108353200; Bastard K, 2006, PROTEINS, V62, P956, DOI 10.1002/prot.20770; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Grange M, 2000, J BIOL CHEM, V275, P33379, DOI 10.1074/jbc.M006329200; HENRY RA, 1995, AM J PHYSIOL-CELL PH, V269, pC349, DOI 10.1152/ajpcell.1995.269.2.C349; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; JONES GA, 1993, J BIOL CHEM, V268, P20845; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Litosch I, 1997, BIOCHEM J, V326, P701, DOI 10.1042/bj3260701; Litosch I, 2000, BIOCHEMISTRY-US, V39, P7736, DOI 10.1021/bi000022y; Litosch I, 2003, BIOCHEMISTRY-US, V42, P1618, DOI 10.1021/bi026414h; Litosch I, 2002, CELL SIGNAL, V14, P259, DOI 10.1016/S0898-6568(01)00251-0; Litosch I, 2002, IUBMB LIFE, V54, P253, DOI 10.1080/15216540215673; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Nakahara M, 2005, J BIOL CHEM, V280, P29128, DOI 10.1074/jbc.M503817200; Ouyang YS, 2003, J BIOL CHEM, V278, P11115, DOI 10.1074/jbc.M212606200; PARK DG, 1993, J BIOL CHEM, V268, P3710; Paulssen RH, 1996, J BIOL CHEM, V271, P26622, DOI 10.1074/jbc.271.43.26622; Pawelczyk T, 1999, EUR J BIOCHEM, V262, P291, DOI 10.1046/j.1432-1327.1999.00388.x; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; RYU SH, 1990, J BIOL CHEM, V265, P17941; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WU DQ, 1993, J BIOL CHEM, V268, P3704	37	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33087	33094		10.1074/jbc.M606487200	http://dx.doi.org/10.1074/jbc.M606487200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950781	hybrid			2022-12-27	WOS:000241621400017
J	Watanabe, S; Shimada, N; Tajima, K; Kodaki, T; Makino, K				Watanabe, Seiya; Shimada, Naoko; Tajima, Kunihiko; Kodaki, Tsutomu; Makino, Keisuke			Identification and characterization of L-arabonate dehydratase, L-2-keto-3-deoxyarabonate dehydratase, and L-arabinolactonase involved in an alternative pathway of L-arabinose metabolism - Novel evolutionary insight into sugar metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-FUCOSE METABOLISM; DIHYDROXY-ACID DEHYDRATASE; ARCHAEON SULFOLOBUS-SOLFATARICUS; ALPHA-KETOGLUTARIC SEMIALDEHYDE; N-ACETYLNEURAMINATE LYASE; ENTNER-DOUDOROFF PATHWAY; IRON-SULFUR PROTEINS; L-XYLULOSE REDUCTASE; GLUCOSE-DEHYDROGENASE; ASPERGILLUS-NIGER	Azospirillum brasiliense possesses an alternative pathway of L-arabinose metabolism, different from the known bacterial and fungal pathways. In the preceding articles, we identified and characterized L-arabinose-1-dehydrogenase and alpha-ketoglutaric semialdehyde dehydrogenase, which catalyzes the first and final reaction steps in this pathway, respectively (Watanabe, S., Kodaki, T., and Makino, K. (2006) J. Biol. Chem. 281, 2612-2623 and Watanabe, S., Kodaki, T., and Makino, K. (2006) J. Biol. Chem. 281, 28876-28888). We here report the remaining three enzymes, L-arabonate dehydratase, L-2-keto-3-deoxyarabonate (L-KDA) dehydratase, and L-arabinolactonase. N-terminal amino acid sequences of L-arabonate dehydratase and L-KDA dehydratase purified from A. brasiliense cells corresponded to those of AraC and AraD genes, which form a single transcriptional unit together with the L-arabinose-1-dehydrogenase gene. Furthermore, the L-arabinolactonase gene (AraB) was also identified as a component of the gene cluster. Genetic characterization of the alternative L-arabinose pathway suggested a significant evolutional relationship with the known sugar metabolic pathways, including the Entner-Doudoroff (ED) pathway and the several modified versions. L-Arabonate dehydratase belongs to the ILVD/EDD family and spectrophotometric and electron paramagnetic resonance analysis revealed it to contain a [4Fe-4S]2(+) cluster. Site-directed mutagenesis identified three cysteine ligands essential for cluster coordination. L-KDA dehydratase was sequentially similar to DHDPS/NAL family proteins. D-2-Keto-3-deoxygluconate aldolase, a member of the DHDPS/NAL family, catalyzes the equivalent reaction to L-KDA aldolase involved in another alternative L-arabinose pathway, probably associating a unique evolutional event between the two alternative L-arabinose pathways by mutation(s) of a common ancestral enzyme. Site-directed mutagenesis revealed a unique catalytic amino acid residue in L-KDA dehydratase, which may be a candidate for such a natural mutation.	Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; Kyoto Univ, Fac Engn, Saikyo Ku, Kyoto 6158530, Japan; Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; Japan Sci & Technol Agcy, JST, CREST, Uji, Kyoto 6110011, Japan	Kyoto University; Kyoto University; Kyoto Institute of Technology; Japan Science & Technology Agency (JST)	Makino, K (corresponding author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan.	kmak@iae.kyoto-u.ac.jp						Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; Allard J, 2001, P NATL ACAD SCI USA, V98, P3679, DOI 10.1073/pnas.071380898; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; Barbosa JARG, 2000, J MOL BIOL, V303, P405, DOI 10.1006/jmbi.2000.4138; BEINERT H, 1990, FASEB J, V4, P2483, DOI 10.1096/fasebj.4.8.2185975; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; DAGLEY S, 1965, BIOCHEM J, V95, P48, DOI 10.1042/bj0950048; DAHMS AS, 1972, J BIOL CHEM, V247, P2228; DAHMS AS, 1972, J BIOL CHEM, V247, P2233; DAHMS AS, 1969, BIOCHEM BIOPH RES CO, V36, P809, DOI 10.1016/0006-291X(69)90681-0; DAHMS AS, 1972, J BIOL CHEM, V247, P2222; DAHMS AS, 1972, J BIOL CHEM, V247, P2238; DELEY J, 1957, J BIOL CHEM, V227, P745; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; DONALD A, 1979, J BIOL CHEM, V254, P2132; DUNCAN MJ, 1979, J GEN MICROBIOL, V113, P177, DOI 10.1099/00221287-113-1-177; DUNCAN MJ, 1979, J BACTERIOL, V137, P415, DOI 10.1128/JB.137.1.415-419.1979; Elshafei AM, 2001, ENZYME MICROB TECH, V29, P76, DOI 10.1016/S0141-0229(01)00346-5; ELZAINY TA, 1973, J BACTERIOL, V114, P457, DOI 10.1128/JB.114.1.457-459.1973; ENTNER N, 1952, J BIOL CHEM, V196, P853; Flint DH, 1996, CHEM REV, V96, P2315, DOI 10.1021/cr950041r; FLINT DH, 1993, J BIOL CHEM, V268, P14732; FLINT DH, 1988, J BIOL CHEM, V263, P3558; GABRIEL O, 1969, ANAL BIOCHEM, V27, P545, DOI 10.1016/0003-2697(69)90068-2; GRABOWSKI R, 1993, TRENDS BIOCHEM SCI, V18, P297, DOI 10.1016/0968-0004(93)90040-T; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; JEFFCOAT R, 1975, BIOCHEM J, V145, P305, DOI 10.1042/bj1450305; JEFFCOAT R, 1969, BIOCHEM J, V115, P977, DOI 10.1042/bj1150977; JOHN J, 1994, STRUCTURE, V2, P385, DOI 10.1016/S0969-2126(00)00040-X; KANAGASUNDARAM V, 1992, BIOCHIM BIOPHYS ACTA, V1171, P198, DOI 10.1016/0167-4781(92)90120-O; Kim S, 2006, J BIOCHEM, V139, P591, DOI 10.1093/jb/mvj057; Kobayashi M, 1998, P NATL ACAD SCI USA, V95, P12787, DOI 10.1073/pnas.95.22.12787; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamble FJ, 2004, FEBS LETT, V576, P133, DOI 10.1016/j.febslet.2004.08.074; Lawrence MC, 1997, J MOL BIOL, V266, P381, DOI 10.1006/jmbi.1996.0769; LELOIR LF, 1951, ARCH BIOCHEM BIOPHYS, V33, P186, DOI 10.1016/0003-9861(51)90096-3; LINDAHL PA, 1987, J BIOL CHEM, V262, P14945; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macchiarulo A, 2004, NAT BIOTECHNOL, V22, P1039, DOI 10.1038/nbt999; MACGEE J, 1954, J BIOL CHEM, V210, P617; MATHIAS AL, 1989, J BACTERIOL, V171, P5206, DOI 10.1128/jb.171.9.5206-5209.1989; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Moore RA, 2004, INFECT IMMUN, V72, P4172, DOI 10.1128/IAI.72.7.4172-4187.2004; Moore S, 1940, J BIOL CHEM, V133, P293; MULLER HM, 1986, ARCH MICROBIOL, V144, P151, DOI 10.1007/BF00414726; NOVICK NJ, 1982, J BACTERIOL, V149, P364, DOI 10.1128/JB.149.1.364-367.1982; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Oro J, 1995, Adv Space Res, V15, P81, DOI 10.1016/S0273-1177(99)80067-2; OTANI M, 1986, J BACTERIOL, V167, P148, DOI 10.1128/jb.167.1.148-152.1986; Oubrie A, 1999, J MOL BIOL, V289, P319, DOI 10.1006/jmbi.1999.2766; PEDROSA FO, 1974, J BACTERIOL, V119, P336, DOI 10.1128/JB.119.1.336-338.1974; PORTSMOUTH D, 1967, J BIOL CHEM, V242, P2751; Richard P, 2002, BIOCHEMISTRY-US, V41, P6432, DOI 10.1021/bi025529i; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; Rodriguez M, 1996, BIOCHEM MOL BIOL INT, V38, P783; Sambrook J., 2001, MOL CLONING LAB MANU; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; STOOLMILLER AC, 1966, J BIOL CHEM, V241, P5764; STRYER L, 1988, BIOCHEMISTRY-US, P805; SZUMILO T, 1981, BIOCHIM BIOPHYS ACTA, V661, P240, DOI 10.1016/0005-2744(81)90010-3; Theodossis A, 2004, J BIOL CHEM, V279, P43886, DOI 10.1074/jbc.M407702200; TSAI CS, 1995, ARCH BIOCHEM BIOPHYS, V316, P163, DOI 10.1006/abbi.1995.1024; Verho R, 2004, J BIOL CHEM, V279, P14746, DOI 10.1074/jbc.M312533200; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; Watanabe S, 2006, J BIOL CHEM, V281, P28876, DOI 10.1074/jbc.M602585200; WELMBERG R, 1961, J BIOL CHEM, V236, P629; WELMBERG R, 1955, J BIOL CHEM, V217, P607; ZACHARIOU M, 1986, J BACTERIOL, V167, P863, DOI 10.1128/jb.167.3.863-869.1986	70	63	80	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33521	33536		10.1074/jbc.M606727200	http://dx.doi.org/10.1074/jbc.M606727200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950779				2022-12-27	WOS:000241621400063
J	Whiteford, JR; Couchman, JR				Whiteford, James R.; Couchman, John R.			A conserved NXIP motif is required for cell adhesion properties of the syndecan-4 ectodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; PDZ PROTEIN; BINDING; IDENTIFICATION; PROTEOGLYCAN; LOCALIZATION; INTEGRINS; ALPHA	Syndecans are cell surface proteoglycans involved in cell adhesion and motility. Syndecan-4 is an important component of focal adhesions and is involved in cytoskeletal reorganization. Previous work has shown that the syndecan-4 ectodomain can support cell attachment. Here, three vertebrate syndecan-4 ectodomains were compared, including that of the zebrafish, and we have demonstrated that the cell binding activity of the syndecan-4 ectodomain is conserved. Cell adhesion to the syndecan-4 ectodomain appears to be a characteristic of mesenchymal cells. Comparison of syndecan-4 ectodomain sequences led to the identification of three conserved regions of sequence, of which the NXIP motif is important for cell binding activity. We have shown that cell adhesion to the syndecan-4 ectodomain involves beta 1 integrins in several cell types.	Imperial Coll London, Fac Nat Sci, Biomed Sci Div, London SW7 2AZ, England	Imperial College London	Couchman, JR (corresponding author), Imperial Coll London, Fac Nat Sci, Biomed Sci Div, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	j.couchman@imperial.ac.uk		Whiteford, James/0000-0002-8967-7389	Wellcome Trust [065940] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baciu PC, 2000, J CELL SCI, V113, P315; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Couchman JR, 2002, J BIOL CHEM, V277, P49296, DOI 10.1074/jbc.M209679200; Couchman JR, 2001, INT REV CYTOL, V207, P113; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; FAULL RJ, 1994, J EXP MED, V179, P1307, DOI 10.1084/jem.179.4.1307; Fears CY, 2006, J BIOL CHEM, V281, P14533, DOI 10.1074/jbc.C600075200; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Greene DK, 2003, J BIOL CHEM, V278, P7617, DOI 10.1074/jbc.M207123200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Lee D, 1998, J BIOL CHEM, V273, P13022, DOI 10.1074/jbc.273.21.13022; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Longley RL, 1999, J CELL SCI, V112, P3421; McFall AJ, 1997, J BIOL CHEM, V272, P12901, DOI 10.1074/jbc.272.20.12901; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oh ES, 2004, MOL CELLS, V17, P181; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183	30	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32156	32163		10.1074/jbc.M605553200	http://dx.doi.org/10.1074/jbc.M605553200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16936286	hybrid			2022-12-27	WOS:000241414500013
J	Soria, RB; Spitzner, M; Schreiber, R; Kunzelmann, K				Soria, Rene Barro; Spitzner, Melanie; Schreiber, Rainer; Kunzelmann, Karl			Bestrophin-1 Enables Ca2+-activated Cl- Conductance in Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNELS; CYSTIC-FIBROSIS; MACULAR DYSTROPHY; PRIMARY CULTURES; PROTEIN-KINASE; HT(29) CELLS; CALCIUM; MOUSE; TRANSPORT; CURRENTS	Epithelial cells express calcium-activated Cl- channels of unknown molecular identity. These Cl- channels play a central role in diseases such as secretory diarrhea, polycystic kidney disease, and cystic fibrosis. The family of bestrophins has been suggested to form calcium-activated Cl- channels. Here, we demonstrate molecular and functional expression of bestrophin-1 (BEST1) in mouse and human airways, colon, and kidney. Endogenous calcium-activated whole cell Cl- currents coincide with endogenous expression of the Vmd2 gene product BEST1 in murine and human epithelial cells, whereas calcium-activated Cl- currents are absent in epithelial tissues lacking BEST1 expression. Blocking expression of BEST1 with short interfering RNA or applying an anti-BEST1 antibody to a patch pipette suppressed ATP-induced whole cell Cl- currents. Calcium-dependent Cl- currents were activated by ATP in HEK293 cells expressing BEST1. Thus, BEST1 may form the Ca2+-activated Cl- current, or it may be a component of a Cl- channel complex in epithelial tissues.	[Soria, Rene Barro; Spitzner, Melanie; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany	University of Regensburg	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	uqkkunze@mailbox.uq.edu		Spitzner, Melanie/0000-0002-3673-0625	Deutsche Forschungsgemeinschaft [KU 756/9-1, SFB699]; Else Kroner-Fresenius-Stiftung [P36/05/A44/05]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Grants KU 756/9-1 and SFB699 and Else Kroner-Fresenius-Stiftung P36/05/A44/05.	Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Barriere H, 2003, AM J PHYSIOL-RENAL, V284, pF796, DOI 10.1152/ajprenal.00237.2002; BERSCHNEIDER HM, 1988, FASEB J, V2, P2625, DOI 10.1096/fasebj.2.10.2838365; Bidet M, 1996, AM J PHYSIOL-RENAL, V271, pF940, DOI 10.1152/ajprenal.1996.271.4.F940; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Dong YJ, 1997, P NATL ACAD SCI USA, V94, P3960, DOI 10.1073/pnas.94.8.3960; Duta V, 2004, FEBS LETT, V577, P551, DOI 10.1016/j.febslet.2004.10.068; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Greger R, 1996, PFLUG ARCH EUR J PHY, V432, P579, DOI 10.1007/s004240050173; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Grubb BR, 2006, AM J PHYSIOL-LUNG C, V290, pL270, DOI 10.1152/ajplung.00249.2005; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Ho MWY, 2001, J BIOL CHEM, V276, P18673, DOI 10.1074/jbc.M101128200; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; KUBITZ R, 1992, PFLUG ARCH EUR J PHY, V421, P447, DOI 10.1007/BF00370255; Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1; Kunzelmann K, 2002, PFLUG ARCH EUR J PHY, V444, P220, DOI 10.1007/s00424-002-0796-y; KUNZELMANN K, 1992, PFLUG ARCH EUR J PHY, V421, P238, DOI 10.1007/BF00374833; Kunzelmann K., 1997, PFLUGERS ARCH, V434, P178, DOI DOI 10.1007/S004240050498; Kunzelmann Karl, 2003, Am J Respir Med, V2, P299; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Lo CWY, 2006, FASEB J, V20, pA1301; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; LU L, 1993, J MEMBRANE BIOL, V135, P181; Mall M, 2000, AM J PHYSIOL-GASTR L, V278, pG617, DOI 10.1152/ajpgi.2000.278.4.G617; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 1998, AM J PHYSIOL-GASTR L, V275, pG1274, DOI 10.1152/ajpgi.1998.275.6.G1274; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Pauli BU, 2000, CLIN EXP PHARMACOL P, V27, P901, DOI 10.1046/j.1440-1681.2000.03358.x; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, AM J PHYSIOL-RENAL, V285, pF326, DOI 10.1152/ajprenal.00034.2003; SCHLATTER E, 1990, PFLUG ARCH EUR J PHY, V417, P317, DOI 10.1007/BF00370998; Stanton JB, 2006, BBA-BIOMEMBRANES, V1758, P241, DOI 10.1016/j.bbamem.2006.01.024; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Wei L, 1999, PFLUG ARCH EUR J PHY, V438, P635, DOI 10.1007/s004240051087; WORRELL RT, 1991, AM J PHYSIOL, V260, pC877, DOI 10.1152/ajpcell.1991.260.4.C877	51	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29405	29412		10.1074/jbc.M605716200	http://dx.doi.org/10.1074/jbc.M605716200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	17003041	Green Published, hybrid			2022-12-27	WOS:000270896800022
J	Byun, HJ; Hong, IK; Kim, E; Jin, YJ; Jeoung, DI; Hahn, JH; Kim, YM; Park, SH; Lee, H				Byun, Hee-Jung; Hong, In-Kee; Kim, Eunsook; Jin, Young-June; Jeoung, Doo-Il; Hahn, Jang-Hee; Kim, Young-Myoung; Park, Seong Hoe; Lee, Hansoo			A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REED-STERNBERG PHENOTYPE; KAPPA-B ACTIVATION; PROTEIN-KINASE-B; GENE-EXPRESSION; TUMOR-CELLS; IN-VIVO; MONOCLONAL-ANTIBODY; CARCINOMA-CELLS; DOWN-REGULATION; IV COLLAGENASE	The CD99 gene encodes two distinct transmembrane proteins by alternative splicing of its transcript. To examine the effects of two CD99 isoforms on the invasive phenotypes of breast cancer cells, MDA-MB-231 and MCF-7 human breast cancer cell lines were stably transfected with CD99 cDNAs encoding the major wild-type form (type I) or a minor splice variant (type II). As a result, expression of CD99 type II, but not type I, markedly elevated the motility, binding to fibronectin, MMP-9 expression, and invasiveness of MDA-MB-231 and MCF-7 breast cancer cells. In MDA-MB-435 breast cancer cells expressing both CD99 type I and type II, invasion-related cellular activities were inhibited by the transfection of small interfering RNA (siRNA) targeted to CD99 type II. Meanwhile, CD99 type II-induced MMP-9 expression in MDA-MB-231 cells was shown to be mediated by the binding of AP-1 factors to the MMP-9 gene promoter. Gel shift assay revealed that ligation of CD99 type II with antibody resulted in the binding of JunD to the AP-1 site of the MMP-9 promoter region. Initiation of CD99 type II signaling by antibody ligation increased expression of JunD and FosB AP-1 factors, along with phosphorylation of Src, Akt, p38 MAPK, ERK, and JNK. Knockdown of JunD and FosB by siRNA transfection abolished the positive effects of CD99 type II on the motility and MMP-9 expression of MDA-MB-231 cells. Increased expression of JunD and FosB as well as elevated cell motility and MMP-9 expression by CD99 type II ligation were also abrogated by inhibitors, dominant-negative forms, and siRNAs for Akt1, ERK1/2, and JNK1 but not for p38 MAPK. These results suggest that expression of a splice variant of CD99 contributes to the invasive ability of human breast cancer cells by up-regulating AP-1-mediated gene expression through the Akt-dependent ERK and JNK signaling pathways.	Kangwon Natl Univ, Coll Nat Sci, Vasc Syst Res Ctr, Chunchon 200701, Kangwon Do, South Korea; Kangwon Natl Univ, Coll Nat Sci, Div Life Sci, Chunchon 200701, Kangwon Do, South Korea; Kangwon Natl Univ, Coll Med, Dept Anat, Chunchon 200701, Kangwon Do, South Korea; Kangwon Natl Univ, Coll Med, Dept Mol & Cellular Biochem, Chunchon 200701, Kangwon Do, South Korea; Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Seoul National University (SNU)	Lee, H (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Vasc Syst Res Ctr, Chunchon 200701, Kangwon Do, South Korea.	hslee@kangwon.ac.kr	Park, Seong Hoe/C-7353-2011					Alberti I, 2002, FASEB J, V16, P1946, DOI 10.1096/fj.02-0049fje; ALBINI A, 1987, CANCER RES, V47, P3239; AMBROS IM, 1991, CANCER, V67, P1886, DOI 10.1002/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U; Annabi B, 2004, J BIOL CHEM, V279, P21888, DOI 10.1074/jbc.M313694200; AUBRIT F, 1989, EUR J IMMUNOL, V19, P1431, DOI 10.1002/eji.1830190813; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; BALLIN M, 1988, BIOCHEM BIOPH RES CO, V154, P832, DOI 10.1016/0006-291X(88)90215-X; Bamberger AM, 1999, INT J CANCER, V84, P533, DOI 10.1002/(SICI)1097-0215(19991022)84:5<533::AID-IJC16>3.0.CO;2-J; BARSKY SH, 1983, LANCET, V1, P296; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; BERNARD A, 1988, J IMMUNOL, V140, P1802; Bernard G, 2000, EUR J IMMUNOL, V30, P3061, DOI 10.1002/1521-4141(200010)30:10<3061::AID-IMMU3061>3.0.CO;2-M; Bernard G, 1997, J IMMUNOL, V158, P2543; BERNARD G, 1995, J IMMUNOL, V154, P26; BERNHARD EJ, 1994, P NATL ACAD SCI USA, V91, P4293, DOI 10.1073/pnas.91.10.4293; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; Bos TJ, 1999, INT J CANCER, V81, P404, DOI 10.1002/(SICI)1097-0215(19990505)81:3<404::AID-IJC14>3.0.CO;2-I; BROWN NH, 1989, CELL, V59, P185, DOI 10.1016/0092-8674(89)90880-5; Brown RE, 2003, ANN CLIN LAB SCI, V33, P131; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Choi FY, 1998, J IMMUNOL, V161, P749; CONNOLLY JM, 1993, CANCER LETT, V75, P137, DOI 10.1016/0304-3835(93)90198-I; COOPER HM, 1991, J CELL BIOL, V115, P843, DOI 10.1083/jcb.115.3.843; DAVIES B, 1993, BRIT J CANCER, V67, P1126, DOI 10.1038/bjc.1993.207; Dunn C, 2002, CELL SIGNAL, V14, P585, DOI 10.1016/S0898-6568(01)00275-3; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Dworzak MN, 2004, LEUKEMIA, V18, P703, DOI 10.1038/sj.leu.2403303; ELBAHASSI M, 2004, CLIN EXP METASTAS, V21, P293; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; Fisher C, 1998, Ann Diagn Pathol, V2, P401, DOI 10.1016/S1092-9134(98)80042-7; GELIN C, 1991, EUR J IMMUNOL, V21, P715, DOI 10.1002/eji.1830210326; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; GUO YJ, 1994, CANCER RES, V54, P1561; Hah N, 2003, BIOCHEM BIOPH RES CO, V305, P428, DOI 10.1016/S0006-291X(03)00788-5; Hahn JH, 1997, J IMMUNOL, V159, P2250; Hahn MJ, 2000, FEBS LETT, V470, P350, DOI 10.1016/S0014-5793(00)01330-2; HAMILTON G, 1988, CANCER RES, V48, P6127; HENNIGAN RF, 1994, ONCOGENE, V9, P3591; HOFMANN M, 1993, CANCER RES, V53, P1516; JAMAL HH, 1994, ONCOGENE, V9, P417; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Jee B, 2003, EXP MOL MED, V35, P30, DOI 10.1038/emm.2003.5; Jung KC, 2002, J KOREAN MED SCI, V17, P483, DOI 10.3346/jkms.2002.17.4.483; Kasinrerk W, 2000, IMMUNOL LETT, V71, P33, DOI 10.1016/S0165-2478(99)00165-0; Kim HY, 2004, MOL CELLS, V18, P24; Kim SH, 1998, BLOOD, V92, P4287, DOI 10.1182/blood.V92.11.4287.423k41_4287_4295; Kim SH, 2000, BLOOD, V95, P294; Kim YI, 2003, BIOCHEM BIOPH RES CO, V307, P281, DOI 10.1016/S0006-291X(03)01195-1; KOVAR H, 1990, ONCOGENE, V5, P1067; Lamb RF, 1997, MOL CELL BIOL, V17, P963, DOI 10.1128/MCB.17.2.963; Lee HJ, 2002, EXP MOL MED, V34, P177, DOI 10.1038/emm.2002.26; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; LEVY R, 1979, P NATL ACAD SCI USA, V76, P6552, DOI 10.1073/pnas.76.12.6552; Lim SH, 1998, CANCER LETT, V133, P143, DOI 10.1016/S0304-3835(98)00219-5; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LIU XH, 1995, CANCER LETT, V92, P21, DOI 10.1016/0304-3835(95)03752-I; Maitra A, 2003, CLIN CANCER RES, V9, P5988; MAYER B, 1993, LANCET, V342, P1019, DOI 10.1016/0140-6736(93)92879-X; Milanezi F, 2001, HISTOPATHOLOGY, V39, P578, DOI 10.1046/j.1365-2559.2001.01309.x; Milde-Langosch K, 2004, BREAST CANCER RES TR, V86, P139, DOI 10.1023/B:BREA.0000032982.49024.71; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Na HJ, 2004, J IMMUNOL, V173, P1276, DOI 10.4049/jimmunol.173.2.1276; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Pelosi G, 2000, VIRCHOWS ARCH, V437, P270, DOI 10.1007/s004280000240; Pettersen RD, 2001, J IMMUNOL, V166, P4931, DOI 10.4049/jimmunol.166.8.4931; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; PIROZZI G, 1994, CELL ADHES COMMUN, V2, P549, DOI 10.3109/15419069409014218; Price JT, 1997, CRIT REV BIOCHEM MOL, V32, P175, DOI 10.3109/10409239709082573; RAMANI P, 1993, HISTOPATHOLOGY, V23, P557, DOI 10.1111/j.1365-2559.1993.tb01243.x; Rinehart-Kim J, 2000, INT J CANCER, V88, P180, DOI 10.1002/1097-0215(20001015)88:2<180::AID-IJC6>3.0.CO;2-H; SATO H, 1993, ONCOGENE, V8, P395; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Shen Q, 2003, J MAMMARY GLAND BIOL, V8, P45, DOI 10.1023/A:1025783221557; Sohn HW, 2001, J IMMUNOL, V166, P787, DOI 10.4049/jimmunol.166.2.787; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; THOMAS L, 1993, J INVEST DERMATOL, V100, P115, DOI 10.1111/1523-1747.ep12462776; Waclavicek M, 1998, J IMMUNOL, V161, P4671; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wingett D, 1999, CELL IMMUNOL, V193, P17, DOI 10.1006/cimm.1999.1470; Yoon SS, 2004, MOL CELLS, V18, P186; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; ZORN AM, 1992, DEV BIOL, V149, P197, DOI 10.1016/0012-1606(92)90276-M	88	85	94	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34833	34847		10.1074/jbc.M605483200	http://dx.doi.org/10.1074/jbc.M605483200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16984917	hybrid			2022-12-27	WOS:000241933700016
J	Forneris, F; Binda, C; Dall'Aglio, A; Fraaije, MW; Battaglioli, E; Mattevi, A				Forneris, Federico; Binda, Claudia; Dall'Aglio, Annachiara; Fraaije, Marco W.; Battaglioli, Elena; Mattevi, Andrea			A highly specific mechanism of histone H3-K4 recognition by histone demethylase LSD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLATION; CHROMATIN; H3K4ME3; OXIDASE	Human lysine-specific demethylase (LSD1) is a chromatin-modifying enzyme that specifically removes methyl groups from mono- and dimethylated Lys(4) of histone H3 (H3-K4). We used a combination of in vivo and in vitro experiments to characterize the substrate specificity and recognition by LSD1. Biochemical assays on histone peptides show that essentially all epigenetic modifications on the 21 N-terminal amino acids of histone H3 cause a significant reduction in enzymatic activity. Replacement of Lys(4) with Arg greatly enhances binding affinity, and a histone peptide incorporating this mutation has a strong inhibitory power. Conversely, a peptide bearing a trimethylated Lys(4) is only a weak inhibitor of the enzyme. Rapid kinetics measurements evidence that the enzyme is efficiently reoxidized by molecular oxygen with a second-order rate constant of 9.6 x 10(3) M-1 s(-1), and that the presence of the reaction product does not greatly influence the rate of flavin reoxidation. In vivo experiments provide a correlation between the in vitro inhibitory properties of the tested peptides and their ability of affecting endogenous LSD1 activity. Our results show that epigenetic modifications on histone H3 need to be removed before Lys4 demethylation can efficiently occur. The complex formed by LSD1 with histone deacetylases 1/2 may function as a "double-blade razor" that first eliminates the acetyl groups from acetylated Lys residues and then removes the methyl group from Lys4. We suggest that after H3-K4 demethylation, LSD1 recruits the forthcoming chromatin remodelers leading to the introduction of gene repression marks.	Univ Pavia, Dipartimento Gen & Microbiol, I-27100 Pavia, Italy; Univ Milan, Dipartimento Biol & Genet Sci Med, I-20133 Milan, Italy; Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands	University of Pavia; University of Milan; University of Groningen	Mattevi, A (corresponding author), Univ Pavia, Dipartimento Gen & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	mattevi@ipvgen.unipv.it	Forneris, Federico/AAL-5361-2020; Forneris, Federico/B-1145-2011; Mattevi, Andrea/R-4469-2019; Fraaije, Marco/E-8421-2014; mattevi, andrea/K-5464-2012; battaglioli, elena/H-9350-2017	Forneris, Federico/0000-0002-7818-1804; Forneris, Federico/0000-0002-7818-1804; Mattevi, Andrea/0000-0002-9523-7128; mattevi, andrea/0000-0002-9523-7128; Binda, Claudia/0000-0003-2038-9845; Fraaije, Marco/0000-0001-6346-5014; Battaglioli, Elena/0000-0001-9168-7212				Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bevington P. R., 1969, DATA REDUCTION ERROR, P56; Biel M, 2005, ANGEW CHEM INT EDIT, V44, P3186, DOI 10.1002/anie.200461346; Chin HG, 2005, BIOCHEMISTRY-US, V44, P12998, DOI 10.1021/bi0509907; Culhane JC, 2006, J AM CHEM SOC, V128, P4536, DOI 10.1021/ja0602748; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2006, ENZYMES, V24, P229, DOI 10.1016/S1874-6047(06)80010-7; Heinrichs A, 2006, NAT REV MOL CELL BIO, V7, P466, DOI 10.1038/nrm1967; Holbert MA, 2005, CURR OPIN STRUC BIOL, V15, P673, DOI 10.1016/j.sbi.2005.10.006; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012	25	100	108	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35289	35295		10.1074/jbc.M607411200	http://dx.doi.org/10.1074/jbc.M607411200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16987819	hybrid, Green Published			2022-12-27	WOS:000241933700063
J	Verzijl, D; Pardo, L; van Dijk, M; Gruijthuijsen, YK; Jongejan, A; Timmerman, H; Nicholas, J; Schwarz, M; Murphy, PM; Leurs, R; Smit, MJ				Verzijl, Dennis; Pardo, Leonardo; van Dijk, Marie; Gruijthuijsen, Yvonne K.; Jongejan, Aldo; Timmerman, Henk; Nicholas, John; Schwarz, Mario; Murphy, Philip M.; Leurs, Rob; Smit, Martine J.			Helix 8 of the viral chemokine receptor ORF74 directs chemokine binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; KAPOSIS-SARCOMA; CONSTITUTIVE ACTIVITY; INVERSE AGONISTS; CARBOXYL-TERMINUS; CHARGED RESIDUES; ACTIVATION; RHODOPSIN; LIGAND; IDENTIFICATION	The constitutively active G-protein-coupled receptor and viral oncogene ORF74, encoded by Kaposi sarcoma-associated herpesvirus (human herpesvirus 8), binds a broad range of chemokines, including CXCL1 (agonist), CXCL8 ( neutral ligand), and CXCL10 (inverse agonist). Although chemokines interact with the extracellular N terminus and loops of the receptor, we demonstrate that helix 8 (Hx8) in the intracellular carboxyl tail (C-tail) of ORF74 directs chemokine binding. Partial deletion of the C-tail resulted in a phenotype with reduced constitutive activity but intact regulation by ligands. Complete deletion of the C-tail, including Hx8, resulted in an inactive phenotype that lacks CXCL8 binding sites and has an increased number of binding sites for CXCL10. Similar effects were obtained with the single R7.61(322)W or Q7.62(323)P mutations in Hx8. We propose that the conserved charged or polar side chain at position 7.61 has a specific role in stabilizing the end of transmembrane domain 7 (TM7). Disruption of Hx8 by deletion or mutation distorts an H-bonding network, involving highly conserved amino acids within TM2, TM7, and Hx8, that is crucial for positioning of the TM domains, coupling to G alpha q, and CXCL8 binding. Thus, Hx8 appears to exert a key role in receptor stabilization through the conserved residue R7.61, directing the ligand binding profile of ORF74 and likely also that of other class A G-protein-coupled receptors.	Vrije Univ Amsterdam, Div Med Chem, Leiden Amsterdam Ctr Drug Res, NL-1081 HV Amsterdam, Netherlands; Univ Autonoma Barcelona, Fac Med, Unidad Bioestadist, Lab Med Computac, E-08193 Barcelona, Spain; Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Med Microbiol, NL-6202 AZ Maastricht, Netherlands; Johns Hopkins Univ, Mol Virol Labs, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Autonomous University of Barcelona; University of Barcelona; Maastricht University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Smit, MJ (corresponding author), Vrije Univ Amsterdam, Div Med Chem, Leiden Amsterdam Ctr Drug Res, Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	MJ.Smit@few.vu.nl	Leurs, Rob/ABB-4299-2021; Leurs, Rob/AAC-8508-2022; van Dijk, Marie/L-1901-2014	Leurs, Rob/0000-0003-1354-2848; Smit, Martine/0000-0003-2713-0238; van Dijk, Marie/0000-0003-1461-3441; Pardo, Leonardo/0000-0003-1778-7420; Verzijl, Dennis/0000-0002-7716-9838	NATIONAL CANCER INSTITUTE [R55CA076445, R01CA076445, P01CA113239, R21CA119887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000615] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA119887, P01 CA113239, CA119887, CA76445, CA113239] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahuja SK, 1996, J BIOL CHEM, V271, P225, DOI 10.1074/jbc.271.1.225; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Deupi X, 2004, BIOPHYS J, V86, P105, DOI 10.1016/S0006-3495(04)74088-6; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fan GH, 2001, J BIOL CHEM, V276, P16960, DOI 10.1074/jbc.M009292200; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gruijthuijsen YK, 2002, J VIROL, V76, P1328, DOI 10.1128/JVI.76.3.1328-1338.2002; Ho HH, 1999, J BIOL CHEM, V274, P31327, DOI 10.1074/jbc.274.44.31327; Ho HH, 2001, J BIOL CHEM, V276, P1376, DOI 10.1074/jbc.M007885200; Hoare S, 1999, J BIOL CHEM, V274, P28682, DOI 10.1074/jbc.274.40.28682; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Holst PJ, 2001, J CLIN INVEST, V108, P1789, DOI 10.1172/JCI13622; Jensen KK, 2005, J IMMUNOL, V174, P3686, DOI 10.4049/jimmunol.174.6.3686; Johnson MS, 2006, CELL SIGNAL, V18, P1793, DOI 10.1016/j.cellsig.2006.02.002; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; Kang DS, 2002, MOL PHARMACOL, V62, P281, DOI 10.1124/mol.62.2.281; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Liu CQ, 2004, J VIROL, V78, P2460, DOI 10.1128/JVI.78.5.2460-2471.2004; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Murphy PM, 2000, PHARMACOL REV, V52, P145; Natochin M, 2003, J BIOL CHEM, V278, P37574, DOI 10.1074/jbc.M305136200; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Prioleau C, 2002, J BIOL CHEM, V277, P36577, DOI 10.1074/jbc.M206223200; Rosenkilde MM, 2004, J BIOL CHEM, V279, P32524, DOI 10.1074/jbc.M313392200; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; Santos N. M. D., 2006, J BIOL CHEM, V281, P12896; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Smit MJ, 2002, J VIROL, V76, P1744, DOI 10.1128/JVI.76.4.1744-1752.2002; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Verzijl D, 2004, J VIROL, V78, P3343, DOI 10.1128/JVI.78.7.3343-3351.2004; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200	44	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35327	35335		10.1074/jbc.M606877200	http://dx.doi.org/10.1074/jbc.M606877200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16997914	hybrid, Green Submitted			2022-12-27	WOS:000241933700067
J	Yi, L; Fang, J; Isik, N; Chim, J; Jin, T				Yi, Ling; Fang, Jun; Isik, Nilgun; Chim, Jimmy; Jin, Tian			HIV gp120-induced interaction between CD4 and CCR5 requires cholesterol-rich microenvironments revealed by live cell fluorescence resonance energy transfer imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTORS; T-CELLS; GP120; ENTRY; GLYCOPROTEIN; MICRODOMAINS; CORECEPTORS; INHIBITION; DYNAMICS	Binding of the human immunodeficiency virus (HIV) envelope gp120 glycoprotein to CD4 and CCR5 receptors on the plasma membrane initiates the viral entry process. Although plasma membrane cholesterol plays an important role in HIV entry, its modulating effect on the viral entry process is unclear. Using fluorescence resonance energy transfer imaging, we have provided evidence here that CD4 and CCR5 localize in different microenvironments on the surface of resting cells. Binding of the third variable region V3-containing gp120 core to CD4 and CCR5 induced association between these receptors, which could be directly monitored by fluorescence resonance energy transfer on the plasma membrane of live cells. Depletion of cholesterol from the plasma membrane abolished the gp120 core-induced associations between CD4 and CCR5, and reloading cholesterol restored the associations in live cells. Our studies suggest that, during the first step of the HIV entry process, gp120 binding alters the microenvironments of unbound CD4 and CCR5, with plasma membrane cholesterol required for the formation of the HIV entry complex.	NIAID, Lab Immunogenet, Twinbrook Facil 2, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jin, T (corresponding author), NIAID, Lab Immunogenet, Twinbrook Facil 2, NIH, Rockville, MD 20852 USA.	tjin@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000928, Z01AI000928] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Edidin M, 2003, NAT REV MOL CELL BIO, V4, P414, DOI 10.1038/nrm1102; GELDERBLOM HR, 1987, VIROLOGY, V156, P171, DOI 10.1016/0042-6822(87)90449-1; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Heveker N, 1998, CURR BIOL, V8, P369, DOI 10.1016/S0960-9822(98)70155-1; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kinter A, 1998, P NATL ACAD SCI USA, V95, P11880, DOI 10.1073/pnas.95.20.11880; Kramer JM, 2006, J IMMUNOL, V176, P711, DOI 10.4049/jimmunol.176.2.711; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lehner T, 2002, TRENDS IMMUNOL, V23, P347, DOI 10.1016/S1471-4906(02)02252-4; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Lusso P, 2002, VACCINE, V20, P1964, DOI 10.1016/S0264-410X(02)00079-8; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nguyen DH, 2002, J IMMUNOL, V168, P4121, DOI 10.4049/jimmunol.168.8.4121; OZEL M, 1988, ARCH VIROL, V100, P255, DOI 10.1007/BF01487688; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Percherancier Y, 2003, J BIOL CHEM, V278, P3153, DOI 10.1074/jbc.M207371200; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Steffens CM, 2004, J VIROL, V78, P9573, DOI 10.1128/JVI.78.17.9573-9578.2004; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; van Meer G, 2002, SCIENCE, V296, P855, DOI 10.1126/science.1071491; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; Xu XH, 2005, MOL BIOL CELL, V16, P676, DOI 10.1091/mbc.E04-07-0544; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	40	32	34	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35446	35453		10.1074/jbc.M607302200	http://dx.doi.org/10.1074/jbc.M607302200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16963439	hybrid			2022-12-27	WOS:000241933700078
J	Dupre, DJ; Robitaille, M; Ethier, N; Villeneuve, LR; Mamarbachi, AM; Hebert, TE				Dupre, Denis J.; Robitaille, Melanie; Ethier, Nathalie; Villeneuve, Louis R.; Mamarbachi, Aida M.; Hebert, Terence E.			Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; G-BETA-GAMMA; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; RECTIFYING POTASSIUM CHANNELS; CELL-SURFACE EXPRESSION; FORM STABLE COMPLEXES; GTP REGULATORY UNIT; YEAST G-PROTEIN; ENDOPLASMIC-RETICULUM; ADENYLATE-CYCLASE	Much is known about beta(2)-adrenergic receptor trafficking and internalization following prolonged agonist stimulation. However, less is known about outward trafficking of the beta(2)-adrenergic receptor to the plasma membrane or the role that trafficking might play in the assembly of receptor signaling complexes, important for targeting, specificity, and rapidity of subsequent signaling events. Here, by using a combination of bioluminescence resonance energy transfer, bimolecular fluorescence complementation, and confocal microscopy, we evaluated the steps in the formation of the core receptor-G protein heterotrimer complex. By using dominant negative Rab and Sar GTPase constructs, we demonstrate that receptor dimers and receptor-G beta gamma complexes initially associate in the endoplasmic reticulum, whereas G alpha subunits are added to the complex during endoplasmic reticulum-Golgi transit. We also observed that G protein heterotrimers adopt different trafficking itineraries when expressed alone or with stoichiometric co-expression with receptor. Furthermore, deliberate mistargeting of specific components of these complexes leads to diversion of other members from their normal subcellular localization, confirming the role of these early interactions in targeting and formation of specific signaling complexes.	McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada	McGill University; Universite de Montreal; Universite de Montreal	Hebert, TE (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada.	terence.hebert@mcgill.ca	Robitaille, Melanie/ABA-5861-2020; Dupre, Denis J/AAI-2631-2021	Robitaille, Melanie/0000-0001-9354-5162; Dupre, Denis J/0000-0001-6401-6157				Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; ARAD H, 1984, P NATL ACAD SCI-BIOL, V81, P6579, DOI 10.1073/pnas.81.21.6579; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Berthele A, 2001, NEUROREPORT, V12, P3269, DOI 10.1097/00001756-200110290-00025; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Clark JA, 2000, BRAIN RES, V860, P41, DOI 10.1016/S0006-8993(00)01958-2; DAVID M, 2006, IN PRESS CELL SIGNAL; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dunigan CD, 2002, BIOCHEMISTRY-US, V41, P8019, DOI 10.1021/bi025538r; Dupre DJ, 2006, CELL SIGNAL, V18, P1549, DOI 10.1016/j.cellsig.2006.03.009; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Fishburn CS, 2000, P NATL ACAD SCI USA, V97, P1085, DOI 10.1073/pnas.97.3.1085; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Klein S, 2000, P NATL ACAD SCI USA, V97, P3219, DOI 10.1073/pnas.050015797; Lachance M, 1999, CELL SIGNAL, V11, P523, DOI 10.1016/S0898-6568(99)00024-8; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; LEVITZKI A, 1981, CRC CR REV BIOCH MOL, V10, P81, DOI 10.3109/10409238109114550; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; LEVITZKI A, 1984, J RECEPTOR RES, V4, P399, DOI 10.3109/10799898409042564; LEVITZKI A, 1986, PHYSIOL REV, V66, P819, DOI 10.1152/physrev.1986.66.3.819; LEVITZKI A, 1988, TRENDS BIOCHEM SCI, V13, P298, DOI 10.1016/0968-0004(88)90122-3; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; MARBACH I, 1990, J BIOL CHEM, V265, P9999; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Michaelson D, 2002, MOL BIOL CELL, V13, P3294, DOI 10.1091/mbc.E02-02-0095; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Pellegrino S, 1997, J BIOL CHEM, V272, P25360, DOI 10.1074/jbc.272.40.25360; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rebois RV, 2003, RECEPTOR CHANNEL, V9, P169, DOI 10.1080/10606820308243; Rebois RV, 1997, CELL SIGNAL, V9, P141, DOI 10.1016/S0898-6568(96)00133-7; Reddy PS, 1998, BIOESSAYS, V20, P546, DOI 10.1002/(SICI)1521-1878(199807)20:7<546::AID-BIES5>3.0.CO;2-I; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rodman JS, 2000, J CELL SCI, V113, P183; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SCHMIDT CJ, 1991, J BIOL CHEM, V266, P4538; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takida S, 2004, FEBS LETT, V567, P209, DOI 10.1016/j.febslet.2004.04.062; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; TOLKOVSKY AM, 1981, J CYCLIC NUCL PROT, V7, P139; TOLKOVSKY AM, 1982, P NATL ACAD SCI-BIOL, V79, P213, DOI 10.1073/pnas.79.2.213; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Xiao RP, 1999, CIRC RES, V84, P43	66	127	129	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34561	34573		10.1074/jbc.M605012200	http://dx.doi.org/10.1074/jbc.M605012200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16959776	hybrid			2022-12-27	WOS:000241767600076
J	Kunz, RC; Horng, YC; Ragsdale, SW				Kunz, Ryan C.; Horng, Yih-Chern; Ragsdale, Stephen W.			Spectroscopic and kinetic studies of the reaction of bromopropanesulfonate with methyl-coenzyme M reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOAUTOTROPHICUM STRAIN MARBURG; BIOLOGICAL METHANE FORMATION; F430 PENTAMETHYL ESTER; X-RAY-ABSORPTION; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOGENIC BACTERIA; TITANIUM(III) CITRATE; LIGAND-EXCHANGE; F-430 COFACTOR; ACTIVE-SITE	Methyl-coenzyme M reductase (MCR) catalyzes the final step of methanogenesis in which coenzyme B and methyl-coenzyme M are converted to methane and the heterodisulfide, CoMS-SCoB. MCR also appears to initiate anaerobic methane oxidation (reverse methanogenesis). At the active site of MCR is coenzyme F-430, a nickel tetrapyrrole. This paper describes the reaction of the active MCRred1 state with the potent inhibitor, 3-bromopropanesulfonate (BPS; I-50 = 50 nM) by UV-visible and EPR spectroscopy and by steady-state and rapid kinetics. BPS was shown to be an alternative substrate of MCR in an ionic reaction that is coenzyme B-independent and leads to debromination of BPS and formation of a distinct state ("MCRPS") with an EPR signal that was assigned to a Ni(III)-propylsulfonate species (Hinderberger, D., Piskorski, R. P., Goenrich, M., Thauer, . K., Schweiger, A., Harmer, J., and Jaun, B. (2006) Angew. Chem. Int. Ed. Engl. 45, 3602-3607). A similar EPR signal was generated by reacting MCRred1 with several halogenated sulfonate and carboxylate substrates. In rapid chemical quench experiments, the propylsulfonate ligand was identified by NMR spectroscopy and high performance liquid chromatography as propanesulfonic acid after protonolysis of the MCRPS complex. Propanesulfonate formation was also observed in steady-state reactions in the presence of Ti(III) citrate. Reaction of the alkyl-nickel intermediate with thiols regenerates the active MCRred1 state and eliminates the propylsulfonate group, presumably as the thioether. MCRPS is catalytically competent in both the generation of propanesulfonate and reformation of MCRred1. These results provide evidence for the intermediacy of an alkyl-nickel species in the final step in anaerobic methane oxidation and in the initial step of methanogenesis.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Ragsdale, SW (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	sragsdale1@unl.edu	Horng, Yih-Chern/I-6682-2018	Horng, Yih-Chern/0000-0001-9558-3189	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NCRR NIH HHS [1P20RR17675] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALBRACHT SPJ, 1988, BIOCHIM BIOPHYS ACTA, V955, P86, DOI 10.1016/0167-4838(88)90182-3; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Becker DF, 1998, BIOCHEMISTRY-US, V37, P2639, DOI 10.1021/bi972145x; BERKESSEL A, 1991, BIOORG CHEM, V19, P101, DOI 10.1016/0045-2068(91)90047-S; BOBIK TA, 1988, P NATL ACAD SCI USA, V85, P60, DOI 10.1073/pnas.85.1.60; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER MC, 1993, J BIOL CHEM, V268, P18491; Craft JL, 2004, J AM CHEM SOC, V126, P4068, DOI 10.1021/ja038082p; Craft JL, 2004, J BIOL INORG CHEM, V9, P77, DOI 10.1007/s00775-003-0499-7; DIEKERT G, 1980, FEBS LETT, V119, P118, DOI 10.1016/0014-5793(80)81011-8; DIEKERT G, 1980, ARCH MICROBIOL, V124, P103, DOI 10.1007/BF00407036; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Duin EC, 2003, J BIOL INORG CHEM, V8, P141, DOI 10.1007/s00775-002-0399-2; ELLERMANN J, 1989, EUR J BIOCHEM, V184, P63, DOI 10.1111/j.1432-1033.1989.tb14990.x; ELLERMANN J, 1988, EUR J BIOCHEM, V172, P669, DOI 10.1111/j.1432-1033.1988.tb13941.x; ELLERMANN J, 1987, FEBS LETT, V220, P358, DOI 10.1016/0014-5793(87)80846-3; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Goenrich M, 2005, J BIOL INORG CHEM, V10, P333, DOI 10.1007/s00775-005-0636-6; Goenrich M, 2004, J BIOL INORG CHEM, V9, P691, DOI 10.1007/s00775-004-0552-1; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Grabarse W, 2001, J MOL BIOL, V309, P315, DOI 10.1006/jmbi.2001.4647; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; GUNSALUS RP, 1978, BIOCHEMISTRY-US, V17, P2374, DOI 10.1021/bi00605a019; Harmer J, 2005, J AM CHEM SOC, V127, P17744, DOI 10.1021/ja053794w; Hinderberger D, 2006, ANGEW CHEM INT EDIT, V45, P3602, DOI 10.1002/anie.200600366; HOLLIGER C, 1993, J AM CHEM SOC, V115, P5651, DOI 10.1021/ja00066a034; Horng YC, 2001, BIOCHEMISTRY-US, V40, P12875, DOI 10.1021/bi011196y; JAUN B, 1990, HELV CHIM ACTA, V73, P2209, DOI 10.1002/hlca.19900730818; LAHIRI GK, 1993, INORG CHEM, V32, P4409, DOI 10.1021/ic00072a041; LIN SK, 1992, HELV CHIM ACTA, V75, P1478, DOI 10.1002/hlca.19920750504; LIN SK, 1991, HELV CHIM ACTA, V74, P1725, DOI 10.1002/hlca.19910740814; Mahlert F, 2002, J BIOL INORG CHEM, V7, P500, DOI 10.1007/s00775-001-0325-z; NOLL KM, 1987, J BIOL CHEM, V262, P513; Pelmenschikov V, 2003, J BIOL INORG CHEM, V8, P653, DOI 10.1007/s00775-003-0461-8; Pelmenschikov V, 2002, J AM CHEM SOC, V124, P4039, DOI 10.1021/ja011664r; PFALTZ A, 1982, HELV CHIM ACTA, V65, P828, DOI 10.1002/hlca.19820650320; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; ROSPERT S, 1992, EUR J BIOCHEM, V210, P101, DOI 10.1111/j.1432-1033.1992.tb17396.x; ROSPERT S, 1990, EUR J BIOCHEM, V194, P871, DOI 10.1111/j.1432-1033.1990.tb19481.x; ROSPERT S, 1991, FEBS LETT, V291, P371, DOI 10.1016/0014-5793(91)81323-Z; SCHONHEIT P, 1980, ARCH MICROBIOL, V127, P59, DOI 10.1007/BF00414356; Signor L, 2000, CHEM-EUR J, V6, P3508, DOI 10.1002/1521-3765(20001002)6:19<3508::AID-CHEM3508>3.3.CO;2-N; Singh K, 2003, J AM CHEM SOC, V125, P2436, DOI 10.1021/ja028525+; Tang Q, 2002, J AM CHEM SOC, V124, P13242, DOI 10.1021/ja020314h; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; WHITMAN WB, 1980, BIOCHEM BIOPH RES CO, V92, P1196, DOI 10.1016/0006-291X(80)90413-1; Wondimagegn T, 2001, J AM CHEM SOC, V123, P1543, DOI 10.1021/ja001870j; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008	49	30	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34663	34676		10.1074/jbc.M606715200	http://dx.doi.org/10.1074/jbc.M606715200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966321	hybrid			2022-12-27	WOS:000241767600085
J	Chang, DJ; Lupardus, PJ; Cimprich, KA				Chang, Debbie J.; Lupardus, Patrick J.; Cimprich, Karlene A.			Monoubiquitination of proliferating cell nuclear antigen induced by stalled replication requires uncoupling of DNA polymerase and mini-chromosome maintenance helicase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; SINGLE-STRANDED-DNA; TRANSLESION SYNTHESIS; DAMAGE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; FREE SYSTEM; ATR; PCNA; ACTIVATION; INITIATION	Proliferating cell nuclear antigen ( PCNA) is a homotrimeric, ring-shaped protein complex that functions as a processivity factor for DNA polymerases. Following genotoxic stress, PCNA is modified at a conserved site by either a single ubiquitin moiety or a polyubiquitin chain. These modifications are required to coordinate DNA damage tolerance processes with ongoing replication. The molecular mechanisms responsible for inducing PCNA ubiquitination are not well understood. Using Xenopus egg extracts, we show that ultraviolet radiation and aphidicolin treatment induce the mono- and diubiquitination of PCNA. PCNA ubiquitination is replication-dependent and coincides with activation of the ataxia telangiectasia mutated and Rad3-related (ATR)-dependent DNA damage checkpoint pathway. However, loss of ATR signaling by depletion of the ATR-interacting protein ( ATRIP) or Rad1, a component of the 911 checkpoint clamp, does not impair PCNA ubiquitination. Primed single-stranded DNA generated by uncoupling of mini-chromosome maintenance helicase and DNA polymerase activities has been shown previously to be necessary for ATR activation. Here we show that PCNA ubiquitination also requires uncoupling of helicase and polymerase activities. We further demonstrate that replicating single-stranded DNA, which mimics the structure produced upon uncoupling, is sufficient to induce PCNA monoubiquitination. Our results suggest that PCNA ubiquitination and ATR activation are two independent events that occur in response to a common single-stranded DNA intermediate generated by functional uncoupling of mini-chromosome maintenance (MCM) helicase and DNA polymerase activities.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Cimprich, KA (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, 318 Campus Dr, Stanford, CA 94305 USA.	cimprich@stanford.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062193] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES016486] Funding Source: Medline; NIGMS NIH HHS [GM 62193] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arias EE, 2004, FRONT BIOSCI-LANDMRK, V9, P3029, DOI 10.2741/1457; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Frampton J, 2006, MOL BIOL CELL, V17, P2976, DOI 10.1091/mbc.e05-11-1008; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Hirano Y, 2006, CURR BIOL, V16, P586, DOI 10.1016/j.cub.2006.01.063; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kai M, 2003, MUTAT RES-FUND MOL M, V532, P59, DOI 10.1016/j.mrfmmm.2003.08.010; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; Lehmann AR, 2005, FEBS LETT, V579, P873, DOI 10.1016/j.febslet.2004.11.029; Liu QH, 2000, GENE DEV, V14, P1448; Lupardus PJ, 2006, MOL BIOL CELL, V17, P1559, DOI 10.1091/mbc.E05-09-0865; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mattock H, 2001, EXP CELL RES, V265, P242, DOI 10.1006/excr.2001.5181; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Paulovich AG, 1998, GENETICS, V150, P75; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sarkaria JN, 1999, CANCER RES, V59, P4375; SHEEHAN MA, 1988, J CELL BIOL, V106, P1, DOI 10.1083/jcb.106.1.1; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stokes MP, 2002, J CELL BIOL, V158, P863, DOI 10.1083/jcb.200204127; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	50	82	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32081	32088		10.1074/jbc.M606799200	http://dx.doi.org/10.1074/jbc.M606799200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16959771	hybrid			2022-12-27	WOS:000241414500005
J	Eastmond, DL; Nelson, HCM				Eastmond, Dawn L.; Nelson, Hillary C. M.			Genome-wide analysis reveals new roles for the activation domains of the Saccharomyces cerevisiae heat shock transcription factor (Hsf1) during the transient heat shock response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNF1 PROTEIN-KINASE; DNA-BINDING DOMAIN; STRESS-RESPONSE; FACTOR CONTAINS; ENVIRONMENTAL-CHANGES; GLUCOSE STARVATION; COILED-COIL; YEAST; EXPRESSION; GENES	In response to elevated temperatures, cells from many organisms rapidly transcribe a number of mRNAs. In Saccharomyces cerevisiae, this protective response involves two regulatory systems: the heat shock transcription factor (Hsf1) and the Msn2 and Msn4 (Msn2/4) transcription factors. Both systems modulate the induction of specific heat shock genes. However, the contribution of Hsf1, independent of Msn2/4, is only beginning to emerge. To address this question, we constructed an msn2/4 double mutant and used microarrays to elucidate the genomewide expression program of Hsf1. The data showed that 7.6% of the genome was heat-induced. The up-regulated genes belong to a wide range of functional categories, with a significant increase in the chaperone and metabolism genes. We then focused on the contribution of the activation domains of Hsf1 to the expression profile and extended our analysis to include msn2/4 Delta strains deleted for the N-terminal or C-terminal activation domain of Hsf1. Cluster analysis of the heat-induced genes revealed activation domain-specific patterns of expression, with each cluster also showing distinct preferences for functional categories. Computational analysis of the promoters of the induced genes affected by the loss of an activation domain showed a distinct preference for positioning and topology of the Hsf1 binding site. This study provides insight into the important role that both activation domains play for the Hsf1 regulatory system to rapidly and effectively transcribe its regulon in response to heat shock.	Univ Penn, Sch Med, Dept Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Nelson, HCM (corresponding author), Univ Penn, Sch Med, Dept Biochem & Mol Biophys, Rm 814,Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	hnelson@mail.med.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044086] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044086, R01 GM044086-15, R01 GM044086-14S1, R01 GM044086-12, GM 44086, R01 GM044086-16, R01 GM044086-14, R01 GM044086-13] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; [Anonymous], 2004, CURRENT PROTOCOLS MO; BALAKRISHNAN R, 2005, SACCHAROMYCES GENOME; Ball CA, 2000, NUCLEIC ACIDS RES, V28, P77, DOI 10.1093/nar/28.1.77; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; BONNER JJ, 1994, MOL CELL BIOL, V14, P501, DOI 10.1128/MCB.14.1.501; BONNER JJ, 1992, MOL CELL BIOL, V12, P1021, DOI 10.1128/MCB.12.3.1021; Boy-Marcotte E, 1999, MOL MICROBIOL, V33, P274, DOI 10.1046/j.1365-2958.1999.01467.x; Bulman AL, 2001, J BIOL CHEM, V276, P40254, DOI 10.1074/jbc.M106301200; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHEN YQ, 1993, EMBO J, V12, P5007, DOI 10.1002/j.1460-2075.1993.tb06194.x; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Ferguson SB, 2005, GENETICS, V169, P1203, DOI 10.1534/genetics.104.034256; FERGUSON SB, 2005, THESIS U PENNSYLVANI; FERNANDES M, 1994, NUCLEIC ACIDS RES, V22, P167, DOI 10.1093/nar/22.2.167; GALLO GJ, 1993, MOL CELL BIOL, V13, P749, DOI 10.1128/MCB.13.2.749; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Grably MR, 2002, MOL MICROBIOL, V44, P21, DOI 10.1046/j.1365-2958.2002.02860.x; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; KOBAYASHI N, 1993, MOL CELL BIOL, V13, P248, DOI 10.1128/MCB.13.1.248; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Mai B, 1997, MOL CELL BIOL, V17, P6491, DOI 10.1128/MCB.17.11.6491; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; NIETOSOTELO J, 1990, CELL, V62, P807, DOI 10.1016/0092-8674(90)90124-W; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Peteranderl R, 1999, BIOCHEMISTRY-US, V38, P3559, DOI 10.1021/bi981774j; PETERANDERL R, 1992, BIOCHEMISTRY-US, V31, P12272, DOI 10.1021/bi00163a042; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; ROWLEY A, 1993, MOL CELL BIOL, V13, P1034, DOI 10.1128/MCB.13.2.1034; Sakurai H, 2003, GENES CELLS, V8, P951, DOI 10.1046/j.1356-9597.2003.00689.x; Sakurai H, 2001, BIOCHEM BIOPH RES CO, V285, P696, DOI 10.1006/bbrc.2001.5234; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; SHUEY DJ, 1986, J BIOL CHEM, V261, P7934; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Tachibana T, 2002, J BIOL CHEM, V277, P22140, DOI 10.1074/jbc.M201267200; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Treger JM, 1998, J BIOL CHEM, V273, P26875, DOI 10.1074/jbc.273.41.26875; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; YOUNG MR, 1993, MOL CELL BIOL, V13, P5637, DOI 10.1128/MCB.13.9.5637	63	67	69	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32909	32921		10.1074/jbc.M602454200	http://dx.doi.org/10.1074/jbc.M602454200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16926161	hybrid, Green Accepted			2022-12-27	WOS:000241414500089
J	Uliana, AS; Crespo, PM; Martina, JA; Daniotti, JL; Maccioni, HJF				Uliana, Andrea S.; Crespo, Pilar M.; Martina, Jose A.; Daniotti, Jose L.; Maccioni, Hugo J. F.			Modulation of GalT1 and SialT1 sub-golgi localization by SialT2 expression reveals an organellar level of glycolipid synthesis control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CULTURED NEURONS; BREFELDIN-A; GANGLIOSIDE BIOSYNTHESIS; CHO-K1 CELLS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; GA2/GM2/GD2 SYNTHASE; NEURAL RETINA; GD3; GLYCOSYLTRANSFERASES	Ganglioside glycosyltransferases organize as multienzyme complexes that localize in different sub-Golgi compartments. Here we studied whether in CHO-K1 cells lacking CMP-NeuAc: GM3 sialyltransferase (SialT2), the sub-Golgi localization of UDPGal: glucosylceramide beta-1,4-galactosyltransferase (GalT1) and CMP-NeuAc: lactosylceramide sialyltransferase (SialT1) complex is affected when SialT2, another member of this complex, is coexpressed. GalT1 and SialT1 sub-Golgi localization was determined by studying the effect of brefeldin A (BFA) and monensin on the synthesis of glycolipids and on the sub-Golgi localization of GalT1(1-52)-CFP (cyan fluorescent protein) and SialT1(1)-(54)-YFP (yellow fluorescent protein) chimeras by single cell fluorescence microscopy and by isopycnic subfractionation. We found that BFA, and also monensin, impair the synthesis of glycolipids beyond GM3 ganglioside in wild type (WT) cells but beyond GlcCer in SialT2(+) cells. Although BFA redistributed GalT1-CFP and SialT1-YFP to the endoplasmic reticulum in WT cells, a fraction of these chimeras remained associated with a distal Golgi compartment, enriched in trans Golgi network, and recycling endosome markers in SialT2(+) cells. In BFA-treated cells, the percentage of GalT1-CFP and SialT1-YFP associated with Golgi-like membrane fractions separated by isopycnic subfractionation was higher in SialT2(+) cells than in WT cells. These effects were reverted by knocking down the expression of SialT2 with specific siRNA. Results indicate that sub-Golgi localization of glycosyltransferase complexes may change according to the relative levels of the expression of participating enzymes and reveal a capacity of the organelle to adapt the topology of the glycolipid synthesis machinery to functional states of the cell.	Univ Nacl Cordoba, CSIC, CIQUIBIC, CONICET,Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Maccioni, HJF (corresponding author), Univ Nacl Cordoba, CSIC, CIQUIBIC, CONICET,Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	maccioni@dqb.fcq.unc.edu.ar	Martina, Jose A/C-2772-2013	Martina, Jose/0000-0001-5814-8807				Allende ML, 2000, GLYCOBIOLOGY, V10, P1025, DOI 10.1093/glycob/10.10.1025; Bieberich E, 2002, BIOCHEMISTRY-US, V41, P11479, DOI 10.1021/bi0259958; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; Crespo PM, 2004, J BIOL CHEM, V279, P47610, DOI 10.1074/jbc.M407181200; Crespo PM, 2004, BIOCHEM J, V377, P561, DOI 10.1042/BJ20031016; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; Daniotti JL, 2000, J NEUROCHEM, V74, P1711, DOI 10.1046/j.1471-4159.2000.0741711.x; DANIOTTI JL, 1991, J NEUROCHEM, V57, P2054, DOI 10.1111/j.1471-4159.1991.tb06421.x; DANIOTTI JL, 1994, J NEUROCHEM, V62, P1131; ELAZAR Z, 1994, J CELL BIOL, V124, P415, DOI 10.1083/jcb.124.4.415; Fritz VMR, 1997, BBA-GENE STRUCT EXPR, V1354, P153, DOI 10.1016/S0167-4781(97)00117-6; FRITZ VMR, 1995, J NEUROCHEM, V65, P1859; Fritz VMR, 1996, J NEUROCHEM, V67, P1393; Giraudo CG, 1999, BIOCHEM J, V342, P633, DOI 10.1042/0264-6021:3420633; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gomez GA, 2005, J BIOL CHEM, V280, P34997, DOI 10.1074/jbc.M506256200; Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; Li RX, 2000, J BIOL CHEM, V275, P34213, DOI 10.1074/jbc.M906368199; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Maccioni HJF, 1999, BBA-MOL CELL BIOL L, V1437, P101, DOI 10.1016/S1388-1981(99)00002-5; MAXZUD MK, 1995, J BIOL CHEM, V270, P20207, DOI 10.1074/jbc.270.34.20207; Milland J, 2002, J BIOL CHEM, V277, P10374, DOI 10.1074/jbc.M111799200; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NORES GA, 1984, J NEUROCHEM, V42, P1205, DOI 10.1111/j.1471-4159.1984.tb02773.x; ORCI L, 1991, CELL, V64, P1183; RUSSO RN, 1992, J BIOL CHEM, V267, P9241; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANECHTEN G, 1989, J NEUROCHEM, V52, P207; VANECHTEN G, 1990, J BIOL CHEM, V265, P9333; YOUNG WW, 1990, P NATL ACAD SCI USA, V87, P6838, DOI 10.1073/pnas.87.17.6838; Yu RK, 2004, J LIPID RES, V45, P783, DOI 10.1194/jlr.R3000020-JLR200; ZHANG GF, 1993, J CELL SCI, V104, P819	42	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32852	32860		10.1074/jbc.M605805200	http://dx.doi.org/10.1074/jbc.M605805200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950784	hybrid			2022-12-27	WOS:000241414500083
J	El-Shewy, HM; Johnson, KR; Lee, MH; Jaffa, AA; Obeid, LM; Luttrell, LM				El-Shewy, Hesham M.; Johnson, Korey R.; Lee, Mi-Hye; Jaffa, Ayad A.; Obeid, Lina M.; Luttrell, Louis M.			Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; BC3H-1 MURINE MYOCYTES; MANNOSE 6-PHOSPHATE; SPHINGOSINE 1-PHOSPHATE; KINASE-C; FACTOR-II/MANNOSE-6-PHOSPHATE RECEPTOR; G(BETA-GAMMA) SUBUNITS; BETA-ARRESTIN; EGF RECEPTOR; CELLS	Although several studies have shown that a subset of insulin-like growth factor (IGF) signals require the activation of heterotrimeric G proteins, the molecular mechanisms underlying IGF-stimulated G protein signaling remain poorly understood. Here, we have studied the mechanism by which endogenous IGF receptors activate the ERK1/2 mitogen-activated protein kinase cascade in HEK293 cells. In these cells, treatment with pertussis toxin and expression of a G alpha(q/11)-305-359) peptide that inhibits G(q/11) signaling additively inhibited IGF-stimulated ERK1/2 activation, indicating that the signal was almost completely G protein-dependent. Treatment with IGF-1 or IGF-2 promoted translocation of green fluorescent protein (GFP)-tagged sphingosine kinase (SK) 1 from the cytosol to the plasma membrane, increased endogenous SK activity within 30 s of stimulation, and caused a statistically significant increase in intracellular and extracellular sphingosine 1-phosphate (S1P) concentration. Using a GFP-tagged S1P(1) receptor as a biological sensor for the generation of physiologically relevant S1P levels, we found that IGF-1 and IGF-2 induced GFP-S1P receptor internalization and that the effect was blocked by pretreatment with the SK inhibitor, dimethylsphingosine. Treating cells with dimethylsphingosine, silencing SK1 expression by RNA interference, and blocking endogenous S1P receptors with the competitive antagonist VPC23019 all significantly inhibited IGF-stimulated ERK1/2 activation, suggesting that IGFs elicit G protein-dependent ERK1/2 activation by stimulating SK1-dependent transactivation of S1P receptors. Given the ubiquity of SK and S1P receptor expression, S1P receptor transactivation may represent a general mechanism for G protein-dependent signaling by non-G protein-coupled receptors.	Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Luttrell, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 96 Jonathan Lucas St,816 CSB,POB 250624, Charleston, SC 29425 USA.	luttrell@musc.edu		obeid, lina/0000-0002-0734-0847; Luttrell, Louis/0000-0003-2805-6949	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK58283] Funding Source: Medline; NIGMS NIH HHS [GM62887] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; El-Shewy HM, 2004, MOL ENDOCRINOL, V18, P2727, DOI 10.1210/me.2004-0174; Fedorov YV, 1998, MOL CELL BIOL, V18, P5780, DOI 10.1128/MCB.18.10.5780; Gaborik Z, 2004, TRENDS ENDOCRIN MET, V15, P286, DOI 10.1016/j.tem.2004.06.009; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Groskopf JC, 1997, ENDOCRINOLOGY, V138, P2835, DOI 10.1210/en.138.7.2835; Hallak H, 2000, J BIOL CHEM, V275, P2255, DOI 10.1074/jbc.275.4.2255; Hassan AB, 2003, AM J PATHOL, V162, P3, DOI 10.1016/S0002-9440(10)63791-1; Hawkes C, 2006, J NEUROSCI, V26, P585, DOI 10.1523/JNEUROSCI.2730-05.2006; Hawkes C, 2003, J COMP NEUROL, V458, P113, DOI 10.1002/cne.10578; Heringdorf DMZ, 2001, EUR J PHARMACOL, V414, P145, DOI 10.1016/S0014-2999(01)00789-0; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Janez A, 2000, J BIOL CHEM, V275, P26870; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kanzaki M, 1997, J BIOL CHEM, V272, P4964, DOI 10.1074/jbc.272.8.4964; Keummerle JF, 2001, J BIOL CHEM, V276, P7187, DOI 10.1074/jbc.M011145200; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KriegerBrauer HI, 1997, J BIOL CHEM, V272, P10135; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; LUTTRELL L, 1990, J BIOL CHEM, V265, P16873; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; LUTTRELL LM, 1988, J BIOL CHEM, V263, P6134; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; NISHIMOTO I, 1989, J BIOL CHEM, V264, P14029; OKAMOTO T, 1990, CELL, V62, P709, DOI 10.1016/0092-8674(90)90116-V; OKAMOTO T, 1993, FEBS LETT, V334, P143, DOI 10.1016/0014-5793(93)81700-A; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Patel TB, 2004, PHARMACOL REV, V56, P371, DOI 10.1124/pr.56.3.4; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; PURCHIO AF, 1988, J BIOL CHEM, V263, P14211; Pyne NJ, 2003, BIOCHEM SOC T, V31, P1220; ROMERO G, 1988, SCIENCE, V240, P509, DOI 10.1126/science.3282305; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; SALTIEL AR, 1986, SCIENCE, V233, P967, DOI 10.1126/science.3016898; SASAOKA T, 1994, J BIOL CHEM, V269, P10734; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Uehara T, 1999, EUR J BIOCHEM, V259, P801, DOI 10.1046/j.1432-1327.1999.00100.x; Valentinis, 1997, BIOCHIM BIOPHYS ACTA, V1332, P105; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; Waters C, 2003, J BIOL CHEM, V278, P6282, DOI 10.1074/jbc.M208560200; Waters D, 2006, FASEB J, V20, pA1058; Watterson KR, 2005, CELL SIGNAL, V17, P289, DOI 10.1016/j.cellsig.2004.09.013; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; WHITE MF, 1994, J BIOL CHEM, V269, P1; Yau L, 1999, EUR J BIOCHEM, V266, P1147, DOI 10.1046/j.1432-1327.1999.00968.x; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	58	73	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31399	31407		10.1074/jbc.M605339200	http://dx.doi.org/10.1074/jbc.M605339200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16926156				2022-12-27	WOS:000241235300024
J	Sumathipala, R; Xu, CS; Seago, J; Mould, AP; Humphries, MJ; Craig, SE; Patel, Y; Wijelath, ES; Sobel, M; Rahman, S				Sumathipala, Rushika; Xu, Cunshuan; Seago, Julian; Mould, A. Paul; Humphries, Martin J.; Craig, Sue E.; Patel, Yatin; Wijelath, Errol S.; Sobel, Michael; Rahman, Salman			The "linker" region (amino acids 38-47) of the disintegrin elegantin is a novel inhibitory domain of integrin alpha(5)beta(1)-dependent cell adhesion on fibronectin - Evidence for the negative regulation of fibronectin synergy site biological activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; SNAKE-VENOM PROTEINS; RGD SEQUENCE MOTIFS; HETERODIMERIC DISINTEGRIN; LIGAND RECOGNITION; 10TH-FIII DOMAINS; BINDING-SITES; FIBRINOGEN; COMPLEX; ALPHA(IIB)BETA(3)	Disintegrins are a family of potent inhibitors of cell-cell and cell-matrix adhesion. In this study we have identified a region of the disintegrin elegantin, termed the "linker domain" (amino acids 38-47), with inhibitory activity toward alpha(5)beta(1)-mediated cell adhesion on fibronectin (Fn). Using a chimeric structure-function approach in which sequences of the functionally distinct disintegrin kistrin were introduced into the elegantin template at targeted sites, a loss of inhibitory function toward alpha(5)beta(1)-mediated adhesion on Fn was observed when the elegantin linker domain was substituted. Subsequent analysis comparing the inhibitory efficacies of the panel of elegantin-kistrin chimeras toward CHO alpha(5) cell adhesion on recombinant Fn III6-10 fragments showed that the loss of inhibitory activity associated with the disruption of the elegantin linker domain was dependent upon the presence of a functional Fn III9 synergy site within the Fn III6-10 substrate. This suggested that the elegantin linker domain inhibits primarily the activity of the Fn synergy domain in promoting alpha(5)beta(1) integrin-mediated cell adhesion. Construction of a cyclic peptide corresponding to the entire region of the elegantin linker domain showed that this domain has intrinsic alpha(5)beta(1) inhibitory activity comparable with the activity of the RGDS peptide. These data demonstrate a novel biological function for a disintegrin domain that antagonizes integrin-mediated cell adhesion.	Kings Coll London, Sch Med, St Thomas Hosp, Div Cardiovasc Med,Lab Thrombosis & Vasc Remodell, London SE1 7EH, England; Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Univ Washington, Sch Med, Div Vasc Surg, Seattle, WA 98108 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Manchester; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Rahman, S (corresponding author), Kings Coll London, Sch Med, St Thomas Hosp, Div Cardiovasc Med,Lab Thrombosis & Vasc Remodell, London SE1 7EH, England.	salman.rahman@kcl.ac.uk	Rahman, Salman/ABG-5006-2021	Humphries, Martin/0000-0002-4331-6967; Mould, Paul/0000-0003-0076-6228				Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200; Altroff H, 2003, J BIOL CHEM, V278, P491, DOI 10.1074/jbc.M209992200; AOTA S, 1994, J BIOL CHEM, V269, P24756; Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045; Calvete JJ, 2005, CURR PHARM DESIGN, V11, P829, DOI 10.2174/1381612053381783; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; Davidson LA, 2002, DEV BIOL, V242, P109, DOI 10.1006/dbio.2002.0537; HUANG TF, 1987, J BIOL CHEM, V262, P16157; Kisiel DG, 2004, FEBS LETT, V577, P478, DOI 10.1016/j.febslet.2004.10.050; LU XJ, 1993, BIOCHEM J, V296, P21, DOI 10.1042/bj2960021; Lu XJ, 1996, J BIOL CHEM, V271, P289, DOI 10.1074/jbc.271.1.289; Marcinkiewicz C, 1999, BIOCHEMISTRY-US, V38, P13302, DOI 10.1021/bi9906930; Marcinkiewicz C, 1999, J BIOL CHEM, V274, P12468, DOI 10.1074/jbc.274.18.12468; MARDON HJ, 1994, FEBS LETT, V340, P197, DOI 10.1016/0014-5793(94)80137-1; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; Moursi AM, 1996, J CELL SCI, V109, P1369; NAGAI T, 1991, J CELL BIOL, V114, P1295, DOI 10.1083/jcb.114.6.1295; RAHMAN S, 1995, BIOCHEM J, V312, P223, DOI 10.1042/bj3120223; Rahman S, 1998, BIOCHEM J, V335, P247, DOI 10.1042/bj3350247; Rahman S, 2000, BIOCHEM J, V345, P701, DOI 10.1042/0264-6021:3450701; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Sanz L, 2005, J BIOL CHEM, V280, P40714, DOI 10.1074/jbc.M509738200; Scaloni A, 1996, BIOCHEM J, V319, P775, DOI 10.1042/bj3190775; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; Suehiro K, 1997, J BIOL CHEM, V272, P5360, DOI 10.1074/jbc.272.8.5360; SUTCLIFFE MJ, 1994, NAT STRUCT BIOL, V1, P802, DOI 10.1038/nsb1194-802; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tselepis VH, 1997, J BIOL CHEM, V272, P21341, DOI 10.1074/jbc.272.34.21341; Wierzbicka-Patynowski I, 1999, J BIOL CHEM, V274, P37809, DOI 10.1074/jbc.274.53.37809; WILLIAMS J, 1990, BIOCHIM BIOPHYS ACTA, V1039, P81, DOI 10.1016/0167-4838(90)90229-9; WRIGHT PS, 1993, BIOCHEM J, V293, P263, DOI 10.1042/bj2930263; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040	37	3	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37686	37696		10.1074/jbc.M603943200	http://dx.doi.org/10.1074/jbc.M603943200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16982624	hybrid			2022-12-27	WOS:000242477100046
J	Meng, QJ; Lux, A; Holloschi, A; Li, J; Hughes, JMX; Foerg, T; McCarthy, JEG; Heagerty, AM; Kioschis, P; Hafner, M; Garland, JM				Meng, QingJun; Lux, Andreas; Holloschi, Andreas; Li, Jian; Hughes, John M. X.; Foerg, Tassilo; McCarthy, John E. G.; Heagerty, Anthony M.; Kioschis, Petra; Hafner, Mathias; Garland, John M.			Identification of Tctex2 beta, a novel dynein light chain family member that interacts with different transforming growth factor-beta receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CELLULAR-RESPONSES; PROTEIN-STRUCTURE; ENDOGLIN; EXPRESSION; MOTOR; TCTEX-1; COMPLEX; BINDING; PROLIFERATION	Endoglin is a membrane-inserted protein that is preferentially synthesized in angiogenic vascular endothelial and smooth muscle cells. Endoglin associates with members of the transforming growth factor-beta(TGF-beta) receptor family and has been identified as the gene involved in hereditary hemorrhagic telangiectasia. Although endoglin is known to affect cell responses to TGF-beta, its mode of action is largely unknown. We performed yeast two-hybrid screening of a human placental cDNA library and isolated a new endoglin-binding partner, a novel 221-amino acid member of the Tctex1/2 family of cytoplasmic dynein light chains named Tctex2 beta, as the founder of a new Tctex1/2 subfamily. The interaction was localized exclusively to the cytoplasmic domain of endoglin. Reverse transcription-PCR showed expression of Tctex2 beta in a wide range of tissues, including vascular endothelial and smooth muscle cells, placenta, and testis, as well as in several tumor cell lines. High expression levels were found in human umbilical vein endothelial cells and the large cell lung cancer cell line. Forced expression of Tctex2 beta had a profound inhibitory effect on TGF-beta signaling. Additional Tctex2 beta-interacting receptors were identified to be the TGF-beta type II receptor and most likely betaglycan, but not ALK5, ALK1, or the bone morphogenetic protein type II receptor. Upon fluorescence tagging, co-localization of Tctex2 beta and endoglin, as well as Tctex2 beta, endoglin, and the TGF-beta type II receptor, was observed by different microscopy techniques. Our findings link endoglin for the first time to microtubule-based minus end-directed transport machinery, suggesting that some endoglin functions might be regulated and directed by its interaction with the cytoplasmic dynein light chain Tctex2 beta.	Univ Manchester, Manchester Royal Infirm, Dept Med, Cardiovasc Clin Acad Grp, Manchester M13 9WL, Lancs, England; Univ Hosp, D-68163 Mannheim, Germany; Univ Appl Sci, Inst Mol Cell Biol, D-68163 Mannheim, Germany; Manchester Interdisciplinary Bioctr, Manchester M60 1QD, Lancs, England	University of Manchester; Ruprecht Karls University Heidelberg; University of Manchester	Meng, QJ (corresponding author), Univ Manchester, Manchester Royal Infirm, Dept Med, Cardiovasc Clin Acad Grp, Oxford Rd, Manchester M13 9WL, Lancs, England.	qjmeng@manchester.ac.uk; a.lux@hs-mannheim.de		Meng, Qing Jun/0000-0002-9426-8336; Heagerty, Anthony/0000-0002-9043-2119	Biotechnology and Biological Sciences Research Council [BBS/B/02436] Funding Source: Medline; Medical Research Council [G0900414] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adam PJ, 1998, BIOCHEM BIOPH RES CO, V247, P33, DOI 10.1006/bbrc.1998.8734; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3583; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; Conley BA, 2000, ATHEROSCLEROSIS, V153, P323, DOI 10.1016/S0021-9150(00)00422-6; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DiBella LM, 2001, J BIOL CHEM, V276, P14366, DOI 10.1074/jbc.M011456200; Ding W, 2005, CANCER RES, V65, P6526, DOI 10.1158/0008-5472.CAN-04-4385; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; GOUGOS A, 1988, J IMMUNOL, V141, P1925; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Higgins D G, 1994, Methods Mol Biol, V25, P307; James P, 1996, GENETICS, V144, P1425; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; LADER E, 1989, CELL, V58, P969, DOI 10.1016/0092-8674(89)90948-3; LASTRES P, 1992, EUR J IMMUNOL, V22, P393, DOI 10.1002/eji.1830220216; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Lux A, 2000, HUM MOL GENET, V9, P745, DOI 10.1093/hmg/9.5.745; Ma XL, 2000, ARTERIOSCL THROM VAS, V20, P2546, DOI 10.1161/01.ATV.20.12.2546; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; MARCHUK DA, 2001, METABOLIC MOL BASES, V4, P5419; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Postiglione L, 2005, INT J ONCOL, V26, P1193; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Schmidt-Weber CB, 2005, INT IMMUNOL, V17, P921, DOI 10.1093/intimm/dxh272; STJACQUES S, 1994, ENDOCRINOLOGY, V134, P2645, DOI 10.1210/en.134.6.2645; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Williams JC, 2005, J BIOL CHEM, V280, P21981, DOI 10.1074/jbc.M414643200	49	35	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					37069	37080		10.1074/jbc.M608614200	http://dx.doi.org/10.1074/jbc.M608614200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16982625	hybrid			2022-12-27	WOS:000242220800068
J	Ring, MW; Schwar, G; Thiel, V; Dickschat, JS; Kroppenstedt, RM; Schulz, S; Bode, HB				Ring, Michael W.; Schwaer, Gertrud; Thiel, Verena; Dickschat, Jeroen S.; Kroppenstedt, Reiner M.; Schulz, Stefan; Bode, Helge B.			Novel iso-branched ether lipids as specific markers of developmental sporulation in the myxobacterium Myxococcus xanthus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUITING BODY FORMATION; SER/THR KINASE CASCADE; BIOSYNTHETIC GENE-CLUSTER; CHAIN FATTY-ACIDS; STIGMATELLA-AURANTIACA; MASS-SPECTROMETRY; PHOSPHATIDYLGLYCEROL ACETAL; CLOSTRIDIUM-BUTYRICUM; MEGASPHAERA-ELSDENII; VEGETATIVE CELLS	Iso-fatty acids (FAs) are the dominant FA family in all myx-obacteria analyzed. Furthermore, it was postulated that isoFAs or compounds derived thereof are involved in fruiting body formation in Myxococcus xanthus, since mutants with a reduced level of iso-FA due to a reduced level of the precursor isovaleryl-CoA, are delayed in aggregation and produce only few myxospores. To elucidate the function of iso-FAs and their corresponding lipids we have analyzed the developmental phenotype of mutants having different levels of iso-FAs resulting in a clear correlation between the amount of iso-FAs and the delay of aggregation and reduction in spore yield. Addition of either isovalerate or 13-methyltetradecanoic acid resulted in restoration of the wild-type FA profile and normal development. Detailed analysis of the fatty acid (FA) profile during fruiting body formation in Myxococcus xanthus wildtype revealed the specific accumulation of 13-methyltetradecanal and 1-O-13-methyltetradecylglycerol which were produced specifically in the myxospores and which are derived from 1-O-(13-methyl-1-Z-tetradecenyl)-2-O-(13-methyltetradecanoyl)glycero-3-phosphatidylethanolamine(VEPE) and 1,2-di-(13-methyltetradecanoyl)-3-(13-methyltetradecyl) glycerol (TG-1), respectively. The structures of these unusual ether lipids have been determined by spectrometric methods and synthesis (for TG-1). Analysis of several mutants blocked at different stages of development indicated that the biosynthesis of TG-1 is developmentally regulated and that VEPE might be an intermediate in the TG-1 biosynthesis. Finally, addition of TG-1 to mutants blocked in the biosynthesis of isovaleryl- CoA could restore aggregation and sporulation emphasizing the important role of iso-branched lipids for myxobacterial development.	Univ Saarland, Inst Pharmazeut Biotechnol, D-66041 Saarbrucken, Germany; Tech Univ Carolo Wilhelmina Braunschweig, Inst Org Chem, D-38106 Braunschweig, Germany; Deutsch Sammlung von Mikroorganismen & Zellkuture, D-38124 Braunschweig, Germany	Saarland University; Braunschweig University of Technology	Bode, HB (corresponding author), Univ Saarland, Inst Pharmazeut Biotechnol, D-66041 Saarbrucken, Germany.	h.bode@mx.uni-saarland.de	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909; Schafer, Gertrud/0000-0001-5159-0539; Schulz, Stefan/0000-0002-4810-324X				Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Alvarez HM, 2000, APPL MICROBIOL BIOT, V54, P218, DOI 10.1007/s002530050012; Alvarez HM, 1997, FETT-LIPID, V99, P239, DOI 10.1002/lipi.19970990704; Alvarez HM, 1996, ARCH MICROBIOL, V165, P377, DOI 10.1007/s002030050341; BAILEY SJ, 1983, J CHEM SOC PERK T 1, P851, DOI 10.1039/p19830000851; Biermann J, 1999, EUR J BIOCHEM, V261, P492, DOI 10.1046/j.1432-1327.1999.00295.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bode HB, 2005, J AM CHEM SOC, V127, P532, DOI 10.1021/ja043570y; Bode HB, 2006, J BACTERIOL, V188, P6524, DOI 10.1128/JB.00825-06; Bode HB, 2006, J BACTERIOL, V188, P5632, DOI 10.1128/JB.00438-06; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Brouwers JFHM, 1999, J LIPID RES, V40, P164; CAILLON E, 1983, J BACTERIOL, V153, P1348, DOI 10.1128/JB.153.3.1348-1351.1983; Cheng CF, 1998, ANAL CHEM, V70, P4417, DOI 10.1021/ac9805192; COREY EJ, 1979, TETRAHEDRON LETT, P399; de Vet ECJM, 1999, J LIPID RES, V40, P1998; Dickschat JS, 2005, CHEMBIOCHEM, V6, P2023, DOI 10.1002/cbic.200500174; Dickschat JS, 2005, ORG BIOMOL CHEM, V3, P2824, DOI 10.1039/b504889c; DOWNARD J, 1993, J BACTERIOL, V175, P7762, DOI 10.1128/JB.175.24.7762-7770.1993; DOWNARD J, 1995, MOL MICROBIOL, V16, P171, DOI 10.1111/j.1365-2958.1995.tb02290.x; DUTTON CJ, 1991, J ANTIBIOT, V44, P357, DOI 10.7164/antibiotics.44.357; DWORKIN M, 1964, SCIENCE, V146, P243, DOI 10.1126/science.146.3641.243; Ellehauge E, 1998, MOL MICROBIOL, V30, P807, DOI 10.1046/j.1365-2958.1998.01113.x; FAUTZ E, 1979, J BACTERIOL, V140, P852, DOI 10.1128/JB.140.3.852-858.1979; FILER D, 1977, J BACTERIOL, V131, P751, DOI 10.1128/JB.131.3.751-758.1977; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Han XL, 1995, J AM SOC MASS SPECTR, V6, P1202, DOI 10.1016/1044-0305(95)00568-4; Hsu FF, 1999, J AM SOC MASS SPECTR, V10, P587, DOI 10.1016/S1044-0305(99)00035-5; JOHNSON RY, 1972, J BACTERIOL, V112, P849, DOI 10.1128/JB.112.2.849-855.1972; JOHNSTON NC, 1994, EUR J BIOCHEM, V223, P957, DOI 10.1111/j.1432-1033.1994.tb19073.x; JOHNSTON NC, 1988, BIOCHIM BIOPHYS ACTA, V961, P1, DOI 10.1016/0005-2760(88)90124-5; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; Kearns DB, 2001, P NATL ACAD SCI USA, V98, P13990, DOI 10.1073/pnas.251484598; KOTTEL RH, 1975, J BACTERIOL, V124, P550, DOI 10.1128/JB.124.1.550-557.1975; KROOS L, 1987, GENE DEV, V1, P840, DOI 10.1101/gad.1.8.840; KROOS L, 1986, DEV BIOL, V117, P252, DOI 10.1016/0012-1606(86)90368-4; Kunze B, 2005, J ANTIBIOT, V58, P244, DOI 10.1038/ja.2005.28; KUSPA A, 1989, P NATL ACAD SCI USA, V86, P8917, DOI 10.1073/pnas.86.22.8917; Lewis T, 2000, J MICROBIOL METH, V43, P107, DOI 10.1016/S0167-7012(00)00217-7; Licking E, 2000, J BACTERIOL, V182, P3553, DOI 10.1128/JB.182.12.3553-3558.2000; Liu LR, 2006, WORLD J GASTROENTERO, V12, P539, DOI 10.3748/wjg.v12.i4.539; Lux R, 2005, MOL MICROBIOL, V58, P345, DOI 10.1111/j.1365-2958.2005.04856.x; MACDONALD DL, 1990, BIOCHEM CELL BIOL, V68, P225, DOI 10.1139/o90-030; Mahmud T, 2002, J BIOL CHEM, V277, P32768, DOI 10.1074/jbc.M205222200; Mahmud T, 2005, CHEMBIOCHEM, V6, P322, DOI 10.1002/cbic.200400261; MALINS DC, 1968, J LIPID RES, V9, P687; MCBRIDE MJ, 1989, J BACTERIOL, V171, P6383, DOI 10.1128/jb.171.11.6383-6386.1989; MICHAL G, 1999, BIOCH PATHWAYS, V1; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; OCONNOR KA, 1991, J BACTERIOL, V173, P3334, DOI 10.1128/jb.173.11.3334-3341.1991; OCONNOR KA, 1988, J BACTERIOL, V170, P4103, DOI 10.1128/jb.170.9.4103-4112.1988; OCONNOR KA, 1991, J BACTERIOL, V173, P3342, DOI 10.1128/jb.173.11.3342-3355.1991; Ogawa M, 1996, MOL MICROBIOL, V22, P757, DOI 10.1046/j.1365-2958.1996.d01-1725.x; ORLOWSKI M, 1974, J BACTERIOL, V118, P96, DOI 10.1128/JB.118.1.96-102.1974; ORLOWSKI M, 1972, Journal of Bacteriology, V111, P784; ORNDORFF PE, 1980, J BACTERIOL, V141, P914, DOI 10.1128/JB.141.2.914-927.1980; Pasciak M, 2003, J BIOL CHEM, V278, P3948, DOI 10.1074/jbc.M206013200; PRINS RA, 1976, FEBS LETT, V63, P107, DOI 10.1016/0014-5793(76)80204-9; PRINS RA, 1974, BIOCHIM BIOPHYS ACTA, V348, P361, DOI 10.1016/0005-2760(74)90216-1; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; ROSENBLUH A, 1989, J BACTERIOL, V171, P4521, DOI 10.1128/JB.171.8.4521-4524.1989; ROSENBLUH A, 1989, J BACTERIOL, V171, P1513, DOI 10.1128/jb.171.3.1513-1518.1989; ROSENBLUH A, 1990, J BACTERIOL, V172, P4307, DOI 10.1128/jb.172.8.4307-4314.1990; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Silakowski B, 2001, CHEM BIOL, V8, P59, DOI 10.1016/S1074-5521(00)00056-9; Silakowski B, 1999, J BIOL CHEM, V274, P37391, DOI 10.1074/jbc.274.52.37391; Sogaard-Andersen L, 2003, MOL MICROBIOL, V48, P1, DOI 10.1046/j.1365-2958.2003.03399.x; SogaardAndersen L, 1996, GENE DEV, V10, P740, DOI 10.1101/gad.10.6.740; STARCK JP, 1995, TETRAHEDRON, V51, P2629, DOI 10.1016/0040-4020(95)00011-V; STEIN J, 1987, Z NATURFORSCH B, V42, P1017, DOI 10.1515/znb-1987-0815; Stoveken T, 2005, J BACTERIOL, V187, P1369, DOI 10.1128/JB.187.4.1369-1376.2005; TOAL DR, 1995, MOL MICROBIOL, V16, P177, DOI 10.1111/j.1365-2958.1995.tb02291.x; Tzeng LF, 2005, P NATL ACAD SCI USA, V102, P14428, DOI 10.1073/pnas.0506969102; VANDENBOSCH H, 1993, BIOCHIMIE, V75, P183, DOI 10.1016/0300-9084(93)90076-5; VANGOLDE LM, 1973, BIOCHIM BIOPHYS ACTA, V326, P314, DOI 10.1016/0005-2760(73)90133-1; VARON M, 1984, J BACTERIOL, V160, P1146, DOI 10.1128/JB.160.3.1146-1150.1984; Wagner F, 2000, EUR J BIOCHEM, V267, P6276, DOI 10.1046/j.1432-1327.2000.01709.x; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x; WARE JC, 1973, J BACTERIOL, V115, P253, DOI 10.1128/JB.115.1.253-261.1973	85	52	54	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36691	36700		10.1074/jbc.M607616200	http://dx.doi.org/10.1074/jbc.M607616200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16990257	hybrid			2022-12-27	WOS:000242220800026
J	Carroll, BT; Dubyak, GR; Sedensky, MM; Morgan, PG				Carroll, Bryan T.; Dubyak, George R.; Sedensky, Margaret M.; Morgan, Phil G.			Sulfated signal from ASJ sensory neurons modulates stomatin-dependent coordination in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; MEMBRANE-PROTEIN; CHEMOSENSORY NEURONS; VOLATILE ANESTHETICS; DEGENERIN INTERACT; PLASMA-MEMBRANE; DAUER FORMATION; NERVOUS-SYSTEM; FTSH HFLB; COMPLEX	The neuronal stomatin-like proteins UNC-1 and UNC-24 play important roles in the nervous system of Caenorhabditis elegans. These neuronal stomatin-like proteins are putative chaperone proteins that can modify volatile anesthetic sensitivity and disrupt coordinated locomotion. A suppressor of unc-1 and unc-24, named ssu-1(fc73) ( for suppressor of stomatin uncoordination), suppresses three phenotypes of neuronal stomatin-like protein deficiency as follows: volatile anesthetic sensitivity, uncoordinated locomotion, and a constitutive alternative developmental phenotype known as dauer. Here we provide the first phenotypic characterization of ssu-1, predicted to be the only C. elegans cytosolic alcohol sulfotransferase, a family of enzymes that catalyze a sulfate linkage with the alcohol group of small molecules for the purposes of detoxification or modification of signaling. In vitro enzyme analysis of bacterially expressed SSU-1 demonstrates sulfotransferase activity and thus confirms the function predicted by protein sequence similarities. Whereas unc-1 is expressed in the majority of neurons of C. elegans, expression of SSU-1 protein in only the two ASJ amphid interneurons is sufficient to restore the wild type phenotype. This work demonstrates that SSU- 1 is a functional sulfotransferase that likely modifies endocrine signaling in C. elegans. The expression of SSU- 1 in the ASJ neurons refines the understanding of the function of these cells and supports their classification as endocrine tissue. The relationship of unc-1, unc-24, and ssu-1 is the first association of neuronal stomatin-like proteins sharing regulatory roles with a sulfotransferase enzyme.	Univ Hosp & Case Sch Med, Dept Anesthesiol, Cleveland, OH 44106 USA; Univ Hosp & Case Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University	Morgan, PG (corresponding author), Univ Hosp & Case Sch Med, Dept Anesthesiol, 11100 Euclid Ave, Cleveland, OH 44106 USA.	philip.morgan@uhhs.com		Carroll, Bryan T/0000-0001-5712-6307; Dubyak, George/0000-0001-9720-4226	NIGMS NIH HHS [T32 GM07250, GM-45402] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM045402] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyama Y, 1999, BIOCHEMISTRY-US, V38, P11693, DOI 10.1021/bi991177c; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asikainen S, 2005, NEUROREPORT, V16, P1995, DOI 10.1097/00001756-200512190-00005; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Barnes TM, 1996, J NEUROCHEM, V67, P46; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; BRENNER S, 1974, GENETICS, V77, P71; Fricke B, 2003, BLOOD, V102, P2268, DOI 10.1182/blood-2002-06-1705; Fricke B, 2004, BRIT J HAEMATOL, V125, P796, DOI 10.1111/j.1365-2141.2004.04965.x; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Hattori K, 2006, J BIOCHEM, V139, P355, DOI 10.1093/jb/mvj041; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Javitt NB, 2001, ENDOCRINOLOGY, V142, P2978, DOI 10.1210/en.142.7.2978; Kihara A, 1996, EMBO J, V15, P6122, DOI 10.1002/j.1460-2075.1996.tb01000.x; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; LANDE WM, 1982, J CLIN INVEST, V70, P1273, DOI 10.1172/JCI110726; Li J, 2004, DEVELOPMENT, V131, P5741, DOI 10.1242/dev.01408; Ma B, 2003, DRUG METAB DISPOS, V31, P1300, DOI 10.1124/dmd.31.11.1300; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Matyash V, 2004, PLOS BIOL, V2, P1561, DOI 10.1371/journal.pbio.0020280; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORGAN PG, 1985, ANESTHESIOLOGY, V62, P738, DOI 10.1097/00000542-198506000-00007; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; PARK EC, 1986, GENETICS, V113, P821; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Rajaram S, 1999, GENETICS, V153, P1673; Rajaram S, 1998, P NATL ACAD SCI USA, V95, P8761, DOI 10.1073/pnas.95.15.8761; Riddle DL, 1997, C ELEGANS, P739; Saikawa N, 2004, J STRUCT BIOL, V146, P123, DOI 10.1016/j.jsb.2003.09.020; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Sedensky MM, 2004, AM J PHYSIOL-CELL PH, V287, pC468, DOI 10.1152/ajpcell.00182.2003; Sedensky MM, 2001, AM J PHYSIOL-CELL PH, V280, pC1340, DOI 10.1152/ajpcell.2001.280.5.C1340; Steglich G, 1999, MOL CELL BIOL, V19, P3435; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; STEWART GW, 2003, NEPHRON PHYSIOL, V93, P29; Strott CA, 1996, ENDOCR REV, V17, P670, DOI 10.1210/er.17.6.670; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; van Swinderen B, 2002, GENETICS, V161, P109; WAUD DR, 1972, J PHARMACOL EXP THER, V183, P577; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLIAMS BD, 1992, GENETICS, V131, P609; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhu YW, 1999, BLOOD, V93, P2404, DOI 10.1182/blood.V93.7.2404.407k13_2404_2410	48	19	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35989	35996		10.1074/jbc.M606086200	http://dx.doi.org/10.1074/jbc.M606086200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16973616	hybrid			2022-12-27	WOS:000242100500046
J	Joseph, JW; Jensen, MV; Ilkayeva, O; Palmieri, F; Alarcon, C; Rhodes, CJ; Newgard, CB				Joseph, Jamie W.; Jensen, Mette V.; Ilkayeva, Olga; Palmieri, Ferdinando; Alarcon, Cristina; Rhodes, Christopher J.; Newgard, Christopher B.			The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC COUPLING FACTORS; NMR ISOTOPOMER ANALYSIS; MALONYL-COA; PANCREATIC-ISLETS; BETA-CELLS; PYRUVATE; ATP; ADENOVIRUS; GLUTAMATE; PATHWAY	Glucose-stimulated insulin secretion (GSIS) is mediated in part by glucose metabolism-driven increases in ATP/ADP ratio, but by-products of mitochondrial glucose metabolism also play an important role. Here we investigate the role of the mitochondrial citrate/isocitrate carrier (CIC) in regulation of GSIS. Inhibition of CIC activity in INS-1-derived 832/13 cells or primary rat islets by the substrate analogue 1,2,3-benzenetricarboxylate (BTC) resulted in potent inhibition of GSIS, involving both first and second phase secretion. A recombinant adenovirus containing a CIC-specific siRNA (Ad-siCIC) dose-dependently reduced CIC expression in 832/13 cells and caused parallel inhibitory effects on citrate accumulation in the cytosol. Ad-siCIC treatment did not affect glucose utilization, glucose oxidation, or ATP/ADP ratio but did inhibit glucose incorporation into fatty acids and glucose-induced increases in NADPH/NADP(+) ratio relative to cells treated with a control siRNA virus (Ad-siControl). Ad-siCIC also inhibited GSIS in 832/13 cells, whereas overexpression of CIC enhanced GSIS and raised cytosolic citrate levels. In normal rat islets, Ad-siCIC treatment also suppressed CIC mRNA levels and inhibited GSIS. We conclude that export of citrate and/or isocitrate from the mitochondria to the cytosol is an important step in control of GSIS.	Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Independence Pk Facil, Durham, NC 27704 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27704 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27704 USA; Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; Univ Bari, Natl Res Council, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy; Univ Chicago, Dept Med, Ctr Diabet, Chicago, IL 60637 USA; Univ Chicago, Div Endocrine, Chicago, IL 60637 USA	Duke University; Duke University; Duke University; Duke University; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Chicago; University of Chicago	Newgard, CB (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Independence Pk Facil, 4321 Med Pk Dr,Suite 200, Durham, NC 27704 USA.	newga002@mc.duke.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42583, DK58398] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antinozzi PA, 1998, J BIOL CHEM, V273, P16146, DOI 10.1074/jbc.273.26.16146; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; CAPOBIANCO L, 1995, FEBS LETT, V357, P297, DOI 10.1016/0014-5793(94)01379-F; Civelek VN, 1996, BIOCHEM J, V318, P615, DOI 10.1042/bj3180615; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; Fox JEM, 2004, MOL ENDOCRINOL, V18, P679, DOI 10.1210/me.2003-0431; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; HENQUIN JC, 1987, HORM RES, V27, P168, DOI 10.1159/000180806; Henquin JC, 2004, DIABETES, V53, pS48, DOI 10.2337/diabetes.53.suppl_3.S48; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Koshkin V, 2004, J BIOL CHEM, V279, P41368, DOI 10.1074/jbc.M406914200; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; MacDonald PE, 2003, J PHYSIOL-LONDON, V546, P647, DOI 10.1113/jphysiol.2002.035709; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2000, J PHYSIOL-LONDON, V529, P49, DOI 10.1111/j.1469-7793.2000.00049.x; Matschinsky F.M., 2001, HDB PHYSL 7, P125; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SCHULTZ V, 1993, ANAL BIOCHEM, V215, P302, DOI 10.1006/abio.1993.1591; Stanley CA, 2004, MOL GENET METAB, V81, pS45, DOI 10.1016/j.ymgme.2003.10.013	49	127	132	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35624	35632		10.1074/jbc.M602606200	http://dx.doi.org/10.1074/jbc.M602606200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17001083	hybrid			2022-12-27	WOS:000242100500007
J	Choi, SM; Choi, KO; Park, YK; Cho, H; Yang, EG; Park, H				Choi, Su Mi; Choi, Kyung-Ok; Park, Young-Kwon; Cho, Hyunju; Yang, Eun Gyeong; Park, Hyunsung			Clioquinol, a Cu(II)/Zn(II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1 alpha, leading to expression of vascular endothelial growth factor and erythropoietin in normoxic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TUMOR-SUPPRESSOR PROTEIN; ZINC CHELATOR; HIF-ALPHA; IN-VIVO; DISEASE; PROLYL; BRAIN; NEUROPROTECTION	We found that the Cu(II) and Zn(II)-specific chelator Clioquinol (10-50 mu M) increased functional hypoxia-inducible factor 1 alpha(HIF-1 alpha) protein, leading to increased expression of its target genes, vascular endothelial growth factors and erythropoietin, in SH-SY5Y cells and HepG2 cells. Clioquinol inhibited ubiquitination of HIF-1 alpha in a Cu(II)- and Zn(II)-dependent manner. It prevents FIH-1 from hydroxylating the asparagine residue (803) of HIF-1 alpha in a Cu(II)- and Zn(II)-independent fashion. Therefore, it leads to the accumulation of HIF-1 alpha that is prolyl but not asparaginyl hydroxylated. Consistent with this, co-immunoprecipitation assays showed that Clioquinol-induced HIF-1 alpha interacted with cAMP-responsive element-binding protein in normoxic cells, implying that Clioquinol stabilizes the trans-active form of HIF-1 alpha. Our results indicate that Clioquinol could be useful as an inducer of HIF-1 alpha and its target genes in ischemic diseases.	Univ Seoul, Dept Life Sci, Seoul 130743, South Korea; Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea	University of Seoul; Korea Institute of Science & Technology (KIST)	Park, H (corresponding author), Univ Seoul, Dept Life Sci, 90 Cheonnong Dong, Seoul 130743, South Korea.	hspark@uos.ac.kr		Park, Young-Kwon/0000-0002-3473-7233				AGRAWAL YK, 1986, J PHARM SCI, V75, P190, DOI 10.1002/jps.2600750219; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Choi KO, 2005, MOL PHARMACOL, V68, P1803, DOI 10.1124/mol.105.015271; Choi SM, 2006, BIOCHEM BIOPH RES CO, V343, P1002, DOI 10.1016/j.bbrc.2006.03.039; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Doraiswamy PM, 2004, LANCET NEUROL, V3, P431, DOI 10.1016/S1474-4422(04)00809-9; Ehrenreich H, 2004, METAB BRAIN DIS, V19, P195, DOI 10.1023/B:MEBR.0000043969.96895.3c; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferriero DM, 2005, EPILEPSIA, V46, P45, DOI 10.1111/j.1528-1167.2005.00302.x; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hur E, 2001, MOL PHARMACOL, V59, P1216, DOI 10.1124/mol.59.5.1216; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Li LM, 2005, CANCER RES, V65, P7249, DOI 10.1158/0008-5472.CAN-04-4426; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Masson N, 2003, J CELL SCI, V116, P3041, DOI 10.1242/jcs.00655; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Raman B, 2005, J BIOL CHEM, V280, P16157, DOI 10.1074/jbc.M500309200; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226; Zhu W, 2005, NEUROSURGERY, V57, P325, DOI 10.1227/01.NEU.0000166682.50272.BC	42	56	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34056	34063		10.1074/jbc.M603913200	http://dx.doi.org/10.1074/jbc.M603913200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973622	hybrid			2022-12-27	WOS:000241767600026
J	O'Hara, L; Han, GS; Peak-Chew, S; Grimsey, N; Carman, GM; Siniossoglou, S				O'Hara, Laura; Han, Gil-Soo; Peak-Chew, Sew; Grimsey, Neil; Carman, George M.; Siniossoglou, Symeon			Control of phospholipid synthesis by phosphorylation of the yeast lipin Pah1p/Smp2p Mg2+-dependent phosphatidate phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; NUCLEAR-ENVELOPE; ENDOPLASMIC-RETICULUM; MEMBRANE; BIOSYNTHESIS; METABOLISM; COMPLEX; SUPERFAMILY; BIOGENESIS	Phosphorylation of the conserved lipin Pah1p/Smp2p in Saccharomyces cerevisiae was previously shown to control transcription of phospholipid biosynthetic genes and nuclear structure by regulating the amount of membrane present at the nuclear envelope (Santos-Rosa, H., Leung, J., Grimsey, N., Peak-Chew, S., and Siniossoglou, S. (2005) EMBO J. 24, 1931 1941). A recent report identified Pah1p as a Mg2+-dependent phosphatidate (PA) phosphatase that regulates de novo lipid synthesis (Han G.-S., Wu, W. I., and Carman, G. M. ( 2006) J. Biol. Chem. 281, 9210-9218). In this work we use a combination of mass spectrometry and systematic mutagenesis to identify seven Ser/Thr-Pro motifs within Pah1p that are phosphorylated in vivo. We show that phosphorylation on these sites is required for the efficient transcriptional derepression of key enzymes involved in phospholipid biosynthesis. The phosphorylation-deficient Pah1p exhibits higher PA phosphatase-specific activity than the wild-type Pah1p, indicating that phosphorylation of Pah1p controls PA production. Opi1p is a transcriptional repressor of phospholipid biosynthetic genes, responding to PA levels. Genetic analysis suggests that Pah1p regulates transcription of these genes through both Opi1p-dependent and -independent mechanisms. We also provide evidence that derepression of phospholipid biosynthetic genes is not sufficient to induce the nuclear membrane expansion shown in the pah1 Delta cells.	Univ Cambridge, Wellcome Trust, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Rutgers State Univ, New Jersey Agr Expt Stn, Cook Coll, Dept Food Sci, New Brunswick, NJ 08901 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Cambridge; Wellcome Trust Sanger Institute; Rutgers State University New Brunswick; MRC Laboratory Molecular Biology	Siniossoglou, S (corresponding author), Univ Cambridge, Wellcome Trust, Cambridge Inst Med Res, MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	ss560@cam.ac.uk	Grimsey, Neil/B-1634-2015; Grimsey, Neil/AAB-9153-2020	Grimsey, Neil/0000-0002-0481-4920; Grimsey, Neil/0000-0002-0481-4920; O'Hara, Laura/0000-0001-7790-9261	Medical Research Council [G0701446] Funding Source: Medline; NIGMS NIH HHS [GM-28140, R37 GM028140, R01 GM028140] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Campbell JL, 2006, MOL BIOL CELL, V17, P1768, DOI 10.1091/mbc.E05-09-0839; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; HOSHIZAKI DK, 1990, J BIOL CHEM, V265, P4736; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LIN YP, 1989, J BIOL CHEM, V264, P8641; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; NIKOLOFF DM, 1992, NUCLEIC ACIDS RES, V20, P3253, DOI 10.1093/nar/20.12.3253; Nunnari J, 1996, CELL, V84, P389, DOI 10.1016/S0092-8674(00)81283-0; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Prunuske AJ, 2006, CURR OPIN CELL BIOL, V18, P108, DOI 10.1016/j.ceb.2005.12.004; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Rudge SA, 1998, J CELL BIOL, V140, P81, DOI 10.1083/jcb.140.1.81; Rudge SA, 2004, MOL BIOL CELL, V15, P207, DOI 10.1091/mbc.e03-04-0245; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Shemesh T, 2003, BIOPHYS J, V85, P3813, DOI 10.1016/S0006-3495(03)74796-1; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Stensballe A, 2001, PROTEOMICS, V1, P207, DOI 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.3.CO;2-V; Tange Y, 2002, J CELL SCI, V115, P4375, DOI 10.1242/jcs.00135; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wagner C, 1999, YEAST, V15, P843, DOI 10.1002/(SICI)1097-0061(199907)15:10A<843::AID-YEA424>3.0.CO;2-M; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429	48	146	152	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34537	34548		10.1074/jbc.M606654200	http://dx.doi.org/10.1074/jbc.M606654200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16968695	Green Accepted, hybrid			2022-12-27	WOS:000241767600074
J	Ferreira-da-Silva, F; Pereira, PJB; Gales, L; Roessle, M; Svergun, DI; Moradas-Ferreira, P; Damas, AM				Ferreira-da-Silva, Frederico; Pereira, Pedro J. B.; Gales, Luis; Roessle, Manfred; Svergun, Dmitri I.; Moradas-Ferreira, Pedro; Damas, Ana M.			The crystal and solution structures of glyceraldehyde-3-phosphate dehydrogenase reveal different quaternary structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-WALL; HOLO-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GLYCERAIDEHYDE-3-PHOSPHATE DEHYDROGENASE; KLUYVEROMYCES-MARXIANUS; D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SCHISTOSOMA-MANSONI; CANDIDA-ALBICANS; PROTEIN; GENE	The presence of an isoform of glyceraldehyde-3-phosphate dehydrogenase (kmGAPDH1p) associated with the cell wall of a flocculent strain of Kluyveromyces marxianus was the first report of a non-cytosolic localization of a glycolytic enzyme, but the mechanism by which the protein is transported to the cell surface is not known. To identify structural features that could account for the multiple localizations of the protein, the three-dimensional structure of kmGAPDH1p was determined by x-ray crystallography and small angle x-ray scattering. The x-ray crystallographic structure of kmGAPDH1p revealed a dimer, although all GAPDH homologs studied thus far have a tetrameric structure with 222 symmetry. Interestingly, the structure of kmGAPDH1p in solution revealed a tetramer with a 70 degrees tilt angle between the dimers. Moreover, the separation between the centers of the dimers composing the kmGAPDH1p tetramer diminished from 34 to 30 angstrom upon NAD(+) binding, this latter value being similar to the observed in the crystallographic models of GAPDH homologs. The less compact structure of apo-kmGAPDH1p could already be the first image of the transition intermediate between the tetramer observed in solution and the dimeric form found in the crystal structure, which we postulate to exist in vivo because of the protein's multiple subcellular localizations in this yeast species.	Univ Porto, Inst Mol & Cellular Biol, P-4150180 Oporto, Portugal; Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal; European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	Universidade do Porto; Universidade do Porto; European Molecular Biology Laboratory (EMBL); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Damas, AM (corresponding author), Univ Porto, Inst Mol & Cellular Biol, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	amdamas@ibmc.up.pt	Pereira, Pedro/F-8972-2011; Silva, Frederico F/K-3820-2013; MORADAS-FERREIRA, PEDRO/E-6357-2012; Gales, Luis/J-8716-2013	Pereira, Pedro/0000-0003-0969-5438; Silva, Frederico F/0000-0002-8890-4228; MORADAS-FERREIRA, PEDRO/0000-0003-2994-0314; Gales, Luis/0000-0002-8352-6539; Rossle, Manfred/0000-0003-4196-0430; Svergun, Dmitri/0000-0003-0830-5696				Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Angiolella L, 1996, J INFECT DIS, V173, P684, DOI 10.1093/infdis/173.3.684; Antonyuk SV, 2003, ACTA CRYSTALLOGR D, V59, P835, DOI 10.1107/S0907444903041441; Arutyunova EI, 2003, BIOCHEM BIOPH RES CO, V307, P547, DOI 10.1016/S0006-291X(03)01222-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOULIN C, 1986, NUCL INSTRUM METH A, V249, P399, DOI 10.1016/0168-9002(86)90694-7; BOULIN CJ, 1988, NUCL INSTRUM METH A, V269, P312, DOI 10.1016/0168-9002(88)90895-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Charron C, 1999, ACTA CRYSTALLOGR D, V55, P1353, DOI 10.1107/S0907444999005363; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Delgado ML, 2003, YEAST, V20, P713, DOI 10.1002/yea.993; Delgado ML, 2001, MICROBIOL-SGM, V147, P411, DOI 10.1099/00221287-147-2-411; Duee E, 1996, J MOL BIOL, V257, P814, DOI 10.1006/jmbi.1996.0204; Engel M, 1998, J BIOL CHEM, V273, P20058, DOI 10.1074/jbc.273.32.20058; Falcao-Moreira R, 2000, YEAST, V16, P231; FERNANDES PA, 1995, YEAST, V11, P725, DOI 10.1002/yea.320110804; FERNANDES PA, 1993, YEAST, V9, P859, DOI 10.1002/yea.320090806; FERNANDES PA, 1992, BIOCHIM BIOPHYS ACTA, V1159, P67, DOI 10.1016/0167-4838(92)90076-P; Fleming TM, 1998, ACTA CRYSTALLOGR D, V54, P671, DOI 10.1107/S0907444997018076; GARCIA DLT, 2000, BIOPHYS J, V78, P719; GOUDOTCROZEL V, 1989, J EXP MED, V170, P2065, DOI 10.1084/jem.170.6.2065; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Ismail SA, 2005, ACTA CRYSTALLOGR D, V61, P1508, DOI 10.1107/S0907444905026740; KIHN JC, 1988, CAN J MICROBIOL, V34, P773, DOI 10.1139/m88-131; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KORNDORFER I, 1995, J MOL BIOL, V246, P511, DOI 10.1006/jmbi.1994.0103; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; LEE KW, 1995, MOL BIOCHEM PARASIT, V71, P221, DOI 10.1016/0166-6851(95)91598-O; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P50; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Moreira RF, 1998, MICROBIOL-SGM, V144, P681, DOI 10.1099/00221287-144-3-681; MURTHY MRN, 1980, J MOL BIOL, V138, P859, DOI 10.1016/0022-2836(80)90069-8; Nakagawa T, 2003, J BIOL CHEM, V278, P20395, DOI 10.1074/jbc.M210824200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; Pardo M, 1999, YEAST, V15, P459, DOI 10.1002/(SICI)1097-0061(199904)15:6<459::AID-YEA387>3.0.CO;2-L; Pavao F, 2002, FEBS LETT, V520, P13, DOI 10.1016/S0014-5793(02)02700-X; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Robien MA, 2006, PROTEINS, V62, P570, DOI 10.1002/prot.20801; Roitel O, 2003, J MOL BIOL, V326, P1513, DOI 10.1016/S0022-2836(03)00049-4; ROUSSEL A, 1989, TURBO FRODO SILICON; Shen YQ, 2000, J STRUCT BIOL, V130, P1, DOI 10.1006/jsbi.2000.4220; SHOEMAKER C, 1992, P NATL ACAD SCI USA, V89, P1842, DOI 10.1073/pnas.89.5.1842; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; SKARZYNSKI T, 1987, J MOL BIOL, V193, P171, DOI 10.1016/0022-2836(87)90635-8; Song SY, 1998, ACTA CRYSTALLOGR D, V54, P558, DOI 10.1107/S090744499701620X; Suresh S, 2001, J MOL BIOL, V309, P423, DOI 10.1006/jmbi.2001.4588; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2000, J BIOL CHEM, V275, P297, DOI 10.1074/jbc.275.1.297; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VELLIEUX FMD, 1993, P NATL ACAD SCI USA, V90, P2355, DOI 10.1073/pnas.90.6.2355; YANG WG, 1994, MOL BIOCHEM PARASIT, V64, P253, DOI 10.1016/0166-6851(93)00020-A; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	64	23	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33433	33440		10.1074/jbc.M605267200	http://dx.doi.org/10.1074/jbc.M605267200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16963457	hybrid			2022-12-27	WOS:000241621400053
J	Goodman, OB; Febbraio, M; Simantov, R; Zheng, R; Shen, RQ; Silverstein, RL; Nanus, DM				Goodman, Oscar B., Jr.; Febbraio, Maria; Simantov, Ronit; Zheng, Rong; Shen, Ruoqian; Silverstein, Roy L.; Nanus, David M.			Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROSTATE-CANCER; HUMAN ENDOTHELIAL-CELLS; NEUTRAL ENDOPEPTIDASE; EXPRESSION; BINDING; PROTEIN; IDENTIFICATION; HEPARIN; BETA; THROMBOSPONDIN-1	Neprilysin is a cell surface peptidase that catalytically inactivates neuropeptide substrates and functions as a tumor suppressor via its enzymatic function and multiple protein-protein interactions. We investigated whether neutral endopeptidase could inhibit angiogenesis in vivo utilizing a murine corneal pocket angiogenesis model and found that it reduced fibroblast growth factor-2-induced angiogenesis by 85% (p < 0.01) but had no effect on that of vascular endothelial growth factor. Treatment with recombinant neprilysin, but not enzymatically inactive neprilysin, resulted in a slight increase in basic fibroblast growth factor electrophoretic mobility from proteolytic cleavage between amino acids Leu-135 and Gly-136, which was inhibited by the neutral endopeptidase inhibitor CGS24592 and heparin. Cleavage kinetics were rapid, comparable with that of other known neprilysin substrates. Functional studies involving neprilysin-expressing vascular endothelial cells demonstrated that neutral endopeptidase inhibition significantly enhanced fibroblast growth factor-mediated endothelial cell growth, capillary array formation, and signaling, whereas exogenous recombinant neprilysin inhibited signaling. Recombinant constructs confirmed that cleavage products neither promoted capillary array formation nor induced signaling. Moreover, mutation of the cleavage site resulted in concomitant loss of cleavage and increased the potency of fibroblast growth factor-2 to induce capillary array formation. These data indicate that neprilysin proteolytically inactivates fibroblast growth factor-2, resulting in negative regulation of angiogenesis.	Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Urol Oncol Res Lab,Dept Urol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Div Hematol & Med Oncol,Dept Med, New York, NY 10021 USA; Bayer Pharmaceut Inc, West Haven, CT 06516 USA; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA	Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Bayer AG; Bayer Healthcare Pharmaceuticals; Cleveland Clinic Foundation	Nanus, DM (corresponding author), Cornell Univ, Weill Med Coll, 525 E 68th St,ST-359, New York, NY 10021 USA.	dnanus@med.cornell.edu		Goodman, Oscar/0000-0002-0882-3621	NATIONAL CANCER INSTITUTE [R01CA080240] Funding Source: NIH RePORTER; NCI NIH HHS [CA80240] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAM JA, 1986, COLD SPRING HARB SYM, V51, P657, DOI 10.1101/SQB.1986.051.01.078; Antezana MA, 2002, J INVEST DERMATOL, V119, P1400, DOI 10.1046/j.1523-1747.2002.19618.x; Bagnato A, 2003, TRENDS ENDOCRIN MET, V14, P44, DOI 10.1016/S1043-2760(02)00010-3; Bajo AM, 2004, BRIT J CANCER, V90, P245, DOI 10.1038/sj.bjc.6601404; Carpentier M, 2002, J NEUROPATH EXP NEUR, V61, P849, DOI 10.1093/jnen/61.10.849; CASSCELLS W, 1990, J CLIN INVEST, V85, P433, DOI 10.1172/JCI114456; Chua CC, 2004, CIRC RES, V94, P316, DOI 10.1161/01.RES.0000112965.70691.AC; Cronauer MV, 2003, EUR UROL, V43, P309, DOI 10.1016/S0302-2838(03)00005-8; CUMMINGS BJ, 1993, EXP NEUROL, V124, P315, DOI 10.1006/exnr.1993.1202; Dai J, 2001, CLIN CANCER RES, V7, P1370; Dorkin TJ, 1999, J PATHOL, V189, P564, DOI 10.1002/(SICI)1096-9896(199912)189:4<564::AID-PATH480>3.0.CO;2-1; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Giri D, 1999, CLIN CANCER RES, V5, P1063; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; GRAF K, 1995, HYPERTENSION, V26, P230, DOI 10.1161/01.HYP.26.2.230; Hoffman AD, 1996, CLIN CANCER RES, V2, P1077; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Iwase A, 2004, J BIOL CHEM, V279, P11898, DOI 10.1074/jbc.M212737200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; KAJIO T, 1992, FEBS LETT, V306, P243, DOI 10.1016/0014-5793(92)81009-B; Kastrup JS, 1997, ACTA CRYSTALLOGR D, V53, P160, DOI 10.1107/S0907444996012711; KENNY J, 1993, BIOCHEM SOC T, V21, P663, DOI 10.1042/bst0210663; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; LLORENSCORTES C, 1992, J BIOL CHEM, V267, P14012; Maniara WM, 1998, J CHROMATOGR B, V706, P287, DOI 10.1016/S0378-4347(97)00566-5; NAKAMOTO T, 1992, CANCER RES, V52, P571; Nanus DM, 2003, CLIN CANCER RES, V9, P6307; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; OLSEN E, 1992, INT ARCH ALLERGY IMM, V98, P343, DOI 10.1159/000236209; Osman I, 2004, CLIN CANCER RES, V10, P4096, DOI 10.1158/1078-0432.CCR-04-0120; Papandreou CN, 1998, NAT MED, V4, P50, DOI 10.1038/nm0198-050; Peifley KA, 1998, BIOCHEM BIOPH RES CO, V242, P202, DOI 10.1006/bbrc.1997.7940; Peng H, 2004, BLOOD, V103, P2114, DOI 10.1182/blood-2003-08-2638; Polnaszek N, 2003, CANCER RES, V63, P5754; Ropiquet F, 1997, INT J CANCER, V72, P543, DOI 10.1002/(SICI)1097-0215(19970729)72:3<543::AID-IJC26>3.0.CO;2-B; Sahni A, 2006, BLOOD, V107, P126, DOI 10.1182/blood-2005-06-2460; Schweitzer KM, 1997, LAB INVEST, V76, P25; Shih SJ, 2003, PROSTATE CANCER P D, V6, P131, DOI 10.1038/sj.pcan.4500637; Simantov R, 2001, J CLIN INVEST, V107, P45, DOI 10.1172/JCI9061; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; Sumitomo M, 2000, J CLIN INVEST, V106, P1399, DOI 10.1172/JCI10536; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Sumitomo M, 2001, CANCER RES, V61, P3294; Volpert OV, 1998, P NATL ACAD SCI USA, V95, P6343, DOI 10.1073/pnas.95.11.6343; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1	46	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33597	33605		10.1074/jbc.M602490200	http://dx.doi.org/10.1074/jbc.M602490200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16940054	hybrid			2022-12-27	WOS:000241621400069
J	Leach, RN; Gell, C; Wigneshweraraj, S; Buck, M; Smith, A; Stockley, PG				Leach, Robert N.; Gell, Christopher; Wigneshweraraj, Sivaramesh; Buck, Martin; Smith, Alastair; Stockley, Peter George			Mapping ATP-dependent activation at sigma(54) promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RNA-POLYMERASE; PROMOTER DNA COMPLEX; ESCHERICHIA-COLI; SIGMA-FACTOR; TRANSCRIPTION ACTIVATOR; BINDING-ACTIVITY; FLAP DOMAIN; SUBUNIT; HOLOENZYME; ROLES	The sigma(54) promoter specificity factor is distinct from other bacterial RNA polymerase (RNAP) sigma factors in that it forms a transcriptionally silent closed complex upon promoter binding. Transcriptional activation occurs through a nucleotide-dependent isomerization of sigma(54), mediated via its interactions with an enhancer- binding activator protein that utilizes the energy released in ATP hydrolysis to effect structural changes in sigma(54) and core RNA polymerase. The organization of sigma(54)-promoter and sigma(54)-RNAP-promoter complexes was investigated by fluorescence resonance energy transfer assays using sigma(54) single cysteine-mutants labeled with an acceptor fluorophore and donor fluorophore- labeled DNA sequences containing mismatches that mimic nifH early-and late-melted promoters. The results show that sigma(54) undergoes spatial rearrangements of functionally important domains upon closed complex formation. sigma(54) and sigma(54)-RNAP promoter complexes reconstituted with the different mismatched DNA constructs were assayed by the addition of the activator phage shock protein F in the presence or absence of ATP and of non-hydrolysable analogues. Nucleotide-dependent alterations in fluorescence resonance energy transfer efficiencies identify different functional states of the activator-sigma(54)-RNAP-promoter complex that exist throughout the mechano-chemical transduction pathway of transcriptional activation, i.e. from closed to open promoter complexes. The results suggest that open complex formation only occurs efficiently on replacement of a repressive fork junction with downstream melted DNA.	Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Biol, London SW7 2AZ, England	University of Leeds; University of Leeds; Imperial College London	Stockley, PG (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	stockley@bmb.leeds.ac.uk		Gell, Christopher/0000-0002-6628-8292; Wigneshweraraj, Sivaramesh/0000-0002-1418-4029; Stockley, Peter/0000-0002-1360-2751	Biotechnology and Biological Sciences Research Council [B19279] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Bordes P, 2004, MOL MICROBIOL, V54, P489, DOI 10.1111/j.1365-2958.2004.04280.x; BUCK M, 1992, NATURE, V358, P422, DOI 10.1038/358422a0; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; Burrows PC, 2004, EMBO J, V23, P4253, DOI 10.1038/sj.emboj.7600406; Burrows PC, 2003, J BIOL CHEM, V278, P29728, DOI 10.1074/jbc.M303596200; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Cannon W, 2003, J BIOL CHEM, V278, P19815, DOI 10.1074/jbc.M301296200; Cannon W, 2002, NUCLEIC ACIDS RES, V30, P886, DOI 10.1093/nar/30.4.886; Cannon W, 1999, GENE DEV, V13, P357, DOI 10.1101/gad.13.3.357; Cannon W, 2001, J BIOL CHEM, V276, P386, DOI 10.1074/jbc.M007779200; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Chaney M, 1999, MOL MICROBIOL, V33, P1200, DOI 10.1046/j.1365-2958.1999.01566.x; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Guo YL, 2000, GENE DEV, V14, P2242, DOI 10.1101/gad.794800; Guo YL, 1999, EMBO J, V18, P3736, DOI 10.1093/emboj/18.13.3736; Huo YX, 2006, MOL MICROBIOL, V59, P168, DOI 10.1111/j.1365-2958.2005.04943.x; Jovanovic G, 1999, J MOL BIOL, V285, P469, DOI 10.1006/jmbi.1998.2263; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; MORRIS L, 1994, J BIOL CHEM, V269, P11563; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Scott DJ, 2000, BIOCHEM J, V352, P539, DOI 10.1042/0264-6021:3520539; Wang L, 2001, J BIOL CHEM, V276, P8979, DOI 10.1074/jbc.M009587200; Wigneshweplaraj SR, 2005, PROG NUCLEIC ACID RE, V79, P339, DOI 10.1016/S0079-6603(04)79007-8; Wigneshweraraj SR, 2003, METHOD ENZYMOL, V370, P646; Wigneshweraraj SR, 2003, J BIOL CHEM, V278, P3455, DOI 10.1074/jbc.M209442200; Wigneshweraraj SR, 2001, J MOL BIOL, V306, P681, DOI 10.1006/jmbi.2000.4393; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	35	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33717	33726		10.1074/jbc.M605731200	http://dx.doi.org/10.1074/jbc.M605731200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16926155	hybrid			2022-12-27	WOS:000241621400079
J	Li, L; Shaw, PE				Li, Li; Shaw, Peter E.			Elevated activity of STAT3C due to higher DNA binding affinity of phosphotyrosine dimer rather than covalent dimer formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; TYROSINE PHOSPHORYLATION; ACTIVATION; CELLS; PROTEINS; DIMERIZATION; DOMAINS	Signal transducer and activator of transcription (STAT) proteins are involved in cell proliferation and survival, aspects of tissue differentiation and immune function. STAT3 appears to be fundamentally important for vertebrate organisms, being required for the self-renewal of embryonal stem cells in response to leukemia inhibitory factor signaling and for proliferation of some somatic cell types. Moreover, STAT3 is up-regulated in a range of tumors, and a modified version of STAT3 (STAT3C) has been shown to function as an oncogene, whereas inhibition of STAT3 can suppress tumor cell growth. The constitutive activity of oncogenic STAT3C was reported to depend on spontaneous dimerization directed by disulfide bonds in the absence of tyrosine phosphorylation. In fact, tyrosine phosphorylation consequent upon cytokine or mitogen-induced signaling events remains obligatory for STAT3C activation. Instead, the DNA-binding affinity of phospho-STAT3C is elevated resulting in a faster on-rate and slower off-rate. The faster onrate sensitizes STAT3C to cytokine stimulation, and the slower off-rate protects it from inactivation by nuclear phosphatases. These changes account for the ability of STAT3C to up- regulate persistently the expression of STAT3 target genes and promote cell cycle progression.	Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Ctr Biochem & Cell Biol, Nottingham NG7 2UH, England	University of Nottingham	Shaw, PE (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Ctr Biochem & Cell Biol, Nottingham NG7 2UH, England.	shaw@nottingham.ac.uk		SHAW, Peter/0000-0002-2598-4283				Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; Bild AH, 2002, EMBO J, V21, P3255, DOI 10.1093/emboj/cdf351; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; Haan S, 2000, BIOCHEM J, V345, P417, DOI 10.1042/0264-6021:3450417; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Ihara S, 1997, EMBO J, V16, P5345, DOI 10.1093/emboj/16.17.5345; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; Li L, 2002, J BIOL CHEM, V277, P17397, DOI 10.1074/jbc.M109962200; Liddle FJ, 2006, BIOCHEMISTRY-US, V45, P5599, DOI 10.1021/bi0525674; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Meyer T, 2002, EXP CELL RES, V272, P45, DOI 10.1006/excr.2001.5405; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Novak U, 1998, BIOCHEM BIOPH RES CO, V247, P558, DOI 10.1006/bbrc.1998.8829; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Schroder M, 2004, J LEUKOCYTE BIOL, V75, P792, DOI 10.1189/jlb.1003496; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Taylor JD, 2000, NUCLEIC ACID PROTOCOLS HANDBOOK, P745; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang Y, 2005, J BIOL CHEM, V280, P34306, DOI 10.1074/jbc.M503263200; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	39	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33172	33181		10.1074/jbc.M606940200	http://dx.doi.org/10.1074/jbc.M606940200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956893	hybrid			2022-12-27	WOS:000241621400025
J	Nho, RS; Xia, H; Diebold, D; Kahm, J; Kleidon, J; White, E; Henke, CA				Nho, Richard Seonghun; Xia, Hong; Diebold, Deanna; Kahm, Judy; Kleidon, Jill; White, Eric; Henke, Craig A.			PTEN regulates fibroblast elimination during collagen matrix contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; VIABILITY SIGNALING PATHWAY; FOCAL ADHESION KINASE; GRANULATION-TISSUE; PULMONARY FIBROSIS; PROTEIN STABILITY; SURVIVAL PATHWAY; CELL-SURVIVAL; APOPTOSIS; ACTIN	During tissue repair, excess fibroblasts are eliminated by apoptosis. This physiologic process limits fibrosis and restores normal anatomic patterns. Replicating physiologic apoptosis associated with tissue repair, fibroblasts incorporated into type I collagen matrices undergo apoptosis in response to collagen matrix contraction. In this in vitro model of wound repair, fibroblasts first attach to collagen via alpha 2 beta 1 integrin. This provides a survival signal via activation of the phosphatidylinositol 3-kinase/Akt signal pathway. However, during subsequent collagen matrix contraction, the level of phosphorylated Akt progressively declines, triggering apoptosis. The mechanism underlying the fall in phosphorylated Akt is incompletely understood. Here we show that PTEN phosphatase becomes activated during collagen matrix contraction and is responsible for antagonizing phosphatidylinositol 3-kinase activity and promoting a decline in phosphorylated Akt and fibroblast apoptosis in response to collagen contraction. PTEN null fibroblasts displayed enhanced levels of phosphorylated Akt and were resistant to collagen matrix contraction-induced apoptosis. Reconstitution of PTEN in PTEN null cells conferred susceptibility to apoptosis in response to contraction of collagen matrices. Consistent with this, knockdown of PTEN in PTEN+/+ embryonic fibroblasts by small interfering RNA augmented Akt activity and suppressed apoptosis in contractile collagen matrices. Furthermore, inhibition of Akt activity restored the sensitivity of PTEN null cells to collagen contraction-induced apoptosis, indicating that the mechanism by which PTEN alters fibroblast viability is through modulation of phosphorylated Akt levels. Our work suggests that collagen matrix contraction activates PTEN by a mechanism involving cytoskeletal disassembly. Our studies indicate a key role for PTEN in regulating fibroblast viability during tissue repair.	Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan	Nho, RS (corresponding author), Univ Minnesota, Dept Med, Box 276,420 Delaware St SE, Minneapolis, MN 55455 USA.	nhoxx002@umn.edu; henke002@umn.edu		White, Eric/0000-0003-4060-8443	NHLBI NIH HHS [R01 HL085083, L30 HL074723] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085083] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berry DP, 1998, PLAST RECONSTR SURG, V102, P124, DOI 10.1097/00006534-199807000-00019; Chen HY, 2000, BIOCHEM J, V351, P403, DOI 10.1042/0264-6021:3510403; Cooke ME, 2000, J CELL SCI, V113, P2375; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FUKUDA Y, 1987, AM J PATHOL, V126, P171; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Huang YP, 2005, ONCOGENE, V24, P3819, DOI 10.1038/sj.onc.1208527; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; KUHN C, 1991, AM J PATHOL, V138, P1257; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Lin YC, 1997, MOL BIOL CELL, V8, P59, DOI 10.1091/mbc.8.1.59; LO SH, 1994, J CELL BIOL, V125, P1067, DOI 10.1083/jcb.125.5.1067; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tamura M, 1999, JNCI-J NATL CANCER I, V91, P1820, DOI 10.1093/jnci/91.21.1820; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yamada KM, 2001, J CELL SCI, V114, P2375	34	41	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33291	33301		10.1074/jbc.M606450200	http://dx.doi.org/10.1074/jbc.M606450200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16963781	hybrid			2022-12-27	WOS:000241621400039
J	Wijewickrama, GT; Albanese, A; Kim, YJ; Oh, YS; Murray, PS; Takayanagi, R; Tobe, T; Masuda, S; Murakami, M; Kudo, I; Ucker, DS; Murray, D; Cho, W				Wijewickrama, Gihani T.; Albanese, Alexandra; Kim, Young Jun; Oh, Youn Sang; Murray, Paul S.; Takayanagi, Risa; Tobe, Takashi; Masuda, Seiko; Murakami, Makoto; Kudo, Ichiro; Ucker, David S.; Murray, Diana; Cho, Wonhwa			Unique membrane interaction mode of group IIF phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; POLYMERIZED MIXED LIPOSOMES; CELL-PENETRATING PEPTIDES; ARACHIDONIC-ACID RELEASE; GROUP-V; GROUP-X; EICOSANOID GENERATION; PROTEIN INTERACTIONS; INTERFACIAL BINDING; DIFFERENTIAL ROLES	The mechanisms by which secretory phospholipases A(2) (PLA(2)s) exert cellular effects are not fully understood. Group IIF PLA(2) (gIIFPLA(2)) is a structurally unique secretory PLA(2) with a long C-terminal extension. Homology modeling suggests that the membrane-binding surface of this acidic PLA(2) contains hydrophobic residues clustered near the C-terminal extension. Vesicle leakage and monolayer penetration measurements showed that gIIFPLA(2) had a unique ability to penetrate and disrupt compactly packed monolayers and bilayers whose lipid composition recapitulates that of the outer plasma membrane of mammalian cells. Fluorescence imaging showed that gIIFPLA(2) could also readily enter and deform plasma membrane-mimicking giant unilamellar vesicles. Mutation analysis indicates that hydrophobic residues (Tyr(115), Phe(116), Val(118), and Tyr(119)) near the C-terminal extension are responsible for these activities. When gIIFPLA(2) was exogenously added to HEK293 cells, it initially bound to the plasma membrane and then rapidly entered the cells in an endocytosis-independent manner, but the cell entry did not lead to a significant degree of phospholipid hydrolysis. GIIFPLA(2) mRNA was detected endogenously in human CD4(+) helper T cells after in vitro stimulation and exogenously added gIIFPLA(2) inhibited the proliferation of a T cell line, which was not seen with group IIA PLA(2). Collectively, these data suggest that unique membrane-binding properties of gIIFPLA(2) may confer special functionality on this secretory PLA(2) under certain physiological conditions.	Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60607 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Showa Univ, Sch Pharmaceut Sci, Shinagawa Ku, Tokyo 1428555, Japan; Tokyo Metropolitan Inst Med Sci, Biomembrane Signaling Project, Tokyo 1138613, Japan; Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cornell University; Showa University; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST)	Cho, W (corresponding author), Univ Illinois, Dept Chem, M-C 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066147, R01GM052598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024234] Funding Source: NIH RePORTER; NIA NIH HHS [AG 24234] Funding Source: Medline; NIGMS NIH HHS [GM 66147, GM 52598] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Chang SH, 2002, EXP CELL RES, V277, P15, DOI 10.1006/excr.2002.5539; Cho W, 2000, BBA-MOL CELL BIOL L, V1488, P48, DOI 10.1016/S1388-1981(00)00109-8; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Farber SA, 1999, J BIOL CHEM, V274, P19338, DOI 10.1074/jbc.274.27.19338; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Green I, 2003, TRENDS PHARMACOL SCI, V24, P213, DOI 10.1016/S0165-6147(03)00076-2; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Kates M., 1986, TECHNIQUES LIPIDOLOG, P114; Kim KP, 2000, BIOCHEM J, V348, P643, DOI 10.1042/0264-6021:3480643; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kim YJ, 2002, J BIOL CHEM, V277, P9358, DOI 10.1074/jbc.M110987200; KINI RM, 1987, J BIOL CHEM, V262, P14402; Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Menger FM, 1998, CURR OPIN CHEM BIOL, V2, P726, DOI 10.1016/S1367-5931(98)80110-5; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; Murakami M, 2002, J BIOL CHEM, V277, P19145, DOI 10.1074/jbc.M112385200; Murakami M, 2002, BIOCHEM BIOPH RES CO, V292, P689, DOI 10.1006/bbrc.2002.6716; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Snitko Y, 1997, BIOCHEMISTRY-US, V36, P14325, DOI 10.1021/bi971200z; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; SUGA H, 1993, EUR J BIOCHEM, V218, P807, DOI 10.1111/j.1432-1033.1993.tb18435.x; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; VADAS P, 1985, LIFE SCI, V36, P579, DOI 10.1016/0024-3205(85)90640-X; VADAS P, 1986, LAB INVEST, V55, P391; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Valentin E, 2000, BIOCHEM BIOPH RES CO, V279, P223, DOI 10.1006/bbrc.2000.3908; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; VERGER R, 1982, CHEM PHYS LIPIDS, V30, P189, DOI 10.1016/0009-3084(82)90052-4; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Wijewickrama GT, 2006, J BIOL CHEM, V281, P10935, DOI 10.1074/jbc.M512657200; WU SK, 1994, ANAL BIOCHEM, V221, P152, DOI 10.1006/abio.1994.1391; WU SK, 1993, BIOCHEMISTRY-US, V32, P13902, DOI 10.1021/bi00213a020; Zasloff M, 2002, NEW ENGL J MED, V347, P1199, DOI 10.1056/NEJMe020106	64	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32741	32754		10.1074/jbc.M606311200	http://dx.doi.org/10.1074/jbc.M606311200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16931517	hybrid			2022-12-27	WOS:000241414500073
J	Fribley, AM; Evenchik, B; Zeng, QH; Park, BK; Guan, JY; Zhang, HL; Hale, TJ; Soengas, MS; Kaufman, RJ; Wang, CY				Fribley, Andrew M.; Evenchik, Benjamin; Zeng, Qinghua; Park, Bae Keun; Guan, Jean Y.; Zhang, Honglai; Hale, Timothy J.; Soengas, Maria S.; Kaufman, Randal J.; Wang, Cun-Yu			Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THAPSIGARGIN-INDUCED APOPTOSIS; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; BCL-2 FAMILY; KAPPA-B; HEAD; BORTEZOMIB; EXPRESSION; CANCER; CHEMOTHERAPY	Cisplatin is one of the most common DNA-damaging agents used for treating patients with solid tumors such as squamous cell carcinoma (SCC). Unfortunately, significant levels of resistance in SCC cells emerge rapidly following cisplatin treatment. Here we report that the proteasome inhibitor PS-341, the representative of a new class of chemotherapeutic drugs, was capable of inducing apoptosis in cisplatin-resistant SCC cells via the endoplasmic reticulum stress. PS-341 stimulated the phosphorylation of PERK and the unfolded protein response, resulting in the induction of the transcription factor ATF-4. Importantly, the Bcl-2 homology domain 3-only (BH3-only) protein Noxa was found to be strongly induced in cisplatin-resistant SCC cells by PS-341 but not by cisplatin. The knock-down of Noxa using small interference RNA significantly abolished PS-341-mediated apoptosis in SCC cells. Using eIF2 alpha mutant mouse embryonic fibroblasts, we found that functional eIF2 alpha played an essential role in PS-341-induced Noxa expression. Taken together, our novel findings reveal a direct link between PS-341-induced endoplasmic reticulum stress and the mitochondria-dependent apoptotic pathway and suggest that PS-341 may be utilized for overcoming cisplatin-resistance in human SCC.	Univ Michigan, Lab Mol Signaling & Apoptosis, Dept Biol & Mat Sci, Sch Dent, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, CY (corresponding author), Univ Michigan, Lab Mol Signaling & Apoptosis, Dept Biol & Mat Sci, Sch Dent, 1101 N Univ Ave, Ann Arbor, MI 48109 USA.	cunywang@umich.edu	Soengas, Maria S/H-6455-2015	Soengas, Maria S/0000-0003-0612-6299; Fribley, Andrew/0000-0002-2046-1600	NIDCR NIH HHS [R01DE013848, T32-DE0757, R01DE15964] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013848] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Akervall J, 2004, CLIN CANCER RES, V10, P8204, DOI 10.1158/1078-0432.CCR-04-0722; Akervall J, 2004, ACTA OTO-LARYNGOL, V124, P851, DOI 10.1080/00016480410017323; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Duffey DC, 1999, CANCER RES, V59, P3468; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Foote RL, 2005, CANCER-AM CANCER SOC, V103, P559, DOI 10.1002/cncr.20803; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Futami T, 2005, J BIOL CHEM, V280, P826, DOI 10.1074/jbc.M409948200; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Lenz HJ, 2003, CANCER TREAT REV, V29, P41, DOI 10.1016/S0305-7372(03)00082-3; Licitra L, 2003, J CLIN ONCOL, V21, P327, DOI 10.1200/JCO.2003.06.146; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nikrad M, 2005, MOL CANCER THER, V4, P443; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Patel V, 2001, CRIT REV ORAL BIOL M, V12, P55, DOI 10.1177/10454411010120010401; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Qin JZ, 2004, MOL CANCER THER, V3, P895; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; SHIRAISHI T, CAN RES, V65, P6364; SIMON NW, 2005, GENE DEV, V19, P1294; Sturgis EM, 2004, SEMIN ONCOL, V31, P726, DOI 10.1053/j.seminoncol.2004.09.013; Torigoe Takayuki, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P15, DOI 10.2174/1568011053352587; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wang XD, 2001, GENE DEV, V15, P2922; Yamaguchi H, 2003, CANCER RES, V63, P1483; Yeung BHY, 2006, J BIOL CHEM, V281, P11923, DOI 10.1074/jbc.M508533200; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683	41	104	108	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31440	31447		10.1074/jbc.M604356200	http://dx.doi.org/10.1074/jbc.M604356200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16928686				2022-12-27	WOS:000241235300028
J	Liu, Y; Sitaraman, S; Chang, A				Liu, Yu; Sitaraman, Sujatha; Chang, Amy			Multiple degradation pathways for misfolded mutants of the yeast plasma membrane ATPase, PMA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOID BASE SYNTHESIS; CELL-SURFACE STABILITY; H+-ATPASE; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; MOLECULAR-GENETICS; ENDOCYTOSIS; ER; IDENTIFICATION	To understand protein sorting and quality control in the secretory pathway, we have analyzed intracellular trafficking of the yeast plasma membrane ATPase, Pma1. Pma1 is ideal for such studies because it is a very abundant polytopic membrane protein, and its localization and activity at the plasma membrane are essential for cell viability and growth. We have tested whether the cytoplasmic amino- and carboxyl-terminal domains of Pma1 carry sorting information. As the sole copy of Pma1, mutants truncated at either NH2 or COOH termini are targeted at least partially to the plasma membrane and have catalytic activity to sustain cell viability. The mutants are also delivered to degradative pathways. Strikingly, NH2- and COOH-terminal Pma1 mutants are differentially recognized for degradation at distinct cellular locales. COOH-terminal mutants are recognized for destruction by endoplasmic reticulum-associated degradation. By contrast, NH2- terminal mutants escape detection by endoplasmic reticulum-associated degradation entirely, and undergo endocytosis for vacuolar degradation after apparently normal cell surface targeting. Both NH2- and COOH-terminal mutants are conformationally abnormal, as revealed by increased sensitivity to tryptic cleavage, but are able to assemble to form oligomers. We propose that different quality control mechanisms may assess discrete domains of Pma1 rather than a global conformational state.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chang, A (corresponding author), 830 N Univ, Ann Arbor, MI 48109 USA.	amychang@umich.edu	Chang, Amy/AAS-5491-2020; Liu, Yu/X-5864-2019	Chang, Amy/0000-0003-3682-6456; 	NIGMS NIH HHS [GM 58212] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058212, R55GM058212] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BENITO B, 1991, BIOCHIM BIOPHYS ACTA, V1063, P265, DOI 10.1016/0005-2736(91)90381-H; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; Chang A, 2002, METHOD ENZYMOL, V351, P339; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; EPPING E, 2002, J BIOL CHEM, V277, P34680; Friant S, 2003, EMBO J, V22, P3783, DOI 10.1093/emboj/cdg375; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; GOORMAGHTIGH E, 1986, J BIOL CHEM, V261, P7466; Hasper A, 1999, BBA-BIOMEMBRANES, V1420, P214, DOI 10.1016/S0005-2736(99)00100-5; JONES EW, 1991, J BIOL CHEM, V266, P7963; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Liu Y, 2006, J CELL SCI, V119, P360, DOI 10.1242/jcs.02749; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MANDALA SM, 1988, J BIOL CHEM, V263, P15122; Mason AB, 2006, J BIOL CHEM, V281, P23887, DOI 10.1074/jbc.M601818200; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Nothwehr SF, 1996, MOL CELL BIOL, V16, P2700; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rose MD., 1990, METHODS YEAST GENETI; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	41	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31457	31466		10.1074/jbc.M606643200	http://dx.doi.org/10.1074/jbc.M606643200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16928681	Bronze			2022-12-27	WOS:000241235300030
J	Oh, KJ; Barbuto, S; Pitter, K; Morash, J; Walensky, LD; Korsmeyer, SJ				Oh, Kyoung Joon; Barbuto, Scott; Pitter, Kenneth; Morash, Joel; Walensky, Loren D.; Korsmeyer, Stanley J.			A membrane-targeted BID BCL-2 homology 3 peptide is sufficient for high potency activation of BAX in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; OUTER MITOCHONDRIAL-MEMBRANE; CONFORMATIONAL-CHANGE; PROAPOPTOTIC BAX; CONTACT SITES; FAMILY-MEMBER; TUMOR-CELLS; BH3 DOMAINS; X-L; APOPTOSIS	The multidomain pro-apoptotic proteins BAX and BAK constitute an essential gateway to mitochondrial dysfunction and programmed cell death. Among the "BCL-2 homology (BH) 3-only" members of pro-apoptotic proteins, truncated BID (tBID) has been implicated in direct BAX activation, although an explicit molecular mechanism remains elusive. We find that BID BH3 peptide alone at submicromolar concentrations cannot activate BAX or complement BID BH3 mutant-tBID in mitochondrial and liposomal release assays. Because tBID contains structurally defined membrane association domains, we investigated whether membrane targeting of BID BH3 peptide would be sufficient to restore its pro-apoptotic activity. We developed a Ni2+-nitrilotriacetic acid liposomal assay system that efficiently conjugates histidine-tagged peptides to a simulated outer mitochondrial membrane surface. Strikingly, nanomolar concentrations of a synthetic BID BH3 peptide that is chemically tethered to the liposomal membrane activated BAX almost as efficiently as tBID itself. These results highlight the importance of membrane targeting of the BID BH3 domain in tBID-mediated BAX activation and support a model in which tBID engages BAX to trigger its pro-apoptotic activity.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol & Med,Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA; Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Oh, KJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol & Med,Howard Hughes Med Inst, 1 Jimmy Fund Way,Smith Bldg 758, Boston, MA 02115 USA.	kyoung_joon_oh@dfci.harvard.edu		Pitter, Kenneth/0000-0002-9450-313X; OH, KYOUNG JOON/0000-0002-4729-9674	NATIONAL CANCER INSTITUTE [P01CA068484, R01CA050239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074049] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA68484, R01 CA50239] Funding Source: Medline; NHLBI NIH HHS [K08 HL074049] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Becattini B, 2004, CHEM BIOL, V11, P389, DOI 10.1016/j.chembiol.2004.02.020; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Ellerby HM, 1997, J NEUROSCI, V17, P6165; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Heimlich G, 2004, BIOCHEM J, V378, P247, DOI 10.1042/BJ20031152; Hochman A, 1998, J NEUROCHEM, V71, P741; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hu X, 2003, APOPTOSIS, V8, P277, DOI 10.1023/A:1023676906857; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Ladokhin AS, 1999, J MOL BIOL, V285, P1363, DOI 10.1006/jmbi.1998.2346; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liu J, 2004, APOPTOSIS, V9, P533, DOI 10.1023/B:APPT.0000038034.16230.ea; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Lutter M, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-22; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Meijerink JPP, 1998, BLOOD, V91, P2991, DOI 10.1182/blood.V91.8.2991.2991_2991_2997; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; SCHMITT L, 1994, AM CHEM SOC, V166, P8485; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Van Mau N, 2005, J MEMBRANE BIOL, V207, P1, DOI 10.1007/s00232-005-0799-7; Vila R, 2001, J BIOL CHEM, V276, P46429, DOI 10.1074/jbc.M106952200; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang JL, 2000, CANCER RES, V60, P1498; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	58	71	72	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36999	37008		10.1074/jbc.M602341200	http://dx.doi.org/10.1074/jbc.M602341200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16987815	hybrid			2022-12-27	WOS:000242220800061
J	Yoon, SI; Logsdon, NJ; Sheikh, F; Donnelly, RP; Walter, MR				Yoon, Sung Il; Logsdon, Naomi J.; Sheikh, Faruk; Donnelly, Raymond P.; Walter, Mark R.			Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; SOLUBLE RECEPTOR; GROWTH-HORMONE; INTERLEUKIN-22; CELLS; CHAIN; CRYSTALLIZATION; CYTOKINES; HOMOLOG	Interleukin-10 receptor 2 (IL-10R2) is a critical component of the IL-10 center dot IL-10R1 center dot IL-10R2 complex which regulates IL-10-mediated immunomodulatory responses. The ternary IL-10 signaling complex is assembled in a sequential order with the IL-10 center dot IL-10R1 interaction occurring first followed by engagement of the IL-10R2 chain. In this study we map the IL-10R2 binding site on IL-10 using surface plasmon resonance and cell-based assays. Critical IL-10R2 binding residues are located in helix A adjacent to the previously identified IL-10R1 recognition surface. Interestingly, IL-10R2 binding residues located in the N-terminal end of helix A exhibit large structural differences between unbound cIL-10 and cIL-10 center dot IL-10R1 crystal structures. This suggests IL-10R1-induced conformational changes regulate IL-10R2 binding and assembly of the ternary IL-10 center dot IL10R1 center dot IL-10R2 complex. The basic mechanistic features of the assembly process are likely shared by six additional class-2 cytokines (viral IL-10s, IL-22, IL-26, IL-28A, IL28B, and IL-29) to promote IL-10R2 binding to six additional receptor complexes. These studies highlight the importance of structure in regulating low affinity protein-protein interactions and IL-10 signal transduction.	Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Food & Drug Administration (FDA)	Walter, MR (corresponding author), Univ Alabama, Dept Microbiol, CBSE Rm 144,1025 18th St S, Birmingham, AL 35294 USA.	walter@uab.edu	Donnelly, Raymond P./AFT-8600-2022	Donnelly, Raymond P./0000-0002-0695-5276	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047300] Funding Source: NIH RePORTER; NIAID NIH HHS [AI47300, R01 AI047300] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beebe AM, 2002, CYTOKINE GROWTH F R, V13, P403, DOI 10.1016/S1359-6101(02)00025-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; DE WMR, 1991, J EXP MED, V174, P1209; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Jones BC, 2002, P NATL ACAD SCI USA, V99, P9404, DOI 10.1073/pnas.152147499; Josephson K, 2000, J BIOL CHEM, V275, P13552, DOI 10.1074/jbc.275.18.13552; Josephson K, 2002, STRUCTURE, V10, P981, DOI 10.1016/S0969-2126(02)00791-8; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Josephson K, 2001, ACTA CRYSTALLOGR D, V57, P1908, DOI 10.1107/S0907444901016249; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Krause CD, 2006, BIOCHEM BIOPH RES CO, V340, P377, DOI 10.1016/j.bbrc.2005.11.182; Li J, 2004, INT IMMUNOPHARMACOL, V4, P693, DOI 10.1016/j.intimp.2004.01.010; Liu Y, 1997, J IMMUNOL, V158, P604; Lockridge KM, 2000, VIROLOGY, V268, P272, DOI 10.1006/viro.2000.0195; Logsdon NJ, 2002, J INTERF CYTOK RES, V22, P1099, DOI 10.1089/10799900260442520; Logsdon NJ, 2004, J MOL BIOL, V342, P503, DOI 10.1016/j.jmb.2004.07.069; MACNEIL IA, 1990, J IMMUNOL, V145, P4167; MALEFYT RD, 1991, J EXP MED, V174, P915; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nagem RAP, 2002, STRUCTURE, V10, P1051, DOI 10.1016/S0969-2126(02)00797-9; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pletnev S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-10; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Usacheva A, 2002, J IMMUNOL, V169, P1302, DOI 10.4049/jimmunol.169.3.1302; Walsh STR, 2003, PROTEIN SCI, V12, P1960, DOI 10.1110/ps.03133903; Walter MR, 2004, ADV PROTEIN CHEM, V68, P171; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WINDSOR WT, 1993, BIOCHEMISTRY-US, V32, P8807, DOI 10.1021/bi00085a011; Wolk K, 2005, GENES IMMUN, V6, P8, DOI 10.1038/sj.gene.6364144; Xu T, 2004, ACTA CRYSTALLOGR D, V60, P1295, DOI 10.1107/S0907444904010492; Yoon SI, 2005, STRUCTURE, V13, P551, DOI 10.1016/j.str.2005.01.016; Zdanov A, 1996, PROTEIN SCI, V5, P1955, DOI 10.1002/pro.5560051001	39	93	106	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35088	35096		10.1074/jbc.M606791200	http://dx.doi.org/10.1074/jbc.M606791200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16982608	hybrid			2022-12-27	WOS:000241933700042
J	Park, HJ; Kim, SS; Seong, YM; Kim, KH; Goo, HG; Yoon, EJ; Min, DS; Kang, S; Rhim, H				Park, Hyo-Jin; Kim, Sang-Soo; Seong, Young-Mo; Kim, Kyung-Hee; Goo, Hui Gwan; Yoon, Eun Jin; Min, Do Sik; Kang, Seongman; Rhim, Hyangshuk			beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease - Implications for the physiological function of HtrA2 in the mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-APOPTOTIC PROTEIN; PROMOTES CELL-DEATH; ALZHEIMERS-DISEASE; CASPASE ACTIVATION; OMI/HTRA2; INHIBITOR; SECRETASE; INTERACTS; NEURONS; BINDING	The processing and metabolism of amyloid precursor protein (APP) is a major interest in Alzheimer disease (AD) research, because not only amyloid beta(A beta) peptide, but also cellular or mitochondrial APP are intimately involved in cellular dysfunction and AD pathogenesis. Here we demonstrate that APP is directly and efficiently cleaved by the HtrA2 serine protease in vitro and in vivo. Using several APP mutants and N-terminal amino acid sequencing, we identified that the HtrA2-mediated APP cleavage product is the C161 fragment encompassing amino acids 535 - 695 of APP695. The immunofluorescence and subcellular fractionation studies indicate that APP is partly colocalized with HtrA2 in the mitochondria where HtrA2 can cleave APP under normal conditions. The HtrA2-cleaved C161 fragment was detected in the cytosolic fraction; therefore, we postulate that the C161 fragment is released into the cytosol after cleavage of APP by HtrA2. Interestingly, the level of C161 was remarkably decreased in motor neuron degeneration (mnd2) mice in which the serine protease activity of HtrA2 was greatly reduced. These results show that the protease activity of HtrA2 is essential for the production of C161 and that processing of APP into C161 is a natural event occurring under normal physiological conditions. Our study suggests that the direct cleavage of mitochondrial APP by HtrA2 may prevent mitochondrial dysfunction caused by accumulation of APP and that the regulation of HtrA2 protease activity may be a therapeutic target in AD.	Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; Catholic Univ, Coll Med, Dept Biomed Sci, Seoul 137701, South Korea; Catholic Univ, Coll Med, Res Inst Mol Genet, Seoul 137701, South Korea; Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea	Korea University; Catholic University of Korea; Catholic University of Korea; Pusan National University	Kang, S (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	skang@korea.ac.kr; hrhim@catholic.ac.kr	Kim, Hyung-Kwan/R-8375-2019					Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Barnes NY, 1998, J NEUROSCI, V18, P5869; Caswell MD, 1999, EUR J BIOCHEM, V266, P509, DOI 10.1046/j.1432-1327.1999.00886.x; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Citron M, 2000, ANN NY ACAD SCI, V920, P192; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Grant SM, 1999, NEUROREPORT, V10, P41, DOI 10.1097/00001756-199901180-00008; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kienlen-Campard P, 2000, EXP GERONTOL, V35, P843, DOI 10.1016/S0531-5565(00)00170-4; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Martins LM, 2002, CELL DEATH DIFFER, V9, P699, DOI 10.1038/sj.cdd.4401044; Nishimura I, 1998, J NEUROSCI, V18, P2387, DOI 10.1523/jneurosci.18-07-02387.1998; Park HJ, 2004, NEUROSCI LETT, V357, P63, DOI 10.1016/j.neulet.2003.11.068; Sekine K, 2005, BIOCHEM BIOPH RES CO, V330, P279, DOI 10.1016/j.bbrc.2005.02.165; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Seong YM, 2004, J BIOL CHEM, V279, P37588, DOI 10.1074/jbc.M401408200; Seong YM, 2004, PROTEIN EXPRES PURIF, V33, P200, DOI 10.1016/j.pep.2003.10.002; SIMAN R, 1990, J NEUROSCI, V10, P2400; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Srinivasula SM, 2003, J BIOL CHEM, V278, P31469, DOI 10.1074/jbc.C300240200; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; Tesco G, 2003, J BIOL CHEM, V278, P46074, DOI 10.1074/jbc.M307809200; Trencia A, 2004, J BIOL CHEM, V279, P46566, DOI 10.1074/jbc.M406317200; Uetsuki T, 1999, J NEUROSCI, V19, P6955, DOI 10.1523/JNEUROSCI.19-16-06955.1999; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	35	89	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34277	34287		10.1074/jbc.M603443200	http://dx.doi.org/10.1074/jbc.M603443200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16968707	hybrid			2022-12-27	WOS:000241767600048
J	Teh, CHL; Lam, KKY; Loh, CC; Loo, JM; Yan, T; Lim, TM				Teh, Christina H. L.; Lam, Kevin K. Y.; Loh, Chin C.; Loo, Jia M.; Yan, Tie; Lim, Tit Meng			Neuronal PAS domain protein 1 is a transcriptional repressor and requires arylhydrocarbon nuclear translocator for its nuclear localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AH-RECEPTOR; DNA-BINDING; DROSOPHILA; CLONING; ACTIVATION; EXPRESSION; IDENTIFICATION; RECRUITMENT; SIGNAL; BRAIN	Neuronal PAS domain protein 1 (NPAS1), a basic helix-loop-helix-PAS transcription factor expressed in the central nervous system, has been suggested to be involved in neuronal differentiation. However, relatively little is known about the molecular mechanism underlying the role of NPAS1 during development. In this study we set out to characterize the different domains within NPAS1. We showed that the nuclear localization of NPAS1 is dependent on the presence of ARNT. In addition, the transcriptional potential of ARNT is not required for this localization. In the absence of ARNT, NPAS1 is excluded from the nucleus, and this exclusion is due to the presence of a nuclear export signal within the N terminus of NPAS1. The interaction between NPAS1 and ARNT is via their N termini. We found no transactivation domain within NPAS1; instead, we mapped out at least three repression domains within NPAS1, suggesting that NPAS1 acts as a repressor. Furthermore, our experiments showed that NPAS1 is able to repress the transactivation functions of ARNT and ARNT2. We suggest that NPAS1 is guided into the nucleus by ARNT via the ARNT nuclear localization signal, and NPAS1 can override the activation function of adjacent transcription factors, providing a mechanism by which NPAS1 may inhibit transcription.	Natl Univ Singapore, Dept Biol Sci, Singapore 117542, Singapore	National University of Singapore	Lim, TM (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4,Kent Ridge, Singapore 117542, Singapore.	dbsltm@nus.edu.sg		Loo, Jia Min/0000-0002-6605-4031				Brunskill EW, 1999, MECH DEVELOP, V88, P237, DOI 10.1016/S0925-4773(99)00182-3; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; Chee JLY, 2005, CELL MOL LIFE SCI, V62, P227, DOI 10.1007/s00018-004-4413-4; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Drutel G, 1996, BIOCHEM BIOPH RES CO, V225, P333, DOI 10.1006/bbrc.1996.1176; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Fukunaga BN, 1996, J BIOL CHEM, V271, P3743; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Hirose K, 1996, MOL CELL BIOL, V16, P1706; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; JAIN S, 1994, J BIOL CHEM, V269, P31518; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; LI H, 1994, J BIOL CHEM, V269, P28098; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; MASON GGF, 1994, J BIOL CHEM, V269, P4438; Moffett P, 1997, MOL CELL BIOL, V17, P4933, DOI 10.1128/MCB.17.9.4933; Nambu JR, 1996, GENE, V172, P249, DOI 10.1016/0378-1119(96)00060-1; Ohsawa S, 2005, J NEUROSCI RES, V79, P451, DOI 10.1002/jnr.20365; Probst MR, 1997, J BIOL CHEM, V272, P4451, DOI 10.1074/jbc.272.7.4451; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; Salceda S, 1996, ARCH BIOCHEM BIOPHYS, V334, P389, DOI 10.1006/abbi.1996.0469; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Studer L, 2000, J NEUROSCI, V20, P7377; Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; Ward MP, 1998, DEVELOPMENT, V125, P1599; Wenger RH, 1997, BIOL CHEM, V378, P609; WHITELAW M, 1993, MOL CELL BIOL, V13, P2504, DOI 10.1128/MCB.13.4.2504; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zhou ZD, 2005, EXP CELL RES, V312, P156, DOI 10.1016/j.yexcr.2005.10.012	41	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34617	34629		10.1074/jbc.M604409200	http://dx.doi.org/10.1074/jbc.M604409200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16954219	hybrid			2022-12-27	WOS:000241767600081
J	Wang, J; Yin, L; Lazar, MA				Wang, Jing; Yin, Lei; Lazar, Mitchell A.			The orphan nuclear receptor Rev-erb alpha regulates circadian expression of plasminogen activator inhibitor type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE-RECEPTOR; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; MYOCARDIAL-INFARCTION; ROR-ALPHA; CARDIOVASCULAR-DISEASE; OPPOSITE STRAND; TRANSGENIC MICE; PAI-1 PROMOTER; TRANSCRIPTION	Plasminogen activator inhibitor type 1 (PAI-1) is a major physiologic regulator of the fibrinolytic system and has recently gained recognition as a modulator of inflammation and atherosclerosis. PAI-1 exhibits circadian rhythmicity in its expression, peaking in the early morning, which is associated with increased risk for cardiovascular events. However, the mechanisms that determine PAI-1 circadian rhythmicity remain poorly understood. We discovered that the orphan nuclear receptor Reverb alpha, a core component of the circadian loop, represses human PAI-1 gene expression through two Rev-erb alpha binding sites in the PAI-1 promoter. Mutations of these sites, as well as RNA interference targeting endogenous Rev-erb alpha and its corepressors, led to increased expression of the PAI-1 gene. Furthermore, glycogen synthase kinase 3 beta (GSK3 beta) contributes to pai-1 repression by phosphorylating and stabilizing Rev-erb alpha protein, which can be blocked by lithium. Interestingly, serum shock generated circadian oscillations in PAI-1 mRNA in NIH3T3 cells, suggesting that PAI-1 is a direct output gene of the circadian loop. Ectopic expression of a stabilized form of Rev-erb alpha that mimics GSK3 beta phosphorylation dramatically dampened PAI-1 circadian oscillations. Thus, our results suggest that Rev-erb alpha is a major determinant of the circadian PAI-1 expression and a potential modulator of the morning susceptibility to myocardial infarction.	Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, 611 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019		NIDDK NIH HHS [DK45586] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; ANDREOTTI F, 1988, AM J CARDIOL, V62, P635, DOI 10.1016/0002-9149(88)90669-8; ANGLETON P, 1989, CIRCULATION, V79, P101, DOI 10.1161/01.CIR.79.1.101; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Carmeliet P, 1997, CIRCULATION, V96, P3180, DOI 10.1161/01.CIR.96.9.3180; Chauvet C, 2005, MOL ENDOCRINOL, V19, P2517, DOI 10.1210/me.2005-0153; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; CHOMIKI N, 1994, THROMB HAEMOSTASIS, V72, P44; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Coste H, 2002, J BIOL CHEM, V277, P27120, DOI 10.1074/jbc.M203421200; De Taeye B, 2005, CURR OPIN PHARMACOL, V5, P149, DOI 10.1016/j.coph.2005.01.007; Eitzman DT, 2000, BLOOD, V96, P4212; Eren M, 2003, J THROMB HAEMOST, V1, P2389, DOI 10.1046/j.1538-7836.2003.00437.x; Eren M, 2002, CIRCULATION, V106, P491, DOI 10.1161/01.CIR.0000023186.60090.FB; Genoux A, 2005, ARTERIOSCL THROM VAS, V25, P1186, DOI 10.1161/01.ATV.0000163841.85333.83; GIGUERE V, 1995, MOL CELL BIOL, V15, P2517; Gruber F, 2003, BLOOD, V101, P3042, DOI 10.1182/blood-2002-07-2331; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Harding HP, 1997, MOL ENDOCRINOL, V11, P1737, DOI 10.1210/me.11.11.1737; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Hou BD, 2004, J BIOL CHEM, V279, P18127, DOI 10.1074/jbc.M310438200; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Kapiotis S, 1997, CIRCULATION, V96, P19; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; MARLER JR, 1989, STROKE, V20, P473, DOI 10.1161/01.STR.20.4.473; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Nagoshi E, 2005, METHOD ENZYMOL, V393, P543, DOI 10.1016/S0076-6879(05)93028-0; PARAMO JA, 1990, THROMB HAEMOSTASIS, V64, P3; Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Samad F, 1996, MOL MED, V2, P568, DOI 10.1007/BF03401641; Schafer K, 2001, FASEB J, V15, P1840, DOI 10.1096/fj.00-0750fje; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Sobel BE, 1998, CIRCULATION, V97, P2213, DOI 10.1161/01.CIR.97.22.2213; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835	48	101	105	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33842	33848		10.1074/jbc.M607873200	http://dx.doi.org/10.1074/jbc.M607873200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16968709	hybrid			2022-12-27	WOS:000241767600005
J	Chini, CCS; Chen, JJ				Chini, Claudia C. S.; Chen, Junjie			Repeated phosphopeptide motifs in human claspin are phosphorylated by Chk1 and mediate claspin function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; RADIOSENSITIZING AGENT; ACTIVATION; ATR; PROTEIN; DEGRADATION; RECOVERY; BINDING; ROLES	Claspin is a checkpoint protein involved in ATR ((a) under bar taxia (t) under bar elangiectasia mutated-and (R) under bar ad3-related)-dependent Chk1 activation in Xenopus and human cells. In Xenopus, Claspin interacts with Chk1 after DNA damage through a region containing two highly conserved repeats, which becomes phosphorylated during the checkpoint response. Because this region is also conserved in human Claspin, we investigated the regulation and function of these potential phosphorylation sites in human Claspin. We found that Claspin is phosphorylated in vivo at Thr-916 in response to replication stress and UV damage. Mutation of these phosphorylation sites on Claspin inhibited Claspin-Chk1 interaction in vivo, impaired Chk1 activation, and induced premature chromatin condensation in cells, indicating a defect in replication checkpoint. In addition, we found that Thr-916 on Claspin is phosphorylated by Chk1, suggesting that Chk1 regulates Claspin during checkpoint response. These results together indicate that phosphorylation of Claspin repeats in human Claspin is important for Claspin function and the regulation of Claspin-Chk1 interaction in human cells.	Mayo Clin & Mayo Fdn, Coll Med, Dept Oncol Res, Rochester, MN 55905 USA	Mayo Clinic	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, Hunter Bldg,Rm 213C,333 Cedar St, New Haven, CT 06520 USA.	Junjie.Chen@yale.edu			NATIONAL CANCER INSTITUTE [R01CA100109, R01CA089239, R01CA092312] Funding Source: NIH RePORTER; NCI NIH HHS [CA92312, CA89239, CA100109] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bennett LN, 2006, FEBS LETT, V580, P4176, DOI 10.1016/j.febslet.2006.06.071; Busby EC, 2000, CANCER RES, V60, P2108; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Chini CCS, 2004, DNA REPAIR, V3, P1033, DOI 10.1016/j.dnarep.2004.03.001; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; MAMELY I, 2006, IN PRESS CURR BIOL; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9	25	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33276	33282		10.1074/jbc.M604373200	http://dx.doi.org/10.1074/jbc.M604373200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16963448	hybrid			2022-12-27	WOS:000241621400037
J	Marathe, C; Bradley, MN; Hong, C; Lopez, F; de Galarreta, CMR; Tontonoz, P; Castrillo, A				Marathe, Chaitra; Bradley, Michelle N.; Hong, Cynthia; Lopez, Felix; Ruiz de Galarreta, Carlos M.; Tontonoz, Peter; Castrillo, Antonio			The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-3; NITRIC-OXIDE SYNTHASE; L-ARGININE; DIFFERENTIAL REGULATION; RECIPROCAL REGULATION; NUCLEAR RECEPTORS; LIPID-METABOLISM; MOUSE MODEL; LXR; CHOLESTEROL	The liver X receptors (LXRs) are ligand-dependent transcription factors that have been implicated in lipid metabolism and inflammation. LXRs also inhibit the expression of inflammatory genes in macrophages, including inducible nitric oxide synthase (iNOS). Some of these actions are mediated through LXR antagonism of NF-kappa B activity. The potential for LXRs to positively regulate the expression of anti-inflammatory molecules, however, has not been explored. Here we show that the arginase II (ArgII) gene is a direct target for LXR regulation. ArgII catalyzes the conversion of L-arginine into L-ornithine and urea, leading to the synthesis of polyamines. Expression of ArgII is induced by LXR agonists in macrophage cell lines and primary murine macrophages in a receptor-dependent manner. The ArgII promoter contains a functional LXR response elements that mediates promoter induction by LXR/RXR (retinoid X receptor) in transfection assays. Since ArgII and iNOS utilize a common substrate, induction of ArgII expression has the potential to exert anti-inflammatory effects by shifting arginine metabolism toward polyamine synthesis at the expense of NO production. In support of this hypothesis, we demonstrate that forced expression of ArgII mimics the inhibitory effect of LXR activation on macrophage NO production. Furthermore, inhibition of arginase activity partially reverses the inhibitory effect of LXR agonists on NO production. These studies suggest that regulation of ArgII may contribute to the immunomodulatory effects of LXRs.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Las Palmas Gran Canaria, Dept Bioquim & Biol Mol, Las Palmas Gran Canaria 35016, Spain	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Universidad de Las Palmas de Gran Canaria	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Inst Mol Biol, Box 951662, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu; acastrillo@ramonycajal.ulpgc.es		Lopez Blanco, Felix/0000-0003-1167-9787	NHLBI NIH HHS [HL 30568, HL 66088] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL066088] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Castrillo A, 2000, MOL CELL BIOL, V20, P1692, DOI 10.1128/MCB.20.5.1692-1698.2000; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Cederbaum SD, 2004, MOL GENET METAB, V81, pS38, DOI 10.1016/j.ymgme.2003.10.012; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Colleluori DM, 2001, BIOCHEMISTRY-US, V40, P9356, DOI 10.1021/bi010783g; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Grandvaux N, 2005, FEBS J, V272, P3120, DOI 10.1111/j.1742-4658.2005.04726.x; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kakuda DK, 1999, BIOCHEM J, V340, P549, DOI 10.1042/0264-6021:3400549; King NE, 2004, J NUTR, V134, p2830S, DOI 10.1093/jn/134.10.2830S; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; LOUIS CA, 1999, AM J PHYSIOL, V276, P237; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Morris SM, 2005, VASC MED, V10, pS83, DOI 10.1191/1358863x05vm601oa; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; NAGASAKI AS, 1999, AM J PHYSIOL, V277, P110; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Redington AE, 2006, EUR J PHARMACOL, V533, P263, DOI 10.1016/j.ejphar.2005.12.069; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tenu JP, 1999, NITRIC OXIDE-BIOL CH, V3, P427, DOI 10.1006/niox.1999.0255; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Zimmermann N, 2006, EUR J PHARMACOL, V533, P253, DOI 10.1016/j.ejphar.2005.12.047	48	77	82	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32197	32206		10.1074/jbc.M605237200	http://dx.doi.org/10.1074/jbc.M605237200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943198	hybrid			2022-12-27	WOS:000241414500017
J	Operario, DJ; Balakrishnan, M; Bambara, RA; Kim, B				Operario, Darwin J.; Balakrishnan, Mini; Bambara, Robert A.; Kim, Baek			Reduced dNTP interaction of human immunodeficiency virus type 1 reverse transcriptase promotes strand transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRONG STOP TRANSFER; DNA-POLYMERASE; RETROVIRAL RECOMBINATION; ESCHERICHIA-COLI; NUCLEOCAPSID PROTEIN; INVASION MECHANISM; GENETIC SELECTION; DRUG-RESISTANCE; LEUKEMIA-VIRUS; TARGET-CELLS	We have recently demonstrated that HIV-1 RT mutants characterized by low dNTP binding affinity display significantly reduced dNTP incorporation kinetics in comparison to wildtype RT. This defect is particularly emphasized at low dNTP concentrations where WT RT remains capable of efficient synthesis. Kinetic interference in DNA synthesis can induce RT pausing and slow down the synthesis rate. RT stalling and slow synthesis rate can enhance RNA template cleavage by RT-RNase H, facilitating transfer of the primer to a homologous template. We therefore hypothesized that reduced dNTP binding RT mutants can promote template switching during minus strand synthesis more efficiently than WT HIV-1 RT at low dNTP concentrations. To test this hypothesis, we employed two dNTP binding HIV-1 RT mutants, Q151N and V148I. Indeed, as the dNTP concentration was decreased, the template switching frequency progressively increased for both WT and mutant RTs. However, as predicted, the RT mutants promoted more transfers compared with WTRT. The WT and mutant RTs were similar in their intrinsic RNase H activity, supporting that the elevated template switching efficiency of the mutants was not the result of the mutations enhancing RNase H activity. Rather, kinetic interference leading to stalled DNA synthesis likely enhanced transfers. These results suggest that the RT-dNTP substrate interaction mechanistically influences strand transfer and recombination of HIV-1 RT.	Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, F31AI056668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 49781, AI 056668] Funding Source: Medline; NIGMS NIH HHS [GM 49573] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Chen JB, 2005, J VIROL, V79, P9337, DOI 10.1128/JVI.79.14.9337-9340.2005; Chen Y, 2005, J BIOL CHEM, V280, P14443, DOI 10.1074/jbc.M412190200; Chen Y, 2003, J BIOL CHEM, V278, P38368, DOI 10.1074/jbc.M305700200; Chen Y, 2003, J BIOL CHEM, V278, P8006, DOI 10.1074/jbc.M210959200; Derebail SS, 2004, J BIOL CHEM, V279, P47446, DOI 10.1074/jbc.M408927200; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Diamond TL, 2003, J BIOL CHEM, V278, P29913, DOI 10.1074/jbc.M211754200; Dykes C, 2004, VIROLOGY, V326, P262, DOI 10.1016/j.virol.2004.02.033; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Jamburuthugoda VK, 2005, BIOCHEMISTRY-US, V44, P10635, DOI 10.1021/bi050611+; Kim B, 1997, METHODS, V12, P318, DOI 10.1006/meth.1997.0485; Kim B, 1996, J BIOL CHEM, V271, P4872, DOI 10.1074/jbc.271.9.4872; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Kraynov VS, 2000, BIOCHEMISTRY-US, V39, P16008, DOI 10.1021/bi0008480; Lanciault C, 2006, J VIROL, V80, P2483, DOI 10.1128/JVI.80.5.2483-2494.2006; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; Meyer AS, 2004, J BIOL CHEM, V279, P33043, DOI 10.1074/jbc.C400232200; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Nikolenko GN, 2004, J VIROL, V78, P8761, DOI 10.1128/JVI.78.16.8761-8770.2004; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; Roda RH, 2002, J BIOL CHEM, V277, P46900, DOI 10.1074/jbc.M208638200; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Suo ZC, 1998, J BIOL CHEM, V273, P27259, DOI 10.1074/jbc.273.42.27259; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; Yusa K, 1997, ANTIVIR RES, V36, P179, DOI 10.1016/S0166-3542(97)00053-3	40	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32113	32121		10.1074/jbc.M604665200	http://dx.doi.org/10.1074/jbc.M604665200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16926150	hybrid			2022-12-27	WOS:000241414500008
J	Ortiz, PA; Ulloque, R; Kihara, GK; Zheng, HY; Kinzy, TG				Ortiz, Pedro A.; Ulloque, Rory; Kihara, George K.; Zheng, Haiyan; Kinzy, Terri Goss			Translation elongation factor 2 anticodon mimicry domain mutants affect fidelity and diphtheria toxin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; PHENOTYPIC SUPPRESSION; RIBOSOMAL TRANSLOCASE; FACTOR-II; PROTEIN; YEAST; DIPHTHAMIDE; MUTATIONS; IDENTIFICATION	Eukaryotic elongation factor 2 (eEF2) mediates translocation in protein synthesis. The molecular mimicry model proposes that the tip of domain IV mimics the anticodon loop of tRNA. His-699 in this region is post-translationally modified to diphthamide, the target for Corynebacterium diphtheriae and Pseudomonas aeruginosa toxins. ADP-ribosylation by these toxins inhibits eEF2 function causing cell death. Mutagenesis of the tip of domain IV was used to assess both functions. A H694A mutant strain was non-functional, whereas D696A, I698A, and H699N strains conferred conditional growth defects, sensitivity to translation inhibitors, and decreased total translation in vivo. These mutant strains and those lacking diphthamide modification enzymes showed increased -1 frameshifting. The effects are not due to reduced protein levels, ribosome binding, or GTP hydrolysis. Functional eEF2 forms substituted in domain IV confer dominant diphtheria toxin resistance, which correlates with an in vivo effect on translation-linked phenotypes. These results provide a new mechanism in which the translational machinery maintains the accurate production of proteins, establishes a role for the diphthamide modification, and provides evidence of the ability to suppress the lethal effect of a toxin targeted to eEF2.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu		Kinzy, Terri/0000-0003-1394-9226	NIGMS NIH HHS [R01 GM062789, F31 GM 070068, GM 62789, F31 GM070068] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM070068, R01GM062789] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; AUSUBEL FM, 1992, CURRENT PROTOCOLS MO; Burke D., 2000, METHODS YEAST GENETI; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; DINMAN JD, 1995, YEAST, V11, P1115, DOI 10.1002/yea.320111202; Dinman JD, 1997, RNA, V3, P870; DUMONTMISCOPEIN A, 1994, FEBS LETT, V356, P283, DOI 10.1016/0014-5793(94)01272-5; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Harger JW, 2001, VIROLOGY, V286, P216, DOI 10.1006/viro.2001.0997; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jorgensen R, 2004, J BIOL CHEM, V279, P45919, DOI 10.1074/jbc.M406218200; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; KIMATA Y, 1994, J BIOL CHEM, V269, P13497; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; MATTHEAKIS LC, 1993, GENE, V132, P149, DOI 10.1016/0378-1119(93)90528-B; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; OHYA Y, 1991, J BIOL CHEM, V266, P12784; OPPENHEIMER NJ, 1981, J BIOL CHEM, V256, P8579; Ortiz PA, 2005, NUCLEIC ACIDS RES, V33, P5740, DOI 10.1093/nar/gki882; PALMER E, 1979, NATURE, V277, P148, DOI 10.1038/277148a0; PAUSCH MH, 1991, EMBO J, V10, P1511, DOI 10.1002/j.1460-2075.1991.tb07671.x; PERENTESIS JP, 1992, J BIOL CHEM, V267, P1190; PHAN LD, 1993, J BIOL CHEM, V268, P8665; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; SINGH A, 1979, NATURE, V277, P146, DOI 10.1038/277146a0; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Teige M, 2001, P NATL ACAD SCI USA, V98, P5625, DOI 10.1073/pnas.091610798; Valente L, 2003, CELL MOL LIFE SCI, V60, P2115, DOI 10.1007/s00018-003-2334-2; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8	42	82	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32639	32648		10.1074/jbc.M607076200	http://dx.doi.org/10.1074/jbc.M607076200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950777	hybrid			2022-12-27	WOS:000241414500062
J	Shridas, P; Waechter, CJ				Shridas, Preetha; Waechter, Charles J.			Human dolichol kinase, a polytopic endoplasmic reticulum membrane protein with a cytoplasmically oriented CTP-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDP-DIACYLGLYCEROL SYNTHASE; SACCHAROMYCES-CEREVISIAE; RAT-LIVER; PYROPHOSPHATE PHOSPHATASE; ENZYMATIC PHOSPHORYLATION; ALCOHOL PHOSPHOKINASE; HUMAN CDNA; IN-VIVO; CLONING; BRAIN	Dolichol kinase (DK) catalyzes the CTP-dependent phosphorylation of dolichol in the biosynthesis de novo and possibly the recycling of dolichyl monophosphate in yeast and mammals. A cDNA clone from human brain encoding the mammalian homologue, hDKp, of the yeast enzyme has recently been identified. In this study hDK has been overexpressed in Chinese hamster ovary cells and shown to be a polytopic membrane protein localized in the endoplasmic reticulum with an N terminus extended into the lumen and a cytoplasmically oriented C terminus. A conserved sequence, (D) under bar XX (A) under bar XXX (G) under bar XXX (G) under barX(8)K (KT) under barX (E) under barG, found in several enzymes utilizing CTP as substrate including DKs, phytol kinases, and several CDP-diacylglycerol synthetases has been identified, and the possibility that it is part of the CTP-binding domain of hDKp has been investigated. Topological studies indicate that the loop between transmembrane domains (TMD) 11 and TMD12 of hDKp, containing the putative CTP binding domain, faces the cytoplasm. Deletion of the loop between TMD11-12, hDK(Delta 459-474), or mutation of selected conserved residues within the cytoplasmic loop results in either a partial or total loss of activity and significant reductions in the affinity for CTP. In addition, the SEC59 gene in the yeast DK mutant was sequenced, and a G420D substitution was found. Conversion of the corresponding residue Gly-443 in hDKp to aspartic acid resulted in inactivation of the mammalian enzyme. These results extend the information on the topological arrangement of hDKp and indicate that the cytoplasmic loop between TMDs 11-12, containing the critical conserved residues, lysine 470 and lysine 471 in the (470)KKTXEG(475) motif, is part of the CTP-binding site in hDK.	Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Waechter, CJ (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, BBSRB 741 S Limestone St, Lexington, KY 40536 USA.	waechte@uky.edu			NIGMS NIH HHS [GM36035] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAIR WL, 1983, BIOCHIM BIOPHYS ACTA, V751, P21, DOI 10.1016/0005-2760(83)90252-7; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; ALLEN CM, 1978, BIOCHEMISTRY-US, V17, P5020, DOI 10.1021/bi00616a025; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BHAT NR, 1991, J NEUROCHEM, V56, P339, DOI 10.1111/j.1471-4159.1991.tb02600.x; BURTON WA, 1979, J BIOL CHEM, V254, P7129; BURTON WA, 1981, J BIOL CHEM, V256, P632; Crick DC, 1997, BIOCHEM BIOPH RES CO, V237, P483, DOI 10.1006/bbrc.1997.7145; Fernandez F, 2002, GLYCOBIOLOGY, V12, P555, DOI 10.1093/glycob/cwf068; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Halford S, 1998, GENOMICS, V54, P140, DOI 10.1006/geno.1998.5547; Heacock AM, 1996, J NEUROCHEM, V67, P2200; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HELLER L, 1992, P NATL ACAD SCI USA, V89, P7013, DOI 10.1073/pnas.89.15.7013; HIGASHI Y, 1970, J BIOL CHEM, V245, P3691; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lykidis A, 1997, J BIOL CHEM, V272, P33402, DOI 10.1074/jbc.272.52.33402; Martin D, 2000, MOL BIOCHEM PARASIT, V110, P93, DOI 10.1016/S0166-6851(00)00260-7; Mitaku S, 1999, PROTEIN ENG, V12, P953, DOI 10.1093/protein/12.11.953; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; Nakashima A, 1997, J BIOL CHEM, V272, P9567; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Park YS, 1997, J BIOL CHEM, V272, P15161, DOI 10.1074/jbc.272.24.15161; RODRIGUEZVICO F, 1989, ANAL BIOCHEM, V183, P275, DOI 10.1016/0003-2697(89)90479-X; ROSSIGNOL DP, 1981, J BIOL CHEM, V256, P538; ROSSLER HH, 1982, MOL CELL BIOCHEM, V48, P183, DOI 10.1007/BF00421227; Rush JS, 2002, J BIOL CHEM, V277, P45226, DOI 10.1074/jbc.M207076200; SAGAMI H, 1993, J BIOL CHEM, V268, P10109; Saito S, 1997, J BIOL CHEM, V272, P9503; SANDERMA.H, 1971, P NATL ACAD SCI USA, V68, P2441, DOI 10.1073/pnas.68.10.2441; SCHENK B, 2001, GLYCOBIOLOGY, V11, P61; SCHER MG, 1984, ARCH BIOCHEM BIOPHYS, V231, P293, DOI 10.1016/0003-9861(84)90391-6; SCHER MG, 1985, J BIOL CHEM, V260, P3742; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; SUMBILLA C, 1985, METHOD ENZYMOL, V111, P471; SZKOPINSKA A, 1988, ARCH BIOCHEM BIOPHYS, V266, P124, DOI 10.1016/0003-9861(88)90242-1; Thai L, 1999, P NATL ACAD SCI USA, V96, P13080, DOI 10.1073/pnas.96.23.13080; Vainauskas S, 2002, J BIOL CHEM, V277, P30535, DOI 10.1074/jbc.M205402200; Valentin HE, 2006, PLANT CELL, V18, P212, DOI 10.1105/tpc.105.037077; VOLPE JJ, 1987, DEV BRAIN RES, V31, P193, DOI 10.1016/0165-3806(87)90117-9; Volta M, 1999, GENOMICS, V55, P68, DOI 10.1006/geno.1998.5610; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0	46	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31696	31704		10.1074/jbc.M604087200	http://dx.doi.org/10.1074/jbc.M604087200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923818	Bronze			2022-12-27	WOS:000241235300055
J	Lotito, SB; Frei, B				Lotito, Silvina B.; Frei, Balz			Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells - Structure-function relationships and activity after first pass metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; NF-KAPPA-B; RAT-LIVER; OXIDATIVE STRESS; PLANT FLAVONOIDS; INHIBITION; QUERCETIN; INFLAMMATION; MECHANISMS; PLASMA	Flavonoids have been suggested to exert human health benefits by anti-oxidant and anti-inflammatory mechanisms. In this study, we investigated whether and by what mechanisms dietary flavonoids inhibit expression of cellular adhesion molecules, which is relevant to inflammation and atherosclerosis. We found that the capacity of flavonoids to inhibit tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells was dependent on specific structural features of the flavonoids. The 5,7-dihydroxyl substitution of a flavonoid A-ring and 2,3-double bond and 4-keto group of the C-ring were the main structural requirements for inhibition of adhesion molecule expression. In striking contrast, hydroxyl substitutions of the B- and C-rings but not the A-ring were essential for antioxidant activity. Hence, only hydroxyl flavones, such as apigenin and chrysin, and flavonols, such as galangin, kaempferol, and quercetin, were able to inhibit endothelial adhesion molecule expression, whereas flavone, chromone, the flavanone, naringenin, and the flavanol, (-)-epicatechin, were ineffectual. At low concentrations, the active flavonoids significantly attenuated expression of E-selectin and intercellular adhesion molecule 1 but not vascular cell adhesion molecule 1. In addition, exposure of apigenin and kaempferol to cultured hepatocytes, mimicking first pass metabolism, greatly diminished the inhibitory effect of flavonoids on endothelial intercellular adhesion molecule 1 expression. We conclude that the effect of dietary flavonoids on endothelial adhesion molecule expression depends on their molecular structure, concentration, and metabolic transformation but not their antioxidant activity.	Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA	Oregon State University	Frei, B (corresponding author), Oregon State Univ, Linus Pauling Inst, 571 Weniger Hall, Corvallis, OR 97331 USA.	balz.frei@oregonstate.edu			NCCIH NIH HHS [AT002034] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT002034] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Choi JS, 2004, J NUTR, V134, P1013, DOI 10.1093/jn/134.5.1013; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Di Paola R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-66; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; FERRIOLA PC, 1989, BIOCHEM PHARMACOL, V38, P1617, DOI 10.1016/0006-2952(89)90309-2; GERRITSEN ME, 1995, AM J PATHOL, V147, P278; Gradolatto A, 2004, DRUG METAB DISPOS, V32, P58, DOI 10.1124/dmd.32.1.58; HAGIWARA M, 1988, BIOCHEM PHARMACOL, V37, P2987; Huang MT, 2006, MOL NUTR FOOD RES, V50, P115, DOI 10.1002/mnfr.200500101; JINSART W, 1992, BIOL CHEM H-S, V373, P205, DOI 10.1515/bchm3.1992.373.1.205; JINSART W, 1991, BIOL CHEM H-S, V372, P819, DOI 10.1515/bchm3.1991.372.2.819; Kalfin R, 2002, FREE RADICAL RES, V36, P819, DOI 10.1080/1071576021000005249; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Kobuchi H, 1999, AM J PHYSIOL-CELL PH, V277, pC403, DOI 10.1152/ajpcell.1999.277.3.C403; Koga T, 2001, AM J CLIN NUTR, V73, P941; Kwon HM, 2005, J AGR FOOD CHEM, V53, P5150, DOI 10.1021/jf047854d; LAUGHTON MJ, 1991, BIOCHEM PHARMACOL, V42, P1673, DOI 10.1016/0006-2952(91)90501-U; LEE TP, 1982, LIFE SCI, V31, P2765, DOI 10.1016/0024-3205(82)90723-8; Liang YC, 2001, FEBS LETT, V496, P12, DOI 10.1016/S0014-5793(01)02393-6; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LOTITO SB, 2006, IN PRESS FREE RADIC; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; MATTER WF, 1992, BIOCHEM BIOPH RES CO, V186, P624, DOI 10.1016/0006-291X(92)90792-J; Middleton E, 2000, PHARMACOL REV, V52, P673; Morikawa K, 2003, LIFE SCI, V74, P709, DOI 10.1016/j.lfs.2003.06.036; Natsume M, 2003, FREE RADICAL BIO MED, V34, P840, DOI 10.1016/S0891-5849(02)01434-X; O'Leary KA, 2001, FEBS LETT, V503, P103, DOI 10.1016/S0014-5793(01)02684-9; Panes Julian, 1996, Microcirculation (Philadelphia), V3, P279, DOI 10.3109/10739689609148302; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; RACKER E, 1985, ARCH BIOCHEM BIOPHYS, V240, P836, DOI 10.1016/0003-9861(85)90093-1; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Shimoi K, 2001, DRUG METAB DISPOS, V29, P1521; SHOSHAN V, 1980, P NATL ACAD SCI-BIOL, V77, P4435, DOI 10.1073/pnas.77.8.4435; SHOSHAN V, 1981, J BIOL CHEM, V256, P887; Singh U, 2005, ANNU REV NUTR, V25, P151, DOI 10.1146/annurev.nutr.24.012003.132446; Spencer JPE, 2004, ARCH BIOCHEM BIOPHYS, V423, P148, DOI 10.1016/j.abb.2003.11.010; SRIVASTAVA AK, 1985, BIOCHEM BIOPH RES CO, V131, P1, DOI 10.1016/0006-291X(85)91761-9; Surh YJ, 2005, J NUTR, V135, p2993S, DOI 10.1093/jn/135.12.2993S; Williamson G, 2005, FREE RADICAL RES, V39, P457, DOI 10.1080/10715760500053610; Yodogawa S, 2003, BIOL PHARM BULL, V26, P1120, DOI 10.1248/bpb.26.1120; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	46	143	149	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					37102	37110		10.1074/jbc.M606804200	http://dx.doi.org/10.1074/jbc.M606804200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16987811	hybrid			2022-12-27	WOS:000242220800071
J	Marohnic, CC; Panda, SP; Martasek, P; Masters, BS				Marohnic, Christopher C.; Panda, Satya P.; Martasek, Pavel; Masters, Bettie Sue			Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-I DEFICIENCY; P450 OXIDOREDUCTASE; REDOX PROPERTIES; P-450 REDUCTASE; NADPH-CYTOCHROME-P-450 REDUCTASE; DISORDERED STEROIDOGENESIS; ELECTRON-TRANSFER; NADPH; RIBOFLAVIN; MUTATIONS	Numerous mutations/polymorphisms of the POR gene, encoding NADPH: cytochrome P450 oxidoreductase (CYPOR), have been described in patients with Antley-Bixler syndrome (ABS), presenting with craniofacial dysmorphogenesis, and/or disordered steroidogenesis, exhibiting ambiguous genitalia. CYPOR is the obligate electron donor to 51 microsomal cytochromes P450 that catalyze critical steroidogenic and xenobiotic reactions, and to two heme oxygenase isoforms, among other redox partners. To address the molecular basis of CYPOR dysfunction in ABS patients, the soluble catalytic domain of human CYPOR was bacterially expressed. WT enzyme was green, due to air-stable FMN semiquinone ( blue) and oxidized FAD ( yellow). The ABS mutant V492E was blue-gray. Flavin analysis indicated that WT had a protein: FAD: FMN ratio of similar to 1:1: 1, whereas similar to 1:0.1:0.9 was observed for V492E, which retained 9% of the WT k(cat)/K-m in NADPH: cytochrome c reductase assays. V492E was reconstituted upon addition of FAD, post-purification, as shown by flavin analysis, activity assay, and near UV-visible CD. Both Y459H and V492E were expressed as membrane anchor-containing proteins, which also exhibited FAD deficiency. CYP4A4-catalyzed omega-hydroxylation of prostaglandin E-1 was supported by WT CYPOR but not by either of the ABS mutants. Hydroxylation activity was rescued for both Y459H and V492E upon addition of FAD to the reaction. Based on these findings, decreased FAD-binding affinity is proposed as the basis of the observed loss of CYPOR function in the Y459H and V492E POR mutations in ABS.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA; Charles Univ Prague, Sch Med 1, Dept Pediat, CR-11636 Prague, Czech Republic	University of Texas System; University of Texas Health San Antonio; Charles University Prague	Masters, BS (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, 7703 Floyd Curl Dr,7760, San Antonio, TX 78229 USA.	masters@uthscsa.edu	Martásek, Pavel/G-6622-2017	Martásek, Pavel/0000-0001-6165-4444	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030050, R37HL030050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081568] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30050] Funding Source: Medline; NIGMS NIH HHS [R01 GM081568] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi M, 2004, AM J MED GENET A, V128A, P333, DOI 10.1002/ajmg.a.30169; Aitken AE, 2001, ARCH BIOCHEM BIOPHYS, V393, P329, DOI 10.1006/abbi.2001.2501; Antley R, 1975, Birth Defects Orig Artic Ser, V11, P397; Arlt W, 2004, LANCET, V363, P2128, DOI 10.1016/S0140-6736(04)16503-3; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; BELL RB, 1990, NEUROLOGY, V40, P1779, DOI 10.1212/WNL.40.11.1779; BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B; Bewley MC, 2003, BIOCHEMISTRY-US, V42, P13145, DOI 10.1021/bi034915c; BLACK SD, 1982, J BIOL CHEM, V257, P5929; BLACK SD, 1979, BIOCHEM BIOPH RES CO, V91, P1528, DOI 10.1016/0006-291X(79)91238-5; BLASS JP, 1977, NEW ENGL J MED, V297, P1367, DOI 10.1056/NEJM197712222972503; Bonina TA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P357, DOI 10.1007/s10541-005-0122-3; Chun K, 1998, AM J MED GENET, V77, P219, DOI 10.1002/(SICI)1096-8628(19980518)77:3<219::AID-AJMG6>3.0.CO;2-K; Davydov DR, 2000, BIOCHEMISTRY-US, V39, P6489, DOI 10.1021/bi992936u; EDMONDSO.DE, 1971, BIOCHEMISTRY-US, V10, P113; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Fukami M, 2005, J CLIN ENDOCR METAB, V90, P414, DOI 10.1210/jc.2004-0810; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Homma K, 2006, J CLIN ENDOCR METAB, V91, P2643, DOI 10.1210/jc.2005-2460; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; IYANAGI T, 1977, BIOCHEMISTRY-US, V16, P2725, DOI 10.1021/bi00631a021; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; KMOCH S, 1995, J INHERIT METAB DIS, V18, P227, DOI 10.1007/BF00711774; Kondo S, 1999, BIOCHEM BIOPH RES CO, V257, P273, DOI 10.1006/bbrc.1999.0455; KURZBAN GP, 1986, J BIOL CHEM, V261, P7824; KURZBAN GP, 1990, J BIOL CHEM, V265, P12272; KUZBAN GP, 1986, J CHROMATOGR, V358, P296; Makovec T, 2002, J STEROID BIOCHEM, V82, P89, DOI 10.1016/S0960-0760(02)00145-0; Masters B, 1967, METHOD ENZYMOL, V10, P565; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; PASCAL TA, 1975, SCIENCE, V190, P1209, DOI 10.1126/science.1198108; PIETTA P, 1982, J CHROMATOGR, V229, P445, DOI 10.1016/S0378-4347(00)84288-7; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SCHOLTE HR, 1992, J INHERIT METAB DIS, V15, P331, DOI 10.1007/BF02435969; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P6804, DOI 10.1021/bi030081m	46	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35975	35982		10.1074/jbc.M607095200	http://dx.doi.org/10.1074/jbc.M607095200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16998238	hybrid			2022-12-27	WOS:000242100500044
J	Nagae, M; Nishi, N; Murata, T; Usui, T; Nakamura, T; Wakatsuki, S; Kato, R				Nagae, Masamichi; Nishi, Nozomu; Murata, Takeomi; Usui, Taichi; Nakamura, Takanori; Wakatsuki, Soichi; Kato, Ryuichi			Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL RECONSTITUTION; LINKER PEPTIDE; BINDING LECTIN; FAMILY; PROGRAM	The galectins are a family of beta-galactoside-binding animal lectins with a conserved carbohydrate recognition domain (CRD). They have a high affinity for small beta-galactosides, but binding specificity for complex glycoconjugates varies considerably within the family. The ligand recognition is essential for their proper function, and the structures of several galectins have suggested their mechanism of carbohydrate binding. Galectin-9 has two tandem CRDs with a short linker, and we report the crystal structures of mouse galectin-9N-terminal CRD (NCRD) in the absence and the presence of four ligand complexes. All structures form the same dimer, which is quite different from the canonical 2-fold symmetric dimer seen for galectin-1 and -2. The beta-galactoside recognition mechanism in the galectin-9 NCRD is highly conserved among other galectins. In the apo form structure, water molecules mimic the ligand hydrogen-bond network. The galectin-9 NCRD can bind both N-acetyllactosamine (Gal beta 1-4GlcNAc) and T-antigen (Gal beta 1-3GalNAc) with the proper location of Arg-64. Moreover, the structure of the N-acetyllactosamine dimer (Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4GlcNAc) complex shows a unique binding mode of galectin-9. Finally, surface plasmon resonance assay showed that the galectin-9 NCRD forms a homophilic dimer not only in the crystal but also in solution.	High Energy Acclerator Res Org, Photon Factory, Inst Mat Struct Sci, Struct Biol Res Ctr, Tsukuba, Ibaraki 3050801, Japan; Kagawa Univ, Fac Med, Dept Endocrinol, Kagawa 7610793, Japan; Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Suruga Ku, Shizuoka 4228529, Japan	High Energy Accelerator Research Organization (KEK); Kagawa University; Shizuoka University	Kato, R (corresponding author), High Energy Acclerator Res Org, Photon Factory, Inst Mat Struct Sci, Struct Biol Res Ctr, Tsukuba, Ibaraki 3050801, Japan.	ryuichi.kato@kek.jp		Nishi, Nozomu/0000-0001-7050-3226; Kato, Ryuichi/0000-0003-2087-2896; Nagae, Masamichi/0000-0002-5470-3807; Wakatsuki, Soichi/0000-0001-5896-7968				Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bianchet MA, 2000, PROTEINS, V40, P378, DOI 10.1002/1097-0134(20000815)40:3<378::AID-PROT40>3.0.CO;2-7; Birdsall B, 2001, BIOCHEMISTRY-US, V40, P4859, DOI 10.1021/bi002907f; Brewer CF, 2002, BBA-GEN SUBJECTS, V1572, P255, DOI 10.1016/S0304-4165(02)00312-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cooper DN, 2002, BIOCHIM BIOPHYS ACTA, V1572, P198; Dunphy JL, 2002, J BIOL CHEM, V277, P14916, DOI 10.1074/jbc.M200214200; GITT MA, 1995, J BIOL CHEM, V270, P5032, DOI 10.1074/jbc.270.10.5032; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; Hughes RC, 2001, BIOCHIMIE, V83, P667; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LealPinto E, 1997, J BIOL CHEM, V272, P617; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; Lipkowitz MS, 2001, J CLIN INVEST, V107, P1103, DOI 10.1172/JCI12471; Liu FT, 2000, CLIN IMMUNOL, V97, P79, DOI 10.1006/clim.2000.4912; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsushita N, 2000, J BIOL CHEM, V275, P8355, DOI 10.1074/jbc.275.12.8355; Mehul B, 1997, J CELL SCI, V110, P1169; Merritt EA, 1997, PROTEIN SCI, V6, P1516, DOI 10.1002/pro.5560060716; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelletier I, 2003, J BIOL CHEM, V278, P22223, DOI 10.1074/jbc.M302693200; Rabinovich GA, 2002, BBA-GEN SUBJECTS, V1572, P274, DOI 10.1016/S0304-4165(02)00314-8; Rabinovich GA, 1999, CELL DEATH DIFFER, V6, P711, DOI 10.1038/sj.cdd.4400535; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; SAKAI K, 1992, J CARBOHYD CHEM, V11, P553, DOI 10.1080/07328309208016148; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Sato S, 2002, TRENDS GLYCOSCI GLYC, V14, P285, DOI 10.4052/tigg.14.285; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; SIEBERT HC, 2003, BIOCHEMISTRY-US, V42, P14672; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; Varela PF, 1999, J MOL BIOL, V294, P537, DOI 10.1006/jmbi.1999.3273; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	48	65	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35884	35893		10.1074/jbc.M606648200	http://dx.doi.org/10.1074/jbc.M606648200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16990264	hybrid			2022-12-27	WOS:000242100500035
J	Della Valle, MC; Sleat, DE; Sohar, I; Wen, T; Pintar, JE; Jadot, M; Lobel, P				Della Valle, Maria Cecilia; Sleat, David E.; Sohar, Istvan; Wen, Ting; Pintar, John E.; Jadot, Michel; Lobel, Peter			Demonstration of lysosomal localization for the mammalian ependymin-related protein using classical approaches combined with a novel density shift method	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID STORAGE DISORDER; NCTR-BALB/C MICE; MANNOSE 6-PHOSPHATE; PROTEOMIC ANALYSIS; HUMAN BRAIN; RAT-BRAIN; IDENTIFICATION; GLYCOPROTEINS; FRACTIONS; CELLS	Most newly synthesized soluble lysosomal proteins are delivered to the lysosome via the mannose 6-phosphate (Man-6-P)targeting pathway. The presence of the Man-6-P post-translational modification allows these proteins to be affinity-purified on immobilized Man-6-P receptors. This approach has formed the basis for a number of proteomic studies that identified multiple as yet uncharacterized Man-6-P glycoproteins that may represent new lysosomal proteins. Although the presence of Man-6-P is suggestive of lysosomal function, the subcellular localization of such candidates requires experimental verification. Here, we have investigated one such candidate, ependymin-related protein (EPDR). EPDR is a protein of unknown function with some sequence similarity to ependymin, a fish protein thought to play a role in memory consolidation and learning. Using classical subcellular fractionation on rat brain, EPDR co-distributes with lysosomal proteins, but there is significant overlap between lysosomal and mitochondrial markers. For more definitive localization, we have developed a novel approach based upon a selective buoyant density shift of the brain lysosomes in a mutant mouse lacking NPC2, a lysosomal protein involved in lipid transport. EPDR, in parallel with lysosomal markers, shows this density shift in gradient centrifugation experiments comparing mutant and wild type mice. This approach, combined with morphological analyses, demonstrates that EPDR resides in the lysosome. In addition, the lipidosis-induced density shift approach represents a valuable tool for identification and validation of both luminal and membrane lysosomal proteins that should be applicable to high throughput proteomic studies.	Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Dept Pharmacol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Dept Neurosci & Cell Biol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; Fac Univ Notre Dame Paix, Unite Rech Physiol Mol, Lab Chim Physiol, B-5000 Namur, Belgium	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Namur	Lobel, P (corresponding author), Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Dept Pharmacol, Robert Wood Johnson Med Sch, 679 Hoes Ln, Piscataway, NJ 08854 USA.	lobel@cabm.rutgers.edu			NIDDK NIH HHS [DK054317] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054317] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Apostolopoulos J, 2001, DNA CELL BIOL, V20, P625, DOI 10.1089/104454901753340613; BEAUFAY H, 1964, BIOCHEM J, V92, P184, DOI 10.1042/bj0920184; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BHUVANESWARAN C, 1982, AM J PATHOL, V108, P160; Bhuvaneswaran C, 2000, MOL CELL BIOCHEM, V214, P15, DOI 10.1023/A:1007180800941; BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642; COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; De Duve C, 1965, Harvey Lect, V59, P49; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Gregorio-King CC, 2002, GENE, V286, P249, DOI 10.1016/S0378-1119(02)00434-1; HOTLZMAN E, 1989, LYSOSOMES; Jadot M, 1999, J BIOL CHEM, V274, P21104, DOI 10.1074/jbc.274.30.21104; Journet A, 2000, ELECTROPHORESIS, V21, P3411, DOI 10.1002/1522-2683(20001001)21:16<3411::AID-ELPS3411>3.0.CO;2-M; Journet A, 2002, PROTEOMICS, V2, P1026, DOI 10.1002/1615-9861(200208)2:8<1026::AID-PROT1026>3.0.CO;2-I; Kollmann K, 2005, PROTEOMICS, V5, P3966, DOI 10.1002/pmic.200401247; LEIGHTON F, 1968, J CELL BIOL, V37, P482, DOI 10.1083/jcb.37.2.482; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; PATEL CC, 1960, NATURE, V186, P803, DOI 10.1038/186803a0; SCHMIDT R, 1995, BEHAV BRAIN RES, V66, P65, DOI 10.1016/0166-4328(94)00126-Z; Scriver C.R., 2001, METABOLIC MOL BASES; SELLINGER OZ, 1971, BRAIN RES, V26, P361, DOI 10.1016/S0006-8993(71)80010-0; SHASHOUA VE, 1979, BRAIN RES, V166, P349, DOI 10.1016/0006-8993(79)90220-8; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Sleat DE, 1996, J BIOL CHEM, V271, P19191, DOI 10.1074/jbc.271.32.19191; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; Sleat DE, 2005, PROTEOMICS, V5, P1520, DOI 10.1002/pmic.200401054; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; SLEAT DE, 2006, IN PRESS MOL CELL PR; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Tribl F, 2005, MOL CELL PROTEOMICS, V4, P945, DOI 10.1074/mcp.M400117-MCP200; VALENZANO KJ, 1993, ANAL BIOCHEM, V209, P156, DOI 10.1006/abio.1993.1096; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; WATTIAUX R, 1963, CIBA F S LYSOSOMES, P176; YOUNG JDE, 1986, ANAL BIOCHEM, V158, P28, DOI 10.1016/0003-2697(86)90583-X	37	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35436	35445		10.1074/jbc.M606208200	http://dx.doi.org/10.1074/jbc.M606208200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16954209	hybrid			2022-12-27	WOS:000241933700077
J	Michalakis, S; Reisert, J; Geiger, H; Wetzel, C; Zong, XG; Bradley, J; Spehr, M; Huttl, S; Gerstner, A; Pfeifer, A; Hatt, H; Yau, KW; Biel, M				Michalakis, Stylianos; Reisert, Johannes; Geiger, Heidi; Wetzel, Christian; Zong, Xiangang; Bradley, Jonathan; Spehr, Marc; Huettl, Sabine; Gerstner, Andrea; Pfeifer, Alexander; Hatt, Hanns; Yau, King-Wai; Biel, Martin			Loss of CNGB1 protein leads to olfactory dysfunction and subciliary cyclic nucleotide-gated channel trapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III ADENYLYL-CYCLASE; RECEPTOR NEURONS; CATION CHANNEL; ROD PHOTORECEPTOR; SENSORY NEURONS; ION CHANNELS; MICE LACKING; BETA-SUBUNIT; CALCIUM; STOICHIOMETRY	Olfactory receptor neurons (ORNs) employ a cyclic nucleotide-gated (CNG) channel to generate a receptor current in response to an odorant-induced rise in cAMP. This channel contains three types of subunits, the principal CNGA2 subunit and two modulatory subunits (CNGA4 and CNGB1b). Here, we have analyzed the functional relevance of CNGB1 for olfaction by gene targeting in mice. Electro-olfactogram responses of CNGB1-deficient (CNGB1(-/-)) mice displayed a reduced maximal amplitude and decelerated onset and recovery kinetics compared with wild-type mice. In a behavioral test, CNGB1(-/-) mice exhibited a profoundly decreased olfactory performance. Electrophysiological recordings revealed that ORNs of CNGB1(-/-) mice weakly expressed a CNG current with decreased cAMP sensitivity, very rapid flicker-gating behavior and no fast modulation by Ca2+-calmodulin. Co-immunoprecipitation confirmed the presence of a CNGA2/CNGA4 channel in the olfactory epithelium of CNGB1(-/-) mice. This CNGA2/CNGA4 channel was targeted to the plasma membrane of olfactory knobs, but failed to be trafficked into olfactory cilia. Interestingly, we observed a similar trafficking defect in mice deficient for the CNGA4 subunit. In conclusion, these results demonstrate that CNGB1 has a dual function in vivo. First, it endows the olfactory CNG channel with a variety of biophysical properties tailored to the specific requirements of olfactory transduction. Second, together with the CNGA4 subunit, CNGB1 is needed for ciliary targeting of the olfactory CNG channel.	Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-81377 Munich, Germany; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Ruhr Univ Bochum, Lehrstuhl Zell Biol, D-44780 Bochum, Germany	University of Munich; Johns Hopkins University; Ruhr University Bochum	Biel, M (corresponding author), Univ Munich, Dept Pharm Pharmakol Nat Wissensch, Butenandtstr 7, D-81377 Munich, Germany.	mbiel@cup.uni-muenchen.de	Spehr, Marc/AAK-3162-2021; Spehr, Marc/B-3140-2011; Wetzel, Christian H/N-9880-2017; Michalakis, Stylianos/W-2094-2018; Biel, Martin/G-1175-2014; Wetzel, Christian/C-2501-2009; Michalakis, Stylianos/M-4677-2019; Wetzel, Christian/F-1366-2018	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Wetzel, Christian H/0000-0002-5762-0003; Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052; Wetzel, Christian/0000-0002-5762-0003; Michalakis, Stylianos/0000-0001-5092-9238; Bradley, Jonathan/0000-0002-6933-1153	NEI NIH HHS [R01 EY006837-18, R01 EY006837-19, R01 EY006837, R01 EY014596, R01 EY014596-02, R01 EY014596-04, R01 EY006837-16A1, R01 EY006837-20A1, R01 EY006837-17, R01 EY014596-01, R01 EY014596-03] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904-02, R01 DC006904-01, R01 DC006904, DC06904] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014596, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Baker H, 1999, J NEUROSCI, V19, P9313; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Biel M, 1999, Rev Physiol Biochem Pharmacol, V135, P151, DOI 10.1007/BFb0033672; Biel M, 1996, J BIOL CHEM, V271, P6349, DOI 10.1074/jbc.271.11.6349; Bonigk W, 1999, J NEUROSCI, V19, P5332; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; FINN JT, 1996, ANNU REV PHYSIOL, V58, P396; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; McClintock TS, 2003, NEUROREPORT, V14, P1547, DOI 10.1097/00001756-200308260-00001; Menco BPM, 1997, CHEM SENSES, V22, P295, DOI 10.1093/chemse/22.3.295; MENCO BPM, 1992, NEURON, V8, P441, DOI 10.1016/0896-6273(92)90272-F; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; NAKAMURA T, 1994, NEUROSCI LETT, V171, P197, DOI 10.1016/0304-3940(94)90638-6; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Washburn KB, 2002, CHEM SENSES, V27, P635, DOI 10.1093/chemse/27.7.635; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	49	61	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35156	35166		10.1074/jbc.M606409200	http://dx.doi.org/10.1074/jbc.M606409200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16980309	hybrid, Green Accepted			2022-12-27	WOS:000241933700049
J	Kriz, V; Agren, N; Lindholm, CK; Lenell, S; Saldeen, J; Mares, J; Welsh, M				Kriz, Vitezslav; Agren, Nina; Lindholm, Cecilia K.; Lenell, Samuel; Saldeen, Johan; Mares, Jaroslav; Welsh, Michael			The SHB adapter protein is required for normal maturation of mesoderm during in vitro differentiation of embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR-2; JURKAT T-CELLS; DEFINITIVE HEMATOPOIESIS; PRIMITIVE ERYTHROPOIESIS; EXPRESSION DEFINES; ENDOTHELIAL-CELLS; COMMON PRECURSOR; ES CELLS; ENDODERM; VASCULOGENESIS	Definitive mesoderm arises from a bipotent mesendodermal population, and to study processes controlling its development at this stage, embryonic stem (ES) cells can be employed. SHB ((S) under bar rc (h) under bar omology 2 protein in beta-cells) is an adapter protein previously found to be involved in ES cell differentiation to mesoderm. To further study the role of SHB in this context, we have established ES cell lines deficient for one (SHB+/-) or both SHB alleles (SHB-/-). Differentiating embryoid bodies (EBs) derived from these ES cell lines were used for gene expression analysis. Alternatively, EBs were stained for the blood vessel marker CD31. For hematopoietic differentiation, EBs were differentiated in methylcellulose. SHB-/- EBs exhibited delayed down-regulation of the early mesodermal marker Brachyury. Later mesodermal markers relatively specific for the hematopoietic, vascular, and cardiac lineages were expressed at lower levels on day 6 or 8 of differentiation in EBs lacking SHB. The expression of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 was also reduced in SHB-/- EBs. SHB-/- EBs demonstrated impaired blood vessel formation after vascular endothelial growth factor stimulation. In addition, the SHB-/- ES cells formed fewer blood cell colonies than SHB+/+ ES cells. It is concluded that SHB is required for appropriate hematopoietic and vascular differentiation and that delayed down-regulation of Brachyury expression may play a role in this context.	Univ Uppsala, Dept Med Cell Biol, SE-75123 Uppsala, Sweden; Karolinska Univ Hosp, Dept Lab Med, Div Clin Chem, S-14186 Huddinge, Sweden; Charles Univ, Inst Biol & Med Genet, Prague 15006, Czech Republic	Uppsala University; Karolinska Institutet; Karolinska University Hospital; Charles University Prague	Welsh, M (corresponding author), Univ Uppsala, Dept Med Cell Biol, POB 571,Husargatan 3, SE-75123 Uppsala, Sweden.	michael.welsh@mcb.uu.se	Welsh, Michael/AAF-8564-2020; Kriz, Vitezslav/G-6353-2014	Welsh, Michael/0000-0002-5467-9755; Lenell, Samuel/0000-0001-8914-5086				Abe K, 1996, EXP CELL RES, V229, P27, DOI 10.1006/excr.1996.0340; Bagutti C, 1996, DEV BIOL, V179, P184, DOI 10.1006/dbio.1996.0250; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Bielinska M, 1996, BLOOD, V88, P3720, DOI 10.1182/blood.V88.10.3720.bloodjournal88103720; Carlsson L, 2003, METHOD ENZYMOL, V365, P202; Choi K, 1998, DEVELOPMENT, V125, P725; Cross MJ, 2002, MOL BIOL CELL, V13, P2881, DOI 10.1091/mbc.E02-02-0103; Dixelius J, 2000, BLOOD, V95, P3403, DOI 10.1182/blood.V95.11.3403.011k07_3403_3411; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Hallonet M, 2002, DEV BIOL, V243, P20, DOI 10.1006/dbio.2001.0536; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Kabrun N, 1997, DEVELOPMENT, V124, P2039; KALLIANPUR AR, 1994, BLOOD, V83, P1200; KARLSSON T, 1995, ONCOGENE, V10, P1475; Karlsson T, 1996, ONCOGENE, V13, P955; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Kriz V, 2003, EXP CELL RES, V286, P40, DOI 10.1016/S0014-4827(03)00099-5; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lindholm CK, 1999, J BIOL CHEM, V274, P28050, DOI 10.1074/jbc.274.39.28050; Lindholm CK, 2002, EUR J BIOCHEM, V269, P3279, DOI 10.1046/j.1432-1033.2002.03008.x; Lu LG, 2002, CELL GROWTH DIFFER, V13, P141; Lu LG, 2000, EXP CELL RES, V259, P370, DOI 10.1006/excr.2000.4984; Magnusson P, 2004, J CELL SCI, V117, P1513, DOI 10.1242/jcs.00999; Magnusson PU, 2005, ARTERIOSCL THROM VAS, V25, P944, DOI 10.1161/01.ATV.0000163182.73190.f9; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Otani T, 2005, EXP HEMATOL, V33, P632, DOI 10.1016/j.exphem.2005.03.006; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; Rolny C, 2005, EXP CELL RES, V308, P381, DOI 10.1016/j.yexcr.2005.04.020; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Soria B, 2001, DIABETOLOGIA, V44, P407, DOI 10.1007/s001250051636; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; WELSH M, 1994, ONCOGENE, V9, P19; Welsh M, 1999, MOL MED, V5, P169, DOI 10.1007/BF03402060; Welsh M, 1998, ONCOGENE, V16, P891, DOI 10.1038/sj.onc.1201607; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	44	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34484	34491		10.1074/jbc.M604084200	http://dx.doi.org/10.1074/jbc.M604084200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16971391	hybrid			2022-12-27	WOS:000241767600069
J	Montagna, GN; Donelson, JE; Frasch, ACC				Montagna, Georgina N.; Donelson, John E.; Frasch, Alberto C. C.			Procyclic Trypanosoma brucei expresses separate sialidase and trans-sialidase enzymes on its surface membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; SEQUENCES; PROTEINS; FORMS; ACIDS	The procyclic stage of (T) under bar rypanosoma (b) under bar rucei in the insect vector expresses a surface-bound (t) under bar rans-(s) under bar ialidase (TbTS) that transfers sialic acid from glycoconjugates in the environment to glycosylphosphatidylinositol-anchored proteins on its surface membrane. RNA interference against TbTS abolished transsialidase activity in procyclic cells but did not diminish sialidase activity, suggesting the presence of a separate sialidase enzyme for hydrolyzing sialic acid. A search of the T. brucei genome sequence revealed seven other putative genes encoding proteins with varying similarity to TbTS. RNA interference directed against one of these proteins, TbSA C, greatly decreased the sialidase activity but had no effect on trans-sialidase activity. The deduced amino acid sequence of TbSA C shares only 40% identity with TbTS but conserves most of the relevant residues required for catalysis. However, the sialidase has a tryptophan substitution for a tyrosine at position 170 that is crucial in binding the terminal galactose that accepts the transferred sialic acid. When this same tryptophan substitution in the sialidase was placed into the recombinant trans-sialidase, the mutant enzyme lost almost all of its trans-sialidase activity and increased its sialidase activity, further confirming that the gene and protein identified correspond to the parasite sialidase. Thus, in contrast to all other trypanosomes analyzed to date that express either a trans-sialidase or a sialidase but not both, T. brucei expresses these two enzymatic activities in two separate proteins. These results suggest that African trypanosomes could regulate the amount of critical sialic acid residues on their surface by modulating differential expression of each of these enzymes.	Univ Gen San Martin, Inst Invest Biotechnol, Inst Tecnol Chascomus, INTI, RA-1650 San Martin, Pcia de Buenos, Argentina; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Instituto Nacional de Tecnologia Industrial (INTI); University of Iowa	Frasch, ACC (corresponding author), Univ Gen San Martin, Inst Invest Biotechnol, Inst Tecnol Chascomus, INTI, Ave Gral Paz 5445,Edificio 24,Casilla Correo 30, RA-1650 San Martin, Pcia de Buenos, Argentina.	cfrasch@iib.unsam.edu.ar	Donelson, John E/F-5795-2010; Montagna, Georgina/D-1202-2013	Montagna, Georgina/0000-0003-0283-8977; Frasch, Alberto Carlos/0000-0001-7532-653X				Basseri HR, 2002, EXP PARASITOL, V100, P226, DOI 10.1016/S0014-4894(02)00026-7; Borst P, 2002, CELL, V109, P5, DOI 10.1016/S0092-8674(02)00711-0; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 1997, GLYCOBIOLOGY, V7, P1167, DOI 10.1093/glycob/7.8.1167; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Buschiazzo A, 1996, CELL MOL BIOL, V42, P703; CREMONA ML, 1995, GENE, V160, P123, DOI 10.1016/0378-1119(95)00175-6; DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465; ENGLSTLER M, 1992, MOL BIOCHEM PARASIT, V54, P21; ENGLSTLER M, 1993, MOL BIOCHEM PARASIT, V61, P1; Engstler M, 1997, GLYCOBIOLOGY, V7, P955, DOI 10.1093/glycob/7.7.955; Hill KL, 1999, J CELL SCI, V112, P3091; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; LOW MG, 1991, BIOCHEM J, V279, P483, DOI 10.1042/bj2790483; Montagna G, 2002, EUR J BIOCHEM, V269, P2941, DOI 10.1046/j.1432-1033.2002.02968.x; Nagamune K, 2004, J EXP MED, V199, P1445, DOI 10.1084/jem.20030635; Paris G, 2005, J MOL BIOL, V345, P923, DOI 10.1016/j.jmb.2004.09.031; Paris G, 2001, GLYCOBIOLOGY, V11, P305, DOI 10.1093/glycob/11.4.305; PARODI AJ, 1992, EMBO J, V11, P1705, DOI 10.1002/j.1460-2075.1992.tb05221.x; PEREIRA MEA, 1991, J EXP MED, V174, P179, DOI 10.1084/jem.174.1.179; POWELL LD, 1986, ANAL BIOCHEM, V157, P179, DOI 10.1016/0003-2697(86)90211-3; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567; SCHENKMAN S, 1993, PARASITOL TODAY, V9, P218, DOI 10.1016/0169-4758(93)90017-A; Tiralongo E, 2003, BIOL CHEM, V384, P1203, DOI 10.1515/BC.2003.133; Tiralongo E, 2003, J BIOL CHEM, V278, P23301, DOI 10.1074/jbc.M212909200; Tomlinson S, 1998, PARASITOL TODAY, V14, P354, DOI 10.1016/S0169-4758(98)01295-2; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200	33	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33949	33958		10.1074/jbc.M604951200	http://dx.doi.org/10.1074/jbc.M604951200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16956887	hybrid			2022-12-27	WOS:000241767600016
J	Schwender, J; Shachar-Hill, Y; Ohlrogge, JB				Schwender, Jorg; Shachar-Hill, Yair; Ohlrogge, John B.			Mitochondrial metabolism in developing embryos of Brassica napus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAIZE ROOT-TIPS; CHROMATOGRAPHY-MASS-SPECTROMETRY; NUCLEAR-MAGNETIC-RESONANCE; FATTY-ACID SYNTHESIS; ATP-CITRATE LYASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; OILSEED RAPE; PYRUVATE-KINASE; VICIA-NARBONENSIS; DEVELOPING SEEDS	The metabolism of developing plant seeds is directed toward transforming primary assimilatory products ( sugars and amino acids) into seed storage compounds. To understand the role of mitochondria in this metabolism, metabolic fluxes were determined in developing embryos of Brassica napus. After labeling with [1,2-C-13(2)] glucose + [U-C-13(6)] glucose, [U-C-13(3)] alanine, [U-C-13(5)] glutamine, [N-15] alanine, (amino)-[N-15] glutamine, or (amide)-[N-15] glutamine, the resulting labeling patterns in protein amino acids and in fatty acids were analyzed by gas chromatographymass spectrometry. Fluxes through mitochondrial metabolism were quantified using a steady state flux model. Labeling information from experiments using different labeled substrates was essential for model validation and reliable flux estimation. The resulting flux map shows that mitochondrial metabolism in these developing seeds is very different from that in either heterotrophic or autotrophic plant tissues or in most other organisms: (i) flux around the tricarboxylic acid cycle is absent and the small fluxes through oxidative reactions in the mitochondrion can generate (via oxidative phosphorylation) at most 22% of the ATP needed for biosynthesis; (ii) isocitrate dehydrogenase is reversible in vivo; (iii) about 40% of mitochondrial pyruvate is produced by malic enzyme rather than being imported from the cytosol; (iv) mitochondrial flux is largely devoted to providing precursors for cytosolic fatty acid elongation; and (v) the uptake of amino acids rather than anaplerosis via PEP carboxylase determines carbon flow into storage proteins.	Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Michigan State University	Schwender, J (corresponding author), Brookhaven Natl Lab, Dept Biol, Bldg 463, Upton, NY 11973 USA.	Schwender@BNL.gov	Schwender, Jorg/P-2282-2014; Shachar-Hill, Yair/B-6165-2013	Schwender, Jorg/0000-0003-1350-4171; Shachar-Hill, Yair/0000-0001-8793-5084				Asokanthan PS, 1997, PHYSIOL PLANTARUM, V101, P353, DOI 10.1034/j.1399-3054.1997.1010215.x; Bao XM, 1998, PLANT PHYSIOL, V118, P183, DOI 10.1104/pp.118.1.183; Bowsher CG, 2001, J EXP BOT, V52, P513, DOI 10.1093/jexbot/52.356.513; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; Dieuaide-Noubhani M, 1997, PLANT PHYSIOL, V115, P1505, DOI 10.1104/pp.115.4.1505; DIEUAIDENOUBHANI M, 1995, J BIOL CHEM, V270, P13147, DOI 10.1074/jbc.270.22.13147; DOUCE R, 1989, ANNU REV PLANT PHYS, V40, P371, DOI 10.1146/annurev.pp.40.060189.002103; Eastmond P, 1996, J EXP BOT, V47, P1763, DOI 10.1093/jxb/47.11.1763; Eastmond PJ, 1998, J EXP BOT, V49, P1105, DOI 10.1093/jexbot/49.324.1105; Eastmond PJ, 2000, PLANT PHYSIOL, V122, P767, DOI 10.1104/pp.122.3.767; Edwards S, 1998, PLANT PHYSIOL, V116, P1073, DOI 10.1104/pp.116.3.1073; Fatland BL, 2005, PLANT CELL, V17, P182, DOI 10.1105/tpc.104.026211; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; GALVEZ S, 1995, PLANT SCI, V105, P1, DOI 10.1016/0168-9452(94)04041-E; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Goffman FD, 2005, PLANT PHYSIOL, V138, P2269, DOI 10.1104/pp.105.063628; Goffman FD, 2004, PLANT PHYSIOL BIOCH, V42, P703, DOI 10.1016/j.plaphy.2004.07.003; Gupta R, 1997, INDIAN J BIOCHEM BIO, V34, P288; Hernandez-Sebastia C, 2005, J EXP BOT, V56, P1951, DOI 10.1093/jxb/eri191; KANG F, 1994, PLANT J, V6, P795, DOI 10.1046/j.1365-313X.1994.6060795.x; King SP, 1998, AUST J PLANT PHYSIOL, V25, P377, DOI 10.1071/PP97157; KROMER S, 1995, ANNU REV PLANT PHYS, V46, P45, DOI 10.1146/annurev.pp.46.060195.000401; Kubis SE, 2004, J EXP BOT, V55, P1455, DOI 10.1093/jxb/erh157; Mollney M, 1999, BIOTECHNOL BIOENG, V66, P86, DOI 10.1002/(SICI)1097-0290(1999)66:2<86::AID-BIT2>3.0.CO;2-A; MURPHY DJ, 1989, J PLANT PHYSIOL, V135, P63, DOI 10.1016/S0176-1617(89)80225-1; Rees T.A.P., 1990, PLANT PHYSIOL, P106; Rolletschek H, 2005, PLANT PHYSIOL, V137, P1236, DOI 10.1104/pp.104.056523; Rolletschek H, 2004, PLANT BIOTECHNOL J, V2, P211, DOI 10.1111/j.1467-7652.2004.00064.x; Rontein D, 2002, J BIOL CHEM, V277, P43948, DOI 10.1074/jbc.M206366200; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; SALON C, 1988, J BIOL CHEM, V263, P12278; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Schwender J, 2003, J BIOL CHEM, V278, P29442, DOI 10.1074/jbc.M303432200; Schwender J, 2002, PLANT PHYSIOL, V130, P347, DOI 10.1104/pp.004275; SINGAL HR, 1995, J BIOSCIENCE, V20, P49, DOI 10.1007/BF02711580; SINGAL HR, 1987, PLANT PHYSIOL, V83, P1043, DOI 10.1104/pp.83.4.1043; SMITH AJ, 1989, CROP SCI, V29, P349, DOI 10.2135/cropsci1989.0011183X002900020024x; Smith CR, 2000, EUR J BIOCHEM, V267, P4477, DOI 10.1046/j.1432-1327.2000.01494.x; Sriram G, 2004, PLANT PHYSIOL, V136, P3043, DOI 10.1104/pp.104.050625; STEFANOPOULOS GN, 1998, METABOLIC ENG PRINCI; SUGIMOTO T, 1989, AGR BIOL CHEM TOKYO, V53, P885, DOI 10.1080/00021369.1989.10869369; Tcherkez G, 2005, PLANT PHYSIOL, V138, P1596, DOI 10.1104/pp.105.062141; VIGEOLAS H, 2003, PLANT PHYSIOL, V133, P2048, DOI DOI 10.1104/PP.103.031963; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188	49	188	189	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34040	34047		10.1074/jbc.M606266200	http://dx.doi.org/10.1074/jbc.M606266200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16971389	hybrid			2022-12-27	WOS:000241767600024
J	Thankamony, SP; Knudson, W				Thankamony, Sai P.; Knudson, Warren			Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-PROTEIN THIOESTERASE; ARTICULAR CHONDROCYTES; MEDIATED ENDOCYTOSIS; PERICELLULAR MATRIX; PALMITOYLATION; DOMAIN; INTERNALIZATION; UBIQUITINATION; DEGRADATION; ACTIVATION	CD44 is a cell surface receptor for the extracellular matrix macromolecule hyaluronan. In addition, CD44 mediates the endocytosis of hyaluronan leading to its subsequent degradation within lysosomes. Using model systems of COS-7 and Flp-293 cells, we demonstrate that the association of CD44 with lipid rafts is essential for the endocytosis of hyaluronan but not the extracellular binding. Further, we demonstrate that palmitoylation of CD44 on two highly conserved cysteine residues is essential for the association with lipid rafts as determined by density gradient ultracentrifugation. Mutations of either cysteine residues or pretreatment of cells with the palmitic acid analog 2-bromopalmitate, reduced the [H-3] palmitic acid incorporation into CD44 and prevented CD44-lipid rafts association. Preventing CD44 palmitoylation had no effect on the binding of hyaluronan but inhibited hyaluronan internalization. The turnover of the CD44 receptor itself was also affected by blocking its association with lipid rafts. Using cycloheximide to prevent de novo protein synthesis, palmitoylation-deficient cysteine mutants underwent slower turnover from cell surface compared with the palmitoylation-intact wild type, as determined by immunofluorescence and Western blotting. These results indicate that palmitoylation of CD44 is a critical driving determinant to CD44 association with lipid rafts and, concomitantly, the rates of hyaluronan endocytosis and CD44 turnover from cell surface.	Rush Univ, Med Ctr, Rush Med Coll, Dept Biochem, Chicago, IL 60612 USA	Rush University	Knudson, W (corresponding author), Rush Univ, Med Ctr, Rush Med Coll, Dept Biochem, 1735 W Harrison St, Chicago, IL 60612 USA.	Warren_Knudson@rush.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043384, P50AR039239] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR043384-15, R01 AR043384, P50-AR39239, R01-AR43384, P50 AR039239] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Aguiar DJ, 1999, EXP CELL RES, V252, P292, DOI 10.1006/excr.1999.4641; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BOURGUIGNON LYW, 1991, J BIOL CHEM, V266, P11761; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Embry JJ, 2003, ARTHRITIS RHEUM-US, V48, P3431, DOI 10.1002/art.11323; Foger N, 2000, EUR J IMMUNOL, V30, P2888; GUO YJ, 1994, INT IMMUNOL, V6, P213, DOI 10.1093/intimm/6.2.213; GUO YJ, 1993, CELL IMMUNOL, V152, P186, DOI 10.1006/cimm.1993.1278; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; HUA Q, 1993, J CELL SCI, V106, P365; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Jiang H, 2001, ARTHRITIS RHEUM-US, V44, P2599, DOI 10.1002/1529-0131(200111)44:11<2599::AID-ART440>3.0.CO;2-Y; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Knudson W, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P83; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; KNUDSON W, 2004, CURR OPIN ORTHOP, V15, P369; KNUDSON W, 2005, HYALURONAN STRUCTURE, V1, P213; Li M, 2002, J VIROL, V76, P11845, DOI 10.1128/JVI.76.23.11845-11852.2002; Liu D, 1996, J EXP MED, V183, P1987, DOI 10.1084/jem.183.5.1987; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Munshi UM, 2005, MOL ENDOCRINOL, V19, P749, DOI 10.1210/me.2004-0335; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Radeva G, 2004, BIOCHEM J, V380, P219, DOI 10.1042/BJ20031348; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Stickney JT, 2004, CANCER RES, V64, P2717, DOI 10.1158/0008-5472.CAN-03-3798; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148	36	93	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34601	34609		10.1074/jbc.M601530200	http://dx.doi.org/10.1074/jbc.M601530200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16945930	Green Accepted, hybrid			2022-12-27	WOS:000241767600079
J	Xuan, DY; Li, X; Deng, ZH; Zhang, HL; Feng, PX; Duan, XY; Jin, Y				Xuan, Dong-Ying; Li, Xin; Deng, Zhi-Hong; Zhang, Hua-Li; Feng, Pei-xun; Duan, Xiao-Yan; Jin, Yan			Identification and characterization of a novel gene, Mcpr1, and its possible function in the proliferation of embryonic palatal mesenchymal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CLEFT-PALATE; TRANS-RETINOIC ACID; TGF-BETA; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; IN-VITRO; PROTEIN; TRANSCRIPTION; CHONDROGENESIS; MORPHOGENESIS	We cloned a novel mouse cDNA, Mcpr1 ((m) under bar ouse (c) under bar left (p) under bar alate-(r) under bar elated gene (1) under bar), between retinoic acid (RA)-treated murine embryonic palatal and control shelves by improved subtractive hybridization. Its transcript was identified by Northern blotting. The open reading frame encodes 132 amino acids and shows almost no identity to other genetic products. Mcpr1 expression could be detected extensively in adult mouse tissues and during murine embryonic development. It was identified to be significantly stimulated by RA in murine palatal shelves at embryonic day 12 and in palatal mesenchymal cells in vitro. We demonstrate that MCPR1 protein was localized primarily in the cytoplasm and could be synthesized and secreted by transfected COS-7 cells. Both the secretory and recombinant proteins of Mcpr1 inhibited proliferation of murine embryonic palatal mesenchymal cells and impeded the progression from the G(1) to S phase in the cell cycle. The cells were prone to apoptosis after exposure to glutathione S-transferase- MCPR1. Furthermore, knockdown of MCPR1 protein levels by antisense oligode-oxynucleotides promoted progression of cells from the G1 to S phase and completely abolished the RA-induced block of the cell cycle from the G1 to S phase. These findings suggest that Mcpr1 might function as one of the RA-up-regulated genes involved in inhibiting cell proliferation during palatogenesis and RA-induced cleft palate by regulating proliferation and apoptosis of embryonic palatal mesenchymal cells and might even play a role in the development of many other organs.	Fourth Mil Med Univ, Coll Stomatol, Dept Oral Histol & Pathol, Xian 710032, Shaanxi, Peoples R China; Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Xian 710032, Shaanxi, Peoples R China; Fourth Mil Med Univ, Dept Otolaryngol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Jin, Y (corresponding author), Fourth Mil Med Univ, Coll Stomatol, Dept Oral Histol & Pathol, 7 Kangfu Rd, Xian 710032, Shaanxi, Peoples R China.	yanjin@fmmu.edu.cn	Jin, Yan/I-4204-2013					Abbott BD, 1999, TOXICOL SCI, V47, P62, DOI 10.1093/toxsci/47.1.62; ABBOTT BD, 1989, TERATOLOGY, V40, P533, DOI 10.1002/tera.1420400602; ABBOTT BD, 1990, TERATOLOGY, V41, P299, DOI 10.1002/tera.1420410307; Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bhasin N, 2004, DEV DYNAM, V230, P201, DOI 10.1002/dvdy.20038; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell JL, 2004, BIRTH DEFECTS RES B, V71, P289, DOI 10.1002/bdrb.20015; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cho SH, 2003, J CELL BIOCHEM, V89, P837, DOI 10.1002/jcb.10553; Dhulipala V C, 2004, Orthod Craniofac Res, V7, P227, DOI 10.1111/j.1601-6343.2004.00299.x; Dhulipala VC, 2004, TOXICOL APPL PHARM, V194, P270, DOI 10.1016/j.taap.2003.09.014; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Fujita Y, 2006, ENDOCRINOLOGY, V147, P1377, DOI 10.1210/en.2005-0644; Hanumegowda UM, 2002, TOXICOL SCI, V66, P159, DOI 10.1093/toxsci/66.1.159; Jakowlew SB, 2000, PEPTIDES, V21, P1831, DOI 10.1016/S0196-9781(00)00344-2; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KAS K, 1992, BIOCHEM BIOPH RES CO, V187, P927, DOI 10.1016/0006-291X(92)91286-Y; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lai LH, 2003, DEVELOPMENT, V130, P6465, DOI 10.1242/dev.00887; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Laudet V., 2001, NUCL RECEPTOR FACTSB; LEE SW, 1991, P NATL ACAD SCI USA, V88, P2825, DOI 10.1073/pnas.88.7.2825; LEWIS CA, 1978, DEV BIOL, V64, P31, DOI 10.1016/0012-1606(78)90058-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LUKAS J, 1995, ONCOGENE, V10, P2125; Maeda T, 2001, J BIOL CHEM, V276, P3628, DOI 10.1074/jbc.M007898200; Makhijani NS, 2005, J CELL PHYSIOL, V202, P304, DOI 10.1002/jcp.20128; Mark M, 2003, PURE APPL CHEM, V75, P1709, DOI 10.1351/pac200375111709; Mehra A, 2002, BIOCHEM CELL BIOL, V80, P605, DOI 10.1139/O02-161; MICHIELS L, 1993, ONCOGENE, V8, P2537; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nishida J, 2002, J BIOCHEM, V131, P485, DOI 10.1093/oxfordjournals.jbchem.a003125; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Nugent P, 1998, J CELL PHYSIOL, V177, P36, DOI 10.1002/(SICI)1097-4652(199810)177:1<36::AID-JCP4>3.0.CO;2-F; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Reynolds PR, 2003, BIRTH DEFECTS RES A, V67, P168, DOI 10.1002/bdra.10036; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sasaki Y, 2004, J PEDIATR SURG, V39, P170, DOI 10.1016/j.jpedsurg.2003.10.009; SATRE MA, 1989, DEV BIOL, V133, P529, DOI 10.1016/0012-1606(89)90055-9; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Shibamoto S, 2004, EXP CELL RES, V292, P11, DOI 10.1016/j.yexcr.2003.08.009; SWAROOP A, 1991, NUCLEIC ACIDS RES, V19, P1954, DOI 10.1093/nar/19.8.1954; Ueno M, 2002, HISTOL HISTOPATHOL, V17, P789, DOI 10.14670/HH-17.789; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Yano H, 1996, CLEFT PALATE-CRAN J, V33, P379, DOI 10.1597/1545-1569(1996)033<0379:COCREP>2.3.CO;2; Yu ZL, 2006, BIOCHEM BIOPH RES CO, V340, P929, DOI 10.1016/j.bbrc.2005.12.100; Yu ZL, 2005, TOXICOL SCI, V83, P349, DOI 10.1093/toxsci/kfi030; Zhao ZL, 1999, J BIOTECHNOL, V73, P35, DOI 10.1016/S0168-1656(99)00006-1; Zheng YQ, 2006, ACTA PHARMACOL SIN, V27, P111, DOI 10.1111/j.1745-7254.2006.00234.x	54	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33997	34008		10.1074/jbc.M605467200	http://dx.doi.org/10.1074/jbc.M605467200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16963447	hybrid			2022-12-27	WOS:000241767600020
J	Koo, AJK; Chung, HS; Kobayashi, Y; Howe, GA				Koo, Abraham J. K.; Chung, Hoo Sun; Kobayashi, Yuichi; Howe, Gregg A.			Identification of a peroxisomal acyl-activating enzyme involved in the biosynthesis of jasmonic acid in arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; METHYL JASMONATE; BETA-OXIDATION; OCTADECANOID PRECURSORS; GENE-EXPRESSION; REVEALS; DEFENSE; MUTANTS; VISUALIZATION; SUPERFAMILY	Jasmonic acid (JA) is a lipid-derived signal that regulates a wide variety of developmental and defense-related processes in higher plants. JA is synthesized from linolenic acid via an enzymatic pathway that initiates in the plastid and terminates in peroxisomes. The C18 JA precursor 12-oxo-phytodienoic acid (OPDA) is converted in the peroxisome to 3-oxo-2-(2'-[Z]-pentenyl) cyclopentane-1-octanoic acid (OPC-8:0), which subsequently undergoes three rounds of beta-oxidation to yield JA. Although most JA biosynthetic enzymes have been identified, several key steps in the pathway remain to be elucidated. To address this knowledge gap, we employed co-expression analysis to identify genes that are coordinately regulated with known JA biosynthetic components in Arabidopsis. Among the candidate genes uncovered by this approach was a 4-coumarate-CoA ligase-like member of the acyl-activating enzyme (AAE) gene family, which we have named OPC-8:0 CoA Ligase1 (OPCL1). In response to wounding, opcl1 null mutants exhibited reduced levels of JA and hyperaccumulation of OPC-8:0. Recombinant OPCL1 was active against both OPDA and OPC-8: 0, as well as medium-to-long straight-chain fatty acids. Subcellular localization studies with green fluorescent protein-tagged OPCL1 showed that the protein is targeted to peroxisomes. These findings establish a physiological role for OPCL1 in the activation of JA biosynthetic precursors in leaf peroxisomes, and further indicate that OPC-8: 0 is a physiological substrate for the activation step. The results also demonstrate the utility of co-expression analysis for identification of factors that contribute to jasmonate homeostasis.	Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; Tokyo Inst Technol, Dept Biol Engn, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Tokyo Institute of Technology; Michigan State University	Howe, GA (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	howeg@msu.edu	Koo, Abraham J/H-9721-2017; Howe, Gregg A/N-1887-2014	Howe, Gregg A/0000-0002-9218-979X; Koo, Abraham/0000-0003-2162-2987	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057795] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM57795] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ainai T, 2003, J ORG CHEM, V68, P7825, DOI 10.1021/jo0348571; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Benning C, 2006, CURR OPIN PLANT BIOL, V9, P241, DOI 10.1016/j.pbi.2006.03.012; Buseman CM, 2006, PLANT PHYSIOL, V142, P28, DOI 10.1104/pp.106.082115; Castillo MC, 2004, PLANT PHYSIOL, V135, P85, DOI 10.1104/pp.104.039925; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Costa MA, 2005, PHYTOCHEMISTRY, V66, P2072, DOI 10.1016/j.phytochem.2005.06.022; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Cukovic D, 2001, BIOL CHEM, V382, P645, DOI 10.1515/BC.2001.076; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Devoto A, 2005, PHYSIOL PLANTARUM, V123, P161, DOI 10.1111/j.1399-3054.2004.00418.x; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051, DOI 10.1074/jbc.M100884200; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fliegmann J, 2003, BIOL CHEM, V384, P437, DOI 10.1515/BC.2003.049; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Gfeller A, 2004, SCIENCE, V306, P1515, DOI 10.1126/science.1104352; Halitschke R, 2004, J PLANT GROWTH REGUL, V23, P238, DOI 10.1007/s00344-004-0037-z; Howe GA, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P610; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Jedd G, 2002, PLANT CELL PHYSIOL, V43, P384, DOI 10.1093/pcp/pcf045; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; Koo AJK, 2004, J BIOL CHEM, V279, P16101, DOI 10.1074/jbc.M311305200; Li CY, 2005, PLANT CELL, V17, P971, DOI 10.1105/tpc.104.029108; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Mandaokar A, 2006, PLANT J, V46, P984, DOI 10.1111/j.1365-313X.2006.02756.x; Mueller MJ, 2006, PLANT J, V45, P472, DOI 10.1111/j.1365-313X.2005.02614.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Reumann S, 2004, PLANT PHYSIOL, V136, P2587, DOI 10.1104/pp.104.043695; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Schaller F, 2004, J PLANT GROWTH REGUL, V23, P179, DOI 10.1007/s00344-004-0047-x; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Schmelz EA, 2004, PLANT J, V39, P790, DOI 10.1111/j.1365-313X.2004.02168.x; Schneider K, 2005, J BIOL CHEM, V280, P13962, DOI 10.1074/jbc.M413578200; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; SMITH WL, 1992, AM J PHYSIOL, V263, pF181; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stelmach BA, 2001, J BIOL CHEM, V276, P12832, DOI 10.1074/jbc.M010743200; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; VICK BA, 1984, PLANT PHYSIOL, V75, P458, DOI 10.1104/pp.75.2.458; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Wasternack C, 2006, J PLANT PHYSIOL, V163, P297, DOI 10.1016/j.jplph.2005.10.014; Weber H, 1997, P NATL ACAD SCI USA, V94, P10473, DOI 10.1073/pnas.94.19.10473; WEILER EW, 1993, PHYTOCHEMISTRY, V32, P591, DOI 10.1016/S0031-9422(00)95142-2; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; ZIEGLER K, 1987, ARCH MICROBIOL, V149, P62, DOI 10.1007/BF00423138; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	61	141	150	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33511	33520		10.1074/jbc.M607854200	http://dx.doi.org/10.1074/jbc.M607854200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16963437	hybrid			2022-12-27	WOS:000241621400062
J	Piessevaux, J; Lavens, D; Montoye, T; Wauman, J; Catteeuw, D; Vandekerckhove, J; Belsham, D; Peelman, F; Tavernier, J				Piessevaux, Julie; Lavens, Delphine; Montoye, Tony; Wauman, Joris; Catteeuw, Dominiek; Vandekerckhove, Joel; Belsham, Denise; Peelman, Frank; Tavernier, Jan			Functional cross-modulation between SOCS proteins can stimulate cytokine signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING SUPPRESSOR; CONFERS RESISTANCE; LEPTIN SENSITIVITY; KINASE-ACTIVITY; SH2 DOMAIN; BOX MOTIF; RECEPTOR; INHIBITION; PHOSPHORYLATION; BINDING	SOCS (suppressors of cytokine signaling) proteins are negative regulators of cytokine signaling that function primarily at the receptor level. Remarkably, in vitro and in vivo observations revealed both inhibitory and stimulatory effects of SOCS2 on growth hormone signaling, suggesting an additional regulatory level. In this study, we examined the possibility of direct cross-modulation between SOCS proteins and found that SOCS2 could interfere with the inhibitory actions of other SOCS proteins in growth hormone, interferon, and leptin signaling. This SOCS2 effect was SOCS box-dependent, required recruitment of the elongin BC complex, and coincided with degradation of target SOCS proteins. Detailed mammalian protein-protein interaction trap (MAPPIT) analysis indicated that SOCS2 can interact with all members of the SOCS family. SOCS2 may thus function as a molecular bridge between a ubiquitin-protein isopeptide ligase complex and SOCS proteins, targeting them for proteasomal turnover. We furthermore extended these observations to SOCS6 and SOCS7. Our findings point to a unique regulatory role for SOCS2, SOCS6, and SOCS7 within the SOCS family and provide an explanation for the unexpected phenotypes observed in SOCS2 and SOCS6 transgenic mice.	Univ Ghent VIB, Fac Med & Hlth Sci, Dept Med Prot Res, B-9000 Ghent, Belgium; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	Flanders Institute for Biotechnology (VIB); Ghent University; University of Toronto	Tavernier, J (corresponding author), Univ Ghent VIB, Fac Med & Hlth Sci, Dept Med Prot Res, Baertsoenkaai 3, B-9000 Ghent, Belgium.	jan.tavernier@ugent.be	Tavernier, Jan/AAG-3636-2019; Wauman, Joris/GZL-0902-2022					Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Brender C, 2001, EXP CLIN IMMUNOGENET, V18, P80, DOI 10.1159/000049186; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Cohney SJ, 1999, MOL CELL BIOL, V19, P4980; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Dif F, 2001, ENDOCRINOLOGY, V142, P5286, DOI 10.1210/en.142.12.5286; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Favre H, 1999, FEBS LETT, V453, P63, DOI 10.1016/S0014-5793(99)00681-X; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Haan S, 2003, J BIOL CHEM, V278, P31972, DOI 10.1074/jbc.M303170200; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Krebs DL, 2004, P NATL ACAD SCI USA, V101, P15446, DOI 10.1073/pnas.0406870101; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Landsman T, 2005, J BIOL CHEM, V280, P37471, DOI 10.1074/jbc.M504125200; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Li L, 2004, J BIOL CHEM, V279, P34107, DOI 10.1074/jbc.M312672200; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Montoye T, 2005, BLOOD, V105, P4264, DOI 10.1182/blood-2004-07-2733; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Ouyang X, 2006, J CELL PHYSIOL, V207, P428, DOI 10.1002/jcp.20579; Pattyn E, 1999, J BIOL CHEM, V274, P34838, DOI 10.1074/jbc.274.49.34838; Pezet A, 1999, J BIOL CHEM, V274, P24497, DOI 10.1074/jbc.274.35.24497; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Rawlings JS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-38; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Stofega MR, 2000, MOL ENDOCRINOL, V14, P1338, DOI 10.1210/me.14.9.1338; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Tavernier J, 2002, CLIN EXP ALLERGY, V32, P1397, DOI 10.1046/j.1365-2745.2002.01520.x; Tyers M, 1999, P NATL ACAD SCI USA, V96, P12230, DOI 10.1073/pnas.96.22.12230; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; van de Geijn GJM, 2004, BLOOD, V104, P667, DOI 10.1182/blood-2003-08-2913; Verdier F, 1998, J BIOL CHEM, V273, P28185, DOI 10.1074/jbc.273.43.28185; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	57	85	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					32953	32966		10.1074/jbc.M600776200	http://dx.doi.org/10.1074/jbc.M600776200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956890	hybrid			2022-12-27	WOS:000241621400004
J	Zhu, JX; Doyle, HA; Mamula, MJ; Aswad, DW				Zhu, Jeff X.; Doyle, Hester A.; Mamula, Mark J.; Aswad, Dana W.			Protein repair in the brain, proteomic analysis of endogenous substrates for protein L-isoaspartyl methyltransferase in mouse brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVELY MODIFIED PROTEINS; RESPONSE MEDIATOR PROTEINS; ALZHEIMERS-DISEASE BRAIN; CARBOXYL METHYLTRANSFERASE; SYNAPSIN-I; METHYL ESTERIFICATION; O-METHYLTRANSFERASE; DAMAGED PROTEINS; ALPHA-INTERNEXIN; DEAMIDATION	Protein L-isoaspartyl methyltransferase ( PIMT) catalyzes repair of L-isoaspartyl peptide bonds, a major source of protein damage under physiological conditions. PIMT knock-out ( KO) mice exhibit brain enlargement and fatal epileptic seizures. All organs accumulate isoaspartyl proteins, but only the brain manifests an overt pathology. To further explore the role of PIMT in brain function, we undertook a global analysis of endogenous substrates for PIMT in mouse brain. Extracts from PIMT-KO mice were subjected to two-dimensional gel electrophoresis and blotted onto membranes. Isoaspartyl proteins were radiolabeled on-blot using [methyl-3H] S-adenosyl-L-methionine and recombinant PIMT. Fluorography of the blot revealed 30-35 H-3-labeled proteins, 22 of which were identified by peptide mass fingerprinting. These isoaspartate-prone proteins represent a wide range of cellular functions, including neuronal development, synaptic transmission, cytoskeletal structure and dynamics, energy metabolism, nitrogen metabolism, pH homeostasis, and protein folding. The following five proteins, all of which are rich in neurons, accumulated exceptional levels of isoaspartate: collapsin response mediator protein 2 (CRMP2/ULIP2/DRP-2), dynamin 1, synapsin I, synapsin II, and tubulin. Several of the proteins identified here are prone to age-dependent oxidation in vivo, and many have been identified as autoimmune antigens, of particular interest because isoaspartate can greatly enhance the antigenicity of self-peptides. We propose that the PIMT-KO phenotype results from the cumulative effect of isoaspartate-related damage to a number of the neuron-rich proteins detected in this study. Further study of the isoaspartate-prone proteins identified here may help elucidate the molecular basis of one or more developmental and/or age-related neurological diseases.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Yale Univ, Sch Med, Rheumatol Sect, New Haven, CT 06510 USA	University of California System; University of California Irvine; Yale University	Aswad, DW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA.	dwaswad@uci.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048120, R21AI048120, P01AI036529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR047759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017269] Funding Source: NIH RePORTER; NIAID NIH HHS [AI36529, AI48120] Funding Source: Medline; NIAMS NIH HHS [F32-AR47759] Funding Source: Medline; NINDS NIH HHS [NS17269] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; ASWAD DW, 1984, J BIOL CHEM, V259, P714; ASWAD DW, 1983, J NEUROCHEM, V40, P1718, DOI 10.1111/j.1471-4159.1983.tb08147.x; AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Castegna A, 2002, FREE RADICAL BIO MED, V33, P562, DOI 10.1016/S0891-5849(02)00914-0; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Chretien-Leprince P, 2005, ANN NY ACAD SCI, V1050, P266, DOI 10.1196/annals.1313.028; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Dale RC, 2006, J NEUROIMMUNOL, V172, P187, DOI 10.1016/j.jneuroim.2005.10.014; David CL, 1998, J BIOL CHEM, V273, P32063, DOI 10.1074/jbc.273.48.32063; DILIBERT.EJ, 1974, P NATL ACAD SCI USA, V71, P1701, DOI 10.1073/pnas.71.5.1701; Doyle HA, 2005, ANN NY ACAD SCI, V1050, P1, DOI 10.1196/annals.1313.001; Doyle HA, 2003, J IMMUNOL, V171, P2840, DOI 10.4049/jimmunol.171.6.2840; Farrar C, 2005, AGING CELL, V4, P1, DOI 10.1111/j.1474-9728.2004.00136.x; Farrar CE, 2005, J COMP NEUROL, V493, P524, DOI 10.1002/cne.20780; Ferreira A, 2000, J NEUROSCI, V20, P3736, DOI 10.1523/JNEUROSCI.20-10-03736.2000; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gitlits VM, 2001, J INVEST MED, V49, P276, DOI 10.2310/6650.2001.33973; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hattori T, 2006, INVEST OPHTH VIS SCI, V47, P249, DOI 10.1167/iovs.05-0774; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Honnorat J, 1999, EUR J NEUROSCI, V11, P4226, DOI 10.1046/j.1460-9568.1999.00864.x; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; Ingrosso D, 2000, EUR J BIOCHEM, V267, P4397, DOI 10.1046/j.1432-1327.2000.01485.x; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1993, NEUROCHEM RES, V18, P87, DOI 10.1007/BF00966926; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1985, BIOCHEMISTRY-US, V24, P2581, DOI 10.1021/bi00331a028; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; KIM S, 1973, ARCH BIOCHEM BIOPHYS, V157, P476, DOI 10.1016/0003-9861(73)90665-6; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lanthier J, 2002, J NEUROCHEM, V83, P581, DOI 10.1046/j.1471-4159.2002.01150.x; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lindner H, 2001, EXP GERONTOL, V36, P1551, DOI 10.1016/S0531-5565(01)00140-1; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; Mor F, 2005, J IMMUNOL, V175, P3439, DOI 10.4049/jimmunol.175.5.3439; MORIN AM, 1973, BIOCHEM BIOPH RES CO, V52, P373, DOI 10.1016/0006-291X(73)90721-3; MURRAY ED, 1984, J BIOL CHEM, V259, P722; Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Ochi H, 2002, FEBS LETT, V528, P197, DOI 10.1016/S0014-5793(02)03307-0; OCONNOR CM, 1985, ANAL BIOCHEM, V148, P79, DOI 10.1016/0003-2697(85)90630-X; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OHTA K, 1987, BIOCHIMIE, V69, P1227, DOI 10.1016/0300-9084(87)90150-7; OTA IM, 1990, ARCH BIOCHEM BIOPHYS, V279, P320, DOI 10.1016/0003-9861(90)90498-N; Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rajasalu T, 2004, IMMUNOL LETT, V94, P153, DOI 10.1016/j.imlet.2004.05.002; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Shimizu T, 2002, J NEUROSCI RES, V69, P341, DOI 10.1002/jnr.10301; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; Tanaka Y, 2006, MICROBIOL IMMUNOL, V50, P117, DOI 10.1111/j.1348-0421.2006.tb03776.x; Tontsch D, 2000, CLIN EXP IMMUNOL, V121, P270, DOI 10.1046/j.1365-2249.2000.01283.x; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Volkin DB, 1997, MOL BIOTECHNOL, V8, P105, DOI 10.1007/BF02752255; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yang ML, 2006, J IMMUNOL, V177, P4541, DOI 10.4049/jimmunol.177.7.4541; Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200; Young GW, 2005, J BIOL CHEM, V280, P26094, DOI 10.1074/jbc.M503624200	74	66	67	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33802	33813		10.1074/jbc.M606958200	http://dx.doi.org/10.1074/jbc.M606958200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959769	hybrid			2022-12-27	WOS:000241621400086
J	Dang, YJ; Kedersha, N; Low, WK; Romo, D; Gorospe, M; Kaufman, R; Anderson, P; Liu, JO				Dang, Yongjun; Kedersha, Nancy; Low, Woon-Kai; Romo, Daniel; Gorospe, Myriam; Kaufman, Randal; Anderson, Paul; Liu, Jun O.			Eukaryotic initiation factor 2 alpha-independent pathway of stress granule induction by the natural product pateamine A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN TIAR; MESSENGER-RNA; TRANSLATION; RECRUITMENT; PHOSPHORYLATION; ARSENITE; INHIBITION; COMPLEXES	Stress granules are aggregates of small ribosomal subunits, mRNA, and numerous associated RNA-binding proteins that include several translation initiation factors. Stress granule assembly occurs in the cytoplasm of higher eukaryotic cells under a wide variety of stress conditions, including heat shock, UV irradiation, hypoxia, and exposure to arsenite. Thus far, a unifying principle of eukaryotic initiation factor 2 alpha phosphorylation prior to stress granule formation has been observed from the majority of experimental evidence. Pateamine A, a natural product isolated from marine sponge, was recently reported to inhibit eukaryotic translation initiation and induce the formation of stress granules. In this report, the protein composition and fundamental progression of stress granule formation and disassembly induced by pateamine A was found to be similar to that for arsenite. However, pateamine A-induced stress granules were more stable and less prone to disassembly than those formed in the presence of arsenite. Most significantly, pateamine A induced stress granules independent of eukaryotic initiation factor 2 alpha phosphorylation, suggesting an alternative mechanism of formation from that previously described for other cellular stresses. Taking into account the known inhibitory effect of pateamine A on eukaryotic translation initiation, a model is proposed to account for the induction of stress granules by pateamine A as well as other stress conditions through perturbation of any steps prior to the rejoining of the 60S ribosomal subunit during the entire translation initiation process.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol & Immunol, Boston, MA 02115 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA; NIA, RNA Regulat Sect, NIH, Baltimore, MD 21224 USA; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Liu, JO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Hunterian 516,725 N Wolfe St, Baltimore, MD 21205 USA.	joliu@jhu.edu	dang, yongjun/M-6531-2016; dang, yongjun/A-8095-2011	dang, yongjun/0000-0001-7237-1132; 	NIAID NIH HHS [AI 033600] Funding Source: Medline; NIDDK NIH HHS [DK 42394] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033600, R56AI033600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK042394] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Bernstam L, 2000, J TOXICOL ENV HEAL B, V3, P293, DOI 10.1080/109374000436355; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Bredfeldt TG, 2004, TOXICOL APPL PHARM, V198, P412, DOI 10.1016/j.taap.2003.10.013; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Fechir M, 2005, CELL MOL BIOL, V51, P299, DOI 10.1170/T631; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Kayali F, 2005, NEUROSCIENCE, V134, P1223, DOI 10.1016/j.neuroscience.2005.05.047; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; THOMPSON DJ, 1993, CHEM-BIOL INTERACT, V88, P89, DOI 10.1016/0009-2797(93)90086-E; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128	34	191	194	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32870	32878		10.1074/jbc.M606149200	http://dx.doi.org/10.1074/jbc.M606149200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16951406	hybrid			2022-12-27	WOS:000241414500085
J	Rogacheva, M; Ishchenko, A; Saparbaev, M; Kuznetsova, S; Ogryzko, V				Rogacheva, Maria; Ishchenko, Alexander; Saparbaev, Murat; Kuznetsova, Svetlana; Ogryzko, Vasily			High resolution characterization of formamidopyrimidine-DNA glycosylase interaction with its substrate by chemical cross-linking and mass Spectrometry using substrate analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI FPG PROTEIN; EXCISION-REPAIR ENZYMES; ESCHERICHIA-COLI; RESTRICTION-ENDONUCLEASE; CATALYTIC-ACTIVITIES; LESION RECOGNITION; SINGLE MUTATIONS; PHOSPHATE GROUPS; DAMAGED DNA; SITE	Escherichia coli formamidopyrimidine-DNA glycosylase (Fpg) and human 8-oxoguanine-DNA glycosylase (hOgg1) initiate the base excision repair pathway for 7,8-dihydro-8-oxoguanine (8-oxoG) residues present in DNA. Recent structural and biochemical studies of Fpg-DNA and hOgg1-DNA complexes point to the existence of extensive interactions between phosphate groups and amino acids. However, the role of these contacts and their physiological relevance remains unclear. In the present study, we combined chemical cross-linking and electrospray ionization mass spectrometry (ESI/MS/MS) approaches to identify interacting residues in the Fpg-DNA and hOgg1-DNA complexes. The active centers of Fpg and hOgg1 were cross-linked with a series of reactive oligonucleotide duplexes containing both a single 8-oxoG residue and an O-ethyl-substituted pyrophosphate internucleotide (SPI) group at different positions in duplex DNA. The cross-linking efficiency reached 50% for Fpg and 30% for hOgg1. We have identified seven phosphate groups on both strands of the DNA duplex specifically interacting with nucleophilic amino acids in Fpg, and eight in hOgg1. MS/MS analysis of the purified proteolytic fragments suggests that lysine 56 of Fpg and lysine 249 of hOgg1 cross-link to the phosphate located 3' to the 8-oxoG residue. Site-specific mutagenesis analysis of Fpg binding to DNA substrate confirms the conclusions of our approach. Our results are consistent with crystallographic data on the Fpg-DNA complex and provide new data on the hOgg1-DNA interaction. The approach developed in this work provides a useful tool to study pro- and eukaryotic homologues of Fpg as well as other repair enzymes.	Univ Paris Sud, Inst Gustave Roussy, CNRS, UMR 8126,Mol Epigenet Grp, F-94805 Villejuif, France; Moscow MV Lomonosov State Univ, Dept Chem, Lab Nucle Acids Chem, Moscow 119992, Russia; Univ Paris Sud, Inst Gustave Roussy, CNRS, UMR 8126,DNA Repair Grp, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Lomonosov Moscow State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Ogryzko, V (corresponding author), Univ Paris Sud, Inst Gustave Roussy, CNRS, UMR 8126,Mol Epigenet Grp, F-94805 Villejuif, France.	ogryzko@igr.fr	Ishchenko, Alexander/D-4133-2013; Saparbaev, Murat K/N-3225-2015; Kuznetsova, Svetlana/I-8394-2012; Ogryzko, Vasily/M-6665-2015; Saparbaev, Murat/AAC-5478-2020	Ishchenko, Alexander/0000-0002-0488-8858; Saparbaev, Murat K/0000-0002-4630-1074; Ogryzko, Vasily/0000-0002-8548-1389; Saparbaev, Murat/0000-0002-4630-1074				Back JW, 2003, J MOL BIOL, V331, P303, DOI 10.1016/S0022-2836(03)00721-6; BOITEUX S, 1990, J BIOL CHEM, V265, P3916; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Castaing B, 1999, NUCLEIC ACIDS RES, V27, P608, DOI 10.1093/nar/27.2.608; CASTAING B, 1993, NUCLEIC ACIDS RES, V21, P2899, DOI 10.1093/nar/21.12.2899; CASTAING B, 1992, NUCLEIC ACIDS RES, V20, P389, DOI 10.1093/nar/20.3.389; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Fromme JC, 2002, NAT STRUCT BIOL, V9, P544, DOI 10.1038/nsb809; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; KIRPOTA OO, 2006, MOL BIOL, V5, P512; Kuznetsov SV, 1998, EUR J BIOCHEM, V253, P413, DOI 10.1046/j.1432-1327.1998.2530413.x; Kuznetsova S, 2003, BIOCHIMIE, V85, P511, DOI 10.1016/S0300-9084(03)00067-1; Kuznetsova SA, 1996, NUCLEIC ACIDS RES, V24, P4783, DOI 10.1093/nar/24.23.4783; Laval J, 1998, MUTAT RES-FUND MOL M, V402, P93, DOI 10.1016/S0027-5107(97)00286-8; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; Naryshkin NA, 1997, BIOCHEMISTRY-US, V36, P3496, DOI 10.1021/bi962789p; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Norman DPG, 2001, J AM CHEM SOC, V123, P359, DOI 10.1021/ja003144m; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; PURMAL AA, 1992, NUCLEIC ACIDS RES, V20, P3713, DOI 10.1093/nar/20.14.3713; Rogacheva MV, 2005, BIOCHIMIE, V87, P1079, DOI 10.1016/j.biochi.2005.05.011; Rudakova EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P640; Saparbaev M, 2002, ENVIRON MOL MUTAGEN, V39, P10, DOI 10.1002/em.10041; Serre L, 2002, EMBO J, V21, P2854, DOI 10.1093/emboj/cdf304; SHABAROVA ZA, 1994, BIOORG KHIM+, V20, P413; Sheflyan GY, 1996, FEBS LETT, V390, P307, DOI 10.1016/0014-5793(96)00645-X; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sidorkina O, 2001, FREE RADICAL BIO MED, V31, P816, DOI 10.1016/S0891-5849(01)00659-1; Sidorkina OM, 1998, NUCLEIC ACIDS RES, V26, P5351, DOI 10.1093/nar/26.23.5351; Sidorkina OM, 2000, J BIOL CHEM, V275, P9924, DOI 10.1074/jbc.275.14.9924; Speina E, 2005, ACTA BIOCHIM POL, V52, P167; TCHOU J, 1994, J BIOL CHEM, V269, P15318; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; Wiederholt CJ, 2002, BIOCHEMISTRY-US, V41, P15838, DOI 10.1021/bi025903e; Wong SS, 1991, CHEM PROTEIN CONJUGA; Zaika EI, 2004, J BIOL CHEM, V279, P4849, DOI 10.1074/jbc.M310262200; Zharkov DO, 2003, MUTAT RES-FUND MOL M, V531, P141, DOI 10.1016/j.mrfmmm.2003.09.002	40	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32353	32365		10.1074/jbc.M606217200	http://dx.doi.org/10.1074/jbc.M606217200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16928690	hybrid			2022-12-27	WOS:000241414500033
J	Schneider, S; Sharp, KH; Barker, PD; Paoli, M				Schneider, Sabine; Sharp, Katherine H.; Barker, Paul D.; Paoli, Max			An induced fit conformational change underlies the binding mechanism of the heme transport proteobacteria-protein HemS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHIGELLA-DYSENTERIAE; YERSINIA-ENTEROCOLITICA; CRYSTAL-STRUCTURE; UPTAKE SYSTEM; IRON; REFINEMENT; IDENTIFICATION; SIDEROPHORES; GENETICS; RECEPTOR	Bacteria rely on their environment and/or host to acquire iron and have evolved specialized systems to sequester and transport heme. The heme uptake system HemRSTUV is common to proteobacteria, and a major challenge is to understand the molecular mechanism of heme binding and transfer between the protein molecules that underlie this heme transport relay process. In the Gram-negative pathogen Yersinia enterocolitica, the HemRSTUV system culminates with the cytoplasmic recipient HemS, which stores and delivers heme for cellular needs. HemS belongs to a family of proteins essential and unique to proteobacteria. Here we report on the binding mechanism of HemS based on structural data from its apo- and ligand-loaded forms. This heme carrier protein associates with its cargo through a novel, partly preformed binding pocket, formed between a large beta-sheet dome and a three-helix subdomain. In addition to a histidine interacting with the iron, the complex is stabilized by a distal non-coordinating arginine that packs along the porphyrin plane and extensive electrostatic contacts that firmly anchor the heme propionate groups within the protein. Comparison of apoand ligand-bound HemS crystal structures reveals striking conformational changes that underlie a "heme- induced fit" binding mechanism. Local shifts in amino acid positions combine with global, rigid body-like domain movements, and together, these bring about a switch from an open, apo- form to a closed, bound state. This is the first report in which both liganded and unliganded forms of a heme transport protein are described, thus providing penetrating insights into its mechanism of heme binding and release.	Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England; Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Nottingham; University of Nottingham; University of Cambridge	Paoli, M (corresponding author), Univ Nottingham, Sch Pharm, Univ Pk, Nottingham NG7 2RD, England.	max.paoli@nottingham.ac.uk	Schneider, Sabine/G-2908-2013	Schneider, Sabine/0000-0003-1054-8689				Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnoux P, 1999, NAT STRUCT BIOL, V6, P516; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; Bracken CS, 1999, J BACTERIOL, V181, P6063, DOI 10.1128/JB.181.19.6063-6072.1999; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hartshorn MJ, 2002, J COMPUT AID MOL DES, V16, P871, DOI 10.1023/A:1023813504011; Henderson DP, 2001, J BACTERIOL, V183, P2715, DOI 10.1128/JB.183.9.2715-2723.2001; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MILLS M, 1995, J BACTERIOL, V177, P3004, DOI 10.1128/jb.177.11.3004-3009.1995; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Olczak T, 2001, J BACTERIOL, V183, P5599, DOI 10.1128/JB.183.19.5599-5608.2001; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; POULOS TL, 1993, J BIOL CHEM, V268, P4429; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Schneider S, 2005, ACTA CRYSTALLOGR F, V61, P802, DOI 10.1107/S1744309105023523; Smulevich G, 1998, BIOSPECTROSCOPY, V4, pS3, DOI 10.1002/(SICI)1520-6343(1998)4:5+<S3::AID-BSPY2>3.0.CO;2-R; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; STOJILJKOVIC I, 1992, EMBO J, V11, P4359, DOI 10.1002/j.1460-2075.1992.tb05535.x; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Suits MDL, 2005, P NATL ACAD SCI USA, V102, P16955, DOI 10.1073/pnas.0504289102; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wilks A, 2001, ARCH BIOCHEM BIOPHYS, V387, P137, DOI 10.1006/abbi.2000.2250; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wyckoff EE, 1998, MOL MICROBIOL, V28, P1139, DOI 10.1046/j.1365-2958.1998.00873.x	35	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32606	32610		10.1074/jbc.M607516200	http://dx.doi.org/10.1074/jbc.M607516200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943192	hybrid			2022-12-27	WOS:000241414500058
J	Brandan, E; Retamal, C; Cabello-Verrugio, C; Marzolo, MP				Brandan, Enrique; Retamal, Claudio; Cabello-Verrugio, Claudio; Marzolo, Maria-Paz			The low density lipoprotein receptor-related protein functions as an Endocytic receptor for decorin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; DERMATAN SULFATE PROTEOGLYCAN; GROWTH-FACTOR-BETA; HEPARAN-SULFATE; TYROSINE PHOSPHORYLATION; ALPHA-2-MACROGLOBULIN RECEPTOR; MYOBLAST DIFFERENTIATION; SYNDECAN-1 EXPRESSION; ANTISENSE INHIBITION; EXTRACELLULAR-MATRIX	Decorin is a small leucine-rich proteoglycan that modulates the activity of transforming growth factor type beta and other growth factors and thereby influences the processes of proliferation and differentiation in a wide array of physiological and pathological reactions. Hence, understanding the regulatory mechanisms of decorin activity has broad implications. Here we report that the extracellular levels of decorin are controlled by receptor-mediated catabolism, involving the low density lipoprotein receptor family member, low density lipoprotein receptor-related protein (LRP). We show that decorin is endocytosed and degraded by C2C12 myoblast cells and that both processes are blocked by suppressing LRP expression using short interfering RNA. The same occurs with CHO cells, but not with CHO cells genetically deficient in LRP. Finally, we show that LRP-null CHO cells, transfected to express mini-LRP polypeptides containing either the second or fourth LRP ligand-binding domains, carry out decorin endocytosis and lysosomal degradation. These findings point to LRP-mediated catabolism as a new control pathway for the biological activities of decorin, specifically for its ability to influence extracellular matrix signaling.	Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regulac Celular & Patol Joaquin V Luco, Dept Biol Celular & Mol,MIFAB, Santiago, Chile	Pontificia Universidad Catolica de Chile	Marzolo, MP (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regulac Celular & Patol Joaquin V Luco, Dept Biol Celular & Mol,MIFAB, Santiago, Chile.	mmarzolo@bio.puc.cl	Cabello-Verrugio, Claudio/AAD-1454-2020; Brandan, Enrique/A-7063-2017	Cabello-Verrugio, Claudio/0000-0001-7273-2102; Brandan, Enrique/0000-0002-6820-5059; Retamal, Claudio/0000-0001-8618-2260				ASUNDI VK, 1992, EUR J CELL BIOL, V59, P314; Benes P, 2003, BREAST CANCER RES, V5, pR77, DOI 10.1186/bcr591; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Biglari A, 2004, CANCER GENE THER, V11, P721, DOI 10.1038/sj.cgt.7700783; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Boucher P, 2002, BBA-MOL BASIS DIS, V1588, P226, DOI 10.1016/S0925-4439(02)00169-2; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; BRANDAN E, 1991, EUR J CELL BIOL, V55, P209; BRANDAN E, 1992, J NEUROSCI RES, V32, P51, DOI 10.1002/jnr.490320107; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; BU GJ, 1994, J BIOL CHEM, V269, P29874; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Caceres S, 2000, EUR J CELL BIOL, V79, P173, DOI 10.1078/S0171-9335(04)70020-5; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Chen H, 1996, BIOCHEM J, V318, P959, DOI 10.1042/bj3180959; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Desrosiers RR, 2006, PEDIATR BLOOD CANCER, V46, P40, DOI 10.1002/pbc.20566; FLORINI JR, 1986, J BIOL CHEM, V261, P6509; Fuentealba L, 1999, J BIOL CHEM, V274, P37876, DOI 10.1074/jbc.274.53.37876; Gauthier A, 2003, J BIOL CHEM, V278, P11945, DOI 10.1074/jbc.M212989200; GODYNA S, 1995, J CELL BIOL, V129, P1403, DOI 10.1083/jcb.129.5.1403; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Harris-White M. E., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P469, DOI 10.2174/156800705774322102; Hausser H, 1998, ARCH BIOCHEM BIOPHYS, V349, P363, DOI 10.1006/abbi.1997.0471; HAUSSER H, 1991, J CELL BIOL, V114, P45, DOI 10.1083/jcb.114.1.45; HAUSSER H, 1989, BIOCHEM J, V263, P137, DOI 10.1042/bj2630137; Hausser H, 1996, EUR J CELL BIOL, V71, P325; HAUSSER H, 1993, EXP CELL RES, V208, P398, DOI 10.1006/excr.1993.1261; HAUSSER H, 1992, J BIOL CHEM, V267, P11559; Hausser H, 1999, BIOCHEM J, V344, P827, DOI 10.1042/0264-6021:3440827; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hollborn M, 2004, INVEST OPHTH VIS SCI, V45, P2033, DOI 10.1167/iovs.03-0656; Huang SS, 2004, FASEB J, V18, P1719, DOI 10.1096/fj.04-1872fje; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Larrain J, 1997, J BIOL CHEM, V272, P18418, DOI 10.1074/jbc.272.29.18418; Larrain J, 1998, J BIOL CHEM, V273, P32288, DOI 10.1074/jbc.273.48.32288; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Llorente-Cortes V, 2002, CIRCULATION, V106, P3104, DOI 10.1161/01.CIR.0000041434.28573.0B; Lopez-Casillas F, 2003, J BIOL CHEM, V278, P382, DOI 10.1074/jbc.M208520200; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Marzolo MP, 2003, TRAFFIC, V4, P273, DOI 10.1034/j.1600-0854.2003.00081.x; Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I; Merle B, 1999, J CELL BIOCHEM, V75, P538; Merle B, 1997, J CELL BIOCHEM, V67, P75; MIKHAILENKO I, 1995, J BIOL CHEM, V270, P9543, DOI 10.1074/jbc.270.16.9543; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Obermoeller LM, 1998, J BIOL CHEM, V273, P22374, DOI 10.1074/jbc.273.35.22374; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Salicioni AM, 2002, J BIOL CHEM, V277, P16160, DOI 10.1074/jbc.M201401200; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; SCHMIDT G, 1990, BIOCHEM J, V266, P591; SCHMIDT G, 1991, BIOCHEM J, V280, P411, DOI 10.1042/bj2800411; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; SCOTT JE, 1986, CONNECT TISSUE RES, V14, P267, DOI 10.3109/03008208609017470; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; SCOTT PG, 2003, J BIOL CHEM, V21, P21; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Stander M, 1998, GENE THER, V5, P1187, DOI 10.1038/sj.gt.3300709; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; TRUPPE W, 1978, EUR J BIOCHEM, V85, P351, DOI 10.1111/j.1432-1033.1978.tb12246.x; Tseng WF, 2004, FEBS LETT, V562, P71, DOI 10.1016/S0014-5793(04)00185-1; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; Warshawsky I, 1996, J BIOL CHEM, V271, P25873, DOI 10.1074/jbc.271.42.25873; Webb DJ, 2000, J CELL SCI, V113, P123; Wilsie LC, 2003, J BIOL CHEM, V278, P15758, DOI 10.1074/jbc.M208786200; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200	86	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31562	31571		10.1074/jbc.M602919200	http://dx.doi.org/10.1074/jbc.M602919200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16936287	Bronze			2022-12-27	WOS:000241235300042
J	Galuska, SP; Oltmann-Norden, I; Geyer, H; Weinhold, B; Kuchelmeister, K; Hildebrandt, H; Gerardy-Schahn, R; Geyer, R; Muhlenhoff, M				Galuska, Sebastian P.; Oltmann-Norden, Imke; Geyer, Hildegard; Weinhold, Birgit; Kuchelmeister, Klaus; Hildebrandt, Herbert; Gerardy-Schahn, Rita; Geyer, Rudolf; Muehlenhoff, Martina			Polysialic acid profiles of mice expressing variant allelic combinations of the polysialyltransferases ST8SiaII and ST8SiaIV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; ENDO-BETA-GALACTOSIDASE; CENTRAL-NERVOUS-SYSTEM; II STX; COOPERATIVE POLYSIALYLATION; DIFFERENTIAL BIOSYNTHESIS; ALZHEIMERS-DISEASE; MESSENGER-RNA; MOUSE-BRAIN; RAT-BRAIN	The post-translational modification of the neural cell adhesion molecule ( NCAM) by polysialic acid (polySia) represents a remarkable example of dynamic modulation of homo- and heterophilic cell interactions by glycosylation. The synthesis of this unique carbohydrate polymer depends on the polysialyltransferases ST8SiaII and ST8SiaIV. Aiming to understand in more detail the contributions of ST8SiaII and ST8SiaIV to polySia biosynthesis in vivo, we used mutant mouse lines that differ in the number of functional polysialyltransferase alleles. The 1,2diamino-4,5-methylenedioxybenzene method was used to qualitatively and quantitatively assess the polySia patterns. Similar to the wild-type genotype, long polySia chains (> 50 residues) were detected in all genotypes expressing at least one functional polysialyltransferase allele. However, variant allelic combinations resulted in distinct alterations in the total amount of polySia; the relative abundance of long, medium, and short polymers; and the ratio of polysialylated to non-polysialylated NCAM. In ST8SiaII-null mice, 45% of the brain NCAM was non-polysialylated, whereas a single functional allele of ST8SiaII was sufficient to polysialylate similar to 90% of the NCAM pool. Our data reveal a complex polysialylation pattern and show that, under in vivo conditions, the coordinated action of ST8SiaII and ST8SiaIV is crucial to fine-tune the amount and structure of polySia on NCAM.	Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; Univ Giessen, Fac Med, Inst Neuropathol, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen; Justus Liebig University Giessen	Muhlenhoff, M (corresponding author), Hannover Med Sch, Abt Zellulare Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de	Hildebrandt, Herbert/A-7873-2010	Hildebrandt, Herbert/0000-0002-1044-0881				Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2002, J BIOL CHEM, V277, P36808, DOI 10.1074/jbc.M204632200; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; GERARDYSCHAHN R, 1994, INT J CANCER, P38; Geyer H, 2001, EUR J BIOCHEM, V268, P6587, DOI 10.1046/j.0014-2956.2001.02613.x; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; HE HT, 1987, J CELL BIOL, V105, P2489, DOI 10.1083/jcb.105.6.2489; HEKMAT A, 1990, J COMP NEUROL, V291, P457, DOI 10.1002/cne.902910311; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Inoue S, 2000, J BIOL CHEM, V275, P29968, DOI 10.1074/jbc.M004150200; Inoue S, 2003, METHOD ENZYMOL, V362, P543; Inoue S, 2001, BIOCHIMIE, V83, P605, DOI 10.1016/S0300-9084(01)01307-4; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Johnson CP, 2005, BIOCHEMISTRY-US, V44, P546, DOI 10.1021/bi048263j; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; Kitazume-Kawaguchi S, 2001, J BIOL CHEM, V276, P15696, DOI 10.1074/jbc.M010371200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; MANZI AE, 1994, J BIOL CHEM, V269, P23617; Mikkonen M, 1999, EUR J NEUROSCI, V11, P1754, DOI 10.1046/j.1460-9568.1999.00593.x; Mikkonen M, 1998, ANN NEUROL, V44, P923, DOI 10.1002/ana.410440611; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Murata T, 2003, EUR J BIOCHEM, V270, P3709, DOI 10.1046/j.1432-1033.2003.03757.x; NAKAGAWA H, 1980, J BIOL CHEM, V255, P5955; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips GR, 1997, DEV BRAIN RES, V102, P143, DOI 10.1016/S0165-3806(97)00069-2; Sato C, 1999, ANAL BIOCHEM, V266, P102, DOI 10.1006/abio.1998.2921; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; Storms SD, 1998, J BIOL CHEM, V273, P27124, DOI 10.1074/jbc.273.42.27124; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Vaithianathan T, 2004, J BIOL CHEM, V279, P47975, DOI 10.1074/jbc.M407138200; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wood GK, 1997, MOL BRAIN RES, V51, P69, DOI 10.1016/S0169-328X(97)00209-X; YANG PF, 1994, J BIOL CHEM, V269, P23039	50	63	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31605	31615		10.1074/jbc.M606516200	http://dx.doi.org/10.1074/jbc.M606516200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16940046	Bronze			2022-12-27	WOS:000241235300046
J	Li, Q; Montalbetti, N; Wu, YL; Ramos, A; Raychowdhury, MK; Chen, XZ; Cantiello, HF				Li, Qiang; Montalbetti, Nicolas; Wu, Yuliang; Ramos, Arnolt; Raychowdhury, Malay K.; Chen, Xing-Zhen; Cantiello, Horacio F.			Polycystin-2 cation channel function is under the control of microtubular structures in primary cilia of renal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-RIGHT ASYMMETRY; KIDNEY-DISEASE; PKD2 INTERACTS; TROPONIN-I; PROTEIN; GENE; LOCALIZATION; CYSTIN	Mutations in the gene encoding polycystin-2 (PC2) result in autosomal dominant polycystic kidney disease and defects in left-right asymmetry during embryogenesis. PC2 is a TRP-type Ca2+-permeable non-selective cation channel, which is expressed in kidney and other organs. PC2 is present and functional in microtubule-containing primary cilia of renal epithelial cells. However, no information is yet available as to whether PC2 interacts with microtubules. Here, we assessed the role of microtubular dynamics in regulating PC2 channel function in primary cilia. Isolated ciliary membranes from LLC-PK1 epithelial cells were reconstituted in a lipid bilayer system. The acute addition of the microtubular disrupter colchicine ( 15 mu M) rapidly abolished, whereas the addition of the microtubular stabilizer paclitaxel (taxol, 15 mu M) increased ciliary PC2 channel activity. The further addition of alpha-tubulin plus GTP also stimulated PC2 channel activity in ciliary membranes. However, alpha-tubulin and GTP had no effect on in vitro translated PC2. Using the yeast two-hybrid assay, we found that PC2 interacts with the microtubule-dependent motor kinesin-2 subunit KIF3A, a protein involved in polycystic kidney disease. The interaction occurred through the carboxyl termini domain of both proteins, which was further confirmed by in vitro glutathione S-transferase pull-down and dot blot overlay assays. Co-immunoprecipitation experiments showed that PC2 and KIF3A are in the same complex in native HEK293, Madin-Darby canine kidney cells (MDCK), and LLC-PK1 cells. Immunofluorescent staining also showed substantial PC2 and KIF3A co-localization in primary cilia of renal epithelial cells. The data indicate that microtubular organization regulates PC2 function, which may explain, among others, the regulatory role of PC2 in the sensory function of primary cilia.	Massachusetts Gen Hosp, Renal Unit, Dept Med, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; Univ Buenos Aires, Fac Farm & Bioquim, Dept Fisioquim & Quim Analit, Lab Canales Ion, RA-1113 Buenos Aires, DF, Argentina	Harvard University; Massachusetts General Hospital; Harvard University; University of Alberta; University of Buenos Aires	Chen, XZ (corresponding author), Massachusetts Gen Hosp, Renal Unit, Dept Med, 149 13th St, Charlestown, MA 02129 USA.	xzchen@ualberta.ca	Montalbetti, Nicolas/T-4212-2019	Montalbetti, Nicolas/0000-0003-2897-9540				Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; GLUCK U, 1994, J CELL SCI, V107, P1773; Gonzalez-Perrett S, 2002, J BIOL CHEM, V277, P24959, DOI 10.1074/jbc.M105084200; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Howarth FC, 1999, J PHYSIOL-LONDON, V516, P409, DOI 10.1111/j.1469-7793.1999.0409v.x; JOHNSON BD, 1994, PFLUG ARCH EUR J PHY, V429, P14, DOI 10.1007/BF02584025; KARR TL, 1980, J BIOL CHEM, V255, P1853; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li Q, 2003, BIOCHEMISTRY-US, V42, P7618, DOI 10.1021/bi034210a; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Montalbetti N, 2005, J PHYSIOL-LONDON, V566, P309, DOI 10.1113/jphysiol.2005.087072; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OBrien ET, 1997, CELL MOTIL CYTOSKEL, V36, P125, DOI 10.1002/(SICI)1097-0169(1997)36:2<125::AID-CM3>3.0.CO;2-8; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P193, DOI 10.1007/s00232-002-1055-z; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Raychowdhury MK, 2005, J BIOL CHEM, V280, P34718, DOI 10.1074/jbc.M507793200; Raychowdhury MK, 2004, J BIOL CHEM, V279, P20137, DOI 10.1074/jbc.M311946200; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; SNEDECOR GW, 1973, STATISTICAL METHODS, P91; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Unno T, 1999, BRIT J PHARMACOL, V127, P1703, DOI 10.1038/sj.bjp.0702711; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Woo DDL, 1997, KIDNEY INT, V51, P1613, DOI 10.1038/ki.1997.222; Xu GM, 2003, J BIOL CHEM, V278, P1457, DOI 10.1074/jbc.M209996200; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	38	176	184	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37566	37575		10.1074/jbc.M603643200	http://dx.doi.org/10.1074/jbc.M603643200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16950792	hybrid			2022-12-27	WOS:000242477100033
J	Hyde, TJ; Bryan, MA; Brodsky, B; Baum, J				Hyde, Timothy J.; Bryan, Michael A.; Brodsky, Barbara; Baum, Jean			Sequence dependence of renucleation after a Gly mutation in model collagen peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS ISOMERIZATION; TRIPLE-HELIX FORMATION; AMINO-ACID-SEQUENCE; OSTEOGENESIS IMPERFECTA; GLYCINE SUBSTITUTIONS; FIBRILLAR COLLAGENS; I COLLAGEN; NUCLEATION; STABILITY; DISEASES	Missense mutations in the collagen triple helix that replace one Gly residue in the (Gly-X-Y)(n) repeating pattern by a larger amino acid have been shown to delay triple helix folding. One hypothesis is that such mutations interfere with the C- to N-terminal directional propagation and that the identity of the residues immediately N-terminal to the mutation site may determine the delay time and the degree of clinical severity. Model peptides are designed to clarify the role of tripeptide sequences N-terminal to the mutation site, with respect to length, stability, and nucleation propensity, to complete triple helix folding. Two sets of peptides with different N-terminal sequences, one with the natural sequence alpha 1(I) 886-900, which is just adjacent to the Gly(901) mutation, and one with a GPO(GAO)(3) sequence, which occurs at alpha 1(I) 865-879, are studied by CD and NMR. Placement of the five tripeptides of the natural alpha 1(I) collagen sequence N-terminal to the Gly to Ala mutation site results in a peptide that is folded only C-terminal to the mutation site. In contrast, the presence of the Hyp-rich sequence GPO(GAO)(3) N-terminal to the mutation allows complete refolding in the presence of the mutation. The completely folded peptide contains an ordered central region with unusual hydrogen bonding while maintaining standard triple helix structure at the N- and C-terminal ends. These peptide results suggest that the location and sequences of downstream regions favorable for renucleation could be the key factor in the completion of a triple helix N-terminal to a mutation.	Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Baum, J (corresponding author), Wright Rieman Labs, Dept Chem & Biol Chem, 610 Taylor Rd, Piscataway, NJ 08854 USA.	baum@rutchem.rutgers.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008319, F31GM072149, R29GM045302, R01GM060048, R01GM045302] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45302, 5 T32 GM08319, GM60048, 1F31 GM072149] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x; Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918; Baum J., 2000, MECH PROTEIN FOLDING, V2nd, P330; Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5; Bella J, 1996, CONNECT TISSUE RES, V35, P401, DOI 10.3109/03008209609029218; BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; Buevich A, 2001, PHILOS T R SOC B, V356, P159, DOI 10.1098/rstb.2000.0761; Buevich AV, 2004, J BIOL CHEM, V279, P46890, DOI 10.1074/jbc.M407061200; Buevich AV, 2000, BIOCHEMISTRY-US, V39, P4299, DOI 10.1021/bi992584r; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; Byers PH, 2001, PHILOS T ROY SOC B, V356, P151, DOI 10.1098/rstb.2000.0760; Byers PH, 2002, CONNECTIVE TISSUE IT, P385; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KILTY CM, 1993, COLLAGEN FAMILY STRU, P159; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Liu XY, 1998, BIOCHEMISTRY-US, V37, P15528, DOI 10.1021/bi981147u; LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027; McLaughlin SH, 1998, MATRIX BIOL, V16, P369, DOI 10.1016/S0945-053X(98)90010-5; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; PROCKOP DJ, 1988, T AM CLIN CLIMAT ASS, V100, P70; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; VOGEL BE, 1988, J BIOL CHEM, V263, P19249; WENSTRUP RJ, 1991, J BIOL CHEM, V266, P2590; Xu YJ, 2003, BIOCHEMISTRY-US, V42, P8696, DOI 10.1021/bi034006n; Xu YJ, 2002, BIOCHEMISTRY-US, V41, P8143, DOI 10.1021/bi015952b; Yang W, 1997, BIOCHEMISTRY-US, V36, P6930, DOI 10.1021/bi970051h	39	42	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36937	36943		10.1074/jbc.M605135200	http://dx.doi.org/10.1074/jbc.M605135200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16998200	hybrid			2022-12-27	WOS:000242220800053
J	Roche, CJ; Dantsker, D; Samuni, U; Friedman, JM				Roche, Camille J.; Dantsker, David; Samuni, Uri; Friedman, Joel M.			Nitrite reductase activity of sol-gel-encapsulated deoxyhemoglobin - Influence of quaternary and tertiary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADULT HEMOGLOBIN; T-STATE; OXIDE BINDING; FUNCTIONAL-CHARACTERIZATION; GEMINATE RECOMBINATION; AFFINITY CONFORMATIONS; ALLOSTERIC REGULATION; MAXIMUM-ENTROPY; ALPHA-SUBUNIT; RED-CELL	Nitrite reductase activity of deoxyhemoglobin (HbA) in the red blood cell has been proposed as a non-nitric-oxide synthase source of deliverable nitric oxide (NO) within the vasculature. An essential element in this scheme is the dependence of this reaction on the quaternary/tertiary structure of HbA. In the present work sol-gel encapsulation is used to trap and stabilize deoxy-HbA in either the T or R quaternary state, thus allowing for the clear-cut monitoring of nitrite reductase activity as a function of quaternary state with and without effectors. The results indicate that reaction is not only R-T-dependent but also heterotropic effector-dependent within a given quaternary state. The use of the maximum entropy method to analyze carbon monoxide ( CO) recombination kinetics from fully and partially liganded sol-gel-encapsulated T-state species provides a framework for understanding effector modulation of T-state reactivity by influencing the distribution of high and low reactivity T-state conformations.	Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Friedman, JM (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	jfriedma@aecom.yu.edu			NHLBI NIH HHS [P01HL071064] Funding Source: Medline; NIAID NIH HHS [R01AI052258] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052258] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbruzzetti S, 2001, J NANOSCI NANOTECHNO, V1, P407, DOI 10.1166/jnn.2001.058; ACHARYA AS, 1983, J BIOL CHEM, V258, P2296; Ackers GK, 2004, METHOD ENZYMOL, V379, P3; Ackers GK, 2002, P NATL ACAD SCI USA, V99, P9777, DOI 10.1073/pnas.152225999; ALAYASH AI, 1993, ARCH BIOCHEM BIOPHYS, V303, P332, DOI 10.1006/abbi.1993.1292; ALPERT B, 1979, CHEM PHYS LETT, V64, P11, DOI 10.1016/0009-2614(79)87265-6; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; ANTONINI E, HEMOGLOBINS MYGLOBIN; Bettati S, 1997, J BIOL CHEM, V272, P32050, DOI 10.1074/jbc.272.51.32050; Bonaventura C, 1999, J BIOL CHEM, V274, P8686, DOI 10.1074/jbc.274.13.8686; Bonaventura C, 1998, BIOCHEMISTRY-US, V37, P496, DOI 10.1021/bi971574s; Bruno S, 2001, PROTEIN SCI, V10, P2401, DOI 10.1110/ps.20501; Colombo MF, 1996, J BIOL CHEM, V271, P4895; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dantsker D, 2005, J BIOL CHEM, V280, P38740, DOI 10.1074/jbc.M506333200; Das TK, 2004, J BIOL CHEM, V279, P10433, DOI 10.1074/jbc.M309590200; Das TK, 1999, BIOSPECTROSCOPY, V5, pS64, DOI 10.1002/(SICI)1520-6343(1999)5:5+<S64::AID-BSPY7>3.0.CO;2-W; Dejam A, 2004, BLOOD CELL MOL DIS, V32, P423, DOI 10.1016/j.bcmd.2004.02.002; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; DUDDELL DA, 1980, PHOTOCHEM PHOTOBIOL, V31, P479, DOI 10.1111/j.1751-1097.1980.tb03732.x; FAULKNER KM, 1995, J BIOL CHEM, V270, P13604, DOI 10.1074/jbc.270.23.13604; FRIEDMAN JM, 1980, NATURE, V284, P570, DOI 10.1038/284570a0; Gladwin MT, 2005, NAT CHEM BIOL, V1, P245, DOI 10.1038/nchembio1005-245; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Goldbeck RA, 2004, BIOCHEMISTRY-US, V43, P12065, DOI 10.1021/bi0493923; Goldbeck RA, 2001, BIOPHYS J, V81, P2919, DOI 10.1016/S0006-3495(01)75932-2; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; HENRY ER, 1983, J MOL BIOL, V166, P443, DOI 10.1016/S0022-2836(83)80094-1; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; HOFRICHTER J, 1985, BIOCHEMISTRY-US, V24, P2667, DOI 10.1021/bi00332a012; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Huang Z, 2002, BIOCHEM BIOPH RES CO, V292, P812, DOI 10.1006/bbrc.2002.6730; Huang Z, 2001, BBA-GEN SUBJECTS, V1568, P252, DOI 10.1016/S0304-4165(01)00227-6; Hui HL, 2004, BIOCHEMISTRY-US, V43, P7843, DOI 10.1021/bi030263g; Imai K, 2002, BIOPHYS CHEM, V98, P79, DOI 10.1016/S0301-4622(02)00086-8; JUSZCZAK L, 2006, RAMAN SPECTROSCOPY, V36, P350; Karasik E, 2004, BIOCHEMISTRY-US, V43, P7851, DOI 10.1021/bi0302649; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P6101, DOI 10.1021/bi047813a; Khan I, 2001, BIOCHEMISTRY-US, V40, P7581, DOI 10.1021/bi010051o; Khan I, 2000, BIOCHEMISTRY-US, V39, P16099, DOI 10.1021/bi000536x; LALEZARI I, 1990, BIOCHEMISTRY-US, V29, P1515, DOI 10.1021/bi00458a024; Luchsinger BP, 2005, J INORG BIOCHEM, V99, P912, DOI 10.1016/j.jinorgbio.2004.12.010; Manjula BN, 1998, PROTEIN ENG, V11, P583, DOI 10.1093/protein/11.7.583; Miyazaki G, 1999, J MOL BIOL, V292, P1121, DOI 10.1006/jmbi.1999.3124; MOZZARELLI A, 1991, NATURE, V351, P416, DOI 10.1038/351416a0; Mueser TC, 2000, BIOCHEMISTRY-US, V39, P15353, DOI 10.1021/bi0012944; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Parsegian VA, 2002, INT REV CYTOL, V215, P1; PERUTZ MF, 1976, BIOCHEMISTRY-US, V15, P378, DOI 10.1021/bi00647a022; PERUTZ MF, 1974, BIOCHEMISTRY-US, V13, P2163, DOI 10.1021/bi00707a026; Peterson ES, 2004, BIOCHEMISTRY-US, V43, P4832, DOI 10.1021/bi035481o; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P4346, DOI 10.1021/bi9708693; Salvay AG, 2003, BIOPHYS J, V84, P564, DOI 10.1016/S0006-3495(03)74876-0; Samuni U, 2006, BIOCHEMISTRY-US, V45, P2820, DOI 10.1021/bi050010i; Samuni U, 2004, BIOCHEMISTRY-US, V43, P13674, DOI 10.1021/bi048531d; Samuni U, 2003, BIOCHEMISTRY-US, V42, P8272, DOI 10.1021/bi020648j; Samuni U, 2002, J BIOL CHEM, V277, P25783, DOI 10.1074/jbc.M200301200; SHIBAYAMA N, 1995, J MOL BIOL, V251, P203, DOI 10.1006/jmbi.1995.0427; Shibayama N, 2001, FEBS LETT, V492, P50, DOI 10.1016/S0014-5793(01)02225-6; SIEMIARCZUK A, 1990, J PHYS CHEM-US, V94, P1661, DOI 10.1021/j100367a080; SIEMIARCZUK A, 1989, J PHYS CHEM-US, V93, P7609, DOI 10.1021/j100359a017; SILVA MM, 1992, J BIOL CHEM, V267, P17248; STEINBACH PJ, 1992, BIOPHYS J, V61, P235, DOI 10.1016/S0006-3495(92)81830-1; Tsuneshige A, 2004, J BIOL CHEM, V279, P48959, DOI 10.1074/jbc.M405909200; Tsuneshige A, 2002, BIOPHYS CHEM, V98, P49, DOI 10.1016/S0301-4622(02)00084-4; Unzai S, 1996, J BIOL CHEM, V271, P12451, DOI 10.1074/jbc.271.21.12451; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101	72	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36874	36882		10.1074/jbc.M603914200	http://dx.doi.org/10.1074/jbc.M603914200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16984908	hybrid			2022-12-27	WOS:000242220800046
J	Bulliard, Y; Wiznerowicz, M; Barde, I; Trono, D				Bulliard, Yannick; Wiznerowicz, Maciej; Barde, Isabelle; Trono, Didier			KRAB can repress lentivirus proviral transcription independently of integration site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 INTEGRATION; GENE-EXPRESSION; HUMAN GENOME; IN-VIVO; PROMOTERS; PROTEINS; REGIONS; HP1	The KRAB transcriptional repressor domain, commonly found in zinc finger proteins, acts by inducing the formation of heterochromatin. We previously exploited this property to achieve drug-regulated transgenesis and knock down by combining doxycycline-controllable KRAB-containing fusion proteins and lentiviral vectors. Here, we asked whether KRAB-induced repression is widespread or limited to specific regions of the genome. For this, we transduced cells with a lentiviral vector expressing a target reporter and a KRAB-containing transcriptional repressor from a bicistronic mRNA. We found that similar to 1.4% of the resulting proviruses escaped repression. However, this phenotype could be reverted by expressing the KRAB-containing protein in trans. Accordingly, the irrepressible proviruses all contained, in the DNA sequence encoding the KRAB-containing effector or its upstream internal ribosomal entry site, mutations or deletions likely resulting from errors or recombination during reverse transcription. These results indicate that KRAB-induced transcriptional repression is robust and active over a variety of genomic contexts that include at least the wide range of sites targeted by lentiviral integration.	Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; Univ Geneva, Natl Ctr Competence Res, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Stn 15, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch						Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Ayyanathan K, 2000, CANCER RES, V60, P5803; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Kulkarni A, 2004, BIOCHEM BIOPH RES CO, V322, P672, DOI 10.1016/j.bbrc.2004.07.170; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Papworth M, 2003, P NATL ACAD SCI USA, V100, P1621, DOI 10.1073/pnas.252773399; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; ZHANG JY, 1993, SCIENCE, V259, P234, DOI 10.1126/science.8421784	17	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35742	35746		10.1074/jbc.M602843200	http://dx.doi.org/10.1074/jbc.M602843200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16997916	hybrid			2022-12-27	WOS:000242100500019
J	Kubetzko, S; Balic, E; Waibel, R; Zangemeister-Wittke, U; Pluckthun, A				Kubetzko, Susanne; Balic, Ela; Waibel, Robert; Zangemeister-Wittke, Uwe; Plueckthun, Andreas			PEGylation and multimerization of the anti-p185(HER-2) single chain Fv fragment 4D5 - Effects on tumor targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT ANTIBODY FRAGMENTS; IN-VIVO; ESCHERICHIA-COLI; POLYETHYLENE-GLYCOL; HIGH AVIDITY; MONOCLONAL-ANTIBODIES; MODELING ANALYSIS; BREAST-CANCER; ANTIGEN; BINDING	A major goal in antibody design for cancer therapy is to tailor the pharmacokinetic properties of the molecule according to specific treatment requirements. Key parameters determining the pharmacokinetics of therapeutic antibodies are target specificity, affinity, stability, and size. Using the p185(HER-2) (HER-2)-specific scFv 4D5 as model system, we analyzed how changes in molecular weight and valency independently affect antigen binding and tumor localization. By employing multimerization and PEGylation, four different antibody formats were generated and compared with the scFv 4D5. First, dimeric and tetrameric miniantibodies were constructed by fusion of self-associating, disulfide-linked peptides to the scFv 4D5. Second, we attached a 20-kDa PEG moiety to the monovalent scFv and to the divalent miniantibody at the respective C terminus. In all formats, serum stability and full binding reactivity of the scFv 4D5 were retained. Functional affinity, however, did change. An avidity increase was achieved by multimerization, whereas PEGylation resulted in a 5-fold decreased affinity. Nevertheless, the PEGylated monomer showed an 8.5-fold, and the PEGylated dimer even a 14.5-fold higher tumor accumulation than the corresponding scFv, 48 h post-injection, because of a significantly longer serum half-life. In comparison, the non-PEGylated bivalent and tetravalent miniantibodies showed only a moderate increase in tumor localization compared with the scFv, which correlated with the degree of multimerization. However, these non-PEGylated formats resulted in higher tumor-to-blood ratios. Both multimerization and PEGylation represent thus useful strategies to tailor the pharmacokinetic properties of therapeutic antibodies and their combined use can additively improve tumor targeting.	Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; Univ Zurich Hosp, Dept Oncol, CH-8044 Zurich, Switzerland; Paul Scherrer Inst, CH-5232 Villigen, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Pluckthun, A (corresponding author), Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.	plueckthun@bioc.unizh.ch	Plückthun, Andreas/C-2746-2009	Plückthun, Andreas/0000-0003-4191-5306				Adams GP, 2001, CANCER RES, V61, P4750; Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; Adams GP, 2006, CLIN CANCER RES, V12, P1599, DOI 10.1158/1078-0432.CCR-05-2217; Adams GP, 1998, CANCER RES, V58, P485; Adams GP, 1998, BRIT J CANCER, V77, P1405, DOI 10.1038/bjc.1998.233; Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996; Batra SK, 2002, CURR OPIN BIOTECH, V13, P603, DOI 10.1016/S0958-1669(02)00352-X; Berndorff D, 2005, CLIN CANCER RES, V11, p7053S, DOI 10.1158/1078-0432.CCR-1004-0015; Borrebaeck Carl A. K., 2001, Current Opinion in Pharmacology, V1, P404; Caliceti P, 2003, ADV DRUG DELIVER REV, V55, P1261, DOI 10.1016/S0169-409X(03)00108-X; Carter P, 1997, CURR OPIN BIOTECH, V8, P449, DOI 10.1016/S0958-1669(97)80067-5; CARTER P, 1992, BIO-TECHNOL, V10, P163, DOI 10.1038/nbt0292-163; Casey JL, 1996, BRIT J CANCER, V74, P1397, DOI 10.1038/bjc.1996.555; CHANG RLS, 1975, BIOPHYS J, V15, P887, DOI 10.1016/S0006-3495(75)85863-2; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; CHESTER KA, 1995, TRENDS BIOTECHNOL, V13, P294, DOI 10.1016/S0167-7799(00)88968-4; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Christensen EI, 2004, PEDIATR NEPHROL, V19, P714, DOI 10.1007/s00467-004-1494-0; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; CUNNINGHAMRUNDLES C, 1992, J IMMUNOL METHODS, V152, P177, DOI 10.1016/0022-1759(92)90139-K; De Lorenzo C, 2005, CARCINOGENESIS, V26, P1890, DOI 10.1093/carcin/bgi146; Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916; FUJIMORI K, 1990, J NUCL MED, V31, P1191; FUJIMORI K, 1989, CANCER RES, V49, P5656; Ge L, 1995, ANTIBODY ENG, P229; Graff CP, 2003, CANCER RES, V63, P1288; Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hill RB, 1998, J AM CHEM SOC, V120, P1138, DOI 10.1021/ja9733649; Horn U, 1996, APPL MICROBIOL BIOT, V46, P524, DOI 10.1007/s002530050855; Hu SZ, 1996, CANCER RES, V56, P3055; Hudson PJ, 1999, J IMMUNOL METHODS, V231, P177, DOI 10.1016/S0022-1759(99)00157-X; HUSTON JS, 1994, CELL BIOPHYS, V24-5, P267, DOI 10.1007/BF02789238; Jackson H, 1998, BRIT J CANCER, V78, P181, DOI 10.1038/bjc.1998.462; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kang N, 2000, CLIN CANCER RES, V6, P4921; KELLEY RF, 1992, BIOCHEMISTRY-US, V31, P5434, DOI 10.1021/bi00139a003; KING DJ, 1994, CANCER RES, V54, P6176; KNAPPIK A, 1995, PROTEIN ENG, V8, P81, DOI 10.1093/protein/8.1.81; Kubetzko S, 2005, MOL PHARMACOL, V68, P1439, DOI 10.1124/mol.105.014910; Le Gall F, 1999, FEBS LETT, V453, P164, DOI 10.1016/S0014-5793(99)00713-9; Lee LS, 1999, BIOCONJUGATE CHEM, V10, P973, DOI 10.1021/bc990076o; LeSauteur L, 1996, NAT BIOTECHNOL, V14, P1120, DOI 10.1038/nbt0996-1120; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; Miller K, 2003, J IMMUNOL, V170, P4854, DOI 10.4049/jimmunol.170.9.4854; Mittl PRE, 1998, ACTA CRYSTALLOGR D, V54, P86, DOI 10.1107/S0907444997006550; Moroney S, 2005, MODERN BIOPHARMACEUT, P1147; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nahta R, 2003, ONCOLOGIST, V8, P5, DOI 10.1634/theoncologist.8-1-5; Olafsen T, 2005, CANCER RES, V65, P5907, DOI 10.1158/0008-5472.CAN-04-4472; Olafsen T, 2004, PROTEIN ENG DES SEL, V17, P315, DOI 10.1093/protein/gzh040; PACK P, 1995, J MOL BIOL, V246, P28, DOI 10.1006/jmbi.1994.0062; PACK P, 1992, BIOCHEMISTRY-US, V31, P1579, DOI 10.1021/bi00121a001; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Rheinnecker M, 1996, J IMMUNOL, V157, P2989; Ros R, 1998, P NATL ACAD SCI USA, V95, P7402, DOI 10.1073/pnas.95.13.7402; Ross JS, 2003, AM J CLIN PATHOL, V119, P472, DOI 10.1309/Y6LPC0LR726L9DX9; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Schibli R, 2000, BIOCONJUGATE CHEM, V11, P345, DOI 10.1021/bc990127h; Schmiedl A, 2000, J IMMUNOL METHODS, V242, P101, DOI 10.1016/S0022-1759(00)00243-X; SCHOTT ME, 1992, CANCER RES, V52, P6413; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Trikha M, 2002, CURR OPIN BIOTECH, V13, P609, DOI 10.1016/S0958-1669(02)00348-8; Viti F, 1999, CANCER RES, V59, P347; Waibel R, 1999, NAT BIOTECHNOL, V17, P897, DOI 10.1038/12890; Weiner LM, 2005, NAT BIOTECHNOL, V23, P556, DOI 10.1038/nbt0505-556; WEINSTEIN JN, 1987, ANN NY ACAD SCI, V507, P199, DOI 10.1111/j.1749-6632.1987.tb45802.x; Werlen RC, 1996, CANCER RES, V56, P809; Willuda J, 1999, CANCER RES, V59, P5758; Willuda J, 2001, J BIOL CHEM, V276, P14385, DOI 10.1074/jbc.M011669200; Worn A, 1998, FEBS LETT, V427, P357, DOI 10.1016/S0014-5793(98)00463-3; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Yang K, 2003, PROTEIN ENG, V16, P761, DOI 10.1093/protein/gzg093; YOKOTA T, 1992, CANCER RES, V52, P3402	81	101	111	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35186	35201		10.1074/jbc.M604127200	http://dx.doi.org/10.1074/jbc.M604127200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16963450	hybrid			2022-12-27	WOS:000241933700052
J	Liu, JJ; Grimison, B; Lewellyn, AL; Maller, JL				Liu, Junjun; Grimison, Bryn; Lewellyn, Andrea L.; Maller, James L.			The anaphase-promoting complex/cyclosome inhibitor Emi2 is essential for meiotic but not mitotic cell cycles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSTATIC FACTOR ARREST; XENOPUS-OOCYTES; METAPHASE ARREST; REGULATED PROTEOLYSIS; DEPENDENT PROTEOLYSIS; VERTEBRATE EGGS; MEIOSIS-II; COMPLEX; KINASE; EXIT	Vertebrate oocytes awaiting fertilization are arrested at metaphase of meiosis II by cytostatic factor (CSF). This arrest is due to inhibition of the anaphase-promoting complex/cyclosome, in part by a newly identified protein, Emi2 (xErp1). Emi2 is required for maintenance of CSF arrest in egg extracts, but its function in CSF establishment in oocytes and the normal embryonic cell cycle is unknown. Here we show that during oocyte maturation, Emi2 appears only after metaphase I, and its level peaks at CSF arrest (metaphase II). In M phase, Emi2 undergoes a phosphorylation-dependent electrophoretic shift. Microinjection of antisense oligonucleotides against Emi2 into stage VI oocytes blocks progression through meiosis II and the establishment of CSF arrest. Recombinant Emi2 rescues CSF arrest in these oocytes and also causes CSF arrest in egg extracts and in blastomeres of two-cell embryos. Fertilization triggers rapid, complete degradation of Emi2, but it is resynthesized in the first embryonic cell cycle to reach levels 5-fold lower than during CSF arrest. However, depletion of the protein from cycling egg extracts does not prevent mitotic cell cycle progression. Thus, Emi2 plays an essential role in meiotic but not mitotic cell cycles.	Univ Colorado, Sch Med, Dept Pharmacol, HHMI, Denver, CO 80262 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Maller, JL (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, HHMI, 4200 E 9th Ave,Box C-236, Denver, CO 80262 USA.	jim.maller@uchsc.edu						Bastians H, 1999, MOL BIOL CELL, V10, P3927, DOI 10.1091/mbc.10.11.3927; D'Angiolella V, 2001, CURR BIOL, V11, P1221, DOI 10.1016/S0960-9822(01)00352-9; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Frank-Vaillant M, 1999, MOL BIOL CELL, V10, P3279, DOI 10.1091/mbc.10.10.3279; Furuno N, 1997, EMBO J, V16, P3860, DOI 10.1093/emboj/16.13.3860; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Grimison B, 2006, CURR BIOL, V16, P1968, DOI 10.1016/j.cub.2006.08.055; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hartley RS, 1996, DEV BIOL, V173, P408, DOI 10.1006/dbio.1996.0036; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; Roy LM, 1996, ONCOGENE, V12, P2203; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Tunquist BJ, 2002, CURR BIOL, V12, P1027, DOI 10.1016/S0960-9822(02)00894-1; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x	32	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34736	34741		10.1074/jbc.M606607200	http://dx.doi.org/10.1074/jbc.M606607200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16982610	hybrid			2022-12-27	WOS:000241933700004
J	Paarmann, I; Schmitt, B; Meyer, B; Karas, M; Betz, H				Paarmann, Ingo; Schmitt, Bertram; Meyer, Bjorn; Karas, Michael; Betz, Heinrich			Mass spectrometric analysis of glycine receptor-associated gephyrin splice variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC PROTEINS; NEUROTRANSMITTER RECEPTORS; IDENTIFICATION; MOLYBDENUM; SEQUENCE; BINDING; DOMAIN; SITES; BRAIN; RAT	Gephyrin is an ubiquitously expressed protein that, in the nervous system, is essential for synaptic anchoring of glycine receptors (GlyRs) and major GABA(A) receptor subtypes. The binding of gephyrin to the GlyR depends on an amphipathic motif within the large intracellular loop of the GlyR beta subunit. The mouse gephyrin gene consists of 30 exons. Ten of these exons, encoding cassettes of 5-40 amino acids, are subject to alternative splicing (C1-C7, C4 '-C6 '). Since one of the cassettes, C5 ', has recently been reported to exclude GlyRs from GABAergic synapses, we investigated which cassettes are found in gephyrin associated with the GlyR. Gephyrin variants were purified from rat spinal cord, brain, and liver by binding to the glutathione S-transferase-tagged GlyR beta loop or copurified with native GlyR from spinal cord by affinity chromatography and analyzed by mass spectrometry. In addition to C2 and C6 ', already known to be prominent, C4 was found to be abundant in gephyrin from all tissues examined. The nonneuronal cassette C3 was easily detected in liver but not in GlyR-associated gephyrin from spinal cord. C5 was present in brain and spinal cord polypeptides, whereas C5 ' was coisolated mainly from liver. Notably C5 '-containing gephyrin bound to the GlyR beta loop, inconsistent with its proposed selectivity for GABAA receptors. Our data show that GlyR-associated gephyrin, lacking C3, but enriched in C4 without C5, differs from other neuronal and nonneuronal gephyrin isoforms.	Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Betz, H (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de						Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOISSEL JP, 1988, J BIOL CHEM, V263, P8443; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Ding QX, 2003, PROTEOMICS, V3, P1313, DOI 10.1002/pmic.200300452; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Godovac-Zimmermann J, 2005, PROTEOMICS, V5, P699, DOI 10.1002/pmic.200401051; Harris WA, 2002, RAPID COMMUN MASS SP, V16, P1714, DOI 10.1002/rcm.775; Heck S, 1997, DEV BRAIN RES, V98, P211, DOI 10.1016/S0165-3806(96)00181-2; Hermann A, 2001, BIOCHEM BIOPH RES CO, V282, P67, DOI 10.1006/bbrc.2001.4553; JOHNSON JL, 1989, INHERITED BASIS META; KIRSCH J, 1993, EUR J NEUROSCI, V5, P1109, DOI 10.1111/j.1460-9568.1993.tb00965.x; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; Meier J, 2004, J NEUROSCI, V24, P1398, DOI 10.1523/JNEUROSCI.4260-03.2004; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Nagradova N, 2003, IUBMB LIFE, V55, P459, DOI 10.1080/15216540310001602805; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Ramming M, 2000, P NATL ACAD SCI USA, V97, P10266, DOI 10.1073/pnas.97.18.10266; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Roth MJ, 2005, MOL CELL PROTEOMICS, V4, P1002, DOI 10.1074/mcp.M500064-MCP200; Sachs L., 1984, ANGEW STAT; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; Thiede B, 2005, METHODS, V35, P237, DOI 10.1016/j.ymeth.2004.08.015; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Wilkins MR, 1999, J MOL BIOL, V289, P645, DOI 10.1006/jmbi.1999.2794	43	29	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34918	34925		10.1074/jbc.M607764200	http://dx.doi.org/10.1074/jbc.M607764200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	17001074	hybrid			2022-12-27	WOS:000241933700024
J	Yuan, J; Xiao, XZ; McGeehan, J; Dong, ZQ; Cali, I; Fujioka, H; Kong, QZ; Kneale, G; Gambetti, P; Zou, WQ				Yuan, Jue; Xiao, Xiangzhu; McGeehan, John; Dong, Zhiqian; Cali, Ignazio; Fujioka, Hisashi; Kong, Qingzhong; Kneale, Geoff; Gambetti, Pierluigi; Zou, Wen-Quan			Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRP 27-30; SCRAPIE; DISEASE; CONFORMATION; MECHANISM; CAVEOLIN; GENE; TRANSMISSIBILITY; CLASSIFICATION; IDENTIFICATION	Aggregated prion protein (PrPSc), which is detergent-insoluble and partially proteinase K (PK)-resistant, constitutes the major component of infectious prions that cause a group of transmissible spongiform encephalopathies in animals and humans. PrPSc derives from a detergent-soluble and PK-sensitive cellular prion protein (PrPC) through an alpha-helix to beta-sheet transition. This transition confers on the PrPSc molecule unique physicochemical and biological properties, including insolubility in nondenaturing detergents, an enhanced tendency to form aggregates, resistance to PK digestion, and infectivity, which together are regarded as the basis for distinguishing PrPSc from PrPC. Here we demonstrate, using sedimentation and size exclusion chromatography, that small amounts of detergent-insoluble PrP aggregates are present in uninfected human brains. Moreover, PK-resistant PrP core fragments are detectable following PK treatment. This is the first study that provides experimental evidence supporting the hypothesis that there might be silent prions lying dormant in normal human brains.	Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Lab, Portsmouth PO1 2DT, Hants, England	Case Western Reserve University; Case Western Reserve University; University of Portsmouth	Zou, WQ (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	wenquan.zou@case.edu	xiao, xiangzhu/B-9300-2014; Zou, Wenquan/ABF-2875-2020; cali, ignazio/AAS-1127-2020	xiao, xiangzhu/0000-0002-8013-9074; cali, ignazio/0000-0001-5770-3848; DONG, ZHIQIAN/0000-0002-8748-4532; McGeehan, John/0000-0002-6750-1462	NIA NIH HHS [AG08702, AG-14359] Funding Source: Medline; PHS HHS [UR8/CCU515004] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG014359, P50AG008702] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Apetri AC, 2002, J BIOL CHEM, V277, P44589, DOI 10.1074/jbc.C200507200; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Buschmann A, 1998, BIOCHEM BIOPH RES CO, V253, P693, DOI 10.1006/bbrc.1998.9838; Cali I, 2006, BRAIN, V129, P2266, DOI 10.1093/brain/awl224; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hall D, 2004, J MOL BIOL, V336, P775, DOI 10.1016/j.jmb.2003.12.004; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Krasemann S, 1999, J BIOTECHNOL, V73, P119, DOI 10.1016/S0168-1656(99)00115-7; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Lu BY, 2002, BIOCHEM J, V364, P81, DOI 10.1042/bj3640081; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Oliver AW, 2000, J MOL BIOL, V301, P575, DOI 10.1006/jmbi.2000.3991; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2005, J VIROL, V79, P934, DOI 10.1128/JVI.79.2.934-943.2005; Pan T, 2002, J NEUROCHEM, V81, P1092, DOI 10.1046/j.1471-4159.2002.00909.x; Pastore M, 2005, AM J PATHOL, V167, P1729, DOI 10.1016/S0002-9440(10)61254-0; Pergami P, 1999, BIOCHEM BIOPH RES CO, V264, P972, DOI 10.1006/bbrc.1999.1430; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; SAFAR J, 1994, BIOCHEMISTRY-US, V33, P8375, DOI 10.1021/bi00193a027; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	62	91	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34848	34858		10.1074/jbc.M602238200	http://dx.doi.org/10.1074/jbc.M602238200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16987816	hybrid			2022-12-27	WOS:000241933700017
J	Azad, N; Vallyathan, V; Wang, LY; Tantishaiyakul, V; Stehlik, C; Leonard, SS; Rojanasakul, Y				Azad, Neelam; Vallyathan, Val; Wang, Liying; Tantishaiyakul, Vimon; Stehlik, Christian; Leonard, Stephen S.; Rojanasakul, Yon			S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation - A novel antiapoptotic mechanism that suppresses apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; LUNG-CANCER; CHROMIUM(VI)-INDUCED APOPTOSIS; PROTEIN-KINASE; UP-REGULATION; CYTOCHROME-C; CELLS; EXPRESSION; FAS; PHOSPHORYLATION	Bcl-2 is a key apoptosis regulatory protein of the mitochondrial death pathway whose function is dependent on its expression levels. Although Bcl-2 expression is controlled by various mechanisms, post-translational modifications, such as ubiquitination and proteasomal degradation, have emerged as important regulators of Bcl-2 function. However, the underlying mechanisms of this regulation are unclear. We report here that Bcl-2 undergoes S-nitrosylation by endogenous nitric oxide ( NO) in response to multiple apoptotic mediators and that this modification inhibits ubiquitin-proteasomal degradation of Bcl-2. Inhibition of NO production by the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide and by NO synthase inhibitor aminoguanidine effectively inhibited S-nitrosylation of Bcl-2, increased its ubiquitination, and promoted apoptotic cell death induced by chromium ( VI). In contrast, the NO donors dipropylenetriamine NONOate and sodium nitroprusside showed opposite effects. The effect of NO on Bcl-2 stability was shown to be independent of its dephosphorylation. Mutational analysis of Bcl-2 further showed that the two cysteine residues of Bcl-2 (Cys(158) and Cys(229)) are important in the S-nitrosylation process and that mutations of these cysteines completely inhibited Bcl-2 S-nitrosylation. Treatment of the cells with other stress inducers, including Fas ligand and buthionine sulfoxide, also induced Bcl-2 S-nitrosylation, suggesting that this is a general phenomenon that regulates Bcl-2 stability and function under various stress conditions. These findings indicate a novel function of NO and its regulation of Bcl-2, which provides a key mechanism for the control of apoptotic cell death and cancer development.	W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA; W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; NIOSH, Pathol & Physiol Res Branch, Morgantown, WV 26505 USA; Songkla Univ, Dept Pharmaceut Chem, Songkhla 90110, Thailand	West Virginia University; West Virginia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Prince of Songkla University	Rojanasakul, Y (corresponding author), W Virginia Univ, Dept Pharmaceut Sci, POB 9530, Morgantown, WV 26506 USA.	yrojanasakul@hsc.wvu.edu	高, 雨莉/HGU-8187-2022; Stehlik, Christian/AAG-2132-2021	Stehlik, Christian/0000-0002-3782-2484; Rojanasakul, Yon/0000-0002-8839-6462	NHLBI NIH HHS [HL076340] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076340] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V49, P1; ARIASDIAZ J, 1994, CANCER, V74, P1546, DOI 10.1002/1097-0142(19940901)74:5<1546::AID-CNCR2820740509>3.0.CO;2-F; ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; BENEZRA JM, 1994, AM J PATHOL, V145, P1036; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Buolamwini JK, 1999, CURR OPIN CHEM BIOL, V3, P500, DOI 10.1016/S1367-5931(99)80073-8; Carlisle DL, 2000, MOL CARCINOGEN, V28, P111, DOI 10.1002/1098-2744(200006)28:2<111::AID-MC7>3.0.CO;2-Y; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; De Flora S, 2000, CARCINOGENESIS, V21, P533, DOI 10.1093/carcin/21.4.533; DelaTorre A, 1997, BIOCHEM BIOPH RES CO, V238, P703, DOI 10.1006/bbrc.1997.7279; Delikouras A, 2001, TRANSPLANTATION, V71, P599, DOI 10.1097/00007890-200103150-00004; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Fujimoto H, 1997, JPN J CANCER RES, V88, P1190, DOI 10.1111/j.1349-7006.1997.tb00348.x; Fukuo K, 1996, HYPERTENSION, V27, P823, DOI 10.1161/01.HYP.27.3.823; GOPALAKRISHNA R, 1993, J BIOL CHEM, V268, P27180; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griscavage J M, 1995, Adv Pharmacol, V34, P215; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Heigold S, 2002, CARCINOGENESIS, V23, P929, DOI 10.1093/carcin/23.6.929; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; IKEGAKI N, 1994, CANCER RES, V54, P6; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; JIANG SX, 1995, J PATHOL, V177, P135, DOI 10.1002/path.1711770206; Jourd'Heuil D, 2002, FREE RADICAL BIO MED, V33, P676, DOI 10.1016/S0891-5849(02)00955-3; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kuzushima M, 2006, ARCH ORAL BIOL, V51, P1048, DOI 10.1016/j.archoralbio.2006.05.004; LANGARD S, 1990, AM J IND MED, V17, P189, DOI 10.1002/ajim.4700170205; LANGARD S, 1993, SCAND J WORK ENV HEA, V19, P81; Li CQ, 2004, CANCER RES, V64, P3022, DOI 10.1158/0008-5472.CAN-03-1880; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu CY, 1998, BRIT J CANCER, V78, P534, DOI 10.1038/bjc.1998.528; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Moon KH, 2005, FEBS LETT, V579, P6115, DOI 10.1016/j.febslet.2005.09.082; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Oxford SME, 2004, CURR MED CHEM, V11, P1031, DOI 10.2174/0929867043455486; Park HS, 2000, P NATL ACAD SCI USA, V97, P14382, DOI 10.1073/pnas.97.26.14382; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Pritchard DE, 2000, CARCINOGENESIS, V21, P2027, DOI 10.1093/carcin/21.11.2027; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Shi XL, 1999, J TOXICOL ENV HEAL B, V2, P87, DOI 10.1080/109374099281241; SIMONATO L, 1991, BRIT J IND MED, V48, P145; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Teng KK, 1999, J BIOL CHEM, V274, P37315, DOI 10.1074/jbc.274.52.37315; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang SW, 2004, MOL CELL BIOCHEM, V255, P129, DOI 10.1023/B:MCBI.0000007269.74532.98; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Wink DA, 1999, METHOD ENZYMOL, V301, P201; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Ye JP, 1999, J BIOL CHEM, V274, P34974, DOI 10.1074/jbc.274.49.34974; Zhang Z, 2001, MOL CELL BIOCHEM, V222, P77, DOI 10.1023/A:1017963307358	61	156	158	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34124	34134		10.1074/jbc.M602551200	http://dx.doi.org/10.1074/jbc.M602551200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16980304	hybrid			2022-12-27	WOS:000241767600033
J	Lee, PA; Orriss, GL; Buchanan, G; Greene, NP; Bond, PJ; Punginelli, C; Jack, RL; Sansom, MSP; Berks, BC; Palmer, T				Lee, Philip A.; Orriss, George L.; Buchanan, Grant; Greene, Nicholas P.; Bond, Peter J.; Punginelli, Claire; Jack, Rachael L.; Sansom, Mark S. P.; Berks, Ben C.; Palmer, Tracy			Cysteine-scanning mutagenesis and disulfide mapping studies of the conserved domain of the twin-arginine translocase TatB component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; ESCHERICHIA-COLI; TRANSPORT SYSTEM; EXPORT PATHWAY; SIGNAL PEPTIDE; MEMBRANE; COMPLEXES; RESIDUES; BINDING; ASSOCIATION	The cytoplasmic membrane protein TatB is an essential component of the Escherichia coli twin-arginine (Tat) protein translocation pathway. Together with the TatC component it forms a complex that functions as a membrane receptor for substrate proteins. Structural predictions suggest that TatB is anchored to the membrane via an N-terminal transmembrane alpha-helix that precedes an amphipathic alpha-helical section of the protein. From truncation analysis it is known that both these regions of the protein are essential for function. Here we construct 31 unique cysteine substitutions in the first 42 residues of TatB. Each of the substitutions results in a TatB protein that is competent to support Tat-dependent protein translocation. Oxidant-induced disulfide cross-linking shows that both the N-terminal and amphipathic helices form contacts with at least one other TatB protomer. For the transmembrane helix these contacts are localized to one face of the helix. Molecular modeling and molecular dynamics simulations provide insight into the possible structural basis of the transmembrane helix interactions. Using variants with double cysteine substitutions in the transmembrane helix, we were able to detect cross-links between up to five TatB molecules. Protein purification showed that species containing at least four cross-linked TatB molecules are found in correctly assembled TatBC complexes. Our results suggest that the transmembrane helices of TatB protomers are in the center rather than the periphery of the TatBC complex.	John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Oxford; University of East Anglia	Berks, BC (corresponding author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.	ben.berks@bioch.ox.ac.uk; tracy.palmer@bbsrc.ac.uk	Bond, Peter J/C-4918-2009; Punginelli, Claire/M-1759-2014; Jack, Rachael L/E-2869-2017; Sansom, Mark S.P./C-5157-2009	Sansom, Mark S.P./0000-0001-6360-7959; Bond, Peter/0000-0003-2900-098X; Palmer, Tracy/0000-0001-9043-2592; Greene, Nicholas/0000-0002-3631-0380; Berks, Ben/0000-0001-9685-4067	Medical Research Council [G117/519] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G117/519] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Barrett CML, 2005, FEBS J, V272, P2261, DOI 10.1111/j.1742-4658.2005.04654.x; Barrett CML, 2003, FEBS LETT, V537, P42, DOI 10.1016/S0014-5793(03)00068-1; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chanal A, 1998, MOL MICROBIOL, V30, P674, DOI 10.1046/j.1365-2958.1998.01095.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; COHEN N, 1956, ANN I PASTEUR PARIS, V91, P693; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Fincher V, 2003, EUR J BIOCHEM, V270, P4930, DOI 10.1046/j.1432-1033.2003.03894.x; Flemming D, 2003, J BIOL CHEM, V278, P47602, DOI 10.1074/jbc.M308967200; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hicks MG, 2005, J BACTERIOL, V187, P2920, DOI 10.1128/JB.187.8.2920-2925.2005; Hicks MG, 2003, FEBS LETT, V539, P61, DOI 10.1016/S0014-5793(03)00198-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; KI JJ, 2004, J MOL BIOL, V341, P901, DOI DOI 10.1016/J.JMB.2004.05.078; Koch HG, 2002, J BIOL CHEM, V277, P5715, DOI 10.1074/jbc.C100683200; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Masip L, 2004, SCIENCE, V303, P1185, DOI 10.1126/science.1092612; McDevitt CA, 2005, BIOCHEM BIOPH RES CO, V329, P693, DOI 10.1016/j.bbrc.2005.02.038; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785; Mori H, 2001, BBA-MOL CELL RES, V1541, P80, DOI 10.1016/S0167-4889(01)00150-1; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Oates J, 2003, J MOL BIOL, V330, P277, DOI 10.1016/S0022-2836(03)00621-1; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Russell DW, 2001, MOL CLONING LAB MANU; Sal-Man N, 2004, BIOCHEMISTRY-US, V43, P2309, DOI 10.1021/bi0356294; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; SILVESTRO A, 1988, BIOCHIM BIOPHYS ACTA, V954, P1, DOI 10.1016/0167-4838(88)90049-0; Smith SO, 1996, NAT STRUCT BIOL, V3, P252, DOI 10.1038/nsb0396-252; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stockner T, 2004, BIOPHYS J, V87, P1650, DOI 10.1529/biophysj.104.045310; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	60	49	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34072	34085		10.1074/jbc.M607295200	http://dx.doi.org/10.1074/jbc.M607295200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973610	hybrid			2022-12-27	WOS:000241767600028
J	Login, FH; Shevchik, VE				Login, Frederic H.; Shevchik, Vladimir E.			The single transmembrane segment drives self-assembly of OutC and the formation of a functional type II secretion system in Erwinia chrysanthemi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY GRADIENT CENTRIFUGATION; CATION-PI INTERACTIONS; PROTEIN SECRETION; MEMBRANE ASSOCIATION; POLAR RESIDUES; PATHWAY; DOMAINS; IDENTIFICATION; SPECIFICITY; CAROTOVORA	Many pathogenic Gram-negative bacteria secrete toxins and lytic enzymes via a multiprotein complex called the type II secretion system. This system, named Out in Erwinia chrysanthemi, consists of 14 proteins integrated or associated with the two bacterial membranes. OutC, a key player in this process, is probably implicated in the recognition of secreted proteins and signal transduction. OutC possesses a short cytoplasmic sequence, a single transmembrane segment (TMS), and a large periplasmic region carrying a putative PDZ domain. A hydrodynamic study revealed that OutC forms stable dimers of an elongated shape, whereas the PDZ domain adopts a globular shape. Bacterial two-hybrid, crosslinking, and pulldown assays revealed that the self-association of OutC is driven by the TMS, whereas the periplasmic region is dispensable for self-association. Site-directed mutagenesis of the TMS revealed that cooperative interactions between three polar residues located at the same helical face provide adequate stability for OutC self-assembly. An interhelical H-bonding mediated by Gln(29) appears to be the main driving force, and two Arg residues located at the TMS boundaries are essential for the stabilization of OutC oligomers. Stepwise mutagenesis of these residues gradually diminished OutC functionality and self-association ability. The triple OutC mutant R15V/Q29L/R36A became monomeric and nonfunctional. Self-association and functionality of the triple mutant were partially restored by the introduction of a polar residue at an alternative position in the interhelical interface. Thus, the OutC TMS is more than just a membrane anchor; it drives the protein self-association that is essential for formation of a functional secretion system.	Univ Lyon 1, INSA, CNRS, UMG UMR 5122, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Shevchik, VE (corresponding author), Univ Lyon 1, INSA, CNRS, UMG UMR 5122, Bat Lwoff,10 Rue Dubois, F-69622 Villeurbanne, France.	vladimir.shevchik@insa-lyon.fr		Shevchik, Vladimir/0000-0002-8031-8638				Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Bleves S, 1999, J BACTERIOL, V181, P4012, DOI 10.1128/JB.181.13.4012-4019.1999; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Dawson JP, 2003, J MOL BIOL, V331, P255, DOI 10.1016/S0022-2836(03)00714-9; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gerard-Vincent M, 2002, MOL MICROBIOL, V44, P1651, DOI 10.1046/j.1365-2958.2002.02991.x; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; GROWLEY PB, 2005, PROTEINS, V59, P231; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; GURRAN AR, 2003, CURR OPIN STRUC BIOL, V13, P412; HARDING SE, 1995, ANAL BIOCHEM, V228, P131, DOI 10.1006/abio.1995.1324; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HM, 2004, J BACTERIOL, V186, P2946, DOI 10.1128/JB.186.10.2946-2955.2004; Lee HM, 2000, J BACTERIOL, V182, P1549, DOI 10.1128/JB.182.6.1549-1557.2000; Lindeberg M, 1996, MOL MICROBIOL, V20, P175, DOI 10.1111/j.1365-2958.1996.tb02499.x; Miller J. H, 1972, EXPT MOL GENETICS; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Pallen MJ, 1997, MOL MICROBIOL, V26, P411, DOI 10.1046/j.1365-2958.1997.5591911.x; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000; Possot OM, 1999, J BACTERIOL, V181, P4004, DOI 10.1128/JB.181.13.4004-4011.1999; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Robert V, 2002, J BACTERIOL, V184, P1779, DOI 10.1128/JB.184.6.1779-1782.2002; Robien MA, 2003, J MOL BIOL, V333, P657, DOI 10.1016/j.jmb.2003.07.015; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SADLER JE, 1979, J BIOL CHEM, V254, P4443; Sandkvist M, 2000, J BACTERIOL, V182, P742, DOI 10.1128/JB.182.3.742-748.2000; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219; SHEVCHIK VE, 1995, MOL MICROBIOL, V16, P745, DOI 10.1111/j.1365-2958.1995.tb02435.x; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; TANFORD C, 1974, BIOCHEMISTRY-US, V13, P2369, DOI 10.1021/bi00708a021; Thomas JD, 1997, MICROBIOL-UK, V143, P713, DOI 10.1099/00221287-143-3-713; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	50	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33152	33162		10.1074/jbc.M606245200	http://dx.doi.org/10.1074/jbc.M606245200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956883	hybrid			2022-12-27	WOS:000241621400023
J	Overton, TW; Whitehead, R; Li, Y; Snyder, LAS; Saunders, NJ; Smith, H; Cole, JA				Overton, Tim W.; Whitehead, Rebekah; Li, Ying; Snyder, Lori A. S.; Saunders, Nigel J.; Smith, Harry; Cole, Jeff A.			Coordinated regulation of the Neisseria gonorrhoeae-truncated denitrification pathway by the nitric oxide-sensitive repressor, NsrR, and nitrite-insensitive NarQ-NarP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; ANAEROBIC GROWTH; CHROMOSOMAL GENES; BLOOD-CELLS; EXPRESSION; NITRATE; ANIA; RESISTANCE; REDUCTASE	Neisseria gonorrhoeae survives anaerobically by reducing nitrite to nitrous oxide catalyzed by the nitrite and nitric oxide reductases, AniA and NorB. P-aniA is activated by FNR (regulator of fumarate and nitrate reduction), the two-component regulatory system NarQ-NarP, and induced by nitrite; P-norB is induced by NO independently of FNR by an uncharacterized mechanism. We report the results of microarray analysis, bioinformatic analysis, and chromatin immunoprecipitation, which revealed that only five genes with readily identified NarP-binding sites are differentially expressed in narP(+) and narP strains. These include three genes implicated in the truncated gonococcal denitrification pathway: aniA, norB, and narQ. We also report that (i) nitrite induces aniA transcription in a narP mutant; (ii) nitrite induction involves indirect inactivation by nitric oxide of a gonococcal repressor, NsrR, identified from a multigenome bioinformatic study; (iii) in an nsrR mutant, aniA, norB, and dnrN (encoding a putative reactive nitrogen species response protein) were expressed constitutively in the absence of nitrite, suggesting that NsrR is the only NO-sensing transcription factor in N. gonorrhoeae; and (iv) NO rather than nitrite is the ligand to which NsrR responds. When expressed in Escherichia coli, gonococcal NarQ and chimaeras of E. coli and gonococcal NarQ are ligand-insensitive and constitutively active: a "locked-on" phenotype. We conclude that genes involved in the truncated denitrification pathway of N. gonorrhoeae are key components of the small NarQP regulon, that NarP indirectly regulates PnorB by stimulating NO production by AniA, and that NsrR plays a critical role in enabling gonococci to evade NO generated as a host defense mechanism.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Univ Oxford, Sir William Dunn Sch Pathol, Bacterial Pathogenesis & Funct Genom Grp, Oxford OX1 3RE, England; Univ Birmingham, Sch Med, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Oxford; University of Birmingham	Cole, JA (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	j.a.cole@bham.ac.uk	Saunders, Nigel J/W-6745-2019; Overton, Tim W/F-3284-2011	Overton, Tim W/0000-0003-3050-2549; Saunders, Nigel/0000-0002-0160-4573; Snyder, Lori/0000-0003-3172-3984				Aparicio O., 2005, CURRENT PROTOCOLS MO, V21, P31; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Beaumont HJE, 2004, J BACTERIOL, V186, P4417, DOI 10.1128/JB.186.13.4417-4421.2004; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Boulanger MJ, 2002, J MOL BIOL, V315, P1111, DOI 10.1006/jmbi.2001.5251; Cairo G, 2002, FREE RADICAL BIO MED, V32, P1237, DOI 10.1016/S0891-5849(02)00825-0; Cardinale JA, 2000, INFECT IMMUN, V68, P4368, DOI 10.1128/IAI.68.7.4368-4369.2000; CLARK VL, 1987, INFECT IMMUN, V55, P1359, DOI 10.1128/IAI.55.6.1359-1364.1987; CLARK VL, 1988, MICROB PATHOGENESIS, V5, P381, DOI 10.1016/0882-4010(88)90038-1; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FRANGIPANE JV, 1993, INFECT IMMUN, V61, P1657, DOI 10.1128/IAI.61.5.1657-1666.1993; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Grifantini R, 2004, MOL MICROBIOL, V54, P962, DOI 10.1111/j.1365-2958.2004.04315.x; Hartig E, 1999, J BACTERIOL, V181, P3658; Householder TC, 1999, J BACTERIOL, V181, P541, DOI 10.1128/JB.181.2.541-551.1999; Householder TC, 2000, INFECT IMMUN, V68, P5241, DOI 10.1128/IAI.68.9.5241-5246.2000; JAYARAMAN PS, 1987, J MOL BIOL, V196, P781, DOI 10.1016/0022-2836(87)90404-9; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; KNAPP JS, 1984, INFECT IMMUN, V46, P176, DOI 10.1128/IAI.46.1.176-181.1984; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lissenden S, 2000, MOL MICROBIOL, V37, P839, DOI 10.1046/j.1365-2958.2000.02050.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mellies J, 1997, MOL GEN GENET, V256, P525, DOI 10.1007/s004380050597; NAIRN CA, 1988, J GEN MICROBIOL, V134, P3295; PARSONS NJ, 1988, MICROB PATHOGENESIS, V5, P303, DOI 10.1016/0882-4010(88)90103-9; POPE NR, 1982, J GEN MICROBIOL, V128, P219; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; SILVER LE, 1995, GENE, V166, P101, DOI 10.1016/0378-1119(95)00605-6; Snyder LAS, 2005, MICROBIOL-SGM, V151, P4005, DOI 10.1099/mic.0.27925-0; Snyder LAS, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-23; Snyder LAS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-128; STEWART V, 1993, MOL MICROBIOL, V9, P425, DOI 10.1111/j.1365-2958.1993.tb01704.x; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Ward SM, 2002, MOL MICROBIOL, V44, P709, DOI 10.1046/j.1365-2958.2002.02902.x	39	79	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33115	33126		10.1074/jbc.M607056200	http://dx.doi.org/10.1074/jbc.M607056200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16954205	Green Accepted, hybrid			2022-12-27	WOS:000241621400020
J	Vaisanen, T; Vaisanen, MR; Pihlajaniemi, T				Vaisanen, Timo; Vaisanen, Marja-Riitta; Pihlajaniemi, Taina			Modulation of the cellular cholesterol level affects shedding of the type XIII collagen ectodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-ASSOCIATED PROTEIN; ALZHEIMERS BETA-SECRETASE; LIPID RAFTS; PLASMA-MEMBRANE; PHASE-SEPARATION; MICRODOMAINS; DEPLETION; DOMAINS; SURFACE; MATRIX	Type XIII collagen is a transmembrane protein that also exists as a soluble extracellular variant because of ectodomain shedding by proprotein convertases. Because ectodomain shedding in a growing number of transmembrane proteins has recently been shown to be dependent on their localization in cholesterol-enriched detergent-resistant membrane microdomains, this work aimed at analyzing this aspect of type XIII collagen ectodomain processing. In HT-1080 cells type XIII collagen and its cleaving proprotein convertase furin localized partially in detergent-resistant cholesterol-containing membrane microdomains. Disruption of these domains by lowering either the level or availability of the cellular cholesterol reduced ectodomain shedding, implying that, in such membrane domains correct cholesterol level is important for the regulation of type XIII collagen ectodomain processing. In addition, we show here that ectodomain of type XIII collagen is also shed intracellularly. HT-1080 cells released vesicles from the Golgi apparatus, which contained only the cleaved variant. Intracellular processing and the subsequent entry of the cleaved ectodomain into the vesicles was totally blocked by inhibition of the proprotein convertase function by cell-permeable chloromethylketone, but not with cell-impermeable alpha 1-antitrypsin Portland. This supports the hypothesis of type XIII collagen ectodomain also being cleaved intracellularly in the Golgi and suggests that the intracellular cleavage may act as a gating event in the vesicle-mediated ectodomain secretion.	Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; Univ Oulu, Collagen Res Unit, Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Pihlajaniemi, T (corresponding author), Univ Oulu, Dept Med Biochem & Mol Biol, POB 5000, FIN-90014 Oulu, Finland.	taina.pihlajaniemi@oulu.fi		Pihlajaniemi, Taina/0000-0002-1664-9045				Angelucci A, 2000, CLIN EXP METASTAS, V18, P163, DOI 10.1023/A:1006778000173; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Baldwin TA, 2002, J BIOL CHEM, V277, P50333, DOI 10.1074/jbc.M209075200; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; Dolo V, 1998, CANCER RES, V58, P4468; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; FOLCH J, 1957, J BIOL CHEM, V226, P497; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Ginestra A, 1998, ANTICANCER RES, V18, P3433; GOMEZ L, 1993, PLANT CELL, V5, P1113, DOI 10.1105/tpc.5.9.1113; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hagg P, 1998, J BIOL CHEM, V273, P15590, DOI 10.1074/jbc.273.25.15590; Hagg P, 2001, MATRIX BIOL, V19, P727, DOI 10.1016/S0945-053X(00)00119-0; Hansen GH, 2000, J BIOL CHEM, V275, P5136, DOI 10.1074/jbc.275.7.5136; HOLM C, 1986, J BIOL CHEM, V261, P5659; HOWELL KE, 1982, J CELL BIOL, V92, P822, DOI 10.1083/jcb.92.3.822; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Karacsonyi C, 2005, J LEUKOCYTE BIOL, V78, P1097, DOI 10.1189/jlb.0405189; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kvist AP, 2001, AM J PATHOL, V159, P1581, DOI 10.1016/S0002-9440(10)62542-4; Lai EC, 2003, J CELL BIOL, V162, P365, DOI 10.1083/jcb.200307087; Leitinger B, 2002, J CELL SCI, V115, P963; Maile LA, 2002, J BIOL CHEM, V277, P1800, DOI 10.1074/jbc.M108380200; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Phong MC, 2003, BIOCHEM BIOPH RES CO, V300, P563, DOI 10.1016/S0006-291X(02)02886-3; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Radeva G, 2005, FEBS J, V272, P4924, DOI 10.1111/j.1742-4658.2005.04905.x; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Snellman A, 2000, EMBO J, V19, P5051, DOI 10.1093/emboj/19.19.5051; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; SUBRAMANIAM VN, 1992, J BIOL CHEM, V267, P12016; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tu HM, 2002, J BIOL CHEM, V277, P23092, DOI 10.1074/jbc.M107583200; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Vaisanen MR, 2006, BIOCHEM J, V393, P43, DOI 10.1042/BJ20051073; Vaisanen MR, 2004, BIOCHEM J, V380, P685, DOI 10.1042/BJ20031974; Vaisanen T, 2005, J PATHOL, V207, P324, DOI 10.1002/path.1836; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Werb Z, 1998, SCIENCE, V282, P1279, DOI 10.1126/science.282.5392.1279; Wickstrom SA, 2003, J BIOL CHEM, V278, P37895, DOI 10.1074/jbc.M303569200; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Young WW, 1999, GLYCOBIOLOGY, V9, P689, DOI 10.1093/glycob/9.7.689; Zimina EP, 2005, J BIOL CHEM, V280, P34019, DOI 10.1074/jbc.M503751200	60	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33352	33362		10.1074/jbc.M605896200	http://dx.doi.org/10.1074/jbc.M605896200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950783	hybrid			2022-12-27	WOS:000241621400045
J	Carroll, J; Fearnley, IM; Skehel, JM; Shannon, RJ; Hirst, J; Walker, JE				Carroll, Joe; Fearnley, Ian M.; Skehel, J. Mark; Shannon, Richard J.; Hirst, Judy; Walker, John E.			Bovine complex I is a complex of 45 different subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; PROTON-TRANSLOCATING NADH; NUCLEAR-ENCODED SUBUNITS; ACYL-CARRIER PROTEIN; HEART-MITOCHONDRIA; MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; SUBCOMPLEXES; SEQUENCES; CHAIN	Mammalian mitochondrial complex I is a multisubunit membrane-bound assembly with a molecular mass approaching 1 MDa. By comprehensive analyses of the bovine complex and its constituent subcomplexes, 45 different subunits have been characterized previously. The presence of a 46th subunit was suspected from the consistent detection of a molecular mass of 10,566 by electrospray ionization mass spectrometry of subunits fractionated by reverse-phase high pressure liquid chromatography. The component was found associated with both the intact complex and subcomplex I beta, which represents most of the membrane arm of the complex, and it could not be resolved chromatographically from subunit SGDH( the subunit of bovine complex I with the N-terminal sequence Ser-Gly-Asp-His). It has now been characterized by tandem mass spectrometry of intact protein ions and shown to be a C-terminal fragment of subunit SGDH arising from a specific peptide bond cleavage between Ile-55 and Pro-56 during the electrospray ionization process. Thus, the subunit composition of bovine complex I has been established. It is a complex of 45 different proteins plus non-covalently bound FMN and eight iron-sulfur clusters.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Walker, JE (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.	walker@mrc-dunn.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797; Walker, John/0000-0001-7929-2162	Medical Research Council [MC_U105663148, MC_U105663141] Funding Source: Medline; MRC [MC_U105663148, MC_U105663141] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ARIZMENDI JM, 1992, FEBS LETT, V313, P80, DOI 10.1016/0014-5793(92)81189-S; ARIZMENDI JM, 1992, FEBS LETT, V301, P237, DOI 10.1016/0014-5793(92)80248-F; Baker ME, 1999, CELL MOL LIFE SCI, V55, P450, DOI 10.1007/s000180050301; Breci LA, 2003, ANAL CHEM, V75, P1963, DOI 10.1021/ac026359i; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; FEARNLEY IM, 1994, BIOCHEM SOC T, V22, P551, DOI 10.1042/bst0220551; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; FINEL M, 1992, BIOCHEMISTRY-US, V31, P11425, DOI 10.1021/bi00161a022; FINEL M, 1994, EUR J BIOCHEM, V226, P237, DOI 10.1111/j.1432-1033.1994.tb20046.x; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; HILLENKAMP F, 1990, METHOD ENZYMOL, V193, P280, DOI 10.1016/0076-6879(90)93420-P; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Johnson RW, 2005, ANAL BIOCHEM, V341, P22, DOI 10.1016/j.ab.2005.03.009; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; SACKMANN U, 1991, EUR J BIOCHEM, V200, P463, DOI 10.1111/j.1432-1033.1991.tb16205.x; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2000, J MOL BIOL, V302, P455, DOI 10.1006/jmbi.2000.4079; Schaaff TG, 2000, ANAL CHEM, V72, P899, DOI 10.1021/ac991344e; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Skehel JM, 1998, FEBS LETT, V438, P301, DOI 10.1016/S0014-5793(98)01317-9; Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800; WALKER JE, 1992, J MOL BIOL, V226, P1051, DOI 10.1016/0022-2836(92)91052-Q; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; WILM MS, 1994, INT J MASS SPECTROM, V136, P167, DOI 10.1016/0168-1176(94)04024-9; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yano T, 1997, J BIOL CHEM, V272, P4201, DOI 10.1074/jbc.272.7.4201	34	365	388	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32724	32727		10.1074/jbc.M607135200	http://dx.doi.org/10.1074/jbc.M607135200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950771	hybrid			2022-12-27	WOS:000241414500071
J	Fiedler, B; Feil, R; Hofmann, F; Willenbockel, C; Drexler, H; Smolenski, A; Lohmann, SM; Wollert, KC				Fiedler, Beate; Feil, Robert; Hofmann, Franz; Willenbockel, Christian; Drexler, Helmut; Smolenski, Albert; Lohmann, Suzanne M.; Wollert, Kai C.			cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; VASODILATOR-STIMULATED PHOSPHOPROTEIN; INDUCED MYOCARDIAL APOPTOSIS; MUSCLE LIM PROTEIN; NF-KAPPA-B; REPERFUSION INJURY; ISCHEMIA-REPERFUSION; CARDIOMYOCYTE APOPTOSIS; ISCHEMIA/REPERFUSION INJURY; INDEPENDENT ACTIVATION	Cardiac myocyte apoptosis during ischemia and reperfusion (I/R) is tightly controlled by a complex network of stress-responsive signaling pathways. One pro-apoptotic pathway involves the interaction of the scaffold protein TAB1 with p38 mitogen-activated protein kinase (p38 MAPK) leading to the autophosphorylation and activation of p38 MAPK. Conversely, NO and its second messenger cGMP protect cardiac myocytes from apoptosis during I/R. We provide evidence that the cGMP target cGMP-dependent protein kinase type I (PKGI) interferes with TAB1-p38 MAPK signaling to protect cardiac myocytes from I/R injury. In isolated neonatal cardiac myocytes, activation of PKGI inhibited the interaction of TAB1 with p38 MAPK, p38 MAPK phosphorylation, and apoptosis induced by simulated I/R. During I/R in vivo, mice with a cardiac myocyte-restricted deletion of PKGI displayed a more pronounced interaction of TAB1 with p38 MAPK and a stronger phosphorylation of p38 MAPK in the myocardial area at risk during reperfusion and more apoptotic cardiac myocytes in the infarct border zone as compared with wild-type littermates. Notably, adenoviral expression of a constitutively active PKGI mutant truncated at the N terminus(PKGI-Delta N1-92) did not inhibit p38 MAPK phosphorylation and apoptosis induced by simulated I/R in vitro, indicating that the N terminus of PKGI is required. As shown by co-immunoprecipitation experiments in HEK293 cells, cGMP-activated PKGI, but not constitutively active PKGI-Delta N1-92 or PKGI mutants carrying point mutations in the N-terminal leucine-isoleucine zipper, interacted with p38 MAPK, and prevented the binding of TAB1 to p38 MAPK. Together, our data identify a novel interaction between the cGMP target PKG I and the TAB1-p38 MAPK signaling pathway that serves as a defense mechanism against myocardial I/R injury.	Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany; Tech Univ Munich, Inst Pharmacol & Toxicol, D-80802 Munich, Germany; Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany	Hannover Medical School; Technical University of Munich; University of Wurzburg	Wollert, KC (corresponding author), Hannover Med Sch, Abt Kardiol & Angiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	wollert.kai@mh-hannover.de	Feil, Robert/B-8918-2014	Feil, Robert/0000-0002-7335-4841; Smolenski, Albert/0000-0001-9210-9406				Agullo L, 1999, AM J PHYSIOL-HEART C, V276, pH1574, DOI 10.1152/ajpheart.1999.276.5.H1574; Arstall MA, 1999, CIRC RES, V85, P829, DOI 10.1161/01.RES.85.9.829; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; BUTT E, 1992, BIOCHEM PHARMACOL, V43, P2591, DOI 10.1016/0006-2952(92)90148-C; Communal C, 2000, J BIOL CHEM, V275, P19395, DOI 10.1074/jbc.M910471199; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; Heineke J, 2003, CIRCULATION, V107, P1424, DOI 10.1161/01.CIR.0000055319.94801.FC; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Hoover HE, 2000, J BIOL CHEM, V275, P23825, DOI 10.1074/jbc.M003864200; Jones SP, 2006, J MOL CELL CARDIOL, V40, P16, DOI 10.1016/j.yjmcc.2005.09.011; Jones SP, 2004, AM J PHYSIOL-HEART C, V286, pH276, DOI 10.1152/ajpheart.00129.2003; Jones SP, 1999, AM J PHYSIOL-HEART C, V276, pH1567, DOI 10.1152/ajpheart.1999.276.5.H1567; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kang YJ, 2000, J BIOL CHEM, V275, P13690, DOI 10.1074/jbc.275.18.13690; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kumar R, 1999, J PHARMACOL EXP THER, V291, P967; Lalu Manoj M, 2002, Heart Fail Rev, V7, P359, DOI 10.1023/A:1020766502316; Li QH, 2003, CIRC RES, V92, P741, DOI 10.1161/01.RES.0000065441.72685.29; Ma XL, 1999, CIRCULATION, V99, P1685, DOI 10.1161/01.CIR.99.13.1685; Maejima Y, 2003, CARDIOVASC RES, V59, P308, DOI 10.1016/S0008-6363(03)00425-5; MARKERT T, 1995, J CLIN INVEST, V96, P822, DOI 10.1172/JCI118128; Matsuyama W, 2003, J IMMUNOL, V171, P3520, DOI 10.4049/jimmunol.171.7.3520; MEINECKE M, 1994, MOL PHARMACOL, V46, P283; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Oldenburg O, 2004, AM J PHYSIOL-HEART C, V286, pH468, DOI 10.1152/ajpheart.00360.2003; Otsu K, 2003, BIOCHEM BIOPH RES CO, V302, P56, DOI 10.1016/S0006-291X(03)00096-2; Pabla R, 1996, CIRC RES, V78, P65, DOI 10.1161/01.RES.78.1.65; Sasaki N, 2000, CIRCULATION, V101, P439, DOI 10.1161/01.CIR.101.4.439; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Smolenski A, 2000, J BIOL CHEM, V275, P25723, DOI 10.1074/jbc.M909632199; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Stephanou A, 2000, J BIOL CHEM, V275, P10002, DOI 10.1074/jbc.275.14.10002; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Weiland U, 2000, CARDIOVASC RES, V45, P671, DOI 10.1016/S0008-6363(99)00347-8; Wollert KC, 2002, HYPERTENSION, V39, P87, DOI 10.1161/hy1201.097292; Yoshida H, 2000, HYPERTENSION, V35, P25, DOI 10.1161/01.HYP.35.1.25; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zechner D, 1998, J BIOL CHEM, V273, P8232, DOI 10.1074/jbc.273.14.8232; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zingarelli B, 2002, FASEB J, V16, DOI 10.1096/fj.01-0533com	54	71	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32831	32840		10.1074/jbc.M603416200	http://dx.doi.org/10.1074/jbc.M603416200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943189	hybrid			2022-12-27	WOS:000241414500081
J	Yan, ZH; Liang, ZD; Obsil, T; Stojilkovic, SS				Yan, Zonghe; Liang, Zhaodong; Obsil, Tomas; Stojilkovic, Stanko S.			Participation of the Lys(313)-Ile(333) sequence of the purinergic P2X4 receptor in agonist binding and transduction of signals to the channel gate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P2X(1) RECEPTORS; ATP-BINDING; TRANSMEMBRANE SEGMENTS; DEPENDENT CHANGES; SWISS-MODEL; AMINO-ACIDS; ION-CHANNEL; SITE; PORE; IDENTIFICATION	To study the roles of the Lys(313)-Ile(333) ectodomain sequence of the rat P2X(4) receptor in ATP binding and transduction of signals to the channel gate, the conserved Lys(313), Tyr(315), Gly(316), Ike(317), Arg(318), Asp(320), Val(323), Lys(329), Phe(330), and Ile(333) residues were mutated. Current recordings were done on lifted cells and ATP was applied using an ultrafast solution-switching system. The rates of wild type channel opening and closing in the presence of ATP, but not the rate of washout-induced closing, were dependent on agonist concentration. All mutants other than I317A were expressed in the plasma membrane at comparable levels. The majority of mutants showed significant changes in the peak amplitude of responses and the EC50 values for ATP. When stimulated with the supramaximal (1.4mM) ATP concentration, mutants also differed in the kinetics of their activation, deactivation, and/or desensitization. The results suggest a critical role of the Lys(313) residue in receptor function other than coordination of the phosphate group of ATP and possible contribution of the Tyr(315) residue to the agonist binding module. The pattern of changes of receptor function by mutation of other residues was consistent with the operation of the Gly(316) Ile(333) sequence as a signal transduction module between the ligand binding domain and the channel gate in the second transmembrane domain.	NICHD, ERRB, Sect Cellular Signaling, NIH, Bethesda, MD 20892 USA; Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Charles University Prague	Stojilkovic, SS (corresponding author), NICHD, ERRB, Sect Cellular Signaling, NIH, Bldg 49,Rm 6A-36,49 Convent Dr, Bethesda, MD 20892 USA.	stankos@helix.nih.gov	Obsil, Tomas/B-7142-2012	Obsil, Tomas/0000-0003-4602-1272	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000195] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000195] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Beckstein O, 2003, FEBS LETT, V555, P85, DOI 10.1016/S0014-5793(03)01151-7; BELRHALI H, 1994, SCIENCE, V263, P1432, DOI 10.1126/science.8128224; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Chen NS, 2004, MOL PHARMACOL, V65, P157, DOI 10.1124/mol.65.1.157; Clyne JD, 2003, NEUROPHARMACOLOGY, V44, P403, DOI 10.1016/S0028-3908(02)00406-9; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Digby HR, 2005, J NEUROCHEM, V95, P1746, DOI 10.1111/j.1471-4159.2005.03494.x; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, CURR TOP MED CHEM, V4, P821, DOI 10.2174/1568026043451005; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2001, BIOCHEM BIOPH RES CO, V289, P700, DOI 10.1006/bbrc.2001.6034; Freist W, 1998, FEBS LETT, V434, P61, DOI 10.1016/S0014-5793(98)00958-2; Fujiwara Y, 2004, J PHYSIOL-LONDON, V558, P31, DOI 10.1113/jphysiol.2004.064568; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; MORRIS JM, 1987, J COMPUT CHEM, V19, P1639; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nakazawa K, 2004, EUR J PHARMACOL, V483, P29, DOI 10.1016/j.ejphar.2003.10.026; Nakazawa K, 1998, EUR J PHARMACOL, V347, P141, DOI 10.1016/S0014-2999(98)00207-6; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Stojilkovic SS, 2005, ANN NY ACAD SCI, V1048, P116, DOI 10.1196/annals.1342.011; Torres GE, 1999, J BIOL CHEM, V274, P22359, DOI 10.1074/jbc.274.32.22359; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; WILKINSON WJ, 2006, IN PRESS MOL PHARM; Worthington RA, 2002, FEBS LETT, V512, P43, DOI 10.1016/S0014-5793(01)03311-7; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Zemkova H, 2004, J NEUROSCI, V24, P6968, DOI 10.1523/JNEUROSCI.1471-04.2004	49	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32649	32659		10.1074/jbc.M512791200	http://dx.doi.org/10.1074/jbc.M512791200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954225	hybrid			2022-12-27	WOS:000241414500063
J	Gautam, M; Shen, Y; Thirkill, TL; Douglas, GC; Barakat, AI				Gautam, Mamta; Shen, Yue; Thirkill, Twanda L.; Douglas, Gordon C.; Barakat, Abdul I.			Flow-activated chloride channels in vascular endothelium - Shear stress sensitivity, desensitization dynamics, and physiological implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; ATHEROSCLEROSIS; PHOSPHORYLATION; APOPTOSIS; PULSATILE; RESPONSES; KINASE; MODEL; WALL; AKT	Although activation of outward rectifying Cl- channels is one of the fastest responses of endothelial cells (ECs) to shear stress, little is known about these channels. In this study, we used whole-cell patch clamp recordings to characterize the flow-activated Cl- current in bovine aortic ECs (BAECs). Application of shear stress induced rapid development of a Cl- current that was effectively blocked by the Cl- channel antagonist 5-nitro-2(3-phenopropylamino) benzoic acid (100 mu M). The current initiated at a shear stress as low as 0.3 dyne/cm(2), attained its peak within minutes of flow onset, and saturated above 3.5 dynes/cm(2) (similar to 2.5-3.5-fold increase over pre-flow levels). The Cl- current desensitized slowly in response to sustained flow, and step increases in shear stress elicited increased current only if the shear stress levels were below the 3.5 dynes/cm(2) saturation level. Oscillatory flow with a physiological oscillation frequency of 1 Hz, as occurs in disturbed flow zones prone to atherosclerosis, failed to elicit the Cl- current, whereas lower oscillation frequencies led to partial recovery of the current. Nonreversing pulsatile flow, generally considered protective of atherosclerosis, was as effective in eliciting the current as steady flow. Measurements using fluids of different viscosities indicated that the Cl- current is responsive to shear stress rather than shear rate. Blocking the flow-activated Cl- current abolished flow-induced Akt phosphorylation in BAECs, whereas blocking flow-sensitive K+ currents had no effect, suggesting that flow-activated Cl+ channels play an important role in regulating EC flow signaling.	Univ Calif Davis, Dept Mech & Aeronaut Engn, Davis, CA 95616 USA; Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Barakat, AI (corresponding author), Univ Calif Davis, Dept Mech & Aeronaut Engn, 1 Shields Ave, Davis, CA 95616 USA.	abarakat@ucdavis.edu	Barakat, Abdul I/AAI-3117-2020	Barakat, Abdul I/0000-0002-7551-3631				ANDO J, 1993, BIOCHEM BIOPH RES CO, V190, P716, DOI 10.1006/bbrc.1993.1108; Barakat AI, 1999, CIRC RES, V85, P820, DOI 10.1161/01.RES.85.9.820; Barakat AI, 2006, BIOMATERIALS, V27, P671, DOI 10.1016/j.biomaterials.2005.07.036; Barakat AI, 2001, J THEOR BIOL, V210, P221, DOI 10.1006/jtbi.2001.2290; Britt JC, 1997, PFLUG ARCH EUR J PHY, V434, P38, DOI 10.1007/s004240050360; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; Go YM, 2001, J APPL PHYSIOL, V91, P1574, DOI 10.1152/jappl.2001.91.4.1574; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; JACOBS ER, 1995, PFLUG ARCH EUR J PHY, V431, P129, DOI 10.1007/BF00374386; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Lieu DK, 2004, AM J PHYSIOL-CELL PH, V286, pC1367, DOI 10.1152/ajpcell.00243.2003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAKACHE M, 1988, P NATL ACAD SCI USA, V85, P1841, DOI 10.1073/pnas.85.6.1841; NEREM RM, 1992, J BIOMECH ENG-T ASME, V114, P274, DOI 10.1115/1.2891384; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; POHL U, 1986, HYPERTENSION, V8, P37, DOI 10.1161/01.HYP.8.1.37; Qiu WP, 2003, AM J PHYSIOL-HEART C, V285, pH341, DOI 10.1152/ajpheart.01072.2002; Romanenko VG, 2002, AM J PHYSIOL-CELL PH, V282, pC708, DOI 10.1152/ajpcell.00247.2001; Suvatne J, 2001, AM J PHYSIOL-CELL PH, V280, pC216, DOI 10.1152/ajpcell.2001.280.1.C216; Wiesner TF, 1997, P NATL ACAD SCI USA, V94, P3726, DOI 10.1073/pnas.94.8.3726	27	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36492	36500		10.1074/jbc.M605866200	http://dx.doi.org/10.1074/jbc.M605866200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16973617	hybrid			2022-12-27	WOS:000242220800004
J	Ahmad, R; Raina, D; Meyer, C; Kharbanda, S; Kufe, D				Ahmad, Rehan; Raina, Deepak; Meyer, Colin; Kharbanda, Surender; Kufe, Donald			Triterpenoid CDDO-Me blocks the NF-kappa B pathway by direct inhibition of IKK beta on Cys-179	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-CYANO-3,12-DIOXOOLEANA-1,9-DIEN-28-OIC ACID CDDO; TUMOR-NECROSIS-FACTOR; INDUCE APOPTOSIS; 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; KINASE; CANCER; CELLS; DIFFERENTIATION; EXPRESSION; LIGAND	The novel oleanane triterpenoid 2-cyano-3,12-dioxooleana-1,9,-dien-28-oic acid ( CDDO) and the C-28 methyl ester (CDDO-Me) induce apoptosis of human tumor cells by disruption of redox balance and are currently in clinical trials. The present studies show that CDDO and CDDO-Me block tumor necrosis factor alpha-induced targeting of NF-kappa B p65 to the nucleus. CDDO- Me also blocked tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha. In concert with these results, we found that CDDO- Me inhibits I kappa B alpha kinase beta(IKK beta) activity in cells. In support of a direct mechanism, CDDO- Me inhibited recombinant IKK beta activity in vitro. The results also demonstrate that (i) CDDO and CDDO- Me form adducts with IKK beta, but not IKK beta with mutation of Cys-179 to Ala, and (ii)CDDO- Me inhibits IKK beta by a mechanism dependent on oxidation of Cys-179. These findings indicate that CDDO and CDDO-Me directly block IKK beta activity and thereby the NF-kappa B pathway by interacting with Cys-179 in the IKK beta activation loop.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Reata Pharmaceut Inc, Dallas, TX 75207 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu	Rather, R A/J-3509-2019		NCI NIH HHS [CA98628, CA100707, CA42802] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042802, R01CA098628, P50CA100707] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bernier M, 2006, J BIOL CHEM, V281, P2551, DOI 10.1074/jbc.M511878200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Couch RD, 2005, BIOORG MED CHEM LETT, V15, P2215, DOI 10.1016/j.bmcl.2005.03.031; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Honda T, 2004, J MED CHEM, V47, P4923, DOI 10.1021/jm049727e; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Ikeda T, 2005, CELL DEATH DIFFER, V12, P523, DOI 10.1038/sj.cdd.4401574; Ikeda T, 2004, MOL CANCER THER, V3, P39, DOI 10.2463/mrms.3.39; Ikeda T, 2003, CANCER RES, V63, P5551; Ito Y, 2001, MOL PHARMACOL, V59, P1094, DOI 10.1124/mol.59.5.1094; Ito Y, 2000, CELL GROWTH DIFFER, V11, P261; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kharbanda S, 1996, CANCER RES, V56, P3617; Kim KB, 2002, MOL CANCER THER, V1, P177; Konopleva M, 2004, CANCER RES, V64, P7927, DOI 10.1158/0008-5472.CAN-03-2402; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Lapillonne H, 2003, CANCER RES, V63, P5926; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Samudio I, 2005, J BIOL CHEM, V280, P36273, DOI 10.1074/jbc.M507518200; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Stadheim TA, 2002, J BIOL CHEM, V277, P16448, DOI 10.1074/jbc.M108974200; Suh NJ, 1999, CANCER RES, V59, P336; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Zhang YD, 2004, CANCER RES, V64, P1902, DOI 10.1158/0008-5472.CAN-03-3361; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238	30	206	240	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35764	35769		10.1074/jbc.M607160200	http://dx.doi.org/10.1074/jbc.M607160200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16998237	hybrid			2022-12-27	WOS:000242100500022
J	Fujita-Becker, S; Tsiavaliaris, G; Ohkura, R; Shimada, T; Manstein, DJ; Sutoh, K				Fujita-Becker, Setsuko; Tsiavaliaris, Georgios; Ohkura, Reiko; Shimada, Takashi; Manstein, Dietmar J.; Sutoh, Kazuo			Functional characterization of the N-terminal region of myosin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM-DISCOIDEUM MYOSIN; SMOOTH-MUSCLE MYOSIN; MOTOR DOMAIN; CRYSTAL-STRUCTURE; HEAVY-MEROMYOSIN; POWER STROKE; LIGHT-CHAIN; RELAY LOOP; 2 HEADS; ACTIN	All class 2 myosins contain an N-terminal extension of similar to 80 residues that includes an Src homology 3 (SH3)-like subdomain. To explore the functional importance of this region, which is also present in most other myosin classes, we generated truncated constructs of Dictyostelium discoideum myosin-2. Truncation at position 80 resulted in the complete loss of myosin-2 function in vivo. Actin affinity was more than 80-fold, and the rate of ADP release similar to 40-fold decreased in this mutant. In contrast, a myosin construct that lacks only the SH3-like subdomain, corresponding to residues 33-79, displayed much smaller functional defects. In complementation experiments with myosin-2 null cells, this construct rescued myosin-2-dependent processes such as cytokinesis, fruiting body formation, and sporogenesis. An 8-fold reduction in motile activity and changes of similar extent in the affinity for ADP and filamentous actin indicate the importance of the SH3-like subdomain for correct communication between the functional regions within the myosin motor domain and suggest that local perturbations in this region can play a role in modulating myosin-2 motor activity.	Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; Max Planck Inst Med Res, D-69120 Heidelberg, Germany; Univ Tokyo, Dept Life Sci, Tokyo 1538902, Japan	Hannover Medical School; Max Planck Society; University of Tokyo	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, OE4350,Carl Neubergstr 1, D-30625 Hannover, Germany.	manstein@bpc.mh-hannover.de	Manstein, Dietmar J. J/M-1034-2013; Manstein, Dietmar J./AAG-2640-2019	Manstein, Dietmar J. J/0000-0003-0763-0147; Manstein, Dietmar J./0000-0003-0763-0147				Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Geeves MA, 2005, CELL MOL LIFE SCI, V62, P1462, DOI 10.1007/s00018-005-5015-5; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Ito K, 1999, BIOPHYS J, V76, P985, DOI 10.1016/S0006-3495(99)77262-0; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Nikolaeva OP, 2002, EUR J BIOCHEM, V269, P5678, DOI 10.1046/j.1432-1033.2002.03279.x; ONISHI H, 1990, J BIOL CHEM, V265, P19362; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; Tsiavaliaris G, 2002, EMBO REP, V3, P1099, DOI 10.1093/embo-reports/kvf214; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; van Duffelen M, 2005, BIOCHEM BIOPH RES CO, V329, P563, DOI 10.1016/j.bbrc.2005.01.152; van Duffelen M, 2004, BIOPHYS J, V87, P1767, DOI 10.1529/biophysj.104.044388; Woodward SKA, 1995, BIOCHEMISTRY-US, V34, P16056, DOI 10.1021/bi00049a020	34	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36102	36109		10.1074/jbc.M605171200	http://dx.doi.org/10.1074/jbc.M605171200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16982629	hybrid			2022-12-27	WOS:000242100500059
J	Chakraborty, S; Reineke, EL; Lam, M; Li, XF; Liu, Y; Gao, CZ; Khurana, S; Kao, HY				Chakraborty, Sharmistha; Reineke, Erin L.; Lam, Minh; Li, Xiaofang; Liu, Yu; Gao, Chengzhuo; Khurana, Simran; Kao, Hung-Ying			alpha-actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; CELL MOTILITY; CROSS-LINKING; BINDING PROTEIN; NUCLEAR EXPORT; ASSOCIATION; REPRESSION; ACTININ-4; CANCER; PHOSPHORYLATION	Histone deacetylase 7 (HDAC7) is a member of class IIa HDACs that regulate myocyte enhancer factor-2 (MEF2)-mediated transcription and participate in multiple cellular processes such as T cell apoptosis. We have identified alpha-actinin 1 and 4 as class IIa HDAC-interacting proteins. The interaction domains are mapped to C terminus of alpha-actinin 4 and amino acids 72-172 of HDAC7. A point mutation in HDAC7 that disrupts its association with MEF2A also disrupts its association with alpha-actinin 4, indicating that MEF2A and alpha-actinin 4 binding sites largely overlap. We have also isolated a novel splice variant of alpha-actinin 4 that is predominantly localized in the nucleus, a pattern distinct from the full-length alpha-actinin 4, which is primarily distributed in the cytoplasm and plasma membrane. Using small interfering RNA, chromatin immunoprecipitation, and transient transfection assays, we show that alpha-actinin 4 potentiates expression of TAF55, a putative MEF2 target gene. Loss of MEF2A interaction correlates with loss of the ability of alpha-actinin 4 to potentiate TAF55 promoter activity. Ectopic expression of alpha-actinin 4, but not the mutant defective in MEF2A association, leads to disruption of HDAC7 center dot MEF2A association and enhancement of MEF2-mediated transcription. Taken together, we have identified a novel mechanism by which HDAC7 activity is negatively regulated and uncovered a previously unknown function of alpha-actinin 4.	Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Comprehens Canc, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Inst Res, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@po.cwru.edu	Gao, Chengzhuo/G-6361-2010		NCI NIH HHS [T32 CA059366-11, P30 CA43703-12] Funding Source: Medline; NIDDK NIH HHS [R01 DK62985] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA059366, P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062985] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babakov V N, 2004, Tsitologiia, V46, P1064; Berger I, 2003, J BIOL CHEM, V278, P17625, DOI 10.1074/jbc.M301646200; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; DUBREUIL RR, 1991, BIOESSAYS, V13, P219, DOI 10.1002/bies.950130504; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Gao CZ, 2006, FEBS LETT, V580, P5096, DOI 10.1016/j.febslet.2006.08.038; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Honda K, 2004, ONCOGENE, V23, P5257, DOI 10.1038/sj.onc.1207652; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kao HY, 2000, GENE DEV, V14, P55; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Liu QY, 2004, CELL DEATH DIFFER, V11, P645, DOI 10.1038/sj.cdd.4401401; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; Nikolopoulos SN, 2000, ONCOGENE, V19, P380, DOI 10.1038/sj.onc.1203310; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Poch MT, 2004, TOXICOL APPL PHARM, V199, P239, DOI 10.1016/j.taap.2003.12.023; TRAVE G, 1995, EMBO J, V14, P4922, DOI 10.1002/j.1460-2075.1995.tb00175.x; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; Zhou TY, 2001, J BIOL CHEM, V276, P25503, DOI 10.1074/jbc.M102875200	29	56	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35070	35080		10.1074/jbc.M602474200	http://dx.doi.org/10.1074/jbc.M602474200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16980305	hybrid			2022-12-27	WOS:000241933700040
J	Schrader, R; Young, C; Kozian, D; Hoffmann, R; Lottspeich, F				Schrader, Rainer; Young, Craig; Kozian, Detlef; Hoffmann, Reinhard; Lottspeich, Friedrich			Temperature-sensitive eIF5A mutant accumulates transcripts targeted to the nonsense-mediated decay pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 5A; DEOXYHYPUSINE SYNTHASE; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; HYPUSINE FORMATION; GENE DISRUPTION; SHUTTLE VECTORS; YEAST GENES; AMINO-ACID; RNA	The highly conserved protein eIF5A found in Archaea and all eukaryotes uniquely contains the posttranslationally formed amino acid hypusine. Despite being essential the functions of this protein and its modification remain unclear. To gain more insight into these functions temperature-sensitive mutants of the human EIF5A1 were characterized in the yeast Saccharomyces cerevisiae. Expression of the point mutated form V81G in a Delta eIF5A strain of yeast led to a strongly temperature-sensitive phenotype and to a significantly reduced protein level at restrictive temperature. The mutant showed accumulation of a subset of mRNAs that was also observed in nonsense-mediated decay (NMD)-deficient yeast strains. After short incubation at restrictive temperature the mutant exhibited increased half-lives of the intron containing CYH2 pre-mRNA and mature transcripts of NMD-dependent genes. Reduced telomere silencing and shortening was detected in the V81G mutant further supporting similarities to NMD-deficient strains. Our data suggest that eIF5A mediates important cellular processes like cell viability and senescence through its effects on the stability of certain mRNAs.	Max Planck Inst Biochem, Dept Prot Analyt, D-82152 Martinsried, Germany; Aventis Pharma Germany GmbH, D-65929 Frankfurt, Germany; Max Von Pettenkofer Inst, Dept Bacteriol, D-80336 Munich, Germany	Max Planck Society; Sanofi-Aventis; University of Munich	Schrader, R (corresponding author), Max Planck Inst Biochem, Dept Prot Analyt, Klopferspitz 18, D-82152 Martinsried, Germany.	schrader@biochem.mpg.de	Hoffmann, Reinhard/I-8748-2018	Hoffmann, Reinhard/0000-0003-1514-1183				Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Atkin AL, 1997, J BIOL CHEM, V272, P22163, DOI 10.1074/jbc.272.35.22163; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Burhans WC, 2003, MUTAT RES-FUND MOL M, V532, P227, DOI 10.1016/j.mrfmmm.2003.08.019; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chen ZP, 1997, J CELL PHYSIOL, V170, P248, DOI 10.1002/(SICI)1097-4652(199703)170:3<248::AID-JCP5>3.0.CO;2-O; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Dahlseid JN, 2003, EUKARYOT CELL, V2, P134, DOI 10.1128/EC.2.1.134-142.2003; Enomoto S, 2004, MOL CELL BIOL, V24, P837, DOI 10.1128/MCB.24.2.837-845.2004; Facchiano AM, 2001, PROTEIN ENG, V14, P881, DOI 10.1093/protein/14.11.881; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HANAUSKEABEL HM, 1995, FEBS LETT, V366, P92, DOI 10.1016/0014-5793(95)00493-S; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HODGSON VJ, 1994, FEMS MICROBIOL LETT, V120, P201, DOI [10.1111/j.1574-6968.1994.tb07031.x, 10.1016/0378-1097(94)90090-6]; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Jao DLE, 2002, J CELL BIOCHEM, V86, P590, DOI 10.1002/jcb.10235; Jin Bao-Feng, 2003, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V11, P325; KANG HA, 1994, J BIOL CHEM, V269, P3934; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Kim KK, 1998, P NATL ACAD SCI USA, V95, P10419, DOI 10.1073/pnas.95.18.10419; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lelivelt MJ, 1999, MOL CELL BIOL, V19, P6710; Lendvay TS, 1996, GENETICS, V144, P1399; Lew JE, 1998, MOL CELL BIOL, V18, P6121, DOI 10.1128/MCB.18.10.6121; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Liu YP, 1997, BIOL SIGNAL, V6, P166; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; MAGDOLEN V, 1994, MOL GEN GENET, V244, P646, DOI 10.1007/BF00282755; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Park MH, 1997, BIOL SIGNAL, V6, P115; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRKER R, 1919, GUIDE YEAST GENETICS, V149, P415; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rosorius O, 1999, J CELL SCI, V112, P2369; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; Schatz O, 1998, P NATL ACAD SCI USA, V95, P1607, DOI 10.1073/pnas.95.4.1607; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHWELBERGER HG, 1993, J BIOL CHEM, V268, P14018; Sherman F., 1986, METHODS YEAST GENETI; Shi XP, 1996, BBA-MOL CELL RES, V1310, P119, DOI 10.1016/0167-4889(95)00165-4; SIKORSKI RS, 1989, GENETICS, V122, P19; SPRAGUE GF, 1983, CELL, V32, P409, DOI 10.1016/0092-8674(83)90460-9; Taylor CA, 2004, INVEST OPHTH VIS SCI, V45, P3568, DOI 10.1167/iovs.03-1367; THOMAS A, 1979, EUR J BIOCHEM, V98, P329, DOI 10.1111/j.1432-1033.1979.tb13192.x; TUSHER VG, 2001, P NATL ACAD SCI USA, V98, P5115; Valentini SR, 2002, GENETICS, V160, P393; Wang TW, 2003, PLANT MOL BIOL, V52, P1223, DOI 10.1023/B:PLAN.0000004332.80792.4d; Wang TW, 2001, J BIOL CHEM, V276, P17541, DOI 10.1074/jbc.M008544200; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; WOHL T, 1993, MOL GEN GENET, V241, P305; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	63	53	59	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35336	35346		10.1074/jbc.M601460200	http://dx.doi.org/10.1074/jbc.M601460200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16987817	Green Published, hybrid			2022-12-27	WOS:000241933700068
J	Shiraishi, N; Utsunomiya, H; Nishikimi, M				Shiraishi, Noriyuki; Utsunomiya, Hirotoshi; Nishikimi, Morimitsu			Combination of NADPH and copper ions generates proteinase K-resistant aggregates from recombinant prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO CONVERSION; AMINO-TERMINUS; BINDING-SITES; METAL-BINDING; FULL-LENGTH; SCRAPIE; CONFORMATION; PRP; DISEASE; DEPOLARIZATION	Recent studies have demonstrated that the octapeptide repeats of the N-terminal region of prion protein may be responsible for de novo generation of infectious prions in the absence of template. Here we demonstrate that PrP-(23-98), an N-terminal portion of PrP, is converted to aggregates upon incubation with NADPH and copper ions. Other pyridine nucleotides possessing a phosphate group on the adenine-linked ribose moiety (the reduced form of nicotinamide adenine dinucleotide 3 '-phosphate, nicotinic acid adenine dinucleotide phosphate, and NADP) were also effective in promoting aggregation, but NADH and NAD had no effect. The aggregation was attenuated by the metal chelator EDTA or by modification of histidyl residues with diethyl pyrocarbonate. The aggregates are amyloid-like as judged by the binding of thioflavin T, a fluorescent probe for amyloid, but do not exhibit fibrillar structures according to electron micrography. Interestingly the aggregates were resistant to proteinase K digestion. Likewise NADPH and zinc ions caused aggregation of PrP-(23-98), but the resulting aggregates were susceptible to degradation by proteinase K. Upon incubation with NADPH and copper ions, the full-length molecule PrP-(23-231) also formed proteinase K-resistant amyloid-like aggregates. Because it is possible that PrP, NADPH, and copper ions could associate in certain tissues, the aggregation observed in this study may be involved in prion initiation especially in the nonfamilial types of prion diseases.	Wakayama Med Univ, Dept Biochem, Wakayama 6418509, Japan; Wakayama Med Univ, Cent Res Lab, Wakayama 6418509, Japan	Wakayama Medical University; Wakayama Medical University	Shiraishi, N (corresponding author), Wakayama Med Univ, Dept Biochem, 811-1 Kimiidera, Wakayama 6418509, Japan.	nshirais@wakayamamed.ac.jp						Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2001, J NEUROCHEM, V76, P69, DOI 10.1046/j.1471-4159.2001.00009.x; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Campbell TA, 1996, NEUROLOGY, V46, P761, DOI 10.1212/WNL.46.3.761; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Daggett V, 1998, CURR OPIN BIOTECH, V9, P359, DOI 10.1016/S0958-1669(98)80008-6; DeFlora A, 1996, BIOCHEM J, V320, P665, DOI 10.1042/bj3200665; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Frankenfield KN, 2005, PROTEIN SCI, V14, P2154, DOI 10.1110/ps.051434005; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Garnett AP, 2003, J BIOL CHEM, V278, P6795, DOI 10.1074/jbc.M209280200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; HARTTER DE, 1988, SYNAPSE, V2, P412, DOI 10.1002/syn.890020408; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Hijazi N, 2003, BRAIN RES, V993, P192, DOI 10.1016/j.brainres.2003.09.014; Hopt A, 2003, J NEUROSCI METH, V128, P159, DOI 10.1016/S0165-0270(03)00173-0; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Jones EM, 2006, J BIOL CHEM, V281, P8190, DOI 10.1074/jbc.M513417200; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Kelleher SL, 2006, AM J PHYSIOL-REG I, V291, pR1181, DOI 10.1152/ajpregu.00206.2005; Kuczius T, 2004, BIOL CHEM, V385, P739, DOI 10.1515/BC.2004.090; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Lawson VA, 2004, J BIOL CHEM, V279, P13689, DOI 10.1074/jbc.M303697200; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehmann S, 2002, CURR OPIN CHEM BIOL, V6, P187, DOI 10.1016/S1367-5931(02)00295-8; Leliveld SR, 2006, J BIOL CHEM, V281, P3268, DOI 10.1074/jbc.M510606200; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; McKenzie D, 1998, J BIOL CHEM, V273, P25545, DOI 10.1074/jbc.273.40.25545; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Miles E W, 1977, Methods Enzymol, V47, P431; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; PATTISON IH, 1971, NATURE, V230, P115, DOI 10.1038/230115a0; Post K, 1998, BIOL CHEM, V379, P1307, DOI 10.1515/bchm.1998.379.11.1307; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Qin KF, 2002, J BIOL CHEM, V277, P1981, DOI 10.1074/jbc.M108744200; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; ROZELL B, 1988, EUR J CELL BIOL, V46, P470; Shiraishi N, 2005, BIOCHEM J, V387, P247, DOI 10.1042/BJ20041561; Shiraishi N, 2002, FEBS LETT, V511, P118, DOI 10.1016/S0014-5793(01)03324-5; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Stewart RS, 2005, J BIOL CHEM, V280, P15855, DOI 10.1074/jbc.M412298200; Supattapone S, 2001, J VIROL, V75, P1408, DOI 10.1128/JVI.75.3.1408-1413.2001; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Whittal RM, 2000, PROTEIN SCI, V9, P332; Wise DD, 2004, NEUROSCIENCE, V128, P263, DOI 10.1016/j.neuroscience.2004.06.058; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102	63	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34880	34887		10.1074/jbc.M606581200	http://dx.doi.org/10.1074/jbc.M606581200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16990274	hybrid			2022-12-27	WOS:000241933700020
J	Zahnd, C; Pecorari, F; Straumann, N; Wyler, E; Pluckthun, A				Zahnd, Christian; Pecorari, Frederic; Straumann, Nadine; Wyler, Emanuel; Plueckthun, Andreas			Selection and characterization of Her2 binding-designed ankyrin repeat proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; BREAST-CANCER; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; COMBINATORIAL LIBRARIES; RECEPTOR; HERCEPTIN; COMPLEX; EXPRESSION; EVOLUTION	Designed ankyrin repeat proteins (DARPins) are a novel class of binding proteins that bind their target protein with high affinity and specificity and have very favorable expression and stability properties. We describe here the in vitro selection of DARPins against human epidermal growth factor receptor 2 (Her2), an important target for cancer therapy and diagnosis. Several DARPins bind to the same epitope as trastuzumab (Herceptin), but none were selected that bind to the epitope of pertuzumab (Omnitarg). Some of the selected DARPins bind with low nanomolar affinity (K-d = 7.3 nm) to the target. Further analysis revealed that all DARPins are highly specific and do not cross-react with epidermal growth factor receptor I (EGFR1) or any other investigated protein. The selected DARPins specifically bind to strongly Her2-overexpressing cell lines such as SKBR-3 but also recognize small amounts of Her2 on weakly expressing cell lines such as MCF-7. Furthermore, the DARPins also lead to a highly specific and strong staining of plasma membranes of paraffinated sections of human mamma-carcinoma tissue. Thus, the selected DARPins might be used for the development of diagnostic tests for the status of Her2 overexpression in different adenocarcinomas, and they may be further evaluated for their potential in targeted therapy since their favorable expression properties make the construction of fusion proteins very convenient.	Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; ETH, Inst Cell Biol, ETH Honggerberg, CH-8093 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pluckthun, A (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	plueckthun@bioc.unizh.ch	Plückthun, Andreas/C-2746-2009; Pecorari, Frederic/L-2942-2015	Plückthun, Andreas/0000-0003-4191-5306; Wyler, Emanuel/0000-0002-9884-1806; Pecorari, Frederic/0000-0002-7854-0643				Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Amstutz P, 2005, J BIOL CHEM, V280, P24715, DOI 10.1074/jbc.M501746200; Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; deFazio A, 2000, INT J CANCER, V87, P487, DOI 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.0.CO;2-J; Forrer P, 2004, CHEMBIOCHEM, V5, P183, DOI 10.1002/cbic.200300762; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Ge L, 1995, ANTIBODY ENG, P229; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Jacobs TW, 2000, AM J CLIN PATHOL, V113, P251, DOI 10.1309/980M-E24R-V19K-595D; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Maur AAD, 2002, J BIOL CHEM, V277, P45075, DOI 10.1074/jbc.M205264200; Mayfield S, 2001, BREAST CANCER RES TR, V70, P123, DOI 10.1023/A:1012999012192; Molina MA, 2001, CANCER RES, V61, P4744; Moroney S, 2005, MODERN BIOPHARMACEUT, P1147; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Willuda J, 2001, J BIOL CHEM, V276, P14385, DOI 10.1074/jbc.M011669200; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200	33	83	101	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35167	35175		10.1074/jbc.M602547200	http://dx.doi.org/10.1074/jbc.M602547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16963452	hybrid			2022-12-27	WOS:000241933700050
J	Hwang, WC; Lin, YQ; Santelli, E; Sui, JH; Jaroszewski, L; Stec, B; Farzan, M; Marasco, WA; Liddington, RC				Hwang, William C.; Lin, Yaqiong; Santelli, Eugenio; Sui, Jianhua; Jaroszewski, Lukasz; Stec, Boguslaw; Farzan, Michael; Marasco, Wayne A.; Liddington, Robert C.			Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS-CORONAVIRUS; MOLECULAR REPLACEMENT; RECEPTOR; DETERMINANTS; ENTRY	Severe acute respiratory syndrome (SARS) is a newly emerged infectious disease that caused pandemic spread in 2003. The etiological agent of SARS is a novel coronavirus (SARS-CoV). The coronaviral surface spike protein S is a type I transmembrane glycoprotein that mediates initial host binding via the cell surface receptor angiotensin-converting enzyme 2 (ACE2), as well as the subsequent membrane fusion events required for cell entry. Here we report the crystal structure of the S1 receptor binding domain (RBD) in complex with a neutralizing antibody, 80R, at 2.3 angstrom resolution, as well as the structure of the uncomplexed S1 RBD at 2.2 angstrom resolution. We show that the 80R-binding epitope on the S1 RBD overlaps very closely with the ACE2-binding site, providing a rationale for the strong binding and broad neutralizing ability of the antibody. We provide a structural basis for the differential effects of certain mutations in the spike protein on 80R versus ACE2 binding, including escape mutants, which should facilitate the design of immunotherapeutics to treat a future SARS outbreak. We further show that the RBD of S1 forms dimers via an extensive interface that is disrupted in receptor- and antibody-bound crystal structures, and we propose a role for the dimer in virus stability and infectivity.	Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA	Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University	Liddington, RC (corresponding author), Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@burnham.org		Farzan, Michael/0000-0002-2990-5319; Stec, Boguslaw/0000-0002-8696-0349; SUI, JIANHUA/0000-0002-1272-9662	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048436, R01AI028785, U01AI061318] Funding Source: NIH RePORTER; NIAID NIH HHS [AI28785, AI48436, AI061318, AI053822] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRAGG WL, 1954, ACTA CRYSTALLOGR, V7, P409, DOI 10.1107/S0365110X54001235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakraborti S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-73; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holmes KV, 2003, J CLIN INVEST, V111, P1605, DOI [10.1172/JCI18819, 10.1172/JCI200318819]; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewicki DN, 2002, J BIOL CHEM, V277, P19727, DOI 10.1074/jbc.M201837200; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Lin Y, 2004, ANTIVIR THER, V9, P287; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nurani G, 2003, J VIROL, V77, P11985, DOI 10.1128/JVI.77.22.11985-11991.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Sui JH, 2005, J VIROL, V79, P5900, DOI 10.1128/JVI.79.10.5900-5906.2005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JM, 2005, ACTA CRYSTALLOGR D, V61, P67, DOI 10.1107/S0907444904026721; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200	28	143	153	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34610	34616		10.1074/jbc.M603275200	http://dx.doi.org/10.1074/jbc.M603275200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16954221	hybrid, Green Published			2022-12-27	WOS:000241767600080
J	Pinto, MP; Grou, CP; Alencastre, IS; Oliveira, ME; Sa-Miranda, C; Fransen, M; Azevedo, JE				Pinto, Manuel P.; Grou, Claudia P.; Alencastre, Ines S.; Oliveira, Marcia E.; Sa-Miranda, Clara; Fransen, Marc; Azevedo, Jorge E.			The import competence of a peroxisomal membrane protein is determined by Pex19p before the docking step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; ZELLWEGER-SYNDROME; RAT-LIVER; IN-VITRO; MAMMALIAN PEROXISOMES; SACCHAROMYCES-CEREVISIAE; POTENTIAL ROLE; PTS1 RECEPTOR; HUMAN PEX3; IDENTIFICATION	Biogenesis of the mammalian peroxisomal membrane requires the action of Pex3p and Pex16p, two proteins present in the organelle membrane, and Pex19p, a protein that displays a dual subcellular distribution (peroxisomal and cytosolic). Pex19p interacts with most peroxisomal intrinsic membrane proteins, but whether this property reflects its role as an import receptor for this class of proteins or a chaperone-like function in the assembly/ disassembly of peroxisomal membrane proteins has been the subject of much controversy. Here, we describe an in vitro system particularly suited to address this issue. It is shown that insertion of a reporter protein into the peroxisomal membrane is a Pex3p-dependent process that does not require ATP/GTP hydrolysis. The system can be programmed with recombinant versions of Pex19p, allowing us to demonstrate that Pex19p-cargo protein complexes formed in the absence of peroxisomes are the substrates for the peroxisomal docking/insertion machinery. Data suggesting that cargo-loaded Pex19p displays a much higher affinity for Pex3p than Pex19p alone are also provided. These results suggest that soluble Pex19p participates in the targeting of newly synthesized peroxisomal membrane proteins to the organelle membrane and support the existence of a cargo-induced peroxisomal targeting mechanism for Pex19p.	Univ Porto, Inst Mol & Celular Biol, P-4150180 Oporto, Portugal; Univ Porto, ICBAS, P-4099003 Oporto, Portugal; Katholieke Univ Leuven, Fac Geneeskunde, Dept Mol Celbiol, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, Inst Mol & Celular Biol, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Grou, Claudia P/K-5472-2013; Azevedo, Jorge E/A-4113-2008; Pinto, Manuel/K-6425-2013; Fransen, Marc/C-6262-2008; sá Miranda, Maria Clara/K-3920-2013; Fransen, Marc/ADL-0723-2022	Grou, Claudia P/0000-0001-5197-2270; Azevedo, Jorge E/0000-0001-7714-5302; Pinto, Manuel/0000-0001-9778-2093; Fransen, Marc/0000-0001-9284-1197; sá Miranda, Maria Clara/0000-0003-0123-5525; Oliveira, Marcia/0000-0003-2437-2004; Alencastre, Ines/0000-0002-5591-5596				CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DIESTELKOTTER P, 1993, J CELL BIOL, V123, P1717, DOI 10.1083/jcb.123.6.1717; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fransen M, 2004, J BIOL CHEM, V279, P12615, DOI 10.1074/jbc.M304941200; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; Fransen M, 1999, BIOCHEM J, V340, P561, DOI 10.1042/0264-6021:3400561; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GALLAGER SR, 1999, CURRENT PROTOCOLS MO; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AMM, 1999, ANAL BIOCHEM, V274, P270, DOI 10.1006/abio.1999.4281; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Hadden DA, 2006, MOL MEMBR BIOL, V23, P325, DOI 10.1080/09687860600738221; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Imanaka T, 1996, J BIOL CHEM, V271, P3706; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kammerer S, 1998, FEBS LETT, V429, P53, DOI 10.1016/S0014-5793(98)00557-2; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; Lambkin GR, 2001, MOL BIOL CELL, V12, P3353, DOI 10.1091/mbc.12.11.3353; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Mayerhofer PU, 2002, BIOCHEM BIOPH RES CO, V291, P1180, DOI 10.1006/bbrc.2002.6568; Michels PAM, 2005, MOL MEMBR BIOL, V22, P133, DOI 10.1080/09687860400024186; Mullen RT, 1999, PLANT CELL, V11, P2167, DOI 10.1105/tpc.11.11.2167; Muntau AC, 2000, AM J HUM GENET, V67, P967, DOI 10.1086/303071; Muntau AC, 2003, EUR J CELL BIOL, V82, P333, DOI 10.1078/0171-9335-00325; Pause B, 2000, FEBS LETT, V471, P23, DOI 10.1016/S0014-5793(00)01332-6; Pause B, 1997, FEBS LETT, V414, P95, DOI 10.1016/S0014-5793(97)00975-7; Reguenga C, 1999, BBA-GENE STRUCT EXPR, V1445, P337, DOI 10.1016/S0167-4781(99)00061-5; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; SANTOS MJ, 1988, SCIENCE, V239, P1536, DOI 10.1126/science.3281254; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Shimozawa N, 2000, HUM MOL GENET, V9, P1995, DOI 10.1093/hmg/9.13.1995; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Soukupova M, 1999, EUR J CELL BIOL, V78, P357, DOI 10.1016/S0171-9335(99)80078-8; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Titorenko VI, 1998, MOL CELL BIOL, V18, P2789, DOI 10.1128/MCB.18.5.2789; van der Zand A, 2006, J CELL SCI, V119, P989, DOI 10.1242/jcs.02893; Vizeacoumar FJ, 2006, J BIOL CHEM, V281, P14805, DOI 10.1074/jbc.M601808200; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; WENDLAND M, 1993, J CELL BIOL, V120, P675, DOI 10.1083/jcb.120.3.675; Yernaux C, 2006, MOL MEMBR BIOL, V23, P157, DOI 10.1080/09687860500460124	58	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34492	34502		10.1074/jbc.M607183200	http://dx.doi.org/10.1074/jbc.M607183200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16980692	hybrid			2022-12-27	WOS:000241767600070
J	Sztalryd, C; Bell, M; Lu, XY; Mertz, P; Hickenbottom, S; Chang, BHJ; Chan, L; Kimmel, AR; Londos, C				Sztalryd, Carole; Bell, Ming; Lu, Xinyue; Mertz, Pamela; Hickenbottom, Sabrina; Chang, Benny H. -J.; Chan, Lawrence; Kimmel, Alan R.; Londos, Constantine			Functional compensation for adipose differentiation-related protein (ADFP) by Tip47 in an ADFP null embryonic cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID DROPLETS; PERILIPIN; LIPOLYSIS; LIPASE; LIVER; RAB18; MILK; ADRP	Ectopic accumulation of lipid droplets in non-adipose tissues correlates with the degree of insulin resistance in these tissues. Emerging evidence indicates that lipid droplets are specialized organelles that participate in lipid metabolism and intracellular trafficking. These properties are thought to derive from the lipid droplet-associated PAT protein family (perilipin, ADFP, and Tip47). The functions of the ubiquitously distributed adipose differentiation-related protein (ADFP) and Tip47 remain unknown. To evaluate the roles of ADFP and Tip47 in lipid biogenesis and metabolism, ADFP null and wild type (wt) clonal cell lines were established from ADFP null and wt mice, respectively. In ADFP null cells, Tip47 was identified as the sole lipid droplet-associated protein from the PAT family by mass spectroscopy, which was further confirmed by immunoblotting and immunocytochemistry. Following incubation with oleic acid, ADFP null cells were able to form lipid droplets to the same extent as wt cells. No statistical differences between the two cell types were observed in NEFA uptake or lipolysis. Small interference RNAs (siRNAs) against Tip47 were found to down-regulate protein levels for Tip47 by 85%. ADFP null cells treated with Tip47 siRNA retained the ability to form lipid droplets but to a lesser extent and shunted the utilization of exogenously added NEFA from triglycerides to phospholipids. These data support the hypothesis that Tip47 plays an important role in lipid metabolism. Tip47 and ADFP in peripheral tissues may play a critical role in regulating the formation and turnover, and hence metabolic consequences, of ectopic fat.	Univ Maryland, Sch Med, Geriatr Res Educ & Clin Ctr, Baltimore Vet Affairs Hlth Care Ctr,Dept Med, Baltimore, MD 21201 USA; NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Baylor College of Medicine; Baylor College of Medicine	Sztalryd, C (corresponding author), Vet Affairs Med Ctr, GRECC Geriatr, 10 N Greene St, Baltimore, MD 21201 USA.	csztalry@grecc.umaryland.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015609, P30DK056338, Z01DK015503, Z01DK015505] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [HL51586] Funding Source: Medline; NIDDK NIH HHS [DK56338] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Heid HW, 1996, BIOCHEM J, V320, P1025, DOI 10.1042/bj3201025; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; JIANG HP, 1992, P NATL ACAD SCI USA, V89, P7856, DOI 10.1073/pnas.89.17.7856; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lu XY, 2001, MAMM GENOME, V12, P741, DOI 10.1007/s00335-01-2055-5; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Meigs JB, 2002, AM J MANAG CARE, V8, pS283; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schultz CJ, 2002, AM J PHYSIOL-LUNG C, V283, pL288, DOI 10.1152/ajplung.00204.2001; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; SZTALRYD C, 1989, CELL MOL BIOL, V35, P81; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Than NG, 2003, EUR J BIOCHEM, V270, P1176, DOI 10.1046/j.1432-1033.2003.03475.x; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200	39	98	105	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34341	34348		10.1074/jbc.M602497200	http://dx.doi.org/10.1074/jbc.M602497200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16968708	hybrid			2022-12-27	WOS:000241767600054
J	Aburaya, M; Tanaka, KI; Hoshino, T; Tsutsumi, S; Suzuki, K; Makise, M; Akagi, R; Mizushima, T				Aburaya, Mayuko; Tanaka, Ken-Ichiro; Hoshino, Tatsuya; Tsutsumi, Shinji; Suzuki, Keitarou; Makise, Masaki; Akagi, Reiko; Mizushima, Tohru			Heme oxygenase-1 protects gastric mucosal cells against non-steroidal anti-inflammatory drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NRF2 TRANSCRIPTION FACTOR; HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; INDUCED APOPTOSIS; ENDOTHELIAL-CELLS; ENZYME INDUCERS; PRIMARY CULTURE; UP-REGULATION; NITRIC-OXIDE; LUNG INJURY	Gastric mucosal cell death by non-steroidal anti-inflammatory drugs (NSAIDs) is suggested to be involved in NSAID-induced gastric lesions. Therefore, cellular factors that suppress this cell death are important for protection of the gastric mucosa from NSAIDs. Heme oxygenase-1 (HO-1) is up-regulated by various stressors and protects cells against stressors. Here, we have examined up-regulation of HO-1 by NSAIDs and the contribution of HO-1 to the protection of gastric mucosal cells against NSAIDs both in vitro and in vivo. In cultured gastric mucosal cells, all NSAIDs tested up-regulated HO-1. In rats, orally administered indomethacin up-regulated HO-1, induced apoptosis, and produced lesions at gastric mucosa. An inhibitor of HO-stimulated NSAID-induced apoptosis in vitro and in vivo and also stimulated NSAID-produced gastric lesions, suggesting that NSAID-induced up-regulation of HO-1 protects the gastric mucosa from NSAID-induced gastric lesions by inhibiting NSAID-induced apoptosis. Indomethacin activated the HO-1 promoter and caused nuclear accumulation of NF-E2-related factor 2 (Nrf2), a transcription factor for the HO-1 gene. Examination of phosphorylation of p38 mitogen-activated protein kinase (MAPK) and experiments with its inhibitor strongly suggest that the nuclear accumulation of Nrf2 and resulting up-regulation of HO-1 by NSAIDs is mediated through NSAID-dependent activation (phosphorylation) of p38 MAPK. This is the first report showing the protective role of HO-1 against irritant-induced gastric lesions.	Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; Okayama Prefectural Univ, Fac Hlth & Welfare Sci, Soja 7191197, Japan	Kumamoto University; Okayama Prefectural University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp						Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alam J, 2000, J BIOL CHEM, V275, P27694; Alcaraz MJ, 2001, BBA-GEN SUBJECTS, V1526, P13, DOI 10.1016/S0304-4165(01)00112-X; BARRIER CH, 1989, ARTHRITIS RHEUM, V32, P926; Ben-Chetrit E, 2005, RHEUMATOL INT, V25, P332, DOI 10.1007/s00296-004-0442-4; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Buckley BJ, 2003, BIOCHEM BIOPH RES CO, V307, P973, DOI 10.1016/S0006-291X(03)01308-1; Cantoni L, 2003, J HEPATOL, V38, P776, DOI 10.1016/S0168-8278(03)00095-3; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Chou YH, 2005, INT J BIOCHEM CELL B, V37, P604, DOI 10.1016/j.biocel.2004.08.006; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Elbirt KK, 1998, J BIOL CHEM, V273, P8922, DOI 10.1074/jbc.273.15.8922; FRIES JF, 1989, GASTROENTEROLOGY, V96, P647, DOI 10.1016/S0016-5085(89)80061-7; Gehrmann M, 2004, CLIN CANCER RES, V10, P3354, DOI 10.1158/1078-0432.CCR-03-0382; Ghattas MH, 2002, INT J BIOCHEM CELL B, V34, P1619, DOI 10.1016/S1357-2725(02)00097-3; Gong PF, 2003, J BIOL CHEM, V278, P29693, DOI 10.1074/jbc.M304728200; Grosser N, 2003, BIOCHEM BIOPH RES CO, V308, P956, DOI 10.1016/S0006-291X(03)01504-3; Hawkey CJ, 2000, GASTROENTEROLOGY, V119, P521, DOI 10.1053/gast.2000.9561; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Hou CC, 2005, ANN NY ACAD SCI, V1042, P235, DOI 10.1196/annals.1338.026; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kawai S, 1998, EUR J PHARMACOL, V347, P87, DOI 10.1016/S0014-2999(98)00078-8; Kiemer AK, 2003, ENDOCRINOLOGY, V144, P802, DOI 10.1210/en.2002-220610; Kietzmann T, 2003, J BIOL CHEM, V278, P17927, DOI 10.1074/jbc.M203929200; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lichtenberger LM, 2001, BIOCHEM PHARMACOL, V61, P631, DOI 10.1016/S0006-2952(00)00576-1; Linden T, 1998, NEUROSCI LETT, V247, P103, DOI 10.1016/S0304-3940(98)00278-X; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mathew A, 1998, ANN NY ACAD SCI, V851, P99, DOI 10.1111/j.1749-6632.1998.tb08982.x; Mima S, 2005, CANCER RES, V65, P1868, DOI 10.1158/0008-5472.CAN-04-2770; Nakahira K, 2003, BIOCHEM PHARMACOL, V66, P1091, DOI 10.1016/S0006-2952(03)00444-1; Nascimento-Silva V, 2005, AM J PHYSIOL-CELL PH, V289, pC557, DOI 10.1152/ajpcell.00045.2005; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rockwell P, 2004, CELL SIGNAL, V16, P343, DOI 10.1016/j.cellsig.2003.08.006; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schroeder CR, 2004, CANCER BIOL THER, V3, P847, DOI 10.4161/cbt.3.9.1037; SMALLEY WE, 1995, AM J EPIDEMIOL, V141, P539, DOI 10.1093/oxfordjournals.aje.a117469; Takano T, 2002, DIGEST DIS SCI, V47, P1546, DOI 10.1023/A:1015819203084; Takeda A, 2000, J BIOL CHEM, V275, P5395, DOI 10.1074/jbc.275.8.5395; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; TANAKA Y, 1983, CHEM PHARM BULL, V31, P3656; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tomisato W, 2004, BIOCHEM BIOPH RES CO, V323, P1032, DOI 10.1016/j.bbrc.2004.08.205; Tomisato W, 2004, BIOCHEM PHARMACOL, V67, P575, DOI 10.1016/j.bcp.2003.09.020; Tomisato W, 2002, DIGEST DIS SCI, V47, P2125, DOI 10.1023/A:1019653719397; Tomisato W, 2001, BIOL PHARM BULL, V24, P887, DOI 10.1248/bpb.24.887; Tomisato W, 2001, AM J PHYSIOL-GASTR L, V281, pG1092, DOI 10.1152/ajpgi.2001.281.4.G1092; Tomisato W, 2000, DIGEST DIS SCI, V45, P1674, DOI 10.1023/A:1005597902470; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Tsutsumi S, 2003, EXP BIOL MED, V228, P1089, DOI 10.1177/153537020322800917; Tsutsumi S, 2002, BBA-MOL CELL RES, V1589, P168, DOI 10.1016/S0167-4889(02)00171-4; VALAES T, 1994, PEDIATRICS, V93, P1; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhang XC, 2003, J BIOL CHEM, V278, P1248, DOI 10.1074/jbc.M208419200	68	72	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33422	33432		10.1074/jbc.M602074200	http://dx.doi.org/10.1074/jbc.M602074200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16945925	hybrid			2022-12-27	WOS:000241621400052
J	Drinane, M; Walsh, J; Mollmark, J; Simons, M; Mulligan-Kehoe, MJ				Drinane, Mary; Walsh, Jannine; Mollmark, Jessica; Simons, Michael; Mulligan-Kehoe, Mary Jo			The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; IN-VIVO; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; PROTEIN-KINASE; TUMOR-GROWTH; APOPTOSIS; EXPRESSION; ALPHA; JNK2	Many angiogenesis inhibitors are breakdown products of endogenous extracellular matrix proteins. Plasmin and matrix metalloproteinase-3 generate breakdown products of matrix-bound plasminogen activator inhibitor-1(PAI-1). We produced a truncated form of PAI-1, rPAI-1(23), that possesses significant anti- angiogenic activity and stimulates high levels of apoptosis in quiescent arterial endothelial cells. Quiescent endothelial cells are less susceptible to apoptosis than angiogenic endothelial cells. The present study was designed to determine the mechanism of the rPAI-1(23) effects in bovine aortic endothelial cells. Apoptosis was measured in annexin V and caspase 3 assays. Expression of death and survival signaling molecules were examined by Western blot and kinase activity. Fibroblast growth factor 2 (FGF2) functions were analyzed in angiogenesis assays. The early response to rPAI-1(23) was an increase in annexin V-positive cells and phosphorylated (p)JNK isoform expression followed by an increase in p-Akt and p-c-Jun expression. Caspase 3 was activated at 4 h, whereas p-Akt was reduced to control levels. By 6 h of rPAI-1(23) treatment cell number was reduced by 35%, and p-c-Jun and p-JNK were degraded by proteasomes. Confocal microscopic images showed increased amounts of FGF2 in the extracellular matrix. However, rPAI-1(23) blocked FGF2 signaling through FGF receptor 1 and syndecan-4, inhibiting cell migration, tubulogenesis, and proliferation. Exogenous FGF2 stimulation could not reverse these effects. We conclude that rPAI-1(23) stimulation of apoptosis in BAEC triggers a cascade of death versus survival events that includes release of FGF2. The rPAI-1(23) anti- angiogenic activity inhibits FGF2 pro-angiogenic functions by blocking FGF2 signaling through FGF receptor 1 and syndecan-4 and downstream effectors p-Akt, p-JNK, and p-c-Jun.	Dartmouth Med Sch, Dept Surg, Vasc Sect, Lebanon, NH 03756 USA; Dartmouth Med Sch, Dept Med, Cardiol Sect, Lebanon, NH 03756 USA; Dartmouth Med Sch, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA; Dartmouth Med Sch, Angiogenesis Res Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Mulligan-Kehoe, MJ (corresponding author), Dartmouth Med Sch, Dept Surg, Vasc Sect, Borwell 530E,1 Med Ctr Dr, Lebanon, NH 03756 USA.	mary.j.mulligan-kehoe@dartmouth.edu	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734; Drinane, Mary/0000-0001-6081-5330	NHLBI NIH HHS [HL069948, HL62289] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062289, R01HL069948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Asselin E, 2001, CANCER RES, V61, P1862; BACHARACH E, 1992, P NATL ACAD SCI USA, V89, P10686, DOI 10.1073/pnas.89.22.10686; Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cao YH, 1996, J BIOL CHEM, V271, P29461, DOI 10.1074/jbc.271.46.29461; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Doseff AI, 2004, STEM CELLS DEV, V13, P473, DOI 10.1089/1547328042417255; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Kerbel RS, 2000, EUR J CANCER, V36, P1248, DOI 10.1016/S0959-8049(00)00092-7; Keshet E, 1999, J CLIN INVEST, V104, P1497, DOI 10.1172/JCI8849; Kuntzen C, 2005, CANCER RES, V65, P6780, DOI 10.1158/0008-5472.CAN-04-2618; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Lijnen HR, 2000, J BIOL CHEM, V275, P37645, DOI 10.1074/jbc.M006475200; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Mulligan-Kehoe MJ, 2002, J BIOL CHEM, V277, P49077, DOI 10.1074/jbc.M208757200; Mulligan-Kehoe MJ, 2001, J BIOL CHEM, V276, P8588, DOI 10.1074/jbc.M006434200; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Simons M, 2004, MOL CELL BIOCHEM, V264, P99, DOI 10.1023/B:MCBI.0000044379.25823.03; Simons M, 2001, CELL SIGNAL, V13, P855, DOI 10.1016/S0898-6568(01)00190-5; Stefansson S, 2001, J BIOL CHEM, V276, P8135, DOI 10.1074/jbc.M007609200; Stupack DG, 2003, ONCOGENE, V22, P9022, DOI 10.1038/sj.onc.1207110; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; vanMeijer M, 1997, BLOOD, V90, P1874, DOI 10.1182/blood.V90.5.1874; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; VOLK RSJ, J BIOL CHEM, V274, P24417; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	45	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33336	33344		10.1074/jbc.M607097200	http://dx.doi.org/10.1074/jbc.M607097200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950776	hybrid			2022-12-27	WOS:000241621400043
J	Fan, ACY; Bhangoo, MK; Young, JC				Fan, Anna C. Y.; Bhangoo, Melanie K.; Young, Jason C.			Hsp90 functions in the targeting and outer membrane translocation steps of Tom70-mediated mitochondrial import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP ATP CARRIER; TOM CORE COMPLEX; SHOCK-PROTEIN 90; ADP/ATP CARRIER; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; INNER MEMBRANE; MAMMALIAN MITOCHONDRIA; PREPROTEIN TRANSLOCASE	The Tom70 import receptor on the mitochondrial outer membrane specifically recognizes Hsp90 and Hsc70, a critical step for the import of mitochondrial preproteins, the targeting of which depends on these cytosolic chaperones. To analyze the role of Hsp90 in mitochondrial import, the effects of the Hsp90 inhibitors geldanamycin and novobiocin were compared. Geldanamycin occludes the N-terminal ATP-binding site of Hsp90, whereas novobiocin targets the C-terminal region of the chaperone. Here, novobiocin was found to inhibit preprotein import and, in particular, targeting to the purified cytosolic fragment of Tom70. Hsp90 cross-linking to preprotein and coprecipitation of Hsp90 with Tom70 were both impaired by novobiocin. Overall, novobiocin treatment increased preprotein aggregation, contributing to reduced import competence. In contrast, geldanamycin had no apparent effect on preprotein interactions with Hsp90, formation of preprotein-chaperone complexes, Hsp90 docking onto Tom70, or preprotein association with the outer membrane. Instead, geldanamycin impaired formation of preprotein import intermediates at the outer membrane. This suggests a novel active role for Hsp90 in import steps subsequent to Tom70 targeting. Our results outline the mechanisms of Hsp90 function in preprotein targeting and transport.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University	Young, JC (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	jason.young2@mcgill.ca						Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Ahting U, 2005, J BIOL CHEM, V280, P48, DOI 10.1074/jbc.M410905200; Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Bauer MF, 1999, FEBS LETT, V464, P41, DOI 10.1016/S0014-5793(99)01665-8; Beddoe T, 2004, J BIOL CHEM, V279, P46448, DOI 10.1074/jbc.M405639200; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brix J, 2000, J MOL BIOL, V303, P479, DOI 10.1006/jmbi.2000.4120; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Citri A, 2004, CELL CYCLE, V3, P51; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; del Arco A, 2005, CELL MOL LIFE SCI, V62, P2204, DOI 10.1007/s00018-005-5197-x; Endres M, 1999, EMBO J, V18, P3214, DOI 10.1093/emboj/18.12.3214; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; Kanelakis KC, 2002, J BIOL CHEM, V277, P33698, DOI 10.1074/jbc.M204164200; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Koehler CM, 1998, EMBO J, V17, P6477, DOI 10.1093/emboj/17.22.6477; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Leuenberger D, 1999, EMBO J, V18, P4816, DOI 10.1093/emboj/18.17.4816; LINGELBACH KR, 1986, EUR J BIOCHEM, V161, P19, DOI 10.1111/j.1432-1033.1986.tb10119.x; Luciano P, 2001, EMBO J, V20, P4099, DOI 10.1093/emboj/20.15.4099; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Muhlenbein N, 2004, J BIOL CHEM, V279, P13540, DOI 10.1074/jbc.M312485200; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; PFANNER N, 1987, J BIOL CHEM, V262, P7528; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Reichert AS, 2004, TRENDS GENET, V20, P555, DOI 10.1016/j.tig.2004.08.012; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Suzuki H, 2002, J CELL SCI, V115, P1895; Suzuki H, 2004, J BIOL CHEM, V279, P50619, DOI 10.1074/jbc.M408604200; Taylor P, 2001, STRUCTURE, V9, P431, DOI 10.1016/S0969-2126(01)00603-7; Terada K, 1996, MOL CELL BIOL, V16, P6103; Truscott KN, 2002, MOL CELL BIOL, V22, P7780, DOI 10.1128/MCB.22.22.7780-7789.2002; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; VIJAYASARATHY C, 1989, J BIOL CHEM, V264, P7772; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Yano M, 2000, MOL CELL BIOL, V20, P7205, DOI 10.1128/MCB.20.19.7205-7213.2000; Yano M, 1998, J BIOL CHEM, V273, P26844, DOI 10.1074/jbc.273.41.26844; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Young JC, 1996, EMBO J, V15, P172, DOI 10.1002/j.1460-2075.1996.tb00345.x; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yun BG, 2004, BIOCHEMISTRY-US, V43, P8217, DOI 10.1021/bi0497998; ZARA V, 1992, J BIOL CHEM, V267, P12077; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	75	71	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33313	33324		10.1074/jbc.M605250200	http://dx.doi.org/10.1074/jbc.M605250200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16968702	hybrid			2022-12-27	WOS:000241621400041
J	He, YW; Wang, C; Zhou, L; Song, HW; Dow, JM; Zhang, LH				He, Ya-Wen; Wang, Chao; Zhou, Lian; Song, Haiwei; Dow, J. Maxwell; Zhang, Lian-Hui			Dual signaling functions of the hybrid sensor kinase RpfC of Xanthomonas campestris involve either phosphorelay or receiver domain-protein interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SYSTEM; PATHOGENICITY; GENE; EXPRESSION; VIRULENCE; ENZYMES	The hybrid sensor kinase RpfC positively regulates the expression of a range of virulent genes and negatively modulates the synthesis of the quorum sensing signal diffusible signal factor (DSF) in Xanthomonas campestris. Three conserved amino acid residues of RpfC implicated in phosphorelay (His(198) in the histidine kinase domain, Asp(512) in the receiver domain, and His(657) in the histidine phosphotransfer domain) were essential for activation of the production of extracellular enzymes and extracellular polysaccharide (EPS) virulence factors but were not essential for repression of DSF biosynthesis. Domain deletion and subsequent in trans expression analysis revealed that the receiver domain of RpfC alone was sufficient to repress DSF overproduction in an rpfC deletion mutant. Further deletion and alanine scanning mutagenesis analyses identified a peptide of 107 amino acids and three amino acid residues (Gln(496), Glu(504), and Ile(552)) involved in modulating DSF production. Co-immunoprecipitation and far Western blot analyses suggested an interaction between the receiver domain and RpfF, the enzyme involved in DSF biosynthesis. These data support a model in which RpfC modulates two different functions ( virulence factor synthesis and DSF synthesis) by utilization of a conserved phosphorelay system and a novel domain-specific protein-protein interaction mechanism, respectively. This latter mechanism represents an added dimension to conventional two-component signaling paradigms.	Inst Mol & Cell Biol, Singapore 138673, Singapore; Natl Univ Ireland Univ Coll Cork, Biosci Inst, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University College Cork	Zhang, LH (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	lianhui@imcb.a-star.edu.sg	song, haiwei/H-6082-2011					ARICO B, 1989, P NATL ACAD SCI USA, V86, P6671, DOI 10.1073/pnas.86.17.6671; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; BOYER MH, 1984, J BIOTECHNOL, V1, P229, DOI 10.1016/0168-1656(84)90008-7; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Hall Randy A, 2004, Methods Mol Biol, V261, P167; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; HRABAK EM, 1992, J BACTERIOL, V174, P3011, DOI 10.1128/JB.174.9.3011-3020.1992; HWANG IY, 1994, P NATL ACAD SCI USA, V91, P4639, DOI 10.1073/pnas.91.11.4639; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jourlin C, 1996, MOL MICROBIOL, V20, P1297, DOI 10.1111/j.1365-2958.1996.tb02648.x; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEED PC, 1995, J BACTERIOL, V177, P654, DOI 10.1128/jb.177.3.654-659.1995; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; Uhl MA, 1996, J BIOL CHEM, V271, P33176, DOI 10.1074/jbc.271.52.33176; Wang LH, 2004, MOL MICROBIOL, V51, P903, DOI 10.1046/j.1365-2958.2003.03883.x; Wolanin PM, 2002, GENOME BIOL, V3; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang LH, 1997, P NATL ACAD SCI USA, V94, P9984, DOI 10.1073/pnas.94.18.9984	33	95	110	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33414	33421		10.1074/jbc.M606571200	http://dx.doi.org/10.1074/jbc.M606571200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16940295	hybrid			2022-12-27	WOS:000241621400051
J	Kim, E; Clark, AL; Kiss, A; Hahn, JW; Wesselschmidt, R; Coscia, CJ; Belcheva, MM				Kim, Eunhae; Clark, Amy L.; Kiss, Alexi; Hahn, Jason W.; Wesselschmidt, Robin; Coscia, Carmine J.; Belcheva, Mariana M.			mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; RECEPTOR GENE-EXPRESSION; EPIDERMAL-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASES; FACTOR SIGNALING PATHWAYS; SELF-RENEWAL; RETINOIC ACID; MAP KINASE; ENDODERM DIFFERENTIATION; DNA-SYNTHESIS	Growth factors, hormones, and neurotransmitters have been implicated in the regulation of stem cell fate. Since various neural precursors express functional neurotransmitter receptors, which include G protein-coupled receptors, it is anticipated that they are involved in cell fate decisions. We detected mu-opioid receptor (MOR-1) and kappa-opioid receptor (KOR-1) expression and immunoreactivity in embryonic stem (ES) cells and in retinoic acid-induced ES cell-derived, nestin-positive, neural progenitors. Moreover, these G protein-coupled receptors are functional, since [D-Ala(2), MePhe(4), Gly-ol(5)] enkephalin, a MOR-selective agonist, and U69,593, a KOR-selective agonist, induce a sustained activation of extracellular signal-regulated kinase (ERK) signaling throughout a 24-h treatment period in undifferentiated, self-renewing ES cells. Both opioids promote limited proliferation of undifferentiated ES cells via the ERK/MAP kinase signaling pathway. Importantly, biochemical and immunofluorescence data suggest that [D-Ala2, MePhe4, Gly-ol5] enkephalin and U69,593 divert ES cells from self-renewal and coax the cells to differentiate. In retinoic acid-differentiated ES cells, opioid-induced signaling features a biphasic ERK activation profile and an opioid-induced, ERK- independent inhibition of proliferation in these neural progenitors. Collectively, the data suggest that opioids may have opposite effects on ES cell self-renewal and ES cell differentiation and that ERK activation is only required by the latter. Finally, opioid modulation of ERK activity may play an important role in ES cell fate decisions by directing the cells to specific lineages.	St Louis Univ, Sch Med, EA Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Primogenix Inc, Los Angeles, CA 90033 USA	Saint Louis University	Belcheva, MM (corresponding author), St Louis Univ, Sch Med, EA Doisy Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.	beltchem@slu.edu	Kiss, Alexi/AAH-6830-2021	Kiss, Alexi/0000-0003-2330-6929	NIDA NIH HHS [DA-05412, R01 DA005412, R01 DA005412-16] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA005412, R01DA005412] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adi S, 2002, ENDOCRINOLOGY, V143, P511, DOI 10.1210/en.143.2.511; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Aubert J, 1999, J BIOL CHEM, V274, P24965, DOI 10.1074/jbc.274.35.24965; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BARG J, 1992, J NEUROCHEM, V59, P1145, DOI 10.1111/j.1471-4159.1992.tb08357.x; BARG J, 1993, J NEUROCHEM, V60, P1505, DOI 10.1111/j.1471-4159.1993.tb03314.x; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Bi J, 2001, J NEUROSCI, V21, P1590, DOI 10.1523/JNEUROSCI.21-05-01590.2001; Boeuf H, 2001, J BIOL CHEM, V276, P46204, DOI 10.1074/jbc.M106718200; Bohn LM, 2000, J NEUROCHEM, V74, P574, DOI 10.1046/j.1471-4159.2000.740574.x; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chakrabarti S, 2005, MOL BRAIN RES, V135, P217, DOI 10.1016/j.molbrainres.2004.12.016; Chen HC, 1999, NEUROSCIENCE, V92, P1143, DOI 10.1016/S0306-4522(99)00030-5; Chen JR, 2005, J BIOL CHEM, V280, P4632, DOI 10.1074/jbc.M411530200; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; FUKUDA M, 1995, ONCOGENE, V11, P239; GARZON J, 1995, MOL PHARMACOL, V47, P738; Gottlieb DI, 1999, CELLS TISSUES ORGANS, V165, P165, DOI 10.1159/000016696; Gottlieb DI, 2002, ANNU REV NEUROSCI, V25, P381, DOI 10.1146/annurev.neuro.25.112701.142904; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; HEO IS, 2006, AM J PHYSIOL, V290, pC123; Hu XL, 2002, MOL PHARMACOL, V62, P881, DOI 10.1124/mol.62.4.881; Hwang CK, 2003, J BIOL CHEM, V278, P3742, DOI 10.1074/jbc.M208780200; Jin XW, 2003, MOL CELL BIOL, V23, P1054, DOI 10.1128/MCB.23.3.1054-1060.2003; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; Li BS, 2001, J NEUROSCI, V21, P1569, DOI 10.1523/JNEUROSCI.21-05-01569.2001; LIUCHEN LY, 1993, MOL PHARMACOL, V44, P749; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luk KC, 2003, J NEUROSCI, V23, P2239; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Park SW, 2005, J NEUROSCI, V25, P3350, DOI 10.1523/JNEUROSCI.0186-05.2005; Persson PAI, 2000, J NEUROSCI RES, V61, P371, DOI 10.1002/1097-4547(20000815)61:4<371::AID-JNR3>3.0.CO;2-H; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Reffas S, 2000, BIOCHEM J, V352, P701, DOI 10.1042/0264-6021:3520701; Rohrer DK, 1998, ANNU REV PHARMACOL, V38, P351, DOI 10.1146/annurev.pharmtox.38.1.351; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Tighe AP, 2004, J CELL PHYSIOL, V198, P223, DOI 10.1002/jcp.10424; Ventura C, 2005, EVID-BASED COMPL ALT, V2, P277, DOI 10.1093/ecam/neh100; Ventura C, 2000, CIRC RES, V87, P189, DOI 10.1161/01.RES.87.3.189; Ventura C, 2003, CIRC RES, V92, P623, DOI 10.1161/01.RES.0000065169.23780.0E; Ventura C, 2003, CIRC RES, V92, P617, DOI 10.1161/01.RES.0000065168.31147.5B; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wei LN, 2000, MOL PHARMACOL, V57, P401; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138	81	72	77	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33749	33760		10.1074/jbc.M603862200	http://dx.doi.org/10.1074/jbc.M603862200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16954126	Green Accepted, hybrid			2022-12-27	WOS:000241621400082
J	Urschel, S; Hoher, T; Schubert, T; Alev, C; Sohl, G; Worsdorfer, P; Asahara, T; Dermietzel, R; Weiler, R; Willecke, K				Urschel, Stephanie; Hoeher, Thorsten; Schubert, Timm; Alev, Cantas; Soehl, Goran; Woersdoerfer, Philipp; Asahara, Takayuki; Dermietzel, Rolf; Weiler, Reto; Willecke, Klaus			Protein kinase A-mediated phosphorylation of Connexin36 in mouse retina results in decreased gap junctional communication between AII amacrine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE BIPOLAR CELLS; MAMMALIAN RETINA; RABBIT RETINA; ELECTRICAL SYNAPSES; NEURONAL CONNEXIN36; VISUAL TRANSMISSION; GENE CONNEXIN36; EXPRESSION; MODULATION; PATHWAYS	Gap junctions in AII amacrine cells of mammalian retina participate in the coordination of the rod and cone signaling pathway involved in visual adaptation. Upon stimulation by light, released dopamine binds to D-1 receptors on AII amacrine cells leading to increased intracellular cAMP (cyclic adenosine monophosphate) levels. AII amacrine cells express the gap junctional protein connexin36 (Cx36). Phosphorylation of Cx36 has been hypothesized to regulate gap junctional activity of AII amacrine cells. However, until now in vivo phosphorylation of Cx36 has not been reported. Indeed, it had been concluded that Cx36 in bovine retina is not phosphorylated, but in vitro phosphorylation for Cx35, the bass ortholog of Cx36, had been shown. To clarify this experimental discrepancy, we examined protein kinase A (PKA)-induced phosphorylation of Cx36 in mouse retina as a possible mechanism to modulate the extent of gap junctional coupling. The cytoplasmic domains of Cx36 and the total Cx36 protein were phosphorylated in vitro by PKA. Mass spectroscopy revealed that all four possible PKA consensus motifs were phosphorylated; however, domains point mutated at the sites in question showed a prevalent usage of Ser-110 and Ser-293. Additionally, we demonstrated that Cx36 was phosphorylated in cultured mouse retina. Furthermore, activation of PKA increased the level of phosphorylation of Cx36. cAMP-stimulated, PKA-mediated phosphorylation of Cx36 protein was accompanied by a decrease of tracer coupling between AII amacrine cells. Our results link increased phosphorylation of Cx36 to down-regulation of permeability through gap junction channels mediating light adaptation in the retina.	Univ Bonn, Inst Genet, D-53117 Bonn, Germany; Carl von Ossietzky Univ Oldenburg, Inst Biol, D-2900 Oldenburg, Germany; RIKEN, Ctr Dev Biol, Lab Stem Cell Translat Res, Kobe, Hyogo 6500047, Japan; Int Grad Sch Neurosci, D-44780 Bochum, Germany; Ruhr Univ Bochum, Inst Neuroanat & Mol Brain Res, D-44780 Bochum, Germany	University of Bonn; Carl von Ossietzky Universitat Oldenburg; RIKEN; Ruhr University Bochum	Willecke, K (corresponding author), Univ Bonn, Inst Genet, Romer Str 164, D-53117 Bonn, Germany.	genetik@uni-bonn.de	Alev, Cantas/W-1493-2018	Alev, Cantas/0000-0002-4879-8782; Worsdorfer, Philipp/0000-0003-3398-3229				Al-Ubaidi MR, 2000, J NEUROSCI RES, V59, P813, DOI 10.1002/(SICI)1097-4547(20000315)59:6<813::AID-JNR14>3.3.CO;2-R; Bird GC, 2005, J PHYSIOL-LONDON, V564, P907, DOI 10.1113/jphysiol.2005.084780; BLITZER RD, 2005, SCI STKE, V280, pTR12; Bloomfield SA, 2004, VISION RES, V44, P3297, DOI 10.1016/j.visres.2004.07.012; Bloomfield SA, 1997, VISUAL NEUROSCI, V14, P565, DOI 10.1017/S0952523800012220; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Bortolotto ZA, 1998, NEUROPHARMACOLOGY, V37, P535, DOI 10.1016/S0028-3908(98)00058-6; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; HAMPSON ECGM, 1992, J NEUROSCI, V12, P4911; Han Y, 2005, P NATL ACAD SCI USA, V102, P13313, DOI 10.1073/pnas.0505067102; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; He SG, 2000, J COMP NEUROL, V418, P33, DOI 10.1002/(SICI)1096-9861(20000228)418:1<33::AID-CNE3>3.0.CO;2-J; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Lin B, 2005, J NEUROSCI, V25, P6696, DOI 10.1523/JNEUROSCI.1894-05.2005; Maxeiner S, 2005, J NEUROSCI, V25, P566, DOI 10.1523/JNEUROSCI.3232-04.2005; Mills SL, 2001, J COMP NEUROL, V436, P336; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; O'Brien J, 2004, J NEUROSCI, V24, P5632, DOI 10.1523/JNEUROSCI.1248-04.2004; Ouyang XS, 2005, MOL BRAIN RES, V135, P1, DOI 10.1016/j.molbrainres.2004.10.045; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; Patel LS, 2006, CELL COMMUN ADHES, V13, P41, DOI 10.1080/15419060600631474; Sambrook J., 2001, MOL CLONING LAB MANU; Sitaramayya A, 2003, VISUAL NEUROSCI, V20, P385, DOI 10.1017/S0952523803204041; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Sohl G, 1998, FEBS LETT, V428, P27, DOI 10.1016/S0014-5793(98)00479-7; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Veruki ML, 2002, J NEUROSCI, V22, P10558; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Weiler R, 2000, BRAIN RES REV, V32, P121, DOI 10.1016/S0165-0173(99)00071-5; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Xia XB, 2004, VISUAL NEUROSCI, V21, P791, DOI 10.1017/S0952523804215127; Zoidl G, 2002, J NEUROSCI RES, V69, P448, DOI 10.1002/jnr.10284	37	105	107	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33163	33171		10.1074/jbc.M606396200	http://dx.doi.org/10.1074/jbc.M606396200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956882	hybrid			2022-12-27	WOS:000241621400024
J	Wojcik, M; Seidle, HF; Bieganowski, P; Brenner, C				Wojcik, Marzena; Seidle, Heather F.; Bieganowski, Pawel; Brenner, Charles			Glutamine-dependent NAD(+) synthetase - How a two-domain, three-substrate enzyme avoids waste	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDOTRANSFERASE DOMAIN; INTERMEDIATE; CATALYSIS	Glutamine-dependent NAD(+) synthetase, Qns1, utilizes a glutamine aminotransferase domain to supply ammonia for amidation of nicotinic acid adenine dinucleotide (NaAD(+)) to NAD(+). Earlier characterization of Qns1 suggested that glutamine consumption exceeds NAD(+) production by 40%. To explore whether Qns1 is systematically wasteful or whether additional features account for this behavior, we performed a careful kinetic and molecular genetic analysis. In fact, Qns1 possesses remarkable properties to reduce waste. The glutaminase active site is stimulated by NaAD(+) more than 50-fold such that glutamine is not appreciably consumed in the absence of NaAD(+). Glutamine consumption exceeds NAD(+) production over the whole range of glutamine and NaAD(+) substrate concentrations with greatest efficiency occurring at saturation of both substrates. Kinetic data coupled with site-directed mutagenesis of amino acids in the predicted ammonia channel indicate that NaAD(+) stimulates the glutaminase active site in the k(cat) term by a synergistic mechanism that does not require ammonia utilization by the NaAD(+) substrate. Six distinct classes of Qns1 mutants that fall within the glutaminase domain and the synthetase domain selectively inhibit components of the coordinated reaction.	Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; Polish Acad Sci, Ctr Mol & Macromol Studies, Dept Bioorgan Sci, PL-90363 Lodz, Poland; Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Polish Academy of Sciences; Centre of Molecular & Macromolecular Studies of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Brenner, C (corresponding author), Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA.	charles.brenner@dartmouth.edu	Bieganowski, Pawel/ABC-8554-2021; Wojcik, Marzena/S-9411-2016; Brenner, Charles/D-6339-2014	Bieganowski, Pawel/0000-0002-1169-4517; Brenner, Charles/0000-0002-4955-3226; wojcik, marzena/0000-0001-5563-8122	NATIONAL CANCER INSTITUTE [P01CA077738] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA077738-01A20003, P01 CA077738] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bera AK, 2000, J BIOL CHEM, V275, P7975, DOI 10.1074/jbc.275.11.7975; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; BRIDGER WA, 1968, BIOCHEMISTRY-US, V7, P3608, DOI 10.1021/bi00850a038; Cantoni R, 1998, J BACTERIOL, V180, P3218, DOI 10.1128/JB.180.12.3218-3221.1998; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Jauch R, 2005, J BIOL CHEM, V280, P15131, DOI 10.1074/jbc.M413195200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MCELROY WD, 1967, SCIENCE, V157, P150, DOI 10.1126/science.157.3785.150; Miles BW, 1998, BIOCHEMISTRY-US, V37, P16773, DOI 10.1021/bi982018g; Pace HC, 2001, GENOME BIOL, V2; PREISS J, 1958, J BIOL CHEM, V233, P493; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Rizzi M, 1998, STRUCTURE, V6, P1129, DOI 10.1016/S0969-2126(98)00114-2; YU CK, 1972, J BIOL CHEM, V247, P4794; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87	18	41	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33395	33402		10.1074/jbc.M607111200	http://dx.doi.org/10.1074/jbc.M607111200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16954203	hybrid			2022-12-27	WOS:000241621400049
J	Gao, TY; Newton, AC				Gao, Tianyan; Newton, Alexandra C.			Invariant Leu preceding turn motif phosphorylation site controls the interaction of protein kinase C with Hsp70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; APOPTOSIS; AUTOPHOSPHORYLATION; DEPHOSPHORYLATION; DEGRADATION; DEPLETION; PATHWAYS; ISOTYPES	Heat shock proteins play important roles in regulating signal transduction in cells by associating with, and stabilizing, diverse signaling molecules, including protein kinases. Previously, we have shown that heat shock protein Hsp70 associates with protein kinase C (PKC) via an interaction that is triggered by dephosphorylation at the turn phosphorylation motif. Here we have identified an invariant residue in the carboxyl terminus of PKC that mediates the binding to Hsp70. Specifically, we show that Hsp70 binds to Leu (Leu-640) immediately preceding the conserved turn motif autophosphorylation site (Thr-641) in PKC beta II. Co-immunoprecipitation experiments reveal that mutation of Leu-640 to Gly decreases the interaction of Hsp70 with PKC beta II. This weakened interaction between Hsp70 and the mutant PKCs results in accumulation of dephosphorylated PKC in the detergent-insoluble fraction of cells. In addition, the Hsp70-binding mutant is considerably more sensitive to downregulation compared with WT PKC: disruption of Hsp70 binding leads to accelerated dephosphorylation and enhanced ubiquitination of mutant PKC upon phorbol ester treatment. Last, pulse-chase experiments demonstrate that Hsp70 preferentially binds the species of mature PKC that has become dephosphorylated compared with the newly synthesized protein that has yet to be phosphorylated. Thus, Hsp70 binds a hydrophobic residue preceding the turn motif, protecting PKC from down-regulation and sustaining the signaling lifetime of the kinase.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA 10209-03] Funding Source: Medline; NIDDK NIH HHS [P01 DK 54441] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; CHIDA K, 1986, J BIOL CHEM, V261, P3013; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Gabai VL, 2000, MOL CELL BIOL, V20, P6826, DOI 10.1128/MCB.20.18.6826-6836.2000; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; JAATTELA M, 1995, INT J CANCER, V60, P689, DOI 10.1002/ijc.2910600520; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; MURRAY NR, 1993, J BIOL CHEM, V268, P15847; Murray NR, 1999, J CELL BIOL, V145, P699, DOI 10.1083/jcb.145.4.699; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nollen EAA, 2002, J CELL SCI, V115, P2809; Nylandsted J, 2002, CANCER RES, V62, P7139; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200	26	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32461	32468		10.1074/jbc.M604076200	http://dx.doi.org/10.1074/jbc.M604076200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954220	hybrid			2022-12-27	WOS:000241414500044
J	Porter, SL; Wadhams, GH; Martin, AC; Byles, ED; Lancaster, DE; Armitage, JP				Porter, Steven L.; Wadhams, George H.; Martin, Angela C.; Byles, Elaine D.; Lancaster, David E.; Armitage, Judith P.			The CheYs of Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTACTIC RESPONSE REGULATOR; SIGNAL-TRANSDUCTION CASCADE; HISTIDINE PROTEIN-KINASE; BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PHOSPHATASE-ACTIVITY; FLAGELLAR ROTATION; RHIZOBIUM-MELILOTI; MASS-SPECTROMETRY	The Escherichia coli two-component chemosensory pathway has been extensively studied, and its response regulator, CheY, has become a paradigm for response regulators. However, unlike E. coli, most chemotactic nonenteric bacteria have multiple CheY homologues. The roles and cellular localization of the CheYs in Rhodobacter sphaeroides were determined. Only two CheYs were required for chemotaxis, CheY(6) and either CheY(3) or CheY(4). These CheYs were partially localized to either of the two chemotaxis signaling clusters, with the remaining protein delocalized. Interestingly, mutation of the CheY(6) phosphorylatable aspartate to asparagine produced a stopped motor, caused by phosphorylation on alternative site Ser-83 by CheA. Extensive mutagenesis of E. coli CheY has identified a number of activating mutations, which have been extrapolated to other response regulators (D13K, Y106W, and I95V). Analogous mutations in R. sphaeroides CheYs did not cause activation. These results suggest that although the R. sphaeroides and E. coli CheYs are similar in that they require phosphorylation for activation, they may differ in both the nature of the phosphorylation-induced conformational change and their subsequent interactions with the flagellar motor. Caution should therefore be used when projecting from E. coli CheY onto novel response regulators.	Univ Oxford, Dept Biochem, Microbiol Unit, Oxford OX1 3QU, England	University of Oxford	Armitage, JP (corresponding author), Univ Oxford, Dept Biochem, Microbiol Unit, S Parks Rd, Oxford OX1 3QU, England.	judith.armitage@bioch.ox.ac.uk		Porter, Steven/0000-0002-7851-236X; Martin, Angela/0000-0001-6196-0409				Appleby JL, 1999, MOL MICROBIOL, V34, P915, DOI 10.1046/j.1365-2958.1999.01653.x; ARMITAGE JP, 1987, J BACTERIOL, V169, P514, DOI 10.1128/jb.169.2.514-518.1987; Batycka M, 2006, RAPID COMMUN MASS SP, V20, P2074, DOI 10.1002/rcm.2563; Berleman JE, 2005, MOL MICROBIOL, V55, P1390, DOI 10.1111/j.1365-2958.2005.04489.x; Berry RM, 2000, BIOPHYS J, V78, P1207, DOI 10.1016/S0006-3495(00)76678-1; BISCHOFF DS, 1991, J BIOL CHEM, V266, P12301; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Ferre A, 2004, J BACTERIOL, V186, P5172, DOI 10.1128/jb.186.15.5172-5177.2004; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Hamblin PA, 1997, MOL MICROBIOL, V26, P1083, DOI 10.1046/j.1365-2958.1997.6502022.x; Harrison DM, 1999, MOL MICROBIOL, V31, P885, DOI 10.1046/j.1365-2958.1999.01226.x; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; HESS JF, 1988, NATURE, V336, P139, DOI 10.1038/336139a0; Hyakutake A, 2005, J BACTERIOL, V187, P8403, DOI 10.1128/JB.187.24.8403-8410.2005; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Jiang MY, 1997, J BIOL CHEM, V272, P11850, DOI 10.1074/jbc.272.18.11850; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; LUKAT GS, 1993, J CELL BIOCHEM, V51, P41, DOI 10.1002/jcb.240510109; LUPAS A, 1989, J BIOL CHEM, V264, P17337; Mackenzie C, 2001, PHOTOSYNTH RES, V70, P19, DOI 10.1023/A:1013831823701; Martin AC, 2001, J BACTERIOL, V183, P7135, DOI 10.1128/JB.183.24.7135-7144.2001; MOORE JB, 1993, J BACTERIOL, V175, P2692, DOI 10.1128/JB.175.9.2692-2701.1993; Motaleb MA, 2005, J BACTERIOL, V187, P7963, DOI 10.1128/JB.187.23.7963-7969.2005; NINFA EG, 1991, J BIOL CHEM, V266, P9764; Porter SL, 2002, J MOL BIOL, V324, P35, DOI 10.1016/S0022-2836(02)01031-8; Porter SL, 2004, J BIOL CHEM, V279, P54573, DOI 10.1074/jbc.M408855200; Porter SL, 2002, MOL MICROBIOL, V46, P1081, DOI 10.1046/j.1365-2958.2002.03218.x; Rasmussen AA, 2006, MOL MICROBIOL, V60, P525, DOI 10.1111/j.1365-2958.2006.05118.x; Ray WK, 2005, J BACTERIOL, V187, P4270, DOI 10.1128/JB.187.12.4270-4275.2005; REYRAT JM, 1994, J BACTERIOL, V176, P1969, DOI 10.1128/jb.176.7.1969-1976.1994; Riepll H, 2004, J MOL BIOL, V338, P287, DOI 10.1016/j.jmb.2004.02.054; Romagnoli S, 2002, J BACTERIOL, V184, P5590, DOI 10.1128/JB.184.20.5590-5598.2002; Sambrook J., 2001, MOL CLONING LAB MANU; SANNA MG, 1995, MOL MICROBIOL, V15, P1069, DOI 10.1111/j.1365-2958.1995.tb02282.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Schuster M, 1998, MOL MICROBIOL, V27, P1065, DOI 10.1046/j.1365-2958.1998.00756.x; Schuster M, 2000, J BIOL CHEM, V275, P19752, DOI 10.1074/jbc.M909908199; Shah DSH, 2000, EMBO J, V19, P4601, DOI 10.1093/emboj/19.17.4601; Shah DSH, 2000, MOL MICROBIOL, V35, P101, DOI 10.1046/j.1365-2958.2000.01680.x; Sockett R, 1990, FEMS S, V53, P473; Sourjik V, 1998, BIOCHEMISTRY-US, V37, P2327, DOI 10.1021/bi972330a; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Taylor GK, 2005, RAPID COMMUN MASS SP, V19, P3420, DOI 10.1002/rcm.2225; TRACH KA, 1993, MOL MICROBIOL, V8, P69, DOI 10.1111/j.1365-2958.1993.tb01204.x; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wadhams GH, 2003, MOL MICROBIOL, V50, P763, DOI 10.1046/j.1365-2958.2003.03716.x; Wadhams GH, 2002, MOL MICROBIOL, V46, P1211, DOI 10.1046/j.1365-2958.2002.03252.x; WARD MJ, 1995, MOL MICROBIOL, V17, P357, DOI 10.1111/j.1365-2958.1995.mmi_17020357.x; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; Wolanin PM, 2003, BIOCHEMISTRY-US, V42, P14075, DOI 10.1021/bi034883t	58	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32694	32704		10.1074/jbc.M606016200	http://dx.doi.org/10.1074/jbc.M606016200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950782	hybrid			2022-12-27	WOS:000241414500068
J	dela Cruz, RGC; Jairajpuri, MA; Bock, SC				dela Cruz, Richard Glenn C.; Jairajpuri, Mohamad Aman; Bock, Susan C.			Disruption of a tight cluster surrounding tyrosine 131 in the native conformation of antithrombin III activates it for factor Xa inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN ACTIVATION; HIGH-AFFINITY; HELIX-D; MECHANISM; BINDING; SEQUENCE; ELIMINATION; EXPRESSION; RESIDUES; DELETION	The native conformation of antithrombin III (ATIII) is a poor inhibitor of its coagulation pathway target enzymes because of the partial insertion of its reactive center loop (RCL) in its central A beta-sheet. This study focused on tyrosine 131, which is located at the helix D-sheet A interface, adjacent to the ATIII pentasaccharide and heparin cofactor-binding sites and some 17 A away from the RCL insertion. Crystallographic structures show that the Tyr(131) ring is buried in native ATIII and then becomes exposed when pentasaccharide binds to the inhibitor and activates it. This change suggested that Tyr(131) might serve as a switch for ATIII conformational activation. The hypothesis is supported by results from this study, which progressively removed atoms from the Tyr(131) side chain. Rates of heparin-independent Y131L and Y131A factor Xa inhibition were 25 and 29 times faster than for the control and Y131F, suggesting that Tyr(131) ring interactions with neighboring helix D and strand 2A residues shift the uncatalyzed native-to-activated conformational equilibrium toward the RCL-inserted state. Thermal denaturation experiments showed Y131A and Y131L were less stable than the control and Y131F, implying an increased tendency toward A-sheet mobility in these genetically activated molecules. Thus, the tight Tyr(131)-Asn(127)-Leu(130)-Leu(140)-Ser(142) cluster at the helix D-strand 2A interface of native antithrombin contributes significantly to the stability of the ground state conformation, and tyrosine 131 serves as a heparin-responsive molecular switch during the allosteric activation of ATIII anticoagulant activity.	Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84132 USA; Univ Utah, Dept Bioengn, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Bock, SC (corresponding author), Univ Utah, Hlth Sci Ctr, Div Pulm, Wintrobe 739,50 N Med Dr, Salt Lake City, UT 84132 USA.	Susan.Bock@m.cc.utah.edu	Jairajpuri, Mohamad/AAS-2556-2020		NHLBI NIH HHS [HL76819] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076819] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arocas V, 2000, BIOCHEMISTRY-US, V39, P8512, DOI 10.1021/bi9928243; Backovic M, 2002, J PROTEOME RES, V1, P367, DOI 10.1021/pr025515z; Belzar KJ, 2002, J BIOL CHEM, V277, P8551, DOI 10.1074/jbc.M110807200; BJORK I, 1992, BIOCHEM J, V286, P793; BOCK SC, 1982, NUCLEIC ACIDS RES, V10, P8113, DOI 10.1093/nar/10.24.8113; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Desai U, 2000, J BIOL CHEM, V275, P18976, DOI 10.1074/jbc.M001340200; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Jairajpuri MA, 2003, J BIOL CHEM, V278, P15941, DOI 10.1074/jbc.M212319200; Jairajpuri MA, 2002, J BIOL CHEM, V277, P24460, DOI 10.1074/jbc.M203127200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; Meagher JL, 1996, J BIOL CHEM, V271, P29353, DOI 10.1074/jbc.271.46.29353; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P331, DOI 10.1016/S1050-1738(02)00183-4; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P198, DOI 10.1016/S1050-1738(02)00160-3; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; PICARD V, 1996, METHODS MOL BIOL PCR, P183; Raja SM, 2003, J BIOL CHEM, V278, P13688, DOI 10.1074/jbc.M300062200; Rezaie AR, 2002, J BIOL CHEM, V277, P1235, DOI 10.1074/jbc.M108544200; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492	30	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31668	31676		10.1074/jbc.M604826200	http://dx.doi.org/10.1074/jbc.M604826200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16940049	Bronze			2022-12-27	WOS:000241235300052
J	Rostovtseva, TK; Kazemi, N; Weinrich, M; Bezrukov, SM				Rostovtseva, Tatiana K.; Kazemi, Namdar; Weinrich, Michael; Bezrukov, Sergey M.			Voltage gating of VDAC is regulated by nonlamellar lipids of mitochondrial membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-SELECTIVE CHANNEL; CYTOCHROME-C RELEASE; OUTER-MEMBRANE; NEUROSPORA-CRASSA; PHOSPHATIDYLSERINE BILAYERS; MECHANOSENSITIVE CHANNELS; TRANSMEMBRANE CHANNEL; GRAMICIDIN CHANNELS; YEAST MITOCHONDRIA; LATERAL PRESSURE	Evidence is accumulating that lipids play important roles in permeabilization of the mitochondria outer membrane (MOM) at the early stage of apoptosis. Lamellar phosphatidylcholine (PC) and nonlamellar phosphatidylethanolamine (PE) lipids are the major membrane components of the MOM. Cardiolipin (CL), the characteristic lipid from the mitochondrial inner membrane, is another nonlamellar lipid recently shown to play a role in MOM permeabilization. We investigate the effect of these three key lipids on the gating properties of the voltage-dependent anion channel (VDAC), the major channel in MOM. We find that PE induces voltage asymmetry in VDAC current-voltage characteristics by promoting channel closure at cis negative applied potentials. Significant asymmetry is also induced by CL. The observed differences in VDAC behavior in PC and PE membranes cannot be explained by differences in the insertion orientation of VDAC in these membranes. Rather, it is clear that the two nonlamellar lipids affect VDAC gating. Using gramicidin A channels as a tool to probe bilayer mechanics, we show that VDAC channels are much more sensitive to the presence of CL than could be expected from the experiments with gramicidin channels. We suggest that this is due to the preferential insertion of VDAC into CL-rich domains. We propose that the specific lipid composition of the mitochondria outer membrane and/or of contact sites might influence MOM permeability by regulating VDAC gating.	NICHD, Lab Phys & Struct Biol, NIH, Bethesda, MD 20892 USA; NICHD, Natl Ctr Med Rehabil Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rostovtseva, TK (corresponding author), NICHD, Lab Phys & Struct Biol, NIH, Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov			Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000072] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Bezrukov SM, 1998, FARADAY DISCUSS, V111, P173; BEZRUKOV SM, 1993, BIOPHYS J, V64, P16, DOI 10.1016/S0006-3495(93)81336-5; Booth PJ, 2005, CURR OPIN STRUC BIOL, V15, P435, DOI 10.1016/j.sbi.2005.06.002; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; Colombini M, 1996, Ion Channels, V4, P169; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; COLOMBINI M, 1994, CURR TOP MEMBR, V42, P73, DOI 10.1016/S0070-2161(08)60819-9; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V693, P1, DOI 10.1016/0005-2736(82)90464-3; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; DORING C, 1985, J MEMBRANE BIOL, V83, P81, DOI 10.1007/BF01868740; EHRENSTEIN G, 1970, J GEN PHYSIOL, V55, P119, DOI 10.1085/jgp.55.1.119; ELLIOTT JR, 1983, BIOCHIM BIOPHYS ACTA, V735, P95, DOI 10.1016/0005-2736(83)90264-X; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; FREITAG H, 1983, METHOD ENZYMOL, V97, P286; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; GAWRISCH K, 1992, BIOCHEMISTRY-US, V31, P2856, DOI 10.1021/bi00126a003; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P659, DOI 10.1038/sj.cdd.4401585; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Grijalba MT, 1999, BIOCHEMISTRY-US, V38, P13279, DOI 10.1021/bi9828674; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Gurnev PA, 2006, J MOL BIOL, V359, P1447, DOI 10.1016/j.jmb.2006.04.034; Harroun TA, 1999, BIOPHYS J, V76, P3176, DOI 10.1016/S0006-3495(99)77469-2; HAUSER H, 1981, J BIOL CHEM, V256, P1377; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Huster D, 1999, BIOPHYS J, V77, P879, DOI 10.1016/S0006-3495(99)76939-0; Iverson SL, 2004, J BIOL CHEM, V279, P1100, DOI 10.1074/jbc.M305020200; Karginov VA, 2005, P NATL ACAD SCI USA, V102, P15075, DOI 10.1073/pnas.0507488102; KELLER SL, 1993, BIOPHYS J, V65, P23, DOI 10.1016/S0006-3495(93)81040-3; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; LEMASTER JJ, 2005, BIOCHIM BIOPHYS ACTA, V1762, P181; Levadny V, 2002, BIOPHYS J, V82, P1773, DOI 10.1016/S0006-3495(02)75528-8; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; Lundbaek JA, 1997, BIOCHEMISTRY-US, V36, P5695, DOI 10.1021/bi9619841; Lundbaek JA, 2006, J PHYS-CONDENS MAT, V18, pS1305, DOI 10.1088/0953-8984/18/28/S13; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; Merzlyak PG, 1999, BIOPHYS J, V77, P3023, DOI 10.1016/S0006-3495(99)77133-X; Nestorovich EM, 2006, J BIOL CHEM, V281, P16230, DOI 10.1074/jbc.M600650200; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; OCONNELL AM, 1990, SCIENCE, V250, P1256, DOI 10.1126/science.1700867; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; PENG S, 1992, BIOPHYS J, V62, P123, DOI 10.1016/S0006-3495(92)81799-X; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Polcic P, 2005, CELL DEATH DIFFER, V12, P310, DOI 10.1038/sj.cdd.4401566; POWELL GL, 1987, BIOCHEMISTRY-US, V26, P8138, DOI 10.1021/bi00399a018; RAND RP, 1972, BIOCHIM BIOPHYS ACTA, V225, P484, DOI 10.1016/0005-2736(72)90152-6; Rokitskaya TI, 1997, BIOPHYS J, V73, P850, DOI 10.1016/S0006-3495(97)78117-7; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Rostovtseva TK, 2002, BIOPHYS J, V82, P193, DOI 10.1016/S0006-3495(02)75386-1; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Templer RH, 1998, FARADAY DISCUSS, V111, P41; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; Tristram-Nagle S, 1998, BIOPHYS J, V75, P917, DOI 10.1016/S0006-3495(98)77580-0; URRY DW, 1971, P NATL ACAD SCI USA, V68, P1907, DOI 10.1073/pnas.68.8.1907; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; VIK SB, 1981, P NATL ACAD SCI-BIOL, V78, P1456, DOI 10.1073/pnas.78.3.1456; Waterhouse NJ, 2002, BIOCHIMIE, V84, P113, DOI 10.1016/S0300-9084(02)01379-2; Xu X, 2001, J MEMBRANE BIOL, V180, P73, DOI 10.1007/s002320010060; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; ZAMBROWICZ EB, 1993, BIOPHYS J, V65, P1093, DOI 10.1016/S0006-3495(93)81148-2; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; ZIZI M, 1995, J MEMBRANE BIOL, V144, P121; Zizi M, 1998, BIOPHYS J, V75, P704, DOI 10.1016/S0006-3495(98)77560-5	92	106	107	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37496	37506		10.1074/jbc.M602548200	http://dx.doi.org/10.1074/jbc.M602548200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16990283	hybrid			2022-12-27	WOS:000242477100026
J	Bundschu, K; Walter, U; Schuh, K				Bundschu, Karin; Walter, Ulrich; Schuh, Kai			The VASP-Spred-Sprouty domain puzzle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							VASODILATOR-STIMULATED PHOSPHOPROTEIN; PROTEIN-KINASE PHOSPHORYLATION; INTACT HUMAN PLATELETS; RICH FOCAL ADHESION; TYROSINE KINASE; ERK ACTIVATION; EVH1 DOMAIN; MAP KINASE; TRANSLOCATION DOMAIN; SIGNALING PATHWAYS	Sprouty-related proteins with an EVH1 domain (Spreds) belong to a new protein family harboring a conserved N-terminal EVH1 domain, which is related to the VASP (vasodilator-stimulated phosphoprotein) EVH1 domain (Enabled/VASP homology 1 domain) and a C-terminal Sprouty-related domain, typical for Sprouty proteins. Spreds were, like Sproutys, initially discovered as inhibitors of the Ras/MAPK pathway, and the SPR (Sprouty-related) domains of both protein families seem to be very important for many protein interactions and cellular processes. VASP was initially characterized as a proline-rich substrate of protein kinases A and G in human platelets and later shown to be a scaffold protein, regulating both signal transduction pathways and the actin filament system. The VASP-EVH1 domain is known to bind specifically to a FP4 binding motif, which is, for example, present in the focal adhesion proteins vinculin and zyxin. In this review we give a structural and functional overview on these three protein families and ask whether nature plays a modular protein domain puzzle with stable exchangeable elements or if these closely related domains have various functions when pasted in a different protein context.	Univ Ulm, Abt Biochem & Mol Biol, D-89081 Ulm, Germany; Univ Wurzburg, Int Klin Biochem & Pathobiochem, D-97080 Wurzburg, Germany; Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany	Ulm University; University of Wurzburg; University of Wurzburg	Bundschu, K (corresponding author), Univ Ulm, Abt Biochem & Mol Biol, D-89081 Ulm, Germany.	karin.bundschu@gmx.de	Walter, ulrich/W-2478-2017	Walter, ulrich/0000-0001-6784-2307				ABEL K, 1995, FEBS LETT, V370, P184, DOI 10.1016/0014-5793(95)00817-S; Ahern-Djamali SM, 1999, P NATL ACAD SCI USA, V96, P4977, DOI 10.1073/pnas.96.9.4977; Anteby EY, 2005, PLACENTA, V26, P476, DOI 10.1016/j.placenta.2004.08.008; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Ball LJ, 2002, FEBS LETT, V513, P45, DOI 10.1016/S0014-5793(01)03291-4; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Brading AF, 2005, NAT CLIN PRACT UROL, V2, P546, DOI 10.1038/ncpuro0340; Bundschu K, 2005, J BIOL CHEM, V280, P28572, DOI 10.1074/jbc.M503640200; Bundschu K, 2006, GENE EXPR PATTERNS, V6, P247, DOI 10.1016/j.modgep.2005.08.003; BUTT E, 1994, J BIOL CHEM, V269, P14509; Cabrita MA, 2003, THROMB HAEMOSTASIS, V90, P586, DOI 10.1160/TH03-04-0217; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chitaley K, 2004, FEBS LETT, V556, P211, DOI 10.1016/S0014-5793(03)01435-2; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; DeMille MMC, 1996, GENE, V183, P103, DOI 10.1016/S0378-1119(96)00506-9; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; HAFFNER C, 1995, EMBO J, V14, P19, DOI 10.1002/j.1460-2075.1995.tb06971.x; Haimov-Kochman R, 2005, MOL HUM REPROD, V11, P537, DOI 10.1093/molehr/gah203; HALBRUGGE M, 1989, EUR J BIOCHEM, V185, P41, DOI 10.1111/j.1432-1033.1989.tb15079.x; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hanani M, 2000, ACTA PHYSIOL SCAND, V170, P177, DOI 10.1111/j.1365-201X.2000.00769.x; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Harmer NJ, 2005, FEBS LETT, V579, P1161, DOI 10.1016/j.febslet.2004.11.114; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; Jarvis LA, 2006, DEVELOPMENT, V133, P1133, DOI 10.1242/dev.02255; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; King JAJ, 2006, J HEPATOL, V44, P758, DOI 10.1016/j.jhep.2005.10.031; King JAJ, 2005, BIOCHEM J, V388, P445, DOI 10.1042/BJ20041284; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; Kramer S, 1999, DEVELOPMENT, V126, P2515; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Massberg S, 2004, BLOOD, V103, P136, DOI 10.1182/blood-2002-11-3417; Menzies AS, 2004, J NEUROSCI, V24, P8029, DOI 10.1523/JNEUROSCI.1057-04.2004; Minowada G, 1999, DEVELOPMENT, V126, P4465; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Nobuhisa I, 2004, J EXP MED, V199, P737, DOI 10.1084/jem.20030830; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Ozaki K, 2005, J CELL SCI, V118, P5861, DOI 10.1242/jcs.02711; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Reich A, 1999, DEVELOPMENT, V126, P4139; Reinhard M, 1996, FEBS LETT, V399, P103, DOI 10.1016/S0014-5793(96)01295-1; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Renfranz PJ, 2002, CURR OPIN CELL BIOL, V14, P88, DOI 10.1016/S0955-0674(01)00299-X; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Rubin C, 2005, J BIOL CHEM, V280, P9735, DOI 10.1074/jbc.M408308200; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Tefft D, 2002, AM J PHYSIOL-LUNG C, V283, pL700, DOI 10.1152/ajplung.00372.2001; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Tsumura Y, 2005, BIOCHEM J, V387, P627, DOI 10.1042/BJ20041181; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200; Zimmermann J, 2004, J BIOMOL NMR, V29, P435, DOI 10.1023/B:JNMR.0000032526.17586.8c	95	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36477	36481		10.1074/jbc.R600023200	http://dx.doi.org/10.1074/jbc.R600023200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16987806	hybrid			2022-12-27	WOS:000242220800002
J	Bjursell, MK; Martens, EC; Gordon, JI				Bjursell, Magnus K.; Martens, Eric C.; Gordon, Jeffrey I.			Functional genomic and metabolic studies of the adaptations of a prominent adult human gut symbiont, Bacteroides thetaiotaomicron, to the suckling period	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTENSIVE DNA INVERSIONS; OUTER-MEMBRANE PROTEINS; INTESTINAL FLORA; MICROBIAL DIVERSITY; FECAL MICROFLORA; CELL-SURFACE; HUMAN-MILK; IN-VIVO; STARCH; GENE	The adult human gut microbiota is dominated by two divisions of Bacteria, the Bacteroidetes and the Firmicutes. Assembly of this community begins at birth through processes that remain largely undefined. In this report, we examine the adaptations of Bacteroides thetaiotaomicron, a prominent member of the adult distal intestinal microbiota, during the suckling and weaning periods. Germ-free NMRI mice were colonized at birth from their gnotobiotic mothers, who harbored this anaerobic Gram-negative saccharolytic bacterium. B. thetaiotaomicron was then harvested from the ceca of these hosts during the suckling period ( postnatal day 17) and after weaning ( postnatal day 30). Whole genome transcriptional profiles were obtained at these two time points using custom B. thetaiotaomicron Gene-Chips. Transcriptome-based in silico reconstructions of bacterial metabolism and gas chromatography-mass spectrometry and biochemical assays of carbohydrate utilization in vivo indicated that in the suckling gut B. thetaiotaomicron prefers host-derived polysaccharides, as well as mono-and oligosaccharides present in mother's milk. After weaning, B. thetaiotaomicron expands its metabolism to exploit abundant, plant-derived dietary polysaccharides. The bacterium's responses to postnatal alterations in its nutrient landscape involve expression of gene clusters encoding environmental sensors, outer membrane proteins involved in binding and import of glycans, and glycoside hydrolases. These expression changes are interpreted in light of a phylogenetic analysis that revealed unique expansions of related polysaccharide utilization loci in three human alimentary tract-associated Bacteroidetes, expansions that likely reflect the evolutionary adaptations of these species to different nutrient niches.	Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, Campus Box 8510,4444 Forest Pk Ave, St Louis, MO 63108 USA.	jgordon@wustl.edu			NICHD NIH HHS [T32 HD07409] Funding Source: Medline; NIDDK NIH HHS [DK30292] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALMER SE, 1989, ARCH DIS CHILD, V64, P1678, DOI 10.1136/adc.64.12.1678; Braun V, 2006, BIOMETALS, V19, P103, DOI 10.1007/s10534-005-8253-y; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Cho KH, 2001, J BACTERIOL, V183, P7198, DOI 10.1128/JB.183.24.7198-7205.2001; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; DElla JN, 1996, J BACTERIOL, V178, P7173; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; George Mary, 1996, Upsala Journal of Medical Sciences, V101, P233; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hall LMC, 2005, INFECT IMMUN, V73, P4253, DOI 10.1128/IAI.73.7.4253-4262.2005; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mandar R, 1996, BIOL NEONATE, V69, P30; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PASSONNEAU JV, 1993, ENZYMATIC ANAL PRACT, P85; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reeves AR, 1996, J BACTERIOL, V178, P823, DOI 10.1128/jb.178.3.823-830.1996; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; ROBERTS AK, 1992, ACTA PAEDIATR, V81, P119, DOI 10.1111/j.1651-2227.1992.tb12186.x; SAKATA H, 1985, EUR J PEDIATR, V144, P186, DOI 10.1007/BF00451911; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Steuber J, 2002, EUR J BIOCHEM, V269, P1287, DOI 10.1046/j.1432-1033.2002.02770.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSAI MH, 1995, RES MICROBIOL, V146, P397, DOI 10.1016/0923-2508(96)80285-3; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Westover BP, 2005, BIOINFORMATICS, V21, P880, DOI 10.1093/bioinformatics/bti123; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; YOSHIOKA H, 1983, PEDIATRICS, V72, P317; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	45	203	213	2	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36269	36279		10.1074/jbc.M606509200	http://dx.doi.org/10.1074/jbc.M606509200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16968696	hybrid			2022-12-27	WOS:000242100500079
J	Soskine, M; Mark, S; Tayer, N; Mizrachi, R; Schuldiner, S				Soskine, Misha; Mark, Shirley; Tayer, Naama; Mizrachi, Roy; Schuldiner, Shimon			On parallel and antiparallel topology of a homodimeric multidrug transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; LIGAND-BINDING; CROSS-LINKING; EMRE; REVEALS; IDENTIFICATION	The recently suggested antiparallel topology of EmrE has intriguing implications for many aspects of the biology of ion-coupled transporters. However, it is at odds with biochemical data that demonstrated the same topology for all protomers in the intact cell and with extensive cross-linking studies. To examine this apparent contradiction we chemically cross-linked dimers with a rigid bifunctional maleimide using Cys replacements at positions not permissible by an antiparallel topology. A purified cross-linked dimer binds substrate and transports it in proteoliposomes with kinetic constants similar to those of the non-cross-linked dimer. The cross-linked dimers do not interact with non-cross-linked dimers as judged from the fact that inactive mutants do not affect their activity ( negative dominance). The results support the contention that EmrE with parallel topology is fully functional. We show that the detergents used in crystallization increase the fraction of monomers in solution. We suggest that the antiparallel orientation observed is a result of the arrangement of the monomers in the crystal. Functionality of EmrE with the suggested antiparallel orientation of the monomers remains to be characterized.	Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	Shimon.Schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237; Soskine, Misha/0000-0002-2198-9466	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16708] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Andersen OS, 1999, NAT STRUCT BIOL, V6, P609, DOI 10.1038/10648; Bowie JU, 2006, NAT STRUCT MOL BIOL, V13, P94, DOI 10.1038/nsmb0206-94; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davidson AL, 2005, SCIENCE, V308, P963, DOI 10.1126/science.1113414; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Locher KP, 2003, SCIENCE, V301, P603, DOI 10.1126/science.1088621; LOLKEMA JS, 1983, EUR J BIOCHEM, V130, P287, DOI 10.1111/j.1432-1033.1983.tb07149.x; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Pornillos O, 2006, FEBS LETT, V580, P358, DOI 10.1016/j.febslet.2005.12.054; Pornillos O, 2005, SCIENCE, V310, P1950, DOI 10.1126/science.1119776; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Sikora CW, 2005, BIOPHYS J, V88, P475, DOI 10.1529/biophysj.104.049247; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Steiner-Mordoch S., 1999, J BIOL CHEM, V274, P19480; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200	35	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36205	36212		10.1074/jbc.M607186200	http://dx.doi.org/10.1074/jbc.M607186200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17003034	hybrid			2022-12-27	WOS:000242100500071
J	Macey, TA; Lowe, JD; Chavkin, C				Macey, Tara A.; Lowe, Janet D.; Chavkin, Charles			Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESENSITIZATION; KINASE; MORPHINE; PHOSPHORYLATION; INTERNALIZATION; EFFICACY; RESENSITIZATION; ENDOCYTOSIS; EXPRESSION; TOLERANCE	In this study we investigated the mechanisms responsible for MAP kinase ERK1/2 activation following agonist activation of endogenous mu opioid receptors (MOR) normally expressed in cultured striatal neurons. Treatment with the MOR agonist fentanyl caused significant activation of ERK1/2 in neurons derived from wild type mice. Fentanyl effects were blocked by the opioid antagonist naloxone and were not evident in neurons derived from MOR knock-out (-/-) mice. In contrast, ERK1/2 activation by fentanyl was not evident in neurons from GRK3(-/-) mice or neurons pretreated with small inhibitory RNA for arrestin3. Consistent with this observation, treatment with the opiate morphine (which is less able to activate arrestin) did not elicit ERK1/2 activation in wild type neurons; however, transfection of arrestin3-(R170E) (a dominant positive form of arrestin that does not require receptor phosphorylation for activation) enabled morphine activation of ERK1/2. In addition, activation of ERK1/2 by fentanyl and morphine was rescued in GRK3(-/-) neurons following transfection with dominant positive arrestin3(R170E). The activation of ERK1/2 appeared to be selective as p38 MAP kinase activation was not increased by either fentanyl or morphine treatment in neurons from wild type, MOR-/-, or GRK3(-/-) mice. In addition, U0126 (a selective inhibitor of MEK kinase responsible for ERK phosphorylation) blocked ERK1/2 activation by fentanyl. These results support the hypothesis that MOR activation of ERK1/2 requires opioid receptor phosphorylation by GRK3 and association of arrestin3 to initiate the cascade resulting in ERK1/2 phosphorylation in striatal neurons.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chavkin, C (corresponding author), Box 357280,1959 Pacific Ave NE, Seattle, WA 98195 USA.	cchavkin@u.washington.edu	Chavkin, Charles/G-2797-2010		NIDA NIH HHS [R37 DA011672-08, R01DA11672, R37 DA011672, R37 DA011672-07, R01 DA016898-05, R01 DA016898, R37 DA011672-06, R01 DA011672] Funding Source: Medline; NINDS NIH HHS [T32NS07332, T32 NS007332] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA011672, R01DA011672, R01DA016898] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Belcheva MM, 1998, J NEUROCHEM, V70, P635; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Celver J, 2004, MOL PHARMACOL, V65, P528, DOI 10.1124/mol.65.3.528; Clark MJ, 2004, J PHARMACOL EXP THER, V310, P215, DOI 10.1124/jpet.103.064824; Dang VC, 2005, MOL PHARMACOL, V68, P1127, DOI 10.1124/mol.105.013185; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Kovoor A, 1998, MOL PHARMACOL, V54, P704; KOVOOR A, 1995, J BIOL CHEM, V270, P589, DOI 10.1074/jbc.270.2.589; Kovoor A, 1997, J BIOL CHEM, V272, P27605, DOI 10.1074/jbc.272.44.27605; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; McDonald PH, 2001, CELL SIGNAL, V13, P683, DOI 10.1016/S0898-6568(01)00203-0; Narita M, 2002, NEUROSCI LETT, V324, P97, DOI 10.1016/S0304-3940(02)00141-6; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Schuller AGP, 1999, NAT NEUROSCI, V2, P151, DOI 10.1038/5706; Schulz R, 2004, EUR J PHARMACOL, V500, P487, DOI 10.1016/j.ejphar.2004.07.010; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Terman GW, 2004, BRIT J PHARMACOL, V141, P55, DOI 10.1038/sj.bjp.0705595; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Yu YK, 1997, J BIOL CHEM, V272, P28869, DOI 10.1074/jbc.272.46.28869; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	32	58	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34515	34524		10.1074/jbc.M604278200	http://dx.doi.org/10.1074/jbc.M604278200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16982618	Green Accepted, hybrid			2022-12-27	WOS:000241767600072
J	Xu, LH; Han, C; Wu, T				Xu, Lihong; Han, Chang; Wu, Tong			A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E-2 signaling pathways for human cholangiocarcinoma cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); PPAR-GAMMA; DIFFERENTIAL EXPRESSION; MEDIATED ACTIVATION; AKT INACTIVATION; CYCLOOXYGENASE-2; APOPTOSIS; ALPHA; COX-2; AGONISTS	Peroxisome proliferator-activated receptor-delta (PPAR delta) is a nuclear receptor implicated in lipid oxidation and the pathogenesis of obesity and diabetes. This study was designed to examine the potential effect of PPAR delta on human cholangiocarcinoma cell growth and its mechanism of actions. Overexpression of PPAR delta or activation of PPAR delta by its pharmacological ligand, GW501516, at low doses (0.5-50 nM) promoted the growth of three human cholangiocarcinoma cell lines (CCLP1, HuCCT1, and SG231). This effect was mediated by induction of cyclooxygenase-2 (COX-2) gene expression and production of prostaglandin E-2 (PGE(2)) that in turn transactivated epidermal growth factor receptor (EGFR) and Akt. In support of this, inhibition of COX-2, EGFR, and Akt prevented the PPAR delta-induced cell growth. Furthermore, PPAR delta activation or PGE2 treatment induced the phosphorylation of cytosolic phospholipase A(2)alpha (cPLA(2)alpha), a key enzyme that releases arachidonic acid ( AA) substrate for PG production via COX. Overexpression or activation of cPLA(2)alpha enhanced PPAR delta binding to PPAR delta response element (DRE) and increased PPAR delta reporter activity, indicating a novel role of cPLA(2)alpha for PPAR delta activation. Consistent with this, AA enhanced the binding of PPAR delta to DRE, in vitro, suggesting a direct role of AA for PPAR delta activation. In contrast, although PGE2 treatment increased the DRE reporter activity in intact cells, it failed to induce PPAR delta binding to DRE in cell-free system, suggesting that cPLA(2)alpha-mediated AA release is required for PGE(2)-induced PPAR delta activation. Taken together, these observations reveal that PPAR delta induces COX-2 expression in human cholangiocarcinoma cells and that the COX-2-derived PGE2 further activates PPAR delta through phosphorylation of cPLA(2)alpha. This positive feedback loop plays an important role for cholangiocarcinoma cell growth and may be targeted for chemoprevention and treatment.	Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, T (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, MUH E-740,200 Lothrop St, Pittsburgh, PA 15213 USA.	wut@upmc.edu	xu, li/GNH-3667-2022		NCI NIH HHS [R01 CA106280, R01 CA102325] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102325, R01CA106280] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Berthiaume EP, 2004, SEMIN LIVER DIS, V24, P127, DOI 10.1055/s-2004-828890; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Burdick AD, 2006, CELL SIGNAL, V18, P9, DOI 10.1016/j.cellsig.2005.07.009; Chariyalertsak S, 2001, GUT, V48, P80, DOI 10.1136/gut.48.1.80; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Endo K, 2002, HEPATOLOGY, V36, P439, DOI 10.1053/jhep.2002.34435; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fajas L, 2001, J MOL ENDOCRINOL, V27, P1, DOI 10.1677/jme.0.0270001; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Glinghammar B, 2003, BIOCHEM BIOPH RES CO, V308, P361, DOI 10.1016/S0006-291X(03)01384-6; Gonzalez FJ, 1997, ADV EXP MED BIOL, V422, P109; Gores GJ, 2003, HEPATOLOGY, V37, P961, DOI 10.1053/jhep.2003.50200; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Han C, 2005, J BIOL CHEM, V280, P24053, DOI 10.1074/jbc.M500562200; Han C, 2004, CANCER RES, V64, P1369, DOI 10.1158/0008-5472.CAN-03-1086; Han C, 2002, AM J PHYSIOL-GASTR L, V282, pG586, DOI 10.1152/ajpgi.00305.2001; Han C, 2006, J CELL PHYSIOL, V207, P261, DOI 10.1002/jcp.20560; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hayashi N, 2001, HEPATOLOGY, V34, P638, DOI 10.1053/jhep.2001.28198; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hughes-Fulford M, 2005, CARCINOGENESIS, V26, P1520, DOI 10.1093/carcin/bgi112; Jain S, 1998, AM J PATHOL, V153, P349, DOI 10.1016/S0002-9440(10)65577-0; Kim MJ, 2001, MOL GENET METAB, V74, P362, DOI 10.1006/mgme.2001.3242; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kopelovich L, 2002, MOL CANCER THER, V1, P357; Lai GH, 2003, MOL CANCER THER, V2, P265; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Leng J, 2003, HEPATOLOGY, V38, P756, DOI 10.1053/jhep.2003.50380; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Luquet S, 2005, BBA-MOL BASIS DIS, V1740, P313, DOI 10.1016/j.bbadis.2004.11.011; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; Nzeako UC, 2002, HEPATOLOGY, V35, P552, DOI 10.1053/jhep.2002.31774; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Pawliczak R, 2002, J BIOL CHEM, V277, P33153, DOI 10.1074/jbc.M200246200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sapirstein A, 2005, AM J PHYSIOL-REG I, V288, pR1774, DOI 10.1152/ajpregu.00815.2004; Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Sirica AE, 2002, SEMIN LIVER DIS, V22, P303, DOI 10.1055/s-2002-34507; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Stephen RL, 2004, CANCER RES, V64, P3162, DOI 10.1158/0008-5472.CAN-03-2760; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tsubouchi Y, 2001, BIOCHEM BIOPH RES CO, V283, P750, DOI 10.1006/bbrc.2001.4847; Vichai V, 2005, INFLAMM RES, V54, P163, DOI 10.1007/s00011-004-1338-1; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu T, 2005, BBA-REV CANCER, V1755, P135, DOI 10.1016/j.bbcan.2005.04.002; Wu T, 2004, MOL CANCER THER, V3, P299; Wu T, 2002, HEPATOLOGY, V36, P363, DOI 10.1053/jhep.2002.34743; Zhang ZC, 2004, HEPATOLOGY, V39, P1028, DOI 10.1002/hep.20143	69	65	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33982	33996		10.1074/jbc.M600135200	http://dx.doi.org/10.1074/jbc.M600135200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966336	hybrid			2022-12-27	WOS:000241767600019
J	Morrison, AR; Moss, J; Stevens, LA; Evans, JE; Farrell, C; Merithew, E; Lambright, DG; Greiner, DL; Mordes, JP; Rossini, AA; Bortell, R				Morrison, Alan R.; Moss, Joel; Stevens, Linda A.; Evans, James E.; Farrell, Caitlin; Merithew, Eric; Lambright, David G.; Greiner, Dale L.; Mordes, John P.; Rossini, Aldo A.; Bortell, Rita			ART2, a T cell surface mono-ADP-ribosyltransferase, generates extracellular poly(ADP-ribose)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADENOSINE DIPHOSPHATE RIBOSE); NICOTINAMIDE ADENINE-DINUCLEOTIDE; CRYSTAL-STRUCTURE; NAD GLYCOHYDROLASE; IN-VITRO; RAT; RIBOSYLATION; RT6; POLYMERASE; ACTIVATION	NAD functions in multiple aspects of cellular metabolism and signaling through enzymes that covalently transfer ADP-ribose from NAD to acceptor proteins, thereby altering their function. NAD is a substrate for two enzyme families, mono-ADP-ribosyltransferases (mARTs) and poly(ADP-ribose) polymerases (PARPs), that covalently transfer an ADP-ribose monomer or polymer, respectively, to acceptor proteins. ART2, a mART, is a phenotypic marker of immunoregulatory cells found on the surface of T lymphocytes, including intestinal intraepithelial lymphocytes (IELs). We have shown that the auto-ADP-ribosylation of the ART2.2 allelic protein is multimeric. Our backbone structural alignment of ART2 (two alleles of the rat art2 gene have been reported, for simplicity, the ART2.2 protein investigated in this study will be referred to as ART2) and PARP suggested that multimeric auto-ADP-ribosylation of ART2 may represent an ADP-ribose polymer, rather than multiple sites of mono-ADP-ribosylation. To investigate this, we used highly purified recombinant ART2 and demonstrated that ART2 catalyzes the formation of an ADP-ribose polymer by sequencing gel and by HPLC and MS/MS mass spectrometry identification of PR-AMP, a breakdown product specific to poly(ADP-ribose). Furthermore, we identified the site of ADP-ribose polymer attachment on ART2 as Arg-185, an arginine in a crucial loop of its catalytic core. We found that endogenous ART2 on IELs undergoes multimeric auto-ADP-ribosylation more efficiently than ART2 on peripheral T cells, suggesting that these distinct lymphocyte populations differ in their ART2 surface topology. Furthermore, ART2.2 IELs are more resistant to NAD-induced cell death than ART2.1 IELs that do not have multimeric auto-ADP-ribosylation activity. The data suggest that capability of polymerizing ADP-ribose may not be unique to PARPs and that poly(ADP-ribosylation), an established nuclear activity, may occur extracellularly and modulate cell function.	Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; NHLBI, Pulm & Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Bortell, R (corresponding author), Diabet Div, Suite 218,373 Plantat St, Worcester, MA 01605 USA.	rita.bortell@umassmed.edu	Morrison, Alan R./ABH-3831-2020	Morrison, Alan R./0000-0002-2412-7669	Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [DK25306, DK32520, DK36024, DK49106] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025306, R01DK049106, R01DK025306, P30DK032520, R01DK036024] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALVAREZGONZALEZ R, 1987, BIOCHEMISTRY-US, V26, P3218, DOI 10.1021/bi00385a042; Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Bortell R, 2001, J IMMUNOL, V167, P2049, DOI 10.4049/jimmunol.167.4.2049; Chen J, 2006, J IMMUNOL, V176, P4590, DOI 10.4049/jimmunol.176.8.4590; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hara N, 1996, J BIOL CHEM, V271, P29552, DOI 10.1074/jbc.271.47.29552; IKEJIMA M, 1985, BIOCHEMISTRY-US, V24, P5039, DOI 10.1021/bi00340a013; INAGAKI F, 1978, BIOCHEM BIOPH RES CO, V85, P415, DOI 10.1016/S0006-291X(78)80058-8; JUNG S, 1994, J MOL BIOL, V244, P114, DOI 10.1006/jmbi.1994.1709; KochNolte F, 1996, J BIOL CHEM, V271, P7686, DOI 10.1074/jbc.271.13.7686; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; MIWA M, 1981, J BIOL CHEM, V256, P2916; MIWA M, 1977, NUCLEIC ACIDS RES, V4, P3997, DOI 10.1093/nar/4.11.3997; Mordes JP, 2002, DIABETES, V51, P3254, DOI 10.2337/diabetes.51.11.3254; MOSS J, 1980, J BIOL CHEM, V255, P7835; MOSS J, 1976, P NATL ACAD SCI USA, V73, P4424, DOI 10.1073/pnas.73.12.4424; Mueller-Dieckmann C, 2002, J MOL BIOL, V322, P687, DOI 10.1016/S0022-2836(02)00818-5; Okazaki IJ, 1999, ANNU REV NUTR, V19, P485, DOI 10.1146/annurev.nutr.19.1.485; Okazaki IJ, 1996, J BIOL CHEM, V271, P22052, DOI 10.1074/jbc.271.36.22052; OPPENHEIMER NJ, 1978, J BIOL CHEM, V253, P4907; Rigby MR, 1996, J IMMUNOL, V156, P4259; Rigby MR, 1996, DIABETES, V45, P1419, DOI 10.2337/diabetes.45.10.1419; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Stevens LA, 2003, J BIOL CHEM, V278, P19591, DOI 10.1074/jbc.M210364200; SUGIMURA T, 1994, MOL CELL BIOCHEM, V138, P5, DOI 10.1007/BF00928437; TAKADA T, 1994, J BIOL CHEM, V269, P9420; Todd D, 1999, J IMMUNOL METHODS, V224, P111, DOI 10.1016/S0022-1759(99)00015-0; Todd DJ, 2004, J IMMUNOL, V172, P5356, DOI 10.4049/jimmunol.172.9.5356; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; WAITE DJ, 1993, CELL IMMUNOL, V152, P82, DOI 10.1006/cimm.1993.1269; WILLIAMS GT, 1985, EXP CELL RES, V160, P419, DOI 10.1016/0014-4827(85)90189-2; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352	37	24	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33363	33372		10.1074/jbc.M607259200	http://dx.doi.org/10.1074/jbc.M607259200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16931513	hybrid			2022-12-27	WOS:000241621400046
J	O'Connor, MN; Smethurst, PA; Davies, LW; Joutsi-Korhonen, L; Onley, DJ; Herr, AB; Farndale, RW; Ouwehand, WH				O'Connor, Marie N.; Smethurst, Peter A.; Davies, Lorna W.; Joutsi-Korhonen, Lotta; Onley, David J.; Herr, Andrew B.; Farndale, Richard W.; Ouwehand, Willem H.			Selective blockade of glycoprotein VI clustering on collagen helices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR GAMMA-CHAIN; INDUCED THROMBUS FORMATION; PLATELET COLLAGEN; IMMUNOGLOBULIN SUPERFAMILY; TYROSINE PHOSPHORYLATION; BINDING; ALPHA(2)BETA(1); ACTIVATION; RESPONSES; ANTIBODY	Platelet activation by collagen relies on the interaction of the receptor glycoprotein VI ( GPVI) with collagen helices. We have previously generated two recombinant single chain human antibodies (scFvs) to human GPVI. The first, 10B12, binds to the collagen-binding site on the apical surface between the two immunoglobulin-like domains (D1D2) of the receptor and so directly inhibits GPVI function. The second, 1C3, binds D1D2 independently of 10B12 and has been shown to have a more subtle effect on platelet responses to collagen. Here we have shown that 1C3 potentiates the effect of 10B12 on platelet aggregation induced by collagen and cross-linked collagen-related peptide (CRP-XL). We investigated this by measuring the effect of both scFvs on the binding of D1D2 to immobilized collagen and CRP. As expected, 10B12 completely inhibited binding of GPVI to each ligand in a dose-dependent manner. However, 1C3 inhibited only a proportion of GPVI binding to its ligands, implying that it interferes with another aspect of ligand recognition by GPVI. To further understand the mode of inhibition, we used a unique set of CRPs in which the content of critical glycine-proline-hydroxyproline (GPO) triplets was varied in relation to an "inert" scaffold sequence of GPP motifs. We observed that a stepwise increase in D1D2 binding with (GPO) 2 content was blocked by 1C3. Together these results indicate that 1C3 inhibits clustering of the immunoglobulin- like domains of GPVI on collagen/CRPs, a conclusion that is supported by mapping the 1C3 epitope to the region including isoleucine 148 in D2.	Univ Cambridge, Dept Haematol, Div Transfus Med, Cambridge CB2 2PT, England; Natl Blood Serv Cambridge, Cambridge CB2 2PT, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Cambridge; University of Cambridge; University System of Ohio; University of Cincinnati	Smethurst, PA (corresponding author), Univ Cambridge, Dept Haematol, Div Transfus Med, Long Rd, Cambridge CB2 2PT, England.	pas28@cam.ac.uk	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399	Medical Research Council [G0400701] Funding Source: Medline; MRC [G0400701] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asselin J, 1999, BIOCHEM J, V339, P413, DOI 10.1042/0264-6021:3390413; BERNATOWICZ MS, 1986, ANAL BIOCHEM, V155, P95, DOI 10.1016/0003-2697(86)90231-9; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; DeLano WL, 2002, PYMOL USERS MANUAL; Farndale RW, 2003, BIOCHEM SOC SYMP, V70, P81, DOI 10.1042/bss0700081; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Heemskerk JWM, 1999, THROMB HAEMOSTASIS, V81, P782; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; JENNINGS NS, 2006, IN PRESS J IMMUNOL M; Joutsi-Korhonen L, 2003, BLOOD, V101, P4372, DOI 10.1182/blood-2002-08-2591; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; Montigiani S, 1996, J MOL BIOL, V258, P6, DOI 10.1006/jmbi.1996.0229; O'Connor MN, 2006, J THROMB HAEMOST, V4, P869, DOI 10.1111/j.1538-7836.2005.01764.x; Penz S, 2005, FASEB J, V19, P898, DOI 10.1096/fj.04-2748com; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Smethurst PA, 2004, BLOOD, V103, P903, DOI 10.1182/blood-2003-01-0308; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; Watkins NA, 2006, J THROMB HAEMOST, V4, P1197, DOI 10.1111/j.1538-7836.2006.01937.x; Watkins NA, 2000, TISSUE ANTIGENS, V55, P219, DOI 10.1034/j.1399-0039.2000.550305.x	26	21	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33505	33510		10.1074/jbc.M606480200	http://dx.doi.org/10.1074/jbc.M606480200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956881	hybrid			2022-12-27	WOS:000241621400061
J	Hozumi, K; Suzuki, N; Nielsen, PK; Nomizu, M; Yamada, Y				Hozumi, Kentaro; Suzuki, Nobuharu; Nielsen, Peter K.; Nomizu, Motoyoshi; Yamada, Yoshihiko			Laminin alpha 1 chain LG4 module promotes cell attachment through syndecans and cell spreading through integrin alpha 2 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; SITE-DIRECTED MUTAGENESIS; G-DOMAIN; BINDING-SITES; DYSTROGLYCAN-BINDING; SYNTHETIC PEPTIDES; GLOBULAR DOMAIN; BASEMENT-MEMBRANES; CARCINOMA CELLS; SWISS-MODEL	The laminin alpha 1 chain is a subunit of laminin-1, a heterotrimeric basement membrane protein. The LG4-5 module at the C terminus of laminin alpha 1 contains major binding sites for heparin, sulfatide, and alpha-dystroglycan and plays a critical role in early embryonic development. We previously identified active synthetic peptides AG73 and EF-1 from the sequence of laminin alpha 1 LG4 for binding to syndecan and integrin alpha 2 beta 1, respectively. However, their activity and functional relationship within the laminin-1 and LG4 as well as the functional relation between these sites and alpha-dystroglycan binding sites in LG4 are not clear. To address these questions, we created mutant recombinant LG4 proteins containing alanine substitutions within the AG73 (M1), EF-1 (M2, M3), and alpha-dystroglycan binding sites (M4, M5) and analyzed their activities. We found that recombinant proteins rec-M1 and rec-M5, containing mutations within M1 and M5, respectively, did not bind heparin or lymphoid cell lines expressing syndecans. These results suggest that LG4 binds to heparin and syndecans through M1 and M5. Rec-M1 and rec-M5 reduced fibroblast attachment, whereas mutant rec-M2 and rec-M3 retained cell attachment activity but did not promote cell spreading. Fibroblast attachment to rec- LG4 was inhibited by heparin but not by integrin antibodies. Spreading of fibroblasts on rec-LG4 was inhibited by anti-integrin alpha 2 and beta 1 but not by anti-integrin alpha 1 and alpha 6. These results suggest that the M1 and M5 sites are necessary for cell attachment on LG4 through syndecans and that the EF-1 site is for cell spreading activity through integrin alpha 2 beta 1. In contrast, laminin-1-mediated fibroblast attachment and spreading were not inhibited by heparin or anti-integrin alpha 2. Our findings indicate that LG4 has a unique function distinct from laminin-1 and suggest that laminin alpha 1 LG4-5 may also be produced by a proteolytic cleavage in certain tissues where it exerts its activity.	NIDCR, Mol Biol Sect, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tokyo University of Pharmacy & Life Sciences	Yamada, Y (corresponding author), NIDCR, Mol Biol Sect, Craniofacial Dev Biol & Regenerat Branch, NIH, Bldg 30,Rm 407,30 Convent Dr MSC 4370, Bethesda, MD 20892 USA.	yoshi.yamada@nih.gov		Hozumi, Kentaro/0000-0002-6671-4386	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000483, ZIADE000485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000485, Z01DE000483] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Aumailley M, 2003, MATRIX BIOL, V22, P49, DOI 10.1016/S0945-053X(03)00013-1; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Colognato H, 1997, J BIOL CHEM, V272, P29330, DOI 10.1074/jbc.272.46.29330; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; Dogic D, 1998, J CELL SCI, V111, P793; Durbeej M, 2001, DIFFERENTIATION, V69, P121, DOI 10.1046/j.1432-0436.2001.690206.x; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Kusano Y, 2004, J BIOCHEM, V135, P129, DOI 10.1093/jb/mvh015; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Makino M, 2002, EXP CELL RES, V277, P95, DOI 10.1006/excr.2002.5540; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Nguyen BP, 2000, CURR OPIN CELL BIOL, V12, P554, DOI 10.1016/S0955-0674(00)00131-9; Nielsen PK, 2001, J BIOL CHEM, V276, P10906, DOI 10.1074/jbc.M008743200; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; PFAFF M, 1994, EUR J BIOCHEM, V225, P975, DOI 10.1111/j.1432-1033.1994.0975b.x; Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304; SASAKI M, 1988, J BIOL CHEM, V263, P16536; Scheele S, 2005, P NATL ACAD SCI USA, V102, P1502, DOI 10.1073/pnas.0405095102; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145; Sung U, 1997, EUR J BIOCHEM, V250, P138, DOI 10.1111/j.1432-1033.1997.00138.x; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Talts JF, 1999, FEBS LETT, V458, P319, DOI 10.1016/S0014-5793(99)01180-1; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Utani A, 2003, J BIOL CHEM, V278, P34483, DOI 10.1074/jbc.M304827200; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Wilson R, 2005, J BIOL CHEM, V280, P15544, DOI 10.1074/jbc.M410758200; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X	55	64	64	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32929	32940		10.1074/jbc.M605708200	http://dx.doi.org/10.1074/jbc.M605708200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16945929	hybrid			2022-12-27	WOS:000241414500091
J	Komoda, T; Sato, NS; Phelps, SS; Namba, N; Joseph, S; Suzuki, T				Komoda, Taeko; Sato, Neuza S.; Phelps, Steven S.; Namba, Naoki; Joseph, Simpson; Suzuki, Tsutomu			The a-site finger in 23 S rRNA acts as a functional attenuator for translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-ENZYMATIC TRANSLOCATION; ANTICODON STEM-LOOP; MESSENGER-RNA; MAMMALIAN MITOCHONDRIAL; ANGSTROM RESOLUTION; CENTRAL FOLD; CROSS-LINKS; ELONGATION; PROTEINS; VISUALIZATION	Helix 38 (H38) in 23 S rRNA, which is known as the "A- site finger (ASF)," is located in the intersubunit space of the ribosomal 50 S subunit and, together with protein S13 in the 30 S subunit, it forms bridge B1a. It is known that throughout the decoding process, ASF interacts directly with the A-site tRNA. Bridge B1a becomes disrupted by the ratchet-like rotation of the 30 S subunit relative to the 50 S subunit. This occurs in association with elongation factor G (EF-G)-catalyzed translocation. To further characterize the functional role(s) of ASF, variants of Escherichia coli ribosomes with a shortened ASF were constructed. The E. coli strain bearing such ASF-shortened ribosomes had a normal growth rate but enhanced +1 frameshift activity. ASF-shortened ribosomes showed normal subunit association but higher activity in poly(U)-dependent polyphenylalanine synthesis than the wild type (WT) ribosome at limited EF-G concentrations. In contrast, other ribosome variants with shortened bridge-forming helices 34 and 68 showed weak subunit association and less efficient translational activity than the WT ribosome. Thus, the higher translational activity of ASF-shortened ribosomes is caused by the disruption of bridge B1a and is not due to weakened subunit association. Single round translocation analyses clearly demonstrated that the ASF-shortened ribosomes have higher translocation activity than the WT ribosome. These observations indicate that the intrinsic translocation activity of ribosomes is greater than that usually observed in the WT ribosome and that ASF is a functional attenuator for translocation that serves to maintain the reading frame.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo 1138656, Japan; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Tokyo; University of Tokyo; University of California System; University of California San Diego	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp	SATO, Neuza/C-8102-2012; Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731	NIGMS NIH HHS [GM 65265] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065265] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971; CONWAY TW, 1964, P NATL ACAD SCI USA, V52, P1462, DOI 10.1073/pnas.52.6.1462; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; GAVRILOV.LP, 1971, FEBS LETT, V17, P324, DOI 10.1016/0014-5793(71)80177-1; GAVRILOVA LP, 1974, FEBS LETT, V39, P13, DOI 10.1016/0014-5793(74)80005-0; GAVRILOVA LP, 1974, FEBS LETT, V45, P324, DOI 10.1016/0014-5793(74)80872-0; Hanada T, 2001, GENES CELLS, V6, P1019, DOI 10.1046/j.1365-2443.2001.00491.x; Hirabayashi N, 2006, J BIOL CHEM, V281, P17203, DOI 10.1074/jbc.M511728200; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; Miller JH., 1992, SHORT COURSE BACTERI, P72; OConnor M, 1997, NUCLEIC ACIDS RES, V25, P1185, DOI 10.1093/nar/25.6.1185; OSSWALD M, 1995, NUCLEIC ACIDS RES, V23, P4635, DOI 10.1093/nar/23.22.4635; Phelps SS, 2004, J MOL BIOL, V338, P439, DOI 10.1016/j.jmb.2004.02.070; Phelps SS, 2002, MOL CELL, V10, P799, DOI 10.1016/S1097-2765(02)00686-X; Razga F, 2005, BIOPHYS J, V88, P3466, DOI 10.1529/biophysj.104.054916; RinkeAppel J, 1995, RNA, V1, P1018; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; SATO NS, 2006, IN PRESS P NATL ACAD; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2005, J MOL BIOL, V353, P116, DOI 10.1016/j.jmb.2005.08.006; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Southworth DR, 2002, J MOL BIOL, V324, P611, DOI 10.1016/S0022-2836(02)01196-8; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; SPEDDING G, 1990, ISOLATION ANAL RIBOS, P1; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Terasaki M, 2004, J MOL BIOL, V336, P331, DOI 10.1016/j.jmb.2003.12.034; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	35	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32303	32309		10.1074/jbc.M607058200	http://dx.doi.org/10.1074/jbc.M607058200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950778	hybrid			2022-12-27	WOS:000241414500027
J	Grenha, R; Rzechorzek, NJ; Brannigan, JA; de Jong, RN; Ab, E; Diercks, T; Truffault, V; Ladds, JC; Fogg, MJ; Bongiorni, C; Perego, M; Kaptein, R; Wilson, KS; Folkers, GE; Wilkinson, AJ				Grenha, Rosa; Rzechorzek, Neil J.; Brannigan, James A.; de Jong, Rob N.; Ab, Eiso; Diercks, Tammo; Truffault, Vincent; Ladds, Joanne C.; Fogg, Mark J.; Bongiorni, Cristina; Perego, Marta; Kaptein, Robert; Wilson, Keith S.; Folkers, Gert E.; Wilkinson, Anthony J.			Structural characterization of Spo0E-like protein-aspartic acid phosphatases that regulate sporulation in bacilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SPO0A; TORSION ANGLE DYNAMICS; RESPONSE REGULATOR; MOLECULAR RECOGNITION; SUBTILIS SPORULATION; HISTIDINE KINASES; ESCHERICHIA-COLI; PHOSPHORELAY; ASSIGNMENT; MECHANISM	Spore formation is an extreme response of many bacterial species to starvation. In the case of pathogenic species of Bacillus and Clostridium, it is also a component of disease transmission. Entry into the pathway of sporulation in Bacillus subtilis and its relatives is controlled by an expanded two-component system in which starvation signals lead to the activation of sensor kinases and phosphorylation of the master sporulation response regulator Spo0A. Accumulation of threshold concentrations of Spo0A similar to P heralds the commitment to sporulation. Countering the activities of the sensor kinases are phosphatases such as Spo0E, which dephosphorylate Spo0A similar to P and inhibit sporulation. Spo0E-like protein-aspartic acid-phosphate phosphatases, consisting of 50-90 residues, are conserved in sporeforming bacteria and unrelated in sequence to proteins of known structure. Here we determined the structures of the Spo0A similar to P phosphatases BA1655 and BA5174 from Bacillus anthracis using nuclear magnetic resonance spectroscopy. Each is composed of two anti-parallel alpha-helices flanked by flexible regions at the termini. The signature SQELD motif (SRDLD in BA1655) is situated in the middle of helix alpha 2 with its polar residues projecting outward. BA5174 is a monomer, whereas BA1655 is a dimer. The four-helix bundle structure in the dimer is reminiscent of the phosphotransferase Spo0B and the chemotaxis phosphatase CheZ, although in contrast to these systems, the subunits in BA1655 are in head-to-tail rather than head-to-head apposition. The implications of the structures for interactions between the phosphatases and their substrate Spo0A similar to P are discussed.	Univ Utrecht, Bijvoet Ctr, NMR Dept, NL-3584 CH Utrecht, Netherlands; Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England; Scripps Res Inst, Div Cellular Biol, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Utrecht University; University of York - UK; Scripps Research Institute	Folkers, GE (corresponding author), Univ Utrecht, Bijvoet Ctr, NMR Dept, NL-3584 CH Utrecht, Netherlands.	g.folkers@chem.uu.nl	Diercks, Tammo/G-1167-2011; Folkers, Gert E/C-2863-2009; Diercks, Tammo/AAT-3731-2021; AB, Eiso/H-8177-2012	Diercks, Tammo/0000-0002-5200-0905; Folkers, Gert E/0000-0003-1070-0505; Diercks, Tammo/0000-0002-5200-0905; Rzechorzek, Neil/0000-0003-2068-1424; Wilkinson, Anthony/0000-0003-4577-9479; AB, Eiso/0000-0002-5758-0435; Wilson, Keith/0000-0002-3581-2194; de Jong, Rob N./0000-0002-9300-6633; Fogg, Mark/0000-0002-6692-122X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055594] Funding Source: NIH RePORTER; NIAID NIH HHS [AI52289] Funding Source: Medline; NIGMS NIH HHS [GM55594] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; BRUNGER AT, 1997, CRYSTALLOGRAPHY NMR; Brunsing RL, 2005, J BACTERIOL, V187, P6972, DOI 10.1128/JB.187.20.6972-6981.2005; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; DeLano W.L, PYMOL MOL GRAPHICS S; Diercks T, 1999, J BIOMOL NMR, V15, P177, DOI 10.1023/A:1008367912535; FERRARI E, 1986, J BACTERIOL, V166, P173, DOI 10.1128/JB.166.1.173-179.1986; Folkers G. E., 2004, Journal of Structural and Functional Genomics, V5, P119, DOI 10.1023/B:JSFG.0000029200.66197.0c; Goddard T. D., 2006, SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Jansson M, 1996, J BIOMOL NMR, V7, P131; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; KOBAYASHI K, 1995, J BACTERIOL, V177, P176, DOI 10.1128/jb.177.1.176-182.1995; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Leutner M, 1998, J BIOMOL NMR, V11, P31, DOI 10.1023/A:1008298226961; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; Lewis RJ, 2002, J MOL BIOL, V316, P235, DOI 10.1006/jmbi.2001.5331; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Madhusudan, 1996, STRUCTURE, V4, P679, DOI 10.1016/S0969-2126(96)00074-3; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muchova K, 2004, MOL MICROBIOL, V53, P829, DOI 10.1111/j.1365-2958.2004.04171.x; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; OHLSEN KL, 1994, P NATL ACAD SCI USA, V91, P1756, DOI 10.1073/pnas.91.5.1756; Park SY, 2004, MOL CELL, V16, P563, DOI 10.1016/j.molcel.2004.10.018; Perego M, 1997, P NATL ACAD SCI USA, V94, P8612, DOI 10.1073/pnas.94.16.8612; PEREGO M, 1994, CELL, V79, P1047, DOI 10.1016/0092-8674(94)90035-3; Perego M, 2001, PEPTIDES, V22, P1541, DOI 10.1016/S0196-9781(01)00490-9; Perego M, 2001, MOL MICROBIOL, V42, P133, DOI 10.1046/j.1365-2958.2001.02611.x; PEREGO M, 1991, J BACTERIOL, V173, P2514, DOI 10.1128/jb.173.8.2514-2520.1991; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Stephenson K, 2002, MOL MICROBIOL, V46, P297, DOI 10.1046/j.1365-2958.2002.03186.x; Stephenson SJ, 2002, MOL MICROBIOL, V44, P1455, DOI 10.1046/j.1365-2958.2002.02974.x; Varughese KI, 1998, MOL CELL, V2, P485, DOI 10.1016/S1097-2765(00)80148-3; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Whitehead B, 1997, J BIOMOL NMR, V9, P313, DOI 10.1023/A:1018687127330; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X; Zapf JW, 1996, BIOCHEMISTRY-US, V35, P2926, DOI 10.1021/bi9519361; Zhao R, 2002, NAT STRUCT BIOL, V9, P570; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	53	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37993	38003		10.1074/jbc.M607617200	http://dx.doi.org/10.1074/jbc.M607617200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	17001075	hybrid, Green Published			2022-12-27	WOS:000242477100078
J	Huff, LM; Lee, JS; Robey, RW; Fojo, T				Huff, Lyn M.; Lee, Jong-Seok; Robey, Robert W.; Fojo, Tito			Characterization of gene rearrangements leading to activation of MDR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DISTANT UPSTREAM PROMOTER; MULTIDRUG-RESISTANCE; CELL-LINE; THERAPEUTIC STRATEGIES; TOPOISOMERASE-II; P-GLYCOPROTEIN; DNA BREAKS; REPAIR; TRANSCRIPTION	Expression of the MDR-1/P-glycoprotein gene confers drug resistance both in vitro and in vivo. We previously reported that gene rearrangements resulting in a hybrid MDR-1 transcript represent a common mechanism for acquired activation of MDR-1/P-glycoprotein. We have identified hybrid MDR-1 transcripts in nine MDR-1- overexpressing cell lines and two patients with relapsed ALL. We characterize these rearrangements as follows. 1) Non-MDR-1 sequences in the hybrid MDR-1 transcripts are expressed in unselected cell lines, showing that these sequences are constitutively expressed. 2) The rearrangements occur randomly and involve partner genes (sequences) on chromosome 7 and on chromosomes other than 7. Breakpoints have been characterized in six cell lines. In one, the rearrangement occurred within intron 2 of MDR-1; in the other five, the rearrangement occurred 24 to > 96 kb 5' of the normal start of transcription of MDR-1. In one cell line, homologous recombination involving an Alu repeat was observed. However, in the remaining five cell lines, nonhomologous recombination was observed. 3) The rearrangements arise during drug selection. The acquired rearrangements are not detected in parental cells. 4) Five of the six active promoters that captured MDR-1 controlled MDR-1 from a distance of 29 to more than 110 kb 5' to MDR-1. Transcription was initiated in an antegrade or retrograde direction. We conclude that drug selection with natural products targeting DNA or microtubules leads to DNA damage, nonhomologous recombination, and acquired drug resistance, wherein MDR-1 expression is driven by a random but constitutively active promoter.	NCI, NIH, Canc Res Ctr, Med Oncol Branch, Bethesda, MD 20892 USA; Seoul Natl Univ, Bandung Hosp, Seoul 151742, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU)	Fojo, T (corresponding author), NCI, NIH, Canc Res Ctr, Med Oncol Branch, Bldg 10,Rm 12N226,9000 Rockville Pike, Bethesda, MD 20892 USA.	tfojo@helix.nih.gov		Robey, Rob/0000-0002-0857-3650	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIASC006732, Z01SC006732] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Baker EK, 2005, ONCOGENE, V24, P8061, DOI 10.1038/sj.onc.1208955; Barnes DJ, 2002, ACTA HAEMATOL-BASEL, V108, P180, DOI 10.1159/000065655; Binaschi M, 1997, MOL PHARMACOL, V51, P1053, DOI 10.1124/mol.51.6.1053; Blagosklonny MV, 2001, CARCINOGENESIS, V22, P861, DOI 10.1093/carcin/22.6.861; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P6611, DOI 10.1093/nar/18.22.6611; Chen KG, 2005, CANCER RES, V65, P9388, DOI 10.1158/0008-5472.CAN-04-4133; COHEN D, 1992, J BIOL CHEM, V267, P20248; DALTON WS, 1986, CANCER RES, V46, P5125; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Eastman A, 2004, J CELL BIOCHEM, V91, P223, DOI 10.1002/jcb.10699; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Froelich JJ, 1999, CLIN CHEM LAB MED, V37, P403, DOI 10.1515/CCLM.1999.066; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Harada Taishi, 2000, International Journal of Cancer, V86, P506, DOI 10.1002/(SICI)1097-0215(20000515)86:4<506::AID-IJC10>3.0.CO;2-8; Huff LM, 2005, CANCER RES, V65, P11694; Jones I, 2003, THYROID, V13, P1057, DOI 10.1089/105072503770867228; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kotchetkov R, 2003, INT J CANCER, V104, P36, DOI 10.1002/ijc.10917; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Kuwano M, 2004, MOL CANCER THER, V3, P1485; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li ZY, 2005, LEUKEMIA, V19, P183, DOI 10.1038/sj.leu.2403602; Mahadevan D, 2004, BLOOD, V104, P1940, DOI 10.1182/blood-2003-07-2490; MEAD DA, 1991, BIO-TECHNOL, V9, P657, DOI 10.1038/nbt0791-657; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Mickley LA, 1997, J CLIN INVEST, V99, P1947, DOI 10.1172/JCI119362; Mickley LA, 1998, BLOOD, V91, P1749, DOI 10.1182/blood.V91.5.1749.1749_1749_1756; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.1208506; PASQUALUCCI L, 2004, LEUKEMIA LYMPHOMA S3, V44, P5; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Rao VK, 2005, MUTAT RES-GEN TOX EN, V583, P105, DOI 10.1016/j.mrgentox.2005.01.013; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; ROTHENBERG ML, 1989, BLOOD, V74, P1388; SAMBROOK J, 1989, MOL CLONING LAB MANU, P931; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; SIEBER SM, 1978, TERATOLOGY, V18, P31, DOI 10.1002/tera.1420180107; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; Tada Y, 2000, CLIN CANCER RES, V6, P4618; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; UEDA K, 1987, J BIOL CHEM, V262, P17432; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vossebeld PJM, 1999, BLOOD REV, V13, P67, DOI 10.1016/S0268-960X(99)90013-9; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; WHANGPENG J, 1984, RISK FACTORS MULTIPL, P45; Yoshida S, 1999, ONCOGENE, V18, P7994, DOI 10.1038/sj.onc.1203293; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	57	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36501	36509		10.1074/jbc.M602998200	http://dx.doi.org/10.1074/jbc.M602998200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16956878	hybrid			2022-12-27	WOS:000242220800005
J	Ledin, J; Ringvall, M; Thuveson, M; Eriksson, I; Wilen, M; Kusche-Gullberg, M; Forsberg, E; Kjellen, L				Ledin, Johan; Ringvall, Maria; Thuveson, Maria; Eriksson, Inger; Wilen, Maria; Kusche-Gullberg, Marion; Forsberg, Erik; Kjellen, Lena			Enzymatically active N-deacetylase/N-sulfotransferase-2 is present in liver but does not contribute to heparan sulfate N-sulfation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEACETYLASE/N-SULFOTRANSFERASE ISOZYMES; FIBROBLAST GROWTH-FACTOR; NEONATAL LETHALITY; TUMOR SUPPRESSORS; LIGAND-BINDING; IDURONIC ACID; MOUSE; BIOSYNTHESIS; CELLS; MICE	Heparan sulfate (HS) proteoglycans influence embryonic development through interactions with growth factors and morphogens. The interactions depend on HS structure, which is largely determined during biosynthesis by Golgi enzymes. NDST ( glucosaminyl N-deacetylase/N-sulfotransferase), responsible for HSN-sulfation, is a key enzyme directing further modifications including O-sulfation. To elucidate the roles of the different NDST isoforms in HS biosynthesis, we took advantage of mice with targeted mutations in NDST1 and NDST2 and used liver as our model organ. Of the four NDST isoforms, only NDST1 and NDST2 transcripts were shown to be expressed in control liver. The absence of NDST1 or NDST2 in the knock-out mice did not affect transcript levels of other NDST isoforms or other HS modification enzymes. Although the sulfation level of HS synthesized in NDST1(-/-) mice was drastically lowered, liver HS from wild-type mice, from NDST1(-/-), NDST2(-/-), and NDST1(-/-), NDST2(-/-) mice all had the same structure despite greatly reduced NDST enzyme activity (30% of control levels in NDST1(-/-) NDST2(-/-) embryonic day 18.5 embryos). Enzymatically active NDST2 was shown to be present in similar amounts in wild-type, NDST1(-/-), and NDST1(-/-) embryonic day 18.5 liver. Despite the substantial contribution of NDST2 to total NDST enzyme activity in embryonic day 18.5 liver (approximate to 40%), its presence did not appear to affect HS structure as long as NDST1 was also present. In NDST1(-/-) embryonic day 18.5 liver, in contrast, NDST2 was responsible for N-sulfation of the low sulfated HS. A tentative model to explain these results is presented.	Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, SE-75123 Uppsala, Sweden	Uppsala University	Kjellen, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582, SE-75123 Uppsala, Sweden.	lena.kjellen@imbim.uu.se	Kjellen, Lena/F-1362-2011; Kusche-Gullberg, Marion/P-4466-2016	Kusche-Gullberg, Marion/0000-0002-5636-1695; Ledin, Johan/0000-0002-7319-7735				Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Grobe K, 2002, J BIOL CHEM, V277, P30699, DOI 10.1074/jbc.M111904200; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Humphries DE, 1997, BIOCHEM J, V325, P351, DOI 10.1042/bj3250351; KATO M, 1994, J BIOL CHEM, V269, P18881; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Pikas DS, 2000, BIOCHEMISTRY-US, V39, P4552, DOI 10.1021/bi992524l; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; RIESENFELD J, 1982, J BIOL CHEM, V257, P7050; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Safaiyan F, 2000, BIOCHEMISTRY-US, V39, P10823, DOI 10.1021/bi000411s; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SCHULZE B, 1995, EUR J BIOCHEM, V231, P551, DOI 10.1111/j.1432-1033.1995.tb20731.x; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; van den Born J, 2003, GLYCOBIOLOGY, V13, P1, DOI 10.1093/glycob/cwg011; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200	38	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35727	35734		10.1074/jbc.M604113200	http://dx.doi.org/10.1074/jbc.M604113200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16984905	hybrid			2022-12-27	WOS:000242100500017
J	Sikora, B; Eoff, RL; Matson, SW; Raney, KD				Sikora, Bartek; Eoff, Robert L.; Matson, Steven W.; Raney, Kevin D.			DNA unwinding by Escherichia coli DNA helicase I (Tral) provides evidence for a processive monomeric molecular motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; BACTERIOPHAGE-T4 DDA HELICASE; STEP-SIZE; RECBCD ENZYME; TURNOVER KINETICS; MECHANISM; PROTEIN; TRANSLOCATION; REVEALS; MACHINES	The F plasmid TraI protein ( DNA helicase I) plays an essential role in conjugative DNA transfer as both a transesterase and a helicase. Previous work has shown that the 192-kDa TraI protein is a highly processive helicase, catalytically separating > 850 bp under steady-state conditions. In this report, we examine the kinetic mechanism describing DNA unwinding of TraI. The kinetic step size of TraI was measured under both single turnover and pre-steady-state conditions. The resulting kinetic stepsize estimate was similar to 6-8 bp step(-1). TraI can separate double-stranded DNA at a rate of similar to 1100 bp s(-1), similar to the measured unwinding rate of the RecBCD helicase, and appears to dissociate very slowly from the 3' terminus following translocation and strand-separation events. Analyses of pre-steady-state burst amplitudes indicate that TraI can function as a monomer, similar to the bacteriophage T4 helicase, Dda. However, unlike Dda, TraI is a highly processive monomeric helicase, making it unique among the DNA helicases characterized thus far.	Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; Univ N Carolina, Dept Biol, Curriculum Genet & Mol Biol, Program Mol & Cellular BIophys, Chapel Hill, NC 27599 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of North Carolina; University of North Carolina Chapel Hill	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham St, Little Rock, AR 72205 USA.	raneykevind@uams.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059400, R01GM061020] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM61020, R01 GM059400] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P441, DOI 10.1111/j.1432-1033.1976.tb10359.x; ABDELMONEM M, 1977, J MOL BIOL, V110, P667, DOI 10.1016/S0022-2836(77)80083-1; ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P431, DOI 10.1111/j.1432-1033.1976.tb10358.x; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; BEDINGER P, 1983, CELL, V34, P115, DOI 10.1016/0092-8674(83)90141-1; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BJORNSON KP, 1994, BIOCHEMISTRY-US, V33, P14306, DOI 10.1021/bi00251a044; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd DR, 2002, J BIOL CHEM, V277, P42645, DOI 10.1074/jbc.M205984200; Csitkovits VC, 2003, J BIOL CHEM, V278, P48696, DOI 10.1074/jbc.M310025200; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; GEIDER K, 1981, ANNU REV BIOCHEM, V50, P233, DOI 10.1146/annurev.bi.50.070181.001313; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lisal J, 2005, J BIOL CHEM, V280, P23157, DOI 10.1074/jbc.M502658200; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Matson SW, 2005, J BACTERIOL, V187, P697, DOI 10.1128/JB.187.2.697-706.2005; Matson SW, 2001, J BIOL CHEM, V276, P2372, DOI 10.1074/jbc.M008728200; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2004, NAT STRUCT MOL BIOL, V11, P494, DOI 10.1038/nsmb0604-494; WILLIAMS MMR, 1979, ANN NUCL ENERGY, V6, P145, DOI 10.1016/0306-4549(79)90082-3	34	41	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36110	36116		10.1074/jbc.M604412200	http://dx.doi.org/10.1074/jbc.M604412200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16984922	hybrid, Green Published			2022-12-27	WOS:000242100500060
J	Amer, A; Franchi, L; Kanneganti, TD; Body-Malapel, M; Ozoren, N; Brady, G; Meshinchi, S; Jagirdar, R; Gewirtz, A; Akira, S; Nunez, G				Amer, Amal; Franchi, Luigi; Kanneganti, Thirumala-Devi; Body-Malapel, Mathilde; Ozoren, Nesrin; Brady, Graham; Meshinchi, Sasha; Jagirdar, Rajesh; Gewirtz, Andrew; Akira, Shizuo; Nunez, Gabriel			Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; LEGIONNAIRES-DISEASE; PNEUMOPHILA INFECTION; HUMAN-MONOCYTES; A/J MICE; INTERLEUKIN-1-BETA; CASPASE-1; BACTERIUM; GENE; SUSCEPTIBILITY	Legionella pneumophila is an intracellular bacterium that causes an acute form of pneumonia called Legionnaires' disease. After infection of human macrophages, the Legionella-containing phagosome (LCP) avoids fusion with the lysosome allowing intracellular replication of the bacterium. In macrophages derived from most mouse strains, the LCP is delivered to the lysosome resulting in Legionella degradation and restricted bacterial growth. Mouse macrophages lacking the NLR protein Ipaf or its downstream effector caspase-1 are permissive to intracellular Legionella replication. However, the mechanism by which Ipaf restricts Legionella replication is not well understood. Here we demonstrate that the presence of flagellin and a competent type IV secretion system are critical for Legionella to activate caspase-1 in macrophages. Activation of caspase-1 in response to Legionella infection also required host Ipaf, but not TLR5. In the absence of Ipaf or caspase-1 activation, the LCP acquired endoplasmic reticulum-derived vesicles, avoided fusion with the lysosome, and allowed Legionella replication. Accordingly a Legionella mutant lacking flagellin did not activate caspase-1, avoided degradation, and replicated in wild-type macrophages. The regulation of phagosome maturation by Ipaf occurred within 2 h after infection and was independent of macrophage cell death. In vivo studies confirmed that flagellin and Ipaf play an important role in the control of Legionella clearance. These results reveal that Ipaf restricts Legionella replication through the regulation of phagosome maturation, providing a novel function for NLR proteins in host defense against an intracellular bacterium.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol Unit, Atlanta, GA 30322 USA; Osaka Univ, Dept Host Def, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Emory University; Osaka University	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 4215 CCGC,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Jagirdar, Rajesh/AAO-2327-2021; Ozoren, Nesrin/AAS-3279-2020; Body-Malapel, Mathilde/K-9981-2018; Akira, Shizuo/C-3134-2009; Kanneganti, Thirumala-Devi/M-9435-2018; Nuñez, Gabriel/A-7160-2014; Kanneganti, Thirumala-Devi/Y-2503-2019; Amer, Amal/E-2643-2011	Jagirdar, Rajesh/0000-0001-7005-7772; Body-Malapel, Mathilde/0000-0003-3392-4229; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; OZOREN, NESRIN/0000-0002-8580-618X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331, R56AI063331, R37AI063331, R01AI064748] Funding Source: NIH RePORTER; NHLBI NIH HHS [5/T32/HL007517] Funding Source: Medline; NIAID NIH HHS [AI063331, AI064748] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; BERGER KH, 1994, MOL MICROBIOL, V14, P809, DOI 10.1111/j.1365-2958.1994.tb01317.x; BRIELAND J, 1994, AM J PATHOL, V145, P1537; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; DIETRICH WF, 1995, GENOMICS, V26, P443, DOI 10.1016/0888-7543(95)80161-E; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Fortier A, 2005, TRENDS MICROBIOL, V13, P328, DOI 10.1016/j.tim.2005.05.007; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gerhardt H, 2000, FEMS MICROBIOL LETT, V192, P145, DOI 10.1111/j.1574-6968.2000.tb09373.x; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Philpott DJ, 2004, MOL IMMUNOL, V41, P1099, DOI 10.1016/j.molimm.2004.06.012; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tilney LG, 2001, J CELL SCI, V114, P4637; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; YAMAMOTO Y, 1988, INFECT IMMUN, V56, P370, DOI 10.1128/IAI.56.2.370-375.1988; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	37	369	378	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35217	35223		10.1074/jbc.M604933200	http://dx.doi.org/10.1074/jbc.M604933200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16984919	hybrid			2022-12-27	WOS:000241933700055
J	Meley, D; Bauvy, C; Houben-Weerts, JHPM; Dubbelhuis, PF; Helmond, MTJ; Codogno, P; Meijer, AJ				Meley, Daniel; Bauvy, Chantal; Houben-Weerts, Judith H. P. M.; Dubbelhuis, Peter F.; Helmond, Mariette T. J.; Codogno, Patrice; Meijer, Alfred J.			AMP-activated protein kinase and the regulation of autophagic proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE; SKELETAL-MUSCLE; LIPID KINASE; HT-29 CELLS; S6 KINASE; IN-VITRO; INHIBITION; PHOSPHORYLATION; METFORMIN	Interruption of mTOR-dependent signaling by rapamycin is known to stimulate autophagy, both in mammalian cells and in yeast. Because activation of AMPK also inhibits mTOR-dependent signaling one would expect stimulation of autophagy by AMPK activation. According to the literature, this is true for yeast but, unexpectedly, not for mammalian cells on the basis of the use of AICAR, a pharmacological activator of AMPK. In the present study, carried out with hepatocytes, HT-29 cells, and HeLa cells, we have reexamined the possible role of AMPK in the control of mammalian autophagy. Inhibition of AMPK activity by compound C or by transfection with a dominant negative form of AMPK almost completely inhibited autophagy. These results suggest that the inhibition of autophagy by AICAR is not related to its ability to activate AMPK. We conclude that in mammalian cells, as in yeast, AMPK is required for autophagy.	Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; Univ Paris 11, Fac Pharm, INSERM U756, F-92296 Chatenay Malabry, France	University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Meijer, AJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	a.j.meijer@amc.uva.nl		Meley, Daniel/0000-0002-0708-2139				Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dubbelhuis PF, 2002, FEBS LETT, V521, P39, DOI 10.1016/S0014-5793(02)02815-6; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Fryer LGD, 2002, FEBS LETT, V531, P189, DOI 10.1016/S0014-5793(02)03501-9; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HOYVIK H, 1986, EXP CELL RES, V166, P1, DOI 10.1016/0014-4827(86)90503-3; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Leverve XM, 2003, DIABETES METAB, V29, pS88; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Luiken JJFP, 1996, EUR J BIOCHEM, V235, P564; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Meijer AJ, 2004, BIOCHEM BIOPH RES CO, V313, P397, DOI 10.1016/j.bbrc.2003.07.012; Moller MTN, 2004, TOXICOL SCI, V82, P628, DOI 10.1093/toxsci/kfh273; MOLLER TN, 2004, AUTOPHAGY, P48; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Munafo DB, 2001, J CELL SCI, V114, P3619; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; PLOMP PJAM, 1989, J BIOL CHEM, V264, P6699; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267; Vincent MF, 1996, BIOCHEM PHARMACOL, V52, P999, DOI 10.1016/0006-2952(96)00413-3; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Williamson J R, 1979, Methods Enzymol, V55, P200; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Wu GY, 1996, BIOL REPROD, V54, P1261, DOI 10.1093/biolreprod/54.6.1261; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	50	376	389	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34870	34879		10.1074/jbc.M605488200	http://dx.doi.org/10.1074/jbc.M605488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16990266	hybrid			2022-12-27	WOS:000241933700019
J	Moses, DN; Harreld, JH; Stucky, GD; Waite, JH				Moses, Dana N.; Harreld, John H.; Stucky, Galen D.; Waite, J. Herbert			Melanin and glycera jaws - Emerging dark side of a robust biocomposite structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CHARACTERIZATION; SEPIA MELANIN; 5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACID; OXIDATIVE-DEGRADATION; MASS-SPECTROMETRY; INSECT CUTICLE; PYRROLE ACIDS; ION-EXCHANGE; COPPER; EUMELANIN	Defining the design principles guiding the fabrication of superior biocomposite structures from an assemblage of ordinary molecules is a key goal of biomimetics. Considering their low degree of mineralization, Glycera jaws have been shown to be extraordinarily resistant to abrasion based on the metric hardness(3)/Young's modulus(2). The jaws also exhibit an impressive chemical inertness withstanding boiling concentrated hydrochloric acid as well as boiling concentrated sodium hydroxide. A major organic component largely responsible for the chemical inertness of the jaws has been characterized using a spectrophotometric assay for melanin content, C-13 solid state nuclear magnetic resonance, IR spectroscopy, and laser desorption ionization-time of flight mass spectrometry and is identified here as a melanin-like network. Although melanin is widely distributed as a pigment in tissues and other structural biomaterials, to our knowledge, Glycera jaws represent the first known integument to exploit melanin as a cohesive load- and shape-bearing material.	Univ Calif Santa Barbara, Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Moses, DN (corresponding author), Univ Calif Santa Barbara, Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA.	moses@lifesci.ucsb.edu			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014672] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE 014672] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adhyaru BB, 2003, MAGN RESON CHEM, V41, P466, DOI 10.1002/mrc.1193; Alaluf S, 2002, PIGM CELL RES, V15, P112, DOI 10.1034/j.1600-0749.2002.1o071.x; Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O; BARDANI L, 1982, BIOCHIM BIOPHYS ACTA, V716, P8, DOI 10.1016/0304-4165(82)90196-9; BARR FE, 1983, MED HYPOTHESES, V11, P1, DOI 10.1016/0306-9877(83)90122-6; BERNARDS MA, 1995, J BIOL CHEM, V270, P7382, DOI 10.1074/jbc.270.13.7382; Bilinska B, 1996, SPECTROCHIM ACTA A, V52, P1157, DOI 10.1016/0584-8539(96)01691-1; Birkedal H, 2006, CHEMBIOCHEM, V7, P1392, DOI 10.1002/cbic.200600160; BRATOSIN S, 1973, J INVEST DERMATOL, V60, P224, DOI 10.1111/1523-1747.ep12724518; Bridelli MG, 1999, FEBS LETT, V457, P18, DOI 10.1016/S0014-5793(99)01001-7; Broomell CC, 2006, J EXP BIOL, V209, P3219, DOI 10.1242/jeb.02373; Butler M, 2004, J EXP BIOL, V207, P285, DOI 10.1242/jeb.00746; CHENG J, 1994, PIGM CELL RES, V7, P255, DOI 10.1111/j.1600-0749.1994.tb00060.x; CHENG J, 1994, PIGM CELL RES, V7, P263, DOI 10.1111/j.1600-0749.1994.tb00061.x; CLANCY CMR, 2005, BIOCHEMISTRY-US, V40, P13353; Di JW, 2003, SPECTROCHIM ACTA A, V59, P3075, DOI 10.1016/S1386-1425(03)00127-6; Doss RP, 2003, PHYTOCHEMISTRY, V63, P687, DOI 10.1016/S0031-9422(03)00323-6; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; GIBBS PE, 1980, J MAR BIOL ASSOC UK, V60, P205, DOI 10.1017/S0025315400024267; HACKMAN RH, 1971, ANAL BIOCHEM, V41, P279, DOI 10.1016/0003-2697(71)90214-4; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Hutchison KA, 2002, MYCOL RES, V106, P729, DOI 10.1017/S095375620200597X; ITO S, 1993, ANAL BIOCHEM, V215, P273, DOI 10.1006/abio.1993.1586; ITO S, 1986, BIOCHIM BIOPHYS ACTA, V883, P155, DOI 10.1016/0304-4165(86)90146-7; Kronstrand R, 1999, CLIN CHEM, V45, P1485; Lichtenegger HC, 2002, SCIENCE, V298, P389, DOI 10.1126/science.1075433; Liu Y, 2005, PIGM CELL RES, V18, P42, DOI 10.1111/j.1600-0749.2004.00197.x; Liu Y, 2004, PIGM CELL RES, V17, P262, DOI 10.1111/j.1600-0749.2004.00140.x; Marneros AG, 2003, INVEST OPHTH VIS SCI, V44, P2367, DOI 10.1167/iovs.02-1180; McGraw KJ, 2005, FUNCT ECOL, V19, P816, DOI 10.1111/j.1365-2435.2005.01032.x; MICHEL C, 1973, Bulletin Biologique de la France et de la Belgique, V107, P301; Money NP, 1996, FUNGAL GENET BIOL, V20, P217, DOI 10.1006/fgbi.1996.0037; Money NP, 1998, FUNGAL GENET BIOL, V24, P240, DOI 10.1006/fgbi.1998.1052; Moses DN, 2006, ACTA BIOMATER, V2, P521, DOI 10.1016/j.actbio.2006.05.002; NAPOLITANO A, 1995, TETRAHEDRON, V51, P5913, DOI 10.1016/0040-4020(95)00259-B; Napolitano A, 1996, TETRAHEDRON, V52, P8775, DOI 10.1016/0040-4020(96)00418-8; NICOLAUS RA, 1968, CHEM NATURAL PRODUCT, P9; Ozeki H, 1997, ANAL BIOCHEM, V248, P149, DOI 10.1006/abio.1997.2079; Pezzella A, 1997, RAPID COMMUN MASS SP, V11, P368, DOI 10.1002/(SICI)1097-0231(19970228)11:4<368::AID-RCM859>3.0.CO;2-E; Pezzella A, 1997, TETRAHEDRON, V53, P8281, DOI 10.1016/S0040-4020(97)00494-8; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; RILEY PA, 1992, PIGM CELL RES, V5, P101, DOI 10.1111/j.1600-0749.1992.tb00005.x; SARNA T, 1976, SCIENCE, V192, P1132, DOI 10.1126/science.179142; SERAGLIA R, 1993, BIOL MASS SPECTROM, V22, P687, DOI 10.1002/bms.1200221204; Smith-Thomas LC, 2000, CURR EYE RES, V21, P518, DOI 10.1076/0271-3683(200007)21:1;1-Z;FT518; STEPIEN KB, 1989, BIOCHIM BIOPHYS ACTA, V997, P49, DOI 10.1016/0167-4838(89)90134-9; SUGUMARAN M, 1987, BIOORG CHEM, V15, P194, DOI 10.1016/0045-2068(87)90019-8; Szpoganicz B, 2002, J INORG BIOCHEM, V89, P45, DOI 10.1016/S0162-0134(01)00406-8; Tai KS, 2005, J MATER SCI-MATER M, V16, P947, DOI 10.1007/s10856-005-4429-9; THATHACHARI YT, 1976, PIGMENT CELL, V3, P64; Voss-Foucart M.-F., 1973, Biochemical Syst, V1, P119, DOI 10.1016/0305-1978(73)90025-2; Waite JH, 2004, BIOCHEMISTRY-US, V43, P7653, DOI 10.1021/bi049380h; Wakamatsu K, 2003, J NEUROCHEM, V86, P1015, DOI 10.1046/j.1471-4159.2003.01917.x; WATTS KP, 1981, CANCER RES, V41, P467; Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935	55	42	42	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34826	34832		10.1074/jbc.M603429200	http://dx.doi.org/10.1074/jbc.M603429200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16984906	hybrid			2022-12-27	WOS:000241933700015
J	Wei, YZ; Sowers, JR; Nistala, R; Gong, HP; Uptergrove, GME; Clark, SE; Morris, EM; Szary, N; Manrique, C; Stump, CS				Wei, Yongzhong; Sowers, James R.; Nistala, Ravi; Gong, Heping; Uptergrove, Grace M. -E.; Clark, Suzanne E.; Morris, E. Matthew; Szary, Nicholas; Manrique, Camila; Stump, Craig S.			Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; OXIDATIVE STRESS; NAD(P)H OXIDASE; RECEPTOR SUBSTRATE-1; GLUT4 TRANSLOCATION; CARDIOVASCULAR MORBIDITY; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; DOWN-REGULATION; GLUCOSE-UPTAKE	The renin-angiotensin system (RAS) and reactive oxygen species (ROS) have been implicated in the development of insulin resistance and its related complications. There is also evidence that angiotensin II (Ang II)-induced generation of ROS contributes to the development of insulin resistance in skeletal muscle, although the precise mechanisms remain unknown. In the present study, we found that Ang II markedly enhanced NADPH oxidase activity and consequent ROS generation in L6 myo-tubes. These effects were blocked by the angiotensin II type 1 receptor blocker losartan, and by the NADPH oxidase inhibitor apocynin. Ang II also promoted the translocation of NADPH oxidase cytosolic subunits p47(phox) and p67(phox) to the plasma membrane within 15 min. Furthermore, Ang II abolished insulin-induced tyrosine phosphorylation of insulin receptor substrate 1 (IRS1), activation of protein kinase B (Akt), and glucose transporter-4 (GLUT4) translocation to the plasma membrane, which was reversed by pretreating myotubes with losartan or apocynin. Finally, small interfering RNA (siRNA)-specific gene silencing targeted specifically against p47(phox) (p47siRNA), in both L6 and primary myotubes, reduced the cognate protein expression, decreased NADPH oxidase activity, restored Ang II-impaired IRS1 and Akt activation as well as GLUT4 translocation by insulin. These results suggest a pivotal role for NADPH oxidase activation and ROS generation in Ang II-induced inhibition of insulin signaling in skeletal muscle cells.	Univ Missouri, Dept Internal Med, Columbia, MO 65212 USA; Univ Missouri, Dept Physiol & Pharmacol, Columbia, MO 65212 USA; Harry S Truman Mem Vet Med Ctr, Columbia, MO 65201 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital	Stump, CS (corresponding author), Univ Arizona, Dept Med, Diabet Res Ctr, 1656 E Mabel St,PO 245218, Tucson, AZ 85724 USA.	stumpc@email.arizona.edu		Morris, E. Matthew/0000-0001-7046-3623	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073101] Funding Source: NIH RePORTER; NHLBI NIH HHS [5R01 HL073101-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Blendea MC, 2005, AM J PHYSIOL-ENDOC M, V288, pE353, DOI 10.1152/ajpendo.00402.2004; Chakravarthy MV, 2000, J APPL PHYSIOL, V89, P1365, DOI 10.1152/jappl.2000.89.4.1365; DEADAMS MI, 1996, EMBO J, V15, P1211; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Folli F, 1997, J CLIN INVEST, V100, P2158, DOI 10.1172/JCI119752; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Henriksen EJ, 2003, EXERC SPORT SCI REV, V31, P79, DOI 10.1097/00003677-200304000-00005; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Hsieh TJ, 2004, J ENDOCRINOL, V183, P535, DOI 10.1677/joe.1.05871; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Huang C, 2002, DIABETES, V51, P2090, DOI 10.2337/diabetes.51.7.2090; Izawa Y, 2005, EXP CELL RES, V308, P291, DOI 10.1016/j.yexcr.2005.04.028; Javesghani D, 2002, AM J RESP CRIT CARE, V165, P412, DOI 10.1164/ajrccm.165.3.2103028; Katovich MJ, 2001, J HYPERTENS, V19, P1553, DOI 10.1097/00004872-200109000-00006; Kinnick TR, 2002, J APPL PHYSIOL, V93, P805, DOI 10.1152/japplphysiol.00236.2002; Kjeldsen SE, 2002, JAMA-J AM MED ASSOC, V288, P1491, DOI 10.1001/jama.288.12.1491; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Laufs U, 2003, J BIOL CHEM, V278, P5956, DOI 10.1074/jbc.M209813200; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; McFarlane SI, 2001, J CLIN ENDOCR METAB, V86, P713, DOI 10.1210/jc.86.2.713; MITSUMOTO Y, 1991, BIOCHEM BIOPH RES CO, V175, P652, DOI 10.1016/0006-291X(91)91615-J; Mizuki K, 2005, ARCH BIOCHEM BIOPHYS, V444, P185, DOI 10.1016/j.abb.2005.10.012; Motley ED, 2003, HYPERTENSION, V41, P775, DOI 10.1161/01.HYP.0000051891.90321.12; NouroozZadeh J, 1997, DIABETOLOGIA, V40, P647, DOI 10.1007/s001250050729; Ogihara T, 2002, HYPERTENSION, V40, P872, DOI 10.1161/01.HYP.0000040262.48405.A8; Peraldi P, 1998, MOL CELL BIOCHEM, V182, P169, DOI 10.1023/A:1006865715292; RICHEY JM, 1999, AM J PHYSIOL, V277, pR920; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; SECHI LA, 1992, METABOLISM, V41, P1261, DOI 10.1016/0026-0495(92)90019-7; Shiuchi T, 2004, HYPERTENSION, V43, P1003, DOI 10.1161/01.HYP.0000125142.41703.64; Sloniger JA, 2005, AM J PHYSIOL-ENDOC M, V288, pE1074, DOI 10.1152/ajpendo.00396.2004; Sowers JR, 2004, AM J PHYSIOL-HEART C, V286, pH1597, DOI 10.1152/ajpheart.00026.2004; Sowers JR, 2002, NEW ENGL J MED, V346, P1999, DOI 10.1056/NEJMe020054; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Szocs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, P981, DOI 10.1161/01.ATV.0000069236.27911.68; Touyz RM, 2002, CIRC RES, V90, P1205, DOI 10.1161/01.RES.0000020404.01971.2F; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; vanKats JP, 1997, HYPERTENSION, V30, P42, DOI 10.1161/01.HYP.30.1.42; VUORINENMARKKOLA H, 1995, METABOLISM, V44, P85, DOI 10.1016/0026-0495(95)90293-7; Watanabe Y, 2006, COMPUT BIOL CHEM, V30, P303, DOI 10.1016/j.compbiolchem.2006.04.004; Xia RH, 2003, AM J PHYSIOL-CELL PH, V285, pC215, DOI 10.1152/ajpcell.00034.2002; Yusuf S, 2000, NEW ENGL J MED, V342, P145	59	235	247	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35137	35146		10.1074/jbc.M601320200	http://dx.doi.org/10.1074/jbc.M601320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16982630	hybrid			2022-12-27	WOS:000241933700047
J	Hiesberger, T; Gourley, E; Erickson, A; Koulen, P; Ward, CJ; Masyuk, TV; Larusso, NF; Harris, PC; Igarashi, P				Hiesberger, Thomas; Gourley, Eric; Erickson, Andrea; Koulen, Peter; Ward, Christopher J.; Masyuk, Tatyana V.; Larusso, Nicholas F.; Harris, Peter C.; Igarashi, Peter			Proteolytic cleavage and nuclear translocation of fibrocystin is regulated by intracellular Ca2+ and activation of protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; GENE; DISEASE; PKHD1; TRANSCRIPTION; EXPRESSION; RECEPTORS; STIMULATION; MUTATION; ENCODES	Fibrocystin, a type I membrane protein of unknown function, is the protein affected in the autosomal recessive form of polycystic kidney disease. Here we show that fibrocystin undergoes regulated proteolysis. Several proteolytic cleavages occur within the predicted ectodomain, whereas at least one cleavage occurs within the cytoplasmic portion. The latter generates a C-terminal intracellular fragment that harbors the nuclear localization signal KRKVSRLAVTGERTATPAPKIPRIT and translocates to the nucleus. Proteolytic cleavage of fibrocystin occurs constitutively in long term cultures of polarized inner medullary collecting duct cells (mIMCD-3). Activation of protein kinase C and release of intracellular Ca2+ are required for proteolysis under these conditions. In short term cultures of human embryonic kidney 293 cells (HEK-293), proteolytic cleavage of fibrocystin can be elicited by stimulation of intracellular Ca2+ release or activation of protein kinase C. These results identify a novel Ca2+-dependent pathway that signals from fibrocystin located in the cell membrane to the nucleus.	Univ Texas, SW Med Ctr, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Div Basic Sci, Dallas, TX 75390 USA; Univ N Texas, Hlth Sci Ctr, Ft Worth, TX 76107 USA; Mayo Clin & Mayo Fdn, Coll Med, Div Nephrol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Internal Med, Rochester, MN 55905 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of North Texas System; University of North Texas Health Science Center; Mayo Clinic; Mayo Clinic	Hiesberger, T (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Nephrol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Thomas.Hiesberger@UTSouthwestern.edu		Igarashi, Peter/0000-0001-8698-1185; Masyuk, Tatyana/0000-0003-3290-9879	NIA NIH HHS [P01 AG22550, P01 AG022550] Funding Source: Medline; NIDDK NIH HHS [R01 DK-67565, R01 DK067565] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022550] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Hiesberger T, 2005, J BIOL CHEM, V280, P10578, DOI 10.1074/jbc.M414121200; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Landman N, 2004, CYTOKINE GROWTH F R, V15, P337, DOI 10.1016/j.cytogfr.2004.04.001; Leung AKL, 2003, CRIT REV EUKAR GENE, V13, P39, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.40; LIEBERMAN E, 1971, MEDICINE, V50, P277, DOI 10.1097/00005792-197107000-00003; Masyuk TV, 2003, GASTROENTEROLOGY, V125, P1303, DOI 10.1016/j.gastro.2003.09.001; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Menezes LFC, 2004, KIDNEY INT, V66, P1345, DOI 10.1111/j.1523-1755.2004.00844.x; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Querfurth HW, 1998, BIOCHEM J, V334, P79, DOI 10.1042/bj3340079; SCHMIDT M, 1994, EUR J BIOCHEM, V225, P667, DOI 10.1111/j.1432-1033.1994.00667.x; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Xiong HQ, 2002, GENOMICS, V80, P96, DOI 10.1006/geno.2002.6802; YANG J, 1995, MOL PHARMACOL, V48, P477; Young HS, 2004, J MEMBRANE BIOL, V198, P55, DOI 10.1007/s00232-004-0666-y; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; ZERRES K, 1994, NAT GENET, V7, P429, DOI 10.1038/ng0794-429	25	59	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34357	34364		10.1074/jbc.M606740200	http://dx.doi.org/10.1074/jbc.M606740200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16956880	hybrid			2022-12-27	WOS:000241767600056
J	Hunter, I; Nixon, GF				Hunter, Irene; Nixon, Graeme F.			Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells - Lipid rafts are essential for TNF-alpha-mediated activation of RhoA but dispensable for the activation of the NF-kappa B and MAPK pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; PLASMA-MEMBRANE; CAVEOLAE; PROTEIN; COMPLEX; TRANSDUCTION; RECRUITMENT; MOLECULES; APOPTOSIS; DOMAIN	Tumor necrosis factor (TNF)-alpha-induced activation of RhoA, mediated by TNF receptor 1 (TNFR1), is a prerequisite step in a pathway that leads to increased 20-kDa light chain of myosin (MLC20) phosphorylation and airway smooth muscle contraction. In this study, we have investigated the proximal events in TNF-alpha-induced RhoA activation. TNFR1 is localized to both lipid raft and nonraft regions of the plasma membrane in primary human airway smooth muscle cells. TNF-alpha engagement of TNFR1 recruited the adaptor proteins TRADD, TRAF-2, and RIP into lipid rafts and activated RhoA, NF-kappa B, and MAPK pathways. Depletion of cholesterol from rafts with methyl-beta-cyclodextrin caused a redistribution of TNFR1 to nonraft plasma membrane and prevented ligand-induced RhoA activation. By contrast, TNF-alpha-induced activation of NF-kappa B and MAPKs was unaffected by methyl-beta-cyclodextrin indicating that, in airway smooth muscle cells, activation of these pathways occurred independently of lipid rafts. Targeted knockdown of caveolin-1 completely abrogated TNF-alpha-induced RhoA activation, identifying this raft-resident protein as a positive regulator of the activation process. The signaling adaptors TRADD and RIP were also found to be necessary for ligand-induced RhoA activation. Taken together, our results suggest that in airway smooth muscle cells, spatial compartmentalization of TNFR1 provides a mechanism for generating distinct signaling outcomes in response to ligand engagement and define a mechanistic role for lipid rafts and caveolin-1 in TNF-alpha-induced activation of RhoA.	Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Hunter, I (corresponding author), Univ Aberdeen, Sch Med Sci, IMS Bldg,Foresterhill, Aberdeen AB25 2ZD, Scotland.	i.hunter@abdn.ac.uk		Nixon, Graeme/0000-0002-9581-3332	Wellcome Trust [074107] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amrani Y, 2000, Respir Res, V1, P49, DOI 10.1186/rr12; Amrani Y, 1997, AM J PHYSIOL-LUNG C, V273, pL1020, DOI 10.1152/ajplung.1997.273.5.L1020; Arudchandran R, 2000, J EXP MED, V191, P47, DOI 10.1084/jem.191.1.47; Barker TH, 2004, EXP CELL RES, V295, P488, DOI 10.1016/j.yexcr.2004.01.026; BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cottin V, 2002, J IMMUNOL, V168, P4095, DOI 10.4049/jimmunol.168.8.4095; D'Alessio A, 2005, AM J PATHOL, V166, P1273, DOI 10.1016/S0002-9440(10)62346-2; Dienz O, 2003, J IMMUNOL, V170, P365, DOI 10.4049/jimmunol.170.1.365; Doan JES, 2004, J IMMUNOL, V172, P7654, DOI 10.4049/jimmunol.172.12.7654; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Fessler MB, 2004, J BIOL CHEM, V279, P39989, DOI 10.1074/jbc.M401080200; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Hunter I, 2003, MOL PHARMACOL, V63, P714, DOI 10.1124/mol.63.3.714; Jaksits S, 2004, J IMMUNOL, V173, P1628, DOI 10.4049/jimmunol.173.3.1628; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Jupp OJ, 2001, BIOCHEM J, V359, P525, DOI 10.1042/0264-6021:3590525; Karacsonyi C, 2005, J LEUKOCYTE BIOL, V78, P1097, DOI 10.1189/jlb.0405189; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kieser A, 1999, EMBO J, V18, P2511, DOI 10.1093/emboj/18.9.2511; Kim BC, 1999, J BIOL CHEM, V274, P24372, DOI 10.1074/jbc.274.34.24372; Kim KB, 2004, PROTEOMICS, V4, P3527, DOI 10.1002/pmic.200401001; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Ko YG, 1999, J IMMUNOL, V162, P7217; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li HY, 2004, AM J PHYSIOL-RENAL, V286, pF711, DOI 10.1152/ajprenal.00308.2003; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; MacLellan DL, 2005, PROTEOMICS, V5, P4733, DOI 10.1002/pmic.200500044; Michaely PA, 1999, J BIOL CHEM, V274, P21430, DOI 10.1074/jbc.274.30.21430; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Nosaka Y, 2001, BIOCHEM BIOPH RES CO, V285, P675, DOI 10.1006/bbrc.2001.5222; Papakonstanti EA, 2004, MOL BIOL CELL, V15, P1273, DOI 10.1091/mbc.E03-07-0491; PARAHARALAMBUS C, 2005, J BIOL CHEM, V280, P18790; Parris JRM, 1999, J PHYSIOL-LONDON, V518, P561, DOI 10.1111/j.1469-7793.1999.0561p.x; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Puls A, 1999, J CELL SCI, V112, P2983; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sebald A, 2005, EUR J IMMUNOL, V35, P318, DOI 10.1002/eji.200425024; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Veldman RJ, 2001, BIOCHEM J, V355, P859, DOI 10.1042/bj3550859; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Yamaga M, 2004, GENES CELLS, V9, P25, DOI 10.1111/j.1356-9597.2004.00698.x; ZOU L, 2005, ARTERIOSCLER THROMB, V25, P1824	66	79	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34705	34715		10.1074/jbc.M605738200	http://dx.doi.org/10.1074/jbc.M605738200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16982613	Green Accepted, hybrid			2022-12-27	WOS:000241767600089
J	Nagy, G; Ward, J; Mosser, DD; Koncz, A; Gergely, P; Stancato, C; Qian, YM; Fernandez, D; Niland, B; Grossman, CE; Telarico, T; Banki, K; Perl, A				Nagy, Gyorgy; Ward, Jeffrey; Mosser, Dick D.; Koncz, Agnes; Gergely, Peter, Jr.; Stancato, Christina; Qian, Yueming; Fernandez, David; Niland, Brian; Grossman, Craig E.; Telarico, Tiffany; Banki, Katalin; Perl, Andras			Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 VPU PROTEIN; HUMAN TRANSALDOLASE; T-CELLS; ENDOGENOUS RETROVIRUSES; MEDIATED DEGRADATION; TRANSCRIPTION FACTOR; CYTOPLASMIC DOMAIN; MAMMALIAN-CELLS; DOWN-MODULATION	A novel 2986-base transcript encoded by the antisense strand of the HRES-1 human endogenous retrovirus was isolated from peripheral blood lymphocytes. This transcript codes for a 218-amino acid protein, termed HRES-1/Rab4, based on homology to the Rab4 family of small GTPases. Antibody 13407 raised against recombinant HRES-1/Rab4 detected a native protein of identical molecular weight in human T cells. HRES-1 nucleotides 2151-1606, located upstream of HRES-1/Rab4 exon 1, have promoter activity when oriented in the direction of HRES1/Rab4 transcription. The human immunodeficiency virus, type 1 (HIV-1), tat gene stimulates transcriptional activity of the HRES-1/Rab4 promoter via trans-activation of the HRES-1 long terminal repeat. Transfection of HIV-1 tat into HeLa cells or infection of H9 and Jurkat cells by HIV-1 increased HRES-1/Rab4 protein levels. Overexpression of HRES-1/Rab4 in Jurkat cells abrogated HIV infection, gag p24 production, and apoptosis, whereas dominant- negative HRES-1/Rab4(S27N) had the opposite effects. HRES-1/Rab4 inhibited surface expression of CD4 and targeted it for lysosomal degradation. HRES-1/Rab4(S27N) enhanced surface expression, recycling, and total cellular CD4 content. Infection by HIV elicited a coordinate downregulation of CD4 and up-regulation of HRES-1/Rab4 in PBL. Moreover, overexpression of HRES-1/Rab4 reduced CD4 expression on peripheral blood CD4+ T cells. Stimulation by HIV-1 of HRES-1/Rab4 expression and its regulation of CD4 recycling reveal novel coordinate interactions between an infectious retrovirus and the human genome.	SUNY Syracuse, Coll Med, Dept Med, Syracuse, NY 13210 USA; SUNY Syracuse, Coll Med, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; SUNY Syracuse, Coll Med, Dept Pathol, Syracuse, NY 13210 USA; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) System; University of Guelph	Perl, A (corresponding author), SUNY Syracuse, Coll Med, Dept Med, 750 E Adams St, Syracuse, NY 13210 USA.	perla@upstate.edu	Mosser, Dick D/A-7391-2008; Nagy, György/W-6254-2019	Nagy, György/0000-0003-1198-3228; Ward, Jeffrey/0000-0002-9707-895X; Caza, Tiffany/0000-0001-8988-8998; Perl, Andras/0000-0002-5017-1348; Qian, Yueming/0000-0001-7340-6421; Mosser, Richard/0000-0002-9183-2288	FOGARTY INTERNATIONAL CENTER [F05TW005421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048079, R56AI048079, R21AI061066] Funding Source: NIH RePORTER; FIC NIH HHS [F05 TW05421] Funding Source: Medline; NIAID NIH HHS [AI 61066, AI 48079] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACRES RB, 1986, J BIOL CHEM, V261, P6210; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Baban S, 1996, GENOMICS, V33, P463, DOI 10.1006/geno.1996.0221; Banki K, 1998, J BIOL CHEM, V273, P11944, DOI 10.1074/jbc.273.19.11944; BANKI K, 1994, J BIOL CHEM, V269, P2847; Banki K, 1996, FEBS LETT, V378, P161, DOI 10.1016/0014-5793(95)01446-2; BANKI K, 1992, P NATL ACAD SCI USA, V89, P1939, DOI 10.1073/pnas.89.5.1939; Banki K, 1999, J IMMUNOL, V162, P1466; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; BERKHOUT B, 1991, NUCLEIC ACIDS RES, V19, P6169, DOI 10.1093/nar/19.22.6169; CAPUTO A, 1990, J ACQ IMMUN DEF SYND, V3, P372; COFFIN JM, 1997, RETROVIRUSES, P343; Collins KL, 2004, MICROBES INFECT, V6, P494, DOI 10.1016/j.micinf.2003.12.014; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Grossman CE, 2004, BIOCHEM J, V382, P725, DOI 10.1042/BJ20040413; Grossman CE, 2004, J BIOL CHEM, V279, P12190, DOI 10.1074/jbc.M307039200; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; Hastings ML, 1997, NUCLEIC ACIDS RES, V25, P4296, DOI 10.1093/nar/25.21.4296; HOXIE JA, 1986, J IMMUNOL, V137, P1194; Huthoff H, 2004, RNA, V10, P412, DOI 10.1261/rna.5161304; JACOB MC, 1991, CYTOMETRY, V12, P550, DOI 10.1002/cyto.990120612; KARACOSTAS V, 1989, P NATL ACAD SCI USA, V86, P8964, DOI 10.1073/pnas.86.22.8964; Kazazian HH, 2000, SCIENCE, V289, P1152, DOI 10.1126/science.289.5482.1152; LERNER A, 1993, J IMMUNOL, V151, P3152; Li AW, 1997, MOL CELL ENDOCRINOL, V133, P177, DOI 10.1016/S0303-7207(97)00148-2; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Marodon G, 2001, IMMUNOL LETT, V79, P165, DOI 10.1016/S0165-2478(01)00286-3; Massie B, 1998, J VIROL, V72, P2289, DOI 10.1128/JVI.72.3.2289-2296.1998; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Mosser DD, 1997, BIOTECHNIQUES, V22, P150, DOI 10.2144/97221rr02; NAGY K, 1994, J VIROL, V68, P757, DOI 10.1128/JVI.68.2.757-765.1994; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; Perl A, 2003, RHEUM DIS CLIN N AM, V29, P123, DOI 10.1016/S0889-857X(02)00098-4; PERL A, 1989, NUCLEIC ACIDS RES, V17, P6841, DOI 10.1093/nar/17.17.6841; PERL A, 1991, GENOMICS, V11, P1172, DOI 10.1016/0888-7543(91)90052-G; Perl A, 2001, J RHEUMATOL, V28, P461; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; Rose JJ, 2005, J BIOL CHEM, V280, P7413, DOI 10.1074/jbc.M409420200; ROSEN CA, 1986, NATURE, V319, P555, DOI 10.1038/319555a0; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Segal DJ, 2004, J BIOL CHEM, V279, P14509, DOI 10.1074/jbc.M400349200; STEIMER KS, 1986, VIROLOGY, V150, P283, DOI 10.1016/0042-6822(86)90289-8; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Tiganos E, 1997, J VIROL, V71, P4452, DOI 10.1128/JVI.71.6.4452-4460.1997; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wilkinson D. A., 1994, RETROVIRIDAE, P465	54	48	52	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34574	34591		10.1074/jbc.M606301200	http://dx.doi.org/10.1074/jbc.M606301200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16935861	hybrid			2022-12-27	WOS:000241767600077
J	Zhang, DY; Song, L; Li, JX; Wu, KJ; Huang, CS				Zhang, Dongyun; Song, Lun; Li, Jingxia; Wu, Kangjian; Huang, Chuanshu			Coordination of JNK1 and JNK2 is critical for GADD45 alpha induction and its mediated cell apoptosis in arsenite responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; ACUTE PROMYELOCYTIC LEUKEMIA; KAPPA-B; SODIUM ARSENITE; DNA-REPAIR; ACTIVATION; EXPRESSION; PATHWAYS; GENE; PHOSPHORYLATION	Arsenite is a well documented environmental pathogen, whereas it has also been applied as medication to treat various neoplasmas. The pathogenic and therapeutic effects of arsenite are associated with cellular apoptotic responses. However, the molecular mechanisms of arsenite-induced apoptosis are not very well understood. Our previous study has shown that arsenite exposure is able to activate JNKs, which subsequently mediate the apoptotic outcome. The present study further revealed that the coordination of JNK1 and JNK2 was critical for the arsenite-induced expression of GADD45 alpha ( growth arrest and DNA damage 45 alpha), which in turn mediated the cellular apoptosis. The arsenite-induced apoptosis and GADD45 alpha expression were significantly impaired in mouse embryonic fibroblasts deficient in either jnk1 (JNK1(-/-)) or jnk2 (JNK2(-/-)). Knockdown of GADD45 alpha by its specific small interfering RNA also dramatically reduced the apoptotic responses, and overexpression of GADD45 alpha in either JNK1(-/-) or JNK2(-/-) mouse embryonic fibroblasts partially resensitized the cell death. Furthermore, it was found that the regulation of GADD45 alpha by JNK1 and JNK2 was achieved through mediating the activation of c-Jun, since in the JNK1(-/-) and JNK2(-/-) cells the c-Jun activation was impaired, and overexpression of the dominant negative mutant of c-Jun (TAM67) in wild type cells could also block GADD45 alpha induction as well as cellular apoptosis. Our results demonstrate that the coordination of JNK1 and JNK2 is critical for c-Jun/GADD45 alpha-mediated cellular apoptosis induced by arsenite.	NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA	New York University	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu@env.med.nyu.edu		Huang, Chuanshu/0000-0003-4133-5096	NATIONAL CANCER INSTITUTE [R01CA112557, R01CA103180, R01CA094964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES012451] Funding Source: NIH RePORTER; NCI NIH HHS [CA103180, CA094964, CA112557] Funding Source: Medline; NIEHS NIH HHS [ES012451, ES000260] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bernstam L, 2000, J TOXICOL ENV HEAL B, V3, P293, DOI 10.1080/109374000436355; BETTLEY FR, 1975, BRIT J DERMATOL, V92, P563; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chen F, 2001, J BIOL CHEM, V276, P11414, DOI 10.1074/jbc.M011682200; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Chou RH, 2002, J CELL BIOCHEM, V84, P615; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Das T, 1999, BIOCHEM BIOPH RES CO, V260, P105, DOI 10.1006/bbrc.1999.0712; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dong ZG, 2002, ENVIRON HEALTH PERSP, V110, P757, DOI 10.1289/ehp.02110s5757; FUENTE HD, 2002, CLIN EXP IMMUNOL, V129, P69; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hildesheim J, 2002, CANCER RES, V62, P7305; Hollander MC, 2001, CANCER RES, V61, P2487; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Huang CS, 2000, J BIOL CHEM, V275, P32516, DOI 10.1074/jbc.M005366200; Huang CS, 1999, CANCER RES, V59, P3053; Huang CS, 1999, J BIOL CHEM, V274, P14595, DOI 10.1074/jbc.274.21.14595; Huang CS, 2001, ANTICANCER RES, V21, P261; Huang SC, 2000, BIOCHEM PHARMACOL, V60, P771, DOI 10.1016/S0006-2952(00)00397-X; *INT AG RES CANC, 1980, LYON IARC, V23, P39; Ivanov VN, 2004, J BIOL CHEM, V279, P22747, DOI 10.1074/jbc.M314131200; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Larochette N, 1999, EXP CELL RES, V249, P413, DOI 10.1006/excr.1999.4519; Lau ATY, 2004, CARCINOGENESIS, V25, P21, DOI 10.1093/carcin/bgg179; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li JX, 2004, MOL CARCINOGEN, V40, P104, DOI 10.1002/mc.20020; Liebermann DA, 2002, LEUKEMIA, V16, P527, DOI 10.1038/sj.leu.2402477; McCabe MJ, 2000, J PHARMACOL EXP THER, V295, P724; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; Muscarella DE, 2003, TOXICOL SCI, V74, P66, DOI 10.1093/toxsci/kfg052; Muscarella DE, 2002, TOXICOL SCI, V68, P82, DOI 10.1093/toxsci/68.1.82; MUYAO L, 2002, J CELL BIOCHEM, V87, P29; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; Namgung U, 2001, TOXICOL APPL PHARM, V174, P130, DOI 10.1006/taap.2001.9200; Nuntharatanapong N, 2005, AM J PHYSIOL-HEART C, V289, pH99, DOI 10.1152/ajpheart.00901.2004; Nutt LK, 2005, CANCER BIOL THER, V4, P459; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pawate S, 2006, ANTIOXID REDOX SIGN, V8, P903, DOI 10.1089/ars.2006.8.903; Qu W, 2002, CARCINOGENESIS, V23, P151, DOI 10.1093/carcin/23.1.151; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Sciandrello G, 2002, MUTAGENESIS, V17, P99, DOI 10.1093/mutage/17.2.99; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Solary E, 2003, LEUKEMIA LYMPHOMA, V44, P563, DOI 10.1080/1042819021000038001; Tong T, 2001, EXP CELL RES, V269, P64, DOI 10.1006/excr.2001.5312; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; WANG Y, 2006, IN PRESS BIOCH J; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Yin F, 2004, ONCOGENE, V23, P4614, DOI 10.1038/sj.onc.1207598; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhao HC, 2000, EXP CELL RES, V258, P92, DOI 10.1006/excr.2000.4906	65	31	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34113	34123		10.1074/jbc.M602821200	http://dx.doi.org/10.1074/jbc.M602821200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973625	hybrid			2022-12-27	WOS:000241767600032
J	McMillan, PJ; Arscott, LD; Ballou, DP; Becker, K; Williams, CH; Muller, S				McMillan, Paul J.; Arscott, L. David; Ballou, David P.; Becker, Katja; Williams, Charles H., Jr.; Mueller, Sylke			Identification of acid-base catalytic residues of high-M-r thioredoxin reductase from Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; GLUTATHIONE-REDUCTASE; ESCHERICHIA-COLI; ACTIVE-SITE; LIPOAMIDE DEHYDROGENASE; DROSOPHILA-MELANOGASTER; AZOTOBACTER-VINELANDII; HIS450-GLU455 DIAD; MUTATED ENZYMES; WILD-TYPE	High-M-r thioredoxin reductase from the malaria parasite Plasmodium falciparum (PfTrxR) contains three redox active centers (FAD, Cys-88/Cys-93, and Cys-535/Cys-540) that are in redox communication. The catalytic mechanism of PfTrxR, which involves dithiol-disulfide interchanges requiring acid-base catalysis, was studied by steady-state kinetics, spectral analyses of anaerobic static titrations, and rapid kinetics analysis of wild-type enzyme and variants involving the His-509-Glu-514 dyad as the presumed acid-base catalyst. The dyad is conserved in all members of the enzyme family. Substitution of His-509 with glutamine and Glu-514 with alanine led to TrxR with only 0.5 and 7% of wild type activity, respectively, thus demonstrating the crucial roles of these residues for enzymatic activity. The H509Q variant had rate constants in both the reductive and oxidative half-reactions that were dramatically less than those of wild-type enzyme, and no thiolate-flavin charge-transfer complex was observed. Glu-514 was shown to be involved in dithiol-disulfide interchange between the Cys-88/Cys-93 and Cys-535/Cys-540 pairs. In addition, Glu-514 appears to greatly enhance the role of His-509 in acid-base catalysis. It can be concluded that the His-509-Glu-514 dyad, in analogy to those in related oxidoreductases, acts as the acid-base catalyst in PfTrxR.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Glasgow, Inst Biomed & Life Sci Infect & Immun, Glasgow G12 8TA, Lanark, Scotland; Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; Univ Giessen, Interdisciplinary Res Ctr, D-35392 Giessen, Germany	University of Michigan System; University of Michigan; University of Glasgow; University of Glasgow; Justus Liebig University Giessen	Williams, CH (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	chaswill@umich.edu; s.muller@bio.gla.ac.uk	dballou@umich.edu, David P/A-1298-2007; McMillan, Paul/B-5081-2008; McMillan, Paul James/P-6441-2019	McMillan, Paul James/0000-0001-5629-1175	NIGMS NIH HHS [GM11106] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM011106, R37GM011106] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andricopulo AD, 2006, BIOORG MED CHEM LETT, V16, P2283, DOI 10.1016/j.bmcl.2006.01.027; Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161; Bauer H, 2003, J BIOL CHEM, V278, P33020, DOI 10.1074/jbc.M303762200; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; BENEN J, 1991, EUR J BIOCHEM, V202, P863, DOI 10.1111/j.1432-1033.1991.tb16444.x; BENEN J, 1992, EUR J BIOCHEM, V207, P487, DOI 10.1111/j.1432-1033.1992.tb17075.x; Biterova EI, 2005, P NATL ACAD SCI USA, V102, P15018, DOI 10.1073/pnas.0504218102; Bohme CC, 2000, J BIOL CHEM, V275, P37317, DOI 10.1074/jbc.M007695200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braman J, 1996, Methods Mol Biol, V57, P31; Brandt W, 2005, CHEMBIOCHEM, V6, P386, DOI 10.1002/cbic.200400276; Coombs GH, 2004, J BIOL CHEM, V279, P5249, DOI 10.1074/jbc.M304359200; Davioud-Charvet E, 2003, BIOCHEMISTRY-US, V42, P13319, DOI 10.1021/bi0353629; Davioud-Charvet E, 1999, ANAL BIOCHEM, V268, P1, DOI 10.1006/abio.1998.3061; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gilberger TW, 1997, J BIOL CHEM, V272, P29584, DOI 10.1074/jbc.272.47.29584; Gilberger TW, 1998, FEBS LETT, V425, P407, DOI 10.1016/S0014-5793(98)00270-1; Gladyshev VN, 1999, BIOCHEM BIOPH RES CO, V259, P244, DOI 10.1006/bbrc.1999.0765; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Krnajski Z, 2001, MOL BIOCHEM PARASIT, V112, P219, DOI 10.1016/S0166-6851(00)00372-8; Krnajski Z, 2000, J BIOL CHEM, V275, P40874, DOI 10.1074/jbc.M008443200; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Maitland K, 2004, CURR OPIN INFECT DIS, V17, P405, DOI 10.1097/00001432-200410000-00004; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; PAI EF, 1983, J BIOL CHEM, V258, P1752; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; PRONGAY AJ, 1992, J BIOL CHEM, V267, P25181; RIETVELD P, 1994, BIOCHEMISTRY-US, V33, P13888, DOI 10.1021/bi00250a043; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Stewart LB, 2004, ANN TROP MED PARASIT, V98, P763, DOI 10.1179/000349804X3144; Wang PF, 1999, BIOCHEMISTRY-US, V38, P3187, DOI 10.1021/bi982674g; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121	43	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					32967	32977		10.1074/jbc.M601141200	http://dx.doi.org/10.1074/jbc.M601141200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950793	hybrid			2022-12-27	WOS:000241621400005
J	DeBosch, B; Sambandam, N; Weinheimer, C; Courtois, M; Muslin, AJ				DeBosch, Brian; Sambandam, Nandakumar; Weinheimer, Carla; Courtois, Michael; Muslin, Anthony J.			Akt2 regulates cardiac metabolism and cardiomyocyte survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; MYOCARDIAL-INFARCTION; GLYCOGEN-SYNTHASE; GLUCOSE-UPTAKE; MICE LACKING; MOUSE HEART; IN-VITRO; HYPERTROPHY; GROWTH; PHOSPHORYLATION	The Akt family of serine-threonine kinases participates in diverse cellular processes, including the promotion of cell survival, glucose metabolism, and cellular protein synthesis. All three known Akt family members, Akt1, Akt2 and Akt3, are expressed in the myocardium, although Akt1 and Akt2 are most abundant. Previous studies demonstrated that Akt1 and Akt3 overexpression results in enhanced myocardial size and function. Yet, little is known about the role of Akt2 in modulating cardiac metabolism, survival, and growth. Here, we utilize murine models with targeted disruption of the akt2 or the akt1 genes to demonstrate that Akt2, but not Akt1, is required for insulin-stimulated 2-[H-3] deoxyglucose uptake and metabolism. In contrast, akt2 (-/-) mice displayed normal cardiac growth responses to provocative stimulation, including ligand stimulation of cultured cardiomyocytes, pressure overload by transverse aortic constriction, and myocardial infarction. However, akt2 (-/-) mice were found to be sensitized to cardiomyocyte apoptosis in response to ischemic injury, and apoptosis was significantly increased in the peri-infarct zone of akt2 (-/-) hearts 7 days after occlusion of the left coronary artery. These results implicate Akt2 in the regulation of cardiomyocyte metabolism and survival.	Washington Univ, Sch Med, Dept Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Muslin, AJ (corresponding author), Washington Univ, Sch Med, Dept Med, Cardiovasc Res Ctr, 4940 Parkview Pl,Box 8086,Rm 9912 CSRB, St Louis, MO 63110 USA.	amuslin@im.wustl.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, T32HL007873, R01HL076670, R01HL061567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, P30DK056341] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL057278-090006, HL 057278, T32 HL 07873, HL 076670, T32 HL007873, P01 HL057278-100006, R01 HL061567, R01 HL076670-01A2, HL 61567, P01 HL057278, R01 HL076670] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-06, P30 DK056341, P30 DK056341-05S2, P30 DK052574, P30 DK 52574] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 2004, CURR HYPERTENS REP, V6, P416, DOI 10.1007/s11906-004-0034-4; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Cheatham B, 2000, TRENDS ENDOCRIN MET, V11, P356, DOI 10.1016/S1043-2760(00)00308-8; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Colao A, 2004, EUR J ENDOCRINOL, V151, pS93, DOI 10.1530/eje.0.151S093; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Kanno S, 2002, J AM SOC ECHOCARDIOG, V15, P601, DOI 10.1067/mje.2002.117560; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Matsui T, 2005, J MOL CELL CARDIOL, V38, P63, DOI 10.1016/j.yjmcc.2004.11.005; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040; Ren J, 2005, J MOL CELL CARDIOL, V38, P617, DOI 10.1016/j.yjmcc.2005.01.012; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Sambrano GR, 2002, NATURE, V420, P712, DOI 10.1038/nature01306; Serneri GGN, 2001, CIRC RES, V89, P977, DOI 10.1161/hh2301.100982; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Somwar R, 2001, J BIOL CHEM, V276, P46079, DOI 10.1074/jbc.M109093200; Southgate RJ, 2005, FASEB J, V19, P2072, DOI 10.1096/fj.05-3993fje; TNIYAMA Y, 2005, J BIOL CHEM, V38, P375; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182	29	131	141	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32841	32851		10.1074/jbc.M513087200	http://dx.doi.org/10.1074/jbc.M513087200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950770	Green Accepted, hybrid			2022-12-27	WOS:000241414500082
J	Zha, WJ; Rubin-Pitel, SB; Zhao, HM				Zha, Wenjuan; Rubin-Pitel, Sheryl B.; Zhao, Huimin			Characterization of the substrate specificity of PhlD, a type III polyketide synthase from Pseudomonas fluorescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHALCONE SYNTHASE; ANTIBIOTIC 2,4-DIACETYLPHLOROGLUCINOL; BACTERIAL POLYKETIDE; STREPTOMYCES-GRISEUS; GENE-CLUSTER; ACTIVE-SITE; BIOSYNTHESIS; PHLOROGLUCINOL; MUTAGENESIS; STILBENE	PhlD, a type III polyketide synthase from Pseudomonas fluorescens, catalyzes the synthesis of phloroglucinol from three molecules of malonyl-CoA. Kinetic analysis by direct measurement of the appearance of the CoASH product (k(cat) = 24 +/- 4 min(-1) and Km = 13 +/- 1 mu M) gave a k(cat) value more than an order of magnitude higher than that of any other known type III polyketide synthase. PhlD exhibits broad substrate specificity, accepting C-4-C-12 aliphatic acyl-CoAs and phenylacetyl-CoA as the starters to form C6-polyoxoalkylated alpha-pyrones from sequential condensation with malonyl-CoA. Interestingly, when primed with long chain acyl-CoAs, PhlD catalyzed extra polyketide elongation to form up to heptaketide products. A homology structural model of PhlD showed the presence of a buried tunnel extending out from the active site to assist the binding of long chain acyl-CoAs. To probe the structural basis for the unusual ability of PhlD to accept long chain acyl-CoAs, both site-directed mutagenesis and saturation mutagenesis were carried out on key residues lining the tunnel. Three mutations, M21I, H24V, and L59M, were found to significantly reduce the reactivity of PhlD with lauroyl-CoA while still retaining its physiological activity to synthesize phloroglucinol. Our homology modeling and mutational studies indicated that even subtle changes in the tunnel volume could affect the ability of PhlD to accept long chain acyl-CoAs. This suggested novel strategies for combinatorial biosynthesis of unnatural pharmaceutically important polyketides.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Dept Biomol Engn & Chem, Ctr Biophys & Computat Biol, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhao, HM (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.	zhao5@uiuc.edu						Abe I, 2005, J AM CHEM SOC, V127, P12709, DOI 10.1021/ja053945v; Achkar J, 2005, J AM CHEM SOC, V127, P5332, DOI 10.1021/ja042340g; Austin MB, 2004, J BIOL CHEM, V279, P45162, DOI 10.1074/jbc.M406567200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Bangera MG, 1999, J BACTERIOL, V181, P3155, DOI 10.1128/JB.181.10.3155-3163.1999; Bangera MG, 1996, MOL PLANT MICROBE IN, V9, P83, DOI 10.1094/MPMI-9-0083; Chen HW, 2001, P NATL ACAD SCI USA, V98, P14901, DOI 10.1073/pnas.221582098; Chockalingam K, 2005, P NATL ACAD SCI USA, V102, P5691, DOI 10.1073/pnas.0409206102; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; EDWARDS ML, 1990, J MED CHEM, V33, P1948, DOI 10.1021/jm00169a021; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Funa N, 2002, J BIOL CHEM, V277, P4628, DOI 10.1074/jbc.M110357200; Georgescu Radu, 2003, Methods Mol Biol, V231, P75; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; KATZ L, 1993, ANNU REV MICROBIOL, V47, P875, DOI 10.1146/annurev.mi.47.100193.004303; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; Lee JK, 2006, J BACTERIOL, V188, P6179, DOI 10.1128/JB.00259-06; Moore BS, 2001, CHEMBIOCHEM, V2, P35, DOI 10.1002/1439-7633(20010105)2:1<35::AID-CBIC35>3.3.CO;2-T; Rawlings BJ, 2001, NAT PROD REP, V18, P231, DOI 10.1039/b100191o; Rawlings BJ, 1999, NAT PROD REP, V16, P425, DOI 10.1039/a900566h; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Saxena P, 2003, J BIOL CHEM, V278, P44780, DOI 10.1074/jbc.M306714200; SCHUZ R, 1983, J BIOL CHEM, V258, P6730; SHEN B, 1993, SCIENCE, V262, P1535, DOI 10.1126/science.8248801; Shen B, 2000, TOP CURR CHEM, V209, P1; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; TROPF S, 1995, J BIOL CHEM, V270, P7922, DOI 10.1074/jbc.270.14.7922; Tseng CC, 2004, BIOCHEMISTRY-US, V43, P970, DOI 10.1021/bi035714b; UEDA K, 1995, J ANTIBIOT, V48, P638, DOI 10.7164/antibiotics.48.638	36	50	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					32036	32047		10.1074/jbc.M606500200	http://dx.doi.org/10.1074/jbc.M606500200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16931521	Bronze			2022-12-27	WOS:000241235300089
J	Barquera, B; Ramirez-Silva, L; Morgan, JE; Nilges, MJ				Barquera, Blanca; Ramirez-Silva, Leticia; Morgan, Joel E.; Nilges, Mark J.			A new flavin radical signal in the Na+-pumping NADH : quinone oxidoreductase from Vibrio cholerae - An EPR/electron nuclear double resonance investigation of the role of the covalently bound flavins in subunits B and C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; DNA PHOTOLYASE; NQRC SUBUNITS; ALGINOLYTICUS; REDUCTASE; EPR; SPECTROSCOPY; PURIFICATION; MUTAGENESIS	The Na+ pumping NADH-ubiquinone oxidoreductase has six polypeptide subunits (NqrA-F) and a number of redox cofactors, including a noncovalently bound FAD and a 2Fe-2S center in subunit F, covalently bound FMNs in subunits B and C, and a noncovalently bound riboflavin in an undisclosed location. The FMN cofactors in subunits B and C are bound to threonine residues by phosphoester linkages. A neutral flavin-semiquinone radical is observed in the oxidized enzyme, whereas an anionic flavin-semiquinone has been reported in the reduced enzyme. For this work, we have altered the binding ligands of the FMNs in subunits B and C by replacing the threonine ligands with other amino acids, and we studied the resulting mutants by EPR and electron nuclear double resonance spectroscopy. We conclude that the sodium-translocating NADH: quinone oxidoreductase forms three spectroscopically distinct flavin radicals as follows: 1) a neutral radical in the oxidized enzyme, which is observed in all of the mutants and most likely arises from the riboflavin; 2) an anionic radical observed in the fully reduced enzyme, which is present in wild type, and the NqrC-T225Y mutant but not the NqrB-T236Y mutant; 3) a second anionic radical, seen primarily under weakly reducing conditions, which is present in wild type, and the NqrB-T236Y mutant but not the NqrC-T225Y mutant. Thus, we can tentatively assign the first anionic radical to the FMN in subunit B and the second to the FMN in subunit C. The second anionic radical has not been reported previously. In electron nuclear double resonance spectra, it exhibits a larger line width and larger 8 alpha-methyl proton splittings, compared with the first anionic radical.	Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; Illinois EPR Res Ctr, Urbana, IL 61801 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Universidad Nacional Autonoma de Mexico	Barquera, B (corresponding author), Rensselaer Polytech Inst, Dept Biol, 110 8th St, Troy, NY 12180 USA.	barqub@rpi.edu; mjnilges@uiuc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016101, R37HL016101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069936] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL16101] Funding Source: Medline; NIGMS NIH HHS [R01-GM069936] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALIVERTI A, 1995, FEBS LETT, V368, P220, DOI 10.1016/0014-5793(95)00648-S; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Bogachev AV, 1997, FEBS LETT, V409, P475, DOI 10.1016/S0014-5793(97)00536-X; EDMONDSON DE, 1978, BIOL MAGN RESON, P205; Galli C, 1996, BIOCHEMISTRY-US, V35, P2804, DOI 10.1021/bi9520444; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; Kay CWM, 1999, BIOCHEMISTRY-US, V38, P16740, DOI 10.1021/bi991442u; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nilges M. J., 1979, THESIS U ILLINOIS UR; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; TOKUDA H, 1984, J BIOL CHEM, V259, P7785; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Weber S, 2001, J AM CHEM SOC, V123, P3790, DOI 10.1021/ja003426m; Wunsch P, 2005, J BACTERIOL, V187, P1992, DOI 10.1128/JB.187.6.1992-2001.2005; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	25	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36482	36491		10.1074/jbc.M605765200	http://dx.doi.org/10.1074/jbc.M605765200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16973619	hybrid			2022-12-27	WOS:000242220800003
J	Davis, CW; Mattei, LM; Nguyen, HY; Ansarah-Sobrinho, C; Doms, RW; Pierson, TC				Davis, Carl W.; Mattei, Lisa M.; Nguyen, Hai-Yen; Ansarah-Sobrinho, Camilo; Doms, Robert W.; Pierson, Theodore C.			The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS ENVELOPE PROTEINS; RECEPTORS DC-SIGN; C-TYPE LECTIN; DENGUE VIRUS; EXTRACELLULAR GLYCOSIDASES; CARBOHYDRATE-RECOGNITION; DIPLOCOCCUS PNEUMONIAE; STRUCTURAL BASIS; LIGAND-BINDING; HIGH-MANNOSE	Mammalian cell-derived West Nile virus preferentially infects cells expressing the C-type lectin CD209L (dendritic cell-specific ICAM-3 grabbing nonintegrin-related protein; liver- and lymph node-specific ICAM-3 grabbing nonintegrin) but not cells expressing CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin). In contrast, Dengue virus infection is enhanced in cells expressing either attachment factor. The West Nile virus envelope (E) protein contains a single N-linked glycosylation site at residue 154, whereas Dengue virus E contains sites at residues 153 and 67. We introduced a glycosylation site at position 67 into West Nile virus E. Reporter virus particles pseudotyped with this E protein infected cells using either CD209 or CD209L. We also introduced glycosylation sites at several novel positions. All sites allowed CD209L-mediated infection, but only a subset promoted CD209 use. As seen for other viruses, mannose-rich glycans on West Nile virus were required for its interactions with CD209. Surprisingly, however, mannose-rich glycans were not required for CD209L-mediated infection. Complex glycans, particularly N-acetylglucosamine-terminated structures, were able to mediate reporter virus particle interactions with CD209L. We propose that CD209L recognizes glycosylated flaviviruses with broad specificity, whereas CD209 is selective for flaviviruses bearing mannose-rich glycans. The location of the N-linked glycosylation sites on a virion determines the types of glycans incorporated, thus controlling viral tropism for CD209-expressing cells.	NIH, Viral Dis Lab, Viral Pathogenesis Sect, Bethesda, MD 20892 USA; Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; University of Pennsylvania	Pierson, TC (corresponding author), NIH, Viral Dis Lab, Viral Pathogenesis Sect, 4 Ctr Dr,Bldg 4,Room 216, Bethesda, MD 20892 USA.	piersontc@mail.nih.gov		Mattei, Lisa/0000-0002-2238-0281	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [U54 AI57168, T32 AI07632, AI50469] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001022, U54AI057168, R01AI050469, T32AI007632] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Bashirova AA, 2003, J VIROL, V77, P217, DOI 10.1128/JVI.77.1.217-227.2003; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Beasley DWC, 2004, EMERG INFECT DIS, V10, P2221, DOI 10.3201/eid1012.040647; Beasley DWC, 2004, ARCH VIROL, P35; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Chambers TJ, 1998, J GEN VIROL, V79, P2375, DOI 10.1099/0022-1317-79-10-2375; CHU FK, 1986, J BIOL CHEM, V261, P172; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Drickamer K, 1996, BIOCHEM SOC T, V24, P146, DOI 10.1042/bst0240146; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; FUHRMANN U, 1984, NATURE, V307, P755, DOI 10.1038/307755a0; Gehrke R, 2003, J VIROL, V77, P8924, DOI 10.1128/JVI.77.16.8924-8933.2003; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; HSIEH P, 1984, J BIOL CHEM, V259, P2375; HUGHES RC, 1964, BIOCHEMISTRY-US, V3, P1535, DOI 10.1021/bi00898a025; HUGHES RC, 1964, BIOCHEMISTRY-US, V3, P1543, DOI 10.1021/bi00898a026; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481; Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034; Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004; Khromykh AA, 1998, J VIROL, V72, P5967, DOI 10.1128/JVI.72.7.5967-5977.1998; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Koppel EA, 2005, CELL MICROBIOL, V7, P157, DOI 10.1111/J.1462-5822.2004.00480.x; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Pohlmann S, 2001, TRENDS IMMUNOL, V22, P643, DOI 10.1016/S1471-4906(01)02081-6; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; ROBBINS PW, 1992, GENE, V111, P69, DOI 10.1016/0378-1119(92)90604-N; Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; Scherret JH, 2001, ANN NY ACAD SCI, V951, P361, DOI 10.1111/j.1749-6632.2001.tb02719.x; Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; WENGLER G, 1989, J VIROL, V63, P2521, DOI 10.1128/JVI.63.6.2521-2526.1989; Wu L, 2002, P NATL ACAD SCI USA, V99, P1568, DOI 10.1073/pnas.032654399; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; YAMASHITA K, 1981, BIOCHEM BIOPH RES CO, V100, P226, DOI 10.1016/S0006-291X(81)80086-1; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	63	78	83	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					37183	37194		10.1074/jbc.M605429200	http://dx.doi.org/10.1074/jbc.M605429200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	17001080	hybrid			2022-12-27	WOS:000242220800079
J	Abid, MR; Shih, SC; Otu, HH; Spokes, KC; Okada, Y; Curiel, DT; Minami, T; Aird, WC				Abid, Md. Ruhul; Shih, Shu-Ching; Otu, Hasan H.; Spokes, Katherine C.; Okada, Yoshiaki; Curiel, David T.; Minami, Takashi; Aird, William C.			A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO3A; PHOSPHOINOSITIDE 3-KINASE PATHWAY; PROTEIN-KINASE-C; SIGNALING PATHWAY; OXIDATIVE STRESS; CELL GROWTH; FACTOR FKHR; PHOSPHOENOLPYRUVATE CARBOXYKINASE; TERMINAL FRAGMENT; KAPPA-B	Recently, we have shown that transient phosphorylation and inhibition of the pro-apoptotic transcription factor, forkhead, by vascular endothelial growth factor (VEGF) is essential for endothelial cell (EC) survival and proliferation. The goal of the present study was to determine whether forkhead (FKHR) also plays a positive role in agonist-mediated gene induction. Human coronary artery ECs were transduced with adenovirus overexpressing constitutively active phosphorylation-resistant triple mutant FKHR or transfected with small interference RNA (siRNA) against FKHR. The cells were then treated in the absence or presence of VEGF and assayed for gene expression using quantitative real-time PCR and Northern blots analyses. The data revealed a novel set of VEGF-responsive genes that require FKHR activity for optimal expression in ECs, including bone morphogenic protein 2, cbp/p300-interacting transactivator 2, decay accelerating factor (DAF), vascular cell adhesion molecule-1 (VCAM-1), manganese superoxide dismutase, endothelial-specific molecule-1, RING1 and YY1-binding protein, and matrix metalloproteinase-10. Consistent with a positive role for FKHR in mediating VEGF induction of DAF and VCAM-1 mRNA, siRNA against FKHR attenuated the effect of VEGF on complement-mediated EC lysis and monocyte adhesion, respectively. VEGF induction of the forkhead-dependent genes was down-regulated by the NF-kappa B inhibitor, constitutively active Ad-I kappa B, and in some cases by the nuclear factor of activated T-cells (NF-AT) inhibitor, cyclosporin. Together, these findings suggest that the VEGF-forkhead signaling axis plays an important functional role in ECs beyond the regulation of cell survival/apoptosis and cell cycle.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Genom Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Vasc Biol Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Mol & Vasc Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Human Gene Therapy, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL 35294 USA; Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 153, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Tokyo	Abid, MR (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Genom Ctr, E-RW-663,330 Brookline Ave, Boston, MA 02215 USA.	rabid@bidmc.harvard.edu	Okada, Yoshiaki/M-8718-2017	Otu, Hasan/0000-0002-9253-8152	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077348] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL077348, R01 HL077348] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bilbao G, 1999, J VIROL, V73, P6992, DOI 10.1128/JVI.73.8.6992-7000.1999; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen ZQ, 1997, CANCER RES, V57, P2013; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374; Dvorak HF, 2000, SEMIN PERINATOL, V24, P75, DOI 10.1016/S0146-0005(00)80061-0; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Korpelainen EI, 1999, ONCOGENE, V18, P1, DOI 10.1038/sj.onc.1202288; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Mukhopadhyay D, 2004, MOL CELL BIOCHEM, V264, P51, DOI 10.1023/B:MCBI.0000044374.85095.df; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Shih SC, 2002, AM J PATHOL, V161, P35, DOI 10.1016/S0002-9440(10)64154-5; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Zachary I, 2000, ARTERIOSCL THROM VAS, V20, P1512, DOI 10.1161/01.ATV.20.6.1512	49	43	43	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35544	35553		10.1074/jbc.M608620200	http://dx.doi.org/10.1074/jbc.M608620200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16980307	hybrid			2022-12-27	WOS:000241933700087
J	Sehgal, BU; DeBiase, PJ; Matzno, S; Chew, TL; Claiborne, JN; Hopkinson, SB; Russell, A; Marinkovich, MP; Jones, JCR				Sehgal, Bernd U.; DeBiase, Phillip J.; Matzno, Sumio; Chew, Teng-Leong; Claiborne, Jessica N.; Hopkinson, Susan B.; Russell, Alan; Marinkovich, M. Peter; Jones, Jonathan C. R.			Integrin beta 4 regulates migratory behavior of keratinocytes by determining laminin-332 organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-3-BETA-1 INTEGRIN; ALPHA-6-BETA-4 INTEGRIN; EPITHELIAL-CELLS; LIM-KINASE; MATRIX METALLOPROTEASE-2; PLASMINOGEN-ACTIVATOR; BETA(4) SUBUNIT; GAMMA-2 CHAIN; RHO-GTPASES; COFILIN	hether alpha 6 beta 4 integrin regulates migration remains controversial. beta 4 integrin-deficient (JEB) keratinocytes display aberrant migration in that they move in circles, a behavior that mirrors the circular arrays of laminin (LM)-332 in their matrix. In contrast, wild-type keratinocytes and JEB keratinocytes, induced to express beta 4 integrin, assemble laminin-332 in linear tracks over which they migrate. Moreover, laminin-332-dependent migration of JEB keratinocytes along linear tracks is restored when cells are plated on wild-type keratinocyte matrix, whereas wild-type keratinocytes show rotation over circular arrays of laminn-332 in JEB keratinocyte matrix. The activities of Rac1 and the actin cytoskeleton-severing protein cofilin are low in JEB keratinocytes compared with wild-type cells but are rescued following expression of wild-type beta 4 integrin in JEB cells. Additionally, in wild-type keratinocytes Rac1 is complexed with alpha 6 beta 4 integrin. Moreover, Rac1 or cofilin inactivation induces wild-type keratinocytes to move in circles over rings of laminin-332 in their matrix. Together these data indicate that laminin-332 matrix organization is determined by the alpha 6 beta 4 integrin/actin cytoskeleton via Rac1/cofilin signaling. Furthermore, our results imply that the organizational state of laminin-332 is a key determinant of the motility behavior of keratinocytes, an essential element of skin wound healing and the successful invasion of epidermal-derived tumor cells.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Cytokinet Inc, Dept Mol & Cell Biol, San Francisco, CA 94080 USA; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA 94305 USA	Northwestern University; Feinberg School of Medicine; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Jones, JCR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922; Russell, Alan/0000-0001-7545-5008	NIAMS NIH HHS [T32 AR007593, R01 AR054184, R01 AR054184-17, R01 AR054184-18] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007593, R01AR054184] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BANNON LJ, 2001, CELL ADHESION, P324; Baudoin C, 2005, J INVEST DERMATOL, V125, P883, DOI 10.1111/j.0022-202X.2005.23881.x; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; CARTER BZ, 1991, LAB INVEST, V65, P610; Choma DP, 2004, J CELL SCI, V117, P3947, DOI 10.1242/jcs.01251; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; DeHart GW, 2003, EXP CELL RES, V283, P67, DOI 10.1016/S0014-4827(02)00028-9; deHart GW, 2004, CELL MOTIL CYTOSKEL, V57, P107, DOI 10.1002/cm.10161; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Gonzales M, 1999, MOL BIOL CELL, V10, P259, DOI 10.1091/mbc.10.2.259; Henry MD, 2001, J CELL SCI, V114, P1137; Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Kainulainen T, 1997, BRIT J DERMATOL, V136, P331, DOI 10.1046/j.1365-2133.1997.5581514.x; Katayama M, 2004, J MOL HISTOL, V35, P277; KAUR P, 1989, J GEN VIROL, V70, P1261, DOI 10.1099/0022-1317-70-5-1261; Kosmehl H, 1999, BRIT J CANCER, V81, P1071, DOI 10.1038/sj.bjc.6690809; LANGHOFER M, 1993, J CELL SCI, V105, P753; Litjens SHM, 2003, MOL BIOL CELL, V14, P4039, DOI 10.1091/mbc.E03-05-0268; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MATSUI C, 1995, J BIOL CHEM, V270, P23496, DOI 10.1074/jbc.270.40.23496; McGowan KA, 2000, MICROSC RES TECHNIQ, V51, P262, DOI 10.1002/1097-0029(20001101)51:3<262::AID-JEMT6>3.0.CO;2-V; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Niki T, 2002, AM J PATHOL, V160, P1129, DOI 10.1016/S0002-9440(10)64933-4; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Ortiz-Urda S, 2005, SCIENCE, V307, P1773, DOI 10.1126/science.1106209; PILCHER BK, 2002, CELL INVASION, P148; PYKE C, 1995, CANCER RES, V55, P4132; Rabinovitz I, 2001, MOL BIOL CELL, V12, P4030, DOI 10.1091/mbc.12.12.4030; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; Tsuruta D, 2003, CELL MOTIL CYTOSKEL, V54, P122, DOI 10.1002/cm.10089; VAILLY J, 1994, EUR J BIOCHEM, V219, P209, DOI 10.1111/j.1432-1033.1994.tb19932.x; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112; Wiche G, 1998, J CELL SCI, V111, P2477; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	69	100	101	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35487	35498		10.1074/jbc.M606317200	http://dx.doi.org/10.1074/jbc.M606317200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16973601	Green Accepted, hybrid			2022-12-27	WOS:000241933700082
J	Grant, GA				Grant, Gregory A.			The ACT domain: A small molecule binding domain and its role as a common regulatory element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMINO-ACID-METABOLISM; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP-PHOSPHORIBOSYLTRANSFERASE; THREONINE DEAMINASE; PROTEINS; ARABIDOPSIS; SUBUNIT; FAMILY; SITES		Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Grant, GA (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	ggrant@wustl.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056676] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56676] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Chivers PT, 2005, J MOL BIOL, V348, P597, DOI 10.1016/j.jmb.2005.03.017; Cho Y, 2003, J BIOL CHEM, V278, P8333, DOI 10.1074/jbc.M212124200; Devedjiev Y, 2004, J MOL BIOL, V343, P395, DOI 10.1016/j.jmb.2004.08.037; Ettema TJG, 2002, J BIOL CHEM, V277, P37464, DOI 10.1074/jbc.M206063200; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Hayakawa T, 2006, PLANT CELL PHYSIOL, V47, P891, DOI 10.1093/pcp/pcj062; Hsieh MH, 2002, PLANT PHYSIOL, V130, P1797, DOI 10.1104/pp.007484; Kaplun A, 2006, J MOL BIOL, V357, P951, DOI 10.1016/j.jmb.2005.12.077; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Kozlov G, 2004, J BACTERIOL, V186, P8083, DOI 10.1128/JB.186.23.8083-8088.2004; Leonard PM, 2001, EMBO J, V20, P990, DOI 10.1093/emboj/20.5.990; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Lohkamp B, 2004, J MOL BIOL, V336, P131, DOI 10.1016/j.jmb.2003.12.020; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; NAGAI K, 1995, TRENDS BIOCHEM SCI, V20, P235, DOI 10.1016/S0968-0004(00)89024-6; Schreiter ER, 2003, NAT STRUCT BIOL, V10, P794, DOI 10.1038/nsb985; SCHUDSON M, 1995, FORBES MEDIA CRITIC, V2, P76; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; Wessel PM, 2000, BIOCHEMISTRY-US, V39, P15136, DOI 10.1021/bi001625c	23	151	153	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33825	33829		10.1074/jbc.R600024200	http://dx.doi.org/10.1074/jbc.R600024200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16987805	hybrid			2022-12-27	WOS:000241767600002
J	Parameswaran, N; Pao, CS; Leonhard, KS; Kang, DS; Kratz, M; Ley, SC; Benovic, JL				Parameswaran, Narayanan; Pao, Christina S.; Leonhard, Kristi S.; Kang, Dong Soo; Kratz, Michelle; Ley, Steven C.; Benovic, Jeffrey L.			Arrestin-2 and G protein-coupled receptor kinase 5 interact with NF kappa B1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COUPLED RECEPTOR KINASE; TOLL-LIKE RECEPTORS; BETA-ARRESTIN; INNATE IMMUNITY; PROTEIN-KINASE; PATHOGEN RECOGNITION; SIGNALING PATHWAYS; CLATHRIN ADAPTER; PHOSPHORYLATION	Toll-like receptors (TLRs) are a recently described receptor class involved in the regulation of innate and adaptive immunity. Here, we demonstrate that arrestin-2 and GRK5 (G protein-coupled receptor kinase 5), proteins that regulate G protein-coupled receptor signaling, play a negative role in TLR4 signaling in Raw264.7 macrophages. We find that lipopolysaccharide (LPS)-induced ERK1/2 phosphorylation is significantly enhanced in arrestin-2 and GRK5 knockdown cells. To elucidate the mechanisms involved, we tested the effect of arrestin-2 and GRK5 knockdown on LPS-stimulated signaling components that are upstream of ERK phosphorylation. Upon LPS stimulation, I kappa B kinase promotes phosphorylation and degradation of NF kappa B1 p105 (p105), which releases TPL2 (a MAP3K), which phosphorylates MEK1/2, which in turn phosphorylates ERK1/2. We demonstrate that knockdown of arrestin-2 leads to enhanced LPS-induced phosphorylation and degradation of p105, enhanced TPL2 release, and enhanced MEK1/2 phosphorylation. GRK5 knockdown also results in enhanced I kappa B kinase-mediated p105 phosphorylation and degradation, whereas GRK2 and GRK6 knockdown have no effect on this pathway. In vitro analysis demonstrates that arrestin-2 directly binds to the COOH-terminal domain of p105, whereas GRK5 binds to and phosphorylates p105. Taken together, these results suggest that p105 phosphorylation by GRK5 and binding of arrestin-2 negatively regulates LPS-stimulated ERK activation. These results reveal that arrestin-2 and GRK5 are important negative regulatory components in TLR4 signaling.	Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	Jefferson University; MRC National Institute for Medical Research	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu	Parameswaran, Narayanan/V-1969-2019	Parameswaran, Narayanan/0000-0002-8894-5564	NIDDK NIH HHS [T32-DK07705] Funding Source: Medline; NIGMS NIH HHS [GM44944, GM47417] Funding Source: Medline; Medical Research Council [U117532003] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944, R01GM047417, R37GM047417] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; AOKI M, 1991, ONCOGENE, V6, P1515; Babu GR, 2006, BBA-MOL CELL RES, V1763, P174, DOI 10.1016/j.bbamcr.2005.12.010; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1998, J BIOL CHEM, V273, P20308, DOI 10.1074/jbc.273.32.20308; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Day PW, 2004, METHOD ENZYMOL, V390, P295; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Freeman JLR, 2002, BIOCHEMISTRY-US, V41, P12850, DOI 10.1021/bi020145d; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hehner SP, 2000, MOL CELL BIOL, V20, P2556, DOI 10.1128/MCB.20.7.2556-2568.2000; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kim YM, 2002, J BIOL CHEM, V277, P30760, DOI 10.1074/jbc.M204528200; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Moorthy AK, 2003, J BIOL CHEM, V278, P556, DOI 10.1074/jbc.M207515200; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Pao CS, 2005, J BIOL CHEM, V280, P11052, DOI 10.1074/jbc.M412996200; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Piu F, 2006, ONCOGENE, V25, P218, DOI 10.1038/sj.onc.1209024; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sanz-Rosa D, 2005, J HYPERTENS, V23, P1167, DOI 10.1097/01.hjh.0000170379.08214.5a; Shi L, 2002, AM J PHYSIOL-CELL PH, V282, pC1205, DOI 10.1152/ajpcell.00511.2001; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Suzuki N, 2002, TRENDS IMMUNOL, V23, P503, DOI 10.1016/S1471-4906(02)02298-6; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005	55	79	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34159	34170		10.1074/jbc.M605376200	http://dx.doi.org/10.1074/jbc.M605376200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16980301	hybrid			2022-12-27	WOS:000241767600036
J	Szeszel-Fedorowicz, W; Talukdar, I; Griffith, BN; Walsh, CM; Salati, LM				Szeszel-Fedorowicz, Wioletta; Talukdar, Indrani; Griffith, Brian N.; Walsh, Callee M.; Salati, Lisa M.			An exonic splicing silencer is involved in the regulated splicing of glucose 6-phosphate dehydrogenase mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR POSTTRANSCRIPTIONAL MECHANISM; IMMUNODEFICIENCY-VIRUS TYPE-1; POLYUNSATURATED FATTY-ACIDS; HNRNP A/B PROTEINS; SR PROTEINS; RIBONUCLEOPROTEIN-PARTICLES; NUTRITIONAL REGULATION; SPLICEOSOMAL COMPLEX; RAT-LIVER; IDENTIFICATION	The inhibition of glucose-6-phosphate dehydrogenase (G6PD) expression by arachidonic acid occurs by changes in the rate of pre-mRNA splicing. Here, we have identified a cis-acting RNA element required for regulated splicing of G6PD mRNA. Using transfection of G6PD RNA reporter constructs into rat hepatocytes, the cis-acting RNA element involved in this regulation was localized to nucleotides 43 - 72 of exon 12 in the G6PD mRNA. In in vitro splicing assays, RNA substrates containing exon 12 were not spliced. In contrast, RNA substrates containing other regions ( exons 8 and 9 or exons 10 and 11) of the G6PD mRNA were efficiently spliced. Furthermore, exon 12 can inhibit splicing when substituted for other exons in RNA substrates that are readily spliced. This activity of the exon 12 regulatory element suggests that it is an exonic splicing silencer. Consistent with its activity as a splicing silencer, spliceosome assembly was inhibited on RNA substrates containing exon 12 compared with RNAs representing other regions of the G6PD transcript. Elimination of nucleotides 43 - 72 of exon 12 did not restore splicing of exon 12-containing RNA; thus, the 30-nucleotide element may not be exclusively a silencer. The binding of heterogeneous nuclear ribonucleoproteins K, L, and A2/B1 from both HeLa and hepatocyte nuclear extracts to the element further supports its activity as a silencer. In addition, SR proteins bind to the element, consistent with the presence of enhancer activity within this sequence. Thus, an exonic splicing silencer is involved in the inhibition of splicing of a constitutively spliced exon in the G6PD mRNA.	W Virginia Univ, Hlth Sci Ctr, Dept Biochem & Mol Pharmacol, Morgantown, WV 26506 USA	West Virginia University	Salati, LM (corresponding author), W Virginia Univ, Hlth Sci Ctr, Dept Biochem & Mol Pharmacol, POB 9142, Morgantown, WV 26506 USA.	Lsalati@hsc.wvu.edu		Walsh, Callee/0000-0002-3368-9209	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046897, R56DK046897, R01DK046897] Funding Source: NIH RePORTER; NCRR NIH HHS [P20RR016440] Funding Source: Medline; NIDDK NIH HHS [DK46897, R01 DK046897] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amir-Ahmady B, 2001, J BIOL CHEM, V276, P10514, DOI 10.1074/jbc.M010535200; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; BURMEISTER LA, 1991, J BIOL CHEM, V266, P22905; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Caputi M, 2002, EMBO J, V21, P845, DOI 10.1093/emboj/21.4.845; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Cochran W.G., 1967, STAT METHODS; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; EDWALDSGILBERT G, 1995, MOL CELL BIOL, V15, P6420; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725; Furuyama S, 2002, MOL CELL BIOL, V22, P5337, DOI 10.1128/MCB.22.15.5337-5346.2002; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Grabowski PJ, 2004, BIOCHEM SOC T, V32, P924, DOI 10.1042/BST0320924; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Hodge DL, 1997, ARCH BIOCHEM BIOPHYS, V348, P303, DOI 10.1006/abbi.1997.0373; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kamma H, 2001, IMMUNOL LETT, V76, P49, DOI 10.1016/S0165-2478(00)00318-7; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; LANGLAND JO, 1995, PROTEIN EXPRES PURIF, V6, P25, DOI 10.1006/prep.1995.1004; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lopato S, 1996, P NATL ACAD SCI USA, V93, P3074, DOI 10.1073/pnas.93.7.3074; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; MOONEY RA, 1981, J BIOL CHEM, V256, P1724; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Query CC, 1997, MOL CELL BIOL, V17, P2944, DOI 10.1128/MCB.17.5.2944; Reed R, 1999, METHODS, V18, P3, DOI 10.1006/meth.1999.0751; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Schaal TD, 1999, MOL CELL BIOL, V19, P261; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; SHIH HM, 1995, BIOTECHNIQUES, V18, P813; Siculella L, 2004, J LIPID RES, V45, P1333, DOI 10.1194/jlr.M400061-JLR200; Stabile LP, 1998, J LIPID RES, V39, P1951; Stabile LP, 1996, ARCH BIOCHEM BIOPHYS, V332, P269, DOI 10.1006/abbi.1996.0342; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; STAKNIS D, 1994, MOL CELL BIOL, V14, P2994, DOI 10.1128/MCB.14.5.2994; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Talukdar I, 2005, J BIOL CHEM, V280, P40660, DOI 10.1074/jbc.M505531200; Tao HM, 2002, J BIOL CHEM, V277, P31270, DOI 10.1074/jbc.M203196200; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Walker JD, 1996, ENDOCRINOLOGY, V137, P2293, DOI 10.1210/en.137.6.2293; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	57	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34146	34158		10.1074/jbc.M603825200	http://dx.doi.org/10.1074/jbc.M603825200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16980303	Green Published, hybrid			2022-12-27	WOS:000241767600035
J	Terenzi, F; Hui, DJ; Merrick, WC; Sen, GC				Terenzi, Fulvia; Hui, Daniel J.; Merrick, William C.; Sen, Ganes C.			Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PROTEIN P56; RIG-I; ACTIVATION; INITIATION; EXPRESSION; RECEPTOR; TRANSCRIPTION; RECOGNITION	Human P54 and P56 proteins are tetratricopeptide proteins that are encoded by two closely related genes, ISG54 and ISG56. These genes are induced strongly but transiently when cells are treated with interferons or double-stranded RNA or infected with a variety of viruses. We observed that, although double-stranded RNA or Sendai virus infection induced the two genes with similar kinetics, their induction kinetics in response to interferon-beta were quite different. The induction kinetics by virus infection were also different between two cell lines. Functionally the two proteins were similar. Like P56, P54 bound to the translation initiation factor eIF3 and inhibited translation. However, unlike P56, P54 bound to both the "e" and the "c" subunits of eIF3. Consequently, P54 inhibited two functions of eIF3. Like P56, it inhibited the ability of eIF3 to stabilize the eIF2 center dot GTP center dot Met-tRNA(i) ternary complex. But in addition, it also inhibited the formation of the 48 S pre-initiation complex between the 40 S ribosomal subunit and the 20 S complex composed of eIF3, ternary complex, eIF4F, and mRNA. Thus, although similar in structure, the human P54 and P56 proteins are induced differently and function differently.	Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Sen, GC (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	seng@ccf.org	Hui, Daniel J/H-8855-2013	Hui, Daniel J/0000-0003-0294-3582	NCI NIH HHS [CA62220, CA68782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068782, P01CA062220] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; BANDYOPADHYAY SK, 1995, J BIOL CHEM, V270, P19624, DOI 10.1074/jbc.270.33.19624; BENNE R, 1976, P NATL ACAD SCI USA, V73, P3005, DOI 10.1073/pnas.73.9.3005; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; COHEN B, 1988, EMBO J, V7, P1411, DOI 10.1002/j.1460-2075.1988.tb02958.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; de Veer MJ, 1998, GENOMICS, V54, P267, DOI 10.1006/geno.1998.5555; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Geiss G, 2001, J BIOL CHEM, V276, P30178, DOI 10.1074/jbc.C100137200; Geiss GK, 2003, J VIROL, V77, P6367, DOI 10.1128/JVI.77.11.6367-6375.2003; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; Guo JJ, 2000, VIROLOGY, V267, P209, DOI 10.1006/viro.1999.0135; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Leonard GT, 1996, VIROLOGY, V224, P25, DOI 10.1006/viro.1996.0503; Leonard GT, 1997, J VIROL, V71, P5095, DOI 10.1128/JVI.71.7.5095-5101.1997; LEVY D, 1986, P NATL ACAD SCI USA, V83, P8929, DOI 10.1073/pnas.83.23.8929; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Malewicz M, 2003, J BIOL CHEM, V278, P32825, DOI 10.1074/jbc.M304000200; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; MERRICK WC, 1973, P NATL ACAD SCI USA, V70, P2220, DOI 10.1073/pnas.70.8.2220; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; PETERSON DT, 1979, J BIOL CHEM, V254, P2509; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; WATHELET M, 1986, EUR J BIOCHEM, V155, P11, DOI 10.1111/j.1432-1033.1986.tb09452.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	52	124	132	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34064	34071		10.1074/jbc.M605771200	http://dx.doi.org/10.1074/jbc.M605771200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973618	hybrid			2022-12-27	WOS:000241767600027
J	Catlett, MG; Kaplan, KB				Catlett, Michael G.; Kaplan, Kenneth B.			Sgt1p is a unique co-chaperone that acts as a client adaptor to link Hsp90 to Skp1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEINS; DISEASE RESISTANCE PROTEIN; UBIQUITIN-LIGASE COMPLEX; TETRATRICOPEPTIDE REPEAT; MOLECULAR CHAPERONE; SACCHAROMYCES-CEREVISIAE; ATPASE ACTIVITY; KINETOCHORE COMPLEX; ESSENTIAL COMPONENT; YEAST KINETOCHORE	Sgt1p is a conserved, essential protein required for kinetochore assembly in both yeast and animal cells. Sgt1p has homology to both TPR and p23 domains, sequences often found in proteins that interact with and regulate the molecular chaperone, Hsp90. The presence of these domains and the recent findings that Sgt1p interacts with Hsp90 has led to the speculation that Sgt1p and Hsp90 form a co-chaperone complex. To test this possibility, we have used purified recombinant proteins to characterize the in vitro interactions between yeast Sgt1p and Hsp82p (an Hsp90 homologue in yeast). We show that Sgt1p interacts directly with Hsp82p via its p23 homology region in a nucleotide-dependent manner. However, Sgt1p binding does not alter the enzymatic activity of Hsp82p, suggesting that it is distinct from other co-chaperones. We find that Sgt1p can form a ternary chaperone complex with Hsp82p and Sti1p, a well characterized Hsp90 co-chaperone. Sgt1p interacts with its binding partner Skp1p through its TPR domains and links Skp1p to the core Hsp82p-Sti1p co-chaperone complex. The multidomain nature of Sgt1p and its ability to bridge the interaction between Skp1p and Hsp82p argue that Sgt1p acts as a "client adaptor" recruiting specific clients to Hsp82p co-chaperone complexes.	Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Kaplan, KB (corresponding author), Univ Calif Davis, Sect Mol & Cellular Biol, 1 Shields Ave,Briggs 149, Davis, CA 95616 USA.	kbkaplan@ucdavis.edu			NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD000262] Funding Source: NIH RePORTER; NIMHD NIH HHS [P20MD000262] Funding Source: Medline	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Fang YF, 1998, MOL CELL BIOL, V18, P3727, DOI 10.1128/MCB.18.7.3727; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; GERBER MR, 1995, P NATL ACAD SCI USA, V92, P4651, DOI 10.1073/pnas.92.10.4651; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lee P, 2004, MOL BIOL CELL, V15, P1785, DOI 10.1091/mbc.E03-07-0480; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Muskett P, 2003, MICROBES INFECT, V5, P969, DOI 10.1016/S1286-4579(03)00183-7; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; Oxelmark E, 2003, J BIOL CHEM, V278, P36547, DOI 10.1074/jbc.M305960200; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Rodrigo-Brenni MC, 2004, MOL BIOL CELL, V15, P3366, DOI 10.1091/mbc.E03-12-0887; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schadick K, 2002, EUKARYOT CELL, V1, P558, DOI 10.1128/EC.1.4.558-567.2002; Scholz G, 2000, MOL CELL BIOL, V20, P6984, DOI 10.1128/MCB.20.18.6984-6995.2000; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Verma R, 1997, MOL BIOL CELL, V8, P1427, DOI 10.1091/mbc.8.8.1427; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	64	98	100	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33739	33748		10.1074/jbc.M603847200	http://dx.doi.org/10.1074/jbc.M603847200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16945921	hybrid			2022-12-27	WOS:000241621400081
J	Gardner, LA; Tavalin, SJ; Goehring, AS; Scott, JD; Bahouth, SW				Gardner, Lidia A.; Tavalin, Steven J.; Goehring, April S.; Scott, John D.; Bahouth, Suleiman W.			AKAP79-mediated targeting of the cyclic AMP-dependent protein kinase to the beta(1)-arenergic receptor promotes recycling and functional resensitization of the receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA(1)-ADRENERGIC RECEPTOR; TRANSFER FRET MICROSCOPY; BETA(2)-ADRENERGIC RECEPTOR; COUPLED RECEPTORS; ANCHORING PROTEINS; GLUTAMATE RECEPTORS; SCAFFOLD PROTEIN; BETA-ARRESTIN; CAMP; PHOSPHORYLATION	Resensitization of G protein-coupled receptors (GPCR) following prolonged agonist exposure is critical for restoring the responsiveness of the receptor to subsequent challenges by agonist. The 3'-5' cyclic AMP- dependent protein kinase (PKA) and serine 312 in the third intracellular loop of the human beta(1)- adrenergic receptor (beta(1)-AR) were both necessary for efficient recycling and resensitization of the agonist- internalized beta(1)-AR (Gardner, L. A., Delos Santos, N. M., Matta, S. G., Whitt, M. A., and Bahouth, S. W. (2004) J. Biol. Chem. 279, 21135 - 21143). Because PKA is compartmentalized near target substrates by interacting with protein kinase A anchoring proteins (AKAPs), the present study was undertaken to identify the AKAP involved in PKA- mediated phosphorylation of the beta(1)-AR and in its recycling and resensitization. Here, we report that Ht-31 peptide- mediated disruption of PKA/ AKAP interactions prevented the recycling and functional resensitization of heterologously expressed beta(1)-AR in HEK- 293 cells and endogenously expressed beta(1)-AR in SK-N-MC cells and neonatal rat cortical neurons. Whereas several endogenous AKAPs were identified in HEK-293 cells, small interfering RNA- mediated down- regulation of AKAP79 prevented the recycling of the beta(1)-AR in this cell line. Co-immunoprecipitations and fluorescence resonance energy transfer (FRET) microscopy experiments in HEK-293 cells revealed that the beta(1)-AR, AKAP79, and PKA form a ternary complex at the carboxyl terminus of the beta(1)-AR. This complex was involved in PKA- mediated phosphorylation of the third intracellular loop of the beta(1)- AR because disruption of PKA/ AKAP interactions or small interfering RNA- mediated down- regulation of AKAP79 both inhibited this response. Thus, AKAP79 provides PKA to phosphorylate the beta(1)-AR and thereby dictate the recycling and resensitization itineraries of the beta(1)- AR.	Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, Portland, OR 97239 USA	University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute; Oregon Health & Science University	Bahouth, SW (corresponding author), 874 Union Ave, Memphis, TN 38163 USA.	sbahouth@utmem.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046661] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-71419] Funding Source: Medline; NIGMS NIH HHS [GM-18231] Funding Source: Medline; NINDS NIH HHS [NS-46661] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bahouth SW, 1996, MOL PHARMACOL, V49, P1049; BAHOUTH SW, 1995, BIOCHEM J, V307, P831, DOI 10.1042/bj3070831; Bahouth SW, 2001, BIOCHEM PHARMACOL, V62, P1211, DOI 10.1016/S0006-2952(01)00789-4; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1991, J BIOL CHEM, V266, P14188; CHRIVIA JC, 1988, J BIOL CHEM, V263, P5739; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fan GF, 2001, J BIOL CHEM, V276, P24005, DOI 10.1074/jbc.M011199200; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Garland AM, 1996, MOL PHARMACOL, V49, P438; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Katsura T, 1997, Am J Physiol, V272, pF817; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Krueger KM, 1997, J BIOL CHEM, V272, P5; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; LUO KX, 1991, METHOD ENZYMOL, V201, P149; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Malbon CC, 2004, BIOCHEM SOC T, V32, P861, DOI 10.1042/BST0320861; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; SCOTT JD, 1986, P NATL ACAD SCI USA, V83, P1613, DOI 10.1073/pnas.83.6.1613; SEIBERT FS, 1995, J BIOL CHEM, V270, P2158, DOI 10.1074/jbc.270.5.2158; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Suvarna NU, 2002, J PHARMACOL EXP THER, V302, P249, DOI 10.1124/jpet.302.1.249; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; WU JZ, 1994, BIOCHEMISTRY-US, V33, P14825, DOI 10.1021/bi00253a022; Xiao RP, 2004, TRENDS PHARMACOL SCI, V25, P358, DOI 10.1016/j.tips.2004.05.007; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; YU SS, 1993, J BIOL CHEM, V268, P337; YUTING T, 1999, P NATL ACAD SCI USA, V96, P12559	62	68	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33537	33553		10.1074/jbc.M601809200	http://dx.doi.org/10.1074/jbc.M601809200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16940053	Green Submitted, hybrid			2022-12-27	WOS:000241621400064
J	Roy, AA; Nunn, C; Ming, H; Zou, MX; Penninger, J; Kirshenbaum, LA; Dixon, SJ; Chidiac, P				Roy, Anju Anne; Nunn, Caroline; Ming, Hong; Zou, Min-Xu; Penninger, Josef; Kirshenbaum, Lorrie A.; Dixon, S. Jeffrey; Chidiac, Peter			Up-regulation of endogenous RGS2 mediates cross-desensitization between G(s) and G(q) signaling in osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; PARATHYROID-HORMONE; ADENYLYL-CYCLASE; ENDOTHELIN RECEPTORS; PHOSPHOLIPASE-C; OSTEOSARCOMA CELLS; DYNAMIC REGULATION; CYCLIC-AMP; BONE; PATHWAYS	Regulator of G protein signaling (RGS) proteins limit G protein signals. In this study, we investigated the role of RGS2 in the control of G protein signaling cascades in osteoblasts, the cells responsible for bone formation. Expression of RGS2 was up-regulated in primary cultures of mouse calvarial osteoblasts by parathyroid hormone-related peptide (PTHrP)-(1-34), which stimulates Gs signaling. RGS2 was also up-regulated by extracellular ATP, which selectively activates G(q), as well as by forskolin and phorbol myristate acetate, which activate targets downstream of G(s) and G(q), respectively. To assess the role of endogenous RGS2, we characterized Gs and Gq signaling in osteoblasts derived from wild type and rgs2(-/-) mice. Under control conditions, nucleotide-stimulated calcium release, endothelin-stimulated accumulation of inositol phosphates, and PTHrP-stimulated cAMP accumulation were equivalent in osteoblasts isolated from wild type and rgs2(-/-) mice. Thus, basal levels of endogenous RGS2 do not appear to regulate G(s) or G(q) signaling in osteoblasts. Interestingly, forskolin treatment of wild type but not rgs2(-/-) osteoblasts suppressed both endothelin-stimulated accumulation of inositol phosphates and nucleotide-stimulated calcium release, indicating that up-regulation of RGS2 by G(s) signaling desensitizes G(q) signals. Furthermore, pretreatment with ATP suppressed PTHrP-dependent cAMP accumulation in wild type but not rgs2(-/-) osteoblasts, implying that up-regulation of RGS2 by G(q) signaling desensitizes G(s) signals. Our findings demonstrate that endogenously expressed RGS2 can limit G(s) signaling. Moreover, up-regulation of RGS2 contributes to cross-desensitization of G(s)- and G(q)-coupled signals.	Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; Univ Western Ontario, Canadian Inst Hlth Res Grp Skeletal Dev & Remodel, London, ON N6A 5C1, Canada; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Manitoba, Fac Med, Inst Cardiovasc Sci, Dept Physiol, Winnipeg, MB R2H 2A6, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Manitoba	Chidiac, P (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	Peter.Chidiac@schulich.uwo.ca	Dixon, S. Jeffrey/G-3657-2013; Chidiac, Peter/L-5906-2015; Penninger, Josef M/I-6860-2013	Dixon, S. Jeffrey/0000-0001-9162-1686; Chidiac, Peter/0000-0001-8365-6109; Penninger, Josef M/0000-0002-8194-3777; Ryplanski, Kairee/0000-0002-3737-7181				Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Bellows CG, 2001, J BONE MINER RES, V16, P1983, DOI 10.1359/jbmr.2001.16.11.1983; Bowler Wayne B., 1998, Frontiers in Bioscience, V3, pD769; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Chidiac P, 2003, RECEPTOR CHANNEL, V9, P135, DOI 10.3109/10606820308244; Chidiac P, 2002, METHOD ENZYMOL, V344, P686; Cho H, 2003, BIOCHEM J, V371, P973, DOI 10.1042/BJ20021769; Cladman W, 2002, MOL PHARMACOL, V62, P654, DOI 10.1124/mol.62.3.654; Dixon SJ, 2000, DRUG DEVELOP RES, V49, P187, DOI 10.1002/(SICI)1098-2299(200003)49:3<187::AID-DDR9>3.0.CO;2-F; Duncan RL, 1998, SEMIN NEPHROL, V18, P178; Erclik MS, 2002, AM J PHYSIOL-ENDOC M, V282, pE534, DOI 10.1152/ajpendo.00417.2001; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Homme M, 2003, ENDOCRINOLOGY, V144, P2496, DOI 10.1210/en.2002-0160; Ingi T, 1998, J NEUROSCI, V18, P7178; Johnson EN, 2002, J BIOL CHEM, V277, P16768, DOI 10.1074/jbc.M200751200; KAPLAN AD, 1995, ENDOCRINOLOGY, V136, P1674, DOI 10.1210/en.136.4.1674; Ko JK, 2001, BIOCHEM BIOPH RES CO, V287, P1025, DOI 10.1006/bbrc.2001.5692; Langlois C, 2005, PEPTIDES, V26, P1436, DOI 10.1016/j.peptides.2005.03.017; Larminie C, 2004, MOL BRAIN RES, V122, P24, DOI 10.1016/j.molbrainres.2003.11.014; Lax AJ, 2004, INT J MED MICROBIOL, V293, P505, DOI 10.1078/1438-4221-00287; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Miles RR, 2000, ENDOCRINOLOGY, V141, P28, DOI 10.1210/en.141.1.28; Mundell SJ, 2004, MOL PHARMACOL, V65, P1507, DOI 10.1124/mol.65.6.1507; NAMBI P, 1995, MOL PHARMACOL, V47, P266; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy AA, 2006, CELL SIGNAL, V18, P336, DOI 10.1016/j.cellsig.2005.05.004; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Sakamoto A, 2005, J BIOL CHEM, V280, P21369, DOI 10.1074/jbc.M500346200; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; SALOMON Y, 1991, METHOD ENZYMOL, V195, P22; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; SEMLER DE, 1995, J PHARMACOL EXP THER, V272, P1052; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; STERN PH, 1995, J NUTR, V125, pS2028, DOI 10.1093/jn/125.suppl_7.2028S; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Thirunavukkarasu K, 2002, J CELL BIOCHEM, V85, P837, DOI 10.1002/jcb.10176; Tseng CC, 1998, ENDOCRINOLOGY, V139, P4470, DOI 10.1210/en.139.11.4470; Tsingotjidou A, 2002, BONE, V30, P677, DOI 10.1016/S8756-3282(02)00698-1; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Wang XH, 2004, J BIOL CHEM, V279, P133, DOI 10.1074/jbc.M310040200; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Wu YH, 2000, J BONE MINER RES, V15, P879, DOI 10.1359/jbmr.2000.15.5.879; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Zou MX, 2006, CELL SIGNAL, V18, P1655, DOI 10.1016/j.cellsig.2006.01.012	54	133	135	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32684	32693		10.1074/jbc.M604416200	http://dx.doi.org/10.1074/jbc.M604416200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950788	hybrid			2022-12-27	WOS:000241414500067
J	Topark-Ngarm, A; Golonzhka, O; Peterson, VJ; Barrett, B; Martinez, B; Crofoot, K; Filtz, TM; Leid, M				Topark-Ngarm, Acharawan; Golonzhka, Olga; Peterson, Valerie J.; Barrett, Brian, Jr.; Martinez, Brigetta; Crofoot, Kristi; Filtz, Theresa M.; Leid, Mark			CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLATION; CELL FATE; BCL11B; EXPRESSION; P57(KIP2); FAMILY; SIR2; DIFFERENTIATION	Chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2 (CTIP2), also known as Bcl11b, is a transcriptional repressor that functions by direct, sequence-specific DNA binding activity or by recruitment to the promoter template by interaction with COUP-TF family members. CTIP2 is essential for both T cell development and axonal projections of corticospinal motor neurons in the central nervous system. However, little is known regarding the molecular mechanism(s) by which CTIP2 contributes to either process. CTIP2 complexes that were isolated from SK-N-MC neuroblastoma cells were found to harbor substantial histone deacetylase activity, which was likely conferred by the nucleosome remodeling and deacetylation ( NuRD) complex. CTIP2 was found to associate with the NuRD complex through direct interaction with both RbAp46 and RbAp48, and components of the NuRD complex were found to be recruited to an artificial promoter template in a CTIP2-dependent manner in transfected cells. Finally, the NuRD complex and CTIP2 were found to co-occupy the promoter template of p57KIP2, a gene encoding a cyclin-dependent kinase inhibitor, and identified herein as a novel transcriptional target of CTIP2 in SK-N-MC cells. Therefore, it seems likely that the NuRD complex may be involved in transcriptional repression of CTIP2 target genes and contribute to the function(s) of CTIP2 within a neuronal context.	Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Leid, M (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	Mark.Leid@oregonstate.edu		Filtz, Theresa/0000-0002-5348-1114	NIEHS NIH HHS [T35 ES 07316, ES 00210, P30 ES000210] Funding Source: Medline; NIGMS NIH HHS [GM 60852, R01 GM060852, R01 GM060852-04] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T35ES007316, P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060852] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Bezrookove V, 2004, CANCER GENET CYTOGEN, V149, P72, DOI 10.1016/S0165-4608(03)00302-9; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Christian M, 2004, J BIOL CHEM, V279, P15645, DOI 10.1074/jbc.M313906200; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Cunningham JJ, 2001, CELL GROWTH DIFFER, V12, P387; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dowell P, 1997, J BIOL CHEM, V272, P2013, DOI 10.1074/jbc.272.3.2013; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hohl M, 2005, EUR J NEUROSCI, V22, P2216, DOI 10.1111/j.1460-9568.2005.04404.x; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; Kantor B, 2003, GENE EXPR PATTERNS, V3, P697, DOI 10.1016/j.modgep.2003.07.003; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; MacLeod RAF, 2003, GENE CHROMOSOME CANC, V37, P84, DOI 10.1002/gcc.10194; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Murawsky CM, 2001, EMBO REP, V2, P1089, DOI 10.1093/embo-reports/kve252; Nagel S, 2003, CANCER RES, V63, P5329; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Sakata J, 2004, CARCINOGENESIS, V25, P1069, DOI 10.1093/carcin/bgh094; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Solari F, 1999, DEVELOPMENT, V126, P2483; Su XY, 2004, GENE CHROMOSOME CANC, V41, P243, DOI 10.1002/gcc.20088; von Zelewsky T, 2000, DEVELOPMENT, V127, P5277; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Wang Y, 2004, COLD SPRING HARB SYM, V69, P161, DOI 10.1101/sqb.2004.69.161; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	45	81	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32272	32283		10.1074/jbc.M602776200	http://dx.doi.org/10.1074/jbc.M602776200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950772	Green Accepted, hybrid			2022-12-27	WOS:000241414500024
J	Chung, MC; Popova, TG; Millis, BA; Mukherjee, DV; Zhou, WD; Liotta, LA; Petricoin, EF; Chandhoke, V; Bailey, C; Popov, SG				Chung, Myung-Chul; Popova, Taissia G.; Millis, Bryan A.; Mukherjee, Dhritiman V.; Zhou, Weidong; Liotta, Lance A.; Petricoin, Emanuel F.; Chandhoke, Vikas; Bailey, Charles; Popov, Serguei G.			Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; HEPARAN-SULFATE PROTEOGLYCANS; PSEUDOMONAS-AERUGINOSA; INHALATIONAL ANTHRAX; LETHAL FACTOR; CYTOKINE RESPONSE; SYNDECAN-1; PLASMINOGEN; TOXIN; VIRULENCE	To evaluate the pathogenic potential of Bacillus anthracissecreted proteases distinct from lethal toxin, two neutral zinc metalloproteases were purified to apparent homogeneity from the culture supernatant of a non-virulent delta Ames strain (pXO1(-), pXO2(-)). The first (designated Npr599) is a thermolysin-like enzyme highly homologous to bacillolysins from other Bacillus species. The second (designated InhA) is a homolog of the Bacillus thuringiensis immune inhibitor A. These proteases belong to the M4 and M6 families, respectively. Both enzymes digested various substrates, including extracellular matrix proteins, endogenous inhibitors, and coagulation proteins, with some differences in specificity. In addition, InhA accelerated urokinase-mediated plasminogen activation, suggesting that InhA acts as a modulator of plasmin in the host inflammatory system. Relevant to epithelial barrier function, Npr599 and InhA significantly enhanced syndecan-1 shedding from cultured normal murine mammary gland cells without affecting their viability through stimulation of the host cell ectodomain shedding mechanism. In addition, Npr599 and InhA directly cleaved recombinant syndecan-1 fused to glutathione S-transferase. Mass spectrometric analysis suggested that the cleavage sites of Npr599 and InhA are the Asp(39)-Asp(40) and Gly(48)-Thr(49) bonds, respectively. We propose that Npr599 and InhA from B. anthracis are multifunctional pathogenic factors that may contribute to anthrax pathology through direct degradation of host tissues, increases in barrier permeability, and/or modulation of host defenses.	George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; George Mason Univ, Ctr Appl Proteom & Mol Med, Manassas, VA 20110 USA; George Mason Univ, Coll Arts & Sci, Manassas, VA 20110 USA	George Mason University; George Mason University; George Mason University	Popov, SG (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, MSN 1H8,10900 Univ Blvd, Manassas, VA 20110 USA.	spopov@gmu.edu		Millis, Bryan/0000-0002-5770-627X				ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Andrian E, 2006, ORAL MICROBIOL IMMUN, V21, P123, DOI 10.1111/j.1399-302X.2006.00248.x; Antelmann H, 2005, PROTEOMICS, V5, P3684, DOI 10.1002/pmic.200401218; Aronson AI, 2005, J BACTERIOL, V187, P3133, DOI 10.1128/JB.187.9.3133-3138.2005; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Barrett AJ, 2004, CURR OPIN DRUG DISC, V7, P334; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BONVENTRE PF, 1963, J BACTERIOL, V85, P490, DOI 10.1128/JB.85.2.490-491.1963; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Charlton S, 1999, J APPL MICROBIOL, V87, P241, DOI 10.1046/j.1365-2672.1999.00878.x; Chitlaru T, 2006, J BACTERIOL, V188, P3551, DOI 10.1128/JB.188.10.3551-3571.2006; COOK L, 1988, BIOCHEM INT, V17, P637; Dinwiddie R, 2000, RESPIRATION, V67, P3, DOI 10.1159/000029453; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; LAHTEENMAKI K, 1995, INFECT IMMUN, V63, P3659; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lamonica JM, 2005, INFECT IMMUN, V73, P3646, DOI 10.1128/IAI.73.6.3646-3658.2005; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Loy JA, 2001, BIOCHEMISTRY-US, V40, P14686, DOI 10.1021/bi011309d; Marshall LJ, 2003, J IMMUNOL, V171, P2057, DOI 10.4049/jimmunol.171.4.2057; McCain DF, 2004, J BIOL CHEM, V279, P14713, DOI 10.1074/jbc.M312488200; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Narasaki R, 2005, J BIOL CHEM, V280, P14278, DOI 10.1074/jbc.M500241200; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Pickering AK, 2004, INFECT IMMUN, V72, P6382, DOI 10.1128/IAI.72.11.6382-6389.2004; Popov SG, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-25; Popov SG, 2004, CELL MICROBIOL, V6, P225, DOI 10.1046/j.1462-5822.2003.00358.x; Popova TG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-8; Ralevic V, 1998, PHARMACOL REV, V50, P413; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Schmidt A, 2005, J BIOL CHEM, V280, P34441, DOI 10.1074/jbc.M501903200; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Supuran CT, 2003, MED RES REV, V23, P535, DOI 10.1002/med.10047; TRAVIS J, 1995, TRENDS MICROBIOL, V3, P405, DOI 10.1016/S0966-842X(00)88988-X; Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; WETMORE DR, 1992, MOL MICROBIOL, V6, P1593, DOI 10.1111/j.1365-2958.1992.tb00884.x; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127; Zhang YL, 1998, J BIOL CHEM, V273, P12281, DOI 10.1074/jbc.273.20.12281	57	86	90	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31408	31418		10.1074/jbc.M605526200	http://dx.doi.org/10.1074/jbc.M605526200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16926147	Bronze			2022-12-27	WOS:000241235300025
J	Zeold, A; Pormuller, L; Dentice, M; Harney, JW; Curcio-Morelli, C; Tente, SM; Bianco, AC; Gereben, B				Zeold, Aniko; Pormuller, Livia; Dentice, Monica; Harney, John W.; Curcio-Morelli, Cyntia; Tente, Susana M.; Bianco, Antonio C.; Gereben, Balazs			Metabolic instability of type 2 deiodinase is transferable to stable proteins independently of subcellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; THYROID-HORMONE ACTIVATION; ENDOPLASMIC-RETICULUM; UBIQUITIN LIGASE; IODOTHYRONINE SELENODEIODINASES; MEMBRANE-PROTEINS; ANCHORED PROTEIN; GOLGI-APPARATUS; O-GLYCOSYLATION; RETENTION	Thyroid hormone activation is catalyzed by two deiodinases, D1 and D2. Whereas D1 is a stable plasma membrane protein, D2 is resident in the endoplasmic reticulum (ER) and has a 20-min half-life due to selective ubiquitination and proteasomal degradation. Here we have shown that stable retention explains D2 residency in the ER, a mechanism that is nevertheless overridden by fusion to the long-lived plasma membrane protein, sodium-iodine symporter. Fusion to D2, but not D1, dramatically shortened sodium-iodine symporter half-life through a mechanism dependent on an 18-amino acid D2-specific instability loop. Similarly, the D2-specific loop-mediated protein destabilization was also observed after D2, but not D1, was fused to the stable ER resident protein SEC62. This indicates that the instability loop in D2, but not its subcellular localization, is the key determinant of D2 susceptibility to ubiquitination and rapid turnover rate. Our data also show that the 6 N-terminal amino acids, but not the 12 C-terminal ones, are the ones required for D2 recognition by WSB-1.	Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, H-1083 Budapest, Hungary; Brigham & Womens Hosp, Thyroid Sect, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gereben, B (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Szigony St 43, H-1083 Budapest, Hungary.	gereben@koki.hu	Bianco, Antonio/AAK-6336-2020; Bianco, Antonio C/A-4965-2008	Bianco, Antonio/0000-0001-7737-6813; Bianco, Antonio C/0000-0001-7737-6813	FIC NIH HHS [TW006467] Funding Source: Medline; NIDDK NIH HHS [DK58538, DK36246] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW006467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058538] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; BAQUI M, 2002, J BIOL CHEM, V4, P4; Baqui MMA, 2000, ENDOCRINOLOGY, V141, P4309, DOI 10.1210/en.141.11.4309; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Botero D, 2002, MOL ENDOCRINOL, V16, P1999, DOI 10.1210/me.2002-0135; Callebaut I, 2003, J BIOL CHEM, V278, P36887, DOI 10.1074/jbc.M305725200; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; Gereben B, 2000, MOL ENDOCRINOL, V14, P1697, DOI 10.1210/me.14.11.1697; Hardt B, 2002, BIOCHEM BIOPH RES CO, V291, P751, DOI 10.1006/bbrc.2002.6515; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kim BW, 2003, MOL ENDOCRINOL, V17, P2603, DOI 10.1210/me.2003-0082; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; LEONARD JL, 1981, SCIENCE, V214, P571, DOI 10.1126/science.7291997; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; PILLER V, 1990, J BIOL CHEM, V265, P9264; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; ROTH J, 1984, J CELL BIOL, V98, P399, DOI 10.1083/jcb.98.2.399; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Steinsapir J, 1998, J CLIN INVEST, V102, P1895, DOI 10.1172/JCI4672; STGERMAIN DL, 1988, ENDOCRINOLOGY, V122, P1860, DOI 10.1210/endo-122-5-1860; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Vasiliauskas D, 1999, MECH DEVELOP, V82, P79, DOI 10.1016/S0925-4773(99)00014-3; Wrzeszczynski KO, 2004, CELL MOL LIFE SCI, V61, P1341, DOI 10.1007/s00018-004-4005-3; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; Yoshida A, 1997, J BIOL CHEM, V272, P16884, DOI 10.1074/jbc.272.27.16884	29	38	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31538	31543		10.1074/jbc.M604728200	http://dx.doi.org/10.1074/jbc.M604728200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16928685	Bronze			2022-12-27	WOS:000241235300039
J	Chen, F; Lu, YJ; Castranova, V; Li, ZW; Karin, M				Chen, Fei; Lu, Yongju; Castranova, Vince; Li, Zhiwei; Karin, Michael			Loss of Ikk beta promotes migration and proliferation of mouse embryo fibroblast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; KINASE ACTIVATION; JNK ACTIVATION; CANCER-THERAPY; MESSENGER-RNA; ALPHA; TNF	The I kappa B kinase complex (IKK) is central to the activation of NF-kappa B, a critical transcription factor governing expression of genes involved in cell proliferation and anti-apoptotic responses. Mice with genetic disruptions of the Ikk beta or Ikk gamma gene loci die during embryogenesis because of severe hepatic apoptosis. We now show that Ikk beta gene deficiency promotes migration and proliferation of mouse embryo fibroblast cells. Morphological analyses revealed an unusual protrusion of the cytoplasm in Ikk beta(-/-) cells when cultured at a lower density. In a Boyden chamber assay, Ikk beta(-/-) cells exhibited a high rate of invasion and migration. Enhanced formation of actin stress fibers was also observed in the Ikk beta(-/-) cells. Mechanistic studies indicated that IKK beta affects the expression of proteins involved in the assembly of cytoskeleton and cell movement. Furthermore, re-expression of Ikk beta and antioxidant treatment in Ikk beta(-/-) cells caused a reversal of protrusive phenotype and high motility, respectively. Furthermore, elimination of reactive oxygen species (ROS) blocked expression of snail and subsequently derepressed E-cadherin expression. Although the underlying mechanism is likely entangled and complicated, the data presented indicate that generation of ROS played a key role in the morphological and mobility changes in Ikk beta(-/-) cells. These data thus suggest that IKK beta provides inhibitory signals for cell mobility and growth. Deficiency in the Ikk gamma gene promotes cell mobilization, at least partially, through a ROS-dependent mechanism.	NIOSH, PPRB, Hlth Effects Lab Div, Morgantown, WV 26505 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of California System; University of California San Diego	Chen, F (corresponding author), NIOSH, PPRB, Hlth Effects Lab Div, 1095 Willowdale Rd, Morgantown, WV 26505 USA.	lfd3@cdc.gov	Chen, Fei/A-3056-2008					Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Cazals V, 1999, BBA-MOL CELL RES, V1448, P349, DOI 10.1016/S0167-4889(98)00095-0; Chen F, 1999, CLIN CHEM, V45, P7; Chen F, 2003, CANCER RES, V63, P7689; Chen F, 2002, J BIOL CHEM, V277, P3342, DOI 10.1074/jbc.M101089200; Chen F, 2002, CRIT REV ONCOL HEMAT, V42, P105, DOI 10.1016/S1040-8428(01)00211-6; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Chen F, 2001, J BIOL CHEM, V276, P11414, DOI 10.1074/jbc.M011682200; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Eichten A, 2004, VIROLOGY, V319, P81, DOI 10.1016/j.virol.2003.11.008; Gapuzan MER, 2005, ONCOGENE, V24, P6574, DOI 10.1038/sj.onc.1208809; Gapuzan MER, 2002, ONCOGENE, V21, P2484, DOI 10.1038/sj.onc.1205333; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; REDDEL RR, 1988, CANCER RES, V48, P1904; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; SUN Y, 1995, J BIOL CHEM, V270, P19312, DOI 10.1074/jbc.270.33.19312; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; van Hogerlinden M, 1999, CANCER RES, V59, P3299; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; YEBRA M, 1995, MOL BIOL CELL, V6, P841, DOI 10.1091/mbc.6.7.841; Yoon H, 2002, P NATL ACAD SCI USA, V99, P15632, DOI 10.1073/pnas.242597299; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zheng X, 2005, BIOCHEM BIOPH RES CO, V329, P95, DOI 10.1016/j.bbrc.2005.01.105	51	28	28	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					37142	37149		10.1074/jbc.M603631200	http://dx.doi.org/10.1074/jbc.M603631200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16966325	hybrid			2022-12-27	WOS:000242220800075
J	Heinrich, A; Woyda, K; Brauburger, K; Meiss, G; Detsch, C; Stulke, J; Forchhammer, K				Heinrich, Annette; Woyda, Kathrin; Brauburger, Katja; Meiss, Gregor; Detsch, Christian; Stuelke, Joerg; Forchhammer, Karl			Interaction of the membrane-bound GlnK-AmtB complex with the master regulator of nitrogen metabolism TnrA in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; PHOSPHOPROTEIN P-II; ESCHERICHIA-COLI; MECHANISTIC FEATURES; GENE-EXPRESSION; PII; BINDING; OPERON; PHOSPHORYLATION; SEQUESTRATION	P-II proteins are widespread and highly conserved signal transduction proteins occurring in bacteria, Archaea, and plants and play pivotal roles in controlling nitrogen assimilatory metabolism. This study reports on biochemical properties of the P-II-homologue GlnK (originally termed NrgB) in Bacillus subtilis (BsGlnK). Like other P-II proteins, the native BsGlnK protein has a trimeric structure and readily binds ATP in the absence of divalent cations, whereas 2-oxoglutarate is only weakly bound. In contrast to other P-II-like proteins, Mg2+ severely affects its ATP-binding properties. BsGlnK forms a tight complex with the membrane-bound ammonium transporter AmtB (NrgA), from which it can be relieved by millimolar concentrations of ATP. Immunoprecipitation and co-localization experiments identified a novel interaction between the BsGlnK-AmtB complex and the major transcription factor of nitrogen metabolism, TnrA. In vitro in the absence of ATP, TnrA is completely tethered to membrane (AmtB)-bound GlnK, whereas in extracts from BsGlnK- or AmtB-deficient cells, TnrA is entirely soluble. The presence of 4 mM ATP leads to concomitant solubilization of BsGlnK and TnrA. This ATP-dependent membrane re-localization of TnrA by BsGlnK/AmtB may present a novel mechanism to control the global nitrogen-responsive transcription regulator TnrA in B. subtilis under certain physiological conditions.	Univ Giessen, Inst Mikrobiol & Mol Biol, D-35392 Giessen, Germany; Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; Univ Erlangen Nurnberg, Inst Mikrobiol Biochem & Genet, Lehrstuhl Mikrobiol, D-91058 Erlangen, Germany; Univ Gottingen, Inst Mikrobiol & Genet, D-37077 Gottingen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Erlangen Nuremberg; University of Gottingen	Forchhammer, K (corresponding author), Univ Giessen, Inst Mikrobiol & Mol Biol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	Karl.Forchhammer@mikro.bio.uni-giessen.de	Stülke, Jörg/AAD-1600-2021	Stulke, Jorg/0000-0001-5881-5390				ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Belitsky BR, 2000, J BACTERIOL, V182, P5939, DOI 10.1128/JB.182.21.5939-5947.2000; Benelli EM, 2002, EUR J BIOCHEM, V269, P3296, DOI 10.1046/j.1432-1033.2002.03011.x; Bohm A, 2004, CURR OPIN MICROBIOL, V7, P151, DOI 10.1016/j.mib.2004.02.009; Detsch C, 2003, MICROBIOL-SGM, V149, P3289, DOI 10.1099/mic.0.26512-0; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Dodsworth JA, 2006, P NATL ACAD SCI USA, V103, P9779, DOI 10.1073/pnas.0602278103; Ehlers C, 2005, MOL MICROBIOL, V55, P1841, DOI 10.1111/j.1365-2958.2005.04511.x; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Fisher SH, 2002, J BACTERIOL, V184, P4636, DOI 10.1128/JB.184.16.4636-4639.2002; Forchhammer K, 1997, EUR J BIOCHEM, V244, P869, DOI 10.1111/j.1432-1033.1997.00869.x; FORCHHAMMER K, 1995, J BACTERIOL, V177, P2033, DOI 10.1128/jb.177.8.2033-2040.1995; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; Gorke B, 2005, NUCLEIC ACIDS RES, V33, P2504, DOI 10.1093/nar/gki549; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Hesketh A, 2002, MOL MICROBIOL, V46, P319, DOI 10.1046/j.1365-2958.2002.03149.x; Huergo LF, 2006, MOL MICROBIOL, V59, P326, DOI 10.1111/j.1365-2958.2005.04944.x; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Kessler PS, 2001, J BACTERIOL, V183, P882, DOI 10.1128/JB.183.3.882-889.2001; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Mahren S, 2002, J BACTERIOL, V184, P3704, DOI 10.1128/JB.184.13.3704-3711.2002; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; MOORHEAD GBG, 2003, PLANT PHYSIOL, V133, P1; Nakano MM, 1998, J BACTERIOL, V180, P5344, DOI 10.1128/JB.180.20.5344-5350.1998; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Palinska KA, 2002, MICROBIOL-SGM, V148, P2405, DOI 10.1099/00221287-148-8-2405; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Ruppert U, 2002, MOL MICROBIOL, V44, P855, DOI 10.1046/j.1365-2958.2002.02927.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHREIER HJ, 1989, J MOL BIOL, V210, P51, DOI 10.1016/0022-2836(89)90290-8; Smith CS, 2004, BBA-PROTEINS PROTEOM, V1699, P145, DOI 10.1016/j.bbapap.2004.02.009; Smith CS, 2003, PLANT J, V33, P353, DOI 10.1046/j.1365-313X.2003.01634.x; Strosser J, 2004, MOL MICROBIOL, V54, P132, DOI 10.1111/j.1365-2958.2004.04247.x; VOELKER U, 1995, J BACTERIOL, V177, P3771, DOI 10.1128/jb.177.13.3771-3780.1995; WRAY LV, 1994, J BACTERIOL, V176, P108, DOI 10.1128/JB.176.1.108-114.1994; Wray LV, 1996, P NATL ACAD SCI USA, V93, P8841, DOI 10.1073/pnas.93.17.8841; Wray LV, 1997, J BACTERIOL, V179, P5494, DOI 10.1128/jb.179.17.5494-5501.1997; Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Yoshida K, 2003, MOL MICROBIOL, V49, P157, DOI 10.1046/j.1365-2958.2003.03567.x; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005	43	67	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34909	34917		10.1074/jbc.M607582200	http://dx.doi.org/10.1074/jbc.M607582200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	17001076	hybrid			2022-12-27	WOS:000241933700023
J	Joly, N; Schumacher, J; Buck, M				Joly, Nicolas; Schumacher, Jorg; Buck, Martin			Heterogeneous nucleotide occupancy stimulates functionality of phage shock protein F, an AAA plus transcriptional activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER DNA COMPLEX; ESCHERICHIA-COLI; RNA-POLYMERASE; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; IN-VITRO; ATP; DOMAIN; BINDING	The catalytic AAA+ domain (PspF(1-275)) of an enhancer-binding protein is necessary and sufficient to contact sigma 54-RNA polymerase holoenzyme (E sigma(54)), remodel it, and in so doing catalyze open promoter complex formation. Whether ATP binding and hydrolysis is coordinated between subunits of PspF and the precise nature of the nucleotide(s) bound to the oligomeric forms responsible for substrate remodeling are unknown. We demonstrate that ADP stimulates the intrinsic ATPase activity of PspF(1-275) and propose that this heterogeneous nucleotide occupancy in a PspF(1-275) hexamer is functionally important for specific activity. Binding of ADP and ATP triggers the formation of functional PspF(1-275) hexamers as shown by a gain of specific activity. Furthermore, ATP concentrations congruent with stoichiometric ATP binding to PspF(1-275) inhibit ATP hydrolysis and E sigma(54)-promoter open complex formation. Demonstration of a heterogeneous nucleotide-bound state of a functional PspF(1-275)center dot E sigma(54) complex provides clear biochemical evidence for heterogeneous nucleotide occupancy in this AAA+ protein. Based on our data, we propose a stochastic nucleotide binding and a coordinated hydrolysis mechanism in PspF(1-275) hexamers.	Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England	Imperial College London	Buck, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	m.buck@imperial.ac.uk	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827				Ades SE, 2006, CURR BIOL, V16, pR46, DOI 10.1016/j.cub.2006.01.005; BERGER DK, 1995, J BACTERIOL, V177, P191, DOI 10.1128/jb.177.1.191-199.1995; Beuron F, 2003, J MOL BIOL, V327, P619, DOI 10.1016/S0022-2836(03)00178-5; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Burrows PC, 2004, EMBO J, V23, P4253, DOI 10.1038/sj.emboj.7600406; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Cannon WV, 2004, NUCLEIC ACIDS RES, V32, P4596, DOI 10.1093/nar/gkh755; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; De Carlo S, 2006, GENE DEV, V20, P1485, DOI 10.1101/gad.1418306; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Elderkin S, 2002, J MOL BIOL, V320, P23, DOI 10.1016/S0022-2836(02)00404-7; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Jovanovic G, 1999, J MOL BIOL, V285, P469, DOI 10.1006/jmbi.1998.2263; Jovanovic G, 2006, J BIOL CHEM, V281, P21147, DOI 10.1074/jbc.M602323200; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; KLOSE KE, 1994, J MOL BIOL, V241, P233, DOI 10.1006/jmbi.1994.1492; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Lloyd LJ, 2004, J BIOL CHEM, V279, P55707, DOI 10.1074/jbc.M408994200; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; MITCHELL AH, 1994, J MOL BIOL, V243, P208, DOI 10.1006/jmbi.1994.1648; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Pelton JG, 1999, J MOL BIOL, V292, P1095, DOI 10.1006/jmbi.1999.3140; PerezMartin J, 1996, CELL, V86, P331, DOI 10.1016/S0092-8674(00)80104-X; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Rombel I, 1999, J BACTERIOL, V181, P4628, DOI 10.1128/JB.181.15.4628-4638.1999; Sallai L, 2005, J STRUCT BIOL, V151, P160, DOI 10.1016/j.jsb.2005.05.006; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Schumacher J, 2004, J MOL BIOL, V338, P863, DOI 10.1016/j.jmb.2004.02.071; SCHUMACHER J, 2006, IN PRESS J STRUCT BI; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Wigneshweplaraj SR, 2005, PROG NUCLEIC ACID RE, V79, P339, DOI 10.1016/S0079-6603(04)79007-8; Wigneshweraraj SR, 2005, J BIOL CHEM, V280, P36176, DOI 10.1074/jbc.M506416200; Wigneshweraraj SR, 2003, METHOD ENZYMOL, V370, P646; Wikstrom P, 2001, J MOL BIOL, V314, P971, DOI 10.1006/jmbi.2000.5212; Xu H, 2001, CURR OPIN MICROBIOL, V4, P138, DOI 10.1016/S1369-5274(00)00179-X; Xu H, 2004, J BACTERIOL, V186, P3499, DOI 10.1128/JB.186.11.3499-3507.2004; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	49	46	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34997	35007		10.1074/jbc.M606628200	http://dx.doi.org/10.1074/jbc.M606628200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16973614	hybrid			2022-12-27	WOS:000241933700033
J	Xu, LJ; Deng, XM				Xu, Lijun; Deng, Xingming			Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; PHOSPHORYLATION; TRANSFORMATION; ACTIVATION; GROWTH; ZYMOGRAPHY; APOPTOSIS; PROTEASES; MEMBRANE; CLEAVAGE	The mu-and m-calpains are major members of the calpain family that play an essential role in regulating cell motility. We have recently discovered that nicotine-activated protein kinase C i enhances calpain phosphorylation in association with enhanced calpain activity and accelerated migration and invasion of human lung cancer cells. Here we found that specific disruption of protein phosphatase 2A (PP2A) activity by expression of SV40 small tumor antigen up-regulates phosphorylation of mu-and m-calpains whereas C2-ceramide, a potent PP2A activator, reduces nicotine-induced calpain phosphorylation, suggesting that PP2A may function as a physiological calpain phosphatase. PP2A co-localizes and interacts with mu-and m-calpains. Purified, active PP2A directly dephosphorylates mu-and m-calpains in vitro. Overexpression of the PP2A catalytic subunit (PP2A/C) suppresses nicotine-stimulated phosphorylation of mu-and m-calpains, which is associated with inhibition of calpain activity, wound healing, cell migration, and invasion. By contrast, depletion of PP2A/C by RNA interference enhances calpain phosphorylation, calpain activity, cell migration, and invasion. Importantly, C2-ceramide-induced suppression of calpain phosphorylation results in decreased secretion of mu-and m-calpains from lung cancer cells into culture medium, which may have potential clinic relevance in controlling metastasis of lung cancer. These findings reveal a novel role for PP2A as a physiological calpain phosphatase that not only directly dephosphorylates but also inactivates mu-and m-calpains, leading to suppression of migration and invasion of human lung cancer cells.	Univ Florida, Shands Canc Ctr, Dept Med, Hlth Sci Ctr, Gainesville, FL 32610 USA; Univ Florida, Hlth Sci Ctr, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Deng, XM (corresponding author), Univ Florida, Shands Canc Ctr, Dept Med, Hlth Sci Ctr, 1376 Mowry Rd,Canc Genet Res Complex,Rm 262,POB 1, Gainesville, FL 32610 USA.	xdeng@ufscc.ufl.edu			NCI NIH HHS [R01 CA112183] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112183] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBINI A, 1987, CANCER RES, V47, P3239; Arthur JSC, 2000, METH MOL B, V144, P109; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Gomez DE, 1999, ONCOL REP, V6, P1363; Gulbins E, 2003, PHARMACOL RES, V47, P393, DOI 10.1016/S1043-6618(03)00052-5; HEINO J, 2002, CELL INVASION MED IN, V33, P1; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; LAW B, 1995, J BIOL CHEM, V270, P12808, DOI 10.1074/jbc.270.21.12808; Mamoune A, 2003, CANCER RES, V63, P4632; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Palecek SP, 1998, J CELL SCI, V111, P929; Pullar CE, 2003, J BIOL CHEM, V278, P22555, DOI 10.1074/jbc.M300205200; RASER KJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P211, DOI 10.1006/abbi.1995.1284; REPESH LA, 1989, INVAS METAST, V9, P192; Rita M, 2003, INT J CANCER, V103, P38, DOI 10.1002/ijc.10772; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Witkowski JM, 2002, BLOOD, V100, P1802, DOI 10.1182/blood-2001-11-0073; Wu MQ, 2006, FEBS LETT, V580, P3246, DOI 10.1016/j.febslet.2006.05.003; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Xu LJ, 2004, J BIOL CHEM, V279, P53683, DOI 10.1074/jbc.M409889200; Young MRI, 2002, INT J CANCER, V100, P276, DOI 10.1002/ijc.10491	33	59	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35567	35575		10.1074/jbc.M607702200	http://dx.doi.org/10.1074/jbc.M607702200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16982626	hybrid			2022-12-27	WOS:000241933700089
J	Li, QF; Spinelli, AM; Wang, RP; Anfinogenova, Y; Singer, HA; Tang, DD				Li, Qing-Fen; Spinelli, Amy M.; Wang, Ruping; Anfinogenova, Yana; Singer, Harold A.; Tang, Dale D.			Critical role of vimentin phosphorylation at Ser-56 by p21-activated kinase in vimentin cytoskeleton signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; INTERMEDIATE-FILAMENT NETWORK; PROTEIN-KINASE; CONTRACTILE STIMULATION; ACTIN POLYMERIZATION; TENSION DEVELOPMENT; ANGIOTENSIN-II; LD4 MOTIF; PAK; REORGANIZATION	Phosphorylation and spatial reorganization of the vimentin network have been implicated in mediating smooth muscle contraction, cell migration, and mitosis. In this study, stimulation of cultured smooth muscle cells with 5-hydroxytryptamine (5-HT) induced PAK1 phosphorylation at Thr-423 (an indication of p21-activated kinase (PAK) activation). Treatment with PAK led to disassembly of wild-type (but not mutant S56A) vimentin filaments as assessed by an in vitro filament assembly assay. Furthermore, stimulation with 5-HT resulted in the dissociation of Crk-associated substrate (CAS; an adapter protein associated with smooth muscle force development) from cytoskeletal vimentin. Expression of mutant S56A vimentin in cells inhibited the increase in phosphorylation at Ser-56 and in the ratios of soluble to insoluble vimentin (an index of vimentin disassembly) and the dissociation of CAS from cytoskeletal vimentin in response to 5-HT activation compared with cells expressing wild-type vimentin. Because CAS may be involved in PAK activation, PAK phosphorylation was evaluated in cells expressing the S56A mutant. Expression of mutant S56A vimentin depressed PAK phosphorylation at Thr-423 induced by 5-HT. Expression of the S56A mutant also inhibited the spatial reorientation of vimentin filaments in cells in response to 5-HT stimulation. Our results suggest that vimentin phosphorylation at Ser-56 may inversely regulate PAK activation possibly via the increase in the amount of soluble CAS upon agonist stimulation of smooth muscle cells. Additionally, vimentin phosphorylation at this position is critical for vimentin filament spatial rearrangement elicited by agonists.	Albany Med Coll, Ctr Cardiovasc Res, Albany, NY 12208 USA	Albany Medical College	Tang, DD (corresponding author), Albany Med Coll, Ctr Cardiovasc Res, 47 New Scotland Ave,MC-8, Albany, NY 12208 USA.	tangd@mail.amc.edu	T, Dale/AAE-9643-2020; Anfinogenova, Nina D./E-7458-2014; Anfinogenova, Yana/AAH-3946-2021	T, Dale/0000-0002-7339-9249; Anfinogenova, Nina D./0000-0003-1106-0730; Anfinogenova, Yana/0000-0003-1106-0730; Wang, Ruping/0000-0003-4233-7755	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075388] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075388, HL-75388] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Bruel A, 2001, ANTICANCER RES, V21, P3973; Chan W, 2002, EUR J CELL BIOL, V81, P692, DOI 10.1078/0171-9335-00281; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Dechert MA, 2001, AM J PHYSIOL-CELL PH, V281, pC123, DOI 10.1152/ajpcell.2001.281.1.C123; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Finley NL, 2004, J BIOL CHEM, V279, P54833, DOI 10.1074/jbc.M408304200; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Li QF, 2006, FASEB J, V20, pA1243; Marganski WA, 2005, CIRC RES, V97, P541, DOI 10.1161/01.RES.0000182630.29093.0d; McFawn PK, 2003, AM J PHYSIOL-LUNG C, V284, pL863, DOI 10.1152/ajplung.00068.2002; Meriane M, 2000, J BIOL CHEM, V275, P33046, DOI 10.1074/jbc.M001566200; OGDEN K, 2006, IN PRESS AM J PHYSL; PARROTT DP, 1991, ATHEROSCLEROSIS, V88, P213, DOI 10.1016/0021-9150(91)90083-F; Sin WC, 1998, MOL CELL BIOL, V18, P6325, DOI 10.1128/MCB.18.11.6325; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; SMALL JV, 1995, BIOESSAYS, V17, P785, DOI 10.1002/bies.950170908; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, HYPERTENSION, V42, P858, DOI 10.1161/01.HYP.0000085333.76141.33; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Woolfolk EA, 2005, AM J PHYSIOL-CELL PH, V289, pC1286, DOI 10.1152/ajpcell.00448.2004	31	109	114	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34716	34724		10.1074/jbc.M607715200	http://dx.doi.org/10.1074/jbc.M607715200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16990256	hybrid, Green Accepted			2022-12-27	WOS:000241767600090
J	Sudo, Y; Furutani, Y; Kandori, H; Spudich, JL				Sudo, Yuki; Furutani, Yuji; Kandori, Hideki; Spudich, John L.			Functional importance of the interhelical hydrogen bond between Thr(204) and Tyr(174) of sensory rhodopsin II and its alteration during the signaling process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROXIMAL DOMAIN; PHARAONIS PHOBORHODOPSIN; NATRONOBACTERIUM-PHARAONIS; STRUCTURAL-CHANGES; COGNATE TRANSDUCER; FTIR SPECTROSCOPY; HTRI TRANSDUCER; LINKER REGION; COMPLEX; PHOTOISOMERIZATION	Sensory rhodopsin II (SRII), a receptor for negative phototaxis in haloarchaea, transmits light signals through changes in protein-protein interaction with its transducer HtrII. Light-induced structural changes throughout the SRII-HtrII interface, which spans the periplasmic region, membrane-embedded domains, and cytoplasmic domains near the membrane, have been identified by several studies. Here we demonstrate by site-specific mutagenesis and analysis of phototaxis behavior that two residues in SRII near the membrane-embedded interface (Tyr(174) on helix F and Thr(204) on helix G) are essential for signaling by the SRII-HtrII complex. These residues, which are the first in SRII shown to be required for phototaxis function, provide biological significance to the previous observation that the hydrogen bond between them is strengthened upon the formation of the earliest SRII photointermediate (SRIIK) only when SRII is complexed with HtrII. Here we report frequency changes of the S-H stretch of a cysteine substituted for SRII Thr(204) in the signaling state intermediates of the SRII photocycle, as well as an influence of HtrII on the hydrogen bond strength, supporting a direct role of the hydrogen bond in SRII-HtrII signal relay chemistry. Our results suggest that the light signal is transmitted to HtrII from the energized interhelical hydrogen bond between Thr(204) and Tyr(174), which is located at both the retinal chromophore pocket and in helices F and G that form the membrane-embedded interaction surface to the signal-bearing second transmembrane helix of HtrII. The results argue for a critical process in signal relay occurring at this membrane interfacial region of the complex.	Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto 6068502, Japan	University of Texas System; University of Texas Health Science Center Houston; Nagoya Institute of Technology; Japan Science & Technology Agency (JST)	Spudich, JL (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA.	John.L.Spudich@uth.tmc.edu	Furutani, Yuji/J-8337-2019; Sudo, Yuki/AGY-0493-2022	Furutani, Yuji/0000-0001-5284-8773; Sudo, Yuki/0000-0001-8155-9356	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027750] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergo VB, 2005, J BIOL CHEM, V280, P28365, DOI 10.1074/jbc.M505555200; Bordignon E, 2005, J BIOL CHEM, V280, P38767, DOI 10.1074/jbc.M509391200; Chen XP, 2004, J BIOL CHEM, V279, P42964, DOI 10.1074/jbc.M406503200; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P2909, DOI 10.1021/bi047893i; Furutani Y, 2004, BIOCHEMISTRY-US, V43, P5204, DOI 10.1021/bi036316b; Furutani Y, 2003, BIOCHEMISTRY-US, V42, P4837, DOI 10.1021/bi034317y; Furutani Y, 2002, BIOPHYS J, V83, P3482, DOI 10.1016/S0006-3495(02)75347-2; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; HE YW, 1993, BIOCHEMISTRY-US, V32, P2282, DOI 10.1021/bi00060a021; Hippler-Mreyen S, 2003, J MOL BIOL, V330, P1203, DOI 10.1016/S0022-2836(03)00656-9; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Iwamoto M, 2005, BIOPHYS J, V88, P1215, DOI 10.1529/biophysj.104.045583; Jung KH, 1996, P NATL ACAD SCI USA, V93, P6557, DOI 10.1073/pnas.93.13.6557; Jung KH, 2001, J BACTERIOL, V183, P6365, DOI 10.1128/JB.183.21.6365-6371.2001; Kamo N, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1277, DOI 10.1023/A:1013187403599; Kandori H, 2000, P NATL ACAD SCI USA, V97, P4643, DOI 10.1073/pnas.080064797; Kandori H, 2001, BIOCHEMISTRY-US, V40, P9238, DOI 10.1021/bi0103819; Kandori H, 1999, BIOCHEMISTRY-US, V38, P9676, DOI 10.1021/bi990713y; Kandori H, 1998, J AM CHEM SOC, V120, P5828, DOI 10.1021/ja980837i; Klare JP, 2004, PHOTOCH PHOTOBIO SCI, V3, P543, DOI 10.1039/b402656j; Klare JP, 2002, BIOPHYS J, V82, P2156, DOI 10.1016/S0006-3495(02)75562-8; Krebs MP, 1995, PROTEIN EXPRES PURIF, V6, P780, DOI 10.1006/prep.1995.0009; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; OLSON KD, 1993, BIOPHYS J, V65, P2578, DOI 10.1016/S0006-3495(93)81295-5; Pebay-Peyroula E, 2002, BBA-BIOMEMBRANES, V1565, P196, DOI 10.1016/S0005-2736(02)00569-2; Perazzona B, 1996, J BACTERIOL, V178, P6475, DOI 10.1128/jb.178.22.6475-6478.1996; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Sasaki J, 1999, BIOPHYS J, V77, P2145, DOI 10.1016/S0006-3495(99)77055-4; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Spudich J, 2002, NAT STRUCT BIOL, V9, P797, DOI 10.1038/nsb1102-797; Spudich JL, 2002, CURR OPIN STRUC BIOL, V12, P540, DOI 10.1016/S0959-440X(02)00359-7; Sudo Y, 2006, J MOL BIOL, V357, P1274, DOI 10.1016/j.jmb.2006.01.061; Sudo Y, 2005, J AM CHEM SOC, V127, P16036, DOI 10.1021/ja056203a; Sudo Y, 2005, BIOCHEMISTRY-US, V44, P6144, DOI 10.1021/bi047573z; Sudo Y, 2003, BIOCHEMISTRY-US, V42, P14166, DOI 10.1021/bi035678g; Sudo Y, 2003, PHOTOCHEM PHOTOBIOL, V78, P511, DOI 10.1562/0031-8655(2003)078<0511:IONPPS>2.0.CO;2; Sudo Y, 2002, BIOPHYS J, V83, P427, DOI 10.1016/S0006-3495(02)75180-1; Sudo Y, 2001, PHOTOCHEM PHOTOBIOL, V74, P489, DOI 10.1562/0031-8655(2001)074<0489:PPBTIC>2.0.CO;2; Sudo Y., 2004, RECENT RES DEV BIOPH, V3, P1; SUDO Y, 2006, IN PRESS P NATL ACAD; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; Yang CS, 2004, J BIOL CHEM, V279, P42970, DOI 10.1074/jbc.M406504200; Yang CS, 2001, BIOCHEMISTRY-US, V40, P14207, DOI 10.1021/bi010985c	46	47	47	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34239	34245		10.1074/jbc.M605907200	http://dx.doi.org/10.1074/jbc.M605907200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16968701	hybrid			2022-12-27	WOS:000241767600044
J	Hentschke, M; Kurth, I; Borgmeyer, U; Hubner, CA				Hentschke, Moritz; Kurth, Ingo; Borgmeyer, Uwe; Huebner, Christian A.			Germ cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE PROTAMINE GENES; ORPHAN RECEPTOR; DNA-BINDING; RETINOIC ACID; DIFFERENTIAL EXPRESSION; RESPONSE ELEMENT; OCT4 EXPRESSION; THYROID-HORMONE; STEM-CELLS; TERATOCARCINOMA	The pluripotency of embryonic stem and embryonic carcinoma cells is maintained by the expression of a set of "stemness" genes. Whereas these genes are down-regulated upon induction of differentiation, the germ cell nuclear factor (GCNF) is transiently up-regulated and represses several pluripotency genes. CRIPTO-1, a co-receptor for the morphogen nodal, is strongly expressed in undifferentiated cells and is rapidly down-regulated during retinoic acid-induced differentiation. Although CRIPTO-1 is expressed at very low levels in adult tissues under normal conditions, it is found highly expressed in a broad range of tumors, where it acts as a potent oncogene. We show that expression of CRIPTO-1 is directly repressed by GCNF during differentiation of the human teratocarcinoma cell line, NT2. GCNF bound to a DR0 element of the CRIPTO-1 promoter in vitro, as shown by electrophoretic mobility shift assays, and in vivo, as demonstrated by chromatin immunoprecipitation. Reporter gene assays demonstrated that GCNF-mediated repression of the CRIPTO-1 promoter is dependent upon the DR0 site. Overexpression of GCNF in NT2 cells resulted in repression of CRIPTO-1 transcription, whereas expression of the transcription-activating fusion construct GCNF-VP16 led to an induction of theCRIPTO-1 gene and prevented its retinoic acid-induced down-regulation. Furthermore, we demonstrated that CRIPTO-3, a processed pseudogene of CRIPTO-1 on the X chromosome, is expressed in undifferentiated NT2 cells and is regulated by GCNF in parallel to CRIPTO-1. Thus, our study supports the hypothesis of GCNF playing a central role during differentiation of stem cells by repression of stem cell-specific genes.	Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol, D-20246 Hamburg, Germany; Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-22529 Hamburg, Germany; Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20251 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hentschke, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol, Martinistr 52, D-20246 Hamburg, Germany.	m.hentschke@uke.uni-hamburg.de; c.huebner@uke.uni-hamburg.de	Borgmeyer, Uwe/D-4662-2012; Hübner, Christian/A-2950-2017	Borgmeyer, Uwe/0000-0003-3727-4083; Hübner, Christian/0000-0002-1030-4943; Kurth, Ingo/0000-0002-5642-8378				Baldassarre G, 1997, ONCOGENE, V15, P927, DOI 10.1038/sj.onc.1201260; Barreto G, 2003, DEV BIOL, V257, P329, DOI 10.1016/S0012-1606(03)00109-X; Bianco C, 2005, J NATL CANCER I, V97, P132, DOI 10.1093/jnci/dji011; Bianco C, 2004, GROWTH FACTORS, V22, P133, DOI 10.1080/08977190410001723290; Borgmeyer U, 1997, EUR J BIOCHEM, V244, P120, DOI 10.1111/j.1432-1033.1997.00120.x; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; CHEN F, 1994, MOL ENDOCRINOL, V8, P1434, DOI 10.1210/me.8.10.1434; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; CICCODICOLA A, 1989, EMBO J, V8, P1987, DOI 10.1002/j.1460-2075.1989.tb03605.x; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; DONO R, 1991, AM J HUM GENET, V49, P555; Elliman SJ, 2006, J BIOL CHEM, V281, P16, DOI 10.1074/jbc.C500415200; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Greschik H, 1999, MOL CELL BIOL, V19, P690; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Gu PL, 2005, J BIOL CHEM, V280, P31818, DOI 10.1074/jbc.M501924200; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Heinzer C, 1998, BIOL CHEM, V379, P349, DOI 10.1515/bchm.1998.379.3.349; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hummelke GC, 2004, MOL REPROD DEV, V68, P394, DOI 10.1002/mrd.20092; Hummelke GC, 1998, MOL REPROD DEV, V50, P396, DOI 10.1002/(SICI)1098-2795(199808)50:4<396::AID-MRD3>3.0.CO;2-D; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Lan ZJ, 2003, EMBO J, V22, P4070, DOI 10.1093/emboj/cdg405; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Minchiotti G, 2005, ONCOGENE, V24, P5668, DOI 10.1038/sj.onc.1208917; Minchiotti G, 2002, GENE, V287, P33, DOI 10.1016/S0378-1119(01)00892-7; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niemeyer CC, 1998, CELL DEATH DIFFER, V5, P440, DOI 10.1038/sj.cdd.4400368; Normanno N, 2001, FRONT BIOSCI-LANDMRK, V6, pD685, DOI 10.2741/Normano; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Rajkovic M, 2004, J BIOL CHEM, V279, P52493, DOI 10.1074/jbc.M404467200; Sattler U, 2004, MOL ENDOCRINOL, V18, P2714, DOI 10.1210/me.2004-0251; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schmitz TP, 1999, BBA-GENE STRUCT EXPR, V1446, P173, DOI 10.1016/S0167-4781(99)00079-2; Scognamiglio B, 1999, CYTOGENET CELL GENET, V84, P220, DOI 10.1159/000015263; Shen MM, 2003, J CLIN INVEST, V112, P500, DOI 10.1172/JCI200319546; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Susens U, 1997, DEV NEUROSCI-BASEL, V19, P410, DOI 10.1159/000111238; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Xu CH, 1998, DEV BIOL, V196, P237, DOI 10.1006/dbio.1998.8862; Xu CH, 1999, DEVELOPMENT, V126, P483; Yan ZH, 1997, J BIOL CHEM, V272, P10565; Yan ZJ, 2000, J BIOL CHEM, V275, P35077, DOI 10.1074/jbc.M005566200; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200	51	28	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33497	33504		10.1074/jbc.M606975200	http://dx.doi.org/10.1074/jbc.M606975200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16954206	hybrid			2022-12-27	WOS:000241621400060
J	Pu, YM; Peach, ML; Garfield, SH; Wincovitch, S; Marquez, VE; Blumberg, PM				Pu, Yongmei; Peach, Megan L.; Garfield, Susan H.; Wincovitch, Stephen; Marquez, Victor E.; Blumberg, Peter M.			Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL 12-MYRISTATE 13-ACETATE; PKC-IOTA; NUCLEAR IMPORT; DELTA; ZETA; INHIBITION; DIACYLGLYCEROLS; LOCALIZATION; ACTIVATION; ISOZYMES	The C1 domain zinc finger structure is highly conserved among the protein kinase C (PKC) superfamily members. As the interaction site for the second messenger sn-1,2-diacylglycerol (DAG) and for the phorbol esters, the C1 domain has been an important target for developing selective ligands for different PKC isoforms. However, the C1 domains of the atypical PKC members are DAG/phorbol ester-insensitive. Compared with the DAG/phorbol ester-sensitive C1 domains, the rim of the binding cleft of the atypical PKC C1 domains possesses four additional positively charged arginine residues ( at positions 7, 10, 11, and 20). In this study, we showed that mutation to arginines of the four corresponding sites in the C1b domain of PKC delta abolished its high potency for phorbol 12,13-dibutyrate in vitro, with only marginal remaining activity for phorbol 12-myristate 13-acetate in vivo. We also demonstrated both in vitro and in vivo that the loss of potency to ligands was cumulative with the introduction of the arginine residues along the rim of the binding cavity rather than the consequence of loss of a single, specific residue. Computer modeling reveals that these arginine residues reduce access of ligands to the binding cleft and change the electrostatic profile of the C1 domain surface, whereas the basic structure of the binding cleft is still maintained. Finally, mutation of the four arginine residues of the atypical PKC C1 domains to the corresponding residues in the delta C1b domain conferred response to phorbol ester. We speculate that the arginine residues of the C1 domain of atypical PKCs may provide an opportunity for the design of ligands selective for the atypical PKCs.	NCI, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bethesda, MD 20892 USA; NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NCI, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA; NCI, Med Chem Lab, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumberg, PM (corresponding author), NCI, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bldg 37,Rm 4048,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov	Marquez, Victor/AAP-3549-2021	Peach, Megan/0000-0002-4290-5268	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Braun DC, 2005, MOL CANCER THER, V4, P141; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Goekjian PG, 1999, CURR MED CHEM, V6, P877; Gustafson WC, 2004, J BIOL CHEM, V279, P9400, DOI 10.1074/jbc.M312840200; Hall C, 2005, TRENDS BIOCHEM SCI, V30, P169, DOI 10.1016/j.tibs.2005.02.003; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hurley JH, 1997, PROTEIN SCI, V6, P477; Ito Y, 2001, CELL DEATH DIFFER, V8, P794, DOI 10.1038/sj.cdd.4400886; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kato M, 2005, IMMUNOLOGY, V116, P193, DOI 10.1111/j.1365-2567.2005.02210.x; Kazanietz MG, 2005, BBA-PROTEINS PROTEOM, V1754, P296, DOI 10.1016/j.bbapap.2005.07.034; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Lewin Nancy E, 2003, Methods Mol Biol, V233, P129; Marquez VE, 2003, ACCOUNTS CHEM RES, V36, P434, DOI 10.1021/ar020124b; Mizukami Y, 1997, FEBS LETT, V401, P247, DOI 10.1016/S0014-5793(96)01481-0; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Perander M, 2001, J BIOL CHEM, V276, P13015, DOI 10.1074/jbc.M010356200; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; RAPPAPORT HP, 1979, J THEOR BIOL, V79, P157, DOI 10.1016/0022-5193(79)90244-3; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; Slater SJ, 1996, J BIOL CHEM, V271, P4627; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; SZALLASI Z, 1994, MOL PHARMACOL, V46, P840; SZALLASI Z, 1993, CANCER RES, V53, P2507; Toker A., 1998, FRONT BIOSCI-LANDMRK, V3, P1134, DOI 10.2741/A350; Tortora G, 2003, SEMIN ONCOL, V30, P26, DOI 10.1016/S0093-7754(03)00282-3; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; WAYS DK, 1992, J BIOL CHEM, V267, P4799; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhou M, 2002, J MOL BIOL, V315, P435, DOI 10.1006/jmbi.2001.5263	50	41	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33773	33788		10.1074/jbc.M606560200	http://dx.doi.org/10.1074/jbc.M606560200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950780	hybrid			2022-12-27	WOS:000241621400084
J	Hara, S; Motohashi, K; Arisaka, F; Romano, PGN; Hosoya-Matsuda, N; Kikuchi, N; Fusada, N; Hisabori, T				Hara, Satoshi; Motohashi, Ken; Arisaka, Fumio; Romano, Patrick G. N.; Hosoya-Matsuda, Naomi; Kikuchi, Nobuhiro; Fusada, Naoki; Hisabori, Toru			Thioredoxin-h1 reduces and reactivates the oxidized cytosolic malate dehydrogenase dimer in higher plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; REFINED CRYSTAL-STRUCTURE; CELL-FREE SYNTHESIS; ARABIDOPSIS-THALIANA; REDUCTIVE ACTIVATION; STRUCTURAL BASIS; CHLOROPLAST THIOREDOXIN; LIGHT; PROTEINS; SYSTEM	Cytosolic malate dehydrogenase (cytMDH) was captured by thioredoxin affinity chromatography as a possible target protein of cytosolic thioredoxin (Yamazaki, D., Motohashi, K., Kasama, T., Hara, Y., and Hisabori, T. (2004) Plant Cell Physiol. 45, 18-27). To further dissect this interaction, we aimed to determine whether cytMDH can interact with the cytosolic thioredoxin and whether its activity is redox-regulated. We obtained the active recombinant cytMDH that could be oxidized and rendered inactive. Inactivation was reversed by incubation with low concentrations of dithiothreitol in the presence of recombinant Arabidopsis thaliana thioredoxin-h1. Inactivation of cytMDH was found to result from formation of a homodimer. By cysteine mutant analysis and peptide mapping analysis, we were able to determine that the cytMDH homodimer occurs by formation of a disulfide bond via the Cys330 residue. Moreover, we found this bond to be efficiently reduced by the reduced form of thioredoxin-h1. These results demonstrate that the oxidized form cytMDH dimer is a preferable target protein of the reduced form thioredoxin-h1 as suggested by thioredoxin affinity chromatography.	Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Japan Sci & Technol Corp, ATP Syst Project, ERATO, Midori Ku, Yokohama, Kanagawa 2260026, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Proc, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Hara, Satoshi/C-1341-2015; Motohashi, Ken/I-4970-2019; Hisabori, Toru/E-5205-2014	Hara, Satoshi/0000-0001-6275-6469; Motohashi, Ken/0000-0002-8414-2836; Hisabori, Toru/0000-0003-2046-0277				Ballicora MA, 2000, J BIOL CHEM, V275, P1315, DOI 10.1074/jbc.275.2.1315; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; BIRKTOFT JJ, 1989, BIOCHEMISTRY-US, V28, P6065, DOI 10.1021/bi00440a051; Brehelin C, 2004, PHOTOSYNTH RES, V79, P295, DOI 10.1023/B:PRES.0000017165.55488.ca; BUCHANAN BB, 1991, ARCH BIOCHEM BIOPHYS, V288, P1, DOI 10.1016/0003-9861(91)90157-E; Carr PD, 1999, STRUCTURE, V7, P461, DOI 10.1016/S0969-2126(99)80058-6; CRAWFORD NA, 1989, ARCH BIOCHEM BIOPHYS, V271, P223, DOI 10.1016/0003-9861(89)90273-7; CRETIN C, 1990, EUR J BIOCHEM, V192, P299, DOI 10.1111/j.1432-1033.1990.tb19227.x; Dalhus B, 2002, J MOL BIOL, V318, P707, DOI 10.1016/S0022-2836(02)00050-5; Entus R, 2002, PLANT PHYSIOL, V129, P1866, DOI 10.1104/pp.002626; FASKE M, 1995, BBA-PROTEIN STRUCT M, V1247, P135, DOI 10.1016/0167-4838(94)00203-S; FLORENCIO FJ, 1988, ARCH BIOCHEM BIOPHYS, V266, P496, DOI 10.1016/0003-9861(88)90282-2; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; GLEASON WB, 1994, BIOCHEMISTRY-US, V33, P2078, DOI 10.1021/bi00174a014; HALL MD, 1992, J MOL BIOL, V226, P867, DOI 10.1016/0022-2836(92)90637-Y; Hisabori T, 2005, J EXP BOT, V56, P1463, DOI 10.1093/jxb/eri170; HOCK B, 1982, ANN NY ACAD SCI, V386, P350, DOI 10.1111/j.1749-6632.1982.tb21427.x; Igamberdiev AU, 2003, BBA-BIOENERGETICS, V1606, P117, DOI 10.1016/S0005-2728(03)00106-3; Irimia A, 2004, J MOL BIOL, V335, P343, DOI 10.1016/j.jmb.2003.10.054; ISSAKIDIS E, 1992, J BIOL CHEM, V267, P21577; Johansson K, 1999, BIOCHEMISTRY-US, V38, P4319, DOI 10.1021/bi982876c; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; Lemaire M, 1996, EUR J BIOCHEM, V236, P947, DOI 10.1111/j.1432-1033.1996.00947.x; Lemaire M, 1996, FEBS LETT, V382, P137, DOI 10.1016/0014-5793(96)00153-6; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Marchand C, 2004, PROTEOMICS, V4, P2696, DOI 10.1002/pmic.200400805; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Miller SS, 1998, PLANT J, V15, P173, DOI 10.1046/j.1365-313X.1998.00192.x; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; OCHERETINA O, 1993, BIOCHIM BIOPHYS ACTA, V1163, P10, DOI 10.1016/0167-4838(93)90272-S; RIVERAMADRID R, 1995, P NATL ACAD SCI USA, V92, P5620, DOI 10.1073/pnas.92.12.5620; Ruelland E, 1997, J BIOL CHEM, V272, P19851, DOI 10.1074/jbc.272.32.19851; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sasaki Y, 1997, P NATL ACAD SCI USA, V94, P11096, DOI 10.1073/pnas.94.20.11096; SCHEIBE R, 1981, BIOCHIM BIOPHYS ACTA, V636, P58, DOI 10.1016/0005-2728(81)90075-X; SCHEIBE R, 1991, BIOCHIM BIOPHYS ACTA, V1076, P1, DOI 10.1016/0167-4838(91)90212-I; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stumpp MT, 1999, BIOCHEM J, V341, P157, DOI 10.1042/0264-6021:3410157; Taniguchi M, 2002, PLANT CELL PHYSIOL, V43, P706, DOI 10.1093/pcp/pcf109; Trejo F, 2001, PROTEIN ENG, V14, P911, DOI 10.1093/protein/14.11.911; Vignols F, 2005, P NATL ACAD SCI USA, V102, P16729, DOI 10.1073/pnas.0506880102; WALK RA, 1978, BIOCHEM BIOPH RES CO, V81, P636, DOI 10.1016/0006-291X(78)91583-8; Yamazaki D, 2004, PLANT CELL PHYSIOL, V45, P18, DOI 10.1093/pcp/pch019; Yano H, 2001, P NATL ACAD SCI USA, V98, P4794, DOI 10.1073/pnas.071041998; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438	51	51	52	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32065	32071		10.1074/jbc.M605784200	http://dx.doi.org/10.1074/jbc.M605784200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16945919	hybrid			2022-12-27	WOS:000241414500003
J	Zhao, W; Chen, TLL; Vertel, BM; Colley, KJ				Zhao, Weihan; Chen, Tung-Ling L.; Vertel, Barbara M.; Colley, Karen J.			The CMP-sialic acid transporter is localized in the medial-trans Golgi and possesses two specific endoplasmic reticulum export motifs in its carboxyl-terminal cytoplasmic tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SUGAR TRANSPORTER; GDP-MANNOSE TRANSPORTER; UDP-GALACTOSE TRANSPORTER; POLYSIALIC ACID; LEUKOCYTE-ADHESION; CAENORHABDITIS-ELEGANS; SUBSTRATE RECOGNITION; FUNCTIONAL EXPRESSION; CONGENITAL DISORDERS; GLYCOSYLATION	The addition of sialic acid to glycoproteins and glycolipids requires Golgi sialyltransferases to have access to their glycoconjugate substrates and nucleotide sugar donor, CMP-sialic acid. CMP-sialic acid is transported into the lumen of the Golgi complex through the CMP-sialic acid transporter, an antiporter that also functions to transport CMP into the cytosol. We localized the transporter using immunofluorescence and deconvolution microscopy to test the prediction that it is broadly distributed across the Golgi stack to serve the many sialyltransferases involved in glycoconjugate sialylation. The transporter co-localized with ST6GalI in the medial and trans Golgi, showed partial overlap with a medial Golgi marker and little overlap with early Golgi or trans Golgi network markers. Endoplasmic reticulum-retained forms of sialyltransferases did not redistribute the transporter from the Golgi to the endoplasmic reticulum, suggesting that transporter-sialyltransferase complexes are not involved in transporter localization. Next we evaluated the role of the transporter's N- and C-terminal cytoplasmic tails in its trafficking and localization. The N- tail was not required for either endoplasmic reticulum export or Golgi localization. The C-tail was required for endoplasmic reticulum export and contained di-Ile and terminal Val motifs at its very C terminus that function as independent endoplasmic reticulum export signals. Deletion of the last four amino acids of the C-tail (IIGV) eliminated these export signals and prevented endoplasmic reticulum export of the transporter. This form of the transporter supplied limited amounts of CMP-sialic acid to Golgi sialyltransferases but was unable to completely rescue the transporter defect of Lec2 Chinese hamster ovary cells.	Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, N Chicago, IL 60064 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rosalind Franklin University Medical & Science	Colley, KJ (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048134] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM48134] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe M, 2004, J CELL SCI, V117, P5687, DOI 10.1242/jcs.01491; Aoki K, 2003, J BIOL CHEM, V278, P22887, DOI 10.1074/jbc.M302620200; Aoki K, 2001, J BIOL CHEM, V276, P21555, DOI 10.1074/jbc.M101462200; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; BERNACKI RJ, 1975, EUR J BIOCHEM, V58, P477, DOI 10.1111/j.1432-1033.1975.tb02395.x; Berninsone P, 1997, J BIOL CHEM, V272, P12616, DOI 10.1074/jbc.272.19.12616; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; Chen TLL, 2003, GLYCOBIOLOGY, V13, P109, DOI 10.1093/glycob/cwg015; Chiaramonte M, 2001, BIOCHEMISTRY-US, V40, P14260, DOI 10.1021/bi011262w; COATES SW, 1980, J BIOL CHEM, V255, P9225; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Corse E, 2002, J VIROL, V76, P1273, DOI 10.1128/JVI.76.3.1273-1284.2002; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Fukuda M, 1996, CANCER RES, V56, P2237; Gao XD, 2000, J BIOL CHEM, V275, P17718, DOI 10.1074/jbc.M909946199; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Glick BS, 1997, FEBS LETT, V414, P177, DOI 10.1016/S0014-5793(97)00984-8; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Grabenhorst E, 1999, J BIOL CHEM, V274, P36107, DOI 10.1074/jbc.274.51.36107; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helmus Y, 2006, BLOOD, V107, P3959, DOI 10.1182/blood-2005-08-3334; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Hildebrandt H, 1998, CANCER RES, V58, P779; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Kabuss R, 2005, GLYCOBIOLOGY, V15, P905, DOI 10.1093/glycob/cwi085; Kean EL, 2004, BBA-GEN SUBJECTS, V1673, P56, DOI 10.1016/j.bbagen.2004.04.006; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LEE EU, 1989, J BIOL CHEM, V264, P13848; LOCKER JK, 1994, J BIOL CHEM, V269, P28263; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Ma JY, 1999, J BIOL CHEM, V274, P8046, DOI 10.1074/jbc.274.12.8046; Maccioni HJF, 1999, BBA-MOL CELL BIOL L, V1437, P101, DOI 10.1016/S1388-1981(99)00002-5; Maccioni HJF, 2002, NEUROCHEM RES, V27, P629, DOI 10.1023/A:1020271932760; Martinez-Duncker I, 2005, BLOOD, V105, P2671, DOI 10.1182/blood-2004-09-3509; MATSUOKA Y, 1994, J BIOL CHEM, V269, P22565; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Nufer O, 2002, J CELL SCI, V115, P619; Opat AS, 2001, BIOCHIMIE, V83, P763, DOI 10.1016/S0300-9084(01)01312-8; Orci L, 2003, P NATL ACAD SCI USA, V100, P4586, DOI 10.1073/pnas.0730885100; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; RABOUILLE C, 1995, J CELL SCI, V108, P1617; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Schnaar RL, 2004, ARCH BIOCHEM BIOPHYS, V426, P163, DOI 10.1016/j.abb.2004.02.019; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Tiralongo J, 2006, GLYCOBIOLOGY, V16, P73, DOI 10.1093/glycob/cwj029; Toma L, 1996, J BIOL CHEM, V271, P3897; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200	88	36	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31106	31118		10.1074/jbc.M605564200	http://dx.doi.org/10.1074/jbc.M605564200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16923816	hybrid			2022-12-27	WOS:000241075900086
J	Johnson, DJD; Langdown, J; Li, W; Luis, SA; Baglin, TP; Huntington, JA				Johnson, Daniel J. D.; Langdown, Jonathan; Li, Wei; Luis, Stephan A.; Baglin, Trevor P.; Huntington, James A.			Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN AFFINITY; TERNARY COMPLEX; FACTOR XA; ACTIVATION; MECHANISM; SERPIN; SPECIFICITY; SUBSTRATE; ALLOSTERY; BINDING	The poor inhibitory activity of circulating antithrombin ( AT) is critical to the formation of blood clots at sites of vascular damage. AT becomes an efficient inhibitor of the coagulation proteases only after binding to a specific heparin pentasaccharide, which alters the conformation of the reactive center loop (RCL). The molecular basis of this activation event lies at the heart of the regulation of hemostasis and accounts for the anticoagulant properties of the low molecular weight heparins. Although several structures of AT have been solved, the conformation of the RCL in native AT remains unknown because of the obligate crystal contact between the RCL of native AT and its latent counterpart. Here we report the crystallographic structure of a variant of AT in its monomeric native state. The RCL shifted similar to 20 angstrom, and a salt bridge was observed between the P1 residue (Arg-393) and Glu-237. This contact explains the effect of mutations at the P1 position on the affinity of AT for heparin and also the properties of AT-Truro (E237K). The relevance of the observed conformation was verified through mutagenesis studies and by solving structures of the same variant in different crystal forms. We conclude that the poor inhibitory activity of the circulating form of AT is partially conferred by intramolecular contacts that restrain the RCL, orient the P1 residue away from attacking proteases, and additionally block the exosite utilized in protease recognition.	Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Div Struct Med,Thrombosis Res Unit, Cambridge CB2 2XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Div Struct Med,Thrombosis Res Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	jah52@cam.ac.uk			Medical Research Council [G117/444] Funding Source: Medline; NHLBI NIH HHS [R01 HL068629-06, R01 HL068629, R01 HL68629] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068629] Funding Source: NIH RePORTER; MRC [G117/444] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Garone L, 1996, BIOCHEMISTRY-US, V35, P8881, DOI 10.1021/bi960542m; Huntington J. A., 2005, CHEM BIOL HEPARIN HE, P367; Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2004, J BIOL CHEM, V279, P4913, DOI 10.1074/jbc.M311644200; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; LESLIE AWG, 1992, JOINT CCP4 ESFEACMB; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mushunje A, 2003, BLOOD, V102, P4028, DOI 10.1182/blood-2003-05-1560; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P331, DOI 10.1016/S1050-1738(02)00183-4; OWEN MC, 1988, FEBS LETT, V231, P317, DOI 10.1016/0014-5793(88)80841-X; Pike RN, 1997, J BIOL CHEM, V272, P19652, DOI 10.1074/jbc.272.32.19652; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Whisstock JC, 2000, J MOL BIOL, V301, P1287, DOI 10.1006/jmbi.2000.3982; Zhou AW, 2003, J BIOL CHEM, V278, P15116, DOI 10.1074/jbc.M211663200	28	53	55	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35478	35486		10.1074/jbc.M607204200	http://dx.doi.org/10.1074/jbc.M607204200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16973611	Green Accepted, hybrid			2022-12-27	WOS:000241933700081
J	Lewin, A; Crow, A; Oubrie, A; Le Brun, NE				Lewin, Allison; Crow, Allister; Oubrie, Arthur; Le Brun, Nick E.			Molecular basis for specificity of the extracytoplasmic thioredoxin ResA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; THIOL-DISULFIDE OXIDOREDUCTASES; ACTIVE-SITE CYSTEINE; STRUCTURAL BASIS; CRYSTAL-STRUCTURES; REDOX PROPERTIES; PK(A) VALUES; REACTIVITY; DSBA; IONIZATION	ResA, an extracytoplasmic thioredoxin from Bacillus subtilis, acts in cytochrome c maturation by reducing the disulfide bond present in apocytochromes prior to covalent attachment of heme. This reaction is (and has to be) specific, as broad substrate specificity would result in unproductive shortcircuiting with the general oxidizing thioredoxin(s) present in the same compartment. Using mutational analysis and subsequent biochemical and structural characterization of active site variants, we show that reduced ResA displays unusually low reactivity at neutral pH, consistent with the observed high pK(a) values > 8 for both active site cysteines. Residue Glu(80) is shown to play a key role in controlling the acid-base properties of the active site. A model in which substrate binding dramatically enhances the reactivity of the active site cysteines is proposed to account for the specificity of the protein. Such a substrate-mediated activation mechanism is likely to have wide relevance for extracytoplasmic thioredoxins.	Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Biol Sci, Ctr Metalloprot Spect & Biol, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk	Crow, Allister/F-2147-2018	Crow, Allister/0000-0001-6856-5962; Oubrie, Arthur/0000-0001-6765-9246; Le Brun, Nick/0000-0001-9780-4061	Biotechnology and Biological Sciences Research Council [BB/C503597/1] Funding Source: Medline; Wellcome Trust [076017/Z/04/Z] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Allen JWA, 2003, PHILOS T ROY SOC B, V358, P255, DOI 10.1098/rstb.2002.1192; Aslund F, 1999, J BACTERIOL, V181, P1375; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BERGLUND O, 1970, J BIOL CHEM, V245, P6030; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Colbert CL, 2006, P NATL ACAD SCI USA, V103, P4410, DOI 10.1073/PNAS.0600552103; Crow A, 2005, BIOCHEM SOC T, V33, P149, DOI 10.1042/BST0330149; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; Dillet V, 1998, BIOCHEMISTRY-US, V37, P10298, DOI 10.1021/bi980333x; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Edeling MA, 2004, J BACTERIOL, V186, P4030, DOI 10.1128/JB.186.12.4030-4033.2004; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlendsson LS, 2004, J BACTERIOL, V186, P6230, DOI 10.1128/JB.186.18.6230-6238.2004; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; HAUGLAND RP, 2005, HBD GUIDE FLUORESCNE; Hutchings MI, 2000, J BACTERIOL, V182, P6434, DOI 10.1128/JB.182.22.6434-6439.2000; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; JOCELYN PC, 1972, BIOCH SH GROUP, P51; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; KALLIS GB, 1980, J BIOL CHEM, V255, P261; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Brun NE, 2000, MOL MICROBIOL, V36, P638, DOI 10.1046/j.1365-2958.2000.01883.x; LeMaster DM, 1997, J BIOL CHEM, V272, P29998, DOI 10.1074/jbc.272.48.29998; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mossner E, 2000, FEBS LETT, V477, P21, DOI 10.1016/S0014-5793(00)01738-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; NIKKOLA M, 1991, J BIOL CHEM, V266, P16105; Nordstrand K, 1999, FEBS LETT, V449, P196, DOI 10.1016/S0014-5793(99)00401-9; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Stevens JM, 2004, ACCOUNTS CHEM RES, V37, P999, DOI 10.1021/ar030266l; Stirnimann CU, 2006, J MOL BIOL, V358, P829, DOI 10.1016/j.jmb.2006.02.030; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503	54	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35467	35477		10.1074/jbc.M607047200	http://dx.doi.org/10.1074/jbc.M607047200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16971393	hybrid			2022-12-27	WOS:000241933700080
J	He, XZ; Wang, XQ; Dixon, RA				He, Xian-Zhi; Wang, Xiaoqiang; Dixon, Richard A.			Mutational analysis of the Medicago glycosyltransferase UGT71G1 reveals residues that control regioselectivity for (Iso) flavonoid glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; UDP-GLUCOSE; ARABIDOPSIS GLYCOSYLTRANSFERASES; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; KEY ENZYME; QUERCETIN; BIOSYNTHESIS; ABSORPTION; GLUCOSYLTRANSFERASES	The plant glycosyltransferase UGT71G1 from the model legume barrel medic ( Medicago truncatula) glycosylates flavonoids, isoflavonoids, and triterpenes. It can transfer glucose to each of the five hydroxyl groups of the flavonol quercetin, with the 3'-O-glucoside as the major product, and to the A-ring 7-hydroxyl of the isoflavone genistein. The sugar donor and acceptor binding pockets are located in the N and C termini, respectively, of the recently determined crystal structure of UGT71G1. The residues forming the binding pockets of UGT71G1 were systematically altered by site-directed mutagenesis. Mutation of Phe(148) to Val, or Tyr(202) to Ala, drastically changed the regioselectivity for quercetin glycosylation from predominantly the 3'-O-position of the B-ring to the 3-O-position of the C ring. The Y202A mutant exhibited comparable catalytic efficiency with quercetin to the wild-type enzyme, whereas efficiency was reduced 3-4-fold in the F148V mutant. The Y202A mutant gained the ability to glycosylate the 5-hydroxyl of genistein. Additional mutations affected the relative specificities for the sugar donors UDP-galactose and UDP-glucuronic acid, although UDP-glucose was always preferred. The results are discussed in relation to the design of novel biocatalysts for production of therapeutic flavonoids.	Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA	Noble Research Institute	Dixon, RA (corresponding author), 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	radixon@noble.org						Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Arend J, 2001, BIOTECHNOL BIOENG, V76, P126, DOI 10.1002/bit.1152; BARPELED M, 1991, J BIOL CHEM, V266, P20953; Bouktaib M, 2002, TETRAHEDRON LETT, V43, P6263, DOI 10.1016/S0040-4039(02)01264-9; Chong J, 2002, PLANT CELL, V14, P1093, DOI 10.1105/tpc.010436; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Day AJ, 2003, BIOCHEM PHARMACOL, V65, P1199, DOI 10.1016/S0006-2952(03)00039-X; Day AJ, 2000, FREE RADICAL BIO MED, V29, P1234, DOI 10.1016/S0891-5849(00)00416-0; Frydman A, 2004, PLANT J, V40, P88, DOI 10.1111/j.1365-313X.2004.02193.x; Fukuchi-Mizutani M, 2003, PLANT PHYSIOL, V132, P1652, DOI 10.1104/pp.102.018242; Geerlings A, 2000, J BIOL CHEM, V275, P3051, DOI 10.1074/jbc.275.5.3051; Harborne J.B, 1999, HDB NATURAL FLAVONOI, V1; HOLLMAN PCH, 1995, AM J CLIN NUTR, V62, P1276, DOI 10.1093/ajcn/62.6.1276; Hollman PCH, 1996, FREE RADICAL BIO MED, V21, P703, DOI 10.1016/0891-5849(96)00129-3; Hollman PCH, 1999, FREE RADICAL RES, V31, P569, DOI 10.1080/10715769900301141; Huhman DV, 2002, PHYTOCHEMISTRY, V59, P347, DOI 10.1016/S0031-9422(01)00432-0; Jackson RG, 2001, J BIOL CHEM, V276, P4350, DOI 10.1074/jbc.M006185200; Jones PR, 2000, RECENT ADV PHYTOCHEM, V34, P191, DOI 10.1016/S0079-9920(00)80008-8; Kita M, 2000, FEBS LETT, V469, P173, DOI 10.1016/S0014-5793(00)01275-8; Kramer CM, 2003, PHYTOCHEMISTRY, V64, P1069, DOI 10.1016/S0031-9422(03)00507-7; Kubo A, 2004, ARCH BIOCHEM BIOPHYS, V429, P198, DOI 10.1016/j.abb.2004.06.021; Li M, 2002, TETRAHEDRON LETT, V43, P9467, DOI 10.1016/S0040-4039(02)02139-1; Lim EK, 2004, BIOTECHNOL BIOENG, V87, P623, DOI 10.1002/bit.20154; Lim EK, 2003, BIOCHEM J, V373, P987, DOI 10.1042/BJ20021453; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Martin RC, 2000, PLANT GROWTH REGUL, V32, P289, DOI 10.1023/A:1010708001981; Miller KD, 1999, J BIOL CHEM, V274, P34011, DOI 10.1074/jbc.274.48.34011; Richman A, 2005, PLANT J, V41, P56, DOI 10.1111/j.1365-313X.2004.02275.x; Sawada S, 2005, J BIOL CHEM, V280, P899, DOI 10.1074/jbc.M410537200; Schulz JM, 2004, J BIOL CHEM, V279, P32796, DOI 10.1074/jbc.M405005200; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Taguchi G, 2000, PLANT SCI, V157, P105, DOI 10.1016/S0168-9452(00)00270-3; Vogt T, 1997, PLANTA, V203, P349, DOI 10.1007/s004250050201; Vogt T, 2002, PLANTA, V214, P492, DOI 10.1007/s00425-001-0685-1; VOGT T, 1995, PLANT PHYSIOL, V108, P903, DOI 10.1104/pp.108.3.903; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Willits MG, 2004, PHYTOCHEMISTRY, V65, P31, DOI 10.1016/j.phytochem.2003.10.005; Woo HH, 1999, PLANT CELL, V11, P2303, DOI 10.1105/tpc.11.12.2303	38	93	104	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34441	34447		10.1074/jbc.M605767200	http://dx.doi.org/10.1074/jbc.M605767200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16982612	hybrid			2022-12-27	WOS:000241767600064
J	Kim, M; Li, D; Cui, YX; Mueller, K; Chears, WC; DeJong, J				Kim, MinJung; Li, Dan; Cui, Yunxia; Mueller, Konrad; Chears, William C.; DeJong, Jeff			Regulatory factor interactions and somatic silencing of the germ cell-specific ALF gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H1T GENE; TRANSCRIPTION FACTOR SP1; BINDING PROTEIN; DNA-BINDING; PROXIMAL PROMOTER; FACTOR TFIIA; TESTIS; EXPRESSION; SPERMATOGENESIS; CTCF	Germ cell-specific genes are active in oocytes and spermatocytes but are silent in all other cell types. To understand the basis for this seemingly simple pattern of regulation, we characterized factors that recognize the promoter-proximal region of the germ cell-specific TFIIA alpha/beta-like factor (ALF) gene. Two of the protein-DNA complexes formed with liver extracts (C4 and C5) are due to the zinc finger proteins Sp1 and Sp3, respectively, whereas another complex (C6) is due to the transcription factor RFX1. Two additional complexes (C1 and C3) are due to the multivalent zinc finger protein CTCF, a factor that plays a role in gene silencing and chromatin insulation. An investigation of CTCF binding revealed a recognition site of only 17 bp that overlaps with the Sp1/Sp3 site. This site is predictive of other genomic CTCF sites and can be aligned to create a functional consensus. Studies on the activity of the ALF promoter in somatic 293 cells revealed mutations that result in increased reporter activity. In addition, RNAi-mediated down-regulation of CTCF is associated with activation of the endogenous ALF gene, and both CTCF and Sp3 repress the promoter in transient transfection assays. Overall, the results suggest a role for several factors, including the multivalent zinc finger chromatin insulator protein CTCF, in mediating somatic repression of the ALF gene. Release of such repression, perhaps in conjunction with other members of the CTCF, RFX, and Sp1 families of transcription factors, could be an important aspect of germ cell gene activation.	Univ Texas, Dept Mol & Cell Biol, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas	DeJong, J (corresponding author), Univ Texas, Dept Mol & Cell Biol, 2601 N Floyd Rd, Richardson, TX 75080 USA.	dejong@utdallas.edu		Li, Dan/0000-0002-8841-8991				Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bonny C, 1998, BIOL REPROD, V58, P754, DOI 10.1095/biolreprod58.3.754; Clare SE, 1997, J BIOL CHEM, V272, P33028, DOI 10.1074/jbc.272.52.33028; DeJong J, 2006, GENE, V366, P39, DOI 10.1016/j.gene.2005.10.012; DeLuca P, 1996, J BIOL CHEM, V271, P8533, DOI 10.1074/jbc.271.15.8533; Filippova GN, 2002, CANCER RES, V62, P48; Grimes SR, 2005, J CELL BIOCHEM, V94, P317, DOI 10.1002/jcb.20320; Han SY, 2004, BIOL REPROD, V71, P933, DOI 10.1095/biolreprod.104.030247; Han SY, 2003, J BIOL CHEM, V278, P45586, DOI 10.1074/jbc.M302884200; Han SY, 2001, BIOL REPROD, V64, P507, DOI 10.1095/biolreprod64.2.507; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Horvath GC, 2004, BIOL REPROD, V71, P1551, DOI 10.1095/biolreprod.104.032268; Horvath GC, 2001, BIOL REPROD, V65, P1074, DOI 10.1095/biolreprod65.4.1074; Huang M, 2006, INT J MOL MED, V17, P599; IANNELLO RC, 1993, J BIOL CHEM, V268, P22581; Jethanandani P, 2001, J BIOL CHEM, V276, P35414, DOI 10.1074/jbc.M101269200; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; MIZUNO K, 1992, GENE, V119, P293, DOI 10.1016/0378-1119(92)90286-X; Morotami-Yano K, 2002, J BIOL CHEM, V277, P836, DOI 10.1074/jbc.M108638200; Muller C, 1999, J BIOL CHEM, V274, P11220, DOI 10.1074/jbc.274.16.11220; Nakayama A, 2003, J BIOL CHEM, V278, P233, DOI 10.1074/jbc.M209574200; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ozer J, 2000, J BIOL CHEM, V275, P122, DOI 10.1074/jbc.275.1.122; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Persengiev SP, 1996, ENDOCRINOLOGY, V137, P638, DOI 10.1210/en.137.2.638; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Reddi PP, 2003, DEV BIOL, V262, P173, DOI 10.1016/S0012-1606(03)00349-X; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; Santti H, 2003, BIOCHEM BIOPH RES CO, V308, P139, DOI 10.1016/S0006-291X(03)01339-1; Schmidt EE, 1997, J BIOL CHEM, V272, P5326, DOI 10.1074/jbc.272.8.5326; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; SIERRA F, 1990, LAB GUIDE IN VITRO T, P29; Storre J, 2005, J BIOL CHEM, V280, P41380, DOI 10.1074/jbc.M506797200; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Thomas K, 2005, BIOL REPROD, V72, P898, DOI 10.1095/biolreprod.104.030528; Upadhyaya AB, 1999, J BIOL CHEM, V274, P18040, DOI 10.1074/jbc.274.25.18040; Upadhyaya AB, 2002, J BIOL CHEM, V277, P34208, DOI 10.1074/jbc.M204808200; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Veenstra GJC, 2001, TRENDS BIOCHEM SCI, V26, P665, DOI 10.1016/S0968-0004(01)01970-3; Wilkerson DC, 2002, BIOL REPROD, V67, P1157, DOI 10.1095/biolreprod67.4.1157; Xie WS, 2002, J BIOL CHEM, V277, P17765, DOI 10.1074/jbc.M200954200; Zhang LP, 1999, BIOL REPROD, V60, P1329, DOI 10.1095/biolreprod60.6.1329	48	23	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34288	34298		10.1074/jbc.M607168200	http://dx.doi.org/10.1074/jbc.M607168200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966320	hybrid			2022-12-27	WOS:000241767600049
J	Pan, S; Wang, R; Zhou, X; He, G; Koomen, J; Kobayashi, R; Sun, L; Corvera, J; Gallick, GE; Kuang, J				Pan, Shujuan; Wang, Ruoning; Zhou, Xi; He, Guangan; Koomen, John; Kobayashi, Ryuji; Sun, Le; Corvera, Joe; Gallick, Gary E.; Kuang, Jian			Involvement of the conserved adaptor protein Alix in actin cytoskeleton assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; BINDING PARTNER; INTERACTS; BRO1; PHALLOIDIN; APOPTOSIS; PATHWAY; ALG-2; GENE; TUMORIGENICITY	The conserved adaptor protein Alix, also called AIP1 or Hp95, promotes flattening and alignment of cultured mammalian fibroblasts; however, the mechanism by which Alix regulates fibroblast morphology is not understood. Here we demonstrate that Alix in WI38 cells, which require Alix expression for maintaining typical fibroblast morphology, associates with filamentous actin (F-actin) and F-actin-based structures lamellipodia and stress fibers. Reducing Alix expression by small interfering RNA (siRNA) decreases F-actin content and inhibits stress fiber assembly. In cell-free systems, Alix directly interacts with F-actin at both the N-terminal Bro1 domain and the C-terminal proline-rich domain. In Alix immunoprecipitates from WI38 cell lysates, actin is the most abundant partner protein of Alix. In addition, the N-terminal half of the middle region of Alix binds cortactin, an activator of the ARP2/3 complex-mediated initiation of actin polymerization. Alix is required for lamellipodial localization of cortactin. The C-terminal half of the middle region of Alix interacts with alpha-actinin, a key factor that bundles F-actin in stress fibers. Alix knockdown decreases the amount of alpha-actinin that associates with F-actin. These findings establish crucial involvement of Alix in actin cytoskeleton assembly.	Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; A&G Pharmaceut Inc, Baltimore, MD 21202 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kuang, J (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd,Box 019, Houston, TX 77030 USA.	jkuang@mdanderson.org	Wang, Ruoning/C-1683-2014; Koomen, John/D-1844-2013; Zhou, Xi/J-1902-2012	Zhou, Xi/0000-0002-3846-5079	NCI NIH HHS [1 R01 CA93941, CA16672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093941, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMANKWAH KS, 1994, EXP CELL RES, V210, P315, DOI 10.1006/excr.1994.1044; Banan A, 2000, GUT, V46, P830, DOI 10.1136/gut.46.6.830; BEREITERHAHN J, 1988, HISTOCHEMISTRY, V90, P271, DOI 10.1007/BF00495970; Blystone SD, 2004, BBA-MOL CELL RES, V1692, P47, DOI 10.1016/j.bbamcr.2004.04.011; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; CARTER CA, 1994, EXP CELL RES, V212, P141, DOI 10.1006/excr.1994.1128; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; JONGSTRABILEN J, 1992, J CELL BIOL, V118, P1443, DOI 10.1083/jcb.118.6.1443; KAHN P, 1983, CYTOGENET CELL GENET, V36, P605, DOI 10.1159/000131983; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Krebs J, 2000, BBA-MOL CELL RES, V1498, P153, DOI 10.1016/S0167-4889(00)00091-4; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; LENGSFEL.AM, 1974, P NATL ACAD SCI USA, V71, P2803, DOI 10.1073/pnas.71.7.2803; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Nakamura K, 1999, FEBS LETT, V445, P9, DOI 10.1016/S0014-5793(99)00087-3; Nickas ME, 1996, MOL CELL BIOL, V16, P2585; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Peck JW, 2002, J BIOL CHEM, V277, P43924, DOI 10.1074/jbc.M203569200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Sadoul R, 2006, BIOL CELL, V98, P69, DOI 10.1042/BC20050007; Schmidt MHH, 2003, J CELL SCI, V116, P2845, DOI 10.1242/jcs.00522; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Trioulier Y, 2004, J BIOL CHEM, V279, P2046, DOI 10.1074/jbc.M309243200; VERDERAME M, 1980, P NATL ACAD SCI-BIOL, V77, P6624, DOI 10.1073/pnas.77.11.6624; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Wu Y, 2001, DIFFERENTIATION, V67, P139, DOI 10.1046/j.1432-0436.2001.670406.x; Wu Y, 2002, ONCOGENE, V21, P6801, DOI 10.1038/sj.onc.1205849; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Yates-Siilata KE, 2004, CELL BIOL INT, V28, P33, DOI 10.1016/j.cellbi.2003.09.003	47	52	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34640	34650		10.1074/jbc.M602263200	http://dx.doi.org/10.1074/jbc.M602263200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966331	hybrid			2022-12-27	WOS:000241767600083
J	Chong, YP; Chan, AS; Chan, KC; Williamson, NA; Lerner, EC; Smithgall, TE; Bjorge, JD; Fujita, DJ; Purcell, AW; Scholz, G; Mulhern, TD; Cheng, HC				Chong, Yuh-Ping; Chan, Andrew S.; Chan, Khai-Chew; Williamson, Nicholas A.; Lerner, Edwina C.; Smithgall, Thomas E.; Bjorge, Jeffrey D.; Fujita, Donald J.; Purcell, Anthony W.; Scholz, Glen; Mulhern, Terrence D.; Cheng, Heung-Chin			C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SH2 DOMAIN; CRYSTAL-STRUCTURE; PROTEIN-KINASES; CELL BEHAVIOR; ACTIVATION; HCK; PHOSPHORYLATION; BINDING; AUTOPHOSPHORYLATION	The Src family of protein kinases (SFKs) mediates mitogenic signal transduction, and constitutive SFK activation is associated with tumorigenesis. To prevent constitutive SFK activation, the catalytic activity of SFKs in normal mammalian cells is suppressed mainly by two inhibitors called C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK), which inactivate SFKs by phosphorylating a consensus tyrosine near the C terminus of SFKs (Y-T). The phosphorylated Y-T intramolecularly binds to the SH2 domain of SFKs. This interaction, known as pY(T)/SH2 interaction, together with binding between the SH2 kinase linker and the SH3 domain of SFKs (linker/SH3 interaction) stabilizes SFKs in a "closed" inactive conformation. We previously discovered an alternative mechanism CHK employs to inhibit SFKs. This mechanism, referred to as the non-catalytic inhibitory mechanism, involves tight binding of CHK to SFKs; the binding alone is sufficient to inhibit SFKs. Herein, we constructed multiple active conformations of an SFK member, Hck, by systematically disrupting the two inhibitory interactions. We found that CHK employs the non-catalytic mechanism to inactivate these active conformations of Hck. However, CHK does not bind Hck when it adopts the inactive conformation in which both inhibitory interactions are intact. These data indicate that binding of CHK to SFKs via the non-catalytic mechanism is governed by the conformations of SFKs. Although CSK is also an inhibitor of SFKs, it does not inhibit SFKs by a similar non-catalytic mechanism. Thus, the non-catalytic inhibitory mechanism is a unique property of CHK that allows it to down-regulate multiple active conformations of SFKs.	Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Melbourne; University of Melbourne; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Mulhern, TD (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	tmulhern@unimelb.edu.au; heung@unimelb.edu.au	Mulhern, Terrence/A-1206-2007; Purcell, Anthony/AAH-1942-2019; Williamson, Nicholas A/O-9812-2016	Purcell, Anthony/0000-0003-0532-8331; Williamson, Nicholas A/0000-0002-2173-3452; Mulhern, Terrence/0000-0002-1609-7498; Scholz, Glen/0000-0003-2722-6344; Cheng, Heung-Chin/0000-0002-4965-7148; Chong, Yuh Ping/0000-0002-9596-3242				Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P9083, DOI 10.1021/bi973147k; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; CHENG HC, 2006, AFCS NATURE MOL PAGE, DOI DOI 10.1038/MP.A000705.01; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Chong YP, 2004, J BIOL CHEM, V279, P20752, DOI 10.1074/jbc.M309865200; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Johnson TM, 2000, J BIOL CHEM, V275, P33353, DOI 10.1074/jbc.M002022200; Johnson TM, 1997, J PEPT RES, V50, P365; KOEGL M, 1994, BIOCHEM J, V302, P737, DOI 10.1042/bj3020737; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lim WA, 2002, CURR OPIN STRUC BIOL, V12, P61, DOI 10.1016/S0959-440X(02)00290-7; Miller WT, 2003, ACCOUNTS CHEM RES, V36, P393, DOI 10.1021/ar020116v; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Mulhern TD, 2002, J BIOMOL NMR, V24, P363, DOI 10.1023/A:1021657406480; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; Nitabach MN, 2002, J NEUROSCI, V22, P7913; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schulte RJ, 2003, BIOCHEMISTRY-US, V42, P9424, DOI 10.1021/bi034519u; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sicilia RJ, 1998, J BIOL CHEM, V273, P16756, DOI 10.1074/jbc.273.27.16756; SOTIRELLIS N, 1995, J BIOL CHEM, V270, P29773; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	41	31	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					32988	32999		10.1074/jbc.M602951200	http://dx.doi.org/10.1074/jbc.M602951200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959780	hybrid			2022-12-27	WOS:000241621400007
J	Hatziapostolou, M; Polytarchou, C; Katsoris, P; Courty, J; Papadimitriou, E				Hatziapostolou, Maria; Polytarchou, Christos; Katsoris, Panagiotis; Courty, Jose; Papadimitriou, Evangelia			Heparin affin regulatory peptide/pleiotrophin mediates fibroblast growth factor 2 stimulatory effects on human prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; ACTIVATOR PROTEIN-1; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; SIGNAL-TRANSDUCTION; RECEPTOR; EXPRESSION; PLEIOTROPHIN; PEPTIDE	Fibroblast growth factor 2 (FGF2) is a pleiotropic growth factor that has been implicated in prostate cancer formation and progression. In the present study we found that exogenous FGF2 significantly increased human prostate cancer LNCaP cell proliferation and migration. Heparin affin regulatory peptide ( HARP) or pleiotrophin seems to be an important mediator of FGF2 stimulatory effects, since the latter had no effect on stably transfected LNCaP cells that did not express HARP. Moreover, FGF2, through FGF receptors (FGFRs), significantly induced HARP expression and secretion by LNCaP cells and increased luciferase activity of a reporter gene vector carrying the full-length promoter of HARP gene. Using a combination of Western blot analyses, as well as genetic and pharmacological inhibitors, we found that activation of FGFR by FGF2 in LNCaP cells leads to NAD(P) H oxidase-dependent hydrogen peroxide production, phosphorylation of ERK1/2 and p38, activation of AP-1, increased expression and secretion of HARP, and, finally, increased cell proliferation and migration. These results establish the role and the mode of activity of FGF2 in LNCaP cells and support an interventional role of HARP in FGF2 effects, providing new insights on the interplay among growth factor pathways within prostate cancer cells.	Univ Patras, Dept Pharm, Mol Pharmacol Lab, GR-26504 Patras, Greece; Univ Patras, Dept Biol, Div Genet Cell & Dev Biol, GR-26504 Patras, Greece; Univ Paris 12, Lab Rech Croissance Cellulaire Reparat & Regenera, CNRS, UMR 7149, F-94010 Creteil, France	University of Patras; University of Patras; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Papadimitriou, E (corresponding author), Univ Patras, Dept Pharm, Mol Pharmacol Lab, GR-26504 Patras, Greece.	epapad@upatras.gr	Courty, Jose/Q-3702-2018; Papadimitriou, Evangelia/ABG-1356-2020; Papadimitriou, Evangelia/F-3396-2010; Hatziapostolou, Maria/N-1820-2015	Papadimitriou, Evangelia/0000-0001-6429-4325; Hatziapostolou, Maria/0000-0003-2493-7028				Aigner A, 2003, ANN ONCOL, V14, P1525, DOI 10.1093/annonc/mdg416; Aslan M, 2003, ANTIOXID REDOX SIGN, V5, P781, DOI 10.1089/152308603770380089; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Connolly JM, 1998, J UROLOGY, V160, P932, DOI 10.1016/S0022-5347(01)62835-0; Cook SJ, 1999, MOL CELL BIOL, V19, P330; COURTY J, 1991, BIOCHEM BIOPH RES CO, V180, P145, DOI 10.1016/S0006-291X(05)81267-7; Cronauer MV, 1997, PROSTATE, V31, P223; Ding M, 2001, J BIOL CHEM, V276, P9108, DOI 10.1074/jbc.M007666200; Dow JK, 2000, UROLOGY, V55, P800, DOI 10.1016/S0090-4295(00)00457-X; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Freeman KW, 2003, CANCER RES, V63, P8256; Giri D, 1999, CLIN CANCER RES, V5, P1063; Hatziapostolou M, 2005, PROSTATE, V65, P151, DOI 10.1002/pros.20270; Huss WJ, 2003, PROSTATE, V54, P8, DOI 10.1002/pros.10163; Jackson MW, 2002, CANCER RES, V62, P854; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kesavan K, 2004, J CELL PHYSIOL, V199, P140, DOI 10.1002/jcp.10457; Kwabi-Addo B, 2004, ENDOCR-RELAT CANCER, V11, P709, DOI 10.1677/erc.1.00535; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Mehta PB, 2001, ONCOGENE, V20, P5359, DOI 10.1038/sj.onc.1204688; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; MOSCATELLI D, 1986, J CELL PHYSIOL, V129, P273, DOI 10.1002/jcp.1041290220; NAKAMOTO T, 1992, CANCER RES, V52, P571; OKUMURA N, 1989, J BIOCHEM-TOKYO, V106, P904, DOI 10.1093/oxfordjournals.jbchem.a122950; Papadimitriou E, 2004, CURR CANCER DRUG TAR, V4, P471, DOI 10.2174/1568009043332835; Polnaszek N, 2003, CANCER RES, V63, P5754; Polykratis A, 2005, J BIOL CHEM, V280, P22454, DOI 10.1074/jbc.M414407200; Polytarchou C, 2005, J BIOL CHEM, V280, P40428, DOI 10.1074/jbc.M505120200; Polytarchou C, 2005, EUR J PHARMACOL, V510, P31, DOI 10.1016/j.ejphar.2005.01.004; Ryoo SW, 2004, CARDIOVASC RES, V62, P185, DOI 10.1016/j.cardiores.2004.01.002; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Thannickal VJ, 2000, FASEB J, V14, P1741, DOI 10.1096/fj.99-0878com; Udayakumar TS, 2003, MOL CARCINOGEN, V38, P70, DOI 10.1002/mc.10146; Ulbricht U, 2003, J NEUROPATH EXP NEUR, V62, P1265, DOI 10.1093/jnen/62.12.1265; Vega A, 2006, J LEUKOCYTE BIOL, V80, P152, DOI 10.1189/jlb.0705411; Wang ZB, 2001, BIOCHEM BIOPH RES CO, V285, P669, DOI 10.1006/bbrc.2001.5232; Wartenberg M, 2005, FEBS LETT, V579, P4541, DOI 10.1016/j.febslet.2005.06.078	41	38	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32217	32226		10.1074/jbc.M607104200	http://dx.doi.org/10.1074/jbc.M607104200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16940294	hybrid			2022-12-27	WOS:000241414500019
J	Hosoya-Ohmura, S; Mochizuki, N; Suzuki, M; Ohneda, O; Ohneda, K; Yamamoto, M				Hosoya-Ohmura, Sakie; Mochizuki, Naomi; Suzuki, Mikiko; Ohneda, Osamu; Ohneda, Kinuko; Yamamoto, Masayuki			GATA-4 incompletely substitutes for GATA-1 in promoting both primitive and definitive erythropoiesis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; EMBRYONIC STEM-CELLS; ZINC-FINGER PROTEIN; SMALL MAF PROTEINS; ERYTHROID-DIFFERENTIATION; SELF-ASSOCIATION; EKLF; DROSOPHILA; HEMATOPOIESIS; SURVIVAL	Vertebrate GATA transcription factors have been classified into two subgroups; GATA-1, GATA-2, and GATA-3 are expressed in hematopoietic cells, whereas GATA-4, GATA-5, and GATA-6 are expressed in mesoendoderm-derived tissues. We previously discovered that expression of GATA-2 or GATA-3 under the transcriptional control for the Gata1 gene eliminates lethal anemia in Gata1 germ line mutant mice (Gata1.05/Y). Here, we show that the GATA-4 expression by the same regulatory cassette prolongs the life span of Gata1.05/Y embryos from embryonic day 12.5 to 15.5 but fails to abrogate its embryonic lethality. Gata1.05/Y mice bearing the GATA-4 transgene showed impaired maturation of both primitive and definitive erythroid cells and defective erythroid cell expansion in fetal liver. Moreover, the incidence of apoptosis was observed prominently in primitive erythroid cells. In contrast, a GATA4- GATA-1 chimeric protein prepared by linking the N-terminal region of GATA-4 to the C-terminal region of GATA-1 significantly promoted the differentiation and survival of primitive erythroid cells, although this protein is still insufficient for rescuing Gata1.05/Y embryos from lethal anemia. These data thus show a functional incompatibility between hematopoietic and endodermal GATA factors in vivo and provide evidence indicating specific roles of the C-terminal region of GATA-1 in primitive erythropoiesis.	Univ Tsukuba, Grad Sch Comprehens Human Sci, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Environm Response Project, Exploratory Res adv Technol, Japan Sci & Technol Corp, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba	Ohneda, K (corresponding author), Takasaki Univ Hlth & Welfare, Dept Pharm, Fac Pharm, 60 Nalaorui, Takasaki, Gumma 3700033, Japan.	kohneda@takasaki-u.ac.jp; masi@tara.tsukuba.ac.jp	Yamamoto, Masayuki/A-4873-2010; Suzuki, Mikiko/B-5177-2010; Ohneda, Kinuko/AAC-8822-2019	Yamamoto, Masayuki/0000-0002-9073-9436; 				Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; BLOBEL GA, 1995, MOL CELL BIOL, V15, P626; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; BROTHERTON TW, 1979, P NATL ACAD SCI USA, V76, P2853, DOI 10.1073/pnas.76.6.2853; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hung HL, 1999, MOL CELL BIOL, V19, P3496; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Katsuoka F, 2000, EMBO J, V19, P2980, DOI 10.1093/emboj/19.12.2980; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; Osawa M, 2002, BLOOD, V100, P2769, DOI 10.1182/blood-2002-01-0182; Pan XQ, 2005, J BIOL CHEM, V280, P22385, DOI 10.1074/jbc.M500081200; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; PERKINS AC, 1995, NATURE, V375, P318; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Rhodes MM, 2005, BLOOD, V106, P1857, DOI 10.1182/blood-2004-11-4344; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Wagner KU, 2000, DEVELOPMENT, V127, P4949; WASSARMAN PM, 1993, GUIDE TECHNIQUES MOU; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	43	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32820	32830		10.1074/jbc.M605735200	http://dx.doi.org/10.1074/jbc.M605735200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16945928	hybrid			2022-12-27	WOS:000241414500080
J	Wang, DW; Tan, YC; Kreitzer, GE; Nakai, Y; Shan, DD; Zheng, Y; Huang, XY				Wang, Dawei; Tan, Ying-cai; Kreitzer, Geri E.; Nakai, Yoko; Shan, Dandan; Zheng, Yi; Huang, Xin-Yun			G proteins G(12) and G(13) control the dynamic turnover of growth factor-induced dorsal ruffles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN REORGANIZATION; HUMAN-FIBROBLASTS; STIMULATED CELLS; MEMBRANE; G-ALPHA(13); ACTIVATION; CYTOSKELETON; INDUCTION; PODOSOMES; MIGRATION	Growth factors induce massive actin cytoskeletal remodeling in cells. These reorganization events underlie various cellular responses such as cell migration and morphological changes. One major form of actin reorganization is the formation and disassembly of dorsal ruffles (also named waves, dorsal rings, or circular ruffles). Dorsal ruffles are involved in physiological functions including cell migration, invasion, macropinocytosis, plasma membrane recycling, and others. Growth factors initiate rapid formation (within 5 min) of circular membrane ruffles, and these ruffles move along the dorsal side of the cells, constrict, close, and eventually disassemble (similar to 20 min). Considerable attention has been devoted to the mechanism by which growth factors induce the formation of dorsal ruffles. However, little is known of the mechanism by which these ruffles are disassembled. Here we have shown that G proteins G(12) and G(13) control the rate of disassembly of dorsal ruffles. In G alpha(12) (-/-)G alpha(-/-)(13) fibroblast cells, dorsal ruffles induced by growth factor treatment remain visible substantially longer (similar to 60 min) than in wild-type cells, whereas the rate of formation of these ruffles was the same with or without G alpha(12) and G alpha(13). Thus, G alpha(12)/G alpha(13) critically regulate dorsal ruffle turnover.	Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol, Cincinnati, OH 45229 USA	Cornell University; Cornell University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA.	xyhuang@med.cornell.edu			NATIONAL INSTITUTE ON AGING [R01AG023202] Funding Source: NIH RePORTER; NIA NIH HHS [AG 23202] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; BLUMEJENSEN P, 1991, EMBO J, V10, P4121, DOI 10.1002/j.1460-2075.1991.tb04989.x; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Edgar AJ, 1997, EUR J CELL BIOL, V73, P132; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; HEDBERG KM, 1993, CELL MOTIL CYTOSKEL, V24, P139, DOI 10.1002/cm.970240207; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; MELLSTROM K, 1983, J MUSCLE RES CELL M, V4, P589, DOI 10.1007/BF00712117; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Ruthel G, 1999, J NEUROBIOL, V39, P97, DOI 10.1002/(SICI)1097-4695(199904)39:1<97::AID-NEU8>3.0.CO;2-Z; SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; WARN R, 1993, X SOC EXP BIOL, V47, P325	30	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32660	32667		10.1074/jbc.M604588200	http://dx.doi.org/10.1074/jbc.M604588200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943201	hybrid			2022-12-27	WOS:000241414500064
J	Yamamoto, M; Chen, MZ; Wang, YJ; Sun, HQ; Wei, YJ; Martinez, M; Yin, HL				Yamamoto, Masaya; Chen, Mark Z.; Wang, Ying-Jie; Sun, Hui-Qiao; Wei, Yongjie; Martinez, Manuel; Yin, Helen L.			Hypertonic stress increases phosphatidylinositol 4,5-bisphosphate levels by activating PIP5KI beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-PHOSPHATE 5-KINASE; PLASMA-MEMBRANE; OSMOTIC-STRESS; CELL-VOLUME; KINASE; PROTEIN; RHO; ARF6; RAC; PHOSPHORYLATION	Hyperosmotic stress increases phosphoinositide levels, reorganizes the actin cytoskeleton, and induces multiple acute and adaptive physiological responses. Here we showed that phosphatidylinositol 4,5-bisphosphate (PIP2) level increased rapidly in HeLa cells during hypertonic treatment. Depletion of the human type I phosphatidylinositol 4-phosphate 5-kinase beta isoform (PIP5KI beta) by RNA interference impaired both the PIP2 and actin cytoskeletal responses. PIP5KI beta was recruited to membranes and was activated by hypertonic stress through Ser/Thr dephosphorylation. Calyculin A, a protein phosphatase 1 inhibitor, blocked the hypertonicity-induced PIP5KI beta dephosphorylation/activation as well as PIP2 increase in cells. Urea, which raises osmolarity without inducing cell shrinkage, did not promote dephosphorylation nor increase PIP2 levels. Disruption or stabilization of the actin cytoskeleton, or inhibition of the Rho kinase, did not block the PIP2 increase nor PIP5KI beta dephosphorylation. Therefore, PIP5KI beta is dephosphorylated in a volume-dependent manner by a calyculin A-sensitive protein phosphatase, which is activated upstream of actin remodeling and independently of Rho kinase activation. Our results establish a cause-and-effect relation between PIP5KI beta dephosphorylation, lipid kinase activation, and PIP2 increase in cells. This PIP2 increase can orchestrate multiple downstream responses, including the reorganization of the actin cytoskeleton.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Yin, HL (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	helen.yin@utsouthwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062, P50GM021681, R01GM066110] Funding Source: NIH RePORTER; NIGMS NIH HHS [5P50 GM 21681, R01 GM 066110, GM 007062] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Chatah NEH, 2001, J BIOL CHEM, V276, P34059, DOI 10.1074/jbc.M104917200; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cuschieri J, 2002, J IMMUNOL, V168, P1389, DOI 10.4049/jimmunol.168.3.1389; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Di Ciano-Oliveira C, 2003, AM J PHYSIOL-CELL PH, V285, pC555, DOI 10.1152/ajpcell.00086.2003; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Divecha N, 2000, EMBO J, V19, P5440, DOI 10.1093/emboj/19.20.5440; Eggermont J, 2003, AM J PHYSIOL-CELL PH, V285, pC509, DOI 10.1152/ajpcell.00214.2003; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Horton JW, 2006, AM J PHYSIOL-HEART C, V290, pH1642, DOI 10.1152/ajpheart.00586.2005; Ikonomov OC, 2002, J BIOL CHEM, V277, P46785, DOI 10.1074/jbc.M208068200; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 2000, J BIOL CHEM, V275, P19389, DOI 10.1074/jbc.M000426200; Kashani AH, 2001, J PHYSIOL-LONDON, V530, P243, DOI 10.1111/j.1469-7793.2001.0243l.x; Kisseleva M, 2005, MOL CELL BIOL, V25, P3956, DOI 10.1128/MCB.25.10.3956-3966.2005; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lewis A, 2002, AM J PHYSIOL-CELL PH, V282, pC271, DOI 10.1152/ajpcell.00427.2001; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; McNamee HP, 1996, EXP CELL RES, V224, P116, DOI 10.1006/excr.1996.0118; Mejillano M, 2001, J BIOL CHEM, V276, P1865, DOI 10.1074/jbc.M007271200; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Papakonstanti EA, 2000, CELL PHYSIOL BIOCHEM, V10, P257, DOI 10.1159/000016366; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Powner DJ, 2005, J CELL SCI, V118, P2975, DOI 10.1242/jcs.02432; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Rizoli SB, 2000, AM J PHYSIOL-CELL PH, V279, pC619, DOI 10.1152/ajpcell.2000.279.3.C619; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Saito K, 2003, IMMUNITY, V19, P669, DOI 10.1016/S1074-7613(03)00297-8; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; Sbrissa D, 2005, J BIOL CHEM, V280, P7883, DOI 10.1074/jbc.M412729200; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Shukla A, 2004, SHOCK, V21, P391, DOI 10.1097/00024382-200405000-00001; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; Victorino GP, 2003, J SURG RES, V112, P79, DOI 10.1016/S0022-4804(03)00132-X; vom Dahl S, 2003, J BIOL CHEM, V278, P27088, DOI 10.1074/jbc.M210699200; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yang SA, 2004, J BIOL CHEM, V279, P42331, DOI 10.1074/jbc.M404335200; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	50	37	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32630	32638		10.1074/jbc.M605928200	http://dx.doi.org/10.1074/jbc.M605928200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943196	hybrid			2022-12-27	WOS:000241414500061
J	Liu, Y; Denlinger, CE; Rundall, BK; Smith, PW; Jones, DR				Liu, Yuan; Denlinger, Chadrick E.; Rundall, Brian K.; Smith, Philip W.; Jones, David R.			Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HISTONE DEACETYLASE INHIBITOR; CELL LUNG-CANCER; AKT/PROTEIN KINASE-B; PHASE-I; DEPENDENT TRANSCRIPTION; COACTIVATOR P300; PROTEIN-KINASE; APOPTOSIS; INDUCTION	We have previously demonstrated that the transcription factor NF-kappa B is activated by histone deacetylase inhibitors in a PI3K/Akt-dependent manner. The molecular mechanisms governing this process have not been well described. By virtue of their inhibitory action, it is unclear whether the addition of histone deacetylase inhibitors simply preserves the acetylation status of RelA/p65 or whether they actively stimulate signaling cascades that result in increased acetylation and transcription of NF-kappa B. Here we provide evidence that suberoylanilide hydroxamic acid stimulates NF-kappa B transcription through a signaling cascade that involves activation of both the serine/threonine kinase Akt and the p300 acetyltransferase. Using newly developed phosphospecific antibodies to p300 (pSer(1834)), and site-directed mutant proteins, we find that suberoylanilide hydroxamic acid stimulates Akt activity, which is required to phosphorylate p300 at Ser(1834). Akt-mediated phosphorylation of p300 dramatically increases its acetyltransferase activity as measured by an increased acetylation of RelA/p65 at Lys(310), a modification that is required for full NF-kappa B transcription. Importantly, coordinate activation of Akt/p300 pathway by suberoylanilide hydroxamic acid occurs at the chromatin level, resulting in recruitment of activated Akt (pSer(473)), p300 (pSer(1834)), acetylated RelA/p65 (Lys(310)), and RNA polymerase II to the NF-kappa B-dependent cIAP-2 and Bfl-1/A1 promoters. These studies provide evidence that histone deacetylase inhibitors, such as suberoylanilide hydroxamic acid, not only inhibit deacetylase activity but also stimulate active NF-kappa B transcription and cell survival through signaling pathways involving Akt and increased p300 acetyltransferase activity.	Univ Virginia, Sch Med, Dept Surg, Charlottesville, VA 22908 USA	University of Virginia	Jones, DR (corresponding author), Univ Virginia, Sch Med, Dept Surg, Box 800679, Charlottesville, VA 22908 USA.	djones@virginia.edu	Liu, Yuan/E-6100-2010; Smith, Philip/P-7736-2019	Smith, Philip/0000-0003-3441-1062; Jones, David/0000-0002-3318-0146	NATIONAL CANCER INSTITUTE [K08CA083920, F32CA101497] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA83920, F32 CA101497] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Brognard J, 2001, CANCER RES, V61, P3986; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chen J, 2004, CELL MOL LIFE SCI, V61, P1675, DOI 10.1007/s00018-004-4103-9; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Denlinger CE, 2005, J THORAC CARDIOV SUR, V130, P1422, DOI 10.1016/j.jtcvs.2005.06.051; Denlinger Chadrick E, 2004, Semin Thorac Cardiovasc Surg, V16, P28, DOI 10.1053/j.semtcvs.2003.12.004; Furia B, 2002, J BIOL CHEM, V277, P4973, DOI 10.1074/jbc.M107848200; Gilbert J, 2001, CLIN CANCER RES, V7, P2292; Henderson C, 2003, J BIOL CHEM, V278, P12579, DOI 10.1074/jbc.M213093200; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Mayo MW, 2001, METHOD ENZYMOL, V333, P73; Mayo MW, 2003, J BIOL CHEM, V278, P18980, DOI 10.1074/jbc.M211695200; Rahmani M, 2003, ONCOGENE, V22, P6231, DOI 10.1038/sj.onc.1206646; Reid T, 2004, LUNG CANCER, V45, P381, DOI 10.1016/j.lungcan.2004.03.002; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Rosenzweig KE, 1997, CLIN CANCER RES, V3, P1149; Rundall BK, 2005, SURGERY, V138, P360, DOI 10.1016/j.surg.2005.06.016; Sandor V, 2002, CLIN CANCER RES, V8, P718; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; VAN LC, 1996, GENE EXPRESSION, V5, P245; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Xu WS, 2005, CANCER RES, V65, P7832, DOI 10.1158/0008-5472.CAN-04-4608; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	43	69	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31359	31368		10.1074/jbc.M604478200	http://dx.doi.org/10.1074/jbc.M604478200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16926151				2022-12-27	WOS:000241235300020
J	Ding, J; Zhang, XH; Li, JX; Song, L; Ouyang, W; Zhang, DY; Xue, CF; Costa, M; Melendez, JA; Huang, CS				Ding, Jin; Zhang, Xinhai; Li, Jingxia; Song, Lun; Ouyang, Weiming; Zhang, Dongyun; Xue, Caifang; Costa, Max; Melendez, J. Andres; Huang, Chuanshu			Nickel compounds render anti-apoptotic effect to human bronchial epithelial Beas-2B cells by induction of cyclooxygenase-2 through an IKK beta/p65-dependent and IKK alpha- and p50-independent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; NUCLEAR-FACTOR; COX-2 EXPRESSION; CANCER; ACTIVATION; INHIBITION; TARGET; KINASE; DEATH	The carcinogenicity of nickel compounds has been well documented both in vitro and in vivo; however, the molecular mechanisms by which nickel compounds cause cancers are far from understood. Because suppression of apoptosis is thought to contribute to carcinogenesis, we investigated the mechanisms implicated in nickel-induced anti-apoptotic effect in human bronchial epithelial (Beas-2B) cells. We found that exposure of Beas-2B cells to nickel compounds resulted in increased cyclooxygenase-2 (COX-2) expression and that small interfering RNA (siCOX-2) knockdown of COX-2 expression resulted in increased cell sensitivity to nickel-triggered cell apoptosis, demonstrating that COX-2 induction has an anti-apoptotic effect on Beas-2B cells. Overexpression of IKK beta-KM, a kinase inactive mutant of IKK beta, blocked NF-kappa B activation and COX-2 induction by nickel compounds, indicating that activated NF-kappa B may be a mediator for COX-2 induction. To further explore the contribution of the NF-kappa B pathway in COX-2 induction and in protection from nickel exposure, mouse embryonic fibroblasts deficient in IKK beta, IKK beta, p65, and p50 were analyzed. Loss of IKK beta impaired COX-2 induction by nickel exposure, whereas knockout of IKK beta had a marginal effect. Moreover, the NF-kappa B p65, and not the p50 subunit, was critical for nickel-induced COX-2 expression. In addition, a deficiency of IKK beta or p65 rendered cells more sensitive to nickel-induced apoptosis as compared with those in wild type cells. Finally, it was shown that reactive oxygen species H2O2 were involved in both NF-kappa B activation and COX-2 expression. Collectively, our results demonstrate that COX-2 induction by nickel compounds occurs via an IKK beta/p65 NF-kappa B-dependent but IKK beta and p50-independent pathway and plays a crucial role in antagonizing nickel-induced cell apoptosis in Beas-2B cells.	NYU, Nelson Inst Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; Fourth Mil Med Univ, Dept Etiol, Xian 710032, Peoples R China; Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	New York University; Air Force Military Medical University; Albany Medical College	Huang, CS (corresponding author), NYU, Nelson Inst Environm Med, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu@env.med.nyu.edu	costa, max/H-1754-2012	Melendez, Juan/0000-0001-8021-3097; Huang, Chuanshu/0000-0003-4133-5096	NCI NIH HHS [R01 CA112557, R01 CA103180, R01 CA094964] Funding Source: Medline; NIEHS NIH HHS [R01 ES012451] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112557, R01CA103180, R01CA094964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012451] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BURSCH W, 1990, CARCINOGENESIS, V11, P847, DOI 10.1093/carcin/11.5.847; BURSCH W, 1992, TRENDS PHARMACOL SCI, V13, P245, DOI 10.1016/0165-6147(92)90077-J; BURSCH W, 1993, BRIT J CANCER, V67, P531, DOI 10.1038/bjc.1993.98; Cangul H, 2002, TOXICOL LETT, V127, P69, DOI 10.1016/S0378-4274(01)00485-4; Chang PY, 2006, MOL CANCER RES, V4, P101, DOI 10.1158/1541-7786.MCR-05-0259; Clarke A R, 2000, Symp Soc Exp Biol, V52, P265; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Correa P, 1998, BRIT MED BULL, V54, P151; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Dannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; Gorgoni B, 2001, J BIOL CHEM, V276, P40769, DOI 10.1074/jbc.M106865200; Harris GK, 2003, MUTAT RES-FUND MOL M, V533, P183, DOI 10.1016/j.mrfmmm.2003.08.025; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Huang CS, 2001, CANCER RES, V61, P8051; Huang Y, 2002, ENVIRON HEALTH PERSP, V110, P835, DOI 10.1289/ehp.02110s5835; INT AGCY RES CANC, 1990, IARC MONOG EVAL CARC, V49, P257; Kang J, 2003, TOXICOL SCI, V74, P279, DOI 10.1093/toxsci/kfg137; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kuwano T, 2004, FASEB J, V18, P300, DOI 10.1096/fj.03-0473com; Li JX, 2004, CANCER RES, V64, P94, DOI 10.1158/0008-5472.CAN-03-0737; Li LY, 2003, RADIAT RES, V160, P617, DOI 10.1667/RR3076; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu ZG, 2001, METHOD CELL BIOL, V66, P187; Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Pairet M, 1996, FUND CLIN PHARMACOL, V10, P1, DOI 10.1111/j.1472-8206.1996.tb00144.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Riedl K, 2004, DRUG RESIST UPDATE, V7, P169, DOI 10.1016/j.drup.2004.04.003; Roberts RA, 1995, TOXICOL APPL PHARM, V135, P192, DOI 10.1006/taap.1995.1223; Rodriguez AM, 2000, FREE RADICAL BIO MED, V29, P801, DOI 10.1016/S0891-5849(00)00362-2; SALDANA M, IN PRESS EUR NEUROPS; Salnikow Konstantin, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P307; Samet JM, 1998, AM J PHYSIOL-LUNG C, V275, pL551, DOI 10.1152/ajplung.1998.275.3.L551; SCHULTEHERMANN R, 1990, CANCER RES, V50, P5127; Scott KA, 2003, MOL CANCER THER, V2, P445; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Sivulka DJ, 2005, REGUL TOXICOL PHARM, V43, P117, DOI 10.1016/j.yrtph.2005.06.014; SNYDER RD, 1995, CANCER RES, V55, P3702; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; Szlosarek PW, 2003, LANCET ONCOL, V4, P565, DOI 10.1016/S1470-2045(03)01196-3; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; TOMEI LD, 1988, BIOCHEM BIOPH RES CO, V155, P324, DOI 10.1016/S0006-291X(88)81088-X; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; von Knethen A, 1999, J IMMUNOL, V163, P2858; Weng MW, 2004, TOXICOL LETT, V151, P345, DOI 10.1016/j.toxlet.2004.03.007; Wyllie AH, 1999, BRIT J CANCER, V80, P34; Yoon JM, 2005, LUNG CANCER, V48, P201, DOI 10.1016/j.lungcan.2004.11.005	59	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2006	281	51					39022	39032		10.1074/jbc.M604798200	http://dx.doi.org/10.1074/jbc.M604798200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117UL	16982623	hybrid			2022-12-27	WOS:000242898700008
J	Mukhopadhyay, I; Sausville, EA; Doroshow, JH; Roy, KK				Mukhopadhyay, Indranil; Sausville, Edward A.; Doroshow, James H.; Roy, Krishnendu K.			Molecular mechanism of adaphostin-mediated G(1) arrest in prostate cancer (PC-3) cells - Signaling events mediated by hepatocyte growth factor receptor, c-Met, and p38 MAPK pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN LEUKEMIA-CELLS; TYROSINE KINASE; IN-VITRO; INDUCED APOPTOSIS; TUMOR-CELLS; INHIBITOR; EXPRESSION; INDUCTION; NUCLEOPHOSMIN/B23	Adaphostin (NSC680410), a small molecule congener of tyrphostin AG957, has been demonstrated previously to have significant anti-proliferative effects in several leukemia models. However, this effect of adaphostin in adherent cells/solid tumor models has not been examined. In this study, we investigated the anti-proliferative effects of adaphostin in the human prostate cancer cell line PC-3. Specifically, we explored the potential molecular mechanism(s) by which adaphostin elicits its anti-proliferative effect(s). We demonstrate that adaphostin inhibits the proliferation of PC-3 cells by inducing a G(1) phase cell cycle arrest. This adaphostin-induced G(1) arrest was associated with an increase in the expression of p21 and p27 and a decrease in the expression of G(1)-specific cyclins (cyclin A, D1, and D3) and cyclin-dependent kinases 4 and 6. Consequently, a dramatic decrease in the phosphorylation of retinoblastoma protein was also observed. Additionally, we found that adaphostin treatment induced a decrease in the phosphorylation of nucleophosmin, a major nuclear phosphoprotein, and that this decreased phosphorylation was a result of the p21- and p27-mediated inactivation of cyclin E-cyclin-dependent kinase 2 complex kinase activity. Furthermore, we have determined that the adaphostin-mediated cell cycle arrest of PC-3 cells is dependent upon activation of the p38 MAPK. We also demonstrate that the hepatocyte growth factor receptor-c-Met is involved in the adaphostin-mediated signaling events that regulate p38 MAPK. Taken together, these results identify for the first time a signaling cascade of adaphostin-mediated G(1) phase-specific cell cycle arrest in PC-3 cells. These findings suggest that the tyrphostin member has a broader spectrum of activity than originally predicted.	NCI, Lab Clin Tials Unit, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Roy, KK (corresponding author), NCI, Lab Clin Tials Unit, Div Canc Treatment & Diag, NIH, 37 Convent Dr,Bldg 37,Rm 1052, Bethesda, MD 20892 USA.	kr91w@nih.gov						Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Avramis IA, 2002, CANCER CHEMOTH PHARM, V50, P479, DOI 10.1007/s00280-002-0507-6; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blagden S, 2005, CURR DRUG TARGETS, V6, P325, DOI 10.2174/1389450053765824; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Chandra J, 2003, BLOOD, V102, P4512, DOI 10.1182/blood-2003-02-0562; Chattopadhyay N, 2002, MOL BRAIN RES, V102, P73, DOI 10.1016/S0169-328X(02)00215-2; Chinni SR, 2001, ONCOGENE, V20, P2927, DOI 10.1038/sj.onc.1204365; Christensen JG, 2003, CANCER RES, V63, P7345; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Daly JM, 1999, ONCOGENE, V18, P3440, DOI 10.1038/sj.onc.1202700; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Dasmahapatra G, 2006, BLOOD, V107, P232, DOI 10.1182/blood-2005-06-2302; Dasmahapatra G, 2006, LEUKEMIA RES, V30, P1263, DOI 10.1016/j.leukres.2006.01.005; Dasmahapatra GP, 2004, CLIN CANCER RES, V10, P5242, DOI 10.1158/1078-0432.CCR-03-0534; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; George J, 2005, EXP MOL PATHOL, V78, P233, DOI 10.1016/j.yexmp.2004.11.003; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GRANA X, 1995, ONCOGENE, V11, P211; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Hayami R, 2005, CANCER RES, V65, P6; Hose C, 2005, CLIN CANCER RES, V11, P6370, DOI 10.1158/1078-0432.CCR-05-0291; Hurle RA, 2005, HISTOL HISTOPATHOL, V20, P1339, DOI 10.14670/HH-20.1339; Kaur G, 2005, BIOORGAN MED CHEM, V13, P1749, DOI 10.1016/j.bmc.2004.12.003; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; Kim JT, 2002, J BIOL CHEM, V277, P31938, DOI 10.1074/jbc.M201178200; Kim SJ, 2003, CLIN CANCER RES, V9, P5161; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Liu TZ, 2006, FOOD CHEM TOXICOL, V44, P227, DOI 10.1016/j.fct.2005.07.003; Losada A, 2004, BRIT J CANCER, V91, P1405, DOI 10.1038/sj.bjc.6602166; Losiewicz MD, 1999, BIOCHEM PHARMACOL, V57, P281, DOI 10.1016/S0006-2952(98)00293-7; Maulik G, 2002, J CELL MOL MED, V6, P539, DOI 10.1111/j.1582-4934.2002.tb00453.x; Minami S, 1997, FEBS LETT, V411, P1, DOI 10.1016/S0014-5793(97)00660-1; Miura S, 2005, ATHEROSCLEROSIS, V182, P267, DOI 10.1016/j.atherosclerosis.2005.02.017; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nakashiro K, 2000, AM J PATHOL, V157, P795, DOI 10.1016/S0002-9440(10)64593-2; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Ribatti D, 2005, CURR CANCER DRUG TAR, V5, P573, DOI 10.2174/156800905774932806; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Sato K, 2004, J BIOL CHEM, V279, P30919, DOI 10.1074/jbc.C400169200; Sattler M, 2003, CANCER RES, V63, P5462; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shanafelt TD, 2005, BLOOD, V105, P2099, DOI 10.1182/blood-2004-06-2205; Shen YH, 2005, BIOORGAN MED CHEM, V13, P4960, DOI 10.1016/j.bmc.2005.05.038; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 2000, CANCER RES, V60, P3689; Subong ENP, 1999, PROSTATE, V39, P298; Svingen PA, 2000, CLIN CANCER RES, V6, P237; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; TSAI LH, 1993, ONCOGENE, V8, P1593; Vlahovic G, 2003, ONCOLOGIST, V8, P531, DOI 10.1634/theoncologist.8-6-531; Wang X, 2004, J BIOL CHEM, V279, P5237, DOI 10.1074/jbc.M309271200; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Yim D, 2005, CANCER RES, V65, P1035; Yu CR, 2004, ONCOGENE, V23, P1364, DOI 10.1038/sj.onc.1207248	66	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37330	37344		10.1074/jbc.M605569200	http://dx.doi.org/10.1074/jbc.M605569200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16956884	hybrid			2022-12-27	WOS:000242477100010
J	Wang, L; Zuercher, WJ; Consler, TG; Lambert, MH; Miller, AB; Orband-Miller, LA; McKee, DD; Willson, TM; Nolte, RT				Wang, Liping; Zuercher, William J.; Consler, Thomas G.; Lambert, Millard H.; Miller, Aaron B.; Orband-Miller, Lisa A.; McKee, David D.; Willson, Timothy M.; Nolte, Robert T.			X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT TRANSCRIPTIONAL ACTIVATION; IDENTIFICATION; 4-HYDROXYTAMOXIFEN; DETERMINANTS; ANTAGONISM; AGONISTS; ALPHA; BETA	X-ray crystal structures of the ligand binding domain (LBD) of the estrogen-related receptor-gamma (ERR gamma) were determined that describe this receptor in three distinct states: unliganded, inverse agonist bound, and agonist bound. Two structures were solved for the unliganded state, the ERR gamma LBD alone, and in complex with a coregulator peptide representing a portion of receptor interacting protein140(RIP140). No significant differences were seen between these structures that both exhibited the conformation of ERR gamma seen in studies with other coactivators. Two structures were obtained describing the inverse agonist-bound state, the ERR gamma LBD with 4-hydroxytamoxifen (4-OHT), and the ERR gamma LBD with 4-OHT and a peptide representing a portion of the silencing mediator of retinoid and thyroid hormone action protein (SMRT). The 4-OHT structure was similar to other reported inverse agonist bound structures, showing reorientation of phenylalanine 435 and a displacement of the AF-2 helix relative to the unliganded structures with little other rearrangement occurring. No significant changes to the LBD appear to be induced by peptide binding with the addition of the SMRT peptide to the ERR gamma plus 4-OHT complex. The observed agonist-bound state contains the ERR gamma LBD, a ligand (GSK4716), and the RIP140 peptide and reveals an unexpected rearrangement of the phenol-binding residues. Thermal stability studies show that agonist binding leads to global stabilization of the ligand binding domain. In contrast to the conventional mechanism of nuclear receptor ligand activation, activation of ERR gamma by GSK4716 does not appear to involve a major rearrangement or significant stabilization of the C-terminal helix.	GlaxoSmithKline Inc, Discovery Res, Res Triangle Pk, NC 27909 USA	GlaxoSmithKline	Nolte, RT (corresponding author), GlaxoSmithKline Inc, Computat Analyt & Struct Sci Dept, 5 Moore Dr, Res Triangle Pk, NC 27909 USA.	robert.t.nolte@gsk.com	feinstein, doug/M-9414-2019					BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farnegardh M, 2003, J BIOL CHEM, V278, P38821, DOI 10.1074/jbc.M304842200; Greschik H, 2004, J BIOL CHEM, V279, P33639, DOI 10.1074/jbc.M402195200; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Hentschke M, 2002, EUR J BIOCHEM, V269, P4086, DOI 10.1046/j.1432-1033.2002.03102.x; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Huang HJ, 2002, MOL ENDOCRINOL, V16, P1778, DOI 10.1210/me.2002-0089; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; LAMBERT MH, 1997, PRACTICAL APPL COMPU, P243; Lu DS, 2001, CANCER RES, V61, P6755; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1992, MOL REPLACEMENT, P87; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Vanacker JM, 1998, CELL GROWTH DIFFER, V9, P1007; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Zuercher WJ, 2005, J MED CHEM, V48, P3107, DOI 10.1021/jm050161j	26	101	104	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37773	37781		10.1074/jbc.M608410200	http://dx.doi.org/10.1074/jbc.M608410200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16990259	hybrid			2022-12-27	WOS:000242477100054
J	Sun, F; Zhang, RL; Gong, XY; Geng, XH; Drain, PF; Frizzell, RA				Sun, Fei; Zhang, Ruilin; Gong, Xiaoyan; Geng, Xuehui; Drain, Peter F.; Frizzell, Raymond A.			Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; MISFOLDED PROTEINS; UBIQUITIN LIGASE; QUALITY-CONTROL; ER; PROTEASOME; COMPLEX; RETROTRANSLOCATION; DISLOCATION; INHIBITION	A complex involving Derlin-1 and p97 mediates the retrotranslocation and endoplasmic reticulum (ER)-associated degradation of misfolded proteins in yeast and is used by certain viruses to promote host cell protein degradation (Romisch, K. (2005) Annu. Rev. Cell Dev. Biol. 21, 435-456; Lilley, B. N., and Ploegh, H. L. (2004) Nature 429, 834-840; Ye, Y., Shibata, Y., Yun, C., Ron, D., and Rapoport, T. A. (2004) Nature 429, 841 847). We asked whether the components of this pathway are involved in the endoplasmic reticulum-associated degradation of the mammalian integral membrane protein, the cystic fibrosis transmembrane conductance regulator (CFTR), a substrate for the ubiquitin-proteasome system. We report that Derlin-1 and p97 formed complexes with CFTR in human airway epithelial cells. Derlin-1 interacted with nonubiquitylated CFTR, whereas p97 associated with ubiquitylated CFTR. Exogenous expression of Derlin-1 led to its co-localization with CFTR in the ER where it reduced wild type (WT) CFTR expression and efficiently degraded the disease-associated CFTR folding mutants, Delta F508 and G85E (> 90%). Consistent with this, Derlin-1 also reduced the amount of WT or Delta F508 CFTR appearing in detergent-insoluble aggregates. An similar to 70% knockdown of endogenous Derlin-1 by RNA interference increased the steady-state levels of WT and Delta F508 CFTR by 10-15-fold, reflecting its significant role in CFTR degradation. Derlin-1 mediated the degradation of N-terminal CFTR fragments corresponding to the first transmembrane domain of CFTR, but CFTR fragments that incorporated additional domains were degraded less efficiently. These findings suggest that Derlin-1 recognizes misfolded, nonubiquitylated CFTR to initiate its dislocation and degradation early in the course of CFTR biogenesis, perhaps by detecting structural instability within the first transmembrane domain.	Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frizzell, RA (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, 3500 Terrace St, Pittsburgh, PA 15261 USA.	frizzell@pitt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506, R01DK068196] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK68196, DK72506] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amaral MD, 2005, PEDIATR PULM, V39, P479, DOI 10.1002/ppul.20168; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Loo TW, 2006, BIOCHEM J, V395, P537, DOI 10.1042/BJ20060013; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; PIND S, 1994, J BIOL CHEM, V269, P12784; RIORDAN JR, 1989, SCIENCE, V245, P1066; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Xiong XM, 1997, J CLIN INVEST, V100, P1079, DOI 10.1172/JCI119618; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200	43	114	117	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36856	36863		10.1074/jbc.M607085200	http://dx.doi.org/10.1074/jbc.M607085200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16954204	hybrid			2022-12-27	WOS:000242220800044
J	Landry, YD; Denis, M; Nandi, S; Bell, S; Vaughan, AM; Zha, XH				Landry, Yves D.; Denis, Maxime; Nandi, Shilpi; Bell, Stephanie; Vaughan, Ashley M.; Zha, Xiaohui			ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELL-MEMBRANES; GPI-ANCHORED PROTEINS; CHOLESTEROL EFFLUX; LIPID EFFLUX; PHOSPHOLIPID EFFLUX; MEDIATED TRANSPORT; TANGIER-DISEASE; GOLGI-COMPLEX; APOA-I; ABCA1	ATP-binding cassette transporter A1(ABCA1) is known to mediate cholesterol efflux to lipid-poor apolipoprotein A-I. In addition, ABCA1 has been shown to influence functions of the plasma membrane, such as endocytosis and phagocytosis. Here, we report that ABCA1 expression results in a significant redistribution of cholesterol and sphingomyelin from rafts to non-rafts. Caveolin, a raft/caveolae marker also redistributes from punctate caveolae-like structures to the general area of the plasma membrane upon ABCA1 expression. Furthermore, we observed significant reduction of Akt activation in ABCA1-expressing cells, consistent with raft disruption. Cholesterol content in the plasma membrane is, however, notaltered. Moreover, we provide evidence that a non-functional ABCA1 with mutation in an ATP-binding domain, A937V, fails to redistribute cholesterol, sphingomyelin, or caveolin. A937V also fails to influence Akt activation. Finally, we show that apolipoprotein A-I preferentially associates with non-raft membranes in ABCA1-expressing cells. Our results thus demonstrate that ABCA1 causes a change in overall lipid packing of the plasma membrane, likely through its ATPase-related functions. Such reorganization by ABCA1 effectively expands the non-raft membrane fractions and, consequentially, pre-conditions cells for cholesterol efflux.	Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1Y 4E9, Canada; Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Washington; University of Washington Seattle	Zha, XH (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.	xzha@ohri.ca						Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHANG WJ, 1992, J CELL BIOL, V118, P63, DOI 10.1083/jcb.118.1.63; Drobnik W, 2002, TRAFFIC, V3, P268, DOI 10.1034/j.1600-0854.2002.030404.x; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Haidar B, 2002, J LIPID RES, V43, P2087, DOI 10.1194/jlr.M200235-JLR200; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Kiss RS, 2005, J LIPID RES, V46, P1877, DOI 10.1194/jlr.M400482-JLR200; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P10315, DOI 10.1021/bi025943i; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Sun Y, 2003, J BIOL CHEM, V278, P5813, DOI 10.1074/jbc.M208687200; Takahashi Y, 1999, P NATL ACAD SCI USA, V96, P11358, DOI 10.1073/pnas.96.20.11358; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Wang MM, 2004, BIOCHEMISTRY-US, V43, P2159, DOI 10.1021/bi035982+; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Zha XH, 2001, J BIOL CHEM, V276, P39476, DOI 10.1074/jbc.M105067200; Zhuang LY, 2002, CANCER RES, V62, P2227	42	176	188	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36091	36101		10.1074/jbc.M602247200	http://dx.doi.org/10.1074/jbc.M602247200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16984907	hybrid			2022-12-27	WOS:000242100500058
J	Toth, B; Balla, A; Ma, H; Knight, ZA; Shokat, KM; Balla, T				Toth, Balazs; Balla, Andras; Ma, Hui; Knight, Zachary A.; Shokat, Kevan M.; Balla, Tamas			Phosphatidylinositol 4-kinase III beta regulates the transport of ceramide between the endoplasmic reticulum and Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYSTEROL-BINDING-PROTEIN; PLECKSTRIN HOMOLOGY DOMAINS; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; MOLECULAR MACHINERY; 4-KINASE ACTIVITY; CELL-SURFACE; GENE ENCODES; YEAST; SECRETION	The recently identified ceramide transfer protein, CERT, is responsible for the bulk of ceramide transport from the endoplasmic reticulum ( ER) to the Golgi. CERT has a C-terminal START domain for ceramide binding and an N-terminal pleckstrin homology domain that binds phosphatidylinositol 4-phosphate suggesting that phosphatidylinositol ( PI) 4-kinases are involved in the regulation of CERT-mediated ceramide transport. In the present study fluorescent analogues were used to follow the ER to Golgi transport of ceramide to determine which of the four mammalian PI 4-kinases are involved in this process. Overexpression of pleckstrin homology domains that bind phosphatidylinositol 4-phosphate strongly inhibited the transport of C5-BODIPY-ceramide to the Golgi. A newly identified PI3-kinase inhibitor, PIK93 that selectively inhibits the type III PI4-kinase beta enzyme, and small interfering RNA-mediated down-regulation of the individual PI4-kinase enzymes, revealed that PI4-kinase beta has a dominant role in ceramide transport between the ER and Golgi. Accordingly, inhibition of PI4-kinase III beta either by wortmannin or PIK93 inhibited the conversion of [H-3] serine-labeled endogenous ceramide to sphingomyelin. Therefore, PI4-kinase beta is a key enzyme in the control of spingomyelin synthesis by controlling the flow of ceramide from the ER to the Golgi compartment.	NICHD, Sect Mol Signal Transduct, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Balla, T (corresponding author), Bldg 49,Rm 6A35,49 Convent Dr, Bethesda, MD 20892 USA.	ballat@mail.nih.gov	Toth, Balazs/B-4252-2012	Balla, Andras/0000-0002-6450-2793; Balla, Tamas/0000-0002-9077-3335; Knight, Zachary/0000-0001-7621-1478	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI044009] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Bodennec J, 2000, J LIPID RES, V41, P1524; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Han GS, 2002, J BIOL CHEM, V277, P47709, DOI 10.1074/jbc.M207996200; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2006, MOL CELL BIOCHEM, V286, P23, DOI 10.1007/s11010-005-9044-z; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; LIPSKY NG, 1983, P NATL ACAD SCI-BIOL, V80, P2608, DOI 10.1073/pnas.80.9.2608; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; Perry RJ, 2005, BBA-MOL CELL BIOL L, V1734, P220, DOI 10.1016/j.bbalip.2005.04.001; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; RIDGWAY ND, 1995, BBA-LIPID LIPID MET, V1256, P57, DOI 10.1016/0005-2760(95)00010-A; Routt SM, 2005, TRAFFIC, V6, P1157, DOI 10.1111/j.1600-0854.2005.00350.x; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Trotter PJ, 1998, J BIOL CHEM, V273, P13189, DOI 10.1074/jbc.273.21.13189; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x	39	110	116	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36369	36377		10.1074/jbc.M604935200	http://dx.doi.org/10.1074/jbc.M604935200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17003043	hybrid			2022-12-27	WOS:000242100500088
J	Smirnova, TI; Chadwick, TG; MacArthur, R; Poluektov, O; Song, L; Ryan, MM; Schaaf, G; Bankaitis, VA				Smirnova, Tatyana I.; Chadwick, Thomas G.; MacArthur, Ryan; Poluektov, Oleg; Song, Likai; Ryan, Margaret M.; Schaaf, Gabriel; Bankaitis, Vytas A.			The chemistry of phospholipid binding by the Saccharomyces cerevisiae phosphatidylinositol transfer protein Sec14p as determined by EPR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-FIELD EPR; ELECTRON-SPIN-RESONANCE; NITROXIDE SIDE-CHAINS; CONFORMATIONAL-CHANGES; T4 LYSOZYME; SITE; DYNAMICS; CHANNEL; DOMAIN; ACCESSIBILITY	The major yeast phosphatidylinositol/phosphatidylcholine transfer protein Sec14p is the founding member of a large eukaryotic protein superfamily. Functional analyses indicate Sec14p integrates phospholipid metabolism with the membrane trafficking activity of yeast Golgi membranes. In this regard, the ability of Sec14p to rapidly exchange bound phospholipid with phospholipid monomers that reside in stable membrane bilayers is considered to be important for Sec14p function in cells. How Sec14p-like proteins bind phospholipids remains unclear. Herein, we describe the application of EPR spectroscopy to probe the local dynamics and the electrostatic microenvironment of phosphatidylcholine (PtdCho) bound by Sec14p in a soluble protein-PtdCho complex. We demonstrate that PtdCho movement within the Sec14p binding pocket is both anisotropic and highly restricted and that the C-5 region of the sn-2 acyl chain of bound PtdCho is highly shielded from solvent, whereas the distal region of that same acyl chain is more accessible. Finally, high field EPR reports on a heterogeneous polarity profile experienced by a phospholipid bound to Sec14p. Taken together, the data suggest a headgroup-out orientation of Sec14p-bound PtdCho. The data further suggest that the Sec14p phospholipid binding pocket provides a polarity gradient that we propose is a primary thermodynamic factor that powers the ability of Sec14p to abstract a phospholipid from a membrane bilayer.	N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA; Argonne Natl Lab, Argonne, IL 60439 USA; Florida State Univ, Tallahassee, FL 32310 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; Florida State University; University of North Carolina; University of North Carolina Chapel Hill	Smirnova, TI (corresponding author), N Carolina State Univ, Dept Chem, 2620 Yarborough Dr, Raleigh, NC 27695 USA.	Tatyana_Smirnova@ncsu.edu; vytas@med.unc.edu	Schaaf, Gabriel/F-1956-2014	Schaaf, Gabriel/0000-0001-9022-4515; Smirnova, Tatyana/0000-0001-7867-7116	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NIBIB NIH HHS [EB001980] Funding Source: Medline; NIGMS NIH HHS [GM44530] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alb JG, 2003, J BIOL CHEM, V278, P33501, DOI 10.1074/jbc.M303591200; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Bartucci R, 2003, CHEM PHYS LIPIDS, V124, P111, DOI 10.1016/S0009-3084(03)00047-1; Bomar JM, 2003, NAT GENET, V35, P264, DOI 10.1038/ng1255; CARMENLOPEZ M, 1994, J CELL BIOL, V124, P113; CHEN SC, 1982, BIOCHEMISTRY-US, V21, P5096, DOI 10.1021/bi00263a038; Cleves A, 1991, Trends Cell Biol, V1, P30, DOI 10.1016/0962-8924(91)90067-J; Ding Z, 2001, J CHEM PHYS, V115, P10685, DOI 10.1063/1.1416177; EARLE KA, 1994, BIOPHYS J, V66, P1213, DOI 10.1016/S0006-3495(94)80905-1; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Griffith O.H., 1976, SPIN LABELING THEORY, P454; Gulla AF, 2001, J PHYS CHEM B, V105, P8056, DOI 10.1021/jp0109224; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; HERSCHEL WH, 1917, 100 US DEP COMM BUR; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; HUBBELL WL, 1971, J AM CHEM SOC, V93, P314; Isas JM, 2002, BIOCHEMISTRY-US, V41, P1464, DOI 10.1021/bi011856z; KAWAMURA T, 1967, B CHEM SOC JPN, V40, P1111, DOI 10.1246/bcsj.40.1111; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Merianos HJ, 2000, NAT STRUCT BIOL, V7, P205; Monteoliva L, 1996, YEAST, V12, P1097, DOI 10.1002/(SICI)1097-0061(19960915)12:11<1097::AID-YEA990>3.0.CO;2-E; Nielsen RD, 2005, J AM CHEM SOC, V127, P6430, DOI 10.1021/ja042782s; Oh KJ, 2000, METH MOL B, V145, P147; Owenius R, 2001, J PHYS CHEM A, V105, P10967, DOI 10.1021/jp0116914; Perozo E, 2002, STRUCTURE, V10, P1027, DOI 10.1016/S0969-2126(02)00812-2; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Phillips SE, 2006, CRIT REV BIOCHEM MOL, V41, P21, DOI 10.1080/10409230500519573; Plato M, 2002, MOL PHYS, V100, P3711, DOI 10.1080/00268970210166246; Pyka J, 2005, BIOPHYS J, V89, P2059, DOI 10.1529/biophysj.105.059055; ROBINSON BH, 1994, SCIENCE, V263, P490, DOI 10.1126/science.8290958; Schorn K, 1997, SPECTROCHIM ACTA A, V53, P2235, DOI 10.1016/S1386-1425(97)00136-4; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; SMIRNOV AI, 1995, J MAGN RESON SER A, V113, P65, DOI 10.1006/jmra.1995.1057; Smirnova TI, 2003, J PHYS CHEM B, V107, P7212, DOI 10.1021/jp0349637; SMIRNOVA TI, 1995, MAGNET RESON MED, V33, P801, DOI 10.1002/mrm.1910330610; Smirnova TI, 1998, J AM CHEM SOC, V120, P5060, DOI 10.1021/ja973427n; Steinhoff HJ, 2000, BBA-BIOENERGETICS, V1457, P253, DOI 10.1016/S0005-2728(00)00106-7; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Wegener C, 2001, APPL MAGN RESON, V21, P441, DOI 10.1007/BF03162419; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098	45	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34897	34908		10.1074/jbc.M603054200	http://dx.doi.org/10.1074/jbc.M603054200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16997918	Green Published, hybrid			2022-12-27	WOS:000241933700022
J	Vervoorts, J; Luscher-Firzlaff, J; Luscher, B				Vervoorts, Jorg; Luescher-Firzlaff, Juliane; Luescher, Bernhard			The ins and outs of MYC regulation by posttranslational mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE CK2; C-MYC; P-TEFB; TRANSCRIPTIONAL ACTIVATION; PHOSPHORYLATION SITES; DEGRADATION; DOMAIN; TRANSFORMATION; UBIQUITIN; NETWORK	The proteins of the MYC family are key regulators of cell behavior. MYC, originally identified as an oncoprotein, affects growth, proliferation, differentiation, and apoptosis of cells through its ability to regulate a significant number of genes. In addition MYC governs events associated with tumor progression, including genetic stability, migration, and angiogenesis. The pleiotropic activities attributed to MYC and their balanced control requires that the expression and function of MYC is tightly controlled. Indeed many different pathways and factors have been identified that impinge on MYC gene expression and protein function. In particular the protein is subject to different posttranslational modifications, including phosphorylation, ubiquitinylation, and acetylation. Here we discuss the latest developments regarding these modifications that control various aspects of MYC function, including its stability, the interaction with partner proteins, and the transcriptional potential.	Univ Aachen, Rhein Westfal TH Klinikum, Inst Biochem, Abt Biochem & Mol Biol, D-52057 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Luscher, B (corresponding author), Univ Aachen, Rhein Westfal TH Klinikum, Inst Biochem, Abt Biochem & Mol Biol, Pauwelsstr 30, D-52057 Aachen, Germany.	luescher@rwth-aachen.de	; Luscher, Bernhard/A-7330-2011	Vervoorts, Jorg/0000-0002-3251-6496; Luscher-Firzlaff, Juliane/0000-0001-9265-8536; Luscher, Bernhard/0000-0002-9622-8709				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; BERBERICH SJ, 1992, GENE DEV, V6, P166, DOI 10.1101/gad.6.2.166; BOUSSET K, 1993, ONCOGENE, V8, P3211; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Channavajhala P, 2002, ONCOGENE, V21, P5280, DOI 10.1038/sj.onc.1205640; CLARK EA, 1989, J IMMUNOL, V143, P3873; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Krippner-Heidenreich A, 2001, BIOCHEM J, V358, P705, DOI 10.1042/0264-6021:3580705; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; Luscher B, 2001, GENE, V277, P1, DOI 10.1016/S0378-1119(01)00697-7; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Lutterbach B, 1997, ONCOGENE, V14, P967, DOI 10.1038/sj.onc.1200920; Lutterbach B, 1999, J CELL BIOCHEM, V72, P483, DOI 10.1002/(SICI)1097-4644(19990315)72:4<483::AID-JCB4>3.0.CO;2-I; Marshall RM, 2006, FRONT BIOSCI-LANDMRK, V11, P2598, DOI 10.2741/1994; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; PERSSON H, 1985, MOL CELL BIOL, V5, P2903, DOI 10.1128/MCB.5.11.2903; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang KL, 2005, BIOCHEM BIOPH RES CO, V336, P274, DOI 10.1016/j.bbrc.2005.08.075	62	177	183	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34725	34729		10.1074/jbc.R600017200	http://dx.doi.org/10.1074/jbc.R600017200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16987807	hybrid			2022-12-27	WOS:000241933700002
J	Fearns, C; Pan, Q; Mathison, JC; Chuang, TH				Fearns, Colleen; Pan, Qilin; Mathison, John C.; Chuang, Tsung-Hsien			Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; INTERACTING PROTEIN RIP; DEATH DOMAIN KINASE; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSES; INNATE IMMUNITY; ACTIVATION; NECROSIS; APOPTOSIS	Toll-like receptors (TLRs) play a crucial role in innate immunity by recognizing microbial pathogens. Triad3A is an E3 ubiquitin-protein ligase that interacts with the Toll/interleukin-1 receptor domain of TLRs and promotes their proteolytic degradation. In the present study, we further investigated its activity on signaling molecules downstream of TLRs and tumor necrosis factor (TNF) receptor 1. Triad3A promoted down-regulation of two TIR domain-containing adapter proteins, TIRAP and TRIF, as well as a RIP1 but had no effect on other adapter molecules in either the TLRs or TNF-alpha signaling pathways. Multiple sequence alignment analysis suggested that RIP1 contains a TIR homologous domain, and mutation of amino acid residues in this domain identified three residues critical for its interaction with Triad3A. Moreover, Triad3A acted as a negative regulator in TNF-alpha signaling. Reduction of Triad3A expression by small interference RNAs rendered cells hyperresponsive to TNF-alpha stimulation. Conversely, overexpression of Triad3A in cells blocked TNF-alpha-induced cell activation. This negative regulation was effected independently of changes in the cellular protein level of RIP1. Further studies indicated that RIP1 formed a complex with Triad3A and heat shock protein 90 (Hsp90), which is a chaperone protein capable of maintaining the stability of its client proteins. Treatment of cells with geldanamycin to disrupt the Hsp90 complex led to proteasomal degradation of RIP1. Depletion of Triad3A by small interference RNA treatment inhibited geldanamycin-activated ubiquitination and proteolytic degradation of RIP1. These results suggest that Triad3A is an E3 ubiquitin-protein ligase to RIP1 and that Hsp90 and Triad3A cooperatively maintain the homeostasis of RIP1.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Chuang, TH (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chuang@scripps.edu	Chuang, Tsung-Hsien/F-9679-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069652] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069652] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Beutler B, 2004, MICROBES INFECT, V6, P1374, DOI 10.1016/j.micinf.2004.08.017; Beutler B, 2003, ANNU REV PHARMACOL, V43, P609, DOI 10.1146/annurev.pharmtox.43.100901.135729; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chen DY, 2002, J BIOL CHEM, V277, P15985, DOI 10.1074/jbc.M108675200; Chiosis G, 2003, CURR CANCER DRUG TAR, V3, P371, DOI 10.2174/1568009033481778; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; Daun JM, 2000, J INTERF CYTOK RES, V20, P843, DOI 10.1089/10799900050163217; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Imler J L, 2000, Rev Immunogenet, V2, P294; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; LEE JD, 1993, P NATL ACAD SCI USA, V90, P9930, DOI 10.1073/pnas.90.21.9930; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rubin C, 2005, CELL RES, V15, P66, DOI 10.1038/sj.cr.7290268; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Vanden Berghe T, 2003, J BIOL CHEM, V278, P5622, DOI 10.1074/jbc.M208925200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Younes A., 2005, FUTURE ONCOLOGY, V1, P273; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	40	70	73	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34592	34600		10.1074/jbc.M604019200	http://dx.doi.org/10.1074/jbc.M604019200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16968706	hybrid			2022-12-27	WOS:000241767600078
J	Garza-Sanchez, F; Janssen, BD; Hayes, CS				Garza-Sanchez, Fernando; Janssen, Brian D.; Hayes, Christopher S.			Prolyl-tRNA(Pro) in the A-site of SecM-arrested ribosomes inhibits the recruitment of transfer-messenger RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRANSLATION ARREST; BACILLUS-SUBTILIS; NASCENT-PEPTIDE; QUALITY-CONTROL; DEGRADATION; PROTEIN; EXPRESSION; CLEAVAGE; CODON	Translational pausing can lead to cleavage of the A-site codon and facilitate recruitment of the transfer-messenger RNA (tmRNA) (SsrA) quality control system to distressed ribosomes. We asked whether aminoacyl-tRNA binding site (A-site) mRNA cleavage occurs during regulatory translational pausing using the Escherichia coli SecM-mediated ribosome arrest as a model. We find that SecM ribosome arrest does not elicit efficient A-site cleavage, but instead allows degradation of downstream mRNA to the 3'-edge of the arrested ribosome. Characterization of SecM-arrested ribosomes shows the nascent peptide is covalently linked via glycine 165 to tRNA(3)(Gly) in the peptidyl-tRNA binding site, and prolyl-tRNA(2)(Pro) is bound to the A-site. Although A-site-cleaved mRNAs were not detected, tmRNA-mediated ssrA tagging after SecM glycine 165 was observed. This tmRNA activity results from sequestration of prolyl-tRNA(2)(Pro) on overexpressed SecM-arrested ribosomes, which produces a second population of stalled ribosomes with unoccupied A-sites. Indeed, compensatory overexpression of tRNA(2)(Pro) readily inhibits ssrA tagging after glycine 165, but has no effect on the duration of SecM ribosome arrest. We conclude that, under physiological conditions, the architecture of SecM-arrested ribosomes allows regulated translational pausing without interference from A-site cleavage or tmRNA activities. Moreover, it seems likely that A-site mRNA cleavage is generally avoided or inhibited during regulated ribosome pauses.	Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Life Sci Technol Bldg,Rm 3105, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu	Hayes, Christopher/A-5505-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078634-01, R01 GM078634] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR A, 1993, BIOTECHNIQUES, V14, P366; BECHHOFER DH, 1989, J BACTERIOL, V171, P5803, DOI 10.1128/jb.171.11.5803-5811.1989; BRUCKNER R, 1987, MOL GEN GENET, V207, P486, DOI 10.1007/BF00331619; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Coburn GA, 1998, J MOL BIOL, V279, P1061, DOI 10.1006/jmbi.1998.1842; Collier J, 2004, J BIOL CHEM, V279, P54193, DOI 10.1074/jbc.M314012200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; DREHER J, 1991, MOL MICROBIOL, V5, P3025, DOI 10.1111/j.1365-2958.1991.tb01862.x; DUBNAU D, 1985, EMBO J, V4, P533, DOI 10.1002/j.1460-2075.1985.tb03661.x; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; HAHN J, 1982, MOL GEN GENET, V186, P204, DOI 10.1007/BF00331851; HAJNSDORF E, 1994, EMBO J, V13, P3368, DOI 10.1002/j.1460-2075.1994.tb06639.x; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Jerinic O, 2000, J MOL BIOL, V304, P707, DOI 10.1006/jmbi.2000.4269; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Li Y, 2003, P NATL ACAD SCI USA, V100, P13213, DOI 10.1073/pnas.2235589100; Loomis WP, 2001, MOL MICROBIOL, V39, P693, DOI 10.1046/j.1365-2958.2001.02241.x; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; LOVETT PS, 1990, J BACTERIOL, V172, P1, DOI 10.1128/JB.172.1.1-6.1990; McNicholas P, 1997, J MOL BIOL, V265, P128, DOI 10.1006/jmbi.1996.0723; Mitra K, 2006, MOL CELL, V22, P533, DOI 10.1016/j.molcel.2006.05.003; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Murakami A, 2004, P NATL ACAD SCI USA, V101, P12330, DOI 10.1073/pnas.0404907101; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2005, GENE DEV, V19, P436, DOI 10.1101/gad.1259505; Nakatogawa H, 2004, CURR OPIN MICROBIOL, V7, P145, DOI 10.1016/j.mib.2004.01.001; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Regnier P, 2000, BIOESSAYS, V22, P235; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; ZURAWSKI G, 1978, P NATL ACAD SCI USA, V75, P5988, DOI 10.1073/pnas.75.12.5988	47	75	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34258	34268		10.1074/jbc.M608052200	http://dx.doi.org/10.1074/jbc.M608052200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16968693	Green Accepted, hybrid			2022-12-27	WOS:000241767600046
J	Hochman, E; Castiel, A; Jacob-Hirsch, J; Amariglio, N; Izraeli, S				Hochman, Eldar; Castiel, Asher; Jacob-Hirsch, Jasmine; Amariglio, Ninnette; Izraeli, Shai			Molecular pathways regulating pro-migratory effects of Hedgehog signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGEN SONIC HEDGEHOG; RESPONSIVE GENE; TUBE FORMATION; AXON GUIDANCE; IN-VITRO; NEUROPILIN-1; GROWTH; ANGIOGENESIS; EXPRESSION; CELLS	The Hedgehog proteins play a crucial role in metazoan embryo development. Constitutive activation of the pathway is associated with multiple types of cancer. Recent experimental data suggest involvement of Hedgehog signaling in vascular remodeling, germ cell migration, and axon guidance. The molecular mechanisms underlying these effects remain elusive. Here we show that yolk sac-derived endothelial cells and embryonic fibroblasts can directly respond to the Hedgehog signal by increased migration in an in vitro scratch (wound) assay. We also identify Hedgehog transcriptional target genes in these cells, many of which participate in cell migration, axon guidance, and angiogenesis processes. Inhibition of one such molecular pathway, neuropilin-flavomonooxygenase, blocks Hedgehog-induced cell migration. These findings suggest that Hedgehog signaling directly affects embryonic endothelial and fibroblast cell migration via molecules and pathways known to regulate cell migration in response to a variety of environmental cues.	Safra Childrens Hosp, Sheba Med Ctr, Sheba Canc Res Ctr, Res Sect Childhood Malignancies, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Fac Med, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University	Izraeli, S (corresponding author), Safra Childrens Hosp, Sheba Med Ctr, Sheba Canc Res Ctr, Res Sect Childhood Malignancies, IL-52621 Tel Hashomer, Israel.	sizraeli@sheba.health.gov.il						Abe I, 2000, BIOCHEM BIOPH RES CO, V268, P767, DOI 10.1006/bbrc.2000.2217; Abe I, 2000, FEBS LETT, V483, P131, DOI 10.1016/S0014-5793(00)02100-1; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; BANERJEE S, 2006, IN PRESS MOL CARCINO; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Byrd N, 2002, DEVELOPMENT, V129, P361; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Deshpande G, 2001, CELL, V106, P759, DOI 10.1016/S0092-8674(01)00488-3; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Eickholt BJ, 1999, DEVELOPMENT, V126, P2181; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Garg V, 2001, DEV BIOL, V235, P62, DOI 10.1006/dbio.2001.0283; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Gonzalez-Quevedo R, 2005, J CELL BIOL, V168, P453, DOI 10.1083/jcb.200409078; Herzog Y, 2001, MECH DEVELOP, V109, P115, DOI 10.1016/S0925-4773(01)00518-4; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Kato K, 2004, DEVELOPMENT, V131, P5253, DOI 10.1242/dev.01404; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kellner K, 2002, TISSUE ENG, V8, P561, DOI 10.1089/107632702760240481; Kolpak A, 2005, J NEUROSCI, V25, P3432, DOI 10.1523/JNEUROSCI.4938-04.2005; Kondo T, 2002, CANCER LETT, V180, P139, DOI 10.1016/S0304-3835(02)00007-1; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; LIN L, 2006, IN PRESS DEV BIOL; Louro ID, 2002, CANCER RES, V62, P5867; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Matthies AM, 2002, AM J PATHOL, V160, P289, DOI 10.1016/S0002-9440(10)64372-6; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Ochiumi T, 2006, INT J ONCOL, V29, P105; Oh H, 2002, P NATL ACAD SCI USA, V99, P383, DOI 10.1073/pnas.012074399; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Smoak IW, 2005, DEV BIOL, V283, P357, DOI 10.1016/j.ydbio.2005.04.029; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Ventura A., 2002, SCI STKE, V2002, pPE44; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Vokes SA, 2004, DEVELOPMENT, V131, P4371, DOI 10.1242/dev.01304; Wang SJ, 1996, IN VITRO CELL DEV-AN, V32, P292; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200	56	61	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33860	33870		10.1074/jbc.M605905200	http://dx.doi.org/10.1074/jbc.M605905200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16943197	hybrid			2022-12-27	WOS:000241767600007
J	Nakajima, S; Lan, L; Kanno, SI; Usami, N; Kobayashi, K; Mori, M; Shiomi, T; Yasui, A				Nakajima, Satoshi; Lan, Li; Kanno, Shin-ichiro; Usami, Noriko; Kobayashi, Katsumi; Mori, Masahiko; Shiomi, Tadahiro; Yasui, Akira			Replication-dependent and -independent responses of RAD18 to DNA damage in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; DEFECTIVE POSTREPLICATION REPAIR; RING FINGER PROTEINS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; YEAST RAD6; POLYMERASE-ETA; GENE; PCNA; SUMO	Postreplication repair facilitates tolerance of DNA damage during replication, overcoming termination of replication at sites of DNA damage. A major post-replication repair pathway in mammalian cells is translesion synthesis, which is carried out by specialized polymerase(s), such as polymerase eta, and is identified by focus formation by the polymerase after irradiation with UVC light. The formation of these foci depends on RAD18, which ubiquitinates PCNA for the exchange of polymerases. To understand the initial processes in translesion synthesis, we have here analyzed the response to damage of RAD18 in human cells. We find that human RAD18 accumulates very rapidly and remains for a long period of time at sites of different types of DNA damage, including UVC light-induced lesions, and x-ray microbeam- and laser-induced single-strand breaks, in a cell cycle-independent manner. The accumulation of RAD18 at DNA damage is observed even when DNA replication is inhibited, and a small region containing a zinc finger motif located in the middle of RAD18 is essential and sufficient for the replication-independent damage accumulation. The zinc finger motif of RAD18 is not necessary for UV-induced polymerase eta focus formation, but another SAP (SAF-A/B, Acinus and PIAS) motif near the zinc finger is required. These data indicate that RAD18 responds to DNA damage in two distinct ways, one replication-dependent and one replication-independent, involving the SAP and zinc finger motifs, respectively.	Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Genet, Sendai, Miyagi 9808575, Japan; Natl Inst Radiol Sci, KEK, IMSS, Photon Factory, Chiba 2638555, Japan; Natl Inst Radiol Sci, Low Dose Radiat Effects Project, Chiba 2638555, Japan	Tohoku University; High Energy Accelerator Research Organization (KEK); National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology	Yasui, A (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Genet, Sendai, Miyagi 9808575, Japan.	ayasui@idac.tohoku.ac.jp	Kanno, Shin-ichiro/AAE-4549-2019	Usami, Noriko/0000-0002-6157-8418				Akhtar A, 2001, EMBO REP, V2, P113, DOI 10.1093/embo-reports/kve022; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bohm F, 2005, NUCLEIC ACIDS RES, V33, P1101, DOI 10.1093/nar/gki258; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hishida T, 2002, EMBO J, V21, P2019, DOI 10.1093/emboj/21.8.2019; Hishida T, 2001, P NATL ACAD SCI USA, V98, P8283, DOI 10.1073/pnas.121009098; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Kawabe Y, 2001, J BIOL CHEM, V276, P20364, DOI 10.1074/jbc.C100035200; KOBAYASHI K, 2006, IN PRESS J BIOMED NA; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; LAWRENCE C, 1994, BIOESSAYS, V16, P253, DOI 10.1002/bies.950160408; Lehmann AR, 2005, FEBS LETT, V579, P873, DOI 10.1016/j.febslet.2004.11.029; Lehmann AR, 2002, MUTAT RES-FUND MOL M, V509, P23, DOI 10.1016/S0027-5107(02)00227-0; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Murakumo Y, 2006, GENES CELLS, V11, P193, DOI 10.1111/j.1365-2443.2006.00938.x; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; SUNG P, 1991, J MOL BIOL, V221, P745, DOI 10.1016/0022-2836(91)80169-U; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xin H, 2000, NUCLEIC ACIDS RES, V28, P2847, DOI 10.1093/nar/28.14.2847	48	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34687	34695		10.1074/jbc.M605545200	http://dx.doi.org/10.1074/jbc.M605545200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16980296	hybrid			2022-12-27	WOS:000241767600087
J	Pierobon, N; Renard-Rooney, DC; Gaspers, LD; Thomas, AP				Pierobon, Nicola; Renard-Rooney, Dominique C.; Gaspers, Lawrence D.; Thomas, Andrew P.			Ryanodine receptors in liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CYTOSOLIC CALCIUM OSCILLATIONS; CA2+ RELEASE CHANNEL; SKELETAL-MUSCLE; RAT-LIVER; BINDING-SITES; ENDOPLASMIC-RETICULUM; HEPATOCYTES; CELLS	The ryanodine receptor has been mainly regarded as the Ca2+ release channel from sarcoplasmic reticulum controlling skeletal and cardiac muscle contraction. However, many studies have shown that it is widely expressed, with functions not restricted to muscular contraction. This study examined whether ryanodine receptor plays a role in calcium signaling in the liver. RTPCR analysis of isolated hepatocytes showed expression of a truncated type 1 ryanodine receptor, but no type 2 or type 3 message was detected. We also detected binding sites for [H-3]ryanodine in the microsomal cellular fraction and in permeabilized hepatocytes. This binding was displaced by caffeine and dantrolene, but not by ruthenium red, heparin or cyclic ADP-Ribose. Ryanodine, by itself, did not trigger Ca2+ oscillations in either primary cultured hepatocytes or hepatocytes within the intact perfused rat liver. In both preparations, however, ryanodine significantly increased the frequency of the cytosolic free [Ca2+] oscillations evoked by an alpha(1) adrenergic receptor agonist. Experiments in permeabilized hepatocytes showed that both ryanodine and cyclic ADP-ribose evoked a slow Ca2+ leak from intracellular stores and were able to increase the Ca2+-released response to a subthreshold dose of inositol 1,4,5-trisphosphate. Our findings suggest the presence of a novel truncated form of the type 1 ryanodine receptor in rat hepatocytes. Ryanodine modulates the pattern of cytosolic free [Ca2+] oscillations by increasing oscillation frequency. We propose that the Ca2+ released from ryanodine receptors on the endoplasmic reticulum provides an increased pool of Ca2+ for positive feedback on inositol 1,4,5-trisphosphate receptors.	Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Thomas, AP (corresponding author), Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	thomasap@umdnj.edu	Thomas, Andrew/C-6755-2013; Gaspers, Lawrence/W-8766-2019	Gaspers, Lawrence/0000-0002-5620-3283; Thomas, Andrew/0000-0002-9026-7467	NIAAA NIH HHS [AA014980] Funding Source: Medline; NIDDK NIH HHS [DK38422] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038422, R29DK038422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014980] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ASSIMACOPOULOSJEANNET FD, 1977, J BIOL CHEM, V252, P2662; BAZOTTE RB, 1991, BIOCHEM PHARMACOL, V42, P1799, DOI 10.1016/0006-2952(91)90518-A; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; CALLAWAY C, 1994, J BIOL CHEM, V269, P15876; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; ELLINGSON JS, 1991, BIOCHIM BIOPHYS ACTA, V1062, P199, DOI 10.1016/0005-2736(91)90393-M; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fitzsimmons TJ, 2000, BIOCHEM J, V351, P265, DOI 10.1042/0264-6021:3510265; GALIONE A, 1993, SCIENCE, V261, P348, DOI 10.1126/science.8392748; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Gaspers LD, 2005, CELL CALCIUM, V38, P329, DOI 10.1016/j.ceca.2005.06.009; Gerasimenko J, 2003, BIOCHEM SOC T, V31, P76, DOI 10.1042/bst0310076; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; HAJNOCZKY G, 1994, J BIOL CHEM, V269, P10280; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; HAKAMATA Y, 1994, FEBS LETT, V352, P206, DOI 10.1016/0014-5793(94)00955-4; Hirata K, 2002, GASTROENTEROLOGY, V122, P1088, DOI 10.1053/gast.2002.32363; Joseph SK, 1996, CELL SIGNAL, V8, P1, DOI 10.1016/0898-6568(95)02012-8; Khoo KM, 2000, ARCH BIOCHEM BIOPHYS, V373, P35, DOI 10.1006/abbi.1999.1526; KOGUMA T, 1994, BBA-MOL CELL RES, V1223, P160, DOI 10.1016/0167-4889(94)90087-6; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lee BS, 2002, J MEMBRANE BIOL, V189, P181, DOI 10.1007/s00232-002-1012-x; LILLY LB, 1995, AM J PHYSIOL-GASTR L, V268, pG1017, DOI 10.1152/ajpgi.1995.268.6.G1017; Mackenzie L, 2004, BIOL RES, V37, P553, DOI 10.4067/S0716-97602004000400008; MONCK JR, 1992, J CELL BIOL, V116, P745, DOI 10.1083/jcb.116.3.745; Morgan AJ, 1999, METH MOL B, V114, P93; NATHANSON MH, 1994, AM J PHYSIOL, V267, pG338, DOI 10.1152/ajpgi.1994.267.3.G338; PESSAH IN, 1986, J BIOL CHEM, V261, P8643; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; ROBBGASPERS LD, 1995, J BIOL CHEM, V270, P8102, DOI 10.1074/jbc.270.14.8102; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; RUSINKO N, 1989, J BIOL CHEM, V264, P11725; SANCHEZBUENO A, 1994, BIOCHEM BIOPH RES CO, V198, P728, DOI 10.1006/bbrc.1994.1105; Sei Y, 1999, J BIOL CHEM, V274, P5995, DOI 10.1074/jbc.274.9.5995; SHOSHANBARMATZ V, 1991, BIOCHEM J, V276, P41, DOI 10.1042/bj2760041; SHOSHANBARMATZ V, 1990, FEBS LETT, V263, P317, DOI 10.1016/0014-5793(90)81403-B; TAKESHIMA H, 1993, FEBS LETT, V322, P105, DOI 10.1016/0014-5793(93)81547-D; TARASCHI TF, 1985, BIOCHEMISTRY-US, V24, P7096, DOI 10.1021/bi00346a012; Tunwell REA, 1996, J BIOL CHEM, V271, P29583, DOI 10.1074/jbc.271.47.29583; WALSETH TF, 1991, BIOCHIM BIOPHYS ACTA, V1094, P113, DOI 10.1016/0167-4889(91)90032-S; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; WITCHER DR, 1994, J BIOL CHEM, V269, P13076; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Zhang XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1306, DOI 10.1152/ajpcell.1997.273.4.C1306	48	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34086	34095		10.1074/jbc.M607788200	http://dx.doi.org/10.1074/jbc.M607788200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973607	hybrid			2022-12-27	WOS:000241767600029
J	Unoki, M; Shen, JC; Zheng, ZM; Harris, CC				Unoki, Motoko; Shen, Jiang Cheng; Zheng, Zhi-Ming; Harris, Curtis C.			Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; MESSENGER-RNA; PHD FINGER; BINDING; PROTEINS; ACTIVATION; EXPRESSION; CYTOPLASM; ENHANCER; FAMILY	The ING4 gene is a candidate tumor suppressor gene that functions in cell proliferation, contact inhibition, and angiogenesis. We identified three novel splice variants of ING4 with differing activities in controlling cell proliferation, cell spreading, and cell migration. ING4_v1 (the longest splice variant), originally identified as ING4, encodes an intact nuclear localization signal (NLS), whereas the other three splice variants (ING4_v2, ING4_v3, and ING4_v4) lack the full NLS, resulting in increased cytoplasmic localization of these proteins. We found that one of the three ING4 variants, ING4_v2, is expressed at the same level as the original ING4 (ING4_v1), suggesting that ING4 variants may have significant biological functions. Growth suppressive effects of the variants that have a partial NLS (ING4_v2 and ING4_v4) were attenuated by a weaker effect of the variants on p21(WAF1) promoter activation. ING4_v4 lost cell spreading and migration suppressive effects; on the other hand, ING4_v2 retained a cell migration suppressive effect but lost a cell spreading suppressive effect. Therefore, ING4_v2, which localized primarily into cytoplasm, might have an important role in the regulation of cell migration. We also found that ING4_v4 played dominant-negative roles in the induction of p21(WAF1) promoter activation and in the suppression of cell motility by ING4_v1. In addition, ING4 variants had different binding affinities to two cytoplasmic proteins, protein-tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, and G3BP2a. Understanding the functions of the four splice variants may aid in defining their roles in human carcinogenesis.	NCI, Human Carcinogenesis Lab, CCR, NIH, Bethesda, MD 20892 USA; NCI, HIV & AIDS Malignancy Branch, CCR, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Harris, CC (corresponding author), NCI, Human Carcinogenesis Lab, CCR, NIH, 37 Convent Dr,Bldg 37,Rm 3068, Bethesda, MD 20892 USA.	Curtis_Harris@nih.gov	Zheng, Zhi-Ming/L-6383-2019; Unoki, Motoko/X-3285-2019	Zheng, Zhi-Ming/0000-0001-5547-7912; Unoki, Motoko/0000-0002-9629-3818	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Cox LS, 1997, J PATHOL, V183, P134, DOI 10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; French J, 2002, HISTOCHEM J, V34, P223, DOI 10.1023/A:1021737413055; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Gong W, 2005, INT J BIOCHEM CELL B, V37, P1054, DOI 10.1016/j.biocel.2004.09.008; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gunduz M, 2005, GENE, V356, P109, DOI 10.1016/j.gene.2005.02.014; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; Ladd AN, 2002, GENOME BIOL, V3; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Liu SX, 2003, DRUG RESIST UPDATE, V6, P183, DOI 10.1016/S1368-7646(03)00044-X; Liu XF, 2003, J VIROL, V77, P2105, DOI 10.1128/JVI.77.3.2105-2115.2003; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Parker F, 1996, MOL CELL BIOL, V16, P2561; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Serra-Pages C, 2005, BIOCHEMISTRY-US, V44, P15715, DOI 10.1021/bi051434f; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shiseki M, 2003, CANCER RES, V63, P2373; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Zhang X, 2005, BIOCHEM BIOPH RES CO, V331, P1032, DOI 10.1016/j.bbrc.2005.04.023; Zhang X, 2004, FEBS LETT, V570, P7, DOI 10.1016/j.febslet.2004.06.010; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096	34	82	92	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34677	34686		10.1074/jbc.M606296200	http://dx.doi.org/10.1074/jbc.M606296200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973615	hybrid			2022-12-27	WOS:000241767600086
J	Hou, JC; Suzuki, N; Pessin, JE; Watson, RT				Hou, June Chunqiu; Suzuki, Naoko; Pessin, Jeffrey E.; Watson, Robert T.			A specific dileucine motif is required for the GGA-dependent entry of newly synthesized insulin-responsive aminopeptidase into the insulin-responsive compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; GLUCOSE-TRANSPORTER GLUT4; RAT ADIPOSE-CELLS; REGULATED MEMBRANE AMINOPEPTIDASE; ENDOSOMAL RECYCLING COMPARTMENT; SKELETAL-MUSCLE CELLS; PLASMA-MEMBRANE; STORAGE COMPARTMENT; 3T3-L1 ADIPOCYTES; 3T3L1 ADIPOCYTES	In muscle and adipose cells, the insulin-responsive aminopeptidase ( IRAP) is localized to intracellular storage sites and undergoes insulin-dependent redistribution to the cell surface. Following expression, the newly synthesized IRAP protein traffics to the perinuclear insulin-sensitive compartment and acquires insulin sensitivity 6-9 h following biosynthesis. Knockdown of GGA1 by RNA interference prevented IRAP from entering, but not exiting, the insulin-responsive compartment. Mutation of the dileucine motif at positions 76 and 77 (EGFP-IRAP/AA(76,77)),but not the dileucine motif at positions 53 and 54, resulted in the rapid default of the reporter to the cell surface beginning at 3 h following biosynthesis. Alanine substitution of 9 residues amino- or carboxyl-terminal to LL76,77 did not perturb basal intracellular sequestration or abrogate insulin-stimulated IRAP translocation. Moreover, a dominant interfering GGA mutant (VHS-GAT) potently inhibited insulin-stimulated translocation of EGFP-IRAP/WT but did not block the constitutive exocytotic trafficking of EGFP-IRAP/AA(76,77). In addition, the EGFP-IRAP/WT and EGFP-IRAP/AA(76,77) constructs occupied morphologically distinct tubulovesicular compartments in the perinuclear region. Taken together, these data indicate that LL76,77 functions during the GGA-dependent sorting of newly made IRAP into the insulin-responsive storage compartment.	SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Watson, RT (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	Watson@pharm.stonybrook.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033823, R37DK033823, R01DK055811] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK55811, DK33823] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 2004, MOL ENDOCRINOL, V18, P2491, DOI 10.1210/me.2004-0175; Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brozinick JT, 2004, J BIOL CHEM, V279, P40699, DOI 10.1074/jbc.M402697200; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; El-Jack AK, 1999, MOL BIOL CELL, V10, P1581, DOI 10.1091/mbc.10.5.1581; Elmendorf JS, 1999, J BIOL CHEM, V274, P37357, DOI 10.1074/jbc.274.52.37357; Ghosh P, 2004, EUR J CELL BIOL, V83, P257, DOI 10.1078/0171-9335-00374; Gleeson PA, 2004, TRAFFIC, V5, P315, DOI 10.1111/j.1398-9219.2004.00182.x; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2001, MOL BIOL CELL, V12, P3573, DOI 10.1091/mbc.12.11.3573; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Hou JCQ, 2003, MOL BIOL CELL, V14, P3578, DOI 10.1091/mbc.E03-02-0012; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; KANDROR K, 1994, J BIOL CHEM, V269, P138; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kandror KV, 1998, BIOCHEM J, V331, P829, DOI 10.1042/bj3310829; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Khan AH, 2004, J BIOL CHEM, V279, P37505, DOI 10.1074/jbc.M405694200; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Lampson MA, 2000, J CELL SCI, V113, P4065; Li LV, 2005, MOL ENDOCRINOL, V19, P2145, DOI 10.1210/me.2005-0032; Liu G, 2005, AM J PHYSIOL-ENDOC M, V289, pE746, DOI 10.1152/ajpendo.00175.2005; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Martin S, 1997, J CELL SCI, V110, P2281; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Munro S, 2004, NAT CELL BIOL, V6, P469, DOI 10.1038/ncb0604-469; Palacios S, 2001, J BIOL CHEM, V276, P3371, DOI 10.1074/jbc.M006739200; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2003, MOL BIOL CELL, V14, P1545, DOI 10.1091/mbc.02-07-0109; RODNICK KJ, 1992, J BIOL CHEM, V267, P6278; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; SATOH S, 1993, J BIOL CHEM, V268, P17820; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; SHIBATA H, 1995, J BIOL CHEM, V270, P11489, DOI 10.1074/jbc.270.19.11489; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Subtil A, 2000, J BIOL CHEM, V275, P4787, DOI 10.1074/jbc.275.7.4787; Sumitani S, 1997, ENDOCRINOLOGY, V138, P1029, DOI 10.1210/en.138.3.1029; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Watson RT, 2001, AM J PHYSIOL-CELL PH, V281, pC215, DOI 10.1152/ajpcell.2001.281.1.C215; Watson RT, 2000, J BIOL CHEM, V275, P1261, DOI 10.1074/jbc.275.2.1261; YANG J, 1993, J BIOL CHEM, V268, P4600; Zhou M, 2000, AM J PHYSIOL-ENDOC M, V278, pE1019, DOI 10.1152/ajpendo.2000.278.6.E1019	67	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33457	33466		10.1074/jbc.M601583200	http://dx.doi.org/10.1074/jbc.M601583200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16945927	hybrid			2022-12-27	WOS:000241621400056
J	Ong, LL; Lin, PC; Zhang, X; Chia, SM; Yu, H				Ong, Lee-Lee; Lin, Pao-Chun; Zhang, Xin; Chia, Ser-Mien; Yu, Hanry			Kinectin-dependent assembly of translation elongation factor-1 complex on endoplasmic reticulum regulates protein synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RNA-SYNTHETASE; AMINOACYL-TRANSFER RNA; KINESIN-BINDING PROTEIN; MOLECULAR-CLONING; MESSENGER-RNAS; RAT-LIVER; MEMBRANE; PHOSPHORYLATION; ORGANIZATION; ARTEMIA	Kinectin is an integral membrane protein with many isoforms primarily found on the endoplasmic reticulum. It has been found to bind kinesin, Rho GTPase, and translation elongation factor-1 delta. None of the existing models for the quaternary organization of the elongation factor-1 complex in higher eukaryotes involves kinectin. We have investigated here the assembly of the elongation factor-1 complex onto endoplasmic reticulum via kinectin using in vitro and in vivo assays. We established that the entire elongation factor-1 complex can be anchored to endoplasmic reticulum via kinectin, and the interacting partners are as follows. Kinectin binds EF-1 delta, which in turn binds EF-1 gamma but not EF-1 beta; EF-1 gamma binds EF-1 delta and EF-1 beta but not kinectin. In vivo splice blocking of the kinectin exons 36 and 37 produced kinectin lacking the EF-1 delta binding domain, which disrupted the membrane localization of EF-1 delta, EF-1 gamma, and EF-1 beta on endoplasmic reticulum, similar to the disruptions seen with the overexpression of kinectin fragments containing the EF-1 delta binding domain. The disruptions of the EF-1 delta/kinectin interaction inhibited expression of membrane proteins but enhanced synthesis of cytosolic proteins in vivo. These findings suggest that anchoring the elongation factor-1 complex onto endoplasmic reticulum via EF-1 delta/kinectin interaction is important for regulating protein synthesis in eukaryotic cells.	Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; Natl Univ Singapore, Natl Univ Med Inst, Singapore 117597, Singapore; Natl Univ Singapore, Grad Program Bioengn, Singapore 117597, Singapore; Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; Natl Univ Singapore, NUSTEP, Singapore 117597, Singapore; Singapore MIT Alliance, Singapore 117576, Singapore; Agcy Sci Technol & Res, Inst Bioengn & Technol, Singapore 138669, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN)	Yu, H (corresponding author), Natl Univ Singapore, Dept Physiol, Block MD11,04-01A,10 Med Dr, Singapore 117597, Singapore.	phsyuh@nus.edu.sg	Yu, Hanry/C-1031-2013; Yu, Hanry/L-6050-2019; Yu, Hanry/C-7375-2011	Yu, Hanry/0000-0002-0339-3685; Yu, Hanry/0000-0002-0339-3685; 				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARBARESE E, 1995, J CELL SCI, V108, P2781; BEC G, 1994, J BIOL CHEM, V269, P2086; BIRBECK MS, 1961, NATURE, V189, P558, DOI 10.1038/189558a0; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; DALLNER G, 1966, J CELL BIOL, V30, P97, DOI 10.1083/jcb.30.1.97; DALLNER G, 1966, J CELL BIOL, V30, P73, DOI 10.1083/jcb.30.1.73; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; EISENSTEIN RS, 1984, J BIOL CHEM, V259, P9922; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; FULTON AB, 1980, CELL, V20, P849, DOI 10.1016/0092-8674(80)90331-1; FUTTERER A, 1995, MOL BIOL CELL, V6, P161; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; Harlow E., 1988, ANTIBODIES LAB MANUA; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; HICKS SJ, 1969, SCIENCE, V164, P584, DOI 10.1126/science.164.3879.584; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JANSSEN GMC, 1988, J BIOL CHEM, V263, P1773; JANSSEN GMC, 1988, EUR J BIOCHEM, V171, P119, DOI 10.1111/j.1432-1033.1988.tb13766.x; JANSSEN GMC, 1994, J BIOL CHEM, V269, P31410; KAETHER C, 1995, FEBS LETT, V369, P267, DOI 10.1016/0014-5793(95)00765-2; Kaether C, 1997, EUR J CELL BIOL, V74, P133; KIMBALL SR, 1989, AM J PHYSIOL, V256, pC28, DOI 10.1152/ajpcell.1989.256.1.C28; Kumar J, 1998, J BIOL CHEM, V273, P31738, DOI 10.1074/jbc.273.48.31738; KUMAR J, 1995, SCIENCE, V267, P1834, DOI 10.1126/science.7892610; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; Leung E, 1996, IMMUNOL CELL BIOL, V74, P421, DOI 10.1038/icb.1996.72; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; MERRICK WC, 2000, TRANSLATIONAL CONTRO; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; Minella O, 1998, BIOSCIENCE REP, V18, P119, DOI 10.1023/A:1020140527930; MORRISON TG, 1975, J BIOL CHEM, V250, P6955; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; NEGRUTSKII BS, 1994, P NATL ACAD SCI USA, V91, P964, DOI 10.1073/pnas.91.3.964; OGILVIE A, 1979, BIOCHIM BIOPHYS ACTA, V565, P293, DOI 10.1016/0005-2787(79)90206-5; Ong LL, 2000, J BIOL CHEM, V275, P32854, DOI 10.1074/jbc.M005650200; Ong LL, 2003, J BIOL CHEM, V278, P32115, DOI 10.1074/jbc.M210917200; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pelham HRB, 1996, CELL STRUCT FUNCT, V21, P413, DOI 10.1247/csf.21.413; Potter MD, 2001, TRENDS CELL BIOL, V11, P112, DOI 10.1016/S0962-8924(00)01905-X; PRINT CG, 1994, GENE, V144, P221, DOI 10.1016/0378-1119(94)90381-6; RAPOPORT TA, 1989, BIOCHEM SOC T, V17, P325, DOI 10.1042/bst0170325; REDMAN CM, 1966, J BIOL CHEM, V241, P1150; RICHTER JD, 1981, CELL, V27, P183, DOI 10.1016/0092-8674(81)90372-X; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; RYAZANOV AG, 1987, BIOSYSTEMS, V20, P275, DOI 10.1016/0303-2647(87)90035-9; Sanders J, 1996, J CELL SCI, V109, P1113; Santama N, 2004, J CELL SCI, V117, P4537, DOI 10.1242/jcs.01326; Sheu GT, 1999, MOL CELL BIOCHEM, V191, P181, DOI 10.1023/A:1006802125856; Sheu GT, 1997, J BIOL CHEM, V272, P33290, DOI 10.1074/jbc.272.52.33290; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Toyoshima I, 1996, NEUROSCI LETT, V211, P171, DOI 10.1016/0304-3940(96)12752-X; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; VANDAMME H, 1991, EUR J BIOCHEM, V197, P505, DOI 10.1111/j.1432-1033.1991.tb15938.x; VANDAMME HTF, 1990, BIOCHIM BIOPHYS ACTA, V1050, P241, DOI 10.1016/0167-4781(90)90174-Z; VASSALLI P, 1971, J MOL BIOL, V56, P1, DOI 10.1016/0022-2836(71)90080-5; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wang HC, 2004, BIOCHEM CELL BIOL, V82, P321, DOI 10.1139/o04-003; Xu JW, 2002, MOL REPROD DEV, V62, P37, DOI 10.1002/mrd.10066; YU H, 1995, MOL BIOL CELL, V6, P171, DOI 10.1091/mbc.6.2.171	69	26	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33621	33634		10.1074/jbc.M607555200	http://dx.doi.org/10.1074/jbc.M607555200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950774	hybrid			2022-12-27	WOS:000241621400071
J	Beaulieu, JM; Sotnikova, TD; Gainetdinov, RR; Caron, MG				Beaulieu, Jean-Martin; Sotnikova, Tatyana D.; Gainetdinov, Raul R.; Caron, Marc G.			Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED KINASE; DOPAMINE; ERK; SEROTONIN; RECEPTOR; COCAINE; CASCADE; PHOSPHORYLATION; METHYLPHENIDATE; ACTIVATION	Recent investigations have shown that three major striatal-signaling pathways ( protein kinase A/DARPP-32, Akt/glycogen synthase kinase 3, and ERK) are involved in the regulation of locomotor activity by the monoaminergic neurotransmitter dopamine. Here we used dopamine transporter knock-out mice to examine which particular changes in the regulation of these cell signaling mechanisms are associated with distinct behavioral responses to psychostimulants. In normal animals, amphetamine and methylphenidate increase extracellular levels of dopamine, leading to an enhancement of locomotor activity. However, in dopamine transporter knock-out mice that display a hyperactivity phenotype resulting from a persistent hyperdopaminergic state, these drugs antagonize hyperactivity. Under basal conditions, dopamine transporter knock-out mice show enhanced striatal DARPP-32 phosphorylation, activation of ERK, and inactivation of Akt as compared with wild-type littermates. However, administration of amphetamine or methylphenidate to these mice reveals that inhibition of ERK signaling is a common determinant for the ability of these drugs to antagonize hyperactivity. In contrast, psychostimulants activate ERK and induce hyperactivity in normal animals. In hyperactive mice psychostimulant-mediated behavioral inhibition and ERK regulation are also mimicked by the serotonergic drugs fluoxetine and 5-carboxamidotryptamine, thereby revealing the involvement of serotonin-dependent inhibition of striatal ERK signaling. Furthermore, direct inhibition of the ERK signaling cascade in vivo using the MEK inhibitor SL327 recapitulates the actions of psychostimulants in hyperactive mice and prevents the loco-motor-enhancing effects of amphetamine in normal animals. These data suggest that the inhibitory action of psychostimulants on dopamine-dependent hyperactivity results from altered regulation of striatal ERK signaling. In addition, these results illustrate how altered homeostatic state of neurotransmission can influence in vivo signaling responses and biological actions of pharmacological agents used to manage psychiatric conditions such as Attention Deficit Hyperactivity Disorder (ADHD).	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, 487 CARL Bldg,Box 3287,Res Dr, Durham, NC 27710 USA.	m.caron@cellbio.duke.edu	Gainetdinov, Raul R/G-5875-2011; Sotnikova, Tatyana D/T-9992-2017; Beaulieu, Jean-Martin/A-7598-2008	Gainetdinov, Raul R/0000-0003-2951-6038; Beaulieu, Jean-Martin/0000-0002-0446-7447	NIDA NIH HHS [DA 13511] Funding Source: Medline; NIMH NIH HHS [MH 73853, MH 40159] Funding Source: Medline; NINDS NIH HHS [NS 19576] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853, P30MH040159, R01MH073853, P50MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013511] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Barkley R. A., 1998, ATTENTION DEFICIT HY, V2nd; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Berhow MT, 1996, J NEUROSCI, V16, P4707; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; CARLSSON A, 1987, ANNU REV NEUROSCI, V10, P19; CHEN J, 2004, J BIOL CHEM; Cowen DS, 2005, J NEUROCHEM, V93, P910, DOI 10.1111/j.1471-4159.2005.03107.x; Cyr M, 2003, P NATL ACAD SCI USA, V100, P11035, DOI 10.1073/pnas.1831768100; Einat H, 2003, J NEUROSCI, V23, P7311; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Fukui R, 2003, J NEUROCHEM, V87, P1391, DOI 10.1046/j.1471-4159.2003.02101.x; FULLER RW, 1991, MED RES REV, V11, P17, DOI 10.1002/med.2610110103; Fumagalli F, 2005, J NEUROCHEM, V93, P1551, DOI 10.1111/j.1471-4159.2005.03149.x; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; GREENHILL LL, 1992, PSYCHIAT CLIN N AM, V15, P1; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Horrigan J P, 2001, Expert Opin Pharmacother, V2, P573, DOI 10.1517/14656566.2.4.573; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Lanfumey L, 2004, CNS NEUROL DISORD-DR, V3, P1, DOI 10.2174/1568007043482570; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Molewijk HE, 1996, PSYCHOPHARMACOLOGY, V128, P31, DOI 10.1007/s002130050106; Nelson DL, 2004, CNS NEUROL DISORD-DR, V3, P53, DOI 10.2174/1568007043482606; Nissen SE, 2006, NEW ENGL J MED, V355, P203; Pozzi L, 2003, J NEUROCHEM, V86, P451, DOI 10.1046/j.1471-4159.2003.01851.x; Quist JF, 2001, J AM ACAD CHILD PSY, V40, P253, DOI 10.1097/00004583-200102000-00022; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Sullivan NR, 2005, N-S ARCH PHARMACOL, V371, P18, DOI 10.1007/s00210-004-1005-7; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; WALLIS GG, 1949, BRIT MED J, V2, P1394, DOI 10.1136/bmj.2.4641.1394; Wang CH, 2005, J NEUROCHEM, V93, P899, DOI 10.1111/j.1471-4159.2005.03055.x; ZARATE CA, 2006, BIOL PSYCHIAT; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	44	85	88	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32072	32080		10.1074/jbc.M606062200	http://dx.doi.org/10.1074/jbc.M606062200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954211	hybrid			2022-12-27	WOS:000241414500004
J	Bossuyt, J; Despa, S; Martin, JL; Bers, DM				Bossuyt, Julie; Despa, Sanda; Martin, Jody L.; Bers, Donald M.			Phospholemman phosphorylation alters its fluorescence resonance energy transfer with the Na/K-ATPase pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SARCOLEMMAL PROTEIN; NA,K-ATPASE; IDENTIFICATION; PHOSPHOLAMBAN; SUBUNIT; NA+,K+-ATPASE; EXPRESSION; REGULATORS; SEQUENCE	Phospholemman (PLM) or FXYD1 is a major cardiac myocyte phosphorylation target upon adrenergic stimulation. Prior immunoprecipitation and functional studies suggest that phospholemman associates with the Na/K-pump (NKA) and mediates adrenergic Na/K-pump regulation. Here, we tested whether the NKA-PLM interaction is close enough to allow fluorescence resonance energy transfer (FRET) between cyan and yellow fluorescent (CFP/YFP) fusion proteins of Na/K pump and phospholemman and whether phospholemman phosphorylation alters such FRET. Co-expressed NKA-CFP and PLM-YFP in HEK293 cells co-localized in the plasma membrane and exhibited robust FRET. Selective acceptor photobleach increased donor fluorescence (F-CFP) by 21.5 +/- 4.1% (n = 13), an effect nearly abolished when co-expressing excess phospholemman lacking YFP. Activation of protein kinase C or A progressively and reversibly decreased FRET assessed by either the fluorescence ratio (F-YFP/F-CFP) or the enhancement of donor fluorescence after acceptor bleach. After protein kinase C activation, forskolin did not further reduce FRET, but after forskolin pretreatment, protein kinase C could still reduce FRET. This agreed with phospholemman phosphorylation measurements: by protein kinase C at both Ser-63 and Ser- 68, but by protein kinase A only at Ser-68. Expression of PLM-YFP and PLM-CFP resulted in even stronger FRET than for NKA-PLM (FCFP increased by 37 +/- 1% upon YFP photobleach), and this FRET was enhanced by phospholemman phosphorylation, consistent with phospholemman multimerization. Co-expressed PLM-CFP and Na/Ca exchange-YFP were highly membrane co-localized, but FRET was undetectable. We conclude that phospholemman and Na/K-pump are nin very close proximity (FRET occurs) and that phospholemman phosphorylation alters the interaction of Na/K-pump and phospholemman.	Loyola Univ, Dept Physiol, Maywood, IL 60153 USA; Loyola Univ, Cardiovasc Inst, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago	Bers, DM (corresponding author), Loyola Univ, Dept Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	dbers@lumc.edu	Bers, Donald M/C-4507-2012	Bossuyt, Julie/0000-0001-8874-4765; Bers, Donald/0000-0002-2237-9483	NHLBI NIH HHS [HL 81562, HL 64724] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064724, R01HL081562] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahlers BA, 2005, J BIOL CHEM, V280, P19875, DOI 10.1074/jbc.M414703200; Arystarkhova E, 2002, J BIOL CHEM, V277, P10162, DOI 10.1074/jbc.M111552200; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Bers D. M., 2001, EXCITATION CONTRACTI, P1; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2003, BIOPHYS J, V84, P4157, DOI 10.1016/S0006-3495(03)75140-6; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; FESCHENKO MS, 1994, J BIOL CHEM, V269, P30436; FISONE G, 1994, J BIOL CHEM, V269, P9368; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; FUSEZI M, 2005, J BIOL CHEM, V320, P18291; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; HAN F, 2006, BIOPHYS J, V90, P321; Kowdley GC, 1997, BIOPHYS J, V72, P141, DOI 10.1016/S0006-3495(97)78653-3; LINDEMANN JP, 1986, J BIOL CHEM, V261, P4860; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; MOORMAN JR, 1995, NATURE, V377, P737, DOI 10.1038/377737a0; MOORMAN JR, 1992, J BIOL CHEM, V267, P14551; Mounsey JP, 1999, BBA-MOL CELL RES, V1451, P305, DOI 10.1016/S0167-4889(99)00102-0; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; PRESTI CF, 1985, J BIOL CHEM, V260, P3860; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; SONG J, 2005, AM J PHYSIOL, V328, pH2342; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Zhang XQ, 2006, J BIOL CHEM, V281, P7784, DOI 10.1074/jbc.M512092200; ZHANG XQ, 2003, AM J PHYSIOL, V324, pH225	40	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32765	32773		10.1074/jbc.M606254200	http://dx.doi.org/10.1074/jbc.M606254200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943195	hybrid			2022-12-27	WOS:000241414500075
J	Francke, F; Ward, RJ; Jenkins, L; Kellett, E; Richter, D; Milligan, G; Bachner, D				Francke, Felix; Ward, Richard J.; Jenkins, Laura; Kellett, Elaine; Richter, Dietmar; Milligan, Graeme; Baechner, Dietmar			Interaction of neurochondrin with the melanin-concentrating hormone receptor 1 interferes with G protein-coupled signal transduction but not agonist-mediated internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL TAIL; HORMONE-RECEPTOR; RAT-BRAIN; SCAFFOLDING PROTEINS; TARGETED DISRUPTION; NEURITE-OUTGROWTH; NERVOUS-SYSTEM; MESSENGER-RNA; EXPRESSION; GENE	Screening of a human brain cDNA library using the C-terminal tail of the melanin-concentrating hormone receptor 1(MCHR1) as bait in a yeast two-hybrid assay resulted in the identification of the neurite-outgrowth related factor, neurochondrin. This interaction was verified in overlay, pulldown, and co-immunoprecipitation assays. Deletion mapping confined the binding to the C terminus of neurochondrin and to the proximal C terminus of MCHR1, a region known to be involved in G protein binding and signal transduction. This region of the MCHR1 is also able to interact with the actin- and intermediate filament-binding protein, periplakin. Interactions of MCHR1 with neurochondrin and periplakin were competitive, indicating that these two proteins bind to overlapping regions of MCHR1. Although neurochondrin did not interfere with melanin-concentrating hormone-mediated internalization of the receptor, it did inhibit G protein-coupled signal transduction via both G alpha(i/o) and G alpha(q/11) family G proteins as measured by each of melanin-concentrating hormone-induced G protein-activated inwardly rectifying K+ channel activity of voltage-clamped amphibian oocytes, by calcium mobilization in transfected mammalian cells, and by reduction in the capacity of melanin-concentrating hormone to promote binding of [S-35]guanosine 5'-3-O-(thio)triphosphate to both G alpha(o1) and G alpha(11). Immunohistochemistry revealed co-expression of neurochondrin and MCHR1 within the rodent brain, suggesting that neurochondrin may be involved in the regulation of MCHR1 signaling and play a role in modulating melanin-concentrating hormone-mediated functions in vivo.	Univ Hamburg, Inst Cell Biochem & Clin Neurol, D-20246 Hamburg, Germany; Univ Glasgow, Mol Pharmacol Grp, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Hamburg; University of Glasgow	Bachner, D (corresponding author), Univ Hamburg, Sch Life Sci, Martinistr 52, D-20246 Hamburg, Germany.	baechner@uke.uni-hamburg.de	Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519				Bachner D, 2002, FEBS LETT, V526, P124, DOI 10.1016/S0014-5793(02)03115-0; Bachner D, 1999, FEBS LETT, V457, P522, DOI 10.1016/S0014-5793(99)01092-3; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Bockers TM, 2001, J BIOL CHEM, V276, P40104, DOI 10.1074/jbc.M102454200; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Chen YY, 2002, ENDOCRINOLOGY, V143, P2469, DOI 10.1210/en.143.7.2469; Dateki M, 2005, J BIOL CHEM, V280, P20503, DOI 10.1074/jbc.M414033200; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Hawes BE, 2000, ENDOCRINOLOGY, V141, P4524, DOI 10.1210/en.141.12.4524; Hervieu GJ, 2000, EUR J NEUROSCI, V12, P1194, DOI 10.1046/j.1460-9568.2000.00008.x; Ishizuka Y, 1999, BBA-MOL CELL RES, V1450, P92, DOI 10.1016/S0167-4889(99)00039-7; Istvanffy R, 2004, DEV GENES EVOL, V214, P206, DOI 10.1007/s00427-004-0396-2; Kobayashi T, 2002, BRIT J PHARMACOL, V135, P313, DOI 10.1038/sj.bjp.0704475; Kowalski TJ, 2004, EUR J PHARMACOL, V497, P41, DOI 10.1016/j.ejphar.2004.06.027; Kreienkamp HJ, 2002, CURR OPIN PHARMACOL, V2, P581, DOI 10.1016/S1471-4892(02)00203-5; Ktistakis NT, 2003, BIOCHEM SOC T, V31, P94, DOI 10.1042/bst0310094; Liu S, 2002, J BIOL CHEM, V277, P25707, DOI 10.1074/jbc.M201015200; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Milligan G, 2001, TRENDS PHARMACOL SCI, V22, P513, DOI 10.1016/S0165-6147(00)01801-0; MITCHELL FM, 1991, FEBS LETT, V287, P171, DOI 10.1016/0014-5793(91)80043-3; Mochizuki R, 2003, BIOCHEM BIOPH RES CO, V310, P1219, DOI 10.1016/j.bbrc.2003.09.153; Mochizuki R, 1999, BBA-GENE STRUCT EXPR, V1446, P397, DOI 10.1016/S0167-4781(99)00120-7; MULLANEY I, 1988, BIOCHEM J, V256, P649, DOI 10.1042/bj2560649; Murdoch H, 2005, J BIOL CHEM, V280, P8208, DOI 10.1074/jbc.M405215200; Ohoka Y, 2001, BIOCHEM BIOPH RES CO, V280, P237, DOI 10.1006/bbrc.2000.4080; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pissios P, 2003, ENDOCRINOLOGY, V144, P3514, DOI 10.1210/en.2002-0004; Saito Y, 2004, PEPTIDES, V25, P1597, DOI 10.1016/j.peptides.2004.03.026; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Saito Y, 2000, TRENDS ENDOCRIN MET, V11, P299, DOI 10.1016/S1043-2760(00)00290-3; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shinozaki K, 1999, MOL BRAIN RES, V71, P364, DOI 10.1016/S0169-328X(99)00181-3; Shinozaki K, 1997, BIOCHEM BIOPH RES CO, V240, P766, DOI 10.1006/bbrc.1997.7660; Takekawa S, 2002, EUR J PHARMACOL, V438, P129, DOI 10.1016/S0014-2999(02)01314-6; Tan CP, 2002, GENOMICS, V79, P785, DOI 10.1006/geno.2002.6771; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Tritos NA, 1999, NEUROPEPTIDES, V33, P339, DOI 10.1054/npep.1999.0055; Vitale RM, 2004, PROTEINS, V56, P430, DOI 10.1002/prot.20125; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	44	22	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32496	32507		10.1074/jbc.M602889200	http://dx.doi.org/10.1074/jbc.M602889200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16945926	hybrid			2022-12-27	WOS:000241414500047
J	Andersson, MX; Hamberg, M; Kourtchenko, O; Brunnstrom, A; McPhail, KL; Gerwick, WH; Gobel, C; Feussner, I; Ellerstrom, M				Andersson, Mats X.; Hamberg, Mats; Kourtchenko, Olga; Brunnstrom, Asa; McPhail, Kerry L.; Gerwick, William H.; Goebel, Cornelia; Feussner, Ivo; Ellerstrom, Mats			Oxylipin profiling of the hypersensitive response in Arabidopsis thaliana - Formation of a novel oxo-phytodienoic acid-containing galactolipid, arabidopside E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT STRESS RESPONSES; CELL-DEATH; TOBACCO-LEAVES; ACYLGALACTOSYL DIGLYCERIDE; SIGNALING NETWORK; LIPOXYGENASE; PATHWAY; HYDROPEROXIDES; RESISTANCE; ALPHA	Oxidation products of unsaturated fatty acids, collectively known as oxylipins, function as signaling molecules in plants during development, wounding, and insect and pathogen attack. Certain oxylipins are also known to have direct cytotoxic effects on pathogens. We used inducible expression of bacterial avirulence proteins in planta to study the involvement of oxylipins in race-specific defense against bacterial pathogens. We demonstrate that recognition of the Pseudomonas syringae avirulence protein AvrRpm1 induces 9- and 13-lipoxygenase-dependent oxylipin synthesis in Arabidopsis thaliana. The major oxylipins accumulated were jasmonic acid, 12-oxo-phytodienoic acid, and dinor-oxo-phytodienoic acid. The majority of the newly formed oxylipins (> 90%) was found to be esterified to glycerolipids, whereby 12-oxo-phytodienoic acid and dinor-oxo-phytodienoic acid were found to be esterified to a novel galactolipid. The structure of the substance was determined as a monogalactosyldiacylglycerol containing two 12-oxo-phytodienoic acids and one dinor-oxo-phytodienoic acid acyl chain and was given the trivial name arabidopside E. This substance accumulated to surprisingly high levels, 7 - 8% of total lipid content, and was shown to inhibit growth of a bacterial pathogen in vitro. Arabidopside E was formed also after recognition of the avirulence protein AvrRpt2, suggesting that this could be a conserved feature of defense reactions against bacterial pathogens. In conclusion, the data presented suggest a role of enzymatically formed oxylipins, especially the octadecanoids and arabidopside E in race-specific resistance against bacterial pathogens.	Univ Gothenburg, Dept Plant & Environm Sci, SE-40530 Gothenburg, Sweden; Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Biolipox AB, SE-17165 Solna, Sweden; Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; Univ Gottingen, Albrecht Haller Inst Plant Sci, D-37077 Gottingen, Germany	University of Gothenburg; Karolinska Institutet; Oregon State University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Gottingen	Ellerstrom, M (corresponding author), Univ Gothenburg, Dept Plant & Environm Sci, SE-40530 Gothenburg, Sweden.	mats.ellerstrom@botany.gu.se	Andersson, Mats/E-7958-2010; Feussner, Ivo/H-9320-2013	Andersson, Mats/0000-0003-4279-6572; Feussner, Ivo/0000-0002-9888-7003; Hamberg, Mats/0000-0002-8910-7810; McPhail, Kerry/0000-0003-2076-1002				Andersson MX, 2006, PLANT J, V47, P947, DOI 10.1111/j.1365-313X.2006.02844.x; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Buseman CM, 2006, PLANT PHYSIOL, V142, P28, DOI 10.1104/pp.106.082115; Cacas JL, 2005, PLANT CELL ENVIRON, V28, P1367, DOI 10.1111/j.1365-3040.2005.01369.x; Devoto A, 2005, PHYSIOL PLANTARUM, V123, P161, DOI 10.1111/j.1399-3054.2004.00418.x; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; FISCHER W, 1973, H-S Z PHYSIOL CHEM, V354, P1115, DOI 10.1515/bchm2.1973.354.2.1115; Gobel C, 2002, BBA-MOL CELL BIOL L, V1584, P55, DOI 10.1016/S1388-1981(02)00268-8; Gobel C, 2001, J BIOL CHEM, V276, P6267, DOI 10.1074/jbc.M008606200; Graner G, 2003, PHYTOCHEMISTRY, V63, P89, DOI 10.1016/S0031-9422(02)00724-0; Hamberg M, 2003, J BIOL CHEM, V278, P51796, DOI 10.1074/jbc.M310514200; Hamberg M, 2002, PROSTAG OTH LIPID M, V68-9, P363, DOI 10.1016/S0090-6980(02)00040-0; HAMBERG M, 1988, LIPIDS, V23, P469, DOI 10.1007/BF02535522; HEINZ E, 1967, BIOCHIM BIOPHYS ACTA, V144, P333, DOI 10.1016/0005-2760(67)90162-2; HEINZ E, 1969, H-S Z PHYSIOL CHEM, V350, P493, DOI 10.1515/bchm2.1969.350.1.493; HEINZ E, 1967, BIOCHIM BIOPHYS ACTA, V144, P321, DOI 10.1016/0005-2760(67)90161-0; Hisamatsu Y, 2005, J NAT PROD, V68, P600, DOI 10.1021/np0495938; Hisamatsu Y, 2003, TETRAHEDRON LETT, V44, P5553, DOI 10.1016/S0040-4039(03)01148-1; Hisamatsu Y, 2006, Z NATURFORSCH C, V61, P363; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Montillet JL, 2002, PLANT PHYSIOL BIOCH, V40, P633, DOI 10.1016/S0981-9428(02)01402-X; Mueller MJ, 2004, CURR OPIN PLANT BIOL, V7, P441, DOI 10.1016/j.pbi.2004.04.001; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; PFEFFER PE, 1977, J AM OIL CHEM SOC, V54, P380, DOI 10.1007/BF02802040; PFEFFER PE, 1992, LIPIDS, V27, P258; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Rusterucci C, 1999, J BIOL CHEM, V274, P36446, DOI 10.1074/jbc.274.51.36446; Schaller F, 2004, J PLANT GROWTH REGUL, V23, P179, DOI 10.1007/s00344-004-0047-x; Stelmach BA, 2001, J BIOL CHEM, V276, P12832, DOI 10.1074/jbc.M010743200; Stenzel I, 2003, PLANT MOL BIOL, V51, P895, DOI 10.1023/A:1023049319723; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; VICK BA, 1979, LIPIDS, V14, P734, DOI 10.1007/BF02533899; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; Wasternack C, 2002, PROG NUCLEIC ACID RE, V72, P165, DOI 10.1016/S0079-6603(02)72070-9; Weber H, 1997, P NATL ACAD SCI USA, V94, P10473, DOI 10.1073/pnas.94.19.10473; Weichert H, 1999, FEBS LETT, V464, P133, DOI 10.1016/S0014-5793(99)01697-X; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200	44	114	118	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31528	31537		10.1074/jbc.M604820200	http://dx.doi.org/10.1074/jbc.M604820200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923817				2022-12-27	WOS:000241235300038
J	Higashimoto, Y; Sato, H; Sakamoto, H; Takahashi, K; Palmer, G; Noguchi, M				Higashimoto, Yuichiro; Sato, Hideaki; Sakamoto, Hiroshi; Takahashi, Kenichi; Palmer, Graham; Noguchi, Masato			The reactions of heme- and verdoheme-heme oxygenase-1 complexes with FMN-depleted NADPH-cytochrome P450 reductase - Electrons required for verdoheme oxidation can be transferred through a pathway not involving FMN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P-450 REDUCTASE; FERROUS-NO FORMS; CRYSTAL-STRUCTURE; RAT HEME; CATALYTIC IMPLICATIONS; ALPHA-HYDROXYHEME; SOLUBLE FORM; DEGRADATION; SYSTEM; BILIVERDIN	Electrons utilized in the heme oxygenase (HO) reaction are provided by NADPH-cytochrome P450 reductase (CPR). To investigate the electron transfer pathway from CPR to HO, we examined the reactions of heme and verdoheme, the second intermediate in the heme degradation, complexed with rat HO-1 (rHO-1) using a rat FMN-depleted CPR; the FMN-depleted CPR was prepared by dialyzing the CPR mutant, Y140A/Y178A, against 2 M KBr. Degradation of heme in complex with rHO-1 did not occur with FMN-depleted CPR, notwithstanding that the FMN-depleted CPR was able to associate with the heme-rHO-1 complex with a binding affinity comparable with that of the wild-type CPR. Thus, the first electron to reduce the ferric iron of heme complexed with rHO-1 must be transferred from FMN. In contrast, verdoheme was converted to the ferric biliverdin-iron chelate with FMN-depleted CPR, and this conversion was inhibited by ferricyanide, indicating that electrons are certainly required for conversion of verdoheme to a ferric biliverdin-iron chelate and that they can be supplied from the FMN-depleted CPR through a pathway not involving FMN, probably via FAD. This conclusion was supported by the observation that verdoheme dimethyl esters were accumulated in the reaction of the ferriprotoporphyrin IX dimethyl ester-rHO-1 complex with the wild-type CPR. Ferric biliverdin-iron chelate, generated with the FMN-depleted CPR, was converted to biliverdin by the addition of the wild-type CPR or desferrioxamine.	Kurume Univ, Sch Med, Dept Med Biochem, Kurume, Fukuoka 8300011, Japan; Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka 8208502, Japan; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Kurume University; Kyushu Institute of Technology; Rice University	Higashimoto, Y (corresponding author), Kurume Univ, Sch Med, Dept Med Biochem, Kurume, Fukuoka 8300011, Japan.	higashiy@med.kurume-u.ac.jp; mnoguchi@med.kurume-u.ac.jp	Sakamoto, Hiroshi/A-3181-2011	Higashimoto, Yuichiro/0000-0003-1382-8598	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055807] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 55807] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auclair K., 2003, PORPHYRIN HDB, V12, P183; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; FRYDMAN RB, 1981, BIOCHEMISTRY-US, V20, P5177, DOI 10.1021/bi00521a012; Fujii H, 2001, J AM CHEM SOC, V123, P6475, DOI 10.1021/ja010490a; Hayashi S, 2003, PROTEIN EXPRES PURIF, V29, P1, DOI 10.1016/S1046-5928(03)00023-8; Higashimoto Y, 2005, J BIOL CHEM, V280, P729, DOI 10.1074/jbc.M406203200; Iyanagi T, 2005, BIOCHEM BIOPH RES CO, V338, P520, DOI 10.1016/j.bbrc.2005.08.043; IYANAGI T, 1973, BIOCHEMISTRY-US, V12, P2297, DOI 10.1021/bi00736a018; KURZBAN GP, 1986, J BIOL CHEM, V261, P7824; Lad L, 2004, J INORG BIOCHEM, V98, P1686, DOI 10.1016/j.jinorgbio.2004.07.004; Lad L, 2004, BIOCHEMISTRY-US, V43, P3793, DOI 10.1021/bi035451l; Lad L, 2003, J MOL BIOL, V330, P527, DOI 10.1016/S0022-2836(03)00578-3; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Liu Y, 2000, J BIOL CHEM, V275, P5297, DOI 10.1074/jbc.275.8.5297; Matsui T, 2005, J BIOL CHEM, V280, P36833, DOI 10.1074/jbc.M503529200; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Omata Y, 1998, ACTA CRYSTALLOGR D, V54, P1017, DOI 10.1107/S0907444998003448; Sakamoto H, 1999, J BIOL CHEM, V274, P18196, DOI 10.1074/jbc.274.26.18196; Sakamoto H, 2005, BIOCHEM BIOPH RES CO, V338, P578, DOI 10.1016/j.bbrc.2005.08.176; Sakamoto H, 2002, EUR J BIOCHEM, V269, P5231, DOI 10.1046/j.1432-1033.2002.03230.x; Sakamoto H, 2000, J INORG BIOCHEM, V82, P113, DOI 10.1016/S0162-0134(00)00149-5; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; SHEN AL, 1989, J BIOL CHEM, V264, P7584; Strobel Henry W., 1995, P225; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Sugishima M, 2003, BIOCHEMISTRY-US, V42, P9898, DOI 10.1021/bi027268i; Sugishima M, 2003, J BIOL CHEM, V278, P32352, DOI 10.1074/jbc.M303682200; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TOMARO ML, 1984, BIOCHIM BIOPHYS ACTA, V791, P342, DOI 10.1016/0167-4838(84)90345-5; VERMILION JL, 1978, J BIOL CHEM, V253, P8812; VERMILION JL, 1976, FLAVINS FLAVOPROTEIN, P674; Wang JL, 2006, BIOCHEMISTRY-US, V45, P61, DOI 10.1021/bi051645k; Wang JL, 2005, J BIOL CHEM, V280, P2797, DOI 10.1074/jbc.M411229200; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; YOSHIDA T, 1981, J BIOCHEM-TOKYO, V90, P125, DOI 10.1093/oxfordjournals.jbchem.a133441; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230; YOSHIDA T, 1980, J BIOL CHEM, V255, P4418; YOSHIDA T, 1979, J BIOL CHEM, V254, P4487; YOSHIDA T, 1982, J BIOL CHEM, V257, P9345; Zhou H, 2000, J AM CHEM SOC, V122, P8311, DOI 10.1021/ja0002868	44	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31659	31667		10.1074/jbc.M606163200	http://dx.doi.org/10.1074/jbc.M606163200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16928691	Bronze			2022-12-27	WOS:000241235300051
J	Lindtner, S; Zolotukhin, AS; Uranishi, H; Bear, J; Kulkarni, V; Smulevitch, S; Samiotaki, M; Panayotou, G; Felber, BK; Pavlakis, GN				Lindtner, Susan; Zolotukhin, Andrei S.; Uranishi, Hiroaki; Bear, Jenifer; Kulkarni, Viraj; Smulevitch, Sergey; Samiotaki, Martina; Panayotou, George; Felber, Barbara K.; Pavlakis, George N.			RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MEDIATED POSTTRANSCRIPTIONAL REGULATION; SIMIAN RETROVIRUS TYPE-1; EXON JUNCTION COMPLEX; INTRON-CONTAINING RNA; VIRAL MESSENGER-RNA; NUCLEAR EXPORT; MAMMALIAN-CELLS; MEGAKARYOBLASTIC LEUKEMIA; NUCLEOCYTOPLASMIC EXPORT	Retroviruses/retroelements provide tools enabling the identification and dissection of basic steps for post-transcriptional regulation of cellular mRNAs. The RNA transport element (RTE) identified in mouse retrotransposons is functionally equivalent to constitutive transport element of Type D retroviruses, yet does not bind directly to the mRNA export receptor NXF1. Here, we report that the RNA-binding motif protein 15 (RBM15) recognizes RTE directly and specifically in vitro and stimulates export and expression of RTE-containing reporter mRNAs in vivo. Tethering of RBM15 to a reporter mRNA showed that RBM15 acts by promoting mRNA export from the nucleus. We also found that RBM15 binds to NXF1 and the two proteins cooperate in stimulating RTE-mediated mRNA export and expression. Thus, RBM15 is a novel mRNA export factor and is part of the NXF1 pathway. We propose that RTE evolved as a high affinity RBM15 ligand to provide a splicing-independent link to NXF1, thereby ensuring efficient nuclear export and expression of retrotransposon transcripts.	NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Canc Res Ctr,NIH, Ft Detrick, MD 21702 USA; NCI, Human Retrovirus Sect, Vaccine Branch, Canc Res Ctr,NIH, Ft Detrick, MD 21702 USA; Alexander Fleming Biomed Sci Res Ctr, Vari 16672, Greece	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Alexander Fleming Biomedical Sciences Research Center	Felber, BK (corresponding author), NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Canc Res Ctr,NIH, Bldg 535,Rm 209, Ft Detrick, MD 21702 USA.	felber@ncifcrf.gov	Samiotaki, Martina/B-3851-2018	Samiotaki, Martina/0000-0001-9952-0636	DIVISION OF BASIC SCIENCES - NCI [Z01BC010397] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010750, Z01BC010750, ZIABC010334, Z01BC010334] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Bear J, 1999, MOL CELL BIOL, V19, P6306; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Braun IC, 2001, J BIOL CHEM, V276, P20536, DOI 10.1074/jbc.M100400200; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; De Gregorio E, 2001, RNA, V7, P106, DOI 10.1017/S1355838201000577; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; HAMMARSKJOLD ML, 1989, J VIROL, V63, P1959; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Herold A, 2003, EMBO J, V22, P2472, DOI 10.1093/emboj/cdg233; Herold A, 2001, RNA, V7, P1768; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; Hsiao HH, 2005, AM J HEMATOL, V79, P43, DOI 10.1002/ajh.20298; HUANG XJ, 1991, J VIROL, V65, P2131, DOI 10.1128/JVI.65.4.2131-2134.1991; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Izaurralde Elisa, 2002, Results Probl Cell Differ, V35, P133; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Jin L, 2003, GENE DEV, V17, P3075, DOI 10.1101/gad.1155703; Kawaguchi H, 2005, LEUKEMIA, V19, P1492, DOI 10.1038/sj.leu.2403812; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Levesque L, 2001, J BIOL CHEM, V276, P44953, DOI 10.1074/jbc.M106558200; Lindtner S, 2002, RNA, V8, P345, DOI 10.1017/S1355838202027759; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MCDONALD D, 1992, J VIROL, V66, P7232, DOI 10.1128/JVI.66.12.7232-7238.1992; Mercher T, 2002, GENE CHROMOSOME CANC, V33, P22, DOI 10.1002/gcc.1208; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Nappi F, 2001, J VIROL, V75, P4558, DOI 10.1128/JVI.75.10.4558-4569.2001; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; Saridaki A, 2005, GROWTH FACTORS, V23, P223, DOI 10.1080/08977190500178836; Sasaki M, 2005, GENOMICS, V85, P641, DOI 10.1016/j.ygeno.2005.01.003; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Smulevitch S, 2005, J VIROL, V79, P2356, DOI 10.1128/JVI.79.4.2356-2365.2005; Smulevitch S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-6; Srinivasakumar N, 1997, J VIROL, V71, P5841, DOI 10.1128/JVI.71.8.5841-5848.1997; Stauber RH, 1998, BIOTECHNIQUES, V24, P462, DOI 10.2144/98243rr01; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Tabernero C, 1997, J VIROL, V71, P95, DOI 10.1128/JVI.71.1.95-101.1997; Tabernero C, 1996, J VIROL, V70, P5998, DOI 10.1128/JVI.70.9.5998-6011.1996; Tan W, 2005, NUCLEIC ACIDS RES, V33, P3855, DOI 10.1093/nar/gki706; Tan W, 2000, RNA, V6, P1762, DOI 10.1017/S1355838200000832; Tang HL, 2000, J BIOL CHEM, V275, P32694, DOI 10.1074/jbc.M003933200; Tang HL, 1997, VIROLOGY, V228, P333, DOI 10.1006/viro.1996.8407; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Yang JP, 2001, J BIOL CHEM, V276, P30694, DOI 10.1074/jbc.M102809200; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003; Zolotukhin AS, 2002, J BIOL CHEM, V277, P3935, DOI 10.1074/jbc.M107598200; Zolotukhin AS, 1997, J BIOL CHEM, V272, P11356, DOI 10.1074/jbc.272.17.11356	78	47	49	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36915	36928		10.1074/jbc.M608745200	http://dx.doi.org/10.1074/jbc.M608745200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	17001072	hybrid			2022-12-27	WOS:000242220800051
J	Hayashi, R; Goto, Y; Ikeda, R; Yokoyama, KK; Yoshida, K				Hayashi, Reiko; Goto, Yuya; Ikeda, Ryuji; Yokoyama, Kazunari K.; Yoshida, Kenichi			CDCA4 is an E2F transcription factor family-induced nuclear factor that regulates E2F-dependent transcriptional activation and cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAINS; RETINOBLASTOMA PROTEIN; HISTONE DEACETYLASE; IN-VIVO; REPRESSES TRANSCRIPTION; GROWTH SUPPRESSION; CYCLE PROGRESSION; GENE-PRODUCT; TARGET GENES; TRIP-BR	The TRIP-Br1/p34(SEI-1) family proteins participate in cell cycle progression by coactivating E2F1- or p53-dependent transcriptional activation. Here, we report the identification of human CDCA4 ( also know as SEI-3/Hepp) as a novel target gene of transcription factor E2F and as a repressor of E2F-dependent transcriptional activation. Analysis of CDCA4 promoter constructs showed that an E2F-responsive sequence in the vicinity of the transcription initiation site is necessary for the E2F1-4 induced activation of CDCA4 gene transcription. Chromatin immunoprecipitation analysis demonstrated that E2F1 and E2F4 bound to an E2F-responsive sequence of the human CDCA4 gene. Like TRIP-Br1/p34SEI-1 and TRIP-Br2 (SEI-2), the transactivation domain of CDCA4 was mapped within C-terminal acidic region 175-241. The transactivation function of the CDCA4 protein was inhibited by E2F1-4 and DP2, but not by E2F5-8. Inhibition of CDCA4 transactivation activity by E2F1 partially interfered with retinoblastoma protein overexpression. Conversely, CDCA4 suppressed E2F1-3-induced reporter activity. CDCA4 ( but not acidic region-deleted CDCA4) suppressed E2F1- regulated gene promoter activity. These findings suggest that the CDCA4 protein functions as a suppressor at the E2F-responsive promoter. Small interfering RNA-mediated knockdown of CDCA4 expression in cancer cells resulted in up-regulation of cell growth rates and DNA synthesis. The CDCA4 protein was detected in several human cells and was induced as cells entered the G(1)/S phase of the cell cycle. Taken together, our results suggest that CDCA4 participates in the regulation of cell proliferation, mainly through the E2F/retinoblastoma protein pathway.	Meiji Univ, Sch Agr, Dept Life Sci, Mol & Cellular Biol Lab,Tama Ku, Kawasaki, Kanagawa 2148571, Japan; Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, Kagoshima 8908520, Japan; RIKEN, Tsukuba Inst, Bioresource Ctr, Dept Biol Syst,Gene Engn Div, Tsukuba, Ibaraki 3050074, Japan	Meiji University; Kagoshima University; RIKEN	Yoshida, K (corresponding author), Meiji Univ, Sch Agr, Dept Life Sci, Mol & Cellular Biol Lab,Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.	yoshida@isc.meiji.ac.jp						Abdullah JM, 2001, BLOOD CELL MOL DIS, V27, P667, DOI 10.1006/bcmd.2001.0434; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Bennetts JS, 2006, GENE, V374, P153, DOI 10.1016/j.gene.2006.01.027; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brehm A, 1999, TRENDS BIOCHEM SCI, V24, P142, DOI 10.1016/S0968-0004(99)01368-7; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Calgaro S, 2002, GENETICS, V160, P547; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Cho JM, 2000, NUCLEIC ACIDS RES, V28, P3478, DOI 10.1093/nar/28.18.3478; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ferreira R, 2001, EMBO REP, V2, P794, DOI 10.1093/embo-reports/kve173; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Goto Y, 2006, BBA-GENE STRUCT EXPR, V1759, P60, DOI 10.1016/j.bbaexp.2006.02.004; Gupta S, 2003, VIROLOGY, V317, P155, DOI 10.1016/j.virol.2003.08.008; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Hirose T, 2003, INT J MOL MED, V11, P705; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; KITAGAWA M, 1995, ONCOGENE, V10, P229; LATHANGUE NB, 1994, CURR OPIN CELL BIOL, V6, P443, DOI 10.1016/0955-0674(94)90038-8; Lee CW, 1998, ONCOGENE, V16, P2695, DOI 10.1038/sj.onc.1201818; Li J, 2004, BIOCHEMISTRY-US, V43, P4394, DOI 10.1021/bi035601s; Li JN, 2005, BIOCHEMISTRY-US, V44, P13246, DOI 10.1021/bi0504658; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MAY E, 1991, ONCOGENE, V6, P1363; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; SCHWARZ JK, 1995, P NATL ACAD SCI USA, V92, P483, DOI 10.1073/pnas.92.2.483; Sim KG, 2004, CELL CYCLE, V3, P1296, DOI 10.4161/cc.3.10.1157; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Sugimoto M, 1999, GENE DEV, V13, P3027, DOI 10.1101/gad.13.22.3027; TAKAHASHI Y, 2002, GENE DEV, V14, P804; Takashima T, 1997, INT J CANCER, V72, P31, DOI 10.1002/(SICI)1097-0215(19970703)72:1<31::AID-IJC4>3.0.CO;2-5; Tang DJ, 2005, CANCER RES, V65, P6504, DOI 10.1158/0008-5472.CAN-05-0351; Tang TCM, 2002, CANCER RES, V62, P7157; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trouche D, 1996, NUCLEIC ACIDS RES, V24, P4139, DOI 10.1093/nar/24.21.4139; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; Trouche D, 1996, P NATL ACAD SCI USA, V93, P1439, DOI 10.1073/pnas.93.4.1439; Walker MG, 2001, CURR CANCER DRUG TAR, V1, P73, DOI 10.2174/1568009013334241; Wang S, 2002, EMBO J, V21, P3019, DOI 10.1093/emboj/cdf302; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Watanabe-Fukunaga R, 2005, GENES CELLS, V10, P851, DOI 10.1111/j.1365-2443.2005.00881.x; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yoshida K, 2005, BIOCHEM BIOPH RES CO, V331, P669, DOI 10.1016/j.bbrc.2005.03.222; Yoshida K, 2004, ONCOGENE, V23, P6250, DOI 10.1038/sj.onc.1207829; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488	76	58	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35633	35648		10.1074/jbc.M603800200	http://dx.doi.org/10.1074/jbc.M603800200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16984923	hybrid			2022-12-27	WOS:000242100500008
J	Montero, E; Gonzalez, LM; Rodriguez, M; Oksov, Y; Blackman, MJ; Lobo, CA				Montero, Estrella; Gonzalez, Luis Miguel; Rodriguez, Marilis; Oksov, Yelena; Blackman, Michael J.; Lobo, Cheryl A.			A conserved subtilisin protease identified in Babesia divergens merozoites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELL INVASION; TOXOPLASMA-GONDII; MALARIA PARASITE; SERINE-PROTEASE; DATABASE; DISEASE; ORGANELLES; INFECTION; SEQUENCE	Invasion of erythrocytes is an integral part of the Babesia divergens life cycle. Serine proteases have been shown to play an important role in invasion by related Apicomplexan parasites such as the malaria parasite Plasmodium falciparum. Here we demonstrate the presence of two dominant serine proteases in asexual B. divergens using a biotinylated fluorophosphonate probe. One of these active serine proteases (p48) and its precursors were recognized by anti-PfSUB1 antibodies. These antibodies were used to clone the gene encoding a serine protease using a B. divergens cDNA library. BdSub-1 is a single copy gene with no introns. The deduced gene product (BdSUB-1) clearly belongs to the subtilisin superfamily and shows significant homology to Plasmodium subtilisins, with the highest degree of sequence identity around the four catalytic residues. Like subtilisin proteases in other Apicomplexan parasites, BdSUB-1 undergoes two steps of processing during activation in the secretory pathway being finally converted to an active form ( p48). The mature protease is concentrated in merozoite dense granules, apical secretory organelles involved in erythrocyte invasion. Anti-PfSUB1 antibodies have a potent inhibitory effect on erythrocyte invasion by B. divergens merozoites in vitro. This report demonstrates conservation of the molecular machinery involved in erythrocyte invasion by these two Apicomplexan parasites and paves the way for a comparative analysis of other molecules that participate in this process in the two parasites.	New York Blood Ctr, Lindsley F Kimball Res Inst, Dept Mol Parasitol, New York, NY 10032 USA; Inst Salud Carlos III, Div Parasitol, Madrid 28220, Spain; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England	New York Blood Center; Instituto de Salud Carlos III; MRC National Institute for Medical Research	Lobo, CA (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Dept Mol Parasitol, 310 E 67th St, New York, NY 10032 USA.	clobo@nybloodcenter.org	Montero, Estrella/M-3648-2018; Gonzalez, Luis Miguel/O-6377-2018	Montero, Estrella/0000-0002-3852-960X; Gonzalez, Luis Miguel/0000-0002-9107-2450	MRC [MC_U117532063] Funding Source: UKRI; Medical Research Council [MC_U117532063] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barale JC, 1999, P NATL ACAD SCI USA, V96, P6445, DOI 10.1073/pnas.96.11.6445; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461; Blackman MJ, 2004, CELL MICROBIOL, V6, P893, DOI 10.1111/j.1462-5822.2004.00437.x; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; DAMMIN GJ, 1981, HUM PATHOL, V12, P398, DOI 10.1016/S0046-8177(81)80020-2; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; GARNHAM PCC, 1980, T ROY SOC TROP MED H, V74, P153, DOI 10.1016/0035-9203(80)90232-1; GORENFLOT A, 1991, PARASITOL RES, V77, P3, DOI 10.1007/BF00934377; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hermentin P, 1984, Behring Inst Mitt, P121; Herwaldt BL, 1996, ANN INTERN MED, V124, P643, DOI 10.7326/0003-4819-124-7-199604010-00004; Holman PJ, 2002, MOL BIOCHEM PARASIT, V119, P295, DOI 10.1016/S0166-6851(01)00423-6; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Jack R. M., 1981, Babesiosis. (Internat. Conf. on malaria and babesiosis, Mexico City, 30 Apr. -- 4 May 1979)., P445; Jean L, 2003, J BIOL CHEM, V278, P28572, DOI 10.1074/jbc.M303827200; Kim K, 2004, ACTA TROP, V91, P69, DOI 10.1016/j.actaropia.2003.11.016; Kjemtrup AM, 2000, INT J PARASITOL, V30, P1323, DOI 10.1016/S0020-7519(00)00137-5; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P3873, DOI 10.1093/nar/12.9.3873; Lantos PM, 2002, PEDIATR ANN, V31, P192, DOI 10.3928/0090-4481-20020301-10; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lobo CA, 2005, INFECT IMMUN, V73, P649, DOI 10.1128/IAI.73.1.649-651.2005; Louie K, 1999, MOL BIOCHEM PARASIT, V103, P211, DOI 10.1016/S0166-6851(99)00127-9; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; McQuiston JH, 2000, TRANSFUSION, V40, P274, DOI 10.1046/j.1537-2995.2000.40030274.x; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; PERSING DH, 1995, NEW ENGL J MED, V332, P298, DOI 10.1056/NEJM199502023320504; PRECIGOUT E, 1993, EXP PARASITOL, V77, P425, DOI 10.1006/expr.1993.1102; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rudzinska M. A., 1981, Babesiosis. (Internat. Conf. on malaria and babesiosis, Mexico City, 30 Apr. -- 4 May 1979)., P87; RUEBUSH TK, 1977, NEW ENGL J MED, V297, P825, DOI 10.1056/NEJM197710132971511; Sajid M, 2000, J BIOL CHEM, V275, P631, DOI 10.1074/jbc.275.1.631; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SPIELMAN A, 1985, ANNU REV ENTOMOL, V30, P439, DOI 10.1146/annurev.en.30.010185.002255; Withers-Martinez C, 2004, MOL MICROBIOL, V53, P55, DOI 10.1111/j.1365-2958.2004.04144.x; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200	39	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35717	35726		10.1074/jbc.M604344200	http://dx.doi.org/10.1074/jbc.M604344200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16982617	hybrid			2022-12-27	WOS:000242100500016
J	Leifer, CA; Brooks, JC; Hoelzer, K; Lopez, J; Kennedy, MN; Mazzoni, A; Segal, DM				Leifer, Cynthia A.; Brooks, James C.; Hoelzer, Karin; Lopez, Jody; Kennedy, Margaret N.; Mazzoni, Alessandra; Segal, David M.			Cytoplasmic targeting motifs control localization of toll-like receptor 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CPG-DNA; INTRACELLULAR COMPARTMENTS; SUBCELLULAR-LOCALIZATION; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; CUTTING EDGE; DOMAIN; TLR9; RECOGNITION; ACTIVATION	Toll-like receptors (TLRs) are essential for host defense. Although several TLRs reside on the cell surface, nucleic acid recognition of TLRs occurs intracellularly. For example, the receptor for CpG containing bacterial and viral DNA, TLR9, is retained in the endoplasmic reticulum. Recent evidence suggests that the localization of TLR9 is critical for appropriate ligand recognition. Here we have defined which structural features of the TLR9 molecule control its intracellular localization. Both the cytoplasmic and ectodomains of TLR9 contain sufficient information, whereas the transmembrane domain plays no role in intracellular localization. We identify a 14-amino acid stretch that directs TLR9 intracellularly and confers intracellular localization to the normally cell surface-expressed TLR4. Truncation or mutation of the cytoplasmic tail of TLR9 reveals a vesicle localization motif that targets early endosomes. We propose a model whereby modification of the cytoplasmic tail of TLR9 results in trafficking to early endosomes where it encounters CpG DNA.	Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Leifer, CA (corresponding author), Cornell Univ, Coll Vet Med, VMC C5-153, Ithaca, NY 14853 USA.	cal59@cornell.edu	Hoelzer, Karin/A-8230-2010		Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [K22 CA113705-03, K22 CA113705] Funding Source: Medline; NIAID NIH HHS [T32 AI007643] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC009255, K22CA113705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007643] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bauer M, 2001, J IMMUNOL, V166, P5000, DOI 10.4049/jimmunol.166.8.5000; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gursel M, 2006, J IMMUNOL, V177, P1575, DOI 10.4049/jimmunol.177.3.1575; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kajita E, 2006, BIOCHEM BIOPH RES CO, V343, P578, DOI 10.1016/j.bbrc.2006.03.014; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Subramaniam S, 2004, DEV COMP IMMUNOL, V28, P415, DOI 10.1016/j.dci.2003.09.016; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; UCHIYAMA T, 1981, J IMMUNOL, V126, P1398; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	31	74	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35585	35592		10.1074/jbc.M607511200	http://dx.doi.org/10.1074/jbc.M607511200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16990271	Green Accepted, hybrid			2022-12-27	WOS:000241933700091
J	Liu, Y; Wang, Y; Wu, C; Liu, Y; Zheng, P				Liu, Yan; Wang, Yin; Wu, Cindy; Liu, Yang; Zheng, Pan			Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3 beta phosphorylation, and Wnt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; DUAL-SPECIFICITY PHOSPHATASE; CARBOHYDRATE-BINDING DOMAIN; DISEASE; GLYCOGEN; MUTATIONS; ISOFORM; SUBUNIT; COMPLEX; TARGETS	Epilepsy of progressive myoclonus type 2 gene A (EPM2A) encodes a dual specificity protein phosphatase called Laforin. Laforin is also a tumor suppressor that dephosphorylates GSK3 beta at the critical Ser(9) position and regulates Wnt signaling. The epilepsy-causing mutations have a deleterious effect on phosphatase activity, regardless of whether they locate in the carbohydrate-binding domain (CBD) at the N terminus or the dual specificity phosphatase domain (DSPD) at the C terminus. How mutations outside the DSPD reduce the phosphatase activity of Laforin remains unexplained. Here we report that Laforin expressed in mammalian cells forms dimers that are highly resistant to SDS treatment. Deleting CBD completely abolished the dimerization and phosphatase activity of Laforin. Moreover, all of the naturally occurring Laforin mutations tested impaired laforin dimerization, GSK3 beta dephosphorylation at Ser(9) and beta-catenin accumulation in nucleus. Our results demonstrate a critical role of dimerization in Laforin function and suggest an important new dimension in protein phosphatase function and in molecular pathogenesis of Lafora's disease.	Univ Michigan, Program Mol Med, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University	Zheng, P (corresponding author), Univ Michigan, Program Mol Med, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X				Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; GAMBETTI P, 1971, ARCH NEUROL-CHICAGO, V25, P483, DOI 10.1001/archneur.1971.00490060017002; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Ganesh S, 2004, BIOCHEM BIOPH RES CO, V313, P1101, DOI 10.1016/j.bbrc.2003.12.043; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Ianzano L, 2004, HUM MUTAT, V23, P170, DOI 10.1002/humu.10306; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; SCHWARZ GA, 1965, ARCH NEUROL-CHICAGO, V13, P427, DOI 10.1001/archneur.1965.00470040093015; Stanton T, 2003, P NATL ACAD SCI USA, V100, P5997, DOI 10.1073/pnas.0931490100; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822	21	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34768	34774		10.1074/jbc.M607778200	http://dx.doi.org/10.1074/jbc.M607778200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16971387	hybrid			2022-12-27	WOS:000241933700008
J	Scott, DJ; Layfield, S; Yan, Y; Sudo, S; Hsueh, AJW; Tregear, GW; Bathgate, RAD				Scott, Daniel J.; Layfield, Sharon; Yan, Yan; Sudo, Satoko; Hsueh, Aaron J. W.; Tregear, Geoffrey W.; Bathgate, Ross A. D.			Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST BINDING; MONOCLONAL-ANTIBODIES; PASSIVE-IMMUNIZATION; MYOMETRIAL ACTIVITY; MESSENGER-RNA; RAT RELAXIN; H3 RELAXIN; CLONING; EXPRESSION; PREGNANCY	The relaxin and insulin-like peptide 3 receptors, LGR7 and LGR8, respectively, are unique members of the leucine-rich repeat-containing G-protein-coupled receptor (LGR) family, because they possess an N-terminal motif with homology to the low density lipoprotein class A (LDLa) modules. By characterizing several LGR7 and LGR8 splice variants, we have revealed that the LDLa module directs ligand-activated cAMP signaling. The LGR8-short variant encodes an LGR8 receptor lacking the LDLa module, whereas LGR7-truncate, LGR7-truncate-2, and LGR7-truncate-3 all encode truncated secreted proteins retaining the LGR7 LDLa module. LGR8-short and an engineered LGR7 variant missing its LDLa module, LGR7-short, bound to their respective ligands with high affinity but lost their ability to signal via stimulation of intracellular cAMP accumulation. Conversely, secreted LGR7-truncate protein with the LDLa module was able to block relaxin-induced LGR7 cAMP signaling and did so without compromising the ability of LGR7 to bind to relaxin or be expressed on the cell membrane. Although the LDLa module of LGR7 was N-glycosylated at position Asn-14, an LGR7 N14Q mutant retained relaxin binding affinity and cAMP signaling, implying that glycosylation is not essential for optimal LDLa function. Using real-time PCR, the expression of mouse LGR7-truncate was detected to be high in, and specific to, the uterus of pregnant mice. The differential expression and evolutionary conservation of LGR7-truncate further suggests that it may also play an important role in vivo. This study highlights the essential role of the LDLa module in LGR7 and LGR8 function and introduces a novel model of GPCR regulation.	Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Melbourne, Vic 3010, Australia; Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; Stanford Univ, Sch Med, Div Reprod Biol, Dept Obstet & Gynecol, Stanford, CA 94305 USA; Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Stanford University; Peking University	Bathgate, RAD (corresponding author), Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Melbourne, Vic 3010, Australia.	r.bathgate@hfi.unimelb.edu.au	Yan, Yan/A-3720-2009; Scott, Daniel J/B-9880-2017; Bathgate, Ross/ABE-6471-2020	Yan, Yan/0000-0003-2938-4063; Scott, Daniel J/0000-0001-6332-2793; Bathgate, Ross/0000-0001-6301-861X				Bathgate R. A. D., 2006, PHYSL REPROD, P679; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Burger LL, 1998, ENDOCRINOLOGY, V139, P3984, DOI 10.1210/en.139.9.3984; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Devlin MG, 2002, J NEUROCHEM, V80, P1095, DOI 10.1046/j.0022-3042.2002.00797.x; DOWNING SJ, 1980, BIOL REPROD, V23, P899, DOI 10.1095/biolreprod23.5.899; Fu P, 2004, J PEPT RES, V63, P91, DOI 10.1111/j.1399-3011.2003.00118.x; Goldsmith LT, 2004, P NATL ACAD SCI USA, V101, P4685, DOI 10.1073/pnas.0400776101; GRAVES PN, 1992, BIOCHEM BIOPH RES CO, V187, P1135, DOI 10.1016/0006-291X(92)91315-H; Halls ML, 2005, J PHARMACOL EXP THER, V313, P677, DOI 10.1124/jpet.104.080655; Hann V, 2004, INFLAMM RES, V53, pS67, DOI 10.1007/s00011-003-0332-3; Hisaw FL, 1926, P SOC EXP BIOL MED, V23, P661; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Huang CJ, 1997, ANIM REPROD SCI, V46, P149, DOI 10.1016/S0378-4320(96)01593-X; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; HWANG JJ, 1991, ENDOCRINOLOGY, V129, P3034, DOI 10.1210/endo-129-6-3034; Hwang JJ, 1996, J CLIN ENDOCR METAB, V81, P3379, DOI 10.1210/jc.81.9.3379; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Kraaij R, 1998, J ENDOCRINOL, V158, P127, DOI 10.1677/joe.0.1580127; KUENZI MJ, 1992, ENDOCRINOLOGY, V131, P1841, DOI 10.1210/en.131.4.1841; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; Min GS, 1997, ENDOCRINOLOGY, V138, P560, DOI 10.1210/en.138.2.560; Misrahi M, 1996, MOL CELL ENDOCRINOL, V125, P161, DOI 10.1016/S0303-7207(96)03953-6; Muda M, 2005, MOL HUM REPROD, V11, P591, DOI 10.1093/molehr/gah205; Nakamura K, 2004, MOL ENDOCRINOL, V18, P1461, DOI 10.1210/me.2003-0489; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Palejwala S, 2001, ENDOCRINOLOGY, V142, P3405, DOI 10.1210/en.142.8.3405; PORTER DG, 1971, J REPROD FERTIL, V26, P251; Rai T, 2005, J VIROL, V79, P14962, DOI 10.1128/JVI.79.23.14962-14966.2005; SCHLEGEL JR, 1986, BIOCHEM PHARMACOL, V35, P1943, DOI 10.1016/0006-2952(86)90725-2; Scott DJ, 2005, ANN NY ACAD SCI, V1041, P22, DOI 10.1196/annals.1282.005; Scott DJ, 2003, LETT PEPT SCI, V10, P393, DOI 10.1007/BF02442569; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; SZELE FG, 1993, MOL PHARMACOL, V43, P915; Tena-Sempere M, 1999, BIOL REPROD, V60, P1515, DOI 10.1095/biolreprod60.6.1515; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Van Der Westhuizen ET, 2005, ANN NY ACAD SCI, V1041, P332, DOI 10.1196/annals.1282.053; Wilkinson T. N., 2005, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V5, P369, DOI 10.2174/156801305774322411; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; WIQVIST N, 1959, Acta Endocrinol Suppl (Copenh), V32(Suppl 46), P15; Zhao L, 2000, BIOL REPROD, V63, P697, DOI 10.1095/biolreprod63.3.697; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	46	114	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34942	34954		10.1074/jbc.M602728200	http://dx.doi.org/10.1074/jbc.M602728200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16963451	hybrid			2022-12-27	WOS:000241933700027
J	Zhou, XY; Davis, DR; Sigmund, CD				Zhou, Xiyou; Davis, Deborah R.; Sigmund, Curt D.			The human renin kidney enhancer is required to maintain base-line renin expression but is dispensable for tissue-specific, cell-specific, and regulated expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; BLOOD-PRESSURE; MESSENGER-RNA; ANGIOTENSIN SYSTEM; DEFICIENT MICE; TRANSCRIPTION; PROMOTER; ELEMENTS; CAMP; IDENTIFICATION	Renin is the rate-limiting enzyme in the renin-angiotensin system and thus dictates the level of the pressor hormone angiotensinII. The classical site of renin expression and secretion is the renal juxtaglomerular cell, where its expression is tightly regulated by physiological cues. An evolutionarily conserved transcriptional enhancer located 11 kb upstream of the human RENIN gene has been reported to markedly enhance transcription in renin expressing cells in vitro. However, its importance in vivo remains unclear. We tested whether this enhancer is required for appropriate tissue- and cell-specific expression, or for physiological regulation of the human RENIN gene. To accomplish this, we used a retrofitting technique employing homologous recombination in bacteria to delete the enhancer from a 160-kb P1-artificial chromosome containing human RENIN, two upstream genes and one downstream gene, and then generated two lines of transgenic mice. We previously showed that human renin expression in transgenic mice containing the wild type construct is tightly regulated as is expression of the linked genes. Deletion of the enhancer had no effect on tissue- specific expression of human RENIN, but using the downstream gene as an internal control, found that human RENIN mRNA levels were 3-10-fold decreased compared with constructs containing the enhancer. Despite this decrease in expression, renin protein remained localized to renal juxtaglomerular cells and was appropriately regulated by cues that either increase or decrease expression of renin. Our results suggest that sequences other than the enhancer may be necessary for tissue- specific, cell-specific, and regulated expression of human RENIN.	Univ Iowa, Med Educ & Biomed Res Facil 3181B, Roy J & Lucille A Carver Coll Med, Mol & Cellular Biol Grad Program,Dept Internal Me, Iowa City, IA 52242 USA; Univ Iowa, Dept Mol Physiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Sigmund, CD (corresponding author), Univ Iowa, Med Educ & Biomed Res Facil 3181B, Roy J & Lucille A Carver Coll Med, Mol & Cellular Biol Grad Program,Dept Internal Me, Iowa City, IA 52242 USA.	curt-sigmund@uiowa.edu	Sigmund, Curt D./W-1611-2019	Sigmund, Curt D./0000-0002-1453-0921	NHLBI NIH HHS [HL48058, HL61446, HL55006] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055006, R01HL048058, R37HL048058, R01HL061446] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams DJ, 2006, J BIOL CHEM, V281, P31753, DOI 10.1074/jbc.M605720200; Adams DJ, 2003, J BIOL CHEM, V278, P44894, DOI 10.1074/jbc.M307782200; AHU XG, 2000, MOL CELL BIOL, V20, P2604; Baumann H, 2000, J BIOL CHEM, V275, P22014, DOI 10.1074/jbc.M002830200; Castrop H, 2006, PHYSIOL GENOMICS, V25, P277, DOI 10.1152/physiolgenomics.00302.2005; CHEN L, 2006, IN PRESS AM J PHYSL; Davisson RL, 1997, J CLIN INVEST, V99, P1258, DOI 10.1172/JCI119283; Germain S, 1998, J BIOL CHEM, V273, P25292, DOI 10.1074/jbc.273.39.25292; GILBERT MT, 1994, J BIOL CHEM, V269, P28049; Gribouval O, 2005, NAT GENET, V37, P964, DOI 10.1038/ng1623; Harris JM, 1997, MICROSC RES TECHNIQ, V39, P211, DOI 10.1002/(SICI)1097-0029(19971101)39:3<211::AID-JEMT2>3.0.CO;2-N; Jessen JR, 1998, P NATL ACAD SCI USA, V95, P5121, DOI 10.1073/pnas.95.9.5121; Keen HL, 2001, HYPERTENSION, V37, P403, DOI 10.1161/01.HYP.37.2.403; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; Klar J, 2005, HYPERTENSION, V46, P1340, DOI 10.1161/01.HYP.0000192025.86189.46; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lavoie JL, 2004, AM J PHYSIOL-RENAL, V286, pF965, DOI 10.1152/ajprenal.00402.2003; LIU X, 2006, IN PRESS ENDOCRINOLO; Liu XB, 2003, CIRC RES, V92, P1033, DOI 10.1161/01.RES.0000071355.82009.43; Lochard N, 2003, J BIOL CHEM, V278, P2184, DOI 10.1074/jbc.M209933200; Lopez MLSS, 2004, DEV CELL, V6, P719; NAKAMURA N, 1989, P NATL ACAD SCI USA, V86, P56, DOI 10.1073/pnas.86.1.56; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nistala R, 2004, PHYSIOL GENOMICS, V17, P4, DOI 10.1152/physiolgenomics.00205.2003; Nistala R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e41; Oliverio MI, 1998, AM J PHYSIOL-RENAL, V274, pF43, DOI 10.1152/ajprenal.1998.274.1.F43; Oliverio MI, 1997, AM J PHYSIOL-RENAL, V272, pF515, DOI 10.1152/ajprenal.1997.272.4.F515; Pan L, 2005, J BIOL CHEM, V280, P20860, DOI 10.1074/jbc.M414618200; Pan L, 2005, AM J PHYSIOL-RENAL, V288, pF117, DOI 10.1152/ajprenal.00333.2003; Pan L, 2003, BBA-GENE STRUCT EXPR, V1625, P280, DOI 10.1016/S0167-4781(03)00016-2; Pan L, 2001, J BIOL CHEM, V276, P45530, DOI 10.1074/jbc.M103010200; Pan L, 2001, J BIOL CHEM, V276, P32489, DOI 10.1074/jbc.M011541200; Petrovic N, 1996, J BIOL CHEM, V271, P22499, DOI 10.1074/jbc.271.37.22499; Shi Q, 1999, CIRC RES, V85, P479, DOI 10.1161/01.RES.85.6.479; Shi Q, 2001, HYPERTENSION, V38, P332, DOI 10.1161/01.HYP.38.3.332; Shi Q, 2001, J BIOL CHEM, V276, P3597, DOI 10.1074/jbc.M008361200; SIGMUND CD, 1992, CIRC RES, V70, P1070, DOI 10.1161/01.RES.70.5.1070; Sinn PL, 2000, PHYSIOL GENOMICS, V3, P25, DOI 10.1152/physiolgenomics.2000.3.1.25; Sinn PL, 2000, V CH MO CAR, V1, P259; Sinn PL, 1999, AM J PHYSIOL-RENAL, V277, pF634, DOI 10.1152/ajprenal.1999.277.4.F634; Sinn PL, 1999, HYPERTENSION, V33, P900, DOI 10.1161/01.HYP.33.3.900; Sinn PL, 1999, J BIOL CHEM, V274, P35785, DOI 10.1074/jbc.274.50.35785; Sinn PL, 2000, REGUL PEPTIDES, V86, P77, DOI 10.1016/S0167-0115(99)00097-X; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; SUN JD, 1994, CIRC RES, V75, P624, DOI 10.1161/01.RES.75.4.624; Takahashi N, 2005, J AM SOC NEPHROL, V16, P125, DOI 10.1681/ASN.2004060490; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Todorov VT, 2005, J BIOL CHEM, V280, P24356, DOI 10.1074/jbc.M502968200; Todorov VT, 2004, J BIOL CHEM, V279, P1458, DOI 10.1074/jbc.M308697200; Tomita S, 1999, CIRC RES, V84, P1059, DOI 10.1161/01.RES.84.9.1059; Yan Y, 1998, HYPERTENSION, V32, P205, DOI 10.1161/01.HYP.32.2.205; Yan Y, 1997, CIRC RES, V81, P558, DOI 10.1161/01.RES.81.4.558; Zhang Y, 2001, MOL ENDOCRINOL, V15, P1891, DOI 10.1210/me.15.11.1891	53	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35296	35304		10.1074/jbc.M608055200	http://dx.doi.org/10.1074/jbc.M608055200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16990260	hybrid			2022-12-27	WOS:000241933700064
J	Goto, M; Hayashi, H; Miyahara, I; Hirotsu, K; Yoshida, M; Oikawa, T				Goto, Masaru; Hayashi, Hideyuki; Miyahara, Ikuko; Hirotsu, Ken; Yoshida, Masahiro; Oikawa, Tadao			Crystal structures of nonoxidative zinc-dependent 2,6-dihydroxybenzoate (gamma-resorcylate) decarboxylase from Rhizobium sp strain MTP-10005	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSIBLE 4-HYDROXYBENZOATE DECARBOXYLASE; 2,3-DIHYDROXYBENZOIC ACID DECARBOXYLASE; BINUCLEAR METAL CENTER; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; MOLECULAR-STRUCTURE; D-AMINOACYLASE; MALIC ENZYME; ACTIVE-SITE; PURIFICATION	Reversible 2,6-dihydroxybenzoate decarboxylase from Rhizobium sp. strain MTP-10005 belongs to a nonoxidative decarboxylase family. We have determined the structures of the following three forms of the enzyme: the native form, the complex with the true substrate (2,6-dihydroxybenzoate), and the complex with 2,3-dihydroxybenzaldehyde at 1.7-, 1.9-, and 1.7-angstrom resolution, respectively. The enzyme exists as a tetramer, and the subunit consists of one (alpha beta)(8) triose-phosphate isomerase-barrel domain with three functional linkers and one C-terminal tail. The native enzyme possesses one Zn2+ ion liganded by Glu(8), His(10), His(164), Asp(287), and a water molecule at the active site center, although the enzyme has been reported to require no cofactor for its catalysis. The substrate carboxylate takes the place of the water molecule and is coordinated to the Zn2+ ion. The 2-hydroxy group of the substrate is hydrogen-bonded to Asp(287), which forms a triad together with His(218) and Glu(221) and is assumed to be the catalytic base. On the basis of the geometrical consideration, substrate specificity is uncovered, and the catalytic mechanism is proposed for the novel Zn2+-dependent decarboxylation.	Osaka City Univ, Dept Chem, Grad Sch Sci, Osaka 5588585, Japan; Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan; Kansai Univ, Fac Engn, Dept Biotechnol, Osaka 5648680, Japan; Kansai Univ, High Technol Res Ctr, Osaka 5648680, Japan	Osaka Metropolitan University; Osaka Medical College; Kansai University; Kansai University	Hirotsu, K (corresponding author), Osaka City Univ, Dept Chem, Grad Sch Sci, Osaka 5588585, Japan.	hirotsu@sci.osaka-cu.ac.jp						ANDERSON JJ, 1981, J BACTERIOL, V146, P291, DOI 10.1128/JB.146.1.291-297.1981; Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benini S, 1998, J BIOL INORG CHEM, V3, P268, DOI 10.1007/s007750050231; BENNING MM, 1995, BIOCHEMISTRY-US, V34, P7973, DOI 10.1021/bi00025a002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CANDY JM, 1994, BIOCHEM J, V300, P7, DOI 10.1042/bj3000007; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; GRANT DJW, 1969, ANTON VAN LEE J M S, V35, P325, DOI 10.1007/BF02219153; Hasson MS, 1998, BIOCHEMISTRY-US, V37, P9918, DOI 10.1021/bi973047e; He ZQ, 1996, J BACTERIOL, V178, P3539, DOI 10.1128/jb.178.12.3539-3543.1996; HE ZQ, 1995, EUR J BIOCHEM, V229, P77, DOI 10.1111/j.1432-1033.1995.tb20440.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Huang JB, 1999, J BACTERIOL, V181, P5119, DOI 10.1128/JB.181.16.5119-5122.1999; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; Ishii Y, 2004, BIOCHEM BIOPH RES CO, V324, P611, DOI 10.1016/j.bbrc.2004.09.091; IWAKURA M, 1979, J BIOCHEM-TOKYO, V85, P1355; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jozic D, 2003, J MOL BIOL, V332, P243, DOI 10.1016/S0022-2836(03)00845-3; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAMATH AV, 1987, BIOCHEM BIOPH RES CO, V145, P586, DOI 10.1016/0006-291X(87)91361-1; Kishan KVR, 2005, J MOL BIOL, V347, P95, DOI 10.1016/j.jmb.2005.01.025; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lai WL, 2004, J BIOL CHEM, V279, P13962, DOI 10.1074/jbc.M308849200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liaw SH, 2003, J BIOL CHEM, V278, P4957, DOI 10.1074/jbc.M210795200; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; MATSUI T, 2006, IN PRESS APPL MICROB; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; NAKAMATSU T, 1993, Patent No. 0552912; NAKAZAWA T, 1978, APPL ENVIRON MICROB, V36, P264, DOI 10.1128/AEM.36.2.264-269.1978; Nitanai Y, 2002, J MOL BIOL, V321, P177, DOI 10.1016/S0022-2836(02)00632-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARK SL, 1973, J BACTERIOL, V116, P263, DOI 10.1128/JB.116.1.263-270.1973; PUJAR BG, 1985, APPL ENVIRON MICROB, V49, P374, DOI 10.1128/AEM.49.2.374-376.1985; RAMACHANDRAN A, 1979, FEMS MICROBIOL LETT, V5, P421, DOI 10.1111/j.1574-6968.1979.tb03372.x; RECSEI PA, 1983, J BIOL CHEM, V258, P439; RECSEI PA, 1970, BIOCHEMISTRY-US, V9, P1492, DOI 10.1021/bi00809a003; REID J, 1951, BRIT MED J, V4727, P321; RIBBONS DW, 1960, BIOCHEM J, V76, P310, DOI 10.1042/bj0760310; SAGAWA M, 2000, Patent No. 12323016; Santha R, 1996, BBA-PROTEIN STRUCT M, V1293, P191, DOI 10.1016/0167-4838(95)00242-1; SANTHA R, 1995, EUR J BIOCHEM, V230, P104, DOI 10.1111/j.1432-1033.1995.0104i.x; Steinbacher S, 2003, J MOL BIOL, V327, P193, DOI 10.1016/S0022-2836(03)00092-5; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; TOSHIMOTO M, 1996, Patent No. 08272035; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; WU JY, 1973, J BIOL CHEM, V248, P3029; Yoshida M, 2004, J BACTERIOL, V186, P6855, DOI 10.1128/JB.186.20.6855-6863.2004; Yoshida T, 2004, ARCH MICROBIOL, V181, P391, DOI 10.1007/s00203-004-0668-2	58	37	38	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34365	34373		10.1074/jbc.M607270200	http://dx.doi.org/10.1074/jbc.M607270200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16963440	hybrid			2022-12-27	WOS:000241767600057
J	Yao, YC; Zebboudj, AF; Shao, E; Perez, M; Bostrom, K				Yao, Yucheng; Zebboudj, Amina F.; Shao, Esther; Perez, Martin; Bostrom, Kristina			Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SHEAR-STRESS; TRANSFORMING GROWTH-FACTOR-BETA-1; GENE-EXPRESSION; TGF-BETA; RECEPTOR; CALCIFICATION; ANGIOGENESIS; BINDING; MICE	Matrix GLA protein (MGP) has previously been shown to enhance expression of vascular endothelial growth factor (VEGF) through the activin-like kinase receptor 1 (ALK1) in bovine aortic endothelial cells. MGP has also been identified as an inhibitor of bone morphogenetic protein-2 (BMP-2). This study showed that the effect of MGP on ALK1 signaling and VEGF expression in bovine aortic endothelial cells was dose-dependent, that a progressive increase of MGP levels ceased to be stimulatory and instead turned inhibitory. We identified a new regulatory pathway involving BMP that may explain this response. BMP-2 and BMP-4 induced expression of ALK1 in a dose-dependent fashion as determined by real-time PCR and immunoblotting. Activation of ALK1 signaling induced expression of MGP in addition to that of VEGF, allowing for negative feedback regulation of BMP by MGP. MGP inhibited BMP-4 activity similarly to that of BMP-2 and interacted with BMP-4 on a protein level as determined by co-immunoprecipitation. The dose-dependent effect on ALK1 expression and the stimulation of MGP and VEGF expression were dependent on signaling by transforming growth factor-beta(TGF-beta) and ALK1. Inhibition of TGF-alpha by neutralizing antibodies abolished the inhibitory effect of high BMP-4 levels on ALK1 expression and the induction of MGP and VEGF. Depletion of ALK1 by small interfering RNA abolished the induction of MGP and VEGF. MGP promoter activity was also stimulated by BMP-4 in a TGF-beta dependent fashion. The results suggest that the effects of BMP on endothelial cells occur in part through induction of ALK1, an effect that may be limited by ALK1-induced MGP.	Univ Calif Los Angeles, Div Cardiol, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Bostrom, K (corresponding author), Univ Calif Los Angeles, Div Cardiol, David Geffen Sch Med, Box 951679, Los Angeles, CA 90095 USA.	kbostrom@mednet.ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, K08HL004270] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30568, HL04270, HL81397] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bianchi F, 2004, CLIN CANCER RES, V10, P6023, DOI 10.1158/1078-0432.CCR-04-0619; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Engelse MA, 2001, CARDIOVASC RES, V52, P281, DOI 10.1016/S0008-6363(01)00375-3; Fan CW, 2001, CANCER LETT, V165, P63, DOI 10.1016/S0304-3835(01)00416-5; Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101; Glienke J, 2000, EUR J BIOCHEM, V267, P2820, DOI 10.1046/j.1432-1327.2000.01325.x; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; HALE JE, 1991, J BIOL CHEM, V266, P21145; Harrison RE, 2005, CIRCULATION, V111, P435, DOI 10.1161/01.CIR.0000153798.78540.87; Kirfel J, 1997, P NATL ACAD SCI USA, V94, P2227, DOI 10.1073/pnas.94.6.2227; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lee H, 2000, CIRC RES, V87, P516; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Moser M, 2005, THROMB HAEMOSTASIS, V94, P713, DOI 10.1160/TH05-05-0312; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Newman JH, 2004, J AM COLL CARDIOL, V43, p33S, DOI 10.1016/j.jacc.2004.02.028; Nishimoto SK, 2005, MATRIX BIOL, V24, P353, DOI 10.1016/j.matbio.2005.05.004; Panchenko MP, 1996, AM J PHYSIOL-LUNG C, V270, pL547, DOI 10.1152/ajplung.1996.270.4.L547; PEPPER MS, 1993, EXP CELL RES, V204, P356, DOI 10.1006/excr.1993.1043; Prado CM, 2006, J HYPERTENS, V24, P503, DOI 10.1097/01.hjh.0000209987.51606.23; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Raftery LA, 2003, TRENDS GENET, V19, P701, DOI 10.1016/j.tig.2003.10.009; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Roelen BAJ, 1997, DEV DYNAM, V209, P418, DOI 10.1002/(SICI)1097-0177(199708)209:4<418::AID-AJA9>3.0.CO;2-L; Schurgers LJ, 2004, BLOOD, V104, P3231, DOI 10.1182/blood-2004-04-1277; Simes DC, 2003, J BONE MINER RES, V18, P244, DOI 10.1359/jbmr.2003.18.2.244; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; SUGIYAMA S, 1995, ARTERIOSCL THROM VAS, V15, P1968, DOI 10.1161/01.ATV.15.11.1968; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Vogt RR, 2006, J CELL BIOCHEM, V98, P1196, DOI 10.1002/jcb.20831; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zhao JS, 1997, AM J PHYSIOL-LUNG C, V273, pL282, DOI 10.1152/ajplung.1997.273.1.L282	41	96	98	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33921	33930		10.1074/jbc.M604239200	http://dx.doi.org/10.1074/jbc.M604239200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16950789	hybrid			2022-12-27	WOS:000241767600013
J	Kweon, MH; Adhami, VM; Lee, JS; Mukhtar, H				Kweon, Mee-Hyang; Adhami, Vaqar Mustafa; Lee, Jeong-Sang; Mukhtar, Hasan			Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PROSTATE-CANCER CELLS; NF-E2-RELATED FACTOR-2; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; EPITHELIAL-CELLS; GENE-EXPRESSION; UP-REGULATION; NITRIC-OXIDE; TUMOR-CELLS	Epigallocatechin 3-gallate (EGCG), the major polyphenol found in green tea, exerts antiproliferative and proapoptotic effects in many cancer cells. However, we found that among many cancer cells human lung adenocarcinoma A549 cells are markedly resistant to apoptosis induction by EGCG ( even at 100 mu M for 72 h). Heme oxygenase-1 (HO-1) induced by stress stimuli represents a prime cellular defense mechanism, but it may be associated with enhanced cell proliferation and chemoresistance in some cancer cells. Because we found that A549 cells constitutively overexpress HO-1 and its associated transcription factor Nrf2, we tested an hypothesis that EGCG resistance in these cells may be linked with Nrf2-mediated HO-1 overexpression. HO-1 inhibition with tin-protoporphyrin IX and silencing with RNA interference rendered cells more sensitive to apoptosis induction by EGCG and classical prooxidants. Interestingly, EGCG at high concentration (> 200 mu M) induced apoptosis by suppressing expression of HO-1 protein and mRNA, and this effect correlated with a decrease in both Nrf2-ARE binding and HO-1-ARE- luciferase activity, suggesting Nrf2-driven transcriptional activation of ho-1. Because we observed notably high levels of phosphorylated protein kinase C alpha and its suppression by EGCG and deferoxamine (an iron chelator), a possible mechanism involving phosphorylated protein kinase C alpha and iron in Nrf2-HO-1 activation was further investigated. Collectively, our findings suggest that Nrf2-mediated HO- 1 overexpression confers resistance to apoptosis induction by EGCG; therefore, its inactivation may be a target for overcoming the resistance to chemoprevention and chemotherapy.	Univ Wisconsin, Dept Dermatol, Med Sci Ctr, Madison, WI 53706 USA; Seoul Natl Univ, Coll Pharm, Natl Res Lab Mol Carcinogenesis & Chemoprevent, Seoul 151742, South Korea	University of Wisconsin System; University of Wisconsin Madison; Seoul National University (SNU)	Mukhtar, H (corresponding author), Univ Wisconsin, Dept Dermatol, Med Sci Ctr, 1300 Univ Ave, Madison, WI 53706 USA.	hmukhtar@wisc.edu	Adhami, Vaqar/AAY-2837-2020	Adhami, Vaqar/0000-0002-2048-4570	NATIONAL CANCER INSTITUTE [R01CA101039, R01CA078809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065303] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA78809, R01-CA101039] Funding Source: Medline; NIDDK NIH HHS [P50-DK065303-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Alam J, 2000, J BIOL CHEM, V275, P27694; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Anning PB, 1999, FEBS LETT, V447, P111, DOI 10.1016/S0014-5793(99)00250-1; BARKER S, 1995, FEBS LETT, V369, P263, DOI 10.1016/0014-5793(95)00725-O; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; Bundy RE, 2005, ANTIOXID REDOX SIGN, V7, P14, DOI 10.1089/ars.2005.7.14; Carter EP, 2004, AM J PHYSIOL-LUNG C, V287, pL24, DOI 10.1152/ajplung.00097.2004; Chen CY, 2005, BIOCHEM BIOPH RES CO, V331, P993, DOI 10.1016/j.bbrc.2005.03.237; Chen GG, 2004, J CELL BIOCHEM, V92, P1246, DOI 10.1002/jcb.20157; Chen M, 2006, PEDIATR NEPHROL, V21, P382, DOI 10.1007/s00467-005-2140-1; Cho HY, 2004, FASEB J, V18, P1258, DOI 10.1096/fj.03-1127fje; Dennery PA, 1997, J BIOL CHEM, V272, P14937, DOI 10.1074/jbc.272.23.14937; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; Esposito F, 2004, NEUROCHEM RES, V29, P617, DOI 10.1023/B:NERE.0000014832.78725.1a; Fang J, 2003, CANCER RES, V63, P3567; Fang J, 2004, INT J CANCER, V109, P1, DOI 10.1002/ijc.11644; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Gallego MA, 2004, ONCOGENE, V23, P6282, DOI 10.1038/sj.onc.1207835; Ikuta K, 2005, BIOL PHARM BULL, V28, P707, DOI 10.1248/bpb.28.707; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kim SG, 2004, ARCH PHARM RES, V27, P757, DOI 10.1007/BF02980145; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kweon MH, 2006, FREE RADICAL BIO MED, V40, P1349, DOI 10.1016/j.freeradbiomed.2005.12.002; Kweon MH, 2004, FREE RADICAL BIO MED, V36, P40, DOI 10.1016/j.freeradbiomed.2003.09.023; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Liu XM, 2002, CARDIOVASC RES, V55, P396, DOI 10.1016/S0008-6363(02)00410-8; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Mumby S, 2004, CRIT CARE MED, V32, P1130, DOI 10.1097/01.CCM.0000124869.86399.F2; Nakagawa H, 2004, CARCINOGENESIS, V25, P1567, DOI 10.1093/carcin/bgh168; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nowis D, 2006, ONCOGENE, V25, P3365, DOI 10.1038/sj.onc.1209378; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Reznichenko L, 2006, J NEUROCHEM, V97, P527, DOI 10.1111/j.1471-4159.2006.03770.x; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Saleem M, 2005, CANCER RES, V65, P11203, DOI 10.1158/0008-5472.CAN-05-1965; Saleem M, 2005, CARCINOGENESIS, V26, P1956, DOI 10.1093/carcin/bgi157; Sasaki T, 2005, VIRCHOWS ARCH, V446, P525, DOI 10.1007/s00428-005-1247-x; Schweyer S, 2004, INT J ONCOL, V25, P1671; Seve Pascal, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P73, DOI 10.2174/1568011053352604; Shih A, 2004, MOL CANCER THER, V3, P1355; Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003; Speit G, 2003, MUTAGENESIS, V18, P545, DOI 10.1093/mutage/geg028; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Tanaka S, 2003, BRIT J CANCER, V88, P902, DOI 10.1038/sj.bjc.6600830; Viktorsson K, 2005, BIOCHEM BIOPH RES CO, V331, P868, DOI 10.1016/j.bbrc.2005.03.192; Wang TL, 2005, CANCER RES, V65, P10338, DOI 10.1158/0008-5472.CAN-04-4614; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Zhou YD, 2004, J NAT PROD, V67, P2063, DOI 10.1021/np040140c	56	189	203	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33761	33772		10.1074/jbc.M604748200	http://dx.doi.org/10.1074/jbc.M604748200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950787	hybrid			2022-12-27	WOS:000241621400083
J	Nojiri, H; Shimizu, T; Funakoshi, M; Yamaguchi, O; Zhou, H; Kawakami, S; Ohta, Y; Sami, M; Tachibana, T; Ishikawa, H; Kurosawa, H; Kahn, RC; Otsu, K; Shirasawa, T				Nojiri, Hidetoshi; Shimizu, Takahiko; Funakoshi, Masabumi; Yamaguchi, Osamu; Zhou, Heying; Kawakami, Satoru; Ohta, Yutaka; Sami, Manabu; Tachibana, Toshiaki; Ishikawa, Hiroshi; Kurosawa, Hisashi; Kahn, Ronald C.; Otsu, Kinya; Shirasawa, Takuji			Oxidative stress causes heart failure with impaired mitochondrial respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; MUTANT MICE; LIFE-SPAN; IN-VIVO; OXYGEN; APOPTOSIS; PROTEIN	Elderly people insidiously manifest the symptoms of heart failure, such as dyspnea and/or physical disabilities in an age-dependent manner. Although previous studies suggested that oxidative stress plays a pathological role in the development of heart failure, no direct evidence has been documented so far. In order to investigate the pathological significance of oxidative stress in the heart, we generated heart/muscle-specific manganese superoxide dismutase-deficient mice. The mutant mice developed progressive congestive heart failure with specific molecular defects in mitochondrial respiration. In this paper, we showed for the first time that the oxidative stress caused specific morphological changes of mitochondria, excess formation of superoxide (O-2(center dot)), reduction of ATP, and transcriptional alterations of genes associated with heart failure in respect to cardiac contractility. Accordingly, administration of a superoxide dismutase mimetic significantly ameliorated the symptoms. These results implied that O-2(center dot) generated in mitochondria played a pivotal role in the development and progression of heart failure. We here present a bona fide model for human cardiac failure with oxidative stress valuable for therapeutic interventions.	Tokyo Metropolitan Inst Gerontol, Res Team Mol Biomarkers, Itabashi Ku, Tokyo 1730015, Japan; Juntendo Univ, Sch Med, Dept Orthoped, Bunkyo Ku, Tokyo 1138421, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Hachioji, Tokyo 1920397, Japan; Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; Asahi Brewery Co Ltd, Fundamental Res Lab, Moriya, Ibaraki 3020106, Japan; Jikei Univ, Sch Med, Dept Anat 2, Minato Ku, Tokyo 1058461, Japan; Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan; Anti Aging Sci Inc, Chiyoda Ku, Tokyo 1000001, Japan	Tokyo Metropolitan Institute of Gerontology; Juntendo University; Tokyo Metropolitan University; Osaka University; Asahi Group Holdings Ltd.; Jikei University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Tokyo University of Agriculture & Technology	Shirasawa, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Mol Biomarkers, Itabashi Ku, 35-2 Sakaesho, Tokyo 1730015, Japan.	sirasawa@tmig.or.jp	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Yamaguchi, Osamu/0000-0002-7461-369X				Alameddine Fadi M F, 2002, Congest Heart Fail, V8, P157, DOI 10.1111/j.1527-5299.2002.00719.x; Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0; Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; BROQVIST M, 1994, EUR HEART J, V15, P1641, DOI 10.1093/oxfordjournals.eurheartj.a060447; BROWN JM, 1988, J CLIN INVEST, V81, P1297, DOI 10.1172/JCI113448; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; DiazVelez CR, 1996, AM HEART J, V131, P146, DOI 10.1016/S0002-8703(96)90063-0; Dieterich S, 2000, CIRCULATION, V101, P33, DOI 10.1161/01.CIR.101.1.33; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Givertz MM, 1998, LANCET, V352, P34; Hiroi S, 1999, BIOCHEM BIOPH RES CO, V261, P332, DOI 10.1006/bbrc.1999.1036; Ide T, 2000, CIRC RES, V86, P152, DOI 10.1161/01.RES.86.2.152; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Ikegami T, 2002, BIOCHEM BIOPH RES CO, V296, P729, DOI 10.1016/S0006-291X(02)00933-6; JABR RI, 1995, CIRC RES, V76, P812, DOI 10.1161/01.RES.76.5.812; Keith M, 1998, J AM COLL CARDIOL, V31, P1352, DOI 10.1016/S0735-1097(98)00101-6; Khaper N, 2003, MOL CELL BIOCHEM, V251, P9, DOI 10.1023/A:1025448908694; Kong BW, 2003, BBA-GENE STRUCT EXPR, V1625, P98, DOI 10.1016/S0167-4781(02)00593-6; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li J, 1999, J CELL BIOL, V147, P1391, DOI 10.1083/jcb.147.7.1391; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Melov S, 2001, J NEUROSCI, V21, P8348, DOI 10.1523/JNEUROSCI.21-21-08348.2001; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Morten KJ, 2006, J BIOL CHEM, V281, P3354, DOI 10.1074/jbc.M509261200; Nakai D, 2004, AGING CELL, V3, P273, DOI 10.1111/j.1474-9728.2004.00116.x; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Shimizu T, 2002, J NEUROSCI RES, V69, P341, DOI 10.1002/jnr.10301; Shirasawa T, 2003, J BIOL CHEM, V278, P5035, DOI 10.1074/jbc.M211110200; Strassburger M, 2005, FREE RADICAL BIO MED, V38, P1458, DOI 10.1016/j.freeradbiomed.2005.02.009; SUZUKI S, 1991, BIOCHIM BIOPHYS ACTA, V1074, P95, DOI 10.1016/0304-4165(91)90045-I; Tang WW, 2003, EXPERT OPIN INV DRUG, V12, P1791, DOI 10.1517/13543784.12.11.1791; Valenti L, 2004, J MED GENET, V41, P946, DOI 10.1136/jmg.2004.019588; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661	45	169	172	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33789	33801		10.1074/jbc.M602118200	http://dx.doi.org/10.1074/jbc.M602118200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959785	hybrid			2022-12-27	WOS:000241621400085
J	Bashir, K; Inoue, H; Nagasaka, S; Takahashi, M; Nakanishi, H; Mori, S; Nishizawa, NK				Bashir, Khurram; Inoue, Haruhiko; Nagasaka, Seiji; Takahashi, Michiko; Nakanishi, Hiromi; Mori, Satoshi; Nishizawa, Naoko K.			Cloning and characterization of deoxymugineic acid synthase genes from graminaceous plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTIANAMINE SYNTHASE; IRON-DEFICIENCY; MUGINEIC ACID; HORDEUM-VULGARE; FE-DEFICIENCY; BARLEY; EXPRESSION; RICE; PHYTOSIDEROPHORES; BIOSYNTHESIS	Graminaceous plants have evolved a unique mechanism to acquire iron through the secretion of a family of small molecules, called mugineic acid family phytosiderophores (MAs). All MAs are synthesized from L-Met, sharing the same pathway from L-Met to 2'-deoxymugineic acid (DMA). DMA is synthesized through the reduction of a 3"-keto intermediate by deoxymugineic acid synthase ( DMAS). We have isolated DMAS genes from rice (OsDMAS1), barley (HvDMAS1), wheat (TaDMAS1), and maize (ZmDMAS1). Their nucleotide sequences indicate that OsDMAS1 encodes a predicted polypeptide of 318 amino acids, whereas the other three orthologs all encode predicted polypeptides of 314 amino acids and are highly homologous (82-97.5%) to each other. The DMAS proteins belong to the aldo-keto reductase superfamily 4 (AKR4) but do not fall within the existing subfamilies of AKR4 and appear to constitute a new subfamily within the AKR4 group. All of the proteins showed DMA synthesis activity in vitro. Their enzymatic activities were highest at pH 8-9, consistent with the hypothesis that DMA is synthesized in subcellular vesicles. Northern blot analysis revealed that the expression of each of the above DMAS genes is up-regulated under iron-deficient conditions in root tissue, and that of the genes OsDMAS1 and TaDMAS1 is up-regulated in shoot tissue. OsDMAS1 promoter-GUS analysis in iron-sufficient roots showed that its expression is restricted to cells participating in long distance transport and that it is highly up-regulated in the entire root under iron-deficient conditions. In shoot tissue, OsDMAS1 promoter drove expression in vascular bundles specifically under iron-deficient conditions.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; CREST, Japan Sci & Technol Corp, Urawa, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Nishizawa, NK (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Bashir, Khurram/C-6870-2011; Bashir, Khurram/Z-5650-2019; Nakanishi, Hiromi/C-6461-2015	Bashir, Khurram/0000-0001-7123-8380; Bashir, Khurram/0000-0001-7123-8380; Nakanishi, Hiromi/0000-0001-5556-5058				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; ENGLERBLUM G, 1993, ANAL BIOCHEM, V210, P235, DOI 10.1006/abio.1993.1189; Gavidia I, 2002, EUR J BIOCHEM, V269, P2842, DOI 10.1046/j.1432-1033.2002.02931.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Herbik A, 1999, EUR J BIOCHEM, V265, P231, DOI 10.1046/j.1432-1327.1999.00717.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HIGUCHI K, 1994, PLANT SOIL, V165, P173, DOI 10.1007/BF00008059; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; HIGUCHI K, 1995, J EXP BOT, V46, P1061, DOI 10.1093/jxb/46.8.1061; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; KANAZAWA K, 1994, J EXP BOT, V45, P1903, DOI 10.1093/jxb/45.12.1903; KANAZAWA K, 1995, J EXP BOT, V46, P1241, DOI 10.1093/jxb/46.9.1241; KAWAI S, 1988, J PLANT NUTR, V11, P633, DOI 10.1080/01904168809363829; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Kobayashi T, 2003, PLANT J, V36, P780, DOI 10.1046/j.1365-313X.2003.01920.x; Kobayashi T, 2001, PLANTA, V212, P864, DOI 10.1007/s004250000453; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; MA JF, 1995, J BIOL CHEM, V270, P16549, DOI 10.1074/jbc.270.28.16549; Ma JF, 1999, J EXP BOT, V50, P723, DOI 10.1093/jexbot/50.334.723; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Mizuno D, 2003, PLANT PHYSIOL, V132, P1989, DOI 10.1104/pp.102.019869; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; MORI S, 1991, PLANT SOIL, V130, P143, DOI 10.1007/BF00011869; NAKANISHI H, 1993, PLANT CELL PHYSIOL, V34, P401; Nakanishi H, 2000, PLANT MOL BIOL, V44, P199, DOI 10.1023/A:1006491521586; Negishi T, 2002, PLANT J, V30, P83, DOI 10.1046/j.1365-313X.2002.01270.x; NELSON MJK, 1986, J BIOL CHEM, V261, P5115; NOMOTO K, 1987, IRON TRANSPORT MICRO, P401; Nozoye T, 2004, SOIL SCI PLANT NUTR, V50, P1125, DOI 10.1080/00380768.2004.10408585; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; OHATA T, 1993, SOIL SCI PLANT NUTR, V39, P745, DOI 10.1080/00380768.1993.10419193; OKUMURA N, 1994, PLANT MOL BIOL, V25, P705, DOI 10.1007/BF00029608; ROMHELD V, 1990, PLANT SOIL, V123, P147, DOI 10.1007/BF00011260; RONCARATI R, 1995, PLANT J, V7, P809, DOI 10.1046/j.1365-313X.1995.07050809.x; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; Singh K., 1993, Genetic aspects of plant mineral nutrition. The Fourth International Symposium on Genetic Aspects of Plant Mineral Nutrition, 30 September-4 October 1991, Canberra, Australia., P335; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; Takizawa R, 1996, J PLANT NUTR, V19, P1189, DOI 10.1080/01904169609365190; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Yokochi N, 2004, J BIOL CHEM, V279, P37377, DOI 10.1074/jbc.M405344200; Yoshihara T, 2003, PLANT BIOTECHNOL-NAR, V20, P33	48	211	222	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32395	32402		10.1074/jbc.M604133200	http://dx.doi.org/10.1074/jbc.M604133200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16926158	hybrid			2022-12-27	WOS:000241414500037
J	Corcoran, JA; Salsman, J; de Antueno, R; Touhami, A; Jericho, MH; Clancy, EK; Duncan, R				Corcoran, Jennifer A.; Salsman, Jayme; de Antueno, Roberto; Touhami, Ahmed; Jericho, Manfred H.; Clancy, Eileen K.; Duncan, Roy			The p14 fusion-associated small transmembrane (FAST) protein effects membrane fusion from a subset of membrane microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; HUMAN-IMMUNODEFICIENCY-VIRUS; DISTINCT LIPID MICRODOMAINS; ELEMENT-BINDING PROTEINS; CELL-MEMBRANES; PLASMA-MEMBRANE; REPTILIAN REOVIRUS; RAFT MICRODOMAINS; DOMAIN-STRUCTURE; BABOON REOVIRUS	The reovirus fusion-associated small transmembrane (FAST) proteins are a unique family of viral membrane fusion proteins. These nonstructural viral proteins induce efficient cell-cell rather than virus-cell membrane fusion. We analyzed the lipid environment in which the reptilian reovirus p14 FAST protein resides to determine the influence of the cell membrane on the fusion activity of the FAST proteins. Topographical mapping of the surface of fusogenic p14-containing liposomes by atomic force microscopy under aqueous conditions revealed that p14 resides almost exclusively in thickened membrane microdomains. In transfected cells, p14 was found in both Lubrol WX-and Triton X-100-resistant membrane complexes. Cholesterol depletion of donor cell membranes led to preferential disruption of p14 association with Lubrol WX (but not Triton X-100)resistant membranes and decreased cell-cell fusion activity, both of which were reversed upon subsequent cholesterol repletion. Furthermore, co-patching analysis by fluorescence microscopy indicated that p14 did not co-localize with classical lipid anchored raft markers. These data suggest that the p14 FAST protein associates with heterogeneous membrane microdomains, a distinct subset of which is defined by cholesterol-dependent Lubrol WX resistance and which may be more relevant to the membrane fusion process.	Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; Dalhousie Univ, Dept Phys, Halifax, NS B3H 1X5, Canada	Dalhousie University; Dalhousie University	Duncan, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada.	roy.duncan@dal.ca		Duncan, Roy/0000-0002-5162-5081; Clancy, Eileen/0000-0001-9565-7985				Bared SM, 2004, MOL BIOL CELL, V15, P5399, DOI 10.1091/mbc.E04-03-0182; Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; Blumenthal R, 2003, CHEM REV, V103, P53, DOI 10.1021/cr000036+; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; Cleverley DZ, 1997, EXP CELL RES, V233, P288, DOI 10.1006/excr.1997.3573; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Corcoran JA, 2004, J BIOL CHEM, V279, P51386, DOI 10.1074/jbc.M406990200; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Dawe S, 2005, J VIROL, V79, P6216, DOI 10.1128/JVI.79.10.6216-6226.2005; Dawe S, 2002, J VIROL, V76, P2131, DOI 10.1128/JVI.76.5.2131-2140.2002; DEANTUENO RJ, 1994, LIPIDS, V29, P327, DOI 10.1007/BF02537185; Drobnik W, 2002, TRAFFIC, V3, P268, DOI 10.1034/j.1600-0854.2002.030404.x; Duncan R, 2004, VIROLOGY, V319, P131, DOI 10.1016/j.virol.2003.10.025; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Hansen GH, 2001, J BIOL CHEM, V276, P32338, DOI 10.1074/jbc.M102667200; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Henderson RA, 2004, NEWS PHYSIOL SCI, V19, P39, DOI 10.1152/nips.01505.2003; Huttner WB, 2001, CURR OPIN CELL BIOL, V13, P478, DOI 10.1016/S0955-0674(00)00239-8; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kielian M, 2000, Subcell Biochem, V34, P409; Kozak SL, 2002, J VIROL, V76, P1802, DOI 10.1128/JVI.76.4.1802-1815.2002; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; KUNIMOTO M, 1989, J BIOCHEM-TOKYO, V105, P190, DOI 10.1093/oxfordjournals.jbchem.a122638; Lawrence JC, 2003, BIOPHYS J, V84, P1827, DOI 10.1016/S0006-3495(03)74990-X; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Markosyan RM, 2004, BIOPHYS J, V87, P3291, DOI 10.1529/biophysj.104.047696; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nicolini C, 2006, J AM CHEM SOC, V128, P192, DOI 10.1021/ja055779x; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Reviakine I, 2000, LANGMUIR, V16, P1806, DOI 10.1021/la9903043; Ridgway ND, 2003, BIOCHEM J, V372, P811, DOI 10.1042/BJ20030252; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Saslowsky DE, 2003, J MEMBRANE BIOL, V194, P153, DOI 10.1007/s00232-003-2035-7; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Shmulevitz M, 2004, J VIROL, V78, P2808, DOI 10.1128/JVI.78.6.2808-2818.2004; Shmulevitz M, 2003, J VIROL, V77, P9769, DOI 10.1128/JVI.77.18.9769-9779.2003; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Top D, 2005, EMBO J, V24, P2980, DOI 10.1038/sj.emboj.7600767; Tsukamoto K, 2001, BIOCHEM BIOPH RES CO, V287, P757, DOI 10.1006/bbrc.2001.5575; van Duyl BY, 2003, FEBS LETT, V547, P101, DOI 10.1016/S0014-5793(03)00678-1; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vyas KA, 2001, BIOL CHEM, V382, P241, DOI 10.1515/BC.2001.031; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574	66	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31778	31789		10.1074/jbc.M602566200	http://dx.doi.org/10.1074/jbc.M602566200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16936325	Green Published, Bronze			2022-12-27	WOS:000241235300065
J	Duan, XY; Liang, YY; Feng, XH; Lin, X				Duan, Xueyan; Liang, Yao-Yun; Feng, Xin-Hua; Lin, Xia			Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; IDENTIFICATION; DEGRADATION; CELLS	Bone morphogenetic proteins (BMPs) are secreted polypeptides belonging to the transforming growth factor-ss(TGF-ss) superfamily that activates a broad range of biological responses in the metazoan organism. The BMP-initiated signaling pathway is under tight control by processes including regulation of the ligands, the receptors, and the key downstream intracellular effector Smads. A critical point of control in BMP signaling is the phosphorylation of Smad1, Smad5, and Smad8 in their C-terminal SXS motif. Although such phosphorylation, which is mediated by the type I BMP receptor kinases in response to BMP stimulation, iswellcharacterized, biochemical mechanisms underlying Smad dephosphorylation remain to be elucidated. In this study, we have found that PPM1A, a metal ion-dependent protein serine/threonine phosphatase, physically interacts with and dephosphorylates Smad1 both in vitro and in vivo. Functionally, overexpression of PPM1A abolishes BMP-induced transcriptional responses, whereas RNA interference-mediated knockdown of PPM1A enhances BMP signaling. Collectively, our study suggests that PPM1A plays an important role in controlling BMP signaling through catalyzing Smad dephosphorylation.	Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lin, X (corresponding author), Baylor Coll Med, Dept Surg, 1 Baylor Plaza,Rm 139D, Houston, TX 77030 USA.	xialin@bcm.edu			NCI NIH HHS [R01CA108454, R21CA11293] Funding Source: Medline; NIAMS NIH HHS [R01 AR053591-04, R01 AR053591-03, R01 AR053591-01A2, R01 AR053591-02, R01 AR053591, R01 AR053591-05] Funding Source: Medline; NIDDK NIH HHS [R01DK073932] Funding Source: Medline; NIGMS NIH HHS [R01GM63773] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2006, SMAD SIGNAL TRANSDUC, P253; Gilardelli CN, 2004, DEV DYNAM, V230, P494, DOI 10.1002/dvdy.20073; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; MIYAZONO K, 2002, SCI STKE, pE40; Onichtchouk D, 1998, DEVELOPMENT, V125, P1447; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Tres LL, 2004, MOL REPROD DEV, V68, P1, DOI 10.1002/mrd.20056; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009	27	85	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36526	36532		10.1074/jbc.M605169200	http://dx.doi.org/10.1074/jbc.M605169200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16931515	hybrid			2022-12-27	WOS:000242220800008
J	Li, L; Cook, PF				Li, Lei; Cook, Paul F.			The 2 '-phosphate of NADP is responsible for proper orientation of the nicotinamide ring in the oxidative decarboxylation reaction catalyzed by sheep liver 6-phosphogluconate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-UTILIS; SUBSTRATE-BINDING; MECHANISM; ENZYME; COENZYME	Sheep liver 6-phosphogluconate dehydrogenase shows a high specificity for NADP, with a much lower affinity for NAD. Discrimination between NADP and NAD suggests that the interactions between the 2'-phosphate and 6-phosphogluconate dehydrogenase contribute most of the binding energy for NADP. There are three active site residues, Asn-32, Arg-33, and Thr-34, that hydrogen-bond to the 2'-phosphate of NADP according to the crystal structure of the E center dot Nbr(8)ADP complex. In this study alanine mutagenesis was used to probe the contribution of each of the three residues to binding the cofactor and to catalysis. All mutant enzymes exhibit no significant change in V/E-t or K-6PG but an increase in K-NADP that ranges from 6- to 80-fold. All mutant enzymes also exhibit at least a 7-fold increase in the primary kinetic C-13-isotope effect-1, indicating that the decarboxylation step has become more rate-limiting. Data are consistent with significant roles for Asn-32, Arg-33, and Thr-34 in providing binding energy for NADP, and more importantly, the 2 alpha-phosphate of NADP is required for proper orientation of the cofactor to allow rotation about the N-glycosidic bond as it is reduced in the hydride transfer step.	Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Cook, PF (corresponding author), Univ Oklahoma, Dept Chem & Biochem, 620 Parrington Oval, Norman, OK 73019 USA.	pcook@chemdept.chem.ou.edu						ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; BERDIS AJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P551, DOI 10.1006/abbi.1993.1460; BERDIS AJ, 1993, BIOCHEMISTRY-US, V32, P2041, DOI 10.1021/bi00059a022; BERDIS AJ, 1993, BIOCHEMISTRY-US, V32, P2036, DOI 10.1021/bi00059a021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cervellati C, 2005, BIOCHEMISTRY-US, V44, P2432, DOI 10.1021/bi0476679; Chooback L, 1998, PROTEIN EXPRES PURIF, V13, P251, DOI 10.1006/prep.1998.0896; Cleland W W, 1979, Methods Enzymol, V63, P103; COOK PF, 1980, BIOCHEMISTRY-US, V19, P4853, DOI 10.1021/bi00562a023; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; HERMES JD, 1982, BIOCHEMISTRY-US, V21, P5106, DOI 10.1021/bi00263a040; Hwang CC, 1998, BIOCHEMISTRY-US, V37, P15698, DOI 10.1021/bi981288w; Hwang CC, 1998, BIOCHEMISTRY-US, V37, P12596, DOI 10.1021/bi980611s; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; Karsten WE, 1998, BIOCHEMISTRY-US, V37, P15691, DOI 10.1021/bi9812827; Lei Z, 1999, BIOCHEMISTRY-US, V38, P11231, DOI 10.1021/bi990433i; Li L, 2006, J BIOL CHEM, V281, P25568, DOI 10.1074/jbc.M601154200; O'Leary M H, 1980, Methods Enzymol, V64, P83; PARKIN DW, 1991, ENZYME MECH ISOTOPE, P284; Price NE, 1996, ARCH BIOCHEM BIOPHYS, V336, P215, DOI 10.1006/abbi.1996.0551; Tetaud E, 1999, BIOCHEM J, V338, P55, DOI 10.1042/0264-6021:3380055; Weiss PM, 1991, ENZYME MECH ISOTOPE, P291	22	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36803	36810		10.1074/jbc.M604609200	http://dx.doi.org/10.1074/jbc.M604609200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16959777	hybrid			2022-12-27	WOS:000242220800038
J	van Rossum, DB; Patterson, RL; Cheung, KH; Barrow, RK; Syrovatkina, V; Gessell, GS; Burkholder, SG; Watkins, DN; Foskett, JK; Snyder, SH				van Rossum, Damian B.; Patterson, Randen L.; Cheung, King-Ho; Barrow, Roxanne K.; Syrovatkina, Viktoriya; Gessell, Gregory S.; Burkholder, Scott G.; Watkins, D. Neil; Foskett, J. Kevin; Snyder, Solomon H.			DANGER, a novel regulatory protein of inositol 1,4,5-trisphosphate-receptor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHANNEL KINETICS; PURKINJE NEURONS; CALCIUM-RELEASE; CA2+ RELEASE; TRISPHOSPHATE; RECEPTORS; CELLS; INACTIVATION; APOPTOSIS; BINDS	We report the cloning and characterization of DANGER, a novel protein which physiologically binds to inositol 1,4,5-trisphosphate receptors (IP3R). DANGER is a membrane-associated protein predicted to contain a partial MAB-21 domain. It is expressed in a wide variety of neuronal cell lineages where it localizes to membranes in the cell periphery together with IP3R. DANGER interacts with IP3R in vitro and co-immunoprecipitates with IP3R from cellular preparations. DANGER robustly enhances Ca2+-mediated inhibition of IP3R Ca2+ release without affecting IP3 binding in microsomal assays and inhibits gating in single-channel recordings of IP3R. DANGER appears to allosterically modulate the sensitivity of IP3R to Ca2+ inhibition, which likely alters IP3R-mediated Ca2+ dynamics in cells where DANGER and IP3R are co-expressed.	Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Penn State Univ, Sch Med, Dept Physiol, University Pk, PA 16802 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Watkins, David N/I-6113-2013; Foskett, Kevin/R-2549-2019; /B-3424-2011	/0000-0001-8683-1654; van Rossum, Damian/0000-0003-1011-2586; Foskett, J. Kevin/0000-0002-8854-0268	NIDA NIH HHS [DA-00074] Funding Source: Medline; NIDDK NIH HHS [GM/DK-56328] Funding Source: Medline; NIGMS NIH HHS [R01 GM056328] Funding Source: Medline; NIMH NIH HHS [MH-68830] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Hernjak N, 2005, BIOPHYS J, V89, P3790, DOI 10.1529/biophysj.105.065771; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Nagase T, 2001, DNA RES, V8, P319, DOI 10.1093/dnares/8.6.319; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Womack MD, 2000, J GEN PHYSIOL, V115, P339, DOI 10.1085/jgp.115.3.339	17	31	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					37111	37116		10.1074/jbc.M608760200	http://dx.doi.org/10.1074/jbc.M608760200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16990268	hybrid			2022-12-27	WOS:000242220800072
J	Hoe, HS; Tran, TS; Matsuoka, Y; Howell, BW; Rebeck, GW				Hoe, Hyang-Sook; Tran, Tracy S.; Matsuoka, Yasuji; Howell, Brian W.; Rebeck, G. William			DAB1 and Reelin effects on amyloid precursor protein and apoE receptor 2 trafficking and processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; ADAPTER PROTEIN; DISABLED 1; MICE LACKING; F-SPONDIN; FE65; BINDING; LIGAND; DOMAIN; PHOSPHORYLATION	Numerous cytoplasmic adaptor proteins, including JIP1, FE65, and X11 alpha, affect amyloid precursor protein (APP) processing and A beta production. Dab1 is another adaptor protein that interacts with APP as well as with members of the apoE receptor family. We examined the effect of Dab1 on APP and apoEr2 processing in transfected cells and primary neurons. Dab1 interacted with APP and apoEr2 and increased levels of their secreted extracellular domains and their cytoplasmic C-terminal fragments. These effects depended on the NPXY domains of APP and apoEr2 and on the phosphotyrosine binding domain of Dab1 but did not depend on phosphorylation of Dab1. Dab1 decreased the levels of APP beta-C-terminal fragment and secreted A beta. Full-length Dab1 or its phosphotyrosine binding domain alone increased surface levels of APP, as determined by surface protein biotinylation and live cell staining. A ligand for apoEr2, the extracellular matrix protein Reelin, significantly increased the interaction of apoEr2 with Dab1. Surprisingly, we also found that Reelin treatment significantly increased the interaction of APP and Dab1. Moreover, Reelin treatment increased cleavage of APP and apoEr2 and decreased production of the beta-C-terminal fragment of APP and A beta. Together, these data suggest that Dab1 alters trafficking and processing of APP and apoEr2, and this effect is influenced by extracellular ligands.	Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20057 USA; NINDS, Neurogenet Branch, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Rebeck, GW (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	gwr2@georgetown.edu	Rebeck, George William/J-2192-2012; Tran, Tracy/M-2173-2019	Rebeck, George William/0000-0001-6276-248X; Tran, Tracy/0000-0002-2179-5725; Howell, Brian/0000-0002-0204-0773	NIA NIH HHS [K01 AG022455, R01 AG14473] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014473, K01AG022455] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Bar I, 2000, EUR J MORPHOL, V38, P321, DOI 10.1076/ejom.38.5.321.7361; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Guenette SY, 2002, J NEUROCHEM, V82, P755, DOI 10.1046/j.1471-4159.2002.01009.x; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Herrick TM, 2004, MOL BRAIN RES, V126, P121, DOI 10.1016/j.molbrainres.2004.03.022; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1999, MOL CELL BIOL, V19, P5179; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; PARISIADOU L, 2006, IN PRESS NEUROBIOL A; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Pramatarova A, 2003, MOL CELL BIOL, V23, P7210, DOI 10.1128/MCB.23.20.7210-7221.2003; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Taru H, 2002, J BIOL CHEM, V277, P27567, DOI 10.1074/jbc.M203713200; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200	35	126	134	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35176	35185		10.1074/jbc.M602162200	http://dx.doi.org/10.1074/jbc.M602162200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16951405	hybrid			2022-12-27	WOS:000241933700051
J	Nooh, MM; Aziz, RK; Kotb, M; Eroshkin, A; Chuang, WJ; Proft, T; Kansal, R				Nooh, Mohammed M.; Aziz, Ramy K.; Kotb, Malak; Eroshkin, Alexey; Chuang, Woei-Jer; Proft, Thomas; Kansal, Rita			Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; GENOME SEQUENCE; INFECTIONS; PYOGENES; SURFACE; PATHOGENESIS; INVOLVEMENT; PROTEOLYSIS; EXPRESSION; STRAIN	Superantigens (SAgs) play an important role in the pathogenesis of severe invasive infections caused by Group A Streptococcus (GAS). We had shown earlier that the expression of streptococcal cysteine protease SpeB results in partial loss of the immune-stimulating activity of the native secreted GAS SAgs, namely the streptococcal pyrogenic exotoxins produced by the globally disseminated M1T1 GAS strain, associated with invasive infections worldwide. In this study, we examined the susceptibility of each of the M1T1 recombinant SAgs to degradation by rSpeB. Whereas SmeZ was degraded completely within 30 min of incubation with rSpeB, SpeG, and SpeA were more resistant and SpeJ was completely unaffected by the proteolytic effects of this protease. Proteomic analyses demonstrated that the order of susceptibility of the M1T1 SAgs to SpeB proteolysis is unaltered when they are present in a mixture that reflects their native physiological status. As expected, the degradation of SmeZ abolished its immune stimulatory activity. In silico sequence disorder and structural analyses revealed that SmeZ, unlike the three other structurally related SAgs, possesses a putative SpeB cleavage site within an area of the protein likely to be exposed to the surface. The study provides evidence for the effect of subtle structural differences between highly similar SAgs on their biological activity.	Vet Affairs Med Ctr, Res Ctr, Res Serv 151, Memphis, TN 38104 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; Burnham Inst, La Jolla, CA 92037 USA; Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan; Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Sanford Burnham Prebys Medical Discovery Institute; National Cheng Kung University; University of Auckland	Kansal, R (corresponding author), Vet Affairs Med Ctr, Res Ctr, Res Serv 151, 1030 Jefferson Ave, Memphis, TN 38104 USA.	rkansal@utmem.edu	Proft, Thomas/H-4686-2019; Aziz, Ramy/B-2918-2009	Proft, Thomas/0000-0002-9275-5042; Nooh, Mohammed/0000-0001-9794-4099; Aziz, Ramy/0000-0002-4448-7100	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040198] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Basma H, 1999, INFECT IMMUN, V67, P1871; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; CHERCHI GB, 1992, EUR J CLIN MICROBIOL, V11, P836, DOI 10.1007/BF01960886; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Collin M, 2003, INFECT IMMUN, V71, P2983, DOI 10.1128/IAI.71.6.2983-2992.2003; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; HUBBARD SJ, 1994, PROTEIN SCI, V3, P757; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; Kansal RG, 2003, J INFECT DIS, V187, P398, DOI 10.1086/368022; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Kim SW, 2004, J NEUROPSYCH CLIN N, V16, P252, DOI 10.1176/appi.neuropsych.16.3.252; KOTB M, 1995, CLIN MICROBIOL REV, V8, P411, DOI 10.1128/CMR.8.3.411; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; Norrby-Teglund A, 2000, J MED MICROBIOL, V49, P849, DOI 10.1099/0022-1317-49-10-849; Norrby-Teglund A, 2001, J INFECT DIS, V184, P853, DOI 10.1086/323443; NorrbyTeglund A, 1996, J IMMUNOL, V156, P3057; Proft T, 2003, EMERG INFECT DIS, V9, P1211; Proft T, 1999, J EXP MED, V189, P89, DOI 10.1084/jem.189.1.89; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; Rasmussen M, 1999, J BIOL CHEM, V274, P15336, DOI 10.1074/jbc.274.22.15336; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; SCHLIEVERT PM, 1993, J INFECT DIS, V167, P997, DOI 10.1093/infdis/167.5.997; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Unnikrishnan M, 2002, J IMMUNOL, V169, P2561, DOI 10.4049/jimmunol.169.5.2561; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; WATANABEOHNISHI R, 1995, J INFECT DIS, V171, P74, DOI 10.1093/infdis/171.1.74; Yang L, 2005, J CLIN MICROBIOL, V43, P3570, DOI 10.1128/JCM.43.7.3570-3573.2005; YU CE, 1989, INFECT IMMUN, V57, P3715, DOI 10.1128/IAI.57.12.3715-3719.1989	39	23	23	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35281	35288		10.1074/jbc.M605544200	http://dx.doi.org/10.1074/jbc.M605544200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16980693	hybrid			2022-12-27	WOS:000241933700062
J	Kvist, AJ; Johnson, AE; Morgelin, M; Gustafsson, E; Bengtsson, E; Lindblom, K; Aszodi, A; Fassler, R; Sasaki, T; Timpl, R; Aspberg, A				Kvist, Alexander J.; Johnson, Anna E.; Moergelin, Matthias; Gustafsson, Erika; Bengtsson, Eva; Lindblom, Karin; Aszodi, Attila; Faessler, Reinhard; Sasaki, Takako; Timpl, Rupert; Aspberg, Anders			Chondroitin sulfate perlecan enhances collagen fibril formation - Implications for perlecan chondrodysplasias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWARTZ-JAMPEL-SYNDROME; GLYCOSAMINOGLYCAN MODIFICATION; MATRIX PROTEIN; II COLLAGEN; CHONDROGENIC ACTIVITY; DERMATAN SULFATE; DOMAIN V; PROTEOGLYCAN; CARTILAGE; INHIBITION	Inactivation of the perlecan gene leads to perinatal lethal chondrodysplasia. The similarity to the phenotypes of the Col2A1 knock-out and the disproportionate micromelia mutation suggests perlecan involvement in cartilage collagen matrix assembly. We now present a mechanism for the defect in collagen type II fibril assembly by perlecan-null chondrocytes. Cartilage perlecan is a heparin sulfate or a mixed heparan sulfate/ chondroitin sulfate proteoglycan. The latter form binds collagen and accelerates fibril formation in vitro, with more defined fibril morphology and increased fibril diameters produced in the presence of perlecan. Interestingly, the enhancement of collagen fibril formation is independent on the core protein and is mimicked by chondroitin sulfate E but neither by chondroitin sulfate D nor dextran sulfate. Furthermore, perlecan chondroitin sulfate contains the 4,6-disulfated disaccharides typical for chondroitin sulfate E. Indeed, purified glycosaminoglycans from perlecan-enriched fractions of cartilage extracts contain elevated levels of 4,6-disulfated chondroitin sulfate disaccharides and enhance collagen fibril formation. The effect on collagen assembly is proportional to the content of the 4,6- disulfated disaccharide in the different cartilage extracts, with growth plate cartilage glycosaminoglycan being the most efficient enhancer. These findings demonstrate a role for perlecan chondroitin sulfate side chains in cartilage extracellular matrix assembly and provide an explanation for the perlecan-null chondrodysplasia.	Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Lund University; Lund University; Max Planck Society	Aspberg, A (corresponding author), Univ Copenhagen, Inst Mol Biol & Physiol, August Krogh Bldg,Univ Parken 13, DK-2100 Copenhagen OE, Denmark.	aaspberg@aki.ku.dk	Bengtsson, Eva/AGH-2754-2022; Bengtsson, Eva/AAA-1968-2019	Bengtsson, Eva/0000-0001-7075-1772; Aspberg, Anders/0000-0002-6588-6944				Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Arikawa-Hirasawa E, 2002, AM J HUM GENET, V70, P1368, DOI 10.1086/340390; Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; Costell M, 1997, EUR J BIOCHEM, V243, P115, DOI 10.1111/j.1432-1033.1997.t01-1-00115.x; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Couchman JR, 1996, J BIOL CHEM, V271, P9595, DOI 10.1074/jbc.271.16.9595; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; French MM, 1999, J CELL BIOL, V145, P1103, DOI 10.1083/jcb.145.5.1103; French MM, 2002, J BONE MINER RES, V17, P48, DOI 10.1359/jbmr.2002.17.1.48; Friedrich MVK, 1999, J MOL BIOL, V294, P259, DOI 10.1006/jmbi.1999.3259; GAVRIEL P, 1988, BIOCHEMISTRY-US, V27, P2811, DOI 10.1021/bi00408a022; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Govindraj P, 2002, J BIOL CHEM, V277, P19461, DOI 10.1074/jbc.M200786200; GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901; Gustafsson E, 2003, ANN NY ACAD SCI, V995, P140, DOI 10.1111/j.1749-6632.2003.tb03217.x; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEINEGARD D, 1987, METHOD ENZYMOL, V144, P319; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; JACKSON D. S., 1967, METHODS BIOCHEM ANAL, V15, P25, DOI 10.1002/9780470110331.ch2; KUIJER R, 1988, CONNECT TISSUE RES, V17, P83, DOI 10.3109/03008208809015022; Lauder RM, 2000, GLYCOBIOLOGY, V10, P393, DOI 10.1093/glycob/10.4.393; MACBEATH JRE, 1993, J BIOL CHEM, V268, P19826; MATHEWS MB, 1968, BIOCHEM J, V109, P517, DOI 10.1042/bj1090517; Mo JA, 1996, J IMMUNOL, V157, P2440; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; OBRINK B, 1973, EUR J BIOCHEM, V34, P129, DOI 10.1111/j.1432-1033.1973.tb02739.x; Roden L., 1972, METHODS ENZYMOLOGY, V28, P73; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Sasaki T, 1998, FEBS LETT, V435, P169, DOI 10.1016/S0014-5793(98)01063-1; Sasaki T, 2002, EUR J BIOCHEM, V269, P431, DOI 10.1046/j.0014-2956.2001.02663.x; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; Takagaki K, 2002, J BIOL CHEM, V277, P8882, DOI 10.1074/jbc.M106479200; Tapanadechopone P, 1999, BIOCHEM BIOPH RES CO, V265, P680, DOI 10.1006/bbrc.1999.1714; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; WOOD GC, 1960, BIOCHEM J, V75, P605, DOI 10.1042/bj0750605; Zaucke F, 2001, BIOCHEM J, V358, P17, DOI 10.1042/0264-6021:3580017	47	81	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33127	33139		10.1074/jbc.M607892200	http://dx.doi.org/10.1074/jbc.M607892200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956876	hybrid			2022-12-27	WOS:000241621400021
J	Moore, LJ; Mettert, EL; Kiley, PJ				Moore, Laura J.; Mettert, Erin L.; Kiley, Patricia J.			Regulation of FNR dimerization by subunit charge repulsion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FNR; CAMP RECEPTOR PROTEIN; ESCHERICHIA-COLI; DNA-BINDING; 4FE-4S CLUSTER; OXYGEN; COOA; SULFUR; MUTANT; INTERSUBUNIT	Dimerization of the global anaerobic transcription factor FNR is essential for FNR activity. Under aerobic conditions FNR is an inactive monomeric species because it lacks the oxygen labile [4Fe-4S] cluster required for dimerization. In this study, we investigated the protein side chains that inhibit FNR dimerization under aerobic conditions. Substitution of Asp(154) within the predicted dimerization helix with residues containing neutral or positively charged side chains increased FNR activity under aerobic conditions, whereas replacement of Asp(154) with Glu inhibited FNR activity similar to WT-FNR. Similar results were obtained when making analogous substitutions of Glu(150). In vitro analysis of representative FNR mutant proteins indicated that their increased activity under aerobic conditions resulted from an [4Fe-4S] independent mechanism of dimerization. In addition, simultaneous substitution of residues 150 and 154 with Lys restored inhibition of FNR activity under aerobic growth conditions. Collectively, these data indicate that charge repulsion by side chains at positions 150 and 154 is necessary to inhibit dimerization under aerobic conditions. They also suggest that a [4Fe-4S]-dependent conformational change overcomes charge repulsion between subunits under anaerobic conditions. Comparison of the trypsin sensitivity of [4Fe-4S]-FNR and apoFNR indicated that there are no major differences in protease sensitivity between these forms, whereas circular dichroism suggested that small changes in secondary structure occur between the cluster-containing FNR and apoFNR. Thus, the [4Fe-4S]-dependent conformational change necessary to overcome inter-subunit charge repulsion and create a subunit interface more favorable for dimerization must be small.	Monmouth Coll, Dept Chem, Monmouth, IL 61462 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	Monmouth College; University of Wisconsin System; University of Wisconsin Madison	Moore, LJ (corresponding author), 700 E Broadway, Monmouth, IL 61462 USA.	lmoore@monm.edu		Kiley, Patricia/0000-0002-8771-1782	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045844] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45844, GM19792] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyama S, 2004, J MOL BIOL, V341, P651, DOI 10.1016/j.jmb.2004.06.040; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bates DM, 2000, J BIOL CHEM, V275, P6234, DOI 10.1074/jbc.275.9.6234; BATES DM, 1995, J BACTERIOL, V177, P3972, DOI 10.1128/jb.177.14.3972-3978.1995; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BROWN AM, 1989, P NATL ACAD SCI USA, V86, P7387, DOI 10.1073/pnas.86.19.7387; CHENG XD, 1993, BIOCHEMISTRY-US, V32, P8130, DOI 10.1021/bi00083a011; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; Dong AC, 2002, BIOCHEMISTRY-US, V41, P6660, DOI 10.1021/bi020036z; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; EILEN E, 1978, BIOCHEMISTRY-US, V17, P2469, DOI 10.1021/bi00606a001; Green J, 1996, BIOCHEM J, V316, P887, DOI 10.1042/bj3160887; Guest John R., 1996, P317; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; Kerby RL, 2003, J MOL BIOL, V325, P809, DOI 10.1016/S0022-2836(02)01203-2; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; KHOROSHILOVA N, 1995, P NATL ACAD SCI USA, V92, P2499, DOI 10.1073/pnas.92.7.2499; KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; LAZAZZERA BA, 1993, GENE DEV, V7, P1993, DOI 10.1101/gad.7.10.1993; LEE FJ, 1994, NUCLEIC ACIDS RES, V22, P2894; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Mettert EL, 2005, J MOL BIOL, V354, P220, DOI 10.1016/j.jmb.2005.09.066; Moore LJ, 2001, J BIOL CHEM, V276, P45744, DOI 10.1074/jbc.M106569200; MOUSSET S, 1969, NATURE, V221, P242, DOI 10.1038/221242a0; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Patschkowski T, 2000, BACTERIAL STRESS RESPONSES, P61; Popescu CV, 1998, P NATL ACAD SCI USA, V95, P13431, DOI 10.1073/pnas.95.23.13431; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Shi Y, 2000, BIOCHEMISTRY-US, V39, P7300, DOI 10.1021/bi000225m; Shi Y, 1999, J BIOL CHEM, V274, P6946, DOI 10.1074/jbc.274.11.6946; Sutton VR, 2004, BIOCHEMISTRY-US, V43, P791, DOI 10.1021/bi0357053; Sutton VR, 2003, METHOD ENZYMOL, V370, P300; WEBER IT, 1987, BIOCHEMISTRY-US, V26, P343, DOI 10.1021/bi00376a003; Won HS, 2000, BIOCHEMISTRY-US, V39, P13953, DOI 10.1021/bi000012x; Yamashita T, 2004, J BIOL CHEM, V279, P47320, DOI 10.1074/jbc.M407766200; Youn H, 2006, J BIOL CHEM, V281, P1119, DOI 10.1074/jbc.M509421200	42	33	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33268	33275		10.1074/jbc.M608331200	http://dx.doi.org/10.1074/jbc.M608331200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959764	hybrid			2022-12-27	WOS:000241621400036
J	Nomiyama, T; Nakamachi, T; Gizard, F; Heywood, EB; Jones, KL; Ohkura, N; Kawamori, R; Conneely, OM; Bruemmer, D				Nomiyama, Takashi; Nakamachi, Takafumi; Gizard, Florence; Heywood, Elizabeth B.; Jones, Karrie L.; Ohkura, Naganari; Kawamori, Ryuzo; Conneely, Orla M.; Bruemmer, Dennis			The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; MINICHROMOSOME MAINTENANCE PROTEINS; NGFI-B; TRANSCRIPTIONAL REGULATION; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; NURR1; ATHEROSCLEROSIS; KINASE; ACTIVATION	Members of the nuclear hormone receptor superfamily function as key transcriptional regulators of inflammation and proliferation in cardiovascular diseases. In addition to the ligand-dependent peroxisome proliferator-activated receptors and liver X receptors, this family of transcription factors includes a large number of orphan receptors, and their role in vascular diseases remains to be investigated. The neuron-derived orphan receptor-1 (NOR1) belongs to the ligand-independent NR4A subfamily, which has been implicated in cell proliferation, differentiation, and apoptosis. In this study, we demonstrate NOR1 expressionin vascular smooth muscle cells (SMC) of human atherosclerotic lesions. In response to mitogenic stimulation with platelet-derived growth factor ( PDGF), SMC rapidly express NOR1 through an ERK-MAPK-dependent signaling pathway. 5'- Deletion analysis, site-directed mutagenesis, and transactivation experiments demonstrate that PDGF-induced NOR1 expression is mediated through a cAMP-response element-binding protein (CREB)-dependent transactivation of the NOR1 promoter. Consequently, short interfering RNA mediated depletion of CREB abolished PDGF-induced NOR1 expression in SMC. Furthermore, PDGF induced Ser-133 phosphorylation of CREB and subsequent binding to the CRE sites of the endogenous NOR1 promoter. Functional analysis demonstrated that PDGF induces NOR1 transactivation of its consensus NGFI-B-response elements (NBRE) in SMC. We finally demonstrate that SMC isolated from NOR1-deficient mice exhibit decreased cell proliferation and characterize cyclin D1 and D2 as NOR1 target genes in SMC. These experiments indicate that PDGF-induced NOR1 transcription in SMC is mediated through CREB-dependent transactivation of the NOR1 promoter and further demonstrate that NOR1 functions as a key transcriptional regulator of SMC proliferation.	Univ Kentucky, Coll Med, Div Endocrinol & Mol Med, Lexington, KY 40536 USA; Natl Canc Ctr, Tumor Endocrinol Project, Tokyo 1040045, Japan; Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Tokyo 1138421, Japan; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Kentucky; National Cancer Center - Japan; Juntendo University; Baylor College of Medicine	Bruemmer, D (corresponding author), Wethington Hlth Sci Bldg,Rm 575,900 S Limestone S, Lexington, KY 40536 USA.	Dennis.Bruemmer@uky.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084611] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL084611-01, R01 HL084611] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Bornfeldt KE, 1995, ANN NY ACAD SCI, V766, P416, DOI 10.1111/j.1749-6632.1995.tb26691.x; Bruemmer D, 2005, INT J OBESITY, V29, pS26, DOI 10.1038/sj.ijo.0802910; Bruemmer D, 2003, AM J MED, V115, P87, DOI 10.1016/j.amjmed.2003.09.014; Bruemmer D, 2003, EXP CELL RES, V290, P28, DOI 10.1016/S0014-4827(03)00311-2; Bruemmer D, 2003, CIRC RES, V93, pE38, DOI 10.1161/01.RES.0000088344.15288.E6; Bruemmer D, 2003, MOL ENDOCRINOL, V17, P1005, DOI 10.1210/me.2002-0410; Bruemmer D, 2003, EUR J PHARMACOL, V466, P225, DOI 10.1016/S0014-2999(03)01556-5; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Castro DS, 2001, J BIOL CHEM, V276, P43277, DOI 10.1074/jbc.M107013200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Codina A, 2004, J BIOL CHEM, V279, P53338, DOI 10.1074/jbc.M409096200; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Gennaro G, 2004, CIRCULATION, V110, P3367, DOI 10.1161/01.CIR.0000147773.86866.CD; GORDON D, 1990, P NATL ACAD SCI USA, V87, P4600, DOI 10.1073/pnas.87.12.4600; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Hsueh WA, 2004, HYPERTENSION, V43, P297, DOI 10.1161/01.HYP.0000113626.76571.5b; Hu YH, 2000, ARTERIOSCL THROM VAS, V20, P18, DOI 10.1161/01.ATV.20.1.18; Inuzuka H, 2002, FEBS LETT, V522, P88, DOI 10.1016/S0014-5793(02)02890-9; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Laffitte Bryan A, 2002, Curr Atheroscler Rep, V4, P213; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Law RE, 1996, J CLIN INVEST, V98, P1897, DOI 10.1172/JCI118991; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; MARUYAMA K, 1995, CANCER LETT, V96, P117, DOI 10.1016/0304-3835(95)03921-I; Maruyama K, 1998, INT J ONCOL, V12, P1237; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mii S, 1996, AM J PHYSIOL-HEART C, V270, pH142, DOI 10.1152/ajpheart.1996.270.1.H142; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Ohkubo T, 2000, MOL CELL ENDOCRINOL, V162, P151, DOI 10.1016/S0303-7207(00)00222-7; Ohkura N, 1996, BBA-GENE STRUCT EXPR, V1308, P205, DOI 10.1016/0167-4781(96)00101-7; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; Ohkura N, 1998, GENE, V211, P79, DOI 10.1016/S0378-1119(98)00095-X; Ohkura N, 1999, BBA-GENE STRUCT EXPR, V1444, P69, DOI 10.1016/S0167-4781(98)00247-4; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Pirih FQ, 2003, BIOCHEM BIOPH RES CO, V306, P144, DOI 10.1016/S0006-291X(03)00931-8; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; Ponnio T, 2002, MOL CELL BIOL, V22, P935, DOI 10.1128/MCB.22.3.935-945.2002; Pugazhenthi S, 1999, J BIOL CHEM, V274, P2829, DOI 10.1074/jbc.274.5.2829; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Rius J, 2004, ARTERIOSCL THROM VAS, V24, P697, DOI 10.1161/01.ATV.0000121570.00515.dc; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Tokunou T, 2003, CIRCULATION, V108, P1246, DOI 10.1161/01.CIR.0000085164.13439.89; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Watson PA, 2002, ENDOCRINOLOGY, V143, P2922, DOI 10.1210/en.143.8.2922; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Xiong W, 1997, AM J PHYSIOL-LUNG C, V272, pL1205, DOI 10.1152/ajplung.1997.272.6.L1205; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656	60	99	104	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33467	33476		10.1074/jbc.M603436200	http://dx.doi.org/10.1074/jbc.M603436200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16945922	Green Accepted, hybrid			2022-12-27	WOS:000241621400057
J	Denti, S; Fernandez-Sanchez, ME; Rogge, L; Bianchi, E				Denti, Simona; Fernandez-Sanchez, Maria Elena; Rogge, Lars; Bianchi, Elisabetta			The COP9 signalosome regulates Skp2 levels and proliferation of human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; UBIQUITIN-LIGASE; CAENORHABDITIS-ELEGANS; FISSION YEAST; CYCLIN-E; DROSOPHILA-MELANOGASTER; DNA-DAMAGE; S-PHASE; DEGRADATION; COMPLEX	The COP9 signalosome (CSN) is a conserved, multisubunit complex first identified as a developmental regulator in plants. Gene inactivation of single CSN subunits results in early embryonic lethality in mice, indicating that the CSN is essential for mammalian development. The pleiotropic function of the CSN may be related to its ability to remove the ubiquitin-like peptide Nedd8 from cullin-RING ubiquitin ligases, such as the SCF complex, and therefore regulate their activity. However, the mechanism of CSN regulatory action on cullins has been debated, since, paradoxically, the CSN has an inhibitory role in vitro, while genetic evidence supports a positive regulatory role in vivo. We have targeted expression of CSN subunits 4 and 5 in human cells by lentivirus-mediated small hairpin RNA delivery. Down-regulation of either subunit resulted in disruption of the CSN complex and in Cullin1 hyperneddylation. Functional consequences of CSN down-regulation were decreased protein levels of Skp2, the substrate recognition subunit of SCFSkp2, and stabilization of a Skp2 target, the cyclin-dependent kinase inhibitor p27Kip1. CSN down-regulation caused an impairment in cell proliferation, which could be partially reversed by suppression of p27Kip1. Moreover, restoring Skp2 levels in CSN-deficient cells recovered cell cycle progression, indicating that loss of Skp2 in these cells plays an important role in their proliferation defect. Our data indicate that the CSN is necessary to ensure the assembly of a functional SCFSkp2 complex and therefore contributes to cell cycle regulation of human cells.	Inst Pasteur, Immunoregulat Lab, Dept Immunol, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bianchi, E (corresponding author), Inst Pasteur, Immunoregulat Lab, Dept Immunol, 25 Rue Dr Roux, F-75724 Paris, France.	ebianchi@pasteur.fr	Rogge, Lars/GYJ-6142-2022	Rogge, Lars/0000-0003-1262-9204; Fernandez Sanchez, Maria Elena/0000-0001-8083-8863				Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; CLANDININ TR, 1993, GENETICS, V134, P199; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Dohmann EMN, 2005, PLANT CELL, V17, P1967, DOI 10.1105/tpc.105.032870; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Fukumoto A, 2005, FEBS LETT, V579, P1047, DOI 10.1016/j.febslet.2004.12.076; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gemmill RM, 2005, ONCOGENE, V24, P3503, DOI 10.1038/sj.onc.1208509; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; Oron E, 2002, DEVELOPMENT, V129, P4399; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Qian X, 2005, BIOCHEM J, V389, P389, DOI 10.1042/BJ20050297; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Srayko M, 2000, GENE DEV, V14, P1072; Staub JM, 1996, PLANT CELL, V8, P2047, DOI 10.1105/tpc.8.11.2047; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	56	60	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32188	32196		10.1074/jbc.M604746200	http://dx.doi.org/10.1074/jbc.M604746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943200	hybrid			2022-12-27	WOS:000241414500016
J	He, HJ; Zhu, TN; Xie, Y; Fan, JS; Kole, S; Saxena, S; Bernier, M				He, Hua-Jun; Zhu, Tie-Nian; Xie, Yi; Fan, Jinshui; Kole, Sutapa; Saxena, Satya; Bernier, Michel			Pyrrolidine dithiocarbamate inhibits interleukin-6 signaling through impaired STAT3 activation and association with transcriptional coactivators in hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN ENDOTHELIAL-CELLS; C/EBP-BETA; INSULIN-RESISTANCE; OXIDATIVE STRESS; GENE-EXPRESSION; DNA-BINDING; ALPHA(2)-MACROGLOBULIN GENE; TYROSINE PHOSPHORYLATION; HAPTOGLOBIN GENE	Interleukin (IL)-6 is a proinflammatory cytokine that has been implicated in the expression of acute phase plasma proteins and hepatic insulin resistance through activation of the JAK/STAT3 pathway. Although previous studies have demonstrated that pyrrolidine dithiocarbamate (PDTC) exerts protection against inflammatory responses, its role in the regulation of IL-6 receptor signaling remains unclear. Here we show that treatment of cultured HepG2 hepatoma cells with PDTC inhibits IL-6-stimulated tyrosine phosphorylation and subsequent nuclear translocation of STAT3 in a dose- and time-dependent fashion. No inhibition of JAK-1 activity was observed. To provide insight into PDTC signaling, we constructed a conditionally active STAT3 by fusing it with the ligand binding domain of the estrogen receptor (STAT3-ER). In the presence of 4-hydroxytamoxifen STAT3-ER was translocated in the nucleus of HepG2 cells in a phosphorylation-independent manner, and treatment with PDTC mitigated the response. Although STAT3 coprecipitated with heat-shock protein 90 (Hsp90) in control cells, coprecipitation of the two proteins was greatly reduced after PDTC treatment or after exposure to geldanamycin, an Hsp90 inhibitor. As a result there was a decrease in IL-6-induced association of STAT3 with the transcriptional coactivators FOXO1a and C/EBP beta together with significant reduction in the expression of SOCS-3 protein and that of two major acute phase plasma proteins. Importantly, treatment of HepG2 cells and a primary culture of rat hepatocytes with PDTC restored insulin responsiveness that was abrogated by IL-6. These studies are consistent with the ability of PDTC to down-regulate IL-6-induced STAT3 activation by altering the stability of STAT3-Hsp90 complex.	NIA, Diabet Sect, Clin Invest Lab, NIH, Baltimore, MD 21224 USA; NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA; NIA, Proteom & Mass Spectrometry Unit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bernier, M (corresponding author), NIA, Diabet Sect, Clin Invest Lab, NIH, Box 23,5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	Bernierm@mail.nih.gov	Bernier, Michel/Y-7139-2019; Bernier, Michel/AAO-3983-2021	Bernier, Michel/0000-0002-5948-368X	NATIONAL INSTITUTE ON AGING [ZIAAG000892, Z01AG000892] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; BAUMANN H, 1990, MOL CELL BIOL, V10, P5967, DOI 10.1128/MCB.10.11.5967; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Bogojevic D, 2003, GEN PHYSIOL BIOPHYS, V22, P279; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bruck R, 2004, LIVER INT, V24, P169, DOI 10.1111/j.1478-3231.2004.00900.x; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Gatto L, 2004, J BIOL CHEM, V279, P13746, DOI 10.1074/jbc.M308999200; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Johnston AM, 2003, FEBS LETT, V546, P32, DOI 10.1016/S0014-5793(03)00438-1; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kido Y, 2001, J CLIN ENDOCR METAB, V86, P972, DOI 10.1210/jc.86.3.972; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim HK, 1997, J BIOL CHEM, V272, P14571, DOI 10.1074/jbc.272.23.14571; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kortylewski M, 2003, J BIOL CHEM, V278, P5242, DOI 10.1074/jbc.M205403200; Krasilnikov M, 2003, ONCOGENE, V22, P4092, DOI 10.1038/sj.onc.1206598; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Marette A, 2002, CURR OPIN CLIN NUTR, V5, P377, DOI 10.1097/00075197-200207000-00005; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Milocco LH, 1999, MOL CELL BIOL, V19, P2913; Milosavljevic T, 2003, GEN PHYSIOL BIOPHYS, V22, P181; Milosavljevic TS, 2002, BIOCHEMISTRY-MOSCOW+, V67, P918, DOI 10.1023/A:1019922805828; Munoz C, 1996, J IMMUNOL, V157, P3587; Munoz C, 1996, BLOOD, V88, P3482, DOI 10.1182/blood.V88.9.3482.bloodjournal8893482; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; PAJOVIC S, 1994, J BIOL CHEM, V269, P2215; Pilipuk GP, 2003, J BIOL CHEM, V278, P35668, DOI 10.1074/jbc.M305182200; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Sato N, 2003, BIOCHEM BIOPH RES CO, V300, P847, DOI 10.1016/S0006-291X(02)02941-8; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Streetz KL, 2003, GASTROENTEROLOGY, V125, P532, DOI 10.1016/S0016-5085(03)00901-6; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Tsuchihashi S, 2003, SURGERY, V133, P556, DOI 10.1067/msy.2003.124; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; Waris G, 2005, J VIROL, V79, P1569, DOI 10.1128/JVI.79.3.1569-1580.2005; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	67	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31369	31379		10.1074/jbc.M603762200	http://dx.doi.org/10.1074/jbc.M603762200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16926159				2022-12-27	WOS:000241235300021
J	Ikeda, K; Maegawa, H; Ugi, S; Tao, Y; Nishio, Y; Tsukada, S; Maeda, S; Kashiwagi, A				Ikeda, Kazuhiro; Maegawa, Hiroshi; Ugi, Satoshi; Tao, Yukari; Nishio, Yoshihiko; Tsukada, Shuichi; Maeda, Shiro; Kashiwagi, Atsunori			Transcription factor activating enhancer-binding protein-2 beta - A negative regulator of adiponectin gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-SPECIFIC PROTEIN; FATTY-ACID OXIDATION; CAUSE CHAR-SYNDROME; FACTOR AP-2; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; PLASMA-CONCENTRATIONS; MAMMARY-CARCINOMA; ALPHA GENE; HTLV-I	We previously reported the association between the activating enhancer-binding protein-2 beta (AP-2 beta) transcription factor gene and type 2 diabetes. This gene is preferentially expressed in adipose tissue, and subjects with the disease-susceptible allele of AP-2 beta showed stronger expression in adipose tissue than those without the susceptible allele. Furthermore, overexpression of AP-2 beta leads to lipid accumulation by enhancing glucose transport and inducing insulin resistance in 3T3-L1 adipocytes. In this study we demonstrated that overexpression of AP-2 beta in 3T3-L1 adipocytes decreased the expression and secretion of adiponectin and increased those of interleukin-6 (IL-6). Interestingly, the effects of AP-2 beta on the expressions of adiponectin and IL-6 and the mechanisms by which AP-2 beta modulated their expressions were different. We found that the promoter activity of adiponectin gene was inhibited by AP-2 beta overexpression and enhanced by knockdown of endogenous AP-2 beta, whereas IL-6 was unaffected. Electrophoretic mobility shift assays revealed the existence of putative responsive elements for AP-2 beta and NF-YA in human and mouse adiponectin promoter regions, and mutation of this AP-2 beta binding site abolished the inhibitory effect of AP-2 beta. Furthermore, chromatin immunoprecipitation assays demonstrated that AP-2 beta and NF-YA competitively bind to the same region of the adiponectin promoter. Our results clearly demonstrated that AP-2 beta directly inhibits adiponectin gene expression by displacing NF-YA and binding to its promoter. We conclude that AP-2 beta might modulate the expression of adiponectin by directly inhibiting its transcriptional activity.	Shiga Univ Med Sci, Dept Med, Div Endocrinol & Metab, Shiga 5202192, Japan; Inst Phys & Chem Res, Lab Diabet Nephrol, SNP Res Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Shiga University of Medical Science; RIKEN	Maegawa, H (corresponding author), Shiga Univ Med Sci, Dept Med, Div Endocrinol & Metab, Shiga 5202192, Japan.	maegawa@belle.shiga-med.ac.jp	Kashiwagi, Atsunori/H-8712-2019	Maegawa, Hiroshi/0000-0002-4611-8149				Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Azuma K, 2003, OBES RES, V11, P997, DOI 10.1038/oby.2003.137; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; Bosher JM, 1996, ONCOGENE, V13, P1701; DUAN CM, 1995, J BIOL CHEM, V270, P24844, DOI 10.1074/jbc.270.42.24844; Egawa K, 1999, J BIOL CHEM, V274, P14306, DOI 10.1074/jbc.274.20.14306; Egawa K, 2001, J BIOL CHEM, V276, P10207, DOI 10.1074/jbc.M009489200; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; FRISCH SM, 1990, MOL CELL BIOL, V10, P6524, DOI 10.1128/MCB.10.12.6524; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Hashimoto T, 2005, J BIOL CHEM, V280, P1893, DOI 10.1074/jbc.M410759200; Hosoda K, 1996, BIOCHEM BIOPH RES CO, V221, P234, DOI 10.1006/bbrc.1996.0579; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; Kadowaki T, 2003, EXP BIOL MED, V228, P1111, DOI 10.1177/153537020322801003; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; Matsuzawa Yuji, 2005, Semin Vasc Med, V5, P34, DOI 10.1055/s-2005-871744; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; MOSER M, 1995, DEVELOPMENT, V121, P2779; MUCHARDT C, 1992, NEW BIOL, V4, P541; MUCHARDT C, 1992, EMBO J, V11, P2573, DOI 10.1002/j.1460-2075.1992.tb05322.x; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; PERKINS ND, 1994, J VIROL, V68, P6820, DOI 10.1128/JVI.68.10.6820-6823.1994; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Seo JB, 2004, J BIOL CHEM, V279, P22108, DOI 10.1074/jbc.M400238200; Tao Y, 2006, ENDOCRINOLOGY, V147, P1685, DOI 10.1210/en.2005-1304; Tsukada S, 2006, MOL ENDOCRINOL, V20, P1104, DOI 10.1210/me.2005-0311; Tummala R, 2003, GENE, V321, P93, DOI 10.1016/S0378-1119(03)00840-0; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Wang DY, 1997, J BIOL CHEM, V272, P14244, DOI 10.1074/jbc.272.22.14244; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhao F, 2001, J BIOL CHEM, V276, P40755, DOI 10.1074/jbc.M106284200; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410	46	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31245	31253		10.1074/jbc.M605132200	http://dx.doi.org/10.1074/jbc.M605132200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16954217				2022-12-27	WOS:000241235300009
J	Bhattacharjee, RN; Park, KS; Kumagai, Y; Okada, K; Yamamoto, M; Uematsu, S; Matsui, K; Kumar, H; Kawai, T; Iida, T; Honda, T; Takeuchi, O; Akira, S				Bhattacharjee, Rabindra N.; Park, Kwon-Sam; Kumagai, Yutaro; Okada, Kazuhisa; Yamamoto, Masahiro; Uematsu, Satoshi; Matsui, Kosuke; Kumar, Himanshu; Kawai, Taro; Iida, Tetsuya; Honda, Takeshi; Takeuchi, Osamu; Akira, Shizuo			VP1686, a Vibrio type III secretion protein, induces Toll-like receptor-independent apoptosis in macrophage through NF-kappa B inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; INNATE IMMUNITY; PARAHAEMOLYTICUS; ACTIVATION; EXPRESSION; TOLL-LIKE-RECEPTOR-4; SUPPRESSION; INDUCTION; CHOLERAE; PATHWAY	Vibrio parahaemolyticus, causative agent of human gastrointestinal diseases, possesses several virulent machineries including thermostable direct hemolysin and type III secretion systems (TTSS1 and -2). In this report, we establish that TTSS1-dependent secretion and translocation of a V. parahaemolyticus effector protein VP1686 into the cytosol induces DNA fragmentation in macrophages. We performed yeast two-hybrid screening to identify the molecules involved in VP1686-mediated cell death pathways and showed that nuclear factor RelA p65/NF-kappa B physically interacts with VP1686. To understand the impact of this interaction on the kappa F-kappa B DNA binding activities in infected macrophages, we analyzed a series of deletion mutants for the TTSS and its secreted proteins. Induction of DNA binding activity of NF-kappa B was significantly suppressed, and increased macrophage apoptosis has been associated with V. parahaemolyticus strain, which contains both VP1686 and TTSS1. Macrophages lacking Toll-like receptor adaptor molecules MyD88 (myeloid differentiation primary response protein 88) or TRIF (TIR domain-containing adapter- inducing interferon beta) showed similar sensitivity to VP1686. As a consequence of NF-kappa B suppression, microarray analysis has revealed that VP1686 translocation alerted the expression of many genes that have known functions in cellular responses to apoptosis, cell growth, and transcriptional regulation. Our results suggest an important role for Vibrio effector protein VP1686 that activate a conserved apoptotic pathway in macrophages through suppression of NF-kappa B activation independent of Toll-like receptor signaling.	Osaka Univ, Dept Host Def, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Bacterial Infect, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, Explorat Res Adv Technol, Akira Innate Immun Project, Kunsan 573701, South Korea; Kunsan Natl Univ, Coll Ocean Sci & Technol, Food Sci & Biotechnol Major, Kunsan 573701, South Korea	Osaka University; Osaka University; Kunsan National University	Akira, S (corresponding author), Osaka Univ, Dept Host Def, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Kumar, Himanshu/A-8070-2010; Kumar, Himanshu/J-4494-2012; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/AAG-9359-2019; Kumagai, Yutaro/L-7732-2018; Takeuchi, Osamu/D-6007-2011	Kumar, Himanshu/0000-0001-5246-2694; Takeuchi, Osamu/0000-0002-1260-6232; Kumagai, Yutaro/0000-0002-5039-3979; Kawai, Taro/0000-0001-7510-4662; Okada, Kazuhisa/0000-0002-1225-7933				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bhattacharjee RN, 2005, BIOCHEM BIOPH RES CO, V335, P328, DOI 10.1016/j.bbrc.2005.07.080; Bhattacharjee RN, 2005, FEBS LETT, V579, P6604, DOI 10.1016/j.febslet.2005.10.053; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Haase R, 2003, J IMMUNOL, V171, P4294, DOI 10.4049/jimmunol.171.8.4294; Hauf N, 2003, J IMMUNOL, V170, P2074, DOI 10.4049/jimmunol.170.4.2074; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Park KS, 2005, INFECT IMMUN, V73, P5754, DOI 10.1128/IAI.73.9.5754-5761.2005; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Ruckdeschel K, 2001, J IMMUNOL, V166, P1823, DOI 10.4049/jimmunol.166.3.1823; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	25	58	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36897	36904		10.1074/jbc.M605493200	http://dx.doi.org/10.1074/jbc.M605493200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16984916	hybrid			2022-12-27	WOS:000242220800049
J	Hallay, H; Locker, N; Ayadi, L; Ropers, D; Guittet, E; Branlant, C				Hallay, Houda; Locker, Nicolas; Ayadi, Lilia; Ropers, Delphine; Guittet, Eric; Branlant, Christiane			Biochemical and NMR study on the competition between proteins SC35, SRp40, and heterogeneous nuclear ribonucleoprotein A1 at the HIV-1 tat Exon 2 splicing site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA-BINDING-PROTEINS; HNRNP A/B PROTEINS; MESSENGER-RNA; REGULATORY ELEMENTS; COOPERATIVE BINDING; CRYSTAL-STRUCTURE; SILENCER ELEMENT; BRANCH SITE; IN-VITRO	The human immunodeficiency virus, type 1, Tat protein plays a key role in virus multiplication. Because of its apoptotic property, its production is highly controlled. It depends upon the A3 splicing site utilization. A key control of site A3 activity is the ESS2 splicing silencer, which is located within the long stem-loop structure 3 (SLS3), far downstream from site A3. Here, by enzymatic footprints, we demonstrate the presence of several heterogeneous nuclear ribonucleoprotein (hnRNP) A1-binding sites on SLS3 and show the importance of the C-terminal Gly domain of hnRNP A1 in the formation of stable complexes containing several hnRNP A1 molecules bound on SLS3. Mutations in each of the UAG triplets in ESS2 strongly reduce the overall hnRNP A1 binding, showing the central role of ESS2 in hnRNP A1 assembly on SLS2-SLS3. Using NMR spectroscopy, we demonstrate the direct interaction of ESS2 with the RNA recognition motifs domains of hnRNP A1. This interaction has limited effect on the RNA two-dimensional structure. The SR proteins SC35 and SRp40 were found previously to be strong activators of site A3 utilization. By enzymatic and chemical footprints, we delineate their respective binding sites on SLS2 and SLS3 and find a strong similarity between the hnRNP A1-, SC35-, and SRp40-binding sites. The strongest SC35-binding site only has a modest contribution to site A3 activation. Hence, the main role of SR proteins at site A3 is to counteract hnRNP A1 binding on ESS2 and ESE2. Indeed, we found that ESE2 has inhibitory properties because of its ability to bind hnRNP A1.	Univ Nancy 1, Lab Matuat ARN & Enzymol Mol, UMR 7567, F-54506 Vandoeuvre Les Nancy, France; CNRS, ICSN, Lab Chim & Biol Struct, F-91198 Gif Sur Yvette, France	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Branlant, C (corresponding author), Univ Nancy 1, Lab Matuat ARN & Enzymol Mol, UMR 7567, BP 239, F-54506 Vandoeuvre Les Nancy, France.	christiane.branlant@maem.uhp-nancy.fr		Branlant, Christiane/0000-0003-4728-5499; Guittet, Eric/0000-0002-8368-6719; Locker, Nicolas/0000-0002-0053-2897; Ropers, Delphine/0000-0003-2659-3003				AMENDT BA, 1994, MOL CELL BIOL, V14, P3960, DOI 10.1128/MCB.14.6.3960; AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; Bilodeau PS, 1999, J VIROL, V73, P9764, DOI 10.1128/JVI.73.12.9764-9772.1999; Bonavia R, 2001, BIOCHEM BIOPH RES CO, V288, P301, DOI 10.1006/bbrc.2001.5743; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; CASASFINET JR, 1993, J MOL BIOL, V229, P873, DOI 10.1006/jmbi.1993.1093; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Collin D, 2000, NUCLEIC ACIDS RES, V28, P3386, DOI 10.1093/nar/28.17.3386; Damgaard CK, 2002, RNA, V8, P1401, DOI 10.1017/S1355838202023075; Damier L, 1997, BIOCHEM BIOPH RES CO, V237, P182, DOI 10.1006/bbrc.1997.7091; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x; DYHRMIKKELSEN H, 1995, J BIOL CHEM, V270, P24060, DOI 10.1074/jbc.270.41.24060; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; Jacquenet S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-33; Jacquenet S, 2001, J BIOL CHEM, V276, P40464, DOI 10.1074/jbc.M104070200; Jacquenet S, 2001, NUCLEIC ACIDS RES, V29, P464, DOI 10.1093/nar/29.2.464; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; Marchand V, 2002, J MOL BIOL, V323, P629, DOI 10.1016/S0022-2836(02)00967-1; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; Mayeda A, 1998, RNA, V4, P1111, DOI 10.1017/S135583829898089X; Mouland AJ, 2001, MOL CELL BIOL, V21, P2133, DOI 10.1128/MCB.21.6.2133-2143.2001; OREILLY MM, 1995, VIROLOGY, V213, P373, DOI 10.1006/viro.1995.0010; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; STAFFA A, 1994, J VIROL, V68, P3071, DOI 10.1128/JVI.68.5.3071-3079.1994; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; Swanson AK, 1998, J BIOL CHEM, V273, P34551, DOI 10.1074/jbc.273.51.34551; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Varani G, 1996, PROG NUCL MAG RES SP, V29, P51, DOI 10.1016/0079-6565(96)01028-X; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200	41	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					37159	37174		10.1074/jbc.M603864200	http://dx.doi.org/10.1074/jbc.M603864200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16990281	hybrid			2022-12-27	WOS:000242220800077
J	Neves, AR; Pool, WA; Castro, R; Mingote, A; Santos, F; Kok, J; Kuipers, OP; Santos, H				Neves, Ana R.; Pool, Wietske A.; Castro, Rute; Mingote, Ana; Santos, Filipe; Kok, Jan; Kuipers, Oscar P.; Santos, Helena			The alpha-phosphoglucomutase of Lactococcus lactis is unrelated to the alpha-D-phosphohexomutase superfamily and is encoded by the essential gene pgmH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BETA-PHOSPHOGLUCOMUTASE; LIPOPOLYSACCHARIDE BIOSYNTHESIS; EXOPOLYSACCHARIDE BIOSYNTHESIS; GALACTOSE UTILIZATION; METABOLISM; SEQUENCE; KINETICS; PLASMID; IDENTIFICATION	alpha-Phosphoglucomutase (alpha-PGM) plays an important role in carbohydrate metabolism by catalyzing the reversible conversion of alpha-glucose 1-phosphate to glucose 6-phosphate. Isolation of alpha-PGM activity from cell extracts of Lactococcus lactis strain MG1363 led to the conclusion that this activity is encoded by yfgH, herein renamed pgmH. Its gene product has no sequence homology to proteins in the alpha-D-phosphohexomutase superfamily and is instead related to the eukaryotic phosphomannomutases within the haloacid dehalogenase superfamily. In contrast to known bacterial alpha-PGMs, this 28-kDa enzyme is highly specific for alpha-glucose 1-phosphate and glucose 6-phosphate and showed no activity for mannose phosphate. To elucidate the function of pgmH, the metabolism of glucose and galactose was characterized in mutants overproducing or with a deficiency of alpha-PGM activity. Overproduction of alpha-PGM led to increased glycolytic flux and growth rate on galactose. Despite several attempts, we failed to obtain a deletion mutant of pgmH. The essentiality of this gene was proven by using a conditional knock- out strain in which a native copy of the gene was provided in trans under the control of the nisin promoter. Growth of this strain was severely impaired when alpha-PGM activity was below the control level. We show that the novel L. lactis alpha-PGM is the only enzyme that mediates the interconversion of alpha-glucose 1-phosphate to glucose 6-phosphate and is essential for growth.	Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; Univ Nova Lisboa, Inst Biol Expt & Tecnol, P-2780156 Oeiras, Portugal; Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, NL-9750 AA Haren, Netherlands	Universidade Nova de Lisboa; Universidade Nova de Lisboa; University of Groningen	Santos, H (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Rua Quinta Grande,6 Apartado 127, P-2780156 Oeiras, Portugal.	santos@itqb.unl.pt	Kok, Jan/C-9972-2012; Santos, Filipe/M-7709-2013; Kuipers, Oscar/B-6752-2009; Neves, Ana/B-9476-2008; Santos, Helena/B-9141-2011	Santos, Filipe/0000-0001-7316-1479; Kuipers, Oscar/0000-0001-5596-7735; Neves, Ana/0000-0003-4896-9585; Santos, Helena/0000-0002-8050-9485; Castro, Rute/0000-0002-0899-0649; Branco dos Santos, Filipe/0000-0002-4268-8080				Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Andersson U, 2001, J BIOL CHEM, V276, P42707, DOI 10.1074/jbc.M108279200; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; Boels IC, 2001, APPL ENVIRON MICROB, V67, P3033, DOI 10.1128/AEM.67.7.3033-3040.2001; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandrapati S, 2002, MOL MICROBIOL, V46, P467, DOI 10.1046/j.1365-2958.2002.03163.x; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; COYNE MJ, 1994, J BACTERIOL, V176, P3500, DOI 10.1128/JB.176.12.3500-3507.1994; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Gaona G, 2004, FEMS MICROBIOL LETT, V238, P199, DOI 10.1016/j.femsle.2004.07.044; GASSON MJ, 1983, J BACTERIOL, V154, P1; Grossiord B, 1998, LAIT, V78, P77, DOI 10.1051/lait:1998110; Grossiord BP, 2003, J BACTERIOL, V185, P870, DOI 10.1128/JB.185.3.870-878.2003; Hardy GG, 2000, J BACTERIOL, V182, P1854, DOI 10.1128/JB.182.7.1854-1863.2000; Hardy GG, 2001, INFECT IMMUN, V69, P2309, DOI 10.1128/IAI.69.4.2309-2317.2001; Holo H, 1995, Methods Mol Biol, V47, P195; JOHANSEN E, 1992, PLASMID, V27, P200, DOI 10.1016/0147-619X(92)90022-3; Kleerebezem M, 1999, ANTON LEEUW INT J G, V76, P357, DOI 10.1023/A:1002084822851; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kramer NE, 2006, ANTIMICROB AGENTS CH, V50, P1753, DOI 10.1128/AAC.50.5.1753-1761.2006; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Lahiri SD, 2004, BIOCHEMISTRY-US, V43, P2812, DOI 10.1021/bi0356810; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; Lazarevic V, 2005, APPL ENVIRON MICROB, V71, P39, DOI 10.1128/AEM.71.1.39-45.2005; Leenhouts K, 1998, APPL MICROBIOL BIOT, V49, P417, DOI 10.1007/s002530051192; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Levander F, 2001, APPL ENVIRON MICROB, V67, P2734, DOI 10.1128/AEM.67.6.2734-2738.2001; Levander F, 2001, APPL ENVIRON MICROB, V67, P4546, DOI 10.1128/AEM.67.10.4546-4553.2001; LU M, 1994, J BACTERIOL, V176, P5847, DOI 10.1128/JB.176.18.5847-5851.1994; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; McKay GA, 2003, INFECT IMMUN, V71, P3068, DOI 10.1128/IAI.71.6.3068-3075.2003; Monteiro MA, 2003, CARBOHYD RES, V338, P2905, DOI 10.1016/j.carres.2003.08.014; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Neves AR, 2000, EUR J BIOCHEM, V267, P3859, DOI 10.1046/j.1432-1327.2000.01424.x; Neves AR, 2002, MICROBIOL-SGM, V148, P3467, DOI 10.1099/00221287-148-11-3467; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2002, APPL ENVIRON MICROB, V68, P6332, DOI 10.1128/AEM.68.12.6332-6342.2002; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Pirard M, 1999, BIOCHEM J, V339, P201, DOI 10.1042/0264-6021:3390201; Pirard M, 1997, FEBS LETT, V411, P251, DOI 10.1016/S0014-5793(97)00704-7; QIAN N, 1994, J BACTERIOL, V176, P5304, DOI 10.1128/JB.176.17.5304-5311.1994; Ramos A, 2001, APPL ENVIRON MICROB, V67, P33, DOI 10.1128/AEM.67.1.33-41.2001; Roberts A, 2005, PROTEINS, V58, P790, DOI 10.1002/prot.20267; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanders JW, 1998, MOL GEN GENET, V257, P681, DOI 10.1007/s004380050697; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vaughan EE, 1998, J BACTERIOL, V180, P4893, DOI 10.1128/JB.180.18.4893-4902.1998; Videira PA, 2000, APPL ENVIRON MICROB, V66, P2252, DOI 10.1128/AEM.66.5.2252-2258.2000; West NP, 2000, INFECT IMMUN, V68, P4673, DOI 10.1128/IAI.68.8.4673-4680.2000; Whitehouse DB, 1998, MOL BIOL EVOL, V15, P456, DOI 10.1093/oxfordjournals.molbev.a025942; Zhang GF, 2005, BIOCHEMISTRY-US, V44, P9404, DOI 10.1021/bi050558p	58	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36864	36873		10.1074/jbc.M607044200	http://dx.doi.org/10.1074/jbc.M607044200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16980299	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000242220800045
J	Dehay, B; Bertolotti, A				Dehay, Benjamin; Bertolotti, Anne			Critical role of the proline-rich region in Huntingtin for aggregation and cytotoxicity in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; PROLYL ISOMERASE PIN1; POLYGLUTAMINE EXPANSION; IN-VITRO; PROTEIN; CHAPERONE; EXPRESSION; TOXICITY; FRAGMENT; HSP70	Nine neurodegenerative diseases, such as Huntington, are caused by a polyglutamine ( poly( Q)) expansion in otherwise unrelated proteins. Although poly( Q) expansion causes aggregation of the affected proteins, the protein context might determine the selective neuronal vulnerability found in each disease. Here we have report that, although expression of Huntingtin derivatives with a pathological poly( Q) expansion are innocuous in yeast, deletion of the flanking proline-rich region alters the shape and number of poly( Q) inclusions and unmasks toxic properties. Strikingly, deletion of Hsp104 increases the size of inclusions formed by expanded poly( Q) lacking the proline-rich region and abolishes toxicity. Overexpression of the chaperones Hsp104 or Hsp70 rescues growth defects in affected cells without resolving inclusions. However, aggregates formed by nontoxic Huntingtin derivatives or by toxic derivatives cured by chaperones are physically distinct from aggregates formed by toxic proteins. This study identifies the proline-rich region in Huntingtin as a profound cis-acting modulator of expanded poly( Q) toxicity and distinguishes between aggregates of toxic or non-toxic proteins.	Ecole Normale Super, CNRS, UMR 8541, Genet Mol Lab, F-75230 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Bertolotti, A (corresponding author), MRC, Div Neurobiol, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	aberto@mrc-lmb.cam.ac.uk	DEHAY, Benjamin/I-4713-2016	DEHAY, Benjamin/0000-0003-1723-9045				Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Burke D., 2000, COLD SPRING HARBOR L; Chacinska A, 2001, CURR GENET, V39, P62, DOI 10.1007/s002940000180; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Gellera C, 1996, AM J HUM GENET, V59, P475; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Passani LA, 2000, HUM MOL GENET, V9, P2175, DOI 10.1093/hmg/9.14.2175; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rousseau E, 2004, P NATL ACAD SCI USA, V101, P9648, DOI 10.1073/pnas.0403015101; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schroedel Andrea, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-10; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	34	100	101	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35608	35615		10.1074/jbc.M605558200	http://dx.doi.org/10.1074/jbc.M605558200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16973603	hybrid			2022-12-27	WOS:000242100500005
J	Schoehn, G; Vellieux, FMD; Dura, MA; Receveur-Brechot, V; Fabry, CMS; Ruigrok, RWH; Ebel, C; Roussel, A; Franzetti, B				Schoehn, Guy; Vellieux, Frederic M. D.; Dura, M. Asuncion; Receveur-Brechot, Veronique; Fabry, Celine M. S.; Ruigrok, Rob W. H.; Ebel, Christine; Roussel, Alain; Franzetti, Bruno			An archaeal peptidase assembles into two different quaternary structures - A tetrahedron and a giant octahedron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-COMPARTMENTALIZING PROTEASE; PYROCOCCUS-HORIKOSHII; CRYSTAL-STRUCTURE; TRICORN PROTEASE; DEBLOCKING AMINOPEPTIDASE; AEROMONAS-PROTEOLYTICA; ANGSTROM RESOLUTION; SECONDARY-STRUCTURE; DEGRADATION; COMPLEX	Cellular proteolysis involves large oligomeric peptidases that play key roles in the regulation of many cellular processes. The cobalt-activated peptidase TET1 from the hyperthermophilic Archaea Pyrococcus horikoshii (PhTET1) was found to assemble as a 12-subunit tetrahedron and as a 24-subunit octahedral particle. Both quaternary structures were solved by combining x-ray crystallography and cryoelectron microscopy data. The internal organization of the PhTET1 particles reveals highly self-compartmentalized systems made of networks of access channels extended by vast catalytic chambers. The two edifices display aminopeptidase activity, and their organizations indicate substrate navigation mechanisms different from those described in other large peptidase complexes. Compared with the tetrahedron, the octahedron forms a more expanded hollow structure, representing a new type of giant peptidase complex. PhTET1 assembles into two different quaternary structures because of quasi-equivalent contacts that previously have only been identified in viral capsids.	UJF, CNRS,UMR 5075, CEA, Lab Mol Biophys,Inst Biol Struct JB Ebel, F-38027 Grenoble, France; UJF, CNRS, EMBL, Lab Virol Mol & Struct,FRE 2854, F-38042 Grenoble, France; Univ Aix Marseille 1, CNRS, UMR 6098, F-13288 Marseille, France; Univ Aix Marseille 2, CNRS, UMR 6098, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Franzetti, B (corresponding author), UJF, CNRS,UMR 5075, CEA, Lab Mol Biophys,Inst Biol Struct JB Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	franzetti@ibs.fr	Vellieux, Frederic/J-4829-2019	Vellieux, Frederic/0000-0002-1922-5707; Schoehn, Guy/0000-0002-1459-3201; Ebel, Christine/0000-0002-6912-500X; Receveur-Brechot, Veronique/0000-0002-7464-6192				Ando S, 1999, FEBS LETT, V447, P25, DOI 10.1016/S0014-5793(99)00257-4; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056; BOTBOL V, 1991, J BIOL CHEM, V266, P2151; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1992, J MOL BIOL, V224, P113, DOI 10.1016/0022-2836(92)90580-D; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; DeLano WL, 2002, PYMOL USERS MANUAL; Dura MA, 2005, BIOCHEMISTRY-US, V44, P3477, DOI 10.1021/bi047736j; Fabry CMS, 2005, EMBO J, V24, P1645, DOI 10.1038/sj.emboj.7600653; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Gonzalez JM, 1998, EXTREMOPHILES, V2, P123, DOI 10.1007/s007920050051; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim JS, 2002, J MOL BIOL, V324, P1041, DOI 10.1016/S0022-2836(02)01153-1; Kirschner M, 1999, TRENDS CELL BIOL, V9, pM42, DOI 10.1016/S0962-8924(99)01666-9; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Onoe S, 2002, BIOCHEM BIOPH RES CO, V290, P994, DOI 10.1006/bbrc.2001.6327; Porciero S, 2005, ACTA CRYSTALLOGR F, V61, P239, DOI 10.1107/S1744309105001910; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Remaut H, 2001, NAT STRUCT BIOL, V8, P674, DOI 10.1038/90380; Rockel B, 2005, P NATL ACAD SCI USA, V102, P10135, DOI 10.1073/pnas.0504569102; Rossmann M. G., 1972, MOL REPLACEMENT METH; Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schut GJ, 2003, J BACTERIOL, V185, P3935, DOI 10.1128/JB.185.13.3935-3947.2003; Stamper C, 2001, BIOCHEMISTRY-US, V40, P7035, DOI 10.1021/bi0100891; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Walz J, 1999, J STRUCT BIOL, V128, P65, DOI 10.1006/jsbi.1999.4169; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Yao TT, 1999, CURR BIOL, V9, pR551, DOI 10.1016/S0960-9822(99)80352-2	48	34	36	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36327	36337		10.1074/jbc.M604417200	http://dx.doi.org/10.1074/jbc.M604417200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16973604	hybrid			2022-12-27	WOS:000242100500084
J	Pelis, RM; Zhang, XH; Dangprapai, YY; Wright, SH				Pelis, Ryan M.; Zhang, Xiaohong; Dangprapai, Yodying; Wright, Stephen H.			Cysteine accessibility in the hydrophilic cleft of human organic cation transporter 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING REGION; LACTOSE PERMEASE; ESCHERICHIA-COLI; RAT-KIDNEY; CONTRALUMINAL TRANSPORT; PROXIMAL TUBULE; AMINO-ACIDS; ANION; TETRAETHYLAMMONIUM; LOCALIZATION	Organic cation transporters (OCTs) are involved in the renal elimination of many cationic drugs and toxins. A hypothetical three-dimensional structure of OCT2 based on a homology model that used the Escherichia coli glycerol 3-phosphate transporter as a template has been described (Zhang, X., Shirahatti, N. V., Mahadevan, D., and Wright, S. H. (2005) J. Biol. Chem. 280, 34813-34822). To further define OCT structure, the accessibility to hydrophilic thiol-reactive reagents of the 13 cysteine residues contained in the human ortholog of OCT2 was examined. Maleimide-PEO2-biotin precipitated (surface biotinylation followed by Western blotting) and reduced tetraethylammonium transport by OCT2 expressed in Chinese hamster ovary cells, effects that were largely reversed by co-exposure to substrates and transport inhibitors, suggesting interaction with cysteines that are near to or part of a substrate-binding surface. Cysteines at amino acid position 437, 451, 470, and 474 were identified from the model as being located in transmembrane helices that participate in forming the hydrophilic cleft, the proposed region of substrate-protein interaction. To determine which residues are exposed to the solvent, a mutant with all four of these cysteines converted to alanine, along with four variants of this mutant each with an individual cysteine restored, were created. Maleimide-PEO2-biotin was only effective at precipitating and reducing transport by wild-type OCT2 and the mutant with cysteine 474 restored. Additionally, the smaller thiol-reactive reagent, methanethiosulfonate ethylsulfonate, reduced transport by wild-type OCT2 and the mutant with cysteine 474 restored. These data demonstrate that cysteine 474 of OCT2 is exposed to the aqueous milieu of the cleft and contributes to forming a pathway for organic cation transport.	Univ Arizona, Coll Med, Dept Physiol, Tucson, AZ 85743 USA	University of Arizona	Pelis, RM (corresponding author), Univ Arizona, Coll Med, Dept Physiol, POB 245051, Tucson, AZ 85743 USA.	rpelis@email.arizona.edu			NHLBI NIH HHS [HL07249] Funding Source: Medline; NIDDK NIH HHS [DK58251, DK075242] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK075242, R01DK058251, R56DK058251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bednarczyk D, 2003, MOL PHARMACOL, V63, P489, DOI 10.1124/mol.63.3.489; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bleasby K, 2002, FASEB J, V16, pA459; Dodd JR, 2005, J BIOL CHEM, V280, P32649, DOI 10.1074/jbc.M506723200; Dresser MJ, 2001, J PHARM SCI, V90, P397, DOI 10.1002/1520-6017(200104)90:4<397::AID-JPS1000>3.3.CO;2-4; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P3950, DOI 10.1021/bi952601m; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Gorboulev V, 2005, MOL PHARMACOL, V67, P1612, DOI 10.1124/mol.104.008821; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Karbach U, 2000, AM J PHYSIOL-RENAL, V279, pF679, DOI 10.1152/ajprenal.2000.279.4.F679; Koepsell H, 2004, REV PHYSIOL BIOCH P, V150, P36, DOI 10.1007/s10254-003-0017-x; Koepsell H, 1999, J MEMBRANE BIOL, V167, P103, DOI 10.1007/s002329900475; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Pelis RM, 2006, AM J PHYSIOL-RENAL, V290, pF1118, DOI 10.1152/ajprenal.00462.2005; Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839; Pritchard JB, 1996, KIDNEY INT, V49, P1649, DOI 10.1038/ki.1996.240; Suhre WM, 2005, MOL PHARMACOL, V67, P1067, DOI 10.1124/mol.104.004713; Thomas MC, 2004, J PHARMACOL EXP THER, V311, P456, DOI 10.1124/jpet.104.070672; ULLRICH KJ, 1993, PFLUG ARCH EUR J PHY, V425, P300, DOI 10.1007/BF00374180; ULLRICH KJ, 1991, PFLUG ARCH EUR J PHY, V419, P84, DOI 10.1007/BF00373751; ULLRICH KJ, 1992, PFLUG ARCH EUR J PHY, V420, P29, DOI 10.1007/BF00378638; ULLRICH KJ, 1993, PFLUG ARCH EUR J PHY, V425, P280, DOI 10.1007/BF00374179; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Wright SH, 2005, TOXICOL APPL PHARM, V204, P309, DOI 10.1016/j.taap.2004.10.021; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; Zhang XH, 2005, J BIOL CHEM, V280, P34813, DOI 10.1074/jbc.M506342200	27	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35272	35280		10.1074/jbc.M606561200	http://dx.doi.org/10.1074/jbc.M606561200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16990275	hybrid			2022-12-27	WOS:000241933700061
J	Zegzouti, H; Li, W; Lorenz, TC; Xie, MT; Payne, CT; Smith, K; Glenny, S; Payne, GS; Christensen, SK				Zegzouti, Hicham; Li, Wei; Lorenz, Todd C.; Xie, Mingtang; Payne, C. Thomas; Smith, Kelly; Glenny, Scott; Payne, Gregory S.; Christensen, Sioux K.			Structural and functional insights into the regulation of Arabidopsis AGC VIIIa kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT HAIR-GROWTH; PROTEIN-KINASES; SIGNALING PATHWAY; PDK1; DOMAIN; PHOSPHORYLATION; ADAPTER; CELLS	The AGCVIIIa kinases of Arabidopsis are members of the eukaryotic PKA, PKG, and PKC group of regulatory kinases. One AGCVIIIa kinase, PINOID (PID), plays a fundamental role in the asymmetrical localization of membrane proteins during polar auxin transport. The remaining 16 AGCVIIIa genes have not been associated with single mutant phenotypes, suggesting that the corresponding kinases function redundantly. Consistent with this idea, we find that the genes encoding the Arabidopsis AGCVIIIa kinases have spatially distinct, but overlapping, expression domains. Here we show that the majority of Arabidopsis AGCVIIIa kinases are substrates for the 3-phosphoinositide-dependent kinase 1 (PDK1) and that trans-phosphorylation by PDK1 correlates with activation of substrate AGCVIIIa kinases. Mutational analysis of two conserved regulatory domains was used to demonstrate that sequences located outside of the C-terminal PDK1 interaction (PIF) domain and the activation loop are required for functional interactions between PDK1 and its substrates. A subset of GFP-tagged AGCVIIIa kinases expressed in Saccharomyces cerevisiae and tobacco BY-2 cells were preferentially localized to the cytoplasm (AGC1-7), nucleus (WAG1 and KIPK), and the cell periphery (PID). We present evidence that PID insertion domain sequences are sufficient to direct the observed peripheral localization. We find that PID specifically but non-selectively binds to phosphoinositides and phosphatidic acid, suggesting that PID might directly interact with the plasma membrane through protein-lipid interactions. The initial characterization of the AGCVIIIa kinases presented here provides a framework for elucidating the physiological roles of these kinases in planta.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Christensen, SK (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, David Geffen Sch Med, POB 951606, Los Angeles, CA 90095 USA.	sioux@ucla.edu		Zegzouti, Hicham/0000-0002-0989-6195; Xie, Mingtang/0000-0002-2797-0598; Lorenz, Todd/0000-0001-7847-7325	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064584, R01GM039040] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM64584, R01 GM39040] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Benjamins R, 2001, DEVELOPMENT, V128, P4057; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Day IS, 2000, J BIOL CHEM, V275, P13737, DOI 10.1074/jbc.275.18.13737; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Force A, 1999, GENETICS, V151, P1531; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; MILLWARD T, 1995, P NATL ACAD SCI USA, V92, P5022, DOI 10.1073/pnas.92.11.5022; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oyama T, 2002, PLANT J, V30, P289, DOI 10.1046/j.1365-313X.2002.01290.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Santner AA, 2006, PLANT J, V45, P752, DOI 10.1111/j.1365-313X.2005.02641.x; Suzuki E, 2004, P NATL ACAD SCI USA, V101, P14788, DOI 10.1073/pnas.0406536101; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Turck F, 2004, PLANT PHYSIOL, V134, P1527, DOI 10.1104/pp.103.035873; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Zegzouti H, 2006, P NATL ACAD SCI USA, V103, P6404, DOI 10.1073/pnas.0510283103; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	37	66	72	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35520	35530		10.1074/jbc.M605167200	http://dx.doi.org/10.1074/jbc.M605167200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16973627	hybrid			2022-12-27	WOS:000241933700085
J	An, HJ; Maeng, O; Kang, KH; Lee, JO; Kim, YS; Paik, SG; Lee, H				An, Hyun-Jung; Maeng, Oky; Kang, Kyoung-Hee; Lee, Jie-Oh; Kim, Young-Sang; Paik, Sang-Gi; Lee, Hayyoung			Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; GUANINE-NUCLEOTIDE EXCHANGE; C-HA-RAS; PROTEIN BNIP3; SURVIVAL RESPONSIVENESS; PANCREATIC-CANCER; GENE-EXPRESSION; BH3 DOMAIN; MACROPHAGES; HYPOXIA	Nitric oxide ( NO) produced by NO synthases causes nitration and nitrosylation of cellular factors. We have shown previously that endogenously produced or exogenously added NO induces expression of BNIP3 (Bcl-2/adenovirus E1B 19kDa-interacting protein 3), leading to death of macrophages (Yook, Y.-H., Kang, K.-H., Maeng, O., Kim, T.-R., Lee, J.-O., Kang, K.-i., Kim, Y.-S., Paik, S.-G., and Lee, H. ( 2004) Biochem. Biophys. Res. Commun. 321, 298-305). We now provide evidence that Ras mediates NO-induced BNIP3 expression via the MEK/ERK/hypoxia-inducible factor (HIF)-1 pathway. (a)ras-Q61L, a constitutively active form of Ras, up-regulated BNIP3 protein expression by enhancing Bnip3 promoter activity, and ras-S17N, a dominant-negative form, and ras-C118S, an S-nitrosylation mutant, blocked NO-induced BNIP3 expression, suggesting that Ras acts downstream of NO and that NO activates Ras by nitrosylation. (b) U0126, a specific MEK inhibitor, completely abolished BNIP3 expression and the stimulation of promoter activity by NO and Ras, whereas 1H-[1,2,4] oxadiazolo[4,3-a] quinoxalin-1-one, SB203580, and wortmannin, specific inhibitors of soluble guanylyl cyclase, p38 MAPK, and phosphatidylinositol 3-kinase, respectively, had no effect. Ras, MEK1/2, and ERK1/2 were sequentially activated by NO treatment of macrophages. ( c) Mutation of the HIF-1-binding site (hypoxia-response element) in the Bnip3 promoter abolished BNIP3 induction, and HIF-1 alpha was strongly induced by NO. (d) Transient expression of activated Ras promoted macrophage death, as did NO, and this Ras-mediated cell death was inhibited by silencing BNIP3 expression. These results suggest that NO-induced death of macrophages is mediated, at least in part, by BNIP3 induction.	Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea; Chungnam Natl Univ, Dept Biochem, Sch Biosci & Biotechnol, Taejon 305764, South Korea; Chungnam Natl Univ, Inst Biotechnol, Taejon 305764, South Korea; Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Chungnam National University; Chungnam National University; Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST)	Paik, SG (corresponding author), Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea.	sgpaik@cnu.ac.kr; hlee@cnu.ac.kr	Lee, Jie-Oh/C-1581-2011; Lee, Jie-Oh/AAG-4302-2020	Lee, Jie-Oh/0000-0001-6519-6049				Abe T, 2005, J GASTROENTEROL, V40, P504, DOI 10.1007/s00535-005-1576-1; Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; ALBINA JE, 1993, J IMMUNOL, V150, P5080; Baetz D, 2005, CIRCULATION, V112, P3777, DOI 10.1161/CIRCULATIONAHA.105.573899; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Brockhaus F, 1999, ONCOGENE, V18, P6403, DOI 10.1038/sj.onc.1203058; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chang FM, 2003, INT J ONCOL, V22, P469; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Deguin-Chambon V, 2000, ONCOGENE, V19, P5831, DOI 10.1038/sj.onc.1203960; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Hortelano S, 1999, FASEB J, V13, P2311, DOI 10.1096/fasebj.13.15.2311; Jeong HS, 2002, J NEURO-ONCOL, V60, P97; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kim JY, 2002, ARCH BIOCHEM BIOPHYS, V398, P147, DOI 10.1006/abbi.2001.2673; Kim SO, 2001, J ENDOTOXIN RES, V7, P292, DOI 10.1179/096805101101532873; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; Klampfer L, 2005, ONCOGENE, V24, P3932, DOI 10.1038/sj.onc.1208552; Klampfer L, 2004, J BIOL CHEM, V279, P36680, DOI 10.1074/jbc.M405197200; Lamy L, 2003, J BIOL CHEM, V278, P23915, DOI 10.1074/jbc.M301869200; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Messmer UK, 1996, FEBS LETT, V384, P162; MESSMER UK, 1994, FEBS LETT, V355, P23; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Mizutani A, 2002, J BIOL CHEM, V277, P15851, DOI 10.1074/jbc.M111431200; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; Murai M, 2005, BRIT J CANCER, V92, P1165, DOI 10.1038/sj.bjc.6602422; Murai M, 2005, CLIN CANCER RES, V11, P1021; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Shao JY, 2000, J BIOL CHEM, V275, P22916, DOI 10.1074/jbc.M002235200; Sowter HM, 2001, CANCER RES, V61, P6669; Teng KK, 1999, J BIOL CHEM, V274, P37315, DOI 10.1074/jbc.274.52.37315; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Wan J, 2003, IMMUNOLOGY, V110, P10, DOI 10.1046/j.1365-2567.2003.01710.x; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; Yook YH, 2004, BIOCHEM BIOPH RES CO, V321, P298, DOI 10.1016/j.bbrc.2004.06.144; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773	49	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33939	33948		10.1074/jbc.M605819200	http://dx.doi.org/10.1074/jbc.M605819200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16954213	hybrid			2022-12-27	WOS:000241767600015
J	Archbold, JK; Macdonald, WA; Miles, JJ; Brennan, RM; Kjer-Nielsen, L; McCluskey, J; Burrows, SR; Rossjohn, J				Archbold, Julia K.; Macdonald, Whitney A.; Miles, John J.; Brennan, Rebekah M.; Kjer-Nielsen, Lars; McCluskey, James; Burrows, Scott R.; Rossjohn, Jamie			Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL EPITOPE; MHC CLASS-I; CRYSTAL-STRUCTURE; RECEPTOR; RECOGNITION; AFFINITY; CTL; IDENTIFICATION; ALLORESPONSE	Our understanding of the molecular mechanisms of T cell alloreactivity remains limited by the lack of systems for which both the T cell receptor allo-and cognate ligand are known. Here we provide evidence that a single alloreactive T cell receptor interacts with analogous structural regions of its cognate ligand, HLA-B*0801(FLRGRAYGL), as its allogeneic ligand, HLA-B*3501(KPIVVLHGY). The crystal structures of the binary peptide-major histocompatibility complexes show marked differences in the conformation of the heavy chains as well as the bound peptides. Nevertheless, both epitopes possess a prominent solvent-exposed aromatic residue at position 7 flanked by a small glycine at position 8 of the peptide determinant. Moreover, regions of close structural homology between the heavy chains of HLA B8 and HLA B35 coincided with regions that have previously been implicated in "hot spots" of T cell receptor recognition. The avidity of this human T cell receptor was also comparable for the allo- and cognate ligand, consistent with the modes of T cell receptor binding being broadly similar for these complexes. Collectively, it appears that highly focused structural mimicry against a diverse structural background provides a basis for the observed alloreactivity in this system. This cross-reactivity underpins the T cell degeneracy inherent in the limited mature T cell repertoire that must respond to a vast diversity of microbial antigens.	Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia; Monash Univ, Sch Biomed Sci, Prot Crystallog Unit, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	QIMR Berghofer Medical Research Institute; Monash University; University of Melbourne	Burrows, SR (corresponding author), Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia.	Scott.Burrows@qimr.edu.au; jamie.rossjohn@med.monash.edu.au	Archbold, Julia/N-2884-2013; Engel, Rebekah/AAQ-2644-2020; Miles, John J/ABC-1105-2020; Brennan, Rebekah/C-6172-2013; Rossjohn, Jamie/F-9032-2013; Burrows, Scott/G-2050-2011; McCluskey, James/A-1291-2007	Archbold, Julia/0000-0002-7768-4784; Engel, Rebekah/0000-0003-1951-547X; Miles, John J/0000-0001-5506-6304; Rossjohn, Jamie/0000-0002-2020-7522; Burrows, Scott/0000-0002-1430-0472; McCluskey, James/0000-0002-8597-815X				ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Auchincloss Hugh Jr., 1993, P1099; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BLUESTONE JA, 1993, J IMMUNOL, V151, P3943; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURROWS SR, 1990, J EXP MED, V171, P345, DOI 10.1084/jem.171.1.345; Burrows SR, 1997, EUR J IMMUNOL, V27, P1726, DOI 10.1002/eji.1830270720; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; CHATTOPADHYAY S, 1994, J EXP MED, V179, P213, DOI 10.1084/jem.179.1.213; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; ELLIOTT TJ, 1990, P NATL ACAD SCI USA, V87, P5213, DOI 10.1073/pnas.87.13.5213; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLEISCHHAUER K, 1990, NEW ENGL J MED, V323, P1818, DOI 10.1056/NEJM199012273232607; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; HEATH WR, 1991, P NATL ACAD SCI USA, V88, P5101, DOI 10.1073/pnas.88.12.5101; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kedzierska K, 2005, P NATL ACAD SCI USA, V102, P11432, DOI 10.1073/pnas.0504851102; KEEVER CA, 1994, BONE MARROW TRANSPL, V14, P137; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Macdonald W, 2002, FEBS LETT, V527, P27, DOI 10.1016/S0014-5793(02)03149-6; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obst R, 2000, J EXP MED, V191, P805, DOI 10.1084/jem.191.5.805; Pittet MJ, 2006, J IMMUNOL, V176, P2330, DOI 10.4049/jimmunol.176.4.2330; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rossmann MG, 1999, ACTA CRYSTALLOGR D, V55, P1631, DOI 10.1107/S0907444999008379; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; SHERMAN LA, 1982, J EXP MED, V155, P380, DOI 10.1084/jem.155.2.380; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Smith PA, 1997, J EXP MED, V185, P1023, DOI 10.1084/jem.185.6.1023; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; VILLADANGOS JA, 1994, J IMMUNOL, V152, P2317; Yee C, 1999, J IMMUNOL, V162, P2227; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	49	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34324	34332		10.1074/jbc.M606755200	http://dx.doi.org/10.1074/jbc.M606755200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16963442	hybrid			2022-12-27	WOS:000241767600052
J	Keil, C; Grobe, T; Oei, SL				Keil, Claudia; Groebe, Tina; Oei, Shiao Li			MNNG-induced cell death is controlled by interactions between PARP-1, poly(ADP-ribose) glycohydrolase, and XRCC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; BASE EXCISION-REPAIR; SISTER-CHROMATID EXCHANGE; OXIDATIVE DNA-DAMAGE; MAMMALIAN-CELLS; LIGASE-III; IN-VITRO; POLYMERASE; ATP; METABOLISM	PARP-1 (poly(ADP-ribose) polymerases) modifies proteins with poly(ADP-ribose), which is an important signal for genomic stability. ADP-ribose polymers also mediate cell death and are degraded by poly(ADP-ribose) glycohydrolase (PARG). Here we show that the catalytic domain of PARG interacts with the automodification domain of PARP-1. Furthermore, PARG can directly down-regulate PARP-1 activity. PARG also interacts with XRCC1, a DNA repair factor that is recruited by DNA damage-activated PARP-1. We investigated the role of XRCC1 in cell death after treatment with supralethal doses of the alkylating agent MNNG. Only in XRCC1-proficient cells MNNG induced a considerable accumulation of poly(ADP-ribose). Similarly, extracts of XRCC1-deficient cells produced large ADPribose polymers if supplemented with XRCC1. Consequently, MNNG triggered in XRCC1-proficient cells the translocation of the apoptosis inducing factor from mitochondria to the nucleus followed by caspase-independent cell death. In XRCC1-deficient cells, the same MNNG treatment caused non-apoptotic cell death without accumulation of poly(ADP-ribose). Thus, XRCC1 seems to be involved in regulating a poly(ADP-ribose)mediated apoptotic cell death.	Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany	Free University of Berlin	Oei, SL (corresponding author), Free Univ Berlin, Inst Biochem, Thielallee 63, D-14195 Berlin, Germany.	lity@chemie.fu-berlin.de		Keil, Claudia/0000-0003-0317-0905				Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ariumi Y, 1999, ONCOGENE, V18, P4616, DOI 10.1038/sj.onc.1202823; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; Bonicalzi ME, 2003, BIOL CELL, V95, P635, DOI 10.1016/j.biolcel.2003.10.003; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Gagne JP, 2005, BIOCHEM J, V392, P499, DOI 10.1042/BJ20050792; GOTHGOLDSTEIN R, 1987, MUTAT RES, V177, P267, DOI 10.1016/0027-5107(87)90010-8; Griesenbeck J, 1997, BIOCHEMISTRY-US, V36, P7297, DOI 10.1021/bi962710g; Griesenbeck J, 1999, FEBS LETT, V443, P20, DOI 10.1016/S0014-5793(98)01671-8; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; IKEJIMA M, 1984, MUTAT RES, V128, P213, DOI 10.1016/0027-5107(84)90109-X; Jacobson EL, 1997, METHOD ENZYMOL, V280, P221; James P, 1996, GENETICS, V144, P1425; Keil C, 2004, ARCH BIOCHEM BIOPHYS, V425, P115, DOI 10.1016/j.abb.2004.02.024; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Kun E, 2004, BIOCHEMISTRY-US, V43, P210, DOI 10.1021/bi0301791; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; MALANGA M, 1994, J BIOL CHEM, V269, P17691; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MENARD L, 1990, BIOCHIM BIOPHYS ACTA, V1049, P45, DOI 10.1016/0167-4781(90)90083-E; Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200; Meyer RG, 2003, GENE, V314, P181, DOI 10.1016/S0378-1119(03)00738-8; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng105; Oei SL, 2005, BIOCHEM CELL BIOL, V83, P263, DOI 10.1139/o05-039; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; Ohashi S, 2003, BIOCHEM BIOPH RES CO, V307, P915, DOI 10.1016/S0006-291X(03)01272-5; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Patel CN, 2005, BIOCHEM J, V388, P493, DOI 10.1042/BJ20040942; Petermann E, 2005, CELL MOL LIFE SCI, V62, P731, DOI 10.1007/s00018-004-4504-2; Petermann E, 2003, DNA REPAIR, V2, P1101, DOI 10.1016/S1568-7864(03)00117-4; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rossi L, 2002, BIOCHIMIE, V84, P1229; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tanaka S, 2005, J NEUROCHEM, V95, P179, DOI 10.1111/j.1471-4159.2005.03353.x; THOMPSON LH, 1982, MUTAT RES, V95, P427, DOI 10.1016/0027-5107(82)90276-7; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	58	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34394	34405		10.1074/jbc.M606470200	http://dx.doi.org/10.1074/jbc.M606470200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16963444	hybrid			2022-12-27	WOS:000241767600060
J	Kundu, P; Mukhopadhyay, AK; Patra, R; Banerjee, A; Berg, DE; Swarnakar, S				Kundu, Parag; Mukhopadhyay, Asish K.; Patra, Rajashree; Banerjee, Aditi; Berg, Douglas E.; Swarnakar, Snehasikta			Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; IN-VITRO; INFLAMMATORY RESPONSE; VIRULENCE FACTORS; MOUSE MODEL; STRAIN SS1; COLONIZATION; TIMP-1	Helicobacter pylori cag pathogenicity island (PAI) is a major determinant of gastric injury via induction of several matrix metalloproteinases (MMPs). In the present study, we examined the influence of the cag PAI on gastric infection and MMP-9 production in mice and in cultured cells. A new mouse colonizing Indian H. pylori strain (AM1) that lacks the cag PAI was used to study the cag PAI importance in inflammation. Groups of C57BL/6 mice were inoculated separately with H. pylori strains AM1 and SS1 (cag(+)), gastric tissues were histologically examined, and bacterial colonization was scored by quantitative culture. Mice infected with either cag(+) or cag(-) H. pylori strains showed gastric inflammation and elevated MMP-3 production. Significant up-regulation of pro-MMP-9 secretion and gene expression in H. pylori infected gastric tissues indicate dispensability of cag PAI for increased pro-MMP-9 secretion and synthesis in mice. In agreement, cell culture studies revealed that both AM1 and SS1 were equipotent in pro-MMP-9 induction in human gastric epithelial cells. Both strains showed moderate increase in MMP-2 activity in vivo and in vitro. In addition, increased secretion of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, and IL-6 induced pro-MMP-9 secretion and synthesis in AM1 or SS1 strain-infected mice suggesting elicitation of pro-inflammatory cytokines by both cag(-) and cag(+) genotype. Moreover, tissue inhibitors of metalloproteinase-1 expression were decreased with increase in pro-MMP-9 induction. These data show that H. pylori may act through different pathways other than cag PAI-mediated for gastric inflammation and contribute to upregulation of MMP-9 via pro-inflammatory cytokines.	Indian Inst Chem Biol, Dept Physiol, Kolkata 700032, W Bengal, India; Natl Inst Cholera & Enter Dis, Kolkata 700010, W Bengal, India; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Washington University (WUSTL)	Swarnakar, S (corresponding author), Indian Inst Chem Biol, Dept Physiol, 4 Raja Sc Mullick Rd, Kolkata 700032, W Bengal, India.	snehasiktas@hotmail.com	Das, Rajashree/AAS-4747-2020; Mukhopadhyay, Asish/ABE-7697-2020; Das, Rajashree/D-1755-2017	Das, Rajashree/0000-0003-1202-4942; Swarnakar, Snehasikta/0000-0002-7139-9683; Kundu, Parag/0000-0002-8684-7530				Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Atherton JC, 1998, BRIT MED BULL, V54, P105; Audibert C, 2001, INFECT IMMUN, V69, P1625, DOI 10.1128/IAI.69.3.1625-1629.2001; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Bergin PJ, 2005, FEMS IMMUNOL MED MIC, V45, P159, DOI 10.1016/j.femsim.2005.03.008; Bergin PJ, 2004, HELICOBACTER, V9, P201, DOI 10.1111/j.1083-4389.2004.00232.x; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; BLASER MJ, 1995, CANCER RES, V55, P2111; Campbell S, 1997, INFECT IMMUN, V65, P3708, DOI 10.1128/IAI.65.9.3708-3712.1997; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; CLEMENS J, 1995, J INFECT DIS, V171, P1653, DOI 10.1093/infdis/171.6.1653; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cover TL, 1999, GASTROENTEROLOGY, V117, P257, DOI 10.1016/S0016-5085(99)70575-5; Crabtree JE, 2002, HELICOBACTER, V7, P139, DOI 10.1046/j.1083-4389.2002.00071.x; Crawford HC, 2003, GASTROENTEROLOGY, V125, P1125, DOI 10.1016/S0016-5085(03)01206-X; Dale A, 1998, J PEDIATR GASTR NUTR, V26, P393, DOI 10.1097/00005176-199804000-00006; Datta S, 2003, J CLIN MICROBIOL, V41, P3737, DOI 10.1128/JCM.41.8.3737-3743.2003; Eaton KA, 2002, INFECT IMMUN, V70, P771, DOI 10.1128/IAI.70.2.771-778.2002; Eaton KA, 2001, INFECT IMMUN, V69, P2902, DOI 10.1128/IAI.69.5.2902-2908.2001; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Ferrero RL, 1998, INFECT IMMUN, V66, P1349, DOI 10.1128/IAI.66.4.1349-1355.1998; Gambero A, 2003, FEMS IMMUNOL MED MIC, V38, P193, DOI 10.1016/S0928-8244(03)00171-8; Ganguly K, 2006, FREE RADICAL BIO MED, V41, P911, DOI 10.1016/j.freeradbiomed.2006.04.022; GIONCHETTI P, 1994, AM J GASTROENTEROL, V89, P883; Go M F, 1996, Helicobacter, V1, P107, DOI 10.1111/j.1523-5378.1996.tb00019.x; Gooz M, 2003, GUT, V52, P1250, DOI 10.1136/gut.52.9.1250; Gooz M, 2001, AM J PHYSIOL-GASTR L, V281, pG823, DOI 10.1152/ajpgi.2001.281.3.G823; Graham DY, 2000, HELICOBACTER, V5, pS3; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Guedez L, 1998, BLOOD, V92, P1342, DOI 10.1182/blood.V92.4.1342.416k22_1342_1349; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Ishiguro N, 1999, J RHEUMATOL, V26, P34; Kabashima A, 2000, CLIN CANCER RES, V6, P3581; Kauser F, 2004, J CLIN MICROBIOL, V42, P5302, DOI 10.1128/JCM.42.11.5302-5308.2004; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Kodama K, 1999, J GASTROENTEROL, V34, P6; Kossakowska AE, 1999, BLOOD, V94, P2080, DOI 10.1182/blood.V94.6.2080.418k30_2080_2089; Krueger S, 2006, J BIOL CHEM, V281, P2868, DOI 10.1074/jbc.m511053200; LEE A, 1990, GASTROENTEROLOGY, V99, P1315, DOI 10.1016/0016-5085(90)91156-Z; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lempinen M, 2000, EUR SURG RES, V32, P169, DOI 10.1159/000008759; Lindholm C, 1998, INFECT IMMUN, V66, P5964, DOI 10.1128/IAI.66.12.5964-5971.1998; Maeda S, 1997, DIGEST DIS SCI, V42, P1841, DOI 10.1023/A:1018846723379; Maeda S, 1999, GUT, V44, P336, DOI 10.1136/gut.44.3.336; MARSHALL BJ, 1994, AM J GASTROENTEROL, V89, pS116; Menges M, 2000, Z GASTROENTEROL, V38, P887, DOI 10.1055/s-2000-10300; MOBLEY LTH, 2001, HELICOBACTER PYLORI; Mori N, 2003, GASTROENTEROLOGY, V124, P983, DOI 10.1053/gast.2003.50152; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; Murphy G, 1995, ACTA ORTHOP SCAND, V66, P55, DOI 10.3109/17453679509157648; Nolan KJ, 2002, INFECT IMMUN, V70, P685, DOI 10.1128/IAI.70.2.685-691.2002; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnita K, 2005, WORLD J GASTROENTERO, V11, P1549; Parks WC, 1998, BIOL EXTRAC, P263; Peek RM, 1999, CANCER RES, V59, P6124; Peek RM, 1995, LAB INVEST, V73, P760; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Salama NR, 2001, INFECT IMMUN, V69, P730, DOI 10.1128/IAI.69.2.730-736.2001; Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200; Thompson LJ, 2004, INFECT IMMUN, V72, P4668, DOI 10.1128/IAI.72.8.4668-4679.2004; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Doorn LJ, 1999, GASTROENTEROLOGY, V116, P823, DOI 10.1016/S0016-5085(99)70065-X; von Lampe B, 2000, GUT, V47, P63, DOI 10.1136/gut.47.1.63; Westblom TU, 1999, CURR TOP MICROBIOL, V241, P215; Yanagisawa N, 2005, FEMS IMMUNOL MED MIC, V44, P197, DOI 10.1016/j.femsim.2004.11.009; Yokoyama T, 2000, ALIMENT PHARM THERAP, V14, P193, DOI 10.1046/j.1365-2036.2000.014s1193.x; Zhang YH, 1998, J IMMUNOL, V161, P3071	69	54	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34651	34662		10.1074/jbc.M604574200	http://dx.doi.org/10.1074/jbc.M604574200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966323	hybrid			2022-12-27	WOS:000241767600084
J	Vallon, M; Essler, M				Vallon, Mario; Essler, Markus			Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha(v)beta(3) to glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ADHESION; BINDING; SURFACE; CD97	Tumor endothelial marker (TEM) 5 is a member of the adhesion family of G-protein-coupled receptors and up-regulated in endothelial cells during tumor and physiologic angiogenesis. Here, we report that TEM5 is expressed on the surface of endothelial cells. A soluble TEM5(sTEM5) fragment is shed by endothelial cells during capillary-like network formation and upon growth factor stimulation. We found that sTEM5 binds to several glycosaminoglycans. Furthermore, sequence analysis and functional and biochemical studies revealed that sTEM5 contains a cryptic RGD-binding site for integrin alpha(v)beta(3). Matrix metalloprotease 9-processed, but not full-length, sTEM5 mediated endothelial cell adhesion by direct interaction with integrin alpha(v)beta(3). Adhesion to proteolytically processed sTEM5 (ppsTEM5) or glycosaminoglycan-bound ppsTEM5 promoted survival of growth factor deprived endothelial cells. ppsTEM5-mediated cell survival was inhibited by a function blocking integrin alpha(v)beta(3) antibody. Based on our results we conclude that sTEM5 is shed by endothelial cells during angiogenesis and binds to glycosaminoglycans present on extracellular matrix and cell surface proteoglycans. Further proteolytic processing of sTEM5 leads to exposure of its RGD motif mediating endothelial cell survival by linking integrin alpha(v)beta(3) to glycosaminoglycans.	Tech Univ Munich, Dept Nucl Med, D-81675 Munich, Germany	Technical University of Munich; University of Munich	Essler, M (corresponding author), Tech Univ Munich, Dept Nucl Med, Ismaninger Str 22, D-81675 Munich, Germany.	markus.essler@gmx.de						Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Byzova TV, 1998, J CELL BIOL, V143, P2081, DOI 10.1083/jcb.143.7.2081; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Fredriksson R, 2003, BIOCHEM BIOPH RES CO, V301, P725, DOI 10.1016/S0006-291X(03)00026-3; Gray JX, 1996, J IMMUNOL, V157, P5438; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Lee HK, 2006, FEBS LETT, V580, P2253, DOI 10.1016/j.febslet.2006.03.033; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; St Croix B, 2000, SCIENCE, V289, P1197; Varner Judith A., 1996, P69; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Yamamoto Y, 2004, ONCOGENE, V23, P3889, DOI 10.1038/sj.onc.1207495	17	65	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34179	34188		10.1074/jbc.M605291200	http://dx.doi.org/10.1074/jbc.M605291200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16982628	hybrid			2022-12-27	WOS:000241767600038
J	Bush, EW; Hood, DB; Papst, PJ; Chapo, JA; Minobe, W; Bristow, MR; Olson, EN; McKinsey, TA				Bush, Erik W.; Hood, David B.; Papst, Philip J.; Chapo, Joseph A.; Minobe, Wayne; Bristow, Michael R.; Olson, Eric N.; McKinsey, Timothy A.			Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; CARDIAC-HYPERTROPHY; CATION CHANNELS; TRPC3 CHANNELS; EXPRESSION; INHIBITION; MECHANISM; MYOCYTES; PROTEIN; CELLS	The calcium/calmodulin-dependent phosphatase calcineurin plays a central role in the control of cardiomyocyte hypertrophy in response to pathological stimuli. Although calcineurin is present at high levels in normal heart, its activity appears to be unaffected by calcium during the course of a cardiac cycle. The mechanism(s) whereby calcineurin is selectively activated by calcium under pathological conditions has remained unclear. Here, we demonstrate that diverse signals for cardiac hypertrophy stimulate expression of canonical transient receptor potential (TRPC) channels. TRPC consists of a family of seven membrane-spanning nonselective cation channels that have been implicated in the nonvoltage-gated influx of calcium in response to G protein-coupled receptor signaling, receptor tyrosine kinase signaling, and depletion of internal calcium stores. TRPC3 expression is up-regulated in multiple rodent models of pathological cardiac hypertrophy, whereas TRPC5 expression is induced in failing human heart. We demonstrate that TRPC promotes cardiomyocyte hypertrophy through activation of calcineurin and its downstream effector, the nuclear factor of activated T cells transcription factor. These results define a novel role for TRPC channels in the control of cardiac growth, and suggest that a TRPC-derived pool of calcium contributes to selective activation of calcineurin in diseased heart.	Myogen Inc, Westminster, CO 80021 USA; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA; Univ Colorado, Hlth Sci Ctr, Div Cardiol, Denver, CO 80262 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Bush, EW (corresponding author), Myogen Inc, Westminster, CO 80021 USA.	erik.bush@myogen.com	bristow, michael r/G-7850-2011					Barritt G, 2005, NAT CELL BIOL, V7, P105, DOI 10.1038/ncb0205-105; Bush E, 2004, P NATL ACAD SCI USA, V101, P2870, DOI 10.1073/pnas.0308723101; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Harrison BC, 2004, MOL CELL BIOL, V24, P10636, DOI 10.1128/MCB.24.24.10636-10649.2004; HASS GJ, 1995, AM HEART J, V130, P806, DOI 10.1016/0002-8703(95)90081-0; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hunton DL, 2004, AM J PHYSIOL-HEART C, V286, pH1124, DOI 10.1152/ajpheart.00162.2003; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; Kunichika N, 2004, AM J RESP CRIT CARE, V170, P1101, DOI 10.1164/rccm.200312-1668OC; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lievremont JP, 2005, MOL PHARMACOL, V68, P758, DOI 10.1124/mol.105.012856; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; NILIUS B, 2005, SCI STKE, pRE8; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Putney JW, 2005, PFLUG ARCH EUR J PHY, V451, P29, DOI 10.1007/s00424-005-1416-4; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Seth M, 2004, P NATL ACAD SCI USA, V101, P16683, DOI 10.1073/pnas.0407537101; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Venkatesh N, 2004, P NATL ACAD SCI USA, V101, P8969, DOI 10.1073/pnas.0402803101; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	35	222	234	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33487	33496		10.1074/jbc.M605536200	http://dx.doi.org/10.1074/jbc.M605536200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950785	hybrid			2022-12-27	WOS:000241621400059
J	Yan, FF; Casey, J; Shyng, SL				Yan, Fei-Fei; Casey, Jillene; Shyng, Show-Ling			Sulfonylureas correct trafficking defects of disease-causing ATP-sensitive potassium channels by binding to the channel complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING MUTATIONS; SUBUNIT STOICHIOMETRY; INSULIN-SECRETION; TOLBUTAMIDE SITE; KIR6.2; RECEPTOR; SUR1; GLIBENCLAMIDE; IDENTIFICATION; REPAGLINIDE	ATP-sensitive potassium (K-ATP) channels mediate glucose-induced insulin secretion by coupling metabolic signals to beta-cell membrane potential and the secretory machinery. Reduced K-ATP channel expression caused by mutations in the channel proteins: sulfonylurea receptor 1 (SUR1) and Kir6.2, results in loss of channel function as seen in congenital hyperinsulinism. Previously, we reported that sulfonylureas, oral hypoglycemic drugs widely used to treat type II diabetes, correct the endoplasmic reticulum to the plasma membrane trafficking defect caused by two SUR1 mutations, A116P and V187D. In this study, we investigated the mechanism by which sulfonylureas rescue these mutants. We found that glinides, another class of SUR-binding hypoglycemic drugs, also markedly increased surface expression of the trafficking mutants. Attenuating or abolishing the ability of mutant SUR1 to bind sulfonylureas or glinides by the following mutations: Y230A, S1238Y, or both, accordingly diminished the rescuing effects of the drugs. Interestingly, rescue of the trafficking defects requires mutant SUR1 to be co-expressed with Kir6.2, suggesting that the channel complex, rather than SUR1 alone, is the drug target. Observations that sulfonylureas also reverse trafficking defects caused by neonatal diabetes-associated Kir6.2 mutations in a way that is dependent on intact sulfonylurea binding sites in SUR1 further support this notion. Our results provide insight into the mechanistic and structural basis on which sulfonylureas rescue K-ATP channel surface expression defects caused by channel mutations.	Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA	Oregon Health & Science University	Shyng, SL (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057699] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK57699, R01 DK057699] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 2006, BIOCHEM SOC T, V34, P243, DOI 10.1042/BST0340243; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Babenko AP, 1999, FEBS LETT, V459, P367, DOI 10.1016/S0014-5793(99)01215-6; BROWN GR, 1984, J MED CHEM, V27, P79, DOI 10.1021/jm00367a016; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Cartier EA, 2003, J BIOL CHEM, V278, P7081, DOI 10.1074/jbc.M211395200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Conti LR, 2001, J BIOL CHEM, V276, P41270, DOI 10.1074/jbc.M106555200; Crane A, 2004, J BIOL CHEM, V279, P9080, DOI 10.1074/jbc.M311079200; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Grell W, 1998, J MED CHEM, V41, P5219, DOI 10.1021/jm9810349; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gros L, 1999, BIOCHEM BIOPH RES CO, V257, P766, DOI 10.1006/bbrc.1999.0529; Hansen AMK, 2005, BRIT J PHARMACOL, V144, P551, DOI 10.1038/sj.bjp.0706082; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Hoy M, 2000, J PHYSIOL-LONDON, V527, P109, DOI 10.1111/j.1469-7793.2000.00109.x; Huopio H, 2002, AM J PHYSIOL-ENDOC M, V283, pE207, DOI 10.1152/ajpendo.00047.2002; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Melander A, 2004, DIABETES, V53, pS151, DOI 10.2337/diabetes.53.suppl_3.S151; Mikhailov MV, 2002, BIOCHEM SOC T, V30, P323, DOI 10.1042/BST0300323; Mikhailov MV, 2000, J BIOL CHEM, V275, P3360, DOI 10.1074/jbc.275.5.3360; Mikhailov MV, 2001, FEBS LETT, V499, P154, DOI 10.1016/S0014-5793(01)02538-8; Neagoe I, 2005, J MOL CELL CARDIOL, V38, P887, DOI 10.1016/j.yjmcc.2004.11.023; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Quast U, 2004, DIABETES, V53, pS156, DOI 10.2337/diabetes.53.suppl_3.S156; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Renstrom E, 2002, DIABETES, V51, pS33, DOI 10.2337/diabetes.51.2007.S33; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; Schultz BD, 1996, AM J PHYSIOL-LUNG C, V271, pL192, DOI 10.1152/ajplung.1996.271.2.L192; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; Tonini G, 2006, DIABETOLOGIA, V49, P2210, DOI 10.1007/s00125-006-0329-x; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	49	47	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33403	33413		10.1074/jbc.M605195200	http://dx.doi.org/10.1074/jbc.M605195200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956886	hybrid			2022-12-27	WOS:000241621400050
J	Norstrom, EA; Tran, S; Steen, M; Dahlback, B				Norstrom, Eva A.; Tran, Sinh; Steen, Marten; Dahlback, Bjorn			Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-DERIVED MICROPARTICLES; PEPTIDE-BOND CLEAVAGES; BLOOD-COAGULATION; BINDING-SITE; ANTICOAGULANT ACTIVITY; THROMBOTIC DISEASE; FACTOR VA(R506Q); HEAVY-CHAIN; HONG-KONG; INACTIVATION	Activated protein C inhibits the procoagulant function of activated factor V (FVa) through proteolytic cleavages at Arg-306, Arg-506, and Arg-679. The cleavage at Arg-506 is kinetically favored but protected by factor Xa (FXa). Protein S has been suggested to annihilate the inhibitory effect of FXa, a proposal that has been challenged. To elucidate the effects of FXa and protein S on the individual cleavage sites of FVa, we used recombinant FVa:Q306/Q679 and FVa: Q506/Q679 variants, which can only be cleaved at Arg-506 and Arg-306, respectively. In the presence of active site blocked FXa (FXa-1.5-dansyl-GluGly-Arg), the FVa inactivation was followed over time, and apparent second order rate constants were calculated. Consistent with results on record, we observed that FXa-1.5-dansylGlu-Gly- Arg decreased the Arg-506 cleavage by 20-fold, with a half-maximum inhibition of similar to 2 nM. Interestingly and in contrast to the inhibitory effect of FXa on the 506 cleavage, FXa stimulated the Arg-306 cleavage. Protein S counteracted the inhibition by FXa of the Arg-506 cleavage, whereas protein S and FXa yielded additive stimulatory effect of the cleavage at Arg-306. This suggests that FXa and protein S interact with distinct sites on FVa, which is consistent with the observed lack of inhibitory effect on FXa binding to FVa by protein S. We propose that the apparent annihilation of the FXa protection of the Arg-506 cleavage by protein S is due to an enhanced rate of Arg-506 cleavage of FVa not bound to FXa, resulting in depletion of free FVa and dissociation of FXa-FVa complexes.	Lund Univ, Dept Lab Med Clin Chem, Lund, Sweden; Univ Hosp Malmo, Wallenberg Lab, SE-20502 Malmo, Sweden	Lund University; Lund University; Skane University Hospital	Dahlback, B (corresponding author), Lund Univ, Dept Lab Med Clin Chem, Lund, Sweden.	bjorn.dahlback@med.lu.se		Dahlback, Bjorn/0000-0003-1546-0328				Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; BAKKER HM, 1994, J BIOL CHEM, V269, P20662; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Chan WP, 1998, BLOOD, V91, P1135, DOI 10.1182/blood.V91.4.1135; DAHLBACK B, 1983, BIOCHEM J, V209, P837, DOI 10.1042/bj2090837; DAHLBACK B, 1992, BIOCHEMISTRY-US, V31, P12769, DOI 10.1021/bi00166a009; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; FISKE CH, 1925, J BIOL CHEM, V66, P374; Franco RF, 1998, BRIT J HAEMATOL, V103, P888; Gale AJ, 1997, PROTEIN SCI, V6, P132; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Kalafatis M, 2002, BIOCHEMISTRY-US, V41, P12715, DOI 10.1021/bi026208+; Kalafatis M, 2001, ADV EXP MED BIOL, V489, P31; KALAFATIS M, 1995, J BIOL CHEM, V270, P4053, DOI 10.1074/jbc.270.8.4053; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; Mann KG, 1997, J BIOL CHEM, V272, P20678, DOI 10.1074/jbc.272.33.20678; NESHEIM ME, 1982, J BIOL CHEM, V257, P1443; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Norstrom E, 2002, BLOOD, V100, P524, DOI 10.1182/blood-2002-02-0343; Norstrom EA, 2003, J BIOL CHEM, V278, P24904, DOI 10.1074/jbc.M303829200; Rosing J, 1997, THROMB HAEMOSTASIS, V78, P427; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; ROSING J, 1980, J BIOL CHEM, V255, P274; Shen L, 1997, BIOCHEMISTRY-US, V36, P16025, DOI 10.1021/bi971730v; Shen MC, 2001, THROMB HAEMOSTASIS, V85, P270; Smirnov MD, 1999, BLOOD, V94, P3839, DOI 10.1182/blood.V94.11.3839.423k07_3839_3846; SOLYMOSS S, 1988, J BIOL CHEM, V263, P14884; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Sun YH, 2004, J BIOL CHEM, V279, P47528, DOI 10.1074/jbc.M407366200; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; TANS G, 1991, BLOOD, V77, P2641; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; Williamson D, 1998, BLOOD, V91, P1140, DOI 10.1182/blood.V91.4.1140	43	24	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31486	31494		10.1074/jbc.M606441200	http://dx.doi.org/10.1074/jbc.M606441200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16935856	Green Submitted, Bronze			2022-12-27	WOS:000241235300033
J	Zhou, XY; Yang, WX; Li, JY				Zhou, Xueyuan; Yang, Wenxiu; Li, Junying			Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-kappa B activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; MEDIATED INHIBITION; MURINE MACROPHAGES; RECEPTOR AGONISTS; BINDING PROTEIN; IKK; TNF; PHOSPHORYLATION	Lipopolysaccharide (LPS)-activated macrophages are pivotal in innate immunity. With LPS treatment, extracellular signals are transduced into macrophages via Toll-like receptor 4 and induce inflammatory mediator production by activating signaling pathways, including the nuclear factor-kappa B (NF-kappa B) pathway and the mitogen-activated protein kinase (MAPK) pathway. However, the mechanisms by which the intracellular free Ca2+ concentration ([Ca2+](i)) increases and protein kinase C (PKC) is activated remain unclear. Therefore, we investigated the signaling pathway for Ca2+- and PKC-dependent NF-kappa B activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-alpha (TNF-alpha) production in LPS-stimulated rat peritoneal macrophages. The results demonstrated that the LPS- induced transient ([Ca2+](i)) increase is due to Ca2+ release and influx. Extracellular and intracellular Ca2+ chelators inhibited phosphorylation of PKC alpha and PKC beta. A PKC beta-specific and a general PKC inhibitor blunted phosphorylation of serine in mitogen-activated/extracellular signal-regulated kinase kinase kinase (MEKK) 1. Moreover, aMEKK inhibitor reduced activation of inhibitory kappa B kinase and NF-kappa B. Upstream of the [Ca2+](i) increase, a proteintyrosine kinase inhibitor reduced phosphorylation of phospholipase C (PLC) gamma. Furthermore, a PLC inhibitor eliminated the Ktransient [Ca2+](i) )increase and decreased the amount of activated PKC. Therefore, these results revealed the following roles of Ca2+- and PKC in the signaling pathway for NF-kappa B activation in LPS-stimulated macrophages. After LPS treatment, protein-tyrosine kinase mediates PLC gamma 1/2 phosphorylation, which is followed by a [Ca2+](i) increase. Several PKCs are activated, and PKC beta regulates phosphorylation of serine in MEKK1. Moreover, MEKKs regulate inhibitory kappa B kinase activation. Sequentially, NF-kappa B is activated, and inducible nitric-oxide synthase and tumor necrosis factor-alpha production is promoted.	Nankai Univ, Dept Biophys, Tianjin 300071, Peoples R China; Nankai Univ, Sch Phys, Key Lab Bioact Mat Educ Minist, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Yang, WX (corresponding author), Nankai Univ, Dept Biophys, Tianjin 300071, Peoples R China.	yangwenx@nankai.edu.cn						Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659; Aki D, 2005, GENES CELLS, V10, P357, DOI 10.1111/j.1365-2443.2005.00839.x; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Chadee DN, 2002, MOL CELL BIOL, V22, P737, DOI 10.1128/MCB.22.3.737-749.2002; Chandrasekar B, 2004, BIOCHEM BIOPH RES CO, V319, P304, DOI 10.1016/j.bbrc.2004.04.185; Chen F, 1999, CLIN CHEM, V45, P7; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Cuschieri J, 2004, J SURG RES, V121, P76, DOI 10.1016/j.jss.2004.04.005; Dos Santos CC, 2000, J APPL PHYSIOL, V89, P1645, DOI 10.1152/jappl.2000.89.4.1645; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Fronhofer V, 2006, J LEUKOCYTE BIOL, V79, P408, DOI 10.1189/jlb.0805438; FUJIHARA M, 1994, J BIOL CHEM, V269, P12773; GEPPERT TD, 1994, MOL MED, V1, P93; Gertsch J, 2004, FEBS LETT, V577, P563, DOI 10.1016/j.febslet.2004.10.064; Greenberg SS, 1998, ALCOHOL, V16, P167, DOI 10.1016/S0741-8329(97)00187-0; Haddad JJE, 2001, BIOCHEM J, V355, P29, DOI 10.1042/bj3550029; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Hsu HY, 2004, J IMMUNOL, V173, P5989, DOI 10.4049/jimmunol.173.10.5989; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kim MJ, 2000, EXP MOL MED, V32, P101, DOI 10.1038/emm.2000.18; Lee HZ, 2000, EUR J PHARMACOL, V403, P195, DOI 10.1016/S0014-2999(00)00495-7; LETARI O, 1991, J IMMUNOL, V147, P980; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; Mancuso G, 2005, INFECT IMMUN, V73, P5620, DOI 10.1128/IAI.73.9.5620-5627.2005; Marshall JC, 2001, CRIT CARE MED, V29, pS99, DOI 10.1097/00003246-200107001-00032; Matsubara M, 2005, BIOCHEM PHARMACOL, V69, P433, DOI 10.1016/j.bcp.2004.10.006; Matsuguchi T, 2003, EMBO J, V22, P4455, DOI 10.1093/emboj/cdg438; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Rangaswami H, 2005, J BIOL CHEM, V280, P19381, DOI 10.1074/jbc.M414204200; REIMANN T, 1994, J IMMUNOL, V153, P5740; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Seabra V, 1998, J LEUKOCYTE BIOL, V64, P615, DOI 10.1002/jlb.64.5.615; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Shen FM, 2004, SHOCK, V21, P556, DOI 10.1097/01.shk.0000126647.51109.5c; Shinji H, 1997, J IMMUNOL, V158, P1370; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; [王辉 Wang Hui], 2002, [生物物理学报, Acta Biophysica Sinica], V18, P345; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wheeler M, 2000, FASEB J, V14, P476, DOI 10.1096/fasebj.14.3.476; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355; Zhong J, 2004, MOL CELL BIOL, V24, P9165, DOI 10.1128/MCB.24.20.9165-9175.2004; Zhou LM, 2003, AM J RESP CELL MOL, V28, P762, DOI 10.1165/rcmb.2002-0261OC	50	132	138	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31337	31347		10.1074/jbc.M602739200	http://dx.doi.org/10.1074/jbc.M602739200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16923814				2022-12-27	WOS:000241235300018
J	Gherghe, C; Weeks, KM				Gherghe, Cristina; Weeks, Kevin M.			The SL1-SL2 (stem-loop) domain is the primary determinant for stability of the gamma retroviral genomic RNA dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE-LEUKEMIA-VIRUS; ENCAPSIDATION SIGNAL; DIMERIZATION; RECOMBINATION; SEQUENCES; VIRIONS; REGION; COMPLEMENTARITY; IDENTIFICATION; PREDICTION	Retroviral genomes are assembled from two sense-strand RNAs by noncovalent interactions at their 5' ends, forming a dimer. The RNA dimerization domain is a potential target for antiretroviral therapy and represents a compelling RNA folding problem. The fundamental dimerization unit for the Moloney murine sarcoma gamma retrovirus spans a 170-nucleotide minimal dimerization active sequence. In the dimer, two self-complementary sequences, PAL1 and PAL2, form intermolecular duplexes, and an SL1-SL2 (stem-loop) domain forms loop-loop base pairs, mediated by GACG tetraloops, and extensive tertiary interactions. To develop a framework for assembly of the retroviral RNA dimer, we quantified the stability of and established nucleotide resolution secondary structure models for sequence variants in which each motif was compromised. Base pairing and tertiary interactions between SL1-SL2 domains contribute a large free energy increment of -10 kcal/mol. In contrast, even though the PAL1 and PAL2 intermolecular duplexes span 10 and 16 bp in the dimer, respectively, they contribute only -2.5 kcal/mol to stability, roughly equal to a single new base pair. First, these results emphasize that the energetic costs for disrupting interactions in the monomer state nearly balance the PAL1 and PAL2 base pairing interactions that form in the dimer. Second, intermolecular duplex formation plays a biological role distinct from simply stabilizing the structure of the retroviral genomic RNA dimer.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Weeks, KM (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	weeks@unc.edu			NIGMS NIH HHS [GM064803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064803] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM MA, 1988, J VIROL, V62, P3802, DOI 10.1128/JVI.62.10.3802-3806.1988; Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k; Badorrek CS, 2006, P NATL ACAD SCI USA, V103, P13640, DOI 10.1073/pnas.0606156103; Badorrek CS, 2005, NAT CHEM BIOL, V1, P104, DOI 10.1038/nchembio712; BENDER W, 1976, CELL, V7, P595, DOI 10.1016/0092-8674(76)90210-5; BENDER W, 1978, J VIROL, V25, P888, DOI 10.1128/JVI.25.3.888-896.1978; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Coffin J, 1997, RETROVIRUSES; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; D'Souza V, 2004, J MOL BIOL, V337, P427, DOI 10.1016/j.jmb.2004.01.037; D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; De Tapia M, 1998, BIOCHEMISTRY-US, V37, P6077, DOI 10.1021/bi9800303; Evans MJ, 2004, J VIROL, V78, P7677, DOI 10.1128/JVI.78.14.7677-7684.2004; FU W, 1993, J VIROL, V67, P5443, DOI 10.1128/JVI.67.9.5443-5449.1993; GIRARD PM, 1995, BIOCHEMISTRY-US, V34, P9785, DOI 10.1021/bi00030a016; Hibbert CS, 2005, J VIROL, V79, P8142, DOI 10.1128/JVI.79.13.8142-8148.2005; Hibbert CS, 2004, J VIROL, V78, P10927, DOI 10.1128/JVI.78.20.10927-10938.2004; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; Kim CH, 2000, P NATL ACAD SCI USA, V97, P9396, DOI 10.1073/pnas.170283697; KONINGS DAM, 1992, J VIROL, V66, P632, DOI 10.1128/JVI.66.2.632-640.1992; Ly H, 2002, J VIROL, V76, P3135, DOI 10.1128/JVI.76.7.3135-3144.2002; Ly H, 1999, J VIROL, V73, P7255, DOI 10.1128/JVI.73.9.7255-7261.1999; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mikkelsen JG, 2004, NUCLEIC ACIDS RES, V32, P102, DOI 10.1093/nar/gkh159; Monie TP, 2005, BIOCHEMISTRY-US, V44, P294, DOI 10.1021/bi048529m; Mougel M, 1997, J VIROL, V71, P8061, DOI 10.1128/JVI.71.10.8061-8065.1997; MURTI KG, 1981, J VIROL, V37, P411, DOI 10.1128/JVI.37.1.411-419.1981; Oroudjev EM, 1999, J MOL BIOL, V291, P603, DOI 10.1006/jmbi.1999.2984; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Paillart JC, 1996, BIOCHIMIE, V78, P639, DOI 10.1016/S0300-9084(96)80010-1; Rasmussen SV, 2004, VIROLOGY, V329, P440, DOI 10.1016/j.virol.2004.08.027; Rasmussen SV, 2002, J MOL BIOL, V323, P613, DOI 10.1016/S0022-2836(02)00966-X; Sakuragi J, 2001, J VIROL, V75, P2557, DOI 10.1128/JVI.75.6.2557-2565.2001; STUHLMANN H, 1992, J VIROL, V66, P2378, DOI 10.1128/JVI.66.4.2378-2388.1992; TOUNEKTI N, 1992, J MOL BIOL, V223, P205, DOI 10.1016/0022-2836(92)90726-Z; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; WILKINSON KA, 2006, IN PRESS NAT PROTOCO, V1; YANG SL, 1994, EMBO J, V13, P713, DOI 10.1002/j.1460-2075.1994.tb06311.x	41	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37952	37961		10.1074/jbc.M607380200	http://dx.doi.org/10.1074/jbc.M607380200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16984912	hybrid, Green Published			2022-12-27	WOS:000242477100074
J	Canton, DA; Olsten, MEK; Niederstrasser, H; Cooper, JA; Litchfield, DW				Canton, David A.; Olsten, Mary Ellen K.; Niederstrasser, Hanspeter; Cooper, John A.; Litchfield, David W.			The role of CKIP-1 in cell morphology depends on its interaction with actin-capping protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; FILAMENT BARBED END; BETA-ACTININ; KINASE CK2; IN-VITRO; CAPZ; POLYMERIZATION; MUSCLE; IDENTIFICATION; MOTILITY	CKIP-1 is a pleckstrin homology domain-containing protein that induces alterations of the actin cytoskeleton and cell morphology when expressed in human osteosarcoma cells. CKIP-1 interacts with the heterodimeric actin-capping protein in cells, so we postulated that this interaction was responsible for the observed cytoskeletal and morphological effects of CKIP-1. To test this postulate, we used peptide "walking arrays" and alignments of CKIP-1 with CARMIL, another CP-binding protein, to identify Arg-155 and Arg-157 of CKIP-1 as residues potentially required for its interactions with CP. CKIP-1 mutants harboring Arg-155 and Arg-157 substitutions exhibited greatly decreased CP binding, while retaining wild-type localization, the ability to interact with protein kinase CK2,and self-association. To examine the phenotype associated with expression of these mutants, we generated tetracycline-inducible human osteosarcoma cells lines expressing R155E, R157E mutants of CKIP-1. Examination of these cell lines reveals that CKIP-1 R155E, R157E did not induce the distinct changes in cell morphology and the actin cytoskeleton that are characteristic of wild-type CKIP-1 demonstrating that the interaction between CKIP-1 and CP is required for these cellular effects.	Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent,Siebens Drake Med Res Ins, Regulatory Biol & Funct Genom Res Grp, London, ON N6A 5C1, Canada; Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Western University (University of Western Ontario); Washington University (WUSTL)	Litchfield, DW (corresponding author), Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent,Siebens Drake Med Res Ins, Regulatory Biol & Funct Genom Res Grp, Med Sci Bldg, London, ON N6A 5C1, Canada.	litchfi@uwo.ca	Litchfield, David/E-4636-2015; Cooper, John/E-9389-2012; Canton, David/N-7463-2015; Cooper, John/D-4448-2014	Litchfield, David/0000-0002-2425-6620; Cooper, John/0000-0002-0933-4571	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038542-20, R01 GM038542, GM38542] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alto N, 2002, DIABETES, V51, pS385, DOI 10.2337/diabetes.51.2007.S385; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; BOSC DG, 1995, J BIOL CHEM, V270, P25872, DOI 10.1074/jbc.270.43.25872; Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; DiNubile MJ, 1997, BBA-MOL CELL RES, V1358, P261, DOI 10.1016/S0167-4889(97)00076-1; Dodge K, 2000, FEBS LETT, V476, P58, DOI 10.1016/S0014-5793(00)01671-9; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Eyers CE, 2005, BIOCHEM J, V389, P127, DOI 10.1042/BJ20050387; Falck S, 2004, EMBO J, V23, P3010, DOI 10.1038/sj.emboj.7600310; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; HAUS U, 1991, BIOCHEM BIOPH RES CO, V181, P833, DOI 10.1016/0006-291X(91)91265-E; HEISS SG, 1991, BIOCHEMISTRY-US, V30, P8753, DOI 10.1021/bi00100a006; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kitazawa M, 2005, BIOCHEM BIOPH RES CO, V331, P181, DOI 10.1016/j.bbrc.2005.03.127; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; MARUYAMA K, 1990, J BIOL CHEM, V265, P8712; Olsten MEK, 2004, J BIOL CHEM, V279, P42114, DOI 10.1074/jbc.M407628200; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Remmert K, 2004, J BIOL CHEM, V279, P3068, DOI 10.1074/jbc.M308829200; Safi A, 2004, MOL CELL BIOL, V24, P1245, DOI 10.1128/MCB.24.3.1245-1255.2004; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Soeno Y, 1998, J MUSCLE RES CELL M, V19, P639, DOI 10.1023/A:1005329114263; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Tegge WJ, 1998, METH MOL B, V87, P99; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Zhang LQ, 2005, EMBO J, V24, P766, DOI 10.1038/sj.emboj.7600532	42	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36347	36359		10.1074/jbc.M607595200	http://dx.doi.org/10.1074/jbc.M607595200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16987810	Green Accepted, hybrid			2022-12-27	WOS:000242100500086
J	Ding, MG; di Rago, JP; Trumpower, BL				Ding, Martina G.; di Rago, Jean-Paul; Trumpower, Bernard L.			Investigating the Q(n) site of the cytochrome bc(1) complex in Saccharomyces cerevisiae with mutants resistant to ilicicolin H, a novel Q(n) site inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL BC(1) COMPLEX; C REDUCTASE; ELECTRON-TRANSFER; SEQUENCE-ANALYSIS; DIURON-RESISTANT; MOLECULAR-BASIS; QI SITE; Q-CYCLE; B GENE; ANTIMYCIN	The cytochrome bc(1) complex resides in the inner membrane of mitochondria and transfers electrons from ubiquinol to cytochrome c. This electron transfer is coupled to the translocation of protons across the membrane by the protonmotive Q cycle mechanism. This mechanism topographically separates reduction of quinone and reoxidation of quinol at sites on opposite sites of the membrane, referred to as center N (Q(n) site) and center P (Q(p) site), respectively. Both are located on cytochrome b, a transmembrane protein of the bc1 complex that is encoded on the mitochondrial genome. To better understand the parameters that affect ligand binding at the Qn site, we applied the Qn site inhibitor ilicicolin H to select for mutations conferring resistance in Saccharomyces cerevisiae. The screen resulted in seven different single amino acid substitutions in cytochrome b rendering the yeast resistant to the inhibitor. Six of the seven mutations have not been previously linked to inhibitor resistance. Ubiquinol-cytochrome c reductase activities of mitochondrial membranes isolated from the mutants confirmed that the differences in sensitivity toward ilicicolin H originated in the cytochrome bc1 complex. Comparative in vivo studies using the known Qn site inhibitors antimycin and funiculosin showed little cross-resistance, indicating different modes of binding of these inhibitors at center N of the bc1 complex.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA; Univ Victor Segalen, Inst Biochim & Genet Cellulaires, CNRS, F-33077 Bordeaux, France	Dartmouth College; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Trumpower, BL (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, 7200 Vail, Hanover, NH 03755 USA.	Trumpower@Dartmouth.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020379, R01GM020379] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20379] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDO K, 1969, J ANTIBIOT, V22, P189, DOI 10.7164/antibiotics.22.189; Baggish AL, 2002, ANTIMICROB AGENTS CH, V46, P1163, DOI 10.1128/AAC.46.5.1163-1173.2002; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; BRASSEUR G, 1994, FEBS LETT, V354, P23, DOI 10.1016/0014-5793(94)01077-3; BRIQUET M, 1981, EUR J BIOCHEM, V117, P333, DOI 10.1111/j.1432-1033.1981.tb06342.x; BURGER G, 1976, BIOCHEM BIOPH RES CO, V72, P1201, DOI 10.1016/S0006-291X(76)80258-6; COLSON AM, 1979, MOL GEN GENET, V167, P287, DOI 10.1007/BF00267421; CORIA R, 1989, MOL MICROBIOL, V11, P1599; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; DIRAGO JP, 1990, FEBS LETT, V263, P93, DOI 10.1016/0014-5793(90)80713-S; DIRAGO JP, 1988, J BIOL CHEM, V263, P12564; DIRAGO JP, 1986, FEBS LETT, V208, P208, DOI 10.1016/0014-5793(86)81019-5; ENDO T, 1970, J ANTIBIOT, V23, P91, DOI 10.7164/antibiotics.23.91; ESPOSTI MD, 1992, ARCH BIOCHEM BIOPHYS, V295, P198, DOI 10.1016/0003-9861(92)90506-R; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gutierrez-Cirlos EB, 2004, J BIOL CHEM, V279, P8708, DOI 10.1074/jbc.M311805200; HOWELL N, 1988, J MOL BIOL, V203, P607, DOI 10.1016/0022-2836(88)90195-7; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Kim H, 1999, J AM CHEM SOC, V121, P4902, DOI 10.1021/ja990190h; LEMESLEMEUNIER D, 1993, J BIOL CHEM, V268, P15626; Margoliash E, 1967, METHOD ENZYMOL, V10, P339; MICHAELIS G, 1976, MOL GEN GENET, V146, P133, DOI 10.1007/BF00268081; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; PRATJE E, 1977, MOL GEN GENET, V152, P167, DOI 10.1007/BF00268814; RAPER RB, 1949, MANUAL PENICILLIA, P216; SCHMITT ME, 1991, J BIOL CHEM, V266, P14958; SIDHU A, 1983, J BIOL CHEM, V258, P649; SUBIK J, 1986, CURR GENET, V10, P665, DOI 10.1007/BF00410914; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P102; TRUMPOWER BL, 2004, ENCY BIOL CHEM, V1, P528; TSAI AL, 1985, BIOCHIM BIOPHYS ACTA, V806, P418, DOI 10.1016/0005-2728(85)90249-X; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253	35	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36036	36043		10.1074/jbc.M608026200	http://dx.doi.org/10.1074/jbc.M608026200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16987808	hybrid			2022-12-27	WOS:000242100500052
J	Fass, E; Shvets, E; Degani, I; Hirschberg, K; Elazar, Z				Fass, Ephraim; Shvets, Elena; Degani, Ilan; Hirschberg, Koret; Elazar, Zvulun			Microtubules support production of starvation-induced autophagosomes but not their targeting and fusion with lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; SACCHAROMYCES-CEREVISIAE; PROTEIN-DEGRADATION; TRANSPORT MODULATOR; MEMBRANE-TRANSPORT; CELLS; GATE-16; VACUOLES; GABARAP; MUTANTS	Autophagy is a major catabolic pathway in eukaryotic cells whereby the lack of amino acids induces the formation of autophagosomes, double-bilayer membrane vesicles that mediate delivery of cytosolic proteins and organelles for lysosomal degradation. The biogenesis and turnover of autophagosomes in mammalian cells as well as the molecular mechanisms underlying induction of autophagy and trafficking of these vesicles are poorly understood. Here we utilized different autophagic markers to determine the involvement of microtubules in the autophagic process. We show that autophagosomes associate with microtubules and concentrate near the microtubule-organizing center. Moreover, we demonstrate that autophagosomes, but not phagophores, move along these tracks en route for degradation. Disruption of microtubules leads to a significant reduction in the number of mature autophagosomes but does not affect their life span or their fusion with lysosomes. We propose that microtubules serve to deliver only mature autophagosomes for degradation, thus providing a spatial barrier between phagophores and lysosomes.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Elazar, Z (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	bmzevi@wicc.weizmann.ac.il						APLIN A, 1992, J CELL PHYSIOL, V152, P458, DOI 10.1002/jcp.1041520304; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; HAMMING RW, 1991, ART PROBABILITY SCI, P145; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; KOVACS AL, 1982, ACTA BIOL MED GER, V41, P125; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; MANN SS, 1994, J BIOL CHEM, V269, P11492; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mousavi SA, 2001, BBA-BIOMEMBRANES, V1510, P243, DOI 10.1016/S0005-2736(00)00354-0; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; PUNNONEN EL, 1990, EXP MOL PATHOL, V52, P87, DOI 10.1016/0014-4800(90)90061-H; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; REUNANEN H, 1988, EXP MOL PATHOL, V48, P97, DOI 10.1016/0014-4800(88)90048-2; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; SCHEEL J, 1990, J CELL SCI, V96, P711; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; Seglen PO, 1996, ADV EXP MED BIOL, V389, P103; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shorer H, 2005, J BIOL CHEM, V280, P16219, DOI 10.1074/jbc.M500554200; Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	44	225	232	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36303	36316		10.1074/jbc.M607031200	http://dx.doi.org/10.1074/jbc.M607031200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16963441	hybrid			2022-12-27	WOS:000242100500082
J	Chmelar, RS; Nathanson, NM				Chmelar, Renee S.; Nathanson, Neil M.			Identification of a novel apical sorting motif and mechanism of targeting of the M-2 muscarinic acetylcholine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; POLARIZED EPITHELIAL-CELLS; POLYMERIC IMMUNOGLOBULIN RECEPTOR; INFLUENZA-VIRUS HEMAGGLUTININ; GPI-ANCHORED PROTEINS; TRANS-GOLGI NETWORK; MDCK CELLS; PLASMA-MEMBRANE; CYTOPLASMIC DOMAIN; N-GLYCOSYLATION	Previous studies have shown that the M-2 receptor is localized at steady state to the apical domain in Madin-Darby canine kidney (MDCK) epithelial cells. In this study, we identify the molecular determinants governing the localization and the route of apical delivery of the M-2 receptor. First, by confocal analysis of a transiently transfected glycosylation mutant in which the three putative glycosylation sites were mutated, we determined that N-glycans are not necessary for the apical targeting of the M-2 receptor. Next, using a chimeric receptor strategy, we found that two independent sequences within the M-2 third intracellular loop can confer apical targeting to the basolaterally targeted M-4 receptor, Val(270)-Lys(280) and Lys(280)-Ser(350). Experiments using Triton X-100 extraction followed by OptiPrep (TM) density gradient centrifugation and cholera toxin beta-subunit-induced patching demonstrate that apical targeting is not because of association with lipid rafts. S-35-Metabolic labeling experiments with domain-specific surface biotinylation as well as immunocytochemical analysis of the time course of surface appearance of newly transfected confluent MDCK cells expressing FLAG-M(2)(-)GFP demonstrate that the M-2 receptor achieves its apical localization after first appearing on the basolateral domain. Domain-specific application of tannic acid of newly transfected cells indicates that initial basolateral plasma membrane expression is required for subsequent apical localization. This is the first demonstration that a G-protein-coupled receptor achieves its apical localization in MDCK cells via transcytosis.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nathanson, NM (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Box 357750, Seattle, WA 98195 USA.	nathanso@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026920] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS26920] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adair-Kirk TL, 2003, J CELL SCI, V116, P655, DOI 10.1242/jcs.00260; Alonso MA, 1997, J BIOL CHEM, V272, P30748, DOI 10.1074/jbc.272.49.30748; Aroeti B, 1998, BBA-REV BIOMEMBRANES, V1376, P57, DOI 10.1016/S0304-4157(98)00005-7; Barman S, 2001, VIRUS RES, V77, P61, DOI 10.1016/S0168-1702(01)00266-0; BARTLES JR, 1988, TRENDS BIOCHEM SCI, V13, P181, DOI 10.1016/0968-0004(88)90147-8; Bastaki M, 2002, MOL BIOL CELL, V13, P225, DOI 10.1091/mbc.01-07-0376; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; Breuza L, 2002, EXP CELL RES, V273, P178, DOI 10.1006/excr.2001.5442; Brown A, 2004, AM J PHYSIOL-CELL PH, V286, pC1071, DOI 10.1152/ajpcell.00291.2003; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Burgos PV, 2004, P NATL ACAD SCI USA, V101, P3845, DOI 10.1073/pnas.0400295101; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; Cheng CL, 2002, J NEUROSCI, V22, P10643; Chicka MC, 2003, J BIOL CHEM, V278, P18464, DOI 10.1074/jbc.M301482200; Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245; Corbeil D, 1999, J CELL SCI, V112, P1023; Dempsey PJ, 2003, EXP CELL RES, V285, P159, DOI 10.1016/S0014-4827(03)00035-1; Dunbar LA, 2000, J CELL BIOL, V148, P769, DOI 10.1083/jcb.148.4.769; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Fullekrug J, 2004, ANN NY ACAD SCI, V1014, P164, DOI 10.1196/annals.1294.017; Goldman PS, 1996, J BIOL CHEM, V271, P4215; GREEN RF, 1981, J CELL BIOL, V89, P230, DOI 10.1083/jcb.89.2.230; Gut A, 1998, J BIOL CHEM, V273, P29381, DOI 10.1074/jbc.273.45.29381; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; HOBERT M, 1995, J CELL PHYSIOL, V162, P434, DOI 10.1002/jcp.1041620316; Hodson CA, 2006, TRAFFIC, V7, P456, DOI 10.1111/j.1600-0854.2006.00398.x; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; Inukai K, 2004, MOL ENDOCRINOL, V18, P339, DOI 10.1210/me.2003-0089; Iverson HA, 2005, J BIOL CHEM, V280, P24568, DOI 10.1074/jbc.M501264200; Jacob R, 1999, J BIOL CHEM, V274, P8061, DOI 10.1074/jbc.274.12.8061; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jolimay N, 2000, J NEUROSCI, V20, P9111; Karim-Jimenez Z, 2000, P NATL ACAD SCI USA, V97, P2916, DOI 10.1073/pnas.97.6.2916; KEEFER JR, 1993, J BIOL CHEM, V268, P11340; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; LUETJE CW, 1987, BIOCHEMISTRY-US, V26, P6892, DOI 10.1021/bi00396a003; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; Marzolo MP, 1997, P NATL ACAD SCI USA, V94, P1834, DOI 10.1073/pnas.94.5.1834; Marzolo MP, 2003, TRAFFIC, V4, P273, DOI 10.1034/j.1600-0854.2003.00081.x; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Matthews P, 2000, SIGHT SOUND, V10, P42; Meerson NR, 2000, J CELL SCI, V113, P4193; MONLAUZEUR L, 1995, J BIOL CHEM, V270, P12219, DOI 10.1074/jbc.270.20.12219; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Muth TR, 1998, J BIOL CHEM, V273, P25616, DOI 10.1074/jbc.273.40.25616; Nadler LS, 2001, J BIOL CHEM, V276, P10539, DOI 10.1074/jbc.M007190200; Newman TM, 1996, AM J RESP CELL MOL, V15, P529, DOI 10.1165/ajrcmb.15.4.8879187; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Odorizzi G, 1997, J BIOL CHEM, V272, P11757, DOI 10.1074/jbc.272.18.11757; Orzech E, 1999, J BIOL CHEM, V274, P2201, DOI 10.1074/jbc.274.4.2201; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Pang S, 2004, J CELL SCI, V117, P5079, DOI 10.1242/jcs.01386; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; PETERSON GL, 1986, BIOCHEMISTRY-US, V25, P3189, DOI 10.1021/bi00359a017; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Prydz K, 2001, BIOCHEM J, V357, P11, DOI 10.1042/0264-6021:3570011; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Regeer RR, 2004, AM J PHYSIOL-CELL PH, V287, pC365, DOI 10.1152/ajpcell.00502.2003; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; ROTH MG, 1979, P NATL ACAD SCI USA, V76, P6430, DOI 10.1073/pnas.76.12.6430; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saunders C, 1998, J BIOL CHEM, V273, P24196, DOI 10.1074/jbc.273.37.24196; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schmidt K, 2001, J BIOL CHEM, V276, P14315, DOI 10.1074/jbc.M006221200; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; Slimane TA, 2001, EXP CELL RES, V270, P45, DOI 10.1006/excr.2001.5337; Spodsberg N, 2001, J BIOL CHEM, V276, P46597, DOI 10.1074/jbc.M108187200; Sun AQ, 1998, AM J PHYSIOL-GASTR L, V275, pG1045, DOI 10.1152/ajpgi.1998.275.5.G1045; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; Westlake CJ, 2003, BIOCHEMISTRY-US, V42, P14099, DOI 10.1021/bi035333y; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Zheng XL, 1999, J BIOL CHEM, V274, P1596, DOI 10.1074/jbc.274.3.1596	96	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35381	35396		10.1074/jbc.M605954200	http://dx.doi.org/10.1074/jbc.M605954200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16968700	hybrid			2022-12-27	WOS:000241933700072
J	Han, JW; Leeper, L; Rivero, F; Chung, CY				Han, Ji W.; Leeper, Laura; Rivero, Francisco; Chung, Chang Y.			Role of RacC for the regulation of WASP and phosphatidylinositol 3-kinase during chemotaxis of Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-WASP; ACTIN POLYMERIZATION; CELL POLARITY; RHO-GTPASES; PROTEIN FAMILY; LEADING-EDGE; DISCOIDEUM; COMPLEX; MEMBER; COMPLEMENTARY	WASP family proteins are key players for connecting multiple signaling pathways to F-actin polymerization. To dissect the highly integrated signaling pathways controlling WASP activity, we identified a Rac protein that binds to the GTPase binding domain of WASP. Using two-hybrid and FRET-based functional assays, we identified RacC as a major regulator of WASP. RacC stimulates F-actin assembly in cell-free systems in a WASP-dependent manner. A FRET-based microscopy approach showed local activation of RacC at the leading edge of chemotaxing cells. Cells overexpressing RacC exhibit a significant increase in the level of F-actin polymerization upon cAMP stimulation, which can be blocked by a phosphatidylinositol (PI) 3-kinase inhibitor. Membrane translocation of PI 3-kinase and PI 3,4,5-trisphosphate reporter is absent in racC null cells. Cells overexpressing dominant negative RacC mutants and racC null cells move at a significantly slower speed and show a poor directionality during chemotaxis. Our results suggest that RacC plays an important role in PI 3-kinase activation and WASP activation for dynamic regulation of F-actin assembly during Dictyostelium chemotaxis.	Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Univ Cologne, Fak Med, Zentrum Biochem, D-50931 Cologne, Germany; Univ Cologne, Fak Med, Zentrum Mol Med, D-50931 Cologne, Germany	Vanderbilt University; University of Cologne; University of Cologne	Chung, CY (corresponding author), 468 Robinson Res Bldg,MRB 1,1215 21st Ave S Pierc, Nashville, TN 37232 USA.	chang.chung@vanderbilt.edu	Chung, Chang Y/G-7522-2012; Rivero, Francisco/N-2969-2013	Rivero, Francisco/0000-0001-5435-6991	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068097] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068097-04, GM068097, R01 GM068097] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BUSH J, 1993, GENE, V136, P61, DOI 10.1016/0378-1119(93)90448-C; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; de la Roche M, 2005, MOL BIOL CELL, V16, P238, DOI 10.1091/mbc.E04-06-0534; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dumontier M, 2000, J CELL SCI, V113, P2253; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; FUTRELLE RP, 1982, J CELL BIOL, V92, P807, DOI 10.1083/jcb.92.3.807; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Ho HYH, 2001, P NATL ACAD SCI USA, V98, P11306, DOI 10.1073/pnas.211420498; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Kato M, 2005, BIOCHEM BIOPH RES CO, V328, P1058, DOI 10.1016/j.bbrc.2005.01.058; Larochelle DA, 1996, J CELL BIOL, V133, P1321, DOI 10.1083/jcb.133.6.1321; Lee E, 2003, EUKARYOT CELL, V2, P474, DOI 10.1128/EC.2.3.474-485.2003; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Myers SA, 2005, MOL BIOL CELL, V16, P2191, DOI 10.1091/mbc.E04-09-0844; Palmieri SJ, 2000, CELL MOTIL CYTOSKEL, V46, P285, DOI 10.1002/1097-0169(200008)46:4<285::AID-CM6>3.0.CO;2-N; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Park KC, 2004, EMBO J, V23, P4177, DOI 10.1038/sj.emboj.7600368; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rivero F, 1999, MOL BIOL CELL, V10, P1205, DOI 10.1091/mbc.10.4.1205; Rivero F, 2002, J MUSCLE RES CELL M, V23, P737, DOI 10.1023/A:1024423611223; Rivero F, 2001, NUCLEIC ACIDS RES, V29, P1068, DOI 10.1093/nar/29.5.1068; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Seastone DJ, 1998, MOL BIOL CELL, V9, P2891, DOI 10.1091/mbc.9.10.2891; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Takenawa T, 2001, J CELL SCI, V114, P1801; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Ward ME, 2004, P NATL ACAD SCI USA, V101, P970, DOI 10.1073/pnas.0306258101; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	50	36	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35224	35234		10.1074/jbc.M605997200	http://dx.doi.org/10.1074/jbc.M605997200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16968699	Green Accepted, hybrid			2022-12-27	WOS:000241933700056
J	Roh, JB; Lee, MA; Lee, HJ; Kim, SM; Cho, Y; Kim, YJ; Seok, YJ; Park, SJ; Lee, KH				Roh, Jong-Bok; Lee, Mi-Ae; Lee, Hyun-Jung; Kim, Sung-Min; Cho, Yona; Kim, You-Jin; Seok, Yeong-Jae; Park, Soon-Jung; Lee, Kyu-Ho			Transcriptional regulatory cascade for elastase production in Vibrio vulnificus - LuxO activates luxT expression and LuxT represses smcR expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; QUORUM-SENSING SYSTEM; GENE-EXPRESSION; ELASTOLYTIC PROTEASE; HARVEYI LUXR; CHOLERAE; VIRULENCE; PROMOTER; METALLOPROTEASE; ANGUILLARUM	Vibrio vulnificus causes diseases through actions of various virulence factors, including the elastase encoded by the vvpE gene. Through transposon mutagenesis of V. vulnificus, vvpE expression was shown to be increased by luxO mutation. Since the vvpE gene is known to be positively regulated by SmcR via direct binding to the vvpE promoter, the role of LuxO in smcR expression was investigated. The luxAB-transcriptional fusions containing different lengths of the smcR promoter region indicated that the smcR transcription was negatively regulated by LuxO and that a specific upstream region of the smcR gene was required for this repression. Since LuxO is a known member of positive regulators, the negative regulation of smcR transcription by LuxO prompted us to identify the factor(s) linking LuxO and smcR transcription. LuxT was isolated in a ligand fishing experiment using the smcR upstream region as bait, and smcR expression was increased by luxT mutation. Recombinant LuxT bound to a specific upstream region of the smcR gene, -154 to -129 relative to the smcR transcription start site. The expression of luxT was positively regulated by LuxO, and the luxT promoter region contained a putative LuxO-binding site. Mutagenesis of the LuxO-binding site in the luxT promoter region resulted in a loss of transcriptional control by LuxO. Therefore, this study demonstrates a transcriptional regulatory cascade for elastase production, where LuxO activates luxT transcription and LuxT represses smcR transcription.	Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin 449791, Kyunggi Do, South Korea; Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; Yonsei Univ, Coll Med, Brain Korea Project 21, Dept Parasitol, Seoul 133791, South Korea	Hankuk University Foreign Studies; Seoul National University (SNU); Yonsei University; Yonsei University Health System	Lee, KH (corresponding author), Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin 449791, Kyunggi Do, South Korea.	khlee@hufs.ac.kr		Seok, Yeong-Jae/0000-0003-0379-3619; Park, Soon-Jung/0000-0002-0423-1944				[Anonymous], 2001, MOL CLONING LAB MANU; BERMAN S, 1961, J BACTERIOL, V82, P582, DOI 10.1128/JB.82.4.582-588.1961; Croxatto A, 2004, MOL MICROBIOL, V52, P1677, DOI 10.1111/j.1365-2958.2004.04083.x; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Enos-Berlage JL, 2000, J BACTERIOL, V182, P5513, DOI 10.1128/JB.182.19.5513-5520.2000; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Jeong JY, 2004, J BIOL CHEM, V279, P38513, DOI 10.1074/jbc.M406667200; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; KOTHARY MH, 1985, INFECT IMMUN, V50, P534, DOI 10.1128/IAI.50.2.534-540.1985; Lee HJ, 2003, J BACTERIOL, V185, P5891, DOI 10.1128/JB.185.19.5891-5896.2003; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Lin W, 2005, J BACTERIOL, V187, P3013, DOI 10.1128/JB.187.9.3013-3019.2005; Lin YH, 2000, BBA-GENE STRUCT EXPR, V1494, P226, DOI 10.1016/S0167-4781(00)00236-0; Lin YH, 2000, PROTEIN EXPRES PURIF, V20, P87, DOI 10.1006/prep.2000.1285; Liu Z, 2006, J BACTERIOL, V188, P2446, DOI 10.1128/JB.188.7.2446-2453.2006; MARTIN M, 1989, J BACTERIOL, V171, P2406, DOI 10.1128/jb.171.5.2406-2414.1989; McDougald D, 2000, GENE, V248, P213, DOI 10.1016/S0378-1119(00)00117-7; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Miyamoto CM, 2003, MOL MICROBIOL, V48, P537, DOI 10.1046/j.1365-2958.2003.03453.x; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; OLIVER JD, 1986, DIAGN MICR INFEC DIS, V5, P99, DOI 10.1016/0732-8893(86)90112-4; Park KJ, 2004, J BACTERIOL, V186, P3304, DOI 10.1128/JB.186.11.3304-3312.2004; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Rhee JE, 2002, FEMS MICROBIOL LETT, V208, P245; SCHMIDT TM, 1988, APPL ENVIRON MICROB, V54, P2793, DOI 10.1128/AEM.54.11.2793-2797.1988; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Vance RE, 2003, INFECT IMMUN, V71, P2571, DOI 10.1128/IAI.71.5.2571-2576.2003; WRIGHT AC, 1985, INFECT IMMUN, V50, P922, DOI 10.1128/IAI.50.3.922-924.1985; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	42	39	40	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34775	34784		10.1074/jbc.M607844200	http://dx.doi.org/10.1074/jbc.M607844200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16971386	hybrid			2022-12-27	WOS:000241933700009
J	Wietek, C; Cleaver, CS; Ludbrook, V; Wilde, J; White, J; Bell, DJ; Lee, M; Dickson, M; Ray, KP; O'Neill, LAJ				Wietek, Claudia; Cleaver, Catherine S.; Ludbrook, Valerie; Wilde, Jonathan; White, Julia; Bell, David J.; Lee, Michael; Dickson, Marion; Ray, Keith P.; O'Neill, Luke A. J.			I kappa B kinase epsilon interacts with p52 and promotes transactivation via p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-EPSILON; NF-KAPPA-B2 P100; SPLENIC MICROARCHITECTURE; SIGNALING PATHWAY; ONCOPROTEIN BCL-3; VIRAL-INFECTION; GENE-EXPRESSION; DNA-BINDING; ACTIVATION; PHOSPHORYLATION	The members of the NF-kappa B transcription factor family are key regulators of gene expression in the immune response. Different combinations of NF-kappa B subunits not only diverge in timing to induce transcription but also recognize varying sequences of the NF-kappa B-binding site of their target genes. The p52 subunit is generated as a result of processing of NF-kappa B2 p100. Here, we demonstrate that the non-canonical I kappa B kinase is an element of(IKK is an element of) directly interacts with p100. In a transactivation assay, IKK is an element of promoted the ability of p52 to transactivate gene expression. This effect was indirect, requiring p65, which was shown to be part of the IKK is an element of-p52 complex and to be phosphorylated by IKK is an element of. These novel interactions reveal a hitherto unknown function of IKK is an element of in the regulation of the alternative NF-kappa B activation pathway involving p52 and p65.	Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; GlaxoSmithKline Inc, Med Res Ctr, Dept Dis Biol Rheumatol & Inflammat, Stevenage SG1 2NY, Herts, England; GlaxoSmithKline Inc, Med Res Ctr, Dept Pathway Genom Genom & Proteom Sci, Stevenage SG1 2NY, Herts, England	Trinity College Dublin; GlaxoSmithKline; GlaxoSmithKline	Wietek, C (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	wietekc@gmail.com		O'Neill, Luke/0000-0002-4333-2748				Alcamo E, 2002, J EXP MED, V195, P233, DOI 10.1084/jem.20011885; ALKALAY I, 1995, MOL CELL BIOL, V15, P1294; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Civas A, 2006, J BIOL CHEM, V281, P4856, DOI 10.1074/jbc.M506812200; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Eliopoulos AG, 2003, ONCOGENE, V22, P7557, DOI 10.1038/sj.onc.1207120; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Fuller KJ, 1998, BIOTECHNIQUES, V25, P85, DOI 10.2144/98251st04; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Kravchenko VV, 2003, J BIOL CHEM, V278, P26612, DOI 10.1074/jbc.M303001200; Kuai J, 2004, J BIOL CHEM, V279, P53266, DOI 10.1074/jbc.M411037200; Liao GX, 2003, ONCOGENE, V22, P4868, DOI 10.1038/sj.onc.1206761; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Nijnik A, 2003, NUCLEIC ACIDS RES, V31, P1497, DOI 10.1093/nar/gkg231; Nomura F, 2000, GENES CELLS, V5, P191; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; PERKINS ND, 1992, P NATL ACAD SCI USA, V89, P1529, DOI 10.1073/pnas.89.5.1529; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Qing GL, 2005, J BIOL CHEM, V280, P18, DOI 10.1074/jbc.M406619200; Qing GL, 2005, J BIOL CHEM, V280, P9765, DOI 10.1074/jbc.C400502200; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Takeuchi O, 2004, J ENDOTOXIN RES, V10, P252, DOI 10.1179/096805104225005896; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101	54	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34973	34981		10.1074/jbc.M607018200	http://dx.doi.org/10.1074/jbc.M607018200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	17003035	hybrid, Green Published			2022-12-27	WOS:000241933700030
J	Spassieva, S; Seo, JG; Jiang, JC; Bielawski, J; Alvarez-Vasquez, F; Jazwinski, SM; Hannun, YA; Obeid, LM				Spassieva, Stefka; Seo, Jae-Gu; Jiang, James C.; Bielawski, Jacek; Alvarez-Vasquez, Fernando; Jazwinski, S. Michal; Hannun, Yusuf A.; Obeid, Lina M.			Necessary role for the Lag1p motif in (dihydro)ceramide synthase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGEVITY-ASSURANCE GENE; CERAMIDE SYNTHASE; FAMILY-MEMBERS; YEAST; COA; HOMOLOG; PROTEIN; CLONING; GROWTH; TRANSLOCATION	Lag1 (longevity assurance gene 1) homologues, a family of transmembrane proteins found in all eukaryotes, have been shown to be necessary for (dihydro) ceramide synthesis. All Lag1 homologues contain a highly conserved stretch of 52 amino acids known as the Lag1p motif. However, the functional significance of the conserved Lag1p motif for (dihydro) ceramide synthesis is currently unknown. In this work, we have investigated the function of the motif by introducing eight point mutations in the Lag1p motif of the mouse LASS1 (longevity assurance homologue 1 of yeast Lag1). The (dihydro) ceramide synthase activity of the mutants was tested using microsomes in HeLa cells and in vitro. Six of the mutations resulted in loss of activity in cells and in vitro. In addition, our results showed that C18:0 fatty acid CoA (but not cis-C18:1 fatty acid CoAs) are substrates for LASS1 and that LASS1 in HeLa cells is sensitive to fumonisin B-1, an in vitro inhibitor of ( dihydro)ceramide synthase. Moreover, we mutated the Lag1p motif of another Lag homologue, human LASS5. The amino acid substitutions in the human LASS5 were the same as in mouse LASS1, and had the same effect on the in vitro activity of LASS5, suggesting the Lag1p motif appears to be essential for the enzyme activity of all Lag1 homologues.	Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Hosp, Div Gen Internal Med, Charleston, SC 29401 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, 114 Doughty St,POB 250779, Charleston, SC 29425 USA.	obeidl@musc.edu		Alvarez-Vasquez, Fernando/0000-0003-4008-9858; obeid, lina/0000-0002-0734-0847	NCI NIH HHS [P01 CA97132] Funding Source: Medline; NIA NIH HHS [AG016583, AG006168] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583, R37AG006168, R01AG006168] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Brandwagt BF, 2000, P NATL ACAD SCI USA, V97, P4961, DOI 10.1073/pnas.97.9.4961; Cai XF, 2003, DNA SEQUENCE, V14, P79, DOI 10.1080/1042517021000041831; Desai K, 2002, BBA-MOL CELL BIOL L, V1585, P188, DOI 10.1016/S1388-1981(02)00340-2; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Guillas I, 2003, J BIOL CHEM, V278, P37083, DOI 10.1074/jbc.M307554200; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; MORELL P, 1970, J BIOL CHEM, V245, P342; Pan H, 2001, GENOMICS, V77, P58, DOI 10.1006/geno.2001.6614; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; Spassieva SD, 2002, PLANT J, V32, P561, DOI 10.1046/j.1365-313X.2002.01444.x; SRIBNEY M, 1966, BIOCHIM BIOPHYS ACTA, V125, P542, DOI 10.1016/0005-2760(66)90042-7; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0	30	90	97	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33931	33938		10.1074/jbc.M608092200	http://dx.doi.org/10.1074/jbc.M608092200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16951403	hybrid			2022-12-27	WOS:000241767600014
J	Wang, JH; Wu, XS; Simonavicius, N; Tian, H; Ling, L				Wang, Jinghong; Wu, Xiaosu; Simonavicius, Nicole; Tian, Hui; Ling, Lei			Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE; CELLS; IDENTIFICATION; SECRETION; RESPONSES; OBESITY; GPR120; GPR40; ASSAY; IL-12	Free fatty acids (FFAs) play important physiological roles in many tissues as an energy source and as signaling molecules in various cellular processes. Elevated levels of circulating FFAs are associated with obesity, dyslipidemia, and diabetes. Here we show that GPR84, a previously orphan G protein-coupled receptor, functions as a receptor for medium-chain FFAs with carbon chain lengths of 9 - 14. Medium-chain FFAs elicit calcium mobilization, inhibit 3', 5'-cyclic AMP production, and stimulate [S-35] guanosine 5(')-O-(3-thiotriphosphate) binding in a GPR84-dependent manner. The activation of GPR84 by medium-chain FFAs couples primarily to a pertussis toxin-sensitive G(i/o) pathway. In addition, we show that GPR84 is selectively expressed in leukocytes and markedly induced in monocytes/macrophages upon activation by lipopolysaccharide. Furthermore, we demonstrate that medium-chain FFAs amplify lipopolysaccharide-stimulated production of the proinflammatory cytokine interleukin-12 p40 through GPR84. Our results indicate a role for GPR84 in directly linking fatty acid metabolism to immunological regulation.	Amgen Inc, San Francisco, CA 94080 USA	Amgen	Ling, L (corresponding author), Amgen Inc, San Francisco, CA 94080 USA.	lling@amgen.com						AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Hwang D, 2000, ANNU REV NUTR, V20, P431, DOI 10.1146/annurev.nutr.20.1.431; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Katsuma S, 2005, J BIOL CHEM, V280, P19507, DOI 10.1074/jbc.M412385200; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; Nunez EA, 1997, PROSTAG LEUKOTR ESS, V57, P107, DOI 10.1016/S0952-3278(97)90500-7; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; SPECTOR AA, 1975, SCIENCE, V190, P490, DOI 10.1126/science.1166323; Sperling RI, 1998, P NUTR SOC, V57, P527, DOI 10.1079/PNS19980077; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Takeda S, 2003, LIFE SCI, V74, P367, DOI 10.1016/j.lfs.2003.09.030; Venkataraman C, 2005, IMMUNOL LETT, V101, P144, DOI 10.1016/j.imlet.2005.05.010; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wanten G, 2006, CURR OPIN CLIN NUTR, V9, P79, DOI 10.1097/01.mco.0000214563.21697.55; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Yousefi S, 2001, J LEUKOCYTE BIOL, V69, P1045	36	267	289	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34457	34464		10.1074/jbc.M608019200	http://dx.doi.org/10.1074/jbc.M608019200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966319	hybrid			2022-12-27	WOS:000241767600066
J	Basso, M; Massignan, T; Samengo, G; Cheroni, C; De Biasi, S; Salmona, M; Bendotti, C; Bonetto, V				Basso, Manuela; Massignan, Tania; Samengo, Giuseppina; Cheroni, Cristina; De Biasi, Silvia; Salmona, Mario; Bendotti, Caterina; Bonetto, Valentina			Insoluble mutant SOD1 is partly oligoubiquitinated in amyotrophic lateral sclerosis mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT COMPLEXES; ALS-LINKED SOD1; SUPEROXIDE-DISMUTASE; MOUSE MODEL; CU,ZN-SUPEROXIDE DISMUTASE; PROTEIN AGGREGATION; DISEASE PROGRESSION; TRANSGENIC MICE; ALPHA-SYNUCLEIN; SPINAL-CORD	Mutations in the Cu,Zn-superoxide dismutase (SOD1) gene cause a familial form of amyotrophic lateral sclerosis (ALS) through an unknown gain-of-function mechanism. Mutant SOD1 aggregation may be the toxic property. In fact, proteinaceous inclusions rich in mutant SOD1 have been found in tissues from the familial form of ALS patients and in mutant SOD1 animals, before disease onset. However, very little is known of the constituents and mechanism of formation of aggregates in ALS. We and others have shown that there is a progressive accumulation of detergent-insoluble mutant SOD1 in the spinal cord of G93A SOD1 mice. To investigate the mechanism of SOD1 aggregation, we characterized by proteome technologies SOD1 isoforms in a Triton X-100-insoluble fraction of spinal cord from G93A SOD1 mice at different stages of the disease. This showed that at symptomatic stages of the disease, part of the insoluble SOD1 is unambiguously mono-and oligoubiquitinated, in spinal cord and not in hippocampus, and that ubiquitin branches at Lys(48), the major signal for proteasome degradation. At presymptomatic stages of the disease, only insoluble unmodified SOD1 is recovered. Partial ubiquitination of SOD1-rich inclusions was also confirmed by immunohistochemical and electron microscopy analysis of lumbar spinal cord sections from symptomatic G93A SOD1 mice. On the basis of these results, we propose that ubiquitination occurs only after SOD1 aggregation and that oligoubiquitination may underline alternative mechanisms in disease pathogenesis.	Dulbecco Telethon Inst, I-20157 Milan, Italy; Mario Negri Inst Pharmacol Res, Dept Mol Biol & Pharmacol, I-20157 Milan, Italy; Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy; Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan	Bonetto, V (corresponding author), Dulbecco Telethon Inst, Via Eritrea 62, I-20157 Milan, Italy.	bonetto@marionegri.it	Cheroni, Cristina/AAO-2316-2020; Bonetto, Valentina/I-4694-2018; salmona, mario/ABI-4066-2020; Bonetto, Valentina/ABB-6383-2020; salmona, mario/AAA-7116-2020; Bendotti, Caterina/AAB-2273-2020; Basso, Manuela/AAA-9147-2020	Bonetto, Valentina/0000-0003-0456-2054; Bonetto, Valentina/0000-0003-0456-2054; salmona, mario/0000-0002-9098-9873; Bendotti, Caterina/0000-0003-1055-1271; Basso, Manuela/0000-0002-9278-8960; massignan, tania/0000-0002-6176-2696; Cheroni, Cristina/0000-0002-0832-2333	Telethon [GGP06063, TCP01010] Funding Source: Medline	Telethon(Fondazione Telethon)		Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bendotti C, 2004, J NEUROPATH EXP NEUR, V63, P113, DOI 10.1093/jnen/63.2.113; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Cheroni C, 2005, NEUROBIOL DIS, V18, P509, DOI 10.1016/j.nbd.2004.12.007; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Cooper HJ, 2004, ANAL CHEM, V76, P6982, DOI 10.1021/ac0401063; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Di Noto L, 2005, J BIOL CHEM, V280, P39907, DOI 10.1074/jbc.M506247200; Doskeland AP, 2006, AMINO ACIDS, V30, P99, DOI 10.1007/s00726-005-0227-4; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gilchrist CA, 2005, NEUROPATH APPL NEURO, V31, P20, DOI 10.1111/j.1365-2990.2004.00604.x; Gray DA, 2001, NEUROPATH APPL NEURO, V27, P89, DOI 10.1046/j.1365-2990.2001.00321.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; MATSUI SI, 1982, P NATL ACAD SCI-BIOL, V79, P1535, DOI 10.1073/pnas.79.5.1535; Olsson I, 2002, PROTEOMICS, V2, P1630, DOI 10.1002/1615-9861(200211)2:11<1630::AID-PROT1630>3.0.CO;2-N; Ouyang YB, 2001, NEUROSCI LETT, V298, P159, DOI 10.1016/S0304-3940(00)01721-3; Pastorelli R, 2006, MOL CELL PROTEOMICS, V5, P882, DOI 10.1074/mcp.M500415-MCP200; Persson C, 2005, METHODS, V35, P37, DOI 10.1016/j.ymeth.2004.07.006; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Puttaparthi K, 2005, EXP NEUROL, V196, P441, DOI 10.1016/j.expneurol.2005.08.027; Puttaparthi K, 2003, J NEUROCHEM, V87, P851, DOI 10.1046/j.1471-4159.2003.02028.x; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stieber A, 2000, J NEUROL SCI, V173, P53, DOI 10.1016/S0022-510X(99)00300-7; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Tortarolo M, 2003, MOL CELL NEUROSCI, V23, P180, DOI 10.1016/S1044-7431(03)00022-8; Tummala H, 2005, J BIOL CHEM, V280, P17725, DOI 10.1074/jbc.M501705200; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WENISCH E, 1994, ELECTROPHORESIS, V15, P647, DOI 10.1002/elps.1150150191; Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x	49	78	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33325	33335		10.1074/jbc.M603489200	http://dx.doi.org/10.1074/jbc.M603489200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16943203	hybrid, Green Published			2022-12-27	WOS:000241621400042
J	Suter, M; Riek, U; Tuerk, R; Schlattner, U; Wallimann, T; Neumann, D				Suter, Marianne; Riek, Uwe; Tuerk, Roland; Schlattner, Uwe; Wallimann, Theo; Neumann, Dietbert			Dissecting the role of 5 '-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ENERGY HOMEOSTASIS; CELLULAR-ENERGY; CREATINE-KINASE; UPSTREAM KINASE; PHOSPHORYLATION; SUBUNIT; CELLS; BETA; SUBSTRATE	AMP-activated protein kinase (AMPK) is a heterotrimeric protein kinase that is crucial for cellular energy homeostasis of eukaryotic cells and organisms. Here we report on the activation of AMPK alpha 1 beta 1 gamma 1 and alpha 2 beta 2 gamma 1 by their upstream kinases (Ca2+/calmodulin-dependent protein kinase kinase-beta and LKB1-MO25 alpha-STRAD alpha), the deactivation by protein phosphatase 2C alpha, and on the extent of stimulation of AMPK by its allosteric activator AMP, using purified recombinant enzyme preparations. An accurate high pressure liquid chromatography-based method for AMPK activity measurements was established, which allowed for direct quantitation of the unphosphorylated and phosphorylated artificial peptide substrate, as well as the adenine nucleotides. Our results show a 1000-fold activation of AMPK by the combined effects of upstream kinase and saturating concentrations of AMP. The two AMPK isoforms exhibit similar specific activities ( 6 mu mol/min/ mg) and do not differ significantly by their responsiveness to AMP. Due to the inherent instability of ATP and ADP, it proved impossible to assay AMPK activity in the absolute absence of AMP. However, the half-maximal stimulatory effect of AMP is reached below 2 mu M. AMP does not appear to augment phosphorylation by upstream kinases in the purified in vitro system, but deactivation by dephosphorylation of AMPK alpha-subunits at Thr-172 by protein phosphatase 2C alpha is attenuated by AMP. Furthermore, it is shown that neither purified NAD(+) nor NADH alters the activity of AMPK in a concentration range of 0-300 mu M, respectively. Finally, evidence is provided that ZMP, a compound formed in 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-treated cells to activate AMPK in vivo, allosterically activates purified AMPK in vitro, but compared with AMP, maximal activity is not reached. These data shed new light on physiologically important aspects of AMPK regulation.	ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Neumann, D (corresponding author), ETH, Inst Cell Biol, Schafmattstr 18, CH-8093 Zurich, Switzerland.	dietbert.neumann@cell.biol.ethz.ch	Schlattner, Uwe/D-1267-2009; Wallimann, Theo/C-6047-2008	Schlattner, Uwe/0000-0003-1159-5911; Wallimann, Theo/0000-0003-4957-5836; Neumann, Dietbert/0000-0002-4316-684X				Altarejos JY, 2005, J BIOL CHEM, V280, P183, DOI 10.1074/jbc.M411810200; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Baron SJ, 2005, CIRC RES, V96, P337, DOI 10.1161/01.RES.0000155723.53868.d2; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; CLARKE PR, 1991, ADV PROT PHOSPHATASE, V6, P187; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kishimoto A, 2006, MOL BIOTECHNOL, V32, P17, DOI 10.1385/MB:32:1:017; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; MOORE F, 1991, EUR J BIOCHEM, V199, P691, DOI 10.1111/j.1432-1033.1991.tb16172.x; Musi N, 2006, CURR MED CHEM, V13, P583, DOI 10.2174/092986706776055724; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Neumann D, 2003, BIOCHEM SOC T, V31, P169, DOI 10.1042/bst0310169; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Taylor EB, 2006, AM J PHYSIOL-ENDOC M, V290, pE661, DOI 10.1152/ajpendo.00313.2005; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	42	355	364	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32207	32216		10.1074/jbc.M606357200	http://dx.doi.org/10.1074/jbc.M606357200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943194	hybrid			2022-12-27	WOS:000241414500018
J	Xu, LM; Harada, H; Taniguchi, A				Xu, Liming; Harada, Hidemitsu; Taniguchi, Akiyoshi			The exon 6ABC region of amelogenin mRNA contribute to increased levels of amelogenin mRNA through amelogenin protein-enhanced mRNA stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE SPLICE PRODUCTS; MOUSE AMELOGENIN; CODING REGION; UNTRANSLATED REGION; PORCINE AMELOGENIN; CELL LINE; EXPRESSION; STABILITY; SEQUENCE; ALPHA	We recently demonstrated that the reuptake of full-length amelogenin protein results in increased levels of amelogenin mRNA through enhanced mRNA stabilization (Xu, L., Harada, H., Tamaki, T. Y., Matsumoto, S., Tanaka, J., and Taniguchi, A. (2006) J. Biol. Chem. 281, 2257-2262). Here, we examined the molecular mechanism of enhanced amelogenin mRNA stabilization. To identify the cis-regulatory region within amelogenin mRNA, we tested various reporter systems using a deletion series of reporter plasmids. A deletion at exon 6ABC of amelogenin mRNA resulted in a 2.5-fold increase in the amelogenin mRNA expression level when compared with that of full-length mRNA, indicating that a cis-element exists in exon 6ABC of amelogenin mRNA. Furthermore, Northwestern analysis demonstrated that amelogenin protein binds directly to its mRNA in vitro, suggesting that amelogenin protein acts as a trans-acting protein that specifically binds to this cis-element. Moreover, recombinant mouse amelogenin protein extended the half-life of full-length amelogenin mRNA but did not significantly alter the half-life of exon 6ABC-deletion mutant mRNA. The splice products produced by deletion of exon 6ABC are known as leucine-rich amelogenin peptides and have signaling effects on cells. Our findings also suggest that the regulation of full-length amelogenin protein expression differs from the regulation of leucine-rich amelogenin peptide expression.	Natl Inst Mat Sci, Ctr Biomat, Cell Engn Technol Grp, Tsukuba, Ibaraki 3050044, Japan; Iwate Med Univ, Dept Oral Anat 2, Sch Dent, Morioka, Iwate 0208505, Japan	National Institute for Materials Science; Iwate Medical University	Taniguchi, A (corresponding author), Natl Inst Mat Sci, Ctr Biomat, Cell Engn Technol Grp, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Taniguchi.Akiyoshi@nims.go.jp	TANIGUCHI, Akiyoshi/H-2896-2011; Wada, Ken-Ichi/GVS-5955-2022; Harada, Hidemitsu/P-5692-2017	Wada, Ken-Ichi/0000-0001-5144-905X; Harada, Hidemitsu/0000-0002-9724-8568				Boabaid F, 2004, J PERIODONTOL, V75, P1126, DOI 10.1902/jop.2004.75.8.1126; BONASS WA, 1994, BBA-GENE STRUCT EXPR, V1219, P690, DOI 10.1016/0167-4781(94)90228-3; BROOKES SJ, 1995, ARCH ORAL BIOL, V40, P1, DOI 10.1016/0003-9969(94)00135-X; Cannons AC, 2002, PLANTA, V214, P488, DOI 10.1007/s00425-001-0679-z; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; GIBSON CW, 1992, BIOCHEMISTRY-US, V31, P8384, DOI 10.1021/bi00150a036; Hu CC, 1996, J DENT RES, V75, P1735, DOI 10.1177/00220345960750100501; Ikawa T, 2005, J DENT RES, V84, P144, DOI 10.1177/154405910508400207; Ishibashi Y, 2005, GLYCOCONJUGATE J, V22, P53, DOI 10.1007/s10719-005-0292-7; Kawano S, 2002, CONNECT TISSUE RES, V43, P409, DOI 10.1080/03008200290000637; Koga T, 1999, P NATL ACAD SCI USA, V96, P5680, DOI 10.1073/pnas.96.10.5680; Kurosawa Y, 2005, TISSUE ENG, V11, P1650, DOI 10.1089/ten.2005.11.1650; LAU EC, 1992, BIOCHEM BIOPH RES CO, V188, P1253, DOI 10.1016/0006-291X(92)91366-X; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Li R, 1995, J DENT RES, V74, P1880, DOI 10.1177/00220345950740121101; MoradianOldak J, 1995, CONNECT TISSUE RES, V32, P125, DOI 10.3109/03008209509013714; NAKAHORI Y, 1991, GENOMICS, V9, P264, DOI 10.1016/0888-7543(91)90251-9; Papagerakis P, 2005, J DENT RES, V84, P613, DOI 10.1177/154405910508400706; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SCHIAVI SC, 1994, J BIOL CHEM, V269, P3441; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; Simmer JP, 1995, CONNECT TISSUE RES, V32, P131, DOI 10.3109/03008209509013715; Taguchi T, 2005, BIOMATERIALS, V26, P1247, DOI 10.1016/j.biomaterials.2004.04.029; Tompkins K, 2006, BONE, V38, P172, DOI 10.1016/j.bone.2005.08.013; Tompkins K, 2005, J BONE MINER RES, V20, P341, DOI 10.1359/JBMR.041107; Veis A, 2003, CELL MOL LIFE SCI, V60, P38, DOI 10.1007/s000180300003; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Viswanathan HL, 2003, J PERIODONTOL, V74, P1423, DOI 10.1902/jop.2003.74.10.1423; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; WANG XM, 1995, MOL CELL BIOL, V15, P1769; WELLINGTON CL, 1993, MOL CELL BIOL, V13, P5034, DOI 10.1128/MCB.13.8.5034; WINSTALL E, 1995, MOL CELL BIOL, V15, P3796; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; Xu LM, 2006, J BIOL CHEM, V281, P2257, DOI 10.1074/jbc.M507695200; Yu J, 2001, MOL CELL BIOL, V21, P5879, DOI 10.1128/MCB.21.17.5879-5888.2001; Zhou YL, 2000, J BIOL CHEM, V275, P29066, DOI 10.1074/jbc.M002031200; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273	38	9	9	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32439	32444		10.1074/jbc.M605406200	http://dx.doi.org/10.1074/jbc.M605406200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954216	hybrid			2022-12-27	WOS:000241414500041
J	Glerup, S; Kloverpris, S; Oxvig, C				Glerup, Simon; Kloverpris, Soren; Oxvig, Claus			The proform of the eosinophil major basic protein binds the cell surface through a site distinct from its C-type lectin ligand-binding region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTAMINE-RELEASE; GROWTH-FACTOR; HEPARAN-SULFATE; PRECURSOR; INHIBITION; ACTIVATION; GENERATION; BASOPHIL; PROMBP; SERUM	The highly basic eosinophil major basic protein (MBP), present in the crystalloid core of eosinophil leukocyte granules, has both cytotoxic and cytostimulatory properties and is directly implicated in a number of diseases. The crystal structure of MBP resembles that of the C-type lectin (CTL) superfamily, and recent data showed that MBP binds heparan sulfate glycosaminoglycan (GAG), with the CTL ligand-binding region as the binding site. MBP is synthesized as a proform (pro-MBP) containing an acidic propiece believed to neutralize the basic MBP domain. Using flow cytometry and site-directed mutagenesis, we demonstrate here that the MBP domain of pro-MBP binds to heparan sulfate GAG on the cell surface and that this is independent of GAG covalently bound to pro-MBP. Eight basic residues located in the CTL ligand-binding region of MBP were hypothesized previously to mediate GAG binding, but we found that surface binding was not compromised by the substitution of these residues with alanine. However, the analysis of a series of mutants with surface-exposed residues substituted with alanine showed that Ser-166, Arg-168, and Arg-171 are involved in surface binding. A binding site formed by these residues is located in the MBP domain between loop 1 and beta-strand 5, outside the CTL ligand-binding region. The binding of a cell-surface heparan sulfate proteoglycan may be important in MBP action, and our findings suggest that two regions shown previously to contain the cytotoxic and cytostimulatory properties of MBP are accessible for ligand interaction in cell surface-bound MBP.	Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Aarhus University	Oxvig, C (corresponding author), Aarhus Univ, Dept Mol Biol, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	co@mb.au.dk		Oxvig, Claus/0000-0002-4715-9719				ABUGHAZALEH RI, 1992, J MEMBRANE BIOL, V128, P153; BARKER RL, 1988, J EXP MED, V168, P1493, DOI 10.1084/jem.168.4.1493; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BONNO M, 1994, LAB INVEST, V71, P560; Christiansen M, 2000, CLIN CHEM, V46, P1099; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FOXALL C, 1995, ANAL BIOCHEM, V231, P366, DOI 10.1006/abio.1995.0065; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; Glerup S, 2005, J BIOL CHEM, V280, P9823, DOI 10.1074/jbc.M413228200; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JACOBY DB, 1993, J CLIN INVEST, V91, P1314, DOI 10.1172/JCI116331; Laursen LS, 2002, J BIOL CHEM, V277, P47225, DOI 10.1074/jbc.M209155200; MOY JN, 1990, J IMMUNOL, V145, P2626; ODONNELL MC, 1983, J EXP MED, V157, P1981, DOI 10.1084/jem.157.6.1981; Overgaard MT, 2004, FEBS LETT, V560, P147, DOI 10.1016/S0014-5793(04)00095-X; OXVIG C, 1994, BIOCHEM MOL BIOL INT, V33, P329; OXVIG C, 1993, J BIOL CHEM, V268, P12243; OXVIG C, 1994, BBA-GEN SUBJECTS, V1201, P415, DOI 10.1016/0304-4165(94)90071-X; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Piliponsky AM, 2001, J ALLERGY CLIN IMMUN, V107, P993, DOI 10.1067/mai.2001.114656; Popken-Harris P, 1998, BLOOD, V92, P623, DOI 10.1182/blood.V92.2.623.414k32_623_631; POPKENHARRIS P, 1994, J ALLERGY CLIN IMMUN, V94, P1282, DOI 10.1016/0091-6749(94)90343-3; POPKENHARRIS P, 1995, J IMMUNOL, V155, P1472; Rochester CL, 1996, J IMMUNOL, V156, P4449; Swaminathan GJ, 2005, BIOCHEMISTRY-US, V44, P14152, DOI 10.1021/bi051112b; Swaminathan GJ, 2001, J BIOL CHEM, V276, P26197, DOI 10.1074/jbc.M100848200; Temkin V, 2004, J ALLERGY CLIN IMMUN, V113, P703, DOI 10.1016/j.jaci.2003.11.038; Thomas LL, 2001, IMMUNOL LETT, V78, P175, DOI 10.1016/S0165-2478(01)00249-8; THOMAS LL, 1989, IMMUNOLOGY, V66, P611; WEILER JM, 1988, J IMMUNOL, V140, P1605; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	34	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31509	31516		10.1074/jbc.M605824200	http://dx.doi.org/10.1074/jbc.M605824200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16940047				2022-12-27	WOS:000241235300036
J	Merz, F; Hoffmann, A; Rutkowska, A; Zachmann-Brand, B; Bukau, B; Deuerling, E				Merz, Frieder; Hoffmann, Anja; Rutkowska, Anna; Zachmann-Brand, Beate; Bukau, Bernd; Deuerling, Elke			The C-terminal domain of Escherichia coli trigger factor represents the central module of its chaperone activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS/TRANS ISOMERASE ACTIVITY; NEWLY SYNTHESIZED PROTEINS; NASCENT POLYPEPTIDES; PROLYL ISOMERASE; FUNCTIONAL DISSECTION; ENZYMATIC CATALYSIS; IN-VIVO; DNAK; RIBOSOME; BINDING	In bacteria, ribosome-bound Trigger Factor assists the folding of newly synthesized proteins. The N-terminal domain (N) of Trigger Factor mediates ribosome binding, whereas the middle domain (P) harbors peptidyl-prolyl isomerase activity. The function of the C-terminal domain (C) has remained enigmatic due to structural instability in isolation. Here, we have characterized a stabilized version of the C domain (C-S), designed on the basis of the recently solved atomic structure of Trigger Factor. Strikingly, only the isolated C-S domain or domain combinations thereof (NCS, PCS) revealed substantial chaperone activity in vitro and in vivo. Furthermore, to disrupt the C domain without affecting the overall Trigger Factor structure, we generated a mutant (Delta 53) by deletion of the C-terminal 53 amino acid residues. This truncation caused the complete loss of the chaperone activity of Trigger Factor in vitro and severely impaired its function in vivo. Therefore, we conclude that the chaperone activity of Trigger Factor critically depends on its C-terminal domain as the central structural chaperone module. Intriguingly, a structurally similar module is found in the periplasmic chaperone SurA and in MPN555, a protein of unknown function. We speculate that this conserved module can exist solely or in combination with additional domains to fulfill diverse chaperone functions in the cell.	Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Deuerling, E (corresponding author), Univ Heidelberg, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	e.deuerling@zmbh.uni-heidelberg.de		Bukau, Bernd/0000-0003-0521-7199				Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; BUKAU B, 1989, J BACTERIOL, V171, P2337, DOI 10.1128/jb.171.5.2337-2346.1989; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1996, FEBS LETT, V385, P67, DOI 10.1016/0014-5793(96)00351-1; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Huang GC, 2000, PROTEIN SCI, V9, P1254, DOI 10.1110/ps.9.6.1254; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Liu CP, 2005, J BIOL CHEM, V280, P13315, DOI 10.1074/jbc.M414151200; Liu CP, 2004, BIOCHEM BIOPH RES CO, V313, P509, DOI 10.1016/j.bbrc.2003.11.142; Ludlam AV, 2004, P NATL ACAD SCI USA, V101, P13436, DOI 10.1073/pnas.0405868101; MUCKE M, 1992, BIOCHEMISTRY-US, V31, P7848; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Schaffitzel E, 2001, BIOL CHEM, V382, P1235, DOI 10.1515/BC.2001.154; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Schulze-Gahmen U, 2005, ACTA CRYSTALLOGR D, V61, P1343, DOI [10.1107/S090744490502264X, 10.1107/S09074490502264X]; Stoller G, 1996, FEBS LETT, V384, P117, DOI 10.1016/0014-5793(96)00282-7; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; Zarnt T, 1997, J MOL BIOL, V271, P827, DOI 10.1006/jmbi.1997.1206; ZENG LL, 2005, BIOCHIMIE PARIS	37	73	74	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31963	31971		10.1074/jbc.M605164200	http://dx.doi.org/10.1074/jbc.M605164200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16926148				2022-12-27	WOS:000241235300082
J	Han, Q; Robinson, H; Gao, YG; Vogelaar, N; Wilson, SR; Rizzi, M; Li, JY				Han, Qian; Robinson, Howard; Gao, Yi Gui; Vogelaar, Nancy; Wilson, Scott R.; Rizzi, Menico; Li, Jianyong			Crystal structures of Aedes aegypti alanine glyoxylate aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMBIAE 3-HYDROXYKYNURENINE TRANSAMINASE; PRIMARY HYPEROXALURIA TYPE-1; YELLOW-FEVER MOSQUITO; MAJOR BRANCH PATHWAY; KYNURENINE AMINOTRANSFERASE; XANTHURENIC ACID; PROTEIN; EVOLUTION; MALARIA; ENZYME	Mosquitoes are unique in having evolved two alanine glyoxylate aminotransferases (AGTs). One is 3-hydroxykynurenine transaminase (HKT), which is primarily responsible for catalyzing the transamination of 3-hydroxykynurenine (3-HK) to xanthurenic acid (XA). Interestingly, XA is used by malaria parasites as a chemical trigger for their development within the mosquito. This 3-HK to XA conversion is considered the major mechanism mosquitoes use to detoxify the chemically reactive and potentially toxic 3-HK. The other AGT is a typical dipteran insect AGT and is specific for converting glyoxylic acid to glycine. Here we report the 1.75 angstrom high-resolution three-dimensional crystal structure of AGT from the mosquito Aedes aegypti (AeAGT) and structures of its complexes with reactants glyoxylic acid and alanine at 1.75 and 2.1 angstrom resolution, respectively. This is the first time that the three-dimensional crystal structures of an AGT with its amino acceptor, glyoxylic acid, and amino donor, alanine, have been determined. The protein is dimeric and adopts the type I-fold of pyridoxal 5-phosphate (PLP)-dependent aminotransferases. The PLP co-factor is covalently bound to the active site in the crystal structure, and its binding site is similar to those of other AGTs. The comparison of the AeAGT-glyoxylic acid structure with other AGT structures revealed that these glyoxylic acid binding residues are conserved in most AGTs. Comparison of the AeAGT-alanine structure with that of the Anopheles HKT-inhibitor complex suggests that a Ser-Asn-Phe motif in the latter may be responsible for the substrate specificity of HKT enzymes for 3-HK.	Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA; Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA; Univ Peimonte Orientale Novara, Struct Biol Unit, I-28100 Novara, Italy	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Illinois System; University of Illinois Urbana-Champaign; Virginia Polytechnic Institute & State University; University of Eastern Piedmont Amedeo Avogadro	Li, JY (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.	lij@vt.edu	Han, Qian/AAS-2134-2020; Han, Qian/J-8696-2014	Han, Qian/0000-0001-6245-5252	NIAID NIH HHS [R01 AI44399] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044399] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Birdsey GM, 2004, MOL BIOL EVOL, V21, P632, DOI 10.1093/molbev/msh054; Birdsey GM, 2005, P ROY SOC B-BIOL SCI, V272, P833, DOI 10.1098/rspb.2004.3011; Danpure C. J., 2001, METABOLIC MOL BASES, V2, P3323; Danpure CJ, 1997, BIOESSAYS, V19, P317, DOI 10.1002/bies.950190409; Danpure CJ, 1996, ANN NY ACAD SCI, V804, P477, DOI 10.1111/j.1749-6632.1996.tb18638.x; DeLano W.L, PYMOL MOL GRAPHICS S; Fang J, 2002, INSECT BIOCHEM MOLEC, V32, P943, DOI 10.1016/S0965-1748(02)00032-2; Garcia GE, 1998, J BIOL CHEM, V273, P12003, DOI 10.1074/jbc.273.20.12003; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Han GW, 2005, PROTEINS, V58, P971; Han Q, 2005, FEBS J, V272, P2198, DOI 10.1111/j.1742-4658.2005.04643.x; Han Q, 2004, FEBS LETT, V577, P381, DOI 10.1016/j.febslet.2004.09.088; Han Q, 2002, J BIOL CHEM, V277, P15781, DOI 10.1074/jbc.M201202200; Han Q, 2002, FEBS LETT, V527, P199, DOI 10.1016/S0014-5793(02)03229-5; Han Q, 2006, BIOCHEM J, V397, P473, DOI 10.1042/BJ20060469; Holbrook JD, 2002, J BIOL CHEM, V277, P2336, DOI 10.1074/jbc.M107047200; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JY, 1997, INSECT BIOCHEM MOLEC, V27, P859, DOI 10.1016/S0965-1748(97)00068-4; Li JY, 1999, INSECT BIOCHEM MOLEC, V29, P329, DOI 10.1016/S0965-1748(99)00007-7; Liepman AH, 2001, PLANT J, V25, P487, DOI 10.1046/j.1365-313x.2001.00961.x; Meyer P, 2005, BIOCHIMIE, V87, P1041, DOI 10.1016/j.biochi.2005.09.001; Minor W., 1993, XDISPLAYF PROGRAM; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Okamoto A, 1998, J MOL BIOL, V280, P443, DOI 10.1006/jmbi.1998.1869; OKUNO E, 1980, BIOCHEM J, V189, P581, DOI 10.1042/bj1890581; OKUNO E, 1991, BRAIN RES, V542, P307, DOI 10.1016/0006-8993(91)91583-M; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK DAT, P80; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; REHFELD DW, 1972, J BIOL CHEM, V247, P4803; Rossi F, 2006, P NATL ACAD SCI USA, V103, P5711, DOI 10.1073/pnas.0510233103; Rossi F, 2005, FEBS J, V272, P5653, DOI 10.1111/j.1742-4658.2005.04961.x; Schlosser T, 2004, YEAST, V21, P63, DOI 10.1002/yea.1058; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Takayama T, 2003, J AM SOC NEPHROL, V14, P939, DOI 10.1097/01.ASN.0000059310.67812.4F; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WATTS RWE, 1992, ADV ENZYME REGUL, V32, P309; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	43	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					37175	37182		10.1074/jbc.M607032200	http://dx.doi.org/10.1074/jbc.M607032200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16990263	hybrid			2022-12-27	WOS:000242220800078
J	Melrose, J; Roughley, P; Knox, S; Smith, S; Lord, M; Whitelock, J				Melrose, James; Roughley, Peter; Knox, Sarah; Smith, Susan; Lord, Megan; Whitelock, John			The structure, location, and function of perlecan, a prominent pericellular proteoglycan of fetal, postnatal, and mature hyaline cartilages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; DENSITY-LIPOPROTEIN-RECEPTOR; FIBROBLAST-GROWTH-FACTOR; SCHWARTZ-JAMPEL-SYNDROME; SILVERMAN-HANDMAKER TYPE; CELL-ADHESION MOLECULES; BASEMENT-MEMBRANES; PROTEIN CORE; DOMAIN-I; GLYCOSAMINOGLYCAN MODIFICATION	The aim of this study was to immunolocalize perlecan in human fetal, postnatal, and mature hyaline cartilages and to determine information on the structure and function of chondrocyte perlecan. Perlecan is a prominent component of human fetal (12-14 week) finger, toe, knee, and elbow cartilages; it was localized diffusely in the interterritorial extracellular matrix, densely in the pericellular matrix around chondrocytes, and to small blood vessels in the joint capsules and perichondrium. Aggrecan had a more intense distribution in the marginal regions of the joint rudiments and in para-articular structures. Perlecan also had a strong pericellular localization pattern in postnatal (2-7 month) and mature (55-64 year) femoral cartilages, whereas aggrecan had a prominent extracellular matrix distribution in these tissues. Western blotting identified multiple perlecan core protein species in extracts of the postnatal and mature cartilages, some of which were substituted with heparan sulfate and/or chondroitin sulfate and some were devoid of glycosaminoglycan substitution. Some perlecan core proteins were smaller than intact perlecan, suggesting that proteolytic processing or alternative splicing had occurred. Surface plasmon resonance and quartz crystal microbalance with dissipation experiments demonstrated that chondrocyte perlecan bound fibroblast growth factor (FGF)-1 and -9 less efficiently than endothelial cell perlecan. The latter perlecan supported the proliferation of Baf-32 cells transfected with FGFR3c equally well with FGF-1 and -9, whereas chondrocyte perlecan only supported Baf-32 cell proliferation with FGF-9. The function of perlecan therefore may not be universal but may vary with its cellular origin and presumably its structure.	Univ Sydney, Inst Bone & Joint Res, Raymond Purves Res Labs, St Leonards, NSW, Australia; Univ Sydney, Kolling Inst Med Res, St Leonards, NSW, Australia; Royal N Shore Hosp, St Leonards, NSW 2065, Australia; Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada; Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; McGill University; University of New South Wales Sydney	Melrose, J (corresponding author), Univ Clin, Royal N Shore Hosp, Level 5,Bldg B26, St Leonards, NSW 2065, Australia.	jmelrose@med.usyd.edu.au	Melrose, James/AAG-5445-2019; Lord, Megan/D-4673-2013; Knox, Sarah Monica/GNW-5445-2022	Melrose, James/0000-0001-9237-0524; Lord, Megan/0000-0002-0506-9811; Whitelock, John/0000-0003-1835-802X; Knox, Sarah/0000-0002-7567-083X				Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Arikawa-Hirasawa E, 2002, AM J HUM GENET, V70, P1368, DOI 10.1086/340390; Arikawa-Hirasawa E, 2001, AM J MED GENET, V106, P254, DOI 10.1002/ajmg.10229.abs; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Balasubramani M, 2004, MATRIX BIOL, V23, P143, DOI 10.1016/j.matbio.2004.04.001; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; Chang Z, 2000, FASEB J, V14, P137, DOI 10.1096/fasebj.14.1.137; Clayton A, 2001, KIDNEY INT, V59, P2084, DOI 10.1046/j.1523-1755.2001.00723.x; Costell M, 1997, EUR J BIOCHEM, V243, P115, DOI 10.1111/j.1432-1033.1997.t01-1-00115.x; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; DODGE G, 2002, ORTHOP RES SOC, V27, P358; Dolan M, 1997, J BIOL CHEM, V272, P4316, DOI 10.1074/jbc.272.7.4316; Eriksen GV, 1999, BIOCHEM J, V340, P613, DOI 10.1042/0264-6021:3400613; French MM, 1999, J CELL BIOL, V145, P1103, DOI 10.1083/jcb.145.5.1103; Friedrich MVK, 1999, J MOL BIOL, V294, P259, DOI 10.1006/jmbi.1999.3259; Ghiselli G, 2001, BIOCHEM J, V359, P153, DOI 10.1042/0264-6021:3590153; Gomes RR, 2004, CELLS TISSUES ORGANS, V176, P79, DOI 10.1159/000075029; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Govindraj P, 2002, J BIOL CHEM, V277, P19461, DOI 10.1074/jbc.M200786200; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; Handley CJ, 2002, MATRIX BIOL, V21, P579, DOI 10.1016/S0945-053X(02)00078-1; Hart M, 2001, J PATHOL, V194, P262, DOI 10.1002/1096-9896(200106)194:2<262::AID-PATH882>3.0.CO;2-W; Ho Nicola C, 2003, BMC Neurol, V3, P3, DOI 10.1186/1471-2377-3-3; Hopf M, 2001, J MOL BIOL, V311, P529, DOI 10.1006/jmbi.2001.4878; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Iozzo RV, 2001, J CLIN INVEST, V108, P165, DOI 10.1172/JCI13560; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; Knox S, 2005, FEBS LETT, V579, P5019, DOI 10.1016/j.febslet.2005.07.090; Knox S, 2001, PROTEOMICS, V1, P1534, DOI 10.1002/1615-9861(200111)1:12<1534::AID-PROT1534>3.0.CO;2-A; Knox S, 2002, J BIOL CHEM, V277, P14657, DOI 10.1074/jbc.M111826200; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; KOKENYESI R, 1995, BIOCHEM BIOPH RES CO, V211, P262, DOI 10.1006/bbrc.1995.1805; Melrose J, 2005, HISTOCHEM CELL BIOL, V123, P561, DOI 10.1007/s00418-005-0789-y; Melrose J, 2003, J HISTOCHEM CYTOCHEM, V51, P1331, DOI 10.1177/002215540305101010; Melrose J, 2003, EUR SPINE J, V12, P57, DOI 10.1007/s00586-002-0434-6; Melrose J, 2002, HISTOCHEM CELL BIOL, V118, P269, DOI 10.1007/s00418-002-0049-4; Melrose J, 1998, J VASC SURG, V28, P676, DOI 10.1016/S0741-5214(98)70094-1; Miosge N, 2003, J HISTOCHEM CYTOCHEM, V51, P285, DOI 10.1177/002215540305100303; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Oda O, 1996, CLIN CHIM ACTA, V255, P119, DOI 10.1016/0009-8981(96)06395-4; Olsen BR, 1999, J CELL BIOL, V147, P909, DOI 10.1083/jcb.147.5.909; Ornitz DM, 2001, GENOME BIOL, V2; Patel MI, 1996, J VASC SURG, V24, P82, DOI 10.1016/S0741-5214(96)70148-9; RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; ROUGHLEY PJ, 1980, J BIOL CHEM, V255, P217; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Sasaki T, 1998, FEBS LETT, V435, P169, DOI 10.1016/S0014-5793(98)01063-1; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Schofield KP, 1999, BIOCHEM J, V343, P663, DOI 10.1042/0264-6021:3430663; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; Tapanadechopone P, 2001, BIOCHEM J, V355, P517, DOI 10.1042/0264-6021:3550517; Tapanadechopone P, 1999, BIOCHEM BIOPH RES CO, V265, P680, DOI 10.1006/bbrc.1999.1714; Tu HM, 2002, J BIOL CHEM, V277, P23092, DOI 10.1074/jbc.M107583200; Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 2002, METHOD CELL BIOL, V69, P53, DOI 10.1016/S0091-679X(02)69007-7; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1	67	76	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36905	36914		10.1074/jbc.M608462200	http://dx.doi.org/10.1074/jbc.M608462200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16984910	hybrid			2022-12-27	WOS:000242220800050
J	Goepfert, S; Hiltunen, JK; Poirier, Y				Goepfert, Simon; Hiltunen, J. Kalervo; Poirier, Yves			Identification and functional characterization of a monofunctional peroxisomal enoyl-CoA hydratase 2 that participates in the degradation of even cis-unsaturated fatty acids in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; COENZYME-A HYDRATASE; BETA-OXIDATION; RAT-LIVER; MULTIFUNCTIONAL ENZYME; ESCHERICHIA-COLI; POLYHYDROXYALKANOATE SYNTHESIS; 2-ENOYL-COA HYDRATASE; ISOMERASE ACTIVITIES; PLANT PEROXISOMES	A gene, named AtECH2, has been identified in Arabidopsis thaliana to encode a monofunctional peroxisomal enoyl-CoA hydratase 2. Homologues of AtECH2 are present in several angiosperms belonging to the Monocotyledon and Dicotyledon classes, as well as in a gymnosperm. In vitro enzyme assays demonstrated that AtECH2 catalyzed the reversible conversion of 2E-enoyl-CoA to 3R-hydroxyacyl-CoA. AtECH2 was also demonstrated to have enoyl-CoA hydratase 2 activity in an in vivo assay relying on the synthesis of polyhydroxyalkanoate from the polymerization of 3R-hydroxyacyl-CoA in the peroxisomes of Saccharomyces cerevisiae. AtECH2 contained a peroxisome targeting signal at the C-terminal end, was addressed to the peroxisome in S. cerevisiae, and a fusion protein between AtECH2 and a fluorescent protein was targeted to peroxisomes in onion cells. AtECH2 gene expression was strongest in tissues with high beta-oxidation activity, such as germinating seedlings and senescing leaves. The contribution of AtECH2 to the degradation of unsaturated fatty acids was assessed by analyzing the carbon flux through the beta-oxidation cycle in plants that synthesize peroxisomal polyhydroxyalkanoate and that were over-or under-expressing the AtECH2 gene. These studies revealed that AtECH2 participates in vivo to the conversion of the intermediate 3R-hydroxyacyl-CoA, generated by the metabolism of fatty acids with a cis(Z)-unsaturated bond on an even-numbered carbon, to the 2E-enoyl-CoA for further degradation through the core beta-oxidation cycle.	Univ Lausanne, Dept Biol Mol Vegetale, CH-1015 Lausanne, Switzerland; Oulu Univ, Bioctr Oulu, FIN-90014 Oulu, Finland; Oulu Univ, Dept Biochem, FIN-90014 Oulu, Finland	University of Lausanne; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Poirier, Y (corresponding author), Univ Lausanne, Dept Biol Mol Vegetale, Biophore Bldg, CH-1015 Lausanne, Switzerland.	yves.poirier@unil.ch						Allenbach L, 2000, PLANT PHYSIOL, V124, P1159, DOI 10.1104/pp.124.3.1159; BEHRENDS W, 1988, ARCH BIOCHEM BIOPHYS, V263, P170, DOI 10.1016/0003-9861(88)90625-X; CHU CH, 1984, BIOCHEM BIOPH RES CO, V118, P162, DOI 10.1016/0006-291X(84)91081-7; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; ENGELAND K, 1991, EUR J BIOCHEM, V200, P171, DOI 10.1111/j.1432-1033.1991.tb21064.x; FILPPULA SA, 1995, J BIOL CHEM, V270, P27453, DOI 10.1074/jbc.270.46.27453; Froman BE, 2000, PLANT PHYSIOL, V123, P733, DOI 10.1104/pp.123.2.733; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; GERHARDT B, 1992, PROG LIPID RES, V31, P417, DOI 10.1016/0163-7827(92)90004-3; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goepfert S, 2005, PLANT PHYSIOL, V138, P1947, DOI 10.1104/pp.105.064311; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; Gurvitz A, 1997, MOL MICROBIOL, V26, P675, DOI 10.1046/j.1365-2958.1997.5931969.x; Gurvitz A, 1998, J BIOL CHEM, V273, P31366, DOI 10.1074/jbc.273.47.31366; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Hiltunen JK, 1996, ANN NY ACAD SCI, V804, P116, DOI 10.1111/j.1749-6632.1996.tb18612.x; HILTUNEN JK, 1989, J BIOL CHEM, V264, P13536; HUANG XQ, 1992, GENOMICS, V14, P18, DOI 10.1016/S0888-7543(05)80277-0; Huyghe S, 2006, BBA-MOL CELL BIOL L, V1761, P973, DOI 10.1016/j.bbalip.2006.04.006; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; Marchesini S, 2003, APPL ENVIRON MICROB, V69, P6495, DOI 10.1128/AEM.69.11.6495-6499.2003; Mittendorf V, 1999, PLANT J, V20, P45, DOI 10.1046/j.1365-313X.1999.00572.x; Mittendorf V, 1998, P NATL ACAD SCI USA, V95, P13397, DOI 10.1073/pnas.95.23.13397; PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446; PALOSAARI PM, 1990, J BIOL CHEM, V265, P3347; Poirier Y, 1999, PLANT PHYSIOL, V121, P1359, DOI 10.1104/pp.121.4.1359; Poirier Y, 2002, PROG LIPID RES, V41, P131, DOI 10.1016/S0163-7827(01)00018-2; Poirier Y, 2001, APPL ENVIRON MICROB, V67, P5254, DOI 10.1128/AEM.67.11.5254-5260.2001; PREISIGMULLER R, 1994, J BIOL CHEM, V269, P20475; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; Qin YM, 1997, BIOCHEM J, V321, P21, DOI 10.1042/bj3210021; Reumann S, 2004, PLANT PHYSIOL, V136, P2587, DOI 10.1104/pp.104.043695; Reumann S, 2004, PLANT PHYSIOL, V135, P783, DOI 10.1104/pp.103.035584; Robert J, 2005, BBA-MOL CELL BIOL L, V1734, P169, DOI 10.1016/j.bbalip.2005.02.010; Sambrook J., 2001, MOL CLONING LAB MANU; SCHULZ H, 1987, TRENDS BIOCHEM SCI, V12, P403, DOI 10.1016/0968-0004(87)90196-4; SCHULZ H, 1983, BIOCHEMISTRY-US, V22, P1827, DOI 10.1021/bi00277a013; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuge T, 2000, FEMS MICROBIOL LETT, V184, P193, DOI 10.1111/j.1574-6968.2000.tb09013.x; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; YANG SY, 1995, BIOCHEMISTRY-US, V34, P6441, DOI 10.1021/bi00019a025; YANG SY, 1993, J BIOL CHEM, V268, P6588; YANG SY, 1986, J BIOL CHEM, V261, P5390	48	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35894	35903		10.1074/jbc.M606383200	http://dx.doi.org/10.1074/jbc.M606383200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16982622	hybrid			2022-12-27	WOS:000242100500036
J	Kissova, I; Plamondon, LT; Brisson, L; Priault, M; Renouf, V; Schaeffer, J; Camougrand, N; Manon, S				Kissova, Ingrid; Plamondon, Louis-Thomas; Brisson, Louise; Priault, Muriel; Renouf, Vincent; Schaeffer, Jacques; Camougrand, Nadine; Manon, Stephen			Evaluation of the roles of apoptosis, autophagy, and mitophagy in the loss of plating efficiency induced by Bax expression in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CYTOCHROME-C; MITOCHONDRIAL AUTOPHAGY; REGULATES APOPTOSIS; OXIDATIVE STRESS; BCL-2; PROTEINS; DISTINCT; RELEASE; GENE	We found recently that, in yeast cells, the heterologous expression of Bax induces a loss of plating efficiency different from that induced by acute stress because it is associated with the maintenance of plasma membrane integrity (Camougrand, N., Grelaud-Coq, A., Marza, E., Priault, M., Bessoule, J. J., and Manon ,S. ( 2003) Mol. Microbiol. 47, 495-506). Bax effects were neither dependent on the presence of the yeast metacaspase Yca1p and the apoptosis-inducing factor homolog nor associated with the appearance of typical apoptotic markers such as metacaspase activation, annexin V binding, and DNA cleavage. Yeast cells expressing Bax instead displayed autophagic features, including increased accumulation of Atg8p, activation of vacuolar alkaline phosphatase, and the presence of auto-phagosomes and autophagic bodies. However, the inactivation of autophagy did not prevent and actually slightly accelerated Bax-induced loss of plating efficiency. On the other hand, Bax expression induced a fragmentation of the mitochondrial network, which retained, however, some level of organization in wild-type cells. However, when expressed in cells inactivated for the gene UTH1, previously shown to be involved in mitophagy, Bax induced a complete disorganization of the mitochondrial network. Interestingly, although mitochondrially targeted green fluorescent protein was slowly degraded in the wild-type strain, it remained unaffected in the mutant. Furthermore, the slow loss of plating efficiency in the mutant strain correlated with a loss of plasma membrane integrity. These data suggest that Bax-induced loss of growth capacity is associated with maintenance of plasma membrane integrity dependent on UTH1, suggesting that selective degradation of altered mitochondria is required for a regulated loss of growth capacity.	Univ Bordeaux 2, CNRS, UMR5095, F-33077 Bordeaux, France; Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia; Univ Laval, Dept Biochem & Microbiol, Ste Foy, PQ G1K 7P4, Canada; Univ Bordeaux 2, Serv Commun Microscopie, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Comenius University Bratislava; Laval University; UDICE-French Research Universities; Universite de Bordeaux	Camougrand, N (corresponding author), Univ Bordeaux 2, CNRS, UMR5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	n.camougrand@ibgc.cnrs.fr; stephen.manon@ibgc.cnrs.fr	Manon, Stéphen/C-7088-2017; Bhatia, Ingrid/H-7016-2016; Priault, Muriel/HHT-0658-2022	Priault, Muriel/0000-0001-8193-0389; Manon, Stephen/0000-0002-5792-1084				Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; Abudugupur A, 2002, CELL DEATH DIFFER, V9, P158, DOI 10.1038/sj.cdd.4400942; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Arnoult D, 2002, CELL DEATH DIFFER, V9, P65, DOI 10.1038/sj.cdd.4400951; Arnoult D, 2001, MOL BIOL CELL, V12, P3016, DOI 10.1091/mbc.12.10.3016; Arokium H, 2004, J BIOL CHEM, V279, P52566, DOI 10.1074/jbc.M408373200; Belhocine S, 2004, CELL DEATH DIFFER, V11, P946, DOI 10.1038/sj.cdd.4401422; BONNEU M, 1991, ANAL BIOCHEM, V193, P225, DOI 10.1016/0003-2697(91)90013-J; Camougrand N, 2003, MOL MICROBIOL, V47, P495, DOI 10.1046/j.1365-2958.2003.03311.x; Camougrand NM, 2000, ARCH BIOCHEM BIOPHYS, V375, P154, DOI 10.1006/abbi.1999.1655; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; Cartron PF, 2005, J BIOL CHEM, V280, P10587, DOI 10.1074/jbc.M409714200; Clow A, 1998, EUR J BIOCHEM, V258, P19, DOI 10.1046/j.1432-1327.1998.2580019.x; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dimitrova I, 2004, FEBS LETT, V566, P100, DOI 10.1016/j.febslet.2004.04.012; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Golstein P, 2005, CELL DEATH DIFFER, V12, P1490, DOI 10.1038/sj.cdd.4401607; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P659, DOI 10.1038/sj.cdd.4401585; Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000; Guscetti F, 2005, FASEB J, V19, P464, DOI 10.1096/fj.04-2316fje; HANADA M, 1995, J BIOL CHEM, V270, P11962, DOI 10.1074/jbc.270.20.11962; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; Hazan R, 2004, APPL ENVIRON MICROB, V70, P4449, DOI 10.1128/AEM.70.8.4449-4457.2004; HENGARTNER MO, 1994, CURR OPIN GENET DEV, V4, P581, DOI 10.1016/0959-437X(94)90076-F; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kissova I, 2000, FEBS LETT, V471, P113, DOI 10.1016/S0014-5793(00)01379-X; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Kosta A, 2004, J BIOL CHEM, V279, P48404, DOI 10.1074/jbc.M408924200; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levraud JP, 2003, J CELL BIOL, V160, P1105, DOI 10.1083/jcb.200212104; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Ludovico P, 2005, IUBMB LIFE, V57, P129, DOI 10.1080/15216540500090553; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Marza E, 2002, FEBS LETT, V521, P47, DOI 10.1016/S0014-5793(02)02819-3; Mazzoni C, 2005, EMBO REP, V6, P1076, DOI 10.1038/sj.embor.7400514; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mitsui K, 2005, FEBS LETT, V579, P723, DOI 10.1016/j.febslet.2004.12.051; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pinan-Lucarre B, 2005, EUKARYOT CELL, V4, P1765, DOI 10.1128/EC.4.11.1765-1774.2005; Pinan-Lucarre R, 2003, MOL MICROBIOL, V47, P321, DOI 10.1046/j.1365-2958.2003.03208.x; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Priault M, 1999, FEBS LETT, V456, P232, DOI 10.1016/S0014-5793(99)00957-6; Priault M, 2003, FEMS YEAST RES, V4, P15, DOI 10.1016/S1567-1356(03)00143-0; Priault M, 2003, CELL DEATH DIFFER, V10, P1068, DOI 10.1038/sj.cdd.4401270; Priault M, 2002, EUR J BIOCHEM, V269, P5440, DOI 10.1046/j.1432-1033.2002.03234.x; Priault M, 1999, EUR J BIOCHEM, V260, P684, DOI 10.1046/j.1432-1327.1999.00198.x; Roucou X, 2000, FEBS LETT, V471, P235, DOI 10.1016/S0014-5793(00)01404-6; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Skulachev VP, 2002, FEBS LETT, V528, P23, DOI 10.1016/S0014-5793(02)03319-7; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wysocki R, 2004, J CELL BIOL, V166, P311, DOI 10.1083/jcb.200405016; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zadrag R, 2006, CELL BIOL INT, V30, P205, DOI 10.1016/j.cellbi.2005.10.023; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440	78	53	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36187	36197		10.1074/jbc.M607444200	http://dx.doi.org/10.1074/jbc.M607444200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16990272	hybrid			2022-12-27	WOS:000242100500069
J	Nie, YL; Smirnova, I; Kasho, V; Kaback, HR				Nie, Yiling; Smirnova, Irina; Kasho, Vladimir; Kaback, H. Ronald			Energetics of ligand-induced conformational flexibility in the lactose permease of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; MEMBRANE-TRANSPORT PROTEIN; SUBSTRATE-BINDING; RECOGNITION; MECHANISM; SUGAR; SPECTROSCOPY; ENTHALPY; ANTIBODY; SITE	Isothermal titration calorimetry has been applied to characterize the thermodynamics of ligand binding to wild-type lactose permease ( LacY) and a mutant (C154G) that strongly favors an inward facing conformation. The affinity of wildtype or mutant LacY for ligand and the change in free energy (Delta G) upon binding are similar. However, with the wild type, the change in free energy upon binding is due primarily to an increase in the entropic free energy component (T Delta S), whereas in marked contrast, an increase in enthalpy (Delta H) is responsible for Delta G in the mutant. Thus, wild-type LacY behaves as if there are multiple ligand-bound conformational states, whereas the mutant is severely restricted. The findings also indicate that the structure of the mutant represents a conformational intermediate in the overall transport cycle.	Univ Calif Los Angeles, MacDonald Res Labs, Dept Physiol & Microbiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Immunol & Mol Genet, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kaback, HR (corresponding author), Univ Calif Los Angeles, MacDonald Res Labs, Dept Physiol & Microbiol, Rm 6720,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	rkaback@mednet.ucla.edu			NIDDK NIH HHS [R01 DK051131-09, R01 DK051131-08, R01 DK051131-04, R01 DK051131-13, R01 DK051131-10, R01 DK051131-07, R01 DK051131, R01 DK051131-14, DK51131, R01 DK051131-06, R01 DK051131-05, R56 DK069463, R01 DK069463, R01 DK051131-12, R56 DK051131, R01 DK051131-11] Funding Source: Medline; NIGMS NIH HHS [P50 GM073210] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK069463, R56DK051131, R01DK051131, R01DK069463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; BERES L, 1971, BIOCHEMISTRY-US, V10, P2120; BUNDLE DR, 1994, METHOD ENZYMOL, V247, P288; CHRISTENSEN JJ, 1976, HDB PROTON IONIZATIO, P148; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Ermolova NV, 2005, BIOCHEMISTRY-US, V44, P7669, DOI 10.1021/bi0502801; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guan L, 2006, P NATL ACAD SCI USA, V103, P1723, DOI 10.1073/pnas.0510922103; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Indyk L, 1998, METHOD ENZYMOL, V295, P350; Janin J, 1997, STRUCTURE, V5, P473, DOI 10.1016/S0969-2126(97)00204-9; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114; MENICK DR, 1985, BIOCHEM BIOPH RES CO, V132, P162, DOI 10.1016/0006-291X(85)91002-2; MIRZA O, 2006, EMBO J; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; RAMAN CS, 1995, BIOCHEMISTRY-US, V34, P5831, DOI 10.1021/bi00017a015; RUDNICK G, 1976, BIOCHEMISTRY-US, V15, P5126, DOI 10.1021/bi00668a028; Sahin-Toth M, 2000, BIOCHEMISTRY-US, V39, P5097, DOI 10.1021/bi0000263; Sahin-Toth M, 2001, BIOCHEMISTRY-US, V40, P13015, DOI 10.1021/bi011233l; Sahin-Toth M, 2001, P NATL ACAD SCI USA, V98, P6068, DOI 10.1073/pnas.111139698; SIGURSKJOLD BW, 1991, EUR J BIOCHEM, V197, P239, DOI 10.1111/j.1432-1033.1991.tb15904.x; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; VANIWAARDEN PR, 1993, BIOCHEMISTRY-US, V32, P5419, DOI 10.1021/bi00071a017; Vazquez-Ibar JL, 2004, J BIOL CHEM, V279, P49214, DOI 10.1074/jbc.M407408200; Vazquez-Ibar JL, 2003, P NATL ACAD SCI USA, V100, P12706, DOI 10.1073/pnas.1835645100; Wang CY, 2001, J MOL BIOL, V313, P873, DOI 10.1006/jmbi.2001.5083; Weinglass A, 2004, J BIOL CHEM, V279, P41858, DOI 10.1074/jbc.M407555200; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7	32	45	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35779	35784		10.1074/jbc.M607232200	http://dx.doi.org/10.1074/jbc.M607232200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17003033	hybrid, Green Accepted			2022-12-27	WOS:000242100500024
J	Zheng, SS; Hausmann, S; Hausmann, P; Liu, QS; Ghosh, A; Schwer, B; Lima, CD; Shuman, S				Zheng, Sushuang; Hausmann, Stephane; Hausmann, Phane; Liu, Quansheng; Ghosh, Agnidipta; Schwer, Beate; Lima, Christopher D.; Shuman, Stewart			Mutational analysis of Encephalitozoon cuniculi mRNA cap (guanine-N7) methyltransferase, structure of the enzyme bound to sinefungin, and evidence that cap methyltransferase is the target of sinefungin's antifungal activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPPING APPARATUS; DNA METHYLTRANSFERASE; (GUANINE-7-)-METHYLTRANSFERASE; MECHANISM; COFACTOR; MUTANTS; CLONING; BRUCEI; GROWTH; A9145	Cap (guanine-N7) methylation is an essential step in eukaryal mRNA synthesis and a potential target for antiviral, antifungal, and antiprotozoal drug discovery. Previous mutational and structural analyses of Encephalitozoon cuniculi Ecm1, a prototypal cellular cap methyltransferase, identified amino acids required for cap methylation in vivo, but also underscored the nonessentiality of many side chains that contact the cap and AdoMet substrates. Here we tested new mutations in residues that comprise the guanine-binding pocket, alone and in combination. The outcomes indicate that the shape of the guanine binding pocket is more crucial than particular base edge interactions, and they highlight the contributions of the aliphatic carbons of Phe-141 and Tyr-145 that engage in multiple van der Waals contacts with guanosine and S-adenosylmethionine ( AdoMet), respectively. We purified 45 Ecm1 mutant proteins and assayed them for methylation of GpppA in vitro. Of the 21 mutations that resulted in unconditional lethality in vivo, 14 reduced activity in vitro to <= 2% of the wild-type level and 5 reduced methyltransferase activity to between 4 and 9% of wild- type Ecm1. The natural product antibiotic sinefungin is an AdoMet analog that inhibits Ecm1 with modest potency. The crystal structure of an Ecm1-sinefungin binary complex reveals sinefungin-specific polar contacts with main-chain and side-chain atoms that can explain the 3-fold higher affinity of Ecm1 for sinefungin versus AdoMet or S-adenosylhomocysteine ( AdoHcy). In contrast, sinefungin is an extremely potent inhibitor of the yeast cap methyltransferase Abd1, to which sinefungin binds 900-fold more avidly than AdoHcy or AdoMet. We find that the sensitivity of Saccharomyces cerevisiae to growth inhibition by sinefungin is diminished when Abd1 is overexpressed. These results highlight cap methylation as a principal target of the antifungal activity of sinefungin.	Cornell Univ, Weill Coll Med, Sloan Kettering Inst, Mol Biol Program, New York, NY 10021 USA; Cornell Univ, Weill Coll Med, Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA; Cornell Univ, Weill Coll Med, Dept Immunol & Microbiol, Struct Biol Program, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Shuman, S (corresponding author), Cornell Univ, Weill Coll Med, Sloan Kettering Inst, Mol Biol Program, New York, NY 10021 USA.	s-shuman@ski.mskcc.org		Ghosh, Agnidipta/0000-0002-7753-0240; Lima, Christopher/0000-0002-9163-6092	NIGMS NIH HHS [GM52470, GM61906] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052470, R01GM061906] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRASSEUR P, 1993, ANTIMICROB AGENTS CH, V37, P889, DOI 10.1128/AAC.37.4.889; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chrebet G, 2005, J BIOMOL SCREEN, V10, P355, DOI 10.1177/1087057104273333; DECLERCQ E, 2005, NUCLEOS NUCLEOT, V24, P1295; DUBE DK, 1983, AM J TROP MED HYG, V32, P31, DOI 10.4269/ajtmh.1983.32.31; Fabrega C, 2004, MOL CELL, V13, P77, DOI 10.1016/S1097-2765(03)00522-7; FERRANTE A, 1984, T ROY SOC TROP MED H, V78, P837, DOI 10.1016/0035-9203(84)90039-7; GORDEE RS, 1973, J ANTIBIOT, V26, P466, DOI 10.7164/antibiotics.26.466; Hall MP, 2006, RNA, V12, P488, DOI 10.1261/rna.2250606; HAMILL RL, 1973, J ANTIBIOT, V26, P463, DOI 10.7164/antibiotics.26.463; HAUGHAN PA, 1993, EXP PARASITOL, V77, P147, DOI 10.1006/expr.1993.1071; Hausmann S, 2005, J BIOL CHEM, V280, P20404, DOI 10.1074/jbc.M501073200; Hausmann S, 2002, J BIOL CHEM, V277, P96, DOI 10.1074/jbc.M109649200; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; INSELBURG J, 1984, MOL BIOCHEM PARASIT, V10, P89, DOI 10.1016/0166-6851(84)90021-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMINSKY R, 1989, ANTIMICROB AGENTS CH, V33, P881, DOI 10.1128/AAC.33.6.881; Lawrence F, 1998, MOL BIOCHEM PARASIT, V92, P99, DOI 10.1016/S0166-6851(97)00235-1; LIU S, 1992, ANTIVIR RES, V19, P247, DOI 10.1016/0166-3542(92)90083-H; MAO XD, 1995, MOL CELL BIOL, V15, P4167; Mao XD, 1996, MOL CELL BIOL, V16, P475; MESSIKA E, 1990, TROP MED PARASITOL, V41, P273; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Pertejo Y, 2006, BBA-GEN SUBJECTS, V1760, P10, DOI 10.1016/j.bbagen.2005.09.003; PHELOUZAT MA, 1993, PARASITOL RES, V79, P683, DOI 10.1007/BF00932511; Pillutla RC, 1998, J BIOL CHEM, V273, P21443, DOI 10.1074/jbc.273.34.21443; PUGH CSG, 1978, J BIOL CHEM, V253, P4075; Saha N, 1999, J BIOL CHEM, V274, P16553, DOI 10.1074/jbc.274.23.16553; Schluckebier G, 1999, J MOL BIOL, V289, P277, DOI 10.1006/jmbi.1999.2788; Schluckebier G, 1997, J MOL BIOL, V265, P56, DOI 10.1006/jmbi.1996.0711; Schwer B, 2001, J BIOL CHEM, V276, P1857, DOI 10.1074/jbc.M006072200; Schwer B, 2000, GENETICS, V155, P1561; Schwer B, 2006, J BIOL CHEM, V281, P18953, DOI 10.1074/jbc.M602867200; Shuman S, 2001, COLD SPRING HARB SYM, V66, P301, DOI 10.1101/sqb.2001.66.301; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; SIBLEY LD, 1992, GENETICS, V132, P1003; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Thomas CB, 2003, J BIOL CHEM, V278, P26094, DOI 10.1074/jbc.M303751200; Tsukamoto T, 1998, BIOCHEM BIOPH RES CO, V251, P27, DOI 10.1006/bbrc.1998.9402; Wang SP, 1997, J BIOL CHEM, V272, P14683, DOI 10.1074/jbc.272.23.14683; Yamada-Okabe T, 1999, MICROBIOL-UK, V145, P3023, DOI 10.1099/00221287-145-11-3023; Yokoska J, 2000, BIOCHEM BIOPH RES CO, V268, P617, DOI 10.1006/bbrc.2000.2188	44	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35904	35913		10.1074/jbc.M607292200	http://dx.doi.org/10.1074/jbc.M607292200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16971388	hybrid			2022-12-27	WOS:000242100500037
J	Gui, LQ; Wojciechowski, K; Gildner, CD; Nedelkovska, H; Hocking, DC				Gui, Liqiong; Wojciechowski, Katherine; Gildner, Candace D.; Nedelkovska, Hristina; Hocking, Denise C.			Identification of the heparin-binding determinants within fibronectin repeat III - Role in cell spreading and growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; PLASMA FIBRONECTIN; CYCLE PROGRESSION; MEMBRANE TENSION; ACTIN-FILAMENTS; POLYMERIZATION; MODULE; DOMAIN; SITE; CONTRACTILITY	Fibronectins are high molecular mass glycoproteins that circulate as soluble molecules in the blood, and are also found in an insoluble, multimeric form in extracellular matrices throughout the body. Soluble fibronectins are polymerized into insoluble extracellular matrix (ECM) fibrils via a cell-dependent process. Recent studies indicate that the interaction of cells with the ECM form of fibronectin promotes actin organization and cell contractility, increases cell growth and migration, and enhances the tensile strength of artificial tissue constructs; ligation of integrins alone is insufficient to trigger these responses. Evidence suggests that the effect of ECM fibronectin on cell function is mediated in part by a matricryptic heparin-binding site within the first III1 repeat (FNIII1). In this study, we localized the heparin- binding activity of FNIII1 to a cluster of basic amino acids, Arg(613), Trp(614), Arg(615), and Lys(617). Site- directed mutagenesis of a recombinant fibronectin construct engineered to mimic the ECM form of fibronectin demonstrates that these residues are also critical for stimulating cell spreading and increasing cell proliferation. Cell proliferation has been tightly correlated with cell area. Using integrin-and heparin-binding fibronectin mutants, we found a positive correlation between cell spreading and growth when cells were submaximally spread on ECM protein-coated surfaces at the time of treatment. However, cells maximally spread on vitronectin or fibronectin still responded to the fibronectin matrix mimetic with an increase in growth, indicating that an absolute change in cell area is not required for the increase in cell proliferation induced by the matricryptic site of FNIII1.	Univ Rochester, Med Ctr, Dept Biomed Engn, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Hocking, DC (corresponding author), Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	denise_hocking@urmc.rochester.edu	Hocking, Denise/H-7903-2012	Hocking, Denise/0000-0003-2337-0357	NHLBI NIH HHS [HL64074] Funding Source: Medline; NIBIB NIH HHS [EB00986] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB000986] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998; Berrier AL, 2000, J CELL BIOL, V151, P1549, DOI 10.1083/jcb.151.7.1549; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Davey G, 1999, J CELL SCI, V112, P4663; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; DUNN GA, 1995, J CELL SCI, V108, P1239; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Fransson LA, 2003, INT J BIOCHEM CELL B, V35, P125, DOI 10.1016/S1357-2725(02)00095-X; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gildner CD, 2004, AM J PHYSIOL-HEART C, V287, pH46, DOI 10.1152/ajpheart.00859.2003; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; LITVINOVICH SV, 1992, BIOCHIM BIOPHYS ACTA, V1119, P57, DOI 10.1016/0167-4838(92)90234-5; Mercurius KO, 1998, CIRC RES, V82, P548, DOI 10.1161/01.RES.82.5.548; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Miller TM, 1997, J BIOL CHEM, V272, P9847; MOONEY DJ, 1995, J CELL SCI, V108, P2311; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Mosher, 1989, FIBRONECTIN, P1; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; PETERSEN TE, 1983, P NATL ACAD SCI-BIOL, V80, P137, DOI 10.1073/pnas.80.1.137; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Sechler JL, 1998, J BIOL CHEM, V273, P25533, DOI 10.1074/jbc.273.40.25533; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Sottile J, 1998, J CELL SCI, V111, P2933; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sottile J, 2000, J CELL SCI, V113, P4287; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Woods A, 2001, J CLIN INVEST, V107, P935, DOI 10.1172/JCI12802; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	53	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34816	34825		10.1074/jbc.M608611200	http://dx.doi.org/10.1074/jbc.M608611200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16982604	hybrid			2022-12-27	WOS:000241933700014
J	Cavalier, DM; Keegstra, K				Cavalier, David M.; Keegstra, Kenneth			Two xyloglucan xylosyltransferases catalyze the addition of multiple xylosyl residues to cellohexaose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED SOYBEAN CELLS; BETA-GLUCAN SYNTHETASE; GOLGI MEMBRANES; UDP-XYLOSE; BIOSYNTHESIS; WALL; PEA; GALACTOSYLTRANSFERASE; POLYSACCHARIDE; OLIGOSACCHARIDES	Xyloglucan (XyG) is the principal hemicellulose found in the primary cell walls of most plants. XyG is composed of a beta-(1,4)glucan backbone that is substituted in a regular pattern with xylosyl residues, which are added by at least one and likely two or three xylosyltransferase (XT) enzymes. Previous work identified seven Arabidopsis thaliana candidate genes, one of which (AtXT1) was shown to encode a protein with XT activity (Faik, A., Price, N. J., Raikhel, N. V., and Keegstra, K. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 7797 - 7802). We expressed both AtXT1 and a second closely related gene, now called AtXT2, in insect cells and demonstrated that both have XT activity for cellopentaose and cellohexaose acceptor substrates. Moreover, we showed that cellohexaose was a significantly better acceptor substrate than cellopentaose. Product structural characterization showed that AtXT1 and AtXT2 preferentially added the first xylosyl residue to the fourth glucosyl residue from the reducing end of both acceptors. Furthermore, when the ratio of UDP-xylose to cellohexaose and the reaction time were increased, both AtXT1 and AtXT2 added a second xylosyl residue adjacent to the first, which generated dixylosylated cellohexaose. On the basis of these results, we concluded that AtXT1 and AtXT2 have the same acceptor specificities and generate the same products in vitro. The implications of these results for understanding in vivo XyG biosynthesis are considered.	Michigan State Univ, Dept Energy Plant, Res Lab, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Michigan State Univ, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Cavalier, DM (corresponding author), Michigan State Univ, Dept Energy Plant, Res Lab, 110 Plant Biol Bldg,178 Wilson Rd, E Lansing, MI 48824 USA.	cavalie8@msu.edu						BRUMMELL DA, 1990, J CELL SCI, V96, P705; EDWARDS M, 1992, PLANTA, V187, P67, DOI 10.1007/BF00201625; Edwards ME, 1999, PLANT J, V19, P691, DOI 10.1046/j.1365-313x.1999.00566.x; Edwards ME, 2002, PLANT PHYSIOL, V129, P1391, DOI 10.1104/pp.002592; Faik A, 2000, J BIOL CHEM, V275, P15082, DOI 10.1074/jbc.M000677200; Faik A, 2002, P NATL ACAD SCI USA, V99, P7797, DOI 10.1073/pnas.102644799; Fort S, 2000, J AM CHEM SOC, V122, P5429, DOI 10.1021/ja9936520; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; GORDON R, 1989, PLANT PHYSIOL, V91, P373, DOI 10.1104/pp.91.1.373; HARDY MR, 1989, METHOD ENZYMOL, V179, P76; Harlow E., 1988, ANTIBODIES LAB MANUA; HAYASHI T, 1981, J BIOCHEM-TOKYO, V89, P325, DOI 10.1093/oxfordjournals.jbchem.a133198; HAYASHI T, 1984, AGR BIOL CHEM TOKYO, V48, P1023, DOI 10.1080/00021369.1984.10866244; HAYASHI T, 1981, PLANT CELL PHYSIOL, V22, P1571, DOI 10.1093/oxfordjournals.pcp.a076310; HAYASHI T, 1981, PLANT CELL PHYSIOL, V22, P517; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; Hoffman M, 2005, CARBOHYD RES, V340, P1826, DOI 10.1016/j.carres.2005.04.016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Marry M, 2003, CARBOHYD POLYM, V51, P347, DOI 10.1016/S0144-8617(02)00189-3; ONEILL MA, 2003, PLANT CELL WALL, V8, P1; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; RAY PM, 1969, P NATL ACAD SCI USA, V64, P605, DOI 10.1073/pnas.64.2.605; RAY PM, 1980, BIOCHIM BIOPHYS ACTA, V629, P431, DOI 10.1016/0304-4165(80)90149-X; REID JSG, 1995, PLANTA, V195, P489, DOI 10.1007/BF00195705; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Vincken JP, 1997, PLANT PHYSIOL, V114, P9, DOI 10.1104/pp.114.1.9; WHITE AR, 1993, BIOCHEM J, V294, P231, DOI 10.1042/bj2940231	31	86	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34197	34207		10.1074/jbc.M606379200	http://dx.doi.org/10.1074/jbc.M606379200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16982611	hybrid			2022-12-27	WOS:000241767600040
J	Xu, L; Renaud, L; Muller, JG; Baicu, CF; Bonnema, DD; Zhou, H; Kappler, CS; Kubalak, SW; Zile, MR; Conway, SJ; Menick, DR				Xu, Lin; Renaud, Ludivine; Mueller, Joachim G.; Baicu, Catalin F.; Bonnema, D. Dirk; Zhou, Hongming; Kappler, Christiana S.; Kubalak, Steven W.; Zile, Michael R.; Conway, Simon J.; Menick, Donald R.			Regulation of Ncx1 expression - Identification of regulatory elements mediating cardiac-specific expression and up-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; SERUM RESPONSE FACTOR; GENE-EXPRESSION; PRESSURE-OVERLOAD; IN-VIVO; TRANSCRIPTION; HYPERTROPHY; GATA-4; CARDIOMYOCYTES; ORGANIZATION	The Na+-Ca2+ exchanger (NCX1) is up-regulated in hypertrophy and is often found up-regulated in end-stage heart failure. Studies have shown that the change in its expression contributes to contractile dysfunction. We have previously shown that the 1831-bp Ncx1 H1 (1831Ncx1) promoter directs cardiac-specific expression of the exchanger in both development and in the adult, and is sufficient for the up-regulation of Ncx1 in response to pressure overload. Here, we utilized adenoviral mediated gene transfer and transgenics to identify minimal regions and response elements that mediate Ncx1 expression in the heart. We demonstrate that the proximal 184 bp of the Ncx1 H1 (184Ncx1) promoter is sufficient for expression of reporter genes in adult cardiomyocytes and for the correct spatiotemporal pattern of Ncx1 expression in development but not for up-regulation in response to pressure overload. Mutational analysis revealed that both the -80 CArG and the -50 GATA elements were required for expression in isolated adult cardiomyocytes. Chromatin immunoprecipitation assays in adult cardiocytes demonstrate that SRF and GATA4 are associated with the proximal region of the endogenous Ncx1 promoter. Transgenic lines were established for the 1831Ncx1 promoter-luciferase containing mutations in the -80 CArG or -50 GATA element. No luciferase activity was detected during development, in the adult, or after pressure overload in any of the -80 CArG transgenic lines. The Ncx1 -50 GATA mutant promoter was sufficient for driving the normal spatiotemporal pattern of Ncx1 expression in development and for up-regulation in response to pressure overload but importantly, expression was no longer cardiac restricted. This work is the first in vivo study that demonstrates which cis elements are important for Ncx1 regulation.	Med Univ S Carolina, Dept Med, Div Cardiol, Gazes Cardiac Res Inst, Charleston, SC 29425 USA; Indiana Univ, Sch Med, Wells Ctr Pediat Res, Cardiovasc Dev Grp, Indianapolis, IN 46202 USA	Medical University of South Carolina; Indiana University System; Indiana University-Purdue University Indianapolis	Menick, DR (corresponding author), 114 Doughty St, Charleston, SC 29425 USA.	menickd@musc.edu	Renaud, Ludivine/T-1209-2019	Zile, Michael/0000-0001-7076-221X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063714, T32HL007260, P01HL048788, R01HL060714, R01HL066223] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32HL07260, HL066223, R01 HL063714-04, P01 HL48788, HL60714, R01 HL066223, P01 HL048788, R01 HL063714, R01 HL060714] Funding Source: Medline; PHS HHS [NCRR16434] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; Barnes KV, 1997, J BIOL CHEM, V272, P11510, DOI 10.1074/jbc.272.17.11550; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Cheng GM, 1999, J BIOL CHEM, V274, P12819, DOI 10.1074/jbc.274.18.12819; Conway SJ, 2002, ANN NY ACAD SCI, V976, P268; de Krom M, 2002, MOL CELL, V9, P1319, DOI 10.1016/S1097-2765(02)00558-0; Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9; Hasegawa K, 1997, CIRCULATION, V96, P3943; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; KENT RL, 1989, AM J PHYSIOL, V257, pH1717, DOI 10.1152/ajpheart.1989.257.5.H1717; KENT RL, 1993, AM J PHYSIOL, V265, pH1024, DOI 10.1152/ajpheart.1993.265.3.H1024; Koushik SV, 1999, MECH DEVELOP, V88, P119, DOI 10.1016/S0925-4773(99)00177-X; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Kraev A, 1996, GENOMICS, V37, P105, DOI 10.1006/geno.1996.0526; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; Martin DIK, 2001, TRENDS GENET, V17, P444, DOI 10.1016/S0168-9525(01)02368-X; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morimoto T, 2000, J BIOL CHEM, V275, P13721, DOI 10.1074/jbc.275.18.13721; Muller JG, 2002, J MOL CELL CARDIOL, V34, P807, DOI 10.1006/jmcc.2002.2019; Muller JG, 2002, CIRC RES, V90, P158, DOI 10.1161/hh0202.103231; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Pogwizd SM, 1999, CIRC RES, V85, P1009; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Roten L, 2000, J MOL CELL CARDIOL, V32, P109, DOI 10.1006/jmcc.1999.1052; Scheller T, 1998, J BIOL CHEM, V273, P7643, DOI 10.1074/jbc.273.13.7643; Sepulveda JL, 2002, J BIOL CHEM, V277, P25775, DOI 10.1074/jbc.M203122200; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Wang ZY, 2001, J BIOL CHEM, V276, P17706, DOI 10.1074/jbc.M100544200; Xu L, 2005, J MOL CELL CARDIOL, V38, P735, DOI 10.1016/j.yjmcc.2005.03.002	33	20	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34430	34440		10.1074/jbc.M607446200	http://dx.doi.org/10.1074/jbc.M607446200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966329	hybrid, Green Accepted			2022-12-27	WOS:000241767600063
J	Doyle, HA; Zhou, J; Wolff, MJ; Harvey, BP; Roman, RM; Gee, RJ; Koski, RA; Mamula, MJ				Doyle, Hester A.; Zhou, Jing; Wolff, Martin J.; Harvey, Bohdan P.; Roman, Robert M.; Gee, Renelle J.; Koski, Raymond A.; Mamula, Mark J.			Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC MELANOMA; DENDRITIC CELLS; TUMOR-REGRESSION; ELISPOT ASSAY; ANTIGEN; PEPTIDE; PROTEINS; VACCINES; AUTOIMMUNITY; TARGETS	A hallmark of the immune system is the ability to ignore self-antigens. In attempts to bypass normal immune tolerance, a post-translational protein modification was introduced into self-antigens to break T and B cell tolerance. We demonstrate that immune tolerance is bypassed by immunization with a post-translationally modified melanoma antigen. In particular, the conversion of an aspartic acid to an isoaspartic acid within the melanoma antigen tyrosinase-related protein (TRP)-2 peptide-(181-188) makes the otherwise immunologically ignored TRP-2 antigen immunogenic. Tetramer analysis of isoAsp TRP-2 peptide- immunized mice demonstrated that CD8(+) T cells not only recognized the isoaspartyl TRP-2 peptide but also the native TRP-2 peptide. These CD8(+) T cells functioned as cytotoxic T lymphocytes, as they effectively lysed TRP-2 peptide-pulsed targets both in vitro and in vivo. Potentially, post-translational protein modification can be utilized to trigger strong immune responses to either tumor proteins or potentially weakly immunogenic pathogens.	Yale Univ, Sch Med, New Haven, CT 06520 USA; L2 Diagnost, New Haven, CT 06511 USA	Yale University	Mamula, MJ (corresponding author), Yale Univ, Sch Med, POB 208031, New Haven, CT 06520 USA.	mark.mamula@yale.edu		Wolff, Martin/0000-0003-4391-2395	NCI NIH HHS [CA 101542] Funding Source: Medline; NIAID NIH HHS [AI 48120] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R41CA101542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048120, R21AI048120] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anichini A, 2004, CANCER IMMUNOL IMMUN, V53, P855, DOI 10.1007/s00262-004-0526-8; Anichini A, 1999, J EXP MED, V190, P651, DOI 10.1084/jem.190.5.651; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bernsen MR, 2004, J PATHOL, V202, P70, DOI 10.1002/path.1494; BROWNE WB, 1999, J EXP MED, V190, P1717; CLARKE S, 1985, ANNU REV BIOCHEM, V54, P479, DOI 10.1146/annurev.bi.54.070185.002403; CLARKE S, 1992, STABILITY PROTEIN PH, P2; Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X; Devine L, 2002, J IMMUNOL, V168, P3881, DOI 10.4049/jimmunol.168.8.3881; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Huang YJ, 2005, J IMMUNOL, V175, P3110, DOI 10.4049/jimmunol.175.5.3110; JONES E, 2004, NOVART FDN SYMP, V256, P147; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Lewis JJ, 2000, INT J CANCER, V87, P391, DOI 10.1002/1097-0215(20000801)87:3<391::AID-IJC13>3.0.CO;2-K; LOWENSON J, 1988, BLOOD CELLS, V14, P103; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Mortarini R, 2003, CANCER RES, V63, P2535; Mullins DW, 2006, J IMMUNOL, V176, P4535, DOI 10.4049/jimmunol.176.8.4535; Naftzger C, 1996, P NATL ACAD SCI USA, V93, P14809, DOI 10.1073/pnas.93.25.14809; Okamoto T, 1998, J INVEST DERMATOL, V111, P1034, DOI 10.1046/j.1523-1747.1998.00411.x; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; OVERWIJK WW, 2003, CURRENT PROTOCOLS IM, P29; Paczesny S, 2004, J EXP MED, V199, P1503, DOI 10.1084/jem.20032118; Palucka AK, 2005, J IMMUNOTHER, V28, P158, DOI 10.1097/01.cji.0000154249.74383.17; Pass HA, 1998, CANCER J SCI AM, V4, P316; Phan GQ, 2003, J IMMUNOTHER, V26, P349, DOI 10.1097/00002371-200307000-00007; Rice J, 2004, J IMMUNOL, V173, P4492, DOI 10.4049/jimmunol.173.7.4492; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Takechi Y, 1996, CLIN CANCER RES, V2, P1837; TESHIMA G, 1991, BIOCHEMISTRY-US, V30, P3916, DOI 10.1021/bi00230a016; Utz PJ, 1997, J EXP MED, V185, P843, DOI 10.1084/jem.185.5.843; van Elsas A, 2001, J EXP MED, V194, P481, DOI 10.1084/jem.194.4.481	39	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32676	32683		10.1074/jbc.M604847200	http://dx.doi.org/10.1074/jbc.M604847200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950786				2022-12-27	WOS:000241414500066
J	Jeske, NA; Patwardhan, AM; Gamper, N; Price, TJ; Akopian, AN; Hargreaves, KM				Jeske, Nathaniel A.; Patwardhan, Amol M.; Gamper, Nikita; Price, Theodore J.; Akopian, Armen N.; Hargreaves, Kenneth M.			Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; POTENTIAL VANILLOID-1 TRPV1; DEPENDENT PROTEIN-KINASE; MESENTERIC ARTERIAL BED; CAPSAICIN RECEPTOR VR1; INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR CALCIUM; NEUROPEPTIDE RELEASE; THERMAL HYPERALGESIA; ION CHANNELS	Cannabinoids are known to have multiple sites of action in the nociceptive system, leading to reduced pain sensation. However, the peripheral mechanism(s) by which this phenomenon occurs remains an issue that has yet to be resolved. Because phosphorylation of TRPV1 ((t) under bar ransient (r) under bar eceptor (p) under bar otential subtype (V1) under bar) plays a key role in the induction of thermal hyperalgesia in inflammatory pain models, we evaluated whether the cannabinoid agonist WIN 55,212-2 (WIN) regulates the phosphorylation state of TRPV1. Here, we show that treatment of primary rat trigeminal ganglion cultures with WIN led to dephosphorylation of TRPV1, specifically at threonine residues. Utilizing Chinese hamster ovary cell lines, we demonstrate that Thr(144) and Thr(370) were dephosphorylated, leading to desensitization of the TRPV1 receptor. This post- translational modification occurred through activation of the phosphatase calcineurin (protein phosphatase 2B) following WIN treatment. Furthermore, knockdown of TRPA1 ((t) under bar ransient (r) under bar eceptor (p) under bar otential subtype (A1) under bar) expression in sensory neurons by specific small interfering RNA abolished the WIN effect on TRPV1 dephosphorylation, suggesting that WIN acts through TRPA1. We also confirm the importance of TRPA1 in WIN-induced dephosphorylation of TRPV1 in Chinese hamster ovary cells through targeted expression of one or both receptor channels. These results imply that the cannabinoid WIN modulates the sensitivity of sensory neurons to TRPV1 activation by altering receptor phosphorylation. In addition, our data could serve as a useful strategy in determining the potential use of certain cannabinoids as peripheral analgesics.	Univ Texas, Hlth Sci Ctr, Dept Endodont, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Hargreaves, KM (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Endodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Hargreaves@UTHSCSA.edu	Price, Theodore/A-5094-2010; Price, Theodore/M-3810-2018	Price, Theodore/0000-0002-6971-6221; Gamper, Nikita/0000-0001-5806-0207	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014928, F32DE016500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019585, F31DA006085] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA019585, F31 DA006085, R01 DA 19585, F31 DA006085-03] Funding Source: Medline; NIDCR NIH HHS [R21 DE 014928, R21 DE014928, F32 DE016500, F32 DE 016500, F32 DE016500-01] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALDAPE RA, 1992, J BIOL CHEM, V267, P16029; Baker CL, 2004, BRIT J PHARMACOL, V142, P1361, DOI 10.1038/sj.bjp.0705902; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bridges D, 2003, NEUROSCIENCE, V119, P803, DOI 10.1016/S0306-4522(03)00200-8; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1999, P NATL ACAD SCI USA, V96, P7658, DOI 10.1073/pnas.96.14.7658; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chin CN, 1999, J PHARMACOL EXP THER, V291, P837; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DELRIO E, 1994, J NEUROCHEM, V63, P535; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Duncan M, 2004, J PHARMACOL EXP THER, V311, P411, DOI 10.1124/jpet.104.067587; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; HARGREAVES KM, 1992, J ENDODONT, V18, P597, DOI 10.1016/S0099-2399(06)81329-4; Helyes Z, 2003, LIFE SCI, V73, P2345, DOI 10.1016/S0024-3205(03)00651-9; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Jeske NA, 2004, J NEUROCHEM, V90, P819, DOI 10.1111/j.1471-4159.2004.02557.x; Johanek LM, 2001, PAIN, V93, P303, DOI 10.1016/S0304-3959(01)00336-0; Johanek LM, 2004, PAIN, V109, P432, DOI 10.1016/j.pain.2004.02.020; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Khasabova IA, 2004, J NEUROSCI, V24, P1744, DOI 10.1523/JNEUROSCI.4298-03.2004; Koplas PA, 1997, J NEUROSCI, V17, P3525; KUSTER JE, 1993, J PHARMACOL EXP THER, V264, P1352; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Li J, 1999, PAIN, V81, P25, DOI 10.1016/S0304-3959(98)00263-2; Lizanecz E, 2006, MOL PHARMACOL, V69, P1015, DOI 10.1124/mol.105.015644; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; Malan TP, 2003, CURR OPIN PHARMACOL, V3, P62, DOI 10.1016/S1471-4892(02)00004-8; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; Premkumar LS, 2002, J PHYSIOL-LONDON, V545, P107, DOI 10.1113/jphysiol.2002.016352; Price TJ, 2004, BRIT J PHARMACOL, V141, P1118, DOI 10.1038/sj.bjp.0705711; Price TJ, 2003, NEUROSCIENCE, V120, P155, DOI 10.1016/S0306-4522(03)00333-6; Price TJ, 2004, BRIT J PHARMACOL, V142, P257, DOI 10.1038/sj.bjp.0705778; Ralevic V, 2001, EUR J PHARMACOL, V418, P117, DOI 10.1016/S0014-2999(01)00940-2; Rathee PK, 2002, J NEUROSCI, V22, P4740, DOI 10.1523/JNEUROSCI.22-11-04740.2002; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; RUMSFIELD JA, 1991, DICP ANN PHARMAC, V25, P381, DOI 10.1177/106002809102500409; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; STOEHR SJ, 1986, J NEUROCHEM, V46, P637, DOI 10.1111/j.1471-4159.1986.tb13014.x; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	57	115	121	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32879	32890		10.1074/jbc.M603220200	http://dx.doi.org/10.1074/jbc.M603220200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954222	Green Accepted, hybrid			2022-12-27	WOS:000241414500086
J	Bertani, I; Rusconi, L; Bolognese, F; Forlani, G; Conca, B; De Monte, L; Badaracco, G; Landsberger, N; Kilstrup-Nielsen, C				Bertani, Ilaria; Rusconi, Laura; Bolognese, Fabrizio; Forlani, Greta; Conca, Barbara; De Monte, Lucia; Badaracco, Gianfranco; Landsberger, Nicoletta; Kilstrup-Nielsen, Charlotte			Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET SEIZURES; RETT-SYNDROME; MECP2; PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; VARIANT; REGION; DOMAIN; ERK7	Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been identified in patients with Rett syndrome, West syndrome, and X-linked infantile spasms sharing the common features of generally intractable early seizures and mental retardation. Disease-causing mutations are distributed in both the catalytic domain and in the large COOH terminus. In this report, we examine the functional consequences of some Rett mutations of CDKL5 together with some synthetically designed derivatives useful to underline the functional domains of the protein. The mutated CDKL5 derivatives have been subjected to in vitro kinase assays and analyzed for phosphorylation of the TEY (Thr-Glu-Tyr) motif within the activation loop, their subcellular localization, and the capacity of CDKL5 to interact with itself. Whereas wild-type CDKL5 autophosphorylates and mediates the phosphorylation of the methyl-CpG-binding protein 2 (MeCP2) in vitro, Rett-mutated proteins show both impaired and increased catalytic activity suggesting that a tight regulation of CDKL5 is required for correct brain functions. Furthermore, we show that CDKL5 can self-associate and mediate the phosphorylation of its own TEY (Thr-Glu-Tyr) motif. Eventually, we show that the COOH terminus regulates CDKL5 properties; in particular, it negatively influences the catalytic activity and is required for its proper sub-nuclear localization. We propose a model in which CDKL5 phosphorylation is required for its entrance into the nucleus whereas a portion of the COOH-terminal domain is responsible for a stable residency in this cellular compartment probably through protein-protein interactions.	Univ Insubria, Dipartimento Biol Strutturale & Funz, I-21052 Busto Arsizio, VA, Italy; San Raffaele Sci Inst, I-20132 Milan, Italy	University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landsberger, N (corresponding author), Univ Insubria, Dipartimento Biol Strutturale & Funz, I-21052 Busto Arsizio, VA, Italy.	landsben@uninsubria.it; c.kilstrup-nielsen@uninsubria.it	DeMonte, Lucia/AAN-8336-2020; Kilstrup-Nielsen, Charlotte/A-6348-2014	Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; De Monte, Lucia/0000-0002-9406-7809; FORLANI, GRETA/0000-0003-1987-7761; Bertani, Ilaria/0000-0003-3175-8677; Landsberger, Nicoletta/0000-0003-0820-3155	Telethon [GGP05119] Funding Source: Medline	Telethon(Fondazione Telethon)		Abe MK, 2001, J BIOL CHEM, V276, P21272, DOI 10.1074/jbc.M100026200; Abe MK, 1999, MOL CELL BIOL, V19, P1301; Archer HL, 2006, J MED GENET, V43, P729, DOI 10.1136/jmg.2006.041467; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Evans JC, 2005, EUR J HUM GENET, V13, P1113, DOI 10.1038/sj.ejhg.5201451; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Huopaniemi L, 2000, HUM MUTAT, V16, P307, DOI 10.1002/1098-1004(200010)16:4<307::AID-HUMU3>3.0.CO;2-L; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Scala E, 2005, J MED GENET, V42, P103, DOI 10.1136/jmg.2004.026237; Tao J, 2004, AM J HUM GENET, V75, P1149, DOI 10.1086/426460; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; Zheng QL, 2004, J BIOL CHEM, V279, P8787, DOI 10.1074/jbc.M310212200	22	110	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					32048	32056		10.1074/jbc.M606325200	http://dx.doi.org/10.1074/jbc.M606325200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16935860	Green Published, Bronze			2022-12-27	WOS:000241235300090
J	CHANG, JD; XU, YP; RAYCHOWDHURY, MK; WARE, JA				CHANG, JD; XU, YP; RAYCHOWDHURY, MK; WARE, JA			MOLECULAR-CLONING AND EXPRESSION OF A CDNA-ENCODING A NOVEL ISOENZYME OF PROTEIN-KINASE-C (NPKC) - A NEW MEMBER OF THE NPKC FAMILY EXPRESSED IN SKELETAL-MUSCLE, MEGAKARYOBLASTIC CELLS, AND PLATELETS (VOL 268, PG 14208, 1993)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction, Addition																		CHANG JD, 1993, J BIOL CHEM, V268, P14208	1	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 9	1994	269	49					31322	31322						1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PV510	16964635				2022-12-27	WOS:A1994PV51000088
J	Montalvo, GB; Artalejo, AR; Gilabert, JA				Montalvo, Gema B.; Artalejo, Antonio R.; Gilabert, Juan A.			ATP from subplasmalemmal mitochondria controls Ca2+ dependent inactivation of CRAC channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CALCIUM CURRENT; CURRENT I-CRAC; HUMAN T-CELLS; MAST-CELLS; DEPLETION; LYMPHOCYTES; INFLUX; MICRODOMAINS; MODULATION; INHIBITION	A sustained Ca2+ entry is the primary signal for T lymphocyte activation after antigen recognition. This Ca2+ entry mainly occurs through store-operated Ca2+ channels responsible for a highly selective Ca2+ current known as I-CRAC. Ca2+ ions act as negative feedback regulators of I-CRAC, promoting its inactivation. Mitochondria, which act as intracellular Ca2+ buffers, have been proposed to control all stages of CRAC current and, hence, intracellular Ca2+ signaling in several types of non-excitable cells. Using the whole-cell configuration of the patch clamp technique, which allows control of the intracellular environment, we report here that respiring mitochondria located close to CRAC channels can regulate slow Ca2+-dependent inactivation of I-CRAC by increasing the Ca2+-buffering capacity beneath the plasma membrane, mainly through the release of ATP.	Univ Complutense Madrid, Fac Vet, Inst Farmacol & Toxicol, Dept Pharmacol & Toxicol, E-28040 Madrid, Spain	Complutense University of Madrid	Gilabert, JA (corresponding author), Univ Complutense Madrid, Fac Vet, Inst Farmacol & Toxicol, Dept Pharmacol & Toxicol, Ave Puerta de Hierro,S-N, E-28040 Madrid, Spain.	jagilabe@vet.ucm.es	Artalejo, Antonio R./ABG-2009-2020; Artalejo, Antonio R./H-4378-2015	Artalejo, Antonio R./0000-0001-9720-9190; Artalejo, Antonio R./0000-0001-9720-9190; Gilabert, Juan Antonio/0000-0003-2717-1718				Aneiros E, 2005, J IMMUNOL, V174, P119, DOI 10.4049/jimmunol.174.1.119; Bakowski D, 2001, BIOCHEM J, V353, P561, DOI 10.1042/0264-6021:3530561; Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Gilabert JA, 2001, EMBO J, V20, P2672, DOI 10.1093/emboj/20.11.2672; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; GUNTER TE, 1990, AM J PHYSIOL, V258, P755; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lawrie AM, 1996, J BIOL CHEM, V271, P10753, DOI 10.1074/jbc.271.18.10753; Makowska A, 2000, EUR J BIOCHEM, V267, P877, DOI 10.1046/j.1432-1327.2000.01066.x; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E., 1986, CALCIUM ELECTROGENES, V14, P80; Parekh AB, 2003, NEWS PHYSIOL SCI, V18, P252, DOI 10.1152/nips.01458.2003; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Tiffert T, 2001, CELL CALCIUM, V30, P337, DOI 10.1054/ceca.2001.0241; Varadi A, 2004, CELL CALCIUM, V36, P499, DOI 10.1016/j.ceca.2004.05.003; VILLALBA M, 1994, J BIOL CHEM, V269, P2468; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	36	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35616	35623		10.1074/jbc.M603518200	http://dx.doi.org/10.1074/jbc.M603518200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16982621	hybrid			2022-12-27	WOS:000242100500006
J	Zhang, AL; Lyu, YL; Lin, CP; Zhou, N; Azarova, AM; Wood, LM; Liu, LF				Zhang, Ailing; Lyu, Yi Lisa; Lin, Chao-Po; Zhou, Nai; Azarova, Anna M.; Wood, Laurence M.; Liu, Leroy F.			A protease pathway for the repair of topoisomerase II-DNA covalent complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SISTER-CHROMATID EXCHANGES; CHROMOSOMAL-ABERRATIONS; CLEAVABLE COMPLEXES; KAPPA-B; CELLS; BETA; YEAST; DEGRADATION; EXPRESSION	Despite rapid advances in the field of DNA repair, little is known about the repair of protein-DNA adducts. Previous studies have demonstrated that topoisomerase II (TopII)-DNA adducts (TopII-DNA covalent complexes) are rapidly degraded by the proteasome. It has been hypothesized that proteasomal degradation of TopII-DNA covalent adducts exposes TopII-concealed DNA double-strand breaks (DSBs)for repair. To test this hypothesis, the anticancer drug, VP-16 ( etoposide), was employed to induce TopII-DNA covalent complexes in mammalian cells, and the involvement of proteasome in processing TopII-DNA covalent complexes into DSBs was investigated. Consistent with the hypothesis, VP-16-induced DSBs as monitored by neutral comet assay, as well as DNA damage signals ( e. g. gamma-H2AX) were significantly reduced in the presence of the proteasome inhibitor, MG132. Using both top2 beta knock-out mouse embryonic fibroblasts and Top2 beta small interfering RNA knockdown PC12 cells, as well as postmitotic neurons in which TopII alpha was absent, we showed that VP-16-induced DNA damage signals were attenuated upon proteasome inhibition, suggesting the involvement of proteasome in the repair/processing of both TopII alpha-DNA and TopII beta-DNA adducts. By contrast, hydrogen peroxide-induced gamma-H2AX was unaffected upon proteasome inhibition, suggesting a specific requirement of the proteasome pathway in the processing of TopII-DNA covalent complexes into DNA damage.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Liu, LF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	lliu@umdnj.edu		Azarova, Anna/0000-0002-2901-732X; Liu, Leroy/0000-0001-9396-763X; Lin, Chao-Po/0000-0002-1457-1635	NCI NIH HHS [R01 CA39662, R01 CA102463] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102463, R01CA039662] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andriollo M, 2003, ARCH BIOCHEM BIOPHYS, V413, P75, DOI 10.1016/S0003-9861(03)00114-0; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Boland MP, 2000, J BIOL CHEM, V275, P25231, DOI 10.1074/jbc.275.33.25231; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; CHEN GL, 1984, J BIOL CHEM, V259, P3560; Clifford B, 2003, CANCER RES, V63, P4074; Cuvier O, 2003, J CELL BIOL, V160, P645, DOI 10.1083/jcb.200209023; DARPA P, 1990, CANCER RES, V50, P6919; Degrassi Francesca, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P317, DOI 10.2174/1568011043352920; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 2001, CANCER RES, V61, P5926; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; HSIANG YH, 1989, J BIOL CHEM, V264, P9713; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Kurose A, 2005, CYTOM PART A, V68A, P1, DOI 10.1002/cyto.a.20186; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; LIU JH, 1995, EMBO J, V14, P4599, DOI 10.1002/j.1460-2075.1995.tb00139.x; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Niimi A, 2001, CHROMOSOMA, V110, P102, DOI 10.1007/s004120100140; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; NOVIELLO E, 1994, MUTAT RES-FUND MOL M, V311, P21, DOI 10.1016/0027-5107(94)90069-8; POMMIER Y, 1988, CANCER RES, V48, P512; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; SAITOH N, 1995, BIOESSAYS, V17, P759, DOI 10.1002/bies.950170905; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; TSUTSUI K, 1993, J BIOL CHEM, V268, P19076; Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M; Turley H, 1997, BRIT J CANCER, V75, P1340, DOI 10.1038/bjc.1997.227; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; WATANABE M, 1994, NEUROSCI RES, V19, P51, DOI 10.1016/0168-0102(94)90007-8; Willmore E, 1998, MOL PHARMACOL, V54, P78, DOI 10.1124/mol.54.1.78; WOOD ER, 1990, J CELL BIOL, V111, P2839, DOI 10.1083/jcb.111.6.2839; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200	45	105	105	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35997	36003		10.1074/jbc.M604149200	http://dx.doi.org/10.1074/jbc.M604149200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16973621	hybrid			2022-12-27	WOS:000242100500047
J	Csutora, P; Zarayskiy, V; Peter, K; Monje, F; Smani, T; Zakharov, SI; Litvinov, D; Bolotina, VM				Csutora, Peter; Zarayskiy, Vladislav; Peter, Krisztina; Monje, Francisco; Smani, Tarik; Zakharov, Sergey I.; Litvinov, Dmitry; Bolotina, Victoria M.			Activation mechanism for CRAC current and store-operated Ca2+ entry - Calcium influx factor and Ca2+-independent phospholipase A(2)beta-mediated pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PHOSPHOLIPASE; ARACHIDONIC-ACID; A(2); IDENTIFICATION; PURIFICATION; INHIBITION; EXPRESSION; CHANNELS; IPLA(2); CELLS	Here we tested the role of calcium influx factor (CIF) and calcium-independent phospholipase A(2) (iPLA(2)) in activation of Ca2+ release-activated Ca2+ (CRAC) channels and store-operated Ca2+ entry in rat basophilic leukemia (RBL-2H3) cells. We demonstrate that 1) endogenous CIF production may be triggered by Ca2+ release (net loss) as well as by simple buffering of free Ca2+ within the stores, 2) a specific 82-kDa variant of iPLA(2)beta and its corresponding activity are present in membrane fraction of RBL cells, 3) exogenous CIF (extracted from other species) mimics the effects of endogenous CIF and activates iPLA(2)beta when applied to cell homogenates but not intact cells, 4) activation of I-CRAC can be triggered in resting RBL cells by dialysis with exogenous CIF, 5) molecular or functional inhibition of iPLA(2)beta prevents activation of I-CRAC, which could be rescued by cell dialysis with a human recombinant iPLA(2)beta, 6) dependence of ICRAC on intracellular pH strictly follows pH dependence of iPLA(2)beta activity, and 7) (S)-BEL, a chiral enantiomer of suicidal substrate specific for iPLA(2)beta, could be effectively used for pharmacological inhibition of I-CRAC and store-operated Ca2+ entry. These findings validate and significantly advance our understanding of the CIF-iPLA(2)-dependent mechanism of activation of I-CRAC and store-operated Ca2+ entry.	Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Bolotina, VM (corresponding author), EBRC, Ion Channel & Calcium Signaling Unit, X-704,650 Albany St, Boston, MA 02118 USA.	bolotina@bu.edu	Zakharov, Sergey/L-8511-2014; Hajami, Tarik Smani/D-5372-2016; IBIS, CARDIOVASCULAR/P-3910-2015; Litvinov, Dmitry Y/Q-4561-2016	Zakharov, Sergey/0000-0001-9864-8304; Hajami, Tarik Smani/0000-0002-1877-7438; Litvinov, Dmitry Y/0000-0003-4778-6648; Bolotina, Victoria/0000-0001-5862-181X	NHLBI NIH HHS [HL71793, HL54150] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054150, R01HL071793] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bao SZ, 2004, DIABETES, V53, pS186, DOI 10.2337/diabetes.53.2007.S186; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bolotina VM, 2005, TRENDS BIOCHEM SCI, V30, P378, DOI 10.1016/j.tibs.2005.05.009; Csutora P, 1999, P NATL ACAD SCI USA, V96, P121, DOI 10.1073/pnas.96.1.121; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Forsell PKAL, 1999, EUR J BIOCHEM, V262, P575, DOI 10.1046/j.1432-1327.1999.00418.x; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kerschbaum HH, 1998, J GEN PHYSIOL, V111, P521, DOI 10.1085/jgp.111.4.521; Ma JJ, 2003, CELL CALCIUM, V33, P375, DOI 10.1016/S0143-4160(03)00050-2; Martinez J, 2005, BIOCHEM PHARMACOL, V70, P733, DOI 10.1016/j.bcp.2005.04.045; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Shin KJ, 2002, TOXICOL APPL PHARM, V178, P37, DOI 10.1006/taap.2001.9317; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Song HW, 2004, J AM SOC MASS SPECTR, V15, P1780, DOI 10.1016/j.jasms.2004.08.012; Tay HK, 2004, J BIOL CHEM, V279, P22505, DOI 10.1074/jbc.M308788200; THOMAS D, 1995, J BIOL CHEM, V270, P6429, DOI 10.1074/jbc.270.12.6429; Trepakova ES, 2000, J BIOL CHEM, V275, P26158, DOI 10.1074/jbc.M004666200; Turk J, 2004, CAN J PHYSIOL PHARM, V82, P824, DOI 10.1139/Y04-064; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Vanden Abeele F, 2003, CELL CALCIUM, V33, P357, DOI 10.1016/S0143-4160(03)00049-6; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Wolf MJ, 1996, J BIOL CHEM, V271, P20989, DOI 10.1074/jbc.271.35.20989; Wolf MJ, 1996, J BIOL CHEM, V271, P30879, DOI 10.1074/jbc.271.48.30879; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x; Zablocki K, 2000, ACTA BIOCHIM POL, V47, P591	36	46	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34926	34935		10.1074/jbc.M606504200	http://dx.doi.org/10.1074/jbc.M606504200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	17003039	hybrid			2022-12-27	WOS:000241933700025
J	Sharpley, MS; Hirst, J				Sharpley, Mark S.; Hirst, Judy			The inhibition of mitochondrial complex I (NADH : ubiquinone oxidoreductase) by Zn2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; ACTIVE/DE-ACTIVE TRANSITION; BACTERIAL REACTION CENTERS; BOVINE HEART-MITOCHONDRIA; IRON-SULFUR CLUSTERS; ZINC IONS INHIBIT; PROTON-TRANSFER; SUPEROXIDE-PRODUCTION; DEPENDENT INHIBITION; INACTIVE TRANSITION	NADH: ubiquinone oxidoreductase (complex I) from bovine heart mitochondria is a highly complicated, membrane-bound enzyme. It is central to energy transduction, an important source of cellular reactive oxygen species, and its dysfunction is implicated in neurodegenerative and muscular diseases and in aging. Here, we describe the effects of Zn2+ on complex I to define whether complex I may contribute to mediating the pathological effects of zinc in states such as ischemia and to determine how Zn2+ can be used to probe the mechanism of complex I. Zn2+ inhibits complex I more strongly than Mg2+, Ca2+, Ba2+, and Mn2+ to Cu2+ or Cd2+. It does not inhibit NADH oxidation or intramolecular electron transfer, so it probably inhibits either proton transfer to bound quinone or proton translocation. Thus, zinc represents a new class of complex I inhibitor clearly distinct from the many ubiquinone site inhibitors. No evidence for increased superoxide production by zinc-inhibited complex I was detected. Zinc binding to complex I is mechanistically complicated. During catalysis, zinc binds slowly and progressively, but it binds rapidly and tightly to the resting state(s) of the enzyme. Reactivation of the inhibited enzyme upon the addition of EDTA is slow, and inhibition is only partially reversible. The IC50 value for the Zn2+ inhibition of complex I is high (10-50 mu M, depending on the enzyme state); therefore, complex I is unlikely to be a major site for zinc inhibition of the electron transport chain. However, the slow response of complex I to a change in Zn2+ concentration may enhance any physiological consequences.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Hirst, J (corresponding author), MRC, Dunn Human Nutr Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	jh@mrc-dunn.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797	Medical Research Council [MC_U105663141] Funding Source: Medline; MRC [MC_U105663141] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aagaard A, 2002, BBA-BIOENERGETICS, V1555, P133, DOI 10.1016/S0005-2728(02)00268-2; Aagaard A, 2001, FEBS LETT, V494, P157, DOI 10.1016/S0014-5793(01)02299-2; Axelrod HL, 2000, P NATL ACAD SCI USA, V97, P1542, DOI 10.1073/pnas.97.4.1542; Berry EA, 2000, BBA-BIOENERGETICS, V1459, P440, DOI 10.1016/S0005-2728(00)00182-1; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brown AM, 2000, J BIOL CHEM, V275, P13441, DOI 10.1074/jbc.275.18.13441; BRUNORI M, 1979, J BIOL CHEM, V254, P769; BUTT JN, 1991, J AM CHEM SOC, V113, P6663, DOI 10.1021/ja00017a045; Chen TY, 1998, J GEN PHYSIOL, V112, P715, DOI 10.1085/jgp.112.6.715; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Daniel RM, 2001, TRENDS BIOCHEM SCI, V26, P223, DOI 10.1016/S0968-0004(01)01803-5; DeCoursey TE, 2000, BBA-BIOENERGETICS, V1458, P104, DOI 10.1016/S0005-2728(00)00062-1; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Duffield MD, 2005, J PHYSIOL-LONDON, V568, P5, DOI 10.1113/jphysiol.2005.091777; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Esposti MD, 1996, BIOCHEM J, V313, P327, DOI 10.1042/bj3130327; Faxen K, 2006, BBA-BIOENERGETICS, V1757, P388, DOI 10.1016/j.bbabio.2006.05.010; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; HUNTER FE, 1955, J BIOL CHEM, V216, P357; Hwang PM, 2004, P NATL ACAD SCI USA, V101, P9618, DOI 10.1073/pnas.0402324101; Jancura D, 2006, J BIOL CHEM, V281, P30319, DOI 10.1074/jbc.M605955200; Kannt A, 2001, FEBS LETT, V503, P142, DOI 10.1016/S0014-5793(01)02719-3; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KOTLYAR AB, 1992, BIOCHIM BIOPHYS ACTA, V1098, P144, DOI 10.1016/S0005-2728(05)80329-9; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Kuznetsova SS, 2005, BIOCHEMISTRY-MOSCOW+, V70, P128, DOI 10.1007/s10541-005-0091-6; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; LINK TA, 1995, J BIOL CHEM, V270, P25001, DOI 10.1074/jbc.270.42.25001; LORUSSO M, 1991, EUR J BIOCHEM, V197, P555, DOI 10.1111/j.1432-1033.1991.tb15944.x; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maklashina E, 2002, BBA-BIOENERGETICS, V1556, P6, DOI 10.1016/S0005-2728(02)00280-3; Malaiyandi LM, 2005, J NEUROSCI, V25, P9507, DOI 10.1523/JNEUROSCI.0868-05.2005; Mills DA, 2005, BIOCHEMISTRY-US, V44, P4656, DOI 10.1021/bi0475774; Mills DA, 2002, J BIOL CHEM, V277, P14894, DOI 10.1074/jbc.M111922200; Moody AJ, 1996, BBA-BIOENERGETICS, V1276, P6; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Paddock ML, 1999, P NATL ACAD SCI USA, V96, P6183, DOI 10.1073/pnas.96.11.6183; Sadek HA, 2004, BIOCHEMISTRY-US, V43, P8494, DOI 10.1021/bi049803f; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Sculley MJ, 1996, BBA-PROTEIN STRUCT M, V1298, P78, DOI 10.1016/S0167-4838(96)00118-5; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; SKULACHE.VP, 1967, BIOCHEM BIOPH RES CO, V26, P1, DOI 10.1016/0006-291X(67)90242-2; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Whitehead SJ, 2005, FEBS LETT, V579, P2863, DOI 10.1016/j.febslet.2005.04.026; Wikstrom M, 2002, BBA-BIOENERGETICS, V1555, P128, DOI 10.1016/S0005-2728(02)00267-0; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4	68	59	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34803	34809		10.1074/jbc.M607389200	http://dx.doi.org/10.1074/jbc.M607389200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16980308	hybrid			2022-12-27	WOS:000241933700012
J	Sheng, Y; Tsai-Morris, CH; Gutti, R; Maeda, Y; Dufau, ML				Sheng, Yi; Tsai-Morris, Chon-Hwa; Gutti, Ravi; Maeda, Yuji; Dufau, Maria L.			Gonadotropin-regulated testicular RNA helicase (GRTH/Ddx25) is a transport protein involved in gene-specific mRNA export and protein translation during spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD-BOX PROTEINS; NUCLEAR-EXPORT; PGK-2 ISOZYMES; MOUSE; EXPRESSION; FAMILY; CELLS; DBP5; MRNP	Gonadotropin-regulated testicular RNA helicase (GRTH/Ddx25), a member of the DEAD-box protein family, is essential for completion of spermatogenesis. GRTH is present in the cytoplasm and nucleus of meiotic spermatocytes and round spermatids and functions as a component of mRNP particles, implicating its post-transcriptional regulatory roles in germ cells. In this study, GRTH antibodies specific to N- or C- terminal sequences showed differential subcellular expression of GRTH 56- and 61-kDa species in nucleus and cytoplasm, respectively, of rodent testis and transfected COS1 cells. The 56-kDa nuclear species interacted with CRM1 and participated in mRNA transport. The phosphorylated cytoplasmic 61-kDa species was associated with polyribosomes. Confocal studies on COS-1 cells showed that GRTH-GFP was retained in the nucleus by treatment with a RNA polymerase inhibitor or the nuclear protein export inhibitor. This indicated that GRTH is a shuttling protein associated with RNA export. The N- terminal leucine-rich region (61-74 amino acids) was identified as the nuclear export signal that participated in CRM1-dependent nuclear export pathway. Deletion analysis identified a 14-amino acid GRTH sequence (100-114 amino acids) as a nuclear localization signal. GRTH selectively regulated the translation of specific genes including histone 4 and HMG2 in germ cells. In addition, GRTH participated in the nuclear export of RNA messages (PGK2, tACE, and TP2) in a gene-specific manner. These studies strongly indicate that the mammalian GRTH/Ddx25 gene is a multifunctional RNA helicase that is an essential regulator of sperm maturation.	NICHD, Sect Mol Endocrinol, ERRB, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dufau, ML (corresponding author), NICHD, Sect Mol Endocrinol, ERRB, NIH, Bldg 49,Rm 6A-36,49 Convent Dr,MSC 4510, Bethesda, MD 20892 USA.	dufaum@mail.nih.gov		Gutti, Ravi Kumar/0000-0002-0912-5796; Tsai Morris, Chon Hwa/0000-0002-8113-0979	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000150] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; Askjaer P, 2000, J BIOL CHEM, V275, P11561, DOI 10.1074/jbc.275.16.11561; BUCCI LR, 1986, BIOL REPROD, V34, P195, DOI 10.1095/biolreprod34.1.195; Carrera P, 2000, MOL CELL, V5, P181, DOI 10.1016/S1097-2765(00)80414-1; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; DAY RN, 1989, J BIOL CHEM, V264, P431; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; KRAMER JM, 1981, DEV BIOL, V87, P37, DOI 10.1016/0012-1606(81)90058-0; KRAMER JM, 1981, DEV BIOL, V87, P30, DOI 10.1016/0012-1606(81)90057-9; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; Linder P, 2001, CURR BIOL, V11, pR961, DOI 10.1016/S0960-9822(01)00574-7; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; MAURER RA, 1989, J BIOL CHEM, V264, P6870; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rollenhagen C, 2004, MOL CELL BIOL, V24, P4869, DOI 10.1128/MCB.24.11.4869-4879.2004; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Sheng Y, 2003, J BIOL CHEM, V278, P27796, DOI 10.1074/jbc.M302411200; Shibata N, 2004, MOL REPROD DEV, V67, P1, DOI 10.1002/mrd.20009; SIBONY M, 1994, BIOL REPROD, V50, P1015, DOI 10.1095/biolreprod50.5.1015; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Smillie DA, 2002, J CELL SCI, V115, P395; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176; Suntharalingam M, 2004, J BIOL CHEM, V279, P35384, DOI 10.1074/jbc.M402044200; Tang PZ, 1999, J BIOL CHEM, V274, P37932, DOI 10.1074/jbc.274.53.37932; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177	34	58	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35048	35056		10.1074/jbc.M605086200	http://dx.doi.org/10.1074/jbc.M605086200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16968703	hybrid			2022-12-27	WOS:000241933700038
J	Augustus, AM; Reardon, PN; Heller, WT; Spicer, LD				Augustus, Anne Marie; Reardon, Patrick N.; Heller, William T.; Spicer, Leonard D.			Structural basis for the differential regulation of DNA by the methionine repressor MetJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; S-ADENOSYLMETHIONINE; OPERATOR BINDING; SCATTERING; GENE; BIOSYNTHESIS; RECOGNITION; COREPRESSOR; EVOLUTION; REVEALS	The Met regulon in Escherichia coli encodes several proteins responsible for the biosynthesis of methionine. Regulation of the expression of most of these proteins is governed by the methionine repressor protein MetJ and its co-repressor, the methionine derivative S-adenosylmethionine. Genes controlled by MetJ contain from two to five sequential copies of a homologous 8-bp sequence called the metbox. A crystal structure for one of the complexes, the repressor tetramer bound to two metboxes, has been reported (Somers, W. S., and S. E. Phillips (1992) Nature 359, 387 - 393), but little structural work on the larger assemblies has been done presumably because of the difficulties in crystallization and the variability in the number and sequences of metboxes for the various genes. Small angle neutron scattering was used to study complexes of MetJ and S-adenosylmethionine with double-stranded DNA containing two, three, and five metboxes. Our results demonstrate that the crystal structure of the two-metbox complex is not the native solution conformation of the complex. Instead, the system adopts a less compact conformation in which there is decreased interaction between the adjacent MetJ dimers. Models built of the higher order complexes from the scattering data show that the three-metbox complex is organized much like the two-metbox complex. However, the five-metbox complex differs significantly from the smaller complexes, providing much closer packing of the adjacent MetJ dimers and allowing additional contacts not available in the crystal structure. The results suggest that there is a structural basis for the differences observed in the regulatory effectiveness of MetJ for the various genes of the Met regulon.	Oak Ridge Natl Lab, Ctr Struct Mol Biol, Oak Ridge, TN 37831 USA; Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; Duke Univ, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Duke University; Duke University	Heller, WT (corresponding author), Oak Ridge Natl Lab, Ctr Struct Mol Biol, POB 2008,MS-6142, Oak Ridge, TN 37831 USA.	hellerwt@ornl.gov; spicer@biochem.duke.edu	Heller, William/ABE-1104-2020	Heller, William/0000-0001-6456-2975; Reardon, Patrick/0000-0002-6858-0086				BELFAIZA J, 1986, P NATL ACAD SCI USA, V83, P867, DOI 10.1073/pnas.83.4.867; DAVIDSON BE, 1989, MOL MICROBIOL, V3, P1639, DOI 10.1111/j.1365-2958.1989.tb00149.x; Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002; Glinka CJ, 1998, J APPL CRYSTALLOGR, V31, P430, DOI 10.1107/S0021889897017020; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; HE YY, 1992, NATURE, V359, P431, DOI 10.1038/359431a0; He YY, 1996, J MOL BIOL, V255, P55, DOI 10.1006/jmbi.1996.0006; He YY, 2002, J MOL BIOL, V320, P39, DOI 10.1016/S0022-2836(02)00423-0; Heller WT, 2003, BIOCHEMISTRY-US, V42, P10579, DOI 10.1021/bi0348664; HYRE DE, 1995, BIOCHEMISTRY-US, V34, P3212, DOI 10.1021/bi00010a010; Lawrenson ID, 2004, FEBS LETT, V564, P136, DOI 10.1016/S0014-5793(04)00336-9; Marincs F, 2006, BIOCHEM J, V396, P227, DOI 10.1042/BJ20060021; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; PHILLIPS SEV, 1989, NATURE, V341, P711, DOI 10.1038/341711a0; RAFFERTY JB, 1989, NATURE, V341, P705, DOI 10.1038/341705a0; SAINTGIRONS I, 1986, J BIOL CHEM, V261, P936; SHOEMAN R, 1985, P NATL ACAD SCI USA, V82, P3601, DOI 10.1073/pnas.82.11.3601; SMITH AA, 1985, P NATL ACAD SCI USA, V82, P6104, DOI 10.1073/pnas.82.18.6104; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; WIGNALL GD, 1987, J APPL CRYSTALLOGR, V20, P28, DOI 10.1107/S0021889887087181; Wild CM, 1996, MOL MICROBIOL, V21, P1125, DOI 10.1046/j.1365-2958.1996.00055.x; WU WF, 1993, FEMS MICROBIOL LETT, V108, P145, DOI 10.1016/0378-1097(93)90576-N	25	17	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34269	34276		10.1074/jbc.M605763200	http://dx.doi.org/10.1074/jbc.M605763200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16963446	hybrid			2022-12-27	WOS:000241767600047
J	Burza, AM; Pekala, I; Sikora, J; Siedlecki, P; Malagocki, P; Bucholc, M; Koper, L; Zielenkiewicz, P; Dadlez, M; Dobrowolska, G				Burza, Anna Maria; Pekala, Izabela; Sikora, Jacek; Siedlecki, Pawel; Malagocki, Pawel; Bucholc, Maria; Koper, Luiza; Zielenkiewicz, Piotr; Dadlez, Michal; Dobrowolska, Grazyna			Nicotiana tabacum osmotic stress-activated kinase is regulated by phosphorylation on Ser-154 and Ser-158 in the kinase activation loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PROTEIN-KINASE; ABSCISIC-ACID; HYPEROSMOTIC STRESS; SIGNAL-TRANSDUCTION; STOMATAL CLOSURE; STRUCTURAL BASIS; GENE-EXPRESSION; IDENTIFICATION; HOMOLOG; FAMILY	NtOSAK (Nicotiana tabacum osmotic stress-activated protein kinase), a member of the SnRK2 subfamily, is activated rapidly in response to hyperosmotic stress. Our previous results as well as data presented by others indicate that phosphorylation is involved in activation of SnRK2 kinases. Here, we have mapped the regulatory phosphorylation sites of NtOSAK by mass spectrometry with collision-induced peptide fragmentation. We show that active NtOSAK, isolated from NaCl-treated tobacco BY-2 cells, is phosphorylated on Ser-154 and Ser-158 in the kinase activation loop. Prediction of the NtOSAK three-dimensional structure indicates that phosphorylation of Ser-154 and Ser-158 triggers changes in enzyme conformation resulting in its activation. The involvement of Ser-154 and Ser-158 phosphorylation in regulation of NtOSAK activity was confirmed by site-directed mutagenesis of NtOSAK expressed in bacteria and in maize protoplasts. Our data reveal that phosphorylation of Ser-158 is essential for NtOSAK activation, whereas phosphorylation of Ser-154 most probably facilitates Ser-158 phosphorylation. The time course of NtOSAK phosphorylation on Ser-154 and Ser-158 in BY-2 cells subjected to osmotic stress correlates with NtOSAK activity, indicating that NtOSAK is regulated by reversible phosphorylation of these residues in vivo. Importantly, Ser-154 and Ser-158 are conserved in all SnRK2 subfamily members, suggesting that phosphorylation at these sites may be a general mechanism for SnRK2 activation.	Polish Acad Sci, Dept Plant Biochem, PL-02106 Warsaw, Poland; Polish Acad Sci, Dept Bioinformat, PL-02106 Warsaw, Poland; Polish Acad Sci, Mass Spectrometry Lab, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; Warsaw Univ, Fac Biol, PL-02096 Warsaw, Poland; Warsaw Univ, Plant Mol Biol Lab, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; University of Warsaw	Dobrowolska, G (corresponding author), Polish Acad Sci, Dept Plant Biochem, Ul Pawinskiego 5A, PL-02106 Warsaw, Poland.	dobrowol@ibb.waw.pl	Bucholc, Maria/ABF-5097-2020; Siedlecki, Pawel/Q-3265-2017	Siedlecki, Pawel/0000-0002-7482-1341; Zielenkiewicz, Piotr/0000-0001-8151-6874; Malagocki, Pawel/0000-0002-5534-9731; Bucholc, Maria/0000-0003-0237-1131; Dadlez, Michal/0000-0001-8811-5176; Dobrowolska, Grazyna/0000-0002-2598-9666				Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; ANDERBERG RJ, 1992, P NATL ACAD SCI USA, V89, P10183, DOI 10.1073/pnas.89.21.10183; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Gong DM, 2004, PLANT PHYSIOL, V134, P919, DOI 10.1104/pp.103.037440; Gong DM, 2002, J BIOL CHEM, V277, P42088, DOI 10.1074/jbc.M205504200; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1999, BIOCHEM SOC SYMP, P13; HARMON AC, 2003, GRAVIT SPACE BIOL B, V16, P1; HOLAPPA LD, 1995, PLANT PHYSIOL, V108, P1203, DOI 10.1104/pp.108.3.1203; Hoyos ME, 2000, PLANT PHYSIOL, V122, P1355, DOI 10.1104/pp.122.4.1355; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kelner A, 2004, PLANT PHYSIOL, V136, P3255, DOI 10.1104/pp.104.046151; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; Lamotte O, 2006, FREE RADICAL BIO MED, V40, P1369, DOI 10.1016/j.freeradbiomed.2005.12.006; Li JX, 1996, PLANT CELL, V8, P2359, DOI 10.1105/tpc.8.12.2359; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Monks DE, 2001, PLANT CELL, V13, P1205, DOI 10.1105/tpc.13.5.1205; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; SHEEN J, 1993, EMBO J, V12, P3497, DOI 10.1002/j.1460-2075.1993.tb06024.x; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Wolf I, 2001, J BIOL CHEM, V276, P24490, DOI 10.1074/jbc.M103352200; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yoon HW, 1997, MOL GEN GENET, V255, P359, DOI 10.1007/s004380050507; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; ZHANG JD, 1995, STRUCTURE, V3, P299, DOI 10.1016/S0969-2126(01)00160-5	48	39	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34299	34311		10.1074/jbc.M601977200	http://dx.doi.org/10.1074/jbc.M601977200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16980311	hybrid			2022-12-27	WOS:000241767600050
J	Busam, RD; Thorsell, AG; Flores, A; Hammarstrom, M; Persson, C; Hallberg, BM				Busam, Robert D.; Thorsell, Ann-Gerd; Flores, Alex; Hammarstrom, Martin; Persson, Camilla; Hallberg, B. Martin			First structure of a eukaryotic phosphohistidine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN HISTIDINE PHOSPHATASE; HETEROTRIMERIC G-PROTEINS; KINASE NDPK B; CRYSTAL-STRUCTURE; BETA-SUBUNITS; PHOSPHORYLATION; ALIGNMENT; ACTIVATION; SUBSTRATE; ACCURACY	Phosphatases are a diverse group of enzymes that regulate numerous cellular processes. Much of what is known relates to the tyrosine, threonine, and serine phosphatases, whereas the histidine phosphatases have not been studied as much. The structure of phosphohistidine phosphatase (PHPT1), the first identified eukaryotic-protein histidine phosphatase, has been determined to a resolution of 1.9 angstrom using multiple-wavelength anomalous dispersion methods. This enzyme can dephosphorylate a variety of proteins (e. g. ATP-citrate lyase and the beta-subunit of G proteins). A putative active site has been identified by its electrostatic character, ion binding, and conserved protein residues. Histidine 53 is proposed to play a major role in histidine dephosphorylation based on these observations and previous mutational studies. Models of peptide binding are discussed to suggest possible mechanisms for substrate recognition.	Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet	Hallberg, BM (corresponding author), Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	Martin.Hallberg@ki.se	Hallberg, B. Martin/C-5361-2009	Hallberg, B. Martin/0000-0002-6781-0345	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHEN CC, 1974, BIOCHEMISTRY-US, V13, P3785, DOI 10.1021/bi00715a026; Cuello F, 2003, J BIOL CHEM, V278, P7220, DOI 10.1074/jbc.M210304200; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Ek P, 2002, EUR J BIOCHEM, V269, P5016, DOI 10.1046/j.1432-1033.2002.03206.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser ME, 2000, J MOL BIOL, V299, P1325, DOI 10.1006/jmbi.2000.3807; Hamada K, 2005, GENES CELLS, V10, P1, DOI 10.1111/j.1365-2443.2005.00817.x; Hippe HJ, 2003, J BIOL CHEM, V278, P7227, DOI 10.1074/jbc.M210305200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klumpp S, 2002, J CEREBR BLOOD F MET, V22, P1420, DOI 10.1097/01.wcb.0000045041.03034.99; Klumpp S, 2005, BBA-PROTEINS PROTEOM, V1754, P291, DOI 10.1016/j.bbapap.2005.07.035; Klumpp S, 2003, BIOCHEM BIOPH RES CO, V306, P110, DOI 10.1016/S0006-291X(03)00920-3; Kowluru A, 1996, BIOCHEM J, V313, P97, DOI 10.1042/bj3130097; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Ma RX, 2005, BIOCHEM BIOPH RES CO, V337, P887, DOI 10.1016/j.bbrc.2005.09.134; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; Maurer A, 2005, BIOCHEM BIOPH RES CO, V334, P1115, DOI 10.1016/j.bbrc.2005.06.200; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WIELAND T, 1993, J BIOL CHEM, V268, P18111	33	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33830	33834		10.1074/jbc.C600231200	http://dx.doi.org/10.1074/jbc.C600231200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16990267	hybrid			2022-12-27	WOS:000241767600003
J	Shiou, SR; Datta, PK; Dhawan, P; Law, BK; Yingling, JM; Dixon, DA; Beauchamp, RD				Shiou, Sheng-Ru; Datta, Pran K.; Dhawan, Punita; Law, Brian K.; Yingling, Jonathan M.; Dixon, Dan A.; Beauchamp, R. Daniel			Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER MDA-MB-231 CELLS; PROTEIN-KINASE-C; TGF-BETA; BREAST-CANCER; MESSENGER-RNA; INHIBITOR TYPE-1; II RECEPTOR; MESENCHYMAL TRANSITION; GENE-EXPRESSION; TUMOR INVASION	Metastasis is a primary cause of mortality due to cancer. Early metastatic growth involves both a remodeling of the extracellular matrix surrounding tumors and invasion of tumors across the basement membrane. Up-regulation of extracellular matrix degrading proteases such as urokinase plasminogen activator (uPA) and matrix metalloproteinases has been reported to facilitate tumor cell invasion. Autocrine transforming growth factor-beta (TGF-beta) signaling may play an important role in cancer cell invasion and metastasis; however, the underlying mechanisms remain unclear. In the present study, we report that autocrine TGF-beta supports cancer cell invasion by maintaining uPA levels through protein secretion. Interestingly, treatment of paracrine/exogenous TGF-beta at higher concentrations than autocrine TGF-beta further enhanced uPA expression and cell invasion. The enhanced uPA expression by exogenous TGF-beta is a result of increased uPA mRNA expression due to RNA stabilization. We observed that both autocrine and paracrine TGF-beta mediated regulation of uPA levels was lost upon depletion of Smad4 protein by RNA interference. Thus, through the Smad pathway, autocrine TGF-beta maintains uPA expression through facilitated protein secretion, thereby supporting tumor cell invasiveness, whereas exogenous TGF-beta further enhances uPA expression through mRNA stabilization leading to even greater invasiveness of the cancer cells.	Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; State University System of Florida; University of Florida; Eli Lilly; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Beauchamp, RD (corresponding author), Vanderbilt Univ, Med Ctr, Sect Surg Sci, 1161 21st Ave S,D-4316 Med Ctr N, Nashville, TN 37232 USA.	daniel.beauchamp@vanderbilt.edu	Law, Brian/L-6043-2019	Beauchamp, Robert Daniel/0000-0002-8446-4114	NATIONAL CANCER INSTITUTE [R01CA095195, P50CA095103, R01CA093651, R01CA069457, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052334] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA093651, P30 CA68485, CA69457, R01 CA95195, P50 CA95103] Funding Source: Medline; NIDDK NIH HHS [DK52334] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; BACON RA, 1989, J CELL BIOL, V109, P1015, DOI 10.1083/jcb.109.3.1015; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2002, J CELL SCI, V115, P3193; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; CAULIN C, 1995, CELL GROWTH DIFFER, V6, P1027; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; CHEN RH, 1993, SCIENCE, V260, P1335, DOI 10.1126/science.8388126; D'Orazio D, 1997, GENE, V201, P179, DOI 10.1016/S0378-1119(97)00445-9; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; DUFFY MJ, 1988, CANCER, V62, P531, DOI 10.1002/1097-0142(19880801)62:3<531::AID-CNCR2820620315>3.0.CO;2-B; Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO;2-9; Ellenrieder V, 2001, INT J CANCER, V93, P204, DOI 10.1002/ijc.1330; Farina AR, 1996, BIOTECHNIQUES, V21, P904; Farina AR, 1998, INT J CANCER, V75, P721; Fisher JL, 2000, BREAST CANCER RES TR, V61, P1, DOI 10.1023/A:1006445129195; Frandsen TL, 2001, CANCER RES, V61, P532; Frey RS, 1997, CANCER RES, V57, P628; Higazi AAR, 1996, BLOOD, V87, P3545, DOI 10.1182/blood.V87.9.3545.bloodjournal8793545; Hirashima Y, 2003, J BIOL CHEM, V278, P26793, DOI 10.1074/jbc.M212187200; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; HUANG F, 1995, CELL GROWTH DIFFER, V6, P1635; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; JAMIESON JD, 1967, J CELL BIOL, V34, P577, DOI 10.1083/jcb.34.2.577; JANICKE F, 1991, SEMIN THROMB HEMOST, V17, P303, DOI 10.1055/s-2007-1002624; Kojima S, 2000, BLOOD, V95, P1309; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Kucich U, 2002, AM J RESP CELL MOL, V26, P183, DOI 10.1165/ajrcmb.26.2.4666; LAWRENCE D, 1985, BIOCHEM BIOPH RES CO, V133, P1026, DOI 10.1016/0006-291X(85)91239-2; Lei XF, 2002, ONCOGENE, V21, P7514, DOI 10.1038/sj.onc.1205966; Li HY, 2006, J MED CHEM, V49, P2138, DOI 10.1021/jm058209g; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Martinez-Carpio PA, 1999, CELL SIGNAL, V11, P753, DOI 10.1016/S0898-6568(99)00048-0; Martinez-Carpio PA, 1999, CANCER LETT, V147, P25, DOI 10.1016/S0304-3835(99)00261-X; Matrisian LM, 1999, CURR BIOL, V9, pR776, DOI 10.1016/S0960-9822(00)80011-1; MATRISIAN LM, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P152; MIGNATTI P, 1986, CELL, V47, P487, DOI 10.1016/0092-8674(86)90613-6; Moses H L, 1991, Princess Takamatsu Symp, V22, P183; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nanbu R, 1997, EUR J BIOCHEM, V247, P169, DOI 10.1111/j.1432-1033.1997.00169.x; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Peng SB, 2005, BIOCHEMISTRY-US, V44, P2293, DOI 10.1021/bi048851x; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Ray D, 2005, MOL CELL BIOL, V25, P3338, DOI 10.1128/MCB.25.8.3338-3347.2005; Reuning U, 1998, INT J ONCOL, V13, P893; Roman CD, 2002, J GASTROINTEST SURG, V6, P304, DOI 10.1016/S1091-255X(01)00041-5; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SEGEV M, 2001, SCI STKE, pRE11; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; Sheng HM, 2000, J BIOL CHEM, V275, P6628, DOI 10.1074/jbc.275.9.6628; Sun LZ, 1997, J BIOL CHEM, V272, P25367, DOI 10.1074/jbc.272.40.25367; Suzuki Y, 1999, BLOOD, V93, P4264, DOI 10.1182/blood.V93.12.4264.412k27_4264_4276; Tanaka Y, 2004, J BIOL CHEM, V279, P8567, DOI 10.1074/jbc.M309131200; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; TORREAMIONE G, 1990, P NATL ACAD SCI USA, V87, P1486, DOI 10.1073/pnas.87.4.1486; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; Vrana JA, 1996, CANCER RES, V56, P5063; WALKER RA, 1994, BRIT J CANCER, V69, P1160, DOI 10.1038/bjc.1994.228; WESTERHAUSEN DR, 1991, J BIOL CHEM, V266, P1092; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; WUN TC, 1987, J BIOL CHEM, V262, P3646; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	70	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33971	33981		10.1074/jbc.M607010200	http://dx.doi.org/10.1074/jbc.M607010200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16959768	hybrid			2022-12-27	WOS:000241767600018
J	Simonovic, M; Zhang, Z; Cianci, CD; Steitz, TA; Morrow, JS				Simonovic, Miljan; Zhang, Zhushan; Cianci, Carol D.; Steitz, Thomas A.; Morrow, Jon S.			Structure of the calmodulin alpha II-spectrin complex provides insight into the regulation of cell plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON INITIAL SEGMENTS; BETA-IV-SPECTRIN; MU-CALPAIN; CRYSTAL-STRUCTURE; BINDING DOMAIN; FODRIN; CLEAVAGE; ACTIVATION; SITE; SEQUENCE	alpha II-spectrin is a major cortical cytoskeletal protein contributing to membrane organization and integrity. The Ca2+-activated binding of calmodulin to an unstructured insert in the 11th repeat unit of alpha II-spectrin enhances the susceptibility of spectrin to calpain cleavage but abolishes its sensitivity to several caspases and to at least one bacterially derived pathologic protease. Other regulatory inputs including phosphorylation by c-Src also modulate the proteolytic susceptibility of alpha II-spectrin. These pathways, acting through spectrin, appear to control membrane plasticity and integrity in several cell types. To provide a structural basis for understanding these crucial biological events, we have solved the crystal structure of a complex between bovine calmodulin and the calmodulin-binding domain of human alpha II-spectrin (Protein Data Bank ID code 2FOT). The structure revealed that the entire calmodulin-spectrin-binding interface is hydrophobic in nature. The spectrin domain is also unique in folding into an amphiphilic helix once positioned within the calmodulin-binding groove. The structure of this complex provides insight into the mechanisms by which calmodulin, calpain, caspase, and tyrosine phosphorylation act on spectrin to regulate essential cellular processes.	Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Morrow, JS (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St BML 140, New Haven, CT 06520 USA.	jon.morrow@yale.edu	Steitz, Thomas A./C-6559-2009	Simonovic, Miljan/0000-0002-1576-2222	NHLBI NIH HHS [R01-HL28560] Funding Source: Medline; NIGMS NIH HHS [GM22778] Funding Source: Medline; NINDS NIH HHS [P01-NS35476] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035476] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		An XL, 2004, BIOCHEMISTRY-US, V43, P310, DOI 10.1021/bi035653h; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; BRUNGER AT, 1991, ACTA CRYSTALLOGR A, V47, P195, DOI 10.1107/S0108767390011795; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canizalez-Roman A, 2003, MOL MICROBIOL, V48, P947, DOI 10.1046/j.1365-2958.2003.03492.x; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; DE M, 2000, J CELL SCI, V113, P2331; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; DIAMOND R, 1992, PROTEIN SCI, V1, P1279, DOI 10.1002/pro.5560011006; DOSEMECI A, 1995, SYNAPSE, V20, P91, DOI 10.1002/syn.890200113; Dubreuil RR, 2000, J MUSCLE RES CELL M, V21, P705, DOI 10.1023/A:1005699608893; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Faddis BT, 1997, J NEUROSCI, V17, P951; FOWLER VM, 1992, J CELL BIOL, V119, P1559, DOI 10.1083/jcb.119.6.1559; Gascard P, 2000, CURR OPIN HEMATOL, V7, P123, DOI 10.1097/00062752-200003000-00009; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; HARRIS AS, 1989, J BIOL CHEM, V264, P17401; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; HARRIS AS, 1988, J NEUROSCI, V8, P2640; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee A, 2001, J BIOL CHEM, V276, P20735, DOI 10.1074/jbc.M009723200; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Melloni E, 1998, J BIOL CHEM, V273, P12827, DOI 10.1074/jbc.273.21.12827; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MORROW JS, 1997, HDB PHYSIOL 14, P485; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nedrelow JH, 2003, J BIOL CHEM, V278, P7735, DOI 10.1074/jbc.M210988200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nicolas G, 2002, MOL CELL BIOL, V22, P3527, DOI 10.1128/MCB.22.10.3527-3536.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; PONTREMOLI S, 1985, BIOCHEM BIOPH RES CO, V129, P389, DOI 10.1016/0006-291X(85)90163-9; Pradhan D, 2002, IMMUNITY, V17, P303, DOI 10.1016/S1074-7613(02)00396-5; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rotter B, 2004, BIOCHEM J, V378, P161, DOI 10.1042/BJ20030955; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SHEPPARD A, 1991, SYNAPSE, V9, P231, DOI 10.1002/syn.890090310; SHEPPARD AM, 1993, SYNAPSE, V15, P239, DOI 10.1002/syn.890150309; Sihag RK, 1996, J NEUROSCI RES, V44, P430, DOI 10.1002/(SICI)1097-4547(19960601)44:5<430::AID-JNR3>3.0.CO;2-G; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Suzuki K, 1998, FEBS LETT, V433, P1, DOI 10.1016/S0014-5793(98)00856-4; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Villaseca JM, 2000, INFECT IMMUN, V68, P5920, DOI 10.1128/IAI.68.10.5920-5927.2000; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Williams ST, 2003, APOPTOSIS, V8, P353, DOI 10.1023/A:1024168901003; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; YOSHIZAWA T, 1995, FEBS LETT, V358, P101, DOI 10.1016/0014-5793(94)01401-L	63	39	41	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34333	34340		10.1074/jbc.M604613200	http://dx.doi.org/10.1074/jbc.M604613200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16945920	hybrid			2022-12-27	WOS:000241767600053
J	Singleton, PA; Dudek, SM; Ma, SF; Garcia, JGN				Singleton, Patrick A.; Dudek, Steven M.; Ma, Shwu-Fan; Garcia, Joe G. N.			Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation - Novel role for hyaluronan and CD44 receptor family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; IP3 RECEPTOR; LIPID RAFTS; KINASE; ENHANCEMENT; EXPRESSION; TISSUE; ACID; RHO; SPHINGOSINE-1-PHOSPHATE	The role for hyaluronan (HA) and CD44 in vascular barrier regulation is unknown. We examined high and low molecular weight HA (HMW-HA, similar to 1,000 kDa; LMW- HA, similar to 2.5 kDa) effects on human transendothelial monolayer electrical resistance (TER). HMW-HA increased TER, whereas LMW- HA induced biphasic TER changes ultimately resulting in EC barrier disruption. HMW-HA induced the association of the CD44s isoform with, and AKT-mediated phosphorylation of, the barrier-promoting sphingosine 1-phosphate receptor (S1P(1)) within caveolin-enriched lipid raft microdomains, whereas LMW- HA induced brief CD44s association with S1P1 followed by sustained association of the CD44v10 isoform with, and Src and ROCK 1/2-mediated phosphorylation of, the barrier-disrupting S1P(3) receptor. HA-induced EC cytoskeletal reorganization and TER alterations were abolished by either disruption of lipid raft formation, CD44 blocking antibody or siRNA-mediated reductions in expression of CD44 isoforms. Silencing S1P1, AKT1, or Rac1 blocked the barrier enhancing effects of HA whereas silencing S1P(3), Src, ROCK1/2, or RhoA blocked the barrier disruption induced by LMW- HA. In summary, HA regulates EC barrier function through novel differential CD44 isoform interaction with S1P receptors, S1P receptor transactivation, and RhoA/Rac1 signaling to the EC cytoskeleton.	Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA	University of Chicago	Garcia, JGN (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Med, 5841 S Maryland Ave,W604, Chicago, IL 60637 USA.	jgarcia@medicine.bsd.uchicago.edu	Garcia, Joe GN/E-8862-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL068472] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL68472] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bensadoun ES, 1996, AM J RESP CRIT CARE, V154, P1819, DOI 10.1164/ajrccm.154.6.8970376; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; BOURGUIGNON LYW, 1998, FRONT BIOSCI, V3, P637; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Cantor JO, 2004, CHEST, V125, P288, DOI 10.1378/chest.125.1.288; CARNENISCH TD, 2000, J CLIN INVEST, V106, P349; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gee K, 2004, ARCH IMMUNOL THER EX, V52, P13; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Harris TJC, 2002, BIOESSAYS, V24, P996, DOI 10.1002/bies.10172; HIRANO H, 1994, INT IMMUNOL, V6, P49, DOI 10.1093/intimm/6.1.49; Konttinen Y, 2001, J PATHOL, V194, P384, DOI 10.1002/1096-9896(200107)194:3<384::AID-PATH896>3.0.CO;2-8; Lokeshwar VB, 1996, J BIOL CHEM, V271, P23853, DOI 10.1074/jbc.271.39.23853; Luscher TF, 1997, CLIN CARDIOL, V20, P3; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Mucha DR, 2003, AM J PHYSIOL-HEART C, V284, pH994, DOI 10.1152/ajpheart.00862.2002; NETTELBLADT O, 1989, AM REV RESPIR DIS, V140, P1028, DOI 10.1164/ajrccm/140.4.1028; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; PEARSON JD, 1991, RADIOLOGY, V179, P9, DOI 10.1148/radiology.179.1.2006310; Pyne S, 2000, PHARMACOL THERAPEUT, V88, P115, DOI 10.1016/S0163-7258(00)00084-X; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Scott JE, 2002, BIOMACROMOLECULES, V3, P547, DOI 10.1021/bm010170j; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Singleton PA, 2004, EXP CELL RES, V295, P102, DOI 10.1016/j.yexcr.2003.12.025; Singleton PA, 2002, CELL MOTIL CYTOSKEL, V53, P293, DOI 10.1002/cm.10078; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Teder P, 1997, AM J RESP CELL MOL, V17, P376, DOI 10.1165/ajrcmb.17.3.2698; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Waeber C, 2004, DRUG NEWS PERSPECT, V17, P365, DOI 10.1358/dnp.2004.17.6.829028; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702	49	143	149	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34381	34393		10.1074/jbc.M603680200	http://dx.doi.org/10.1074/jbc.M603680200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16963454	hybrid			2022-12-27	WOS:000241767600059
J	Yogev, O; Anzi, S; Inoue, K; Shaulian, E				Yogev, Orli; Anzi, Shira; Inoue, Kazushi; Shaulian, Eitan			Induction of transcriptionally active jun proteins regulates drug-induced senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN UV RESPONSE; C-JUN; DNA-DAMAGE; HUMAN FIBROBLASTS; MESSENGER-RNA; GROWTH ARREST; AP-1 ACTIVITY; TARGET GENES; HYDROXYUREA	The drug hydroxyurea (HU) is used for cancer therapy and treatment of sickle cell anemia. It inhibits cell cycle progression by blocking DNA synthesis and drives cells to undergo apoptosis or enter senescence. We demonstrate here that HU induces the expression of two AP-1 proteins, c-Jun and JunB, which exert antagonistic effects on the cell cycle. Moreover, the induction of c-Jun is observed following treatment with two other drugs that inhibit the cell cycle in S phase, aphidicolin and camptothecin. The induction of c-Jun, which promotes cell cycle progression, up-regulates expression of cyclin D after exposure of cells to HU. Deficiency in c-jun prevents elevation of cyclin D expression and extends entrance into HU-induced senescence but also renders cells more resistant to HU-dependent apoptosis. The induction of c-Jun is independent of JNK activity, and additionally, of c-Jun autoregulatory activity but is inhibited upon inhibition of protein kinase C activity. Therefore, we suggest that c-Jun activity prevents drug-induced senescence. Conversely, the JunB target gene, tumor suppressor p16(INK4a), a cyclin-dependent kinase inhibitor essential for the induction of drug-induced senescence, is also up-regulated by HU in a JunB-dependent manner. Constitutive expression of JunB up-regulates p16(INK4a) and increases the sensitivity of mouse fibroblasts to drug-induced senescence. Thus, we suggest that in contrast to c-Jun, JunB drives cells to enter HU-dependent senescence. The effect of HU treatment, which regulates the intricate web of AP-1 transcription, depends on the balance between c-Jun and JunB activities.	Hebrew Univ Jerusalem, Sch Med, Dept Expt Med & Canc Res, IL-91120 Jerusalem, Israel; Wake Forest Univ, Dept Pathol, Winston Salem, NC 27157 USA; Wake Forest Univ, Dept Canc Biol, Winston Salem, NC 27157 USA	Hebrew University of Jerusalem; Wake Forest University; Wake Forest University	Shaulian, E (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Expt Med & Canc Res, IL-91120 Jerusalem, Israel.	eshaulian@md.huji.ac.il						ADUNYAH SE, 1995, BBA-GENE STRUCT EXPR, V1263, P123; Ahn JS, 2003, ANN NY ACAD SCI, V1010, P493, DOI 10.1196/annals.1299.090; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Baker GL, 2005, CELL CYCLE, V4, P330; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bulgin D, 2006, THYROID, V16, P217, DOI 10.1089/thy.2006.16.217; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Davies SC, 2003, BLOOD REV, V17, P99, DOI 10.1016/S0268-960X(02)00074-7; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dosch J, 1996, ONCOGENE, V13, P1927; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Han EKH, 1996, CELL GROWTH DIFFER, V7, P699; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HILBERG F, 1992, ONCOGENE, V7, P2371; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Lallemand D, 1997, ONCOGENE, V14, P819, DOI 10.1038/sj.onc.1200901; Lallemand D, 1998, EMBO J, V17, P5615, DOI 10.1093/emboj/17.19.5615; LI JC, 1987, CANCER RES, V47, P2755; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; NAKAOKA T, 1995, J BIOL CHEM, V270, P12147, DOI 10.1074/jbc.270.20.12147; NAKAOKA T, 1993, J BIOCHEM-TOKYO, V114, P449, DOI 10.1093/oxfordjournals.jbchem.a124196; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Navarra P, 1999, CRIT REV ONCOL HEMAT, V29, P249, DOI 10.1016/S1040-8428(98)00032-8; Nayak BK, 2002, ONCOGENE, V21, P7226, DOI 10.1038/sj.onc.1205889; Nead MA, 1998, EMBO J, V17, P2342, DOI 10.1093/emboj/17.8.2342; Park JI, 2000, J CANCER RES CLIN, V126, P455, DOI 10.1007/s004320050013; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Queralt E, 2005, GENETICS, V171, P1485, DOI 10.1534/genetics.105.045005; ROSENTHAL F., 1928, KLIN WOCHENSCHR, V7, P972, DOI 10.1007/BF01716922; Sakano K, 2001, JPN J CANCER RES, V92, P1166, DOI 10.1111/j.1349-7006.2001.tb02136.x; Salomoni P, 2005, BLOOD, V105, P3686, DOI 10.1182/blood-2004-09-3782; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SoferLevi Y, 1996, ONCOGENE, V13, P2431; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; TIMSON J, 1975, MUTAT RES, V32, P115, DOI 10.1016/0165-1110(75)90002-0; WANG E, 1995, CANCER RES, V55, P2284; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yeo EJ, 2000, EXP GERONTOL, V35, P553, DOI 10.1016/S0531-5565(00)00108-X	58	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34475	34483		10.1074/jbc.M602865200	http://dx.doi.org/10.1074/jbc.M602865200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966326	hybrid			2022-12-27	WOS:000241767600068
J	Joyce, CW; Wagner, EM; Basso, F; Amar, MJ; Freeman, LA; Shamburek, RD; Knapper, CL; Syed, J; Wu, J; Vaisman, BL; Fruchart-Najib, J; Billings, EM; Paigen, B; Remaley, AT; Santamarina-Fojo, S; Brewer, HB				Joyce, Charles W.; Wagner, Elke M.; Basso, Federica; Amar, Marcelo J.; Freeman, Lita A.; Shamburek, Robert D.; Knapper, Catherine L.; Syed, Jafri; Wu, Justina; Vaisman, Boris L.; Fruchart-Najib, Jamila; Billings, Eric M.; Paigen, Beverly; Remaley, Alan T.; Santamarina-Fojo, Silvia; Brewer, H. Bryan, Jr.			ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CASSETTE TRANSPORTER 1; REVERSE CHOLESTEROL TRANSPORT; PLASMA RATIO METHOD; TANGIER-DISEASE; TRANSGENIC MICE; AORTIC ATHEROSCLEROSIS; HEPATIC ABCA1; KNOCKOUT MICE; IN-VIVO	The identification of ABCA1 as a key transporter responsible for cellular lipid efflux has led to considerable interest in defining its role in cholesterol metabolism and atherosclerosis. In this study, the effect of overexpressing ABCA1 in the liver of LDLr-KO mice was investigated. Compared with LDLr-KO mice, ABCA1-Tg x LDLr-KO (ABCA1-Tg) mice had significantly increased plasma cholesterol levels, mostly because of a 2.8-fold increase in cholesterol associated with a large pool of apoB-lipoproteins. ApoB synthesis was unchanged but the catabolism of I-125-apoB-VLDL and -LDL were significantly delayed, accounting for the 1.35-fold increase in plasma apoB levels in ABCA1-Tg mice. We also found rapid in vivo transfer of free cholesterol from HDL to apoB-lipoproteins in ABCA1-Tg mice, associated with a significant 2.7-fold increase in the LCAT-derived cholesteryl linoleate content found primarily in apoB-lipoproteins. ABCA1-Tg mice had 1.4-fold increased hepatic cholesterol concentrations, leading to a compensatory 71% decrease in de novo hepatic cholesterol synthesis, as well as enhanced biliary cholesterol, and bile acid secretion. CAV-1, CYP2b10, and ABCG1 were significantly induced in ABCA1-overexpressing livers; however, no differences were observed in the hepatic expression of CYP7 alpha 1, CYP27 alpha 1, or ABCG5/G8 between ABCA1-Tg and control mice. As expected from the pro-atherogenic plasma lipid profile, aortic atherosclerosis was increased 10-fold in ABCA1-Tg mice. In summary, hepatic overexpression of ABCA1 in LDLr-KO mice leads to: 1) expansion of the pro-atherogenic apoB-lipoprotein cholesterol pool size via enhanced transfer of HDL-cholesterol to apoB-lipoproteins and delayed catabolism of cholesterol-enriched apoB-lipoproteins; 2) increased cholesterol concentration in the liver, resulting in up-regulated hepatobiliary sterol secretion; and 3) significantly enhanced aortic atherosclerotic lesions.	NHLBI, NIH, Mol Dis Sect, Bethesda, MD 20892 USA; NHLBI, NIH, Bioinformat Core Facil, Bethesda, MD 20892 USA; Inst Pasteur, Dept Atherosclerose, F-59019 Lille, France; Cardiovasc Res Inst, Washington, DC 20010 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Wagner, EM (corresponding author), NHLBI, NIH, Mol Dis Sect, Bldg 10,Rm 7N105, Bethesda, MD 20892 USA.	ewagner@mail.nih.gov	Vaisman, Boris L/B-3453-2008; Amar, Marcelo/AAD-5599-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002064, Z01HL002058, ZIAHL002058] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Amar MJA, 1998, J LIPID RES, V39, P2436; Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brewer HB, 2004, NEW ENGL J MED, V350, P1491, DOI 10.1056/NEJMp048023; Brewer HB, 2004, ARTERIOSCL THROM VAS, V24, P387, DOI 10.1161/01.ATV.0000121505.88326.d2; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brousseau ME, 2000, J LIPID RES, V41, P433; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; CHEN CH, 1982, J LIPID RES, V23, P680; Christiansen-Weber TA, 2000, AM J PATHOL, V157, P1017, DOI 10.1016/S0002-9440(10)64614-7; DESILVA HV, 1994, J LIPID RES, V35, P1297; Drobnik W, 2001, GASTROENTEROLOGY, V120, P1203, DOI 10.1053/gast.2001.23250; FIELDING CJ, 1995, J LIPID RES, V36, P211; Flood C, 2004, ARTERIOSCL THROM VAS, V24, P564, DOI 10.1161/01.ATV.0000117174.19078.85; Furbee JW, 2002, J LIPID RES, V43, P428; GAMBLE W, 1978, J LIPID RES, V19, P1068; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gnerre C, 2005, J LIPID RES, V46, P1633, DOI 10.1194/jlr.M400453-JLR200; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Groen AK, 2001, J CLIN INVEST, V108, P843, DOI 10.1172/JCI12473; Joyce C, 2003, ARTERIOSCL THROM VAS, V23, P965, DOI 10.1161/01.ATV.0000055194.85073.FF; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; MARCEL YL, 1988, ARTERIOSCLEROSIS, V8, P832, DOI 10.1161/01.ATV.8.6.832; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; Moreno M, 2003, HEPATOLOGY, V38, P1477, DOI 10.1016/j.hep.2003.09.011; Mott S, 2000, ATHEROSCLEROSIS, V152, P457, DOI 10.1016/S0021-9150(99)00498-0; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Ragozin S, 2005, ARTERIOSCL THROM VAS, V25, P1433, DOI 10.1161/01.ATV.0000166616.86723.d0; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Remaley AT, 1999, P NATL ACAD SCI USA, V96, P12685, DOI 10.1073/pnas.96.22.12685; Rudel LL, 1998, ARTERIOSCL THROM VAS, V18, P1818, DOI 10.1161/01.ATV.18.11.1818; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200; Schwartz CC, 2004, J LIPID RES, V45, P1594, DOI 10.1194/jlr.M300511-JLR200; Schwarz M, 1998, J LIPID RES, V39, P1833; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Tsukamoto K, 1997, J LIPID RES, V38, P1869; TURLEY SD, 1994, J LIPID RES, V35, P328; TURLEY SD, 1981, J LIPID RES, V22, P569; VAISMAN BL, 1995, J BIOL CHEM, V270, P12269, DOI 10.1074/jbc.270.20.12269; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; VAUGHAN AM, 2006, IN PRESS J LIPID RES; Wang HB, 2003, CURR DRUG METAB, V4, P515, DOI 10.2174/1389200033489262; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wellington CL, 2003, J LIPID RES, V44, P1470, DOI 10.1194/jlr.M300110-JLR200; Wu JE, 2004, J BIOL CHEM, V279, P22913, DOI 10.1074/jbc.M402838200; ZILVERSMIT DB, 1974, J LIPID RES, V15, P465; Zollner G, 2006, AM J PHYSIOL-GASTR L, V290, pG923, DOI 10.1152/ajpgi.00490.2005	65	69	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33053	33065		10.1074/jbc.M604526200	http://dx.doi.org/10.1074/jbc.M604526200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16928680	hybrid			2022-12-27	WOS:000241621400014
J	Karkhanis, VA; Boniecki, MT; Poruri, K; Martinis, SA				Karkhanis, Vrajesh A.; Boniecki, Michal T.; Poruri, Kiranmai; Martinis, Susan A.			A viable amino acid editing activity in the leucyl-tRNA synthetase CP1-splicing domain is not required in the yeast mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I TRANSFER-RNA; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; SPLICING FUNCTION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CELL VIABILITY; DISCRIMINATION; ISOLEUCINE	Aminoacyl-tRNA synthetases are a family of enzymes that are responsible for translating the genetic code in the first step of protein synthesis. Some aminoacyl-tRNA synthetases have editing activities to clear their mistakes and enhance fidelity. Leucyl-tRNA synthetases have a hydrolytic active site that resides in a discrete amino acid editing domain called CP1. Mutational analysis within yeast mitochondrial leucyl-tRNA synthetase showed that the enzyme has maintained an editing active site that is competent for post-transfer editing of mischarged tRNA similar to other leucyl-tRNA synthetases. These mutations that altered or abolished leucyl-tRNA synthetase editing were introduced into complementation assays. Cell viability and mitochondrial function were largely unaffected in the presence of high levels of non-leucine amino acids. In contrast, these editing-defective mutations limited cell viability in Escherichia coli. It is possible that the yeast mitochondria have evolved to tolerate lower levels of fidelity in protein synthesis or have developed alternate mechanisms to enhance discrimination of leucine from non-cognate amino acids that can be misactivated by leucyl-tRNA synthetase.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, 419 Roger Adams Lab,Box B-4,600 S Matthews Ave, Urbana, IL 61801 USA.	martinis@life.uiuc.edu		poruri, kiran/0000-0002-3127-0244; Martinis, Susan/0000-0001-5730-8346	NIGMS NIH HHS [GM63107, GM63789, R01 GM063789] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063789, R01GM063107] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; FINZI E, 1985, MEMBRANE BIOCHEM, V5, P291, DOI 10.3109/09687688509150283; FREIST W, 1985, BIOCHEMISTRY-US, V24, P7014, DOI 10.1021/bi00345a040; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J BIOL CHEM, V280, P29937, DOI 10.1074/jbc.M502668200; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; GRIVELL LA, 1989, EUR J BIOCHEM, V182, P477, DOI 10.1111/j.1432-1033.1989.tb14854.x; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x; Houman F, 2000, P NATL ACAD SCI USA, V97, P13743, DOI 10.1073/pnas.240465597; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; LABOUESSE M, 1990, MOL GEN GENET, V224, P209, DOI 10.1007/BF00271554; Li GY, 1996, MOL GEN GENET, V252, P667, DOI 10.1007/BF02173972; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; LINCECUM TL, 2005, AMINOACYL TRNA SYNTH, P36; Liu YQ, 2006, BIOCHEM J, V394, P399, DOI 10.1042/BJ20051249; LOFTFIELD RB, 1963, BIOCHEM J, V89, P82, DOI 10.1042/bj0890082; LOW B, 1971, J BACTERIOL, V108, P742, DOI 10.1128/JB.108.2.742-750.1971; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; Martinis SA, 1999, BIOCHIMIE, V81, P683, DOI 10.1016/S0300-9084(99)80126-6; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, V1, P887; MESSENGUY F, 1980, EUR J BIOCHEM, V108, P439, DOI 10.1111/j.1432-1033.1980.tb04740.x; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Mursinna RS, 2004, BIOCHEMISTRY-US, V43, P155, DOI 10.1021/bi034919h; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Passarella S, 2003, MITOCHONDRION, V2, P319, DOI 10.1016/S1567-7249(03)00008-4; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671; Rho SB, 2000, RNA, V6, P1882, DOI 10.1017/S1355838200001254; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SCHMIDT E, 1995, BIOCHEMISTRY-US, V34, P11204, DOI 10.1021/bi00035a028; SERAPHIN B, 1987, P NATL ACAD SCI USA, V84, P6810, DOI 10.1073/pnas.84.19.6810; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Stoll A., 1958, FESTSCHRIFT A STOLL, P597; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tang Y, 2002, BIOCHEMISTRY-US, V41, P10635, DOI 10.1021/bi026130x; Tang Y, 2001, J AM CHEM SOC, V123, P11089, DOI 10.1021/ja016652k; VONHEIJNE G, 1986, FEBS LETT, V198, P1, DOI 10.1016/0014-5793(86)81172-3; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Zhai YX, 2005, BIOCHEMISTRY-US, V44, P15437, DOI 10.1021/bi0514461	61	28	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33217	33225		10.1074/jbc.M607406200	http://dx.doi.org/10.1074/jbc.M607406200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956879	hybrid			2022-12-27	WOS:000241621400030
J	Lee, J; Kim, HK; Rho, JY; Han, YM; Kim, J				Lee, Jungwoon; Kim, Hye Kyoung; Rho, Jeung-Yon; Han, Yong-Mahn; Kim, Jungho			The human OCT-4 isoforms differ in their ability to confer self-renewal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; HUMAN CHORIONIC-GONADOTROPIN; TRANSCRIPTION FACTOR OCT-3/4; POU-DOMAIN; CHROMOSOMAL LOCATION; MOUSE EMBRYO; GERM-LINE; MAMMALIAN EMBRYO; ES CELLS; GENE	OCT-4 transcription factors play an important role in maintaining the pluripotent state of embryonic stem cells and may prevent expression of genes activated during differentiation. Human OCT-4 isoformm RNAs encode proteins that have identical POU DNA binding domains and C-terminal domains but differ in their N-terminal domains. We report here the cloning and characterization of the human OCT-4B isoform. Human OCT-4B cDNA encodes a 265-amino acid protein with a predicted molecular mass of 30 kDa. Embryonic stem (ES) cell-based complementation assays using ZHBTc4 ES cells showed that unlike human OCT-4A, OCT-4B cannot sustain ES cell self-renewal. In addition, OCT-4B does not bind to a probe carrying the OCT-4 consensus binding sequence, and we demonstrate that two separate regions of its N-terminal domain are responsible for inhibiting DNA binding. We also demonstrate that OCT-4B is mainly localized to the cytoplasm. Overexpression of OCT-4B did not activate transcription from OCT-4-dependent promoters, although OCT-4A did as reported previously. Furthermore, transcriptional activation by human OCT-4A was not inhibited by co-expression of OCT-4B. Taken together, these data suggest that the DNA binding, transactivation, and abilities to confer self-renewal of the human OCT-4 isoforms differ.	Sogang Univ, Dept Life Sci, Mol & Cellular Biol Lab, Seoul 121742, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Sogang University; Korea Advanced Institute of Science & Technology (KAIST)	Kim, J (corresponding author), Sogang Univ, Dept Life Sci, Mol & Cellular Biol Lab, Seoul 121742, South Korea.	jkim@sogang.ac.kr	Han, Yong-Mahn/C-1652-2011; Kim, Hye Kyoung/GQB-4102-2022					AAMLID KH, 1990, CARBOHYD RES, V202, P117, DOI 10.1016/0008-6215(90)84075-6; Abate-Shen C, 2003, CANCER CELL, V4, P329, DOI 10.1016/S1535-6108(03)00277-0; ABDELRAHMAN B, 1995, HUM REPROD, V10, P2787, DOI 10.1093/oxfordjournals.humrep.a135792; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Brehm A, 1999, MOL CELL BIOL, V19, P2635; Brehm A, 1997, MOL CELL BIOL, V17, P154, DOI 10.1128/MCB.17.1.154; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Butteroni C, 2000, J MOL BIOL, V304, P529, DOI 10.1006/jmbi.2000.4238; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2001, MOL CELL BIOL, V21, P7883, DOI 10.1128/MCB.21.23.7883-7891.2001; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Goto T, 1999, MOL HUM REPROD, V5, P851, DOI 10.1093/molehr/5.9.851; Hansis C, 2000, MOL HUM REPROD, V6, P999, DOI 10.1093/molehr/6.11.999; HEBERT JM, 1991, DEVELOPMENT, V112, P407; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Kraft HJ, 1996, J BIOL CHEM, V271, P12873, DOI 10.1074/jbc.271.22.12873; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lamb KA, 1998, MOL REPROD DEV, V51, P218; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HJ, 2004, FEBS LETT, V564, P188, DOI 10.1016/S0014-5793(04)00314-X; Lee JW, 2005, STEM CELLS, V23, P738, DOI 10.1634/stemcells.2004-0375; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Liu LM, 1996, J BIOL CHEM, V271, P16683, DOI 10.1074/jbc.271.28.16683; Liu LM, 1997, MOL ENDOCRINOL, V11, P1651, DOI 10.1210/me.11.11.1651; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Park JH, 2003, BIOL REPROD, V69, P2007, DOI 10.1095/biolreprod.103.017467; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Rho JY, 2006, HUM REPROD, V21, P405, DOI 10.1093/humrep/dei328; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Sambrook J., 2001, MOL CLONING LAB MANU; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SIRACUSA LD, 1991, GENOMICS, V10, P313, DOI 10.1016/0888-7543(91)90314-5; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Vigano MA, 1996, NUCLEIC ACIDS RES, V24, P2112, DOI 10.1093/nar/24.11.2112; Yeom YI, 1996, DEVELOPMENT, V122, P881; YEOM YI, 1991, MECH DEVELOP, V35, P171	58	232	249	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33554	33565		10.1074/jbc.M603937200	http://dx.doi.org/10.1074/jbc.M603937200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16951404	hybrid			2022-12-27	WOS:000241621400065
J	Netzel-Arnett, S; Currie, BM; Szabo, R; Lin, CY; Chen, LM; Chai, KX; Antalis, TM; Bugge, TH; List, K				Netzel-Arnett, Sarah; Currie, Brooke M.; Szabo, Roman; Lin, Chen-Yong; Chen, Li-Mei; Chai, Karl X.; Antalis, Toni M.; Bugge, Thomas H.; List, Karin			Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; BARRIER FUNCTION; OVARIAN-CANCER; NETHERTON-SYNDROME; CELLULAR-LOCALIZATION; EPITHELIAL-CELLS; STRATUM-CORNEUM; MESSENGER-RNA; BREAST-CANCER; IN-VIVO	Recent gene ablation studies in mice have shown that matriptase, a type II transmembrane serine protease, and prostasin, a glycosylphosphatidylinositol-anchored membrane serine protease, are both required for processing of the epidermis-specific polyprotein, profilaggrin, stratum corneum formation, and acquisition of epidermal barrier function. Here we present evidence that matriptase acts upstream of prostasin in a zymogen activation cascade that regulates terminal epidermal differentiation and is required for prostasin zymogen activation. Enzymatic gene trapping of matriptase combined with prostasin immunohistochemistry revealed that matriptase was co-localized with prostasin in transitional layer cells of the epidermis and that the developmental onset of expression of the two membrane proteases was coordinated and correlated with acquisition of epidermal barrier function. Purified soluble matriptase efficiently converted soluble prostasin zymogen to an active two-chain form that formed SDS-stable complexes with the serpin protease nexin-1. Whereas two forms of prostasin with molecular weights corresponding to the prostasin zymogen and active prostasin were present in wild type epidermis, prostasin was exclusively found in the zymogen form in matriptase-deficient epidermis. These data suggest that matriptase, an autoactivating protease, acts upstream from prostasin to initiate a zymogen cascade that is essential for epidermal differentiation.	NIDCR, Proteases & Tissue Remodeling Unit, NIH, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Washington, DC 20201 USA; Univ Maryland, Sch Med, Dept Physiol, Washington, DC 20201 USA; Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Washington, DC 20007 USA; Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Georgetown University; State University System of Florida; University of Central Florida	Bugge, TH (corresponding author), NIDCR, Proteases & Tissue Remodeling Unit, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov			Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R01-CA-104944, R01 CA098369, R01-CA-096851, CA098369] Funding Source: Medline; NHLBI NIH HHS [HL07698, R01 HL084387] Funding Source: Medline; NICHD NIH HHS [HD40241] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD040241] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA096851, R01CA104944, R56CA098369, R01CA098369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007698, R01HL084387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000699] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen LM, 2006, AM J PHYSIOL-RENAL, V291, pF567, DOI 10.1152/ajprenal.00047.2006; Chen LM, 2001, PROSTATE, V48, P93, DOI 10.1002/pros.1085; Chen LM, 2002, INT J CANCER, V97, P323, DOI 10.1002/ijc.1601; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Fukushima K, 2004, J GASTROENTEROL, V39, P940, DOI 10.1007/s00535-004-1425-7; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Hoang CD, 2004, CHEST, V125, P1843, DOI 10.1378/chest.125.5.1843; Kang JY, 2003, CANCER RES, V63, P1101; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Mok SC, 2001, J NATL CANCER I, V93, P1458, DOI 10.1093/jnci/93.19.1458; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Pearton DJ, 2001, EXP DERMATOL, V10, P193, DOI 10.1034/j.1600-0625.2001.010003193.x; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; RESING KA, 1993, BIOCHEMISTRY-US, V32, P10036, DOI 10.1021/bi00089a020; RESING KA, 1995, J BIOL CHEM, V270, P28193; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanimoto H, 2005, BRIT J CANCER, V92, P278, DOI 10.1038/sj.bjc.6602320; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388	43	151	154	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					32941	32945		10.1074/jbc.C600208200	http://dx.doi.org/10.1074/jbc.C600208200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16980306	hybrid, Green Submitted			2022-12-27	WOS:000241621400002
J	Spann, NJ; Kang, S; Li, AC; Chen, AZ; Newberry, EP; Davidson, NO; Hui, STY; Davis, RA				Spann, Nathanael J.; Kang, Sohye; Li, Andrew C.; Chen, Amelia Z.; Newberry, Elizabeth P.; Davidson, Nicholas O.; Hui, Simon T. Y.; Davis, Roger A.			Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-ALPHA; UBIQUITIN-PROTEASOME PATHWAY; TISSUE-CULTURE MODEL; APOLIPOPROTEIN-B; EMBRYONIC LETHALITY; PLASMA-CHOLESTEROL; RESPONSE ELEMENT; MTP INHIBITOR; FAO CELL; APO-B	Unlike the livers of humans and mice, and most hepatoma cells, which accumulate triglycerides when treated with microsomal triglyceride transfer protein (MTP) inhibitors, L35 rat hepatoma cells do not express MTP and cannot secrete very low density lipoprotein (VLDL), yet they do not accumulate triglyceride. In these studies we show that transcriptional co-repression of the two lipid transfer proteins, liver fatty acid-binding protein (L-FABP) and MTP, which cooperatively shunt fatty acids into de novo synthesized glycerolipids and the transfer of lipids into VLDL, respectively, act together to maintain hepatic lipid homeostasis. FAO rat hepatoma cells express L-FABP and MTP and demonstrate the ability to assemble and secrete VLDL. In contrast, L35 cells, derived as a single cell clone from FAO cells, do not express L-FABP or MTP nor do they assemble and secrete VLDL. We used these hepatoma cells to elucidate how a conserved DR1 promoter element present in the promoters of L-FABP and MTP affects transcription, expression, and VLDL production. In FAO cells, the DR1 elements of both L-FABP and MTP promoters are occupied by peroxisome proliferator-activated receptor alpha-retinoid x receptor alpha (RXR alpha), with which PGC-1 beta activates transcription. In contrast, in L35 cells the DR1 elements of both L-FABP and MTP promoters are occupied by chicken ovalbumin upstream promoter transcription factor II, and transcription is diminished. The combined findings indicate that peroxisome proliferator-activated receptor alpha-RXR alpha and PGC-1 beta coordinately up-regulate L-FABP and MTP expression, by competing with chicken ovalbumin upstream promoter transcription factor II for the DR1 sites in the proximal promoters of each gene. Additional studies show that ablation of L-FABP prevents hepatic steatosis caused by treating mice with an MTP inhibitor. Our findings show that reducing both L-FABP and MTP is an effective means to reduce VLDL secretion without causing hepatic steatosis.	San Diego State Univ, Dept Biol, Inst Heart, San Diego, CA 92182 USA; Univ Calif San Diego, Dept Cellular & Mol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol, St Louis, MO 63110 USA	California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Davis, RA (corresponding author), San Diego State Univ, Dept Biol, Inst Heart, LS307,5500 Campanile Dr, San Diego, CA 92182 USA.	rdavis@sunstroke.sdsu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180, R01HL051648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL57974, HL38180, HL51648] Funding Source: Medline; NIDDK NIH HHS [DK52574, DK56260] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ameen C, 2005, J BIOL CHEM, V280, P1224, DOI 10.1074/jbc.M412107200; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; BASS NM, 1990, MOL CELL BIOCHEM, V98, P167; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; Bjorkegren J, 2002, J BIOL CHEM, V277, P5476, DOI 10.1074/jbc.M108514200; BOOGAERTS JR, 1984, AM J PHYSIOL, V246, pE77, DOI 10.1152/ajpendo.1984.246.1.E77; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; Cabrero A, 2003, MOL PHARMACOL, V64, P764, DOI 10.1124/mol.64.3.764; CARTER ME, 1994, MOL CELL BIOL, V14, P4360, DOI 10.1128/MCB.14.7.4360; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Davis RA, 1997, J NUTR, V127, pS795, DOI 10.1093/jn/127.5.795S; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; Davis RA, 2001, ARTERIOSCL THROM VAS, V21, P887, DOI 10.1161/01.ATV.21.6.887; DAVIS RA, 1999, BIOCHIM BIOPHYS ACTA, V1441, P1; DU EZ, 1994, J BIOL CHEM, V269, P24169; FARESE RV, 1995, P NATL ACAD SCI USA, V92, P1774, DOI 10.1073/pnas.92.5.1774; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; HOMANICS GE, 1993, P NATL ACAD SCI USA, V90, P2389, DOI 10.1073/pnas.90.6.2389; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Hui TY, 2002, J LIPID RES, V43, P785; Kang S, 2003, J BIOL CHEM, V278, P30478, DOI 10.1074/jbc.M304201200; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; Ksander GM, 2001, J MED CHEM, V44, P4677, DOI 10.1021/jm010294e; LEIGHTON JK, 1990, J LIPID RES, V31, P1663; Liao W, 2003, J LIPID RES, V44, P978, DOI 10.1194/jlr.M300020-JLR200; Lieu HD, 2003, CIRCULATION, V107, P1315, DOI 10.1161/01.CIR.0000054781.50889.0C; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; MIYATA KS, 1993, J BIOL CHEM, V268, P19169; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; PALMER CNA, 1994, J BIOL CHEM, V269, P18083; Pauley CJ, 2002, CELL SIGNAL, V14, P351, DOI 10.1016/S0898-6568(01)00260-1; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Poirier H, 1997, FEBS LETT, V412, P480, DOI 10.1016/S0014-5793(97)00830-2; Poirier H, 2001, BIOCHEM J, V355, P481, DOI 10.1042/0264-6021:3550481; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Rustaeus S, 1999, J NUTR, V129, p463S, DOI 10.1093/jn/129.2.463S; SCARINO ML, 1987, EXP CELL RES, V170, P1, DOI 10.1016/0014-4827(87)90112-1; SCARINO ML, 1987, EXP CELL RES, V170, P15, DOI 10.1016/0014-4827(87)90113-3; Schroeder F, 1998, CHEM PHYS LIPIDS, V92, P1, DOI 10.1016/S0009-3084(98)00003-6; Shiomi M, 2001, EUR J PHARMACOL, V431, P127, DOI 10.1016/S0014-2999(01)01419-4; Siri P, 2001, J BIOL CHEM, V276, P46064, DOI 10.1074/jbc.M108909200; SWIFT LL, 1995, J LIPID RES, V36, P395; Ueshima K, 2005, BIOL PHARM BULL, V28, P247, DOI 10.1248/bpb.28.247; Veniant MM, 1999, J NUTR, V129, p451S, DOI 10.1093/jn/129.2.451S; Wall ME, 2005, J MOL BIOL, V349, P501, DOI 10.1016/j.jmb.2005.04.022; Wang SL, 1997, J BIOL CHEM, V272, P19351, DOI 10.1074/jbc.272.31.19351; WETTERAU JR, 1992, SCIENCE, V258, P999; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0; YAO ZM, 1991, J BIOL CHEM, V266, P3300; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777	64	56	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33066	33077		10.1074/jbc.M607148200	http://dx.doi.org/10.1074/jbc.M607148200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950764	hybrid			2022-12-27	WOS:000241621400015
J	Bartos, JD; Wang, W; Pike, JE; Bambara, RA				Bartos, Jeremy D.; Wang, Wensheng; Pike, Jason E.; Bambara, Robert A.			Mechanisms by which Bloom protein can disrupt recombination intermediates of Okazaki fragment maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME GENE-PRODUCT; SYNDROME HELICASE; FLAP ENDONUCLEASE-1; DNA-REPLICATION; BINDING DOMAIN; WERNER; FEN1; STIMULATION; ASSOCIATION; SUPPRESSES	Bloom syndrome is a familial genetic disorder associated with sunlight sensitivity and a high predisposition to cancers. The mutated gene, Bloom protein (BLM), encodes a DNA helicase that functions in genome maintenance via roles in recombination repair and resolution of recombination structures. We designed substrates representing illegitimate recombination intermediates formed when a displaced DNA flap generated during maturation of Okazaki fragments escapes cleavage by flap endonuclease-1 and anneals to a complementary ectopic DNA site. Results show that displaced, replication protein A (RPA)-coated flaps could readily bind and ligate at the complementary site to initiate recombination. RPA also displayed a strand-annealing activity that hastens the rate of recombination intermediate formation. BLM helicase activity could directly disrupt annealing at the ectopic site and promote flap endonuclease-1 cleavage. Additionally, BLM has its own strand-annealing and strand-exchange activities. RPA inhibited the BLM strand-annealing activity, thereby promoting helicase activity and complex dissolution. BLM strand exchange could readily dissociate invading flaps, e. g. in a D-loop, if the exchange step did not involve annealing of RPA-coated strands. Use of ATP to activate the helicase function did not aid flap displacement by exchange, suggesting that this is a helicase- independent mechanism of complex dissociation. When RPA could bind, it displayed its own strand-exchange activity. We interpret these results to explain how BLM is well equipped to deal with alternative recombination intermediate structures.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_Bambara@urmc.rochester.edu			NATIONAL CANCER INSTITUTE [T32CA009363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA 09363] Funding Source: Medline; NIGMS NIH HHS [GM 024441] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Ellis NA, 1996, HUM MOL GENET, V5, P1457, DOI 10.1093/hmg/5.Supplement_1.1457; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Gaymes TJ, 2002, ONCOGENE, V21, P2525, DOI 10.1038/sj.onc.1205331; GERMAN J, 1998, MOL METABOLIC BASIS, P301; Henricksen LA, 2002, J BIOL CHEM, V277, P22361, DOI 10.1074/jbc.M201765200; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Liao SR, 2000, GENE DEV, V14, P2570, DOI 10.1101/gad.822400; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Liu Y, 2004, MOL CELL BIOL, V24, P4049, DOI 10.1128/MCB.24.9.4049-4064.2004; Liu Z, 1999, STRUCTURE, V7, P1557, DOI 10.1016/S0969-2126(00)88346-X; LONN U, 1990, CANCER RES, V50, P3141; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-1; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Morozov V, 1997, TRENDS BIOCHEM SCI, V22, P417, DOI 10.1016/S0968-0004(97)01128-6; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Ranalli TA, 2002, J BIOL CHEM, V277, P1719, DOI 10.1074/jbc.M109053200; Schawalder J, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-15; Sharma S, 2004, J BIOL CHEM, V279, P9847, DOI 10.1074/jbc.M309898200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Tachibana A, 2004, ADV BIOPHYS, V38, P21, DOI 10.1016/S0065-227X(04)80046-7; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Wang WS, 2000, EMBO J, V19, P3428, DOI 10.1093/emboj/19.13.3428; Wang WS, 2005, J BIOL CHEM, V280, P5391, DOI 10.1074/jbc.M412359200; Wu L, 2002, NUCLEIC ACIDS RES, V30, P4823, DOI 10.1093/nar/gkf611; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	49	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32227	32239		10.1074/jbc.M606310200	http://dx.doi.org/10.1074/jbc.M606310200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950766	hybrid			2022-12-27	WOS:000241414500020
J	Palmer, DA; Thompson, JK; Li, L; Prat, A; Wang, P				Palmer, Daniel A.; Thompson, Jill K.; Li, Lie; Prat, Ashton; Wang, Ping			Gib2, a novel G beta-like/RACK1 homolog, functions as a G beta subunit in cAMP signaling and is essential in Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WD-REPEAT PROTEINS; G-ALPHA SUBUNIT; SCHIZOSACCHAROMYCES-POMBE; PHOSPHODIESTERASE PDE4D5; SACCHAROMYCES-CEREVISIAE; MAMMALIAN RACK1; GENE-EXPRESSION; GAMMA-SUBUNITS; SWISS-MODEL; KINASE-C	Canonical G proteins are heterotrimeric, consisting of alpha, beta, and gamma subunits. Despite multiple G alpha subunits functioning in fungi, only a single G beta subunit per species has been identified, suggesting that non-conventional G protein signaling exists in this diverse group of eukaryotic organisms. Using the G alpha subunit Gpa1 that functions in cAMP signaling as bait in a two-hybrid screen, we have identified a novel G beta-like/RACK1 protein homolog, Gib2, from the human pathogenic fungus Cryptococcus neoformans. Gib2 contains a seven WD-40 repeat motif and is predicted to form a seven-bladed beta propeller structure characteristic of beta transducins. Gib2 is also shown to interact, respectively, with two G gamma subunit homologs, Gpg1 and Gpg2, similar to the conventional G beta subunit Gpb1. In contrast to Gpb1 whose overexpression promotes mating response, overproduction of Gib2 suppresses defects of gpa1 mutation in both melanization and capsule formation, the phenotypes regulated by cAMP signaling and associated with virulence. Furthermore, depletion of Gib2 by antisense suppression results in a severe growth defect, suggesting that Gib2 is essential. Finally, Gib2 is shown to also physically interact with a downstream target of Gpa1-cAMP signaling, Smg1, and the protein kinase C homolog Pkc1, indicating that Gib2 is also a multifunctional RACK1-like protein.	Louisiana State Univ, Hlth Sci Ctr, Res Inst Children, Dept Pediat, New Orleans, LA 70118 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70118 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wang, P (corresponding author), 200 Henry Clay Ave, New Orleans, LA 70118 USA.	pwang@lsuhsc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054958] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 054958] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alspaugh JA, 1998, FUNGAL GENET BIOL, V25, P1, DOI 10.1006/fgbi.1998.1079; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Batlle M, 2003, J CELL SCI, V116, P701, DOI 10.1242/jcs.00266; CARDENAS ME, 1995, EMBO J, V14, P2772, DOI 10.1002/j.1460-2075.1995.tb07277.x; CASEY PJ, 1994, CURR OPIN CELL BIOL, V6, P219, DOI 10.1016/0955-0674(94)90139-2; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chen SH, 2005, J BIOL CHEM, V280, P33445, DOI 10.1074/jbc.M505422200; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Gorlach JM, 2002, MICROBIOL-SGM, V148, P213, DOI 10.1099/00221287-148-1-213; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUILLEMOT F, 1989, P NATL ACAD SCI USA, V86, P4594, DOI 10.1073/pnas.86.12.4594; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Harashima T, 2002, MOL CELL, V10, P163, DOI 10.1016/S1097-2765(02)00569-5; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; Hicks JK, 2005, EUKARYOT CELL, V4, P1971, DOI 10.1128/EC.4.12.1971-1981.2005; Hoffman CS, 2005, EUKARYOT CELL, V4, P495, DOI 10.1128/EC.4.3.495-503.2005; Hoffmann B, 1999, MOL MICROBIOL, V31, P807, DOI 10.1046/j.1365-2958.1999.01219.x; Kasahara S, 1997, MOL PLANT MICROBE IN, V10, P984, DOI 10.1094/MPMI.1997.10.8.984; KAYS AM, 2004, SIGNAL TRANSDUCTION, P175; Landry S, 2001, GENETICS, V157, P1159; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; McLeod M, 2000, MOL CELL BIOL, V20, P4016, DOI 10.1128/MCB.20.11.4016-4027.2000; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Nishimura M, 2003, MOL MICROBIOL, V50, P231, DOI 10.1046/j.1365-2958.2003.03676.x; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Robillard L, 2000, CELL SIGNAL, V12, P673, DOI 10.1016/S0898-6568(00)00118-2; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Rosen S, 1999, EMBO J, V18, P5592, DOI 10.1093/emboj/18.20.5592; SAMBROOK J, 2001, EXPRESSION CLONED GE; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shor B, 2003, J BIOL CHEM, V278, P49119, DOI 10.1074/jbc.M303968200; Sia RA, 2000, FUNGAL GENET BIOL, V29, P153, DOI 10.1006/fgbi.2000.1192; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Steele MR, 2001, CELL SIGNAL, V13, P507, DOI 10.1016/S0898-6568(01)00167-X; STERNWEIS PC, 1994, CURR OPIN CELL BIOL, V6, P198, DOI 10.1016/0955-0674(94)90136-8; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Wang P, 1999, CURR OPIN MICROBIOL, V2, P358, DOI 10.1016/S1369-5274(99)80063-0; Wang P, 2000, MOL CELL BIOL, V20, P352, DOI 10.1128/MCB.20.1.352-362.2000; Wang P, 2004, CURR GENET, V46, P247, DOI 10.1007/s00294-004-0529-1; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; Wang P, 2002, EUKARYOT CELL, V1, P257, DOI 10.1128/EC.1.2.257-272.2002; Wang P, 2005, EVOL GENET, P321; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; WICKES BL, 1995, MOL MICROBIOL, V16, P1099, DOI 10.1111/j.1365-2958.1995.tb02335.x; Xue CY, 2006, MOL BIOL CELL, V17, P667, DOI 10.1091/mbc.E05-07-0699; Yang Q, 2002, EUKARYOT CELL, V1, P378, DOI 10.1128/EC.1.3.378-390.2002; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	66	54	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32596	32605		10.1074/jbc.M602768200	http://dx.doi.org/10.1074/jbc.M602768200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950773	hybrid			2022-12-27	WOS:000241414500057
J	Ren, SM; Higashi, H; Lu, HS; Azuma, T; Hatakeyama, M				Ren, Shumei; Higashi, Hideaki; Lu, Huaisheng; Azuma, Takeshi; Hatakeyama, Masanori			Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; VIRULENCE FACTOR CAGA; TYROSINE PHOSPHORYLATION; BIOLOGICAL-ACTIVITY; IV SECRETION; PROTEIN; SHP-2; TRANSLOCATION; PHOSPHATASE; ANTIGEN	Helicobacter pylori cagA-positive strains are associated with gastric adenocarcinoma. The cagA gene product CagA is delivered into gastric epithelial cells where it localizes to the plasma membrane and undergoes tyrosine phosphorylation at the EPIYA-repeat region, which contains the EPIYA-A segment, EPIYA-B segment, and Western CagA-specific EPIYA-C or East Asian CagA-specific EPIYA-D segment. In host cells, CagA specifically binds to and deregulates SHP-2 phosphatase via the tyrosine-phosphorylated EPIYA-C or EPIYA-D segment, thereby inducing an elongated cell shape known as the hummingbird phenotype. In this study, we found that CagA multimerizes in cells in a manner independent of its tyrosine phosphorylation. Using a series of CagA mutants, we identified a conserved amino acid sequence motif (FPLXRXXXVXDL-SKVG), which mediates CagA multimerization, within the EPIYA-C segment as well as in a sequence that located immediately downstream of the EPIYA-C or EPIYA-D segment. We also found that a phosphorylation-resistant CagA, which multimerizes but cannot bind SHP-2, inhibits the wild-type CagA-SHP-2 complex formation and abolishes induction of the hummingbird phenotype. Thus, SHP-2 binds to a preformed and tyrosine-phosphorylated CagA multimer via its two Src homology 2 domains. These results, in turn, indicate that CagA multimerization is a prerequisite for CagA-SHP-2 interaction and subsequent deregulation of SHP-2. The present work raises the possibility that inhibition of CagA multimerization abolishes pathophysiological activities of CagA that promote gastric carcinogenesis.	Hokkaido Univ, Div Mol Oncol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido 0600815, Japan; Kobe Univ, Grad Sch Med, Internal Ctr Med Res, Kobe, Hyogo 6500017, Japan	Hokkaido University; Kobe University	Hatakeyama, M (corresponding author), Hokkaido Univ, Div Mol Oncol, Inst Med Genet, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	mhata@igm.hokudai.ac.jp	Higashi, Hideaki/F-6872-2012					Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Azuma T, 2004, J INFECT DIS, V189, P820, DOI 10.1086/381782; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; BLASER MJ, 1995, CANCER RES, V55, P2111; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; De Souza D, 2002, BIOCHEMISTRY-US, V41, P9229, DOI 10.1021/bi0259507; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Rugge M, 1999, CANCER-AM CANCER SOC, V85, P2506, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2506::AID-CNCR3>3.3.CO;2-9; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993	25	96	103	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32344	32352		10.1074/jbc.M606172200	http://dx.doi.org/10.1074/jbc.M606172200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954210	hybrid			2022-12-27	WOS:000241414500032
J	Yoon, HJ; Feoktistova, A; Chen, JS; Jennings, JL; Link, AJ; Gould, KL				Yoon, Hyun-Joo; Feoktistova, Anna; Chen, Jun-Song; Jennings, Jennifer L.; Link, Andrew J.; Gould, Kathleen L.			Role of Hcn1 and its phosphorylation in fission yeast anaphase-promoting complex/cyclosome function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-UBIQUITIN LIGASE; GENE-EXPRESSION PROGRAM; SCHIZOSACCHAROMYCES-POMBE; CELL-SEPARATION; SACCHAROMYCES-CEREVISIAE; SPINDLE CHECKPOINT; MITOTIC REGULATION; DESTRUCTION BOX; PROTEIN-KINASES; BUDDING YEAST	The anaphase-promoting complex/cyclosome (APC/C) is a conserved multisubunit ubiquitin ligase required for the degradation of key cell cycle regulators. The APC/C becomes active at the metaphase/anaphase transition and remains active during G(1) phase. One mechanism linked to activation of the APC/C is phosphorylation. Although many sites of mitotic phosphorylation have been identified in core components of the APC/C, the consequence of any individual phosphorylation event has not been elucidated in vivo. In this study, we show that Hcn1 is an essential core component of the fission yeast APC/C and is critical for maintaining complex integrity. Moreover, Hcn1 is a phosphoprotein in vivo. Phosphorylation of Hcn1 occurs at a single Cdk1 site in vitro and in vivo. Mutation of this site to alanine, but not aspartic acid, compromises APC/C function and leads to a specific defect in the completion of cell division.	Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University; Vanderbilt University	Gould, KL (corresponding author), Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, 221 Kirkland Hall, Nashville, TN 37232 USA.	kathy.gould@vanderbilt.edu		Gould, Kathleen/0000-0002-3810-4070	NATIONAL CANCER INSTITUTE [P50CA098131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047728, R01GM064779] Funding Source: NIH RePORTER; NCI NIH HHS [CA 098131] Funding Source: Medline; NHLBI NIH HHS [HL 68744] Funding Source: Medline; NIEHS NIH HHS [ES 11993] Funding Source: Medline; NIGMS NIH HHS [GM 64779, GM 47728] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso-Nunez ML, 2005, MOL BIOL CELL, V16, P2003, DOI 10.1091/mbc.E04-06-0442; Bahler J, 2005, CELL CYCLE, V4, P39, DOI 10.4161/cc.4.1.1336; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Berry LD, 1999, MOL CELL BIOL, V19, P2535; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Burns CG, 2002, MOL CELL BIOL, V22, P801, DOI 10.1128/MCB.22.3.801-815.2002; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Chen RH, 2004, EMBO J, V23, P3113, DOI 10.1038/sj.emboj.7600308; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; He XW, 1998, J CELL SCI, V111, P1635; James P, 1996, GENETICS, V144, P1425; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KEENEY JB, 1994, GENETICS, V136, P849; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; LAHAVBARATZ S, 1995, P NATL ACAD SCI USA, V92, P9303, DOI 10.1073/pnas.92.20.9303; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; May KM, 2002, J CELL BIOL, V156, P23, DOI 10.1083/jcb.200106150; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Peters JM, 1996, SCIENCE, V274, P1199, DOI 10.1126/science.274.5290.1199; Petit CS, 2005, J CELL SCI, V118, P5731, DOI 10.1242/jcs.02687; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P621, DOI 10.1093/nar/20.3.621; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Searle JS, 2004, NAT CELL BIOL, V6, P138, DOI 10.1038/ncb1092; Shteinberg M, 1999, BIOCHEM BIOPH RES CO, V260, P193, DOI 10.1006/bbrc.1999.0884; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Ufano S, 2004, J CELL SCI, V117, P545, DOI 10.1242/jcs.00880; Vanoosthuyse V, 2005, TRENDS CELL BIOL, V15, P231, DOI 10.1016/j.tcb.2005.03.003; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Yamada H, 1997, J CELL SCI, V110, P1793; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamashita YM, 1999, GENES CELLS, V4, P445, DOI 10.1046/j.1365-2443.1999.00274.x; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 2004, MOL CELL, V13, P2, DOI 10.1016/S1097-2765(03)00530-6	61	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32284	32293		10.1074/jbc.M603867200	http://dx.doi.org/10.1074/jbc.M603867200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950791	hybrid			2022-12-27	WOS:000241414500025
J	Treeck, M; Struck, NS; Haase, S; Langer, C; Herrmann, S; Healer, J; Cowman, AF; Gilberger, TW				Treeck, Moritz; Struck, Nicole S.; Haase, Silvia; Langer, Christine; Herrmann, Susann; Healer, Julie; Cowman, Alan F.; Gilberger, Tim W.			A conserved region in the EBL proteins is implicated in microneme targeting of the malaria parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL MEMBRANE ANTIGEN-1; TOXOPLASMA-GONDII; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; QUALITY-CONTROL; ERYTHROCYTE INVASION; LIFE-CYCLE; RECEPTOR; GOLGI; TRAFFICKING	The proliferation of the malaria parasite Plasmodium falciparum within the human host is dependent upon invasion of erythrocytes. This process is accomplished by the merozoite, a highly specialized form of the parasite. Secretory organelles including micronemes and rhoptries play a pivotal role in the invasion process by storing and releasing parasite proteins. The mechanism of protein sorting to these compartments is unclear. Using a transgenic approach we show that trafficking of the most abundant micronemal proteins (members of the EBL-family: EBA-175, EBA-140/BAEBL, and EBA-181/JSEBL) is independent of their cytoplasmic and transmembrane domains, respectively. To identify the minimal sequence requirements for microneme trafficking, we generated parasites expressing EBAGFP chimeric proteins and analyzed their distribution within the infected erythrocyte. This revealed that: (i) a conserved cysteine-rich region in the ectodomain is necessary for protein trafficking to the micronemes and (ii) correct sorting is dependent on accurate timing of expression.	Bernhard Nocht Inst Trop Med, Res Grp Malaria 2, D-20359 Hamburg, Germany; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Bernhard Nocht Institut fur Tropenmedizin; Walter & Eliza Hall Institute	Gilberger, TW (corresponding author), Bernhard Nocht Inst Trop Med, Res Grp Malaria 2, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	gilberger@bni-hamburg.de	Treeck, Moritz/Q-9078-2019; Cowman, Alan F/C-7642-2013; Treeck, Moritz/O-6662-2017; Treeck, Moritz/X-8007-2019	Treeck, Moritz/0000-0002-9727-6657; Cowman, Alan F/0000-0001-5145-9004; Treeck, Moritz/0000-0002-9727-6657; HERRMANN, SUSANN/0000-0002-4953-5685; Haase, Silvia/0000-0003-0870-3715; Gilberger, Tim-Wolf/0000-0002-7965-8272				Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; BANNISTER LH, 1995, ANN TROP MED PARASIT, V89, P105, DOI 10.1080/00034983.1995.11812940; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; BANTING G, 1995, TRENDS CELL BIOL, V5, P340, DOI 10.1016/S0962-8924(00)89060-1; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crabb BS, 2004, METH MOL B, V270, P263; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Deloche O, 2001, MOL BIOL CELL, V12, P475, DOI 10.1091/mbc.12.2.475; Di Cristina M, 2000, MOL CELL BIOL, V20, P7332, DOI 10.1128/MCB.20.19.7332-7341.2000; DOLAN SA, 1994, MOL BIOCHEM PARASIT, V64, P55, DOI 10.1016/0166-6851(94)90134-1; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Haldar Kasturi, 1993, Seminars in Cell Biology, V4, P345, DOI 10.1006/scel.1993.1041; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoppe HC, 2000, NAT CELL BIOL, V2, P449, DOI 10.1038/35017090; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; Humair D, 2001, PLANT CELL, V13, P781, DOI 10.1105/tpc.13.4.781; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Joiner KA, 2002, J CELL BIOL, V157, P557, DOI 10.1083/jcb.200112144; Karsten V, 1998, J CELL BIOL, V141, P1323, DOI 10.1083/jcb.141.6.1323; Karsten V, 2004, J BIOL CHEM, V279, P26052, DOI 10.1074/jbc.M400480200; Keller P, 1997, J CELL SCI, V110, P3001; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Margos G, 2004, PARASITOLOGY, V129, P273, DOI 10.1017/S0031182004005657; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mayer DCG, 2004, P NATL ACAD SCI USA, V101, P2518, DOI 10.1073/pnas.0307318101; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Meissner M, 2002, J CELL SCI, V115, P563; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Noe AR, 2000, MOL BIOCHEM PARASIT, V108, P169, DOI 10.1016/S0166-6851(00)00198-5; PETERSON DS, 1995, P NATL ACAD SCI USA, V92, P7100, DOI 10.1073/pnas.92.15.7100; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Przyborski JM, 2005, PARASITOLOGY, V130, P373, DOI 10.1017/S0031182004006729; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Robinson DG, 2005, TRAFFIC, V6, P615, DOI 10.1111/j.1600-0854.2005.00303.x; Sato K, 2003, MOL BIOL CELL, V14, P3055, DOI 10.1091/mbc.E03-02-0115; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Striepen B, 2001, MOL BIOCHEM PARASIT, V113, P45, DOI 10.1016/S0166-6851(00)00379-0; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Taraschi TF, 1998, EXP PARASITOL, V88, P184, DOI 10.1006/expr.1998.4254; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thiele C, 1997, CURR BIOL, V7, pR496, DOI 10.1016/S0960-9822(06)00247-8; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; VONHEIJNE G, 1988, BIOCHIM BIOPHYS ACTA, V947, P307, DOI 10.1016/0304-4157(88)90013-5; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	76	54	54	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31995	32003		10.1074/jbc.M606717200	http://dx.doi.org/10.1074/jbc.M606717200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16935855	Bronze			2022-12-27	WOS:000241235300085
J	Mattison, K; Wilbur, JS; So, M; Brennan, RG				Mattison, Kirsten; Wilbur, J. Scott; So, Magdalene; Brennan, Richard G.			Structure of FitAB from Neisseria gonorrhoeae bound to DNA reveals a tetramer of toxin-antitoxin heterodimers containing pin domains and ribbon-helix-helix motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ADENINE TRACT; RNA DECAY; INFECTION; ALIGNMENT; COMPLEX; SYSTEM; TOOL; RECOGNITION; DODECAMER	Neisseria gonorrhoeae is a sexually transmitted pathogen that initiates infections in humans by adhering to the mucosal epithelium of the urogenital tract. The bacterium then enters the apical region of the cell and traffics across the cell to exit into the subepithelial matrix. Mutations in the fast intracellular trafficking (fitAB) locus cause the bacteria to transit a polarized epithelial monolayer more quickly than the wild-type parent and to replicate within cells at an accelerated rate. Here, we describe the crystal structure of the toxin-antitoxin heterodimer, FitAB, bound to a high affinity 36-bp DNA fragment from the fitAB promoter. FitA, the antitoxin, binds DNA through its ribbon-helix-helix motif and is tethered to FitB, the toxin, to form a heterodimer by the insertion of a four turn alpha-helix into an extensive FitB hydrophobic pocket. FitB is composed of a PIN (PilT N terminus) domain, with a central, twisted, 5-stranded parallel beta-sheet that is open on one side and flanked by five alpha-helices. FitB in the context of the FitAB complex does not display nuclease activity against tested PIN substrates. The FitAB complex points to the mechanism by which antitoxins with RHH motifs can block the activity of toxins with PIN domains. Interactions between two FitB molecules result in the formation of a tetramer of FitAB heterodimers, which binds to the 36-bp DNA fragment and provides an explanation for how FitB enhances the DNA binding affinity of FitA.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Brennan, RG (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 100, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rgbrenna@mdanderson.org	So, Magdalene/ABB-8918-2020	So, Magdalene/0000-0001-8301-0674; Brennan, Richard/0000-0001-7647-485X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047260] Funding Source: NIH RePORTER; NIAID NIH HHS [AI47260] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXEEV DG, 1987, NATURE, V325, P821, DOI 10.1038/325821a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Apicella MA, 1996, J INFECT DIS, V173, P636, DOI 10.1093/infdis/173.3.636; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Brendler T, 2004, J BACTERIOL, V186, P2504, DOI 10.1128/JB.186.8.2504-2507.2004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGERING MJM, 1994, BIOCHEMISTRY-US, V33, P15036, DOI 10.1021/bi00254a012; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; DIGABRIELE AD, 1989, P NATL ACAD SCI USA, V86, P1816, DOI 10.1073/pnas.86.6.1816; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Edwards JL, 2004, CLIN MICROBIOL REV, V17, P965, DOI 10.1128/CMR.17.4.965-981.2004; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han GW, 1997, J MOL BIOL, V269, P811, DOI 10.1006/jmbi.1997.1085; Hanekamp T, 1997, FEBS LETT, V415, P40, DOI 10.1016/S0014-5793(97)01089-2; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOLMES KH, 1971, ANN INTERN MED, V74, P979, DOI 10.7326/0003-4819-74-6-979; Hopper S, 2000, INFECT IMMUN, V68, P896, DOI 10.1128/IAI.68.2.896-905.2000; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lan RT, 2003, INFECT IMMUN, V71, P6298, DOI 10.1128/IAI.71.11.6298-6306.2003; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; LEROY JL, 1988, BIOCHEMISTRY-US, V27, P8894, DOI 10.1021/bi00425a004; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Makarova KS, 1999, GENOME RES, V9, P608; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; PULLINGER GD, 1992, MOL MICROBIOL, V6, P1631, DOI 10.1111/j.1365-2958.1992.tb00888.x; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Watkins RE, 2003, BIOCHEMISTRY-US, V42, P1430, DOI 10.1021/bi0268753; Wilbur JS, 2005, BIOCHEMISTRY-US, V44, P12515, DOI 10.1021/bi0511080; Zhang YX, 2004, CELL RES, V14, P208, DOI 10.1038/sj.cr.7290221	48	106	109	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37942	37951		10.1074/jbc.M605198200	http://dx.doi.org/10.1074/jbc.M605198200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16982615	hybrid			2022-12-27	WOS:000242477100073
J	Panda, K; Haque, MM; Garcin-Hosfield, ED; Durra, D; Getzoff, ED; Stuehr, DJ				Panda, Koustubh; Haque, Mohammad Mahfuzul; Garcin-Hosfield, Elsa D.; Durra, Deborah; Getzoff, Elizabeth D.; Stuehr, Dennis J.			Surface charge interactions of the FMN module govern catalysis by nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NO COMPLEX-FORMATION; ELECTRON-TRANSFER; REDUCTASE DOMAIN; ACIDIC RESIDUES; HEME REDUCTION; CALMODULIN; NADPH; FLAVODOXIN; BINDING; CYTOCHROME-P450	The FMN module of nitric-oxide synthase (NOS) plays a pivotal role by transferring NADPH-derived electrons to the enzyme heme for use in oxygen activation. The process may involve a swinging mechanism in which the same face of the FMN module accepts and provides electrons during catalysis. Crystal structure shows that this face of the FMN module is electronegative, whereas the complementary interacting surface is electropositive, implying that charge interactions enable function. We used site-directed mutagenesis to investigate the roles of six electronegative surface residues of the FMN module in electron transfer and catalysis in neuronal NOS. Results are interpreted in light of crystal structures of NOS and related flavoproteins. Neutralizing or reversing the negative charge of each residue altered the NO synthesis, NADPH oxidase, and cytochrome c reductase activities of neuronal NOS and also altered heme reduction. The largest effects occurred at the NOS-specific charged residue Glu762. Together, the results suggest that electrostatic interactions of the FMN module help to regulate electron transfer and to minimize flavin autoxidation and the generation of reactive oxygen species during NOS catalysis.	Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA	Cleveland Clinic Foundation; Scripps Research Institute	Stuehr, DJ (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, NC22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Garcin, Elsa D/C-1556-2013; Panda, Koustubh/E-5273-2017	Garcin, Elsa D/0000-0003-0501-8421; HAQUE, MOHAMMAD/0000-0003-0852-6368; Panda, Koustubh/0000-0002-4783-2221	NCI NIH HHS [CA53914] Funding Source: Medline; NHLBI NIH HHS [HL58883, HL76491] Funding Source: Medline; NIGMS NIH HHS [GM51491] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Finn RD, 2003, EUR J BIOCHEM, V270, P1164, DOI 10.1046/j.1432-1033.2003.03474.x; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; GOVINDARAJ S, 1995, BIOCHEMISTRY-US, V34, P11221, DOI 10.1021/bi00035a031; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Hanley SC, 2004, BIOCHEM BIOPH RES CO, V325, P1418, DOI 10.1016/j.bbrc.2004.10.189; KLATT P, 1992, J BIOL CHEM, V267, P11374; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Munro AW, 1996, EUR J BIOCHEM, V239, P403, DOI 10.1111/j.1432-1033.1996.0403u.x; Newman E, 2004, J BIOL CHEM, V279, P33547, DOI 10.1074/jbc.M403892200; Nishida CR, 2001, J BIOL CHEM, V276, P20116, DOI 10.1074/jbc.M101548200; Olteanu H, 2004, BIOCHEMISTRY-US, V43, P1988, DOI 10.1021/bi035910i; Panda K, 2004, J BIOL CHEM, V279, P18323, DOI 10.1074/jbc.M310391200; Porasuphatana S, 2003, COMP BIOCHEM PHYS C, V134, P281, DOI 10.1016/S1532-0456(02)00271-5; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Schrammel A, 1998, BBA-PROTEIN STRUCT M, V1387, P257, DOI 10.1016/S0167-4838(98)00138-1; Sevrioukova I, 1996, BIOCHEMISTRY-US, V35, P7058, DOI 10.1021/bi960060a; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; Shimanuki T, 1999, J BIOL CHEM, V274, P26956, DOI 10.1074/jbc.274.38.26956; Sibille N, 2005, BIOCHEMISTRY-US, V44, P9086, DOI 10.1021/bi050437p; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Stuehr DJ, 2000, HANDB EXP PHARMACOL, V143, P33; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200	41	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36819	36827		10.1074/jbc.M606129200	http://dx.doi.org/10.1074/jbc.M606129200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	17001078	hybrid			2022-12-27	WOS:000242220800040
J	Mendiratta, SS; Sekulic, N; Hernandez-Guzman, FG; Close, BE; Lavie, A; Colley, KJ				Mendiratta, Shalu Shiv; Sekulic, Nikolina; Hernandez-Guzman, Francisco G.; Close, Brett E.; Lavie, Arnon; Colley, Karen J.			A novel alpha-helix in the first fibronectin type III repeat of the neural cell adhesion molecule is critical for N-glycan polysialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID; AMINO-ACIDS; RECOGNITION; POLYSIALYLTRANSFERASES; GLYCOPROTEIN; GROWTH; ACETYLGALACTOSAMINE; AUTOPOLYSIALYLATION; OLIGOSACCHARIDES; REFINEMENT	Polysialic acid is a developmentally regulated, anti-adhesive glycan that is added to the neural cell adhesion molecule, NCAM. Polysialylated NCAM is critical for brain development and plays roles in synaptic plasticity, axon guidance, and cell migration. The first fibronectin type III repeat of NCAM, FN1, is necessary for the polysialylation of N-glycans on the adjacent immunoglobulin domain. This repeat cannot be replaced by other fibronectin type III repeats. We solved the crystal structure of human NCAM FN1 and found that, in addition to a unique acidic surface patch, it possesses a novel alpha-helix that links strands 4 and 5 of its beta-sandwich structure. Replacement of the alpha-helix did not eliminate polysialyltransferase recognition, but shifted the addition of polysialic acid from the N-glycans modifying the adjacent immunoglobulin domain to O-glycans modifying FN1. Other experiments demonstrated that replacement of residues in the acidic surface patch alter the polysialylation of both N-and O-glycans in the same way, while the alpha-helix is only required for the polysialylation of N-glycans. Our data are consistent with a model in which the FN1 alpha-helix is involved in an Ig5-FN1 interaction that is critical for the correct positioning of Ig5N-glycans for polysialylation.	Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; Accelrys Inc, San Diego, CA 92121 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; BIOVIA	Colley, KJ (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu	Sekulic, Nikolina/N-5550-2016; Sekulic, Nikolina/F-8911-2013; Lavie, Arnon/H-4927-2012	Sekulic, Nikolina/0000-0001-7555-3222; Lavie, Arnon/0000-0001-5591-8722	NIGMS NIH HHS [R01 GM63843] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Durbec P, 2001, MOL NEUROBIOL, V24, P53; Gluer S, 1998, J PEDIATR SURG, V33, P1516, DOI 10.1016/S0022-3468(98)90488-2; Goridis C, 1992, Semin Cell Biol, V3, P189; Hildebrandt H, 1998, CANCER RES, V58, P779; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; MICHALIDES R, 1994, INT J CANCER, P34; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oldfield TJ, 2001, ACTA CRYSTALLOGR D, V57, P82, DOI 10.1107/S0907444900014098; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; Tanaka F, 2000, CANCER RES, V60, P3072; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Weinhold B, 2004, GLYCOBIOLOGY, V14, P1141; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	43	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36052	36059		10.1074/jbc.M608073200	http://dx.doi.org/10.1074/jbc.M608073200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17003032	hybrid			2022-12-27	WOS:000242100500054
J	Sai, JQ; Walker, G; Wikswo, J; Richmond, A				Sai, Jiqing; Walker, Glenn; Wikswo, John; Richmond, Ann			The IL sequence in the LLKIL motif in CXCR2 is required for full ligand-induced activation of Erk, Akt, and chemotaxis in HL60 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTORS CXCR1; FORMYL PEPTIDE RECEPTOR; BETA-ARRESTIN; POLYMORPHONUCLEAR LEUKOCYTES; CHEMOATTRACTANT RECEPTOR; INTERLEUKIN-8 RECEPTOR; NEUTROPHIL CHEMOTAXIS; TERMINAL DOMAIN; MAP-KINASE; INTERNALIZATION	The chemotaxis of differentiated HL60 cells stably expressing CXCR2 was examined in a microfluidic gradient device where the steepness of the CXCL8 chemokine gradient was varied from 2 pg/ml/mu m (0-1 ng/ml over a width of 500 mu m) to 50 pg/ml/mu m (0-25 ng/ml over 500 mu m). The differentiated HL60 cells stably expressing CXCR2 exhibited little chemotaxis in response to a 0-1 ng/ml gradient, but displayed an increasing chemotactic response as the gradient steepness increased from 0 to 5, 0 to 10, and 0 to 25 ng/ml, demonstrating that steepness of gradient is a major determinant of the relative ability of cells to persistently migrate up a chemotactic gradient. When HL60 cells expressed CXCR2 mutated in the C terminus LLKIL motif (IL to AA), ligand-induced internalization of receptors was reduced 50%, whereas cell migration along the gradient of CXCL8 was completely lost. Although both mutant and wildtype receptors could mediate Akt and Erk activation in response to CXCL8, the level of activation of these two kinases was much lower in the cell line expressing the mutant receptors. These data imply that the IL amino acid residues in the LLKIL motif are very important for activation of the signal transduction cascade, which is necessary for cells to sense the chemokine gradient and respond with chemotaxis. Moreover, because mutation of the IL residues in the LLKIL motif resulted in only 50% reduction in receptor internalization, and a 50% reduction in Akt and Erk phosphorylation, but a complete loss of chemotactic response, the data imply that IL amino acid residues in the LLKIL motif are key either for amplification or oscillation of crucial signaling events or for establishment of a threshold for signals required for chemotaxis.	Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Vet Affairs, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biomed Engn, Vanderbilt Inst Integrat Biosyst Res & Educ, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Richmond, A (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	NCI NIH HHS [R01 CA034590-21, U54 CA113007, CA68485, P30 CA068485, R01 CA034590-23, CA34590, R01 CA034590, P50 CA113007, R01 CA034590-22] Funding Source: Medline; BLRD VA [IK6 BX005225] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA113007, R23CA034590, P30CA068485, R01CA034590] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BLRD VA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; BEHAR TN, 1994, J NEUROSCI, V14, P29; BHALLA K, 1985, CANCER RES, V45, P3657; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Cooper CR, 2003, CANCER-AM CANCER SOC, V97, P739, DOI 10.1002/cncr.11181; Cross AK, 1997, CYTOKINE, V9, P521, DOI 10.1006/cyto.1996.0196; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fernandis AZ, 2002, J BIOL CHEM, V277, P18111, DOI 10.1074/jbc.M200750200; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Fuhler GM, 2005, J LEUKOCYTE BIOL, V77, P257, DOI 10.1189/jlb.0504306; Fujita T, 2005, CELL SIGNAL, V17, P167, DOI 10.1016/j.cellsig.2004.06.008; GALLAGHER RE, 1985, LEUKEMIA RES, V9, P967, DOI 10.1016/0145-2126(85)90067-0; GRIMES GJ, 1973, EXP CELL RES, V79, P375, DOI 10.1016/0014-4827(73)90457-6; HARRIS H, 1954, PHYSIOL REV, V34, P529, DOI 10.1152/physrev.1954.34.3.529; HERSH EM, 1970, ANNU REV MED, V21, P105, DOI 10.1146/annurev.me.21.020170.000541; Hsu MH, 1997, J BIOL CHEM, V272, P29426, DOI 10.1074/jbc.272.47.29426; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; JONES SA, 1995, FEBS LETT, V364, P211, DOI 10.1016/0014-5793(95)00397-R; Kim JY, 1997, J BIOL CHEM, V272, P27313, DOI 10.1074/jbc.272.43.27313; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; PEREZ HD, 1989, J CLIN INVEST, V83, P1963, DOI 10.1172/JCI114105; RAMSEY WS, 1974, EXP CELL RES, V86, P184, DOI 10.1016/0014-4827(74)90669-7; Richardson RM, 2003, J IMMUNOL, V170, P2904, DOI 10.4049/jimmunol.170.6.2904; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; Roland J, 2003, BLOOD, V101, P399, DOI 10.1182/blood-2002-03-0978; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Sai JQ, 2004, J CELL SCI, V117, P5489, DOI 10.1242/jcs.01398; SAMANTA AK, 1990, J BIOL CHEM, V265, P183; Sambrano GR, 1999, J BIOL CHEM, V274, P20178, DOI 10.1074/jbc.274.29.20178; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Su YJ, 2005, J IMMUNOL, V175, P5396, DOI 10.4049/jimmunol.175.8.5396; VANLINT J, 1993, MOL CELL BIOCHEM, V128, P171, DOI 10.1007/BF01076768; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	49	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35931	35941		10.1074/jbc.M605883200	http://dx.doi.org/10.1074/jbc.M605883200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16990258	hybrid, Green Accepted			2022-12-27	WOS:000242100500040
J	Carter, DM; Miousse, IR; Gagnon, JN; Martinez, E; Clements, A; Lee, J; Hancock, MA; Gagnon, H; Pawelek, PD; Coulton, JW				Carter, David M.; Miousse, Isabelle R.; Gagnon, Jean-Nicolas; Martinez, Eric; Clements, Abigail; Lee, Jongchan; Hancock, Mark A.; Gagnon, Hubert; Pawelek, Peter D.; Coulton, James W.			Interactions between TonB from Escherichia coli and the periplasmic protein FhuD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE RECEPTOR; IRON(III) HYDROXAMATE TRANSPORT; C-TERMINAL DOMAIN; BINDING-PROTEIN; CRYSTAL-STRUCTURE; REVEALS; COMPLEX; ULTRACENTRIFUGATION; SIDEROPHORES; SYSTEM	For uptake of ferrichrome into bacterial cells, FhuA, a TonB-dependent outer membrane receptor of Escherichia coli, is required. The periplasmic protein FhuD binds and transfers ferrichrome to the cytoplasmic membrane-associated permease FhuB/C. We exploited phage display to map protein-protein interactions in the E. coli cell envelope that contribute to ferrichrome transport. By panning random phage libraries against TonB and against FhuD, we identified interaction surfaces on each of these two proteins. Their interactions were detected in vitro by dynamic light scattering and indicated a 1: 1 TonB-FhuD complex. FhuD residue Thr-181, located within the siderophore-binding site and mapping to a predicted TonB-interaction surface, was mutated to cysteine. FhuD T181C was reacted with two thiol-specific fluorescent probes; addition of the siderophore ferricrocin quenched fluorescence emissions of these conjugates. Similarly, quenching of fluorescence from both probes confirmed binding of TonB and established an apparent K-D of similar to 300 nM. Prior saturation of the siderophore-binding site of FhuD with ferricrocin did not alter affinity of TonB for FhuD. Binding, further characterized with surface plasmon resonance, indicated a higher affinity complex with KD values in the low nanomolar range. Addition of FhuD to a preformed TonB-FhuA complex resulted in formation of a ternary complex. These observations led us to propose a novel mechanism in which TonB acts as a scaffold, directing FhuD to regions within the periplasm where it is poised to accept and deliver siderophore.	McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; McGill Univ, Sheldon Biotechnol Ctr, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Coulton, JW (corresponding author), McGill Univ, Dept Microbiol & Immunol, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.	james.coulton@mcgill.ca	Pawelek, Peter/E-7950-2014; Martinez, Eric/ABA-1229-2020; Miousse, Isabelle R./K-3512-2013	Pawelek, Peter/0000-0002-8361-6593; Martinez, Eric/0000-0001-8568-3725; Miousse, Isabelle R./0000-0001-6543-3219; Carter, David Miles/0000-0002-2517-8599; Clements, Abigail/0000-0003-2285-777X				Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Carter DM, 2006, J MOL BIOL, V357, P236, DOI 10.1016/j.jmb.2005.12.039; Chang CS, 2001, J BIOL CHEM, V276, P27535, DOI 10.1074/jbc.M102778200; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Khursigara CM, 2005, PROTEIN SCI, V14, P1266, DOI 10.1110/ps.051342505; Khursigara CM, 2005, BIOCHEMISTRY-US, V44, P3441, DOI 10.1021/bi047882p; Khursigara CM, 2004, J BIOL CHEM, V279, P7405, DOI 10.1074/jbc.M311784200; Kodding J, 2005, J BIOL CHEM, V280, P3022, DOI 10.1074/jbc.M411155200; KOSTER W, 1990, J BIOL CHEM, V265, P21407; Krewulak KD, 2004, IRON TRANSPORT IN BACTERIA, P113; Krewulak KD, 2005, BIOMETALS, V18, P375, DOI 10.1007/s10534-005-3712-z; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P14720, DOI 10.1021/bi002207a; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Mademidis A, 1997, MOL MICROBIOL, V26, P1109, DOI 10.1046/j.1365-2958.1997.6592008.x; Mader C, 2004, J BACTERIOL, V186, P1758, DOI 10.1128/JB.186.6.1758-1768.2004; Mandava S, 2004, PROTEOMICS, V4, P1439, DOI 10.1002/pmic.200300680; Moeck GS, 2001, J BACTERIOL, V183, P2755, DOI 10.1128/JB.183.9.2755-2764.2001; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nakajima H, 2005, BIOCHEM BIOPH RES CO, V328, P1091, DOI 10.1016/j.bbrc.2005.01.056; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Peacock RS, 2006, BIOMETALS, V19, P127, DOI 10.1007/s10534-005-5420-0; Peacock RS, 2005, J MOL BIOL, V345, P1185, DOI 10.1016/j.jmb.2004.11.026; ROHRBACH MR, 1995, J BACTERIOL, V177, P7186, DOI 10.1128/jb.177.24.7186-7193.1995; ROHRBACH MR, 1995, MOL GEN GENET, V248, P33, DOI 10.1007/BF02456611; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHULTZHAUSER G, 1992, J BACTERIOL, V174, P2305, DOI 10.1128/JB.174.7.2305-2311.1992; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Yang YR, 1996, BIOPHYS CHEM, V59, P289, DOI 10.1016/0301-4622(96)00018-X	37	39	40	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35413	35424		10.1074/jbc.M607611200	http://dx.doi.org/10.1074/jbc.M607611200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16928679	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000241933700075
J	Kodama, Y; Sano, H				Kodama, Yutaka; Sano, Hiroshi			Evolution of a basic helix-loop-helix protein from a transcriptional repressor to a plastid-resident regulatory factor - Involvement in hypersensitive cell death in tobacco plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOSAIC-VIRUS; DNA-BINDING; CHLOROPHYLL DEGRADATION; METHYL JASMONATE; SUBCELLULAR-LOCALIZATION; NEGATIVE REGULATOR; ENVELOPE MEMBRANE; CYSTEINE SYNTHASE; MOLECULAR-CLONING; FACTOR FAMILY	The tobacco gene NtWIN4 (Nicotiana tabacum wound-induced clone 4) is transiently up-regulated in response not only to wounding but also to pathogen attack. NtWIN4 encodes a putative basic helix-loop-helix protein with an apparent molecular mass of 28 kDa that exhibited clear nuclear transcription repression activity in Dual-Luciferase assays. However, immunoblotting indicated the existence of a 17-kDa form of NtWIN4 localized exclusively in tobacco leaf chloroplasts. Subsequent peptide dissection analyses with green fluorescent protein fusions revealed that a polypeptide of 81 amino acids starting at position 13 from the N terminus is maximally necessary for this localization. Further fine dissection analysis strongly suggested that the protein actually begins at the second Met located at position 27, yielding a signal peptide of 67 amino acids. However, the last C-terminal 15 amino acids overlap with the conserved basic region critical for DNA binding, so NtWIN4 presumably does not function as a transcription factor in planta. Transgenic tobacco plants constitutively over-expressing NtWIN4 demonstrated mortality with abnormal features, including albinism, and transient expression upon agroinfiltration resulted in distinct necrosis with a sharp decrease in chlorophyll content, consistent with the phenomenon known as chlorosis. Transgenic RNA interference tobacco plants exhibited reduced hypersensitive cell death, showing delayed tissue necrosis upon pathogen infection. These results suggest that NtWIN4 arose by divergence, becoming a chloroplast-resident factor from a nuclear transcriptional repressor by obtaining a transit peptide sequence, and that, upon translocation, it interacts with chloroplast components to induce hypersensitive cell death through chloroplast disruption, thereby contributing to plant stress responses.	Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan	Nara Institute of Science & Technology	Sano, H (corresponding author), Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan.	sano@gtc.naist.jp						Arkus KAJ, 2005, ARCH BIOCHEM BIOPHYS, V438, P146, DOI 10.1016/j.abb.2005.04.019; Benedetti CE, 1998, PLANT PHYSIOL, V116, P1037, DOI 10.1104/pp.116.3.1037; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Benkova E, 1999, PLANT PHYSIOL, V121, P245, DOI 10.1104/pp.121.1.245; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; CORBIN DR, 1987, MOL CELL BIOL, V7, P4337, DOI 10.1128/MCB.7.12.4337; Culver JN, 2002, ANNU REV PHYTOPATHOL, V40, P287, DOI 10.1146/annurev.phyto.40.120301.102400; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fan L, 1999, PLANT PHYSIOL, V119, P1371, DOI 10.1104/pp.119.4.1371; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; GARRELL J, 1991, BIOESSAYS, V13, P493, DOI 10.1002/bies.950131002; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; GIANINAZZI S, 1970, CR ACAD SCI D NAT, V270, P2383; GILBERTOGONZALEZ R, 1980, BIOCHEMISTRY-US, V19, P4299, DOI 10.1021/bi00559a023; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Hara K, 2000, PLANT CELL PHYSIOL, V41, P684, DOI 10.1093/pcp/41.6.684; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; HENDRY GAF, 1987, NEW PHYTOL, V107, P255, DOI 10.1111/j.1469-8137.1987.tb00181.x; HESSE H, 1995, PLANT PHYSIOL, V108, P851, DOI 10.1104/pp.108.2.851; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Jacob-Wilk D, 1999, PLANT J, V20, P653, DOI 10.1046/j.1365-313X.1999.00637.x; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Monosov EZ, 1996, J HISTOCHEM CYTOCHEM, V44, P581, DOI 10.1177/44.6.8666743; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NAGATA T, 1981, MOL GEN GENET, V184, P161, DOI 10.1007/BF00272899; Nakamura T, 2000, EUR J BIOCHEM, V267, P5621, DOI 10.1046/j.1432-1327.2000.01633.x; Nakano T, 1997, PLANT CELL, V9, P1673, DOI 10.1105/tpc.9.9.1673; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; Quail PH, 2000, SEMIN CELL DEV BIOL, V11, P457, DOI 10.1006/scdb.2000.0199; Sato N, 2001, NUCLEIC ACIDS RES, V29, P2244, DOI 10.1093/nar/29.11.2244; Sato N, 2001, TRENDS PLANT SCI, V6, P151, DOI 10.1016/S1360-1385(01)01888-X; Sato N, 1998, PLANT CELL, V10, P859, DOI 10.1105/tpc.10.5.859; SATO N, 1993, EMBO J, V12, P555, DOI 10.1002/j.1460-2075.1993.tb05687.x; SATO N, 1995, PHOTOSYNTHESIS LIGHT, V3, P635; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Seo S, 2000, PLANT CELL, V12, P917, DOI 10.1105/tpc.12.6.917; Sugimoto M, 2004, PLANT MOL BIOL, V56, P973, DOI 10.1007/s11103-004-6459-y; Takamiya K, 2000, TRENDS PLANT SCI, V5, P426, DOI 10.1016/S1360-1385(00)01735-0; Tamura T, 2003, PLANT PHYSIOL, V131, P454, DOI 10.1104/pp.102.011007; Tang L, 2004, Z NATURFORSCH C, V59, P415; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tsuchiya T, 1999, P NATL ACAD SCI USA, V96, P15362, DOI 10.1073/pnas.96.26.15362; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; Uefuji H, 2005, PLANT MOL BIOL, V59, P221, DOI 10.1007/s11103-005-8520-x; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; Wada Y, 2003, J BIOL CHEM, V278, P42386, DOI 10.1074/jbc.M303892200; Waller F, 2006, PLANT CELL PHYSIOL, V47, P1169, DOI 10.1093/pcp/pcj079; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yamaguchi Y, 2000, PLANT CELL PHYSIOL, V41, P465, DOI 10.1093/pcp/41.4.465; Yamamoto YY, 1998, PLANT BIOTECHNOL-NAR, V15, P217; Yasuno R, 1998, PLANT PHYSIOL, V118, P935, DOI 10.1104/pp.118.3.935; Yoda H, 2002, MOL GENET GENOMICS, V267, P154, DOI 10.1007/s00438-002-0651-z	65	15	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35369	35380		10.1074/jbc.M604140200	http://dx.doi.org/10.1074/jbc.M604140200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16966334	hybrid			2022-12-27	WOS:000241933700071
J	Zehelein, J; Kathoefer, S; Khalil, M; Alter, M; Thomas, D; Brockmeier, K; Ulmer, HE; Katus, HA; Koenen, M				Zehelein, Joerg; Kathoefer, Sven; Khalil, Markus; Alter, Markus; Thomas, Dierk; Brockmeier, Konrad; Ulmer, Herbert E.; Katus, Hugo A.; Koenen, Michael			Skipping of exon 1 in the KCNQ1 gene causes Jervell and Lange-Nielsen syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; INHERITED CARDIAC-ARRHYTHMIAS; POTASSIUM CHANNEL GENE; ROMANO-WARD-SYNDROME; CARDIOAUDITORY SYNDROME; MOLECULAR-BASIS; MUTATIONS; KVLQT1; HERG; ISK	The Jervell and Lange-Nielsen syndrome (JLNS) is a rare autosomal recessive form of the long QT syndrome linked with a profound hearing loss caused by mutations affecting both alleles of either the KCNQ1 or the KCNE1 gene. We carried out a mutant screening of the KCNQ1 and KCNE1 genes in a clinical diagnosed German family with JLNS. Family members were examined by single strand conformation polymorphism analysis and PCR and amplified products were characterized by DNA sequence analysis. We identified a splice donor mutation of exon 1 in the KCNQ1 gene (G477 + 1A). Analysis of lymphocyte RNA by RT-PCR revealed that two symptomatic patients, homozygous for the mutant allele, exclusively produce KCNQ1 transcripts lacking exon 1 leading to a frameshift that introduced a premature termination codon at exon 4. Mutant subunits, functionally characterized in Xenpous oocytes, were unable to form homomeric channels but strongly reduced I-Ks (slowly activating delayed rectifier potassium current) in vitro (mutant isoforms 1 and 2 by 62 and 86%, respectively), a fact supposed to lead to severely affected heterozygous individuals. However, individuals heterozygous for the mutant allele exhibit an asymptomatic cardiac phenotype. Thus, the observed dominant-negative effect of mutant subunits in vitro is absent in vivo leaving heterozygous individuals unaffected. These data suggest mechanisms that prevent production of truncated KCNQ1 channel subunits in cardiomyocytes of individuals heterozygous for the mutant allele.	Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany; Univ Klinikum Heidelberg, Innere Med 3, D-69120 Heidelberg, Germany; Univ Klinikum Heidelberg, Kinderheilkunde 2, D-69120 Heidelberg, Germany; Klinikum Univ Koln, Abt Kinderkardiol, D-50931 Cologne, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Cologne	Koenen, M (corresponding author), Max Planck Inst Med Res, Zellphysiol Abt, Jahnstr 29, D-69120 Heidelberg, Germany.	koenen@mpimf-heidelberg.mpg.de	Thomas, Dierk/ABA-4706-2021; Thomas, Dierk/V-3940-2017; Khalil, Markus/AFS-7292-2022	Thomas, Dierk/0000-0002-5687-7843; Khalil, Markus/0000-0001-8897-7200				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Ackerman MJ, 2004, NAT MED, V10, P463, DOI 10.1038/nm0504-463; Ackerman MJ, 1999, MAYO CLIN PROC, V74, P1088, DOI 10.4065/74.11.1088; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Huang LQ, 2001, CARDIOVASC RES, V51, P670, DOI 10.1016/S0008-6363(01)00350-9; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; Mohammad-Panah R, 1999, AM J HUM GENET, V64, P1015, DOI 10.1086/302346; Neuhaus EM, 1998, J STRUCT BIOL, V121, P326, DOI 10.1006/jsbi.1998.3971; Neyroud N, 1999, CIRC RES, V84, P290, DOI 10.1161/01.RES.84.3.290; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Schwartz PJ, 2006, CIRCULATION, V113, P783, DOI 10.1161/CIRCULATIONAHA.105.592899; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Splawski I, 1998, GENOMICS, V51, P86, DOI 10.1006/geno.1998.5361; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Thomas D, 2005, CARDIOVASC RES, V67, P487, DOI 10.1016/j.cardiores.2005.05.003; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Tyson J, 2000, HUM GENET, V107, P499, DOI 10.1007/s004390000402; Van Langen IM, 2003, J MED GENET, V40, P141, DOI 10.1136/jmg.40.2.141; Wagner E, 2002, J CELL SCI, V115, P3033; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang ZQ, 2002, MOL GENET METAB, V75, P308, DOI 10.1016/S1096-7192(02)00007-0; Zehelein J, 2004, BBA-MOL BASIS DIS, V1690, P185, DOI 10.1016/j.bbadis.2004.06.024	31	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35397	35403		10.1074/jbc.M603433200	http://dx.doi.org/10.1074/jbc.M603433200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16987820	hybrid, Green Published			2022-12-27	WOS:000241933700073
J	Felton-Edkins, ZA; Kondrashov, A; Karali, D; Fairley, JA; Dawson, CW; Arrand, JR; Young, LS; White, RJ				Felton-Edkins, Zoe A.; Kondrashov, Alexander; Karali, Dimitra; Fairley, Jennifer A.; Dawson, Christopher W.; Arrand, John R.; Young, Lawrence S.; White, Robert J.			Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN 1; ENCODED SMALL RNAS; BURKITTS-LYMPHOMA; NASOPHARYNGEAL CARCINOMA; DIFFERENTIAL REGULATION; UPSTREAM SEQUENCES; LINE AKATA; IN-VITRO; CELLS; ACTIVATION	The EBER genes of Epstein-Barr virus (EBV) are transcribed by RNA polymerase (pol) III to produce untranslated RNAs that are implicated in oncogenesis. These EBER transcripts are the most highly expressed viral gene products in EBV-transformed cells. We have identified changes to the cellular transcription machinery that may contribute to the high levels of EBER RNA. These include phosphorylation of ATF2, which interacts with EBER promoters. A second is induction of TFIIIC, a pol III-specific factor that activates EBER genes; all five subunits of TFIIIC are overexpressed in EBV-positive cells. In addition, EBV induces BDP1, a subunit of the pol III-specific factor TFIIIB. Although BDP1 is the only TFIIIB subunit induced by EBV, its induction is sufficient to stimulate EBER expression in vivo, implying a limiting function. The elevated levels of BDP1 and TFIIIC in EBV-positive cells stimulate production of tRNA, 7SL, and 5S rRNA. Abnormally high expression of these cellular pol III products may contribute to the ability of EBV to enhance growth potential.	Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Birmingham, Sch Med, Canc Res UK, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Glasgow; Cancer Research UK; University of Birmingham; Beatson Institute	White, RJ (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	rwhite@udcf.gla.ac.uk	Young, Lawrence S/B-7213-2009	Young, Lawrence S/0000-0003-3919-4298; Kondrashov, Alexander/0000-0003-3428-5975				Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; ARRAND JR, 1982, J VIROL, V41, P376, DOI 10.1128/JVI.41.2.376-389.1982; ARRAND JR, 1989, J VIROL, V63, P983, DOI 10.1128/JVI.63.2.983-986.1989; ARRAND JR, 2000, EBV REP, V7, P145; Cairns CA, 1998, EMBO J, V17, P3112, DOI 10.1093/emboj/17.11.3112; Daly NL, 2005, ONCOGENE, V24, P880, DOI 10.1038/sj.onc.1208031; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eliopoulos AG, 1998, ONCOGENE, V16, P1731, DOI 10.1038/sj.onc.1201694; Felton-Edkins ZA, 2003, EMBO J, V22, P2422, DOI 10.1093/emboj/cdg240; Felton-Edkins ZA, 2002, J BIOL CHEM, V277, P48182, DOI 10.1074/jbc.M201333200; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Greifenegger N, 1998, J VIROL, V72, P9323, DOI 10.1128/JVI.72.11.9323-9328.1998; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOWE JG, 1989, CELL, V57, P825, DOI 10.1016/0092-8674(89)90797-6; HOWE JG, 1993, MOL CELL BIOL, V13, P2655, DOI 10.1128/MCB.13.5.2655; Innes F, 2006, NUCLEIC ACIDS RES, V34, P3399, DOI 10.1093/nar/gkl432; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; KHAN G, 1992, J CLIN PATHOL, V45, P616, DOI 10.1136/jcp.45.7.616; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; KLEINERT H, 1988, J BIOL CHEM, V263, P11511; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; Laing KG, 2002, VIROLOGY, V297, P253, DOI 10.1006/viro.2002.1354; LAING KG, 1995, BIOCH SOC T S, V23, P311; Larminie CGC, 1999, MOL CELL BIOL, V19, P4927; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Muller J, 1999, BIOCHEM CELL BIOL, V77, P431, DOI 10.1139/bcb-77-5-431; Murray PG, 1996, J PATHOL, V178, P44, DOI 10.1002/(SICI)1096-9896(199601)178:1<44::AID-PATH471>3.0.CO;2-0; NILLER HH, 2003, MED SCI MONITOR, V9, P1; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; ROONEY C, 1989, J VIROL, V63, P1531, DOI 10.1128/JVI.63.4.1531-1539.1989; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Ruf IK, 2000, J VIROL, V74, P10223, DOI 10.1128/JVI.74.21.10223-10228.2000; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Scott PH, 2001, J BIOL CHEM, V276, P1005, DOI 10.1074/jbc.M005417200; Sethy-Coraci I, 1998, NUCLEIC ACIDS RES, V26, P2344, DOI 10.1093/nar/26.10.2344; Shen YH, 1996, MOL CELL BIOL, V16, P4163; SHIMIZU N, 1994, J VIROL, V68, P6069, DOI 10.1128/JVI.68.9.6069-6073.1994; Sriuranpong V, 2004, CLIN CANCER RES, V10, P4944, DOI 10.1158/1078-0432.CCR-03-0757; Sutcliffe JE, 2000, MOL CELL BIOL, V20, P9192, DOI 10.1128/MCB.20.24.9192-9202.2000; SWAMINATHAN S, 1991, P NATL ACAD SCI USA, V88, P1546, DOI 10.1073/pnas.88.4.1546; TAKIMOTO T, 1984, J NATL CANCER I, V73, P711; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wensing B, 2001, J VIROL, V75, P6235, DOI 10.1128/JVI.75.13.6235-6241.2001; WHITE RJ, 1989, CELL, V59, P1081, DOI 10.1016/0092-8674(89)90764-2; WHITE RJ, 1995, MOL CELL BIOL, V15, P6653; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; WHITE RJ, 1995, MOL CELL BIOL, V15, P1983; WHITE RJ, 2002, LANDES BIOSCIENCE; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yamamoto N, 2000, FEBS LETT, V484, P153, DOI 10.1016/S0014-5793(00)02145-1; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; ZEUTHEN J, 1983, J CANCER RES CLIN, V106, P1, DOI 10.1007/BF00399890; ZEUTHEN J, 1983, ADV VIRAL ONCOL, V3, P183	59	38	40	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33871	33880		10.1074/jbc.M600468200	http://dx.doi.org/10.1074/jbc.M600468200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16956891	hybrid			2022-12-27	WOS:000241767600008
J	Tahiri-Alaoui, A; Sim, VL; Caughey, B; James, W				Tahiri-Alaoui, Abdessamad; Sim, Valerie L.; Caughey, Byron; James, William			Molecular heterosis of prion protein beta-oligomers - A potential mechanism of human resistance to disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; SOLUBLE OLIGOMERS; IN-VITRO; RECOMBINANT; POLYMORPHISM; CONVERSION; GENE; PRP; STABILITY; SUSCEPTIBILITY	The gene encoding prion protein is polymorphic in human populations, with over 40% of native Europeans, for example, being heterozygous for the Met-129 and Val-129 alleles. The polymorphism affects both the incidence and the clinical presentation of a range of prion diseases, with heterozygotes generally showing the highest levels of resistance. It has been suggested that an earlier epidemic of prion diseases exerted balancing selection on the two alleles, and we have previously demonstrated that the two encoded proteins have potentially compensating tendencies to form amyloid and soluble beta-oligomers, respectively, in vitro. More strikingly, here we demonstrate that mixed oligomers, composed of both allelic forms, show an extreme sluggishness in converting to amyloid in comparison with oligomers homogenous for either allele. It may be that this example of molecular heterosis in vitro provides the basis for maintenance of the polymorphism in the population and that beta-oligomers represent a form of PrP sequestered from pathogenic amyloid formation in vivo.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; NIAID, Rocky Mt Lab, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	James, W (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Pk Rd, Oxford OX1 3RE, England.	abdou.tahiri-alaoui@bbsrc.ac.uk; William.james@path.ox.ac.uk	james, william/H-4289-2013; Sim, Valerie/C-4137-2013	james, william/0000-0002-2506-1198; Sim, Valerie/0000-0002-0088-8666	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580, Z01AI000580] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Baskakov I, 2005, FEBS LETT, V579, P2589, DOI 10.1016/j.febslet.2005.03.075; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; BROWN P, 1994, NEUROLOGY, V44, P291, DOI 10.1212/WNL.44.2.291; Calzolai L, 2003, J BIOL CHEM, V278, P35592, DOI 10.1074/jbc.M303005200; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Kovacs GG, 2000, NEUROPATH APPL NEURO, V26, P463, DOI 10.1046/j.1365-2990.2000.00279.x; LAPLANCHE JL, 1994, NEUROLOGY, V44, P2347, DOI 10.1212/WNL.44.12.2347; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lu BY, 2001, BIOCHEMISTRY-US, V40, P13390, DOI 10.1021/bi011111t; MacDonald ST, 1996, NEUROPATH APPL NEURO, V22, P285, DOI 10.1111/j.1365-2990.1996.tb01106.x; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mitrova E, 2005, EUR J NEUROL, V12, P998, DOI 10.1111/j.1468-1331.2005.01110.x; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; NOVITSKAYA V, 2006, J BIOL CHEM; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OWEN F, 1990, AM J HUM GENET, V46, P1215; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; POULTER M, 1992, BRAIN, V115, P675, DOI 10.1093/brain/115.3.675; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; SAFAR J, 1994, BIOCHEMISTRY-US, V33, P8375, DOI 10.1021/bi00193a027; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Soldevila M, 2005, TRENDS GENET, V21, P389, DOI 10.1016/j.tig.2005.05.001; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Tahiri-Alaoui A, 2005, PROTEIN SCI, V14, P942, DOI 10.1110/ps.041000905; Tahiri-Alaoui A, 2004, J BIOL CHEM, V279, P31390, DOI 10.1074/jbc.M401754200; Tattum MH, 2006, J MOL BIOL, V357, P975, DOI 10.1016/j.jmb.2006.01.052; Vendrely C, 2005, BBA-GEN SUBJECTS, V1724, P355, DOI 10.1016/j.bbagen.2005.05.017; Welker E, 2002, J BIOL CHEM, V277, P33477, DOI 10.1074/jbc.M204273200	41	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34171	34178		10.1074/jbc.M606606200	http://dx.doi.org/10.1074/jbc.M606606200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16980300	hybrid			2022-12-27	WOS:000241767600037
J	Bao, LP; Li, YK; Deng, SX; Landry, D; Tabas, I				Bao, Liping; Li, Yankun; Deng, Shi-Xian; Landry, Donald; Tabas, Ira			Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; ACYL-COENZYME-A; CHOLESTEROL ACYLTRANSFERASE ACAT; HUMAN ATHEROSCLEROTIC LESIONS; ACTIVATED PROTEIN-KINASES; LOW-DENSITY-LIPOPROTEIN; SERUM PLANT STEROLS; CELL-DEATH; INFLAMMATORY RESPONSE; ENDOPLASMIC-RETICULUM	Sitosterolemia is a disease characterized by very high levels of sitosterol and other plant sterols and premature atherothrombotic vascular disease. One theory holds that plant sterols can directly promote atherosclerosis, but the mechanism is not known. Unesterified, or "free," cholesterol (FC) is a potent inducer of macrophage death, which causes plaque necrosis, a precursor to atherothrombosis. FC-induced macrophage death, however, requires dysfunction of the sterol esterifying enzyme acyl-coenzyme A-cholesterol acyltransferase (ACAT), which likely occurs slowly during lesion progression. In contrast, plant sterols are relatively poorly esterified by ACAT, and so they may cause macrophage death and plaque necrosis in an accelerated manner. In support of this hypothesis, we show here that macrophages incubated with sitosterol-containing lipoproteins accumulate free sterols and undergo death in the absence of an ACAT inhibitor. As with FC loading, sitosterol-induced macrophage death requires sterol trafficking to the endoplasmic reticulum, and sitosterol-enriched endoplasmic reticulum membranes show evidence of membrane protein dysfunction. However, whereas FC induces caspase-dependent apoptosis through activation of the unfolded protein response and JNK, sitosterol-induced death is caspase-independent and involves neither the unfolded protein response nor JNK. Rather, cell death shows signs of necroptosis and autophagy and is suppressed by inhibitors of both processes. These data establish two new concepts. First, a relatively subtle change in sterol structure fundamentally alters the type of death program triggered in macrophages. Understanding the basis of this alteration should provide new insights into the molecular basis of death pathway signaling. Second, sitosterol-induced macrophage death does not require ACAT dysfunction and so may occur in an accelerated fashion. Pending future in vivo studies, this concept may provide at least one mechanism for accelerated plaque necrosis and atherothrombotic disease in patients with sitosterolemia.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Tabas, I (corresponding author), Columbia Univ, Dept Med, 630 W 168th St, New York, NY 10032 USA.	iat1@columbia.edu			NHLBI NIH HHS [HL081181, HL75662] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, R01HL081181] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aikawa M, 2004, CARDIOVASC PATHOL, V13, P125, DOI 10.1016/S1054-8807(04)00004-3; Araki T, 2006, CELL BIOL INT, V30, P93, DOI 10.1016/j.cellbi.2005.10.020; Assmann G, 2006, NUTR METAB CARDIOVAS, V16, P13, DOI 10.1016/j.numecd.2005.04.001; Awad AB, 2000, J NUTR, V130, P2127, DOI 10.1093/jn/130.9.2127; Awad AB, 2004, PROSTAG LEUKOTR ESS, V70, P511, DOI 10.1016/j.plefa.2003.11.005; Awad AB, 2003, ONCOL REP, V10, P497; BALL RY, 1995, ATHEROSCLEROSIS, V114, P45, DOI 10.1016/0021-9150(94)05463-S; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; BOBERG KM, 1991, SCAND J CLIN LAB INV, V51, P509, DOI 10.3109/00365519109104559; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Burke AP, 2003, J AM COLL CARDIOL, V41, p240A; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Cook AD, 2003, J IMMUNOL, V171, P4816, DOI 10.4049/jimmunol.171.9.4816; Darzynkiewicz Z, 1998, Hum Cell, V11, P3; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Feng B, 2003, P NATL ACAD SCI USA, V100, P10423, DOI 10.1073/pnas.1732494100; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; FIELD FJ, 1983, J LIPID RES, V24, P409; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GLUECK CJ, 1991, METABOLISM, V40, P842, DOI 10.1016/0026-0495(91)90013-M; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Halling KK, 2004, BBA-BIOMEMBRANES, V1664, P161, DOI 10.1016/j.bbamem.2004.05.006; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hegyi L, 1996, J PATHOL, V180, P423, DOI 10.1002/(SICI)1096-9896(199612)180:4<423::AID-PATH677>3.0.CO;2-1; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katayama S, 2003, INTERNAL MED, V42, P591, DOI 10.2169/internalmedicine.42.591; KATZ S S, 1976, Journal of Clinical Investigation, V58, P200; Kellner-Weibel G, 1998, ARTERIOSCL THROM VAS, V18, P423, DOI 10.1161/01.ATV.18.3.423; Klett EL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-5; Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798; Kolovou G, 1996, EUR HEART J, V17, P965; KRIEGER M, 1986, METHOD ENZYMOL, V128, P608; KRUTH HS, 1984, EXP MOL PATHOL, V40, P288, DOI 10.1016/0014-4800(84)90046-7; KWITEROVICH PO, 1981, LANCET, V1, P466; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LEIKIN AI, 1989, BIOCHIM BIOPHYS ACTA, V1005, P187, DOI 10.1016/0005-2760(89)90186-0; Li YK, 2006, J BIOL CHEM, V281, P6707, DOI 10.1074/jbc.M510579200; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Libby Peter, 1993, Current Opinion in Lipidology, V4, P355, DOI 10.1097/00041433-199310000-00003; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MAJNO G, 1995, AM J PATHOL, V146, P3; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; McConkey DJ, 1998, TOXICOL LETT, V99, P157, DOI 10.1016/S0378-4274(98)00155-6; MELLIES MJ, 1976, J LAB CLIN MED, V88, P914; Miettinen TA, 2005, J AM COLL CARDIOL, V45, P1794, DOI 10.1016/j.jacc.2005.02.063; Miettinen TA, 1998, BMJ-BRIT MED J, V316, P1127, DOI 10.1136/bmj.316.7138.1127; Mora MP, 1999, CHEM PHYS LIPIDS, V101, P255, DOI 10.1016/S0009-3084(99)00067-5; MORI M, 2004, 44 ANN M AM SOC CELL, pA324; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nguyen LB, 2001, METABOLISM, V50, P1224, DOI 10.1053/meta.2001.26707; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Rajaratnam RA, 2000, J AM COLL CARDIOL, V35, P1185, DOI 10.1016/S0735-1097(00)00527-1; RAPP JH, 1983, J LIPID RES, V24, P1329; ROSS AC, 1984, J BIOL CHEM, V259, P815; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; RUJANAVECH C, 1986, J BIOL CHEM, V261, P7215; Saito T, 2005, BIOSCI BIOTECH BIOCH, V69, P2207, DOI 10.1271/bbb.69.2207; Salen G, 2004, CIRCULATION, V109, P966, DOI 10.1161/01.CIR.0000116766.31036.03; SALEN G, 1992, J LIPID RES, V33, P945; SALEN G, 1985, J LIPID RES, V26, P1126; SCHULER I, 1990, BIOCHIM BIOPHYS ACTA, V1028, P82, DOI 10.1016/0005-2736(90)90268-S; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sehayek E, 2005, ARTERIOSCL THROM VAS, V25, P5, DOI 10.1161/01.ATV.0000151984.34920.aa; SHIO H, 1979, LAB INVEST, V41, P160; SHIRATORI Y, 1994, J BIOL CHEM, V269, P11337; Sudhop T, 2004, Z KARDIOL, V93, P921, DOI 10.1007/s00392-004-0165-2; Sudhop T, 2002, METABOLISM, V51, P1519, DOI 10.1053/meta.2002.36298; Sutherland WHF, 1998, NUTR METAB CARDIOVAS, V8, P386; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; TABAS I, 1989, J CLIN INVEST, V84, P1713, DOI 10.1172/JCI114354; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Temel RE, 2003, J BIOL CHEM, V278, P47594, DOI 10.1074/jbc.M308235200; von Bergmann K, 2005, AM J CARDIOL, V96, p10D, DOI 10.1016/j.amjcard.2005.03.014; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Wilund KR, 2004, ARTERIOSCL THROM VAS, V24, P2326, DOI 10.1161/01.ATV.0000149140.00499.92; Xu F, 2005, P NATL ACAD SCI USA, V102, P14551, DOI 10.1073/pnas.0503590102; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Yao PM, 2001, J BIOL CHEM, V276, P42468, DOI 10.1074/jbc.M101419200; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G	96	68	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33635	33649		10.1074/jbc.M606339200	http://dx.doi.org/10.1074/jbc.M606339200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16935859	hybrid			2022-12-27	WOS:000241621400072
J	Kim, EJ; Sung, JY; Lee, HJ; Rhim, H; Hasegawa, M; Iwatsubo, T; Min, DS; Kim, J; Paik, SR; Chung, KC				Kim, Eun Joo; Sung, Jee Young; Lee, Hyun Jung; Rhim, Hyewhon; Hasegawa, Masato; Iwatsubo, Takeshi; Min, Do Sik; Kim, Jongsun; Paik, Seung R.; Chung, Kwang Chul			Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL PROGENITOR CELLS; ELEMENT-BINDING PROTEIN; A-BETA COMPONENT; DOWN-SYNDROME; PARKINSONS-DISEASE; ALZHEIMER-DISEASE; LEWY BODIES; NEURONAL DIFFERENTIATION; PRECURSOR PROTEIN; SRC-FAMILY	Lewy bodies (LBs) are pathological hallmarks of Parkinson disease (PD) but also occur in Alzheimer disease (AD) and dementia of LBs. alpha-Synuclein, the major component of LBs, is observed in the brain of Down syndrome (DS) patients with AD. Dyrk1A, a dual specificity tyrosine-regulated kinase (Dyrk) family member, is the mammalian ortholog of the Drosophila minibrain (Mnb) gene, essential for normal postembryonic neurogenesis. The Dyrk1A gene resides in the human chromosome 21q22.2 region, which is associated with DS anomalies, including mental retardation. In this study, we examined whether Dyrk1A interacts with alpha-synuclein and subsequently affects intracellular alpha-synuclein inclusion formation in immortalized hippocampal neuronal (H19-7) cells. Dyrk1A selectively binds to alpha-synuclein in transformed and primary neuronal cells. alpha-Synuclein overexpression, followed by basic fibroblast growth factor-induced neuronal differentiation, resulted in cell death. We observed that accompanying cell death was increased alpha-synuclein phosphorylation and intracytoplasmic aggregation. In addition, the transfection of kinase-inactive Dyrk1A or Dyrk1A small interfering RNA blocked alpha-synuclein phosphorylation and aggregate formation. In vitro kinaseassay of anti-Dyrk1A immunocomplexes demonstrated that Dyrk1A could phosphorylate alpha-synuclein at Ser-87. Furthermore, aggregates formed by phosphorylated alpha-synuclein have a distinct morphology and are more neurotoxic compared with aggregates composed of unmodified wild type alpha-synuclein. These findings suggest alpha-synuclein inclusion formation regulated by Dyrk1A, potentially affecting neuronal cell viability.	Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Dept Med Sci, Seoul 120752, South Korea; Yonsei Univ, Coll Med, Dept Microbiol, Seoul 120752, South Korea; Seoul Natl Univ, Coll Engn, Sch Chem & Biol Engn, Seoul 151744, South Korea; Korea Inst Sci & Technol, Biomed Res Ctr, Seoul 136701, South Korea; Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea; Tokyo Inst Psychiat, Tokyo 1568585, Japan; Univ Tokyo, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Pusan National University; Tokyo Institute of Psychiatry; University of Tokyo	Chung, KC (corresponding author), Yonsei Univ, Coll Sci, Dept Biol, Shinchon Dong 134, Seoul 120749, South Korea.	kchung@yonsei.ac.kr						Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Eves EM, 1996, J NEUROCHEM, V67, P1908; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hashimoto M, 2004, J MOL NEUROSCI, V24, P343, DOI 10.1385/JMN:24:3:343; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Kang JE, 2005, J NEUROSCI RES, V81, P62, DOI 10.1002/jnr.20534; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kim J, 1997, MOL CELLS, V7, P78; Kim SJ, 2003, J BIOL CHEM, V278, P41890, DOI 10.1074/jbc.M306017200; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LEJEUNE J., 1959, BULL ACAD NATL MED [PARIS], V143, P256; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Nakamura T, 2002, FEBS LETT, V521, P190, DOI 10.1016/S0014-5793(02)02861-2; Nakamura T, 2001, BIOCHEM BIOPH RES CO, V280, P1085, DOI 10.1006/bbrc.2000.4253; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Paik SR, 2000, ARCH BIOCHEM BIOPHYS, V378, P269, DOI 10.1006/abbi.2000.1822; PATTERSON D, 1987, SCI AM, V257, P52, DOI 10.1038/scientificamerican0887-52; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Pulsifer M B, 1996, J Int Neuropsychol Soc, V2, P159; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Simard M, 2001, INT J GERIATR PSYCH, V16, P311; Sitz JH, 2004, MOL CELL BIOL, V24, P5821, DOI 10.1128/MCB.24.13.5821-5834.2004; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yang EJ, 2004, J BIOL CHEM, V279, P1827, DOI 10.1074/jbc.M308722200; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141	41	79	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33250	33257		10.1074/jbc.M606147200	http://dx.doi.org/10.1074/jbc.M606147200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959772	hybrid			2022-12-27	WOS:000241621400034
J	Anand, M; Balar, B; Ulloque, R; Gross, SR; Kinzy, TG				Anand, Monika; Balar, Bharvi; Ulloque, Rory; Gross, Stephane R.; Kinzy, Terri Goss			Domain and nucleotide dependence of the interaction between Saccharomyces cerevisiae translation elongation factors 3 and 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-BINDING; TRANSFER-RNA; FACTOR-III; EF-TU; FUNCTIONAL INTERACTIONS; CRYSTAL-STRUCTURE; ABC TRANSPORTERS; RIBOSOMAL ATPASE; FACTOR 1A; E-SITE	Eukaryotic translation elongation factor 3 (eEF3) is a fungal-specific ATPase proposed to catalyze the release of deacylated-tRNA from the ribosomal E-site. In addition, it has been shown to interact with the aminoacyl-tRNA binding GTPase elongation factor 1A (eEF1A), perhaps linking the E and A sites. Domain mapping demonstrates that amino acids 775-980 contain the eEF1A binding sites. Domain III of eEF1A, which is also involved in actin-related functions, is the site of eEF3 binding. The binding of eEF3 to eEF1A is enhanced by ADP, indicating the interaction is favored post-ATP hydrolysis but is not dependent on the eEF1A-bound nucleotide. A temperature-sensitive P915L mutant in the eEF1A binding site of eEF3 has reduced ATPase activity and affinity for eEF1A. These results support the model that upon ATP hydrolysis, eEF3 interacts with eEF1A to help catalyze the delivery of aminoacyl-tRNA at the A-site of the ribosome. The dynamics of when eEF3 interacts with eEF1A may be part of the signal for transition of the post to pre-translocational ribosomal state in yeast.	UMDNJ, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), UMDNJ, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu		gross, stephane/0000-0002-0867-8866; Kinzy, Terri/0000-0003-1394-9226	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057483, GM 57483] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand M, 2003, J BIOL CHEM, V278, P6985, DOI 10.1074/jbc.M209224200; Andersen CF, 2004, ACTA CRYSTALLOGR D, V60, P1304, DOI 10.1107/S0907444904010716; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Blakely G, 2001, J BACTERIOL, V183, P2241, DOI 10.1128/JB.183.7.2241-2248.2001; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Chakraburtty K, 2001, RES MICROBIOL, V152, P391, DOI 10.1016/S0923-2508(01)01210-4; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; DASMAHAPATRA B, 1981, J BIOL CHEM, V256, P9999; DIDOMENICO BJ, 1992, YEAST, V8, P337, DOI 10.1002/yea.320080502; Dinman JD, 1997, RNA, V3, P870; Dinos G, 2005, NUCLEIC ACIDS RES, V33, P5291, DOI 10.1093/nar/gki833; Dong JS, 2005, MOL CELL BIOL, V25, P9859, DOI 10.1128/MCB.25.22.9859-9873.2005; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Elskaya AV, 1997, BIOCHEMISTRY-US, V36, P10492, DOI 10.1021/bi970631e; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; Ganoza MC, 2001, ANTIMICROB AGENTS CH, V45, P2813, DOI 10.1128/AAC.45.10.2813-2819.2001; Gontarek RR, 1998, J BIOL CHEM, V273, P10249, DOI 10.1074/jbc.273.17.10249; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kambampati R, 1997, J BIOL CHEM, V272, P6377, DOI 10.1074/jbc.272.10.6377; Kambampati R, 2000, J BIOL CHEM, V275, P16963, DOI 10.1074/jbc.M001157200; Kambampati R, 1997, PROTEIN EXPRES PURIF, V10, P209, DOI 10.1006/prep.1997.0728; Kiel MC, 2001, EUR J BIOCHEM, V268, P278, DOI 10.1046/j.1432-1327.2001.01873.x; KIEL MC, 1999, BIOCHIMIE, V77, P713; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; KOVALCHUKE O, 1994, EUR J BIOCHEM, V226, P133, DOI 10.1111/j.1432-1033.1994.tb20034.x; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; McKeegan KS, 2003, TRENDS MICROBIOL, V11, P21, DOI 10.1016/S0966-842X(02)00010-0; MERRICK WC, 2000, TRANSLATIONAL CONTRO, P98; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; Nikaido H, 2002, P NATL ACAD SCI USA, V99, P9609, DOI 10.1073/pnas.162375699; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Sarthy AV, 1998, YEAST, V14, P239, DOI 10.1002/(SICI)1097-0061(199802)14:3<239::AID-YEA219>3.0.CO;2-B; Sherman F., 1986, METHODS YEAST GENETI; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; SKOGERSON L, 1976, P NATL ACAD SCI USA, V73, P73, DOI 10.1073/pnas.73.1.73; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sturtevant Joy, 2002, Expert Opin Ther Targets, V6, P545, DOI 10.1517/14728222.6.5.545; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang HM, 1996, BBA-MOL CELL RES, V1310, P303, DOI 10.1016/0167-4889(95)00179-4; YPMAWONG MF, 1992, INFECT IMMUN, V60, P4140, DOI 10.1128/IAI.60.10.4140-4145.1992	47	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32318	32326		10.1074/jbc.M601899200	http://dx.doi.org/10.1074/jbc.M601899200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954224	hybrid, Green Accepted			2022-12-27	WOS:000241414500029
J	Zhao, YY; Nakagawa, T; Itoh, S; Inamori, K; Isaji, T; Kariya, Y; Kondo, A; Miyoshi, E; Miyazaki, K; Kawasaki, N; Taniguchi, N; Gu, JG				Zhao, Yanyang; Nakagawa, Takatoshi; Itoh, Satsuki; Inamori, Kei-ichiro; Isaji, Tomoya; Kariya, Yoshinobu; Kondo, Akihiro; Miyoshi, Eiji; Miyazaki, Kaoru; Kawasaki, Nana; Taniguchi, Naoyuki; Gu, Jianguo			N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha 3 beta 1 integrin-mediated cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1-6 BRANCHED OLIGOSACCHARIDES; BETA-1,6-BRANCHED OLIGOSACCHARIDES; ACETYLLACTOSAMINE SEQUENCES; LINKED OLIGOSACCHARIDES; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; EPITHELIAL-CELLS; LUNG METASTASIS; HUMAN CANCERS; GLYCOSYLATION	N-Acetylglucosaminyltransferase V (GnT-V) catalyzes the addition of beta 1,6-GlcNAc branching of N-glycans, which contributes to metastasis. N-Acetylglucosaminyltransferase III (GnT-III) catalyzes the formation of a bisecting GlcNAc structure in N-glycans, resulting in the suppression of metastasis. It has long been hypothesized that the suppression of GnT-V product formation by the action of GnT-III would also exist in vivo, which will consequently lead to the inhibition of biological functions of GnT-V. To test this, we draw a comparison among MKN45 cells, which were transfected with GnT-III, GnT-V, or both, respectively. We found that alpha 3 beta 1 integrin-mediated cell migration on laminin 5 was greatly enhanced in the case of GnT-V transfectant. This enhanced cell migration was significantly blocked after the introduction of GnT-III. Consistently, an increase in bisected GlcNAc but a decrease in beta 1,6-GlcNAc-branched N-glycans on integrin alpha 3 subunit was observed in the double transfectants of GnT-III and GnT-V. Conversely, GnT-III knockdown resulted in increased migration on laminin 5, concomitant with an increase in beta 1,6-GlcNAc-branched N-glycans on the alpha 3 subunit in CHP134 cells, a human neuroblastoma cell line. Therefore, in this study, the priority of GnT-III for the modification of the alpha 3 subunit may be an explanation for why GnT-III inhibits GnT-V-induced cell migration. Taken together, our results demonstrate for the first time that GnT-III and GnT-V can competitively modify the same target glycoprotein and furthermore positively or negatively regulate its biological functions.	Osaka Univ, Res Inst Microbial Dis, Dept Dis Glycom, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Glycotherapeut, Suita, Osaka 5650871, Japan; Yokohama City Univ, Div Cell Biol, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Osaka University; Osaka University; Osaka University; Yokohama City University; National Institute of Health Sciences - Japan; Tohoku Medical & Pharmaceutical University	Taniguchi, N (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Dis Glycom, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	tani52@wd5.so-net.ne.jp; jgu@tohoku-pharm.ac.jp	Taniguchi, Naoyuki/A-7086-2016; Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021; Inamori, Kei-ichiro/ABA-2926-2020; Taniguchi, Naoyuki/I-4182-2014	Inamori, Kei-ichiro/0000-0002-5947-3633; Taniguchi, Naoyuki/0000-0001-5889-5968; Zhao, Yanyang/0000-0001-5139-5311				Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; CHAMMAS R, 1993, P NATL ACAD SCI USA, V90, P1795, DOI 10.1073/pnas.90.5.1795; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; FERNANDES B, 1991, CANCER RES, V51, P718; GEHLSEN KR, 1992, J CELL BIOL, V117, P449, DOI 10.1083/jcb.117.2.449; Granovsky M, 2000, NAT MED, V6, P306; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Guo HB, 2002, CANCER RES, V62, P6837; Handerson T, 2003, CANCER RES, V63, P5363; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Itoh S, 2006, J CHROMATOGR A, V1103, P296, DOI 10.1016/j.chroma.2005.11.043; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; LEMARER N, 1995, GLYCOBIOLOGY, V5, P219, DOI 10.1093/glycob/5.2.219; LU Y, 1994, CLIN EXP METASTAS, V12, P47, DOI 10.1007/BF01784333; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; MELCHIORI A, 1995, EXP CELL RES, V219, P233, DOI 10.1006/excr.1995.1223; MIWA K, 1985, GENE, V39, P281; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PIERCE M, 1986, J BIOL CHEM, V261, P772; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; SAITO H, 1994, BIOCHEM BIOPH RES CO, V198, P318, DOI 10.1006/bbrc.1994.1045; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Seberger PJ, 1999, GLYCOBIOLOGY, V9, P235, DOI 10.1093/glycob/9.3.235; Seelentag WKF, 1998, CANCER RES, V58, P5559; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; TANIGUCHI N, 1989, METHOD ENZYMOL, V179, P397; Tsuji T, 2002, CLIN EXP METASTAS, V19, P127, DOI 10.1023/A:1014573204062; Tysnes BB, 1996, INT J CANCER, V67, P777, DOI 10.1002/(SICI)1097-0215(19960917)67:6<777::AID-IJC5>3.0.CO;2-O; Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112; Yamamoto H, 2001, CANCER RES, V61, P6822; YAMASHITA K, 1989, J BIOL CHEM, V264, P17873; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754	47	113	121	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32122	32130		10.1074/jbc.M607274200	http://dx.doi.org/10.1074/jbc.M607274200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16940045	hybrid			2022-12-27	WOS:000241414500009
J	Panasenko, O; Landrieux, E; Feuermann, M; Finka, A; Paquet, N; Collart, MA				Panasenko, Olesya; Landrieux, Emilie; Feuermann, Marc; Finka, Andrija; Paquet, Nicole; Collart, Martine A.			The yeast Ccr4-not complex controls ubiquitination of the nascent-associated polypeptide (NAC-EGD) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEADENYLASE; DIFFERENTIALLY AFFECTS; TRANSCRIPTION; PROTEIN; EXPRESSION; SUBUNITS; REVEALS; ELEMENT; MOTIF; UBC4	In this work, we determine that the Saccharomyces cerevisiae Ccr4-Not complex controls ubiquitination of the conserved ribosome-associated heterodimeric EGD (enhancer of Gal4p DNA binding) complex, which consists of the Egd1p and Egd2p subunits in yeast and is named NAC (nascent polypeptide-associated complex) in mammals. We show that the EGD complex subunits are ubiquitinated proteins, whose ubiquitination status is regulated during cell growth. Egd2p has a UBA domain that is not essential for interaction with Egd1p but is required for stability of Egd2p and Egd1p. Ubiquitination of Egd1p requires Not4p. Ubiquitination of Egd2p also requires Not4p, an intact Not4p RING finger domain, and all other subunits of the Ccr4-Not complex tested. In the absence of Not4p, Egd2p mis-localizes to punctuate structures. Finally, the EGD complex can be ubiquitinated in vitro by Not4p and Ubc4p, one of the E2 enzymes with which Not4p can interact. Taken together our results reveal that the EGD ribosome-associated complex is ubiquitinated in a regulated manner, and they show a new role for the Ccr4-Not complex in this ubiquitination.	Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland	University of Geneva	Collart, MA (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland.	martine.collart@medecine.unige.ch	Panasenko, Olesya/AAC-1194-2021; Finka, Andrija/A-6387-2009	Panasenko, Olesya/0000-0002-0990-7472; Finka, Andrija/0000-0001-7608-4771; Feuermann, Marc/0000-0002-4187-2863; Collart, Martine/0000-0001-6955-1773				Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Chuang SM, 2005, GENETICS, V171, P1477, DOI 10.1534/genetics.105.046888; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; COLLART MA, 1993, EMBO J, V12, P177, DOI 10.1002/j.1460-2075.1993.tb05643.x; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Creton S, 2002, GENE DEV, V16, P3265, DOI 10.1101/gad.234002; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Franke J, 2001, J CELL SCI, V114, P2641; Grallath S, 2006, EMBO REP, V7, P78, DOI 10.1038/sj.embor.7400551; Hanzawa H, 2001, J BIOL CHEM, V276, P10185, DOI 10.1074/jbc.M009298200; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenssen E, 2005, MOL CELL BIOL, V25, P488, DOI 10.1128/MCB.25.1.488-498.2005; Lenssen E, 2002, MOL MICROBIOL, V43, P1023, DOI 10.1046/j.1365-2958.2002.02799.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; PARTHUN MR, 1992, MOL CELL BIOL, V12, P5683, DOI 10.1128/MCB.12.12.5683; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Quelo I, 2004, J BIOL CHEM, V279, P43893, DOI 10.1074/jbc.M406310200; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Spreter T, 2005, J BIOL CHEM, V280, P15849, DOI 10.1074/jbc.M500160200; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; Winkler GS, 2004, J MOL BIOL, V337, P157, DOI 10.1016/j.jmb.2004.01.031; Yoshida K, 2005, GENES CELLS, V10, P465, DOI 10.1111/j.1365-2443.2005.00848.x; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; ZHENG XM, 1990, NATURE, V344, P556, DOI 10.1038/344556a0; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	38	75	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31389	31398		10.1074/jbc.M604986200	http://dx.doi.org/10.1074/jbc.M604986200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16926149	Bronze			2022-12-27	WOS:000241235300023
J	Nishi, E; Hiraoka, Y; Yoshida, K; Okawa, K; Kita, T				Nishi, Eiichiro; Hiraoka, Yoshinori; Yoshida, Kazuhiro; Okawa, Katsuya; Kita, Toru			Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE DIBASIC CONVERTASE; PROTEIN-COUPLED RECEPTORS; BUD-SITE SELECTION; FACTOR HB-EGF; METALLOPROTEINASE CLEAVAGE; NRD CONVERTASE; CELL-SURFACE; PROHB-EGF; METALLOENDOPEPTIDASE; DISINTEGRIN	Like other members of the epidermal growth factor family, heparin-binding epidermal growth factor-like growth factor (HB-EGF) is synthesized as a transmembrane protein that can be shed enzymatically to release a soluble growth factor. Ectodomain shedding is essential to the biological functions of HB-EGF and is strictly regulated. However, the mechanism that induces the shedding remains unclear. We have recently identified nardilysin (N-arginine dibasic convertase (NRDc)), a metalloendopeptidase of the M16 family, as a protein that specifically binds HB-EGF (Nishi, E., Prat, A., Hospital, V., Elenius, K., and Klagsbrun, M. (2001) EMBO J. 20, 3342-3350). Here, we show that NRDc enhances ectodomain shedding of HB-EGF. When expressed in cells, NRDc enhanced the shedding in cooperation with tumor necrosis factor-alpha-converting enzyme (TACE; ADAM17). NRDc formed a complex with TACE, a process promoted by phorbol esters, general activators of ectodomain shedding. NRDc enhanced TACE-induced HB-EGF cleavage in a peptide cleavage assay, indicating that the interaction with NRDc potentiates the catalytic activity of TACE. The metalloendopeptidase activity of NRDc was not required for the enhancement of HB-EGF shedding. Notably, a reduction in the expression of NRDc caused by RNA interference was accompanied by a decrease in ectodomain shedding of HB-EGF. These results indicate the essential role of NRDc in HB-EGF ectodomain shedding and reveal how the shedding is regulated by the modulation of sheddase activity.	Kyoto Univ, Grad Sch Med, Horizontal Med Res Org, Mol Pathol Unit,Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Biomol Characterizat Unit, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University	Nishi, E (corresponding author), Kyoto Univ, Grad Sch Med, Horizontal Med Res Org, Mol Pathol Unit,Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	nishi@kuhp.kyoto-u.ac.jp	Nishi, Eiichiro/A-8246-2019	Nishi, Eiichiro/0000-0002-8188-8026				ADAMES N, 1995, SCIENCE, V270, P464, DOI 10.1126/science.270.5235.464; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2003, BIOCHEM SOC SYMP, V70, P39, DOI 10.1042/bss0700039; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Chesneau V, 1996, J CELL SCI, V109, P2737; CHESNEAU V, 1994, J BIOL CHEM, V269, P2056; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Fumagalli P, 1998, GENOMICS, V47, P238, DOI 10.1006/geno.1997.5078; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; Hirata M, 2001, BIOCHEM BIOPH RES CO, V283, P915, DOI 10.1006/bbrc.2001.4879; Hospital V, 2002, BIOCHEM J, V367, P229, DOI 10.1042/BJ20020822; Hospital V, 2000, BIOCHEM J, V349, P587, DOI 10.1042/0264-6021:3490587; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nishi E, 2004, GROWTH FACTORS, V22, P253, DOI 10.1080/08977190400008448; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; PIEROTTI AR, 1994, P NATL ACAD SCI USA, V91, P6078, DOI 10.1073/pnas.91.13.6078; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schlondorff J, 1999, J CELL SCI, V112, P3603; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Suzuki M, 1997, J BIOL CHEM, V272, P31730, DOI 10.1074/jbc.272.50.31730; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	40	56	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					31164	31172		10.1074/jbc.M601316200	http://dx.doi.org/10.1074/jbc.M601316200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16923819	hybrid			2022-12-27	WOS:000241075900091
J	Rangarajan, ES; Proteau, A; Wagner, J; Hung, MN; Matte, A; Cygler, M				Rangarajan, Erumbi S.; Proteau, Ariane; Wagner, John; Hung, Ming-Ni; Matte, Allan; Cygler, Miroslaw			Structural snapshots of Escherichia coli histidinol phosphate phosphatase along the reaction pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALOACID DEHALOGENASE FOLD; CRYSTAL-STRUCTURE; SALMONELLA-TYPHIMURIUM; PHOSPHOSERINE PHOSPHATASE; DEPENDENT PHOSPHOHYDROLASES; SUPERFAMILY; ENZYME; DEHYDRATASE; EVOLUTION; BACTERIAL	HisB from Escherichia coli is a bifunctional enzyme catalyzing the sixth and eighth steps of L-histidine biosynthesis. The N-terminal domain (HisB-N) possesses histidinol phosphate phosphatase activity, and its crystal structure shows a single domain with fold similarity to the haloacid dehalogenase (HAD) enzyme family. HisB-N forms dimers in the crystal and in solution. The structure shows the presence of a structural Zn2+ ion stabilizing the conformation of an extended loop. Two metal binding sites were also identified in the active site. Their presence was further confirmed by isothermal titration calorimetry. HisB-N is active in the presence of Mg2+, Mn2+, Co2+, or Zn2+, but Ca2+ has an inhibitory effect. We have determined structures of several intermediate states corresponding to snapshots along the reaction pathway, including that of the phosphoaspartate intermediate. A catalytic mechanism, different from that described for other HAD enzymes, is proposed requiring the presence of the second metal ion not found in the active sites of previously characterized HAD enzymes, to complete the second half-reaction. The proposed mechanism is reminiscent of two-Mg2+ ion catalysis utilized by DNA and RNA polymerases and many nucleases. The structure also provides an explanation for the inhibitory effect of Ca2+.	Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	National Research Council Canada; McGill University; McGill University	Matte, A (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	allan.matte@nrc-cnrc.gc.ca; mirek.cygler@nrc-cnrc.gc.ca						Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; AMES BN, 1960, J GEN MICROBIOL, V22, P369, DOI 10.1099/00221287-22-2-369; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; BRADY DR, 1973, J BIOL CHEM, V248, P2588; Brilli M, 2004, J MOL EVOL, V58, P225, DOI 10.1007/s00239-003-2547-x; Calderone V, 2006, J MOL BIOL, V355, P708, DOI 10.1016/j.jmb.2005.10.068; Calderone V, 2004, J MOL BIOL, V335, P761, DOI 10.1016/j.jmb.2003.10.050; CARLOMAGNO MS, 1988, J MOL BIOL, V203, P585, DOI 10.1016/0022-2836(88)90194-5; CHIARIOTTI L, 1986, MOL GEN GENET, V202, P42, DOI 10.1007/BF00330514; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Deshpande RA, 2004, BIOCHEMISTRY-US, V43, P8579, DOI 10.1021/bi049434n; Glynn SE, 2005, STRUCTURE, V13, P1809, DOI 10.1016/j.str.2005.08.012; HOUSTON LL, 1974, ARCH BIOCHEM BIOPHYS, V162, P513, DOI 10.1016/0003-9861(74)90211-2; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOPER JC, 1961, P NATL ACAD SCI USA, V47, P1440, DOI 10.1073/pnas.47.9.1440; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Omi R, 2004, ACTA CRYSTALLOGR D, V60, P574, DOI 10.1107/S0907444904000277; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JF, 2002, PROTEINS, V46, P393, DOI 10.1002/prot.10057; Peeraer Y, 2004, EUR J BIOCHEM, V271, P3421, DOI 10.1111/j.0014-2956.2004.04277.x; Peisach E, 2004, BIOCHEMISTRY-US, V43, P12770, DOI 10.1021/bi0490688; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; ROTH JR, 1981, J MOL BIOL, V145, P697, DOI 10.1016/0022-2836(81)90310-7; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Selengut JD, 2001, BIOCHEMISTRY-US, V40, P12704, DOI 10.1021/bi011405e; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Shin DH, 2003, PROTEIN SCI, V12, P1464, DOI 10.1110/ps.0302703; Sinha SC, 2004, J BIOL CHEM, V279, P15491, DOI 10.1074/jbc.M312733200; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Winkler ME, 1996, ESCHERICHIA COLI SAL, P485; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	45	34	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37930	37941		10.1074/jbc.M604916200	http://dx.doi.org/10.1074/jbc.M604916200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16966333	hybrid			2022-12-27	WOS:000242477100072
J	Suzuki, H; Ohnishi, Y; Furusho, Y; Sakuda, S; Horinouchi, S				Suzuki, Hirokazu; Ohnishi, Yasuo; Furusho, Yasuhide; Sakuda, Shohei; Horinouchi, Sueharu			Novel benzene ring biosynthesis from C-3 and C-4 primary metabolites by two enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III POLYKETIDE SYNTHASES; 3-AMINO-4-HYDROXYBENZOIC ACID; CRYSTAL-STRUCTURE; STREPTOMYCES; EXPRESSION; MANUMYCIN; PATHWAY; GENE; SEMIALDEHYDE; ASUKAMYCIN	The shikimate pathway, including seven enzymatic steps for production of chorismate via shikimate from phosphoenolpyruvate and erythrose-4-phosphate, is common in various organisms for the biosynthesis of not only aromatic amino acids but also most biogenic benzene derivatives. 3-Amino-4-hydroxybenzoic acid (3,4-AHBA) is a benzene derivative serving as a precursor for several secondary metabolites produced by Streptomyces, including grixazone produced by Streptomyces griseus. Our study on the biosynthesis pathway of grixazone led to identification of the biosynthesis pathway of 3,4-AHBA from two primary metabolites. Two genes, griI and griH, within the grixazone biosynthesis gene cluster were found to be responsible for the biosynthesis of 3,4-AHBA; the two genes conferred the in vivo production of 3,4-AHBA even on Escherichia coli. In vitro analysis showed that GriI catalyzed aldol condensation between two primary metabolites, L-aspartate-4-semialdehyde and dihydroxyacetone phosphate, to form a 7-carbon product, 2-amino4,5-dihydroxy-6-one-heptanoic acid-7-phosphate, which was subsequently converted to 3,4-AHBA by GriH. The latter reaction required Mn2+ ion but not any cofactors involved in reduction or oxidation. This pathway is independent of the shikimate pathway, representing a novel, simple enzyme system responsible for the synthesis of a benzene ring from the C-3 and C-4 primary metabolites.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Horinouchi, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asuhori@mail.ecc.u-tokyo.ac.jp	Suzuki, Hirokazu/AAG-2285-2020	Suzuki, Hirokazu/0000-0002-9507-6467; Sakuda, Shohei/0000-0001-7966-1167; Ohnishi, Yasuo/0000-0001-7633-9236				Arakawa K, 2002, J AM CHEM SOC, V124, P10644, DOI 10.1021/ja0206339; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; BLACK S, 1955, J BIOL CHEM, V213, P39; Carpenter EP, 1998, NATURE, V394, P299, DOI 10.1038/28431; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Gould SJ, 1996, J AM CHEM SOC, V118, P9228, DOI 10.1021/ja9524356; HILLIS LR, 1985, J AM CHEM SOC, V107, P4593, DOI 10.1021/ja00301a061; HOWPOOD DA, 1985, GENETIC MANIPULATION; Hu YD, 2004, J AM CHEM SOC, V126, P3837, DOI 10.1021/ja039336+; Hu YD, 1997, J AM CHEM SOC, V119, P4301, DOI 10.1021/ja9701016; KATZ E, 1983, J GEN MICROBIOL, V129, P2703; Knaggs AR, 2003, NAT PROD REP, V20, P119, DOI 10.1039/b100399m; Li YF, 2000, TETRAHEDRON LETT, V41, P5181, DOI 10.1016/S0040-4039(00)00772-3; Lorentzen E, 2003, J BIOL CHEM, V278, P47253, DOI 10.1074/jbc.M305922200; Maniatis T., 1982, MOL CLONING; Martyn DC, 2003, ORG BIOMOL CHEM, V1, P2103, DOI 10.1039/b302411c; Ohnishi Y, 2004, J ANTIBIOT, V57, P218, DOI 10.7164/antibiotics.57.218; Rascher A, 2005, APPL ENVIRON MICROB, V71, P4862, DOI 10.1128/AEM.71.8.4862-4871.2005; Suzuki H, 2006, J BIOL CHEM, V281, P824, DOI 10.1074/jbc.M505806200; TAKANO E, 1995, GENE, V166, P133, DOI 10.1016/0378-1119(95)00545-2; THIERICKE R, 1990, J AM CHEM SOC, V112, P3979, DOI 10.1021/ja00166a039; Wang XL, 2001, PLANT PHYSIOL, V125, P1778, DOI 10.1104/pp.125.4.1778; Westwood IM, 2005, BIOCHEM J, V385, P605, DOI 10.1042/BJ20041330; White RH, 2004, BIOCHEMISTRY-US, V43, P7618, DOI 10.1021/bi0495127; Woodard RW, 2004, BIOORG CHEM, V32, P309, DOI 10.1016/j.bioorg.2004.06.003; Yeh JI, 2002, BIOCHEMISTRY-US, V41, P11649, DOI 10.1021/bi026292t	27	56	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					36944	36951		10.1074/jbc.M608103200	http://dx.doi.org/10.1074/jbc.M608103200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	17003031	hybrid			2022-12-27	WOS:000242220800054
J	Herbert, SP; Walker, JH				Herbert, Shane P.; Walker, John H.			Group VIA calcium-independent phospholipase A(2) mediates endothelial cell S phase progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED DISCRIMINATION; ARACHIDONIC-ACID METABOLISM; SIGNAL-TRANSDUCTION; DNA-REPLICATION; CYCLIN-A; A(2); PROLIFERATION; ANGIOGENESIS; GROWTH; INHIBITION	Arachidonic acid and its metabolites have been previously implicated in the regulation of endothelial cell proliferation. Arachidonic acid may be liberated from cellular phospholipids by the action of group VIA calcium-independent phospholipase A(2) (iPLA(2)-VIA). Consequently, we tested the hypothesis that iPLA(2)-VIA activity is linked to the regulation of endothelial cell proliferation. Inhibition of iPLA(2) activity by bromoenol lactone (BEL) was sufficient to entirely block endothelial cell growth. BEL dose-dependently inhibited endothelial cell DNA synthesis in a manner that was reversed upon the exogenous addition of arachidonic acid. DNA synthesis was inhibited by the S-isomer and not by the R-isomer of BEL, demonstrating that endothelial cell proliferation is mediated specifically by iPLA(2)-VIA. iPLA(2)-VIA activity was critical to the progression of endothelial cells through S phase and is required for the expression of the cyclin A/cdk2 complex. Thus, inhibition of iPLA(2)-VIA blocks S phase progression and results in exit from the cell cycle. Inhibition of iPLA(2)-VIA-mediated endothelial cell proliferation is sufficient to block angiogenic tubule formation in co-culture assays. Consequently, iPLA(2)-VIA is a novel regulator of endothelial cell S phase progression, cell cycle residence, and angiogenesis.	Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Walker, JH (corresponding author), Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	j.h.walker@leeds.ac.uk		Herbert, Shane/0000-0003-2517-1845				ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Antoniotti S, 2003, J CELL PHYSIOL, V197, P370, DOI 10.1002/jcp.10359; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Choudhury QG, 2000, BRIT J PHARMACOL, V131, P255, DOI 10.1038/sj.bjp.0703573; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; DETHLEFSEN SM, 1994, EXP CELL RES, V212, P262, DOI 10.1006/excr.1994.1142; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; FAFEUR V, 1991, J CELL PHYSIOL, V149, P277, DOI 10.1002/jcp.1041490214; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GERDES J, 1984, J IMMUNOL, V133, P1710; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Herbert SP, 2005, MOL BIOL CELL, V16, P3800, DOI 10.1091/mbc.E05-02-0164; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; Jackson CJ, 1997, INT J BIOCHEM CELL B, V29, P1167, DOI 10.1016/S1357-2725(97)00061-7; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Ma ZM, 2001, LIPIDS, V36, P689, DOI 10.1007/s11745-001-0774-9; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; McHowat J, 2001, BIOCHEMISTRY-US, V40, P14921, DOI 10.1021/bi0156153; Nie DT, 2000, BLOOD, V95, P2304, DOI 10.1182/blood.V95.7.2304.007k23_2304_2311; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Rickard A, 2005, AM J PHYSIOL-RENAL, V288, pF714, DOI 10.1152/ajprenal.00288.2004; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; SA G, 1995, J BIOL CHEM, V270, P2360, DOI 10.1074/jbc.270.5.2360; Sanchez T, 2002, J CELL PHYSIOL, V193, P293, DOI 10.1002/jcp.10162; Sanchez T, 2001, BIOCHEM PHARMACOL, V61, P811, DOI 10.1016/S0006-2952(01)00555-X; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; TAKAHASHI T, 1993, J NEUROCYTOL, V22, P1096, DOI 10.1007/BF01235751; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANE JR, 1990, NEW ENGL J MED, V323, P27; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Yellaturu CR, 2003, J BIOL CHEM, V278, P43831, DOI 10.1074/jbc.M301472200	48	30	31	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35709	35716		10.1074/jbc.M600699200	http://dx.doi.org/10.1074/jbc.M600699200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16966332	hybrid			2022-12-27	WOS:000242100500015
J	Lamant, M; Smih, F; Harmancey, R; Philip-Couderc, P; Pathak, A; Roncalli, J; Galinier, M; Collet, X; Massabuau, P; Senard, JM; Rouet, P				Lamant, Matthieu; Smih, Fatima; Harmancey, Romain; Philip-Couderc, Pierre; Pathak, Atul; Roncalli, Jerome; Galinier, Michel; Collet, Xavier; Massabuau, Pierre; Senard, Jean-Michel; Rouet, Philippe			ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LINKED MENTAL-RETARDATION; B-CONTAINING LIPOPROTEINS; A-I; CARDIOVASCULAR-DISEASE; CELLULAR CHOLESTEROL; CHONDROITIN SULFATE; LIPID-ACCUMULATION; OBESITY; CELLS	Obesity is an independent risk factor for cardiac failure. Obesity promotes excessive deposition of fat in adipose and nonadipose tissues. Intramyocardial lipid overload is a relatively common finding in nonischemic heart failure, especially in obese and diabetic patients, and promotes lipoapoptosis that contributes to the alteration of cardiac function. Lipoprotein production has been proposed as a heart-protective mechanism through the unloading of surplus cellular lipids. We previously analyzed the heart transcriptome in a dog nutritional model of obesity, and we identified a new apolipoprotein, regulated by obesity in heart, which is the subject of this study. We detected this new protein in the following lipoproteins: high density lipoprotein, low density lipoprotein, and very low density lipoprotein. We designated it apolipoprotein O. Apolipoprotein O is a 198-amino acid protein that contains a 23-amino acid-long signal peptide. The apolipoprotein O gene is expressed in a set of human tissues. Confocal immunofluorescence microscopy colocalized apolipoprotein O and perilipins, a cellular marker of the lipid droplet. Chondroitinase ABC deglycosylation analysis or cell incubation with p-nitrophenyl-beta-D-xyloside indicated that apolipoprotein O belongs to the proteoglycan family. Naringenin or CP-346086 treatments indicated that apolipoprotein O secretion requires microsomal triglyceride transfer protein activity. Apolipoprotein O gene expression is up-regulated in the human diabetic heart. Apolipoprotein O promoted cholesterol efflux from macrophage cells. To our knowledge, apolipoprotein O is the first chondroitin sulfate chain containing apolipoprotein. Apolipoprotein O may be involved in myocardium-protective mechanisms against lipid accumulation, or it may have specific properties mediated by its unique glycosylation pattern.	UPS, CHU Rangueil, Unite Rech Obes, INSERM,U586,Inst Louis Bugnard,IFR 31, F-31432 Toulouse 4, France; Hop Purpan, INSERM, U563, F-31432 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Rouet, P (corresponding author), Fac Med Toulouse, INSERM, U586, Lab Pharmacol Med & Clin, 37 Allees Jules Guesde, F-31073 Toulouse, France.	Philippe.rouet@Toulouse.inserm.fr	Pathak, Atul/ABC-5223-2020; Pathak, Atul/E-7532-2010; Collet, Xavier/M-6938-2017	Pathak, Atul/0000-0001-6151-0096; GALINIER, Michel/0000-0003-1735-3390; Senard, Jean-Michel/0000-0001-7679-1281; Rouet, Philippe/0000-0001-6204-2079				ARN P, 1994, HUM GENET, V93, P389; Basdevant A, 2000, ANN ENDOCRINOL-PARIS, V61, P6; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Bjorkegren J, 2001, J BIOL CHEM, V276, P38511, DOI 10.1074/jbc.M106839200; Campos H, 2001, J LIPID RES, V42, P1239; CARPENTER HM, 1962, AM HEART J, V63, P491, DOI 10.1016/0002-8703(62)90305-8; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COLLET X, 1990, BIOCHIM BIOPHYS ACTA, V1043, P301, DOI 10.1016/0005-2760(90)90031-R; Contaldo F, 2002, NUTR METAB CARDIOVAS, V12, P190; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Daugherty DL, 1998, J BIOL CHEM, V273, P33961, DOI 10.1074/jbc.273.51.33961; Duk M, 1997, ANAL BIOCHEM, V253, P98, DOI 10.1006/abio.1997.9994; GALANAKIS DK, 1994, J CLIN INVEST, V93, P303, DOI 10.1172/JCI116960; Gambino R, 1999, CHEM PHYS LIPIDS, V103, P161, DOI 10.1016/S0009-3084(99)00108-5; HALL JE, 1993, HYPERTENSION, V22, P292, DOI 10.1161/01.HYP.22.3.292; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Harsha HC, 2005, NAT GENET, V37, P331, DOI 10.1038/ng0405-331; Hirabayashi J, 2002, J CHROMATOGR B, V771, P67, DOI 10.1016/S1570-0232(02)00057-0; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; KAGAYA Y, 1990, CIRCULATION, V81, P1353, DOI 10.1161/01.CIR.81.4.1353; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lee Y, 2004, P NATL ACAD SCI USA, V101, P13624, DOI 10.1073/pnas.0405499101; LEE Y, 2001, J BIOL CHEM, V276, P5629; LEIPER JM, 1994, J BIOL CHEM, V269, P21951; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Listenberger LL, 2002, TRENDS CARDIOVAS MED, V12, P134, DOI 10.1016/S1050-1738(02)00152-4; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; MYKKANEN L, 1993, DIABETOLOGIA, V36, P553, DOI 10.1007/BF02743273; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nielsen LB, 2002, SCAND J CLIN LAB INV, V62, P35, DOI 10.1080/003655102762377475; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Nielsen LB, 1998, CIRCULATION, V98, P13, DOI 10.1161/01.CIR.98.1.13; Nielsen LB, 2002, ARTERIOSCL THROM VAS, V22, P1489, DOI 10.1161/01.ATV.0000030199.06252.26; O'Bryan MK, 2004, ENDOCRINOLOGY, V145, P5231, DOI 10.1210/en.2004-0630; Oganesyan Natalia, 2005, Journal of Structural and Functional Genomics, V6, P177, DOI 10.1007/s10969-005-2827-3; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Oram JF, 1996, J LIPID RES, V37, P2473; Oynebraten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183; Panagotopulos SE, 2002, PROTEIN EXPRES PURIF, V25, P353, DOI 10.1016/S1046-5928(02)00020-7; Philip-Couderc P, 2004, PHYSIOL GENOMICS, V19, P32, DOI 10.1152/physiolgenomics.00001.2004; Philip-Couderc P, 2003, HYPERTENSION, V41, P414, DOI 10.1161/01.HYP.0000057573.32425.95; POWNALL HJ, 1978, BIOCHEMISTRY-US, V17, P1183, DOI 10.1021/bi00600a008; ROUET P, 1992, J BIOL CHEM, V267, P20765; Sacks Frank M., 1994, Current Opinion in Lipidology, V5, P236, DOI 10.1097/00041433-199405030-00012; Sakr SW, 1999, BBA-MOL CELL BIOL L, V1438, P85, DOI 10.1016/S1388-1981(99)00041-4; Salier JP, 1996, BIOCHEM J, V315, P1, DOI 10.1042/bj3150001; Saphir O, 1933, ARCH INTERN MED, V52, P410, DOI 10.1001/archinte.1933.00160030071006; SAWHNEY RS, 1991, J BIOL CHEM, V266, P9231; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Silva EPP, 2004, CELL BIOCHEM FUNCT, V22, P23, DOI 10.1002/cbf.1048; Smih F, 2002, DIABETES, V51, P293, DOI 10.2337/diabetes.51.2.293; Smith HL, 1933, ARCH INTERN MED, V52, P911, DOI 10.1001/archinte.1933.00160060085007; Soulages JL, 1998, BIOCHEMISTRY-US, V37, P10203, DOI 10.1021/bi980622l; Stromme P, 1999, J MED GENET, V36, P374; Su X, 2005, BIOCHEMISTRY-US, V44, P5234, DOI 10.1021/bi047773a; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; THRIFT RN, 1992, P NATL ACAD SCI USA, V89, P9161, DOI 10.1073/pnas.89.19.9161; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Veniant MM, 1999, TRENDS CARDIOVAS MED, V9, P103, DOI 10.1016/S1050-1738(99)00011-0; Verwaerde P, 1999, J HYPERTENS, V17, P1135, DOI 10.1097/00004872-199917080-00013; Wang S, 1996, J BIOL CHEM, V271, P14124, DOI 10.1074/jbc.271.24.14124; Wilcox LJ, 2001, J LIPID RES, V42, P725; Williams KJ, 2001, CURR OPIN LIPIDOL, V12, P477, DOI 10.1097/00041433-200110000-00002; WOOD KM, 1976, BIOCHEM J, V158, P39, DOI 10.1042/bj1580039; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	75	59	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36289	36302		10.1074/jbc.M510861200	http://dx.doi.org/10.1074/jbc.M510861200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16956892	hybrid			2022-12-27	WOS:000242100500081
J	Amiott, EA; Jaehning, JA				Amiott, Elizabeth A.; Jaehning, Judith A.			Sensitivity of the yeast mitochondrial RNA polymerase to+1 and+2 initiating nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN COMPLEX-FORMATION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; SPECIFICITY FACTOR; TRANSCRIPTION INITIATION; CHAIN INITIATION; PROMOTER; BACTERIOPHAGE-T7; MECHANISM; KINETICS	Despite a simple consensus sequence, there is considerable variation of promoter strengths, transcription rates, and the kinetics of initiating nucleotide incorporation among the promoters found in the Saccharomyces cerevisiae mitochondrial genome. We asked how changes in the initiating (+1 and +2) nucleotides, conformation of the promoter DNA template, and mutation of the mitochondrial RNA polymerase (mtRNAP) affect the kinetics of nucleotide (NTP) utilization. Using a highly purified in vitro mitochondrial transcription system, we found that 1) the mtRNAP requires the highest concentrations of the +1 and +2 initiating NTPs, intermediate concentrations of NTPs at positions 5 to 11, and low concentrations of elongating NTPs; 2) the mtRNAP requires a higher concentration of the +2 NTP than the +1 NTP for initiation; 3) the kinetics of +2 NTP utilization are altered by a point mutation in the mtRNAP subunit Mtf1; and 4) a supercoiled or pre-melted promoter DNA template restores normal +2 NTP utilization by the Mtf1 mutant. Based on comparisons to the structural and biochemical properties of the bacterial RNAP and the closely related T7 RNAP, we propose that initiating nucleotides, particularly the +2 NTP, are required at high concentrations to drive mitochondrial promoter opening or to stabilize a productive open complex.	Univ Colorado, Dept Biochem & Mol Genet, Denver, CO 80202 USA; Hlth Sci Ctr, Aurora, CO 80045 USA; Univ Colorado, Program Mol Biol, Denver, CO 80202 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Jaehning, JA (corresponding author), Univ Colorado, Dept Biochem & Mol Genet, Mail Stop 8101,POB 6511, Denver, CO 80202 USA.	Judith.Jaehning@UCHSC.edu						Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Biswas TK, 1999, BIOCHEMISTRY-US, V38, P9693, DOI 10.1021/bi982804l; BISWAS TK, 1986, P NATL ACAD SCI USA, V83, P270, DOI 10.1073/pnas.83.2.270; BISWAS TK, 1990, P NATL ACAD SCI USA, V87, P9338, DOI 10.1073/pnas.87.23.9338; BISWAS TK, 1987, J BIOL CHEM, V262, P13690; BISWAS TK, 1985, P NATL ACAD SCI USA, V82, P1954, DOI 10.1073/pnas.82.7.1954; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; DEHASETH PL, 1995, MOL MICROBIOL, V16, P817, DOI 10.1111/j.1365-2958.1995.tb02309.x; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Huang JB, 1999, J MOL BIOL, V293, P457, DOI 10.1006/jmbi.1999.3135; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; JANG SH, 1991, J BIOL CHEM, V266, P22671; Jia YP, 1997, J BIOL CHEM, V272, P30147, DOI 10.1074/jbc.272.48.30147; Karlok MA, 2002, J BIOL CHEM, V277, P28143, DOI 10.1074/jbc.M204123200; KELLY JL, 1986, J BIOL CHEM, V261, P348; Kuzmine I, 2001, J MOL BIOL, V305, P559, DOI 10.1006/jmbi.2000.4316; Lew CM, 2004, BIOCHEMISTRY-US, V43, P12660, DOI 10.1021/bi0492814; Lew CM, 2004, J BIOL CHEM, V279, P19481, DOI 10.1074/jbc.M401285200; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; MCALLISTER WT, 1993, CELL MOL BIOL RES, V39, P385; MUELLER DM, 1986, J BIOL CHEM, V261, P1816; MUELLER DM, 1986, J BIOL CHEM, V261, P1756; NIERMAN WC, 1979, J BIOL CHEM, V254, P7921; NIERMAN WC, 1980, J BIOL CHEM, V255, P1819; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Schneider DA, 2003, CURR OPIN MICROBIOL, V6, P151, DOI 10.1016/S1369-5274(03)00038-9; Schneider DA, 2002, P NATL ACAD SCI USA, V99, P8602, DOI 10.1073/pnas.132285199; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Stano NM, 2004, J BIOL CHEM, V279, P16136, DOI 10.1074/jbc.M400139200; Stano NM, 2002, J BIOL CHEM, V277, P37292, DOI 10.1074/jbc.M201600200; ULERY TL, 1994, MOL CELL BIOL, V14, P1160, DOI 10.1128/MCB.14.2.1160; Villemain J, 1997, J MOL BIOL, V273, P958, DOI 10.1006/jmbi.1997.1358; WETTSTEINEDWARDS J, 1986, J BIOL CHEM, V261, P2905; WINKLEY CS, 1985, J BIOL CHEM, V260, P4214	38	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34982	34988		10.1074/jbc.M608638200	http://dx.doi.org/10.1074/jbc.M608638200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	17003030	hybrid			2022-12-27	WOS:000241933700031
J	Kujawa, M; Ebner, H; Leitner, C; Hallberg, BM; Prongjit, M; Sucharitakul, J; Ludwig, R; Rudsander, U; Peterbauer, C; Chaiyen, P; Haltrich, D; Divne, C				Kujawa, Magdalena; Ebner, Heidemarie; Leitner, Christian; Hallberg, B. Martin; Prongjit, Methinee; Sucharitakul, Jeerus; Ludwig, Roland; Rudsander, Ulla; Peterbauer, Clemens; Chaiyen, Pimchai; Haltrich, Dietmar; Divne, Christina			Structural basis for substrate binding and regioselective oxidation of monosaccharides at C3 by pyranose 2-oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; P-CRESOL METHYLHYDROXYLASE; FUNGUS TRAMETES-MULTICOLOR; CRYSTAL-STRUCTURE; PHANEROCHAETE-CHRYSOSPORIUM; CELLOBIOSE DEHYDROGENASE; ALCOHOL OXIDASE; COVALENT FLAVINYLATION; CATALYTIC MECHANISM; LIGNIN DEGRADATION	Pyranose2-oxidase(P2Ox) participates in fungal lignin degradation by producing the H2O2 needed for lignin-degrading peroxidases. The enzyme oxidizes cellulose- and hemicellulose-derived aldopyranoses at C2 preferentially, but also on C3, to the corresponding ketoaldoses. To investigate the structural determinants of catalysis, covalent flavinylation, substrate binding, and regios-electivity, wild-type and mutant P2Ox enzymes were produced and characterized biochemically and structurally. Removal of the histidyl-FAD linkage resulted in a catalytically competent enzyme containing tightly, but noncovalently bound FAD. This mutant (H167A) is characterized by a 5-fold lower k(cat), and a 35-mV lower redox potential, although no significant structural changes were seen in its crystal structure. In previous structures of P2Ox, the substrate loop (residues 452-457) covering the active site has been either disordered or in a conformation incompatible with carbohydrate binding. We present here the crystal structure of H167A in complex with a slow substrate, 2-fluoro-2-deoxy-D-glucose. Based on the details of 2-fluoro-2-deoxy-D-glucose binding in position for oxidation at C3, we also outline a probable binding mode for D-glucose positioned for regioselective oxidation at C2. The tentative determinant for discriminating between the two binding modes is the position of the O6 hydroxyl group, which in the C2-oxidation mode can make favorable interactions with Asp(452) in the substrate loop and, possibly, a nearby arginine residue (Arg(472)). We also substantiate our hypothesis with steady-state kinetics data for the alanine replacements of Asp(452) and Arg(472) as well as the double alanine 452/472 mutant.	Royal Inst Technol, Sch Biotechnol, Albanova Univ Ctr, SE-10691 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand; Univ Nat Resources & Appl Life Sci, Dept Food Sci & Technol, A-1190 Vienna, Austria	Royal Institute of Technology; Karolinska Institutet; Mahidol University; Mahidol University; University of Natural Resources & Life Sciences, Vienna	Divne, C (corresponding author), Royal Inst Technol, Sch Biotechnol, Albanova Univ Ctr, SE-10691 Stockholm, Sweden.	divne@biotech.kth.se	Haltrich, Dietmar/N-2624-2019; Chaiyen, Pimchai/R-5052-2019; Chaiyen, Pimchai/A-8236-2010; Divne, Christina/E-8646-2010; Hallberg, B. Martin/C-5361-2009	Haltrich, Dietmar/0000-0002-8722-8176; Chaiyen, Pimchai/0000-0002-8533-1604; Divne, Christina/0000-0002-5805-2693; Hallberg, B. Martin/0000-0002-6781-0345; Ludwig, Roland/0000-0002-5058-5874; Peterbauer, Clemens/0000-0002-8033-198X	Austrian Science Fund FWF [L 213] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Albrecht M, 2003, BIOINFORMATICS, V19, P1216, DOI 10.1093/bioinformatics/btg140; Ander P, 1997, J BIOTECHNOL, V53, P115, DOI 10.1016/S0168-1656(97)01680-5; Artolozaga MJ, 1997, APPL MICROBIOL BIOT, V47, P508, DOI 10.1007/s002530050964; Ausubel F.M., 2002, SHORT PROTOCOLS MOL, V1; Bannwarth M, 2004, BIOCHEMISTRY-US, V43, P11683, DOI 10.1021/bi048609q; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; DANIEL G, 1994, APPL ENVIRON MICROB, V60, P2524, DOI 10.1128/AEM.60.7.2524-2532.1994; DANNEEL HJ, 1993, EUR J BIOCHEM, V214, P795, DOI 10.1111/j.1432-1033.1993.tb17982.x; Efimov I, 2004, BIOCHEMISTRY-US, V43, P10532, DOI 10.1021/bi049375d; Efimov I, 2001, BIOCHEMISTRY-US, V40, P2155, DOI 10.1021/bi001644m; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan F, 2005, J AM CHEM SOC, V127, P2067, DOI 10.1021/ja044541q; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Freimund S, 1998, CHEM-EUR J, V4, P2442, DOI 10.1002/(SICI)1521-3765(19981204)4:12<2442::AID-CHEM2442>3.3.CO;2-1; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Gurr SJ, 1987, GENE STRUCTURE EUKAR, P93; Halada P, 2003, ANAL BIOCHEM, V314, P235, DOI 10.1016/S0003-2697(02)00661-9; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Hallberg BM, 2004, ACTA CRYSTALLOGR D, V60, P197, DOI 10.1107/S0907444903024922; Hallberg BM, 2003, J BIOL CHEM, V278, P7160, DOI 10.1074/jbc.M210961200; Hallberg BM, 2002, J MOL BIOL, V315, P421, DOI 10.1006/jmbi.2001.5246; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Leitner C, 2001, APPL ENVIRON MICROB, V67, P3636, DOI 10.1128/AEM.67.8.3636-3644.2001; Leitner C, 1998, APPL BIOCHEM BIOTECH, V70-2, P237, DOI 10.1007/BF02920140; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; MENON V, 1995, BIOORG CHEM, V23, P42, DOI 10.1006/bioo.1995.1004; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Rotsaert FAJ, 2003, BIOCHEMISTRY-US, V42, P4049, DOI 10.1021/bi027092k; Salazar D, 1997, J BIOL CHEM, V272, P26425, DOI 10.1074/jbc.272.42.26425; Schafer A, 1996, APPL ENVIRON MICROB, V62, P2586, DOI 10.1128/AEM.62.7.2586-2592.1996; ten Have R, 2001, CHEM REV, V101, P3397, DOI 10.1021/cr000115l; Vecerek B, 2004, APPL MICROBIOL BIOT, V64, P525, DOI 10.1007/s00253-003-1516-z; Volc J, 1996, ARCH MICROBIOL, V165, P421, DOI 10.1007/s002030050348; VOLC J, 1985, FOLIA MICROBIOL, V30, P141, DOI 10.1007/BF02922207; Volc Jindrich, 1995, Carbohydrate Research, V278, P59, DOI 10.1016/0008-6215(95)00247-3; VRIELINK A, 1991, J MOL BIOL, V219, P533, DOI 10.1016/0022-2836(91)90192-9	44	70	72	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35104	35115		10.1074/jbc.M604718200	http://dx.doi.org/10.1074/jbc.M604718200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16984920	hybrid			2022-12-27	WOS:000241933700044
J	Peters, GA; Li, SD; Sen, GC				Peters, Gregory A.; Li, Shoudong; Sen, Ganes C.			Phosphorylation of specific serine residues in the PKR activation domain of PACT is essential for its ability to mediate apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; NF-KAPPA-B; IN-VITRO; CELLULAR ACTIVATOR; INTERFERON; BINDING; STRESS; PATHWAYS; INHIBITION	Activation of the latent protein kinase, PKR, by extracellular stresses and triggering of resultant cellular apoptosis are mediated by the protein, PACT, which itself gets phosphorylated in stressed cells. We have analyzed the underlying biochemical mechanism by carrying out alanine-scanning mutagenesis of the PKR activation domain of PACT. Among the indispensable residues identified were two serine residues, whose phosphorylation was essential for the cellular actions of PACT. Two-dimensional gel analysis, Western analysis using phosphoamino acid-specific antiserum, and in vivo P-32 labeling of PACT demonstrated that constitutive phosphorylation of one of the two residues, Ser(246), was required for stress-induced phosphorylation of the other, Ser(287). Substitution of either of them by threonine or aspartic acid, but not alanine, was tolerated. Substitution of both residues with the phosphoserine mimetic, aspartic acid, produced a mutant PACT that, unlike the wild-type protein, caused PKR activation and apoptosis, even in unstressed cells. These results indicate that phosphorylation of specific serine residues in the activation domain of PACT is the major mode of transmission of cellular stress response to PKR.	Cleveland Clin Fdn, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA; Case Western Reserve Univ, Grad Program Mol Virol, Sch Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Sen, GC (corresponding author), Cleveland Clin Fdn, Dept Mol Genet, Lerner Res Inst, NE 20,9500 Euclid Ave, Cleveland, OH 44195 USA.	seng@ccf.org		Peters, Gregory/0000-0001-6914-7316	NCI NIH HHS [CA-68782, R01 CA068782, P01 CA062220, CA-62220] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068782, P01CA062220] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bennett RL, 2004, J BIOL CHEM, V279, P42687, DOI 10.1074/jbc.M403321200; BISCHOFF JR, 1985, J BIOL CHEM, V260, P8237; Carpick BW, 1997, J BIOL CHEM, V272, P9510, DOI 10.1074/jbc.272.14.9510; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; DACQUISTO F, 2001, SCI STKE; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; Iordanov MS, 2000, MOL CELL BIOL, V20, P617, DOI 10.1128/MCB.20.2.617-627.2000; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; PATEL RC, 1992, J BIOL CHEM, V267, P7671; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peters GA, 2002, J VIROL, V76, P11054, DOI 10.1128/JVI.76.21.11054-11064.2002; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Pogulis R J, 1996, Methods Mol Biol, V57, P167; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Williams B.R., 2001, SCI STKE, V2001, pre2; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000	27	43	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35129	35136		10.1074/jbc.M607714200	http://dx.doi.org/10.1074/jbc.M607714200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16982605	hybrid			2022-12-27	WOS:000241933700046
J	Tarutina, M; Ryjenkov, DA; Gomelsky, M				Tarutina, Marina; Ryjenkov, Dmitri A.; Gomelsky, Mark			An unorthodox bacteriophytochrome from Rhodobacter sphaeroides involved in turnover of the second messenger c-di-GMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3',5'-CYCLIC DIGUANYLIC ACID; ACETOBACTER-XYLINUM; CYCLIC DIGUANYLATE; AGROBACTERIUM-TUMEFACIENS; PHYTOCHROME SUPERFAMILY; CELLULOSE SYNTHESIS; ALLOSTERIC CONTROL; HISTIDINE KINASES; PROTEIN DOMAIN; LIGHT	Bacteriophytochromes are bacterial photoreceptors that sense red/far red light using the biliverdin chromophore. Most bacteriophytochromes work as photoactivated protein kinases. The Rhodobacter sphaeroides bacteriophytochrome BphG1 is unconventional in that it has GGDEF and EAL output domains, which are involved, respectively, in synthesis (diguanylate cyclase) and degradation (phosphodiesterase) of the bacterial second messenger c-di-GMP. The GGDEF-EAL proteins studied to date displayed either diguanylate cyclase or phosphodiesterase activity but not both. To elucidate the function of BphG1, the holoprotein was purified from an Escherichia coli overexpression system designed to produce biliverdin. The holoprotein contained covalently bound biliverdin and interconverted between the red (dark) and far red (light-activated) forms. BphG1 had c-di-GMP-specific phosphodiesterase activity. Unexpectedly for a photochromic protein, this activity was essentially light-independent. BphG1 expressed in E. coli was found to undergo partial cleavage into two species. The smaller species was identified as the EAL domain of BphG1. It possessed c-di-GMP phosphodiesterase activity. Surprisingly, the larger species lacking EAL possessed diguanylate cyclase activity, which was dependent on biliverdin and strongly activated by light. BphG1 therefore is the first phytochrome with a non-kinase photoactivated enzymatic activity. This shows that the photosensory modules of phytochromes can transmit light signals to various outputs. BphG1 is potentially the first "bifunctional" enzyme capable of both c-di-GMP synthesis and hydrolysis. A model for the regulation of the "opposite" activities of BphG1 is presented.	Univ Wyoming, Dept Mol Biol, Dept 3944, Laramie, WY 82071 USA	University of Wyoming	Gomelsky, M (corresponding author), Univ Wyoming, Dept Mol Biol, Dept 3944, 1000 E Univ Ave, Laramie, WY 82071 USA.	gomelsky@uwyo.edu	Tarutina, Marina/AAG-1691-2021; gomelsky, mark/F-6209-2010	Gomelsky, Mark/0000-0003-4077-3932				AMIKAM D, 1995, BIOCHEM J, V311, P921, DOI 10.1042/bj3110921; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Braslavsky SE, 1997, PLANT CELL ENVIRON, V20, P700, DOI 10.1046/j.1365-3040.1997.d01-101.x; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Chen M, 2005, CURR BIOL, V15, P637, DOI 10.1016/j.cub.2005.02.028; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Franklin KA, 2005, INT J DEV BIOL, V49, P653, DOI 10.1387/ijdb.051989kf; Galperin MY, 2005, ASM NEWS, V71, P326; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Karaolis DKR, 2005, BIOCHEM BIOPH RES CO, V329, P40, DOI 10.1016/j.bbrc.2005.01.093; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 2001, EUR J BIOCHEM, V268, P4720, DOI 10.1046/j.1432-1327.2001.02395.x; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Steinberger O, 1999, FEBS LETT, V444, P125, DOI 10.1016/S0014-5793(99)00036-8; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wilde A, 2002, MOL MICROBIOL, V44, P981, DOI 10.1046/j.1365-2958.2002.02923.x; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	45	118	126	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34751	34758		10.1074/jbc.M604819200	http://dx.doi.org/10.1074/jbc.M604819200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16968704	hybrid			2022-12-27	WOS:000241933700006
J	Hanano, A; Burcklen, M; Flenet, M; Ivancich, A; Louwagie, M; Garin, J; Blee, E				Hanano, Abdulsamie; Burcklen, Michel; Flenet, Martine; Ivancich, Anabella; Louwagie, Mathilde; Garin, Jerome; Blee, Elizabeth			Plant seed peroxygenase is an original heme-oxygenase with an EF-hand calcium binding motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPEROXIDE-DEPENDENT OXYGENASE; ELECTRON-PARAMAGNETIC-RESONANCE; UNSATURATED FATTY-ACIDS; HORSERADISH-PEROXIDASE; OIL BODIES; LIPID BODIES; ARABIDOPSIS-THALIANA; LINOLEIC-ACID; PROTEINS; SITE	A growing body of evidence indicates that phytooxylipins play important roles in plant defense responses. However, many enzymes involved in the biosynthesis of these metabolites are still elusive. We have purified one of these enzymes, the peroxygenase (PXG), from oat microsomes and lipid droplets. It is an integral membrane protein requiring detergent for its solubilization. Proteinase K digestion showed that PXG is probably deeply buried in lipid droplets or microsomes with only about 2 kDa at the C-terminal region accessible to proteolytic digestion. Sequencing of the N terminus of the purified protein showed that PXG had no sequence similarity with either a peroxidase or a cytochrome P450 but, rather, with caleosins, i. e. calcium-binding proteins. In agreement with this finding, we demonstrated that recombinant thale cress and rice caleosins, expressed in yeast, catalyze hydroperoxide-dependent mono-oxygenation reactions that are characteristic of PXG. Calcium was also found to be crucial for peroxygenase activity, whereas phosphorylation of the protein had no impact on catalysis. Site-directed mutagenesis studies revealed that PXG catalytic activity is dependent on two highly conserved histidines, the 9 GHz EPR spectrum being consistent with a high spin pentacoordinated ferric heme.	CNRS, UPR 2357, Inst Biol Mol Plantes, Lab Phytooxlipines, F-67083 Strasbourg, France; CEA Saclay, Dept Biol Joliot Curie, CNRS URA 2096, Serv Bioenerget, F-91191 Gif Sur Yvette, France; Commisariat Energie Atom Saclay, INSERM, ERM 0201, Lab Chim Prot, F-38054 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Blee, E (corresponding author), CNRS, UPR 2357, Inst Biol Mol Plantes, Lab Phytooxlipines, 28 Rue Goethe, F-67083 Strasbourg, France.	elizabeth.blee@ibmp-ulp.u-strasbg.fr	Hanano, Abdulsamie/V-6835-2019; Hanano, Abdulsamie/G-2623-2014	Ivancich, Anabella/0000-0002-4275-0980; Hanano, Abdulsamie/0000-0002-1699-106X				Autieri MV, 2005, EXP CELL RES, V307, P204, DOI 10.1016/j.yexcr.2005.03.002; BAEK HK, 1992, J AM CHEM SOC, V114, P718, DOI 10.1021/ja00028a046; Baltzer L, 1998, CURR OPIN STRUC BIOL, V8, P466, DOI 10.1016/S0959-440X(98)80124-3; BANCI L, 1997, J BIOTECHNOL, V53, P897; BLEE E, 1993, PLANT J, V4, P113, DOI 10.1046/j.1365-313X.1993.04010113.x; BLEE E, 1986, BIOCHEM BIOPH RES CO, V135, P922, DOI 10.1016/0006-291X(86)91016-8; BLEE E, 1993, J BIOL CHEM, V268, P1708; BLEE E, 1990, J BIOL CHEM, V265, P12887; BLEE E, 1987, ARCH BIOCHEM BIOPHYS, V254, P43, DOI 10.1016/0003-9861(87)90079-8; BLEE E, 1989, BIOCHEMISTRY-US, V28, P4962, DOI 10.1021/bi00438a009; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Blee Elizabeth, 1996, P138, DOI 10.1201/9781439831977.ch8; Chen ECF, 1998, PLANT CELL PHYSIOL, V39, P935, DOI 10.1093/oxfordjournals.pcp.a029457; Chen JCF, 1999, PLANT CELL PHYSIOL, V40, P1079, DOI 10.1093/oxfordjournals.pcp.a029490; Chen MCM, 2004, J AGR FOOD CHEM, V52, P3982, DOI 10.1021/jf035533g; DEMONTELLANO PRO, 1987, ACCOUNTS CHEM RES, V20, P289; Dunford B.H., 1999, HEME PEROXIDASES; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Frandsen G, 1996, J BIOL CHEM, V271, P343, DOI 10.1074/jbc.271.1.343; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Hamberg M, 1996, PLANT PHYSIOL, V110, P807, DOI 10.1104/pp.110.3.807; HAMBERG M, 1990, ARCH BIOCHEM BIOPHYS, V283, P409, DOI 10.1016/0003-9861(90)90662-I; HAMBERG M, 1991, LIPIDS, V26, P407, DOI 10.1007/BF02536065; HASCHKE RH, 1978, BIOCHEM BIOPH RES CO, V80, P1039, DOI 10.1016/0006-291X(78)91350-5; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; ISHIMARU A, 1977, J BIOL CHEM, V252, P6118; Ivancich A, 2001, BIOCHEMISTRY-US, V40, P6860, DOI 10.1021/bi002826j; Jakopitsch C, 2006, J INORG BIOCHEM, V100, P1091, DOI 10.1016/j.jinorgbio.2006.02.009; KATO T, 1993, BIOSCI BIOTECH BIOCH, V57, P283, DOI 10.1271/bbb.57.283; KAWASAKI H, 1994, PROTEIN PROFILE, V1, P343; Lequeu J, 2003, PLANT J, V36, P155, DOI 10.1046/j.1365-313X.2003.01865.x; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matsunaga I, 2002, FEBS LETT, V528, P90, DOI 10.1016/S0014-5793(02)03261-1; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; MORISHIMA I, 1986, J BIOL CHEM, V261, P9391; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Murphy DJ, 2001, J PLANT PHYSIOL, V158, P471, DOI 10.1078/0176-1617-00359; Naested H, 2000, PLANT MOL BIOL, V44, P463, DOI 10.1023/A:1026564411918; NAMAI T, 1993, BIOSCI BIOTECH BIOCH, V57, P611, DOI 10.1271/bbb.57.611; Noordermeer MA, 2000, EUR J BIOCHEM, V267, P2473, DOI 10.1046/j.1432-1327.2000.01283.x; Nuccio ML, 1999, PLANT MOL BIOL, V39, P1153, DOI 10.1023/A:1006101404867; OHTA H, 1990, PLANT CELL PHYSIOL, V31, P1117; PALMER G, 1983, IRON PORPHYRINS 2, P43; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shin K, 2001, BIOCHEM BIOPH RES CO, V281, P1024, DOI 10.1006/bbrc.2001.4448; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Takahashi J, 2000, IEEE T NUCL SCI, V47, P903, DOI 10.1109/23.856715; Tanaka M, 1996, BIOCHEM BIOPH RES CO, V227, P393, DOI 10.1006/bbrc.1996.1518; Tanaka M, 1997, BIOCHEMISTRY-US, V36, P9889, DOI 10.1021/bi970906q; Ting JTL, 1997, J BIOL CHEM, V272, P3699, DOI 10.1074/jbc.272.6.3699; Toorop PE, 2005, PLANTA, V221, P637, DOI 10.1007/s00425-004-1477-1; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Yi XW, 1999, P NATL ACAD SCI USA, V96, P12412, DOI 10.1073/pnas.96.22.12412	60	114	122	4	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33140	33151		10.1074/jbc.M605395200	http://dx.doi.org/10.1074/jbc.M605395200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956885	hybrid			2022-12-27	WOS:000241621400022
J	Isaji, T; Sato, Y; Zhao, YY; Miyoshi, E; Wada, Y; Taniguchi, N; Gu, JG				Isaji, Tomoya; Sato, Yuya; Zhao, Yanyang; Miyoshi, Eiji; Wada, Yoshinao; Taniguchi, Naoyuki; Gu, Jianguo			N-glycosylation of the beta-propeller domain of the integrin alpha 5 subunit is essential for alpha 5 beta 1 heterodimerization, expression on the cell surface, and its biological function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID FIBRONECTIN RECEPTORS; ENDOPLASMIC-RETICULUM; EXTRACELLULAR SEGMENT; ADHESION RECEPTORS; MESODERMAL DEFECTS; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; QUALITY-CONTROL; LIGAND-BINDING; DEFICIENT MICE	The N-glycosylation of integrin alpha 5 beta 1 is thought to play crucial roles in cell spreading, cell migration, ligand binding, and dimer formation, but the underlying mechanism remains unclear. To investigate the importance of the N-glycans of this integrin in detail, sequential site-directed mutagenesis was carried out to remove single or combined putative N-glycosylationsitesonthe alpha 5 integrin. Removal of the putative N-glycosylation sites on the beta-propeller, Thigh, Calf-1, or Calf-2 domains of the alpha 5 subunit resulted in a decrease in molecular weight compared with the wild type, suggesting that all of these domains contain attached N-glycans. Importantly, the absence of N-glycosylation sites (sites1-5) on the beta-propeller resulted in the persistent association of integrin subunit with calnexin in the endoplasmic reticulum, which subsequently blocked heterodimerization and its expression on the cell surface. Interestingly, the activities for cell spreading and migration for the alpha 5 subunit carrying only three potential N-glycosylationsites(3-5sites) on the beta-propellerwerecomparablewiththose of the wild type. In contrast, mutation of these three sites resulted in a significant decrease in cell spreading as well as functional expression, although the total expression level of the Delta 3-5 mutant on the cell surface was comparable with that of wild type. Furthermore, we found that site 5 is a most important site for its expression on the cell surface, whereas the S5 mutant did not show any biological functions. Taken together, this study reveals for the first time that the N-glycosylation on the beta-propeller domain of the alpha 5 subunit is essential for heterodimerization and biological functions of alpha 5 beta 1 integrin and might also be useful for studies of the molecular structure.	Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan; Osaka Med Ctr, Dept Mol Med, Osaka 5941101, Japan; Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; Osaka Univ, Dept Dis Glycom, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan	Tohoku Medical & Pharmaceutical University; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan.	jgu@tohoku.pharm.ac.jp	Taniguchi, Naoyuki/I-4182-2014; Isaji, Tomoya/ABC-9285-2021; Taniguchi, Naoyuki/A-7086-2016; Gu, Jianguo/ABC-9257-2020	Taniguchi, Naoyuki/0000-0001-5889-5968; 				ADAMS JC, 1993, DEVELOPMENT, V117, P1183; AKIYAMA SK, 1989, J BIOL CHEM, V264, P18011; AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Berditchevski F, 2001, J CELL SCI, V114, P4143; BROWN PJ, 1988, EXP CELL RES, V177, P303, DOI 10.1016/0014-4827(88)90464-8; Cao ZJ, 1998, J BIOL CHEM, V273, P31670, DOI 10.1074/jbc.273.48.31670; CHAMMAS R, 1991, J BIOL CHEM, V266, P3349; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Dennis JW, 2002, BBA-GEN SUBJECTS, V1573, P414, DOI 10.1016/S0304-4165(02)00411-7; DWEK RA, 1995, BIOCHEM SOC T, V23, P1; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ethier M, 2005, RAPID COMMUN MASS SP, V19, P721, DOI 10.1002/rcm.1844; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GIPSON IK, 1984, DEV BIOL, V101, P212, DOI 10.1016/0012-1606(84)90131-3; Goh KL, 1997, DEVELOPMENT, V124, P4309; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Guo HB, 2002, CANCER RES, V62, P6837; Guo L, 2002, J BIOL CHEM, V277, P50776, DOI 10.1074/jbc.M209900200; HEINO J, 1989, J BIOL CHEM, V264, P380; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hoffmeister KM, 2003, SCIENCE, V301, P1531, DOI 10.1126/science.1085322; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Jasiulionis MG, 1996, CANCER RES, V56, P1682; Josefsson EC, 2005, J BIOL CHEM, V280, P18025, DOI 10.1074/jbc.M501178200; Karamyshev AL, 2005, J BIOL CHEM, V280, P40489, DOI 10.1074/jbc.M509168200; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LENTER M, 1994, J BIOL CHEM, V269, P12263; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Miyoshi E, 1999, CANCER RES, V59, P2237; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saxon E, 2001, ANNU REV CELL DEV BI, V17, P1, DOI 10.1146/annurev.cellbio.17.1.1; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2005, EMBO REP, V6, P239, DOI 10.1038/sj.embor.7400351; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325	54	89	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33258	33267		10.1074/jbc.M607771200	http://dx.doi.org/10.1074/jbc.M607771200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959765	hybrid			2022-12-27	WOS:000241621400035
J	Mero, P; Zhang, CY; Huang, ZY; Kim, MK; Schreiber, AD; Grinstein, S; Booth, JW				Mero, Patricia; Zhang, Christine Y.; Huang, Zhen-Yu; Kim, Moo-Kyung; Schreiber, Alan D.; Grinstein, Sergio; Booth, James W.			Phosphorylation-independent ubiquitylation and endocytosis of Fc gamma RIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; UBIQUITIN-BINDING PROTEINS; TYROSINE PHOSPHORYLATION; CELL-LINE; RECEPTOR; PHAGOCYTOSIS; INTERNALIZATION; DEGRADATION; ENDOSOMES; KINASES	Endocytosis of the Fc receptor Fc gamma RIIA depends on a functional ubiquitin conjugation system, and the receptor becomes ubiquitylated upon ligand binding. Phosphorylation of tyrosines in Fc gamma RIIA by Src family kinases is thought to be the initiating event in its signaling. However, although the Src family kinase inhibitor PP1 inhibited both ligand-induced phosphorylation of Fc gamma RIIA and phagocytosis in ts20 cells expressing Fc gamma RIIA, it did not inhibit receptor ubiquitylation or endocytosis of soluble ligands. Conversely, genistein and the proteasomal inhibitor MG132 did not inhibit receptor phosphorylation but strongly inhibited both receptor ubiquitylation and endocytosis. A region of the receptor lying within the immunoreceptor tyrosine-based activation motif was found to be necessary for both ubiquitylation and endocytosis. Ubiquitylation occurs at the plasma membrane before internalization. Endocytosis of Fc gamma RIIA is dependent on clathrin but independent of the adaptor protein AP-2. These findings point to a novel mechanism for ubiquitylation and endocytosis of this immunoreceptor.	Sunnybrook Res Inst, Mol & Cellular Biol Res, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Booth, JW (corresponding author), Sunnybrook Res Inst, Mol & Cellular Biol Res, 2075 Bayview Ave,Rm S-116, Toronto, ON M4N 3M5, Canada.	James.Booth@sunnybrook.ca						Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Belouzard S, 2006, EMBO J, V25, P932, DOI 10.1038/sj.emboj.7600989; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Cannons JL, 2004, CURR OPIN IMMUNOL, V16, P296, DOI 10.1016/j.coi.2004.03.011; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DAVIS W, 1995, EMBO J, V14, P432, DOI 10.1002/j.1460-2075.1995.tb07019.x; GHAZIZADEH S, 1994, J IMMUNOL, V152, P30; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; GRABER M, 1992, INT IMMUNOL, V4, P1201, DOI 10.1093/intimm/4.11.1201; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; KANAKURA Y, 1991, J BIOL CHEM, V266, P490; Kelm KB, 2004, TRAFFIC, V5, P165, DOI 10.1111/j.1600-0854.2004.00168.x; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200	30	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33242	33249		10.1074/jbc.M605372200	http://dx.doi.org/10.1074/jbc.M605372200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959774	hybrid			2022-12-27	WOS:000241621400033
J	Ramana, KV; Fadl, AA; Tammali, R; Reddy, ABM; Chopra, AK; Srivastava, SK				Ramana, Kota V.; Fadl, Amin A.; Tammali, Ravinder; Reddy, Aramati B. M.; Chopra, Ashok K.; Srivastava, Satish K.			Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages (Publication with Expression of Concern. See vol. 294, pg. 1633, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Publication with Expression of Concern							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; MULTIPLE ORGAN DYSFUNCTION; SMOOTH-MUSCLE-CELLS; INDUCED EXPRESSION; UP-REGULATION; SEPTIC SHOCK; IN-VITRO; ACTIVATION; RESPONSES	Abnormal production of inflammatory cytokines and chemokines is a key feature of bacterial endotoxin, lipopolysaccharide (LPS)-induced inflammation, and cytotoxicity; however, the mechanisms regulating production of inflammatory markers remain unclear. Herein, we show that inhibition of the aldehyde-metabolizing enzyme aldose reductase (AR; AKR1B3) modulates NF-kappa B-dependent activation of inflammatory cytokines and chemokines in mouse serum, liver, heart, and spleen. Pharmacological inhibition or small interfering RNA ablation of AR prevented the biosynthesis of tumor necrosis factor-alpha, interleukin 1 beta, interleukin-6, macrophage-chemoattractant protein-1, and cyclooxygenase-2 and prostaglandin E-2 in LPS-activated RAW264.7 murine macrophages. The AR inhibition or ablation significantly attenuated LPS-induced activation of protein kinase C (PKC) and phospholipase C (PLC), nuclear translocation of NF-kappa B, and phosphorylation and proteolytic degradation of I kappa B kappa in macrophages. Furthermore, treatment of macrophages with 4-hydroxy-trans-2-nonenal (HNE), and cell-permeable esters of glutathionyl-4-hydroxynonanal (GS-HNE) and glutathionyl-1,4-dihydroxynonane (GSDHN) activated NF-kappa B and PLC/PKC. Pharmacological inhibition or antisense ablation of AR that catalyzes the reduction of GS-HNE to GS-DHN prevented PLC, PKC, IKK alpha/beta, and NF-kappa B activation caused by HNE and GS-HNE, but not by GS-DHN, suggesting that reduced GS-lipid aldehydes catalyzed by AR propagate LPS-induced production of inflammatory markers. Collectively, these data provide evidence that inhibition of AR may be a significant therapeutic approach in preventing bacterial endotoxin-induced sepsis and tissue damage.	Univ Texas, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Ramana, KV (corresponding author), Univ Texas, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	kvramana@utmb.edu	Ramana, Kota/C-5460-2012	Ramana, Kota/0000-0001-6502-7800	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041611, R01AI064389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK036118, R01DK036118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071036] Funding Source: NIH RePORTER; NIAID NIH HHS [AI041611, AI064389] Funding Source: Medline; NIDDK NIH HHS [DK36118] Funding Source: Medline; NIGMS NIH HHS [GM71036] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Antonicelli F, 2004, AM J PHYSIOL-LUNG C, V286, pL1319, DOI 10.1152/ajplung.00329.2003; Balk RA, 2000, CRIT CARE CLIN, V16, P337, DOI 10.1016/S0749-0704(05)70113-5; Beutler B, 1995, J CARDIOVASC PHARM, V25, pS1, DOI 10.1097/00005344-199500252-00002; Bluth MH, 2006, CRIT CARE MED, V34, P188, DOI 10.1097/01.CCM.0000196212.56885.50; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Goode S, 2006, GUT, V55, P590, DOI 10.1136/gut.2005.085449; Hall AJ, 1999, J BIOL CHEM, V274, P376, DOI 10.1074/jbc.274.1.376; Hsu BG, 2004, J BIOMED SCI, V11, P152, DOI 10.1159/000076027; Hulten LM, 1998, TRANSPLANTATION, V66, P364, DOI 10.1097/00007890-199808150-00014; Jacobs AT, 2001, J BIOL CHEM, V276, P47950, DOI 10.1074/jbc.M106639200; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kobayashi M, 2006, CURR DRUG TARGETS, V7, P119, DOI 10.2174/138945006775270169; Kubota T, 1997, J Card Fail, V3, P117, DOI 10.1016/S1071-9164(97)90045-2; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Lindros KO, 2005, METAB BRAIN DIS, V20, P393, DOI 10.1007/s11011-005-7924-2; MOHLER KM, 1993, J IMMUNOL, V151, P1548; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Neveu PJ, 2003, STRESS, V6, P5, DOI 10.1080/1025389031000087472; Pittard A J, 1994, Clin Intensive Care, V5, P186; Pollara G, 2006, SCAND J IMMUNOL, V63, P151, DOI 10.1111/j.1365-3083.2006.01727.x; Ramana KV, 2006, J BIOL CHEM, V281, P17652, DOI 10.1074/jbc.M600270200; Ramana KV, 2000, BIOCHEMISTRY-US, V39, P12172, DOI 10.1021/bi000796e; Ramana KV, 2005, DIABETES, V54, P818, DOI 10.2337/diabetes.54.3.818; Ramana KV, 2004, FASEB J, V18, P1209, DOI 10.1096/fj.04-1650com; Ramana KV, 2004, DIABETES, V53, P2910, DOI 10.2337/diabetes.53.11.2910; Ramana KV, 2002, FASEB J, V16, P315, DOI 10.1096/fj.02-0568fje; Ramana KV, 2002, J BIOL CHEM, V277, P32063, DOI 10.1074/jbc.M202126200; Sablotzki A, 2001, THORAC CARDIOV SURG, V49, P273, DOI 10.1055/s-2001-17803; Srivastava S, 1999, BIOCHEMISTRY-US, V38, P42, DOI 10.1021/bi981794l; Srivastava S, 2006, DIABETES, V55, P901, DOI 10.2337/diabetes.55.04.06.db05-0932; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Triantafilou M, 2005, J ENDOTOXIN RES, V11, P5, DOI 10.1179/096805105225006641; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Velasco M, 1997, J BIOL CHEM, V272, P23025, DOI 10.1074/jbc.272.37.23025; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414	39	129	137	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33019	33029		10.1074/jbc.M603819200	http://dx.doi.org/10.1074/jbc.M603819200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956889	hybrid			2022-12-27	WOS:000241621400010
J	Tran, QM; Rothery, RA; Maklashina, E; Cecchini, G; Weiner, JH				Tran, Quang M.; Rothery, Richard A.; Maklashina, Elena; Cecchini, Gary; Weiner, Joel H.			The quinone binding site in Escherichia coli succinate dehydrogenase is required for electron transfer to the heme b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-II SUCCINATE; FUMARATE REDUCTASE; UBIQUINONE OXIDOREDUCTASE; 3FE-4S CLUSTER; CAENORHABDITIS-ELEGANS; CATALYTIC-ACTIVITY; OXIDATIVE STRESS; MUTATIONS; MEMBRANE; DOMAIN	We have examined the role of the quinone-binding (QP) site of Escherichia coli succinate: ubiquinone oxidoreductase (succinate dehydrogenase) in heme reduction and reoxidation during enzyme turnover. The SdhCDAB electron transfer pathway leads from a cytosolically localized flavin adenine dinucleotide cofactor to a Q(P) site located within the membrane-intrinsic domain of the enzyme. The Q(P) site is sandwiched between the [3Fe-4S] cluster of the SdhB subunit and the heme b(556) that is coordinated by His residues from the SdhC and SdhD subunits. The intercenter distances between the cluster, heme, and Q(P) site are all within the theoretical 14 A limit proposed for kinetically competent intercenter electron transfer. Using EPR spectroscopy, we have demonstrated that the Q(P) site of SdhCDAB stabilized a ubisemiquinone radical intermediate during enzyme turnover. Potentiometric titrations indicate that this species has an E-m,E-8 of similar to 60 mV and a stability constant (K-STAB) of similar to 1.0. Mutants of the following conserved Q(P) site residues, SdhC-S27, SdhC-R31, and SdhD-D82, have severe consequences on enzyme function. Mutation of the conserved SdhD-Y83 suggested to hydrogen bond to the ubiquinone cofactor had a less severe but still significant effect on function. In addition to loss of overall catalysis, these mutants also affect the rate of succinate-dependent heme reduction, indicating that the Q(P) site is an essential stepping stone on the electron transfer pathway from the [3Fe-4S] cluster to the heme. Furthermore, the mutations result in the elimination of EPR-visible ubisemiquinone during potentiometric titrations. Overall, these results demonstrate the importance of a functional, semiquinone-stabilizing Q(P) site for the observation of rapid succinate-dependent heme reduction.	Univ Alberta, Dept Biochem, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Alberta; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Weiner, JH (corresponding author), Univ Alberta, Dept Biochem, Membrane Prot Res Grp, 473 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	joel.weiner@ualberta.ca		Rothery, Richard/0000-0003-3265-1783	NIGMS NIH HHS [GM 61606] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKRELL BAC, 1974, J BIOL CHEM, V249, P2021; Anderson RF, 2005, J BIOL CHEM, V280, P33331, DOI 10.1074/jbc.M506002200; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1996, FEBS LETT, V389, P25, DOI 10.1016/0014-5793(96)00529-7; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Horsefield R, 2004, CURR PROTEIN PEPT SC, V5, P107, DOI 10.2174/1389203043486847; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Hung SC, 2000, J BIOL INORG CHEM, V5, P593, DOI 10.1007/s007750000142; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Matsson M, 2000, BIOCHEMISTRY-US, V39, P8617, DOI 10.1021/bi000271m; Nakamura K, 1996, J BIOL CHEM, V271, P521, DOI 10.1074/jbc.271.1.521; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; Rothery RA, 2001, BIOCHEMISTRY-US, V40, P5260, DOI 10.1021/bi002393k; Rothery RA, 1998, EUR J BIOCHEM, V254, P588, DOI 10.1046/j.1432-1327.1998.2540588.x; RUZICKA FJ, 1975, P NATL ACAD SCI USA, V72, P2886, DOI 10.1073/pnas.72.8.2886; Sambrook J., 2001, MOL CLONING LAB MANU; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Singer TP, 1971, METHODS ENZYMOL    B, V18, P416; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Vibat CRT, 1998, BIOCHEMISTRY-US, V37, P4148, DOI 10.1021/bi9716635; WEINER JH, 1974, J MEMBRANE BIOL, V15, P1, DOI 10.1007/BF01870078; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	39	47	47	4	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32310	32317		10.1074/jbc.M607476200	http://dx.doi.org/10.1074/jbc.M607476200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950775	hybrid			2022-12-27	WOS:000241414500028
J	Daviau, A; Proulx, R; Robitaille, K; Di Fruscio, M; Tanguay, RM; Landry, J; Patterson, C; Durocher, Y; Blouin, R				Daviau, Alex; Proulx, Roxanne; Robitaille, Karine; Di Fruscio, Marco; Tanguay, Robert M.; Landry, Jacques; Patterson, Cam; Durocher, Yves; Blouin, Richard			Down-regulation of the mixed-lineage dual leucine zipper-bearing kinase by heat shock protein 70 and its co-chaperone CHIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; N-TERMINAL KINASE; DIFFERENTIAL ACTIVATION; PROTEASOMAL DEGRADATION; MOLECULAR CHAPERONES; NEGATIVE REGULATOR; INHIBITORY PROTEIN; CELLULAR FUNCTIONS; APAF-1 APOPTOSOME; UBIQUITIN LIGASE	Dual leucine zipper-bearing kinase (DLK) is a mixed-lineage kinase family member that acts as an upstream activator of the c-Jun N-terminal kinases. As opposed to other components of this pathway, very little is currently known regarding the mechanisms by which DLK is regulated in mammalian cells. Here we identify the stress-inducible heat shock protein 70 (Hsp70) as a negative regulator of DLK expression and activity. Support for this notion derives from data showing that Hsp70 induces the proteasomal degradation of DLK when both proteins are co-expressed in COS-7 cells. Hsp70-mediated degradation occurs with expression of wild-type DLK, which functions as a constitutively activated protein in these cells but not kinase-defective DLK. Interestingly, the Hsp70 co-chaperone CHIP, an E3 ubiquitin ligase, seems to be indispensable for this process since Hsp70 failed to induce DLK degradation in COS-7 cells expressing a CHIP mutant unable to catalyze ubiquitination or in immortalized fibroblasts derived from CHIP knock-out mice. Consistent with these data, we have found that endogenous DLK becomes sensitive to CHIP-dependent proteasomal degradation when it is activated by okadaic acid and that down-regulation of Hsp70 levels with an Hsp70 antisense attenuates this sensitivity. Therefore, our studies suggest that Hsp70 contributes to the regulation of activated DLK by promoting its CHIP-dependent proteasomal degradation.	Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; Univ Laval, Dept Med, Lab Genet Cellulaire & Dev, Ste Foy, PQ G1K 7P4, Canada; Univ Laval, CHU Quebec, Ctr Rech Cancerol, Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada; Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA; Natl Res Council Canada, Biotechnol Res Inst, Anim Cell Technol & Downstream Proc Grp, Montreal, PQ H4P 2R2, Canada	University of Sherbrooke; Laval University; Laval University; University of North Carolina; University of North Carolina Chapel Hill; National Research Council Canada	Blouin, R (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	Richard.Blouin@USherbrooke.ca	Durocher, Yves/K-8709-2019					Alberti S, 2003, CELL STRESS CHAPERON, V8, P225, DOI 10.1379/1466-1268(2003)008<0225:BNEFOH>2.0.CO;2; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cuenda A, 1998, BIOCHEM J, V333, P11, DOI 10.1042/bj3330011; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Douziech M, 1999, J HISTOCHEM CYTOCHEM, V47, P1287, DOI 10.1177/002215549904701008; EZOE K, 1994, ONCOGENE, V9, P935; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fan G, 1996, J BIOL CHEM, V271, P24788, DOI 10.1074/jbc.271.40.24788; Fukuyama K, 2000, J BIOL CHEM, V275, P21247, DOI 10.1074/jbc.M001488200; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; Hirai S, 1998, J BIOL CHEM, V273, P7406, DOI 10.1074/jbc.273.13.7406; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Imai J, 2003, CELL CYCLE, V2, P585, DOI 10.4161/cc.2.6.586; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Laplante AF, 1998, J HISTOCHEM CYTOCHEM, V46, P1291, DOI 10.1177/002215549804601109; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Maki CG, 1996, CANCER RES, V56, P2649; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Maroney AC, 2001, J BIOL CHEM, V276, P25302, DOI 10.1074/jbc.M011601200; Maroney AC, 1998, J NEUROSCI, V18, P104; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Merritt SE, 1999, J BIOL CHEM, V274, P10195, DOI 10.1074/jbc.274.15.10195; MILARSKI KL, 1989, J CELL BIOL, V109, P1947, DOI 10.1083/jcb.109.5.1947; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Nihalani D, 2000, J BIOL CHEM, V275, P7273, DOI 10.1074/jbc.275.10.7273; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Nihalani D, 2003, J BIOL CHEM, V278, P28694, DOI 10.1074/jbc.M304212200; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Rasmussen RK, 1998, BIOCHEM J, V335, P119, DOI 10.1042/bj3350119; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Sakuma H, 1997, J BIOL CHEM, V272, P28622, DOI 10.1074/jbc.272.45.28622; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Saporito MS, 2002, PROGR MED CHEM, V40, P23, DOI 10.1016/S0079-6468(08)70081-X; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; TANGUAY RM, 1993, DEV GENET, V14, P112, DOI 10.1002/dvg.1020140205; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	67	23	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31467	31477		10.1074/jbc.M607612200	http://dx.doi.org/10.1074/jbc.M607612200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16931512	Bronze, Green Published			2022-12-27	WOS:000241235300031
J	Kukimoto-Niino, M; Takagi, T; Akasaka, R; Murayama, K; Uchikubo-Kamo, T; Terada, T; Inoue, M; Watanabe, S; Tanaka, A; Hayashizaki, Y; Kigawa, T; Shirouzu, M; Yokoyama, S				Kukimoto-Niino, Mutsuko; Takagi, Tetsuo; Akasaka, Ryogo; Murayama, Kazutaka; Uchikubo-Kamo, Tomomi; Terada, Takaho; Inoue, Makoto; Watanabe, Satoru; Tanaka, Akiko; Hayashizaki, Yoshihide; Kigawa, Takanori; Shirouzu, Mikako; Yokoyama, Shigeyuki			Crystal structure of the RUN domain of the RAP2-interacting protein x	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS-BINDING DOMAIN; CAENORHABDITIS-ELEGANS; PUTATIVE EFFECTOR; DEATH DOMAIN; FYVE-FINGER; RAP2; IDENTIFICATION; ACTIVATION; KINASE; SUPERFAMILY	Rap2-interacting protein x (RPIPx) is a homolog of RPIP8, a specific effector of Rap2 GTPase. The N-terminal region of RPIP8, which contains the RUN domain, interacts with Rap2. Using cell-free synthesis and NMR, we determined that the region encompassing residues 83-255 of mouse RPIPx, which is 40-residues larger than the predicted RUN domain (residues 113-245), is the minimum fragment that forms a correctly folded protein. This fragment, the RPIPx RUN domain, interacted specifically with Rap2B in vitro in a nucleotide-dependent manner. The crystal structure of the RPIPx RUN domain was determined at 2.0 angstrom of resolution by the multiwavelength anomalous dispersion (MAD) method. The RPIPx RUN domain comprises eight anti-parallel alpha-helices, which form an extensive hydrophobic core, followed by an extended segment. The residues in the core region are highly conserved, suggesting the conservation of the RUN domain-fold among the RUN domain-containing proteins. The residues forming a positively charged surface are conserved between RPIP8 and its homologs, suggesting that this surface is important for Rap2 binding. In the crystal the putative Rap2 binding site of the RPIPx RUN domain interacts with the extended segment in a segment-swapping manner.	RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Tohoku Univ, Biomed Engn Res Org, Sendai, Miyagi 9808575, Japan; Tokyo Inst Technol, Yokohama, Kanagawa 2268502, Japan; Univ Tokyo, Grad Sch Sci, Tokyo 1130033, Japan	RIKEN; Tohoku University; Tokyo Institute of Technology; University of Tokyo	Yokoyama, S (corresponding author), RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Hayashizaki, Yoshihide/N-6590-2015; Kukimoto-Niino, Mutsuko/C-6704-2017; watanabe, satoru s/E-9501-2012; Kigawa, Takanori/A-7679-2010; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016	Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; watanabe, satoru s/0000-0001-5329-9278; Kigawa, Takanori/0000-0003-0146-9719; Yokoyama, Shigeyuki/0000-0003-3133-7338; 				Bayer M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-15; BOKOCH GM, 1993, BIOCHEM J, V289, P17, DOI 10.1042/bj2890017; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Cherfils J, 1997, EMBO J, V16, P5582, DOI 10.1093/emboj/16.18.5582; Christian SL, 2003, J BIOL CHEM, V278, P41756, DOI 10.1074/jbc.M303180200; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; DeLano W, 2002, PYMOL 0 99; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; EMERSON SD, 1995, BIOCHEMISTRY-US, V34, P6911, DOI 10.1021/bi00021a001; Esser D, 1998, BIOCHEMISTRY-US, V37, P13453, DOI 10.1021/bi9811664; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; JIMENEZ B, 1991, INT J CANCER, V49, P471, DOI 10.1002/ijc.2910490327; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kigawa T, 1998, FEBS LETT, V441, P413, DOI 10.1016/S0014-5793(98)01596-8; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kigawa Takanori, 2002, Journal of Structural and Functional Genomics, V2, P29, DOI 10.1023/A:1013203532303; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; Mari M, 2001, J BIOL CHEM, V276, P42501, DOI 10.1074/jbc.M104885200; Matsuda S, 2000, BBA-GENE STRUCT EXPR, V1491, P321, DOI 10.1016/S0167-4781(00)00049-X; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nancy V, 1999, J BIOL CHEM, V274, P8737, DOI 10.1074/jbc.274.13.8737; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedelacq JD, 2002, NAT BIOTECHNOL, V20, P927, DOI 10.1038/nbt732; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Raguz S, 2005, INT J CANCER, V117, P934, DOI 10.1002/ijc.21252; SAKODA T, 1992, ONCOGENE, V7, P1705; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Sukits SF, 2001, J MOL BIOL, V310, P895, DOI 10.1006/jmbi.2001.4790; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1763, DOI 10.1107/S0907444901013749; TERWILLIGER TC, 2002, CRYSTALLOGR D, V59, P1174; Vaughn DE, 1999, J MOL BIOL, V293, P439, DOI 10.1006/jmbi.1999.3177; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang SR, 2003, BRAIN RES REV, V41, P13, DOI 10.1016/S0165-0173(02)00217-5; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; YATANI A, 1991, J BIOL CHEM, V266, P22872; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712	60	34	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31843	31853		10.1074/jbc.M604960200	http://dx.doi.org/10.1074/jbc.M604960200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16928684				2022-12-27	WOS:000241235300071
J	Reinert, RB; Oberle, LM; Wek, SA; Bunpo, P; Wang, XP; Mileva, I; Goodwin, LO; Aldrich, CJ; Durden, DL; McNurlan, MA; Wek, RC; Anthony, TG				Reinert, Rachel B.; Oberle, L. Morgan; Wek, Sheree A.; Bunpo, Piyawan; Wang, Xue Ping; Mileva, Izolda; Goodwin, Leslie O.; Aldrich, Carla J.; Durden, Donald L.; McNurlan, Margaret A.; Wek, Ronald C.; Anthony, Tracy G.			Role of glutamine depletion in directing tissue-specific nutrient stress responses to L-asparaginase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INITIATION FACTOR-2-ALPHA KINASE; UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; AMINO-ACID DEPRIVATION; ANTI-LYMPHOMA ACTIVITY; CELL-CYCLE ARREST; GENE-EXPRESSION; EUKARYOTIC INITIATION-FACTOR-2; ESCHERICHIA-COLI	L-Asparaginase is important in the induction regimen for treating acute lymphoblastic leukemia. Cytotoxic complications are clinically significant problems lacking mechanistic insight. To reveal tissue-specific molecular responses to this drug, mice were administered asparaginase from either Escherichia coli ( clinically used) or Wolinella succinogenes ( novel, glutaminase-free form). Both enzymes abolished serum asparagine, but only the E. coli form reduced circulating glutamine. E. coli asparaginase reduced protein synthesis in liver and spleen but not pancreas via increased phosphorylation of the translation factor eIF2. In contrast, treatment with Wolinella caused no untoward changes in protein synthesis in any tissue examined. Treating mice deleted for the eIF2 kinase, GCN2, with the E. coli enzyme showed eIF2 phosphorylation to be GCN2-dependent, but only initially. Furthermore, although eIF2 phosphorylation was not increased in the pancreas or by Wolinella asparaginase, expression of the amino acid stress response genes, asparagine synthetase and CHOP/GADD153, increased as a result of both enzymes, even in tissues demonstrating no change in eIF2 phosphorylation. Finally, signaling downstream of the mammalian target of rapamycin kinase was repressed in liver and pancreas by E. coli but not Wolinella asparaginase. These data demonstrate that the nutrient stress response to asparaginase is tissue-specific and exacerbated by glutamine depletion. Importantly, increased expression of asparagine synthetase and CHOP does not require eIF2 phosphorylation, signifying alternate or auxiliary means of inducing gene expression under conditions of amino acid depletion in the whole animal.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Evansville, IN 47712 USA; Indiana Univ, Sch Med, Indianapolis, IN 46202 USA; N Shore Long Isl Jewish Res Inst, Manhasset, NY 11030 USA; Indiana Univ Sch Med, Dept Microbiol & Immunol, Evansville, IN 47712 USA; Emory Univ, Sch Med, AFLAC, Ctr Canc & Blood Disorders, Atlanta, GA 30322 USA; SUNY Stony Brook, Dept Surg, Stony Brook, NY 11794 USA	Indiana University System; Indiana University System; Indiana University-Purdue University Indianapolis; Northwell Health; Indiana University System; Emory University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Anthony, TG (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 8600 Univ Blvd, Evansville, IN 47712 USA.	tganthon@iupui.edu	Anthony, Tracy/K-7951-2017	Anthony, Tracy/0000-0002-8586-5884; Reinert, Rachel/0000-0001-7778-4219	NIA NIH HHS [R01AG17446] Funding Source: Medline; NIGMS NIH HHS [R01GM49164] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017446] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abcouwer SF, 1999, J BIOL CHEM, V274, P28645, DOI 10.1074/jbc.274.40.28645; Anand P, 2006, J NUTR, V136, P27, DOI 10.1093/jn/136.1.27; Anthony JC, 2000, J NUTR, V130, P2413; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Anthony TG, 2001, AM J PHYSIOL-ENDOC M, V281, pE430, DOI 10.1152/ajpendo.2001.281.3.E430; Appel IM, 2006, BLOOD, V107, P4244, DOI 10.1182/blood-2005-06-2597; Aslanian AM, 2001, BIOCHEM J, V358, P59, DOI 10.1042/0264-6021:3580059; Bark TH, 1998, AM J PHYSIOL-ENDOC M, V275, pE118, DOI 10.1152/ajpendo.1998.275.1.E118; BOSMANN HB, 1970, LIFE SCI 2-BIOCH GEN, V9, P851; Bregendahl K, 2004, J NUTR, V134, P2722, DOI 10.1093/jn/134.10.2722; BROOME JD, 1981, CANCER TREAT REP, V65, P111; BROOME JD, 1965, J NATL CANCER I, V35, P967; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; CAIRO MS, 1982, AM J PEDIAT HEMATOL, V4, P335; Caso G, 2002, AM J PHYSIOL-ENDOC M, V282, pE1029, DOI 10.1152/ajpendo.00215.2001; CELLE G, 1977, ARZNEIMITTEL-FORSCH, V27-2, P2046; Chan Ka Wah, 2002, Curr Probl Pediatr Adolesc Health Care, V32, P40, DOI 10.1067/mps.2002.121790; DISTASIO JA, 1982, INT J CANCER, V30, P343, DOI 10.1002/ijc.2910300314; DISTASIO JA, 1977, P SOC EXP BIOL MED, V155, P528; DISTASIO JA, 1982, CANCER RES, V42, P252; DISTASIO JA, 1976, J BIOL CHEM, V251, P6929; DURDEN DL, 1980, CANCER RES, V40, P1125; DURDEN DL, 1983, CANCER RES, V43, P1602; Fine BM, 2005, CANCER RES, V65, P291; GONG SS, 1991, MOL CELL BIOL, V11, P6059, DOI 10.1128/MCB.11.12.6059; Grigoryan RS, 2004, IN VIVO, V18, P107; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HILL JM, 1967, J AMER MED ASSOC, V202, P882, DOI 10.1001/jama.202.9.882; Holcenberg J, 2004, J PEDIAT HEMATOL ONC, V26, P273, DOI 10.1097/00043426-200405000-00001; HOLCENBERG JS, 1975, CANCER RES, V35, P1320; Huang QH, 1999, BIOCHEM J, V341, P225, DOI 10.1042/0264-6021:3410225; Hutson RG, 1997, AM J PHYSIOL-CELL PH, V272, pC1691, DOI 10.1152/ajpcell.1997.272.5.C1691; Iiboshi Y, 1999, BIOCHEM BIOPH RES CO, V260, P534, DOI 10.1006/bbrc.1999.0920; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Jousse C, 1999, FEBS LETT, V448, P211, DOI 10.1016/S0014-5793(99)00373-7; KAFKEWITZ D, 1983, AM J CLIN NUTR, V37, P1025; Kimball Sr, 2004, TOP CURR GENET, V7, P113; KIMBALL SR, 1991, J BIOL CHEM, V266, P1969; Krejci O, 2004, LEUKEMIA, V18, P434, DOI 10.1038/sj.leu.2403259; LEONARD JV, 1986, LANCET, V1, P162; LOOS M, 1972, CANCER RES, V32, P2292; LUNDHOLM K, 1991, ACTA PHYSIOL SCAND, V141, P207, DOI 10.1111/j.1748-1716.1991.tb09069.x; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; McNurlan MA, 1997, J CLIN INVEST, V100, P2125, DOI 10.1172/JCI119747; MESCHI F, 1981, HORM RES, V15, P237, DOI 10.1159/000179462; Mohi MG, 2004, P NATL ACAD SCI USA, V101, P3130, DOI 10.1073/pnas.0400063101; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; OLLENSCHLAGER G, 1988, EUR J CLIN INVEST, V18, P512, DOI 10.1111/j.1365-2362.1988.tb01049.x; Panosyan EH, 2004, ANTICANCER RES, V24, P1121; Panwalkar A, 2004, CANCER-AM CANCER SOC, V100, P657, DOI 10.1002/cncr.20026; Pinheiro JPV, 2004, BRIT J HAEMATOL, V125, P117, DOI 10.1111/j.1365-2141.2004.04863.x; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Reiff A, 2001, CLIN EXP RHEUMATOL, V19, P639; Reiter AK, 2004, INT J BIOCHEM CELL B, V36, P2169, DOI 10.1016/j.biocel.2004.04.004; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; Rotoli BM, 2005, CELL PHYSIOL BIOCHEM, V15, P281, DOI 10.1159/000087238; Ruud E, 2006, PEDIATR HEMAT ONCOL, V23, P207, DOI 10.1080/08880010500506701; Sans MD, 2004, AM J PHYSIOL-GASTR L, V287, pG667, DOI 10.1152/ajpgi.00505.2003; Sans MD, 2003, AM J PHYSIOL-GASTR L, V285, pG517, DOI 10.1152/ajpgi.00540.2002; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Stams WAG, 2003, BLOOD, V101, P2743, DOI 10.1182/blood-2002-08-2446; VILLA P, 1986, TOXICOL LETT, V32, P235, DOI 10.1016/0378-4274(86)90113-X; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; WARRELL RP, 1982, CANCER TREAT REP, V66, P1479; Wek RC, 2004, TOP CURR GENET, V7, P171; WU MC, 1978, INT J CANCER, V22, P728, DOI 10.1002/ijc.2910220615; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	77	81	92	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31222	31233		10.1074/jbc.M604511200	http://dx.doi.org/10.1074/jbc.M604511200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16931516				2022-12-27	WOS:000241235300007
J	Nduati, V; Yan, YT; Dalmasso, G; Driss, A; Sitaraman, S; Merlin, D				Nduati, Vivienne; Yan, Yutao; Dalmasso, Guillaume; Driss, Adel; Sitaraman, Shanthi; Merlin, Didier			Leptin transcriptionally enhances peptide transporter (hPepT1) expression and activity via the cAMP-response element-binding protein and Cdx2 transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; RAT SMALL-INTESTINE; EPITHELIAL TRANSPORT; LUMINAL LEPTIN; HUMAN STOMACH; OBESE GENE; CELLS; SECRETION; RECEPTOR; LOCALIZATION	PepT1 is an intestinal epithelial apical membrane transporter that is expressed in the small intestine, with little or no expression in the normal colon. However, we previously demonstrated that colonic PepT1 may be expressed during chronic inflammation. To begin elucidating inflammatory hPepT1 signaling, we herein investigated the long term leptin treatments, on PepT1 expression and activity in Caco2-BBE cells, and began to reveal the involved signaling pathways. We successfully cloned the 723-bp hPepT1 promoter region and identified the human transcription initiation site 86 bp upstream from the translation start site. Leptin treatment dose- and time-dependently increased hPepT1 promoter and transport activities in Caco2-BBE cells, with maximal activity observed in cells treated with 100 nM leptin for 8 h. Under these conditions, we observed 2-fold increases in hPepT1 mRNA and protein expression, as well as increased transport activity. Our molecular analyses of possible signal- transduction pathways revealed that leptin treatment enhanced the intracellular levels of cAMP and phosphorylated cAMP-response element-binding protein (CREB) protein in Caco2-BBE cells, whereas our deletion, mutation, and CDX2 overexpression analyses demonstrated that interaction of the Cdx2 and phosphorylated CREB transcription factors was essential for leptin-induced hPepT1 transcription in Caco2-BBE cells. Our results indicate that leptin, which is increased in inflamed colonic mucosa, triggers colonic expression of hPepT1 via the CREB and Cdx2 transcription factors. These findings provide important new insights into the mechanisms of intestinal inflammation and may suggest new therapeutic modalities in the future.	Emory Univ, Dept Med, Div Digest Dis, Sch Med, Atlanta, GA 30322 USA	Emory University	Merlin, D (corresponding author), Emory Univ, Dept Med, Div Digest Dis, Sch Med, 615 Michael St, Atlanta, GA 30322 USA.	dmerlin@emory.edu	Driss, Adel/A-4151-2008; Dalmasso, Guillaume/N-2443-2018; Driss, Adel/X-6772-2019	Dalmasso, Guillaume/0000-0002-3433-870X; 	NIDDK NIH HHS [R01-DK071594, R01-DK061941, R24-DK-064399, R01-DK55850] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071594, R01DK055850, R01DK061941, R24DK064399] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adibi SA, 2003, AM J PHYSIOL-GASTR L, V285, pG779, DOI 10.1152/ajpgi.00056.2003; Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Ahren B, 1999, AM J PHYSIOL-REG I, V277, pR959, DOI 10.1152/ajpregu.1999.277.4.R959; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Buyse M, 2002, J BIOL CHEM, V277, P28182, DOI 10.1074/jbc.M203281200; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Charrier L, 2006, LAB INVEST, V86, P490, DOI 10.1038/labinvest.3700413; Charrier L, 2006, LAB INVEST, V86, P538, DOI 10.1038/labinvest.3700423; Couce ME, 1997, NEUROENDOCRINOLOGY, V66, P145, DOI 10.1159/000127232; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Doi T, 2001, AM J PHYSIOL-REG I, V281, pR753, DOI 10.1152/ajpregu.2001.281.3.R753; Fei YJ, 2000, BBA-GENE STRUCT EXPR, V1492, P145, DOI 10.1016/S0167-4781(00)00101-9; Fei YJ, 1998, PROG NUCLEIC ACID RE, V58, P239; Freund JN, 1998, BIOCHEM CELL BIOL, V76, P957, DOI 10.1139/bcb-76-6-957; Goodman RH, 2000, GENE DEV, V14, P1553; Hill RA, 1998, INT J OBESITY, V22, P765, DOI 10.1038/sj.ijo.0800656; Jin L, 2000, ENDOCRINOLOGY, V141, P333, DOI 10.1210/en.141.1.333; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lostao MP, 1998, FEBS LETT, V423, P302, DOI 10.1016/S0014-5793(98)00110-0; Meredith D, 2000, CELL MOL LIFE SCI, V57, P754, DOI 10.1007/s000180050040; Merlin D, 1998, J CLIN INVEST, V102, P2011, DOI 10.1172/JCI4179; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Morton NM, 1998, J BIOL CHEM, V273, P26194, DOI 10.1074/jbc.273.40.26194; Mutoh H, 2005, INT J DEV BIOL, V49, P867, DOI 10.1387/ijdb.052016hm; Ogihara H, 1999, HISTOCHEM J, V31, P169, DOI 10.1023/A:1003515413550; Ogihara H, 1996, BIOCHEM BIOPH RES CO, V220, P848, DOI 10.1006/bbrc.1996.0493; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; RONG LA, 1995, J BIOL CHEM, V270, P6456, DOI 10.1074/jbc.270.12.6456; Schneider R, 2001, HORM METAB RES, V33, P1, DOI 10.1055/s-2001-12617; Shimakura J, 2005, AM J PHYSIOL-GASTR L, V289, pG471, DOI 10.1152/ajpgi.00025.2005; Shiraga T, 1999, GASTROENTEROLOGY, V116, P354, DOI 10.1016/S0016-5085(99)70132-0; Sitaraman S, 2004, FASEB J, V18, P696, DOI 10.1096/fj.03-0422fje; Sobhani I, 2000, GUT, V47, P178, DOI 10.1136/gut.47.2.178; Sobhani I, 2002, GASTROENTEROLOGY, V122, P259, DOI 10.1053/gast.2002.31385; Stan S, 2001, FEBS LETT, V508, P80, DOI 10.1016/S0014-5793(01)03032-0; Sweeney G, 2001, ENDOCRINOLOGY, V142, P4806, DOI 10.1210/en.142.11.4806; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Wang X, 1996, AM J PHYSIOL-HEART C, V270, pH476, DOI 10.1152/ajpheart.1996.270.2.H476; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Ziegler TR, 2002, AM J CLIN NUTR, V75, P922, DOI 10.1093/ajcn/75.5.922	44	38	41	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2007	282	2					1359	1373		10.1074/jbc.M604267200	http://dx.doi.org/10.1074/jbc.M604267200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	123KQ	16963449	hybrid			2022-12-27	WOS:000243295200062
J	Schweinfest, CW; Spyropoulos, DD; Henderson, KW; Kim, JH; Chapman, JM; Barone, S; Worrell, RT; Wang, ZH; Soleimani, M				Schweinfest, Clifford W.; Spyropoulos, Demetri D.; Henderson, Kelly W.; Kim, Jae-Ho; Chapman, Jeannie M.; Barone, Sharon; Worrell, Roger T.; Wang, Zhaohui; Soleimani, Manoocher			slc26a3 (dra)-deficient mice display chloride-losing diarrhea, enhanced colonic proliferation, and distinct up-regulation of ion transporters in the colon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABERRANT CRYPT FOCI; PUTATIVE ANION TRANSPORTER; DRA GENE ENCODES; ADENOMA DRA; SULFATE TRANSPORTER; CL-/HCO3-EXCHANGER; FUNCTIONAL-CHARACTERIZATION; CELLS; IDENTIFICATION; MEMBRANE	Mutations in the SLC26A3 (DRA (down-regulated in adenoma)) gene constitute the molecular etiology of congenital chloride-losing diarrhea in humans. To ascertain its role in intestinal physiology, gene targeting was used to prepare mice lacking slc26a3. slc26a3-deficient animals displayed postpartum lethality at low penetrance. Surviving dra-deficient mice exhibited high chloride content diarrhea, volume depletion, and growth retardation. In addition, the large intestinal loops were distended, with colonic mucosa exhibiting an aberrant growth pattern and the colonic crypt proliferative zone being greatly expanded in slc26a3-null mice. Apical membrane chloride/base exchange activity was sharply reduced, and luminal content was more acidic in slc26a3-null mouse colon. The epithelial cells in the colon displayed unique adaptive regulation of ion transporters; NHE3 expression was enhanced in the proximal and distal colon, whereas colonic H, K-ATPase and the epithelial sodium channel showed massive up-regulation in the distal colon. Plasma aldosterone was increased in slc26a3- null mice. We conclude that slc26a3 is the major apical chloride/base exchanger and is essential for the absorption of chloride in the colon. In addition, slc26a3 regulates colonic crypt proliferation. Deletion of slc26a3 results in chloride-rich diarrhea and is associated with compensatory adaptive up-regulation of ion-absorbing transporters.	Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; Univ Cincinnati, Dept Med, Cincinnati, OH 45267 USA; Vet Affairs Med Ctr, Cincinnati, OH 45220 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center	Soleimani, M (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, Rm 321-A,86 Jonathan Lucas St, Charleston, SC 29425 USA.	Manoocher.Soleimani@uc.edu			NCI NIH HHS [R01 CA095172] Funding Source: Medline; NIDDK NIH HHS [R01 DK62809] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062809] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alrefai WA, 2001, AM J PHYSIOL-GASTR L, V280, pG603, DOI 10.1152/ajpgi.2001.280.4.G603; Antalis TM, 1998, CLIN CANCER RES, V4, P1857; BISSIG M, 1994, J BIOL CHEM, V269, P3017; Byeon MK, 1998, PROTEIN EXPRES PURIF, V12, P67, DOI 10.1006/prep.1997.0809; Byeon MK, 1996, ONCOGENE, V12, P387; Chapman JM, 2002, CANCER RES, V62, P5083; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Greeley T, 2001, AM J PHYSIOL-GASTR L, V281, pG1301, DOI 10.1152/ajpgi.2001.281.5.G1301; Haila S, 2000, HISTOCHEM CELL BIOL, V113, P279, DOI 10.1007/s004180000131; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HOGAN B, 1986, MANIPULATING MOUSE E; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; HOLMBERG C, 1986, CLIN GASTROENTEROL, V15, P583; Jacob P, 2002, GASTROENTEROLOGY, V122, P709, DOI 10.1053/gast.2002.31875; Jiang Z, 2002, J BIOL CHEM, V277, P33963, DOI 10.1074/jbc.M202660200; Lamprecht G, 2006, PFLUG ARCH EUR J PHY, V452, P307, DOI 10.1007/s00424-006-0049-6; Lee CH, 2003, J CELL PHYSIOL, V195, P61, DOI 10.1002/jcp.10225; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Lohi H, 2000, GENOMICS, V70, P102, DOI 10.1006/geno.2000.6355; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Papanikolaou A, 1998, CANCER LETT, V130, P29, DOI 10.1016/S0304-3835(98)00101-3; Papanikolaou A, 2000, CARCINOGENESIS, V21, P1567, DOI 10.1093/carcin/21.8.1567; Paulsen JE, 2000, SCAND J GASTROENTERO, V35, P534; Paulsen JE, 2001, CANCER RES, V61, P5010; Pereira MA, 1999, ADV EXP MED BIOL, V470, P55; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rajendran VM, 1999, AM J PHYSIOL-GASTR L, V276, pG132, DOI 10.1152/ajpgi.1999.276.1.G132; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; SILBERG DG, 1995, J BIOL CHEM, V270, P11897, DOI 10.1074/jbc.270.20.11897; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; SOLEIMANI M, 1992, J CLIN INVEST, V90, P211, DOI 10.1172/JCI115838; Song J, 2000, CANCER RES, V60, P5434; Spicer Z, 2001, AM J PHYSIOL-GASTR L, V281, pG1369, DOI 10.1152/ajpgi.2001.281.6.G1369; Tyagi S, 2001, EXP BIOL MED, V226, P912, DOI 10.1177/153537020122601006; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Vincourt JB, 2002, GENOMICS, V79, P249, DOI 10.1006/geno.2002.6689; Wang ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC957, DOI 10.1152/ajpcell.00505.2004; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; Winter DC, 2000, BRIT J SURG, V87, P1684, DOI 10.1046/j.1365-2168.2000.01584.x; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; Xu J, 2005, AM J PHYSIOL-CELL PH, V289, pC493, DOI 10.1152/ajpcell.00030.2005; Xu J, 2006, J AM SOC NEPHROL, V17, P956, DOI 10.1681/ASN.2005111174; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	48	157	159	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37962	37971		10.1074/jbc.M607527200	http://dx.doi.org/10.1074/jbc.M607527200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	17001077	hybrid			2022-12-27	WOS:000242477100075
J	Mochida, Y; Parisuthiman, D; Kaku, M; Hanai, J; Sukhatme, VP; Yamauchi, M				Mochida, Yoshiyuki; Parisuthiman, Duenpim; Kaku, Masaru; Hanai, Jun-ichi; Sukhatme, Vikas P.; Yamauchi, Mitsuo			Nephrocan, a novel member of the small leucine-rich repeat protein family, is an inhibitor of transforming growth factor-beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I COLLAGEN; TYROSINE SULFATION; BINDING-SITES; DECORIN BINDS; PROTEOGLYCANS; BIGLYCAN; MATRIX; FIBRILLOGENESIS; DIFFERENTIATION; IDENTIFICATION	In a search of new, small leucine-rich repeat proteoglycan/protein (SLRP) family members, a novel gene, nephrocan (NPN), has been identified. The gene consists of three exons, and based on the deduced amino acid sequence, NPN has 17 leucine-rich repeat motifs and unique cysteine-rich clusters both in the N and C termini, indicating that this gene belongs to a new class of SLRP family. NPN mRNA was predominantly expressed in kidney in adult mice, and during mouse embryogenesis, the expression was markedly increased in 11-day-old embryos at a time when early kidney development takes place. In the adult mouse kidney, NPN protein was located in distal tubules and collecting ducts. When NPN was overexpressed in cell culture, the protein was detected in the cultured medium, and upon treatment with N-glycosidase F, the molecular mass was lowered by similar to 14 kDa, indicating that NPN is a secreted N-glycosylated protein. Furthermore, transforming growth factor-beta(TGF-beta)-responsive 3TP promoter luciferase activity was down-regulated, and TGF-beta-induced Smad3 phosphorylation was also inhibited by NPN, suggesting that NPN suppresses TGF-beta/Smad signaling. Taken together, NPN is a novel member of the SLRP family that may play important roles in kidney development and pathophysiology by functioning as an endogenous inhibitor of TGF-beta signaling.	Univ N Carolina, Dent Res Ctr, Chapel Hill, NC 27599 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Study Tumor Microenvironm,Div Nephrol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Study Tumor Microenvironm,Div Hematol Oncol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Study Tumor Microenvironm,Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Study Tumor Microenvironm,Dept Pathol, Boston, MA 02215 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Yamauchi, M (corresponding author), Univ N Carolina, Dent Res Ctr, CB 7455, Chapel Hill, NC 27599 USA.	Mitsuo_Yamauchi@dentistry.unc.edu	Sukhatme, Vikas/W-2776-2019; Kaku, Masaru/S-7309-2017; Kaku, Masaru/K-5041-2019	Kaku, Masaru/0000-0002-7988-6435; Kaku, Masaru/0000-0002-7988-6435; Mochida, Yoshiyuki/0000-0002-2115-4303	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR052824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010489] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR052824] Funding Source: Medline; NIDCR NIH HHS [DE10489] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Atsawasuwan P, 2005, BIOCHEM BIOPH RES CO, V327, P1042, DOI 10.1016/j.bbrc.2004.12.119; Barasch J, 1996, AM J PHYSIOL-RENAL, V271, pF50, DOI 10.1152/ajprenal.1996.271.1.F50; Barasch J, 2001, CURR OPIN NEPHROL HY, V10, P429, DOI 10.1097/00041552-200105000-00021; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hocking AM, 1998, MATRIX BIOL, V17, P1; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kresse H, 1997, J BIOL CHEM, V272, P18404, DOI 10.1074/jbc.272.29.18404; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Matsushima N, 2000, PROTEINS, V38, P210, DOI 10.1002/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5; Ohta K, 2004, DEV CELL, V7, P347, DOI 10.1016/j.devcel.2004.08.014; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Plisov SY, 2001, DEVELOPMENT, V128, P1045; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877; Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Shimizu-Hirota R, 2004, FEBS LETT, V563, P69, DOI 10.1016/S0014-5793(04)00250-9; Sini P, 1997, GLYCOCONJUGATE J, V14, P871, DOI 10.1023/A:1018550307649; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; Tasheva E, 2004, MOL VIS, V10, P758; Tenni R, 2002, EUR J BIOCHEM, V269, P1428, DOI 10.1046/j.1432-1033.2002.02784.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2; Wu HW, 2000, NAT STRUCT BIOL, V7, P575; Yu L, 2003, KIDNEY INT, V64, P844, DOI 10.1046/j.1523-1755.2003.00162.x; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang ZL, 2004, CURR OPIN GENET DEV, V14, P328, DOI 10.1016/j.gde.2004.06.003	50	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36044	36051		10.1074/jbc.M604787200	http://dx.doi.org/10.1074/jbc.M604787200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16990280	hybrid, Green Published			2022-12-27	WOS:000242100500053
J	Qian, Y; Prehoda, KE				Qian, Yi; Prehoda, Kenneth E.			Interdomain interactions in the tumor suppressor discs large regulate binding to the synaptic protein GukHolder	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANYLATE KINASE DOMAINS; PDZ DOMAIN; INTRAMOLECULAR INTERACTION; CRYSTAL-STRUCTURE; CELL-JUNCTIONS; GENE DLG; DROSOPHILA; COMPLEX; PSD-95; IDENTIFICATION	Multidomain scaffolding proteins are central components of many signaling pathways and are commonly found at membrane specializations. Here we have shown that multiple interdomain interactions in the scaffold Discs Large (Dlg) regulate binding to the synaptic protein GukHolder (GukH). GukH binds the Src homology 3 (SH3) and guanylate kinase-like (GK) protein interaction domains of Dlg, whereas an intramolecular interaction between the two domains inhibits association with GukH. Regulation occurs through a PDZ domain adjacent to the SH3 that allows GukH to interact with the composite SH3-GK binding site, but PDZ ligands inhibit GukH binding such that Dlg forms mutually exclusive PDZ ligand and GukH cellular complexes. The PDZ-SH3-GK module is a common feature of membrane associate guanylate kinase scaffolds such as Dlg, and these results indicate that its supramodular architecture leads to regulation of Dlg complexes.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Prehoda, KE (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@molbio.uoregon.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068032] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068032-05, R01 GM068032, R01 GM068032-01, R01 GM068032-03, R01 GM068032-02, R01 GM068032-04, GM068032] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Brenman JE, 1998, J NEUROSCI, V18, P8805; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; FERRELL JE, 2000, SCI STKE, pPE1; Harris BZ, 2001, J CELL SCI, V114, P3219; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Katoh M, 2004, INT J ONCOL, V24, P1033; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Sharma S, 2006, HUM MOL GENET, V15, P1972, DOI 10.1093/hmg/ddl120; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Vondriska TM, 2004, J MOL CELL CARDIOL, V37, P391, DOI 10.1016/j.yjmcc.2004.04.021; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	32	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35757	35763		10.1074/jbc.M607057200	http://dx.doi.org/10.1074/jbc.M607057200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16982606	Green Accepted, hybrid			2022-12-27	WOS:000242100500021
J	Vukmirica, J; Monzo, P; Le Marchand-Brustel, Y; Cormont, M				Vukmirica, Jelena; Monzo, Pascale; Le Marchand-Brustel, Yannick; Cormont, Mireille			The Rab4A effector protein Rabip4 is involved in migration of NIH 3T3 fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; FYVE-FINGER; EARLY ENDOSOMES; INTEGRINS; ALPHA-V-BETA-3; TRANSPORT; EEA1; ALPHA-5-BETA-1; ANGIOGENESIS; TRAFFICKING	The small GTP-binding protein Rab4 has been involved in the recycling of alpha v beta 3 integrins in response to platelet-derived growth factor ( PDGF) stimulation suggesting a role for Rab4 in cell adhesion and migration. In this study, we explored the role of Rabip4 and Rabip4, two Rab4 effector proteins, in migration of NIH 3T3 fibroblasts. In these cells, Rabip4 and Rabip4', collectively named Rabip4s, were partially co-localized with the early endosomal marker EEA1. PDGF treatment re-distributed endogenous Rabip4s toward the cell periphery where they co-localized with F-actin. In cells expressing green fluorescent protein (GFP)-Rabip4 or GFP-Rabip4', constitutive appearance of GFP-Rabip4s at the cell periphery was accompanied by local increase in cortical F-actin in membrane ruffles at the leading edge. The expression of GFP-Rabip4 induced an increased migration compared with control cells expressing GFP alone, even in the absence of PDGF stimulation. On the contrary, in cells expressing a mutated form of Rabip4s unable to interact with Rab4, lack of typical leading edge was observed. Furthermore, PDGF treatment did not stimulate the migration of these cells. Furthermore, down-regulation of the expression of Rabip4s inhibited PDGF-stimulated cell migration. Endogenous Rabip4s were localized with alpha v integrins at the leading edge following PDGF treatment, whereas in cells expressing GFP-Rabip4s, alpha v integrins, together with GFP-Rabip4s, were constitutively localized at the leading edge. In contrast, reduction in Rabip4s expression levels using small interfering RNA was associated with impaired PDGF-induced translocation of alpha v integrins toward the leading edge. Taken together, our data provide evidence that Rabip4s, possibly via their interaction with Rab4, regulate integrin trafficking and are involved in the migration of NIH 3T3 fibroblasts.	UFR Med, INSERM, U568, F-06107 Nice 02, France; Univ Nice Sophia Antipolis, UFR Sci, F-06002 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Cormont, M (corresponding author), UFR Med, INSERM, U568, F-06107 Nice 02, France.	cormont@unice.fr		CORMONT, Mireille/0000-0001-6918-2410				BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; Fouraux MA, 2004, MOL BIOL CELL, V15, P611, DOI 10.1091/mbc.E03-05-0343; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Kerr JS, 2002, EXPERT OPIN INV DRUG, V11, P1765, DOI 10.1517/13543784.11.12.1765; Kumar CC, 2003, CURR DRUG TARGETS, V4, P123, DOI 10.2174/1389450033346830; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Mari M, 2006, J CELL SCI, V119, P1297, DOI 10.1242/jcs.02850; Mari M, 2001, J BIOL CHEM, V276, P42501, DOI 10.1074/jbc.M104885200; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Monzo P, 2005, METHOD ENZYMOL, V403, P107, DOI 10.1016/S0076-6879(05)03010-7; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Ruegg C, 2003, CELL MOL LIFE SCI, V60, P1135, DOI 10.1007/s00018-003-2297-3; Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; Stenmark H, 1999, J CELL SCI, V112, P4175; Tucker GC, 2002, CURR OPIN PHARMACOL, V2, P394, DOI 10.1016/S1471-4892(02)00175-3; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Webb GC, 1997, MOL BIOL CELL, V8, P871, DOI 10.1091/mbc.8.5.871; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	39	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36360	36368		10.1074/jbc.M602920200	http://dx.doi.org/10.1074/jbc.M602920200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17001082	hybrid			2022-12-27	WOS:000242100500087
J	Butler, MW; Robertson, I; Greene, CM; O'Neill, SJ; Taggart, CC; McElvaney, NG				Butler, Marcus W.; Robertson, Ian; Greene, Catherine M.; O'Neill, Shane J.; Taggart, Clifford C.; McElvaney, Noel G.			Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappa B activation via an effect on the ubiquitin-proteasome pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SIGNAL-TRANSDUCTION; CHEMOKINE RECEPTOR; ALPHA DEGRADATION; KINASE ACTIVATION; EPITHELIAL-CELLS; GENE-EXPRESSION; PRE-ELAFIN; INHIBITOR; INDUCTION	The serine anti-protease elafin is expressed by monocytes, alveolar macrophages, neutrophils, and at mucosal surfaces and possesses antimicrobial activity. It is also known to reduce lipopolysaccharide-induced neutrophil influx into murine alveoli as well as to abrogate lipopolysaccharide-induced production of matrix metalloprotease 9, macrophage inhibitory protein 2, and tumor necrosis factor-alpha by as-yet unidentified mechanisms. In this report we have shown that elafin inhibits the lipopolysaccharide-induced production of monocyte chemoattractant protein-1 in monocytes by inhibiting AP-1 and NF-kappa B activation. Elafin prevented lipopolysaccharide-induced phosphorylation of AP-1, c-Jun, and JNK but had no effect on phosphorylation of p38. The lipopolysaccharide-induced degradation of IL-1R-associated kinase 1, I kappa B alpha, and I kappa B beta was inhibited by elafin but phosphorylation of I kappa B alpha was unaffected. Polyubiquitinated protein including polyubiquitinated I kappa B alpha was shown to accumulate in the presence of elafin. These results suggest that inhibition by elafin of lipopolysaccharide-induced AP-1 and NF-kappa B activation occurs via an effect on the ubiquitin-proteasome pathway.	Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Med,Pulm Res Div, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Taggart, CC (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Med,Pulm Res Div, Dublin 9, Ireland.	ctaggart@rcsi.ie	Greene, Catherine M/D-3513-2012; Taggart, Clifford C/G-4492-2014; McElvaney, Noel/A-6809-2010; Poubelle, Patrice E/G-6537-2013	Greene, Catherine M/0000-0003-2549-2569; Butler, Marcus/0000-0003-2026-7709; Taggart, Clifford/0000-0002-9930-2978; mcelvaney, Noel/0000-0002-0152-4370				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Arndt PG, 2004, J BIOL CHEM, V279, P10883, DOI 10.1074/jbc.M309901200; Bingle L, 2001, AM J RESP CELL MOL, V25, P84, DOI 10.1165/ajrcmb.25.1.4341; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Gao YH, 2000, J CLIN INVEST, V106, P439, DOI 10.1172/JCI9826; Greene CM, 2004, INFECT IMMUN, V72, P3684, DOI 10.1128/IAI.72.6.3684-3687.2004; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Hall DJ, 2005, J IMMUNOL, V174, P8056, DOI 10.4049/jimmunol.174.12.8056; HANAZAWA S, 1993, J BIOL CHEM, V268, P9526; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; MCELVANEY NG, 2005, CHRONIC OBSTRUCTIVE, P343; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7; Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; SOZZANI S, 1995, J LEUKOCYTE BIOL, V57, P788, DOI 10.1002/jlb.57.5.788; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Taggart CC, 2002, J BIOL CHEM, V277, P33648, DOI 10.1074/jbc.M203710200; Vachon E, 2002, BIOL CHEM, V383, P1249, DOI 10.1515/BC.2002.138; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; ZHANG M, 1995, CANCER RES, V55, P2537; Zhong J, 2004, MOL CELL BIOL, V24, P9165, DOI 10.1128/MCB.24.20.9165-9175.2004	29	62	70	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34730	34735		10.1074/jbc.M604844200	http://dx.doi.org/10.1074/jbc.M604844200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16980310	hybrid			2022-12-27	WOS:000241933700003
J	Milakovic, T; Quintanilla, RA; Johnson, GVW				Milakovic, Tamara; Quintanilla, Rodrigo A.; Johnson, Gail V. W.			Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells - Functional consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; CYTOCHROME-C; DISEASE; CA2+; BRAIN; DYSFUNCTION; IMPAIRMENT; TRANSPORT; CHANNELS; SUPPORT	Huntington disease (HD) is caused by a pathological elongation of CAG repeats in the huntingtin protein gene and is characterized by atrophy and neuronal loss primarily in the striatum. Mitochondrial dysfunction and impaired Ca2+ homeostasis in HD have been suggested previously. Here, we elucidate the effects of Ca2+ on mitochondria from the wild type (STHdh(Q7/Q7)) and mutant (STHdh(Q111/Q111)) huntingtin-expressing cells of striatal origin. When treated with increasing Ca2+ concentrations, mitochondria from mutant huntingtin-expressing cells showed enhanced sensitivity to Ca2+, as they were more sensitive to Ca2+ -induced decreases in state 3 respiration and Delta Psi m, than mitochondria from wild type cells. Further, mutant huntingtin-expressing cells had a reduced mitochondrial Ca2+ uptake capacity in comparison with wild type cells. Decreases in state 3 respiration were associated with increased mitochondrial membrane permeability. The Delta Psi m defect was attenuated in the presence of ADP and the decreases in Ca2+ uptake capacity were abolished in the presence of Permeability Transition Pore (PTP) inhibitors. These findings clearly indicate that mutant huntingtin-expressing cells have mitochondrial Ca2+ handling defects that result in respiratory deficits and that the increased sensitivity to Ca2+ induced mitochondrial permeabilization maybe a contributing mechanism to the mitochondrial dysfunction in HD.	Univ Alabama Birmingham, Dept Psychiat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Johnson, GVW (corresponding author), Univ Alabama Birmingham, Dept Psychiat, 1720 7th Ave S,SC 1061, Birmingham, AL 35294 USA.	gvwj@uab.edu	Johnson, Gail V.W./K-4723-2012; QUINTANILLA, RODRIGO/ABG-8829-2021	Johnson, Gail V.W./0000-0003-3464-0404; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041744] Funding Source: NIH RePORTER; NINDS NIH HHS [NS041744] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abramov AY, 2003, CELL CALCIUM, V33, P101, DOI 10.1016/S0143-4160(02)00203-8; Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; BEAL MF, 1993, J NEUROSCI, V13, P4181; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Calabresi P, 2001, J NEUROSCI, V21, P5110, DOI 10.1523/JNEUROSCI.21-14-05110.2001; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Forte M, 2005, J BIOENERG BIOMEMBR, V37, P121, DOI 10.1007/s10863-005-6565-9; Gizatullina ZZ, 2006, ANN NEUROL, V59, P407, DOI 10.1002/ana.20754; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; HENSHAW R, 1994, BRAIN RES, V647, P161, DOI 10.1016/0006-8993(94)91412-5; Khodorov B, 2004, PROG BIOPHYS MOL BIO, V86, P279, DOI 10.1016/j.pbiomolbio.2003.10.002; Krysko DV, 2001, J HISTOCHEM CYTOCHEM, V49, P1277, DOI 10.1177/002215540104901010; Kushnareva YE, 2005, J BIOL CHEM, V280, P28894, DOI 10.1074/jbc.M503090200; La Piana G, 2005, ARCH BIOCHEM BIOPHYS, V436, P91, DOI 10.1016/j.abb.2004.12.029; La Piana G, 2003, ARCH BIOCHEM BIOPHYS, V410, P201, DOI 10.1016/S0003-9861(02)00687-2; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Leegwater-Kim Julie, 2004, NeuroRx, V1, P128, DOI 10.1602/neurorx.1.1.128; Lemeshko VV, 2001, ARCH BIOCHEM BIOPHYS, V388, P60, DOI 10.1006/abbi.2000.2214; Leski ML, 2002, SYNAPSE, V43, P30, DOI 10.1002/syn.10015; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MANN VM, 1990, LANCET, V336, P749, DOI 10.1016/0140-6736(90)92242-A; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; MORENOSANCHEZ R, 1985, J BIOL CHEM, V260, P4028; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Nicholls DG, 2003, CELL CALCIUM, V34, P407, DOI 10.1016/S0143-4160(03)00144-1; Panov A, 1999, ANN NY ACAD SCI, V893, P365, DOI 10.1111/j.1749-6632.1999.tb07856.x; Panov AV, 2004, ARCH BIOCHEM BIOPHYS, V424, P44, DOI 10.1016/j.abb.2004.01.013; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Paschen W, 1996, J NEUROCHEM, V67, P1735; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Valera AG, 2005, NEUROSCIENTIST, V11, P583, DOI 10.1177/1073858405280639; Vergun O, 2005, BBA-BIOENERGETICS, V1709, P127, DOI 10.1016/j.bbabio.2005.07.006; VOET D, 1995, BIOCHEMISTRY-US, P798; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	49	106	107	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34785	34795		10.1074/jbc.M603845200	http://dx.doi.org/10.1074/jbc.M603845200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16973623	hybrid			2022-12-27	WOS:000241933700010
J	Sommer, F; Drepper, F; Haehnel, W; Hippler, M				Sommer, Frederik; Drepper, Friedel; Haehnel, Wolfgang; Hippler, Michael			Identification of precise electrostatic recognition sites between cytochrome c(6) and the photosystem I subunit PsaF using mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; DIRECTED MUTAGENESIS; SPINACH PLASTOCYANIN; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; SWISS-MODEL; BINDING; PROTEINS; COMPLEX; REDUCTION	The reduction of the photo-oxidized special chlorophyll pair P700 of photosystem I (PSI) in the photosynthetic electron transport chain of eukaryotic organisms is facilitated by the soluble copper-containing protein plastocyanin (pc). In the absence of copper, pc is functionally replaced by the heme-containing protein cytochrome c(6) (cyt c(6)) in the green alga Chlamydomonas reinhardtii. Binding and electron transfer between both donors and PSI follows a two-step mechanism that depends on electrostatic and hydrophobic recognition between the partners. Although the electrostatic and hydrophobic recognition sites on pc and PSI are well known, the precise electrostatic recognition site on cyt c(6) is unknown. To specify the interaction sites on a molecular level, we cross-linked cyt c(6) and PSI using a zero-length cross-linker and obtained a cross-linked complex competent in fast and efficient electron transfer. As shown previously, cyt c(6) cross-links specifically with the PsaF subunit of PSI. Mass spectrometric analysis of tryptic peptides from the cross-linked product revealed specific interaction sites between residues Lys(27) of PsaF and Glu(69) of cyt c(6) and between Lys(23) of PsaF and Glu(69)/Glu(70) of cyt c(6). Using these new data, we present a molecular model of the intermolecular electron transfer complex between eukaryotic cyt c(6) and PSI.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; Univ Freiburg, D-79104 Freiburg, Germany	University of Pennsylvania; University of Freiburg	Hippler, M (corresponding author), Univ Munster, Inst Plant Biochem & Biotechnol, Dept Biol, Hindenburgpl 55, D-48143 Munster, Germany.	mhippler@uni-muenster.de		Michael, Hippler/0000-0001-9670-6101; Drepper, Friedel/0000-0002-2043-5795				Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; CHITNIS PR, 1991, J BIOL CHEM, V266, P20146; De la Cerda B, 1999, J BIOL CHEM, V274, P13292, DOI 10.1074/jbc.274.19.13292; Drepper F, 1996, BIOCHEMISTRY-US, V35, P1282, DOI 10.1021/bi951471e; FARAH J, 1995, EMBO J, V14, P4976, DOI 10.1002/j.1460-2075.1995.tb00180.x; Finazzi G, 2005, P NATL ACAD SCI USA, V102, P7031, DOI 10.1073/pnas.0406288102; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAEHNEL W, 1994, EMBO J, V13, P1028, DOI 10.1002/j.1460-2075.1994.tb06351.x; Haldrup A, 2000, J BIOL CHEM, V275, P31211, DOI 10.1074/jbc.M002933200; Harris E., 1989, CHLAMYDOMONAS SOURCE, P575; Hippler M, 1999, J BIOL CHEM, V274, P4180, DOI 10.1074/jbc.274.7.4180; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; Hippler M, 1998, P NATL ACAD SCI USA, V95, P7339, DOI 10.1073/pnas.95.13.7339; Hippler M, 2002, PROTIST, V153, P197, DOI 10.1078/1434-4610-00098; Hippler M, 1996, EMBO J, V15, P6374, DOI 10.1002/j.1460-2075.1996.tb01028.x; HO KK, 1984, BIOCHIM BIOPHYS ACTA, V766, P310, DOI 10.1016/0005-2728(84)90246-9; Jolley C, 2005, J BIOL CHEM, V280, P33627, DOI 10.1074/jbc.M500937200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KATOH S, 1962, J BIOCHEM-TOKYO, V51, P32, DOI 10.1093/oxfordjournals.jbchem.a127497; KERFELD CA, 1995, J MOL BIOL, V250, P627, DOI 10.1006/jmbi.1995.0404; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE BH, 1995, J BIOCHEM, V117, P1209; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; Molina-Heredia FP, 1999, J BIOL CHEM, V274, P33565, DOI 10.1074/jbc.274.47.33565; Molina-Heredia FP, 2001, J BIOL CHEM, V276, P601, DOI 10.1074/jbc.M007081200; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; NORDLING M, 1991, FEBS LETT, V291, P327, DOI 10.1016/0014-5793(91)81313-W; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; REDINBO MR, 1993, BIOCHEMISTRY-US, V32, P10560, DOI 10.1021/bi00091a005; SANDMANN G, 1986, ARCH MICROBIOL, V21, P6366; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sommer F, 2004, J BIOL CHEM, V279, P20009, DOI 10.1074/jbc.M313986200; Sommer F, 2002, J BIOL CHEM, V277, P6573, DOI 10.1074/jbc.M110633200; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Sun J, 1999, J BIOL CHEM, V274, P19048, DOI 10.1074/jbc.274.27.19048; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; XU QA, 1994, J BIOL CHEM, V269, P3205	37	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35097	35103		10.1074/jbc.M607384200	http://dx.doi.org/10.1074/jbc.M607384200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16984911	hybrid			2022-12-27	WOS:000241933700043
J	Umesh, A; Thompson, MA; Chini, EN; Yip, KP; Sham, JSK				Umesh, Anita; Thompson, Michael A.; Chini, Eduardo N.; Yip, Kay-Pong; Sham, James S. K.			Integrin ligands mobilize Ca2+ from ryanodine receptor-gated stores and lysosome-related acidic organelles in pulmonary arterial smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; ARG-GLY-ASP; ALPHA(V)BETA(3) INTEGRIN; ADHESION RECEPTORS; INTRACELLULAR CA2+; PANCREATIC ACINAR; MEDIATED CALCIUM; FOCAL ADHESION; TENASCIN-C	Extracellular matrix (ECM) protein receptors, or integrins, participate in vascular remodeling and the systemic myogenic response. Synthetic ligands and ECM fragments regulate the vascular smooth muscle cell contractile state by altering intracellular Ca2+ levels ([Ca2+](i)). Information on the Ca2+ effect of integrins in vascular smooth muscle cells is limited, but nonexistent in pulmonary arterial smooth muscle cells (PASMCs). We therefore characterized integrin expression in endothelium-denuded pulmonary arteries, and explored [Ca2+] i mobilization pathways induced by soluble ligands in rat PASMCs. Reverse transcriptase-PCR showed mRNA expression of integrins alpha(1), alpha(2), alpha(3), alpha(4), alpha(5), alpha(7), alpha(8), alpha(v), beta(1), beta(3), and beta(4), and immunoblots of alpha(5), alpha(v), beta(1), and beta(3) confirmed protein expression. Exposure of PASMCs to integrin-binding peptides (0.5 mM) containing the arginine-glycine-aspartate (RGD) motif elicited [Ca2+](i) responses with an order of potency of GRGDNP > GRGDSP > GRGDTP = cyclo-RGD. Pharmacological analysis revealed that the GRGDSP-induced Ca2+ response was unrelated to Ca2+ influx and the inositol triphosphate receptor-gated Ca2+ store, but partially blocked by ryanodine or inhibition of lysosome-related acidic organelles with bafilomycin A1. Simultaneous inhibition of both pathways was necessary to abolish the response. GRGDSP treatment increased cyclic ADP-ribose, the endogenous activator of ryanodine receptors, by 70%. GRGDSP also rapidly reduced Lysotracker Red accumulation, confirming direct modulation of acidic organelles. These data are the first demonstration of integrin-mediated Ca2+ regulation in PASMCs. The presence of an array of integrins, and activation of ryanodine-sensitive Ca2+ stores and lysosome-like organelles by GRGDSP suggest important roles for integrin- dependent Ca2+ signaling in regulating PASMC function.	Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21224 USA; Mayo Clin Rochester, Dept Anesthesiol, Rochester, MN 55905 USA; Univ S Florida, Dept Physiol & Biophys, Tampa, FL 33612 USA	Johns Hopkins University; Mayo Clinic; State University System of Florida; University of South Florida	Sham, JSK (corresponding author), JHAAC, Hopkins Bayview Circle, Baltimore, MD 21224 USA.	jsks@welchlink.welch.jhu.edu	Yip, Kay-Pong D/H-4639-2012	Yip, Kay-Pong D/0000-0003-4364-6701; Sham, James/0000-0002-3571-8712	NHLBI NIH HHS [HL071835, HL075134] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075134, R01HL071835, R56HL071835] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bhattacharya S, 2000, CIRC RES, V86, P456, DOI 10.1161/01.RES.86.4.456; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Buck CA, 1996, CELL ADHES COMMUN, V4, P69, DOI 10.3109/15419069609010764; Campbell S, 2003, ENDOCRINOLOGY, V144, P1486, DOI 10.1210/en.2002-220903; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Ceni C, 2006, BIOCHEM J, V395, P417, DOI 10.1042/BJ20051321; Ceni C, 2003, J BIOL CHEM, V278, P40670, DOI 10.1074/jbc.M301196200; Chan WL, 2001, AM J PHYSIOL-CELL PH, V280, pC593, DOI 10.1152/ajpcell.2001.280.3.C593; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Christensen KA, 2002, J CELL SCI, V115, P599; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CRIDER BP, 1994, J BIOL CHEM, V269, P17379; DAMJANOVICH L, 1992, AM J RESP CELL MOL, V6, P197, DOI 10.1165/ajrcmb/6.2.197; DAngelo G, 1997, AM J PHYSIOL-HEART C, V272, pH2065, DOI 10.1152/ajpheart.1997.272.4.H2065; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Deshpande DA, 2004, AM J RESP CELL MOL, V31, P36, DOI 10.1165/rcmb.2003-0313OC; Dogan S, 2004, BIOL REPROD, V71, P97, DOI 10.1095/biolreprod.103.026245; Evans AM, 2005, PHARMACOL THERAPEUT, V107, P286, DOI 10.1016/j.pharmthera.2005.03.003; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gotwals PJ, 1996, J CLIN INVEST, V97, P2469, DOI 10.1172/JCI118693; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Green LJ, 1998, INT J BIOCHEM CELL B, V30, P179, DOI 10.1016/S1357-2725(97)00107-6; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Higashida H, 2001, PHARMACOL THERAPEUT, V90, P283, DOI 10.1016/S0163-7258(01)00142-5; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; JADOT M, 1990, BIOCHIM BIOPHYS ACTA, V1027, P205, DOI 10.1016/0005-2736(90)90086-4; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; Jones PL, 1999, J CELL SCI, V112, P435; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Mandegar M, 2004, MICROVASC RES, V68, P75, DOI 10.1016/j.mvr.2004.06.001; Martinez-Lemus LA, 2005, AM J PHYSIOL-HEART C, V289, pH322, DOI 10.1152/ajpheart.00923.2003; Martinez-Lemus LA, 2003, J VASC RES, V40, P211, DOI 10.1159/000071886; Medhora MM, 2000, AM J PHYSIOL-HEART C, V279, pH382, DOI 10.1152/ajpheart.2000.279.1.H382; Mogford JE, 1996, CIRC RES, V79, P821, DOI 10.1161/01.RES.79.4.821; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Rabinovitch M, 2001, CLIN CHEST MED, V22, P433, DOI 10.1016/S0272-5231(05)70282-3; SCHNAPP LM, 1995, J CELL SCI, V108, P537; Schottelndreier H, 2001, CELL SIGNAL, V13, P895, DOI 10.1016/S0898-6568(01)00225-X; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Singh B, 2000, AM J PHYSIOL-LUNG C, V278, pL217, DOI 10.1152/ajplung.2000.278.1.L217; Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109; Sjaastad MD, 1996, MOL BIOL CELL, V7, P1025, DOI 10.1091/mbc.7.7.1025; Thompson M, 2004, AM J PHYSIOL-ENDOC M, V287, pE1142, DOI 10.1152/ajpendo.00122.2004; TSAO PW, 1995, J BIOL CHEM, V270, P23747, DOI 10.1074/jbc.270.40.23747; van der Wees CGC, 2006, PFLUG ARCH EUR J PHY, V451, P588, DOI 10.1007/s00424-005-1402-x; Waitkus-Edwards KR, 2002, CIRC RES, V90, P473, DOI 10.1161/hh0402.105899; Wildering WC, 2002, J NEUROSCI, V22, P2419, DOI 10.1523/JNEUROSCI.22-07-02419.2002; Wilson HL, 2001, J BIOL CHEM, V276, P11180, DOI 10.1074/jbc.M004849200; Wu X, 1998, J CELL BIOL, V143, P241, DOI 10.1083/jcb.143.1.241; Wu X, 2001, J BIOL CHEM, V276, P30285, DOI 10.1074/jbc.M102436200; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yao CC, 1997, J CELL SCI, V110, P1477; Yip KP, 1997, AM J PHYSIOL-RENAL, V273, pF768, DOI 10.1152/ajprenal.1997.273.5.F768; Young GS, 2006, BIOCHEM BIOPH RES CO, V346, P188, DOI 10.1016/j.bbrc.2006.05.100; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003	69	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34312	34323		10.1074/jbc.M606765200	http://dx.doi.org/10.1074/jbc.M606765200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16963791	hybrid			2022-12-27	WOS:000241767600051
J	Alanen, HI; Williamson, RA; Howard, MJ; Hatahet, FS; Salo, KEH; Kauppila, A; Kellokumpu, S; Ruddock, LW				Alanen, Heli I.; Williamson, Richard A.; Howard, Mark J.; Hatahet, Feras S.; Salo, Kirsi E. H.; Kauppila, Annika; Kellokumpu, Sakari; Ruddock, Lloyd W.			ERp27, a new non-catalytic endoplasmic reticulum-located human protein disulfide isomerase family member, interacts with ERp57	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING SITE; BOND FORMATION; MOLECULAR CHARACTERIZATION; LOADING COMPLEX; B' DOMAIN; THIOREDOXIN; CALRETICULIN; PEPTIDE; CATALYSIS; PATHWAY	Protein folding and quality control in the endoplasmic reticulum are critical processes for which our current understanding is far from complete. Here we describe the functional characterization of a new human 27.7-kDa protein (ERp27). We show that ERp27 is a two-domain protein located in the endoplasmic reticulum that is homologous to the non-catalytic b and b' domains of protein disulfide isomerase. ERp27 was shown to bind Delta-so-matostatin, the standard test peptide for protein disulfide isomerase-substrate binding, and this ability was localized to the second domain of ERp27. An alignment of human ERp27 and human protein disulfide isomerase allowed for the putative identification of the peptide binding site of ERp27 indicating conservation of the location of the primary substrate binding site within the protein disulfide isomerase family. NMR studies revealed a significant conformational change in the b'-like domain of ERp27 upon substrate binding, which was not just localized to the substrate binding site. In addition, we report that ERp27 is bound by ERp57 both in vitro and in vivo by a similar mechanism by which ERp57 binds calreticulin.	Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Kent	Ruddock, LW (corresponding author), Univ Oulu, Dept Biochem, POB 3000, FIN-90014 Oulu, Finland.	Lloyd.ruddock@oulu.fi		Ruddock, Lloyd/0000-0002-6247-686X; Howard, Mark/0000-0002-0762-2887	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Bass R, 2004, J BIOL CHEM, V279, P5257, DOI 10.1074/jbc.M304951200; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; DARBY NJ, 1994, BIOCHEMISTRY-US, V33, P7937, DOI 10.1021/bi00191a022; DeSilva MG, 1997, DNA CELL BIOL, V16, P269, DOI 10.1089/dna.1997.16.269; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferrari DM, 1998, EUR J BIOCHEM, V255, P570, DOI 10.1046/j.1432-1327.1998.2550570.x; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; GOLDBERGER RF, 1963, J BIOL CHEM, V238, P628; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; KELLOKUMPU S, 1988, SCIENCE, V242, P1308, DOI 10.1126/science.2461589; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Koivunen P, 2005, J BIOL CHEM, V280, P5227, DOI 10.1074/jbc.M412480200; Lappi AK, 2004, J MOL BIOL, V335, P283, DOI 10.1016/j.jmb.2003.10.051; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Liepinsh E, 2001, STRUCTURE, V9, P457, DOI 10.1016/S0969-2126(01)00607-4; Ma QJ, 2003, J BIOL CHEM, V278, P44600, DOI 10.1074/jbc.M307966200; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z; Ruddock LW, 2000, PROTEIN SCI, V9, P758; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wright CA, 2004, BIOL CHEM, V385, P763, DOI 10.1515/BC.2004.100	53	44	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33727	33738		10.1074/jbc.M604314200	http://dx.doi.org/10.1074/jbc.M604314200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16940051	hybrid			2022-12-27	WOS:000241621400080
J	Funderburk, CD; Bowling, KM; Xu, D; Huang, ZN; O'Donnell, JM				Funderburk, Christopher D.; Bowling, Kevin M.; Xu, Dong; Huang, Zhinong; O'Donnell, Janis M.			Atypical N-terminal extensions confer novel regulatory properties on GTP cyclohydrolase isoforms in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE; HEREDITARY PROGRESSIVE DYSTONIA; PROTEIN-KINASE-C; NITRIC-OXIDE; PUNCH LOCUS; TETRAHYDROBIOPTERIN DEFICIENCY; TYROSINE-HYDROXYLASE; BLOOD-PRESSURE; GENE-TRANSFER; I INHIBITION	The cofactor tetrahydrobiopterin plays critical roles in the modulation of the signaling molecules dopamine, serotonin, and nitric oxide. Deficits in cofactor synthesis have been associated with several human hereditary diseases. Responsibility for the regulation of cofactor pools resides with the first enzyme in its biosynthetic pathway, GTP cyclohydrolase I. Because organisms must be able to rapidly respond to environmental and developmental cues to adjust output of these signaling molecules, complex regulatory mechanisms are vital for signal modulation. Mammalian GTP cyclohydrolase is subject to end-product inhibition via an associated regulatory protein and to positive regulation via phosphorylation, although target residues are unknown. GTP cyclohydrolase is composed of a highly conserved homodecameric catalytic core and non-conserved N-terminal domains proposed to be regulatory sites. We demonstrate for the first time in any organism that the N-terminal arms of the protein serve regulatory functions. We identify two different modes of regulation of the enzyme mediated through the N-terminal domains. The first is end-product feedback inhibition, catalytically similar to that of the mammalian enzyme, except that feedback inhibition by the cofactor requires sequences in the N-terminal arms rather than a separate regulatory protein. The second is a novel inhibitory interaction between the N-terminal arms and the active sites, which can be alleviated through the phosphorylation of serine residues within the N termini. Both mechanisms allow for acute and highly responsive regulation of cofactor production as required by downstream signaling pathways.	Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA	University of Alabama System; University of Alabama Tuscaloosa	O'Donnell, JM (corresponding author), Univ Alabama, Dept Biol Sci, Box 870344,411 Hackberry Lane, Tuscaloosa, AL 35487 USA.	jodonnel@bama.ua.edu	Funderburk, Christopher D./X-5473-2019; Funderburk, Christopher D./R-4092-2019; Huang, Zhinong/A-1906-2008	Funderburk, Christopher D./0000-0001-5502-1456; 	NIGMS NIH HHS [GM62879] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062879] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auerbach G, 2000, P NATL ACAD SCI USA, V97, P13567, DOI 10.1073/pnas.240463497; Bader G, 2001, J MOL BIOL, V312, P1051, DOI 10.1006/jmbi.2001.5011; BARFORD PA, 1984, J NEUROL NEUROSUR PS, V47, P736, DOI 10.1136/jnnp.47.7.736; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOTTIGLIERI T, 1992, PSYCHOL MED, V22, P871, DOI 10.1017/S0033291700038447; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown G. M., 1985, FOLATES PTERINS, P115; CHEN XY, 1994, J CELL SCI, V107, P3501; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; COTTON RGH, 1986, J INHERIT METAB DIS, V9, P4, DOI 10.1007/BF01813895; Curtius H C, 1984, Adv Neurol, V40, P463; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Futahashi R, 2006, INSECT BIOCHEM MOLEC, V36, P63, DOI 10.1016/j.ibmb.2005.11.002; GUTLICH M, 1994, BIOCHEM J, V302, P215, DOI 10.1042/bj3020215; HARADA T, 1993, SCIENCE, V260, P1507, DOI 10.1126/science.8502995; HATAKEYAMA K, 1989, J BIOL CHEM, V264, P21660; HATAKEYAMA K, 1991, J BIOL CHEM, V266, P765; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hesslinger C, 1998, J BIOL CHEM, V273, P21616, DOI 10.1074/jbc.273.34.21616; Higashi Y, 2006, ATHEROSCLEROSIS, V186, P390, DOI 10.1016/j.atherosclerosis.2005.07.025; Hirano M, 1998, ANN NEUROL, V44, P365, DOI 10.1002/ana.410440312; Hwu WL, 2003, BIOCHEM BIOPH RES CO, V306, P937, DOI 10.1016/S0006-291X(03)01091-X; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; KAPATOS G, 1992, J NEUROCHEM, V59, P2048; Kase H, 2005, J HYPERTENS, V23, P1375, DOI 10.1097/01.hjh.0000173520.13976.7d; KAUFMAN S, 1963, P NATL ACAD SCI USA, V50, P1085, DOI 10.1073/pnas.50.6.1085; KAUFMAN S, 1990, BIOCHIM BIOPHYS ACTA, V1040, P19, DOI 10.1016/0167-4838(90)90141-2; Kolinsky MA, 2004, J BIOL CHEM, V279, P40677, DOI 10.1074/jbc.M405370200; KOLINSKY MA, 2004, PTERINS FOLATES NEUR, P22; Krishnakumar S, 2000, J NEUROGENET, V14, P1, DOI 10.3109/01677060009083474; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; KWON NS, 1989, J BIOL CHEM, V264, P20496; Lapize C, 1998, BIOCHEM BIOPH RES CO, V251, P802, DOI 10.1006/bbrc.1998.9552; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; MACKAY WJ, 1983, GENETICS, V105, P35; MACKAY WJ, 1985, GENETICS, V111, P885; Maita N, 2004, J BIOL CHEM, V279, P51534, DOI 10.1074/jbc.M409440200; Maita N, 2001, ACTA CRYSTALLOGR D, V57, P1153, DOI 10.1107/S0907444901005558; MCLEAN JR, 1993, J BIOL CHEM, V268, P27191; Meininger CJ, 2004, FASEB J, V18, P1900, DOI 10.1096/fj.04-1702fje; Milstien S, 1996, J BIOL CHEM, V271, P19743, DOI 10.1074/jbc.271.33.19743; Mitchell BM, 2004, J CARDIOVASC PHARM, V43, P758, DOI 10.1097/00005344-200406000-00004; Mitchell BM, 2003, AM J PHYSIOL-HEART C, V285, pH2165, DOI 10.1152/ajpheart.00253.2003; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nagatsu T, 1997, J NEURAL TRANSM-SUPP, P203; REYNOLDS ER, 1988, GENETICS, V119, P609; SCHOEDON G, 1989, EUR J BIOCHEM, V178, P627, DOI 10.1111/j.1432-1033.1989.tb14491.x; Shinozaki K, 2005, J CARDIOVASC PHARM, V46, P505, DOI 10.1097/01.fjc.0000177981.91434.ba; SUZUKI S, 1988, BRAIN RES, V446, P1, DOI 10.1016/0006-8993(88)91290-5; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; Thony B, 1997, HUM MUTAT, V10, P11; TIETZ A, 1964, J BIOL CHEM, V239, P4081; TOGARI A, 1992, BIOCHEM BIOPH RES CO, V187, P359, DOI 10.1016/S0006-291X(05)81501-3; VIVEROS OH, 1981, SCIENCE, V213, P349, DOI 10.1126/science.7017928; WEISBERG EP, 1986, J BIOL CHEM, V261, P1453; Xie LJ, 1998, J BIOL CHEM, V273, P21091, DOI 10.1074/jbc.273.33.21091	56	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33302	33312		10.1074/jbc.M602196200	http://dx.doi.org/10.1074/jbc.M602196200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16966327	hybrid			2022-12-27	WOS:000241621400040
J	Gan, ZJ; Zhao, LY; Yang, L; Huang, P; Zhao, F; Li, WJ; Liu, Y				Gan, Zhenji; Zhao, Liyun; Yang, Liu; Huang, Ping; Zhao, Feng; Li, Wenjun; Liu, Yong			RNA editing by ADAR2 is metabolically regulated in pancreatic islets and beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-DEAMINASE ADAR1; SPLICE-SITE VARIANTS; PRE-MESSENGER-RNA; GLUTAMATE-RECEPTOR; INSULIN-SECRETION; BINDING DOMAINS; INTERFERON; GLUCOSE; EXPRESSION; RESISTANCE	RNA editing via the conversion of adenosine (A) to inosine (I) is catalyzed by two major families of adenosine deaminases acting on RNA (ADARs), ADAR1 and ADAR2. This genetic recoding process is known to play essential roles in the brain, due in part to changes in functional activities of edited neurotransmitter receptors and ion channels. Little is known, however, about the physiological regulation and function of A to I RNA editing in peripheral tissues and other biological processes. Here, we report that both ADAR1 and ADAR2 are expressed in the murine pancreatic islets, and ADAR2 is primarily localized in the islet endocrine cells. In contrast to ADAR1, ADAR2 transcripts in the pancreatic islets exhibit a nearly 2-fold increase in insulin-resistant mice chronically fed a high fat diet. Concurrent with this diet-induced metabolic stress, RNA editing in the islets is dramatically enhanced for the RNA transcripts encoding the ionotropic glutamate receptor subunit B. Moreover, ADAR2 protein expression is repressed in the islets under fuel deficiency condition during fasting, and this repression can be completely reversed by refeeding. We also show that, specifically in pancreatic beta-cell lines, not only the expression of ADAR2 but also the glutamate receptor subunit B editing and ADAR2 self-editing are markedly augmented in response to glucose at the physiological concentration for insulin secretion stimulation. Thus, RNA editing by ADAR2 in pancreatic islets and beta-cells is metabolically regulated by nutritional and energy status, suggesting that A to I RNA editing is most likely involved in the modulation of pancreatic islet and beta-cell function.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Grad Sch, Shanghai 200031, Peoples R China.	liuy@sibs.ac.cn		Gan, Zhenji/0000-0001-5940-207X				Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BERTRAND G, 1992, BRIT J PHARMACOL, V106, P354, DOI 10.1111/j.1476-5381.1992.tb14340.x; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cui YX, 2004, MOL CELL BIOL, V24, P258, DOI 10.1128/MCB.24.1.258-269.2004; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; GONOI T, 1994, J BIOL CHEM, V269, P16989; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2005, GENE, V363, P193, DOI 10.1016/j.gene.2005.07.028; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Kmiec Z, 2005, GERONTOLOGY, V51, P357, DOI 10.1159/000088698; Komatsu M, 2001, ENDOCR J, V48, P275, DOI 10.1507/endocrj.48.275; Koster JC, 2005, DIABETES, V54, P3065, DOI 10.2337/diabetes.54.11.3065; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Liu Y, 1999, J BIOL CHEM, V274, P5070, DOI 10.1074/jbc.274.8.5070; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 2003, J BIOL CHEM, V278, P1391, DOI 10.1074/jbc.R200025200; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Moriyama Y, 2003, TRENDS PHARMACOL SCI, V24, P511, DOI 10.1016/j.tips.2003.08.002; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PATEL YC, 1982, SCIENCE, V217, P1155, DOI 10.1126/science.6126003; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P1; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Straub SG, 2004, DIABETES MELLITUS FU, P3; UNGER RH, 2004, DIABETES MELLITUS FU, P141; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Weir GC, 2004, NAT BIOTECHNOL, V22, P1095, DOI 10.1038/nbt0904-1095; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	51	49	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33386	33394		10.1074/jbc.M604484200	http://dx.doi.org/10.1074/jbc.M604484200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16956888	hybrid			2022-12-27	WOS:000241621400048
J	Mylonis, I; Chachami, G; Samiotaki, M; Panayotou, G; Paraskeva, E; Kalousi, A; Georgatsou, E; Bonanou, S; Simos, G				Mylonis, Ilias; Chachami, Georgia; Samiotaki, Martina; Panayotou, George; Paraskeva, Efrosini; Kalousi, Alkmini; Georgatsou, Eleni; Bonanou, Sofia; Simos, George			Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TUMOR-SUPPRESSOR PROTEIN; NUCLEAR-CYTOPLASMIC TRAFFICKING; ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR EXPRESSION; TRANSCRIPTIONAL ACTIVITY; DNA-BINDING; PROLYL HYDROXYLATION; SIGNAL-TRANSDUCTION; FACTOR 1-ALPHA	Hypoxia-inducible factor 1 (HIF-1) controls the expression of most genes induced by hypoxic conditions. Regulation of expression and activity of its inducible subunit, HIF-1 alpha, involves several post-translational modifications. To study HIF-1 alpha phosphorylation, we have used human full-length recombinant HIF-1 alpha as a substrate in kinase assays. We show that at least two different nuclear protein kinases, one of them identified as p42/p44MAPK, can modify HIF-1 alpha. Analysis of in vitro phosphorylated HIF-1 alpha by mass spectroscopy revealed residues Ser-641 and Ser-643 as possible MAPK phosphorylation sites. Site-directed mutagenesis of these residues reduced significantly the phosphorylation of HIF-1 alpha. When these mutant forms of HIF-1 alpha were expressed in HeLa cells, they exhibited much lower transcriptional activity than the wild-type form. However, expression of the same mutants in yeast revealed that their capacity to stimulate transcription was not significantly compromised. Localization of the green fluorescent protein-tagged HIF-1 alpha mutants in HeLa cells showed their exclusion from the nucleus in contrast to wild-type HIF-1 alpha. Treatment of the cells with leptomycin B, an inhibitor of the major exportin CRM1, reversed this exclusion and led to nuclear accumulation and partial recovery of the activity of the HIF-1 alpha mutants. Moreover, inhibition of the MAPK pathway by PD98059 impaired the phosphorylation, nuclear accumulation, and activity of wild-type GFP-HIF-1 alpha. Overall, these data suggest that phosphorylation of Ser-641/643 by MAPK promotes the nuclear accumulation and transcriptional activity of HIF-1 alpha by blocking its CRM1-dependent nuclear export.	Univ Thessaloniki, Dept Med, Biochem Lab, GR-41222 Larisa, Greece; Univ Thessaloniki, Dept Med, Physiol Lab, GR-41222 Larisa, Greece; Biomed Sci Res Ctr Alexander Flemingt, Prot Chem Lab, GR-16672 Vari, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Simos, G (corresponding author), 22 Papakyriazi Str, GR-41222 Larisa, Greece.	simos@med.uth.gr	Simos, George/AAH-2596-2021; Paraskeva, Efrosyni/E-6449-2015; Samiotaki, Martina/B-3851-2018	Paraskeva, Efrosyni/0000-0002-1312-0322; Samiotaki, Martina/0000-0001-9952-0636; Chachami, Georgia/0000-0002-4771-4196; Mylonis, Ilias/0000-0002-0893-6618; Simos, George/0000-0001-5453-3185				Agani F, 1998, MOL PHARMACOL, V54, P749, DOI 10.1124/mol.54.5.749; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bardos JI, 2004, BIOESSAYS, V26, P262, DOI 10.1002/bies.20002; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Bilton RL, 2003, EUR J BIOCHEM, V270, P791, DOI 10.1046/j.1432-1033.2003.03446.x; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Braliou GG, 2006, BIOCHEM BIOPH RES CO, V346, P1289, DOI 10.1016/j.bbrc.2006.06.043; Bruick RK, 2002, SCIENCE, V295, P807, DOI 10.1126/science.1069825; Carr SA, 2005, METHOD ENZYMOL, V405, P82, DOI 10.1016/S0076-6879(05)05005-6; Chachami G, 2005, BIOCHEM BIOPH RES CO, V331, P464, DOI 10.1016/j.bbrc.2005.03.193; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gradin K, 2002, J BIOL CHEM, V277, P23508, DOI 10.1074/jbc.M201307200; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hofer T, 2001, FASEB J, V15, P2715, DOI 10.1096/fj.01-0546fje; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Hur E, 2001, MOL PHARMACOL, V59, P1216, DOI 10.1124/mol.59.5.1216; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Kubis HP, 2005, BBA-MOL CELL RES, V1745, P187, DOI 10.1016/j.bbamcr.2005.05.007; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Lee S, 1999, MOL CELL BIOL, V19, P1486; Liu XH, 2002, J BIOL CHEM, V277, P50081, DOI 10.1074/jbc.M201095200; Luo JC, 2001, ONCOGENE, V20, P1435, DOI 10.1038/sj.onc.1204228; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2001, BIOCHEM BIOPH RES CO, V287, P292, DOI 10.1006/bbrc.2001.5532; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yoo YG, 2003, J BIOL CHEM, V278, P39076, DOI 10.1074/jbc.M305101200; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	58	212	222	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33095	33106		10.1074/jbc.M605058200	http://dx.doi.org/10.1074/jbc.M605058200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16954218	hybrid			2022-12-27	WOS:000241621400018
J	Soubias, O; Teague, WE; Gawrisch, K				Soubias, Olivier; Teague, Walter E.; Gawrisch, Klaus			Evidence for specificity in lipid-rhodopsin interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SEGMENT DISK MEMBRANES; SARCOPLASMIC-RETICULUM; RECOMBINANT MEMBRANES; CANNABINOID RECEPTOR; ANGSTROM RESOLUTION; PHOSPHOLIPIDS; BOVINE; NMR; BACTERIORHODOPSIN	The interaction of bovine rhodopsin with poly- and monounsaturated lipids was studied by H-1 MAS NMR with magnetization transfer from rhodopsin to lipid. Experiments were conducted on bovine rod outer segment (ROS) disks and on recombinant membranes containing lipids with polyunsaturated, docosahexaenoyl (DHA) chains. Poly- and monounsaturated lipids interact specifically with different sites on the rhodopsin surface. Rates of magnetization transfer from protein to DHA are lipid headgroup-dependent and increased in the sequence PC < PS < PE. Boundary lipids are in fast exchange with the lipid matrix on a time scale of milliseconds or shorter. All rhodopsin photointermediates transferred magnetization preferentially to DHA-containing lipids, but highest rates were observed for Meta-III rhodopsin. The experiments show clearly that the surface of rhodopsin has sites for specific interaction with lipids. Current theories of lipid-protein interaction do not account for such surface heterogeneity.	NIAAA, NMR Sect, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Gawrisch, K (corresponding author), NIAAA, NMR Sect, Lab Membrane Biochem & Biophys, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.	gawrisch@helix.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000003, ZIAAA000003] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Albert AD, 1998, BBA-BIOMEMBRANES, V1368, P52, DOI 10.1016/S0005-2736(97)00200-9; Alves ID, 2005, BIOPHYS J, V88, P198, DOI 10.1529/biophj.104.046722; Andersson AS, 1998, BIOPHYS J, V75, P2877, DOI 10.1016/S0006-3495(98)77730-6; ARNOLD K, 1979, STUD BIOPHYS, V75, P189; BALGAVY P, 1984, BIOCHIM BIOPHYS ACTA, V772, P58, DOI 10.1016/0005-2736(84)90517-0; BELRHALI H, 1999, J MOL BIOL, V7, P909; Botelho AV, 2002, BIOCHEMISTRY-US, V41, P6354, DOI 10.1021/bi011995g; BROWN MF, 1977, BIOCHEMISTRY-US, V16, P2640, DOI 10.1021/bi00631a010; Cantor RS, 1997, J PHYS CHEM B, V101, P1723, DOI 10.1021/jp963911x; DEESE AJ, 1982, BIOPHYS J, V37, P207, DOI 10.1016/S0006-3495(82)84670-5; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Feller SE, 2003, J AM CHEM SOC, V125, P4434, DOI 10.1021/ja0345874; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Gaede HC, 2004, LANGMUIR, V20, P7711, DOI 10.1021/la0493114; Gaede HC, 2003, BIOPHYS J, V85, P1734, DOI 10.1016/S0006-3495(03)74603-7; GIBSON NJ, 1993, BIOCHEMISTRY-US, V32, P2438, DOI 10.1021/bi00060a040; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Huster D, 1999, J PHYS CHEM B, V103, P243, DOI 10.1021/jp983428h; JENSEN JW, 1984, BIOCHEMISTRY-US, V23, P1115, DOI 10.1021/bi00301a012; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; LITMAN BJ, 1982, METHOD ENZYMOL, V81, P150; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Marsh D, 1998, BBA-REV BIOMEMBRANES, V1376, P267, DOI 10.1016/S0304-4157(98)00009-4; MITCHELL DC, 1992, BIOCHEMISTRY-US, V31, P662, DOI 10.1021/bi00118a005; Mitchell DC, 2003, LIPIDS, V38, P437, DOI 10.1007/s11745-003-1081-1; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; MOURITSEN OG, 1984, BIOPHYS J, V46, P141, DOI 10.1016/S0006-3495(84)84007-2; NAVARRO J, 1984, BIOCHEMISTRY-US, V23, P130, DOI 10.1021/bi00296a021; Niu SL, 2001, J BIOL CHEM, V276, P42807, DOI 10.1074/jbc.M105778200; Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200; OBRIEN DF, 1977, BIOCHEMISTRY-US, V16, P1295, DOI 10.1021/bi00626a009; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PINHEIRO TJT, 1994, BIOCHEMISTRY-US, V33, P2459, DOI 10.1021/bi00175a014; Polozova A, 2000, BIOPHYS J, V79, P2632, DOI 10.1016/S0006-3495(00)76502-7; Ritter E, 2004, J BIOL CHEM, V279, P48102, DOI 10.1074/jbc.M406857200; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Soubias O, 2005, J AM CHEM SOC, V127, P13110, DOI 10.1021/ja0538942; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Vogel R, 2004, BIOCHEMISTRY-US, V43, P9457, DOI 10.1021/bi049337u; Wang Y, 2002, J AM CHEM SOC, V124, P7690, DOI 10.1021/ja0200488; WIEDMANN TS, 1988, BIOCHEMISTRY-US, V27, P6469, DOI 10.1021/bi00417a041; Yau WM, 2000, J AM CHEM SOC, V122, P3971, DOI 10.1021/ja9944756; Zimmermann K, 2004, J BIOL CHEM, V279, P48112, DOI 10.1074/jbc.M406856200	47	76	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33233	33241		10.1074/jbc.M603059200	http://dx.doi.org/10.1074/jbc.M603059200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959786	hybrid			2022-12-27	WOS:000241621400032
J	Liu, Q; Kriksunov, IA; Graeff, R; Munshi, C; Lee, HC; Hao, Q				Liu, Qun; Kriksunov, Irina A.; Graeff, Richard; Munshi, Cyrus; Lee, Hon Cheung; Hao, Quan			Structural basis for the mechanistic understanding of human CD38-controlled multiple catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; CD38; HYDROLYSIS; CYCLIZATION; INTERMEDIATE; EXPRESSION; MOLECULE; ENZYMES	The enzymatic cleavage of the nicotinamide-glycosidic bond on nicotinamide adenine dinucleotide (NAD(+)) has been proposed to go through an oxocarbenium ion-like transition state. Because of the instability of the ionic intermediate, there has been no structural report on such a transient reactive species. Human CD38 is an ectoenzyme that can use NAD(+) to synthesize two calcium-mobilizing molecules. By using NAD(+) and a surrogate substrate, NGD(+), we captured and determined crystal structures of the enzyme complexed with an intermediate, a substrate, and a product along the reaction pathway. Our results showed that the intermediate is stabilized by polar interactions with the catalytic residue Glu(226) rather than by a covalent linkage. The polar interactions between Glu(226) and the substrate 2', 3'-OH groups are essential for initiating catalysis. Ser(193) was demonstrated to have a regulative role during catalysis and is likely to be involved in intermediate stabilization. In addition, a product inhibition effect by ADP-ribose (through the reorientation of the product) or GDP-ribose (through the formation of a covalently linked GDP-ribose dimer) was observed. These structural data provide insights into the understanding of multiple catalysis and clues for drug design.	Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; Cornell Univ, Macromol Diffract Facil, Cornell High Energy Syst Source, Ithaca, NY 14853 USA; Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Hong Kong; Cornell University; University of Minnesota System; University of Minnesota Twin Cities	Lee, HC (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	leehc@tc.umn.edu; qh22@cornell.edu	Liu, Qun/A-8757-2011; Lee, Hon Cheung/C-4329-2009; Hao, Quan/C-4304-2009; Graeff, Richard Milton/B-3425-2011	Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514	NCRR NIH HHS [RR 01646] Funding Source: Medline; NIGMS NIH HHS [GM 061568] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061568] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Antonelli A, 2004, J ENDOCRINOL INVEST, V27, P695, DOI 10.1007/BF03347507; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Deaglio S, 2003, BLOOD, V102, P2146, DOI 10.1182/blood-2003-03-0989; DeFlora A, 1997, J BIOL CHEM, V272, P12945, DOI 10.1074/jbc.272.20.12945; Deshpande DA, 2005, AM J PHYSIOL-LUNG C, V288, pL773, DOI 10.1152/ajplung.00217.2004; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guillot B, 2000, ACTA CRYSTALLOGR C, V56, P726; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE HC, 1994, NAT STRUCT BIOL, V1, P143, DOI 10.1038/nsb0394-143; LEE HC, 1993, BIOCHEM BIOPH RES CO, V191, P639, DOI 10.1006/bbrc.1993.1265; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; MullerSteffner HM, 1996, J BIOL CHEM, V271, P23967, DOI 10.1074/jbc.271.39.23967; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; MUNSHI CB, 2002, CYCLIC ADP RIBOSE NA, P81; MUSHI C, 1997, METHOD ENZYMOL, V280, P318; Okamoto H, 2003, ADV EXP MED BIOL, V527, P243; OPPENHEIMER NJ, 1994, MOL CELL BIOCHEM, V138, P245, DOI 10.1007/BF00928468; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Roussanov BV, 2000, AIDS, V14, P2715, DOI 10.1097/00002030-200012010-00011; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Sauve AA, 2000, J AM CHEM SOC, V122, P7855, DOI 10.1021/ja001139c; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; SMAR M, 1991, BIOCHEMISTRY-US, V30, P7908, DOI 10.1021/bi00246a006; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Thornton PD, 2004, HEMATOL J, V5, P145, DOI 10.1038/sj.thj.6200360; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386	35	64	68	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32861	32869		10.1074/jbc.M606365200	http://dx.doi.org/10.1074/jbc.M606365200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16951430	hybrid			2022-12-27	WOS:000241414500084
J	Oleksy, A; Opalinski, L; Derewenda, U; Derewenda, ZS; Otlewski, J				Oleksy, Arkadiusz; Opalinski, Lukasz; Derewenda, Urszula; Derewenda, Zygmunt S.; Otlewski, Jacek			The molecular basis of RhoA specificity in the guanine nucleotide exchange factor PDZ-RhoGEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; LEUKEMIA-ASSOCIATED RHO; STRUCTURAL BASIS; P115 RHOGEF; GTPASES; FAMILY; DOMAIN; COMPLEX; BINDING; ACTIVATION	The Dbl homology nucleotide exchange factors (GEFs) activate Rho family cytosolic GTPases in a variety of physiological and pathophysiological events. These signaling molecules typically act downstream of tyrosine kinase receptors and often facilitate nucleotide exchange on more than one member of the Rho GTPase superfamily. Three unique GEFs, i.e. p115, PDZ-RhoGEF, and LARG, are activated by the G-protein coupled receptors via the G alpha(12/13), and exhibit very selective activation of RhoA, although the mechanism by which this is accomplished is not fully understood. Based on the recently solved crystal structure of the DH-PH tandem of PDZ-RhoGEF in complex with RhoA (Derewenda, U., Oleksy, A., Stevenson, A. S., Korczynska, J., Dauter, Z., Somlyo, A. P., Otlewski, J., Somlyo, A. V., and Derewenda, Z. S. (2004) Structure (Lond.) 12, 1955-1965), we conducted extensive mutational and functional studies of the molecular basis of the RhoA selectivity in PDZ-RhoGEF. We show that while Trp(58) of RhoA is intimately involved in the interaction with the DH domain, it is not a selectivity determinant, and its interaction with PDZ-RhoGEF is unfavorable. The key selectivity determinants are dominated by polar contacts involving residues unique to RhoA. We find that selectivity for RhoA versus Cdc42 is defined by a small number of interactions.	Univ Wroclaw, Inst Biochem & Mol Biol, PL-50137 Wroclaw, Poland; Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Wroclaw; University of Virginia	Otlewski, J (corresponding author), Univ Wroclaw, Inst Biochem & Mol Biol, PL-50137 Wroclaw, Poland.	otlewski@protein.pl	Otlewski, Jacek/B-6340-2008	Opalinski, Lukasz/0000-0001-9656-8714	NHLBI NIH HHS [P01 HL 48807] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048807] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2003, J BIOL CHEM, V278, P9912, DOI 10.1074/jbc.M212695200; Cheng L, 2002, MOL CELL BIOL, V22, P6895, DOI 10.1128/MCB.22.19.6895-6905.2002; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Oleksy A, 2004, ACTA CRYSTALLOGR D, V60, P740, DOI 10.1107/S0907444904002318; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rossman KL, 2002, J BIOL CHEM, V277, P50893, DOI 10.1074/jbc.M208580200; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200	32	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32891	32897		10.1074/jbc.M606220200	http://dx.doi.org/10.1074/jbc.M606220200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954208	hybrid			2022-12-27	WOS:000241414500087
J	Moreschi, I; Bruzzone, S; Nicholas, RA; Fruscione, F; Sturla, L; Benvenuto, F; Usai, C; Meis, S; Kassack, MU; Zocchi, E; De Flora, A				Moreschi, Iliana; Bruzzone, Santina; Nicholas, Robert A.; Fruscione, Floriana; Sturla, Laura; Benvenuto, Federica; Usai, Cesare; Meis, Sabine; Kassack, Matthias U.; Zocchi, Elena; De Flora, Antonio			Extracellular NAD(+) is an agonist of the human P2Y(11) purinergic receptor in human granulocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-ADP-RIBOSE; REGULATES INTRACELLULAR CALCIUM; T-CELL DEATH; PHOSPHOLIPASE-C; CD38; ACTIVATION; NEUTROPHILS; RELEASE; CYCLASE; NAD+	Micromolar concentrations of extracellular beta-NAD(+) (NAD(e)(+)) activate human granulocytes (superoxide and NO generation and chemotaxis) by triggering: (i) overproduction of cAMP, (ii) activation of protein kinase A, (iii) stimulation of ADP-ribosyl cyclase and overproduction of cyclic ADP-ribose (cADPR), a universal Ca2+ mobilizer, and (iv) influx of extracellular Ca2+. Here we demonstrate that exposure of granulocytes to millimolar rather than to micromolar NAD(e)(+) generates both inositol 1,4,5-trisphosphate (IP3) and cAMP, with a two-step elevation of intracellular calcium levels ([Ca2+](i)): a rapid, IP3-mediated Ca2+ release, followed by a sustained influx of extracellular Ca2+ mediated by cADPR. Suramin, an inhibitor of P2Y receptors, abrogated NAD(e)(+)-induced intracellular increases of IP3, cAMP, cADPR, and [Ca2+](i), suggesting a role for a P2Y receptor coupled to both phospholipase C and adenylyl cyclase. The P2Y(11) receptor is the only known member of the P2Y receptor subfamily coupled to both phospholipase C and adenylyl cyclase. Therefore, we performed experiments on hP2Y(11)-transfected 1321N1 astrocytoma cells: micromolar NAD(e)(+) promoted a two-step elevation of the [Ca2+](i) due to the enhanced intracellular production of IP3, cAMP, and cADPR in 1321N1-hP2Y(11) but not in untransfected 1321N1 cells. In human granulocytes NF157, a selective and potent inhibitor of P2Y11, and the down-regulation of P2Y11 expression by short interference RNA prevented NAD(e)(+)-induced intracellular increases of ([Ca2+](i)): and chemotaxis. These results demonstrate that beta-NAD(e)(+) is an agonist of the P2Y(11) purinoceptor and that P2Y11 is the endogenous receptor in granulocytes mediating the sustained ([Ca2+](i)): increase responsible for their functional activation.	Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ Genoa, Neuroimmunol Unit, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; Univ Genoa, CEBR, Genoa, Italy; CNR, Inst Biophys, I-16149 Genoa, Italy; Univ Bonn, Inst Pharmaceut, D-53121 Bonn, Germany	University of Genoa; University of Genoa; University of North Carolina; University of North Carolina Chapel Hill; University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Bonn	Bruzzone, S (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto 15-1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	fruscione, floriana/AAA-8747-2020; Bruzzone, Santina/A-4264-2015	Bruzzone, Santina/0000-0003-2034-3716; fruscione, floriana/0000-0002-4054-645X; Usai, Cesare/0000-0001-8863-7759	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071131] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071131] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beigi RD, 2003, BRIT J PHARMACOL, V140, P507, DOI 10.1038/sj.bjp.0705470; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2006, BIOCHEM J, V393, P697, DOI 10.1042/BJ20051302; Bruzzone S, 2001, J BIOL CHEM, V276, P48300, DOI 10.1074/jbc.M107308200; Bruzzone S, 2001, FASEB J, V15, P10; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; Davies EV, 1998, INT J MOL MED, V1, P485; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DUBYAK GR, 1990, ANN NY ACAD SCI, V603, P227; Esguerra M, 2002, GLIA, V39, P314, DOI 10.1002/glia.10115; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Gerth A, 2004, BIOCHEM J, V382, P849, DOI 10.1042/BJ20040979; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Kawamura H, 2005, J IMMUNOL, V174, P1971, DOI 10.4049/jimmunol.174.4.1971; Kiselyov K, 2001, BIOCHEM J, V360, P17, DOI 10.1042/0264-6021:3600017; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Krebs C, 2005, J IMMUNOL, V174, P3298, DOI 10.4049/jimmunol.174.6.3298; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 2002, CYCLIC ADP RIBOSE NA; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Meshki J, 2004, AM J PHYSIOL-CELL PH, V286, pC264, DOI 10.1152/ajpcell.00287.2003; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Qi AD, 2001, BRIT J PHARMACOL, V132, P318, DOI 10.1038/sj.bjp.0703788; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Ralevic V, 1998, PHARMACOL REV, V50, P413; Romanello M, 2002, BIOCHEM BIOPH RES CO, V299, P424, DOI 10.1016/S0006-291X(02)02665-7; Schwarzmann N, 2002, J BIOL CHEM, V277, P50636, DOI 10.1074/jbc.M209061200; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Smyth LM, 2004, J BIOL CHEM, V279, P48893, DOI 10.1074/jbc.M407266200; Spassova MA, 2004, BBA-MOL CELL RES, V1742, P9, DOI 10.1016/j.bbamcr.2004.09.001; Sun L, 1999, J CELL BIOL, V146, P1161, DOI 10.1083/jcb.146.5.1161; Torres B, 2002, J BIOL CHEM, V277, P7761, DOI 10.1074/jbc.M110352200; Ullmann H, 2005, J MED CHEM, V48, P7040, DOI 10.1021/jm050301p; Verderio C, 2001, J NEUROCHEM, V78, P646, DOI 10.1046/j.1471-4159.2001.00455.x; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; White PJ, 2003, MOL PHARMACOL, V63, P1356, DOI 10.1124/mol.63.6.1356; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x; ZIEGLER M, 2004, BIOCHEM J, V382, P5	43	109	112	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31419	31429		10.1074/jbc.M606625200	http://dx.doi.org/10.1074/jbc.M606625200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16926152	Bronze, Green Published			2022-12-27	WOS:000241235300026
J	Balasubramanian, S; Zhu, L; Eckert, RL				Balasubramanian, Sivaprakasam; Zhu, Ling; Eckert, Richard L.			Apigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase C delta Tyr(311)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN TEA POLYPHENOL; EPSILON TRANSGENIC MICE; GROWTH-FACTOR RECEPTOR; CELL-CYCLE ARREST; CHEMOPREVENTIVE FLAVONOID APIGENIN; EPIDERMAL ORNITHINE DECARBOXYLASE; DISTAL REGULATORY REGION; SKIN TUMOR-PROMOTION; SKH-1 HAIRLESS MICE; FACTOR-KAPPA-B	Apigenin is a plant-derived flavanoid that has significant promise as a skin cancer chemopreventive agent. In the present study, we examine the mechanism whereby apigenin regulates normal human keratinocyte differentiation. Expression of involucrin (hINV), a marker of keratinocyte differentiation, is increased by differentiating agents via a protein kinase C delta(PKC delta), Ras, MEKK1, MEK3 cascade that increases AP1 factor level and AP1 factor binding to DNA elements in the hINV promoter. We show that apigenin inhibits this response. Apigenin suppresses the 12-O-tetradeconylphorbol-13- acetate-dependent increase in AP1 factor expression and binding to the hINV promoter and the increase in hINV promoter activity. Apigenin also inhibits the increase in promoter activity observed following overexpression of PKC delta, constitutively active Ras, or MEKK1. The suppression of PKC delta activity is associated with reduced phosphorylation of PKC delta-Y311. The physiological importance of this phosphorylation event was confirmed by showing that the PKC delta phosphorylation-defective mutant, PKC delta-Y311F, is less able to increase hINV promoter activity. Activation of hINV promoter activity by the green tea polyphenol, (-)-epigellocathecin-3-gallate, is also inhibited by apigenin, suggesting that the two chemopreventive agents can produce opposing actions in keratinocytes. Additional studies show that the apigenin-dependent suppression of differentiation is associated with reduced cell proliferation but that there is no evidence of apoptosis.	Case Western Reserve Univ, Sch Med, Dept Physiol Biophys, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Dermatol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Reprod Biol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Eckert, RL (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol Biophys, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	rle2@po.cwru.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR039750] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39750] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; AGARWAL R, 1993, PHOTOCHEM PHOTOBIOL, V58, P695, DOI 10.1111/j.1751-1097.1993.tb04954.x; Balasubramanian S, 2005, ONCOGENE, V24, P4257, DOI 10.1038/sj.onc.1208586; Balasubramanian S, 2005, CARCINOGENESIS, V26, P1100, DOI 10.1093/carcin/bgi048; Balasubramanian S, 2004, J BIOL CHEM, V279, P24007, DOI 10.1074/jbc.M314331200; Balasubramanian S, 2002, J BIOL CHEM, V277, P1828, DOI 10.1074/jbc.M110376200; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; Birt DF, 1997, ANTICANCER RES, V17, P85; CHAUMONTET C, 1994, CARCINOGENESIS, V15, P2325, DOI 10.1093/carcin/15.10.2325; Chen CC, 2004, MOL PHARMACOL, V66, P683; Chen D, 2005, BIOCHEM PHARMACOL, V69, P1421, DOI 10.1016/j.bcp.2005.02.022; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Dashti SR, 2001, J BIOL CHEM, V276, P27214, DOI 10.1074/jbc.M100465200; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Denning MF, 1998, J BIOL CHEM, V273, P29995, DOI 10.1074/jbc.273.45.29995; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; Droillard MJ, 2004, FEBS LETT, V574, P42, DOI 10.1016/j.febslet.2004.08.001; Eckert RL, 2006, MOL NUTR FOOD RES, V50, P123, DOI 10.1002/mnfr.200500125; Eckert RL, 2004, BIOCHEM PHARMACOL, V68, P1125, DOI 10.1016/j.bcp.2004.04.029; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Eckert RL, 2003, J INVEST DERMATOL, V120, P823, DOI 10.1046/j.1523-1747.2003.12120.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; ENGELHARDT UH, 1993, Z LEBENSM UNTERS FOR, V197, P239, DOI 10.1007/BF01185278; Fotsis T, 1997, CANCER RES, V57, P2916; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Fukunaga M, 2001, BIOCHEM BIOPH RES CO, V289, P573, DOI 10.1006/bbrc.2001.6025; GEAHLEN RL, 1989, J NAT PROD, V52, P982, DOI 10.1021/np50065a011; Gupta S, 2002, ONCOGENE, V21, P3727, DOI 10.1038/sj.onc.1205474; HERTOG MGL, 1994, NUTR CANCER, V22, P175, DOI 10.1080/01635589409514342; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; Hollman PCH, 1999, P SOC EXP BIOL MED, V220, P198, DOI 10.1046/j.1525-1373.1999.d01-33.x; Huang CS, 1996, J BIOL CHEM, V271, P31262, DOI 10.1074/jbc.271.49.31262; Huang CS, 1997, J BIOL CHEM, V272, P26325, DOI 10.1074/jbc.272.42.26325; Huang YT, 1996, EUR J CANCER, V32A, P146, DOI 10.1016/0959-8049(95)00540-4; Jansen AP, 2001, INT J CANCER, V93, P635, DOI 10.1002/ijc.1395; Jansen AP, 2001, CANCER RES, V61, P808; Jost M, 1999, J INVEST DERMATOL, V112, P443, DOI 10.1046/j.1523-1747.1999.00543.x; Jost M, 2001, J BIOL CHEM, V276, P6320, DOI 10.1074/jbc.M008210200; Katiyar SK, 2001, J LEUKOCYTE BIOL, V69, P719; Kim AL, 2005, J INVEST DERMATOL, V124, P1318, DOI 10.1111/j.0022-202X.2005.23747.x; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; LaCelle PT, 1998, SKIN PHARMACOL APPL, V11, P214, DOI 10.1159/000029830; Lepley DM, 1997, MOL CARCINOGEN, V19, P74, DOI 10.1002/(SICI)1098-2744(199707)19:2<74::AID-MC2>3.0.CO;2-L; Lepley DM, 1996, CARCINOGENESIS, V17, P2367, DOI 10.1093/carcin/17.11.2367; Lin JK, 1997, J CELL BIOCHEM, P39; Llorens F, 2004, EXP CELL RES, V299, P15, DOI 10.1016/j.yexcr.2004.05.006; MATERN U, 1983, EUR J BIOCHEM, V133, P439, DOI 10.1111/j.1432-1033.1983.tb07483.x; McVean M, 2002, MOL CARCINOGEN, V33, P36, DOI 10.1002/mc.10016; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Mukhopadhyay A, 2002, ONCOGENE, V21, P8852, DOI 10.1038/sj.onc.1206048; Mukhtar H, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P209; Murphy G, 2001, EXP DERMATOL, V10, P155, DOI 10.1034/j.1600-0625.2001.010003155.x; PERYT B, 1992, MUTAT RES, V269, P201, DOI 10.1016/0027-5107(92)90201-C; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Rutberg SE, 1996, ONCOGENE, V13, P167; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; STONER GD, 1995, J CELL BIOCHEM, P169; Van Dross R, 2003, J NUTR, V133, p3800S, DOI 10.1093/jn/133.11.3800S; Van Dross RT, 2005, MOL CARCINOGEN, V44, P83, DOI 10.1002/mc.20123; Wang WQ, 2000, MOL CARCINOGEN, V28, P102; WATT FM, 1982, NATURE, V295, P434, DOI 10.1038/295434a0; Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2; Way TD, 2004, J BIOL CHEM, V279, P4479, DOI 10.1074/jbc.M305529200; WEI HC, 1990, CANCER RES, V50, P499; Welter JF, 1995, ONCOGENE, V11, P2681; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Wheeler DL, 2003, CANCER RES, V63, P6547; YAFFE MB, 1993, J INVEST DERMATOL, V100, P3, DOI 10.1111/1523-1747.ep12349857; Yin F, 2001, ANTICANCER RES, V21, P413; Yin F, 1999, THYROID, V9, P369, DOI 10.1089/thy.1999.9.369	85	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36162	36172		10.1074/jbc.M605368200	http://dx.doi.org/10.1074/jbc.M605368200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16982614	hybrid			2022-12-27	WOS:000242100500066
J	Boraston, AB; Wang, D; Burke, RD				Boraston, Alisdair B.; Wang, Diana; Burke, Robert D.			Blood group antigen recognition by a Streptococcus pneumoniae virulence factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; ISOTHERMAL TITRATION CALORIMETRY; LIGAND-BINDING; LECTIN; COEFFICIENTS; SPECIFICITY; REFINEMENT; PROTEINS; SEQUENCE	The Streptococcus pneumoniae fucose utilization operon includes a gene encoding a virulence factor that belongs to family 98 in the glycoside hydrolase classification. This protein contains a C-terminal triplet of fucose binding modules that have significant amino acid sequence identity with the Anguilla anguilla fucolectin. Functional studies of these fucose binding modules reveal binding to fucosylated oligosaccharides and suggest the importance of multivalent binding. The high resolution crystal structures of ligand bound forms of one fucose binding module uncovers the molecular basis of fucose, ABH blood group antigen, and Lewis(y) antigen binding. These studies are extended by fluorescence microscopy to show specific binding to mouse lung tissue. These modules define a new family of carbohydrate binding modules now classified as family 47.	Univ Victoria, Victoria, BC V8W 3P6, Canada; Univ Victoria, Victoria, BC V8W 3N5, Canada	University of Victoria; University of Victoria	Boraston, AB (corresponding author), Univ Victoria, POB 3055 CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca		Boraston, Alisdair/0000-0001-6417-0592; Burke, Robert/0000-0001-5527-4410				Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; Baldus SE, 1996, GLYCOCONJUGATE J, V13, P585, DOI 10.1007/BF00731446; Bianchet MA, 2002, NAT STRUCT BIOL, V9, P628, DOI 10.1038/nsb817; Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chan PF, 2003, J BACTERIOL, V185, P2051, DOI 10.1128/JB.185.6.2051-2058.2003; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Doern GV, 1999, EMERG INFECT DIS, V5, P757, DOI 10.3201/eid0506.990603; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	28	48	48	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35263	35271		10.1074/jbc.M607620200	http://dx.doi.org/10.1074/jbc.M607620200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16987809	hybrid			2022-12-27	WOS:000241933700060
J	del Rey, A; Renigunta, V; Dalpke, AH; Leipziger, J; Matos, JE; Robaye, B; Zuzarte, M; Kavelaars, A; Hanley, PJ				del Rey, Adriana; Renigunta, Vijay; Dalpke, Alexander H.; Leipziger, Jens; Matos, Joana E.; Robaye, Bernard; Zuzarte, Marylou; Kavelaars, Annemieke; Hanley, Peter J.			Knock-out mice reveal the contributions of P2Y and P2X receptors to nucleotide-induced Ca2+ signaling in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP; DESENSITIZATION; AGONIST; RELEASE; ACTIVATION; MECHANISMS; MEMBRANE; CELLS; PHOSPHORYLATION; MOLECULES	Immune cell function is modulated by changes in extracellular nucleotide levels. Here we used reverse transcription-PCR analyses, single cell Ca2+ imaging, and knock-out mice to define the receptors mediating nucleotide-induced Ca2+ signaling in resident peritoneal macrophages. In Ca2+-free buffer, the potent (K-0.5 < 1 mu m) stimulatory effect of UTP (or ATP) on endoplasmic reticulum (ER) Ca2+ release was abolished in cells isolated from P2Y(2)/P2Y(4) double knock-out mice. Moreover, P2Y(4)(0/-), but not P2Y(2)(-/-), macrophages responded to UTP. In P2Y(2)(-/-) macrophages, we could elicit Ca2+ responses to "pure" P2X receptor activation by applying ATP in buffer containing Ca2+. Purified UDP and ADP were ineffective agonists, although modest UDP-induced Ca2+ responses could be elicited in macrophages after "activation" with lipopolysaccharide and interferon-gamma. Notably, in Ca2+-free buffer, UTP-induced Ca2+ transients decayed within 1 min, and there was no response to repeated agonist challenge. Measurements of ER [Ca2+] with mag-fluo-4 showed that ER Ca2+ stores were depleted under these conditions. When extracellular Ca2+ was available, ER Ca2+ stores refilled, but Ca2+ increased to only similar to 40% of the initial value upon repeated UTP challenge. This apparent receptor desensitization persisted in GRK2(+/-) and GRK6(-/-) macrophages and after inhibition of candidate kinases protein kinase C and calmodulin-dependent kinase II. Initial challenge with UTP also reduced Ca2+ mobilization by complement component C5a (and vice versa). In conclusion, homologous receptor desensitization is not the major mechanism that rapidly dampens Ca2+ signaling mediated by P2Y(2), the sole G(q)-coupled receptor for UTP or ATP in macrophages. UDP responsiveness (P2Y(6) receptor expression) increases following macrophage activation.	Univ Marburg, Inst Physiol, D-35037 Marburg, Germany; Heidelberg Univ, Dept Hyg & Med Microbiol, D-69120 Heidelberg, Germany; Aarhus Univ, Inst Physiol & Biophys, DK-8000 Aarhus, Denmark; Univ Libre Bruxelles, Inst Biol & Med Mol, Inst Interdisciplinary Res, B-6041 Charleroi, Gosselies, Belgium; Univ Utrecht, Med Ctr, Lab Psychoneuroimmunol, NL-3584 EA Utrecht, Netherlands	Philipps University Marburg; Ruprecht Karls University Heidelberg; Aarhus University; Universite Libre de Bruxelles; Utrecht University	Hanley, PJ (corresponding author), Univ Marburg, Inst Physiol, Deutschhausstr 2, D-35037 Marburg, Germany.	hanley@mailer.uni-marburg.de	Hanley, Peter J/H-4915-2017	Leipziger, Jens/0000-0002-6719-7034				Bowler JW, 2003, BRIT J PHARMACOL, V140, P567, DOI 10.1038/sj.bjp.0705459; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Communi D, 1999, BRIT J PHARMACOL, V128, P1199, DOI 10.1038/sj.bjp.0702909; Coutinho-Silva R, 2005, BIOCHEM PHARMACOL, V69, P641, DOI 10.1016/j.bcp.2004.11.012; Davignon I, 2000, MOL CELL BIOL, V20, P797, DOI 10.1128/MCB.20.3.797-804.2000; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Flores RV, 2005, MOL CELL BIOCHEM, V280, P35, DOI 10.1007/s11010-005-8050-5; Gachet C, 2006, ANNU REV PHARMACOL, V46, P277, DOI 10.1146/annurev.pharmtox.46.120604.141207; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Harden TK, 1997, TRENDS PHARMACOL SCI, V18, P43, DOI 10.1016/S0165-6147(97)89795-7; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Hasko G, 1998, BIOCHEM PHARMACOL, V56, P1079, DOI 10.1016/S0006-2952(98)00153-1; Herold CL, 2004, J BIOL CHEM, V279, P11456, DOI 10.1074/jbc.M301734200; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Kaufmann A, 2005, J BIOL CHEM, V280, P32459, DOI 10.1074/jbc.M505301200; Koizumi S, 2002, LIFE SCI, V72, P431, DOI 10.1016/S0024-3205(02)02273-7; Koshimizu T, 1999, J BIOL CHEM, V274, P37651, DOI 10.1074/jbc.274.53.37651; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lazarowski ER, 2001, J PHARMACOL EXP THER, V297, P43; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Mak DOD, 2001, J GEN PHYSIOL, V117, P435, DOI 10.1085/jgp.117.5.435; Marteau F, 2004, J LEUKOCYTE BIOL, V76, P796, DOI 10.1189/jlb.0104032; Matos JE, 2005, J PHYSIOL-LONDON, V564, P269, DOI 10.1113/jphysiol.2004.080002; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Nicke A, 2005, J NEUROCHEM, V92, P925, DOI 10.1111/j.1471-4159.2004.02939.x; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; Otero M, 2000, MOL CELL BIOCHEM, V205, P115, DOI 10.1023/A:1007018001735; Robaye B, 2003, MOL PHARMACOL, V63, P777, DOI 10.1124/mol.63.4.777; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Tulapurkar ME, 2006, J NEUROCHEM, V96, P624, DOI 10.1111/j.1471-4159.2005.03594.x; Vroon A, 2005, J IMMUNOL, V174, P4400, DOI 10.4049/jimmunol.174.7.4400; Westfall DP, 2002, J PHARMACOL EXP THER, V303, P439, DOI 10.1124/jpet.102.035113; Yoshioka K, 2001, P NATL ACAD SCI USA, V98, P7617, DOI 10.1073/pnas.121587098; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	40	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35147	35155		10.1074/jbc.M607713200	http://dx.doi.org/10.1074/jbc.M607713200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16980298	hybrid			2022-12-27	WOS:000241933700048
J	Gonzalez, A; Ruiz, A; Serrano, R; Arino, J; Casamayor, A				Gonzalez, Asier; Ruiz, Amparo; Serrano, Raquel; Arino, Joaquin; Casamayor, Antonio			Transcriptional profiling of the protein phosphatase 2C family in yeast provides insights into the unique functional roles of ptc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; VACUOLAR H+-ATPASE; INTEGRITY SIGNALING PATHWAY; EXPRESSION DATA-ANALYSIS; GENE-EXPRESSION; CELL INTEGRITY; BUDDING YEAST; WIDE ANALYSIS; SER/THR PHOSPHATASE; ALTERED SENSITIVITY	Type 2C protein phosphatases are encoded in Saccharomyces cerevisiae by several related genes (PTC1-5 and PTC7). To gain insight into the functions attributable to specific members of this gene family, we have investigated the transcriptional profiles of ptc1- 5 mutants. Two main patterns were obtained as follows: the one generated by the ptc1 mutation and the one resulting from the lack of Ptc2-5. ptc4 and ptc5 profiles were quite similar, whereas that of ptc2 was less related to this group. Mutation of PTC1 resulted in increased expression of numerous genes that are also induced by cell wall damage, such as YKL161c, SED1, or CRH1, as well as in higher amounts of active Slt2 mitogen-activated protein kinase, indicating that lack of the phosphatase activates the cell wall integrity pathway. ptc1 cells were even more sensitive than slt2 mutants to a number of cell wall-damaging agents, and both mutations had additive effects. The sensitivity of ptc1 cells was not dependent on Hog1. Besides these phenotypes, we observed that calcineurin was hyperactivated in ptc1 cells, which were also highly sensitive to calcium ions, heavy metals, and alkaline pH, and exhibited a random haploid budding pattern. Remarkably, many of these traits are found in certain mutants with impaired vacuolar function. As ptc1 cells also display fragmented vacuoles, we hypothesized that lack of Ptc1 would primarily cause vacuolar malfunction, from which other phenotypes would derive. In agreement with this scenario, overexpression of VPS73, a gene of unknown function involved in vacuolar protein sorting, largely rescues not only vacuolar fragmentation but also sensitivity to cell wall damage, high calcium, alkaline pH, as well as other ptc1-specific phenotypes.	Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Catalonia, Spain	Autonomous University of Barcelona	Casamayor, A (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Edificio 5, E-08193 Barcelona, Catalonia, Spain.	Antonio.Casamayor@uab.es	Ruiz, Amparo/AAZ-2317-2021; Casamayor, Antonio/C-2509-2017; Arino, Joaquin/D-3756-2011; Casamayor, Antonio/A-3190-2012; González, Asier/A-7064-2012	Ruiz, Amparo/0000-0002-3947-4540; Arino, Joaquin/0000-0002-6774-2987; Casamayor, Antonio/0000-0003-2788-7329; Arino Carmona, Joaquin/0000-0002-0390-4270				Alberola TM, 2004, INT MICROBIOL, V7, P199; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bilsland E, 1998, YEAST, V14, P655, DOI 10.1002/(SICI)1097-0061(199805)14:7<655::AID-YEA257>3.0.CO;2-X; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Cohen PTW, 2004, TOP CURR GENET, V5, P1; de Nadal E, 1998, P NATL ACAD SCI USA, V95, P7357, DOI 10.1073/pnas.95.13.7357; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enyenihi AH, 2003, GENETICS, V163, P47; Gaits F, 1999, MOL BIOL CELL, V10, P2647, DOI 10.1091/mbc.10.8.2647; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Garcia-Rodriguez LJ, 2000, J BACTERIOL, V182, P2428, DOI 10.1128/JB.182.9.2428-2437.2000; Garcia-Rodriguez LJ, 2005, FEBS LETT, V579, P6186, DOI 10.1016/j.febslet.2005.10.001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; HALACHMI D, 1989, FEBS LETT, V256, P55, DOI 10.1016/0014-5793(89)81717-X; Herrero J, 2003, NUCLEIC ACIDS RES, V31, P3461, DOI 10.1093/nar/gkg591; HUANG KN, 1995, GENETICS, V141, P1275; JIANG B, 1995, MOL GEN GENET, V248, P260, DOI 10.1007/BF02191592; Jiang LH, 2002, FEBS LETT, V527, P323, DOI 10.1016/S0014-5793(02)03247-7; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Lussier M, 1997, GENETICS, V147, P435; MAEDA T, 1993, MOL CELL BIOL, V13, P5408, DOI 10.1128/MCB.13.9.5408; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; Markovich S, 2004, ANTIMICROB AGENTS CH, V48, P3871, DOI 10.1128/AAC.48.10.3871-3876.2004; Marsolier MC, 2000, GENETICS, V154, P1523; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MARTIN H, 1993, MOL GEN GENET, V241, P177, DOI 10.1007/BF00280215; Munoz I, 2003, YEAST, V20, P157, DOI 10.1002/yea.938; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Page N, 2003, GENETICS, V163, P875; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBINSON MK, 1994, MOL CELL BIOL, V14, P3634, DOI 10.1128/MCB.14.6.3634; Roeder AD, 1998, MOL BIOL CELL, V9, P917, DOI 10.1091/mbc.9.4.917; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruiz A, 2003, EUKARYOT CELL, V2, P937, DOI 10.1128/EC.2.5.937-948.2003; Ruiz A, 2006, MOL MICROBIOL, V62, P263, DOI 10.1111/j.1365-2958.2006.05370.x; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Sakumoto N, 2002, YEAST, V19, P587, DOI 10.1002/yea.860; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; Shitamukai A, 2004, J BIOL CHEM, V279, P3651, DOI 10.1074/jbc.M306098200; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Tahirovic S, 2005, TRAFFIC, V6, P116, DOI 10.1111/j.1600-0854.2004.00255.x; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Vissi E, 2001, YEAST, V18, P115, DOI 10.1002/1097-0061(20010130)18:2<115::AID-YEA653>3.0.CO;2-G; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Welihinda AA, 1998, MOL CELL BIOL, V18, P1967, DOI 10.1128/MCB.18.4.1967; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Young C, 2002, EUKARYOT CELL, V1, P1032, DOI 10.1128/EC.1.6.1032-1040.2002; Zakrzewska A, 2005, EUKARYOT CELL, V4, P703, DOI 10.1128/EC.4.4.703-715.2005; Zhang JW, 1998, J BIOL CHEM, V273, P18470, DOI 10.1074/jbc.273.29.18470	75	50	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35057	35069		10.1074/jbc.M607919200	http://dx.doi.org/10.1074/jbc.M607919200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16973600	hybrid			2022-12-27	WOS:000241933700039
J	Hammond, MSL; Sims, C; Parameshwaran, K; Suppiramaniam, V; Schachner, M; Dityatev, A				Hammond, Martin S. L.; Sims, Catrina; Parameshwaran, Kodeeswaran; Suppiramaniam, Vishnu; Schachner, Melitta; Dityatev, Alexander			Neural cell adhesion molecule-associated polysialic acid inhibits NR2B-containing N-methyl-D-aspartate receptors and prevents glutamate-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTORS; SUBUNIT COMPOSITION; PSA-NCAM; EXPRESSION; BINDING; SYSTEM; BRAIN; L1; NEURODEGENERATION	The neural cell adhesion molecule (NCAM) and its associated glycan polysialic acid play important roles in the development of the nervous system and N-methyl-D-aspartat(NMDA) receptor-dependent synaptic plasticity in the adult. Here, we investigated the influence of polysialic acid on NMDA receptor activity. We found that glutamate-elicited NMDA receptor currents in cultured hippocampal neurons were reduced by approximate to 30% with the application of polysialic acid or polysialylated NCAM but not by the sialic acid monomer, chondroitin sulfate, or non-polysialylated NCAM. Polysialic acid inhibited NMDA receptor currents elicited by 3 mu M glutamate but not by 30 mu M glutamate, suggesting that polysialic acid acts as a competitive antagonist, possibly at the glutamate binding site. The polysialic acid induced effects were mimicked and fully occluded by the NR2B subunit specific antagonist, ifenprodil. Recordings from single synaptosomal NMDA receptors reconstituted in lipid bilayers revealed that polysialic acid reduced open probability but not the conductance of NR2B-containing NMDA receptors in a polysialic acid and glutamate concentration-dependent manner. The activity of single NR2B-lacking synaptosomal NMDA receptors was not affected by polysialic acid. Application of polysialic acid to hippocampal cultures reduced excitotoxic cell death induced by low micromolar concentration of glutamate via activation of NR2B-containing NMDA receptors, whereas enzymatic removal of polysialic acid resulted in increased cell death that occluded glutamate-induced excitotoxicity. These observations indicate that the cell adhesion molecule-associated glycan polysialic acid is able to prevent excitotoxicity via inhibition of NR2B subunit-containing NMDA receptors.	Auburn Univ, Harrison Sch Pharm, Dept Pharmacal Sci, Auburn, AL 36849 USA; Univ Hamburg, Klinikum Eppendorf, Inst Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; Univ Hamburg, Klinikum Eppendorf, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Dalian Med Univ, Dalian 116023, Peoples R China	Auburn University System; Auburn University; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Dalian Medical University	Suppiramaniam, V (corresponding author), Auburn Univ, Harrison Sch Pharm, Dept Pharmacal Sci, Auburn, AL 36849 USA.	suppivd@auburn.edu; melitta.schachner@zmnh.uni-hamburg.de	Dityatev, Alexander/A-4034-2008	Dityatev, Alexander/0000-0002-0472-0553; Robinson, Catrina/0000-0003-4776-5839				Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Berger C, 2004, NERVENARZT, V75, P113, DOI 10.1007/s00115-003-1627-x; BHAVANANDAN VP, 1993, ANAL BIOCHEM, V213, P438, DOI 10.1006/abio.1993.1445; BOCK E, 1987, FEBS LETT, V225, P33, DOI 10.1016/0014-5793(87)81126-2; Bouzioukh F, 2001, J NEUROSCI, V21, P4721, DOI 10.1523/JNEUROSCI.21-13-04721.2001; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Endo A, 1998, NEUROSCI LETT, V246, P37, DOI 10.1016/S0304-3940(98)00204-3; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fux CM, 2003, MOL CELL NEUROSCI, V24, P939, DOI 10.1016/j.mcn.2003.07.001; GERARDYSCHAHN R, 1995, MOL MICROBIOL, V16, P441, DOI 10.1111/j.1365-2958.1995.tb02409.x; HALLENBECK PC, 1987, ANAL BIOCHEM, V161, P181, DOI 10.1016/0003-2697(87)90670-1; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hoffman KB, 1998, BRAIN RES, V811, P152, DOI 10.1016/S0006-8993(98)00907-X; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kinarsky L, 2005, J PHARMACOL EXP THER, V313, P1066, DOI 10.1124/jpet.104.082990; Kirson ED, 1999, J PHYSIOL-LONDON, V521, P99, DOI 10.1111/j.1469-7793.1999.00099.x; Kiss JZ, 2001, REV NEUROSCIENCE, V12, P297; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kohr G, 2003, J NEUROSCI, V23, P10791; Kundrotiene J, 2004, J NEUROTRAUM, V21, P83, DOI 10.1089/089771504772695977; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Li LJ, 2003, NEUROBIOL AGING, V24, P1113, DOI 10.1016/j.neurobiolaging.2003.04.003; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nagy J, 2004, IDRUGS, V7, P339; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Ritz MF, 2004, BRAIN RES, V1022, P157, DOI 10.1016/j.brainres.2004.07.004; ROCK DM, 1995, ANNU REV PHARMACOL, V35, P463; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sherwin AL, 1999, NEUROCHEM RES, V24, P1385, DOI 10.1023/A:1022580506443; SHIMODA Y, 1994, BIOCHEMISTRY-US, V33, P1202, DOI 10.1021/bi00171a020; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Ueda Y, 2001, J NEUROCHEM, V76, P892, DOI 10.1046/j.1471-4159.2001.00087.x; Vaithianathan H, 2005, CELL BIOCHEM BIOPHYS, V42, P75, DOI 10.1385/CBB:42:1:075; Vaithianathan T, 2004, J BIOL CHEM, V279, P47975, DOI 10.1074/jbc.M407138200; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006	56	87	90	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34859	34869		10.1074/jbc.M602568200	http://dx.doi.org/10.1074/jbc.M602568200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16987814	hybrid			2022-12-27	WOS:000241933700018
J	Hu, YF; Li, Y; Zhang, XX; Guo, XR; Xia, B; Jin, CW				Hu, Yunfei; Li, You; Zhang, Xinxin; Guo, Xianrong; Xia, Bin; Jin, Changwen			Solution structures and backbone dynamics of a flavodoxin MioC from Escherichia coli in both apo- and holo-forms - Implications for cofactor binding and electron transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-BEIJERINCKII FLAVODOXIN; MAGNETIC-RESONANCE RELAXATION; TORSION ANGLE DYNAMICS; MODEL-FREE APPROACH; METHIONINE SYNTHASE; DESULFOVIBRIO-VULGARIS; CRYSTAL-STRUCTURES; CHROMOSOMAL REPLICATION; ANABAENA APOFLAVODOXIN; AZOTOBACTER-VINELANDII	Flavodoxins play central roles in the electron transfer involving various biological processes in microorganisms. The mioC gene of Escherichia coli encodes a 16-kDa flavodoxin and locates next to the chromosomal replication initiation origin (oriC). Extensive researches have been carried out to investigate the relationship between mioC transcription and replication initiation. Recently, the MioC protein was proposed to be essential for the biotin synthase activity in vitro. Nevertheless, the exact role of MioC in biotin synthesis and its physiological function in vivo remain elusive. In order to understand the molecular basis of the biological functions of MioC and the cofactor-binding mechanisms of flavodoxins, we have determined the solution structures of both the apo- and holo-forms of E. coli MioC protein at high resolution by nuclear magnetic resonance spectroscopy. The overall structures of both forms consist of an alpha/beta sandwich, which highly resembles the classical flavodoxin fold. However, significant diversities are observed between the two forms, especially the stabilization of the FMN-binding loops and the notable extension of secondary structures upon FMN binding. Structural comparison reveals fewer negative charged and aromatic residues near the FMN-binding site of MioC, as compared with that of flavodoxin 1 from E. coli, which may affect both the redox potentials and the redox partner interactions. Furthermore, the backbone dynamics studies reveal the conformational flexibility at different time scales for both apo- and holo-forms of MioC, which may play important roles for cofactor binding and electron transfer.	Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Jin, CW (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	changwen@pku.edu.cn	zhang, xinxin/E-8629-2012					Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artali R, 2002, ACTA CRYSTALLOGR D, V58, P1787, DOI 10.1107/S0907444902012234; ASAI T, 1990, EMBO J, V9, P4065, DOI 10.1002/j.1460-2075.1990.tb07628.x; Atkinson RA, 2004, PROG NUCL MAG RES SP, V44, P141, DOI 10.1016/j.pnmrs.2004.01.001; Barsukov I, 1997, J BIOMOL NMR, V10, P63, DOI 10.1023/A:1018313830207; Bates DB, 1997, P NATL ACAD SCI USA, V94, P12497, DOI 10.1073/pnas.94.23.12497; BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9; Birch OM, 2000, J BIOL CHEM, V275, P32277, DOI 10.1074/jbc.M004497200; BIRCH OM, 1995, J BIOL CHEM, V270, P19158, DOI 10.1074/jbc.270.32.19158; Bogan JA, 1996, J BACTERIOL, V178, P3201, DOI 10.1128/jb.178.11.3201-3206.1996; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chang FC, 1999, BIOCHEMISTRY-US, V38, P7168, DOI 10.1021/bi982203u; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; EDMONDSON DE, 1971, BIOCHEMISTRY-US, V10, P124; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Freigang J, 2002, PROTEIN SCI, V11, P253, DOI 10.1110/ps.28602; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Gangeswaran R, 1996, BIOCHEM J, V317, P103, DOI 10.1042/bj3170103; Genzor CG, 1996, NAT STRUCT BIOL, V3, P329, DOI 10.1038/nsb0496-329; Gerstein M, 2004, CURR OPIN CHEM BIOL, V8, P14, DOI 10.1016/j.cbpa.2003.12.006; Gorman J, 2005, PROTEIN SCI, V14, P3004, DOI 10.1110/ps.051680805; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Gulati S, 1997, J BIOL CHEM, V272, P19171, DOI 10.1074/jbc.272.31.19171; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Hall DA, 2000, BIOCHEMISTRY-US, V39, P10711, DOI 10.1021/bi001096c; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hoover DM, 1997, PROTEIN SCI, V6, P2525; Hoover DM, 1997, BIOCHEMISTRY-US, V36, P127, DOI 10.1021/bi961693s; Jarrett JT, 1998, BIOCHEMISTRY-US, V37, P5372, DOI 10.1021/bi9730893; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kasim M, 2000, BIOCHEMISTRY-US, V39, P15322, DOI 10.1021/bi001519a; Kasim M, 2001, BIOCHEMISTRY-US, V40, P13548, DOI 10.1021/bi011587c; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KOLLING R, 1988, MOL GEN GENET, V212, P99, DOI 10.1007/BF00322450; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Langdon GM, 2001, PROTEINS, V43, P476, DOI 10.1002/prot.1059; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12390, DOI 10.1021/bi049131t; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LOBNEROLESEN A, 1992, NUCLEIC ACIDS RES, V20, P3029, DOI 10.1093/nar/20.12.3029; LOBNEROLESEN A, 1987, J BACTERIOL, V169, P2835, DOI 10.1128/jb.169.6.2835-2842.1987; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47184, DOI 10.1074/jbc.M405791200; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47177, DOI 10.1074/jbc.M405792200; Lostao A, 2003, J BIOL CHEM, V278, P24053, DOI 10.1074/jbc.M301049200; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; MARKLEY JL, 1971, J CHEM PHYS, V55, P3604, DOI 10.1063/1.1676626; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McCarthy AA, 2002, BIOCHEMISTRY-US, V41, P10950, DOI 10.1021/bi020225h; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Mulliez E, 2001, BIOCHEMISTRY-US, V40, P3730, DOI 10.1021/bi001746c; NISIMOTO Y, 1986, J BIOL CHEM, V261, P14232; O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k; OGAWA T, 1994, J BACTERIOL, V176, P1609, DOI 10.1128/jb.176.6.1609-1615.1994; OGAWA T, 1991, MOL GEN GENET, V230, P193, DOI 10.1007/BF00290668; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; Puan KJ, 2005, FEBS LETT, V579, P3802, DOI 10.1016/j.febslet.2005.05.047; RAO ST, 1992, PROTEIN SCI, V1, P1413, DOI 10.1002/pro.5560011103; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sawers G, 1998, MOL MICROBIOL, V29, P945, DOI 10.1046/j.1365-2958.1998.00941.x; Setif P, 2001, BBA-BIOENERGETICS, V1507, P161, DOI 10.1016/S0005-2728(01)00205-5; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; Sibille N, 2005, BIOCHEMISTRY-US, V44, P9086, DOI 10.1021/bi050437p; SMILLIE RM, 1965, BIOCHEM BIOPH RES CO, V20, P621, DOI 10.1016/0006-291X(65)90445-6; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; Stok JE, 2000, ARCH BIOCHEM BIOPHYS, V384, P351, DOI 10.1006/abbi.2000.2067; Su'etsugu M, 2003, GENES CELLS, V8, P731, DOI 10.1046/j.1365-2443.2003.00671.x; THEISEN PW, 1993, MOL MICROBIOL, V10, P575, DOI 10.1111/j.1365-2958.1993.tb00929.x; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; ZYSKIND JW, 1992, CELL, V69, P5, DOI 10.1016/0092-8674(92)90112-P	91	16	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35454	35466		10.1074/jbc.M607336200	http://dx.doi.org/10.1074/jbc.M607336200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16963438	hybrid			2022-12-27	WOS:000241933700079
J	Oliveira, MJ; Costa, AC; Costa, AM; Henriques, L; Suriano, G; Atherton, JC; Machado, JC; Carneiro, F; Seruca, R; Mareel, M; Leroy, A; Figueiredo, C				Oliveira, Maria J.; Costa, Ana C.; Costa, Angela M.; Henriques, Lara; Suriano, Gianpaolo; Atherton, John C.; Machado, Jose C.; Carneiro, Fatima; Seruca, Raquel; Mareel, Marc; Leroy, Ancy; Figueiredo, Ceu			Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; MATRIX METALLOPROTEINASES; CAGA; VACA; ACTIVATION; INDUCTION; RECEPTOR; TOXIN; TRANSACTIVATION; DISRUPTION	Helicobacter pylori interacts with gastric epithelial cells, activating signaling pathways important for carcinogenesis. In this study we examined the role of H. pylori on cell invasion and the molecular mechanisms underlying this process. The relevance of H. pylori cag pathogenicity island-encoded type IV secretion system (T4SS), CagA, and VacA for cell invasion was also investigated. We found that H. pylori induces AGS cell invasion in collagen type I and in Matrigel invasion assays. H. pylori-induced cell invasion requires the direct contact between bacteria and cancer cells. H. pylori-mediated cell invasion was dependent on the activation of the c-Met receptor and on increased MMP-2 and MMP-9 activity. The abrogation of the c-Met receptor using the specific NK4 inhibitor or the silencing of c-Met expression with small interference RNA suppressed both cell invasion and MMP activity. Studies with different H. pylori strains revealed that cell invasion, c-Met tyrosine phosphorylation, and increased MMP-2 and MMP-9 activity were all dependent on the presence of a functional bacterial T4SS, but not on VacA cytotoxicity. Our findings demonstrate that H. pylori strains with a functional T4SS stimulate gastric epithelial cell invasion through a c-Met-dependent signaling pathway that comprises an increase in MMP-2 and MMP-9 activity.	Univ Porto, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal; Fac Med Porto, P-4200465 Oporto, Portugal; Univ Nottingham, Inst Infect Immun & Inflammat, Nottingham NG7 2UH, England; Ghent Univ Hosp, Expt Cancerol Lab, B-9000 Ghent, Belgium	Universidade do Porto; Universidade do Porto; University of Nottingham; Ghent University; Ghent University Hospital	Figueiredo, C (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.	cfigueiredo@ipatimup.pt	Figueiredo, Ceu/B-8776-2008; Carneiro, Fatima/AAV-8677-2021; Carneiro, Fatima/J-6432-2013; Machado, Jose Carlos/C-5907-2009; Costa, Ana/X-6874-2019; Costa, Ana C./K-5354-2013; seruca, raquel/F-8187-2011; Oliveira, Maria Jose/K-3275-2013	Figueiredo, Ceu/0000-0001-5247-840X; Carneiro, Fatima/0000-0002-1964-1006; Carneiro, Fatima/0000-0002-1964-1006; Machado, Jose Carlos/0000-0003-4741-8415; Costa, Ana/0000-0003-0062-8714; Costa, Ana C./0000-0003-0062-8714; Costa, Angela/0000-0002-8911-1043; Oliveira, Maria Jose/0000-0002-0724-0272; /0000-0001-6180-0042; Seruca, Raquel/0000-0002-8851-4166				Al-Ghoul L, 2004, BIOCHEM BIOPH RES CO, V322, P860, DOI 10.1016/j.bbrc.2004.07.199; ALBINI A, 1987, CANCER RES, V47, P3239; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Atherton JC, 1997, GASTROENTEROLOGY, V112, P92, DOI 10.1016/S0016-5085(97)70223-3; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Barbier M, 2001, NATURE, V413, P796, DOI 10.1038/35101660; Bebb JR, 2003, GUT, V52, P1408, DOI 10.1136/gut.52.10.1408; Bebb JR, 2003, INFECT IMMUN, V71, P3623, DOI 10.1128/IAI.71.6.3623-3627.2003; BLASER MJ, 1995, CANCER RES, V55, P2111; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; COVER TL, 1992, J BIOL CHEM, V267, P10570; CRABTREE JE, 1995, J CLIN PATHOL, V48, P967, DOI 10.1136/jcp.48.10.967; Crawford HC, 2003, GASTROENTEROLOGY, V125, P1125, DOI 10.1016/S0016-5085(03)01206-X; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; Debruyne PR, 2002, ONCOGENE, V21, P6740, DOI 10.1038/sj.onc.1205729; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El-Etr SH, 2004, J INFECT DIS, V190, P1516, DOI 10.1086/424526; Figueiredo C, 2002, J NATL CANCER I, V94, P1680, DOI 10.1093/jnci/94.22.1680; GIORDANO S, 1993, P NATL ACAD SCI USA, V90, P649, DOI 10.1073/pnas.90.2.649; Gooz M, 2001, AM J PHYSIOL-GASTR L, V281, pG823, DOI 10.1152/ajpgi.2001.281.3.G823; GRIGIONI WF, 1994, MODERN PATHOL, V7, P220; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Mori N, 2003, GASTROENTEROLOGY, V124, P983, DOI 10.1053/gast.2003.50152; Naumann M, 1999, J BIOL CHEM, V274, P31655, DOI 10.1074/jbc.274.44.31655; Nogueira C, 2001, AM J PATHOL, V158, P647, DOI 10.1016/S0002-9440(10)64006-0; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oliveira MJ, 2005, J CANCER RES CLIN, V131, P49, DOI 10.1007/s00432-004-0601-8; Oliveira MJ, 2003, EMBO J, V22, P6161, DOI 10.1093/emboj/cdg586; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 2000, GASTROENTEROLOGY, V118, P48, DOI 10.1016/S0016-5085(00)70413-6; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; Sier CFM, 1996, BRIT J CANCER, V74, P413, DOI 10.1038/bjc.1996.374; Suriano G, 2003, ONCOGENE, V22, P5716, DOI 10.1038/sj.onc.1206672; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; VAKAET L, 1991, INVAS METAST, V11, P249; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wallasch C, 2002, BIOCHEM BIOPH RES CO, V295, P695, DOI 10.1016/S0006-291X(02)00740-4; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; Wroblewski LE, 2003, J CELL SCI, V116, P3017, DOI 10.1242/jcs.00518; Yanagisawa N, 2005, FEMS IMMUNOL MED MIC, V44, P197, DOI 10.1016/j.femsim.2004.11.009	47	80	87	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34888	34896		10.1074/jbc.M607067200	http://dx.doi.org/10.1074/jbc.M607067200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16990273	hybrid			2022-12-27	WOS:000241933700021
J	Gomez, I; Arenas, I; Benitez, I; Miranda-Rios, J; Becerril, B; Grande, R; Almagro, JC; Bravo, A; Soberon, M				Gomez, Isabel; Arenas, Ivan; Benitez, Itzel; Miranda-Rios, Juan; Becerril, Baltazar; Grande, Ricardo; Carlos Almagro, Juan; Bravo, Alejandra; Soberon, Mario			Specific epitopes of domains II and III of Bacillus thuringiensis Cry1Ab toxin involved in the sequential interaction with cadherin and aminopeptidase-N receptors in Manduca sexta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMATION ACTIVITY; DELTA-ENDOTOXIN; CRYSTAL-STRUCTURE; HELIOTHIS-VIRESCENS; INSECTICIDAL TOXIN; BT-R-1 RECEPTOR; BOMBYX-MORI; BINDING; MEMBRANE; MIDGUT	The Bacillus thuringiensis Cry toxins are specific to different insects. In Manduca sexta cadherin (Bt-R-1) and aminopeptidase-N (APN) proteins are recognized as Cry1A receptors. Previous work showed that Cry1Ab binds to Bt-R1 promoting the formation of a pre-pore oligomer that binds to APN leading to membrane insertion. In this work we characterized the binding epitopes involved in the sequential interaction of Cry1Ab with Bt-R1 and APN. A Cry1Ab immune M13 phage repertoire was constructed using antibody gene transcripts of bone marrow or spleen from a rabbit immunized with Cry1Ab. We identified antibodies that recognize domain II loop 3 (scFvL3-3) or beta 16-beta 22 (scFvM22) in domain III. Enzyme-linked immunosorbent assay and toxin overlay binding competition assays in the presence of scFvL3-3, scFvM22, or synthetic peptides showed that domain II loop 3 is an important epitope for interaction with Bt-R1 receptor, whereas domain III beta 16 is involved in the interaction with APN. Both scFvL3-3 and scFvM22 lowered the toxicity of Cry1Ab to M. sexta larvae indicating that interaction with both receptors is important for in vivo toxicity. scFvL3-3 and anti-loop2 scFv (scFv73) promoted the formation of the pre-pore oligomer in contrast to scFvM22. In addition, scFvL3-3 and scFv73 preferentially recognized the monomeric toxin rather than the pre-pore suggesting a conformational change in domain II loops upon oligomerization. These results indicate for the first time that both receptor molecules participate in Cry1Ab toxin action in vivo: first the monomeric toxin binds to Bt-R1 through loops 2 and 3 of domain II promoting the formation of the pre-pore inducing some structural changes, then the pre-pore interacts with APN through beta-16 of domain III promoting membrane insertion and cell death.	Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62250, Morelos, Mexico; Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62250, Morelos, Mexico; Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Soberon, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62250, Morelos, Mexico.	mario@ibt.unam.mx	Miranda Ríos, Juan/ABB-7767-2021; Almagro, Juan/O-2468-2019; de la Parra, Maria Alejandra Bravo/R-6740-2017	ARENAS, IVAN/0000-0003-0384-7437; Almagro, Juan Carlos/0000-0001-9420-1310; Bravo, Alejandra/0000-0002-7573-7475				ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Atsumi S, 2005, APPL ENVIRON MICROB, V71, P3966, DOI 10.1128/AEM.71.7.3966-3977.2005; Boonserm P, 2006, J BACTERIOL, V188, P3391, DOI 10.1128/JB.188.9.3391-3401.2006; Boonserm P, 2005, J MOL BIOL, V348, P363, DOI 10.1016/j.jmb.2005.02.013; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2002, BBA-BIOMEMBRANES, V1562, P63, DOI 10.1016/S0005-2736(02)00360-7; Bravo A., 2005, BACILLUS THURINGIENS, P175, DOI DOI 10.1016/B0-44-451924-6/00081-8; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Galitsky N, 2001, ACTA CRYSTALLOGR D, V57, P1101, DOI 10.1107/S0907444901008186; Gomez I, 2003, BIOCHEMISTRY-US, V42, P10482, DOI 10.1021/bi034440p; Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200; Gomez I, 2002, J BIOL CHEM, V277, P30137, DOI 10.1074/jbc.M203121200; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; Hawlisch H, 2000, J IMMUNOL METHODS, V236, P117, DOI 10.1016/S0022-1759(99)00229-X; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Jenkins J L, 2000, Genet Eng (N Y), V22, P33; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; Keeton TP, 1998, APPL ENVIRON MICROB, V64, P2158; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; Lee MK, 1999, APPL ENVIRON MICROB, V65, P4513; LERECLUS D, 1995, BIO-TECHNOL, V13, P67, DOI 10.1038/nbt0195-67; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Lorence A, 1997, FEBS LETT, V414, P303, DOI 10.1016/S0014-5793(97)01014-4; MASSON L, 1995, J BIOL CHEM, V270, P20309, DOI 10.1074/jbc.270.35.20309; Morse RJ, 2001, STRUCTURE, V9, P409, DOI 10.1016/S0969-2126(01)00601-3; Nakanishi K, 2002, FEBS LETT, V519, P215, DOI 10.1016/S0014-5793(02)02708-4; Rausell C, 2004, BIOCHEMISTRY-US, V43, P166, DOI 10.1021/bi035527d; Soberon M, 2000, FEMS MICROBIOL LETT, V191, P221, DOI 10.1016/S0378-1097(00)00394-3; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	35	78	90	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34032	34039		10.1074/jbc.M604721200	http://dx.doi.org/10.1074/jbc.M604721200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16968705	hybrid			2022-12-27	WOS:000241767600023
J	Jaen, C; Doupnik, CA				Jaen, Cristina; Doupnik, Craig A.			RGS3 and RGS4 differentially associate with G protein-coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS modulation - Precoupling and collision coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; RECTIFYING POTASSIUM CHANNELS; TERMINAL CYSTEINE RESIDUES; P-INDUCED INHIBITION; END RULE PATHWAY; K+ CHANNEL; DEPENDENT RELAXATION; GENE-EXPRESSION; GIRK CHANNELS	RGS3 and RGS4 are GTPase-activating proteins expressed in the brain and heart that accelerate the termination of G(i/o)- and G(q)-mediated signaling. We report here the determinants mediating selective association of RGS4 with several G protein-coupled receptors (GPCRs) that form macromolecular complexes with neuronal G protein-gated inwardly rectifying potassium (Kir3 or GIRK) channels. Kir3 channels are instrumental in regulating neuronal firing in the central and peripheral nervous system and pacemaker activity in the heart. By using an epitope-tagged degradation-resistant RGS4 mutant, RGS4(C2V), immunoprecipitation of several hemagglutinin-tagged Gi/o- coupled and G(q)-coupled receptors expressed in Chinese hamster ovary (CHO-K1) cells readily co-precipitated both Kir3.1/Kir3.2a channels and RGS401(C2V). In contrast to RGS4(C2V), the closely related and functionally active RGS3 "short" isoform (RGS3s) did not interact with any of the GPCR-Kir3 channel complexes examined. Deletion and chimeric RGS constructs indicate both the N-terminal domain and the RGS domain of RGS4(C2V) are necessary for association with m2 receptor-Kir3.1/Kir3.2a channel complexes, where the GPCR was found to be the major target for RGS4(C2V) interaction. The functional impact of RGS4(C2V) "precoupling" to the GPCR-Kir3 channel complex versus RGS3s "collision coupling" was a 100-fold greater potency in the acceleration of G protein-dependent Kir3 channel-gating kinetics with no attenuation in current amplitude. These findings demonstrate that RGS4, a highly regulated modulator and susceptibility gene for schizophrenia, can directly associate with multiple GPCR-Kir3 channel complexes and may affect a wide range of neurotransmitter-mediated inhibitory and excitatory events in the nervous and cardiovascular systems.	Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Doupnik, CA (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, 12901 Bruce B Downs Blvd,MDC8, Tampa, FL 33612 USA.	cdoupnik@health.usf.edu	Doupnik, Craig A/I-3617-2012	Doupnik, Craig A/0000-0002-7314-0747				Benians A, 2005, J BIOL CHEM, V280, P13383, DOI 10.1074/jbc.M410163200; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Bishop GB, 2002, NEUROBIOL DIS, V10, P334, DOI 10.1006/nbdi.2002.0518; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Chen CH, 1999, J BIOL CHEM, V274, P19799, DOI 10.1074/jbc.274.28.19799; Chidiac P, 2003, RECEPTOR CHANNEL, V9, P135, DOI 10.3109/10606820308244; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Delling M, 2002, J NEUROSCI, V22, P7154; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; Doupnik CA, 2001, BBA-GENE STRUCT EXPR, V1522, P97, DOI 10.1016/S0167-4781(01)00342-6; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Druey KM, 1999, J BIOL CHEM, V274, P18836, DOI 10.1074/jbc.274.26.18836; Fujita S, 2000, J PHYSIOL-LONDON, V526, P341, DOI 10.1111/j.1469-7793.2000.00341.x; Garnier M, 2003, J PHARMACOL EXP THER, V304, P1299, DOI 10.1124/jpet.102.043471; Garzon J, 2005, NEUROPHARMACOLOGY, V48, P853, DOI 10.1016/j.neuropharm.2005.01.004; Georgoussi Z, 2006, CELL SIGNAL, V18, P771, DOI 10.1016/j.cellsig.2005.07.003; Geurts M, 2003, BIOCHEM PHARMACOL, V66, P1163, DOI 10.1016/S0006-2952(03)00447-7; Geurts M, 2002, NEUROSCI LETT, V333, P146, DOI 10.1016/S0304-3940(02)01004-2; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gold SJ, 2002, J NEUROCHEM, V82, P828, DOI 10.1046/j.1471-4159.2002.01002.x; Gold SJ, 1997, J NEUROSCI, V17, P8024; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Inanobe A, 2001, J PHYSIOL-LONDON, V535, P133, DOI 10.1111/j.1469-7793.2001.t01-1-00133.x; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Jaen C, 2005, NEUROPHARMACOLOGY, V49, P465, DOI 10.1016/j.neuropharm.2005.04.010; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koike-Tani M, 2005, J PHYSIOL-LONDON, V564, P489, DOI 10.1113/jphysiol.2004.079285; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Muma NA, 2003, SYNAPSE, V47, P58, DOI 10.1002/syn.10153; NAKAJIMA Y, 1988, P NATL ACAD SCI USA, V85, P3643, DOI 10.1073/pnas.85.10.3643; Ni YG, 1999, J NEUROSCI, V19, P3674; Nikolov EN, 2004, J BIOL CHEM, V279, P23630, DOI 10.1074/jbc.M312861200; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Papoucheva E, 2004, J BIOL CHEM, V279, P3280, DOI 10.1074/jbc.M308177200; Ponce A, 1996, J NEUROSCI, V16, P1990; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Taymans JM, 2003, J NEUROCHEM, V84, P1118, DOI 10.1046/j.1471-4159.2003.01610.x; Tu YP, 1999, J BIOL CHEM, V274, P38260, DOI 10.1074/jbc.274.53.38260; Tu YP, 2001, J BIOL CHEM, V276, P20160, DOI 10.1074/jbc.M101599200; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yamada M, 1998, PHARMACOL REV, V50, P723; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zerangue N, 1998, CURR BIOL, V8, pR313, DOI 10.1016/S0960-9822(98)70196-4; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151	74	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34549	34560		10.1074/jbc.M603177200	http://dx.doi.org/10.1074/jbc.M603177200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973624	hybrid			2022-12-27	WOS:000241767600075
J	Ke, YH; Lesperance, J; Zhang, EE; Bard-Chapeau, EA; Oshima, RG; Muller, WJ; Feng, GS				Ke, Yuehai; Lesperance, Jacqueline; Zhang, Eric E.; Bard-Chapeau, Emilie A.; Oshima, Robert G.; Muller, William J.; Feng, Gen-Sheng			Conditional deletion of Shp2 in the mammary gland leads to impaired lobulo-alveolar outgrowth and attenuated Stat5 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASE; CELL-DIFFERENTIATION; PROLACTIN RECEPTOR; TRANSGENIC MICE; PROLIFERATION; REGULATOR; APOPTOSIS; PATHWAY; DEPHOSPHORYLATION; PHOSPHORYLATION	Stat5 and Stat3, two members of the Stat (signal transducer and activator of transcription) family, are known to play critical roles in mammopoiesis/lactogenesis and involution, respectively, in the mammary gland. Phosphotyrosine phosphatase Shp2 has been shown to dephosphorylate and thus inactivate both Stat5 and Stat3 in vitro. Paradoxically, cell culture studies also suggest a positive role of Shp2 in promoting prolactin-stimulated Stat5 activation. We have shown here that selective deletion of Shp2 in mouse mammary glands suppresses Stat5 activity during pregnancy and lactation, resulting in significant impairment of lobulo-alveolar outgrowth and lactation. In contrast, Stat3 activity was slightly up-regulated shortly before/ at involution, leading to normal epithelial cell apoptosis/involution in Shp2-deficient mammary gland. Thus, Shp2 acts to promote Stat5 activation by the JAK2(.)prolactin receptor complex, while negatively modulating Stat3 activity before the onset of involution. This is the first demonstration that Shp2 manipulates Stat5 and Stat3 activities reciprocally in mammary epithelial cells, providing novel insight into the complex mechanisms for regulation of various Stat family members by a cytoplasmic tyrosine phosphatase.	Burnham Inst Med Res, Ctr Canc, La Jolla, CA 92037 USA; Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada	Sanford Burnham Prebys Medical Discovery Institute; McGill University; Royal Victoria Hospital	Feng, GS (corresponding author), Burnham Inst Med Res, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gfeng@burnham.org	Bard-Chapeau, Emilie/H-6091-2011	Zhang, Eric/0000-0002-4472-7493	NCI NIH HHS [P01 CA102583, R01 CA078606, CA078606, R01 CA098778, CA102583] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078606, R01CA098778, P01CA102583] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali S, 2003, J BIOL CHEM, V278, P52021, DOI 10.1074/jbc.M306758200; Ali S, 1996, EMBO J, V15, P135, DOI 10.1002/j.1460-2075.1996.tb00341.x; Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Berchtold S, 1998, MOL ENDOCRINOL, V12, P556, DOI 10.1210/me.12.4.556; Chan RJ, 2003, BLOOD, V102, P2074, DOI 10.1182/blood-2003-04-1171; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Chughtai N, 2002, J BIOL CHEM, V277, P31107, DOI 10.1074/jbc.M200156200; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Groner B, 2000, BREAST CANCER RES, V2, P149, DOI 10.1186/bcr47; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 1997, J BIOL CHEM, V272, P7567, DOI 10.1074/jbc.272.12.7567; Humphreys RC, 2002, ENDOCRINOLOGY, V143, P3641, DOI 10.1210/en.2002-220224; Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.011; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Lai LA, 2003, PROTEIN PHOSPHATASES, P275; Li G, 2002, DEVELOPMENT, V129, P4159; Lindeman GJ, 2001, GENE DEV, V15, P1631, DOI 10.1101/gad.880801; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Philp JAC, 1996, FEBS LETT, V396, P77, DOI 10.1016/0014-5793(96)01069-1; Qu CK, 1998, ONCOGENE, V17, P433, DOI 10.1038/sj.onc.1201920; Radisky DC, 2003, TRENDS CELL BIOL, V13, P426, DOI 10.1016/S0962-8924(03)00146-6; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	34	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34374	34380		10.1074/jbc.M607325200	http://dx.doi.org/10.1074/jbc.M607325200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16959766	Green Accepted, hybrid			2022-12-27	WOS:000241767600058
J	Mateos, JL; Luppi, JP; Ogorodnikova, OB; Sineshchekov, VA; Yanovsky, MJ; Braslavsky, SE; Gartner, W; Casal, JJ				Mateos, Julieta L.; Luppi, Juan Pablo; Ogorodnikova, Ouliana B.; Sineshchekov, Vitaly A.; Yanovsky, Marcelo J.; Braslavsky, Silvia E.; Gaertner, Wolfgang; Casal, Jorge J.			Functional and biochemical analysis of the N-terminal domain of phytochrome A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOPHORE POCKET; LIGHT SENSITIVITY; SEED-GERMINATION; PEA PHYTOCHROME; ARABIDOPSIS; LOCALIZATION; DEGRADATION; BILIVERDIN; DEFICIENT; MUTATIONS	Phytochrome A (phyA) is a versatile plant photoreceptor that mediates responses to brief light exposures (very low fluence responses, VLFR) as well as to prolonged irradiation (high irradiance responses, HIR). We identified the phyA-303 mutant allele of Arabidopsis thaliana bearing an R384K substitution in the GAF subdomain of the N-terminal half of phyA. phyA-303 showed reduced phyA spectral activity, almost normal VLFR, and severely impaired HIR. Recombinant N-terminal half oat of PHYA bearing the phyA-303 mutation showed poor incorporation of chromophore in vitro, despite the predicted relatively long distance (> 13 angstrom) between the mutation and the closest ring of the chromophore. Fusion proteins bearing the N-terminal domain of oat phyA, beta-glucuronidase, green fluorescent protein, and a nuclear localization signal showed physiological activity in darkness and mediated VLFR but not HIR. At equal protein levels, the phyA-303 mutation caused slightly less activity than the fusions containing the wild-type sequence. Taken together, these studies highlight the role of the N-terminal domain of phyA in signaling and of distant residues of the GAF subdomain in the regulation of phytochrome bilin-lyase activity.	Univ Buenos Aires, Fac Agron, IFEVA, RA-1417 Buenos Aires, DF, Argentina; Max Planck Inst Bioanorgan Chem, D-45413 Mulheim, Germany; Moscow MV Lomonosov State Univ, Dept Biol, Moscow 119992, Russia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Max Planck Society; Lomonosov Moscow State University	Casal, JJ (corresponding author), Univ Buenos Aires, Fac Agron, IFEVA, Ave San Martin 4453, RA-1417 Buenos Aires, DF, Argentina.	casal@ifeva.edu.ar	Braslavsky, Silvia E/E-2276-2016; Sineshchekov, Vitaly/AAV-4640-2021	Braslavsky, Silvia E/0000-0002-2796-8586; Gartner, Wolfgang/0000-0002-6898-7011; Mateos, Julieta Lisa/0000-0002-1156-6662; Casal, Jorge/0000-0001-6525-8414				ALCONADAMAGLIAN.T, 2004, PHOTOCHEM PHOTOBIOL, V3, P612; Botto JF, 1996, PLANT PHYSIOL, V110, P439, DOI 10.1104/pp.110.2.439; Casal JJ, 2004, TRENDS PLANT SCI, V9, P309, DOI 10.1016/j.tplants.2004.04.007; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P481, DOI 10.1562/0031-8655(2000)071&lt;0481:TPPOPA&gt;2.0.CO;2; Cerdan PD, 2000, PLANT CELL, V12, P1203, DOI 10.1105/tpc.12.7.1203; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; CHERRY JR, 1993, PLANT CELL, V5, P565, DOI 10.1105/tpc.5.5.565; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Clough RC, 1999, PLANT J, V17, P155, DOI 10.1046/j.1365-313X.1999.00360.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; DEFORCE L, 1993, BIOCHEMISTRY-US, V32, P14165, DOI 10.1021/bi00214a014; Dieterle M, 2005, PLANT J, V41, P146, DOI 10.1111/j.1365-313X.2004.02286.x; EDGERTON MD, 1992, PLANT CELL, V4, P161, DOI 10.1105/tpc.4.2.161; ELICH TD, 1989, J BIOL CHEM, V264, P12902; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Gartner W, 2003, COMP SER PHOTOCHEM, V3, P136; Hennig L, 2000, PLANT CELL ENVIRON, V23, P727, DOI 10.1046/j.1365-3040.2000.00587.x; Hisada A, 2000, PLANT CELL, V12, P1063, DOI 10.1105/tpc.12.7.1063; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; KUFER W, 1979, H-S Z PHYSIOL CHEM, V360, P935, DOI 10.1515/bchm2.1979.360.2.935; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; LI LM, 1992, J BIOL CHEM, V267, P19204; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; MCDONAGH AF, 1980, BIOCHEM J, V189, P193, DOI 10.1042/bj1890193; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; Oka Y, 2004, PLANT CELL, V16, P2104, DOI 10.1105/tpc.104.022350; PARKS BM, 1991, PLANT CELL, V3, P1177, DOI 10.1105/tpc.3.11.1177; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Remberg A, 1999, EUR J BIOCHEM, V266, P201, DOI 10.1046/j.1432-1327.1999.00844.x; Rockwell NC, 2006, PLANT CELL, V18, P4, DOI 10.1105/tpc.105.038513; Ruddat A, 1997, BIOCHEMISTRY-US, V36, P103, DOI 10.1021/bi962012w; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Sch_afer E, 2006, PHOTOMORPHOGENESIS P, V3; Schmidt P, 1998, PHOTOCHEM PHOTOBIOL, V68, P754, DOI 10.1111/j.1751-1097.1998.tb02541.x; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Wagner D, 1996, P NATL ACAD SCI USA, V93, P4011, DOI 10.1073/pnas.93.9.4011; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; XU Y, 1995, PLANT CELL, V7, P1433, DOI 10.1105/tpc.7.9.1433; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; YANOVSKY MJ, 1995, PLANT CELL ENVIRON, V18, P788, DOI 10.1111/j.1365-3040.1995.tb00582.x; Yanovsky MJ, 2002, PLANT CELL, V14, P1591, DOI 10.1105/tpc.000521; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	51	31	33	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34421	34429		10.1074/jbc.M603538200	http://dx.doi.org/10.1074/jbc.M603538200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16966335	hybrid, Green Published			2022-12-27	WOS:000241767600062
J	Petrushenko, ZM; Lai, CH; Rybenkov, VV				Petrushenko, Zoya M.; Lai, Chien-Hung; Rybenkov, Valentin V.			Antagonistic interactions of kleisins and DNA with bacterial condensin MukB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHROMOSOME CONDENSATION; SMC PROTEINS; ELECTRON-MICROSCOPY; MITOTIC CHROMOSOME; COHESIN COMPLEX; SUPERCOILED DNA; ATP HYDROLYSIS; HINGE; CONFORMATIONS	MukBEF is a bacterial SMC (structural maintenance of chromosome) complex required for faithful chromosome segregation in Escherichia coli. The SMC subunit of the complex, MukB, promotes DNA condensation in vitro and in vivo; however, all three subunits are required for the function of MukBEF. We report here that MukEF disrupts MukB center dot DNA complex. Pre-assembled MukBEF was inert in DNA binding or reshaping. Similarly, the association of MukEF with DNA-bound MukB served to displace MukB from DNA. When purified from cells, MukBEF existed as a mixture of MukEF-saturated and unsaturated complexes. The holoenzyme was unstable and could only bind DNA upon dissociation of MukEF. The DNA reshaping properties of unsaturated MukBEF were identical to those of MukB. Furthermore, the unsaturated MukBEF was stable and proficient in DNA binding. These results support the view that kleisins are not directly involved in DNA binding but rather bridge distant DNA-bound MukBs.	Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Rybenkov, VV (corresponding author), Univ Oklahoma, Dept Chem & Biochem, 620 Parrington Oval, Norman, OK 73019 USA.	valya@ou.edu			NIGMS NIH HHS [R01 GM063786, GM63786] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063786] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Cann JR, 1998, ELECTROPHORESIS, V19, P127, DOI 10.1002/elps.1150190202; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P549; Cobbe N, 2000, J STRUCT BIOL, V129, P123, DOI 10.1006/jsbi.2000.4255; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Fennell-Fezzie R, 2005, EMBO J, V24, P1921, DOI 10.1038/sj.emboj.7600680; Folta-Stogniew Ewa, 2006, V328, P97; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hiraga S, 2000, ANNU REV GENET, V34, P21, DOI 10.1146/annurev.genet.34.1.21; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Kido M, 1996, J BACTERIOL, V178, P3917, DOI 10.1128/jb.178.13.3917-3925.1996; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kimura K, 2000, P NATL ACAD SCI USA, V97, P11972, DOI 10.1073/pnas.220326097; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Lammens A, 2004, CURR BIOL, V14, P1778, DOI 10.1016/j.cub.2004.09.044; Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Rybenkov VV, 1997, J MOL BIOL, V267, P312, DOI 10.1006/jmbi.1996.0877; Sawitzke JA, 2000, P NATL ACAD SCI USA, V97, P1671, DOI 10.1073/pnas.030528397; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Stray JE, 2005, J BIOL CHEM, V280, P34723, DOI 10.1074/jbc.M506589200; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang Q, 2006, J BACTERIOL, V188, P4431, DOI 10.1128/JB.00313-06; WASSERMAN SA, 1991, J BIOL CHEM, V266, P20567; Weitao T, 1999, MOL MICROBIOL, V34, P157, DOI 10.1046/j.1365-2958.1999.01589.x; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873; Zechiedrich EL, 1999, METH MOL B, V94, P99	43	50	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34208	34217		10.1074/jbc.M606723200	http://dx.doi.org/10.1074/jbc.M606723200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16982609	hybrid, Green Accepted			2022-12-27	WOS:000241767600041
J	Watanabe, K; Nureki, O; Fukai, S; Endo, Y; Hori, H				Watanabe, Kazunori; Nureki, Osamu; Fukai, Shuya; Endo, Yaeta; Hori, Hiroyuki			Functional categorization of the conserved basic amino acid residues in TrmH (tRNA (Gm18) methyltansferase) enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEEP TREFOIL KNOT; 23S RIBOSOMAL-RNA; THERMUS-THERMOPHILUS HB27; ESCHERICHIA-COLI; M(7)G46 METHYLTRANSFERASE; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; RECOGNITION MECHANISM; MODIFICATION DATABASE; SEQUENCE MOTIFS	Transfer RNA (Gm18) methyltransferase (TrmH) catalyzes the methyl transfer from S-adenosyl-L-methionine (AdoMet) to the 2'-OH group of the G18 ribose in tRNA. To identify amino acid residues responsible for the tRNA recognition, we have carried out the alanine substitution mutagenesis of the basic amino acid residues that are conserved only in TrmH enzymes and not in the other SpoU proteins. We analyzed the mutant proteins by S-adenosyl-L-homocysteine affinity column chromatography, gel mobility shift assay, and kinetic assay of the methyl transfer reaction. Based on these biochemical studies and the crystal structure of TrmH, we found that the conserved residues can be categorized according to their role (i) in the catalytic center (Arg-41), (ii) in the initial site of tRNA binding (Lys-90, Arg-166, Arg-168, and Arg-176), (iii) in the tRNA binding site required for continuation the catalytic cycle (Arg-8, Arg-19, and Lys-32), (iv) in the structural element involved in release of S-adenosyl-L- homocysteine (Arg-11-His-71-Met-147 interaction), (v) in the assisted phosphate binding site (His-34), or (vi) in an unknown function (Arg-109). Furthermore, the difference between the K-d and K-m values for tRNA suggests that the affinity for tRNA is enhanced in the presence of AdoMet. To confirm this idea, we carried out the kinetic studies, a gel mobility shift assay with a mutant protein disrupted in the catalytic center, and the analytical gel-filtration chromatography. Our experimental results clearly show that the enzyme has a semi-ordered sequential mechanism in which AdoMet both enhances the affinity for tRNA and induces formation of the tetramer structure.	Ehime Univ, Fac Engn, Dept Appl Chem, Matsuyama, Ehime 7908577, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan	Ehime University; Tokyo Institute of Technology; Ehime University; Ehime University	Hori, H (corresponding author), Ehime Univ, Fac Engn, Dept Appl Chem, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Watanabe, Kazunori/G-6671-2012; Hori, Hiroyuki/AAB-3911-2021; Fukai, Shuya/X-4838-2018; NUREKI, OSAMU/G-4960-2014	Watanabe, Kazunori/0000-0003-3678-636X; Fukai, Shuya/0000-0002-1241-1443; 				Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Alexandrov A, 2002, RNA, V8, P1253, DOI 10.1017/S1355838202024019; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; ASCHHOFF HJ, 1976, NUCLEIC ACIDS RES, V3, P3109, DOI 10.1093/nar/3.11.3109; Basturea GN, 2006, RNA, V12, P426, DOI 10.1261/rna.2283106; Cavaille J, 1999, RNA, V5, P66, DOI 10.1017/S1355838299981475; Clouet-d'Orval B, 2005, BIOCHIMIE, V87, P889, DOI 10.1016/j.biochi.2005.02.004; De Bie LGS, 2003, J BACTERIOL, V185, P3238, DOI 10.1128/JB.185.10.3238-3243.2003; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Forouhar F, 2003, PROTEINS, V53, P329, DOI 10.1002/prot.10510; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; Hori H, 2002, GENES CELLS, V7, P259, DOI 10.1046/j.1365-2443.2002.00520.x; Hori H, 1998, J BIOL CHEM, V273, P25721, DOI 10.1074/jbc.273.40.25721; KAWAI G, 1992, BIOCHEMISTRY-US, V31, P1040, DOI 10.1021/bi00119a012; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KUMAGAI I, 1980, P NATL ACAD SCI-BIOL, V77, P1922, DOI 10.1073/pnas.77.4.1922; KUMAGAI I, 1982, J BIOL CHEM, V257, P7388; Lim K, 2003, PROTEINS, V51, P56, DOI 10.1002/prot.10323; Lovgren JM, 2001, J BACTERIOL, V183, P6957, DOI 10.1128/JB.183.23.6957-6960.2001; Mallam AL, 2005, J MOL BIOL, V346, P1409, DOI 10.1016/j.jmb.2004.12.055; MATSUMOTO T, 1990, J BIOCHEM-TOKYO, V107, P331, DOI 10.1093/oxfordjournals.jbchem.a123047; McCloskey JA, 1998, NUCLEIC ACIDS RES, V26, P196, DOI 10.1093/nar/26.1.196; Michel G, 2002, STRUCTURE, V10, P1303, DOI 10.1016/S0969-2126(02)00852-3; Mosbacher TG, 2005, J MOL BIOL, V345, P535, DOI 10.1016/j.jmb.2004.10.051; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Nureki O, 2002, ACTA CRYSTALLOGR D, V58, P1129, DOI 10.1107/S0907444902006601; Okamoto H, 2004, J BIOL CHEM, V279, P49151, DOI 10.1074/jbc.M408209200; Persson B. C., 1997, NUCLEIC ACIDS RES, V25, P3969, DOI [10.1093/nar/25.20.4093, DOI 10.1093/NAR/25.20.4093]; Pleshe E, 2005, ACTA CRYSTALLOGR F, V61, P722, DOI 10.1107/S1744309105022980; Renalier MH, 2005, RNA, V11, P1051, DOI 10.1261/rna.2110805; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SIRUMCONNOLLY K, 1993, SCIENCE, V262, P1886, DOI 10.1126/science.8266080; THOMPSON J, 1982, J BIOL CHEM, V257, P7915; Treede I, 2003, MOL MICROBIOL, V49, P309, DOI 10.1046/j.1365-2958.2003.03558.x; Urbonavicius J, 2002, J BACTERIOL, V184, P5348, DOI 10.1128/JB.184.19.5348-5357.2002; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Zarembinski TI, 2003, PROTEINS, V50, P177, DOI 10.1002/prot.10311; Zegers I, 2006, NUCLEIC ACIDS RES, V34, P1925, DOI 10.1093/nar/gkl116; Ziesche SM, 2004, MOL MICROBIOL, V54, P980, DOI 10.1111/j.1365-2958.2004.04319.x	42	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34630	34639		10.1074/jbc.M606141200	http://dx.doi.org/10.1074/jbc.M606141200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16963456	hybrid			2022-12-27	WOS:000241767600082
J	Hsu, YHR; Sarker, KP; Pot, I; Chan, A; Netherton, SJ; Bonni, S				Hsu, Ying-Han R.; Sarker, Krishna P.; Pot, Isabelle; Chan, Angela; Netherton, Stuart J.; Bonni, Shirin			Sumoylated SnoN represses transcription in a promoter-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; HISTONE DEACETYLASE COMPLEX; TGF-BETA; SUMO-1 MODIFICATION; TRANSFORMING ACTIVITY; TUMOR-SUPPRESSOR; SKI ONCOPROTEIN; BINDING PROTEIN; DNA-BINDING; PHOSPHORYLATION	The transcriptional modulator SnoN controls a diverse set of biological processes, including cell proliferation and differentiation. The mechanisms by which SnoN regulates these processes remain incompletely understood. Recent studies have shown that SnoN exerts positive or negative regulatory effects on transcription. Because post-translational modification of proteins by small ubiquitin-like modifier (SUMO) represents an important mechanism in the control of the activity of transcriptional regulators, we asked if this modification regulates SnoN function. Here, we show that SnoN is sumoylated. Our data demonstrate that the SUMO-conjugating E2 enzyme Ubc9 is critical for SnoN sumoylation and that the SUMO E3 ligase PIAS1 selectively interacts with and enhances the sumoylation of SnoN. We identify lysine residues 50 and 383 as the SUMO acceptor sites in SnoN. Analyses of SUMO "loss-of-function" and " gain-of-function" SnoN mutants in transcriptional reporter assays reveal that sumoylation of SnoN contributes to the ability of SnoN to repress gene expression in a promoter-specific manner. Although this modification has little effect on SnoN repression of the plasminogen activator inhibitor-1 promoter and only modestly potentiates SnoN repression of the p21 promoter, SnoN sumoylation robustly augments the ability of SnoN to suppress transcription of the myogenesis master regulatory gene myogenin. In addition, we show that the SnoN SUMO E3 ligase, PIAS1, at its endogenous levels, suppresses myogenin transcription. Collectively, our findings suggest that SnoN is directly regulated by sumoylation leading to the enhancement of the ability of SnoN to repress transcription in a promoter-specific manner. Our study also points to a physiological role for SnoN sumoylation in the control of myogenin expression in differentiating muscle cells.	Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Bonni, S (corresponding author), Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada.	sbonni@ucalgary.ca						Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BLAU HM, 1985, ADV EXP MED BIOL, V182, P231; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; BOYER PL, 1993, ONCOGENE, V8, P457; Cohen SB, 1998, ONCOGENE, V17, P2505, DOI 10.1038/sj.onc.1202177; Cohen SB, 1999, NUCLEIC ACIDS RES, V27, P1006, DOI 10.1093/nar/27.4.1006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Edmiston JS, 2005, CANCER RES, V65, P4782, DOI 10.1158/0008-5472.CAN-04-4354; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; HEYMAN HC, 1994, J BIOL CHEM, V269, P26996; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mimura N, 1996, FEBS LETT, V397, P253, DOI 10.1016/S0014-5793(96)01165-9; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Riquelme C, 2006, J CELL MOL MED, V10, P132, DOI 10.1111/j.1582-4934.2006.tb00295.x; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimokawa T, 1998, BIOCHEM BIOPH RES CO, V246, P287, DOI 10.1006/bbrc.1998.8600; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P3168, DOI 10.1021/bi026861x; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Weston AD, 2003, J CELL SCI, V116, P2885, DOI 10.1242/jcs.00525; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Zhang F, 2003, CANCER RES, V63, P5005	63	44	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33008	33018		10.1074/jbc.M604380200	http://dx.doi.org/10.1074/jbc.M604380200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16966324	hybrid			2022-12-27	WOS:000241621400009
J	Kane, TA; White, CL; DeAngelis, PL				Kane, Tasha A.; White, Carissa L.; DeAngelis, Paul L.			Functional characterization of PmHS1, a Pasteurella multocida heparosan synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULE GENE-CLUSTER; 2 ACTIVE-SITES; HYALURONAN SYNTHASE; ESCHERICHIA-COLI; MOLECULAR-CLONING; HEPARAN-SULFATE; IDENTIFICATION; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; POLYSACCHARIDE	Heparosan synthase 1 (PmHS1) from Pasteurella multocida Type D is a dual action glycosyltransferase enzyme that transfers monosaccharide units from uridine diphospho (UDP) sugar precursors to form the polysaccharide heparosan (N-acetylheparosan), which is composed of alternating (-alpha 4-GlcNAc-beta 1,4-GlcUA-1-) repeats. We have used molecular genetic means to remove regions nonessential for catalytic activity from the amino and the carboxyl-terminal regions as well as characterized the functional regions involved in GlcUA-transferase activity and in GlcNAc-transferase activity. Mutation of either one of the two regions containing aspartate-X-aspartate (DXD) residue-containing motifs resulted in complete or substantial loss of heparosan polymerizing activity. However, certain mutant proteins retained only GlcUA-transferase activity while some constructs possessed only GlcNAc-transferase activity. Therefore, it appears that the PmHS1 polypeptide is composed of two types of glycosyltransferases in a single polypeptide as was found for the Pasteurella multocida Type A PmHAS, the hyaluronan synthase that makes the alternating (-beta 3-GlcNAc-beta 1,4-GlcUA-1-) polymer. However, there is low amino acid similarity between the PmHAS and PmHS1 enzymes, and the relative placement of the GlcUA-transferase and GlcNAc-transferase domains within the two polypeptides is reversed. Even though the monosaccharide compositions of hyaluronan and heparosan are identical, such differences in the sequences of the catalysts are expected because the PmHAS employs only inverting sugar transfer mechanisms whereas PmHS1 requires both retaining and inverting mechanisms.	Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	DeAngelis, PL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, 940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	paul-deangelis@ouhsc.edu						Breton C, 1998, J BIOCHEM, V123, P1000; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; DeAngelis PL, 1998, J BIOL CHEM, V273, P8454, DOI 10.1074/jbc.273.14.8454; DeAngelis PL, 2004, J BACTERIOL, V186, P8529, DOI 10.1128/JB.186.24.8529-8532.2004; DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001; DeAngelis PL, 2002, GLYCOBIOLOGY, V12, p9R, DOI 10.1093/glycob/12.1.9R; DeAngelis PL, 2002, CARBOHYD RES, V337, P1547, DOI 10.1016/S0008-6215(02)00219-7; DeAngelis PL, 2002, J BIOL CHEM, V277, P7209, DOI 10.1074/jbc.M112130200; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Hodson N, 2000, J BIOL CHEM, V275, P27311; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; PETIT C, 1995, MOL MICROBIOL, V17, P611, DOI 10.1111/j.1365-2958.1995.mmi_17040611.x; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200	20	28	33	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33192	33197		10.1074/jbc.M606897200	http://dx.doi.org/10.1074/jbc.M606897200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959770	hybrid			2022-12-27	WOS:000241621400027
J	Almeida, CC; Romao, CV; Lindley, PF; Teixeira, M; Saraiva, LM				Almeida, Claudia C.; Romao, Celia V.; Lindley, Peter F.; Teixeira, Miguel; Saraiva, Ligia M.			The role of the hybrid cluster protein in oxidative stress defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; ESCHERICHIA-COLI K-12; X-RAY STRUCTURES; DESULFURICANS ATCC-27774; PRISMANE PROTEIN; SYNCHROTRON-RADIATION; GENES; IDENTIFICATION; PURIFICATION; CATALASE	Hybrid cluster proteins (HCP) contain two types of Fe/S clusters, namely a [4Fe-4S](2+/1+) or [2Fe-2S](2+/1+) cluster and a novel type of hybrid cluster, [4Fe-2S-2O], in the as-isolated state. Although first isolated from anaerobic sulfate-reducing bacteria, the analysis of the genomic sequences reveals that genes encoding putative hybrid cluster proteins are present in a wide range of organisms, aerobic, anaerobic, or facultative, from the Bacteria, Archaea, and Eukarya domains. Despite a detailed spectroscopic and structural characterization, the precise physiological function of these proteins remained unknown. The present work shows that the transcription of the Escherichia coli hcp gene is induced by hydrogen peroxide, and this induction is regulated by the redox-sensitive transcriptional activator, OxyR. The E. coli hcp mutant strain exhibits higher sensitivity to hydrogen peroxide, a behavior that reverts to the wild type phenotype once a plasmid carrying the hcp gene is reintroduced. Furthermore, the purified HCPs from E. coli and Desulfovibrio desulfuricans ATCC 27774 show an alternative enzymatic activity, which under physiological conditions exhibited K-m values for hydrogen peroxide (similar to 0.3 mM) within the range of other peroxidases. Altogether, the results reveal that HCP is involved in oxidative stress protection.	Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal	Universidade Nova de Lisboa	Saraiva, LM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ, P-2780157 Oeiras, Portugal.	lst@itqb.unl.pt	DE ALMEIDA, CARLOS CAETANO/K-4265-2016; Saraiva, Ligia M/H-8537-2012; Teixeira, Miguel/M-1509-2019; Teixeira, Miguel/A-9098-2011; Romao, Celia V/G-7013-2011	DE ALMEIDA, CARLOS CAETANO/0000-0002-3215-5731; Saraiva, Ligia M/0000-0002-0675-129X; Teixeira, Miguel/0000-0003-4124-6237; Teixeira, Miguel/0000-0003-4124-6237; Romao, Celia V/0000-0002-9474-2405				Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27; Aragao D, 2003, J BIOL INORG CHEM, V8, P540, DOI 10.1007/s00775-003-0443-x; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Briolat V, 2002, J BACTERIOL, V184, P2333, DOI 10.1128/JB.184.9.2333-2343.2002; Cabello P, 2004, J BIOL CHEM, V279, P45485, DOI 10.1074/jbc.M404417200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Filenko NA, 2005, BIOCHEM SOC T, V33, P195, DOI 10.1042/BST0330195; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; He Q, 2006, APPL ENVIRON MICROB, V72, P4370, DOI 10.1128/AEM.02609-05; Kim CC, 2003, INFECT IMMUN, V71, P3196, DOI 10.1128/IAI.71.6.3196-3205.2003; Koga S, 1999, BBA-PROTEIN STRUCT M, V1435, P117, DOI 10.1016/S0167-4838(99)00190-9; Krockel M, 1998, EUR J BIOCHEM, V251, P454, DOI 10.1046/j.1432-1327.1998.2510454.x; Macedo S, 2002, J BIOL INORG CHEM, V7, P514, DOI 10.1007/s00775-001-0326-y; Moore DD, 1995, GLOB MOB SURV; MOURA I, 1992, J BIOL CHEM, V267, P4489; Okinaka Y, 2002, MOL PLANT MICROBE IN, V15, P619, DOI 10.1094/MPMI.2002.15.7.619; Pereira AS, 1999, BIOCHEM BIOPH RES CO, V260, P209, DOI 10.1006/bbrc.1999.0748; PIERIK AJ, 1992, EUR J BIOCHEM, V206, P697, DOI 10.1111/j.1432-1033.1992.tb16976.x; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Roos V, 2006, INFECT IMMUN, V74, P3565, DOI 10.1128/IAI.01959-05; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; van den Berg WAM, 2000, EUR J BIOCHEM, V267, P666, DOI 10.1046/j.1432-1327.2000.01032.x; VANDENBERG WAM, 1994, BBA-PROTEIN STRUCT M, V1206, P240, DOI 10.1016/0167-4838(94)90214-3; WAYNE LG, 1986, ANAL BIOCHEM, V157, P89, DOI 10.1016/0003-2697(86)90200-9; Wolfe MT, 2002, J BACTERIOL, V184, P5898, DOI 10.1128/JB.184.21.5898-5902.2002; Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	29	69	70	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32445	32450		10.1074/jbc.M605888200	http://dx.doi.org/10.1074/jbc.M605888200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16928682	hybrid			2022-12-27	WOS:000241414500042
J	Cordero, CL; Kudryashov, DS; Reisler, E; Satchell, KJF				Cordero, Christina L.; Kudryashov, Dmitry S.; Reisler, Emil; Satchell, Karla J. Fullner			The actin cross-linking domain of the Vibrio cholerae RTX toxin directly catalyzes the covalent cross-linking of actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; PROTECTIVE ANTIGEN; ANTHRAX TOXIN; TISSUE TRANSGLUTAMINASE; MAMMALIAN-CELLS; LETHAL FACTOR; IDENTIFICATION; NUCLEOTIDE; OLIGOMERS; ATP	Vibrio cholerae is a Gram-negative bacterial pathogen that exports enterotoxins to alter host cells and to elicit diarrheal disease. Among the secreted toxins is the multifunctional RTX toxin, which causes cell rounding and actin depolymerization by covalently cross-linking actin monomers into dimers, trimers, and higher multimers. The region of the toxin responsible for cross-linking activity is the actin cross-linking domain (ACD). In this study, we further investigated the role of the ACD in the actin cross-linking reaction. We show that the RTX toxin cross-links actin independently of tissue transglutaminase, thus eliminating an indirect model of ACD activity. We demonstrate that a fusion protein of the ACD and the N-terminal portion of lethal factor from Bacillus anthracis (LF(N)ACD) has cross-linking activity in vivo and in crude cell extracts. Furthermore, we determined that LF(N)ACD directly catalyzes the formation of covalent linkages between actin molecules in vitro and that Mg2+ and ATP are essential cofactors for the cross-linking reaction. In addition, G-actin is proposed as a cytoskeletal substrate of the RTX toxin in vivo. Future studies of the in vitro cross-linking reaction will facilitate characterization of the enzymatic properties of the ACD and contribute to our knowledge of the novel mechanism of covalent actin cross-linking.	Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Satchell, KJF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, 303 E Chicago Ave,Tarry 3-713, Chicago, IL 60611 USA.	k-satchell@northwestern.edu	Kudryashov, Dmitri/P-9004-2014; Satchell, Karla/GSN-3100-2022	Kudryashov, Dmitri/0000-0003-1782-3305	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI052490, R01AI051490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI051490, AI 051490, F31 AI 52490, F31 AI052490, R01 AI051490-04] Funding Source: Medline; NIGMS NIH HHS [GM 077190, R01 GM077190] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTRI AK, 1991, J BIOL CHEM, V266, P6815; Bai RL, 2001, MOL PHARMACOL, V59, P462, DOI 10.1124/mol.59.3.462; Boardman BK, 2004, J BACTERIOL, V186, P8137, DOI 10.1128/JB.186.23.8137-8143.2004; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chow KH, 2001, J CLIN MICROBIOL, V39, P2594, DOI 10.1128/JCM.39.7.2594-2597.2001; COOKE R, 1975, BIOCHEMISTRY-US, V14, P3250, DOI 10.1021/bi00685a035; Dalsgaard A, 2001, J CLIN MICROBIOL, V39, P4086, DOI 10.1128/JCM.39.11.4086-4092.2001; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; Fullner KJ, 2001, INFECT IMMUN, V69, P6310, DOI 10.1128/IAI.69.10.6310-6317.2001; GERSHMAN LC, 1989, BIOCHIM BIOPHYS ACTA, V995, P109, DOI 10.1016/0167-4838(89)90068-X; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HANDEL SE, 1990, J CELL SCI, V97, P325; KABSCH W, 1992, ANNU REV BIOPH BIOM, V21, P49, DOI 10.1146/annurev.biophys.21.1.49; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KOEHLER TM, 1991, MOL MICROBIOL, V5, P1501, DOI 10.1111/j.1365-2958.1991.tb00796.x; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; Lai TS, 1998, J BIOL CHEM, V273, P1776, DOI 10.1074/jbc.273.3.1776; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Murthy SNP, 1999, P NATL ACAD SCI USA, V96, P11815, DOI 10.1073/pnas.96.21.11815; Nemes Z, 1997, J BIOL CHEM, V272, P20577, DOI 10.1074/jbc.272.33.20577; Oda T, 2003, J MOL BIOL, V328, P319, DOI 10.1016/S0022-2836(03)00306-1; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Sambrook J., 2001, MOL CLONING LAB MANU; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Spyres LM, 2001, INFECT IMMUN, V69, P599, DOI 10.1128/IAI.69.1.599-601.2001; TAKASHI R, 1988, BIOCHEMISTRY-US, V27, P938, DOI 10.1021/bi00403a015; Voth DE, 2005, CELL MICROBIOL, V7, P1139, DOI 10.1111/j.1462-5822.2005.00539.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	39	69	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32366	32374		10.1074/jbc.M605275200	http://dx.doi.org/10.1074/jbc.M605275200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954226	Green Accepted, hybrid			2022-12-27	WOS:000241414500034
J	Maier, EA; Dusing, MR; Wiginton, DA				Maier, Elizabeth A.; Dusing, Mary R.; Wiginton, Dan A.			Temporal regulation of enhancer function in intestinal epithelium - A role for onecut factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE NUCLEAR FACTOR-6; TRANSCRIPTION FACTOR; ADENOSINE-DEAMINASE; CELL-DIFFERENTIATION; MAMMALIAN MEMBER; EXPRESSION; ACTIVATION; HOMEODOMAIN; INSIGHTS; NETWORK	An intestine-specific gene regulatory region was previously identified near the second exon of the human adenosine deaminase (ADA) gene. In mammalian intestine, ADA is expressed at high levels only along the villi of the duodenal epithelium, principally if not exclusively in enterocytes. Within the ADA intestinal regulatory region, a potent duodenum-specific enhancer was identified that controls this pattern of expression. This enhancer has been shown to rely on PDX-1, GATA factors, and Cdx factors for its function. Upstream of the enhancer, a separate temporal regulatory region was identified that has no independent enhancer capability but controls the timing of enhancer activation. DNase I footprinting and electrophoretic mobility shift assays were used to begin to characterize temporal region function at the molecular level. In this manner, binding sites for the Onecut (OC) family of factors, YY1, and NFI family members were identified. Identification of the OC site was especially interesting, because almost nothing is known about the function of OC factors in intestine. In transgenic mice, mutation of the OC site to ablate binding resulted in a delay of 2-3 weeks in enhancer activation in the developing postnatal intestine, a result very similar to that observed previously when the entire temporal region was deleted. In mammals, the OC family is comprised of OC-1/ HNF-6, OC-2, and OC-3. An examination of intestinal expression patterns showed that all three OC factors are expressed at detectable levels in adult mouse duodenum, with OC-2 predominant. In postnatal day 2 mice only OC-2 and OC-3 were detected in intestine, with OC-2 again predominant.	Childrens Hosp Res Fdn, Dept Pediat, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Cincinnati	Wiginton, DA (corresponding author), Childrens Hosp Res Fdn, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	dan.wiginton@cchmc.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052343] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 52343] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARONOW BJ, 1992, MOL CELL BIOL, V12, P4170, DOI 10.1128/MCB.12.9.4170; ATCHISON ML, 1988, ANNU REV CELL BIOL, V4, P127, DOI 10.1146/annurev.cellbio.4.1.127; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Bates MD, 2002, GASTROENTEROLOGY, V122, P1467, DOI 10.1053/gast.2002.32975; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Briancon N, 2004, J BIOL CHEM, V279, P33398, DOI 10.1074/jbc.M405312200; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; BUSTAMANTE S, 1981, TXB GASTROENTEROLOGY, P49; CHINSKY JM, 1990, DIFFERENTIATION, V42, P172, DOI 10.1111/j.1432-0436.1990.tb00759.x; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Dusing MR, 1997, J BIOL CHEM, V272, P26634, DOI 10.1074/jbc.272.42.26634; Dusing MR, 2001, J BIOL CHEM, V276, P14434, DOI 10.1074/jbc.M009249200; Dusing MR, 2003, AM J PHYSIOL-GASTR L, V284, pG1053, DOI 10.1152/ajpgi.00483.2002; DUSING MR, 1994, NUCLEIC ACIDS RES, V22, P669, DOI 10.1093/nar/22.4.669; DUSING MR, 2000, AM J PHYSIOL, V279, pR1080; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Hecht A, 1997, GASTROENTEROLOGY, V112, P803, DOI 10.1053/gast.1997.v112.pm9041242; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, GENE EXPR PATTERNS, V3, P639, DOI 10.1016/S1567-133X(03)00110-8; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jacquemin P, 1999, J BIOL CHEM, V274, P2665, DOI 10.1074/jbc.274.5.2665; Landry C, 1997, DEV BIOL, V192, P247, DOI 10.1006/dbio.1997.8757; Lannoy VJ, 2000, J BIOL CHEM, V275, P22098, DOI 10.1074/jbc.M000855200; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; LEE PC, 1973, DEV BIOL, V31, P227, DOI 10.1016/0012-1606(73)90259-5; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Maestro MA, 2003, HUM MOL GENET, V12, P3307, DOI 10.1093/hmg/ddg355; Maier EA, 2005, J BIOL CHEM, V280, P13195, DOI 10.1074/jbc.M413158200; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MOOG F, 1981, TXB GASTROENTEROLOGY, P139; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Pierreux CE, 2004, J BIOL CHEM, V279, P51298, DOI 10.1074/jbc.M409038200; SIMON TC, 1995, CURR OPIN GENET DEV, V5, P577, DOI 10.1016/0959-437X(95)80026-3; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; Vanhorenbeeck V, 2002, BIOCHEM BIOPH RES CO, V292, P848, DOI 10.1006/bbrc.2002.6760; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; WITTE DP, 1991, J CELL BIOL, V115, P179, DOI 10.1083/jcb.115.1.179; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353	40	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32263	32271		10.1074/jbc.M606699200	http://dx.doi.org/10.1074/jbc.M606699200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16950765	hybrid			2022-12-27	WOS:000241414500023
J	Neumeyer, T; Tonello, F; Dal Molin, F; Schiffler, B; Benz, R				Neumeyer, Tobias; Tonello, Fiorella; Dal Molin, Federica; Schiffler, Bettina; Benz, Roland			Anthrax edema factor, voltage-dependent binding to the protective antigen ion channel and comparison to LF binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMMETRICAL TETRAALKYLAMMONIUM IONS; PHOSPHOLIPID-BILAYER MEMBRANES; LETHAL FACTOR; TOXIN CHANNELS; CRYSTAL-STRUCTURE; PORE FORMATION; BLOCK; TRANSLOCATION; INHIBITION; RECEPTOR	Anthrax toxin complex consists of three different molecules, the binding component protective antigen (PA, 83 kDa), and the enzymatic components lethal factor (LF, 90 kDa) and edema factor (EF, 89 kDa). The 63-kDa N-terminal part of PA, PA(63), forms a heptameric channel that inserts at low pH in endosomal membranes and that is necessary to translocate EF and LF in the cytosol of the target cells. EF is an intracellular active enzyme, which is a calmodulin-dependent adenylate cyclase (89 kDa) that causes a dramatic increase of intracellular cAMP level. Here, the binding of full-length EF on heptameric PA(63) channels was studied in experiments with artificial lipid bilayer membranes. Full-length EF blocks the PA(63) channels in a dose, temperature, voltage, and ionic strength-dependent way with half-saturation constants in the nanomolar concentration range. EF only blocked the PA(63) channels when PA(63) and EF were added to the same side of the membrane, the cis side. Decreasing ionic strength and increasing transmembrane voltage at the cis side of the membranes resulted in a strong decrease of the half-saturation constant for EF binding. This result suggests that ion-ion interactions are involved in EF binding to the PA heptamer. Increasing temperature resulted in increasing half-saturation constants for EF binding to the PA(63) channels. The binding characteristics of EF to the PA(63) channels are compared with those of LF binding. The comparison exhibits similarities but also remarkable differences between the bindings of both toxins to the PA(63) channel.	Univ Wurzburg, Lehrstuhl Biotechnol, Theodor Boveri Inst, Biozentrum, D-97074 Wurzburg, Germany; Univ Padua, Dipartimento Sci Biomed, I-35121 Padua, Italy; Univ Padua, Ist Neurosci Consiglio Nazl Ric, I-35121 Padua, Italy	University of Wurzburg; University of Padua; University of Padua	Benz, R (corresponding author), Univ Wurzburg, Lehrstuhl Biotechnol, Theodor Boveri Inst, Biozentrum, D-97074 Wurzburg, Germany.	roland.benz@mail.uni-wuerzburg.de	Tonello, Fiorella/AAM-6737-2021; Tonello, Fiorella/G-8957-2013	Tonello, Fiorella/0000-0001-8935-8938; Tonello, Fiorella/0000-0001-8935-8938; Benz, Roland/0000-0002-9510-9265				Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BENZ R, 1994, EUR J BIOCHEM, V220, P339, DOI 10.1111/j.1432-1033.1994.tb18630.x; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P905, DOI 10.1085/jgp.96.5.905; CATALDI A, 1990, MOL MICROBIOL, V4, P1111, DOI 10.1111/j.1365-2958.1990.tb00685.x; Chauhan V, 2002, INFECT IMMUN, V70, P4477, DOI 10.1128/IAI.70.8.4477-4484.2002; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cunningham K, 2002, P NATL ACAD SCI USA, V99, P7049, DOI 10.1073/pnas.062160399; DANI JA, 1986, BIOPHYS J, V49, P607, DOI 10.1016/S0006-3495(86)83688-8; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; ESCUYER V, 1991, INFECT IMMUN, V59, P3381, DOI 10.1128/IAI.59.10.3381-3386.1991; EZZELL JW, 1992, J GEN MICROBIOL, V138, P543, DOI 10.1099/00221287-138-3-543; FINKELSTEIN A, 1994, TOXICOLOGY, V87, P29, DOI 10.1016/0300-483X(94)90153-8; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Halverson KM, 2005, J BIOL CHEM, V280, P34056, DOI 10.1074/jbc.M507928200; JORDAN PC, 1987, BIOPHYS J, V51, P297, DOI 10.1016/S0006-3495(87)83336-2; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Lacy DB, 2002, CURR TOP MICROBIOL, V271, P61; Lacy DB, 2005, P NATL ACAD SCI USA, V102, P16409, DOI 10.1073/pnas.0508259102; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Neumeyer T, 2006, BIOCHEMISTRY-US, V45, P3060, DOI 10.1021/bi0524316; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Ren G, 2004, STRUCTURE, V12, P2059, DOI 10.1016/j.str.2004.09.010; ROSSIPACCANI S, 2005, J EXP MED, V201, P325; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; TRIAS JQ, 1993, J BIOL CHEM, V268, P6234; Ward CA, 2006, PROG BIOPHYS MOL BIO, V90, P249, DOI 10.1016/j.pbiomolbio.2005.07.003; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864; Zhang S, 2004, BIOCHEMISTRY-US, V43, P6339, DOI 10.1021/bi049794a	48	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32335	32343		10.1074/jbc.M606552200	http://dx.doi.org/10.1074/jbc.M606552200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16954207	hybrid			2022-12-27	WOS:000241414500031
J	Timchenko, LT; Salisbury, E; Wang, GL; Nguyen, H; Albrecht, JH; Hershey, JWB; Timchenko, NA				Timchenko, Lubov T.; Salisbury, Elizabeth; Wang, Guo-Li; Nguyen, Heather; Albrecht, Jeffrey H.; Hershey, John W. B.; Timchenko, Nikolai A.			Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein beta in old liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL INHIBITORY PROTEIN; ACUTE-PHASE RESPONSE; C/EBP-ALPHA; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; ISOFORM EXPRESSION; LIP; CALRETICULIN; INITIATION; INTERACTS	The RNA-binding protein CUGBP1 regulates translation of proteins in a variety of biological processes. In this study, we show that aging liver increases CUGBP1 translational activities by induction of a high molecular weight protein-protein complex of CUGBP1. The complex contains CUGBP1, subunits alpha, beta, and gamma of the initiation translation factor eIF2, and four proteins of the endoplasmic reticulum, eR90, CRT, eR60, and Grp78. The induction of the CUGBP1-eIF2 complex in old livers is associated with the elevation of protein levels of CUGBP1 and with the hyper-phosphorylation of CUGBP1 by a cyclin D3-cdk4 kinase, activity of which is increased with age. We have examined the role of the elevation of CUGBP1 and the role of cyclin D3-cdk4 mediated phosphorylation of CUGBP1 in the formation of the CUGBP1-eIF2 complex by using CUGBP1 transgenic mice and young animals expressing high levels of cyclin D3 after injection with cyclin D3 plasmid. These studies showed that both the increased levels of CUGBP1 and cdk4-mediated hyper-phosphorylation of CUGBP1 are involved in the age-associated induction of the CUGBP1-eIF2 complex. The CUGBP1-eIF2 complex is bound to C/EBP beta mRNA in the liver of old animals, and this binding correlates with the increased amounts of liver-enriched activator protein and liver-enriched inhibitory protein. Consistent with these observations, the purified CUGBP1-eIF2 complex binds to the 5' region of C/EBP beta mRNA and significantly increases translation of the three isoforms of C/EBP beta in a cell-free translation system, in cultured cells, and in the liver. Thus, these studies demonstrated that age-mediated induction of the CUGBP1-eIF2 complex changes translation of C/EBP beta in old livers.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Hennepin Cty Med Ctr, Div Gastroenterol, Minneapolis, MN 55415 USA; Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Hennepin County Medical Center; University of California System; University of California Davis	Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Salisbury, Elizabeth/0000-0003-3607-2367	NCI NIH HHS [CA 100070] Funding Source: Medline; NIAMS NIH HHS [AR 052791, AR 49222, AR 44387] Funding Source: Medline; NIA NIH HHS [AG 025477, AG 20752] Funding Source: Medline; NIDDK NIH HHS [DK 54921] Funding Source: Medline; NIGMS NIH HHS [GM 55188] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052791, R01AR049222, R01AR044387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025477, P01AG020752] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		An MR, 1996, MOL CELL BIOL, V16, P2295; Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Calkhoven CF, 2000, GENE DEV, V14, P1920; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Welm AL, 1999, MOL CELL BIOL, V19, P1695; Welm AL, 2000, J BIOL CHEM, V275, P27406; WIMONWATWATEE T, 1994, AM J PHYSIOL, V267, pG201, DOI 10.1152/ajpgi.1994.267.2.G201; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087	23	75	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32806	32819		10.1074/jbc.M605701200	http://dx.doi.org/10.1074/jbc.M605701200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16931514	hybrid			2022-12-27	WOS:000241414500079
J	Wislet-Gendebien, S; D'Souza, C; Kawarai, T; St George-Hyslop, P; Westaway, D; Fraser, P; Tandon, A				Wislet-Gendebien, Sabine; D'Souza, Cheryl; Kawarai, Toshitaka; St George-Hyslop, Peter; Westaway, David; Fraser, Paul; Tandon, Anurag			RETRACTED: Cytosolic proteins regulate alpha-synuclein dissociation from presynaptic membranes (Retracted article. See vol. 295, pg. 13694, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							A-BETA COMPONENT; PARKINSONS-DISEASE; PRECURSOR PROTEIN; MESSENGER-RNA; BINDING; SITE; LOCALIZATION; ASSOCIATION; MUTATIONS; SEQUENCES	Intracellular accumulation of insoluble alpha-synuclein in Lewy bodies is a key neuropathological trait of Parkinson disease (PD). Neither the normal function of alpha-synuclein nor the biochemical mechanisms that cause its deposition are understood, although both are likely influenced by the interaction of alpha-synuclein with vesicular membranes, either for a physiological role in vesicular trafficking or as a pathological seeding mechanism that exacerbates the propensity of alpha-synuclein to self-assemble into fibrils. In addition to the alpha-helical form that is peripherally-attached to vesicles, a substantial portion of alpha-synuclein is freely diffusible in the cytoplasm. The mechanisms controlling alpha-synuclein exchange between these compartments are unknown and the possibility that chronic dysregulation of membrane-bound and soluble alpha-synuclein pools may contribute to Lewy body pathology led us to search for cellular factors that can regulate alpha-synuclein membrane interactions. Here we reveal that dissociation of membrane-bound alpha-synuclein is dependent on brain-specific cytosolic proteins and insensitive to calcium or metabolic energy. Two PD-linked mutations (A30P and A53T) significantly increase the cytosold-dependent alpha-synuclein off-rate but have no effect on cytosolindependent dissociation. These results reveal a novel mechanism by which cytosolic brain proteins modulate alpha-synuclein interactions with intracellular membranes. Importantly, our finding that alpha-synuclein dissociation is up-regulated by both familial PD mutations implicates cytosolic cofactors in disease pathogenesis and as molecular targets to influence alpha-synuclein aggregation.	Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada	University of Toronto	Tandon, A (corresponding author), Univ Toronto, Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.	a.tandon@utoronto.ca	Kawarai, Toshitaka/C-2822-2013	Kawarai, Toshitaka/0000-0003-4547-8131; wislet, sabine/0000-0003-4279-9669				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; ARAKI S, 1990, J BIOL CHEM, V265, P13007; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; FISCHER V, 1991, NATURE, V349, P79; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kruger R, 2000, J NEURAL TRANSM, V107, P31, DOI 10.1007/s007020050002; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Li WX, 2004, J NEUROCHEM, V88, P401, DOI 10.1046/j.1471-4159.2003.02166.x; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; MAROTEAUX L, 1991, MOL BRAIN RES, V11, P335, DOI 10.1016/0169-328X(91)90043-W; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; UEDA K, 1994, BIOCHEM BIOPH RES CO, V205, P1366, DOI 10.1006/bbrc.1994.2816; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	41	41	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32148	32155		10.1074/jbc.M605965200	http://dx.doi.org/10.1074/jbc.M605965200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16926154	hybrid, Green Published			2022-12-27	WOS:000241414500012
J	Kramer, HF; Witczak, CA; Taylor, EB; Fujii, N; Hirshman, MF; Goodyear, LJ				Kramer, Henning F.; Witczak, Carol A.; Taylor, Eric B.; Fujii, Nobuharu; Hirshman, Michael F.; Goodyear, Laurie J.			AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; GLUT4 TRANSLOCATION; TRANSPORT; PHOSPHORYLATION; EXERCISE; MICE; EXPRESSION; SUBSTRATE; GLYCOGEN; SIGNALS	Insulin and contraction are potent stimulators of GLUT4 translocation and increase skeletal muscle glucose uptake. We recently identified the Rab GTPase-activating protein ( GAP) AS160 as a putative point of convergence linking distinct upstream signaling cascades induced by insulin and contraction in mouse skeletal muscle. Here, we studied the functional implications of these AS160 signaling events by using an in vivo electroporation technique to overexpress wild type and three AS160 mutants in mouse tibialis anterior muscles: 1) AS160 mutated to prevent phosphorylation on four regulatory phospho-Akt-substrate sites (4P); 2) AS160 mutated to abolish Rab GTPase activity (R/K); and 3) double mutant AS160 containing both 4P and R/K mutations (2M). One week following gene injection, protein expression for all AS160 isoforms was elevated over 7-fold. To determine the effects of AS160 on insulin- and contraction-stimulated glucose uptake in transfected muscles, we measured [H-3]2-deoxyglucose uptake in vivo following intravenous glucose administration and in situ muscle contraction, respectively. Insulin-stimulated glucose uptake was significantly inhibited in muscles overexpressing 4P mutant AS160. However, this inhibition was completely prevented by concomitant disruption of AS160 Rab GAP activity. Transfection with 4P mutant AS160 also significantly impaired contraction-stimulated glucose uptake, as did overexpression of wild type AS160. In contrast, overexpressing mutant AS160 lacking Rab GAP activity resulted in increases in both sham and contraction-stimulated muscles. These data suggest that AS160 regulates both insulin- and contraction-stimulated glucose metabolism in mouse skeletal muscle in vivo and that the effects of mutant AS160 on the actions of insulin and contraction are not identical. Our findings directly implicate AS160 as a critical convergence factor for independent stimulators of skeletal muscle glucose uptake.	Joslin Diabet Ctr, Metab Sect, Boston, MA 02215 USA; Joslin Diabet Ctr, Dept Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Goodyear, LJ (corresponding author), Joslin Diabet Ctr, Metab Sect, Boston, MA 02215 USA.	laurie.goodyear@joslin.harvard.edu	Fujii, Nobuharu/J-2724-2014	Fujii, Nobuharu/0000-0002-0974-3033; Taylor, Eric/0000-0003-4549-6567	NIAMS NIH HHS [AR45670, AR42238, AR051663] Funding Source: Medline; NIDDK NIH HHS [F32 DK075851] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045670, R29AR042238, F32AR051663, R01AR042238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK075851] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLBORG G, 1975, J APPL PHYSIOL, V39, P718, DOI 10.1152/jappl.1975.39.5.718; Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Duvivier-Kali VF, 2004, AM J TRANSPLANT, V4, P1991, DOI 10.1111/j.1600-6143.2004.00628.x; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; FERRE P, 1985, BIOCHEM J, V228, P103, DOI 10.1042/bj2280103; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2004, AM J PHYSIOL-CELL PH, V287, pC200, DOI 10.1152/ajpcell.00415.2003; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Ho RC, 2004, AM J PHYSIOL-REG I, V286, pR342, DOI 10.1152/ajpregu.00563.2003; Jessen N, 2005, J APPL PHYSIOL, V99, P330, DOI 10.1152/japplphysiol.00175.2005; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; Koistinen HA, 2002, ANN MED, V34, P410, DOI 10.1080/078538902321012351; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Meeson AP, 2001, CIRC RES, V88, P713, DOI 10.1161/hh0701.089753; MEGENEY LA, 1992, AM J PHYSIOL, V262, pE20, DOI 10.1152/ajpendo.1992.262.1.E20; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; PASSONNEAU JV, 1967, ANAL BIOCHEM, V19, P315, DOI 10.1016/0003-2697(67)90167-4; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Winzell MS, 2004, DIABETES, V53, pS92, DOI 10.2337/diabetes.53.suppl_3.S92; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	30	223	227	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31478	31485		10.1074/jbc.M605461200	http://dx.doi.org/10.1074/jbc.M605461200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16935857				2022-12-27	WOS:000241235300032
J	Shanmugam, N; Ransohoff, RM; Natarajan, R				Shanmugam, Narkunaraja; Ransohoff, Richard M.; Natarajan, Rama			Interferon-gamma-inducible protein (IP)-10 mRNA stabilized by RNA-binding proteins in monocytes treated with s100b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLATION END-PRODUCTS; GENE-EXPRESSION; CYCLOOXYGENASE-2 EXPRESSION; MOLECULAR-MECHANISMS; OXIDANT STRESS; RECEPTOR; CELLS; INDUCTION; CYTOKINE; GLUCOSE	Chemokines mediate the recruitment and activation of blood monocyte/ macrophages and lymphocytes to sites of inflammation. Expression of the chemokine IP-10 (interferon-gamma-inducible protein) has been documented in several inflammatory and autoimmune disorders including type 1 diabetes. However, the mechanism of its expression in monocytes or its functional role in diabetes is not known. Advanced glycation end products acting via their receptor, RAGE, play major roles in diabetic complications. In this study, we observed for the first time that S100b, an inflammatory protein as well as a specific RAGE ligand, significantly increased IP-10 mRNA and protein levels in THP-1 monocytes as well as peripheral blood monocytes. Promoter luciferase assays showed that IP-10 mRNA accumulation by S100b was not via increased transcription. On the other hand, S100b significantly increased IP-10 mRNA half-life and stability. This appeared to be mediated by S100b-induced binding of specific RNA-binding protein(s) to a 3'-untranslated region-responsive region of the IP-10 mRNA. Our results demonstrate for the first time that diabetic stimuli such as RAGE ligands can induce inflammatory gene expression in monocytes via increased message stability.	Beckman Res Inst, Gonda Diabet Res Ctr, Duarte, CA 91010 USA; Lerner Res Inst, Cleveland, OH 44195 USA	City of Hope; Beckman Research Institute of City of Hope; Cleveland Clinic Foundation	Natarajan, R (corresponding author), Beckman Res Inst, Dept Diabet, 1500 E Duarte Rd, Duarte, CA USA.	rnatarajan@coh.org			NCRR NIH HHS [M01RR00043] Funding Source: Medline; NIDDK NIH HHS [R01 DK065073] Funding Source: Medline; NINDS NIH HHS [R01 NS32151] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032151] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Basta G, 2005, ARTERIOSCL THROM VAS, V25, P1401, DOI 10.1161/01.ATV.0000167522.48370.5e; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Derrigo M, 2000, INT J MOL MED, V5, P111; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Guha M, 2000, J BIOL CHEM, V275, P17728, DOI 10.1074/jbc.275.23.17728; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; KHABAR KS, 2005, J INTERFERON CYTOKIN, V1, P1; KIRSTEIN M, 1990, P NATL ACAD SCI USA, V87, P9010, DOI 10.1073/pnas.87.22.9010; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; MOROHOSHI M, 1995, ANN NY ACAD SCI, V748, P562; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; Shanmugam N, 2004, DIABETES, V53, P795, DOI 10.2337/diabetes.53.3.795; Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Shaw SS, 2003, DIABETES, V52, P2381, DOI 10.2337/diabetes.52.9.2381; Shimada A, 2001, DIABETES CARE, V24, P510, DOI 10.2337/diacare.24.3.510; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Vlassara H, 2001, DIABETES-METAB RES, V17, P436, DOI 10.1002/dmrr.233; Vockerodt M, 2005, INT J CANCER, V114, P598, DOI 10.1002/ijc.20759; Westwood ME, 1996, IMMUNOL LETT, V50, P17, DOI 10.1016/0165-2478(96)02496-0	31	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31212	31221		10.1074/jbc.M602445200	http://dx.doi.org/10.1074/jbc.M602445200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16931519				2022-12-27	WOS:000241235300006
J	Lin, Q; Lee, YJ; Yun, Z				Lin, Qun; Lee, Yi-Jang; Yun, Zhong			Differentiation arrest by hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; INDUCIBLE FACTOR; PROMOTES; PREF-1; REPRESSION; PROTEIN; HIF-1; GENE	The stem cell niche is a unique tissue microenvironment that regulates the self-renewal and differentiation of stem cells. Although several stromal cells and molecular pathways have been identified, the microenvironment of the stem cell niche remains largely unclear. Recent evidence suggests that stem cells are localized in areas with low oxygen. We have hypothesized that hypoxia maintains the undifferentiated phenotype of stem/precursor cells. In this report, we demonstrate that hypoxia reversibly arrests preadipocytes in an undifferentiated state. Consistent with this observation, hypoxia maintains the expression of pref-1, a key stem/precursor cell gene that negatively regulates adipogenic differentiation. We further demonstrate that the hypoxia-inducible factor-1 (HIF-1) constitutes an important mechanism for the inhibition of adipogenic differentiation by hypoxia. Our findings suggest that hypoxia in the stem cell niche is critical for the maintenance of the undifferentiated stem or precursor cell phenotype.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA	Yale University	Yun, Z (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St,HRT 313, New Haven, CT 06510 USA.	zhong.yun@yale.edu						Azuma Y, 2003, CLIN CANCER RES, V9, P4944; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen BY, 2006, BIOCHEM BIOPH RES CO, V341, P549, DOI 10.1016/j.bbrc.2006.01.004; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Helczynska K, 2003, CANCER RES, V63, P1441; Jiang MS, 2000, P NATL ACAD SCI USA, V97, P12519, DOI 10.1073/pnas.220426097; Jogi A, 2003, CANCER LETT, V197, P145, DOI 10.1016/S0304-3835(03)00095-8; Lee JS, 2003, PLAST RECONSTR SURG, V111, P461, DOI 10.1097/00006534-200301000-00083; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Rosen ED, 2000, GENE DEV, V14, P1293; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Shimba S, 2004, J BIOL CHEM, V279, P40946, DOI 10.1074/jbc.M400840200; Smas CM, 1999, J BIOL CHEM, V274, P12632, DOI 10.1074/jbc.274.18.12632; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Villena JA, 2002, HORM METAB RES, V34, P664, DOI 10.1055/s-2002-38244; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4	26	149	168	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2006	281	41					30678	30683		10.1074/jbc.C600120200	http://dx.doi.org/10.1074/jbc.C600120200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092CZ	16926163	hybrid			2022-12-27	WOS:000241075900044
J	Bird, JG; Sharma, S; Roshwalb, SC; Hoskins, JR; Wickner, S				Bird, Jeremy G.; Sharma, Suveena; Roshwalb, Sara C.; Hoskins, Joel R.; Wickner, Sue			Functional analysis of CbpA, a DnaJ homolog and nucleoid-associated DNA-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DNAJ; HEAT-SHOCK PROTEINS; J-DOMAIN; THERMUS-THERMOPHILUS; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; HSP40; HSP70; REPLICATION; REPA	DnaK/Hsp70 proteins are universally conserved ATP-dependent molecular chaperones that help proteins adopt and maintain their native conformations. DnaJ/Hsp40 and GrpE are co-chaperones that assist DnaK. CbpA is an Escherichia coli DnaJ homolog. It acts as a multicopy suppressor for dnaJ mutations and functions in vitro in combination with DnaK and GrpE in protein remodeling reactions. CbpA binds nonspecifically to DNA with preference for curved DNA and is a nucleoid-associated protein. The DNA binding and co-chaperone activities of CbpA are modulated by CbpM, a small protein that binds specifically to CbpA. To identify the regions of CbpA involved in the interaction of CbpA with CbpM and those involved in DNA binding, we constructed and characterized deletion and substitution mutants of CbpA. We discovered that CbpA interacted with CbpM through its N-terminal J-domain. We found that the region C-terminal to the J-domain was required for DNA binding. Moreover, we found that the CbpM interaction, DNA binding, and co-chaperone activities were separable; some mutants were proficient in some functions and defective in others.	NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wickner, S (corresponding author), NCI, Mol Biol Lab, NIH, Bldg 37,Rm 5144,37 Convent Dr MSC37-4264, Bethesda, MD 20892 USA.	wickners@mail.nih.gov		Bird, Jeremy/0000-0003-2690-8474	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ali Azam T., 1999, J BACTERIOL, V181, P6361; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chae C, 2004, J BIOL CHEM, V279, P33147, DOI 10.1074/jbc.M404862200; Dumitru GL, 2004, J MOL BIOL, V339, P1179, DOI 10.1016/j.jmb.2004.04.052; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HILL RB, 1995, BIOCHEMISTRY-US, V34, P5587, DOI 10.1021/bi00016a033; Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135; Huang K, 1999, PROTEIN SCI, V8, P203; Klostermeier D, 1999, J MOL BIOL, V287, P511, DOI 10.1006/jmbi.1999.2636; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Motohashi K, 1996, J BIOL CHEM, V271, P17343, DOI 10.1074/jbc.271.29.17343; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Qian YQ, 1996, J MOL BIOL, V260, P224, DOI 10.1006/jmbi.1996.0394; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; SKOWYRA D, 1993, J BIOL CHEM, V268, P25296; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; UEGUCHI C, 1994, P NATL ACAD SCI USA, V91, P1054, DOI 10.1073/pnas.91.3.1054; UEGUCHI C, 1995, J BACTERIOL, V177, P3894, DOI 10.1128/jb.177.13.3894-3896.1995; WALL D, 1994, J BIOL CHEM, V269, P5446; Watanabe Y, 2004, J BIOL CHEM, V279, P15723, DOI 10.1074/jbc.M308782200; WICKNER S, 1991, P NATL ACAD SCI USA, V88, P7903, DOI 10.1073/pnas.88.18.7903; WICKNER S, 1991, NATURE, V350, P165, DOI 10.1038/350165a0; WICKNER SH, 1990, P NATL ACAD SCI USA, V87, P2690, DOI 10.1073/pnas.87.7.2690; YAMASHINO T, 1994, MOL MICROBIOL, V13, P475, DOI 10.1111/j.1365-2958.1994.tb00442.x	32	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34349	34356		10.1074/jbc.M603365200	http://dx.doi.org/10.1074/jbc.M603365200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973605	hybrid			2022-12-27	WOS:000241767600055
J	Draing, C; Pfitzenmaier, M; Zummo, S; Mancuso, G; Geyer, A; Hartung, T; von Aulock, S				Draing, Christian; Pfitzenmaier, Markus; Zummo, Sebastiana; Mancuso, Giuseppe; Geyer, Armin; Hartung, Thomas; von Aulock, Sonja			Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS-SOLUTION STRUCTURE; TOLL-LIKE RECEPTOR-2; C-POLYSACCHARIDE; TEICHOIC-ACID; STAPHYLOCOCCUS-AUREUS; CYTOKINE INDUCTION; VIRULENCE FACTORS; STRAIN R6; EPIDEMIOLOGY; ANTIGEN	Pneumococcal lipoteichoic acid (LTA) is known to have a completely different chemical structure compared with that of Staphylococcus aureus: the polyglycerophosphate in the backbone is replaced in the pneumococcal LTA by a pentamer repeating unit consisting of one ribitol and a tetrasaccharide carrying the unusual substituents phosphocholine andN-acetyl-D-galactosamine. Neither D-alaninenor N-acetyl-D-glucosamine, which play central roles in the biological activity of the staphylococcal LTA, has been reported. The extraction using butanol is more gentle compared with the previously reported chloroform-methanol extraction and results in a higher yield of LTA. We characterized the LTA of two different strains of Streptococcus pneumoniae: R6 (serotype 2) and Fp23 (serotype 4). NMR analysis confirmed the structure of LTA from R6 but showed that its ribitol carries an N-acetyl-D-galactosamine substituent. The NMR data for the LTA from Fp23 indicate that this LTA additionally contains ribitol-bound D-alanine. Dose-response curves of the two pneumococcal LTAs in human whole blood revealed that LTA from Fp23 was significantly more potent than LTA from R6 with regard to the induction of all cytokines measured (tumor necrosis factor, interleukin-1 (IL-1), IL-8, IL-10, granulocyte colony-stimulating factor, and interferon gamma). However, other characteristics, such as lack of inhibition by endotoxin-specific LAL-F, Toll-like receptor 2 and not 4 dependence, and lack of stimulation of neutrophilic granulocytes, were shared by both LTAs. This is the first report of a difference in the structure of LTA between two pneumococcal serotypes resulting in different immunostimulatory potencies.	Univ Konstanz, Dept Biochem Pharmacol, D-78457 Constance, Germany; Univ Marburg, Dept Organ Chem, D-35043 Marburg, Germany; Univ Messina, Dept Pathol & Expt Microbiol, I-98125 Messina, Italy; European Ctr Validat Alternat Methods, Joint Res Ctr, I-21020 Ispra, Italy	University of Konstanz; Philipps University Marburg; University of Messina; European Commission Joint Research Centre; EC JRC ISPRA Site	von Aulock, S (corresponding author), Univ Konstanz, Dept Biochem Pharmacol, POB M668, D-78457 Constance, Germany.	Sonja.v-aulock@uni-konstanz.de	von Aulock, Sonja/AGQ-3420-2022	Mancuso, Giuseppe/0000-0001-5454-3228				ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; BEHR T, 1992, EUR J BIOCHEM, V207, P1063, DOI 10.1111/j.1432-1033.1992.tb17143.x; Bergstrom N, 2000, EUR J BIOCHEM, V267, P7147, DOI 10.1046/j.1432-1327.2000.01821.x-i2; BHAKDI S, 1991, INFECT IMMUN, V59, P4614, DOI 10.1128/IAI.59.12.4614-4620.1991; Bridy-Pappas AE, 2005, PHARMACOTHERAPY, V25, P1193, DOI 10.1592/phco.2005.25.9.1193; BRIESE T, 1985, EUR J BIOCHEM, V146, P417, DOI 10.1111/j.1432-1033.1985.tb08668.x; BRILES EB, 1973, J BIOL CHEM, V248, P6394; Canton R, 2003, J ANTIMICROB CHEMOTH, V52, P944, DOI 10.1093/jac/dkg465; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Farrell DJ, 2004, J MED MICROBIOL, V53, P1109, DOI 10.1099/jmm.0.45647-0; Fischer W, 1997, MICROB DRUG RESIST, V3, P309, DOI 10.1089/mdr.1997.3.309; FISCHER W, 1993, EUR J BIOCHEM, V215, P851, DOI 10.1111/j.1432-1033.1993.tb18102.x; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hartung Thomas, 1995, ALTEX, V12, P70; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Karlsson C, 1998, EUR J BIOCHEM, V255, P296, DOI 10.1046/j.1432-1327.1998.2550296.x; Karlsson C, 1999, EUR J BIOCHEM, V265, P1091, DOI 10.1046/j.1432-1327.1999.00835.x; Kellogg TA, 2001, SHOCK, V15, P124, DOI 10.1097/00024382-200115020-00008; Kim JH, 2005, INFECT IMMUN, V73, P834, DOI 10.1128/IAI.73.2.834-840.2005; KLEIN RA, 1994, CARBOHYD RES, V256, P189, DOI 10.1016/0008-6215(94)84209-4; Klein RA, 1996, CARBOHYD RES, V281, P79, DOI 10.1016/0008-6215(95)00336-3; Morath S, 2002, INFECT IMMUN, V70, P938, DOI 10.1128/IAI.70.2.938-944.2002; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; ORGANIZATION WH, 1998, WKLY EPIDEMIOL REC, V73, P187; Schneider O, 1999, NEUROLOGY, V53, P1584, DOI 10.1212/WNL.53.7.1584; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; SHABAROVA ZA, 1962, BIOCHEM J, V83, P216, DOI 10.1042/bj0830216; STOOL SE, 1989, PEDIATR INFECT DIS J, V8, P11; Stuertz K, 1998, ANTIMICROB AGENTS CH, V42, P277; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; TROLLFORS B, 1983, J CLIN MICROBIOL, V18, P978, DOI 10.1128/JCM.18.4.978-980.1983; Vialle S, 2005, CARBOHYD RES, V340, P91, DOI 10.1016/j.carres.2004.10.021; von Aulock S, 2003, IMMUNOBIOLOGY, V208, P413, DOI 10.1078/0171-2985-00285; Zangwill KM, 1996, J INFECT DIS, V174, P752, DOI 10.1093/infdis/174.4.752	41	76	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					33849	33859		10.1074/jbc.M602676200	http://dx.doi.org/10.1074/jbc.M602676200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16943191	Green Submitted, hybrid			2022-12-27	WOS:000241767600006
J	Siegenthaler, RK; Christen, P				Siegenthaler, Rahel K.; Christen, Philipp			Tuning of DnaK chaperone action by nonnative protein sensor DnaJ and thermosensor GrpE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HEAT-SHOCK-PROTEIN; MOLECULAR-CHAPERONE; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; HSP70 CHAPERONES; SYSTEM; BINDING; TEMPERATURE	DnaK, an Hsp70 molecular chaperone, processes its substrates in an ATP-driven cycle, which is controlled by the co-chaperones DnaJ and GrpE. The kinetic analysis of substrate binding and release has as yet been limited to fluorescence-labeled peptides. Here, we report a comprehensive kinetic analysis of the chaperone action with protein substrates. The kinetic partitioning of the (ATP(.)DnaK)(.)substrate complexes between dissociation and conversion into stable (ADP(.)DnaK)(.)substrate complexes is determined by DnaJ. In the case of substrates that allow the formation of ternary (ATP(.)DnaK)(.)substrate DnaJ complexes, the cis-effect of DnaJ markedly accelerates ATP hydrolysis. This triage mechanism efficiently selects from the (ATP(.)DnaK)(.)substrate complexes those to be processed in the chaperone cycle; at 45 C, the fraction of protein complexes fed into the cycle is 20 times higher than that of peptide complexes. The thermosensor effect of the ADP/ATP exchange factor GrpE retards the release of substrate from the cycle at higher temperatures; the fraction of total DnaK in stable (ADP(.)DnaK)(.)substrate complexes is 2 times higher at 45 C than at 25 degrees C. Monitoring the cellular situation by DnaJ as nonnative protein sensor and GrpE as thermosensor thus directly adapts the operational mode of the DnaK system to heat shock conditions.	Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Christen, P (corresponding author), Univ Zurich, Inst Biochem, Winterhurerstr 190, CH-8057 Zurich, Switzerland.	christen@bioc.unizh.ch						ABELES AL, 1986, J BIOL CHEM, V261, P3548; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chattopadhyay R, 2002, J BIOL CHEM, V277, P33641, DOI 10.1074/jbc.M203197200; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Diamant S, 1998, BIOCHEMISTRY-US, V37, P9688, DOI 10.1021/bi980338u; Feifel B, 1996, EUR J BIOCHEM, V237, P318, DOI 10.1111/j.1432-1033.1996.0318n.x; FEIFEL B, 1998, THESIS U ZURICH ZURI; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Gelinas AD, 2003, BIOCHEMISTRY-US, V42, P9050, DOI 10.1021/bi034416b; Gelinas AD, 2002, J MOL BIOL, V323, P131, DOI 10.1016/S0022-2836(02)00915-4; Grimshaw JPA, 2003, J BIOL CHEM, V278, P19048, DOI 10.1074/jbc.M300924200; Grimshaw JPA, 2001, J BIOL CHEM, V276, P6098, DOI 10.1074/jbc.M009290200; Groemping Y, 2001, J MOL BIOL, V314, P167, DOI 10.1006/jmbi.2001.5116; Han WJ, 2004, FEBS LETT, V563, P146, DOI 10.1016/S0014-5793(04)00290-X; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; HELLEBUST H, 1990, J BACTERIOL, V172, P5030, DOI 10.1128/jb.172.9.5030-5034.1990; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Kim SY, 2002, J BIOL CHEM, V277, P44778, DOI 10.1074/jbc.M206176200; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIU X, 2002, THESIS U ZURICH ZURI; Mayer MP, 2000, BIOL CHEM, V381, P877, DOI 10.1515/BC.2000.109; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Moro F, 2006, J MOL BIOL, V358, P1367, DOI 10.1016/j.jmb.2006.03.027; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pierpaoli EV, 1998, BIOCHEMISTRY-US, V37, P16741, DOI 10.1021/bi981762y; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; Schonfeld HJ, 1995, PROG COLL POL SCI S, V99, P7; Siegenthaler RK, 2005, J BIOL CHEM, V280, P14395, DOI 10.1074/jbc.M413803200; Siegenthaler RK, 2004, FEBS LETT, V562, P105, DOI 10.1016/S0014-5793(04)00190-5; Slepenkov SV, 2002, MOL MICROBIOL, V45, P1197, DOI 10.1046/j.1365-2958.2002.03093.x; Tanaka N, 2002, P NATL ACAD SCI USA, V99, P15398, DOI 10.1073/pnas.242317099; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Wick LM, 2004, ADV BIOCHEM ENG BIOT, V89, P1; WICKNER S, 1991, NATURE, V350, P165, DOI 10.1038/350165a0; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	53	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34448	34456		10.1074/jbc.M606382200	http://dx.doi.org/10.1074/jbc.M606382200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16940296	hybrid			2022-12-27	WOS:000241767600065
J	McAlear, SD; Bevensee, MO				McAlear, Suzanne D.; Bevensee, Mark O.			A cysteine-scanning mutagenesis study of transmembrane domain 8 of the electrogenic sodium/bicarbonate cotransporter NBCe1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ANION-EXCHANGE PROTEIN; CELL BAND-3 PROTEIN; NA+-HCO3-COTRANSPORTER; NA/HCO3 COTRANSPORTER; CARBOXY-TERMINI; PROXIMAL TUBULE; XENOPUS OOCYTES; RAT-KIDNEY; HUMAN AE1	Na/HCO3 cotransporters (NBCs) such as NBCe1 are members of a superfamily of bicarbonate transporters that includes anion exchangers. Residues within putative transmembrane domain 8 (TMD8) of anion exchanger 1 are involved in ion translocation (Tang, X. B., Kovacs, M., Sterling, D., and Casey, J. R. (1999) J. Biol. Chem. 274, 3557-3564), and the corresponding domain in NBCe1 variants is highly homologous. We performed cysteine-scanning mutagenesis to examine the role of TMD8 residues in ion translocation by rat NBCe1-A. We accessed function and/or sulfhydryl sensitivity and p-chloro-mercuribenzene sulfonate (pCMBS) accessibility of 21 cysteine-substituted NBC mutants expressed in Xenopus oocytes using the two-electrode, voltage clamp technique. Five NBC mutants displayed < 10% wild-type activity: P743C, A744C, L746C, D754C, and T758C. For the remaining 16 mutants, we compared transporter-mediated inward currents elicited by removing external Na+ before and after exposing oocytes to either 2-aminoethylmethane thiosulfonate (MTSEA) or pCMBS. MTSEA inhibited NBC mutants T748C, I749C, I751C, F752C, M753C, and Q756C by 9-19% and stimulated mutants A739C, A741C, L745C, V747C, Q755C, and I757C by 11-21%. pCMBS mildly inhibited mutants A739C, A740, V747C, and Q756C by 5 or 8%, and stimulated I749C by 10%. However, both sulfhydryl reagents strongly inhibited the L750C mutant by >= 85%. Using the substituted cysteine accessibility method, we examined the accessibility of the NBC mutant L750C under different transporter conditions. pCMBS accessibility is (i) reduced when the transporter is active in the presence of both Na+ and HCO3-, likely due to substrate competition with pCMBS; (ii) reduced in the presence of a stilbene inhibitor; and (iii) stimulated at more positive membrane potentials. In summary, TMD8 residues of NBCe1, particularly L750, are involved in ion translocation, and accessibility is influenced by the state of transporter activity.	Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bevensee, MO (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, 1918 Univ Blvd,MCLM 812, Birmingham, AL 35294 USA.	bevensee@physiology.uab.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046653] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 046653] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abuladze N, 2005, J PHYSIOL-LONDON, V565, P717, DOI 10.1113/jphysiol.2005.084988; AKABAS MH, 1994, J BIOL CHEM, V269, P14865; AKABAS MH, 1995, BIOCHEMISTRY-US, V34, P12496, DOI 10.1021/bi00039a002; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BARTEL D, 1989, BIOCHIM BIOPHYS ACTA, V985, P355, DOI 10.1016/0005-2736(89)90427-6; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; CABANTCHIK ZI, 1992, AM J PHYSIOL, V262, pC803, DOI 10.1152/ajpcell.1992.262.4.C803; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Grichtchenko I, 2002, FASEB J, V16, pA795; Gross E, 2003, J PHYSIOL-LONDON, V549, P673, DOI 10.1113/jphysiol.2003.042226; Gross E, 2001, J PHYSIOL-LONDON, V537, P659; Gross E, 2001, J PHYSIOL-LONDON, V531, P597, DOI 10.1111/j.1469-7793.2001.0597h.x; JENNINGS ML, 1987, J BIOL CHEM, V262, P1691; JENNINGS ML, 1988, J GEN PHYSIOL, V92, P161, DOI 10.1085/jgp.92.2.161; JENNINGS ML, 1992, J BIOL CHEM, V267, P13964; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Lu J, 2003, FASEB J, V17, pA1221; McAlear SD, 2004, FASEB J, V18, pA1022; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Perry C, 2006, AM J PHYSIOL-RENAL, V290, pF417, DOI 10.1152/ajprenal.00395.2004; REITHMEIER RAF, 1996, HDB BIOL PHYS, P281; Romero MF, 2005, CURR OPIN NEPHROL HY, V14, P495, DOI 10.1097/01.mnh.0000168333.01831.2c; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Salhany JM, 2001, BLOOD CELL MOL DIS, V27, P127, DOI 10.1006/bcmd.2000.0369; Schmitt BM, 1999, AM J PHYSIOL-RENAL, V276, pF27, DOI 10.1152/ajprenal.1999.276.1.F27; Sciortino CM, 1999, AM J PHYSIOL-RENAL, V277, pF611, DOI 10.1152/ajprenal.1999.277.4.F611; SOLEIMANI M, 1987, J CLIN INVEST, V79, P1276, DOI 10.1172/JCI112948; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; WOOD PG, 1992, J MEMBRANE BIOL, V127, P139; XU M, 1993, J BIOL CHEM, V268, P21505	35	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32417	32427		10.1074/jbc.M607253200	http://dx.doi.org/10.1074/jbc.M607253200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16936285	hybrid			2022-12-27	WOS:000241414500039
J	Lee, SA; Kovacs, J; Stahelin, RV; Cheever, ML; Overduin, M; Setty, TG; Burd, CG; Cho, W; Kutateladze, TG				Lee, Stephanie A.; Kovacs, James; Stahelin, Robert V.; Cheever, Matthew L.; Overduin, Michael; Setty, Thanuja Gangi; Burd, Christopher G.; Cho, Wonhwa; Kutateladze, Tatiana G.			Molecular mechanism of membrane docking by the Vam7p PX domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; PHOSPHATIDYLINOSITOL 3-PHOSPHATE RECOGNITION; PLECKSTRIN HOMOLOGY DOMAINS; FYVE DOMAIN; CRYSTAL-STRUCTURE; BINDING; P40(PHOX); MICELLES; PROTEIN; NMR	The Vam7p t-SNARE is an essential component of the vacuole fusion machinery that mediates membrane trafficking and protein sorting in yeast. Vam7p is recruited to vacuoles by its N-terminal PX domain that specifically recognizes PtdIns(3) P in the bilayers, however the precise mechanism of membrane anchoring remains unclear. Here we describe a molecular basis for membrane targeting and penetration by the Vam7p PX domain based on structural and quantitative analysis of its interactions with lipids and micelles. Our results derived from in vitro binding measurements using NMR, monolayer surface tension experiments and mutagenesis reveal a multivalent membrane docking mechanism involving specific PtdIns(3) P recognition that is facilitated by electrostatic interactions and accompanying hydrophobic insertion. Both the hydrophobic and electrostatic components enhance the Vam7p PX domain association with PtdIns(3) P-containing membranes. The inserting Val(70), Leu(71), and Trp(75) residues located next to the PtdIns(3) P binding pocket are surrounded by a basic patch, which is involved in nonspecific electrostatic contacts with acidic lipids, such as PtdSer. Substitution of the insertion residues significantly reduces the binding and penetrating power of the Vam7p PX domain and leads to cytoplasmic redistribution of the EGFP-tagged protein. The affinities of the PX domain for PtdIns(3) P and other lipids reveal a remarkable synergy within the multivalent complex that stably anchors Vam7p at the vacuolar membrane.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA; Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46615 USA; Univ Notre Dame, Walther Ctr Canc Res, Dept Chem & Biochem, South Bend, IN 46617 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ Birmingham, CR UK Inst Canc Studies, Birmingham B15 2T, W Midlands, England; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Indiana University System; Indiana University South Bend; University of Notre Dame; Walther Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Birmingham; University of Pennsylvania	Kutateladze, TG (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 12801 E 17th Ave, Aurora, CO 80045 USA.	Tatiana.Kutateladze@UCHSC.edu	Stahelin, Robert/L-3567-2019; Overduin, Michael/AAG-3632-2020	Overduin, Michael/0000-0002-3114-6585; Kutateladze, Tatiana/0000-0001-7375-6990; Stahelin, Robert/0000-0001-5443-7863; Burd, Christopher/0000-0003-1831-8706	Biotechnology and Biological Sciences Research Council [BBS/B/10714] Funding Source: Medline; NCI NIH HHS [CA95144, R01 CA095144] Funding Source: Medline; NIGMS NIH HHS [R01 GM071424, GM071424, R01 GM068849, GM68849] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849, R01GM071424] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Diraviyam K, 2003, J MOL BIOL, V328, P721, DOI 10.1016/S0022-2836(03)00325-5; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; GRZESIEK S, 1996, BIOCHEMISTRY; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jarvet J, 1997, BIOCHEMISTRY-US, V36, P8153, DOI 10.1021/bi970193b; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lee JS, 2005, J CELL SCI, V118, P4405, DOI 10.1242/jcs.02564; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Lu J, 2002, BIOCHEMISTRY-US, V41, P5956, DOI 10.1021/bi020050b; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; PAPAVOINE CHM, 1994, BIOCHEMISTRY-US, V33, P12990, DOI 10.1021/bi00248a007; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Sankaran VG, 2001, BIOCHEMISTRY-US, V40, P8581, DOI 10.1021/bi010425d; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Singh SM, 2003, PROTEIN SCI, V12, P1934, DOI 10.1110/ps.0358803; Song X, 2001, BIOCHEMISTRY-US, V40, P8940, DOI 10.1021/bi0155100; Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Tochtrop GP, 2002, P NATL ACAD SCI USA, V99, P1847, DOI 10.1073/pnas.012379199; vandenHooven HW, 1996, EUR J BIOCHEM, V235, P394, DOI 10.1111/j.1432-1033.1996.00394.x; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200	50	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2006	281	48					37091	37101		10.1074/jbc.M608610200	http://dx.doi.org/10.1074/jbc.M608610200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	108DP	16984909	hybrid, Green Accepted, Green Submitted			2022-12-27	WOS:000242220800070
J	Canela, N; Orzaez, M; Fucho, R; Mateo, F; Gutierrez, R; Pineda-Lucena, A; Bachs, O; Perez-Paya, E				Canela, Nuria; Orzaez, Mar; Fucho, Raquel; Mateo, Francesca; Gutierrez, Ricardo; Pineda-Lucena, Antonio; Bachs, Oriol; Perez-Paya, Enrique			Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; TRANSCRIPTION FACTOR E2F-1; S-PHASE ENTRY; PEPTIDE INHIBITORS; IN-VIVO; KINASE INHIBITORS; STRUCTURAL BASIS; DNA-REPLICATION; SMALL MOLECULES; CELL-CYCLE	The protein-protein complexes formed between different cyclins and cyclin-dependent kinases (CDKs) are central to cell cycle regulation. These complexes represent interesting points of chemical intervention for the development of antineoplastic molecules. Here we describe the identification of an all D-amino acid hexapeptide, termed NBI1, that inhibits the kinase activity of the cyclin-dependent kinase 2 (cdk2)-cyclin A complex through selective binding to cyclin A. The mechanism of inhibition is non-competitive for ATP and non-competitive for protein substrates. In contrast to the existing CDKs peptide inhibitors, the hexapeptide NBI1 interferes with the formation of the cdk2-cyclin A complex. Furthermore, a cell-permeable derivative of NBI1 induces apoptosis and inhibits proliferation of tumor cell lines. Thus, the NBI1-binding site on cyclin A may represent a new target site for the selective inhibition of activity cdk2-cyclin A complex.	Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Fac Med, Dept Biol Cellular & Anat Patol, E-08036 Barcelona, Spain; Ctr Invest Principe Felipe, Dept Quim Med, E-46013 Valencia, Spain; Univ Pompeu Fabra, Dept Ciencies Expt Salut, Unitat Recerca Farmacol, Inst Municipal Invest Med, E-08003 Barcelona, Spain; CSIC, Inst Biomed Valencia, E-46010 Valencia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Prince Felipe Research Center; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Bachs, O (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Fac Med, Dept Biol Cellular & Anat Patol, C-Casanova 143, E-08036 Barcelona, Spain.	obachs@ub.edu; eperez@cipf.es	Pineda-Lucena, Antonio/B-1320-2014; Fucho, Raquel/A-6684-2016; Mateo, Francesca/K-7746-2015; Orzaez, Mar/B-4992-2014; Canela, Núria/I-5401-2015	Pineda-Lucena, Antonio/0000-0002-3532-8781; Fucho, Raquel/0000-0002-1774-9099; Mateo, Francesca/0000-0002-2342-7010; Orzaez, Mar/0000-0003-3231-5835; Canela, Núria/0000-0003-0261-2396				Adams PD, 1996, MOL CELL BIOL, V16, P6623; Andrews MJI, 2004, ORG BIOMOL CHEM, V2, P2735, DOI 10.1039/b409157d; Arkin M, 2005, CURR OPIN CHEM BIOL, V9, P317, DOI 10.1016/j.cbpa.2005.03.001; Berg T, 2003, ANGEW CHEM INT EDIT, V42, P2462, DOI 10.1002/anie.200200558; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cochran AG, 2001, CURR OPIN CHEM BIOL, V5, P654, DOI 10.1016/S1367-5931(01)00262-9; Cochran AG, 2000, CHEM BIOL, V7, pR85, DOI 10.1016/S1074-5521(00)00106-X; CRIPPSWOLFMAN J, 1989, J BIOL CHEM, V264, P19478; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fischer P M, 2001, Curr Opin Drug Discov Devel, V4, P623; Fischer PM, 2004, CURR MED CHEM, V11, P1563, DOI 10.2174/0929867043365062; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fotedar A, 1996, J BIOL CHEM, V271, P31627, DOI 10.1074/jbc.271.49.31627; Frouin I, 2002, EMBO J, V21, P2485, DOI 10.1093/emboj/21.10.2485; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Gondeau C, 2005, J BIOL CHEM, V280, P13793, DOI 10.1074/jbc.M413690200; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; Humet M, 2003, J COMB CHEM, V5, P597, DOI 10.1021/cc020075u; Huwe A, 2003, ANGEW CHEM INT EDIT, V42, P2122, DOI 10.1002/anie.200200540; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kontopidis G, 2003, STRUCTURE, V11, P1537, DOI 10.1016/j.str.2003.11.006; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Lowe ED, 2002, BIOCHEMISTRY-US, V41, P15625, DOI 10.1021/bi0268910; Luciani MG, 2000, J MOL BIOL, V300, P503, DOI 10.1006/jmbi.2000.3830; McInnes C, 2005, CURR PHARM DESIGN, V11, P1845, DOI 10.2174/1381612053764850; Mendoza N, 2003, CANCER RES, V63, P1020; Montoliu C, 2002, J PHARMACOL EXP THER, V301, P29, DOI 10.1124/jpet.301.1.29; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Planells-Cases R, 2002, J PHARMACOL EXP THER, V302, P163, DOI 10.1124/jpet.302.1.163; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Riera M, 1999, MOL CELL BIOCHEM, V191, P97, DOI 10.1023/A:1006810311743; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Winston N, 2000, DEV BIOL, V223, P139, DOI 10.1006/dbio.2000.9721; Wu SY, 2003, STRUCTURE, V11, P399, DOI 10.1016/S0969-2126(03)00060-1; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Zhang TT, 2001, J BIOL CHEM, V276, P29702, DOI 10.1074/jbc.M011326200; Zheleva DI, 2002, J PEPT RES, V60, P257, DOI 10.1034/j.1399-3011.2002.21014.x	49	46	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35942	35953		10.1074/jbc.M603511200	http://dx.doi.org/10.1074/jbc.M603511200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17001081	hybrid			2022-12-27	WOS:000242100500041
J	Choi, Y; Rajkovic, A				Choi, Youngsok; Rajkovic, Aleksandar			Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; TRANSCRIPTION FACTOR; EARLY FOLLICULOGENESIS; GENE-EXPRESSION; HOMEODOMAIN; PROTEIN; COMPLEX; CELLS; RECOGNITION; FERTILITY	Nobox ( newborn ovary homeobox gene) deficiency disrupts early folliculogenesis and the expression of oocyte-specific genes in mice. Here, we identified several cis-acting sites, TAATTG, TAGTTG, and TAATTA as NOBOX DNA binding elements (NBEs) using a library of randomly generated oligonucleotides by cyclic amplification of sequence target assay and mutation analyses. We show that NOBOX preferentially binds to the NOBOX binding elements with high affinity. In addition, we found that promoter regions of mouse Pou5f1 and Gdf9 contain one (-426) and three NOBOX binding elements (-786, -967, and -1259), respectively. NOBOX binds to these putative NOBOX binding elements with high affinity and augmented transcriptional activity of luciferase reporter driven by mouse Pou5f1 and Gdf9 promoters containing the NOBOX binding elements. In chromatin immunoprecipitation assays, DNA sequences from Pou5f1 and Gdf9 promoters co-precipitated with anti-NOBOX antibody. These results suggest that NOBOX directly regulates the transcription of Pou5f1 and Gdf9 in oocytes during early folliculogenesis.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	Baylor College of Medicine	Rajkovic, A (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, 1709 Dryden St,Suite 1100, Houston, TX 77030 USA.	rajkovic@bcm.edu		Choi, Youngsok/0000-0002-3862-4105	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044858] Funding Source: NIH RePORTER; NICHD NIH HHS [HD44858] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ba-Charvet KTN, 1998, DEVELOPMENT, V125, P4273; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BOTFIELD MC, 1994, BIOCHEMISTRY-US, V33, P6177, DOI 10.1021/bi00186a017; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Choi CY, 1999, J BIOL CHEM, V274, P31543, DOI 10.1074/jbc.274.44.31543; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Dean J, 2002, J REPROD IMMUNOL, V53, P171, DOI 10.1016/S0165-0378(01)00100-0; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Elvin JA, 2000, MOL CELL ENDOCRINOL, V159, P1, DOI 10.1016/S0303-7207(99)00185-9; Elvin JA, 1998, REV REPROD, V3, P183, DOI 10.1530/ror.0.0030183; Epifano O, 2002, TRENDS ENDOCRIN MET, V13, P169, DOI 10.1016/S1043-2760(02)00576-3; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim DW, 2003, J BIOL CHEM, V278, P27532, DOI 10.1074/jbc.M301461200; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Li YH, 1997, DEV BIOL, V188, P85, DOI 10.1006/dbio.1997.8640; Matzuk MM, 2000, MOL CELL ENDOCRINOL, V163, P61, DOI 10.1016/S0303-7207(99)00241-5; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; POMERANTZ JL, 1994, BIOCHEMISTRY-US, V33, P10851, DOI 10.1021/bi00202a001; POMERANTZ JL, 1992, GENE DEV, V6, P2047, DOI 10.1101/gad.6.11.2047; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; RAUSKOLB C, 1993, CELL, V74, P1101, DOI 10.1016/0092-8674(93)90731-5; SPAETE RR, 1985, J VIROL, V56, P135, DOI 10.1128/JVI.56.1.135-143.1985; Steadman DJ, 2000, NUCLEIC ACIDS RES, V28, P2389, DOI 10.1093/nar/28.12.2389; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Vitt UA, 2000, BIOL REPROD, V62, P370, DOI 10.1095/biolreprod62.2.370; Vitt UA, 2001, MOL CELL ENDOCRINOL, V183, P171, DOI 10.1016/S0303-7207(01)00614-1; Yan YT, 2000, MOL CELL BIOL, V20, P661, DOI 10.1128/MCB.20.2.661-671.2000; Yeom YI, 1996, DEVELOPMENT, V122, P881	40	64	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35747	35756		10.1074/jbc.M604008200	http://dx.doi.org/10.1074/jbc.M604008200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16997917	hybrid			2022-12-27	WOS:000242100500020
J	Dempski, RE; Hartung, K; Friedrich, T; Bamberg, E				Dempski, Robert E.; Hartung, Klaus; Friedrich, Thomas; Bamberg, Ernst			Fluorometric measurements of intermolecular distances between the alpha- and beta-subunits of the Na+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-CLAMP FLUOROMETRY; SHAKER K+ CHANNEL; CALCIUM-PUMP; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; XENOPUS OOCYTES; NA/K PUMP; NA,K-ATPASE; FLUORESCENCE; MOVEMENT	The Na+/K+-ATPase maintains the physiological Na+ and K+ gradients across the plasma membrane in most animal cells. The functional unit of the ion pump is comprised of two mandatory subunits including the alpha-subunit, which mediates ATP hydrolysis and ion translocation, as well as the alpha-subunit, which acts as a chaperone to promote proper membrane insertion and trafficking in the plasma membrane. To examine the conformational dynamics between the alpha- and beta-subunits of the Na+/K+-ATPase during ion transport, we have used fluorescence resonance energy transfer, under voltage clamp conditions on Xenopus laevis oocytes, to differentiate between two models that have been proposed for the relative orientation of the alpha- and beta-subunits. These experiments were performed by measuring the time constant of irreversible donor fluorophore destruction with fluorescein-5-maleimide as the donor fluorophore and in the presence or absence of tetramethylrhodamine-6-maleimide as the acceptor fluorophore following labeling on the M3-M4 or M5-M6 loop of the alpha-subunit and the beta-subunit. We have also used fluorescence resonance energy transfer to investigate the relative movement between the two subunits as the ion pump shuttles between the two main conformational states (E-1 and E-2) as described by the Albers-Post scheme. The results from this study have identified a model for the orientation of the beta- subunit in relation to the alpha-subunit and suggest that the alpha- and beta-subunits move toward each other during the E-2 to E-1 conformational transition.	Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Biochem, D-60438 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Chem, D-60438 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Pharmaceut Sci, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Bamberg, E (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany.	ernst.bamberg@mpibp-frankfurt.mpg.de	Friedrich, Thomas/AAA-3418-2022					ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CHEN RF, 1965, SCIENCE, V147, P729, DOI 10.1126/science.147.3659.729; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; Dempski RE, 2005, J GEN PHYSIOL, V125, P505, DOI 10.1085/jgp.200409186; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Geibel S, 2003, P NATL ACAD SCI USA, V100, P964, DOI 10.1073/pnas.0337336100; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Hebert H, 2001, J MOL BIOL, V314, P479, DOI 10.1006/jmbi.2001.5137; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Jorgensen PL, 2001, BBA-BIOENERGETICS, V1505, P57, DOI 10.1016/S0005-2728(00)00277-2; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P395; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; NAKAO M, 1986, NATURE, V323, P628, DOI 10.1038/323628a0; Or E, 1999, J BIOL CHEM, V274, P2802, DOI 10.1074/jbc.274.5.2802; POST RL, 1972, J BIOL CHEM, V247, P6530; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RAKOWSKI RF, 1993, J GEN PHYSIOL, V101, P117, DOI 10.1085/jgp.101.1.117; Rice WJ, 2001, BIOPHYS J, V80, P2187, DOI 10.1016/S0006-3495(01)76191-7; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Therien AG, 2001, J BIOENERG BIOMEMBR, V33, P407, DOI 10.1023/A:1010619623841; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; Zifarelli G, 2003, BIOPHYS J, V84, p268A	39	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36338	36346		10.1074/jbc.M604788200	http://dx.doi.org/10.1074/jbc.M604788200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16980302	hybrid			2022-12-27	WOS:000242100500085
J	De Seranno, S; Benaud, C; Assard, N; Khediri, S; Gerke, V; Baudier, J; Delphin, C				De Seranno, Sandrine; Benaud, Christelle; Assard, Nicole; Khediri, Sami; Gerke, Volker; Baudier, Jacques; Delphin, Christian			Identification of an AHNAK binding motif specific for the Annexin2/S100A10 tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANNEXIN-II; PHOSPHOLIPID-BINDING; ENDOTHELIAL-CELLS; TYROSINE KINASE; CALCIUM-BINDING; FUNCTIONAL EXPRESSION; MEMBRANE DYNAMICS; CHROMAFFIN CELLS; EARLY ENDOSOMES; PROTEIN-KINASE	The Annexin2 tetramer (A2t), which consists of two Annexin2 molecules bound to a S100A10 dimer, is implicated in membrane-trafficking events. Here, we showed using a yeast triple-hybrid experiment and in vitro binding assay that Annexin2 is required for strong binding of S100A10 to the C-terminal domain of the protein Ahnak. We also revealed that this effect involves only the Annexin2 N-terminal tail, which is implicated in S100A10/Annexin2 tetramerization. The minimal A2t binding motif (A2tBP1) in Ahnak was mapped to a 20-amino acid peptide, and this peptide is highly specific for A2t. We also identified a second A2t binding motif (A2tBP2) present in the N-terminal domain of Ahnak, which binds to A2t, albeit with less affinity. When overexpressed as an EGFP fusion protein in MDCK cells, A2tBPs cofractionate in a calcium-dependent manner and co-immunoprecipitate with S100A10 and Annexin2. In living cells, A2tBPs target EGFP to the cytoplasm as does Annexin2. In response to oxidative and mechanical stress, EGFP-A2tBPs relocalize within minutes to the plasma membrane; a behavior shared with Annexin2-GFP. These results suggest that the A2t complex exists within the cytoplasm of resting living cells and that its localization at the plasma membrane relies on cellular signaling. Together, our data demonstrate that A2tBP1 is a specific A2t complex binding domain and may be a powerful tool to help elucidate A2t structure and cellular functions.	CEA, INSERM EMI 0104, TS DRDC, F-38054 Grenoble 9, France; Univ Grenoble 1, F-38041 Grenoble, France; Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, D-48149 Munster, Germany	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Munster	Baudier, J (corresponding author), CEA, INSERM EMI 0104, TS DRDC, 17 Rue Martyrs, F-38054 Grenoble 9, France.	jbaudier@cea.fr	Baudier, Jacques/O-2183-2016; jacques, baudier/T-3300-2019; Benaud, Christelle/M-1178-2018; Christian, Delphin/P-9284-2017	Christian, Delphin/0000-0003-3240-8695; jacques, baudier/0000-0001-8427-4444				ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; BECKER T, 1990, EMBO J, V9, P4207, DOI 10.1002/j.1460-2075.1990.tb07868.x; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Burlando B, 2005, CELL CALCIUM, V38, P507, DOI 10.1016/j.ceca.2005.07.004; ChasserotGolaz S, 1996, J CELL BIOL, V133, P1217, DOI 10.1083/jcb.133.6.1217; Deloulme JC, 2000, J BIOL CHEM, V275, P35302, DOI 10.1074/jbc.M003943200; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Diakonova M, 1997, J CELL SCI, V110, P1199; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Eberhard DA, 2001, J CELL SCI, V114, P3155; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 1997, BBA-MOL CELL RES, V1357, P129, DOI 10.1016/S0167-4889(97)00038-4; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GERKE V, 1985, J BIOL CHEM, V260, P1688; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; GLENNEY J, 1986, J BIOL CHEM, V261, P7247; GLENNEY JR, 1987, J CELL BIOL, V104, P503, DOI 10.1083/jcb.104.3.503; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hinman LE, 1997, AM J PHYSIOL-LUNG C, V273, pL1242, DOI 10.1152/ajplung.1997.273.6.L1242; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Jones AT, 1998, J BIOL CHEM, V273, P25301, DOI 10.1074/jbc.273.39.25301; JONES PG, 1992, J BIOL CHEM, V267, P13993; Jost M, 1997, J CELL SCI, V110, P221; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Liu L, 1997, CELL SIGNAL, V9, P299, DOI 10.1016/S0898-6568(97)89891-9; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Nilius B, 1996, J BIOL CHEM, V271, P30631, DOI 10.1074/jbc.271.48.30631; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Poon WYL, 2004, FEBS LETT, V558, P114, DOI 10.1016/S0014-5793(03)01512-6; POWELL MA, 1987, BIOCHEM J, V247, P321, DOI 10.1042/bj2470321; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Ryzhova EV, 2006, J VIROL, V80, P2694, DOI 10.1128/JVI.80.6.2694-2704.2006; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Spiteller G, 2006, FREE RADICAL BIO MED, V41, P362, DOI 10.1016/j.freeradbiomed.2006.03.013; SWAIRJO MA, 1994, ANNU REV BIOPH BIOM, V23, P193, DOI 10.1146/annurev.bb.23.060194.001205; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Zobiack N, 2001, FEBS LETT, V500, P137, DOI 10.1016/S0014-5793(01)02604-7	48	31	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35030	35038		10.1074/jbc.M606545200	http://dx.doi.org/10.1074/jbc.M606545200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16984913	hybrid			2022-12-27	WOS:000241933700036
J	Fikaris, AJ; Lewis, AE; Abulaiti, A; Tsygankova, OM; Meinkoth, JL				Fikaris, Aphrothiti J.; Lewis, Aurelia E.; Abulaiti, Adili; Tsygankova, Oxana M.; Meinkoth, Judy L.			Ras triggers ataxia-telangiectasia-mutated and Rad-3-related activation and apoptosis through sustained mitogenic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; CELL-CYCLE; DNA-DAMAGE; ONCOGENIC RAS; THYROID-CELLS; MEDIATES APOPTOSIS; EPITHELIAL-CELLS; POINT MUTATIONS; PROTEIN-KINASES; CANCER CELLS	Genetic evidence indicates that Ras plays a critical role in the initiation and progression of human thyroid tumors. Paradoxically, acute expression of activated Ras in normal rat thyroid cells induced deregulated cell cycle progression and apoptosis. We investigated whether cell cycle progression was required for Ras-stimulated apoptosis. Ras increased CDK-2 activity following its introduction into quiescent cells. Apoptotic cells exhibited a sustained increase in CDK-2 activity, accompanied by the loss of CDK-2-associated p27. Blockade of Ras-induced CDK-2 activity and S phase entry via overexpression of p27 inhibited apoptosis. Inactivation of the retinoblastoma protein in quiescent cells through expression of HPV-E7 stimulated cell cycle progression and apoptosis, indicating that deregulated cell cycle progression is sufficient to induce apoptosis. Ras failed to induce G(1) phase growth arrest in normal rat thyroid cells. Rather, Ras-expressing thyroid cells progressed into S and G(2) phases and evoked a checkpoint response characterized by the activation of ATR. Ras-stimulated ATR activity, as evidenced by Chk1 and p53 phosphorylation, was blocked by p27, suggesting that cell cycle progression triggers checkpoint activation, likely as a consequence of replication stress. These data reveal that Ras is capable of inducing a DNA damage response with characteristics similar to those reported in precancerous lesions. Our findings also suggest that the frequent mutational activation of Ras in thyroid tumors reflects the ability of Ras-expressing cells to bypass checkpoints and evade apoptosis rather than to simply increase proliferative potential.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Meinkoth, JL (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 421 Curie Blvd,1251 BRB 2-3, Philadelphia, PA 19104 USA.	meinkoth@pharm.med.upenn.edu	Meinkoth, Judy L/G-2900-2010; Lewis, Aurelia E./F-1589-2013	Lewis, Aurelia E./0000-0002-3613-5770	NIDDK NIH HHS [DK55757] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055757] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BOND JA, 1994, ONCOGENE, V9, P281; Brown EJ, 2000, GENE DEV, V14, P397; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Cheng GJ, 2003, MOL ENDOCRINOL, V17, P450, DOI 10.1210/me.2002-0344; Cheng GJ, 2001, ONCOGENE, V20, P7334, DOI 10.1038/sj.onc.1204928; Chou CK, 2006, LIFE SCI, V78, P1823, DOI 10.1016/j.lfs.2005.08.039; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fagin JA, 2002, MOL ENDOCRINOL, V16, P903, DOI 10.1210/me.16.5.903; Fikaris AJ, 2005, J BIOL CHEM, V280, P32107, DOI 10.1074/jbc.M504432200; Finkielstein CV, 2002, J BIOL CHEM, V277, P38476, DOI 10.1074/jbc.M206184200; Garcia-Rostan G, 2003, J CLIN ONCOL, V21, P3226, DOI 10.1200/JCO.2003.10.130; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Gil-Gomez G, 1998, EMBO J, V17, P7209, DOI 10.1093/emboj/17.24.7209; Gimm O, 2001, CANCER LETT, V163, P143, DOI 10.1016/S0304-3835(00)00697-2; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hahn WC, 2004, CANCER CELL, V6, P215, DOI 10.1016/j.ccr.2004.09.007; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jackson JR, 2000, CANCER RES, V60, P566; Jones CJ, 2000, MOL CELL BIOL, V20, P5690, DOI 10.1128/MCB.20.15.5690-5699.2000; Jones DL, 1996, SEMIN CANCER BIOL, V7, P327, DOI 10.1006/scbi.1996.0042; Joneson T, 1999, MOL CELL BIOL, V19, P5892; KARGA H, 1991, J CLIN ENDOCR METAB, V73, P832, DOI 10.1210/jcem-73-4-832; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Kohn EA, 2003, CANCER RES, V63, P31; Kupperman E, 1996, ENDOCRINOLOGY, V137, P96, DOI 10.1210/en.137.1.96; LEMOINE NR, 1989, ONCOGENE, V4, P159; LEMOINE NR, 1988, CANCER RES, V48, P4459; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Lewis AE, 2004, MOL ENDOCRINOL, V18, P2321, DOI 10.1210/me.2004-0104; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; Meinkoth JL, 2004, CANC TREAT, V122, P131; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; NAMBA H, 1990, MOL ENDOCRINOL, V4, P1474, DOI 10.1210/mend-4-10-1474; NAMBA H, 1990, J CLIN ENDOCR METAB, V71, P223, DOI 10.1210/jcem-71-1-223; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Rudolph B, 1996, EMBO J, V15, P3065, DOI 10.1002/j.1460-2075.1996.tb00669.x; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shi LF, 1996, J IMMUNOL, V157, P2381; Shirokawa JM, 2000, MOL ENDOCRINOL, V14, P1725, DOI 10.1210/me.14.11.1725; Stack JH, 1997, DEVELOPMENT, V124, P3185; Stanelle J, 2006, TRENDS MOL MED, V12, P177, DOI 10.1016/j.molmed.2006.02.002; SUAREZ HG, 1990, ONCOGENE, V5, P565; Tanaka Y, 2002, J BIOL CHEM, V277, P21446, DOI 10.1074/jbc.M202238200; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vasko V, 2003, J CLIN ENDOCR METAB, V88, P2745, DOI 10.1210/jc.2002-021186; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785	74	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34759	34767		10.1074/jbc.M606737200	http://dx.doi.org/10.1074/jbc.M606737200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16968694	hybrid			2022-12-27	WOS:000241933700007
J	Havemeyer, A; Bittner, F; Wollers, S; Mendel, R; Kunze, T; Clement, B				Havemeyer, Antje; Bittner, Florian; Wollers, Silke; Mendel, Ralf; Kunze, Thomas; Clement, Bernd			Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRATE REDUCTASE; RAT-LIVER; OUTER-MEMBRANE; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; ALDEHYDE OXIDASE; XANTHINE-OXIDASE; CYTOCHROME B(5); PIG-LIVER; COFACTOR	Amidoximes can be used as prodrugs for amidines and related functional groups to enhance their intestinal absorption. These prodrugs are reduced to their active amidines. Other N-hydroxylated structures are mutagenic or responsible for toxic effects of drugs and are detoxified by reduction. In this study, a N-reductive enzyme system of pig liver mitochondria using benzamidoxime as a model substrate was identified. A protein fraction free from cytochrome b(5) and cytochrome b(5) reductase was purified, enhancing 250-fold the minor benzamidoxime-reductase activity catalyzed by the membrane-bound cytochrome b(5)/NADH cytochrome b(5) reductase system. This fraction contained a 35-kDa protein with homologies to the C-terminal domain of the human molybdenum cofactor sulfurase. Here it was demonstrated that this 35-kDa protein contains molybdenum cofactor and forms the hitherto ill defined third component of the N-reductive complex in the outer mitochondrial membrane. Thus, the 35-kDa protein represents a novel group of molybdenum proteins in eukaryotes as it forms the catalytic part of a three-component enzyme complex consisting of separate proteins. Supporting these findings, recombinant C-terminal domain of the human molybdenum cofactor sulfurase exhibited N-reductive activity in vitro, which was strictly dependent on molybdenum cofactor.	Univ Kiel, Dept Pharmaceut & Med Chem, Inst Pharmaceut, D-24118 Kiel, Germany; Tech Univ Braunschweig, Dept Plant Biol, D-38023 Braunschweig, Germany	University of Kiel; Braunschweig University of Technology	Clement, B (corresponding author), Univ Kiel, Dept Pharmaceut & Med Chem, Inst Pharmaceut, Gutenbergstr 76, D-24118 Kiel, Germany.	bclement@pharmazie.uni-kiel.de						Altuve A, 2001, BIOCHEMISTRY-US, V40, P9469, DOI 10.1021/bi010636i; Andersson S, 2005, DRUG METAB DISPOS, V33, P570, DOI 10.1124/dmd.104.002972; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; Clement B, 1997, J BIOL CHEM, V272, P19615, DOI 10.1074/jbc.272.31.19615; CLEMENT B, 1988, ARCH PHARM, V321, P955, DOI 10.1002/ardp.19883211228; Clement B, 2005, DRUG METAB DISPOS, V33, P1740, DOI 10.1124/dmd.105.005249; CLEMENT B, 1992, BIOCHEM PHARMACOL, V44, P1501, DOI 10.1016/0006-2952(92)90464-T; Clement B, 2005, LIFE SCI, V77, P205, DOI 10.1016/j.lfs.2004.12.028; Clement B, 2002, DRUG METAB REV, V34, P565, DOI 10.1081/DMR-120005643; Clement B, 2003, DRUG METAB DISPOS, V31, P645, DOI 10.1124/dmd.31.5.645; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Estabrook R W, 1978, Methods Enzymol, V52, P212; Ettmayer P, 2004, J MED CHEM, V47, P2393, DOI 10.1021/jm0303812; Frohlich AK, 2005, XENOBIOTICA, V35, P17, DOI 10.1080/00498250400021895; FUKUSHIMA H, 1981, J BIOL CHEM, V256, P4822; GONENNE A, 1978, ANAL BIOCHEM, V87, P28, DOI 10.1016/0003-2697(78)90565-1; HAUPTMANN J, 1988, PHARMAZIE, V43, P559; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; JOHNSON JL, 1977, J BIOL CHEM, V252, P4994; KADLUBAR FF, 1974, ARCH BIOCHEM BIOPHYS, V162, P83, DOI 10.1016/0003-9861(74)90107-6; Kroneck PMH, 2002, MET IONS BIOL SYST, V39, P369; Kruger P., 1885, BER DTSCH CHEM GES, V18, P1055; Kurian JR, 2004, J PHARMACOL EXP THER, V311, P1171, DOI 10.1124/jpet.104.072389; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mihara K, 1978, Methods Enzymol, V52, P102; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; RAMADOSS CS, 1980, Z NATURFORSCH C, V35, P702; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; TATSUMI K, 1987, ARCH BIOCHEM BIOPHYS, V253, P413, DOI 10.1016/0003-9861(87)90194-9; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337	40	129	140	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34796	34802		10.1074/jbc.M607697200	http://dx.doi.org/10.1074/jbc.M607697200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16973608	hybrid			2022-12-27	WOS:000241933700011
J	Lin, Q; Yang, WN; Baird, D; Feng, QY; Cerione, RA				Lin, Qiong; Yang, Wannian; Baird, Daniel; Feng, Qiyu; Cerione, Richard A.			Identification of a DOCK180-related guanine nucleotide exchange factor that is capable of mediating a positive feedback activation of Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; SMALL GTPASE CDC42; TYROSINE KINASE; P21-ACTIVATED KINASES; ACTIN POLYMERIZATION; BINDING PROTEIN; CELL-MIGRATION; DBL FAMILY; RHO; RAC1	Cdc42, a member of the Rho subfamily of small GTPases, influences a wide range of activities including the establishment of cell polarity, migration, and the regulation of cell growth and differentiation. Here we describe the identification of an similar to 220kDa protein that formed a stable complex with activated forms of Cdc42 and thereby showed characteristics of a downstream target/effector for this GTPase. However, molecular cloning of the cDNA encoding this protein (p220) revealed that it was highly related to Zizimin-1 and identical in sequence to a gene product in the data base designated DOCK11, which are members of the DOCK180 family of guanine nucleotide exchange factors (GEFs) for Cdc42 and Rac. Biochemical characterization shows that p220 is a specific GEF for Cdc42, with the GEF activity originating from its DHR2 (for DOCK homology region 2) domain. Nucleotide-depleted Cdc42 forms a stable complex with the DHR2 domain, whereas the binding of activated Cdc42 requires both the DHR2 domain and residues 66-126 within the amino-terminal portion of p220. Moreover, the full-length protein shows markedly higher GEF activity than the isolated DHR2 domain, whereas removal of the amino-terminal 126 amino acids necessary for binding-activated Cdc42 dramatically diminishes the activity. These and other results point to activated Cdc42 providing a positive feedback regulation of the GEF activity of p220. Thus, we refer to p220/DOCK11 as activated Cdc42-associated GEF, befitting its functional activity.	Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA; Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Yang, Wannian/K-4836-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Driggers PH, 2001, J BIOL CHEM, V276, P46792, DOI 10.1074/jbc.M106927200; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Puls A, 1999, J CELL SCI, V112, P2983; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Wang JB, 2005, J BIOL CHEM, V280, P22883, DOI 10.1074/jbc.M414375200; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819	43	42	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35253	35262		10.1074/jbc.M606248200	http://dx.doi.org/10.1074/jbc.M606248200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16968698	hybrid			2022-12-27	WOS:000241933700059
J	McNeil, AK; Rescher, U; Gerke, V; McNeil, PL				McNeil, Anna K.; Rescher, Ursula; Gerke, Volker; McNeil, Paul L.			Requirement for annexin A1 in plasma membrane repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCULAR-DYSTROPHY; CUT END; FUSION; EXOCYTOSIS; DYSFERLIN; SITES; MACROMOLECULES; AGGREGATION; DISRUPTIONS; MECHANISM	Ca2+ entering a cell through a torn or disrupted plasma membrane rapidly triggers a combination of homotypic and exocytotic membrane fusion events. These events serve to erect a reparative membrane patch and then anneal it to the defect site. Annexin A1 is a cytosolic protein that, when activated by micromolar Ca2+, binds to membrane phospholipids, promoting membrane aggregation and fusion. We demonstrate here that an annexin A1 function-blocking antibody, a small peptide competitor, and a dominant-negative annexin A1 mutant protein incapable of Ca2+ binding all inhibit resealing. Moreover, we show that, coincident with a resealing event, annexin A1 becomes concentrated at disruption sites. We propose that Ca2+ entering through a disruption locally induces annexin A1 binding to membranes, initiating emergency fusion events whenever and wherever required.	Med Coll Georgia, Dept Cellular Biol & Anat, Inst Mol Med & Genet, Augusta, GA 30912 USA; Univ Munster, Inst Med Biochem, Ctr Mol Biol & Inflammat, D-48149 Munster, Germany	University System of Georgia; Augusta University; University of Munster	McNeil, PL (corresponding author), Med Coll Georgia, Dept Cellular Biol & Anat, Inst Mol Med & Genet, 1120 15th St, Augusta, GA 30912 USA.	pmcneil@mail.mcg.edu						Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; CAGLIANI R, HUM MUTAT, V26, P283; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; FRANCIS JW, 1992, J CLIN INVEST, V90, P537, DOI 10.1172/JCI115892; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; MAYORGA LS, 1993, P NATL ACAD SCI USA, V90, P10255, DOI 10.1073/pnas.90.21.10255; McNeil PL, 2000, J CELL SCI, V113, P1891; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; MEERS P, 1992, BIOCHEMISTRY-US, V31, P6372, DOI 10.1021/bi00143a003; MEERS P, 1993, BIOCHIM BIOPHYS ACTA, V1147, P177, DOI 10.1016/0005-2736(93)90002-H; Miyake K, 2001, J CELL SCI, V114, P3487; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; OSHRY L, 1991, BIOCHIM BIOPHYS ACTA, V1066, P239, DOI 10.1016/0005-2736(91)90192-B; OSHRY L, 1991, T ASSOC AM PHYSICIAN, V104, P213; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Probst-Cousin S, 2004, MUSCLE NERVE, V30, P102, DOI 10.1002/mus.20077; Rescher U, 2000, J CELL SCI, V113, P3931; Seemann J, 1996, BIOCHEM J, V319, P123, DOI 10.1042/bj3190123; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; SWANSON JA, 1987, SCIENCE, V238, P548, DOI 10.1126/science.2443981; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; WANG W, 1994, BIOCHEMISTRY-US, V33, P275, DOI 10.1021/bi00167a036; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; YAWO H, 1983, SCIENCE, V222, P1351, DOI 10.1126/science.6658457; YAWO H, 1985, J NEUROSCI, V5, P1626	33	175	181	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35202	35207		10.1074/jbc.M606406200	http://dx.doi.org/10.1074/jbc.M606406200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16984915	hybrid			2022-12-27	WOS:000241933700053
J	Motohashi, K; Hisabori, T				Motohashi, Ken; Hisabori, Toru			HCF164 receives reducing equivalents from stromal thioredoxin across the thylakoid membrane and mediates reduction of target proteins in the thylakoid lumen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-DISULFIDE OXIDOREDUCTASES; CYTOCHROME B(6)F COMPLEX; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; PHOTOSYSTEM-I; CHLOROPLAST THIOREDOXINS; PLASTIDIAL THIOREDOXINS; FUNDAMENTAL PROCESSES; ELECTRON-TRANSFER; REDOX REGULATION	HCF164 is a membrane-anchored thioredoxin-like protein known to be indispensable for assembly of cytochrome b(6)f in the thylakoid membranes. In this study, we report the finding that chloroplast stroma m-type thioredoxin is the source of reducing equivalents for reduction of HCF164 in the thylakoid lumen, providing strong evidence that higher plant chloroplasts possess a trans-membrane reducing equivalent transfer system similar to that found in bacteria. To probe the function of HCF164 in the lumen, a screen to identify the reducing equivalent acceptor proteins of HCF164 was carried out by using a resin-immobilized HCF164 single cysteine mutant, leading to the isolation of putative target thylakoid proteins. Among the newly identified target proteins, the reduction of the PSI-N subunit of photosystem I by HCF164 was confirmed both in vitro and in isolated thylakoids. Two components of the cytochrome b(6)f complex, the cytochrome f and Rieske FeS proteins, were also identified as novel potential target proteins. The data presented here suggest that HCF164 serves as an important transducer of reducing equivalents to proteins in the thylakoid lumen.	JST, ERATO, ATP Syst Project, Midori Ku, Yokohama, Kanagawa 2260026, Japan; Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Hisabori, T (corresponding author), JST, ERATO, ATP Syst Project, Midori Ku, Nagatsuta 5800-3, Yokohama, Kanagawa 2260026, Japan.	thisabor@res.titech.ac.jp	Motohashi, Ken/I-4970-2019; Hisabori, Toru/E-5205-2014	Motohashi, Ken/0000-0002-8414-2836; Hisabori, Toru/0000-0003-2046-0277				Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Broin M, 2002, PLANT CELL, V14, P1417, DOI 10.1105/tpc.001644; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; BUCHANAN BB, 1991, ARCH BIOCHEM BIOPHYS, V288, P1, DOI 10.1016/0003-9861(91)90157-E; Casazza AP, 2001, PHOTOSYNTH RES, V68, P175, DOI 10.1023/A:1011818021875; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Dai SD, 2000, SCIENCE, V287, P655, DOI 10.1126/science.287.5453.655; Dai SD, 2004, PHOTOSYNTH RES, V79, P233, DOI 10.1023/B:PRES.0000017194.34167.6d; Drepper F, 1996, BIOCHEMISTRY-US, V35, P1282, DOI 10.1021/bi951471e; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; GOLBECK JH, 1979, BIOCHIM BIOPHYS ACTA, V547, P347, DOI 10.1016/0005-2728(79)90016-1; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; Hisabori T, 2005, J EXP BOT, V56, P1463, DOI 10.1093/jxb/eri170; HISABORI T, IN PRESS PHOTOCHEM P; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hosoya-Matsuda N, 2005, J BIOL CHEM, V280, P840, DOI 10.1074/jbc.M411493200; Hsu MF, 2005, BIOCHEM PHARMACOL, V70, P1320, DOI 10.1016/j.bcp.2005.07.029; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; Issakidis-Bourguet E, 2001, PLANT J, V25, P127, DOI 10.1046/j.0960-7412.2000.00943.x; Jacquot JP, 1997, NEW PHYTOL, V136, P543, DOI 10.1046/j.1469-8137.1997.00784.x; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Katzen F, 2002, EMBO J, V21, P3960, DOI 10.1093/emboj/cdf405; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kieselbach T, 1998, J BIOL CHEM, V273, P6710, DOI 10.1074/jbc.273.12.6710; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Krupp R, 2001, J BIOL CHEM, V276, P3696, DOI 10.1074/jbc.M009500200; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Lennartz K, 2001, PLANT CELL, V13, P2539, DOI 10.1105/tpc.13.11.2539; Meurer J, 1996, PLANTA, V198, P385, DOI 10.1007/BF00620055; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Mullineaux PM, 2005, PHOTOSYNTH RES, V86, P459, DOI 10.1007/s11120-005-8811-8; Nakamoto SS, 2000, BIOCHIMIE, V82, P603, DOI 10.1016/S0300-9084(00)00605-2; NIELSEN VS, 1994, J BIOL CHEM, V269, P3762; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; OKAYAMA S, 1976, BIOCHIM BIOPHYS ACTA, V440, P331, DOI 10.1016/0005-2728(76)90067-0; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Ortenberg R, 2003, ANTIOXID REDOX SIGN, V5, P403, DOI 10.1089/152308603768295140; Page MLD, 2004, J BIOL CHEM, V279, P32474, DOI 10.1074/jbc.M404285200; Rey P, 2005, PLANT J, V41, P31, DOI 10.1111/j.1365-313X.2004.02271.x; ROST N, 1964, NATURE, V201, P185; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schurmann P, 2000, ANNU REV PLANT PHYS, V51, P371, DOI 10.1146/annurev.arplant.51.1.371; SINGH R, 1995, METHOD ENZYMOL, V251, P167, DOI 10.1016/0076-6879(95)51119-9; Stumpp MT, 1999, BIOCHEM J, V341, P157, DOI 10.1042/0264-6021:3410157; Wong JH, 2004, PHYTOCHEMISTRY, V65, P1629, DOI 10.1016/j.phytochem.2004.05.010; Yamazaki D, 2004, PLANT CELL PHYSIOL, V45, P18, DOI 10.1093/pcp/pch019; Yano H, 2001, P NATL ACAD SCI USA, V98, P4794, DOI 10.1073/pnas.071041998	60	118	124	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35039	35047		10.1074/jbc.M605938200	http://dx.doi.org/10.1074/jbc.M605938200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16997915	hybrid			2022-12-27	WOS:000241933700037
J	Saa, P; Castilla, J; Soto, C				Saa, Paula; Castilla, Joaquin; Soto, Claudio			Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRESYMPTOMATIC DETECTION; SCRAPIE; CONVERSION; VARIANT; MOLECULES; DIAGNOSIS; STRAINS	Prions are the unconventional infectious agents responsible for transmissible spongiform encephalopathies, which appear to be composed mainly or exclusively of the misfolded prion protein (PrPSc). Prion replication involves the conversion of the normal prion protein (PrPC) into the misfolded isoform, catalyzed by tiny quantities of PrPSc present in the infectious material. We have recently developed the protein misfolding cyclic amplification (PMCA) technology to sustain the autocatalytic replication of infectious prions in vitro. Here we show that PMCA enables the specific and reproducible amplification of exceptionally minute quantities of PrPSc. Indeed, after seven rounds of PMCA, we were able to generate large amounts of PrPSc starting from a 1 x 10(-12) dilution of scrapie hamster brain, which contains the equivalent of similar to 26 molecules of protein monomers. According to recent data, this quantity is similar to the minimum number of molecules present in a single particle of infectious PrPSc, indicating that PMCA may enable detection of as little as one oligomeric PrPSc infectious particle. Interestingly, the in vitro generated PrPSc was infectious when injected in wild-type hamsters, producing a disease identical to the one generated by inoculation of the brain infectious material. The unprecedented amplification efficiency of PMCA leads to a several billion-fold increase of sensitivity for PrPSc detection as compared with standard tests used to screen prion-infected cattle and at least 4000 times more sensitivity than the animal bioassay. Therefore, PMCA offers great promise for the development of highly sensitive, specific, and early diagnosis of transmissible spongiform encephalopathy and to further understand the molecular basis of prion propagation.	Univ Texas, Med Branch, Dept Neurol, George & Cynthia Mitchell Ctr Alzheimer Dis & Rel, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Cell Biol & Neurosci, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Autonomous University of Madrid	Soto, C (corresponding author), Univ Texas, Med Branch, Dept Neurol, George & Cynthia Mitchell Ctr Alzheimer Dis & Rel, 301 Univ Blvd, Galveston, TX 77555 USA.	clsoto@utmb.edu	Saa, Paula/AAB-6607-2019; Castilla, Joaquin/D-5261-2011; Castilla, Joaquín/J-8414-2019	Saa, Paula/0000-0001-6077-4532; Castilla, Joaquin/0000-0002-2216-1361; Castilla, Joaquín/0000-0002-2216-1361	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG002246] Funding Source: NIH RePORTER; NIA NIH HHS [AG0224642] Funding Source: Medline; NINDS NIH HHS [NS049173] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALDWIN MA, 1995, J BIOL CHEM, V270, P19197, DOI 10.1074/jbc.270.33.19197; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; CASTILLA J, 2004, METHODS TOOLS BIOSCI, P198; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; FIELD EJ, 1972, NATURE, V240, P104, DOI 10.1038/240104a0; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Grassi J, 2000, Arch Virol Suppl, P197; Ingrosso L, 2002, TRENDS MOL MED, V8, P273, DOI 10.1016/S1471-4914(02)02358-4; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Moynagh J, 1999, NATURE, V400, P105, DOI 10.1038/21981; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Oesch B, 2000, Arch Virol Suppl, P189; Orem NR, 2006, J NEUROCHEM, V96, P1409, DOI 10.1111/j.1471-4159.2006.03650.x; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; ROOS R, 1973, BRAIN, V96, P1; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2004, NAT REV MICROBIOL, V2, P809, DOI 10.1038/nrmicro1003; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	39	234	239	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35245	35252		10.1074/jbc.M603964200	http://dx.doi.org/10.1074/jbc.M603964200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16982620	hybrid			2022-12-27	WOS:000241933700058
J	Vigneron, A; Cherier, J; Barre, B; Gamelin, E; Coqueret, O				Vigneron, Arnaud; Cherier, Julia; Barre, Benjamin; Gamelin, Erick; Coqueret, Olivier			The cell cycle inhibitor p21(waf1) binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; DEPENDENT KINASES; S PHASE; TARGET; P21; P53; ASSOCIATION; PROTEINS; ARREST; REPLICATION	In addition to its function as a cyclin-dependent kinase (cdk) inhibitor, p21(waf1) fulfills additional roles involved in DNA replication and transcriptional regulation that could also contribute to cell cycle arrest. In this study, we have shown that p21(waf1) functions as a transcriptional repressor of the myc and cdc25A genes. Ectopic expression of the cell cycle inhibitor down-modulates myc and cdc25A transcription but has no effect on cdk4 levels. Using chromatin immunoprecipitation, we found that p21(waf1) is recruited to the promoters of these two genes together with the STAT3 and E2F1 transcription factors. Its presence on DNA is associated with an inhibition of the recruitment of the p300 histone acetylase and with a down-regulation of histone H4 acetylation. The same effect was also observed following DNA damage because topoisomerase inhibitors such as sn38 or doxorubicin also induce the association of p21(waf1) with DNA. Following transcriptional repression of the myc and cdc25A genes, cells were arrested in the fraction with 4 N DNA content. By contrast, the expression of these two genes remains elevated in the absence of the cell cycle inhibitor, and p21(waf1-/-) cells re-replicate their DNA and become polyploid. In light of these results, we propose that p21(waf1) simultaneously targets cdk and transcriptional regulators to prevent the expression of oncogenic pathways upon DNA damage.	Canc Ctr Paul Papin, INSERM U564, F-49033 Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Coqueret, O (corresponding author), Ctr Reg Lutte Contre Canc Paul Papin, INSERM U564, 2 Rue Moll, F-49033 Angers, France.	olivier.coqueret@univ-angers.fr	Vigneron, Arnaud/ABC-7306-2021; Coqueret, Olivier/K-9660-2015	Vigneron, Arnaud/0000-0003-4161-0676; Coqueret, Olivier/0000-0002-2843-7867				Andreassen PR, 2001, CANCER RES, V61, P7660; Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Barre B, 2003, J BIOL CHEM, V278, P2990, DOI 10.1074/jbc.M210422200; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Gregory DJ, 2002, CELL CYCLE, V1, P343, DOI 10.4161/cc.1.5.153; HARPER JW, 1993, CELL, V75, P805; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; LUCIBELLO FC, 1995, EMBO J, V14, P132, DOI 10.1002/j.1460-2075.1995.tb06983.x; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Le H, 2005, J BIOL CHEM, V280, P32018, DOI 10.1074/jbc.M504689200; Vigo E, 1999, MOL CELL BIOL, V19, P6379; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Zhu HM, 2002, CELL CYCLE, V1, P59, DOI 10.4161/cc.1.1.101	42	61	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34742	34750		10.1074/jbc.M602492200	http://dx.doi.org/10.1074/jbc.M602492200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16923815	hybrid			2022-12-27	WOS:000241933700005
J	Pasquet, S; Naye, F; Faucheux, C; Bronchain, O; Chesneau, A; Thiebaud, P; Theze, N				Pasquet, Stephanie; Naye, Francois; Faucheux, Corinne; Bronchain, Odile; Chesneau, Albert; Thiebaud, Pierre; Theze, Nadine			Transcription enhancer factor-1-dependent expression of the alpha-tropomyosin gene in the three muscle cell types	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; SERUM RESPONSE FACTOR; CAT BINDING-FACTOR; TROPONIN-T-GENE; IN-VIVO REGULATION; PROTEIN-KINASE-C; SMOOTH-MUSCLE; XENOPUS-LAEVIS; CARDIAC MYOCYTES; DNA-BINDING	In vertebrates, the actin-binding proteins tropomyosins are encoded by four distinct genes that are expressed in a complex pattern during development and muscle differentiation. In this study, we have characterized the transcriptional machinery of the alpha-tropomyosin (alpha-Tm) gene in muscle cells. Promoter analysis revealed that a 284-bp proximal promoter region of the Xenopus laevis alpha-Tm gene is sufficient for maximal activity in the three muscle cell types. The transcriptional activity of this promoter in the three muscle cell types depends on both distinct and common cis-regulatorysequences. We have identified a30-bp conserved sequence unique to all vertebrate alpha-Tm genes that contains anMCATsite that is critical for expression of the gene in all muscle cell types. This site can bind transcription enhancer factor-1 (TEF-1) present in muscle cells both in vitro and in vivo. In serum-deprived differentiated smooth muscle cells, TEF-1 was redistributed to the nucleus, and this correlated with increased activity of the alpha-Tm promoter. Overexpression of TEF-1 mRNA in Xenopus embryonic cells led to activation of both the endogenous alpha-Tm gene and the exogenous 284-bp promoter. Finally, we show that, in transgenic embryos and juveniles, an intact MCAT sequence is required for correct temporal and spatial expression of the 284-bp gene promoter. This study represents the first analysis of the transcriptional regulation of the alpha-Tm gene in vivo and highlights a common TEF-1-dependent regulatory mechanism necessary for expression of the gene in the three muscle lineages.	INSERM, Unite 441, F-33600 Pessac, France; Univ Bordeaux 2, Unite Mixte Rech 5164, CNRS, F-33076 Bordeaux, France; Univ Paris 11, CNRS, Unite Mixte Rech 8080, F-91405 Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Thiebaud, P (corresponding author), INSERM, Unite 441, Ave Haut Leveque, F-33600 Pessac, France.	nadine.theze@bordeaux.inserm.fr; nadine.theze@bordeaux.inserm.fr		Bronchain, Odile/0000-0001-8932-8907; THIEBAUD, Pierre/0000-0003-1174-1616				Anderson JP, 2004, MOL CELL BIOL, V24, P3757, DOI 10.1128/MCB.24.9.3757-3768.2004; Arnone MI, 1997, DEVELOPMENT, V124, P1851; Azakie A, 2005, AM J PHYSIOL-CELL PH, V289, pC1522, DOI 10.1152/ajpcell.00126.2005; Azakie A, 1996, J BIOL CHEM, V271, P8260, DOI 10.1074/jbc.271.14.8260; BERBERICH C, 1993, EUR J BIOCHEM, V216, P395, DOI 10.1111/j.1432-1033.1993.tb18157.x; Blanchard EM, 1997, CIRC RES, V81, P1005; Bronchain OJ, 1999, CURR BIOL, V9, P1195, DOI 10.1016/S0960-9822(00)80025-1; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Camoretti-Mercado B, 2000, J BIOL CHEM, V275, P30387, DOI 10.1074/jbc.M000840200; Carlini LE, 2002, J BIOL CHEM, V277, P8682, DOI 10.1074/jbc.M109754200; CATALA F, 1995, MOL CELL BIOL, V15, P4585; Chen HH, 2004, J BIOL CHEM, V279, P30800, DOI 10.1074/jbc.M400154200; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; Firulli AB, 1997, TRENDS GENET, V13, P364, DOI 10.1016/S0168-9525(97)01171-2; FLINK IL, 1992, J BIOL CHEM, V267, P9917; Gaillard C, 1999, INT J DEV BIOL, V43, P175; Gaillard C, 1998, DEV GENES EVOL, V207, P435, DOI 10.1007/s004270050134; Gaillard C, 1998, GENE, V207, P235, DOI 10.1016/S0378-1119(97)00634-3; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Gupta M, 2001, J BIOL CHEM, V276, P10413, DOI 10.1074/jbc.M008625200; Gupta MP, 1997, MOL CELL BIOL, V17, P3924, DOI 10.1128/MCB.17.7.3924; GUPTA MP, 1994, J BIOL CHEM, V269, P29677; HARDY S, 1995, GENE, V156, P265, DOI 10.1016/0378-1119(94)00929-M; Hardy S, 1999, MECH DEVELOP, V87, P199, DOI 10.1016/S0925-4773(99)00148-3; HARDY S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P239, DOI 10.1016/0167-4781(92)90087-G; HARDY S, 1991, EUR J BIOCHEM, V202, P431, DOI 10.1111/j.1432-1033.1991.tb16392.x; HERRERA VLM, 1990, J BIOL CHEM, V265, P9555; HIPSKIND RA, 1991, J BIOL CHEM, V266, P19583; Hook J, 2004, MOL CELL BIOL, V24, P2318, DOI 10.1128/MCB.24.6.2318-2323.2004; IANNELLO RC, 1991, J BIOL CHEM, V266, P3309; Jiang SW, 2000, BIOCHEMISTRY-US, V39, P3505, DOI 10.1021/bi991048w; Johnson AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1420, DOI 10.1152/ajpcell.1999.276.6.C1420; KARIYA K, 1993, J BIOL CHEM, V268, P26658; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; Kashiwada K, 1997, J BIOL CHEM, V272, P15396, DOI 10.1074/jbc.272.24.15396; KNOTTS S, 1994, J BIOL CHEM, V269, P31275; LARKIN SB, 1999, HEART DEV, P307; Larrieu D, 2005, EXP CELL RES, V310, P166, DOI 10.1016/j.yexcr.2005.07.021; Latinkic BV, 2004, DEVELOPMENT, V131, P669, DOI 10.1242/dev.00953; LEESMILLER JP, 1991, BIOESSAYS, V13, P429, DOI 10.1002/bies.950130902; Lin MH, 1996, P NATL ACAD SCI USA, V93, P4623, DOI 10.1073/pnas.93.10.4623; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MAR JH, 1988, J CELL BIOL, V107, P573, DOI 10.1083/jcb.107.2.573; Mericskay M, 2000, DEV BIOL, V226, P192, DOI 10.1006/dbio.2000.9865; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; MOHUN TJ, 1991, EMBO J, V10, P933, DOI 10.1002/j.1460-2075.1991.tb08027.x; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P5056, DOI 10.1128/MCB.14.8.5056; Nieuwkoop PD, 1967, NORMAL TABLES XENOPU; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pasquet S, 2004, IN VITRO CELL DEV-AN, V40, P133; Phiel CJ, 2001, J BIOL CHEM, V276, P34637, DOI 10.1074/jbc.M105826200; Rethinasamy P, 1998, CIRC RES, V82, P116; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEN A, 1988, J BIOL CHEM, V263, P19132; Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200; SHIMIZU N, 1992, NUCLEIC ACIDS RES, V20, P1793, DOI 10.1093/nar/20.7.1793; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3; Sparrow D B, 2000, Nucleic Acids Res, V28, pE12, DOI 10.1093/nar/28.4.e12; Springer ML, 2002, CELL MOTIL CYTOSKEL, V51, P177, DOI 10.1002/cm.10022; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Swartz EA, 1998, AM J PHYSIOL-CELL PH, V275, pC608, DOI 10.1152/ajpcell.1998.275.2.C608; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; THEZE N, 1995, DEV BIOL, V171, P352, DOI 10.1006/dbio.1995.1287; Tidyman WE, 2003, DEV DYNAM, V227, P484, DOI 10.1002/dvdy.10328; TOUTANT M, 1994, NUCLEIC ACIDS RES, V22, P1838, DOI 10.1093/nar/22.10.1838; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vaudin P, 1999, DEVELOPMENT, V126, P4807; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Zilberman A, 1998, CIRC RES, V82, P566, DOI 10.1161/01.RES.82.5.566	76	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34406	34420		10.1074/jbc.M602282200	http://dx.doi.org/10.1074/jbc.M602282200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16959782	hybrid			2022-12-27	WOS:000241767600061
J	Yang, CY; Kuo, TH; Ting, LP				Yang, Chih-Yung; Kuo, Tzu-Hsing; Ting, Ling-Pai			Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; VACCINIA VIRUS; HEPATOCELLULAR-CARCINOMA; SOLUBLE FORM; CELLS; IL-1; INFECTION; APOPTOSIS; SEROCONVERSION; INFLAMMATION	Human hepatitis B virus (HBV) can cause acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. HBV e antigen (HBeAg), a secreted protein and not required for viral replication, is thought to play an immunoregulatory role during viral infection. However, the functional involvement of HBeAg in host immune response has not been fully elucidated. We report in this study that HBeAg can bind to interleukin-1 receptor accessory protein (IL-1RAcP). Interleukin-1 (IL-1) plays an important role in inflammation and regulation of immune response, and membrane form of IL-1RAcP (mIL-1RAcP) is an essential component of trimeric IL-1/IL-1 receptor/mIL-1RAcP complex. We show that glutathione S-transferase- or polyhistidine-tagged recombinant HBeAg can interact with endogenous mIL-1RAcP in vitro. Purified (His)(6)-HBeAg added in the culture medium can interact with overexpressed FLAG-tagged mIL-1RAcP in vivo. Indirect immunofluorescence and confocal microscopy show that HBeAg colocalizes with mIL-1RAcP on the cell surface. Furthermore, HBeAg is able to induce the interaction of IL-1 receptor I (IL-1RI) with mIL-1RAcP and trigger the recruitment of adaptor protein myeloid differentiation factor 88 (MyD88) to the IL-1RI/ mIL-1RAcP complex. Assembly and activation of IL-1RI/mIL-1RAcP signaling complex by HBeAg can activate downstream NF-kappa B pathway through I kappa B degradation, induce NF-kappa B-dependent luciferase expression, and induce the expression of IL-1-responsive genes. Silencing of IL-1RAcP by small interfering RNA dramatically abolishes HBeAg-mediated NF-kappa B activation. These results demonstrate that HBeAg can trigger host IL-1 response by binding to mIL-1RAcP. The interaction of HBeAg with mIL-1RAcP may play an important role in modulating	Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University	Ting, LP (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 11221, Taiwan.	lpting@ym.edu.tw						al-Ramadi BK, 2001, J IMMUNOL, V167, P6827, DOI 10.4049/jimmunol.167.12.6827; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ALCAMI A, 1995, J VIROL, V69, P4633; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Baumert TF, 1996, HEPATOLOGY, V23, P184, DOI 10.1002/hep.510230125; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; BEASLEY RP, 1981, LANCET, V2, P1129; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Bruix J, 2003, J HEPATOL, V39, pS59, DOI 10.1016/S0168-8278(03)00140-5; BRUNETTO MR, 1991, P NATL ACAD SCI USA, V88, P4186, DOI 10.1073/pnas.88.10.4186; CARMAN WF, 1991, HEPATOLOGY, V14, P219, DOI 10.1002/hep.1840140203; CHAK KF, 1991, J GEN MICROBIOL, V137, P91, DOI 10.1099/00221287-137-1-91; Chen HL, 2004, HEPATOLOGY, V39, P58, DOI 10.1002/hep.20006; Cromlish JA, 1996, TRENDS MICROBIOL, V4, P270, DOI 10.1016/0966-842X(96)10046-9; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; DUNNE A, 2003, SCI STKE; Endres MJ, 1999, J EXP MED, V189, P1993, DOI 10.1084/jem.189.12.1993; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; Jensen LE, 2003, CELL SIGNAL, V15, P793, DOI 10.1016/S0898-6568(03)00039-1; Jensen LE, 2000, J IMMUNOL, V164, P5277, DOI 10.4049/jimmunol.164.10.5277; KATAYAMA K, 1994, SCAND J GASTROENTERO, V29, P849, DOI 10.3109/00365529409092522; Kothny-Wilkes G, 1998, J BIOL CHEM, V273, P29247, DOI 10.1074/jbc.273.44.29247; Kuhn K, 2000, J IMMUNOL, V164, P2233, DOI 10.4049/jimmunol.164.4.2233; Lai CK, 1999, J VIROL, V73, P3197, DOI 10.1128/JVI.73.4.3197-3209.1999; Lee SH, 2002, J BIOCHEM, V131, P161, DOI 10.1093/oxfordjournals.jbchem.a003071; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Milich DR, 1998, J IMMUNOL, V160, P2013; Milich DR, 1997, J VIROL, V71, P2192, DOI 10.1128/JVI.71.3.2192-2201.1997; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Mphahlele MJ, 1997, HEPATOLOGY, V26, P743, DOI 10.1002/hep.510260329; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; Ou JH, 1997, J GASTROEN HEPATOL, V12, pS178, DOI 10.1111/j.1440-1746.1997.tb00499.x; Petit F, 1996, J VIROL, V70, P5860, DOI 10.1128/JVI.70.9.5860-5866.1996; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; RAIMONDO G, 1993, J MED VIROL, V40, P87, DOI 10.1002/jmv.1890400202; REALDI G, 1980, GASTROENTEROLOGY, V79, P195; Reignat S, 2002, J EXP MED, V195, P1089, DOI 10.1084/jem.20011723; Ribeiro RM, 2002, MICROBES INFECT, V4, P829, DOI 10.1016/S1286-4579(02)01603-9; Schmidt M, 1999, J IMMUNOL, V163, P3484; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039; Stine JT, 2000, BLOOD, V95, P1151, DOI 10.1182/blood.V95.4.1151.004k37_1151_1157; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; TERAZAWA S, 1991, PEDIATR RES, V29, P5, DOI 10.1203/00006450-199101000-00002; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; William R, 1998, J IMMUNOL, V161, P957; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215	56	42	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34525	34536		10.1074/jbc.M510981200	http://dx.doi.org/10.1074/jbc.M510981200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16973626	hybrid			2022-12-27	WOS:000241767600073
J	Ban, T; Morigaki, K; Yagi, H; Kawasaki, T; Kobayashi, A; Yuba, S; Naiki, H; Goto, Y				Ban, Tadato; Morigaki, Kenichi; Yagi, Hisashi; Kawasaki, Takashi; Kobayashi, Atsuko; Yuba, Shunsuke; Naiki, Hironobu; Goto, Yuji			Real-time and single fibril observation of the formation of amyloid beta spherulitic structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; IN-VITRO; ALZHEIMERS-DISEASE; LIPID-BILAYERS; PEPTIDE; CONSEQUENCES; FLUORESCENCE; INSULIN; PLAQUES; PROTEIN	In Alzheimer disease, amyloid beta, a 39-43-residue peptide produced by cleavage from a large amyloid precursor protein, undergoes conformational change to form amyloid fibrils and deposits as senile amyloid plaques in the extracellular cerebral cortices of the brain. However, the mechanism of how the intrinsically linear amyloid fibrils form spherical senile plaques is unknown. With total internal reflection fluorescence microscopy combined with the use of thioflavin T, an amyloid-specific fluorescence dye, we succeeded in observing the formation of the senile plaque-like spherulitic structures with diameters of around 15 mu m on the chemically modified quartz surface. Real-time observation at a single fibrillar level revealed that, in the absence of tight contact with the surface, the cooperative and radial growth of amyloid fibrils from the core leads to a huge spherulitic structure. The results suggest the underlying physicochemical mechanism of senile plaque formation, essential for obtaining insight into prevention of Alzheimer disease.	Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan; Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Osaka 5638577, Japan; Japan Sci & Technol Agcy, CREST, Fukui 9101193, Japan; Univ Fukui, Fac Med Sci, Dept Pathol Sci, Fukui 9101193, Japan	Osaka University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Fukui	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014	Kobayashi, Atsuko/0000-0001-8743-9726				Anzai J, 1999, LANGMUIR, V15, P221, DOI 10.1021/la980743m; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fezoui Y, 2000, NAT STRUCT BIOL, V7, P1095, DOI 10.1038/81937; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jin LW, 2003, P NATL ACAD SCI USA, V100, P15294, DOI 10.1073/pnas.2534647100; Jonas U, 2002, P NATL ACAD SCI USA, V99, P5034, DOI 10.1073/pnas.082634799; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Krebs MRH, 2004, P NATL ACAD SCI USA, V101, P14420, DOI 10.1073/pnas.0405933101; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; Morigaki K, 2002, LANGMUIR, V18, P10509, DOI 10.1021/la026579r; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 1996, LAB INVEST, V74, P374; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Raffen R, 1999, PROTEIN SCI, V8, P509; Richter RP, 2005, BIOPHYS J, V88, P3422, DOI 10.1529/biophysj.104.053728; Rogers SS, 2006, BIOPHYS J, V90, P1043, DOI 10.1529/biophysj.105.072660; Sagis LMC, 2004, LANGMUIR, V20, P924, DOI 10.1021/la035390s; Wazawa T, 2005, ADV BIOCHEM ENG BIOT, V95, P77, DOI 10.1007/b102211; Westlind-Danielsson A, 2001, BIOCHEMISTRY-US, V40, P14736, DOI 10.1021/bi010375c; XIA YN, 1995, J AM CHEM SOC, V117, P9576, DOI 10.1021/ja00142a031; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	34	63	69	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33677	33683		10.1074/jbc.M606072200	http://dx.doi.org/10.1074/jbc.M606072200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16959773	hybrid, Green Published			2022-12-27	WOS:000241621400075
J	Colnaghi, R; Connell, CM; Barrett, RMA; Wheatley, SP				Colnaghi, Rita; Connell, Claire M.; Barrett, Rachel M. A.; Wheatley, Sally P.			Separating the anti-apoptotic and mitotic roles of survivin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT; CENTROMERES; EXPRESSION; SPINDLE; PROTEIN	Survivin is a bifunctional protein that acts as a suppressor of apoptosis and has an essential role in mitosis. To date whether these two functions can be divorced has not been addressed. Here we show that the linker region between the BIR ( baculovirus inhibitor of apoptosis repeat) domain of survivin and COOH-terminal alpha helix may be the key to separating its roles. When overexpressed survivin is present in interphase cells and shuttles between the cytoplasm and nucleus. Here we identify a rev-like nuclear exportation signal (NES) in the central domain of survivin and demonstrate that point mutations within this region cause accumulation of survivin in the nucleus. Interestingly cells expressing NES mutants exhibit reduced survival after X-irradiation. Moreover, cells expressing survivin(L98A)-green fluorescent protein (GFP) showed increased poly( ADPribose) polymerase-cleavage and caspase-3 activity after tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL) treatment compared with cells expressing full-length survivin-green fluorescent protein. These data suggest a direct link between the interphase localization of survivin and cellular responsiveness to apoptotic stimuli. Using a cell proliferation assay, we also found that ectopic expression of NES mutants can complement for depletion of endogenous survivin, indicating that they can execute the mitotic duties of survivin. Thus we demonstrate for the first time that 1) survivin has a functional NES; 2) nuclear accumulation of overexpressed survivin correlates with increased sensitivity of cells to ionising radiation; and 3) the anti-apoptotic and mitotic roles of survivin can be separated through mutation of its NES. Separating these two functions of survivin could open up new possibilities for therapeutic strategies aimed at eliminating cancer cells yet preserving normal cell viability.	Univ Sussex, Dept Life Sci, Genom Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Wheatley, SP (corresponding author), Univ Sussex, Dept Life Sci, Genom Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	s.p.wheatley@sussex.ac.uk			Medical Research Council [G0300662B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Beardmore VA, 2004, J CELL SCI, V117, P4033, DOI 10.1242/jcs.01242; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Chakravarti A, 2004, ONCOGENE, V23, P7494, DOI 10.1038/sj.onc.1208049; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Lu B, 2004, CANCER RES, V64, P2840, DOI 10.1158/0008-5472.CAN-03-3547; Noton EA, 2006, J BIOL CHEM, V281, P1286, DOI 10.1074/jbc.M508773200; Okada E, 2001, CANCER LETT, V163, P109, DOI 10.1016/S0304-3835(00)00677-7; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; RODRIGUEZ J, 2006, ONCOGENE, P1; Rodriguez JA, 2002, EXP CELL RES, V275, P44, DOI 10.1006/excr.2002.5492; Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575; Thompson ME, 2005, J BIOL CHEM, V280, P21854, DOI 10.1074/jbc.M502676200; Tonini G, 2005, BRIT J CANCER, V92, P2225, DOI 10.1038/sj.bjc.6602632; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X	21	103	118	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33450	33456		10.1074/jbc.C600164200	http://dx.doi.org/10.1074/jbc.C600164200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16950794	hybrid, Green Accepted			2022-12-27	WOS:000241621400055
J	Barthel, SR; Annis, DS; Mosher, DF; Johansson, MW				Barthel, Steven R.; Annis, Douglas S.; Mosher, Deane F.; Johansson, Mats W.			Differential engagement of modules 1 and 4 of vascular cell adhesion molecule-1 (CD106) by integrins alpha 4 beta 1 (CD49d/29) and alpha M beta 2 (CD11b/18) of eosinophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; ALPHA(4) INTEGRIN; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; COUNTER-RECEPTOR; BINDING-SITES; I DOMAIN; EXTRACELLULAR SEGMENT; DEPENDENT ADHESION; AIRWAY EOSINOPHILS	We have studied adhesion of eosinophils to various forms of vascular cell adhesion molecule 1 (VCAM-1, CD106), an integrin counter-receptor implicated in eosinophil recruitment to the airway in asthma. Full-length 7d-VCAM-1, with seven immunoglobulin-like modules, contains integrin-binding sites in modules 1 and 4. The alternatively spliced six-module protein, 6d-VCAM-1, lacks module 4. In static assays, unactivated purified human blood eosinophils adhered similarly to recombinant soluble human 6d-VCAM-1 and 7d-VCAM-1 coated onto polystyrene microtiter wells. Further experiments, however, revealed differences in recognition of modules 1 and 4. Antibody blocking indicated that eosinophil adhesion to 6d-VCAM-1 or a VCAM-1 construct containing only modules 1-3, 1-3VCAM-1, is mediated by alpha 4 beta 1 (CD49d/29), whereas adhesion to a construct containing modules 4-7,4-7VCAM-1, is mediated by both alpha 4 beta 1 and alpha M beta 2 (CD11b/18). Inhibitors of phosphoinositide 3-kinase, which block adhesion of eosinophils mediated by alpha M beta 2, blocked adhesion to 4-7VCAM-1 but had no effect on adhesion to 6d-VCAM-1. Consistent with the antibody and pharmacological blocking experiments, eosinophilic leukemic cell lines lacking alpha M beta 2 did not adhere to 4-7VCAM-1 but did adhere to 6d-VCAM-1 or 1-3VCAM-1. Activation of eosinophils by interleukin (IL)-5 enhanced static adhesion to 6d-VCAM-1, 7d-VCAM-1, or 4-7VCAM-1; IL-5-enhanced adhesion to all 3 constructs was blocked by anti-alpha M beta 2. Adhesion of unstimulated eosinophils to 7d-VCAM-1 under flow conditions was inhibited by anti-alpha 4 or anti-alpha M. IL-5 treatment decreased eosinophil adhesion to 7d-VCAM-1 under flow, and anti-alpha M had the paradoxical effect of increasing adhesion. These results demonstrate that alpha M beta 2 modulates alpha 4 beta 1-mediated eosinophil adhesion to VCAM-1 under both static and flow conditions.	Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, 4285A Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@facstaff.wisc.edu		Johansson, Mats/0000-0001-5699-978X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007899, P50HL056396] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR 03186] Funding Source: Medline; NHLBI NIH HHS [T32 HL007899, HL 56396, T32 HL 007899, P50 HL056396] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe Y, 1996, J IMMUNOL, V157, P5061; ALEXANDER AG, 1994, THORAX, V49, P1231, DOI 10.1136/thx.49.12.1231; BAGGIOLINI M, 1994, IMMUNOL TODAY, V15, P127, DOI 10.1016/0167-5699(94)90156-2; Barthel SR, 2006, AM J RESP CELL MOL, V35, P378, DOI 10.1165/rcmb.2006-0027OC; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Broide D, 2001, IMMUNOL REV, V179, P163, DOI 10.1034/j.1600-065X.2001.790116.x; Brown DC, 1999, BRIT J HAEMATOL, V107, P86, DOI 10.1046/j.1365-2141.1999.01671.x; CARLOS TM, 1990, BLOOD, V76, P965; Chan JR, 2000, J IMMUNOL, V164, P746, DOI 10.4049/jimmunol.164.2.746; CHANG R, 1981, PHYS CHEM APPL BIOL, P72; CHIU HH, 1995, J IMMUNOL, V155, P5257; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; CHULUYAN HE, 1995, J IMMUNOL, V155, P3135; CLEMENTS JM, 1994, J CELL SCI, V107, P2127; CORRIGAN CJ, 1993, AM REV RESPIR DIS, V147, P540, DOI 10.1164/ajrccm/147.3.540; CYBULSKY MI, 1991, P NATL ACAD SCI USA, V88, P7859, DOI 10.1073/pnas.88.17.7859; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; DEFOUGEROLLES AR, 1993, J EXP MED, V177, P1187, DOI 10.1084/jem.177.4.1187; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; Deng Huojin, 1998, Zhonghua Jiehe He Huxi Zazhi, V21, P108; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; EBISAWA M, 1994, J IMMUNOL, V153, P2153; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; GEORAS SN, 1992, AM J RESP CELL MOL, V7, P261, DOI 10.1165/ajrcmb/7.3.261; Giembycz MA, 1999, PHARMACOL REV, V51, P213; Grayson MH, 1998, J EXP MED, V188, P2187, DOI 10.1084/jem.188.11.2187; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; HESSION C, 1991, J BIOL CHEM, V266, P6682; HICKSTEIN DD, 1992, P NATL ACAD SCI USA, V89, P2105, DOI 10.1073/pnas.89.6.2105; Hogg N, 2001, J LEUKOCYTE BIOL, V69, P893; Hughes JM, 2001, ALLERGY, V56, P412, DOI 10.1034/j.1398-9995.2001.056005412.x; Humphries MJ, 2004, BIOCHEM SOC T, V32, P407, DOI 10.1042/BST0320407; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jia GQ, 1999, INT IMMUNOL, V11, P1, DOI 10.1093/intimm/11.1.1; Johansson MW, 2006, J ALLERGY CLIN IMMUN, V117, P1502, DOI 10.1016/j.jaci.2006.02.032; Johansson MW, 2004, AM J RESP CELL MOL, V31, P413, DOI 10.1165/rcmb.2004-0099OC; KILGER G, 1995, J BIOL CHEM, V270, P5979, DOI 10.1074/jbc.270.11.5979; Kitayama J, 1997, J IMMUNOL, V159, P3929; Kotsimbos ATC, 1997, MEM I OSWALDO CRUZ, V92, P75, DOI 10.1590/S0074-02761997000800012; KROEGEL C, 1994, J ALLERGY CLIN IMMUN, V93, P725, DOI 10.1016/0091-6749(94)90252-6; Lalani T, 1999, ANN ALLERG ASTHMA IM, V82, P317, DOI 10.1016/S1081-1206(10)63281-4; Leitinger B, 2000, MOL BIOL CELL, V11, P677, DOI 10.1091/mbc.11.2.677; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Liu LY, 2002, J IMMUNOL, V169, P6452, DOI 10.4049/jimmunol.169.11.6452; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Matsumoto K, 1997, J ALLERGY CLIN IMMUN, V99, P648, DOI 10.1016/S0091-6749(97)70027-7; Meerschaert J, 1999, J IMMUNOL, V163, P6217; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Mould AP, 2005, J BIOL CHEM, V280, P4238, DOI 10.1074/jbc.M412240200; NEEDHAM LA, 1994, CELL ADHES COMMUN, V2, P87, DOI 10.3109/15419069409004429; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; OHKAWARA Y, 1995, AM J RESP CELL MOL, V12, P4, DOI 10.1165/ajrcmb.12.1.7529029; OSBORN L, 1994, J CELL BIOL, V124, P601, DOI 10.1083/jcb.124.4.601; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Patel KD, 1999, J IMMUNOL, V162, P6209; PEPINSKY B, 1992, J BIOL CHEM, V267, P17820; Rose DM, 2003, J IMMUNOL, V170, P5912, DOI 10.4049/jimmunol.170.12.5912; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; Sano M, 2005, AM J RESP CELL MOL, V33, P65, DOI 10.1165/rcmb.2005-0076OC; SEDGWICK JB, 1992, J IMMUNOL, V149, P3710; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; Sriramarao P, 1996, J IMMUNOL, V157, P4672; SRIRAMARAO P, 1994, J IMMUNOL, V153, P4238; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; Tachimoto H, 2000, CHEM IMMUNOL, V76, P45; Taylor P, 2001, ACTA CRYSTALLOGR D, V57, P1579, DOI 10.1107/S0907444901011209; ten Hacken NHT, 1998, CLIN EXP ALLERGY, V28, P1518; ULTMAN LH, 2001, J IMMUNOL, V166, P588; Van der Vieren M, 1999, J IMMUNOL, V163, P1984; VONDERHEIDE RH, 1994, J CELL BIOL, V125, P215, DOI 10.1083/jcb.125.1.215; VONDERHEIDE RH, 1992, J EXP MED, V175, P1433, DOI 10.1084/jem.175.6.1433; Walsh GM, 1996, IMMUNOLOGY, V89, P112, DOI 10.1046/j.1365-2567.1996.d01-713.x; WALSH GM, 1990, IMMUNOLOGY, V71, P258; Wardlaw AJ, 2001, CLIN MED, V1, P214, DOI 10.7861/clinmedicine.1-3-214; Weber C, 1996, P NATL ACAD SCI USA, V93, P10939, DOI 10.1073/pnas.93.20.10939; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu XD, 1999, J IMMUNOL, V163, P3423	87	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32175	32187		10.1074/jbc.M600943200	http://dx.doi.org/10.1074/jbc.M600943200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943205	hybrid			2022-12-27	WOS:000241414500015
J	Woo, CH; Massett, MP; Shishido, T; Itoh, S; Ding, B; McClain, C; Che, WY; Vulapalli, SR; Yan, C; Abe, J				Woo, Chang-Hoon; Massett, Michael P.; Shishido, Tetsuro; Itoh, Seigo; Ding, Bo; McClain, Carolyn; Che, Wenyi; Vulapalli, Sreesatya Raju; Yan, Chen; Abe, Jun-ichi			ERK5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor delta (PPAR delta) stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; EPIDERMAL-GROWTH-FACTOR; CARBON-MONOXIDE; PROTEIN-KINASE; SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; TRANSCRIPTIONAL ACTIVATION; INSULIN-RESISTANCE; GENE-EXPRESSION; MAP KINASE	Peroxisome proliferator-activated receptors ( PPAR) decrease the production of cytokine and inducible nitric-oxide synthase ( iNOS) expression, which are associated with aging-related inflammation and insulin resistance. Recently, the involvement of the induction of heme oxygenase-1 (HO-1) in regulating inflammation has been suggested, but the exact mechanisms for reducing inflammation by HO-1 remains unclear. We found that overexpression of HO-1 and [Ru(CO)(3)Cl-2](2), a carbon monoxide (CO)-releasing compound, increased not only ERK5 kinase activity, but also its transcriptional activity measured by luciferase assay with the transfection of the Gal4-ERK5 reporter gene. This transcriptional activity is required for coactivation of PPAR delta by ERK5 in C2C12 cells. [Ru(CO)(3)Cl-2](2) activated PPAR delta transcriptional activity via the MEK5/ERK5 signaling pathway. The inhibition of NF-kappa B activity by ERK5 activation was reversed by a dominant negative form of PPAR delta suggesting that ERK5/PPAR delta activation is required for the anti-inflammatory effects of CO and HO-1. Based on these data, we propose a new mechanism by which CO and HO-1 mediate anti-inflammatory effects via activating ERK5/PPAR delta, and ERK5 mediates CO and HO-1-induced PPAR delta activation via its interaction with PPAR delta.	Univ Rochester, Cardiovasc Res Inst, Rochester, NY 14642 USA	University of Rochester	Abe, J (corresponding author), Box 679,601 Elmwood Ave, Rochester, NY 14642 USA.	jun-ichi_abe@urmc.rochester.edu		Yan, Chen/0000-0002-1397-6358	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077789] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 077789-01A1] Funding Source: Medline; NIGMS NIH HHS [GM 071485-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Amersi F, 2002, HEPATOLOGY, V35, P815, DOI 10.1053/jhep.2002.32467; Araujo JA, 2003, J IMMUNOL, V171, P1572, DOI 10.4049/jimmunol.171.3.1572; Barreiro E, 2002, AM J PHYSIOL-LUNG C, V283, pL476, DOI 10.1152/ajplung.00495.2001; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; Berger Joel, 2002, Diabetes Technol Ther, V4, P163, DOI 10.1089/15209150260007381; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Camp HS, 1997, J BIOL CHEM, V272, P10811; Ceriello A, 2002, DIABETES, V51, P1076, DOI 10.2337/diabetes.51.4.1076; Dennery PA, 1997, J BIOL CHEM, V272, P14937, DOI 10.1074/jbc.272.23.14937; Elizalde M, 2000, J LIPID RES, V41, P1244; Grimaldi PA, 2005, BIOCHIMIE, V87, P5, DOI 10.1016/j.biochi.2004.11.009; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kawamura K, 2005, ARTERIOSCL THROM VAS, V25, P155, DOI 10.1161/01.ATV.0000148405.18071.6a; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Lerner-Marmarosh N, 2003, ARTERIOSCL THROM VAS, V23, P1775, DOI 10.1161/01.ATV.0000094432.98445.36; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Michalik L, 1999, CURR OPIN BIOTECH, V10, P564, DOI 10.1016/S0958-1669(99)00030-0; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; MUKHERJEE R, 1994, J STEROID BIOCHEM, V51, P157, DOI 10.1016/0960-0760(94)90089-2; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Rival Y, 2002, EUR J PHARMACOL, V435, P143, DOI 10.1016/S0014-2999(01)01589-8; Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924; SHARMA K, 1995, BIOCHEM BIOPH RES CO, V207, P80, DOI 10.1006/bbrc.1995.1156; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Tannous M, 1999, DIABETOLOGIA, V42, P539, DOI 10.1007/s001250051192; Teng ZP, 2004, NEUROBIOL DIS, V17, P179, DOI 10.1016/j.nbd.2004.07.009; Thom SR, 2000, P NATL ACAD SCI USA, V97, P1305, DOI 10.1073/pnas.97.3.1305; Thorup C, 1999, AM J PHYSIOL-RENAL, V277, pF882, DOI 10.1152/ajprenal.1999.277.6.F882; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Torres SH, 2004, J ENDOCRINOL, V181, P419, DOI 10.1677/joe.0.1810419; Vulapalli SR, 2002, AM J PHYSIOL-HEART C, V283, pH688, DOI 10.1152/ajpheart.00133.2002; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200	48	75	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32164	32174		10.1074/jbc.M602369200	http://dx.doi.org/10.1074/jbc.M602369200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16943204	hybrid			2022-12-27	WOS:000241414500014
J	Mueller, M; Stamme, C; Draing, C; Hartung, T; Seydel, U; Schromm, AB				Mueller, Mareike; Stamme, Cordula; Draing, Christian; Hartung, Thomas; Seydel, Ulrich; Schromm, Andra B.			Cell activation of human macrophages by lipoteichoic acid is strongly attenuated by lipopolysaccharide-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; TOLL-LIKE RECEPTORS; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL SUSCEPTIBILITY; BACTERIAL PEPTIDOGLYCAN; (LPS)-BINDING PROTEIN; CYTOKINE INDUCTION; HUMAN MONOCYTES; SOLUBLE CD14; K+ CHANNEL	Lipoteichoic acid (LTA) represents immunostimulatory molecules expressed by Gram-positive bacteria. They activate the innate immune system via Toll-like receptors. We have investigated the role of serum proteins in activation of human macrophages by LTA from Staphylococcus aureus and found it to be strongly attenuated by serum. In contrast, the same cells showed a sensitive response to LTA and a significantly enhanced production of tumor necrosis factor alpha under serum-free conditions. We show that LTA interacts with the serum protein lipopolysaccharide-binding protein (LBP) and inhibits the integration of LBP into phospholipid membranes, indicating the formation of complexes of LTA and soluble LBP. The addition of recombinant human LBP to serum-free medium inhibited the production of tumor necrosis factor alpha and interleukins 6 and 8 after stimulation of human macrophages with LTA in a dose-dependent manner. Using anti-LBP antibodies, this inhibitory effect could be attributed to soluble LBP, whereas LBP in its recently described transmembrane configuration did not modulate cell activation. Also, using primary alveolar macrophages from rats, we show a sensitive cytokine response to LTA under serum-free culture conditions that was strongly attenuated in the presence of serum. In summary, our data suggest that innate immune recognition of LTA is organ-specific with negative regulation by LBP in serum-containing compartments and sensitive recognition in serum-free compartments like the lung.	Res Ctr Borstel, Dept Immunochem & Biochem Microbiol, Leibniz Ctr Med & Biosci, Div Biophys, D-23845 Borstel, Germany; Res Ctr Borstel, Dept Immunochem & Biochem Microbiol, Leibniz Ctr Med & Biosci, Div Cellular Pneumol, D-23845 Borstel, Germany; Res Ctr Borstel, Dept Immunochem & Biochem Microbiol, Leibniz Ctr Med & Biosci, Div Immunobiophys, D-23845 Borstel, Germany; Univ Konstanz, Dept Biochem Pharmacol, D-7750 Constance, Germany; Univ Lubeck, Dept Anaesthesiol, D-23538 Lubeck, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; University of Konstanz; University of Lubeck	Schromm, AB (corresponding author), Res Ctr Borstel, Dept Immunochem & Biochem Microbiol, Emmy Noether Grp Immunobiophys, Parkallee 10, D-23845 Borstel, Germany.	aschromm@fz-borstel.de	Schromm, Andra/O-3936-2018					Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Blondin C, 1997, EUR J IMMUNOL, V27, P3303, DOI 10.1002/eji.1830271229; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Branger J, 2004, INT IMMUNOL, V16, P1605, DOI 10.1093/intimm/dxh161; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dentener MA, 2000, AM J RESP CELL MOL, V23, P146, DOI 10.1165/ajrcmb.23.2.3855; Diekema DJ, 2000, INT J ANTIMICROB AG, V13, P257, DOI 10.1016/S0924-8579(99)00131-4; Dubin W, 1996, AM J PHYSIOL-LUNG C, V270, pL736, DOI 10.1152/ajplung.1996.270.5.L736; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Fluit AC, 2001, EUR J CLIN MICROBIOL, V20, P617; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Gao JJ, 2001, INFECT IMMUN, V69, P751, DOI 10.1128/IAI.69.2.751-757.2001; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; Gutsmann T, 2001, BIOL CHEM, V382, P425, DOI 10.1515/BC.2001.052; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Hamann L, 2005, INFECT IMMUN, V73, P193, DOI 10.1128/IAI.73.1.193-200.2005; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heine H, 2003, EUR J IMMUNOL, V33, P1399, DOI 10.1002/eji.200323381; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Hermann C, 2002, EUR J IMMUNOL, V32, P541, DOI 10.1002/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO;2-P; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Lotz S, 2004, J LEUKOCYTE BIOL, V75, P467, DOI 10.1189/jlb.0803360; MALMQVIST M, 1993, NATURE, V361, P186, DOI 10.1038/361186a0; Martin TR, 2000, AM J RESP CELL MOL, V23, P128, DOI 10.1165/ajrcmb.23.2.f189; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Mueller M, 2005, J IMMUNOL, V174, P1091, DOI 10.4049/jimmunol.174.2.1091; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; Pfaller MA, 1998, ANTIMICROB AGENTS CH, V42, P1762, DOI 10.1128/AAC.42.7.1762; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rietschel ET, 1998, MICROB DRUG RESIST, V4, P37, DOI 10.1089/mdr.1998.4.37; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schroder NWJ, 2000, J IMMUNOL, V165, P2683, DOI 10.4049/jimmunol.165.5.2683; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Schromm AB, 1996, FEBS LETT, V399, P267, DOI 10.1016/S0014-5793(96)01338-5; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Seydel U, 2003, EUR J IMMUNOL, V33, P1586, DOI 10.1002/eji.200323649; Seydel U, 2001, J ENDOTOXIN RES, V7, P243, DOI 10.1177/09680519010070030901; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stillwell M, 1989, Infect Dis Clin North Am, V3, P155; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Villavicencio RT, 1996, AM J SURG, V172, P291, DOI 10.1016/S0002-9610(96)00102-X; Weber JR, 2003, IMMUNITY, V19, P269, DOI 10.1016/S1074-7613(03)00205-X; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu YD, 2004, AM J RESP CELL MOL, V31, P587, DOI 10.1165/rcmb.2004-0003OC; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	56	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31448	31456		10.1074/jbc.M605966200	http://dx.doi.org/10.1074/jbc.M605966200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16928689	Bronze			2022-12-27	WOS:000241235300029
J	Totani, K; Ihara, Y; Matsuo, I; Ito, Y				Totani, Kiichiro; Ihara, Yoshito; Matsuo, Ichiro; Ito, Yukishige			Substrate specificity analysis of endoplasmic reticulum glucosidase II using synthetic high mannose-type glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL GLUCOSIDASES; ER-ASSOCIATED DEGRADATION; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; SUGAR CHAINS; RAT-LIVER; DIHYDROFOLATE-REDUCTASE; N-GLYCANS; PROTEIN; CALNEXIN	Glucosidase II (Glc'ase II) is a glycan-processing enzyme that trims two alpha 1,3-linked Glc residues in succession from the glycoprotein oligosaccharide Glc2Man9GlcNAc2 to give Glc1Man9GlcNAc2 and Man9GlcNAc2 in the endoplasmic reticulum (ER). Monoglucosylated glycans, such as Glc1Man9GlcNAc2, generated by this process play a key role in glycoprotein quality control in the ER, because they are primary ligands for the lectin chaperones calnexin (CNX) and calreticulin (CRT). A precise analysis of the substrate specificity of Glc'ase II is expected to further our understanding of the molecular basis to glycoprotein quality control, because Glc'ase II potentially competes with CNX/CRT for the same glycans, Glc1Man7-9GlcNAc2. In this study, a quantitative analysis of the specificity of Glc'ase II using a series of structurally defined synthetic glycans was carried out. In the presence of CRT, Glc'ase II-mediated trimming from Glc2Man9GlcNAc2 stopped at Glc1Man9GlcNAc2, supporting the notion that the glycan structure delivered to the CNX/CRT cycle is Glc1Man9GlcNAc2. Unexpectedly, our experiments showed that Glc1Man8(B)GlcNAc2 had nearly the same reactivity as Glc1Man9GlcNAc2, which was markedly greater than that of its positional isomer Glc1Man8(C) GlcNAc2. An analysis with glycoprotein-like probes revealed the stepwise formation of Glc1Man9GlcNAc2 and Man9GlcNAc2 from Glc2Man9GlcNAc2, even in the presence of CRT. It was also shown that Glc1Man8(B) GlcNAc2 had even greater reactivity than Glc1Man9GlcNAc2 at the glycoprotein level. Moreover, inhibitory activities by nonglucosylated glycans suggested that Glc'ase II recognized the C arm (Man alpha 1,2Man alpha 1,6Man-) of high man-nose-type glycans.	RIKEN, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3321102, Japan; Nagasaki Univ, Dept Biochem & Mol Biol Dis, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki 8528523, Japan	RIKEN; Japan Science & Technology Agency (JST); Nagasaki University	Ito, Y (corresponding author), RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yukito@riken.jp	Ito, Yukishige/M-5119-2014; Ito, Yukishige/ACL-6203-2022	Ito, Yukishige/0000-0001-6251-7249; Ito, Yukishige/0000-0001-6251-7249				ALONSO JM, 1993, EUR J BIOCHEM, V215, P37, DOI 10.1111/j.1432-1033.1993.tb18004.x; APPLEMAN JR, 1988, J BIOL CHEM, V263, P9187; BALSH S, 1991, J BIOL CHEM, V266, P21458; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; GRINNA LS, 1979, J BIOL CHEM, V254, P8814; Hagihara S, 2005, J MED CHEM, V48, P3126, DOI 10.1021/jm0489511; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ito Y, 2005, CURR OPIN STRUC BIOL, V15, P481, DOI 10.1016/j.sbi.2005.08.012; Jakob CA, 2001, EMBO REP, V2, P423; Jorgensen CS, 2000, EUR J BIOCHEM, V267, P2945, DOI 10.1046/j.1432-1033.2000.01309.x; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; KORNFELD S, 1978, J BIOL CHEM, V253, P7771; Matsuo I, 2003, J AM CHEM SOC, V125, P3402, DOI 10.1021/ja021288q; Matsuo I, 2003, CARBOHYD RES, V338, P2163, DOI 10.1016/S0008-6215(03)00357-4; Matsuo I, 2006, TETRAHEDRON, V62, P8262, DOI 10.1016/j.tet.2006.06.045; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; PETERSON JR, 1995, MOL BIOL CELL, V6, P1173, DOI 10.1091/mbc.6.9.1173; Petrescu AJ, 1997, EMBO J, V16, P4302, DOI 10.1093/emboj/16.14.4302; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Totani K, 2005, ANGEW CHEM INT EDIT, V44, P7950, DOI 10.1002/anie.200502723; Totani K, 2004, BIOORG MED CHEM LETT, V14, P2285, DOI 10.1016/j.bmcl.2004.01.106; Totani K, 2006, BIOORGAN MED CHEM, V14, P5220, DOI 10.1016/j.bmc.2006.04.001; Trombetta ES, 2005, METHODS, V35, P328, DOI 10.1016/j.ymeth.2004.10.004; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Wilkinson BM, 2006, J BIOL CHEM, V281, P6325, DOI 10.1074/jbc.M510455200; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890	39	84	85	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31502	31508		10.1074/jbc.M605457200	http://dx.doi.org/10.1074/jbc.M605457200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16940048	Bronze			2022-12-27	WOS:000241235300035
J	Ficko-Blean, E; Boraston, AB				Ficko-Blean, Elizabeth; Boraston, Alisdair B.			The interaction of a carbohydrate-binding module from a Clostridium perfringens N-acetyl-beta-hexosaminidase with its carbohydrate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; X-RAY-DIFFRACTION; BACTERIAL SIALIDASE; LIGAND-BINDING; RECOGNITION; GALACTOSE; FAMILY; COEFFICIENTS; MECHANISM; REVEALS	Clostridium perfringens is a notable colonizer of the human gastrointestinal tract. This bacterium is quite remarkable for a human pathogen by the number of glycoside hydrolases found in its genome. The modularity of these enzymes is striking as is the frequent occurrence of modules having amino acid sequence identity with family 32 carbohydrate-binding modules (CBMs), often referred to as F5/8 domains. Here we report the properties of family 32 CBMs from a C. perfringens N-acetyl-beta-hexosaminidase. Macroarray, UV difference, and isothermal titration calorimetry binding studies indicate a preference for the disaccharide LacNAc (beta-D-galactosyl-1,4-beta-D-N-acetylglucosamine). The molecular details of the interaction of this CBM with galactose, LacNAc, and the type II blood group H-trisaccharide are revealed by x-ray crystallographic studies at resolutions of 1.49, 2.4, and 2.3 angstrom, respectively.	Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Victoria	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Ficko-Blean, Elizabeth/N-1746-2013	Ficko-Blean, Elizabeth/0000-0002-3915-4715; Boraston, Alisdair/0000-0001-6417-0592				Bachhawat-Sikder K, 2001, FEBS LETT, V500, P75, DOI 10.1016/S0014-5793(01)02586-8; Bianchet MA, 2002, NAT STRUCT BIOL, V9, P628, DOI 10.1038/nsb817; Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P14679, DOI 10.1021/bi015760g; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BORASTON AB, 2001, BIOCHEMISTRY-US, V40, P6204; Coutinho PM, 1999, ROY SOC CH, P3; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficko-Blean E, 2005, ACTA CRYSTALLOGR F, V61, P834, DOI 10.1107/S1744309105024012; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; GERDING DN, 1997, CLOSTRIDIA MOL BIOL, P117; Gupta D, 1996, GLYCOBIOLOGY, V6, P843, DOI 10.1093/glycob/6.8.843; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; Johnson PE, 1998, BIOCHEMISTRY-US, V37, P12772, DOI 10.1021/bi980978x; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MCDONEL JL, 1980, PHARMACOL THERAPEUT, V10, P617, DOI 10.1016/0163-7258(80)90031-5; Morelle W, 2000, GLYCOBIOLOGY, V10, P295, DOI 10.1093/glycob/10.3.295; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Roske Y, 2004, J MOL BIOL, V340, P543, DOI 10.1016/j.jmb.2004.04.072; Shimizu T, 2001, MICROBIOL IMMUNOL, V45, P179, DOI 10.1111/j.1348-0421.2001.tb01278.x; Sultan NAM, 2005, ARCH BIOCHEM BIOPHYS, V437, P115, DOI 10.1016/j.abb.2005.03.005; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; van Bueren AL, 2004, J MOL BIOL, V340, P869, DOI 10.1016/j.jbm.2004.05.038; van Bueren AL, 2004, BIOCHEMISTRY-US, V43, P15633, DOI 10.1021/bi048215z; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	37	77	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2006	281	49					37748	37757		10.1074/jbc.M606126200	http://dx.doi.org/10.1074/jbc.M606126200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	111TH	16990278	hybrid			2022-12-27	WOS:000242477100052
J	Jin, NL; Kolliputi, N; Gou, DM; Weng, TT; Liu, L				Jin, Nili; Kolliputi, Narasiah; Gou, Deming; Weng, Tingting; Liu, Lin			A novel function of ionotropic gamma-aminobutyric acid receptors involving alveolar fluid homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-CHANNEL ACTIVATION; EPITHELIAL-CELLS; II CELLS; ION-TRANSPORT; PULMONARY-EDEMA; PI-SUBUNIT; RAT LUNGS; IN-VITRO; GABA; SECRETION	Polarized distribution of chloride channels on the plasma membrane of epithelial cells is required for fluid transport across the epithelium of fluid-transporting organs. Ionotropic gamma-aminobutyric acid receptors are primary ligand-gated chloride channels that mediate inhibitory neurotransmission. Traditionally, these receptors are not considered to be contributors to fluid transport. Here, we report a novel function of gamma-aminobutyric acid receptors involving alveolar fluid homeostasis in adult lungs. We demonstrated the expression of functional ionotropic gamma-aminobutyric acid receptors on the apical plasma membrane of alveolar epithelial type II cells. gamma-Aminobutyric acid significantly increased chloride efflux in the isolated type II cells and inhibited apical to basolateral chloride transport on type II cell monolayers. Reduction of the gamma-aminobutyric acid receptor pi subunit using RNA interference abolished the gamma-aminobutyric acid-mediated chloride transport. In intact rat lungs, gamma-aminobutyric acid inhibited both basal and beta agonist-stimulated alveolar fluid clearance. Thus, we provide molecular and pharmacological evidence that ionotropic gamma-aminobutyric acid receptors contribute to fluid transport in the lung via luminal secretion of chloride. This finding may have the potential to develop clinical approaches for pulmonary diseases involving abnormal fluid dynamics.	Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Liu, L (corresponding author), 264 McElroy Hall, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	Kolliputi, Narasaiah/I-6050-2012	Kolliputi, Narasaiah/0000-0002-2654-1900	NHLBI NIH HHS [R01 HL-083188, R01 HL-071628, R01 HL-052146] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052146, R01HL071628, R01HL083188] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACTINIC MK, 1999, NEUROSCI RES, V35, P145; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Braun M, 2004, J GEN PHYSIOL, V123, P191, DOI 10.1085/jgp.200308966; Brochiero E, 2004, AM J PHYSIOL-LUNG C, V287, pL382, DOI 10.1152/ajplung.00320.2002; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Fang X, 2002, J GEN PHYSIOL, V119, P199, DOI 10.1085/jgp.119.2.199; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Franklin IK, 2004, J GEN PHYSIOL, V123, P185, DOI 10.1085/jgp.200409016; Gamel-Didelon K, 2003, J BIOL CHEM, V278, P20192, DOI 10.1074/jbc.M301729200; Gou D, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh129; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jiang X, 2001, J MEMBRANE BIOL, V181, P195, DOI 10.1007/s00232-001-0022-4; Jiang XP, 1998, AM J PHYSIOL-CELL PH, V275, pC1610, DOI 10.1152/ajpcell.1998.275.6.C1610; Jin N, 2005, CELL TISSUE RES, V321, P173, DOI 10.1007/s00441-005-1130-8; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; KEMP PJ, 1994, J PHYSIOL-LONDON, V476, P79; KIM KJ, 1991, RESP PHYSIOL, V85, P245, DOI 10.1016/0034-5687(91)90065-Q; Lazrak A, 2002, AM J PHYSIOL-LUNG C, V282, pL650, DOI 10.1152/ajplung.00370.2001; Lee SY, 2003, J MEMBRANE BIOL, V191, P133, DOI 10.1007/s00232-002-1049-x; Liedtke CM, 2002, AM J PHYSIOL-LUNG C, V282, pL1151, DOI 10.1152/ajplung.00143.2001; Liu L, 1996, AM J PHYSIOL-LUNG C, V270, pL668, DOI 10.1152/ajplung.1996.270.4.L668; Mason RJ, 2002, AM J PHYSIOL-LUNG C, V282, pL249, DOI 10.1152/ajplung.00027.2001; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Mayerhofer Artur, 2001, FASEB Journal, V15, P1089; MEYER KH, 1991, J HISTOCHEM CYTOCHEM, V39, P749, DOI 10.1177/39.6.1674516; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Mutlu GM, 2005, AM J PHYSIOL-LUNG C, V289, pL685, DOI 10.1152/ajplung.00247.2005; Narasaraju TA, 2003, AM J PHYSIOL-LUNG C, V285, pL1037, DOI 10.1152/ajplung.00008.2003; Neelands TR, 1999, MOL PHARMACOL, V56, P598, DOI 10.1124/mol.56.3.598; Nielsen VG, 1998, AM J PHYSIOL-LUNG C, V275, pL1127, DOI 10.1152/ajplung.1998.275.6.L1127; Norlin A, 2001, J APPL PHYSIOL, V90, P1489, DOI 10.1152/jappl.2001.90.4.1489; O'Grady SM, 2003, AM J PHYSIOL-LUNG C, V284, pL689, DOI 10.1152/ajplung.00256.2002; O'Grady SM, 2000, AM J PHYSIOL-LUNG C, V278, pL239, DOI 10.1152/ajplung.2000.278.2.L239; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Park HS, 2000, AM J PHYSIOL-GASTR L, V279, pG677, DOI 10.1152/ajpgi.2000.279.4.G677; Park MK, 2001, P NATL ACAD SCI USA, V98, P10948, DOI 10.1073/pnas.181353798; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Roux J, 2005, J BIOL CHEM, V280, P18579, DOI 10.1074/jbc.M410561200; Scarpelli EM, 2003, COMP BIOCHEM PHYS A, V135, P39, DOI 10.1016/S1095-6433(02)00352-5; TIZZANO EF, 1994, AM J RESP CELL MOL, V10, P355, DOI 10.1165/ajrcmb.10.4.7510983; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	46	33	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					36012	36020		10.1074/jbc.M606895200	http://dx.doi.org/10.1074/jbc.M606895200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17003036	hybrid			2022-12-27	WOS:000242100500049
J	Luu, T; Gage, PW; Tierney, ML				Luu, Tien; Gage, Peter W.; Tierney, M. Louise			GABA increases both the conductance and mean open time of recombinant GABA(A) channels co-expressed with GABARAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; RECEPTOR-ASSOCIATED PROTEIN; CHLORIDE CHANNELS; RAT; DIAZEPAM; CELLS; ACTIVATION; RESPONSES; KINETICS; SUBUNIT	The single channel properties of recombinant gamma-aminobutyric acid type A(GABA(A)) alpha beta gamma receptors co-expressed with the trafficking protein GABARAP were investigated using membrane patches in the outside-out patch clamp configuration from transiently transfected L929 cells. In control cells expressing alpha beta gamma receptors alone, GABA activated single channels whose main conductance was 30 picosiemens (pS) with a subconductance state of 20 pS, and increasing the GABA concentration did not alter their conductance. In contrast, when GABAA receptors were co-expressed with GABARAP, the GABA-activated single channels displayed multiple, high conductances (>= 40 pS), and GABA (>= 10 mu M) was able to increase their conductance, up to a maximum of 60 pS. The mean open time of GABA-activated channels in control cells expressing alpha beta gamma receptors alone was 2.3 +/- 0.1 ms for the main 30-pS channel and shorter for the subconductance state ( 20 pS, 0.8 +/- 0.1 ms). Similar values were measured for the 30- and 20-pS channels active in patches from cells co-expressing GABARAP. However higher conductance channels (>= 40 pS) remained open longer, irrespective of whether GABA or GABA plus diazepam activated them. Plotting mean open times against mean conductances revealed a linear relationship between these two parameters. Since high GABA concentrations increase both the maximum single channel conductance and mean open time of GABA(A) channels co-expressed with GABARAP, trafficking processes must influence ion channel properties. This suggests that the organization of extra-synaptic GABA(A) receptors may provide a range of distinct inhibitory currents in the brain and, further, provide differential drug responses.	Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Tierney, ML (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 0200, Australia.	Louise.Tierney@anu.edu.au	Luu, Tien/C-8303-2009					Benson JA, 1998, FEBS LETT, V431, P400, DOI 10.1016/S0014-5793(98)00803-5; Birnir B, 2001, J MEMBRANE BIOL, V181, P171, DOI 10.1007/s00232-001-0021-5; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Christie SB, 2006, MOL CELL NEUROSCI, V31, P1, DOI 10.1016/j.mcn.2005.08.014; CURMI JP, 1993, J MEMBRANE BIOL, V136, P273; Eghbali M, 2000, MOL PHARMACOL, V58, P463, DOI 10.1124/mol.58.3.463; Eghbali M, 2003, J PHYSIOL-LONDON, V552, P13, DOI 10.1113/jphysiol.2003.047415; Eghbali M, 2003, EUR J PHARMACOL, V468, P75, DOI 10.1016/S0014-2999(03)01641-8; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Everitt AB, 2004, J BIOL CHEM, V279, P21701, DOI 10.1074/jbc.M312806200; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; GRAY R, 1985, J NEUROPHYSIOL, V54, P134, DOI 10.1152/jn.1985.54.1.134; Guyon A, 1999, J PHYSIOL-LONDON, V516, P719, DOI 10.1111/j.1469-7793.1999.0719u.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; HORNE AL, 1993, BRIT J PHARMACOL, V108, P711; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; KROUSE ME, 1986, NATURE, V319, P58, DOI 10.1038/319058a0; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; Luu T, 2005, J MEMBRANE BIOL, V205, P17, DOI 10.1007/s00232-005-0759-2; Nusser Z, 1998, J NEUROSCI, V18, P1693; OLIVERAS JL, 1994, NEUROSCI LETT, V179, P21, DOI 10.1016/0304-3940(94)90925-3; SAKMANN B, 1983, SINGLE CHANNEL RECOR, P163; SMITH SM, 1989, J MEMBRANE BIOL, V108, P45, DOI 10.1007/BF01870424; STUDY RE, 1981, P NATL ACAD SCI-BIOL, V78, P7180, DOI 10.1073/pnas.78.11.7180; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Williams DB, 2000, MOL PHARMACOL, V58, P1129, DOI 10.1124/mol.58.5.1129	28	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35699	35708		10.1074/jbc.M605590200	http://dx.doi.org/10.1074/jbc.M605590200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	16954214	hybrid			2022-12-27	WOS:000242100500014
J	Wang, YP; Su, B; Xia, ZG				Wang, Yupeng; Su, Bing; Xia, Zhengui			Brain-derived neurotrophic factor activates ERK5 in cortical neurons via a Rap1-MEKK2 signaling cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; N-TERMINAL KINASE; C-JUN PROMOTER; PROTEIN-KINASE; GENE-EXPRESSION; NH2-TERMINAL KINASE; CELL-PROLIFERATION; REGULATED KINASE-5; INDUCED APOPTOSIS; TRK RECEPTORS	The extracellular signal-regulated kinase 5 (ERK5)is activated in neurons of the central nervous system by neurotrophins including brain-derived neurotrophic factor ( BDNF). Although MEK5 is known to mediate BDNF stimulation of ERK5 in central nervous system neurons, other upstream signaling components have not been identified. Here, we report that BDNF induces a sustained activation of ERK5 in rat cortical neurons and activates Rap1, a small GTPase, as well as MEKK2,a MEK5 kinase. Our data indicate that activation of Rap1 or MEKK2 is sufficient to stimulate ERK5, whereas inhibition of either Rap1 or MEKK2 attenuates BDNF activation of ERK5. Furthermore, BDNF stimulation of MEKK2 is regulated by Rap1. Our evidence also indicates that Ras and MEKK3, a MEK5 kinase in non- neuronal cells, do not play a significant role in BDNF activation of ERK5. This study identifies Rap1 and MEKK2 as critical upstream signaling molecules mediating BDNF stimulation of ERK5 in central nervous system neurons.	Univ Washington, Dept Environm & Occupat Hlth Sci, Toxicol Program, Seattle, WA 98195 USA; Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; UTMD Anderson Cancer Center	Xia, ZG (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Toxicol Program, Box 357234,HSB,Rm F561C, Seattle, WA 98195 USA.	zxia@u.washington.edu			NIA NIH HHS [AG19193] Funding Source: Medline; NICHD NIH HHS [P30 HD02274] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019193] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Boudin H, 2000, J NEUROSCI, V20, P5932, DOI 10.1523/JNEUROSCI.20-16-05932.2000; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Chayama K, 2001, P NATL ACAD SCI USA, V98, P4599, DOI 10.1073/pnas.081021898; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Devon RS, 2006, P NATL ACAD SCI USA, V103, P9595, DOI 10.1073/pnas.0510197103; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; English JM, 1999, J BIOL CHEM, V274, P31588, DOI 10.1074/jbc.274.44.31588; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; GIBSON AE, 1989, AM J PHYSIOL, V257, pC182, DOI 10.1152/ajpcell.1989.257.2.C182; Grimes ML, 1996, J NEUROSCI, V16, P7950; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Hayashi T, 2000, NEUROSCI LETT, V284, P195, DOI 10.1016/S0304-3940(00)01024-7; Hayashi Y, 2001, BIOCHEM BIOPH RES CO, V281, P682, DOI 10.1006/bbrc.2001.4338; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kesavan K, 2004, J CELL PHYSIOL, V199, P140, DOI 10.1002/jcp.10457; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Poser S, 2003, J NEUROSCI, V23, P4420; Prieto-Sanchez RM, 2006, ONCOGENE, V25, P2961, DOI 10.1038/sj.onc.1209333; Shalizi A, 2003, J NEUROSCI, V23, P7326; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; XIA Z, 1996, MAMMALIAN ADENYLYL C; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; Yano H, 2004, J NEUROBIOL, V58, P244, DOI 10.1002/neu.10321; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zwaagstra JC, 2001, J BIOL CHEM, V276, P27237, DOI 10.1074/jbc.M100033200	62	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2006	281	47					35965	35974		10.1074/jbc.M605503200	http://dx.doi.org/10.1074/jbc.M605503200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	106KX	17003042	hybrid			2022-12-27	WOS:000242100500043
J	Ballar, P; Shen, YX; Yang, H; Fang, SY				Ballar, Petek; Shen, Yuxian; Yang, Hui; Fang, Shengyun			The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; MOTILITY FACTOR-RECEPTOR; PEPTIDE-N-GLYCANASE; UBIQUITIN LIGASE; QUALITY-CONTROL; AAA-ATPASE; P97-UFD1-NPL4 COMPLEX; RETRO-TRANSLOCATION; P97; RETROTRANSLOCATION	Improperly folded proteins in the endoplasmic reticulum (ER) are eliminated via ER-associated degradation, a process that dislocates misfolded proteins from the ER membrane into the cytosol, where they undergo proteasomal degradation. Dislocation requires a subclass of ubiquitin ligases that includes gp78 in addition to the AAA ATPase p97/VCP and its cofactor, the Ufd1-Np14 dimer. We have previously reported that gp78 interacts directly with p97/VCP. Here, we identify a novel p97/VCP-interacting motif (VIM) within gp78 that mediates this interaction. We demonstrate that the VIM of gp78 recruits p97/VCP to the ER, but has no effect on Ufd1 localization. We also show that gp78 VIM interacts with the ND1 domain of p97/VCP that was shown previously to be the binding site for Ufd1. To evaluate the role of Ufd1 in gp78-p97/VCP-mediated degradation of CD3 delta, a known substrate of gp78, RNA interference was used to silence the expression of Ufd1 and p97/VCP. Inhibition of p97/VCP, but not Ufd1, stabilized CD3 delta in cells that overexpress gp78. However, both p97/VCP and Ufd1 appear to be required for CD3 delta degradation in cells expressing physiological levels of gp78. These results raise the possibility that Ufd1 and gp78 may bind p97/VCP in a mutually exclusive manner and suggest that gp78 might act in a Ufd1-independent degradation pathway for misfolded ER proteins, which operates in parallel with the previously established p97/VCP-Ufd1-Npl4-mediated mechanism.	Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, Baltimore, MD 21201 USA; Anhui Med Univ, Inst Clin Pharmacol, Hefei, Peoples R China; Univ Maryland, Sch Med, Program Mol Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Anhui Medical University; University System of Maryland; University of Maryland Baltimore	Fang, SY (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, UMBI Bldg,N359,725 W Lombard St, Baltimore, MD 21201 USA.	fangs@umbi.umd.edu	Kirmizibayrak, Petek Ballar/Y-6869-2018; Fang, Shengyun/H-3802-2011	Kirmizibayrak, Petek Ballar/0000-0002-6189-1818; Shen, Yuxian/0000-0002-0916-0743; Fang, Shengyun/0000-0001-7280-5463	NIGMS NIH HHS [R01 GM69967, R01 GM069967] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069967] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Federovitch CM, 2005, CURR OPIN CELL BIOL, V17, P409, DOI 10.1016/j.ceb.2005.06.010; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Li GT, 2005, P NATL ACAD SCI USA, V102, P15809, DOI 10.1073/pnas.0507155102; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MULLALLYJE, 2006, MOL CELL BIOL, V26, P822; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	43	110	112	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35359	35368		10.1074/jbc.M603355200	http://dx.doi.org/10.1074/jbc.M603355200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16987818	hybrid			2022-12-27	WOS:000241933700070
J	Jenei, V; Deevi, RK; Adams, CA; Axelsson, L; Hirst, DG; Andersson, T; Dib, K				Jenei, Veronika; Deevi, Ravi Kiran; Adams, Catherine Anne; Axelsson, Lena; Hirst, David Graham; Andersson, Tommy; Dib, Karim			Nitric oxide produced in response to engagement of beta 2 integrins on human neutrophils activates the monomeric GTPases Rap1 and Rap2 and promotes adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; ADHERENT HUMAN NEUTROPHILS; DEPENDENT PROTEIN-KINASE; BETA(2) INTEGRIN; TYROSINE KINASE; SELECTIVE-INHIBITION; ACTIN POLYMERIZATION; CHEMOTACTIC PEPTIDE; RESPIRATORY BURST; MEDIATED ADHESION	We found that engagement of beta 2 integrins on human neutrophils increased the levels of GTP-bound Rap1 and Rap2. Also, the activation of Rap1 was blocked by PP1, SU6656, LY294002, GF109203X, or BAPTA-AM, which indicates that the downstream signaling events in Rap1 activation involve Src tyrosine kinases, phosphoinositide 3-kinase, protein kinase C, and release of calcium. Surprisingly, the beta 2 integrin-induced activation of Rap2 was not regulated by any of the signaling pathways mentioned above. However, we identified nitric oxide as the signaling molecule involved in beta 2 integrin-induced activation of Rap1 and Rap2. This was illustrated by the fact that engagement of beta 2 integrins increased the production of nitrite, a stable end-product of nitric oxide. Furthermore, pretreatment of neutrophils with N-omega-mono-methy1-L-arginine, or 1400W, which are inhibitors of inducible nitric- oxide synthase, blocked beta 2 integrin-induced activation of Rap1 and Rap2. Similarly, R-P-8pCPT-cGMPS, an inhibitor of cGMP-dependent serine/threonine kinases, also blunted the beta 2 integrin-induced activation of Rap GTPases. Also nitric oxide production and its downstream activation of cGMP-dependent serine/threonine kinases were essential for proper neutrophil adhesion by beta 2 integrins. Thus, we made the novel findings that beta 2 integrin engagement on human neutrophils triggers production of nitric oxide and its downstream signaling is essential for activation of Rap GTPases and neutrophil adhesion.	Lund Univ, Malmo Univ Hosp, Dept Lab Med, Div Expt Pathol, SE-20502 Malmo, Sweden; Queens Univ Belfast, Ctr Canc Res & Cell Biol, Div Infect & Immun, Immunol Sect, Belfast BT9 7BL, Antrim, North Ireland; Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland	Lund University; Skane University Hospital; Queens University Belfast; Queens University Belfast	Dib, K (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, Div Expt Pathol, SE-20502 Malmo, Sweden.	k.dib@qub.ac.uk						Axelsson L, 2000, EXP CELL RES, V256, P257, DOI 10.1006/excr.2000.4816; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BERTON G, 1992, J CELL BIOL, V116, P1007, DOI 10.1083/jcb.116.4.1007; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P31; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; Cabanis A, 1996, GEN PHARMACOL, V27, P1409, DOI 10.1016/S0306-3623(96)00053-5; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Cedergren J, 2003, APMIS, V111, P963, DOI 10.1034/j.1600-0463.2003.1111008.x; Dib K, 2000, FRONT BIOSCI-LANDMRK, V5, pD438, DOI 10.2741/Pathology; Dib K, 2003, J BIOL CHEM, V278, P24181, DOI 10.1074/jbc.M302300200; Dib K, 2001, J IMMUNOL, V166, P6311, DOI 10.4049/jimmunol.166.10.6311; DING JB, 1995, J BIOL CHEM, V270, P11684, DOI 10.1074/jbc.270.19.11684; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FALLMAN M, 1992, J BIOL CHEM, V267, P2656; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hellberg C, 1996, BIOCHEM J, V317, P403, DOI 10.1042/bj3170403; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; KIKKAWA U, 1984, ADV CYCLIC NUCL PROT, V17, P437; Kinashi T, 2004, BLOOD, V103, P1033, DOI 10.1182/blood-2003-07-2499; KLEBANOFF SJ, 1993, BIOCHEM BIOPH RES CO, V197, P192, DOI 10.1006/bbrc.1993.2459; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Kosonen O, 1999, EUR J PHARMACOL, V382, P111, DOI 10.1016/S0014-2999(99)00581-6; Larfars G, 1999, BLOOD, V93, P1399, DOI 10.1182/blood.V93.4.1399.404k07_1399_1405; LOFGREN R, 1993, J CELL BIOL, V123, P1597, DOI 10.1083/jcb.123.6.1597; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; M'Rabet L, 1998, BLOOD, V92, P2133, DOI 10.1182/blood.V92.6.2133.418k19_2133_2140; MARIDONNEAUPARINI I, 1992, J BIOL CHEM, V267, P6396; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Mittar D, 2004, BIOCHEM BIOPH RES CO, V322, P203, DOI 10.1016/j.bbrc.2004.07.107; Mocsai A, 1999, J IMMUNOL, V162, P1120; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; MOLLINEDO F, 1993, FEBS LETT, V326, P209, DOI 10.1016/0014-5793(93)81792-X; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; OKADA T, 1994, J BIOL CHEM, V269, P3563; PRYZWANSKY KB, 1990, BLOOD, V76, P612; Reedquist KA, 1998, J BIOL CHEM, V273, P4944, DOI 10.1074/jbc.273.9.4944; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; RICHTER J, 1990, P NATL ACAD SCI USA, V87, P9472, DOI 10.1073/pnas.87.23.9472; Saini R, 2006, J LEUKOCYTE BIOL, V79, P519, DOI 10.1189/jlb.0605320; SAKUMA I, 1988, P NATL ACAD SCI USA, V85, P8664, DOI 10.1073/pnas.85.22.8664; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHMIDT HHHW, 1989, FEBS LETT, V244, P357, DOI 10.1016/0014-5793(89)80562-9; SENGELOV H, 1993, J CLIN INVEST, V92, P1467, DOI 10.1172/JCI116724; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wallerath T, 1997, THROMB HAEMOSTASIS, V77, P163; Wanikiat P, 1997, BRIT J PHARMACOL, V122, P1135, DOI 10.1038/sj.bjp.0701477; Webb JL, 2001, CLIN EXP IMMUNOL, V123, P42, DOI 10.1046/j.1365-2249.2001.01402.x; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; WINEGAR DA, 1991, J BIOL CHEM, V266, P4381; Worthington J, 2005, GENE THER, V12, P1417, DOI 10.1038/sj.gt.3302552; WRIGHT CD, 1989, BIOCHEM BIOPH RES CO, V160, P813, DOI 10.1016/0006-291X(89)92506-0; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; Yakubenko VP, 2001, J BIOL CHEM, V276, P13995, DOI 10.1074/jbc.M010174200; Yan SR, 1997, J IMMUNOL, V158, P1902; Zheng LM, 1996, P NATL ACAD SCI USA, V93, P8431, DOI 10.1073/pnas.93.16.8431	68	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35008	35020		10.1074/jbc.M601335200	http://dx.doi.org/10.1074/jbc.M601335200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16963453	hybrid			2022-12-27	WOS:000241933700034
J	Johnson, A; Yao, NY; Bowman, GD; Kuriyan, J; O'Donnell, M				Johnson, Aaron; Yao, Nina Y.; Bowman, Gregory D.; Kuriyan, John; O'Donnell, Mike			The replication factor C clamp loader requires arginine finger sensors to drive DNA binding and proliferating cell nuclear antigen loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; ESCHERICHIA-COLI; POLYMERASE-DELTA; SLIDING CLAMP; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; GAMMA-COMPLEX; STRUCTURAL-ANALYSIS; ACCESSORY PROTEINS	Replication factor C (RFC) is an AAA+ heteropentamer that couples the energy of ATP binding and hydrolysis to the loading of the DNA polymerase processivity clamp, proliferating cell nuclear antigen (PCNA), onto DNA. RFC consists of five subunits in a spiral arrangement (RFC-A, -B, -C, -D, and -E, corresponding to subunits RFC1, RFC4, RFC3, RFC2, and RFC5, respectively). The RFC subunits are AAA+ family proteins and the complex contains four ATP sites (sites A, B, C, and D) located at subunit interfaces. In each ATP site, an arginine residue from one subunit is located near the gamma-phosphate of ATP bound in the adjacent subunit. These arginines act as "arginine fingers" that can potentially perform two functions: sensing that ATP is bound and catalyzing ATP hydrolysis. In this study, the arginine fingers in RFC were mutated to examine the steps in the PCNA loading mechanism that occur after RFC binds ATP. This report finds that the ATP sites of RFC function in distinct steps during loading of PCNA onto DNA. ATP binding to RFC powers recruitment and opening of PCNA and activates a gamma-phosphate sensor in ATP site C that promotes DNA association. ATP hydrolysis in site D is uniquely stimulated by PCNA, and we propose that this event is coupled to PCNA closure around DNA, which starts an ordered hydrolysis around the ring. PCNA closure severs contact to RFC subunits D and E (RFC2 and RFC5), and the gamma-phosphate sensor of ATP site C is switched off, resulting in low affinity of RFC for DNA and ejection of RFC from the site of PCNA loading.	Howard Hughes Med Inst, Lab DNA Replicat, New York, NY 10021 USA; Rockefeller Univ, New York, NY 10021 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Johns Hopkins University	O'Donnell, M (corresponding author), 1230 York Ave,Box 228, New York, NY 10021 USA.	odonnel@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	NIGMS NIH HHS [GM38839, GM45547, F32 GM066586-02, F32 GM066586, F32 GM066586-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, F32GM066586, R01GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Ason B, 2003, J BIOL CHEM, V278, P10033, DOI 10.1074/jbc.M211741200; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Cai JS, 1998, P NATL ACAD SCI USA, V95, P11607, DOI 10.1073/pnas.95.20.11607; CHEN M, 1992, P NATL ACAD SCI USA, V89, P5211, DOI 10.1073/pnas.89.12.5211; CHEN M, 1992, P NATL ACAD SCI USA, V89, P2516, DOI 10.1073/pnas.89.7.2516; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; Ellison V, 1998, J BIOL CHEM, V273, P5979, DOI 10.1074/jbc.273.10.5979; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; Goedken ER, 2005, NAT STRUCT MOL BIOL, V12, P183, DOI 10.1038/nsmb889; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Hingorani MM, 2002, J BIOL CHEM, V277, P47213, DOI 10.1074/jbc.M206764200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; KELMAN Z, 1995, GENE, V166, P177, DOI 10.1016/0378-1119(95)00556-7; Kornberg A., 1992, DNA REPLICATION; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; LEE SH, 1991, J BIOL CHEM, V266, P594; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Mossi R, 1997, J BIOL CHEM, V272, P1769, DOI 10.1074/jbc.272.3.1769; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; Neuwald AF, 1999, GENOME RES, V9, P27; O'Donnell M, 2001, CURR BIOL, V11, pR935, DOI 10.1016/S0960-9822(01)00559-0; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Oku T, 1998, GENES CELLS, V3, P357, DOI 10.1046/j.1365-2443.1998.00199.x; Podust VN, 1998, J BIOL CHEM, V273, P12935, DOI 10.1074/jbc.273.21.12935; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; Seybert A, 2004, EMBO J, V23, P1360, DOI 10.1038/sj.emboj.7600130; Seybert A, 2006, EMBO J, V25, P2209, DOI 10.1038/sj.emboj.7601093; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TAN CK, 1986, J BIOL CHEM, V261, P2310; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Turner J, 1995, METHOD ENZYMOL, V262, P442; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Uhlmann F, 1997, J BIOL CHEM, V272, P10065; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Yao N, 2003, J BIOL CHEM, V278, P50744, DOI 10.1074/jbc.M309206200; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; ZHUANG Z, 2006, P NATL ACAD SCI US	71	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35531	35543		10.1074/jbc.M606090200	http://dx.doi.org/10.1074/jbc.M606090200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16980295	hybrid			2022-12-27	WOS:000241933700086
J	Lindvall, C; Evans, NC; Zylstra, CR; Li, Y; Alexander, CM; Williams, BO				Lindvall, Charlotta; Evans, Nicole C.; Zylstra, Cassandra R.; Li, Yi; Alexander, Caroline M.; Williams, Bart O.			The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; PROGENITOR CELLS; BREAST-CANCER; TRANSGENIC MICE; SELF-RENEWAL; GLAND; MOUSE; EXPRESSION; TUMORS	Canonical Wnt signaling has emerged as a critical regulatory pathway for stem cells. The association between ectopic activation of Wnt signaling and many different types of human cancer suggests that Wnt ligands can initiate tumor formation through altered regulation of stem cell populations. Here we have shown that mice deficient for the Wnt co-receptor Lrp5 are resistant to Wnt1-induced mammary tumors, which have been shown to be derived from the mammary stem/progenitor cell population. These mice exhibit a profound delay in tumorigenesis that is associated with reduced Wnt1-induced accumulation of mammary progenitor cells. In addition to the tumor resistance phenotype, loss of Lrp5 delays normal mammary development. The ductal trees of 5-week-old Lrp5(-/-) females have fewer terminal end buds, which are structures critical for juvenile ductal extension presumed to be rich in stem/progenitor cells. Consequently, the mature ductal tree is hypomorphic and does not completely fill the fat pad. Furthermore, Lrp5(-/-) ductal cells from mature females exhibit little to no stem cell activity in limiting dilution transplants. Finally, we have shown that Lrp5(-/-) embryos exhibit substantially impaired canonical Wnt signaling in the primitive stem cell compartment of the mammary placodes. These findings suggest that Lrp5-mediated canonical signaling is required for mammary ductal stem cell activity and for tumor development in response to oncogenic Wnt effectors.	Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI 49503 USA; Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA	University of Wisconsin System; University of Wisconsin Madison; Van Andel Institute; Baylor College of Medicine	Williams, BO (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	Bart.Williams@vai.org	Williams, Bart/A-3539-2013; Li, Yi/A-7635-2009	Williams, Bart/0000-0002-5261-5301; Li, Yi/0000-0002-9976-518X; Diegel, Cassandra/0000-0002-6526-9372	NATIONAL CANCER INSTITUTE [R01CA113869] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113869-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Brisken C, 2000, GENE DEV, V14, P650; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kenney Nicholas J., 2001, Journal of Biomedicine and Biotechnology, V1, P133, DOI 10.1155/S1110724301000304; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Klopocki E, 2004, INT J ONCOL, V25, P641; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu GZ, 2005, MOL CELL BIOL, V25, P3475, DOI 10.1128/MCB.25.9.3475-3482.2005; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Paguirigan A, 2006, EUR J CANCER, V42, P1225, DOI 10.1016/j.ejca.2006.01.048; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sharpe C, 2001, BIOESSAYS, V23, P311, DOI 10.1002/bies.1045; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tepera SB, 2003, J CELL SCI, V116, P1137, DOI 10.1242/jcs.00334; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; WILLIAMS JM, 1983, DEV BIOL, V97, P274, DOI 10.1016/0012-1606(83)90086-6	43	125	140	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					35081	35087		10.1074/jbc.M607571200	http://dx.doi.org/10.1074/jbc.M607571200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16973609	hybrid			2022-12-27	WOS:000241933700041
J	Park, SS; Kim, JM; Kim, DS; Kim, IH; Kim, SY				Park, Sung-Soo; Kim, Jung-Mo; Kim, Dae-Seok; Kim, In-Hoo; Kim, Soo-Youl			Transglutaminase 2 mediates polymer formation of I-kappa B alpha through C-terminal glutamine cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-THERAPY; ACTIVATION; KINASE; PHOSPHORYLATION; INFLAMMATION; INHIBITION; PEPTIDE; DEGRADATION; PROTEOLYSIS; PROTEASOME	Recently we reported that transglutaminase 2 (TGase 2) activates nuclear factor-kappa B (NF-kappa B) independently of I-kappa B kinase (IKK) activation, by inducing cross-linking and protein polymer formation of inhibitor of nuclear factor-kappa B alpha (I-kappa B alpha). TGase 2 catalyzes covalent isopeptide bond formation between the peptide bound-glutamine and the lysine residues. Using matrix-assisted laser desorption ionization time-of-flight mass spectra analysis of I-kappa B alpha polymers cross-linked by TGase 2, as well as synthetic peptides in an in vitro competition assay, we identified a glutamine cluster at the C terminus of I-kappa B alpha (amino acids 266-268) that appeared to play a key role in the formation of I-kappa B alpha polymers. Although there appeared to be no requirement for specific lysine residues, we found a considerably higher preference for the use of lysine residues at positions 21, 22, and 177 in TGase 2-mediated cross-linking of I-kappa B alpha. We demonstrated that synthetic peptides encompassing the glutamine cluster at amino acid positions 266-268 reversed I-kappa B alpha polymerization in vitro. Furthermore, the depletion of free I-kappa B alpha in EcR/TG cells was completely rescued in vivo by transfection of mutant I-kappa B alpha s in glutamine sites (Q266G, Q267G, and Q313G) as well as in a lysine site (K177G). These findings provide additional clues into the mechanism by which TGase 2 contributes to the inflammatory process via activation of NF-kappa B.	Natl Canc Ctr, Inst Res, Mol Oncol Branch, Div Basic Sci, Goyang 411769, Gyeonggi, South Korea	National Cancer Center - Korea (NCC)	Kim, SY (corresponding author), Natl Canc Ctr, Inst Res, Mol Oncol Branch, Div Basic Sci, 809 Madu 1 Dong, Goyang 411769, Gyeonggi, South Korea.	kimsooyoul@gmail.com						Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Matsumoto N, 2000, BIOORG MED CHEM LETT, V10, P865, DOI 10.1016/S0960-894X(00)00114-1; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; MEHTA K, 1994, INT J CANCER, V58, P400, DOI 10.1002/ijc.2910580316; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Mirza A, 1997, AM J PHYSIOL-GASTR L, V272, pG281, DOI 10.1152/ajpgi.1997.272.2.G281; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; PAWSON T, 1995, NATURE, V373, P477, DOI 10.1038/373477a0; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sohn J, 2003, J CLIN INVEST, V111, P121, DOI 10.1172/JCI200315937; Suh GY, 2006, EXP LUNG RES, V32, P43, DOI 10.1080/01902140600691514; SUN S, 1996, MOL CELL BIOL, V6, P1058; Swaroop N, 2001, PHARMACEUT RES, V18, P1631, DOI 10.1023/A:1013051019098; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Umezawa K, 2002, MOL CELLS, V14, P163; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zavrski I, 2005, ANTI-CANCER DRUG, V16, P475, DOI 10.1097/00001813-200506000-00002	30	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34965	34972		10.1074/jbc.M604150200	http://dx.doi.org/10.1074/jbc.M604150200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16987813	hybrid			2022-12-27	WOS:000241933700029
J	Wang, SY; Iordanov, M; Zhang, QH				Wang, Su-Yan; Iordanov, Mihail; Zhang, Qinghong			C-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN KINASE-2; METASTASIS SUPPRESSOR GENE; SIGNAL-TRANSDUCTION PATHWAY; N-TERMINAL KINASE; OVARIAN-CARCINOMA; CELL-DEATH; CANCER METASTASIS; TUMOR-SUPPRESSOR; BINDING PROTEIN; E1A PROTEIN	Genetic knock out of the transcriptional co-repressor carboxyl-terminal- binding protein (CtBP) in mouse embryonic fibroblasts results in up-regulation of several genes involved in apoptosis. We predicted, therefore, that a propensity toward apoptosis might be regulated through changes in cellular CtBP levels. Previously, we have identified the homeodomain-interacting protein kinase 2 as such a regulator and demonstrated that HIPK2 activation causes Ser-422 phosphorylation and degradation of CtBP. In this study, we found that c-Jun NH2-terminal kinase 1 activation triggered CtBP phosphorylation on Ser-422 and subsequent degradation, inducing p53-independent apoptosis in human lung cancer cells. JNK1 has previously been linked to UV-directed apoptosis. Expression of MKK7-JNK1 or exposure to UV irradiation reduced cellular levels of CtBP via a proteasome-mediated pathway. This effect was prevented by JNK1 deficiency. In addition, sustained activation of the JNK1 pathway by cisplatin similarly triggered CtBP degradation. These findings provide a novel target for chemotherapy in cancers lacking p53.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Zhang, QH (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhangq@ohsu.edu			NCI NIH HHS [R01 CA115468, R01 CA115468-05, 5K01CA096561, K01 CA096561] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA115468, K01CA096561] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; CHINNADURAI G, 2005, CTBP FAMILY PROTEINS; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Debies MT, 2001, J MAMMARY GLAND BIOL, V6, P441, DOI 10.1023/A:1014739131690; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Iordanov Mihail S., 2000, Molecular Cell Biology Research Communications, V4, P122, DOI 10.1006/mcbr.2000.0266; Iordanov MS, 1999, J BIOL CHEM, V274, P25801, DOI 10.1074/jbc.274.36.25801; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kim HL, 2001, CANCER RES, V61, P2833; La Rosee-Borggreve A, 1999, MECH DEVELOP, V89, P133, DOI 10.1016/S0925-4773(99)00219-1; Lai ZC, 1999, GENETICS, V152, P299; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Levresse V, 2002, MOL PHARMACOL, V62, P689, DOI 10.1124/mol.62.3.689; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Mansouri A, 2003, ONCOL RES, V13, P399; Melhuish TA, 2000, J BIOL CHEM, V275, P39762, DOI 10.1074/jbc.C000416200; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; SUBRAMANIAN T, 1989, ONCOGENE, V4, P415; Teng DHF, 1997, CANCER RES, V57, P4177; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Wu CW, 2000, AM J PATHOL, V156, P2007, DOI 10.1016/S0002-9440(10)65073-0; Yamada SD, 2002, CANCER RES, V62, P6717; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yoshida BA, 1999, CANCER RES, V59, P5483; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102	42	40	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2006	281	46					34810	34815		10.1074/jbc.M607484200	http://dx.doi.org/10.1074/jbc.M607484200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104CN	16984892	hybrid			2022-12-27	WOS:000241933700013
J	Gaigg, B; Toulmay, A; Schneiter, R				Gaigg, Barbara; Toulmay, Alexandre; Schneiter, Roger			Very long-chain fatty acid-containing lipids rather than sphingolipids per se are required for raft association and stable surface transport of newly synthesized plasma membrane ATPase in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL PHOSPHORYLCERAMIDE SYNTHASE; SPHINGOID BASE SYNTHESIS; GPI-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; CELL-SURFACE; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; SUBCELLULAR MEMBRANES; SECRETORY VESICLES; EXOCYTIC PATHWAY	The proton-pumping H+-ATPase, Pma1p, is an abundant and very long lived polytopic protein of the yeast plasma membrane. Pma1p constitutes a major cargo of the secretory pathway and thus serves as a model to study plasma membrane biogenesis. Pma1p associates with detergent-resistant membrane domains (lipid "rafts") already in the ER, and a lack of raft association correlates with mistargeting of the protein to the vacuole, where it is degraded. We are analyzing the role of specific lipids in membrane domain formation and have previously shown that surface transport of Pma1p is independent of newly synthesized sterols but that sphingolipids with C26 very long chain fatty acid are crucial for raft association and surface transport of Pma1p (Gaigg, B., Timischl, B., Corbino, L., and Schneiter, R. (2005) J. Biol. Chem. 280, 22515 - 22522). We now describe a more detailed analysis of the function that sphingolipids play in this process. Using a yeast strain in which the essential function of sphingolipids is substituted by glycerophospholipids containing C26 very long chain fatty acids, we find that sphingolipids per se are dispensable for raft association and surface delivery of Pma1p but that the C26 fatty acid is crucial. We thus conclude that the essential function of sphingolipids for membrane domain formation and stable surface delivery of Pma1p is provided by the C26 fatty acid that forms part of the yeast ceramide.	Univ Fribourg, Div Biochem, Dept Med, CH-1700 Fribourg, Switzerland	University of Fribourg	Schneiter, R (corresponding author), Univ Fribourg, Div Biochem, Dept Med, Chem Musee 5, CH-1700 Fribourg, Switzerland.	roger.schneiter@unifr.ch		Schneiter, Roger/0000-0002-9102-8396				Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chung N, 2000, J BIOL CHEM, V275, P17229, DOI 10.1074/jbc.C000229200; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; DICKSON RC, 1990, MOL CELL BIOL, V10, P2176, DOI 10.1128/MCB.10.5.2176; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; DULIC V, 1991, METHOD ENZYMOL, V194, P697; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; GROVE SN, 1968, SCIENCE, V161, P171, DOI 10.1126/science.161.3837.171; Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602; Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; HUI SW, 1984, BIOCHEMISTRY-US, V23, P5570, DOI 10.1021/bi00318a029; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; LESTER RL, 1993, J BIOL CHEM, V268, P845; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; MATTAI J, 1987, BIOCHEMISTRY-US, V26, P3287, DOI 10.1021/bi00386a007; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Ramstedt B, 2002, FEBS LETT, V531, P33, DOI 10.1016/S0014-5793(02)03406-3; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Sutterlin C, 1997, EMBO J, V16, P6374, DOI 10.1093/emboj/16.21.6374; Sutterlin C, 1997, J CELL SCI, V110, P2703; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	49	71	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2006	281	45					34135	34145		10.1074/jbc.M603791200	http://dx.doi.org/10.1074/jbc.M603791200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	101UZ	16980694	Green Submitted, hybrid			2022-12-27	WOS:000241767600034
J	Kar, K; Amin, P; Bryan, MA; Persikov, AV; Mohs, A; Wang, YH; Brodsky, B				Kar, Karunakar; Amin, Priyal; Bryan, Michael A.; Persikov, Anton V.; Mohs, Angela; Wang, Yuh-Hwa; Brodsky, Barbara			Self-association of collagen triple helix peptides into higher order structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE; I COLLAGEN; FIBRIL FORMATION; MODEL PEPTIDES; SALT CONCENTRATION; CRYSTAL-STRUCTURE; STABILITY; SEQUENCE; INVITRO; HYDROXYPROLINE	Interest in self-association of peptides and proteins is motivated by an interest in the mechanism of physiologically higher order assembly of proteins such as collagen as well as the mechanism of pathological aggregation such as beta-amyloid formation. The triple helical form of (Pro-Hyp-Gly)(10), a peptide that has proved a useful model for molecular features of collagen, was found to self-associate, and its association properties are reported here. Turbidity experiments indicate that the triple helical peptide self-assembles at neutral pH via a nucleation-growth mechanism, with a critical concentration near 1 mM. The associated form is more stable than individual molecules by about 25 degrees C, and the association is reversible. The rate of self-association increases with temperature, supporting an entropically favored process. After self-association, (Pro-Hyp-Gly)(10) forms branched filamentous structures, in contrast with the highly ordered axially periodic structure of collagen fibrils. Yet a number of characteristics of triple helix assembly for the peptide resemble those of collagen fibril formation. These include promotion of fibril formation by neutral pH and increasing temperature; inhibition by sugars; and a requirement for hydroxyproline. It is suggested that these similar features for peptide and collagen self-association are based on common lateral underlying interactions between triple helical molecules mediated by hydrogen-bonded hydration networks involving hydroxyproline.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Brodsky, B (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	brodsky@umdnj.edu		/0000-0001-7047-6539	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM072149, R01GM060048] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60048, GM072149] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5; BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Berisio R, 2001, BIOPOLYMERS, V56, P8, DOI 10.1002/1097-0282(2000)56:1<8::AID-BIP1037>3.0.CO;2-W; BIANCHI E, 1967, J BIOL CHEM, V242, P1361; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Brittingham R, 2005, J BIOL CHEM, V280, P191, DOI 10.1074/jbc.M406210200; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Chen M, 2001, J BIOL CHEM, V276, P21649, DOI 10.1074/jbc.M100180200; COMPER WD, 1977, BIOPOLYMERS, V16, P2113, DOI 10.1002/bip.1977.360161004; COOPER A, 1970, BIOCHEM J, V118, P355, DOI 10.1042/bj1180355; ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310; Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W; FRASER RDB, 1973, CONFORMATION FIBROUS, P385; GELMAN RA, 1980, J BIOL CHEM, V255, P8098; Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; GUSTAVSON KH, 1955, NATURE, V175, P70, DOI 10.1038/175070a0; HAYASHI T, 1978, J BIOCHEM-TOKYO, V84, P245, DOI 10.1093/oxfordjournals.jbchem.a132124; Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; KADLER KE, 1988, J BIOL CHEM, V263, P10517; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Kishimoto T, 2005, BIOPOLYMERS, V79, P163, DOI 10.1002/bip.20348; Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; Kuznetsova N, 1998, BIOCHEMISTRY-US, V37, P11888, DOI 10.1021/bi980089+; LEIKIN S, 1995, NAT STRUCT BIOL, V2, P205, DOI 10.1038/nsb0395-205; Martin R, 2003, BIOPOLYMERS, V70, P435, DOI 10.1002/bip.10464; MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; NA GC, 1986, J BIOL CHEM, V261, P2290; NA GC, 1989, BIOCHEMISTRY-US, V28, P7153, DOI 10.1021/bi00444a004; Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288; Oosawa F., 1975, THERMODYNAMICS POLYM; Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Tiktopulo EI, 1998, BIOCHEMISTRY-US, V37, P8147, DOI 10.1021/bi980360n; Valluzzi R, 2000, BIOPOLYMERS, V53, P350, DOI 10.1002/(SICI)1097-0282(20000405)53:4<350::AID-BIP7>3.0.CO;2-O; VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023; Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V; WALLACE DG, 1983, BIOPOLYMERS, V22, P1793, DOI 10.1002/bip.360220713; Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198; YURCHENCO PD, 1988, AM J PATHOL, V132, P278	52	110	114	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33283	33290		10.1074/jbc.M605747200	http://dx.doi.org/10.1074/jbc.M605747200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16963782	hybrid			2022-12-27	WOS:000241621400038
J	Luke, MPS; Sui, GC; Liu, HF; Shi, Y				Luke, Margaret Po-Shan; Sui, Guangchao; Liu, Huifei; Shi, Yang			Yin Yang 1 physically interacts with Hoxa11 and represses Hoxa11-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; DNA-BINDING; FACTOR YY1; HOMEOTIC TRANSFORMATIONS; HISTONE DEACETYLASES; HOMEODOMAIN PROTEINS; TUMOR-SUPPRESSOR; MUTANT MICE; POLYCOMB	Yin Yang 1 (YY1) plays an indispensable role in embryonic development. YY1 contains an evolutionarily conserved, 22-amino acid segment, the PHO homology region (PHR), which is located within its central domain (spacer) and has been shown previously to participate in the recruitment of Polycomb group of proteins and in YY1-mediated transcription. In this report, we show that the PHR physically interacts with several Abd-B-type Hox proteins. Although ectopic expression of Hoxa11 enhanced target promoter activity, overexpression of YY1 repressed this effect, which was abrogated by YY1 siRNA and the histone deacetylase inhibitor trichostatin A. We have further demonstrated that this suppression effect was the result of YY1-dependent recruitment of HDAC2 to the Hoxa11 target promoter. Taken together, our findings show that YY1 represses Hoxa11-dependent transcription via interactions with the Hox proteins and HDAC recruitment, providing a link between an Abd-type Hox protein and a Polycomb group protein at the level of direct protein-protein interactions. These findings not only provide a novel insight into YY1 function but also identify a new regulation of homeotic protein-mediated transcriptional regulation in general.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu		Sui, Guangchao/0000-0002-8164-5585	NIGMS NIH HHS [GM53874] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Bennett MK, 1999, J BIOL CHEM, V274, P13025, DOI 10.1074/jbc.274.19.13025; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bomgardner D, 2003, BIOL REPROD, V68, P644, DOI 10.1095/biolreprod.102.009324; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chariot A, 1999, ONCOGENE, V18, P4007, DOI 10.1038/sj.onc.1202776; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; Huang H, 2005, J BIOL CHEM, V280, P10119, DOI 10.1074/jbc.M413963200; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; KRUMLAUF R, 1992, BIOESSAYS, V14, P245, DOI 10.1002/bies.950140408; Lorente M, 2006, MECH DEVELOP, V123, P312, DOI 10.1016/j.mod.2006.02.003; Lu YF, 2003, J BIOL CHEM, V278, P47792, DOI 10.1074/jbc.M305885200; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P6093, DOI 10.1242/dev.01521; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; PISANESCHI G, 1994, BIOCHEM BIOPH RES CO, V205, P1236, DOI 10.1006/bbrc.1994.2797; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Yakovleva T, 2004, BIOCHEM BIOPH RES CO, V318, P615, DOI 10.1016/j.bbrc.2004.04.065; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0; Zhao YX, 2002, DEV BIOL, V244, P21, DOI 10.1006/dbio.2002.0595	43	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33226	33232		10.1074/jbc.M606584200	http://dx.doi.org/10.1074/jbc.M606584200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16963455	hybrid			2022-12-27	WOS:000241621400031
J	Zhao, XL; Weisleder, N; Han, XH; Pan, Z; Parness, J; Brotto, M; Ma, JJ				Zhao, Xiaoli; Weisleder, Noah; Han, Xuehai; Pan, Zui; Parness, Jerome; Brotto, Marco; Ma, Jianjie			Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT HYPERTHERMIA; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; DANTROLENE INHIBITION; INTRACELLULAR CA2+; CELLS; MUTATION; CHANNEL; IDENTIFICATION; FIBERS	Dantrolene reduces the elevated myoplasmic Ca2+ generated during malignant hyperthermia, a pharmacogenetic crisis triggered by volatile anesthetics. Although specific binding of dantrolene to the type 1 ryanodine receptor (RyR1), the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum, has been demonstrated, there is little evidence for direct dantrolene inhibition of RyR1 channel function. Recent studies suggest store-operated Ca2+ entry (SOCE) contributes to skeletal muscle function, but the effect of dantrolene on this pathway has not been examined. Here we show that azumolene, an equipotent dantrolene analog, inhibits a component of SOCE coupled to activation of RyR1 by caffeine and ryanodine, whereas the SOCE component induced by thapsigargin is not affected. Our data suggest that azumolene distinguishes between two mechanisms of cellular signaling to SOCE in skeletal muscle, one that is coupled to and one independent from RyR1.	Univ Med & Dent New Jersey, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Dept Anesthesiol, Pittsburgh, PA 15213 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brotto, M (corresponding author), Univ Med & Dent New Jersey, Dept Physiol & Biophys, 683 Hoes Lane, Piscataway, NJ 08854 USA.	brottoma@umdnj.edu	Weisleder, Noah L/A-7098-2013	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088; Pan, Zui/0000-0003-4105-901X	NCI NIH HHS [R01-CA95739] Funding Source: Medline; NHLBI NIH HHS [R01-HL69000] Funding Source: Medline; NIAMS NIH HHS [R01-AR45593] Funding Source: Medline; NIA NIH HHS [R01-AG15556] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095739] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015556] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aleman M, 2004, MUSCLE NERVE, V30, P356, DOI 10.1002/mus.20084; ALLEN PD, 1992, ANESTHESIOLOGY, V76, P132, DOI 10.1097/00000542-199201000-00019; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; CHEREDNICHENKO G, 2005, BIOPH SOC ANN M ABST, V88, P639; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Choi SY, 1999, J PHARMACOL EXP THER, V291, P107; Collet C, 2004, BIOPHYS J, V87, P268, DOI 10.1529/biophysj.103.039305; Fagerlund T, 1996, CLIN GENET, V49, P186; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; LESLIE GC, 1989, BRIT J PHARMACOL, V97, P1151, DOI 10.1111/j.1476-5381.1989.tb12573.x; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; Manjunatha B, 1997, J GEN PHYSIOL, V110, P749, DOI 10.1085/jgp.110.6.749; MORTIER W, 1982, BRAIN DEV-JPN, V4, P347, DOI 10.1016/S0387-7604(82)80018-1; Nelson TE, 1996, ANESTHESIOLOGY, V84, P1368, DOI 10.1097/00000542-199606000-00013; Nelson Thomas E., 2002, Current Molecular Medicine (Hilversum), V2, P347, DOI 10.2174/1566524023362429; OHTA T, 1990, EUR J PHARMACOL, V178, P11; Pan Z, 2000, J BIOL CHEM, V275, P19978, DOI 10.1074/jbc.M908329199; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Roberts MC, 2001, ANESTHESIOLOGY, V95, P716, DOI 10.1097/00000542-200109000-00026; Sampieri A, 2005, J BIOL CHEM, V280, P24804, DOI 10.1074/jbc.M501487200; Shin DW, 2003, J BIOL CHEM, V278, P3286, DOI 10.1074/jbc.M209045200; Shin DW, 2002, BIOPHYS J, V83, P2539, DOI 10.1016/S0006-3495(02)75265-X; Szentesi P, 2001, J GEN PHYSIOL, V118, P355, DOI 10.1085/jgp.118.4.355; TAKAGI A, 1983, MUSCLE NERVE, V6, P510, DOI 10.1002/mus.880060707; Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Vazquez G, 1997, BIOCHEM BIOPH RES CO, V234, P125, DOI 10.1006/bbrc.1997.6590; Vazquez G, 1998, J BIOL CHEM, V273, P33954, DOI 10.1074/jbc.273.51.33954; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Weirich J, 2004, CELL CALCIUM, V35, P9, DOI 10.1016/S0143-4160(03)00156-8; Zhang YF, 2005, J PHARMACOL EXP THER, V314, P94, DOI 10.1124/jpet.105.084046; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005	41	68	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2006	281	44					33477	33486		10.1074/jbc.M602306200	http://dx.doi.org/10.1074/jbc.M602306200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	099UJ	16945924	hybrid			2022-12-27	WOS:000241621400058
J	Blume, A; Angulo, J; Biet, T; Peters, H; Benie, AJ; Palcic, M; Peters, T				Blume, Astrid; Angulo, Jesus; Biet, Thorsten; Peters, Hannelore; Benie, Andrew J.; Palcic, Monica; Peters, Thomas			Fragment-based screening of the donor substrate specificity of human blood group B galactosyltransferase using saturation transfer difference NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC-ACID BIOSYNTHESIS; BIFUNCTIONAL KEY ENZYME; METAL-ION ACTIVATION; LIGAND-BINDING; GROUP-A; N-ACETYLGALACTOSAMINYLTRANSFERASE; STEREOCHEMICAL COURSE; PHOSPHORYL TRANSFER; CATALYTIC DOMAIN; STRUCTURAL BASIS	Saturation transfer difference NMR experiments on human blood group B alpha-(1,3)-galactosyltransferase (GTB) for the first time provide a comprehensive set of binding epitopes of donor substrate analogs in relation to the natural donor UDP-Gal. This study revealed that the enzyme binds several UDP-activated sugars, including UDP-Glc, UDP-GlcNAc, and UDP-GalNAc. In all cases, UDP is the dominant binding epitope. To identify the minimum requirements for specific binding, a detailed analysis utilizing a fragment-based approach was employed. The binding of donor substrate to GTB is essentially controlled by the base as a "molecular anchor." Uracil represents the smallest fragment that is recognized, whereas CDP, AMP, and GDP do not exhibit any significant binding affinity for the enzyme. The ribose and beta-phosphate moieties increase the affinity of the ligands, whereas the pyranose sugar apparently weakens the binding, although this part of the molecule controls the specificity of the enzyme. Accordingly, UDP represents the best binder. The binding affinities of UDP-Gal, UDP-Glc, and UMP are about the same, but lower than that of UDP. Furthermore, we observed that beta-D-galactose and beta-D-galactose bind weakly to GTB. Whereas beta-D-galactose binds to the acceptor and donor sites, it is suggested that beta-D-galactose occupies a third hitherto unknown binding pocket. Finally, our experiments revealed that modulation of enzymatic activity by metal ions critically depends on the total enzyme concentration, raising the question as to which of the bivalent metal cations Mg2+ and Mn2+ is more relevant under physiological conditions.	Univ Luebeck, Inst Chem, D-23538 Lubeck, Germany; Carlsberg Lab, DK-2500 Copenhagen, Denmark	University of Lubeck	Peters, T (corresponding author), Univ Luebeck, Inst Chem, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	thomas.peters@chemie.uni-luebeck.de	Peters, Thomas/AAE-1509-2022; Angulo, Jesus/H-1253-2011; Peters, Thomas/GQB-3622-2022	Peters, Thomas/0000-0002-7570-8260; Angulo, Jesus/0000-0001-7250-5639; Benie, Andrew/0000-0001-8274-0456				Benie AJ, 2003, J AM CHEM SOC, V125, P14, DOI 10.1021/ja027691e; Benie AJ, 2004, J BIOL CHEM, V279, P55722, DOI 10.1074/jbc.M410239200; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Biet T, 2001, ANGEW CHEM INT EDIT, V40, P4189, DOI 10.1002/1521-3773(20011119)40:22<4189::AID-ANIE4189>3.0.CO;2-A; Blume A, 2004, J BIOL CHEM, V279, P55715, DOI 10.1074/jbc.M410238200; Blume A, 2002, FEBS LETT, V521, P127, DOI 10.1016/S0014-5793(02)02856-9; Boeggeman E, 2002, GLYCOBIOLOGY, V12, P395, DOI 10.1093/glycob/cwf045; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; BRINKWORTH RI, 1981, J BIOL CHEM, V256, P795; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Grima R, 2006, BIOPHYS CHEM, V124, P1, DOI 10.1016/j.bpc.2006.04.019; Heissigerova H, 2003, GLYCOBIOLOGY, V13, P377, DOI 10.1093/glycob/cwg042; Kamath VP, 1999, GLYCOCONJUGATE J, V16, P599; KEPPLER DOR, 1970, EUR J BIOCHEM, V17, P246, DOI 10.1111/j.1432-1033.1970.tb01160.x; KLEINIG H, 1992, ZELLBIOLOGIE; KUHN NJ, 1977, BIOCHEM J, V168, P423, DOI 10.1042/bj1680423; LOWE G, 1981, BIOCHEM J, V199, P227, DOI 10.1042/bj1990227; Marcus SL, 2003, J BIOL CHEM, V278, P12403, DOI 10.1074/jbc.M212002200; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Norambuena L, 2002, J BIOL CHEM, V277, P32923, DOI 10.1074/jbc.M204081200; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; POLLARDKNIGHT D, 1982, BIOCHEM J, V201, P421, DOI 10.1042/bj2010421; POWELL JT, 1976, J BIOL CHEM, V251, P3645; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Schnell S, 2000, B MATH BIOL, V62, P483, DOI 10.1006/bulm.1999.0163; SCHWYZER M, 1977, J BIOL CHEM, V252, P2346; SCHWYZER M, 1977, J BIOL CHEM, V252, P2338; Seto NOL, 1999, EUR J BIOCHEM, V259, P770, DOI 10.1046/j.1432-1327.1999.00086.x; Seto NOL, 2000, CARBOHYD RES, V324, P161, DOI 10.1016/S0008-6215(99)00297-9; SETO NOL, 1995, EUR J BIOCHEM, V234, P323, DOI 10.1111/j.1432-1033.1995.323_c.x; SINGHAL A, 1990, BIOESSAYS, V12, P223, DOI 10.1002/bies.950120506; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Watkins W M, 1980, Adv Hum Genet, V10, P1; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Zhang YN, 2001, J BIOL CHEM, V276, P11567, DOI 10.1074/jbc.M006530200	46	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2006	281	43					32728	32740		10.1074/jbc.M600424200	http://dx.doi.org/10.1074/jbc.M600424200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	096ZB	16923820	Green Published, hybrid			2022-12-27	WOS:000241414500072
J	Park, SG; Chung, C; Kang, H; Kim, JY; Jung, GH				Park, Sung Gyoo; Chung, Chan; Kang, Hang; Kim, Ji-Yeon; Jung, Guhung			Up-regulation of cyclin D1 by HBx is mediated by NF-kappa B2/BCL3 complex through kappa B site of cyclin D1 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-X PROTEIN; CANCER; TRANSCRIPTION; EXPRESSION; ASSOCIATION; ACTIVATION; BCL-3; INTERACTS; ALPHA; GENE	Cyclin D1 is frequently overexpressed in hepatocellular carcinoma (HCC) exhibiting increased malignant phenotypes. It has also been known that the hepatitis Bx (HBx) protein is strongly associated with HCC development and progression. Although overexpression of both proteins is related to HCC, the relationship between the two has not been well studied. Here we show that HBx up-regulates cyclin D1 and that this process is mediated by the NF-kappa B2(p52)/BCL-3 complex. Our experiments indicate that HBx up-regulates BCL-3 in the mRNA level, which subsequently results in the up-regulation of the NF-kappa B2(p52)/BCL-3 complex in the nucleus. Moreover, impaired HBx-mediated BCL-3 up-regulation by small interfering RNA for BCL-3 reduced HBx-mediated cyclin D1 up-regulation. Down-regulation of the HBx protein level by p53 also reduced HBx-mediated cyclin D1 up-regulation. From these results, we conclude that the up-regulation of cyclin D1 by HBx is mediated by the up-regulation of NF-kappa B2(p52)/BCL-3 in the nucleus. This HBx-mediated cyclin D1 up-regulation might play an important role in the HBx-mediated HCC development and progression.	Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; Seoul Natl Univ, Inst Microbiol, Seoul 151742, South Korea; Seoul Natl Univ, Sch Engn, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Jung, GH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	drjung@snu.ac.kr	Park, Sung-Gyoo/H-8652-2019	Chung, Chan/0000-0003-0510-8996				Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Feitelson MA, 1999, J CELL PHYSIOL, V181, P188; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Ghosh G, 2004, CURR OPIN STRUC BIOL, V14, P21, DOI 10.1016/j.sbi.2004.01.004; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim KH, 2003, EMBO J, V22, P2104, DOI 10.1093/emboj/cdg210; Klein A, 2003, ONCOGENE, V22, P2910, DOI 10.1038/sj.onc.1206539; Lara-Pezzi E, 2002, J CLIN INVEST, V110, P1831, DOI 10.1172/JCI200215887; Lara-Pezzi E, 2001, ONCOGENE, V20, P3323, DOI 10.1038/sj.onc.1204451; Lee JO, 2005, ONCOGENE, V24, P6617, DOI 10.1038/sj.onc.1208827; Lee SH, 2005, BBA-MOL BASIS DIS, V1741, P75, DOI 10.1016/j.bbadis.2004.10.004; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Murakami S, 2001, J GASTROENTEROL, V36, P651, DOI 10.1007/s005350170027; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Ozturk M, 1999, SEMIN LIVER DIS, V19, P235, DOI 10.1055/s-2007-1007113; Park SG, 2006, FEBS LETT, V580, P822, DOI 10.1016/j.febslet.2006.01.004; Park SG, 2005, GASTROENTEROLOGY, V128, P2042, DOI 10.1053/j.gastro.2005.03.002; Park SG, 2003, J BIOL CHEM, V278, P39851, DOI 10.1074/jbc.M301618200; Park SG, 2001, J VIROL, V75, P6962, DOI 10.1128/JVI.75.15.6962-6968.2001; Park YG, 2001, BIOCHEM BIOPH RES CO, V281, P1213, DOI 10.1006/bbrc.2001.4521; Rabe C, 2001, DIGEST DIS, V19, P279, DOI 10.1159/000050694; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Sato Y, 1999, J GASTROENTEROL, V34, P486, DOI 10.1007/s005350050301; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Slagle BL, 1996, MOL CARCINOGEN, V15, P261, DOI 10.1002/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V318, P461, DOI 10.1016/j.bbrc.2004.04.046; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994; Zuckerman AJ, 1999, BRIT MED J, V318, P1213	42	80	93	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2006	281	42					31770	31777		10.1074/jbc.M603194200	http://dx.doi.org/10.1074/jbc.M603194200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	094JI	16940298	Bronze			2022-12-27	WOS:000241235300064
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Insertion of an arginine residue into the transmembrane segments corrects protein misfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; CYSTIC-FIBROSIS MUTATION; CONDUCTANCE REGULATOR; DRUG-BINDING; ENDOPLASMIC-RETICULUM; DELTA-F508 MUTATION; DISRUPTS PACKING; CELL-SURFACE; CFTR; EXPRESSION	Deletion of Phe-508 (Delta F508) in cystic fibrosis transmembrane conductance regulator causes cystic fibrosis because of misfolding of the protein. P-glycoprotein (P-gp) containing the equivalent mutation (Delta Y490) is also misfolded but can be rescued with drug substrates. Whether rescue is due to direct binding of drug substrate to the transmembrane (TM) segments or to indirect effects on cellular protein folding pathways is still controversial. P-gp-drug substrate interactions likely involve hydrogen bonds. If the mechanism of drug rescue involves changes to TM packing then we should be able to identify suppressor mutations in the TM segments that can mimic the drug rescue effects. We predicted that an arginine residue in the TM segments predicted to line the drug-binding pocket of P-gp (I306(TM5) or F343(TM6)) might suppress Delta Y490 P-gp protein misfolding because it has the highest propensity to form hydrogen bonds. We show that R306(TM5) or R343(TM6) increased the relative amount of mature Delta Y490 P-gp by 6-fold. Most other changes to Ile-306 or Phe-343 did not enhance maturation of Delta Y490 P-gp. The I306R mutant also promoted maturation of misprocessed mutants that had mutations in the second nucleotide-binding domain (L1260A), the cytoplasmic loops (G251V, F804A), the linker region (P709A), or in TM segments (G300V, G722A). These results show that arginine residues in the TM domains can mimic the drug rescue effects and are effective suppressor mutations for processing mutations located throughout the molecule.	Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188				Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Ecker GF, 2002, MOL PHARMACOL, V61, P637, DOI 10.1124/mol.61.3.637; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; HOOF T, 1994, J BIOL CHEM, V269, P20575; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 2002, J BIOL CHEM, V277, P27585, DOI 10.1074/jbc.C200330200; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 1998, J BIOL CHEM, V273, P32373, DOI 10.1074/jbc.273.49.32373; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1994, J BIOL CHEM, V269, P28683; Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rothnie A, 2004, J BIOL CHEM, V279, P34913, DOI 10.1074/jbc.M405336200; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200	34	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2006	281	40					29436	29440		10.1074/jbc.C600209200	http://dx.doi.org/10.1074/jbc.C600209200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	089QT	16926162	hybrid			2022-12-27	WOS:000240896300005
